data_2k46_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k46 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.359 0.6 . . . . 1.1299999999999999 110.188 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -56.24 -20.25 17.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.241 -0.891 . . . . 1.1299999999999999 110.972 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -74.07 -17.08 61.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 2.0899999999999999 111.914 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -111.58 -21.49 11.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.488 -0.485 . . . . 2.5 111.835 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 7' ' ' ALA . 11.1 p -43.83 147.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.889 -0.324 . . . . 1.05 111.46 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.4 pt -139.92 -22.96 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 119.782 -0.767 . . . . 1.48 111.623 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.532 ' O ' HG23 ' A' ' 172' ' ' ILE . 26.2 t90 -173.0 134.24 0.56 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 0.33000000000000002 110.24 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -152.29 144.36 23.82 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.443 -0.161 . . . . 1.05 111.211 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.97 126.73 4.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 N-CA-C 114.116 1.154 . . . . 1.3600000000000001 114.116 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 5.8 t30 -115.13 98.82 7.0 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.274 -0.571 . . . . 1.8700000000000001 110.566 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.88 109.3 3.35 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 109.3 -0.629 . . . . 1.1100000000000001 109.3 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.573 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 150.0 -44.55 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 114.806 -1.088 . . . . 0.67000000000000004 112.452 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.37 -140.16 11.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 1.1200000000000001 112.134 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -162.7 119.36 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.552 0.215 . . . . 2.02 110.801 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 62.6 p 33.19 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.607 -0.724 . . . . 1.6499999999999999 112.235 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 10.0 t60 -128.31 150.8 49.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.22 -0.592 . . . . 0.41999999999999998 112.072 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 5.9 p -120.61 109.94 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.374 0.607 . . . . 1.8200000000000001 111.89 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.26 155.58 39.42 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.435 -0.802 . . . . 1.1699999999999999 109.933 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 m -43.89 -52.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.545 0.942 . . . . 1.27 113.545 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -56.89 -20.3 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.226 0.536 . . . . 0.55000000000000004 110.579 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.85 34.83 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.357 -0.838 . . . . 0.32000000000000001 112.287 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.448 HG22 HD12 ' A' ' 27' ' ' ILE . 33.2 mm -103.52 109.45 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.978 0.418 . . . . 1.21 110.191 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 23.4 t60 -96.87 135.55 38.69 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 115.128 1.529 . . . . 0.68999999999999995 115.128 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.645 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.18 135.0 44.53 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 114.21 -1.359 . . . . 3.3199999999999998 107.854 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.4 ptm180 -95.51 112.42 24.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 3.3999999999999999 111.984 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.521 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 2.8 ttpm? -16.3 140.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.603 1.335 . . . . 3.1600000000000001 114.603 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.565 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 4.2 p-10 -18.71 90.02 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 CA-C-N 114.613 -1.176 . . . . 1.98 112.679 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.46 -0.466 0 C-N-CA 122.598 2.198 . . . . 1.53 113.798 -179.56 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 125' ' ' THR . 1.8 mt . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 108.699 -0.852 . . . . 1.45 108.699 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.21 -49.95 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.52 0.933 . . . . 2.29 113.52 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.82 36.42 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.564 0.579 . . . . 3.0600000000000001 112.564 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -150.54 134.75 17.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.992 0.425 . . . . 1.4099999999999999 111.666 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -63.62 148.41 94.19 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.076 -0.713 . . . . 1.96 109.076 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.535 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 5.1 Cg_exo -37.9 -42.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.047 2.498 . . . . 0.78000000000000003 116.112 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.569 ' O ' HG12 ' A' ' 59' ' ' VAL . 9.9 mm-40 -75.82 -55.84 5.24 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.846 0.832 . . . . 1.8200000000000001 110.811 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.4 p-10 -71.42 -0.45 10.33 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.229 -0.656 . . . . 1.9099999999999999 109.229 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 33.1 tt0 -77.4 -61.02 2.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.02 -0.991 . . . . 2.0600000000000001 108.972 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 56' ' ' GLU . 6.1 p -49.59 -39.13 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.1 -0.704 . . . . 1.8500000000000001 109.1 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 62' ' ' GLN . 9.4 tp -66.65 -66.64 0.53 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.412 -0.515 . . . . 1.6000000000000001 110.295 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -53.81 -7.03 0.1 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.154 -0.475 . . . . 1.29 111.101 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' A' ' 60' ' ' LEU . 4.8 tt0 -115.45 -130.65 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.93 -0.577 . . . . 1.8 110.667 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 167' ' ' VAL . 41.4 p 49.59 158.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.339 0.399 . . . . 1.4099999999999999 111.378 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.573 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -141.71 143.68 33.67 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.953 1.094 . . . . 2.0499999999999998 113.953 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.565 ' NE ' ' HB3' ' A' ' 32' ' ' ASP . 1.6 mtt85 -136.48 135.67 38.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.933 -1.031 . . . . 4.2800000000000002 109.654 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -116.51 131.7 56.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 4.4699999999999998 111.42 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.96 -75.35 0.63 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.013 -0.539 . . . . 5.1500000000000004 110.573 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 179.5 -58.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.33 0.493 . . . . 3.1699999999999999 112.33 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -175.98 145.08 0.63 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.575 -0.528 . . . . 2.3900000000000001 109.575 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.471 ' H ' HD22 ' A' ' 164' ' ' ASN . 20.9 t 46.31 76.09 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.604 -0.517 . . . . 1.3200000000000001 109.604 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.447 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -82.99 146.21 28.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.575 -1.268 . . . . 1.77 107.575 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -138.11 129.46 4.6 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 118.415 -1.85 . . . . 0.98999999999999999 115.204 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -108.73 146.59 33.28 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.948 -0.626 . . . . 1.1899999999999999 110.813 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.27 129.7 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 2.27 111.319 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.484 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.0 mp -124.46 87.42 54.23 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.356 -0.384 . . . . 1.0700000000000001 110.875 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.39 127.71 27.07 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.867 1.711 . . . . 1.26 111.868 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.43 151.76 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.947 0.404 . . . . 1.0900000000000001 111.4 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -143.61 4.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 3.4399999999999999 111.216 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -128.42 170.33 13.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.1299999999999999 110.796 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.33 172.28 9.23 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.255 0.55 . . . . 0.37 111.815 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.95 -155.25 22.26 Favored Glycine 0 N--CA 1.454 -0.152 0 N-CA-C 109.848 -1.301 . . . . 0.23000000000000001 109.848 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -98.2 108.61 21.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.009 1.404 . . . . 2.0299999999999998 108.869 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.0 125.99 40.05 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.911 -0.774 . . . . 0.94999999999999996 108.911 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 177' ' ' ALA . 14.2 t -113.27 116.29 52.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.828 -1.078 . . . . 1.21 111.535 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 85' ' ' LEU . 9.5 tt -96.5 105.15 17.2 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.69 -1.141 . . . . 1.79 110.583 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 20.3 t -110.79 132.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.917 -1.038 . . . . 1.95 108.52 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 87' ' ' LEU . 0.6 OUTLIER -142.13 146.22 35.1 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.236 -0.986 . . . . 2.0 111.88 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.705 ' HZ3' ' HB2' ' A' ' 128' ' ' ASP . 3.3 tptp -105.58 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 3.3799999999999999 110.356 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 10.0 m-85 -104.81 143.41 33.16 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.879 -1.156 . . . . 0.34999999999999998 107.879 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.47 0.552 0 C-N-CA 119.543 -0.863 . . . . 1.1499999999999999 112.946 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.684 0.278 . . . . 3.6000000000000001 110.596 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.4 p -116.37 153.16 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.297 0.57 . . . . 1.8899999999999999 112.169 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 49.11 25.17 1.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.065 -0.971 . . . . 2.6899999999999999 112.497 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -119.09 -50.12 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.941 -0.392 . . . . 3.0299999999999998 109.941 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -85.76 77.96 9.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.286 -0.635 . . . . 3.52 109.286 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.45 142.59 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 1.95 110.112 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -130.81 -179.38 5.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.127 0.788 . . . . 0.80000000000000004 113.127 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -121.97 137.45 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.224 -0.443 . . . . 2.0099999999999998 111.564 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 t -129.73 127.26 64.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 115.869 -0.605 . . . . 1.1599999999999999 111.384 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 8.1 mtt180 -125.85 148.56 49.12 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.542 -0.753 . . . . 2.1800000000000002 112.502 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 40.7 t -120.21 117.23 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 114.632 -1.167 . . . . 1.71 109.695 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.51 26.48 7.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.634 -0.876 . . . . 1.77 108.634 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.98 22.63 29.83 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.656 -1.157 . . . . 0.40999999999999998 112.906 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.426 ' CG ' HG12 ' A' ' 142' ' ' VAL . 88.4 m-70 -121.55 111.49 17.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.558 0.947 . . . . 0.58999999999999997 113.558 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 p -64.71 117.33 7.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.681 -0.408 . . . . 1.2 110.868 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 109' ' ' HIS . 3.8 t -112.98 -30.34 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.904 -0.589 . . . . 1.3999999999999999 109.819 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.7 90.18 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.417 -0.586 . . . . 1.21 109.417 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 6.3 ptmm? -105.29 79.16 1.45 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.617 1.199 . . . . 2.9199999999999999 111.777 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.2 p30 156.49 35.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.032 -2.349 . . . . 2.5600000000000001 109.129 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.36 93.28 0.07 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.387 0.613 . . . . 1.71 112.149 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -109.83 85.99 2.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.791 -1.559 . . . . 1.99 106.791 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.9 mt -50.03 -40.98 17.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.138 -0.937 . . . . 1.23 112.405 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.73 -65.47 0.69 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.99 -0.284 . . . . 1.01 111.385 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -52.05 -27.18 12.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.12 0.415 . . . . 0.76000000000000001 112.12 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.64 -60.48 2.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.347 0.499 . . . . 3.0299999999999998 112.347 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 m -104.19 -40.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.405 0.52 . . . . 2.0299999999999998 112.405 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.7 -106.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.873 -0.891 . . . . 1.0600000000000001 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' SER . 37.9 m80 -64.31 170.19 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.651 -0.87 . . . . 4.29 108.651 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' HIS . 75.0 m -35.26 -80.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.05 0.219 . . . . 2.1099999999999999 110.9 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 50' ' ' ILE . 30.0 p 44.02 -164.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.808 0.337 . . . . 1.3300000000000001 111.328 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.568 ' HB1' ' HZ1' ' A' ' 88' ' ' LYS . . . -114.15 138.86 49.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.5 -0.318 . . . . 1.1200000000000001 110.804 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.535 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 2.1 t60 -111.78 147.5 35.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.45000000000000001 108.797 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.705 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 15.2 t70 -143.84 135.19 25.85 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.139 0.792 . . . . 2.0899999999999999 113.139 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -121.53 128.68 52.29 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.373 -0.83 . . . . 2.2799999999999998 109.127 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mt -111.0 120.41 61.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.668 -0.696 . . . . 1.3799999999999999 110.222 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.39 88.89 49.13 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.801 0.667 . . . . 2.0 112.801 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.2 145.9 93.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.927 1.751 . . . . 0.23999999999999999 111.854 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.432 HG21 ' N ' ' A' ' 134' ' ' SER . 11.6 mt -137.16 157.16 34.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.367 -0.379 . . . . 1.0600000000000001 110.604 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 34.6 p -133.31 110.21 9.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.126 0.489 . . . . 1.6599999999999999 111.244 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 19.6 mt -110.66 126.02 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.583 -0.735 . . . . 1.0700000000000001 109.851 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.488 ' HB3' ' HZ2' ' A' ' 137' ' ' LYS . 84.6 mttt -146.08 140.14 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 2.4300000000000002 110.767 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HZ2' ' HB3' ' A' ' 136' ' ' LYS . 1.2 mppt? 60.91 14.57 5.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 3.5600000000000001 111.116 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.69 12.35 58.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.658 -0.782 . . . . 0.32000000000000001 113.202 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 60.0 mttp -112.81 162.0 16.28 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 117.131 0.466 . . . . 2.6800000000000002 111.028 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.624 HD22 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -117.97 139.46 51.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.556 0.576 . . . . 1.1100000000000001 112.556 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.624 ' N ' HD22 ' A' ' 140' ' ' LEU . 28.6 t -128.93 109.61 11.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.765 . . . . 1.3700000000000001 109.678 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.426 HG12 ' CG ' ' A' ' 109' ' ' HIS . 12.1 p -105.46 114.7 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.165 0.507 . . . . 1.23 110.855 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 2.0499999999999998 112.115 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.49 22.03 3.38 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.619 -0.8 . . . . 0.59999999999999998 113.047 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -126.91 138.44 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.93 -0.396 . . . . 2.02 109.93 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.26 139.24 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.37 0.605 . . . . 1.8700000000000001 111.732 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 23.1 t -163.71 126.74 2.6 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.165 -0.925 . . . . 1.46 108.945 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.9 t -61.23 147.63 43.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.547 . . . . 1.55 112.263 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -78.78 142.94 36.55 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.389 -0.823 . . . . 0.34000000000000002 109.773 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.9 p -139.25 95.81 3.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.112 0.782 . . . . 2.02 113.112 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.23 -59.75 2.75 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.729 1.051 . . . . 0.77000000000000002 115.729 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.532 ' HZ2' ' HB2' ' A' ' 154' ' ' SER . 0.0 OUTLIER -153.34 169.12 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.914 0.857 . . . . 2.3199999999999998 112.726 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.79 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.965 -1.495 . . . . 1.8600000000000001 106.965 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.532 ' HB2' ' HZ2' ' A' ' 152' ' ' LYS . 5.0 t -125.52 113.43 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 118.657 -1.217 . . . . 1.72 113.177 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.5 OUTLIER -98.31 98.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.955 -0.566 . . . . 1.27 109.644 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.1 mt-10 -110.69 126.55 54.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.664 -0.698 . . . . 2.48 111.448 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -117.17 127.09 53.77 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 119.643 -0.823 . . . . 1.9199999999999999 110.264 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.512 HG22 HH21 ' A' ' 105' ' ' ARG . 10.8 t -97.2 143.99 11.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 114.185 -1.37 . . . . 1.3899999999999999 112.529 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -54.43 148.37 12.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 113.911 -1.495 . . . . 2.48 111.574 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.8 -53.09 0.17 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 111.843 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -148.64 61.04 1.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 3.8999999999999999 110.972 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 64.96 154.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.052 -0.522 . . . . 4.0999999999999996 111.876 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.37 77.83 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.651 -0.704 . . . . 1.3999999999999999 111.53 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.471 HD22 ' H ' ' A' ' 70' ' ' SER . 3.9 m-20 -50.82 155.52 1.96 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.815 -0.63 . . . . 2.0 109.974 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 164' ' ' ASN . 0.9 OUTLIER -29.86 103.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.467 2.111 . . . . 3.1099999999999999 112.346 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -53.0 -73.1 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.761 -1.108 . . . . 4.1100000000000003 112.649 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 63' ' ' THR . 89.8 t -93.25 133.51 34.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.184 0.438 . . . . 1.5900000000000001 112.184 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.9 130.52 45.27 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 123.928 0.768 . . . . 1.8600000000000001 110.803 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.471 ' HB2' ' H ' ' A' ' 88' ' ' LYS . . . -123.24 36.47 4.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.415 0.894 . . . . 1.04 113.415 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.52 129.86 0.28 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.871 0.367 . . . . 1.6799999999999999 111.834 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -149.27 104.73 3.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.208 -0.451 . . . . 0.38 110.053 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -113.49 126.35 70.92 Favored 'Isoleucine or valine' 0 C--O 1.261 1.708 0 CA-C-O 122.768 1.27 . . . . 1.3500000000000001 112.799 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 ptm -119.99 165.26 14.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.814 -1.539 . . . . 1.26 109.732 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -120.68 145.71 47.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.786 1.402 . . . . 2.3599999999999999 114.786 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.58 -36.05 4.56 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 112.38 -2.191 . . . . 0.23000000000000001 117.767 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.581 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.21 158.73 0.48 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.301 2.05 . . . . 1.1000000000000001 114.277 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.615 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.43 -24.81 25.54 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 114.893 -1.048 . . . . 1.1000000000000001 110.564 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 115.828 -0.624 . . . . 2.3100000000000001 111.551 -178.738 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 tp . . . . . 0 C--O 1.232 0.182 0 CA-C-O 121.126 0.489 . . . . 1.1299999999999999 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -60.24 -21.06 61.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.564 -0.744 . . . . 1.1299999999999999 111.178 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.93 -5.68 47.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 2.0899999999999999 111.579 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 19.5 mttm -123.63 -22.07 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.505 -0.478 . . . . 2.5 111.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 7' ' ' ALA . 14.5 p -43.44 147.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 121.158 -0.217 . . . . 1.05 111.18 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 pt -134.82 -23.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 119.518 -0.873 . . . . 1.48 111.391 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -173.26 136.26 0.61 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.272 -0.571 . . . . 0.33000000000000002 110.769 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.09 145.43 22.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.771 0.286 . . . . 1.05 111.771 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.42 130.63 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 114.191 1.182 . . . . 1.3600000000000001 114.191 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 5.2 t-20 -115.77 88.55 2.91 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.414 -0.514 . . . . 1.8700000000000001 111.174 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.03 103.97 0.27 Allowed 'General case' 0 C--O 1.248 0.988 0 N-CA-C 108.709 -0.849 . . . . 1.1100000000000001 108.709 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.553 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 162.17 -47.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.707 0 O-C-N 124.505 1.128 . . . . 0.67000000000000004 113.227 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.54 -129.86 5.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 1.1200000000000001 112.573 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.031 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 14.8 tt0 -163.72 119.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.73 0.3 . . . . 2.02 110.947 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 8.4 t 38.73 96.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 1.6499999999999999 112.72 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 76.3 t60 -124.01 151.66 43.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 120.235 -0.586 . . . . 0.41999999999999998 112.293 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.8 t -121.05 104.14 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.159 -0.928 . . . . 1.8200000000000001 110.265 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -71.27 153.03 42.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 1.1699999999999999 110.688 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 m -43.85 -50.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.167 0.917 . . . . 1.27 113.065 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -56.42 -22.28 30.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.34 0.59 . . . . 0.55000000000000004 109.928 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . 104.33 35.35 3.38 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.032 -0.986 . . . . 0.32000000000000001 111.852 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.449 HG22 HD13 ' A' ' 27' ' ' ILE . 35.1 mm -103.12 122.29 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.602 -0.518 . . . . 1.21 109.602 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.3 t60 -104.77 134.57 47.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.538 1.31 . . . . 0.68999999999999995 114.538 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.031 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -101.01 134.16 44.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.149 -0.932 . . . . 3.3199999999999998 108.497 176.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -95.9 111.64 23.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.415 0.626 . . . . 3.3999999999999999 112.256 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' ASP . 51.6 tttm -15.47 139.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.176 1.547 . . . . 3.1600000000000001 115.176 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -15.54 89.22 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 114.138 -1.392 . . . . 1.98 112.471 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo . . . . . 0 CA--C 1.536 0.601 0 C-N-CA 122.477 2.118 . . . . 1.53 115.845 -178.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.1 mp . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.955 0.407 . . . . 1.45 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 124' ' ' SER . 4.3 mm? -86.03 -44.08 12.6 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.717 1.006 . . . . 2.29 113.717 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -82.66 32.66 0.42 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.677 0.621 . . . . 3.0600000000000001 112.677 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -146.36 141.89 27.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.334 0.494 . . . . 1.4099999999999999 112.334 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.524 ' OD1' ' HB3' ' A' ' 57' ' ' ASP . 5.8 p-10 -66.21 150.07 97.24 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.728 -0.669 . . . . 1.96 109.5 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.552 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 9.4 Cg_exo -39.84 -48.84 3.62 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.716 2.277 . . . . 0.78000000000000003 115.599 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -57.42 6.19 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.641 0.734 . . . . 1.8200000000000001 112.236 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.524 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -70.07 -13.72 62.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.515 -0.55 . . . . 1.9099999999999999 109.515 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 23.5 tt0 -62.94 -52.28 63.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.994 -1.113 . . . . 2.0600000000000001 107.994 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -51.61 -51.62 25.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.125 -0.943 . . . . 1.8500000000000001 109.187 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 4.2 tp -64.08 -15.87 60.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.809 . . . . 1.6000000000000001 111.353 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.418 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 6.6 m-30 -117.13 19.96 13.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.258 -0.883 . . . . 1.29 111.268 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -142.96 -76.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.775 1.028 . . . . 1.8 113.775 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.446 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 1.2 p -28.75 144.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.502 0.927 . . . . 1.4099999999999999 113.502 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.539 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -135.88 150.57 49.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.318 -0.856 . . . . 2.0499999999999998 110.491 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.553 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 30.9 mtp180 -107.09 -177.3 3.32 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.162 -0.31 . . . . 4.2800000000000002 110.162 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -54.52 166.26 0.47 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 4.4699999999999998 110.848 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -133.14 137.54 46.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 5.1500000000000004 111.008 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 40.1 tt0 -123.44 -91.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 3.1699999999999999 110.442 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 68' ' ' GLU . 3.3 p30 -174.04 125.5 0.35 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.611 0.243 . . . . 2.3900000000000001 111.116 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t 50.06 100.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.117 -0.492 . . . . 1.3200000000000001 111.629 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.555 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 1.6 p90 -151.53 148.95 28.64 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.191 0.519 . . . . 1.77 111.346 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.67 -171.06 17.81 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.479 -0.867 . . . . 0.98999999999999999 114.651 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -126.91 153.64 45.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.907 -0.647 . . . . 1.1899999999999999 111.624 -178.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 122.94 47.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.039 -0.982 . . . . 2.27 110.151 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.492 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.2 mp -114.45 87.25 13.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.153 0.427 . . . . 1.0700000000000001 112.153 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -56.68 134.44 64.43 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.802 1.668 . . . . 1.26 112.359 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 78' ' ' LYS . 26.8 mt -124.82 155.56 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.994 0.426 . . . . 1.0900000000000001 111.115 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.444 ' N ' HG22 ' A' ' 77' ' ' ILE . 95.2 mttt -146.8 3.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.866 -0.606 . . . . 3.4399999999999999 110.839 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.73 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 13.7 mm-40 -130.9 173.08 11.32 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 120.707 0.289 . . . . 2.1299999999999999 111.078 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -129.35 168.7 15.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.237 0.541 . . . . 0.37 111.143 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.01 -151.32 22.06 Favored Glycine 0 CA--C 1.512 -0.113 0 N-CA-C 109.759 -1.337 . . . . 0.23000000000000001 109.759 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -99.95 109.36 21.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.103 1.451 . . . . 2.0299999999999998 108.863 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.73 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.7 m-85 -95.75 126.21 40.86 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.507 0.67 . . . . 0.94999999999999996 109.395 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 177' ' ' ALA . 26.3 t -111.35 117.56 55.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.726 -1.125 . . . . 1.21 111.741 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 tt -88.83 104.42 16.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.526 -1.216 . . . . 1.79 110.179 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 21.4 t -109.69 133.57 54.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.271 -0.877 . . . . 1.95 109.115 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -156.24 135.26 11.98 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.357 -0.937 . . . . 2.0 111.88 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.579 ' HZ3' ' HB3' ' A' ' 128' ' ' ASP . 17.3 tptt -95.64 120.61 36.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.875 . . . . 3.3799999999999999 110.187 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.41 142.44 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.906 -0.775 . . . . 0.34999999999999998 108.906 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.577 ' O ' HG13 ' A' ' 167' ' ' VAL . . . . . . . . 0 C--O 1.239 0.513 0 C-N-CA 120.57 -0.452 . . . . 1.1499999999999999 110.459 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.931 0.396 . . . . 3.6000000000000001 111.274 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.1 t -91.59 163.34 14.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.801 -0.636 . . . . 1.8899999999999999 111.026 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 51.62 28.3 4.61 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.051 -0.522 . . . . 2.6899999999999999 111.12 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -134.11 -42.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 3.0299999999999998 109.853 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -108.76 82.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 3.52 109.485 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -109.5 150.22 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.704 -0.68 . . . . 1.95 110.202 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 114' ' ' ASP . 67.2 m-85 -133.38 -177.13 4.39 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 112.561 0.578 . . . . 0.80000000000000004 112.561 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -132.58 137.75 47.19 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.829 -0.348 . . . . 2.0099999999999998 111.005 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.8 t -131.37 129.76 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 112.758 0.651 . . . . 1.1599999999999999 112.758 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.535 HH21 HG23 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -139.14 149.42 44.46 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.95 0.722 . . . . 2.1800000000000002 112.95 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.9 p -116.15 121.05 66.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 115.211 -0.904 . . . . 1.71 110.566 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.659 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 2.3 t30 52.8 26.89 4.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.239 -0.891 . . . . 1.77 110.419 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.95 16.2 39.52 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 114.451 -1.249 . . . . 0.40999999999999998 113.128 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.2 m-70 -115.22 111.53 21.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.215 0.82 . . . . 0.58999999999999997 113.215 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -67.1 123.08 19.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.054 0.454 . . . . 1.2 111.118 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -39.81 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.572 -0.74 . . . . 1.3999999999999999 109.901 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.86 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.312 0.577 . . . . 1.21 109.933 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -98.94 154.71 17.85 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 2.9199999999999999 110.025 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 102' ' ' PHE . 12.7 m-20 66.91 32.06 6.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.135 -1.393 . . . . 2.5600000000000001 109.256 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 98.31 0.02 OUTLIER 'General case' 0 C--N 1.342 0.268 0 CA-C-O 120.96 0.41 . . . . 1.71 111.166 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 45.1 p-10 -100.72 79.28 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.298 -1.001 . . . . 1.99 108.298 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.91 -48.94 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.298 -0.865 . . . . 1.23 112.533 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.45 -39.99 77.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.711 0.263 . . . . 1.01 111.711 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.97 -27.7 62.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.97 0.359 . . . . 0.76000000000000001 111.97 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 34.5 mmt180 -70.0 -59.09 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.082 0.401 . . . . 3.0299999999999998 112.082 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.8 m -95.77 -40.47 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.228 0.455 . . . . 2.0299999999999998 112.228 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.57 -104.0 2.43 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.63 -0.795 . . . . 1.0600000000000001 112.22 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -63.95 164.78 9.82 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.347 -0.242 . . . . 4.29 110.347 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.458 ' O ' HD22 ' A' ' 51' ' ' LEU . 80.5 p -58.11 98.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.887 0.375 . . . . 2.1099999999999999 110.738 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -144.69 -157.79 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 1.3300000000000001 109.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.72 133.82 50.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.41 0.522 . . . . 1.1200000000000001 112.41 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -109.0 147.73 31.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.922 -0.77 . . . . 0.45000000000000001 108.922 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.579 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . 5.0 p-10 -140.39 124.86 17.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.546 0.573 . . . . 2.0899999999999999 112.546 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -116.81 135.75 53.5 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.467 -0.788 . . . . 2.2799999999999998 109.783 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.5 mt -128.8 133.58 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.85 -0.614 . . . . 1.3799999999999999 111.408 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.0 mp -135.17 92.36 18.18 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.457 -0.338 . . . . 2.0 111.883 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.03 140.1 76.93 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.388 1.392 . . . . 0.23999999999999999 111.193 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 134' ' ' SER . 14.8 mt -132.56 158.9 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.462 -0.336 . . . . 1.0600000000000001 110.992 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.448 ' N ' HG22 ' A' ' 133' ' ' ILE . 48.4 t -134.23 110.95 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.19 0.519 . . . . 1.6599999999999999 111.119 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 17.0 mt -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 115.406 -0.815 . . . . 1.0700000000000001 110.009 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -150.37 142.38 23.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.69 0.281 . . . . 2.4300000000000002 110.867 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm 61.19 19.0 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 3.5600000000000001 110.75 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.12 71.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 0.32000000000000001 113.206 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -111.16 164.77 12.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.891 0.345 . . . . 2.6800000000000002 110.523 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.5 tt -124.16 143.47 50.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.689 0.625 . . . . 1.1100000000000001 112.689 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.8 t -130.69 114.09 14.96 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.343 -0.844 . . . . 1.3700000000000001 109.723 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.432 ' O ' HG11 ' A' ' 142' ' ' VAL . 2.4 p -108.93 96.87 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.738 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 61.74 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 2.0499999999999998 111.752 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.36 6.65 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.464 -0.874 . . . . 0.59999999999999998 113.4 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.97 129.45 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.762 -0.458 . . . . 2.02 109.762 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.2 p -105.27 141.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.31 0.576 . . . . 1.8700000000000001 111.551 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.1 m -156.88 170.4 22.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.293 -0.867 . . . . 1.46 109.301 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.2 p -99.57 139.02 35.84 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.731 -0.388 . . . . 1.55 111.548 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -78.68 142.78 36.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.34000000000000002 109.69 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.1 t -147.27 96.12 2.66 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.038 0.755 . . . . 2.02 113.038 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.8 -65.5 4.05 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 115.511 0.964 . . . . 0.77000000000000002 115.511 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.58 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.56 -179.58 6.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 117.601 0.7 . . . . 2.3199999999999998 112.455 -177.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.43 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 1.3 tp -102.37 133.54 47.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.339 -1.356 . . . . 1.8600000000000001 107.339 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.659 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -111.31 101.07 9.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.555 0.946 . . . . 1.72 113.555 -175.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.63 98.32 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.58 -0.448 . . . . 1.27 109.905 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 155.29 42.42 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.986 -0.552 . . . . 2.48 111.629 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -130.91 146.9 52.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.431 -0.804 . . . . 1.9199999999999999 110.84 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.535 HG23 HH21 ' A' ' 105' ' ' ARG . 19.8 t -117.49 143.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 114.627 -1.17 . . . . 1.3899999999999999 110.705 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -86.6 147.59 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.902 -0.59 . . . . 2.48 110.993 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -88.66 -9.56 68.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 1.1200000000000001 112.606 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -153.35 -64.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.539 0.209 . . . . 3.8999999999999999 111.017 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -146.63 -64.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.844 0.354 . . . . 4.0999999999999996 111.017 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 13.7 m-20 -65.51 150.27 48.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.257 0.551 . . . . 1.3999999999999999 111.556 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.555 ' ND2' ' CE1' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -109.0 -179.0 0.61 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.635 -1.246 . . . . 2.0 107.635 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -11.01 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 CA-C-N 121.461 1.557 . . . . 3.1099999999999999 113.22 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.688 ' HZ1' ' HB2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER 74.92 -77.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 4.1100000000000003 111.32 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 90' ' ' ALA . 1.5 m -104.71 135.8 41.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 C-N-CA 119.398 -0.921 . . . . 1.5900000000000001 110.646 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 4.8 t -131.72 117.28 18.41 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.092 -0.958 . . . . 1.8600000000000001 112.362 -177.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.459 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -100.94 37.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.149 -0.932 . . . . 1.04 113.505 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.68 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.34 0.4 . . . . 1.6799999999999999 111.427 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -159.99 97.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.38 110.433 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.424 ' O ' HG21 ' A' ' 172' ' ' ILE . 0.7 OUTLIER -105.28 125.76 60.42 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 122.426 1.108 . . . . 1.3500000000000001 112.011 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.4 ptm -119.93 166.01 13.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.335 -1.302 . . . . 1.26 109.851 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 11.7 ptmt -120.82 152.5 38.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.899 1.444 . . . . 2.3599999999999999 114.899 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 94.5 -37.8 3.31 Favored Glycine 0 C--N 1.319 -0.401 0 CA-C-N 111.784 -2.462 . . . . 0.23000000000000001 117.058 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.59 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 176.92 166.15 0.52 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.451 1.625 . . . . 1.1000000000000001 112.528 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.625 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -84.78 -52.16 6.25 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.649 -0.705 . . . . 1.1000000000000001 109.538 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.166 -0.924 . . . . 2.3100000000000001 110.251 179.591 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.114 0.483 . . . . 1.1299999999999999 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -55.15 -21.52 13.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.422 -0.808 . . . . 1.1299999999999999 111.308 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.27 -20.97 46.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.159 0.429 . . . . 2.0899999999999999 112.159 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -101.67 -21.36 14.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.756 -0.377 . . . . 2.5 111.528 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 7' ' ' ALA . 10.1 p -45.08 145.6 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 120.577 0.227 . . . . 1.05 111.577 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.619 HG23 ' HZ3' ' A' ' 174' ' ' LYS . 3.4 pt -138.96 -23.52 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 120.142 -0.623 . . . . 1.48 111.181 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.511 ' O ' HG21 ' A' ' 172' ' ' ILE . 20.3 t90 -173.42 136.35 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.696 -0.402 . . . . 0.33000000000000002 110.126 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 28' ' ' HIS . . . -155.57 144.26 20.45 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.429 -0.169 . . . . 1.05 111.382 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -147.15 127.78 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 113.797 1.036 . . . . 1.3600000000000001 113.797 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -115.53 97.18 6.01 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 119.915 -0.714 . . . . 1.8700000000000001 110.997 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.6 100.29 0.87 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.037 -1.097 . . . . 1.1100000000000001 108.037 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.564 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 177.39 -58.0 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.502 -1.226 . . . . 0.67000000000000004 112.609 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.74 -126.26 4.77 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.644 -0.789 . . . . 1.1200000000000001 113.422 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG2' ' HZ1' ' A' ' 31' ' ' LYS . 26.0 mt-10 -151.81 119.51 6.12 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.44 0.296 . . . . 2.02 110.992 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.8 m 29.2 106.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.592 0.96 . . . . 1.6499999999999999 113.592 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 50.1 t60 -133.43 150.4 51.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 120.485 -0.486 . . . . 0.41999999999999998 112.036 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 p -122.81 104.94 15.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 121.4 0.619 . . . . 1.8200000000000001 111.405 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.95 155.45 34.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.425 -0.807 . . . . 1.1699999999999999 110.03 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 m -43.21 -50.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.48 0.919 . . . . 1.27 113.48 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -59.46 -18.3 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.118 0.485 . . . . 0.55000000000000004 110.646 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.94 35.24 3.77 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.487 -0.779 . . . . 0.32000000000000001 112.619 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.413 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 32.7 mm -103.42 111.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.003 0.43 . . . . 1.21 109.897 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 17.9 t60 -101.28 136.66 40.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.171 1.545 . . . . 0.68999999999999995 115.171 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.652 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.9 136.8 41.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.184 -1.371 . . . . 3.3199999999999998 108.189 177.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -97.38 109.98 22.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.415 0.626 . . . . 3.3999999999999999 112.402 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.539 ' H ' ' HG ' ' A' ' 20' ' ' SER . 11.5 tttm -12.22 137.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.62 1.568 . . . . 3.1600000000000001 114.934 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 31' ' ' LYS . 27.9 t70 -13.36 88.95 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.01 -0.995 . . . . 1.98 113.01 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo . . . . . 0 CA--C 1.539 0.74 0 C-N-CA 122.468 2.112 . . . . 1.53 115.818 -179.08 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.438 HD11 ' N ' ' A' ' 50' ' ' ILE . 1.1 mp . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.786 0.327 . . . . 1.45 110.331 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.406 HD21 ' N ' ' A' ' 51' ' ' LEU . 4.3 mm? -95.6 -49.0 5.58 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.292 0.849 . . . . 2.29 113.292 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.95 31.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.939 0.718 . . . . 3.0600000000000001 112.939 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 51' ' ' LEU . 27.0 t -145.63 143.95 30.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.01 0.433 . . . . 1.4099999999999999 111.678 178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 58' ' ' GLN . 34.9 t30 -59.23 148.36 72.34 Favored Pre-proline 0 C--O 1.221 -0.403 0 CA-C-N 115.667 -0.697 . . . . 1.96 109.66 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.605 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.3 Cg_exo -42.0 -51.79 4.43 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.137 1.892 . . . . 0.78000000000000003 113.522 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -55.25 16.4 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.885 0.85 . . . . 1.8200000000000001 111.163 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.15 -12.67 61.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.759 -0.655 . . . . 1.9099999999999999 109.761 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 1.1 tt0 -66.0 -48.16 72.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.974 -1.491 . . . . 2.0600000000000001 106.974 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -50.47 -46.64 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.085 -0.961 . . . . 1.8500000000000001 109.153 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 tp -73.54 -13.12 60.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.975 -1.011 . . . . 1.6000000000000001 111.647 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.631 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 3.7 m-30 -121.06 23.41 10.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.565 -0.743 . . . . 1.29 111.132 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -142.11 -68.4 0.37 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.145 0.794 . . . . 1.8 113.145 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.496 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 74.9 p -29.19 148.85 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.224 0.824 . . . . 1.4099999999999999 113.224 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.564 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 3.1 pp20? -122.97 -22.54 5.21 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.256 1.206 . . . . 2.0499999999999998 114.256 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.517 ' N ' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mtp-105 69.62 -80.77 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.758 0.313 . . . . 4.2800000000000002 110.794 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -170.89 171.55 5.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.158 -0.474 . . . . 4.4699999999999998 110.564 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -97.88 166.88 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.333 -0.394 . . . . 5.1500000000000004 110.875 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -163.79 -120.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.528 -0.306 . . . . 3.1699999999999999 111.25 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -174.53 129.07 0.34 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.355 -0.216 . . . . 2.3900000000000001 110.421 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t 49.45 86.2 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.635 -0.505 . . . . 1.3200000000000001 109.635 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.517 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -92.39 130.3 38.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.628 . . . . 1.77 109.306 -178.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -128.2 129.16 6.2 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.521 -1.323 . . . . 0.98999999999999999 113.646 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 154' ' ' SER . 12.8 m-85 -112.9 144.69 42.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.401 . . . . 1.1899999999999999 110.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.91 126.98 55.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 2.27 111.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.458 HD13 ' N ' ' A' ' 75' ' ' ILE . 4.0 mp -123.21 86.49 51.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.615 -0.266 . . . . 1.0700000000000001 111.35 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.66 129.46 34.03 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.398 2.065 . . . . 1.26 112.764 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.58 149.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.043 -0.526 . . . . 1.0900000000000001 110.796 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -141.04 0.28 1.54 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 3.4399999999999999 111.387 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 80' ' ' GLU . 20.5 tt0 -131.07 167.19 19.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.827 0.346 . . . . 2.1299999999999999 110.32 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -115.84 176.86 4.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.354 0.597 . . . . 0.37 111.865 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.76 -151.13 19.89 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 109.933 -1.267 . . . . 0.23000000000000001 109.933 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.4 mt-10 -103.81 109.59 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.03 1.415 . . . . 2.0299999999999998 109.528 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.754 ' HH ' ' HZ2' ' A' ' 174' ' ' LYS . 3.3 m-85 -96.04 126.81 41.54 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.677 -0.86 . . . . 0.94999999999999996 108.677 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.609 HG22 ' N ' ' A' ' 177' ' ' ALA . 39.6 t -109.97 109.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.043 -0.981 . . . . 1.21 112.035 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.93 104.02 16.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.533 -1.212 . . . . 1.79 110.399 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 p -115.23 141.8 30.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.092 -0.958 . . . . 1.95 108.698 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 87' ' ' LEU . 2.0 pp -153.88 148.69 26.53 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.049 -0.66 . . . . 2.0 111.653 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.631 ' HZ2' ' HB3' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -107.71 127.08 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.82 -0.752 . . . . 3.3799999999999999 109.919 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-85 -109.39 148.51 30.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.353 -0.84 . . . . 0.34999999999999998 109.741 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 116.611 -0.268 . . . . 1.1499999999999999 110.566 178.392 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.457 HE21 ' H ' ' A' ' 97' ' ' SER . 22.4 tp60 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.911 0.386 . . . . 3.6000000000000001 110.896 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.457 ' H ' HE21 ' A' ' 96' ' ' GLN . 40.9 t -99.25 165.57 11.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 1.8899999999999999 110.439 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 71.07 -64.74 0.37 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 2.6899999999999999 111.552 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -45.01 -43.79 9.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.495 -0.32 . . . . 3.0299999999999998 111.362 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 44.7 mtmt -92.01 71.46 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 3.52 110.752 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 t -109.8 132.57 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.35 -0.386 . . . . 1.95 109.971 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -123.04 179.01 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.362 0.504 . . . . 0.80000000000000004 112.362 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.412 ' OD2' HG21 ' A' ' 110' ' ' THR . 4.0 t70 -128.45 138.31 52.24 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 116.237 -0.438 . . . . 2.0099999999999998 112.005 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.44 132.26 64.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.644 -0.707 . . . . 1.1599999999999999 112.169 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 9.3 mtt180 -133.11 146.11 51.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 115.429 -0.805 . . . . 2.1800000000000002 112.611 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 11.8 m -117.53 119.75 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.428 -0.806 . . . . 1.71 109.538 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.465 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.71 26.75 9.76 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.826 -0.805 . . . . 1.77 108.826 -176.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.01 20.6 38.71 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.8 -1.091 . . . . 0.40999999999999998 112.897 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.5 m-70 -118.64 112.29 19.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.432 0.901 . . . . 0.58999999999999997 113.432 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.412 HG21 ' OD2' ' A' ' 103' ' ' ASP . 16.1 p -63.1 120.08 10.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.618 -0.433 . . . . 1.2 111.062 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.5 t -113.85 -32.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.371 -0.603 . . . . 1.3999999999999999 109.371 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.11 89.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.509 -0.552 . . . . 1.21 109.509 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.6 ptpp? -106.09 79.96 1.46 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.488 1.137 . . . . 2.9199999999999999 110.976 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.7 p-10 157.79 40.41 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.462 -2.154 . . . . 2.5600000000000001 108.445 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.91 84.39 0.95 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.238 0.829 . . . . 1.71 113.238 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 15.9 t70 -96.02 84.42 3.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.175 -1.417 . . . . 1.99 107.175 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.2 mt -50.46 -36.97 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.122 -0.945 . . . . 1.23 112.853 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.52 -47.97 79.46 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.73 0.271 . . . . 1.01 111.73 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.4 -27.58 67.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.973 0.36 . . . . 0.76000000000000001 111.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 38.9 mmt180 -67.85 -59.04 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.044 0.387 . . . . 3.0299999999999998 112.044 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.29 -39.39 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.879 0.326 . . . . 2.0299999999999998 111.879 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.22 -56.94 1.47 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.779 -0.724 . . . . 1.0600000000000001 111.999 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -114.6 158.12 22.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.979 -0.378 . . . . 4.29 109.979 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.5 m -55.58 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 2.1099999999999999 111.08 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 50' ' ' ILE . 28.7 p -143.7 -144.9 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 1.3300000000000001 110.355 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.547 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . . . -110.42 126.17 54.03 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.84 0.681 . . . . 1.1200000000000001 112.84 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.431 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 2.5 t60 -103.23 137.83 40.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.553 -0.906 . . . . 0.45000000000000001 108.553 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -144.29 128.37 17.59 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.569 0.581 . . . . 2.0899999999999999 112.569 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.55 134.72 55.03 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.247 -0.888 . . . . 2.2799999999999998 109.666 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.85 128.52 71.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.767 -0.651 . . . . 1.3799999999999999 110.397 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -126.04 84.85 60.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.508 0.558 . . . . 2.0 112.508 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.62 143.03 99.38 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.828 1.685 . . . . 0.23999999999999999 111.635 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 134' ' ' SER . 20.9 mt -135.93 156.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 1.0600000000000001 111.254 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.464 ' N ' HG23 ' A' ' 133' ' ' ILE . 46.3 t -132.62 107.16 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.067 0.46 . . . . 1.6599999999999999 111.147 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 23.6 mt -103.85 128.7 56.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.802 -0.635 . . . . 1.0700000000000001 110.001 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -147.92 143.23 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.866 0.365 . . . . 2.4300000000000002 111.378 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp 56.4 20.59 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 3.5600000000000001 110.817 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.01 24.45 41.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.76 -0.733 . . . . 0.32000000000000001 112.953 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 40.5 mtmt -125.21 152.42 44.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.185 0.492 . . . . 2.6800000000000002 110.943 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 141' ' ' SER . 6.0 tt -109.61 127.39 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 1.1100000000000001 111.84 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.401 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.6 t -117.5 109.5 16.81 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.56 -0.745 . . . . 1.3700000000000001 109.493 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.64 118.85 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 1.23 110.789 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 54.74 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 2.0499999999999998 111.556 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.92 27.84 3.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.794 -0.717 . . . . 0.59999999999999998 112.78 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.48 140.22 51.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.293 . . . . 2.02 110.265 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.44 138.65 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 1.8700000000000001 111.372 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.7 m -161.22 123.55 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 1.46 110.459 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.3 p -54.12 141.2 29.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 1.55 112.06 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -80.57 142.69 33.84 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.305 -0.628 . . . . 0.34000000000000002 109.305 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -140.79 96.35 3.0 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.168 0.803 . . . . 2.02 113.168 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.98 -63.17 2.45 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 115.4 0.92 . . . . 0.77000000000000002 115.4 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.589 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.7 178.5 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.804 0.802 . . . . 2.3199999999999998 112.543 -178.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.465 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.91 131.96 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.514 -1.291 . . . . 1.8600000000000001 107.514 177.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.9 t -120.21 112.02 18.55 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.016 -1.074 . . . . 1.72 113.531 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -94.11 99.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.042 -0.725 . . . . 1.27 109.042 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 37.0 mt-10 -109.04 124.69 51.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.525 -0.762 . . . . 2.48 111.324 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.61 132.92 55.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.894 -0.722 . . . . 1.9199999999999999 110.1 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.422 HG23 HH21 ' A' ' 105' ' ' ARG . 39.4 t -102.45 142.31 16.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.615 -1.175 . . . . 1.3899999999999999 111.851 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.74 148.43 51.28 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 115.4 -0.818 . . . . 2.48 111.106 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.63 -9.1 41.58 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 1.1200000000000001 112.374 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -155.73 -75.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.542 0.211 . . . . 3.8999999999999999 111.203 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -173.64 68.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.736 0.303 . . . . 4.0999999999999996 111.131 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -178.03 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.331 -0.395 . . . . 1.3999999999999999 110.897 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.25 159.12 0.12 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.479 -0.563 . . . . 2.0 109.479 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -40.07 100.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.632 1.555 . . . . 3.1099999999999999 111.371 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.98 -36.07 26.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 4.1100000000000003 112.322 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 79.5 t -126.7 135.3 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.566 0.58 . . . . 1.5900000000000001 112.566 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.7 t -130.47 131.53 45.2 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 123.836 0.71 . . . . 1.8600000000000001 111.653 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.412 ' HB1' ' H ' ' A' ' 88' ' ' LYS . . . -121.73 37.8 4.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.26 -0.882 . . . . 1.04 113.299 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.98 134.17 0.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.433 0.458 . . . . 1.6799999999999999 111.503 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -156.9 98.76 1.79 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.881 -0.145 . . . . 0.38 110.869 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.511 HG21 ' O ' ' A' ' 12' ' ' TRP . 16.5 tt -108.22 125.79 64.9 Favored 'Isoleucine or valine' 0 C--O 1.259 1.601 0 CA-C-O 122.784 1.278 . . . . 1.3500000000000001 112.486 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.16 167.17 11.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.798 -1.546 . . . . 1.26 109.035 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.754 ' HZ2' ' HH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -119.89 146.97 45.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.217 1.562 . . . . 2.3599999999999999 115.217 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.59 -35.99 4.04 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 112.008 -2.36 . . . . 0.23000000000000001 118.251 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.579 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.83 159.14 0.57 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.332 2.066 . . . . 1.1000000000000001 113.955 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.609 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -85.82 -20.05 29.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.079 -0.964 . . . . 1.1000000000000001 110.236 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.756 -0.656 . . . . 2.3100000000000001 111.309 -178.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp . . . . . 0 C--O 1.232 0.167 0 CA-C-O 121.387 0.613 . . . . 1.1299999999999999 110.482 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -55.82 -21.07 17.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 1.1299999999999999 111.198 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.05 -18.36 60.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 2.0899999999999999 111.859 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -103.9 -26.46 12.66 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.712 -0.395 . . . . 2.5 111.267 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 7' ' ' ALA . 8.3 p -43.37 144.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.849 0.315 . . . . 1.05 111.849 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -137.16 -24.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.422 -0.511 . . . . 1.48 110.758 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.544 ' O ' HG22 ' A' ' 172' ' ' ILE . 25.1 t90 -171.04 138.98 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.593 -0.521 . . . . 0.33000000000000002 109.593 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 28' ' ' HIS . . . -159.24 143.87 15.5 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.216 0.45 . . . . 1.05 112.216 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.01 131.3 8.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 114.224 1.194 . . . . 1.3600000000000001 114.224 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 8.4 t30 -114.67 88.63 2.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.265 -0.879 . . . . 1.8700000000000001 109.082 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB3' ' OH ' ' A' ' 73' ' ' TYR . . . -60.82 105.76 0.49 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.114 -0.948 . . . . 1.1100000000000001 110.192 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' N ' ' HD2' ' A' ' 65' ' ' ARG . . . 162.13 -48.05 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.867 -1.061 . . . . 0.67000000000000004 114.324 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.91 -130.89 6.92 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.654 -0.784 . . . . 1.1200000000000001 113.861 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -152.36 119.81 6.0 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 122.317 0.247 . . . . 2.02 111.086 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.5 m 24.14 101.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.358 0.873 . . . . 1.6499999999999999 113.358 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 13.2 t60 -126.44 150.52 48.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 119.971 -0.692 . . . . 0.41999999999999998 111.96 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.79 105.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 1.8200000000000001 110.807 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.8 154.39 42.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.434 -0.348 . . . . 1.1699999999999999 110.36 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 m -44.47 -50.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 124.117 0.885 . . . . 1.27 113.068 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -58.89 -17.22 22.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.261 0.553 . . . . 0.55000000000000004 110.307 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.49 34.76 4.62 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.32000000000000001 112.12 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 27' ' ' ILE . 31.1 mm -103.92 121.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 1.21 110.039 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.9 t60 -99.95 136.99 39.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.578 1.325 . . . . 0.68999999999999995 114.578 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.682 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.65 131.25 47.99 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.768 -1.106 . . . . 3.3199999999999998 108.311 176.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.456 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 14.6 mtt180 -89.63 109.62 20.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.584 0.553 . . . . 3.3999999999999999 112.282 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 30' ' ' ARG . 17.4 tttp -16.42 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.514 1.125 . . . . 3.1600000000000001 113.506 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -18.7 84.11 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.149 0.979 . . . . 1.98 113.165 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 5.3 Cg_endo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 123.035 2.49 . . . . 1.53 112.933 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.184 -0.673 . . . . 1.45 109.184 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 51' ' ' LEU . 7.8 mp -83.16 -32.06 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.385 0.884 . . . . 2.29 113.385 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -79.11 33.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.507 -0.477 . . . . 3.0600000000000001 111.681 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -165.97 142.22 5.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.359 -0.382 . . . . 1.4099999999999999 110.436 178.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -60.97 164.04 8.67 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.516 -0.311 . . . . 1.96 110.943 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 53.8 Cg_exo -47.21 -41.87 27.24 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.393 2.062 . . . . 0.78000000000000003 115.024 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.548 ' O ' HG13 ' A' ' 59' ' ' VAL . 11.3 mm-40 -73.26 -55.81 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.748 0.785 . . . . 1.8200000000000001 110.731 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 40.8 p30 -70.27 -3.02 15.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.701 -0.799 . . . . 1.9099999999999999 109.517 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.527 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -74.36 -60.73 2.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.425 -0.954 . . . . 2.0600000000000001 108.425 177.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 56' ' ' GLU . 7.2 p -49.63 -37.39 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.738 -0.467 . . . . 1.8500000000000001 109.738 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 62' ' ' GLN . 11.1 tp -69.15 -66.48 0.57 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.441 -0.504 . . . . 1.6000000000000001 110.245 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 8.1 m-30 -55.05 -2.71 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.198 0.523 . . . . 1.29 111.147 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.575 ' H ' ' C ' ' A' ' 60' ' ' LEU . 6.9 tt0 -116.67 -131.65 0.32 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 1.8 109.614 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 62' ' ' GLN . 12.3 p 44.23 131.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.444 0.905 . . . . 1.4099999999999999 113.444 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 -128.03 149.31 50.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.767 0.654 . . . . 2.0499999999999998 112.767 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -80.4 -156.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.677 -0.692 . . . . 4.2800000000000002 109.616 177.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -87.12 -87.27 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 121.373 -0.131 . . . . 4.4699999999999998 111.165 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -179.89 155.77 0.63 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.592 0.235 . . . . 5.1500000000000004 110.957 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -176.43 -158.65 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.291 -0.413 . . . . 3.1699999999999999 110.61 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -152.83 135.86 15.58 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.502 -0.317 . . . . 2.3900000000000001 110.987 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t 50.54 79.21 0.09 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.483 -0.326 . . . . 1.3200000000000001 110.397 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -151.43 153.86 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.66 -0.416 . . . . 1.77 111.273 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -170.49 -160.43 18.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.621 -0.8 . . . . 0.98999999999999999 113.914 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.549 ' OH ' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -120.93 164.16 17.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.601 0.715 . . . . 1.1899999999999999 112.917 -177.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.46 125.08 50.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.483 -1.235 . . . . 2.27 109.539 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.498 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.1 mp -115.41 88.5 19.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.242 0.46 . . . . 1.0700000000000001 112.242 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -56.24 127.93 28.04 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.957 1.771 . . . . 1.26 112.16 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.4 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.3 mt -122.69 151.5 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.911 0.386 . . . . 1.0900000000000001 111.048 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -140.45 -0.39 1.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.1 -0.5 . . . . 3.4399999999999999 111.27 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.672 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 40.9 mt-10 -126.06 168.49 13.91 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.616 0.246 . . . . 2.1299999999999999 111.046 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -122.6 168.52 12.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.381 0.61 . . . . 0.37 111.55 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.33 -151.87 23.28 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.739 -1.345 . . . . 0.23000000000000001 109.739 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.41 107.6 18.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.066 1.433 . . . . 2.0299999999999998 108.84 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.672 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.1 m-85 -95.14 126.31 40.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.645 -0.822 . . . . 0.94999999999999996 109.162 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.603 HG23 ' N ' ' A' ' 177' ' ' ALA . 40.6 t -109.47 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.678 -1.146 . . . . 1.21 111.457 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 tp -99.28 105.06 17.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.365 -1.289 . . . . 1.79 110.729 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 p -113.56 135.25 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.774 -0.648 . . . . 1.95 109.929 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.06 135.19 45.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.59 . . . . 2.0 111.614 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.584 ' HZ3' ' HB3' ' A' ' 128' ' ' ASP . 17.9 tptt -102.93 114.83 29.44 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 3.3799999999999999 108.83 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -103.68 140.98 36.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.772 -0.825 . . . . 0.34999999999999998 108.772 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 113.475 0.917 . . . . 1.1499999999999999 113.475 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 . . . . . 0 C--O 1.231 0.089 0 N-CA-C 110.238 -0.282 . . . . 3.6000000000000001 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m -110.61 149.8 29.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.105 0.479 . . . . 1.8899999999999999 112.231 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 46.64 32.85 1.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.319 -0.855 . . . . 2.6899999999999999 111.823 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.42 -41.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.775 -0.454 . . . . 3.0299999999999998 109.775 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -107.11 82.91 1.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.67 . . . . 3.52 109.696 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.506 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.9 OUTLIER -109.14 144.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 1.95 109.733 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.484 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 73.4 m-85 -128.1 -178.05 4.38 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.843 0.683 . . . . 0.80000000000000004 112.843 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -128.23 143.98 51.08 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.572 -0.451 . . . . 2.0099999999999998 112.083 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.2 t -139.15 131.98 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.78 -0.646 . . . . 1.1599999999999999 112.434 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -133.66 149.9 51.55 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 115.239 -0.891 . . . . 2.1800000000000002 112.612 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.9 m -118.7 117.6 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.705 -1.134 . . . . 1.71 109.749 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.405 ' HA ' ' H ' ' A' ' 154' ' ' SER . 3.8 t-20 55.85 26.32 9.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.758 0.789 . . . . 1.77 109.438 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.97 16.46 41.37 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.365 -1.289 . . . . 0.40999999999999998 113.278 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.7 m-70 -115.35 109.51 18.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.199 0.815 . . . . 0.58999999999999997 113.199 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.487 ' HG1' ' HZ1' ' A' ' 113' ' ' LYS . 11.0 p -67.22 113.69 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.115 0.483 . . . . 1.2 111.292 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.37 -30.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.511 -0.768 . . . . 1.3999999999999999 109.898 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.46 91.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.308 -0.405 . . . . 1.21 109.941 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.487 ' HZ1' ' HG1' ' A' ' 110' ' ' THR . 2.7 ptpp? -107.78 84.83 2.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 122.237 1.018 . . . . 2.9199999999999999 112.038 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.9 p-10 151.2 37.31 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.631 -2.077 . . . . 2.5600000000000001 108.79 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 92.36 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.326 0.584 . . . . 1.71 112.512 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.59 84.07 2.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.649 -1.612 . . . . 1.99 106.649 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 53.3 mt -50.21 -38.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.139 -0.937 . . . . 1.23 113.229 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.06 -52.95 52.76 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.217 0.451 . . . . 1.01 112.217 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.19 -27.62 64.65 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.045 0.387 . . . . 0.76000000000000001 112.045 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.15 -58.22 6.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.113 0.412 . . . . 3.0299999999999998 112.113 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.07 -40.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.175 0.435 . . . . 2.0299999999999998 112.175 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.45 -136.52 12.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.605 -0.807 . . . . 1.0600000000000001 112.601 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -56.65 169.54 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.551 0.215 . . . . 4.29 110.868 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -45.81 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.078 0.466 . . . . 2.1099999999999999 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.1 p -152.97 -175.1 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 1.3300000000000001 109.991 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.39 139.19 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 1.1200000000000001 112.161 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.486 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.7 t60 -111.69 148.88 32.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.869 -0.789 . . . . 0.45000000000000001 108.869 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.584 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . 4.1 p30 -141.87 135.1 29.2 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.712 0.634 . . . . 2.0899999999999999 112.712 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -129.85 112.6 13.73 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.151 -0.931 . . . . 2.2799999999999998 109.609 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -101.89 135.45 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.204 -0.453 . . . . 1.3799999999999999 111.043 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.499 HD11 ' N ' ' A' ' 131' ' ' ILE . 4.2 mp -134.89 86.32 32.97 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.888 0.329 . . . . 2.0 111.888 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -62.6 138.94 73.0 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.554 1.503 . . . . 0.23999999999999999 110.812 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 134' ' ' SER . 19.9 mt -130.13 155.73 41.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.769 0.319 . . . . 1.0600000000000001 111.59 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.446 ' N ' HG23 ' A' ' 133' ' ' ILE . 25.3 p -130.07 106.69 8.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.044 -0.525 . . . . 1.6599999999999999 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 26.6 mt -105.64 125.87 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.661 -0.699 . . . . 1.0700000000000001 109.918 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -146.66 144.08 29.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 2.4300000000000002 110.911 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm 60.29 10.88 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.984 -0.553 . . . . 3.5600000000000001 111.656 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.12 18.53 33.65 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.579 -0.82 . . . . 0.32000000000000001 113.067 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 147' ' ' SER . 33.7 mtmt -121.89 153.89 37.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.958 0.379 . . . . 2.6800000000000002 110.943 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -108.7 127.33 53.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 1.1100000000000001 111.739 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.463 ' N ' HD23 ' A' ' 140' ' ' LEU . 16.6 t -119.77 109.28 15.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 1.3700000000000001 110.176 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.489 ' O ' HG11 ' A' ' 142' ' ' VAL . 1.8 p -101.92 135.59 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.124 -0.489 . . . . 1.23 110.174 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 40.21 -91.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.91 0.337 . . . . 2.0499999999999998 111.91 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -135.59 47.28 0.99 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.033 -0.603 . . . . 0.59999999999999998 112.34 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.51 132.74 21.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.998 -0.371 . . . . 2.02 109.998 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.0 135.0 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.933 0.397 . . . . 1.8700000000000001 110.888 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 23.2 t -152.91 171.94 17.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 1.46 110.208 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.13 136.72 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.188 -0.46 . . . . 1.55 111.295 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 28.6 t80 -79.46 126.84 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.297 -1.001 . . . . 0.34000000000000002 108.297 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -124.0 94.86 4.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.086 0.772 . . . . 2.02 113.086 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.9 -52.82 1.31 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 116.056 1.182 . . . . 0.77000000000000002 116.056 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.498 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -154.75 170.94 20.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.272 1.036 . . . . 2.3199999999999998 113.007 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.33 124.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.027 -1.471 . . . . 1.8600000000000001 107.027 176.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.7 t -116.28 110.79 19.22 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.594 0.961 . . . . 1.72 113.594 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.445 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 15.2 t -99.14 114.96 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.871 -0.604 . . . . 1.27 110.363 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -124.46 136.52 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 2.48 111.659 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -118.3 131.71 56.32 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.743 -0.662 . . . . 1.9199999999999999 109.583 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.21 143.68 16.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.435 -0.802 . . . . 1.3899999999999999 111.469 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.71 148.33 39.15 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 114.816 -1.084 . . . . 2.48 111.728 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -126.15 -8.75 4.91 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.049 -0.82 . . . . 1.1200000000000001 111.049 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -151.77 -57.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.331 -0.435 . . . . 3.8999999999999999 110.265 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -174.33 -68.73 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.242 -0.436 . . . . 4.0999999999999996 111.146 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.29 90.65 4.97 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.008 0.433 . . . . 1.3999999999999999 111.281 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 165' ' ' PRO . 4.2 m-20 -48.03 153.18 1.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.414 -0.812 . . . . 2.0 109.35 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.484 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.57 99.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.191 1.927 . . . . 3.1099999999999999 112.226 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.533 ' NZ ' ' HB3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -51.97 -70.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.005 -0.998 . . . . 4.1100000000000003 111.774 -178.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 62' ' ' GLN . 25.0 t -84.95 131.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 119.455 -0.898 . . . . 1.5900000000000001 111.381 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.3 t -132.33 123.37 26.7 Favored 'General case' 0 C--N 1.338 0.095 0 O-C-N 124.136 0.897 . . . . 1.8600000000000001 109.721 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 88' ' ' LYS . . . -115.23 38.19 3.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.231 0.826 . . . . 1.04 113.231 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -40.22 135.21 1.46 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.974 0.416 . . . . 1.6799999999999999 110.431 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.528 ' N ' HD11 ' A' ' 170' ' ' LEU . 0.3 OUTLIER -152.82 102.36 2.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.837 -0.619 . . . . 0.38 110.072 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 12' ' ' TRP . 2.8 tt -105.1 123.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 CA-C-O 122.842 1.306 . . . . 1.3500000000000001 113.026 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.06 163.03 16.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.396 -1.729 . . . . 1.26 109.399 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.079 1.511 . . . . 2.3599999999999999 115.079 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.39 -35.34 5.03 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 112.327 -2.215 . . . . 0.23000000000000001 117.914 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.551 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.51 159.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 120.031 1.916 . . . . 1.1000000000000001 114.291 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.603 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.15 -18.2 32.89 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 115.116 -0.947 . . . . 1.1000000000000001 110.51 176.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 2.3100000000000001 111.926 -178.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.3 tp . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.343 0.592 . . . . 1.1299999999999999 110.332 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.22 -21.08 8.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.181 -0.918 . . . . 1.1299999999999999 111.509 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.68 -23.06 53.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.139 0.422 . . . . 2.0899999999999999 112.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -98.11 -25.54 14.89 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.395 . . . . 2.5 111.436 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.8 p -44.0 145.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 120.648 0.261 . . . . 1.05 111.591 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -138.75 -23.24 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.096 -0.642 . . . . 1.48 111.012 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.517 ' O ' HG21 ' A' ' 172' ' ' ILE . 28.5 t90 -173.34 141.56 0.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.275 -0.42 . . . . 0.33000000000000002 109.944 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.39 150.15 17.78 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.343 -0.223 . . . . 1.05 111.531 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.78 129.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 114.19 1.182 . . . . 1.3600000000000001 114.19 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -115.17 87.2 2.6 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.726 -0.67 . . . . 1.8700000000000001 109.444 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.12 104.27 0.46 Allowed 'General case' 0 C--O 1.253 1.267 0 CA-C-N 115.414 -0.812 . . . . 1.1100000000000001 109.165 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.633 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 157.69 -20.48 0.38 Allowed Glycine 0 N--CA 1.44 -1.066 0 O-C-N 124.91 1.381 . . . . 0.67000000000000004 113.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.32 -133.27 3.13 Favored Glycine 0 C--N 1.329 0.191 0 C-N-CA 119.991 -1.1 . . . . 1.1200000000000001 113.455 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.958 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 35.1 mt-10 -152.65 120.13 5.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.44 0.162 . . . . 2.02 111.108 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.0 m 26.86 107.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.701 1.0 . . . . 1.6499999999999999 113.701 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.563 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 3.7 t60 -135.64 139.17 43.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 120.086 -0.645 . . . . 0.41999999999999998 112.571 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.486 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 4.9 p -110.08 102.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 115.45 -0.795 . . . . 1.8200000000000001 111.194 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.66 157.0 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.995 -1.002 . . . . 1.1699999999999999 110.301 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -43.55 -52.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.4 0.889 . . . . 1.27 113.4 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -56.82 -20.79 24.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.55000000000000004 110.318 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.4 34.98 3.46 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.22 -0.9 . . . . 0.32000000000000001 112.101 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 27' ' ' ILE . 34.7 mm -103.68 112.1 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.46 . . . . 1.21 110.351 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 13.2 t60 -97.93 132.63 43.34 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.981 1.104 . . . . 0.68999999999999995 113.981 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.958 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -97.42 135.27 39.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.804 -1.184 . . . . 3.3199999999999998 107.804 177.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.447 ' NH1' ' HA ' ' A' ' 12' ' ' TRP . 2.2 ptp85 -91.54 108.15 19.7 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.572 0.545 . . . . 3.3999999999999999 112.451 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -10.8 130.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.106 1.363 . . . . 3.1600000000000001 114.286 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.486 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 57.3 m-20 -16.52 85.86 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.632 1.173 . . . . 1.98 113.921 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 123.247 2.631 . . . . 1.53 111.763 178.823 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 50' ' ' ILE . 1.1 mp . . . . . 0 C--O 1.232 0.172 0 N-CA-C 109.798 -0.445 . . . . 1.45 109.798 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -48.3 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 2.29 112.231 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -77.49 37.16 0.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 3.0600000000000001 112.743 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -151.95 140.73 20.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.08 0.467 . . . . 1.4099999999999999 111.966 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.537 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.2 t30 -65.95 149.13 97.92 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.713 -0.676 . . . . 1.96 109.272 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.597 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 6.2 Cg_exo -38.73 -46.99 2.68 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.954 2.436 . . . . 0.78000000000000003 116.402 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.469 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 8.4 mm-40 -73.12 -56.68 4.78 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.856 0.836 . . . . 1.8200000000000001 111.113 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 -10.92 59.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.824 -0.806 . . . . 1.9099999999999999 108.824 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.597 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.7 tt0 -64.66 -47.29 79.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.56 -1.644 . . . . 2.0600000000000001 106.56 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.43 ' O ' HG21 ' A' ' 63' ' ' THR . 92.2 t -54.49 -57.77 5.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.838 -1.074 . . . . 1.8500000000000001 110.452 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.634 HD23 ' O ' ' A' ' 60' ' ' LEU . 4.2 tt -63.11 -14.64 50.94 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.711 -0.677 . . . . 1.6000000000000001 111.09 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.416 ' CE2' ' HD2' ' A' ' 88' ' ' LYS . 6.3 m-30 -110.81 5.79 20.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.101 -0.5 . . . . 1.29 111.11 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.61 ' HG2' ' N ' ' A' ' 63' ' ' THR . 35.6 tt0 -129.28 -104.95 0.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.49 . . . . 1.8 111.558 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.61 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 65.3 p 36.83 -154.7 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.088 -0.482 . . . . 1.4099999999999999 110.669 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.602 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.0 pt-20 168.85 130.68 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.468 0.576 . . . . 2.0499999999999998 112.026 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.633 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 14.9 mtp85 -107.35 -176.73 3.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.39 -0.368 . . . . 4.2800000000000002 110.284 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -168.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.21 -0.45 . . . . 4.4699999999999998 110.89 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -159.03 162.11 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 5.1500000000000004 111.167 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.419 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.4 tp10 -156.74 -92.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 3.1699999999999999 111.053 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.419 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 3.1 p30 -173.56 134.49 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.535 0.207 . . . . 2.3900000000000001 111.084 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.4 t 46.89 84.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.401 -0.363 . . . . 1.3200000000000001 110.693 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -155.92 155.64 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.578 -0.449 . . . . 1.77 111.995 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -175.66 -161.38 24.93 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.601 -0.809 . . . . 0.98999999999999999 113.951 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.01 174.1 6.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.75 0.786 . . . . 1.1899999999999999 113.056 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -127.36 139.67 52.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.322 -1.308 . . . . 2.27 109.128 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.508 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -129.75 88.93 47.91 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.895 0.702 . . . . 1.0700000000000001 112.895 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.38 134.88 67.09 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.61 1.54 . . . . 1.26 111.433 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 77' ' ' ILE . 59.9 mt -126.52 155.14 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.859 0.361 . . . . 1.0900000000000001 111.266 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -147.35 4.11 0.79 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.021 -0.536 . . . . 3.4399999999999999 111.364 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.92 171.86 12.7 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.602 0.239 . . . . 2.1299999999999999 110.864 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.8 mp0 -127.4 173.29 9.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.37 111.419 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.92 -150.31 20.11 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 109.958 -1.257 . . . . 0.23000000000000001 109.958 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 28.4 mt-10 -100.98 108.13 19.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.826 1.313 . . . . 2.0299999999999998 109.038 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -94.81 126.32 40.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 119.772 -0.771 . . . . 0.94999999999999996 109.126 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.607 HG23 ' N ' ' A' ' 177' ' ' ALA . 21.2 t -110.78 109.09 27.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.951 -1.022 . . . . 1.21 111.319 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.4 105.45 17.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.848 -1.524 . . . . 1.79 110.45 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.6 t -110.33 143.39 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.171 -0.922 . . . . 1.95 110.31 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -136.77 133.79 36.38 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.591 -0.444 . . . . 2.0 111.414 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -103.47 110.41 22.43 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.64 -1.245 . . . . 3.3799999999999999 107.64 175.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -102.99 141.62 35.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.41 -0.959 . . . . 0.34999999999999998 108.41 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 114.248 1.203 . . . . 1.1499999999999999 114.248 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.796 0.331 . . . . 3.6000000000000001 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.7 p -97.74 153.17 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 1.8899999999999999 111.423 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 66.56 -71.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.726 -0.67 . . . . 2.6899999999999999 112.178 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -39.18 -44.88 1.26 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.298 -0.41 . . . . 3.0299999999999998 111.866 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -88.92 80.37 7.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.152 0.501 . . . . 3.52 110.939 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.44 142.6 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 1.95 109.934 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.46 177.65 5.8 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.769 0.655 . . . . 0.80000000000000004 112.769 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -125.65 141.43 52.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 115.977 -0.556 . . . . 2.0099999999999998 111.565 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.51 132.41 36.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 116.272 -0.422 . . . . 1.1599999999999999 111.717 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.5 OUTLIER -134.05 150.73 51.21 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.17 0.804 . . . . 2.1800000000000002 113.17 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 17.3 m -118.84 119.64 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.65 -1.159 . . . . 1.71 109.451 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.478 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.79 26.96 12.12 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.341 -0.614 . . . . 1.77 109.341 -176.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.1 53.11 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.40999999999999998 112.879 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.3 m-70 -114.27 109.46 18.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.292 0.849 . . . . 0.58999999999999997 113.292 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -67.36 109.67 3.25 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 1.2 111.168 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.05 -34.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.396 -0.82 . . . . 1.3999999999999999 109.85 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.91 90.36 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.599 -0.519 . . . . 1.21 109.599 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -109.36 81.83 1.5 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.304 1.049 . . . . 2.9199999999999999 111.201 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 157.67 37.16 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 112.462 -2.154 . . . . 2.5600000000000001 108.217 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.39 85.97 0.83 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.695 -0.684 . . . . 1.71 112.292 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 0.6 OUTLIER -100.16 83.64 2.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.597 -1.631 . . . . 1.99 106.597 175.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.2 mt -49.82 -41.57 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.358 -0.837 . . . . 1.23 112.112 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -61.54 -54.8 38.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.571 -0.286 . . . . 1.01 111.22 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.422 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 12.8 t70 -63.26 -27.53 69.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.871 0.323 . . . . 0.76000000000000001 111.871 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -63.69 -59.4 4.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.324 0.49 . . . . 3.0299999999999998 112.324 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.16 -41.39 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.204 -0.598 . . . . 2.0299999999999998 112.152 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.51 -112.13 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.586 -0.816 . . . . 1.0600000000000001 112.655 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -97.42 114.45 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.768 0.318 . . . . 4.29 111.377 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.8 t 54.63 -127.15 2.29 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.089 -0.505 . . . . 2.1099999999999999 111.192 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.7 p 56.15 174.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.946 0.403 . . . . 1.3300000000000001 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.55 139.32 34.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.329 0.585 . . . . 1.1200000000000001 112.134 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.609 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.6 t60 -107.78 149.22 28.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.108 -0.951 . . . . 0.45000000000000001 108.44 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.609 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 1.6 p30 -133.42 137.2 45.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.54 0.941 . . . . 2.0899999999999999 113.54 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -129.68 109.4 10.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.559 -1.2 . . . . 2.2799999999999998 109.464 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 mt -98.71 128.58 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.893 -0.594 . . . . 1.3799999999999999 110.27 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.91 84.33 38.12 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 113.076 0.769 . . . . 2.0 113.076 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.55 143.63 93.18 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.793 1.662 . . . . 0.23999999999999999 111.402 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 134' ' ' SER . 25.1 mt -136.36 159.43 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 1.0600000000000001 111.025 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.484 ' N ' HG23 ' A' ' 133' ' ' ILE . 53.6 p -134.4 107.13 7.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 1.6599999999999999 111.227 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 20.4 mt -105.55 127.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 115.72 -0.673 . . . . 1.0700000000000001 109.955 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -150.49 142.84 24.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.341 . . . . 2.4300000000000002 110.886 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt 60.53 11.83 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.017 -0.538 . . . . 3.5600000000000001 111.596 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.04 14.54 48.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.64 -0.79 . . . . 0.32000000000000001 113.134 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -116.78 153.47 32.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.861 0.33 . . . . 2.6800000000000002 110.907 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.414 HD21 ' N ' ' A' ' 141' ' ' SER . 6.5 tt -111.43 129.52 56.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 1.1100000000000001 111.727 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.414 ' N ' HD21 ' A' ' 140' ' ' LEU . 22.8 t -116.9 109.9 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 1.3700000000000001 109.678 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.06 110.79 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.125 -0.489 . . . . 1.23 111.007 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.14 -89.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.911 -0.586 . . . . 2.0499999999999998 111.769 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.92 22.33 4.3 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.528 -0.844 . . . . 0.59999999999999998 113.243 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -125.81 136.57 53.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 2.02 110.282 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -105.37 137.95 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 1.8700000000000001 111.129 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.1 m -152.67 170.61 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 1.46 110.124 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.44 135.46 38.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 1.55 111.277 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.7 137.79 37.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.928 -1.138 . . . . 0.34000000000000002 107.928 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.8 m -145.8 95.55 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.705 -0.798 . . . . 2.02 112.775 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.18 -65.75 3.97 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.366 -0.834 . . . . 0.77000000000000002 115.163 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.508 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.95 172.14 16.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 117.72 0.76 . . . . 2.3199999999999998 112.694 -178.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.478 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -95.29 125.22 39.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.909 -1.515 . . . . 1.8600000000000001 106.909 176.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 t -116.5 115.66 26.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.729 1.011 . . . . 1.72 113.729 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.469 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 11.7 t -101.46 121.37 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.579 . . . . 1.27 110.197 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 62.2 mm-40 -131.38 144.68 51.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.743 -0.662 . . . . 2.48 110.702 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -128.32 136.27 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 1.9199999999999999 109.782 178.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.73 143.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.226 -0.897 . . . . 1.3899999999999999 111.428 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.35 139.56 49.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.516 -0.765 . . . . 2.48 111.275 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.73 -21.02 27.26 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.856 -0.687 . . . . 1.1200000000000001 111.427 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -158.75 -51.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 3.8999999999999999 109.809 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -178.8 155.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.703 -0.68 . . . . 4.0999999999999996 110.152 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.88 75.65 0.4 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.477 -0.329 . . . . 1.3999999999999999 111.351 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.53 166.21 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.139 -0.482 . . . . 2.0 109.929 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -36.93 110.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.973 1.782 . . . . 3.1099999999999999 111.799 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -71.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.458 -0.792 . . . . 4.1100000000000003 112.268 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 63' ' ' THR . 22.3 t -87.02 132.77 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 120.185 -0.606 . . . . 1.5900000000000001 111.927 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.9 t -131.66 123.94 28.83 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 123.938 0.774 . . . . 1.8600000000000001 111.103 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.429 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -117.21 38.77 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.955 1.094 . . . . 1.04 113.955 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -33.14 141.99 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.872 0.368 . . . . 1.6799999999999999 111.038 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.474 ' N ' HD12 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -159.34 102.66 1.58 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 0.38 110.487 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.517 HG21 ' O ' ' A' ' 12' ' ' TRP . 2.3 tt -112.74 123.16 68.14 Favored 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-O 122.829 1.3 . . . . 1.3500000000000001 112.724 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.81 165.87 13.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.78 -1.555 . . . . 1.26 109.228 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -120.47 143.05 48.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.007 1.484 . . . . 2.3599999999999999 115.007 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.11 -35.27 5.06 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 112.382 -2.19 . . . . 0.23000000000000001 117.781 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.546 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.05 158.8 0.35 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.109 1.954 . . . . 1.1000000000000001 114.452 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.607 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.02 -16.79 37.09 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 115.114 -0.948 . . . . 1.1000000000000001 110.354 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 2.3100000000000001 111.762 -178.903 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.341 0.591 . . . . 1.1299999999999999 110.287 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -54.6 -20.53 8.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.135 -0.939 . . . . 1.1299999999999999 111.515 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.75 -20.19 56.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.314 0.487 . . . . 2.0899999999999999 112.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 61.4 mttt -105.96 -21.83 13.05 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.441 -0.504 . . . . 2.5 111.773 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 7' ' ' ALA . 12.1 p -43.93 145.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 121.03 -0.268 . . . . 1.05 111.465 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.7 pt -136.55 -23.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 119.689 -0.804 . . . . 1.48 110.998 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.518 ' O ' HG22 ' A' ' 172' ' ' ILE . 49.5 t90 -174.77 141.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.867 -0.419 . . . . 0.33000000000000002 109.867 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 14' ' ' VAL . . . -159.67 145.29 15.72 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.191 0.441 . . . . 1.05 112.191 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 13' ' ' ALA . 3.2 t -147.73 131.88 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 114.251 1.204 . . . . 1.3600000000000001 114.251 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 14.8 t30 -115.42 94.59 4.78 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 114.441 -1.254 . . . . 1.8700000000000001 109.71 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.627 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -61.34 96.04 0.05 Allowed 'General case' 0 C--O 1.252 1.222 0 N-CA-C 107.092 -1.447 . . . . 1.1100000000000001 107.092 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.563 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -178.49 -63.86 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.533 -1.667 . . . . 0.67000000000000004 113.746 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -105.17 -120.0 4.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.597 -0.811 . . . . 1.1200000000000001 112.105 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.847 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -172.31 128.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.25 0.548 . . . . 2.02 110.818 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.2 m 42.27 82.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.004 -0.998 . . . . 1.6499999999999999 112.445 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 67.1 t60 -112.77 151.97 29.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.072 -0.651 . . . . 0.41999999999999998 111.807 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.3 t -124.84 103.77 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.374 -0.83 . . . . 1.8200000000000001 110.108 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.58 151.99 39.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.385 -0.37 . . . . 1.1699999999999999 110.228 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 m -43.38 -48.23 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.777 1.029 . . . . 1.27 113.777 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.1 -18.52 47.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.274 0.559 . . . . 0.55000000000000004 110.422 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.09 34.62 3.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.318 -0.856 . . . . 0.32000000000000001 112.459 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 27' ' ' ILE . 28.9 mm -103.16 123.7 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.217 -0.66 . . . . 1.21 109.217 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.8 t60 -108.36 132.35 53.82 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.68999999999999995 114.151 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.847 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -97.25 132.66 42.78 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.232 -1.025 . . . . 3.3199999999999998 108.232 176.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' SER . 80.0 mtp180 -47.67 -109.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.229 1.196 . . . . 3.3999999999999999 114.229 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 179.47 99.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.166 -0.47 . . . . 3.1600000000000001 111.859 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.417 ' OD1' ' HD2' ' A' ' 65' ' ' ARG . 4.3 m-20 32.32 71.68 0.64 Allowed Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.507 0.558 . . . . 1.98 112.507 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo . . . . . 0 CA--C 1.532 0.424 0 C-N-CA 122.679 2.253 . . . . 1.53 114.081 -179.73 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 125' ' ' THR . 1.2 mp . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 120.81 0.338 . . . . 1.45 110.194 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.0 mp -86.41 -177.65 6.25 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.439 -0.949 . . . . 2.29 108.439 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 81.6 mtp180 70.01 -21.48 0.17 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.425 . . . . 3.0600000000000001 111.959 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 51' ' ' LEU . 2.7 t -105.39 172.7 6.65 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.065 0.46 . . . . 1.4099999999999999 111.229 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.5 t30 -90.24 148.57 39.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 109.051 -0.722 . . . . 1.96 109.051 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 18.0 Cg_exo -40.63 -51.41 3.54 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.179 1.919 . . . . 0.78000000000000003 114.065 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.449 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 10.4 mm-40 -63.68 -56.57 14.72 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.101 0.953 . . . . 1.8200000000000001 110.94 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' OD1' HD21 ' A' ' 60' ' ' LEU . 11.0 t0 -68.86 -12.06 61.16 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.694 -0.684 . . . . 1.9099999999999999 109.98 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.9 tt0 -63.51 -45.04 92.49 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.146 -1.798 . . . . 2.0600000000000001 106.146 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -53.21 -50.17 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 114.432 -1.258 . . . . 1.8500000000000001 109.186 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 7.1 tp -69.57 -11.33 60.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.087 -0.96 . . . . 1.6000000000000001 111.465 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.439 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.5 m-30 -121.51 20.06 11.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.833 -0.621 . . . . 1.29 111.246 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -139.64 -59.58 0.56 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.448 0.907 . . . . 1.8 113.448 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 167' ' ' VAL . 77.6 p -43.15 150.78 0.17 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.584 -0.28 . . . . 1.4099999999999999 110.906 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.563 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -135.11 -30.49 1.05 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.913 1.449 . . . . 2.0499999999999998 114.913 -176.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 38.5 mtp85 68.57 -173.7 0.19 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.706 -0.479 . . . . 4.2800000000000002 109.706 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -77.37 156.06 31.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.721 0.296 . . . . 4.4699999999999998 110.373 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -134.0 149.02 51.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.415 -0.357 . . . . 5.1500000000000004 111.054 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -130.04 -101.22 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.27 -0.423 . . . . 3.1699999999999999 111.444 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.76 130.03 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.761 0.315 . . . . 2.3900000000000001 111.403 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.432 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 18.9 t 53.16 95.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.091 -0.504 . . . . 1.3200000000000001 111.507 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -162.66 164.73 26.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 1.77 111.235 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -164.69 -149.63 5.87 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.005 -1.093 . . . . 0.98999999999999999 114.605 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.532 ' OH ' ' HB1' ' A' ' 16' ' ' ALA . 2.2 m-85 -141.31 167.2 22.74 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.116 -0.542 . . . . 1.1899999999999999 111.455 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.33 134.35 55.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.144 -0.935 . . . . 2.27 110.892 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.485 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.5 mp -126.98 87.09 57.46 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.637 -0.256 . . . . 1.0700000000000001 111.48 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -57.56 119.79 7.28 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.875 1.717 . . . . 1.26 112.011 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.71 151.44 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 1.0900000000000001 111.191 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -144.49 3.99 1.17 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.209 -0.45 . . . . 3.4399999999999999 111.559 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 11.3 mm-40 -128.62 171.07 12.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.459 0.171 . . . . 2.1299999999999999 110.76 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -127.09 169.1 13.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.37 111.783 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.18 -155.74 24.1 Favored Glycine 0 CA--C 1.512 -0.133 0 N-CA-C 109.644 -1.382 . . . . 0.23000000000000001 109.644 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.7 mt-10 -96.51 108.5 21.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.048 1.424 . . . . 2.0299999999999998 108.657 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.516 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.8 m-85 -94.29 125.82 39.16 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.968 -0.753 . . . . 0.94999999999999996 108.968 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.629 HG23 ' N ' ' A' ' 177' ' ' ALA . 38.9 t -109.49 112.03 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 1.21 111.289 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -103.11 104.83 15.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.789 -1.551 . . . . 1.79 110.537 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.26 142.56 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.527 -0.761 . . . . 1.95 109.639 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.97 134.18 46.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.569 -0.452 . . . . 2.0 111.168 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HZ2' ' HB1' ' A' ' 126' ' ' ALA . 5.7 tptm -94.16 112.59 24.41 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.106 -1.442 . . . . 3.3799999999999999 107.106 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 14.7 m-85 -104.47 143.64 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.715 -0.476 . . . . 0.34999999999999998 109.715 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.117 -0.492 . . . . 1.1499999999999999 110.605 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.697 0.284 . . . . 3.6000000000000001 110.976 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.5 m -113.05 156.92 22.25 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.569 0.581 . . . . 1.8899999999999999 112.569 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 48.09 27.15 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.145 -0.934 . . . . 2.6899999999999999 112.091 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -129.63 -42.91 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 3.0299999999999998 109.423 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 93.0 mttt -92.47 78.02 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 3.52 109.256 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.54 145.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 1.95 109.705 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.17 178.03 7.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.601 0.593 . . . . 0.80000000000000004 112.601 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.46 137.76 54.73 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.262 -0.426 . . . . 2.0099999999999998 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.25 131.91 52.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.917 -0.583 . . . . 1.1599999999999999 112.323 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 6.7 mtt180 -133.48 146.79 51.44 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.997 0.74 . . . . 2.1800000000000002 112.997 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.8 m -117.14 114.26 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.074 -0.967 . . . . 1.71 109.373 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.503 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 60.62 27.14 16.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.199 -0.667 . . . . 1.77 109.199 -176.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.49 10.12 62.32 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.126 -0.943 . . . . 0.40999999999999998 112.767 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.484 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.7 m-70 -107.46 113.28 26.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.026 0.75 . . . . 0.58999999999999997 113.026 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -64.66 128.95 37.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.178 -0.609 . . . . 1.2 110.634 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.65 -30.87 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.198 -0.667 . . . . 1.3999999999999999 109.198 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.438 HG13 ' OE2' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -135.73 89.77 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.094 -0.706 . . . . 1.21 109.094 177.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.1 OUTLIER -105.33 76.66 1.24 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 122.508 1.147 . . . . 2.9199999999999999 111.146 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.7 p30 154.5 28.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.079 -1.873 . . . . 2.5600000000000001 108.35 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD23 ' CD2' ' A' ' 89' ' ' PHE . 16.6 tp -61.44 97.12 0.06 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.376 -0.829 . . . . 1.71 112.386 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.5 t70 -107.07 93.9 4.81 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 114.669 -1.151 . . . . 1.99 108.345 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.9 mt -51.86 -51.66 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 114.069 1.137 . . . . 1.23 114.069 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -53.51 -55.93 21.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.033 0.383 . . . . 1.01 112.033 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.78 -27.55 68.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.569 0.581 . . . . 0.76000000000000001 112.569 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -67.68 -58.56 4.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.872 0.693 . . . . 3.0299999999999998 112.872 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -106.08 -40.85 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.11 0.411 . . . . 2.0299999999999998 112.11 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.44 -138.9 13.22 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.539 -0.839 . . . . 1.0600000000000001 113.185 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -65.43 118.23 9.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.965 0.412 . . . . 4.29 111.607 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.4 m 39.13 -116.75 0.2 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.576 -0.738 . . . . 2.1099999999999999 112.066 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 50' ' ' ILE . 66.0 p 51.65 -166.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.661 0.267 . . . . 1.3300000000000001 110.953 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.406 ' HB1' ' HZ2' ' A' ' 88' ' ' LYS . . . -113.58 139.09 49.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.753 0.649 . . . . 1.1200000000000001 112.753 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.557 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.7 t60 -107.61 147.95 29.96 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.903 -0.777 . . . . 0.45000000000000001 108.903 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.557 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 4.5 p30 -143.03 131.06 21.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.558 0.577 . . . . 2.0899999999999999 112.558 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.438 ' OE2' HG13 ' A' ' 112' ' ' VAL . 57.8 mt-10 -124.23 109.8 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.508 -0.769 . . . . 2.2799999999999998 109.73 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.422 ' O ' HD13 ' A' ' 131' ' ' ILE . 15.5 mt -94.94 130.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.066 -0.516 . . . . 1.3799999999999999 110.839 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 130' ' ' ILE . 43.8 mm -131.53 85.88 51.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.375 -0.375 . . . . 2.0 111.902 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.59 144.62 97.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.694 1.596 . . . . 0.23999999999999999 111.447 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.496 HG23 ' N ' ' A' ' 134' ' ' SER . 28.3 mt -136.33 159.41 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 1.0600000000000001 110.674 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.496 ' N ' HG23 ' A' ' 133' ' ' ILE . 42.6 p -134.76 108.55 8.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 1.6599999999999999 111.132 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 26.6 mt -106.34 125.99 62.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.695 -0.684 . . . . 1.0700000000000001 109.979 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -150.97 144.04 24.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.699 0.285 . . . . 2.4300000000000002 110.802 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt 61.76 10.15 3.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 3.5600000000000001 111.468 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.01 37.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.621 -0.8 . . . . 0.32000000000000001 113.182 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -119.99 160.46 22.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.075 0.437 . . . . 2.6800000000000002 110.772 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.76 131.53 56.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.089 0.471 . . . . 1.1100000000000001 111.893 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.443 ' HB3' ' OG ' ' A' ' 134' ' ' SER . 22.9 t -116.54 116.64 27.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.631 -0.713 . . . . 1.3700000000000001 110.08 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.0 p -113.03 111.48 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.288 0.566 . . . . 1.23 111.551 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 50.27 -93.97 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.616 -0.72 . . . . 2.0499999999999998 112.441 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -123.94 34.79 3.46 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.544 -0.836 . . . . 0.59999999999999998 113.616 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -146.57 132.64 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.065 -0.346 . . . . 2.02 110.065 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.14 146.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.429 . . . . 1.8700000000000001 111.566 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.6 m -161.12 171.27 18.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.779 -0.646 . . . . 1.46 109.376 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 141.72 31.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.278 0.561 . . . . 1.55 111.496 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -78.66 140.74 38.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.136 -0.938 . . . . 0.34000000000000002 109.653 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.5 p -139.99 95.28 2.87 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.673 0.62 . . . . 2.02 112.673 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.96 -57.73 2.24 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.833 1.093 . . . . 0.77000000000000002 115.833 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.491 ' HB3' ' HZ3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -151.66 174.99 12.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.023 0.912 . . . . 2.3199999999999998 112.695 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.503 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 1.8 tt -101.9 129.03 48.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.407 -1.331 . . . . 1.8600000000000001 107.407 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.469 ' N ' HD22 ' A' ' 153' ' ' LEU . 1.6 t -116.51 114.37 24.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.696 -0.802 . . . . 1.72 112.851 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.407 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 43.7 t -93.1 105.09 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.039 -0.726 . . . . 1.27 109.039 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.1 tt0 -118.4 128.43 54.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 2.48 111.414 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -120.99 145.83 47.34 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.166 0.508 . . . . 1.9199999999999999 109.749 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 143.87 26.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 115.191 -0.913 . . . . 1.3899999999999999 111.261 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.468 ' O ' ' HD2' ' A' ' 159' ' ' LYS . 1.6 pptp? -83.89 148.48 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.471 -0.786 . . . . 2.48 111.394 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.68 0.51 55.41 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.923 -0.656 . . . . 1.1200000000000001 111.619 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -154.64 -76.25 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.847 -0.177 . . . . 3.8999999999999999 110.803 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -178.49 73.61 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.498 -0.319 . . . . 4.0999999999999996 110.713 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -174.37 -44.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.381 -0.372 . . . . 1.3999999999999999 111.165 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.432 ' ND2' ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 62.43 163.15 0.11 Allowed Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.545 -0.539 . . . . 2.0 109.545 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -44.47 103.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.325 1.35 . . . . 3.1099999999999999 111.272 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 6.7 tppt? -53.3 -66.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.301 -0.863 . . . . 4.1100000000000003 112.088 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 63' ' ' THR . 45.5 t -94.45 132.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 120.547 -0.461 . . . . 1.5900000000000001 111.749 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -135.29 127.77 30.56 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 113.194 0.813 . . . . 1.8600000000000001 113.194 -178.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.41 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -122.24 38.56 4.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.697 -1.138 . . . . 1.04 112.647 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 171' ' ' PHE . 6.7 tp -46.79 130.38 11.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.094 0.473 . . . . 1.6799999999999999 110.398 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -142.86 114.47 8.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.75 -0.659 . . . . 0.38 110.373 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -113.92 123.88 70.02 Favored 'Isoleucine or valine' 0 C--O 1.263 1.77 0 CA-C-O 122.841 1.305 . . . . 1.3500000000000001 112.961 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -119.61 166.76 12.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.923 -1.49 . . . . 1.26 109.886 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 8.9 ptmt -120.71 144.67 48.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.008 1.484 . . . . 2.3599999999999999 115.008 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 100.64 -36.31 4.24 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 112.417 -2.174 . . . . 0.23000000000000001 118.181 174.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.576 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.87 158.44 0.43 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.57 2.185 . . . . 1.1000000000000001 114.324 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.629 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.34 -26.93 24.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.953 -1.022 . . . . 1.1000000000000001 110.37 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.693 -0.685 . . . . 2.3100000000000001 111.149 -178.803 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.1 tp . . . . . 0 C--O 1.234 0.242 0 CA-C-O 121.33 0.586 . . . . 1.1299999999999999 110.272 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.2 -19.87 9.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.262 -0.881 . . . . 1.1299999999999999 110.877 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.17 -20.06 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.058 0.392 . . . . 2.0899999999999999 112.058 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -103.5 -28.4 11.79 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.623 -0.431 . . . . 2.5 111.02 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -42.06 147.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.677 0.275 . . . . 1.05 111.601 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -139.6 -22.64 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.815 -0.754 . . . . 1.48 111.085 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.503 ' O ' HG23 ' A' ' 172' ' ' ILE . 32.7 t90 -173.39 139.71 0.78 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.626 -0.429 . . . . 0.33000000000000002 110.011 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.04 146.04 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.605 0.224 . . . . 1.05 111.605 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -146.99 126.7 4.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 114.255 1.206 . . . . 1.3600000000000001 114.255 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.563 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 7.3 t-20 -115.37 97.13 6.0 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.619 -0.718 . . . . 1.8700000000000001 110.146 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.436 ' HB3' ' OH ' ' A' ' 73' ' ' TYR . . . -69.51 107.33 3.33 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 120.552 -0.459 . . . . 1.1100000000000001 110.13 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.573 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 166.14 -74.75 0.15 Allowed Glycine 0 C--N 1.338 0.687 0 O-C-N 124.675 1.234 . . . . 0.67000000000000004 112.662 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.451 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -85.62 -125.13 1.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.883 -0.675 . . . . 1.1200000000000001 111.993 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.497 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -168.0 120.67 0.88 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.65 0.738 . . . . 2.02 111.214 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.705 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 47.61 95.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.319 -1.31 . . . . 1.6499999999999999 113.009 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.529 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 18.5 t60 -125.46 137.08 53.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 118.988 -1.085 . . . . 0.41999999999999998 113.069 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.0 t -107.43 101.59 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.588 -1.187 . . . . 1.8200000000000001 109.912 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.411 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -67.12 157.82 32.69 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.85 -0.613 . . . . 1.1699999999999999 110.627 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.26 -55.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 124.849 1.343 . . . . 1.27 112.828 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -55.53 -22.74 22.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.126 0.489 . . . . 0.55000000000000004 110.339 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.43 36.03 2.75 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.394 -0.821 . . . . 0.32000000000000001 112.165 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.436 HG21 HD11 ' A' ' 27' ' ' ILE . 35.9 mm -103.33 125.49 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.655 -0.498 . . . . 1.21 109.655 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.506 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.4 t60 -106.34 131.32 53.69 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.76 1.393 . . . . 0.68999999999999995 114.76 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.705 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.78 140.84 34.5 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.956 -1.128 . . . . 3.3199999999999998 107.956 175.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 20' ' ' SER . 77.2 mtp180 -63.31 -137.68 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.383 0.427 . . . . 3.3999999999999999 111.135 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.8 100.01 3.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.364 0.266 . . . . 3.1600000000000001 111.484 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.414 ' OD1' ' HD3' ' A' ' 65' ' ' ARG . 34.9 t70 35.59 69.78 1.09 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 111.985 0.365 . . . . 1.98 111.985 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 C-N-CA 122.852 2.368 . . . . 1.53 114.496 -179.44 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 121.333 0.587 . . . . 1.45 110.043 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 53' ' ' SER . 10.3 mp -76.89 -47.78 20.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.784 1.031 . . . . 2.29 113.784 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -70.06 26.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.268 0.84 . . . . 3.0600000000000001 113.268 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 51' ' ' LEU . 8.1 t -147.79 156.79 43.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.09 0.472 . . . . 1.4099999999999999 111.637 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 58' ' ' GLN . 7.9 t30 -71.95 148.22 91.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.729 -0.669 . . . . 1.96 109.878 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.584 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.16 -54.67 2.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.525 2.15 . . . . 0.78000000000000003 114.615 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 9.8 mm-40 -62.39 -57.95 9.44 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.88 0.848 . . . . 1.8200000000000001 110.994 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 23.8 t70 -69.04 -6.57 28.91 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.723 -0.671 . . . . 1.9099999999999999 109.623 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 12.5 tt0 -69.2 -42.44 75.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.61 -1.626 . . . . 2.0600000000000001 106.61 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.65 -57.61 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 114.329 -1.305 . . . . 1.8500000000000001 109.158 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.563 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.3 tt -54.31 -61.04 2.56 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.547 -0.751 . . . . 1.6000000000000001 109.345 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.544 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 2.3 m-85 -52.79 -15.14 0.66 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.585 -0.734 . . . . 1.29 111.097 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HG2' ' N ' ' A' ' 63' ' ' THR . 7.0 tt0 -119.63 -117.94 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.661 0.615 . . . . 1.8 112.661 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.584 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 2.7 p 36.44 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.623 0.769 . . . . 1.4099999999999999 112.669 -176.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.573 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.7 pt-20 -101.53 146.34 27.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.309 0.855 . . . . 2.0499999999999998 113.309 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.414 ' HD3' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -104.43 -144.43 0.37 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.723 -1.126 . . . . 4.2800000000000002 109.935 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.35 -175.51 2.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.496 0.189 . . . . 4.4699999999999998 110.543 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -138.63 160.05 40.58 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.82 0.343 . . . . 5.1500000000000004 111.482 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -154.6 -103.75 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.144 -0.48 . . . . 3.1699999999999999 111.024 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -174.41 124.85 0.31 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.495 0.188 . . . . 2.3900000000000001 110.803 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.468 ' H ' HD22 ' A' ' 164' ' ' ASN . 21.0 t 50.33 96.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.347 -0.388 . . . . 1.3200000000000001 111.699 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -166.31 167.09 16.26 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.217 -0.447 . . . . 1.77 111.105 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.28 -170.59 37.72 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.28 -0.962 . . . . 0.98999999999999999 114.045 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.436 ' OH ' ' HB3' ' A' ' 16' ' ' ALA . 7.4 m-85 -109.31 169.56 8.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.532 0.682 . . . . 1.1899999999999999 112.532 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.23 136.65 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.612 -1.176 . . . . 2.27 110.439 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 153' ' ' LEU . 4.4 mp -127.25 86.84 57.81 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 112.153 0.427 . . . . 1.0700000000000001 112.153 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -54.41 130.34 39.45 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.244 1.963 . . . . 1.26 112.418 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.406 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 74.2 mt -126.48 150.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.206 -0.452 . . . . 1.0900000000000001 111.294 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -142.86 0.75 1.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 3.4399999999999999 111.201 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.11 170.11 12.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.477 0.179 . . . . 2.1299999999999999 110.769 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.04 171.24 9.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.339 0.59 . . . . 0.37 111.912 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.44 -155.58 23.06 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 109.8 -1.32 . . . . 0.23000000000000001 109.8 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.1 mt-10 -97.41 108.38 21.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.128 1.464 . . . . 2.0299999999999998 109.107 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -95.57 126.47 40.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.926 -0.71 . . . . 0.94999999999999996 109.22 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.597 HG23 ' N ' ' A' ' 177' ' ' ALA . 16.1 t -112.68 113.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.906 -1.043 . . . . 1.21 111.386 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tt -95.67 104.02 15.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.566 -1.197 . . . . 1.79 110.445 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.15 126.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 114.507 -1.224 . . . . 1.95 108.705 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 87' ' ' LEU . 1.8 pp -135.67 141.15 44.95 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.569 -0.852 . . . . 2.0 111.04 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.695 ' HZ2' ' H ' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -107.13 124.29 49.48 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.282 -0.967 . . . . 3.3799999999999999 109.495 177.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.445 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 7.7 m-85 -105.73 142.36 35.6 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.398 -0.819 . . . . 0.34999999999999998 109.305 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.979 0.419 . . . . 1.1499999999999999 111.117 -179.833 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.401 ' NE2' ' HG3' ' A' ' 100' ' ' LYS . 14.1 pt20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.875 0.369 . . . . 3.6000000000000001 110.742 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.6 m -107.26 150.47 26.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.07 -0.514 . . . . 1.8899999999999999 112.277 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 47.24 39.93 9.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.518 -0.764 . . . . 2.6899999999999999 111.842 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -133.48 -48.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.751 -0.463 . . . . 3.0299999999999998 109.751 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.401 ' HG3' ' NE2' ' A' ' 96' ' ' GLN . 66.5 mttm -98.05 86.8 3.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.829 -0.623 . . . . 3.52 109.558 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.0 144.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 1.95 109.461 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -130.45 178.59 6.48 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.633 0.605 . . . . 0.80000000000000004 112.633 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -122.05 139.65 53.45 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.94 -0.304 . . . . 2.0099999999999998 111.154 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.1 132.05 52.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-N 116.084 -0.507 . . . . 1.1599999999999999 112.138 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.541 HH21 HG21 ' A' ' 158' ' ' VAL . 8.5 mtt180 -133.72 156.48 47.87 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 113.234 0.827 . . . . 2.1800000000000002 113.234 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 25.3 m -122.15 119.27 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 114.853 -1.067 . . . . 1.71 109.049 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' ' 153' ' ' LEU . 0.6 OUTLIER 56.27 26.39 10.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.922 -0.77 . . . . 1.77 108.922 -175.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.29 39.64 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.40999999999999998 112.784 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -117.83 112.11 19.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.943 0.72 . . . . 0.58999999999999997 112.943 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -61.84 127.67 32.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.634 -0.426 . . . . 1.2 111.24 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 t -123.64 -32.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.107 -0.701 . . . . 1.3999999999999999 109.107 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.99 90.18 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.078 -0.712 . . . . 1.21 109.078 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 16.1 ptpt -107.53 100.91 10.29 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.032 0.92 . . . . 2.9199999999999999 111.76 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 18.5 m-20 131.2 27.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.27 -2.241 . . . . 2.5600000000000001 108.037 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.438 HD21 ' CD2' ' A' ' 89' ' ' PHE . 45.4 tp -56.41 96.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.952 -1.022 . . . . 1.71 112.636 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -108.23 92.31 4.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.605 -1.18 . . . . 1.99 107.829 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 121' ' ' VAL . 43.3 mt -51.88 -35.95 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.47 0.915 . . . . 1.23 113.47 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -69.2 -54.64 13.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.304 0.483 . . . . 1.01 112.304 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.98 -27.28 66.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.545 0.572 . . . . 0.76000000000000001 112.545 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -72.66 -58.27 3.49 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.879 0.696 . . . . 3.0299999999999998 112.879 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 117' ' ' ILE . 8.5 p -97.48 -35.15 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.129 0.418 . . . . 2.0299999999999998 112.129 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.8 -129.2 8.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.651 -0.785 . . . . 1.0600000000000001 112.368 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -88.82 110.47 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.642 0.258 . . . . 4.29 110.619 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.3 t 51.46 -108.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 2.1099999999999999 110.529 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.4 p 48.46 -171.77 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.532 0.206 . . . . 1.3300000000000001 111.325 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.61 ' HA ' ' NZ ' ' A' ' 88' ' ' LYS . . . -102.85 121.95 43.54 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.305 0.854 . . . . 1.1200000000000001 113.305 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.695 ' H ' ' HZ2' ' A' ' 88' ' ' LYS . 2.1 t60 -100.35 135.35 41.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.816 -1.179 . . . . 0.45000000000000001 107.816 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -145.39 130.55 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.075 0.768 . . . . 2.0899999999999999 113.075 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -111.34 125.9 54.34 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.224 -0.898 . . . . 2.2799999999999998 109.403 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -105.86 110.1 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 1.3799999999999999 109.534 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.12 86.03 25.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.744 0.646 . . . . 2.0 112.744 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 140.03 75.57 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.875 1.717 . . . . 0.23999999999999999 111.622 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 134' ' ' SER . 22.0 mt -132.13 156.14 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 1.0600000000000001 110.631 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 19.4 p -130.73 106.76 8.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.121 0.486 . . . . 1.6599999999999999 110.719 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 24.0 mt -107.08 121.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.602 -0.726 . . . . 1.0700000000000001 109.867 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.422 ' HZ1' ' HB3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -145.53 141.22 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.577 -0.283 . . . . 2.4300000000000002 110.571 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm 60.72 20.7 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.56 . . . . 3.5600000000000001 110.984 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.02 60.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.32000000000000001 113.151 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 3.6 mmmm -117.83 155.52 29.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.864 0.332 . . . . 2.6800000000000002 110.32 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.488 HD21 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -115.22 131.36 56.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.077 0.465 . . . . 1.1100000000000001 112.12 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.488 ' N ' HD21 ' A' ' 140' ' ' LEU . 20.8 t -117.9 111.2 18.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.63 -0.714 . . . . 1.3700000000000001 109.5 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.427 ' O ' HG11 ' A' ' 142' ' ' VAL . 6.5 p -107.33 102.27 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.03 -0.532 . . . . 1.23 111.218 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.29 -92.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.904 -0.589 . . . . 2.0499999999999998 111.66 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.44 6.21 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.59999999999999998 113.18 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.4 132.26 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.203 -0.295 . . . . 2.02 110.203 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.5 p -105.48 140.69 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.198 0.523 . . . . 1.8700000000000001 111.658 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.1 m -154.03 173.01 16.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.421 -0.809 . . . . 1.46 109.621 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.28 136.66 38.92 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.86 -0.336 . . . . 1.55 111.163 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.406 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 40.3 t80 -79.72 136.68 36.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.117 -1.068 . . . . 0.34000000000000002 108.117 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.2 m -148.56 95.11 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.835 -0.746 . . . . 2.02 112.495 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.84 -70.0 1.87 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.121 0.809 . . . . 0.77000000000000002 115.121 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.608 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -149.98 178.17 9.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.776 0.788 . . . . 2.3199999999999998 112.945 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.498 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -103.0 128.07 49.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.416 -1.327 . . . . 1.8600000000000001 107.416 177.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.7 t -117.16 118.45 32.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.359 1.244 . . . . 1.72 114.359 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 86.9 t -93.96 99.29 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.471 -0.937 . . . . 1.27 108.471 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.7 tt0 -109.69 129.04 55.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.588 -0.733 . . . . 2.48 111.763 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -121.71 135.6 54.95 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.018 -0.537 . . . . 1.9199999999999999 110.004 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.541 HG21 HH21 ' A' ' 105' ' ' ARG . 11.0 t -109.98 143.87 19.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.043 -0.98 . . . . 1.3899999999999999 111.482 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -59.17 143.37 49.11 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.167 -0.924 . . . . 2.48 111.09 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -120.39 -16.01 4.84 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.951 -0.642 . . . . 1.1200000000000001 111.912 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -156.44 -61.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 3.8999999999999999 110.148 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -177.54 151.2 0.73 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.835 -0.621 . . . . 4.0999999999999996 110.188 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.95 82.09 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.73 0.3 . . . . 1.3999999999999999 110.857 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.468 HD22 ' H ' ' A' ' 70' ' ' SER . 2.9 m-20 -47.3 159.02 0.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 2.0 110.325 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 164' ' ' ASN . 2.8 Cg_exo -32.22 102.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.39 2.06 . . . . 3.1099999999999999 111.711 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.588 ' NZ ' ' HB2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -56.9 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.026 -0.988 . . . . 4.1100000000000003 113.19 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.6 t -91.62 134.45 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 120.246 -0.582 . . . . 1.5900000000000001 112.295 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 4.7 t -130.89 136.47 48.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.818 -0.628 . . . . 1.8600000000000001 112.102 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 88' ' ' LYS . . . -129.42 34.44 4.37 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.304 0.853 . . . . 1.04 113.304 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -36.53 136.76 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.563 0.579 . . . . 1.6799999999999999 112.563 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.466 ' N ' HD12 ' A' ' 170' ' ' LEU . 1.1 t80 -154.84 101.68 2.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.791 -0.641 . . . . 0.38 110.777 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -109.09 128.14 65.22 Favored 'Isoleucine or valine' 0 C--O 1.262 1.761 0 CA-C-O 122.874 1.321 . . . . 1.3500000000000001 112.428 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.427 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.3 ppp? -121.35 166.61 13.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.423 -1.717 . . . . 1.26 109.636 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -120.37 153.24 36.77 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 115.262 1.579 . . . . 2.3599999999999999 115.262 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 92.1 -35.06 4.13 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 111.93 -2.395 . . . . 0.23000000000000001 117.725 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.579 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.94 159.91 0.63 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.035 1.918 . . . . 1.1000000000000001 113.962 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.597 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -85.17 -36.9 20.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.368 -0.833 . . . . 1.1000000000000001 111.688 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.42 . . . . 2.3100000000000001 111.966 -178.542 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.9 tp . . . . . 0 C--O 1.233 0.223 0 CA-C-O 121.258 0.552 . . . . 1.1299999999999999 110.496 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.505 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -56.75 -20.89 24.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.4 -0.818 . . . . 1.1299999999999999 110.985 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.6 -15.74 61.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 2.0899999999999999 111.754 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 41.4 mmtt -107.92 -27.08 10.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.852 -0.339 . . . . 2.5 111.486 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.505 HG11 ' O ' ' A' ' 7' ' ' ALA . 9.0 p -42.87 145.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 111.883 0.327 . . . . 1.05 111.883 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.07 -23.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 119.981 -0.688 . . . . 1.48 111.352 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.543 ' O ' HG23 ' A' ' 172' ' ' ILE . 27.0 t90 -172.25 127.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.773 -0.371 . . . . 0.33000000000000002 110.124 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.21 143.65 29.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.816 -0.175 . . . . 1.05 110.871 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -146.6 126.44 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 114.36 1.244 . . . . 1.3600000000000001 114.36 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.497 HD22 ' HG1' ' A' ' 63' ' ' THR . 14.6 t30 -115.3 95.11 5.02 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.165 -0.614 . . . . 1.8700000000000001 110.454 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.606 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . . . -67.53 116.16 7.95 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.525 -0.761 . . . . 1.1100000000000001 109.64 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 63' ' ' THR . . . 145.35 -51.8 0.6 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.706 -1.588 . . . . 0.67000000000000004 112.157 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.01 -143.8 15.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.896 -0.669 . . . . 1.1200000000000001 112.211 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.16 119.41 5.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.604 0.202 . . . . 2.02 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 80.6 p 36.36 99.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.76 0.663 . . . . 1.6499999999999999 112.584 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 76.4 t60 -122.85 151.94 41.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.267 -0.573 . . . . 0.41999999999999998 112.47 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -122.32 103.5 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.224 -0.898 . . . . 1.8200000000000001 109.784 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.7 153.43 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 1.1699999999999999 110.523 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.8 m -43.31 -52.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 124.217 0.948 . . . . 1.27 113.382 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -57.99 -18.74 25.84 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.12 0.486 . . . . 0.55000000000000004 110.609 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.32 36.29 3.38 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.435 -0.802 . . . . 0.32000000000000001 112.334 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -103.3 122.5 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.401 -0.592 . . . . 1.21 109.401 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.539 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.5 t60 -105.71 133.05 51.07 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 114.456 1.28 . . . . 0.68999999999999995 114.456 -176.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.617 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.2 134.6 41.81 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.323 -0.991 . . . . 3.3199999999999998 108.323 176.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 15.9 ptm180 -96.33 114.11 25.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.362 0.601 . . . . 3.3999999999999999 112.255 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -12.05 139.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.234 1.568 . . . . 3.1600000000000001 115.234 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 65' ' ' ARG . 8.3 p-10 -22.68 89.23 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 114.066 -1.425 . . . . 1.98 113.67 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 CA--C 1.534 0.519 0 C-N-CA 122.909 2.406 . . . . 1.53 113.454 179.24 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.669 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.2 tp . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 110.172 -0.307 . . . . 1.45 110.172 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' A' ' 50' ' ' ILE . 2.6 tt 130.67 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.869 1.667 . . . . 2.29 111.652 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.83 24.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.528 0.566 . . . . 3.0600000000000001 112.528 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -136.6 157.95 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.612 . . . . 1.4099999999999999 112.65 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLN . 35.8 t30 -70.86 153.16 94.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.05 -0.977 . . . . 1.96 108.788 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 59.7 Cg_exo -45.86 -59.53 1.16 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.499 1.466 . . . . 0.78000000000000003 112.872 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 1.3 pm0 -56.18 -54.84 40.39 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 122.174 0.988 . . . . 1.8200000000000001 111.026 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.407 ' OD1' HD22 ' A' ' 60' ' ' LEU . 19.4 t70 -69.51 -13.91 62.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.42 -0.809 . . . . 1.9099999999999999 110.958 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' ASN . 1.6 pt20 -65.27 -40.21 93.62 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.342 -1.725 . . . . 2.0600000000000001 106.342 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -56.16 -52.33 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.668 -1.151 . . . . 1.8500000000000001 109.145 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.4 tp -70.31 -9.14 55.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.209 -0.905 . . . . 1.6000000000000001 111.772 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.401 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 6.7 m-30 -119.7 15.08 12.71 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.458 0.646 . . . . 1.29 110.018 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.532 ' O ' ' O ' ' A' ' 63' ' ' THR . 7.8 tt0 -136.51 -105.37 0.2 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.911 -1.041 . . . . 1.8 110.249 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.57 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 37.4 p 4.6 121.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.485 0.92 . . . . 1.4099999999999999 113.485 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.472 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 9.5 pt-20 -111.59 150.74 29.63 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.067 0.765 . . . . 2.0499999999999998 113.067 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.473 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 1.3 ttt85 -137.25 88.39 2.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.119 -0.946 . . . . 4.2800000000000002 109.809 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -84.48 145.74 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 4.4699999999999998 111.464 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -117.95 -78.99 0.59 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.894 -0.594 . . . . 5.1500000000000004 110.805 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -155.98 -89.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.449 -0.342 . . . . 3.1699999999999999 111.029 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -157.57 155.35 30.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.384 0.135 . . . . 2.3900000000000001 110.77 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t 47.87 86.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.91 0.386 . . . . 1.3200000000000001 110.313 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.454 ' CE2' ' ND2' ' A' ' 164' ' ' ASN . 2.0 p90 -156.13 166.21 34.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 1.77 111.441 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.36 -174.92 43.27 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.923 -1.132 . . . . 0.98999999999999999 114.213 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 16' ' ' ALA . 4.0 m-85 -110.2 173.13 6.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 1.1899999999999999 112.265 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.5 137.14 53.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.804 -1.089 . . . . 2.27 110.212 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.478 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -128.32 87.62 54.78 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.975 0.361 . . . . 1.0700000000000001 111.975 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.94 131.35 44.97 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 121.815 1.677 . . . . 1.26 111.711 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 77' ' ' ILE . 65.4 mt -123.2 153.74 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.883 0.373 . . . . 1.0900000000000001 111.643 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -143.44 -0.51 1.09 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.036 -0.529 . . . . 3.4399999999999999 111.597 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.594 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 37.0 mt-10 -124.77 167.95 13.9 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 120.77 0.319 . . . . 2.1299999999999999 111.2 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -123.99 164.05 20.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.232 0.539 . . . . 0.37 110.877 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.9 -146.43 17.24 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 109.729 -1.349 . . . . 0.23000000000000001 109.729 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 10.8 mm-40 -103.93 108.37 19.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.685 1.243 . . . . 2.0299999999999998 109.146 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.594 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 3.9 m-85 -94.44 126.42 39.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.94999999999999996 108.73 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.646 HG22 ' N ' ' A' ' 177' ' ' ALA . 23.0 t -112.45 110.97 34.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.096 -0.956 . . . . 1.21 111.323 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -97.51 103.65 15.6 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.571 -1.195 . . . . 1.79 110.684 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.42 139.58 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.507 -1.224 . . . . 1.95 108.473 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.447 HD11 ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.38 152.3 40.51 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.838 -0.745 . . . . 2.0 111.826 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.563 ' HZ2' ' HB3' ' A' ' 128' ' ' ASP . 15.3 tptt -108.41 117.74 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.06 -0.656 . . . . 3.3799999999999999 110.615 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.9 m-85 -105.23 145.07 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.169 -1.049 . . . . 0.34999999999999998 108.169 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.47 0.54 0 C-N-CA 119.136 -1.025 . . . . 1.1499999999999999 113.53 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.406 ' HG2' ' NE2' ' A' ' 99' ' ' GLN . 8.5 tp-100 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.813 0.34 . . . . 3.6000000000000001 110.982 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.8 m -97.18 153.97 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 1.8899999999999999 111.056 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 54.75 55.93 7.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.576 . . . . 2.6899999999999999 111.277 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.406 ' NE2' ' HG2' ' A' ' 96' ' ' GLN . 9.2 tt0 -151.16 -51.09 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.128 -0.693 . . . . 3.0299999999999998 109.128 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 30.2 mmtm -90.48 78.26 6.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.729 -0.841 . . . . 3.52 108.729 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.49 111.72 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.587 -0.733 . . . . 1.95 110.437 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.66 178.79 4.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.219 0.822 . . . . 0.80000000000000004 113.219 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.8 139.97 53.45 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 115.83 -0.623 . . . . 2.0099999999999998 111.618 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.4 133.2 33.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 115.99 -0.55 . . . . 1.1599999999999999 111.752 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.608 HH21 HG22 ' A' ' 158' ' ' VAL . 1.0 OUTLIER -133.69 152.26 51.84 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 112.94 0.719 . . . . 2.1800000000000002 112.94 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.6 m -118.17 117.57 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.864 -1.062 . . . . 1.71 109.224 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.452 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 58.55 27.05 15.12 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.043 -0.725 . . . . 1.77 109.043 -176.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.69 20.52 43.66 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.976 -1.011 . . . . 0.40999999999999998 112.734 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.0 m-70 -118.18 109.59 16.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.076 0.769 . . . . 0.58999999999999997 113.076 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.4 p -62.91 118.28 7.56 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.543 -0.463 . . . . 1.2 111.207 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.82 -32.77 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.044 -0.724 . . . . 1.3999999999999999 109.044 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.9 91.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.905 -0.589 . . . . 1.21 109.822 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 16.9 ttmt -107.17 82.34 1.66 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.771 0.796 . . . . 2.9199999999999999 110.283 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.8 p30 151.8 39.8 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.975 -1.92 . . . . 2.5600000000000001 108.594 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.16 88.13 0.17 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.066 0.765 . . . . 1.71 113.066 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -103.29 86.13 2.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.366 -1.346 . . . . 1.99 107.366 175.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 46.0 mt -50.52 -44.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.806 -0.634 . . . . 1.23 112.095 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.73 -58.66 6.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 1.01 111.247 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.97 -27.03 64.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 0.76000000000000001 112.034 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -64.61 -59.63 4.06 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.286 0.476 . . . . 3.0299999999999998 112.286 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.23 -40.81 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.108 0.411 . . . . 2.0299999999999998 112.108 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.92 -129.45 3.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.566 -0.826 . . . . 1.0600000000000001 112.65 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -94.34 110.92 22.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 4.29 110.971 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.491 ' HG ' ' H ' ' A' ' 125' ' ' THR . 12.8 t 63.28 -130.56 0.47 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.843 -0.617 . . . . 2.1099999999999999 111.195 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 4.4 p 58.83 -166.72 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.659 0.266 . . . . 1.3300000000000001 110.351 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.5 135.05 49.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.969 0.729 . . . . 1.1200000000000001 112.969 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.47 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 2.2 t60 -112.54 148.88 33.57 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.812 -0.81 . . . . 0.45000000000000001 108.812 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.563 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 2.5 p-10 -144.47 135.53 25.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.896 0.702 . . . . 2.0899999999999999 112.896 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -124.38 122.02 36.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.483 -0.78 . . . . 2.2799999999999998 108.973 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.36 126.33 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.078 -0.51 . . . . 1.3799999999999999 110.736 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.1 mp -128.83 85.89 58.98 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.279 0.474 . . . . 2.0 112.279 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -62.04 143.28 94.82 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.628 1.552 . . . . 0.23999999999999999 111.413 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.483 HG21 ' N ' ' A' ' 134' ' ' SER . 32.7 mt -136.97 159.22 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 1.0600000000000001 110.941 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.483 ' N ' HG21 ' A' ' 133' ' ' ILE . 41.2 p -134.24 110.22 9.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.6599999999999999 111.195 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 18.0 mt -108.4 128.37 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.793 -0.639 . . . . 1.0700000000000001 110.121 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -146.04 140.64 26.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.321 . . . . 2.4300000000000002 110.86 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt 58.74 14.57 3.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 3.5600000000000001 111.369 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.94 21.15 34.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.622 -0.799 . . . . 0.32000000000000001 112.747 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 96.9 mttt -118.52 152.29 36.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.609 0.205 . . . . 2.6800000000000002 110.659 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.513 HD21 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.24 132.96 54.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.274 0.559 . . . . 1.1100000000000001 112.145 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.513 ' N ' HD21 ' A' ' 140' ' ' LEU . 23.6 t -121.11 109.17 14.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.477 -0.783 . . . . 1.3700000000000001 109.782 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -103.78 112.58 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.272 0.558 . . . . 1.23 111.019 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 54.19 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.704 -0.68 . . . . 2.0499999999999998 112.262 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.43 27.43 3.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.51 -0.852 . . . . 0.59999999999999998 113.176 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -133.8 138.96 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.187 -0.301 . . . . 2.02 110.187 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.52 137.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.106 0.479 . . . . 1.8700000000000001 111.294 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.6 m -159.32 129.68 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 1.46 109.885 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.5 p -59.14 143.21 49.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.207 -0.451 . . . . 1.55 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -79.3 139.18 37.91 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.301 -0.629 . . . . 0.34000000000000002 109.301 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 t -135.37 95.29 3.25 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.078 0.77 . . . . 2.02 113.078 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.48 -59.16 1.2 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.675 1.03 . . . . 0.77000000000000002 115.675 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.478 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -152.64 168.61 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.035 0.918 . . . . 2.3199999999999998 112.68 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.452 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -92.02 126.32 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.833 -1.173 . . . . 1.8600000000000001 107.833 177.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.3 t -114.95 117.85 31.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.517 0.932 . . . . 1.72 113.517 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 92.1 t -93.02 97.89 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.049 -0.723 . . . . 1.27 109.049 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.8 tt0 -104.91 141.08 37.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.546 -0.752 . . . . 2.48 110.717 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -131.04 145.48 52.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 1.9199999999999999 109.844 178.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.608 HG22 HH21 ' A' ' 105' ' ' ARG . 11.5 t -116.74 140.86 37.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.642 -0.708 . . . . 1.3899999999999999 110.662 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.24 148.57 26.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.444 -0.798 . . . . 2.48 111.946 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -124.5 -27.26 1.33 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.487 -0.779 . . . . 1.1200000000000001 111.666 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -175.22 51.22 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.729 0.3 . . . . 3.8999999999999999 110.339 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 62.41 159.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.141 -0.481 . . . . 4.0999999999999996 111.214 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 54.43 91.88 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.588 0.709 . . . . 1.3999999999999999 110.723 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -50.98 174.95 0.08 OUTLIER Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 114.137 -1.392 . . . . 2.0 109.517 178.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -42.49 -16.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.79 1.66 . . . . 3.1099999999999999 112.56 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.615 ' HZ1' ' HB3' ' A' ' 166' ' ' LYS . 1.5 mtpm? 75.73 -76.7 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.736 0.814 . . . . 4.1100000000000003 111.554 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 62' ' ' GLN . 7.4 t -83.72 131.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 C-N-CA 119.451 -0.899 . . . . 1.5900000000000001 111.117 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -133.76 123.48 24.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.093 0.871 . . . . 1.8600000000000001 111.569 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.419 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -119.83 36.94 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.64 -1.164 . . . . 1.04 113.76 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.53 131.77 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.903 0.335 . . . . 1.6799999999999999 111.903 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.477 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -150.38 99.45 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.38 110.395 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -109.16 124.57 65.93 Favored 'Isoleucine or valine' 0 C--O 1.262 1.727 0 CA-C-O 122.763 1.268 . . . . 1.3500000000000001 112.547 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.2 ptm -115.71 164.05 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.102 -1.408 . . . . 1.26 109.441 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 175' ' ' GLY . 1.7 tptp -120.31 137.93 53.98 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.688 1.366 . . . . 2.3599999999999999 114.688 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.15 -34.54 5.71 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 118.198 2.039 . . . . 0.23000000000000001 118.198 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.563 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.79 156.03 0.45 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.732 2.266 . . . . 1.1000000000000001 114.447 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.646 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -85.34 -21.82 28.74 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.099 -0.955 . . . . 1.1000000000000001 110.336 177.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.675 -0.693 . . . . 2.3100000000000001 111.434 -178.748 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 tp . . . . . 0 C--O 1.234 0.273 0 CA-C-O 121.284 0.564 . . . . 1.1299999999999999 110.43 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.555 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -56.38 -21.06 22.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.444 -0.798 . . . . 1.1299999999999999 110.585 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.33 -18.34 64.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.562 . . . . 2.0899999999999999 111.314 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.05 -28.4 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.916 -0.314 . . . . 2.5 111.549 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -44.54 145.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.839 -0.345 . . . . 1.05 111.683 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.7 pt -139.37 -23.44 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 120.222 -0.591 . . . . 1.48 111.137 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.506 ' O ' HG23 ' A' ' 172' ' ' ILE . 31.9 t90 -170.69 126.45 0.73 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.393 -0.523 . . . . 0.33000000000000002 110.355 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -144.41 141.07 29.41 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.675 -0.239 . . . . 1.05 111.275 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -147.18 126.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 114.028 1.122 . . . . 1.3600000000000001 114.028 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 22.2 t-20 -116.8 96.13 5.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.323 -0.551 . . . . 1.8700000000000001 110.933 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HB1' ' OH ' ' A' ' 73' ' ' TYR . . . -65.29 115.1 5.24 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 109.627 -0.508 . . . . 1.1100000000000001 109.627 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 162.62 -56.18 0.3 Allowed Glycine 0 N--CA 1.441 -0.992 0 O-C-N 124.093 0.871 . . . . 0.67000000000000004 113.855 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.51 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -115.19 -120.88 3.41 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.744 -0.741 . . . . 1.1200000000000001 112.946 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.77 ' N ' ' HH ' ' A' ' 29' ' ' TYR . 28.0 tt0 -154.74 120.28 5.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.89 0.33 . . . . 2.02 111.89 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 24.6 t 24.09 115.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.675 1.361 . . . . 1.6499999999999999 114.675 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.481 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 17.1 t60 -137.74 151.19 47.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.303 0.573 . . . . 0.41999999999999998 111.865 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.99 106.97 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.391 -0.822 . . . . 1.8200000000000001 111.507 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.09 153.96 42.13 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.292 -0.413 . . . . 1.1699999999999999 110.231 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.5 m -44.26 -53.07 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 113.445 0.905 . . . . 1.27 113.445 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -55.82 -19.88 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.194 0.521 . . . . 0.55000000000000004 110.565 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.38 35.01 3.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.407 -0.815 . . . . 0.32000000000000001 112.144 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.423 HG22 HD13 ' A' ' 27' ' ' ILE . 33.4 mm -102.75 120.52 52.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 1.21 109.454 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 10.3 t60 -103.52 129.12 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.335 1.235 . . . . 0.68999999999999995 114.335 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.77 ' HH ' ' N ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -100.82 139.44 36.51 Favored 'General case' 0 CA--C 1.524 -0.04 0 N-CA-C 107.468 -1.308 . . . . 3.3199999999999998 107.468 176.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.444 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 15.5 ptm180 -103.82 126.0 50.64 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.529 0.68 . . . . 3.3999999999999999 112.439 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 31' ' ' LYS . 4.5 tmmm? -20.32 141.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.445 1.498 . . . . 3.1600000000000001 114.708 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -27.86 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.072 -1.422 . . . . 1.98 112.467 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 C--N 1.349 0.605 0 C-N-CA 122.939 2.426 . . . . 1.53 114.627 -179.351 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 109.03 -0.73 . . . . 1.45 109.03 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' N ' HD11 ' A' ' 51' ' ' LEU . 10.0 mp -97.51 -37.46 9.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 2.29 112.897 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -82.36 38.94 0.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.594 0.59 . . . . 3.0600000000000001 112.594 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -153.3 165.97 34.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 1.4099999999999999 111.663 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.8 t30 -76.76 146.69 76.73 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.891 -0.595 . . . . 1.96 109.764 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.62 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.44 -55.62 1.83 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.466 2.111 . . . . 0.78000000000000003 114.272 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.627 ' O ' HG12 ' A' ' 59' ' ' VAL . 12.0 mm-40 -64.5 -56.76 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.721 0.772 . . . . 1.8200000000000001 111.167 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -70.58 -2.54 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.15 -0.62 . . . . 1.9099999999999999 110.304 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.62 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 14.5 tt0 -73.32 -56.15 5.45 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.701 -1.222 . . . . 2.0600000000000001 107.701 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 56' ' ' GLU . 11.0 p -52.46 -35.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.039 -1.097 . . . . 1.8500000000000001 108.039 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -65.18 -68.83 0.33 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.42 -0.512 . . . . 1.6000000000000001 110.1 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -54.12 -3.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.026 0.931 . . . . 1.29 111.9 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 63' ' ' THR . 26.7 tt0 -109.96 -113.92 0.31 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.585 -0.734 . . . . 1.8 110.351 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.577 ' O ' ' O ' ' A' ' 62' ' ' GLN . 57.2 p 29.87 123.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.699 1.37 . . . . 1.4099999999999999 114.699 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -127.26 147.44 50.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.868 -0.606 . . . . 2.0499999999999998 110.265 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.51 ' HG3' HH11 ' A' ' 65' ' ' ARG . 2.3 ptm180 -136.81 -173.25 3.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.686 0.279 . . . . 4.2800000000000002 110.45 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -49.21 148.95 2.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.371 0.508 . . . . 4.4699999999999998 112.371 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -135.43 -179.83 5.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 5.1500000000000004 110.525 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -156.6 -120.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.725 -0.216 . . . . 3.1699999999999999 111.106 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -153.29 129.33 10.33 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.468 0.175 . . . . 2.3900000000000001 110.823 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.621 ' H ' HD22 ' A' ' 164' ' ' ASN . 23.0 t 56.59 91.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.977 0.417 . . . . 1.3200000000000001 110.985 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -164.29 163.91 22.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.905 -0.588 . . . . 1.77 110.886 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.45 -174.27 37.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.15 -1.024 . . . . 0.98999999999999999 113.973 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.478 ' OH ' ' HB1' ' A' ' 16' ' ' ALA . 7.8 m-85 -108.51 165.98 11.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.44 0.638 . . . . 1.1899999999999999 112.138 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.74 126.97 51.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.824 -1.08 . . . . 2.27 110.218 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.495 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -118.43 87.53 31.01 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 111.835 0.309 . . . . 1.0700000000000001 111.835 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.12 133.62 58.9 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 121.929 1.753 . . . . 1.26 112.021 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 78' ' ' LYS . 24.1 mt -124.11 153.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.938 0.399 . . . . 1.0900000000000001 111.483 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 77' ' ' ILE . 59.0 mttp -140.85 0.98 1.64 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.888 -0.596 . . . . 3.4399999999999999 111.027 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.73 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 15.4 mm-40 -129.42 170.44 13.68 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.713 0.292 . . . . 2.1299999999999999 111.284 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -123.06 176.87 5.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.095 0.474 . . . . 0.37 111.242 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.36 -152.31 20.18 Favored Glycine 0 C--N 1.329 0.153 0 N-CA-C 109.868 -1.293 . . . . 0.23000000000000001 109.868 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.52 108.55 19.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.858 1.329 . . . . 2.0299999999999998 108.836 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.73 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.9 m-85 -95.01 126.95 40.7 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.578 0.704 . . . . 0.94999999999999996 109.677 -178.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.619 HG23 ' N ' ' A' ' 177' ' ' ALA . 13.9 t -113.6 118.49 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.787 -1.097 . . . . 1.21 111.831 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 105.37 17.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.521 -1.218 . . . . 1.79 111.572 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.64 126.47 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.78 -1.1 . . . . 1.95 108.966 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 129' ' ' GLU . 1.8 pt? -147.17 134.88 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.63 -0.828 . . . . 2.0 111.754 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.619 ' HZ2' ' HB3' ' A' ' 128' ' ' ASP . 5.3 tptp -98.02 120.74 38.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.317 -0.856 . . . . 3.3799999999999999 110.828 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.473 ' CD2' HD23 ' A' ' 115' ' ' LEU . 7.5 m-85 -105.09 136.54 44.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.757 -1.201 . . . . 0.34999999999999998 107.757 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 119.489 -0.884 . . . . 1.1499999999999999 113.074 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.448 ' HB2' ' HZ2' ' A' ' 100' ' ' LYS . 16.7 mt-30 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 120.897 0.38 . . . . 3.6000000000000001 111.069 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 98' ' ' GLN . 73.9 m -119.1 134.4 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.8899999999999999 111.254 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 97' ' ' SER . 15.3 mm100 71.43 -60.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.772 -0.649 . . . . 2.6899999999999999 111.554 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -45.48 -38.29 6.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.409 -0.36 . . . . 3.0299999999999998 111.139 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.687 ' HZ3' ' HB2' ' A' ' 100' ' ' LYS . 4.7 ttmp? -101.95 82.55 2.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.305 0.574 . . . . 3.52 110.778 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.77 139.91 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.293 -0.867 . . . . 1.95 109.618 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.442 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 61.6 m-85 -119.92 176.85 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.756 0.65 . . . . 0.80000000000000004 112.756 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.41 ' OD2' HG22 ' A' ' 110' ' ' THR . 5.7 t70 -127.15 140.43 52.26 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.213 0.53 . . . . 2.0099999999999998 112.31 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.89 136.45 55.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.052 -0.977 . . . . 1.1599999999999999 112.008 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 5.1 mtt180 -135.5 156.68 48.5 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 113.264 0.839 . . . . 2.1800000000000002 113.264 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.586 HG11 ' ND2' ' A' ' 107' ' ' ASN . 39.5 t -122.9 123.34 67.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 114.558 -1.201 . . . . 1.71 109.298 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.599 ' ND2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 53.59 26.1 5.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.556 -0.905 . . . . 1.77 108.556 -175.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.83 17.15 57.03 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.278 -0.873 . . . . 0.40999999999999998 112.74 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 88.9 m-70 -112.37 112.89 24.79 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.895 0.702 . . . . 0.58999999999999997 112.895 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.41 HG22 ' OD2' ' A' ' 103' ' ' ASP . 11.6 p -62.77 127.17 30.0 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.864 -0.734 . . . . 1.2 110.454 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.06 -30.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 1.3999999999999999 109.316 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.37 88.97 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.804 -0.814 . . . . 1.21 108.804 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -106.6 77.72 1.21 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.515 1.15 . . . . 2.9199999999999999 110.773 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 p30 159.44 38.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.348 -1.751 . . . . 2.5600000000000001 108.499 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.473 HD23 ' CD2' ' A' ' 89' ' ' PHE . 20.5 tp -79.36 91.64 5.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.172 0.805 . . . . 1.71 113.172 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -106.48 91.14 3.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.869 -1.16 . . . . 1.99 107.869 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.25 -32.42 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.995 0.739 . . . . 1.23 112.995 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.97 -51.56 15.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.737 -0.385 . . . . 1.01 111.303 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.27 -27.13 65.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.76000000000000001 111.913 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HE ' ' CE1' ' A' ' 127' ' ' HIS . 23.8 mmm180 -77.65 -58.6 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.688 0.625 . . . . 3.0299999999999998 112.688 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.52 -41.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.383 0.512 . . . . 2.0299999999999998 112.383 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.65 -125.66 6.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.438 -0.887 . . . . 1.0600000000000001 112.889 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -72.42 110.34 6.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.382 . . . . 4.29 111.372 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 61.5 m 48.41 -109.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 2.1099999999999999 111.685 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.1 p 50.31 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 1.3300000000000001 110.988 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.61 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . . . -114.16 138.42 50.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.287 0.565 . . . . 1.1200000000000001 112.234 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.543 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.6 t60 -108.0 151.06 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.075 -0.966 . . . . 0.45000000000000001 108.416 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.619 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 4.6 p-10 -136.85 136.51 38.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.772 0.656 . . . . 2.0899999999999999 112.772 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.405 ' O ' HD21 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -127.76 123.86 36.34 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.05 -0.977 . . . . 2.2799999999999998 109.668 178.004 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 53.2 mt -119.08 124.05 72.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.917 -0.583 . . . . 1.3799999999999999 110.396 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.9 mm -131.6 95.5 23.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.122 0.415 . . . . 2.0 112.122 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.99 148.84 93.05 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.646 1.564 . . . . 0.23999999999999999 111.309 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 134' ' ' SER . 21.3 mt -139.64 155.96 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.336 . . . . 1.0600000000000001 110.961 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 29.2 p -131.57 111.2 11.53 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.008 0.432 . . . . 1.6599999999999999 111.168 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 20.3 mt -112.06 127.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.649 -0.705 . . . . 1.0700000000000001 110.217 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -149.32 137.97 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.518 -0.31 . . . . 2.4300000000000002 111.005 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.681 ' HZ1' ' HB2' ' A' ' 137' ' ' LYS . 9.4 mtmp? 62.5 13.4 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.998 -0.546 . . . . 3.5600000000000001 111.468 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.61 7.64 58.89 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.59 -0.814 . . . . 0.32000000000000001 112.986 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -108.12 167.06 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.883 0.341 . . . . 2.6800000000000002 110.645 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.553 HD21 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -127.96 146.36 50.67 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.739 0.644 . . . . 1.1100000000000001 112.739 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.553 ' N ' HD21 ' A' ' 140' ' ' LEU . 23.1 t -132.2 109.7 10.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.027 -0.988 . . . . 1.3700000000000001 109.335 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.71 111.51 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.082 -0.508 . . . . 1.23 110.349 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 61.89 -89.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 2.0499999999999998 111.579 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.07 15.13 4.02 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.712 -0.756 . . . . 0.59999999999999998 112.77 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.42 130.93 57.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.089 -0.337 . . . . 2.02 110.089 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.3 131.82 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.184 0.516 . . . . 1.8700000000000001 110.966 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -149.59 175.37 11.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.637 -0.711 . . . . 1.46 109.496 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.4 p -99.52 138.88 35.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.7 -0.4 . . . . 1.55 111.418 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.059 -0.719 . . . . 0.34000000000000002 109.059 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 t -139.6 95.86 2.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.175 0.805 . . . . 2.02 113.175 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.29 -51.02 3.22 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 115.819 1.087 . . . . 0.77000000000000002 115.819 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.495 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -158.66 174.94 14.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.385 1.093 . . . . 2.3199999999999998 113.543 -177.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.599 ' HG ' ' ND2' ' A' ' 107' ' ' ASN . 1.1 tp -97.69 124.69 42.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.035 -1.439 . . . . 1.8600000000000001 107.123 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.4 t -114.35 116.93 29.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 118.739 -1.184 . . . . 1.72 113.443 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 47.0 t -95.61 98.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.741 -0.837 . . . . 1.27 108.741 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.3 tt0 -109.13 134.63 51.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.658 -0.701 . . . . 2.48 111.207 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -126.33 134.56 51.06 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.276 0.56 . . . . 1.9199999999999999 110.345 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.476 HG23 HH21 ' A' ' 105' ' ' ARG . 99.1 t -105.8 142.04 19.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 114.73 -1.123 . . . . 1.3899999999999999 110.815 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 143.01 44.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.429 -0.805 . . . . 2.48 111.57 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.76 -14.13 16.45 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.458 -0.657 . . . . 1.1200000000000001 111.458 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -158.98 -64.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 3.8999999999999999 110.281 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -176.72 161.9 2.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 4.0999999999999996 110.783 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 57.22 71.24 0.59 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 1.3999999999999999 111.282 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.621 HD22 ' H ' ' A' ' 70' ' ' SER . 5.8 m-20 -49.98 153.31 2.34 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.537 -0.756 . . . . 2.0 109.503 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.442 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -28.71 105.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.381 2.054 . . . . 3.1099999999999999 112.343 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -58.14 -74.0 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.149 -0.932 . . . . 4.1100000000000003 112.584 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 4.8 t -79.1 133.13 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 119.858 -0.737 . . . . 1.5900000000000001 111.281 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 5.2 t -129.12 124.48 34.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.084 -0.962 . . . . 1.8600000000000001 109.817 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.554 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . . . -117.47 35.46 4.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.652 0.982 . . . . 1.04 113.652 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -35.74 131.06 0.54 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.175 0.512 . . . . 1.6799999999999999 111.649 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.455 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -152.46 96.71 2.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.38 109.542 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 12' ' ' TRP . 0.9 OUTLIER -104.82 126.81 59.66 Favored 'Isoleucine or valine' 0 C--O 1.263 1.805 0 CA-C-O 122.625 1.202 . . . . 1.3500000000000001 112.583 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ptm -118.29 162.52 18.13 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.57 -1.65 . . . . 1.26 109.254 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.97 146.45 46.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.818 1.414 . . . . 2.3599999999999999 114.818 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.97 -35.44 5.0 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 112.469 -2.15 . . . . 0.23000000000000001 117.837 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.569 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 153.87 0.36 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.396 2.098 . . . . 1.1000000000000001 115.298 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.619 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -87.75 -31.8 19.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.379 -1.282 . . . . 1.1000000000000001 110.465 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 115.712 -0.677 . . . . 2.3100000000000001 111.63 -178.556 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.145 0.498 . . . . 1.1299999999999999 110.267 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.557 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -57.24 -20.67 28.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 1.1299999999999999 110.642 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.75 -18.29 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 2.0899999999999999 111.738 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HZ1' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -105.95 -27.04 11.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.776 -0.37 . . . . 2.5 111.091 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -45.43 146.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 120.979 -0.289 . . . . 1.05 111.311 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.24 -20.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 119.965 -0.694 . . . . 1.48 110.729 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.548 ' O ' HG21 ' A' ' 172' ' ' ILE . 13.1 t90 -173.51 129.33 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.028 -0.533 . . . . 0.33000000000000002 110.042 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.82 139.29 20.48 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 122.333 -0.229 . . . . 1.05 111.296 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.2 t -147.16 131.89 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 114.324 1.231 . . . . 1.3600000000000001 114.324 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 63.8 t30 -115.34 87.96 2.77 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 116.161 -0.472 . . . . 1.8700000000000001 110.822 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.483 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -57.97 112.21 1.43 Allowed 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.648 -0.706 . . . . 1.1100000000000001 110.046 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.518 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 143.97 -13.81 2.15 Favored Glycine 0 N--CA 1.442 -0.91 0 O-C-N 124.047 0.842 . . . . 0.67000000000000004 114.234 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.622 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -136.08 -131.06 2.97 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 119.961 -1.114 . . . . 1.1200000000000001 113.129 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.644 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 20.4 tt0 -160.99 120.01 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 2.02 111.45 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.6 m 26.4 104.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.921 -1.036 . . . . 1.6499999999999999 113.615 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.601 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.5 t60 -132.77 142.82 49.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 120.334 -0.546 . . . . 0.41999999999999998 112.404 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 22' ' ' VAL . 5.8 p -116.94 105.43 18.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 121.456 0.646 . . . . 1.8200000000000001 111.101 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.59 158.12 34.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.38 -0.827 . . . . 1.1699999999999999 110.512 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.2 m -42.95 -50.99 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.227 0.954 . . . . 1.27 113.261 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -57.33 -22.16 40.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.55000000000000004 110.42 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.54 34.72 3.5 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.228 -0.896 . . . . 0.32000000000000001 111.757 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 27' ' ' ILE . 26.5 mm -103.58 112.65 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.13 0.49 . . . . 1.21 110.403 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.1 t60 -97.59 139.01 34.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.485 1.291 . . . . 0.68999999999999995 114.485 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -104.76 138.02 41.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.458 -1.246 . . . . 3.3199999999999998 108.867 178.024 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 29.6 mtp180 -94.19 109.05 20.87 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.685 0.616 . . . . 3.3999999999999999 112.03 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 32' ' ' ASP . 81.2 tttt -24.05 132.16 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.176 1.176 . . . . 3.1600000000000001 114.176 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' LYS . 77.4 m-20 -2.41 80.11 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.701 1.2 . . . . 1.98 113.998 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.456 -0.685 0 C-N-CA 123.549 2.832 . . . . 1.53 112.561 179.26 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.1 mp . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 109.779 -0.452 . . . . 1.45 109.779 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.439 ' N ' HD21 ' A' ' 51' ' ' LEU . 3.8 mm? -87.11 -60.46 1.97 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.796 1.036 . . . . 2.29 113.796 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -71.76 32.84 0.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.408 0.892 . . . . 3.0600000000000001 113.408 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 t -138.16 140.76 40.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.327 0.491 . . . . 1.4099999999999999 112.327 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.502 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 6.9 t30 -62.27 145.76 93.55 Favored Pre-proline 0 C--O 1.22 -0.451 0 CA-C-N 115.538 -0.755 . . . . 1.96 109.225 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.584 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 11.3 Cg_exo -39.57 -51.18 2.89 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.594 2.196 . . . . 0.78000000000000003 115.425 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.44 -56.19 12.15 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 122.407 1.098 . . . . 1.8200000000000001 110.911 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.58 59.94 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.866 -1.061 . . . . 1.9099999999999999 109.85 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 29.4 tt0 -64.49 -45.68 86.29 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.614 -1.625 . . . . 2.0600000000000001 106.614 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 63' ' ' THR . 96.7 t -57.1 -54.4 30.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.455 -1.248 . . . . 1.8500000000000001 109.99 177.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.9 tp -64.62 -12.75 48.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.9 -0.591 . . . . 1.6000000000000001 112.087 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.466 ' CZ ' ' HE2' ' A' ' 88' ' ' LYS . 4.1 m-30 -108.52 -2.0 19.26 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.916 -0.584 . . . . 1.29 110.21 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.606 ' HG2' ' N ' ' A' ' 63' ' ' THR . 36.7 tt0 -123.58 -107.61 0.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.539 -0.755 . . . . 1.8 112.033 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.606 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 48.2 p 42.08 -168.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.489 -0.323 . . . . 1.4099999999999999 110.994 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.518 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 177.71 128.4 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.977 0.417 . . . . 2.0499999999999998 111.77 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.54 ' NH2' ' HB2' ' A' ' 67' ' ' ASN . 2.2 ttp85 -112.74 -170.97 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.103 -0.499 . . . . 4.2800000000000002 110.336 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -162.91 138.12 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.618 0.247 . . . . 4.4699999999999998 111.128 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.54 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 48.7 t-20 -130.8 -82.54 0.53 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.415 -0.357 . . . . 5.1500000000000004 110.944 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.91 -75.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.549 0.214 . . . . 3.1699999999999999 111.349 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -163.82 143.26 8.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.682 -0.235 . . . . 2.3900000000000001 110.69 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t 50.55 83.42 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.765 0.317 . . . . 1.3200000000000001 110.158 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.434 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 29.9 p90 -150.2 151.65 33.4 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.224 0.535 . . . . 1.77 111.632 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -169.23 -169.37 32.49 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.268 -0.878 . . . . 0.98999999999999999 113.675 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.483 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 1.2 m-85 -102.15 177.73 4.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.578 0.955 . . . . 1.1899999999999999 113.578 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.68 120.89 21.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.661 -1.609 . . . . 2.27 109.663 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.42 HD13 ' N ' ' A' ' 75' ' ' ILE . 4.2 mp -110.99 90.66 11.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.241 0.46 . . . . 1.0700000000000001 112.241 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.7 141.28 90.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.097 1.198 . . . . 1.26 111.118 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.35 151.87 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 1.0900000000000001 111.32 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -144.63 2.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 3.4399999999999999 110.839 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HB2' ' HZ2' ' A' ' 174' ' ' LYS . 15.9 mm-40 -127.33 175.17 8.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.589 0.233 . . . . 2.1299999999999999 110.663 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -131.71 170.33 14.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.37 111.654 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.59 -154.64 22.65 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 109.569 -1.412 . . . . 0.23000000000000001 109.569 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -96.41 109.66 22.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.976 1.388 . . . . 2.0299999999999998 108.929 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.577 ' HH ' ' HZ2' ' A' ' 174' ' ' LYS . 2.1 m-85 -96.08 126.45 41.32 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.769 -0.826 . . . . 0.94999999999999996 108.769 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.611 ' HB ' ' SD ' ' A' ' 173' ' ' MET . 21.2 t -112.59 113.07 43.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.901 -1.045 . . . . 1.21 111.57 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.443 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.4 tt -89.78 103.75 16.37 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.641 -1.163 . . . . 1.79 109.66 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.62 134.44 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.404 -0.816 . . . . 1.95 108.859 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.488 HD11 ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -147.05 154.94 41.78 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.783 -0.767 . . . . 2.0 112.018 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.657 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.89 119.12 37.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.767 -0.652 . . . . 3.3799999999999999 110.172 178.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 7.7 m-85 -105.68 137.74 43.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.918 -0.583 . . . . 0.34999999999999998 109.531 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.537 ' O ' HG11 ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.325 -0.477 0 N-CA-C 110.235 -0.283 . . . . 1.1499999999999999 110.235 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.687 0.279 . . . . 3.6000000000000001 110.631 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -97.7 162.38 13.3 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.158 0.504 . . . . 1.8899999999999999 111.356 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.542 ' C ' ' H ' ' A' ' 100' ' ' LYS . 1.9 mp0 55.63 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.88 -1.054 . . . . 2.6899999999999999 110.818 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 71.33 -30.34 0.21 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.966 -1.016 . . . . 3.0299999999999998 110.602 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 98' ' ' GLN . 66.4 mmtt -108.52 63.1 0.61 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.537 -0.912 . . . . 3.52 108.537 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.4 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 1.1 m -109.11 150.78 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.262 -0.881 . . . . 1.95 110.532 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -118.62 178.32 4.51 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 112.843 0.683 . . . . 0.80000000000000004 112.843 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.67 137.67 52.57 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.062 -0.517 . . . . 2.0099999999999998 111.176 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.88 127.01 51.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 115.89 -0.595 . . . . 1.1599999999999999 111.952 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -128.31 141.44 51.44 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.141 -0.936 . . . . 2.1800000000000002 113.269 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.2 m -116.93 118.76 59.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 114.149 -1.387 . . . . 1.71 109.583 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 61.92 28.5 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.882 -0.784 . . . . 1.77 108.882 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.38 89.91 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.40999999999999998 111.369 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.691 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 58.6 m-70 -102.62 109.15 20.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.759 -0.721 . . . . 0.58999999999999997 112.209 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -68.44 133.42 48.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.477 0.656 . . . . 1.2 112.052 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -31.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.896 -1.047 . . . . 1.3999999999999999 109.636 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.25 91.03 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.197 -0.668 . . . . 1.21 109.197 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 3.3 ptpp? -109.18 77.28 1.05 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.692 1.234 . . . . 2.9199999999999999 112.24 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.1 p30 153.53 40.15 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.197 -2.274 . . . . 2.5600000000000001 109.353 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.18 94.42 0.07 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.247 0.546 . . . . 1.71 112.187 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -102.98 84.11 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.932 -1.507 . . . . 1.99 106.932 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.3 mt -50.32 -41.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.104 -0.953 . . . . 1.23 112.628 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.01 -45.73 87.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.667 0.27 . . . . 1.01 111.482 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.11 -28.82 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.211 0.449 . . . . 0.76000000000000001 112.211 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -68.35 -58.44 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.437 0.532 . . . . 3.0299999999999998 112.437 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.4 p -94.39 -37.1 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.867 0.321 . . . . 2.0299999999999998 111.867 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.16 -114.54 2.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.399 -0.905 . . . . 1.0600000000000001 112.878 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.468 ' O ' HG23 ' A' ' 125' ' ' THR . 57.3 t-80 -104.6 114.05 28.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.714 0.292 . . . . 4.29 111.172 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.3 p 53.3 -143.22 0.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.006 -0.543 . . . . 2.1099999999999999 111.316 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.0 p 64.36 -171.73 0.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.624 0.37 . . . . 1.3300000000000001 110.996 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -104.71 139.54 39.37 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.692 0.626 . . . . 1.1200000000000001 112.692 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.533 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.8 t60 -102.91 152.02 21.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.209 -0.905 . . . . 0.45000000000000001 109.075 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.533 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 1.6 p-10 -144.2 132.89 22.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.635 0.605 . . . . 2.0899999999999999 112.635 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -127.65 128.42 45.46 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 2.2799999999999998 109.893 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.4 mt -117.13 122.03 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.058 -0.519 . . . . 1.3799999999999999 110.496 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mm -124.93 89.71 52.15 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.392 -0.367 . . . . 2.0 111.928 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -60.52 143.12 99.42 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.928 1.752 . . . . 0.23999999999999999 111.918 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 134' ' ' SER . 24.1 mt -134.94 156.54 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 1.0600000000000001 110.367 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.442 ' N ' HG22 ' A' ' 133' ' ' ILE . 25.0 p -130.51 106.51 8.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.938 0.399 . . . . 1.6599999999999999 111.015 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 19.2 mt -107.7 122.98 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 1.0700000000000001 110.222 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.54 140.57 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 2.4300000000000002 110.804 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp 61.49 26.54 16.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.904 -0.589 . . . . 3.5600000000000001 110.82 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.72 27.75 60.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.898 -0.668 . . . . 0.32000000000000001 113.004 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 73.3 mttt -126.15 151.62 47.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.832 0.316 . . . . 2.6800000000000002 111.321 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.541 HD21 ' N ' ' A' ' 141' ' ' SER . 5.3 tt -111.24 129.52 55.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 1.1100000000000001 111.856 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.541 ' N ' HD21 ' A' ' 140' ' ' LEU . 18.3 m -117.35 109.41 16.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 1.3700000000000001 109.658 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.99 105.86 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.255 0.55 . . . . 1.23 111.173 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 56.63 -90.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.823 -0.626 . . . . 2.0499999999999998 111.976 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.77 24.95 4.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.468 -0.873 . . . . 0.59999999999999998 113.537 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -134.16 135.13 42.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.811 0.306 . . . . 2.02 110.178 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.33 139.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.093 0.473 . . . . 1.8700000000000001 111.132 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.2 t -161.35 127.83 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 1.46 109.993 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.6 p -53.69 143.72 19.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 1.55 111.68 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.31 124.81 28.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.914 -0.773 . . . . 0.34000000000000002 108.914 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 t -115.96 92.32 3.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.073 0.768 . . . . 2.02 113.073 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.06 -34.09 0.05 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 117.376 1.71 . . . . 0.77000000000000002 117.376 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.484 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.63 158.42 28.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.598 1.699 . . . . 2.3199999999999998 113.885 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.484 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -96.16 124.78 40.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.618 -1.253 . . . . 1.8600000000000001 107.618 176.089 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -108.09 142.34 38.43 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 113.904 1.075 . . . . 1.72 113.904 -176.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 64.6 t -129.67 97.8 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.54 . . . . 1.27 109.909 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 60.7 mm-40 -112.66 128.92 56.52 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.137 -0.938 . . . . 2.48 111.495 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -116.1 133.54 55.91 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.375 -0.602 . . . . 1.9199999999999999 109.375 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 t -108.79 142.86 20.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 115.303 -0.862 . . . . 1.3899999999999999 111.569 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -63.58 148.52 48.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.669 -1.151 . . . . 2.48 111.634 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -111.82 -10.34 19.0 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.744 -0.662 . . . . 1.1200000000000001 111.652 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -153.5 -51.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 3.8999999999999999 110.397 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -171.39 -64.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.151 -0.477 . . . . 4.0999999999999996 110.626 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.55 117.52 20.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.989 -0.551 . . . . 1.3999999999999999 110.809 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.452 ' C ' ' H ' ' A' ' 166' ' ' LYS . 2.1 m120 -60.09 -178.53 0.15 Allowed Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.211 -0.904 . . . . 2.0 109.506 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -48.18 -8.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.905 1.737 . . . . 3.1099999999999999 113.915 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 164' ' ' ASN . 27.6 tptt 76.64 -75.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.656 0.383 . . . . 4.1100000000000003 111.652 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.537 HG11 ' O ' ' A' ' 90' ' ' ALA . 2.0 m -111.95 137.1 45.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 C-N-CA 119.795 -0.762 . . . . 1.5900000000000001 111.562 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.8 t -131.88 122.54 25.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.738 -1.119 . . . . 1.8600000000000001 112.085 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.461 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -106.19 38.34 2.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.163 -0.926 . . . . 1.04 113.381 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -35.49 133.93 0.34 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.963 0.357 . . . . 1.6799999999999999 111.963 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.518 ' N ' HD13 ' A' ' 170' ' ' LEU . 0.6 OUTLIER -154.16 94.92 1.78 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.148 -0.478 . . . . 0.38 110.843 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.548 HG21 ' O ' ' A' ' 12' ' ' TRP . 6.1 tt -104.19 131.44 53.0 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 CA-C-O 122.643 1.211 . . . . 1.3500000000000001 112.547 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.611 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -122.15 166.6 14.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.858 -1.519 . . . . 1.26 110.416 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -116.1 150.57 37.13 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.959 1.466 . . . . 2.3599999999999999 114.959 -177.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 90.51 -34.49 4.16 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 112.105 -2.316 . . . . 0.23000000000000001 118.176 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.583 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.71 162.07 0.7 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.225 2.012 . . . . 1.1000000000000001 114.187 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.592 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -85.54 -23.58 27.63 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 115.029 -0.987 . . . . 1.1000000000000001 110.968 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 2.3100000000000001 111.496 -179.047 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 tp . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.29 0.567 . . . . 1.1299999999999999 110.402 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.52 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -56.7 -21.09 25.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.309 -0.859 . . . . 1.1299999999999999 111.466 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.24 -16.03 59.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.167 0.432 . . . . 2.0899999999999999 112.167 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -105.23 -28.62 10.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.665 -0.414 . . . . 2.5 111.002 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -40.1 144.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 111.772 0.286 . . . . 1.05 111.772 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.69 -23.75 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.071 -0.652 . . . . 1.48 111.073 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.479 ' O ' HG21 ' A' ' 172' ' ' ILE . 25.4 t90 -173.09 137.98 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.972 -0.381 . . . . 0.33000000000000002 109.972 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -157.27 145.95 19.66 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.343 -0.143 . . . . 1.05 111.121 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.9 t -147.35 124.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 114.075 1.139 . . . . 1.3600000000000001 114.075 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -115.4 101.23 8.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.457 -0.497 . . . . 1.8700000000000001 110.807 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.89 104.74 1.42 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 108.614 -0.884 . . . . 1.1100000000000001 108.614 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.62 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 165.68 -63.78 0.22 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 124.718 1.261 . . . . 0.67000000000000004 112.426 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.0 -131.07 5.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.859 -0.686 . . . . 1.1200000000000001 112.121 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -168.83 119.8 0.75 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.118 -0.327 . . . . 2.02 110.118 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 69.7 m 42.13 83.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.937 -0.574 . . . . 1.6499999999999999 111.068 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.576 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 26.3 t60 -116.89 143.78 45.29 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.036 -0.666 . . . . 0.41999999999999998 112.543 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.59 104.32 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.477 -0.783 . . . . 1.8200000000000001 110.151 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -71.85 157.09 38.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.346 -0.388 . . . . 1.1699999999999999 110.448 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 m -43.95 -51.02 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.255 0.972 . . . . 1.27 113.44 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -58.09 -20.09 37.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.314 0.578 . . . . 0.55000000000000004 110.104 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . 102.94 35.12 3.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.138 -0.937 . . . . 0.32000000000000001 111.987 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.439 HG23 HD11 ' A' ' 27' ' ' ILE . 28.4 mm -103.34 123.17 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.98 -0.378 . . . . 1.21 109.98 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.576 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.4 t60 -100.97 132.23 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.86 1.059 . . . . 0.68999999999999995 113.86 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.667 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 128.89 42.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.114 -1.069 . . . . 3.3199999999999998 108.114 177.228 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -82.72 110.31 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.833 0.708 . . . . 3.3999999999999999 112.12 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' C ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 tmmm? -22.96 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.83 1.252 . . . . 3.1600000000000001 113.708 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -20.05 88.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 114.55 -1.205 . . . . 1.98 113.551 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 CA--C 1.535 0.559 0 C-N-CA 122.714 2.276 . . . . 1.53 113.765 179.392 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.414 ' N ' HD11 ' A' ' 50' ' ' ILE . 1.1 mp . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 109.183 -0.673 . . . . 1.45 109.183 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -54.3 -55.25 30.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.305 -0.861 . . . . 2.29 112.957 -177.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.42 31.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.81 0.67 . . . . 3.0600000000000001 112.81 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 51' ' ' LEU . 23.0 t -147.07 134.95 21.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 1.4099999999999999 111.707 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -69.51 159.76 82.23 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.358 -0.608 . . . . 1.96 109.358 178.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.445 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.8 Cg_exo -40.87 -39.5 3.24 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.532 2.155 . . . . 0.78000000000000003 115.408 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.51 -56.9 4.07 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.56 0.695 . . . . 1.8200000000000001 111.351 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 18.5 p-10 -69.48 -4.89 20.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.747 -0.781 . . . . 1.9099999999999999 109.057 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 14.3 tt0 -73.97 -64.04 1.09 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.281 -0.872 . . . . 2.0600000000000001 108.996 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.11 -35.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 1.8500000000000001 109.322 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 4.5 tp -69.04 -64.98 0.77 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.788 -0.819 . . . . 1.6000000000000001 108.788 176.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -69.55 22.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.673 -1.149 . . . . 1.29 113.177 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -143.94 -65.33 0.36 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.158 1.17 . . . . 1.8 114.158 -178.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -39.98 148.03 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.108 0.781 . . . . 1.4099999999999999 113.108 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -134.47 152.11 51.58 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.803 -0.635 . . . . 2.0499999999999998 111.101 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.62 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 35.9 mtp85 -105.16 -169.51 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.773 0.321 . . . . 4.2800000000000002 110.794 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -86.6 -171.47 3.55 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.159 -0.473 . . . . 4.4699999999999998 111.16 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.9 m120 64.53 156.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.283 -0.417 . . . . 5.1500000000000004 110.937 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.49 84.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.175 0.435 . . . . 3.1699999999999999 112.175 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -175.19 125.46 0.25 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.271 -0.171 . . . . 2.3900000000000001 111.182 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 t 37.83 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.415 0.447 . . . . 1.3200000000000001 110.963 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.523 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -90.36 104.76 17.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.203 -0.453 . . . . 1.77 109.817 -178.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 155' ' ' VAL . . . -120.06 108.57 1.48 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 119.703 -1.237 . . . . 0.98999999999999999 115.355 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.0 154.7 18.73 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.069 0.461 . . . . 1.1899999999999999 110.817 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.27 134.35 54.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.38 -0.827 . . . . 2.27 110.831 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.523 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -127.94 86.96 56.88 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.514 -0.312 . . . . 1.0700000000000001 111.394 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -55.58 128.35 30.01 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.856 1.704 . . . . 1.26 112.357 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.403 HD11 HG23 ' A' ' 77' ' ' ILE . 63.2 mt -121.98 150.93 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.898 0.38 . . . . 1.0900000000000001 111.154 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.07 -1.42 1.38 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.034 -0.53 . . . . 3.4399999999999999 111.125 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.611 ' HB2' ' HZ3' ' A' ' 174' ' ' LYS . 43.1 mt-10 -125.85 169.38 12.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.783 0.325 . . . . 2.1299999999999999 110.924 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.1 mp0 -120.93 -180.0 4.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.37 111.103 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.67 -148.36 17.2 Favored Glycine 0 CA--C 1.509 -0.322 0 N-CA-C 110.062 -1.215 . . . . 0.23000000000000001 110.062 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.9 mm-40 -104.09 110.97 23.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.577 1.189 . . . . 2.0299999999999998 109.488 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.587 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 4.1 m-85 -95.97 126.79 41.46 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.506 -0.924 . . . . 0.94999999999999996 108.506 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.62 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.8 t -112.24 113.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.449 -0.796 . . . . 1.21 111.342 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -97.79 104.49 16.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.684 -1.144 . . . . 1.79 111.008 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 14.3 t -111.56 142.01 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.755 -1.111 . . . . 1.95 108.77 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -149.67 144.12 25.93 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.33 -0.948 . . . . 2.0 112.105 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.455 ' H ' ' HB2' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -101.72 121.95 43.0 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.082 -0.647 . . . . 3.3799999999999999 110.108 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.34 142.2 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.813 -0.81 . . . . 0.34999999999999998 108.813 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 120.474 -0.49 . . . . 1.1499999999999999 110.924 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.412 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 49.9 tp60 . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 121.052 0.454 . . . . 3.6000000000000001 111.609 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -107.03 164.26 12.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.645 . . . . 1.8899999999999999 110.908 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 68.14 -70.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.998 -0.546 . . . . 2.6899999999999999 111.72 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -46.67 -32.08 3.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.692 0.282 . . . . 3.0299999999999998 111.313 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.685 ' HB3' ' HZ3' ' A' ' 100' ' ' LYS . 9.6 mtpm? -91.4 62.9 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 3.52 110.708 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.31 134.41 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.814 0.34 . . . . 1.95 110.206 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.448 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 78.6 m-85 -131.75 -179.28 5.3 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.565 0.58 . . . . 0.80000000000000004 112.565 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.426 ' OD2' HG21 ' A' ' 110' ' ' THR . 7.9 t70 -126.06 143.94 50.92 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.653 -0.419 . . . . 2.0099999999999998 112.123 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.0 OUTLIER -134.15 137.83 51.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 115.67 -0.695 . . . . 1.1599999999999999 111.824 -178.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.521 HH21 HG23 ' A' ' 158' ' ' VAL . 10.0 mtt180 -136.77 151.88 49.69 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 113.204 0.816 . . . . 2.1800000000000002 113.204 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 30.6 m -114.23 114.67 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 114.949 -1.023 . . . . 1.71 108.839 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.652 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 60.1 27.18 16.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.508 -0.769 . . . . 1.77 109.384 -176.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.22 20.18 39.59 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.605 -1.18 . . . . 0.40999999999999998 112.744 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.3 m-70 -119.42 109.56 15.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.925 0.713 . . . . 0.58999999999999997 112.925 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.426 HG21 ' OD2' ' A' ' 103' ' ' ASP . 31.4 p -56.19 135.82 53.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.219 0.533 . . . . 1.2 111.437 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.5 t -132.94 -29.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.276 -0.875 . . . . 1.3999999999999999 108.913 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.16 90.07 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.21 109.662 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 4.1 ptpp? -108.04 98.38 7.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.014 0.911 . . . . 2.9199999999999999 110.818 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 6.2 m-20 138.72 33.85 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.293 -2.231 . . . . 2.5600000000000001 108.198 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.08 89.47 0.06 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 112.852 0.686 . . . . 1.71 112.852 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.2 t70 -106.35 86.6 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.429 -1.323 . . . . 1.99 107.429 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.3 mt -50.96 -42.22 23.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.275 -0.875 . . . . 1.23 112.55 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -60.2 -49.27 78.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.85 0.315 . . . . 1.01 111.85 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.66 -27.52 65.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.869 0.322 . . . . 0.76000000000000001 111.869 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -64.69 -58.65 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.129 0.418 . . . . 3.0299999999999998 112.129 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.83 -40.53 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.054 0.391 . . . . 2.0299999999999998 112.054 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.76 -100.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 1.0600000000000001 111.793 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -114.69 110.76 20.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.728 0.299 . . . . 4.29 110.6 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.5 t 60.0 -124.84 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.16 -0.473 . . . . 2.1099999999999999 110.755 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.4 p 54.83 -175.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 1.3300000000000001 111.664 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -104.91 138.08 41.69 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.95 0.722 . . . . 1.1200000000000001 112.95 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.448 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.7 t60 -110.24 143.15 40.84 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.255 -1.017 . . . . 0.45000000000000001 108.255 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.448 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 5.2 p-10 -144.34 126.43 15.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.107 0.781 . . . . 2.0899999999999999 113.107 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.8 126.75 55.41 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.743 -0.662 . . . . 2.2799999999999998 109.41 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.37 117.86 54.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.584 -0.735 . . . . 1.3799999999999999 109.766 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.7 mt -127.14 87.78 55.76 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.186 0.81 . . . . 2.0 113.186 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -62.32 146.36 95.79 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.764 1.642 . . . . 0.23999999999999999 111.73 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 134' ' ' SER . 29.8 mt -137.34 157.84 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 1.0600000000000001 110.398 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.45 ' N ' HG22 ' A' ' 133' ' ' ILE . 58.6 p -134.09 109.39 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.059 0.457 . . . . 1.6599999999999999 111.513 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 14.2 mt -108.12 128.16 63.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 115.679 -0.692 . . . . 1.0700000000000001 109.82 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -148.59 142.81 26.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 2.4300000000000002 110.912 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm 60.38 15.73 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 3.5600000000000001 111.334 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.87 16.04 55.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.581 -0.818 . . . . 0.32000000000000001 113.204 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.4 ' HA ' ' H ' ' A' ' 149' ' ' PHE . 96.5 mttt -120.5 158.95 26.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.126 0.463 . . . . 2.6800000000000002 111.057 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.511 HD21 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.44 138.93 48.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.09 0.472 . . . . 1.1100000000000001 112.19 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.511 ' N ' HD21 ' A' ' 140' ' ' LEU . 23.1 t -125.32 114.96 19.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.576 -0.738 . . . . 1.3700000000000001 109.589 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 142' ' ' VAL . 3.4 p -111.93 99.8 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.402 0.62 . . . . 1.23 111.435 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 60.3 -86.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.537 -0.756 . . . . 2.0499999999999998 112.401 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.64 16.03 5.93 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.511 -0.852 . . . . 0.59999999999999998 113.088 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.57 134.27 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.785 0.326 . . . . 2.02 110.416 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.68 137.98 32.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.478 . . . . 1.8700000000000001 111.156 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 m -159.69 119.69 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 1.46 109.419 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.0 t -53.69 146.48 13.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.564 . . . . 1.55 112.042 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.4 ' H ' ' HA ' ' A' ' 139' ' ' LYS . 37.2 t80 -79.63 142.49 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.12 -0.946 . . . . 0.34000000000000002 110.031 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.3 p -139.38 95.94 3.01 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.967 0.728 . . . . 2.02 112.967 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.56 -60.5 2.43 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 115.66 1.024 . . . . 0.77000000000000002 115.66 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.97 164.78 36.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.943 0.872 . . . . 2.3199999999999998 112.553 -178.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.458 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -82.16 134.85 35.33 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.119 -1.437 . . . . 1.8600000000000001 107.119 177.084 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.652 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -121.78 103.92 9.21 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.502 1.297 . . . . 1.72 114.502 -174.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.437 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -93.53 126.32 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.96 -0.385 . . . . 1.27 109.96 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 42.0 mt-10 -137.41 127.43 25.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.112 0.412 . . . . 2.48 112.112 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.93 120.08 41.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.408 -0.96 . . . . 1.9199999999999999 108.408 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.521 HG23 HH21 ' A' ' 105' ' ' ARG . 9.7 t -91.09 143.6 10.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.324 0.583 . . . . 1.3899999999999999 111.532 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -57.31 147.96 24.19 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 114.728 -1.124 . . . . 2.48 111.501 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.21 -7.53 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.79 -0.641 . . . . 1.1200000000000001 111.918 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -151.59 -70.28 0.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.573 0.225 . . . . 3.8999999999999999 110.533 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -176.19 -64.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.362 -0.381 . . . . 4.0999999999999996 110.566 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.75 76.59 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 1.3999999999999999 110.89 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.425 ' HA ' ' CE1' ' A' ' 102' ' ' PHE . 5.8 m-20 -48.35 156.0 0.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.266 -0.879 . . . . 2.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.448 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.71 101.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.457 2.105 . . . . 3.1099999999999999 112.395 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -60.14 -45.57 92.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.623 -0.717 . . . . 4.1100000000000003 112.283 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.24 133.63 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 120.337 -0.545 . . . . 1.5900000000000001 111.841 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.8 t -131.92 136.78 47.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 115.945 -0.571 . . . . 1.8600000000000001 111.449 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 88' ' ' LYS . . . -127.55 35.67 4.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.382 0.882 . . . . 1.04 113.382 -178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.12 130.92 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.205 0.316 . . . . 1.6799999999999999 110.902 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 1.1 t80 -150.84 101.97 2.95 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.38 110.864 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.479 HG21 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -111.63 129.69 66.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.66 0 CA-C-O 122.815 1.293 . . . . 1.3500000000000001 112.854 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.538 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -123.24 168.19 12.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.546 -1.661 . . . . 1.26 109.965 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.656 ' HZ2' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -118.98 152.41 36.43 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.715 1.746 . . . . 2.3599999999999999 115.715 -176.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 88.17 -34.68 3.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 111.82 -2.446 . . . . 0.23000000000000001 118.193 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.549 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.63 158.98 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.209 2.004 . . . . 1.1000000000000001 114.252 -179.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.62 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.75 -10.31 55.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.376 -0.829 . . . . 1.1000000000000001 110.712 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 2.3100000000000001 111.28 -178.479 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 tp . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.266 0.555 . . . . 1.1299999999999999 110.531 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.532 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -58.25 -21.11 47.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.373 -0.831 . . . . 1.1299999999999999 111.347 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.51 -16.29 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 2.0899999999999999 111.703 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -109.48 -26.15 10.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.661 -0.416 . . . . 2.5 111.657 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -42.5 145.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.69 0.256 . . . . 1.05 111.69 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.1 pt -140.14 -18.34 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 119.979 -0.689 . . . . 1.48 111.355 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.431 ' O ' HG22 ' A' ' 172' ' ' ILE . 32.2 t90 -173.0 136.67 0.67 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.803 -0.359 . . . . 0.33000000000000002 110.361 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.82 142.37 12.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.513 0.56 . . . . 1.05 112.513 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 15' ' ' ASN . 62.0 t -147.64 134.5 13.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 N-CA-C 114.32 1.23 . . . . 1.3600000000000001 114.32 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 26.6 t-20 -115.66 94.76 4.83 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.607 -0.437 . . . . 1.8700000000000001 110.537 175.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.25 105.46 1.42 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.765 -0.828 . . . . 1.1100000000000001 108.765 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.534 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 155.8 -40.99 0.59 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.115 -0.948 . . . . 0.67000000000000004 113.33 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -135.16 7.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.581 -0.819 . . . . 1.1200000000000001 113.203 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -160.95 119.52 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.537 0.208 . . . . 2.02 110.683 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 70.3 m 34.8 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.697 -0.683 . . . . 1.6499999999999999 112.536 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 67.9 t60 -116.57 151.89 35.26 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.254 0.549 . . . . 0.41999999999999998 112.237 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.27 103.22 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.17 -0.923 . . . . 1.8200000000000001 109.566 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 1.1699999999999999 110.227 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -43.67 -48.07 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 124.251 0.969 . . . . 1.27 113.267 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -59.26 -23.21 62.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.179 0.514 . . . . 0.55000000000000004 110.506 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.3 34.41 2.72 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.423 -0.808 . . . . 0.32000000000000001 112.377 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 27' ' ' ILE . 36.8 mm -103.15 125.34 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.188 -0.671 . . . . 1.21 109.188 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.7 t60 -110.45 131.4 55.09 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.721 1.378 . . . . 0.68999999999999995 114.721 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.636 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.22 134.4 40.58 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.3 -1.0 . . . . 3.3199999999999998 108.3 176.174 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -95.25 105.4 17.34 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.377 0.608 . . . . 3.3999999999999999 112.34 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 32' ' ' ASP . 31.2 ttpt -19.57 135.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.118 1.367 . . . . 3.1600000000000001 114.682 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' LYS . 1.2 m-20 -2.12 85.16 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.783 -1.099 . . . . 1.98 113.329 177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.938 0 C-N-CA 122.854 2.369 . . . . 1.53 115.911 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.912 0.387 . . . . 1.45 110.474 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 51' ' ' LEU . 2.9 mm? -94.42 -47.93 6.36 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.271 0.841 . . . . 2.29 113.271 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -73.44 34.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.232 0.827 . . . . 3.0600000000000001 113.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -150.05 163.34 38.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.19 0.519 . . . . 1.4099999999999999 112.105 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.1 t30 -78.26 148.4 74.31 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.452 -0.794 . . . . 1.96 109.372 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.572 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.83 -57.88 1.18 Allowed 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.383 2.055 . . . . 0.78000000000000003 114.424 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 13.4 mm-40 -58.77 -56.85 16.95 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.191 0.996 . . . . 1.8200000000000001 111.016 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' OD1' HD23 ' A' ' 60' ' ' LEU . 25.7 t70 -69.19 -10.38 57.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.512 -0.767 . . . . 1.9099999999999999 110.171 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.9 tt0 -63.17 -46.43 87.17 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.146 -1.798 . . . . 2.0600000000000001 106.146 176.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.26 -50.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.411 -1.268 . . . . 1.8500000000000001 109.053 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.538 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.8 tp -68.88 -9.68 52.89 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.451 -0.795 . . . . 1.6000000000000001 111.52 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 5.7 m-30 -122.34 17.94 10.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.868 -0.606 . . . . 1.29 111.204 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.421 ' O ' HG23 ' A' ' 167' ' ' VAL . 37.6 tt0 -140.46 -71.95 0.37 Allowed 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.714 1.005 . . . . 1.8 113.714 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 7.4 p -27.18 140.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.606 0.965 . . . . 1.4099999999999999 113.606 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.534 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -130.74 149.97 52.14 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.885 -0.598 . . . . 2.0499999999999998 110.916 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.59 HH12 ' HB2' ' A' ' 67' ' ' ASN . 3.7 ptm180 -136.86 138.66 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.835 0.35 . . . . 4.2800000000000002 110.359 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -78.15 142.92 37.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.048 -0.524 . . . . 4.4699999999999998 111.407 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.59 ' HB2' HH12 ' A' ' 65' ' ' ARG . 5.2 t30 -134.06 -89.88 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.246 -0.434 . . . . 5.1500000000000004 110.941 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.434 ' N ' HD21 ' A' ' 67' ' ' ASN . 41.4 tt0 -175.14 -95.84 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.339 0.126 . . . . 3.1699999999999999 111.339 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -156.27 151.44 26.49 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.483 -0.191 . . . . 2.3900000000000001 110.483 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t 48.06 81.53 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.783 0.325 . . . . 1.3200000000000001 110.132 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.427 ' HZ ' ' C ' ' A' ' 164' ' ' ASN . 2.8 p90 -136.77 152.44 50.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 1.77 110.754 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.09 -155.26 8.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.037 -1.078 . . . . 0.98999999999999999 114.36 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -135.78 154.81 51.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.726 0.639 . . . . 1.1899999999999999 112.726 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -118.49 106.48 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.664 -1.153 . . . . 2.27 110.223 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.35 110.68 64.63 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.909 0.337 . . . . 1.0700000000000001 111.909 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.01 133.81 10.23 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.502 1.468 . . . . 1.26 111.816 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 61.2 mt -120.75 148.83 23.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.43 . . . . 1.0900000000000001 111.496 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -139.75 -3.52 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.803 -0.635 . . . . 3.4399999999999999 110.84 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -121.77 173.93 7.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.582 0.23 . . . . 2.1299999999999999 110.583 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.77 177.31 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.37 111.545 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.18 -161.17 23.1 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.144 -1.582 . . . . 0.23000000000000001 109.144 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 0.1 OUTLIER -95.0 110.68 22.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 118.743 1.272 . . . . 2.0299999999999998 109.913 179.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.27 125.79 40.15 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.94999999999999996 109.577 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.583 HG23 ' C ' ' A' ' 176' ' ' THR . 10.2 t -113.07 116.87 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.477 -1.238 . . . . 1.21 111.939 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.89 104.57 16.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.668 -1.151 . . . . 1.79 110.778 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 58.8 t -103.22 119.39 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.124 -0.944 . . . . 1.95 108.897 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.9 134.22 42.41 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.282 -0.567 . . . . 2.0 111.186 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.614 ' HZ3' ' HB3' ' A' ' 128' ' ' ASP . 19.4 tptt -104.52 120.74 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.755 -0.778 . . . . 3.3799999999999999 109.732 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 8.1 m-85 -104.77 139.23 39.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.922 -1.14 . . . . 0.34999999999999998 107.922 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 119.98 -0.688 . . . . 1.1499999999999999 112.534 -178.674 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.836 0.351 . . . . 3.6000000000000001 110.907 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.6 p -97.27 -76.45 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.974 -0.557 . . . . 1.8899999999999999 111.781 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -78.13 64.11 3.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.04 0.447 . . . . 2.6899999999999999 111.57 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -145.66 -48.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.181 -0.674 . . . . 3.0299999999999998 109.181 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -105.49 78.66 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.429 -0.805 . . . . 3.52 109.33 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.0 113.51 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.332 -0.849 . . . . 1.95 110.196 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -102.47 175.82 5.38 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.038 0.755 . . . . 0.80000000000000004 113.038 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -122.1 140.12 52.91 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.694 -0.685 . . . . 2.0099999999999998 111.09 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.12 123.76 44.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 115.996 -0.547 . . . . 1.1599999999999999 111.768 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.551 HH21 HG22 ' A' ' 158' ' ' VAL . 12.3 mtt180 -117.66 150.47 38.99 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 115.008 -0.996 . . . . 2.1800000000000002 112.401 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 84.4 t -126.2 109.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 114.652 -1.158 . . . . 1.71 109.392 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.426 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 57.02 25.99 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.432 -0.951 . . . . 1.77 108.432 -176.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.55 53.77 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.097 -0.956 . . . . 0.40999999999999998 112.674 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.434 ' CG ' HG13 ' A' ' 142' ' ' VAL . 92.1 m-70 -112.25 111.14 21.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.81 . . . . 0.58999999999999997 113.188 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -68.94 112.16 5.42 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 120.395 -0.522 . . . . 1.2 110.584 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.88 -28.71 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.594 -0.73 . . . . 1.3999999999999999 109.849 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.404 HG21 ' OE1' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -135.02 90.2 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 120.281 -0.568 . . . . 1.21 109.582 177.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.4 ptpp? -110.71 85.08 2.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.935 0.874 . . . . 2.9199999999999999 111.491 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.6 p-10 151.47 36.66 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 112.982 -1.917 . . . . 2.5600000000000001 108.325 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.62 90.15 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.327 0.862 . . . . 1.71 113.327 -177.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.77 83.91 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.351 -1.352 . . . . 1.99 107.351 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -50.44 -30.58 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.084 -0.507 . . . . 1.23 111.793 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -68.38 -43.76 76.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 1.01 111.237 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -69.54 -27.56 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.76000000000000001 111.867 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' NE2' ' A' ' 127' ' ' HIS . 29.7 mmt180 -71.88 -58.45 3.45 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.384 0.513 . . . . 3.0299999999999998 112.384 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.94 -40.66 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.217 0.451 . . . . 2.0299999999999998 112.217 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.53 -92.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.732 -0.747 . . . . 1.0600000000000001 111.784 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.457 ' O ' HG23 ' A' ' 125' ' ' THR . 45.4 t-80 -114.55 110.02 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 4.29 111.056 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.1 t 51.45 -128.23 2.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.083 -0.508 . . . . 2.1099999999999999 111.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 123' ' ' HIS . 26.7 p 58.08 -165.14 0.17 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.592 0.357 . . . . 1.3300000000000001 111.193 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.53 139.18 43.66 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.255 0.835 . . . . 1.1200000000000001 113.255 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.511 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 2.0 t60 -109.07 148.24 31.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.99 -0.744 . . . . 0.45000000000000001 108.99 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.614 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . 4.8 p-10 -143.81 127.12 16.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.674 0.62 . . . . 2.0899999999999999 112.674 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.404 ' OE1' HG21 ' A' ' 112' ' ' VAL . 24.4 mt-10 -120.65 115.67 23.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 2.2799999999999998 109.465 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.1 mt -105.58 126.85 60.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.516 -0.766 . . . . 1.3799999999999999 110.261 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.3 mm -126.12 86.45 57.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.218 0.451 . . . . 2.0 112.218 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -62.48 139.95 79.25 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.875 1.717 . . . . 0.23999999999999999 111.426 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 134' ' ' SER . 18.8 mt -132.86 155.07 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 1.0600000000000001 111.042 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.453 ' N ' HG21 ' A' ' 133' ' ' ILE . 23.8 p -126.21 107.9 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.942 0.401 . . . . 1.6599999999999999 110.859 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 25.6 mt -111.37 122.75 66.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.801 -0.636 . . . . 1.0700000000000001 109.881 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -147.38 143.16 27.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.37 -0.377 . . . . 2.4300000000000002 110.817 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt 62.92 7.81 2.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.098 -0.501 . . . . 3.5600000000000001 110.856 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.2 21.24 25.57 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.83 -0.7 . . . . 0.32000000000000001 112.933 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.641 ' HZ1' ' HB3' ' A' ' 139' ' ' LYS . 8.2 mtpm? -121.03 156.09 32.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.896 0.348 . . . . 2.6800000000000002 110.859 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -114.31 131.95 56.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.112 0.482 . . . . 1.1100000000000001 112.121 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.512 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.1 t -122.92 109.65 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 1.3700000000000001 109.642 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.434 HG13 ' CG ' ' A' ' 109' ' ' HIS . 7.5 p -102.35 108.06 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.198 0.523 . . . . 1.23 111.148 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 53.77 -91.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.765 -0.652 . . . . 2.0499999999999998 112.034 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.33 38.79 2.21 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.59999999999999998 113.516 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -146.61 137.11 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 2.02 110.297 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.3 135.7 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 1.8700000000000001 110.875 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -163.19 121.04 1.94 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.154 -0.684 . . . . 1.46 109.154 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.05 150.11 3.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.981 0.42 . . . . 1.55 111.328 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 t80 -77.55 122.85 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.34000000000000002 110.764 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -75.81 -170.8 1.42 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.955 -1.128 . . . . 2.02 107.955 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.56 -11.92 66.07 Favored Glycine 0 C--N 1.317 -0.503 0 C-N-CA 119.015 -1.564 . . . . 0.77000000000000002 112.93 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.551 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -160.82 151.8 18.72 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.168 0.484 . . . . 2.3199999999999998 112.105 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.626 HD21 ' N ' ' A' ' 154' ' ' SER . 3.5 tt -84.93 148.51 26.19 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.936 -1.135 . . . . 1.8600000000000001 107.936 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 153' ' ' LEU . 3.7 t -139.15 115.86 10.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 118.256 -1.378 . . . . 1.72 113.634 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 7.9 t -98.47 97.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.942 -0.762 . . . . 1.27 108.942 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 34.7 mt-10 -108.82 132.35 54.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.718 -0.674 . . . . 2.48 111.727 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.95 129.83 51.6 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.481 0.658 . . . . 1.9199999999999999 109.929 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.551 HG22 HH21 ' A' ' 105' ' ' ARG . 30.8 t -103.0 143.88 14.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.495 -1.23 . . . . 1.3899999999999999 111.678 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -50.88 148.14 4.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 114.988 -1.005 . . . . 2.48 111.445 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -118.99 -10.66 8.08 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.437 -0.665 . . . . 1.1200000000000001 111.437 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -163.64 -59.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.555 -0.322 . . . . 3.8999999999999999 110.344 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -176.84 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.061 -0.518 . . . . 4.0999999999999996 110.879 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -90.92 46.12 1.3 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.026 0.441 . . . . 1.3999999999999999 111.782 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.71 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 54.9 t30 -55.2 -42.07 93.98 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 115.46 -0.791 . . . . 2.0 109.048 176.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.71 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 36.9 Cg_endo -62.9 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.786 2.324 . . . . 3.1099999999999999 111.843 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 11.0 pttp -97.8 166.01 11.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.063 -0.717 . . . . 4.1100000000000003 109.063 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 62' ' ' GLN . 54.3 t -62.83 132.95 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 C-N-CA 119.533 -0.867 . . . . 1.5900000000000001 110.308 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -130.24 131.6 45.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.671 0.607 . . . . 1.8600000000000001 111.586 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -123.95 37.05 4.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 1.04 112.126 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -33.26 134.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.693 -0.685 . . . . 1.6799999999999999 110.404 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -159.56 95.81 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.533 -0.303 . . . . 0.38 110.813 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.458 ' C ' HD12 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -106.25 130.16 58.37 Favored 'Isoleucine or valine' 0 C--O 1.258 1.526 0 CA-C-O 122.96 1.362 . . . . 1.3500000000000001 112.719 178.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.573 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 ppp? -123.64 157.26 34.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.028 -1.896 . . . . 1.26 108.135 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.9 150.04 39.12 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.138 1.532 . . . . 2.3599999999999999 115.138 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.21 -33.91 6.2 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 112.448 -2.16 . . . . 0.23000000000000001 116.846 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.583 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 156.79 0.44 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.841 1.82 . . . . 1.1000000000000001 114.601 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.572 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.68 -23.37 25.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.161 -0.927 . . . . 1.1000000000000001 110.569 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.864 -0.607 . . . . 2.3100000000000001 111.508 -178.741 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 121.185 0.517 . . . . 1.1299999999999999 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.71 -21.24 6.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.405 -0.816 . . . . 1.1299999999999999 111.314 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -79.29 -21.77 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 2.0899999999999999 112.121 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 34.9 mmtt -98.43 -26.52 14.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.937 -0.305 . . . . 2.5 111.475 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.9 p -44.47 146.82 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 111.961 0.356 . . . . 1.05 111.961 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.2 pt -139.48 -21.73 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.724 . . . . 1.48 111.103 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.524 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.9 t90 -173.7 133.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.55 -0.46 . . . . 0.33000000000000002 110.14 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -150.6 144.26 25.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.809 0.3 . . . . 1.05 111.809 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.2 t -147.63 126.66 4.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.495 1.295 . . . . 1.3600000000000001 114.495 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 11.5 t30 -114.6 100.86 8.59 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.533 -0.467 . . . . 1.8700000000000001 110.31 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.51 103.47 2.98 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 109.021 -0.733 . . . . 1.1100000000000001 109.021 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.57 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 167.9 -45.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.916 0 O-C-N 124.277 0.986 . . . . 0.67000000000000004 113.563 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.77 -123.6 3.48 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.586 -0.816 . . . . 1.1200000000000001 113.124 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.044 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 6.4 tt0 -164.1 120.3 1.62 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.871 0.367 . . . . 2.02 111.489 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.4 m 35.53 99.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.16 -0.927 . . . . 1.6499999999999999 113.231 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 56.3 t60 -130.65 140.16 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.729 -0.788 . . . . 0.41999999999999998 112.462 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 22' ' ' VAL . 4.4 p -114.64 103.91 16.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.637 0.732 . . . . 1.8200000000000001 110.787 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 156.3 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.036 -0.984 . . . . 1.1699999999999999 110.056 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.9 m -44.01 -49.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.175 0.922 . . . . 1.27 113.136 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -59.53 -18.17 38.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.294 0.569 . . . . 0.55000000000000004 110.567 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.72 35.2 3.84 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.34 -0.845 . . . . 0.32000000000000001 112.444 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.44 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 31.1 mm -103.88 111.95 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.026 0.441 . . . . 1.21 110.578 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 10.9 t60 -98.27 135.55 39.73 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.891 1.441 . . . . 0.68999999999999995 114.891 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.044 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -100.47 135.46 41.87 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.864 -1.062 . . . . 3.3199999999999998 108.619 177.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -88.04 111.42 21.51 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 124.001 0.813 . . . . 3.3999999999999999 112.252 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.663 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 5.3 ttpm? -23.44 135.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.349 1.06 . . . . 3.1600000000000001 113.723 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.641 ' HB3' HH11 ' A' ' 65' ' ' ARG . 2.5 m-20 -10.15 83.84 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 CA-C-N 114.2 -1.364 . . . . 1.98 113.708 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 CA--C 1.535 0.531 0 C-N-CA 123.166 2.577 . . . . 1.53 113.582 179.736 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 109.347 -0.612 . . . . 1.45 109.347 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 53' ' ' SER . 4.2 mt -69.87 -49.19 54.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.911 1.449 . . . . 2.29 114.911 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -73.87 25.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.85 0.685 . . . . 3.0600000000000001 112.85 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 51' ' ' LEU . 8.5 t -146.19 144.57 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 1.4099999999999999 111.487 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 58' ' ' GLN . 1.8 p-10 -66.44 153.53 92.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.065 -0.516 . . . . 1.96 109.787 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HB2' ' OE2' ' A' ' 56' ' ' GLU . 14.6 Cg_exo -40.57 -59.14 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.47 2.113 . . . . 0.78000000000000003 114.626 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' OE2' ' HB2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -58.35 -55.43 35.13 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 121.901 0.858 . . . . 1.8200000000000001 111.246 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 11.2 t70 -69.38 -11.98 61.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.325 -0.55 . . . . 1.9099999999999999 110.439 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.671 HE22 HE21 ' A' ' 62' ' ' GLN . 0.9 OUTLIER -68.38 -39.83 81.59 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 106.523 -1.658 . . . . 2.0600000000000001 106.523 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' N ' ' HG3' ' A' ' 58' ' ' GLN . 62.4 t -54.37 -50.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.138 -1.06 . . . . 1.8500000000000001 108.138 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.8 tp -69.81 -13.76 62.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.907 -1.042 . . . . 1.6000000000000001 111.1 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.594 ' C ' ' HZ2' ' A' ' 88' ' ' LYS . 2.6 m-85 -121.89 27.71 7.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.182 -0.917 . . . . 1.29 111.679 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.671 HE21 HE22 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -151.46 -63.36 0.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.261 0.837 . . . . 1.8 113.261 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.53 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 13.7 p -34.13 147.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.815 0.672 . . . . 1.4099999999999999 112.815 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.557 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pp20? -137.52 148.05 45.68 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.691 0.626 . . . . 2.0499999999999998 112.691 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.641 HH11 ' HB3' ' A' ' 32' ' ' ASP . 19.3 mtp180 -114.27 -174.95 2.57 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.98 -0.554 . . . . 4.2800000000000002 109.858 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -66.32 172.0 4.33 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.531 -0.304 . . . . 4.4699999999999998 110.455 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -143.57 162.22 36.44 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.021 0.438 . . . . 5.1500000000000004 111.653 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -144.79 -118.16 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.876 -0.602 . . . . 3.1699999999999999 110.685 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.46 ' OD1' ' HD3' ' A' ' 159' ' ' LYS . 63.6 m-20 -156.62 134.4 10.97 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.44 -0.162 . . . . 2.3900000000000001 111.093 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 53.84 83.53 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.92 0.391 . . . . 1.3200000000000001 110.764 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -162.59 159.6 24.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 1.77 110.826 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -168.93 -168.15 30.56 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.437 -0.887 . . . . 0.98999999999999999 113.418 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -108.36 165.12 11.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.294 0.569 . . . . 1.1899999999999999 111.763 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.03 140.53 49.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.91 -1.041 . . . . 2.27 110.825 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 75' ' ' ILE . 4.0 mp -135.27 109.87 10.56 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.142 -0.481 . . . . 1.0700000000000001 111.171 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.87 133.17 7.83 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.129 1.219 . . . . 1.26 112.045 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 78' ' ' LYS . 23.4 mt -121.32 155.2 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.985 0.421 . . . . 1.0900000000000001 111.577 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' HG23 ' A' ' 77' ' ' ILE . 99.5 mttt -143.19 -0.87 1.09 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.825 -0.625 . . . . 3.4399999999999999 110.995 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.702 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 23.3 mm-40 -127.46 169.03 14.08 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.826 0.345 . . . . 2.1299999999999999 111.562 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -117.48 -177.61 3.27 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.37 111.047 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.78 -151.04 18.05 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.997 -1.241 . . . . 0.23000000000000001 109.997 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 21.2 mt-10 -105.15 108.72 20.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.644 1.222 . . . . 2.0299999999999998 109.71 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.702 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.2 m-85 -95.34 129.68 42.39 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 119.719 -0.792 . . . . 0.94999999999999996 109.156 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 177' ' ' ALA . 22.0 t -116.92 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.686 -1.143 . . . . 1.21 111.806 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.94 105.7 17.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.726 -0.67 . . . . 1.79 110.126 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 38.1 t -101.4 119.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 107.945 -1.131 . . . . 1.95 107.945 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 135.92 23.83 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.671 -0.812 . . . . 2.0 112.437 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.786 ' HZ1' ' HB3' ' A' ' 90' ' ' ALA . 5.9 tmtt? -103.15 132.1 49.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.65 -0.82 . . . . 3.3799999999999999 109.952 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -111.44 149.32 31.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.609 -0.723 . . . . 0.34999999999999998 109.547 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.786 ' HB3' ' HZ1' ' A' ' 88' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 121.073 0.464 . . . . 1.1499999999999999 111.323 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.962 0.41 . . . . 3.6000000000000001 111.153 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -103.8 157.15 17.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.951 -0.568 . . . . 1.8899999999999999 111.235 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 45.25 49.46 10.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.8 -0.636 . . . . 2.6899999999999999 111.647 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -153.47 -46.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.899 -0.778 . . . . 3.0299999999999998 108.899 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -96.89 82.04 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.271 -1.011 . . . . 3.52 108.271 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.434 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.7 OUTLIER -108.87 134.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 1.95 111.227 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -117.89 175.59 5.59 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.576 0.584 . . . . 0.80000000000000004 112.576 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.87 140.06 53.35 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 115.928 -0.578 . . . . 2.0099999999999998 111.459 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.06 131.65 41.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.075 -0.512 . . . . 1.1599999999999999 111.854 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.4 154.8 49.44 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.265 0.839 . . . . 2.1800000000000002 113.265 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 p -121.51 125.24 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.193 -1.367 . . . . 1.71 110.474 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.14 26.1 3.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.663 -0.866 . . . . 1.77 108.663 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.8 27.45 21.7 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 112.976 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 87.1 m-70 -127.35 110.5 12.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.164 0.801 . . . . 0.58999999999999997 113.164 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.0 p -67.24 115.56 7.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.245 0.545 . . . . 1.2 111.723 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.58 -34.71 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.215 -0.902 . . . . 1.3999999999999999 109.369 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.07 89.62 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.995 -0.548 . . . . 1.21 109.548 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.0 ptpp? -110.08 83.39 1.75 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.096 0.951 . . . . 2.9199999999999999 110.759 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 156.82 33.58 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 112.824 -1.989 . . . . 2.5600000000000001 108.557 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 85.92 0.08 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.595 0.591 . . . . 1.71 112.595 -177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 0.6 OUTLIER -98.47 80.42 2.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.714 -1.587 . . . . 1.99 106.714 175.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.7 mt -49.88 -38.48 14.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.516 -0.765 . . . . 1.23 112.291 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.28 -46.69 85.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.462 0.171 . . . . 1.01 111.462 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.407 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 37.1 t70 -70.33 -27.97 64.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.76000000000000001 111.514 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.519 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -61.33 -58.09 9.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.865 0.321 . . . . 3.0299999999999998 111.865 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.13 -40.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.033 0.383 . . . . 2.0299999999999998 112.033 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.93 -87.45 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.912 -0.661 . . . . 1.0600000000000001 112.487 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.478 ' O ' HG22 ' A' ' 125' ' ' THR . 48.6 m80 -112.87 110.46 20.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.641 0.257 . . . . 4.29 111.081 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.9 p 46.79 -116.85 0.72 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.019 -0.537 . . . . 2.1099999999999999 111.769 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 123' ' ' HIS . 41.8 p 50.91 -166.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.209 0.203 . . . . 1.3300000000000001 110.7 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.27 139.09 49.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.087 0.773 . . . . 1.1200000000000001 113.087 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.424 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.8 t60 -105.35 145.08 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.856 -1.164 . . . . 0.45000000000000001 107.856 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.424 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 17.8 t70 -143.75 126.94 16.58 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.056 -0.658 . . . . 2.0899999999999999 112.761 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -117.11 127.84 54.54 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.247 -0.888 . . . . 2.2799999999999998 110.096 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.1 mt -116.43 121.79 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.431 -0.804 . . . . 1.3799999999999999 109.817 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.76 90.09 51.47 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.723 0.638 . . . . 2.0 112.723 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.76 149.74 90.34 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.04 1.827 . . . . 0.23999999999999999 112.053 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 16.9 mt -144.16 156.89 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.452 -0.34 . . . . 1.0600000000000001 111.537 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.448 ' N ' HG21 ' A' ' 133' ' ' ILE . 32.7 t -133.07 110.23 10.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.026 0.441 . . . . 1.6599999999999999 111.077 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 21.8 mt -106.62 137.25 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.799 -0.637 . . . . 1.0700000000000001 110.337 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -145.35 130.36 18.34 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.997 -0.281 . . . . 2.4300000000000002 111.102 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 54.99 19.03 2.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.1 -0.5 . . . . 3.5600000000000001 110.8 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.5 16.14 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.688 -0.768 . . . . 0.32000000000000001 112.782 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -111.5 156.54 21.54 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.084 -0.339 . . . . 2.6800000000000002 110.084 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 141' ' ' SER . 5.1 tt -124.6 126.01 45.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.284 0.564 . . . . 1.1100000000000001 112.496 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.47 ' N ' HD21 ' A' ' 140' ' ' LEU . 9.5 t -115.81 109.23 17.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.302 -0.863 . . . . 1.3700000000000001 109.084 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -102.95 99.57 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.513 -0.767 . . . . 1.23 110.507 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.43 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 2.0499999999999998 111.626 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -132.33 29.58 3.29 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.44 -0.886 . . . . 0.59999999999999998 113.277 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.28 135.78 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.297 . . . . 2.02 110.526 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.83 135.46 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 1.8700000000000001 110.344 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 m -164.46 129.22 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 1.46 109.837 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -53.16 145.03 14.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.181 0.515 . . . . 1.55 112.238 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -78.72 121.67 25.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.516 -0.765 . . . . 0.34000000000000002 110.031 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.4 p -76.14 173.85 10.81 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.51 -0.922 . . . . 2.02 108.51 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.81 -8.8 1.48 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.948 -1.12 . . . . 0.77000000000000002 114.236 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.598 ' HB3' ' HZ3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -160.61 152.09 19.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.894 0.847 . . . . 2.3199999999999998 112.703 -179.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.578 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -80.9 129.63 34.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.794 -1.187 . . . . 1.8600000000000001 107.794 177.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.503 ' HB3' ' OE1' ' A' ' 156' ' ' GLU . 0.1 OUTLIER -121.88 120.71 35.3 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.96 1.096 . . . . 1.72 113.96 -176.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.412 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 96.6 t -106.11 101.13 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.741 -0.466 . . . . 1.27 109.741 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' A' ' 154' ' ' SER . 17.6 mp0 -116.64 150.5 38.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.369 0.604 . . . . 2.48 112.069 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.6 140.11 44.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.178 -0.919 . . . . 1.9199999999999999 110.148 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.67 144.06 24.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.058 -0.973 . . . . 1.3899999999999999 111.168 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.46 ' HD3' ' OD1' ' A' ' 69' ' ' ASP . 19.2 pttm -63.63 139.43 58.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.384 -0.825 . . . . 2.48 111.055 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -108.33 -4.79 32.75 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.116 -0.794 . . . . 1.1200000000000001 111.116 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -169.92 -54.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.327 -0.436 . . . . 3.8999999999999999 110.229 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -178.29 149.03 0.51 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.09 -0.505 . . . . 4.0999999999999996 110.64 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 55.84 87.5 0.05 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.855 0.36 . . . . 1.3999999999999999 111.681 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.41 166.37 0.56 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.848 -0.615 . . . . 2.0 109.886 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -35.78 104.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.015 1.81 . . . . 3.1099999999999999 111.731 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -58.21 -54.11 50.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 4.1100000000000003 113.133 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 63' ' ' THR . 6.8 t -103.55 134.72 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.961 0.726 . . . . 1.5900000000000001 112.961 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.42 138.85 49.26 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.964 -0.562 . . . . 1.8600000000000001 112.149 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 88' ' ' LYS . . . -129.75 35.94 4.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.183 -0.917 . . . . 1.04 112.915 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -36.96 136.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.232 0.539 . . . . 1.6799999999999999 112.404 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -156.62 96.11 1.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.305 -0.861 . . . . 0.38 109.33 178.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -99.93 127.67 52.6 Favored 'Isoleucine or valine' 0 C--O 1.266 1.942 0 CA-C-O 122.663 1.221 . . . . 1.3500000000000001 112.35 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.42 161.35 21.36 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.683 -1.599 . . . . 1.26 109.546 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 16.1 tttm -120.38 139.05 53.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.7 1.37 . . . . 2.3599999999999999 114.7 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.03 -35.05 5.3 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 118.123 2.009 . . . . 0.23000000000000001 118.123 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.551 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.55 158.06 0.5 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.436 2.118 . . . . 1.1000000000000001 114.105 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.59 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -85.34 -24.69 27.52 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.94 -1.027 . . . . 1.1000000000000001 109.858 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.538 -0.756 . . . . 2.3100000000000001 111.132 -179.459 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.1 tp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.354 0.597 . . . . 1.1299999999999999 110.052 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.02 -19.65 7.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.076 -0.966 . . . . 1.1299999999999999 111.652 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.75 -28.65 40.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.498 0.555 . . . . 2.0899999999999999 112.498 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 44.0 mttp -98.89 -18.08 18.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.325 -0.55 . . . . 2.5 112.065 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 7' ' ' ALA . 14.2 p -42.63 144.08 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 121.28 -0.168 . . . . 1.05 111.131 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 12' ' ' TRP . 4.1 pt -139.55 -21.7 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 C-N-CA 119.639 -0.824 . . . . 1.48 111.582 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.497 ' O ' HG23 ' A' ' 172' ' ' ILE . 50.5 t90 -175.99 130.79 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.478 -0.489 . . . . 0.33000000000000002 110.675 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -148.39 146.58 28.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.273 0.471 . . . . 1.05 112.273 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.3 t -147.5 126.77 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 114.229 1.196 . . . . 1.3600000000000001 114.229 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.601 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 18.4 t-20 -117.39 106.36 13.13 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.654 -0.703 . . . . 1.8700000000000001 110.133 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 113.54 15.14 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 120.68 -0.408 . . . . 1.1100000000000001 110.811 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.433 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 142.74 -29.74 2.1 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 114.649 -1.16 . . . . 0.67000000000000004 112.594 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -109.81 -144.75 10.51 Favored Glycine 0 CA--C 1.516 0.135 0 C-N-CA 121.138 -0.553 . . . . 1.1200000000000001 112.021 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' SER . 36.2 mt-10 -156.83 119.45 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.666 -0.124 . . . . 2.02 110.666 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.649 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.3 m 27.7 94.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.803 0.69 . . . . 1.6499999999999999 112.152 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 19.9 t60 -126.26 150.89 48.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 119.922 -0.711 . . . . 0.41999999999999998 112.416 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.56 105.32 18.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.133 -0.939 . . . . 1.8200000000000001 111.019 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 153.77 42.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.981 -0.377 . . . . 1.1699999999999999 109.981 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 m -44.44 -49.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.501 0.926 . . . . 1.27 113.501 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -58.44 -17.84 23.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.282 0.563 . . . . 0.55000000000000004 110.463 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.62 33.71 4.67 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.32000000000000001 112.149 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 27' ' ' ILE . 30.4 mm -103.23 120.72 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.904 -0.406 . . . . 1.21 109.904 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.499 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 12.8 t60 -102.97 132.91 48.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.191 1.182 . . . . 0.68999999999999995 114.191 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.5 134.19 43.82 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.935 -1.135 . . . . 3.3199999999999998 107.935 176.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -94.62 112.52 24.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.444 0.64 . . . . 3.3999999999999999 112.376 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -10.49 138.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.54 1.681 . . . . 3.1600000000000001 115.54 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.45 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 12.5 m-20 -22.54 89.67 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 113.722 -1.581 . . . . 1.98 114.219 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 CA--C 1.545 1.071 0 C-N-CA 122.731 2.287 . . . . 1.53 113.309 178.393 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 50' ' ' ILE . 4.4 mt . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.264 -0.643 . . . . 1.45 109.264 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.68 -42.77 86.02 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.232 1.197 . . . . 2.29 114.232 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -80.25 25.14 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.705 -0.398 . . . . 3.0600000000000001 111.984 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.43 ' OG ' HG23 ' A' ' 50' ' ' ILE . 94.0 p -139.77 130.47 25.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.702 0.287 . . . . 1.4099999999999999 111.347 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 3.0 p-10 -59.73 152.73 56.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.857 -0.794 . . . . 1.96 108.857 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.463 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 7.6 Cg_exo -39.93 -39.52 2.3 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.341 2.027 . . . . 0.78000000000000003 115.251 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' HG11 ' A' ' 59' ' ' VAL . 7.5 mm-40 -75.43 -56.07 5.07 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.755 0.788 . . . . 1.8200000000000001 111.171 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.4 OUTLIER -70.79 -6.57 38.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.034 -0.666 . . . . 1.9099999999999999 109.256 -179.453 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 24.6 tt0 -70.54 -64.88 0.81 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.255 -0.884 . . . . 2.0600000000000001 108.661 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.431 ' O ' HG21 ' A' ' 63' ' ' THR . 2.6 p -48.41 -37.94 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.901 -0.591 . . . . 1.8500000000000001 109.79 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.601 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 4.9 tp -68.07 -68.19 0.41 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.84 -0.744 . . . . 1.6000000000000001 110.071 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -56.36 1.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.184 0.593 . . . . 1.29 111.932 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.599 ' H ' ' C ' ' A' ' 60' ' ' LEU . 1.8 tt0 -122.8 -126.02 0.26 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.115 -0.493 . . . . 1.8 111.734 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.448 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 47.6 p 49.08 -166.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.598 -0.273 . . . . 1.4099999999999999 110.725 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.2 pt-20 -179.3 140.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.628 0.252 . . . . 2.0499999999999998 111.1 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.45 ' NE ' ' HB3' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -123.13 177.15 5.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.012 0.434 . . . . 4.2800000000000002 111.601 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -57.63 169.8 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.718 -0.674 . . . . 4.4699999999999998 111.412 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -142.13 169.32 17.81 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.256 -0.429 . . . . 5.1500000000000004 111.077 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -154.57 -107.52 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.663 -0.244 . . . . 3.1699999999999999 111.446 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.68 125.71 1.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.429 -0.169 . . . . 2.3900000000000001 110.742 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 t 50.9 84.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.047 -0.353 . . . . 1.3200000000000001 110.047 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -159.09 164.72 35.09 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.593 -0.443 . . . . 1.77 111.223 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.6 -167.8 39.0 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 119.066 -1.54 . . . . 0.98999999999999999 116.406 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.99 174.2 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.648 -1.276 . . . . 1.1899999999999999 113.147 -176.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.9 147.34 50.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.33 -1.305 . . . . 2.27 111.187 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.32 113.55 6.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.349 -0.387 . . . . 1.0700000000000001 111.167 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.62 140.25 13.09 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.198 1.266 . . . . 1.26 111.918 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mt -129.49 149.24 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 1.0900000000000001 111.652 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.84 8.45 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.633 -0.712 . . . . 3.4399999999999999 110.809 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.623 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 17.7 mt-10 -127.11 163.76 23.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.134 -0.321 . . . . 2.1299999999999999 110.134 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 2.5 mp0 -125.98 158.73 34.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.37 111.901 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.82 -144.3 11.63 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.793 -1.323 . . . . 0.23000000000000001 109.793 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -105.93 107.8 18.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.622 1.211 . . . . 2.0299999999999998 108.995 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.623 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.8 m-85 -95.26 126.21 40.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.715 -0.846 . . . . 0.94999999999999996 108.715 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.613 HG23 ' N ' ' A' ' 177' ' ' ALA . 12.7 t -114.36 120.75 64.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.007 -0.997 . . . . 1.21 111.915 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.472 ' C ' HD22 ' A' ' 85' ' ' LEU . 8.6 tt -101.46 104.97 15.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.918 -1.037 . . . . 1.79 110.617 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.93 135.93 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.184 -1.043 . . . . 1.95 108.184 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -147.97 150.08 33.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 118.861 -1.136 . . . . 2.0 112.952 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 127' ' ' HIS . 12.2 tptt -107.75 120.43 42.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.341 -0.845 . . . . 3.3799999999999999 110.099 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.79 145.89 31.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.558 -0.534 . . . . 0.34999999999999998 109.558 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.801 0.334 . . . . 1.1499999999999999 110.65 179.18 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.518 ' NE2' ' HB2' ' A' ' 100' ' ' LYS . 17.7 pt20 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.709 0.29 . . . . 3.6000000000000001 110.707 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -126.78 153.42 45.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 1.8899999999999999 111.863 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 47.73 30.71 1.9 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.805 -0.634 . . . . 2.6899999999999999 111.574 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -131.56 -50.42 0.99 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 3.0299999999999998 109.879 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.518 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 22.3 tttp -97.92 90.47 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.087 -0.709 . . . . 3.52 109.087 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.49 147.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.95 110.435 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -121.22 -179.87 4.19 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.392 0.886 . . . . 0.80000000000000004 113.392 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.89 139.39 52.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 115.648 -0.706 . . . . 2.0099999999999998 111.162 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.1 t -135.01 133.47 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 116.152 -0.476 . . . . 1.1599999999999999 112.068 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 10.9 ptt180 -135.89 145.17 46.05 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.684 0.994 . . . . 2.1800000000000002 113.684 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.5 m -113.0 121.06 64.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.584 -1.189 . . . . 1.71 109.694 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.565 ' ND2' ' HA ' ' A' ' 153' ' ' LEU . 3.6 t-20 54.28 26.89 7.27 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.805 0.812 . . . . 1.77 109.332 -176.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 23.17 28.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.047 -1.433 . . . . 0.40999999999999998 112.977 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 81.5 m-70 -120.83 108.03 13.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.277 0.843 . . . . 0.58999999999999997 113.277 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 7.0 p -64.6 116.03 5.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.146 0.498 . . . . 1.2 111.407 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.55 -31.31 2.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.471 -0.786 . . . . 1.3999999999999999 109.99 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.18 91.49 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.351 -0.611 . . . . 1.21 109.351 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 4.2 ptpp? -106.6 77.96 1.23 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.584 1.183 . . . . 2.9199999999999999 112.517 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.1 p30 156.14 36.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.399 -2.182 . . . . 2.5600000000000001 109.453 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 91.78 0.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.352 0.596 . . . . 1.71 111.537 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 1.5 p30 -101.68 79.12 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.008 -1.479 . . . . 1.99 107.008 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.0 mt -50.4 -50.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.709 -1.132 . . . . 1.23 113.002 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -56.19 -51.45 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.83 0.307 . . . . 1.01 111.83 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.493 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 18.0 t70 -65.39 -29.59 70.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.369 0.507 . . . . 0.76000000000000001 112.369 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -64.02 -58.29 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.452 0.538 . . . . 3.0299999999999998 112.452 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 126' ' ' ALA . 10.9 m -103.53 -41.17 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.519 0.563 . . . . 2.0299999999999998 112.519 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.73 -131.23 10.26 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.524 -0.845 . . . . 1.0600000000000001 112.881 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.37 110.43 1.43 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.761 0.315 . . . . 4.29 111.083 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.8 m 45.27 -104.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.867 -0.606 . . . . 2.1099999999999999 111.161 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.405 ' OG1' ' HB ' ' A' ' 121' ' ' VAL . 23.0 p 50.07 178.24 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.084 0.469 . . . . 1.3300000000000001 111.914 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 121' ' ' VAL . . . -105.86 138.95 41.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 1.1200000000000001 111.786 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.486 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.8 t60 -112.57 144.8 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.918 -0.771 . . . . 0.45000000000000001 108.918 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.89 140.48 29.78 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.305 0.854 . . . . 2.0899999999999999 113.305 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.17 133.85 52.63 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.026 -0.988 . . . . 2.2799999999999998 109.092 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.4 mt -115.66 116.4 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.747 -0.66 . . . . 1.3799999999999999 110.187 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.9 mt -124.62 87.87 54.11 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.584 0.587 . . . . 2.0 112.584 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.6 141.82 74.8 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.81 1.674 . . . . 0.23999999999999999 111.602 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 134' ' ' SER . 21.2 mt -132.09 155.82 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 1.0600000000000001 110.505 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.444 ' N ' HG21 ' A' ' 133' ' ' ILE . 30.5 p -131.39 106.73 8.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 1.6599999999999999 110.732 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 23.8 mt -105.4 124.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.747 -0.66 . . . . 1.0700000000000001 109.911 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -146.97 142.1 27.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 2.4300000000000002 110.947 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp 58.91 19.13 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 3.5600000000000001 111.205 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.85 23.62 41.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 0.32000000000000001 113.396 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 25.9 mtmm -123.62 151.75 42.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.1 0.45 . . . . 2.6800000000000002 110.823 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -109.84 126.65 54.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.118 0.485 . . . . 1.1100000000000001 111.658 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.463 ' N ' HD22 ' A' ' 140' ' ' LEU . 24.2 t -114.55 110.99 20.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.723 -0.671 . . . . 1.3700000000000001 110.059 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.03 104.29 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.341 0.591 . . . . 1.23 111.286 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 58.22 -89.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.755 -0.657 . . . . 2.0499999999999998 112.085 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.96 23.41 4.97 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.437 -0.887 . . . . 0.59999999999999998 113.593 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -133.13 136.51 45.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.005 -0.368 . . . . 2.02 110.005 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.16 140.9 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.034 0.445 . . . . 1.8700000000000001 111.491 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.0 m -160.15 122.78 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.718 -0.674 . . . . 1.46 110.233 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.5 p -50.94 143.09 10.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.966 -0.561 . . . . 1.55 111.502 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -79.77 121.91 25.94 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.001 -0.741 . . . . 0.34000000000000002 109.001 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 t -111.19 91.44 3.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.819 0.674 . . . . 2.02 112.819 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.4 -36.73 0.03 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.255 1.662 . . . . 0.77000000000000002 117.255 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -159.75 151.98 20.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.335 1.567 . . . . 2.3199999999999998 113.466 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.565 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 1.3 tt -85.55 132.57 34.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.835 -1.172 . . . . 1.8600000000000001 107.835 176.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.413 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.5 t -122.79 117.7 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.817 -0.753 . . . . 1.72 112.493 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.13 115.62 47.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.864 0.364 . . . . 1.27 110.826 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 166.79 23.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.375 0.607 . . . . 2.48 111.23 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.84 151.24 45.54 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.027 -0.988 . . . . 1.9199999999999999 110.675 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -123.26 143.96 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.671 -1.15 . . . . 1.3899999999999999 110.029 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 145.03 24.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 2.48 111.594 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.56 -14.45 44.02 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.312 -0.715 . . . . 1.1200000000000001 111.312 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -141.55 -79.9 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.227 . . . . 3.8999999999999999 110.694 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -155.16 157.75 37.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.863 0.363 . . . . 4.0999999999999996 111.142 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 54.97 86.93 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.951 -0.568 . . . . 1.3999999999999999 111.861 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 170.96 0.4 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.82 -0.627 . . . . 2.0 110.01 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -41.22 103.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.588 1.525 . . . . 3.1099999999999999 111.159 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -58.55 -64.98 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.287 -0.869 . . . . 4.1100000000000003 113.088 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 63' ' ' THR . 11.9 t -91.71 134.26 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 120.14 -0.624 . . . . 1.5900000000000001 112.385 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.6 t -132.48 137.8 47.35 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.712 -0.676 . . . . 1.8600000000000001 112.616 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.546 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . . . -130.22 34.75 4.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.171 -0.922 . . . . 1.04 111.466 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.1 tp -44.93 128.28 6.92 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.801 -0.636 . . . . 1.6799999999999999 111.656 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.4 OUTLIER -143.15 115.69 8.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.94 -0.573 . . . . 0.38 110.831 -178.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -117.16 131.27 70.35 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-O 123.002 1.382 . . . . 1.3500000000000001 113.029 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -126.42 165.04 19.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.216 -1.811 . . . . 1.26 109.735 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 3.4 ptmm? -121.42 152.75 38.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.424 1.639 . . . . 2.3599999999999999 115.424 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.72 -34.85 4.62 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 112.044 -2.344 . . . . 0.23000000000000001 117.796 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.551 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.67 156.71 0.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.21 2.005 . . . . 1.1000000000000001 114.723 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.613 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.57 -10.5 53.84 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.167 -0.924 . . . . 1.1000000000000001 110.899 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 2.3100000000000001 111.508 -178.323 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.306 0.574 . . . . 1.1299999999999999 110.322 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.578 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -55.39 -20.93 13.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.366 -0.834 . . . . 1.1299999999999999 111.184 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.11 -19.34 61.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 2.0899999999999999 111.856 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -102.05 -29.52 11.72 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.696 -0.401 . . . . 2.5 110.875 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 7' ' ' ALA . 9.9 p -45.38 146.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.796 0.332 . . . . 1.05 111.815 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.512 HG21 ' HZ2' ' A' ' 174' ' ' LYS . 10.2 pt -137.12 -22.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.224 -0.59 . . . . 1.48 110.649 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.501 ' O ' HG22 ' A' ' 172' ' ' ILE . 17.0 t90 -172.51 133.45 0.62 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.233 -0.439 . . . . 0.33000000000000002 109.912 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' HIS . . . -154.23 143.09 21.02 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.74 0.274 . . . . 1.05 111.74 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.409 HG21 ' C ' ' A' ' 13' ' ' ALA . 98.2 t -146.94 131.5 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.598 1.332 . . . . 1.3600000000000001 114.598 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.47 103.05 10.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.058 -0.519 . . . . 1.8700000000000001 110.621 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . -70.82 105.53 3.26 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.124 -0.63 . . . . 1.1100000000000001 109.367 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.08 -27.01 0.14 Allowed Glycine 0 N--CA 1.446 -0.659 0 O-C-N 124.016 0.823 . . . . 0.67000000000000004 114.074 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -138.44 -127.8 2.54 Favored Glycine 0 CA--C 1.511 -0.204 0 C-N-CA 119.98 -1.105 . . . . 1.1200000000000001 113.011 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.73 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 37.1 mt-10 -154.63 119.65 4.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.39 0.138 . . . . 2.02 111.2 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.5 m 29.59 100.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.251 0.834 . . . . 1.6499999999999999 113.251 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 22' ' ' VAL . 6.7 t60 -130.38 150.74 51.47 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 120.394 -0.522 . . . . 0.41999999999999998 111.767 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 55.1 t -115.64 109.54 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.678 -0.692 . . . . 1.8200000000000001 111.755 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.92 157.21 36.67 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.656 -0.247 . . . . 1.1699999999999999 110.424 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.0 m -44.31 -52.66 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.832 1.049 . . . . 1.27 113.832 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -58.38 -13.76 6.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.085 0.469 . . . . 0.55000000000000004 110.406 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.0 34.91 5.5 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.526 -0.761 . . . . 0.32000000000000001 112.299 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.46 HG22 HD12 ' A' ' 27' ' ' ILE . 32.9 mm -103.61 122.64 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.65 -0.5 . . . . 1.21 109.65 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 11.7 t60 -101.91 135.49 43.38 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.714 1.376 . . . . 0.68999999999999995 114.714 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.73 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -98.33 132.9 43.42 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.396 -0.965 . . . . 3.3199999999999998 108.396 176.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 6.9 mtp180 -92.43 112.69 24.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.787 0.662 . . . . 3.3999999999999999 112.787 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.598 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 9.2 tttp -20.24 137.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.247 1.419 . . . . 3.1600000000000001 114.423 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -14.3 84.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.685 1.194 . . . . 1.98 113.807 177.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo . . . . . 0 CA--C 1.542 0.876 0 C-N-CA 122.449 2.1 . . . . 1.53 115.234 179.375 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.435 HD11 ' N ' ' A' ' 50' ' ' ILE . 1.1 mp . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 108.667 -0.864 . . . . 1.45 108.667 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -48.87 8.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.679 0.992 . . . . 2.29 113.679 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -78.9 34.69 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.647 0.61 . . . . 3.0600000000000001 112.647 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -144.2 137.5 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 1.4099999999999999 111.293 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -67.55 161.75 62.76 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.493 -0.558 . . . . 1.96 109.493 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.6 Cg_exo -42.16 -46.89 7.16 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.764 2.31 . . . . 0.78000000000000003 116.141 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 59' ' ' VAL . 12.9 pt-20 -77.71 -53.16 7.87 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.248 0.547 . . . . 1.8200000000000001 111.649 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 8.7 p-10 -70.04 -2.3 12.36 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.717 -0.793 . . . . 1.9099999999999999 109.719 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 20.2 tt0 -80.36 -60.15 2.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.447 -0.797 . . . . 2.0600000000000001 109.218 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 56' ' ' GLU . 2.6 p -47.59 -35.57 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.457 -0.942 . . . . 1.8500000000000001 108.457 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 62' ' ' GLN . 10.2 tp -69.88 -64.52 0.87 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.465 0.65 . . . . 1.6000000000000001 109.41 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-30 -66.95 20.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.9 -1.046 . . . . 1.29 112.703 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.483 ' H ' ' C ' ' A' ' 60' ' ' LEU . 38.4 tt0 -137.54 -67.81 0.48 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.515 0.931 . . . . 1.8 113.515 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 21.0 p -30.6 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.554 0.946 . . . . 1.4099999999999999 113.554 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.552 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -131.98 151.63 51.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.686 -0.688 . . . . 2.0499999999999998 111.464 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.603 ' CZ ' ' HA ' ' A' ' 32' ' ' ASP . 30.2 mtt180 -105.2 -170.41 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.536 -0.542 . . . . 4.2800000000000002 109.536 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.81 -179.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 4.4699999999999998 111.069 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -117.12 164.85 14.14 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.184 -0.462 . . . . 5.1500000000000004 111.413 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -167.69 -150.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.844 -0.616 . . . . 3.1699999999999999 109.969 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 10.1 t70 -141.38 128.06 20.3 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.718 0.294 . . . . 2.3900000000000001 111.418 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 t 51.94 86.03 0.04 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.101 -0.5 . . . . 1.3200000000000001 111.238 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.07 160.5 43.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 1.77 110.909 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.17 -154.14 8.6 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.358 -0.925 . . . . 0.98999999999999999 113.998 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.88 167.84 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.478 0.656 . . . . 1.1899999999999999 112.046 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -120.22 135.62 54.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.638 -1.164 . . . . 2.27 110.047 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.417 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.9 mp -127.64 86.84 57.45 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 111.823 0.305 . . . . 1.0700000000000001 111.823 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -57.69 127.55 25.73 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.975 1.783 . . . . 1.26 112.059 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 78' ' ' LYS . 21.7 mt -119.25 153.69 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.966 0.412 . . . . 1.0900000000000001 111.138 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' N ' HG22 ' A' ' 77' ' ' ILE . 16.9 pttp -147.35 6.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.895 -0.593 . . . . 3.4399999999999999 110.823 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -130.77 171.0 13.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.822 -0.172 . . . . 2.1299999999999999 110.627 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.07 171.96 10.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.277 0.56 . . . . 0.37 111.577 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 -153.89 21.59 Favored Glycine 0 C--N 1.329 0.148 0 N-CA-C 109.901 -1.28 . . . . 0.23000000000000001 109.901 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.5 mm-40 -98.07 110.25 22.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.856 1.328 . . . . 2.0299999999999998 108.859 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.669 ' HH ' ' HZ1' ' A' ' 174' ' ' LYS . 4.1 m-85 -96.55 126.53 41.8 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.906 -0.776 . . . . 0.94999999999999996 108.906 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.634 HG22 ' N ' ' A' ' 177' ' ' ALA . 13.8 t -115.81 116.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.401 -0.818 . . . . 1.21 111.78 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.476 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.8 tt -94.06 105.15 17.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.761 -1.109 . . . . 1.79 111.029 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 42.9 t -108.07 135.59 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.163 -1.051 . . . . 1.95 108.163 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -150.05 148.8 29.46 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.952 -1.099 . . . . 2.0 112.365 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 2.2 tptm -104.59 118.82 37.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.457 -0.792 . . . . 3.3799999999999999 110.011 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -106.01 137.67 43.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.458 -0.941 . . . . 0.34999999999999998 108.458 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.424 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.337 0 C-N-CA 120.026 -0.67 . . . . 1.1499999999999999 111.898 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.977 0.418 . . . . 3.6000000000000001 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.9 m -115.01 153.38 30.75 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.0 -0.545 . . . . 1.8899999999999999 111.774 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 52.03 27.58 4.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.635 -0.711 . . . . 2.6899999999999999 112.144 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -134.27 -47.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 3.0299999999999998 109.636 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.99 86.52 3.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.719 -0.673 . . . . 3.52 109.541 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.17 150.32 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 1.95 109.892 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -127.13 179.04 5.63 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 113.065 0.765 . . . . 0.80000000000000004 113.065 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -123.6 137.58 54.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.124 -0.489 . . . . 2.0099999999999998 111.256 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.414 -0.357 . . . . 1.1599999999999999 111.922 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -130.35 151.2 51.11 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.825 0.676 . . . . 2.1800000000000002 112.825 -178.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 9.5 p -124.6 120.76 59.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 115.425 -0.807 . . . . 1.71 110.021 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.539 ' OD1' HD13 ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.68 25.85 10.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.524 -0.917 . . . . 1.77 108.524 -176.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.58 57.29 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.16 -0.927 . . . . 0.40999999999999998 112.987 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.482 ' CG ' HG13 ' A' ' 142' ' ' VAL . 89.1 m-70 -110.48 112.25 24.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.428 0.899 . . . . 0.58999999999999997 113.428 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 p -70.41 112.66 6.87 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.023 0.44 . . . . 1.2 111.221 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.34 -37.61 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 1.3999999999999999 110.124 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.87 90.31 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 109.337 -0.616 . . . . 1.21 109.337 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.3 ptpp? -108.25 84.58 1.96 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.165 0.983 . . . . 2.9199999999999999 112.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.6 p30 149.92 31.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.437 -2.165 . . . . 2.5600000000000001 108.142 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.32 98.87 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.146 0.498 . . . . 1.71 112.056 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -105.87 80.76 1.57 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.828 -1.175 . . . . 1.99 107.828 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.1 mt -51.0 -47.03 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.085 -0.962 . . . . 1.23 112.721 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.662 0.267 . . . . 1.01 111.671 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.29 -27.63 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.979 0.363 . . . . 0.76000000000000001 111.979 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -68.86 -58.54 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.069 0.396 . . . . 3.0299999999999998 112.069 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.5 m -90.54 -40.47 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.939 0.348 . . . . 2.0299999999999998 111.939 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.34 -82.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 1.0600000000000001 112.439 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -99.99 169.69 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.512 0.196 . . . . 4.29 110.782 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 m -49.88 97.91 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.36 -0.382 . . . . 2.1099999999999999 110.984 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.9 p -150.94 -170.12 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 1.3300000000000001 109.96 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . . . -96.6 131.11 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.741 0.645 . . . . 1.1200000000000001 112.741 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.403 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 2.1 t60 -106.32 147.08 29.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.572 -0.899 . . . . 0.45000000000000001 108.572 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.403 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 36.3 t70 -144.83 127.08 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.437 0.532 . . . . 2.0899999999999999 112.437 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -114.8 135.61 53.99 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.766 -0.652 . . . . 2.2799999999999998 109.568 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.54 120.86 66.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.4 -0.818 . . . . 1.3799999999999999 110.083 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.88 89.18 51.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.353 -0.385 . . . . 2.0 111.947 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.17 146.62 94.26 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.97 1.78 . . . . 0.23999999999999999 111.709 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 134' ' ' SER . 17.6 mt -138.6 156.86 29.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 1.0600000000000001 110.751 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.422 ' N ' HG22 ' A' ' 133' ' ' ILE . 29.1 p -133.53 108.56 8.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.068 0.461 . . . . 1.6599999999999999 111.349 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 18.3 mt -109.67 125.69 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-N 115.667 -0.697 . . . . 1.0700000000000001 110.224 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -149.12 141.69 24.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 2.4300000000000002 111.157 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt 61.36 14.24 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.9 -0.591 . . . . 3.5600000000000001 111.212 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.78 8.76 59.13 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.606 -0.807 . . . . 0.32000000000000001 113.402 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -112.34 165.2 12.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.34 0.57 . . . . 2.6800000000000002 110.669 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 141' ' ' SER . 8.2 tt -127.16 139.74 52.74 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.616 0.598 . . . . 1.1100000000000001 112.616 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.415 ' N ' HD22 ' A' ' 140' ' ' LEU . 36.1 t -126.44 116.03 20.51 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.626 -0.715 . . . . 1.3700000000000001 110.447 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.482 HG13 ' CG ' ' A' ' 109' ' ' HIS . 4.3 p -112.32 104.53 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.094 -0.957 . . . . 1.23 110.575 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.75 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 2.0499999999999998 112.009 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.17 9.87 4.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.352 -0.927 . . . . 0.59999999999999998 113.914 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -124.38 118.87 27.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.147 0.473 . . . . 2.02 110.019 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 140' ' ' LEU . 21.2 t -107.62 130.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.477 0.656 . . . . 1.8700000000000001 112.432 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 t -145.12 143.11 30.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 114.939 -1.028 . . . . 1.46 109.742 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.6 p -55.85 141.36 39.24 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.111 0.411 . . . . 1.55 112.111 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -79.09 143.15 35.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.168 -0.679 . . . . 0.34000000000000002 109.168 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.9 96.45 3.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.776 1.028 . . . . 2.02 113.776 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.66 -57.33 2.55 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.978 1.151 . . . . 0.77000000000000002 115.978 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -153.54 174.72 14.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.934 0.867 . . . . 2.3199999999999998 112.667 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.539 HD13 ' OD1' ' A' ' 107' ' ' ASN . 1.0 OUTLIER -97.06 130.79 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.964 -1.495 . . . . 1.8600000000000001 106.964 176.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.4 t -120.71 112.74 19.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.267 -0.973 . . . . 1.72 112.978 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 57.5 t -98.28 104.04 15.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 1.27 110.548 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 mt-10 -108.47 144.91 35.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.407 -0.815 . . . . 2.48 110.922 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.97 138.16 42.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.637 -0.505 . . . . 1.9199999999999999 109.637 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.6 t -112.25 143.59 21.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.22 -0.9 . . . . 1.3899999999999999 111.261 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.404 ' HD2' ' C ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -74.95 148.45 39.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.533 -0.758 . . . . 2.48 111.375 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.14 -9.2 28.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.943 -0.646 . . . . 1.1200000000000001 111.941 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.45 -61.89 0.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.616 0.246 . . . . 3.8999999999999999 110.489 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -172.69 -28.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 4.0999999999999996 111.048 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.73 90.54 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 1.3999999999999999 111.589 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -53.82 165.82 0.7 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.397 -0.594 . . . . 2.0 109.397 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -37.67 100.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.779 1.653 . . . . 3.1099999999999999 111.575 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -52.0 -57.0 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.975 . . . . 4.1100000000000003 112.384 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 61.3 t -103.04 133.69 46.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 120.495 -0.482 . . . . 1.5900000000000001 112.253 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -132.59 135.29 45.81 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 115.873 -0.603 . . . . 1.8600000000000001 111.065 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.444 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -126.23 35.57 4.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.806 . . . . 1.04 112.611 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -33.36 131.43 0.21 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.499 0.499 . . . . 1.6799999999999999 111.366 179.253 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.89 101.26 2.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.38 110.198 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -107.43 123.32 62.63 Favored 'Isoleucine or valine' 0 C--O 1.265 1.873 0 CA-C-O 122.858 1.313 . . . . 1.3500000000000001 112.587 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.9 ptm -114.76 165.24 13.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.507 -1.678 . . . . 1.26 110.045 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.669 ' HZ1' ' HH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -119.14 145.17 46.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 115.058 1.503 . . . . 2.3599999999999999 115.058 -177.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 101.81 -37.61 3.56 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 112.095 -2.32 . . . . 0.23000000000000001 118.749 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.57 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.06 157.48 0.32 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.883 2.341 . . . . 1.1000000000000001 114.358 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.634 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -86.12 -22.85 26.87 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.673 -1.149 . . . . 1.1000000000000001 108.861 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.232 0.137 0 CA-C-N 115.206 -0.906 . . . . 2.3100000000000001 110.86 -179.678 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 tp . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.4 0.619 . . . . 1.1299999999999999 109.669 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.575 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -59.83 -20.34 56.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.096 -0.956 . . . . 1.1299999999999999 110.599 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.09 -18.5 63.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 2.0899999999999999 111.35 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -107.7 -26.73 10.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.696 -0.401 . . . . 2.5 111.476 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -45.84 145.48 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.756 -0.378 . . . . 1.05 111.505 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.606 HD11 ' O ' ' A' ' 172' ' ' ILE . 0.2 OUTLIER -133.48 -18.86 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 119.861 -0.736 . . . . 1.48 110.345 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.512 ' O ' HG21 ' A' ' 172' ' ' ILE . 44.0 t90 -175.22 144.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.591 -0.444 . . . . 0.33000000000000002 110.311 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -162.05 142.82 10.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.667 0.247 . . . . 1.05 111.667 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.68 128.95 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.988 1.107 . . . . 1.3600000000000001 113.988 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.521 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 10.1 t30 -114.26 93.7 4.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.904 -0.776 . . . . 1.8700000000000001 108.904 176.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HB3' ' OH ' ' A' ' 73' ' ' TYR . . . -63.7 97.41 0.15 Allowed 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.442 -0.799 . . . . 1.1100000000000001 109.757 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.547 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . 176.93 -77.8 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.122 -1.399 . . . . 0.67000000000000004 113.196 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -77.16 -125.36 0.26 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.204 -0.522 . . . . 1.1200000000000001 112.759 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.95 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -162.72 121.48 2.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 120.858 0.361 . . . . 2.02 110.744 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.0 p 35.11 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.809 -0.632 . . . . 1.6499999999999999 112.289 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 55.9 t60 -117.78 152.47 35.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.157 -0.617 . . . . 0.41999999999999998 112.575 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.7 t -123.67 103.6 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.469 -0.787 . . . . 1.8200000000000001 110.427 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -68.45 151.29 47.03 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.275 -0.42 . . . . 1.1699999999999999 110.731 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 m -43.09 -48.69 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 124.367 1.042 . . . . 1.27 112.888 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -57.74 -29.73 65.0 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.319 0.58 . . . . 0.55000000000000004 110.069 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . 113.83 33.81 1.8 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.142 -0.935 . . . . 0.32000000000000001 111.666 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 27' ' ' ILE . 36.1 mm -103.39 123.5 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.607 -0.516 . . . . 1.21 109.607 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.6 t60 -104.38 134.97 46.69 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.614 1.338 . . . . 0.68999999999999995 114.614 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.95 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -97.72 129.31 44.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.564 -0.902 . . . . 3.3199999999999998 108.564 176.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -82.43 113.15 19.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.647 0.61 . . . . 3.3999999999999999 112.647 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -28.12 140.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.445 -1.252 . . . . 3.1600000000000001 113.499 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.511 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 1.6 m-20 -14.75 83.57 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.814 1.246 . . . . 1.98 114.079 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 C--N 1.351 0.682 0 C-N-CA 122.35 2.033 . . . . 1.53 113.783 178.638 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mt . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.758 0.789 . . . . 1.45 109.503 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mt -46.94 -52.48 14.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.171 -1.377 . . . . 2.29 113.937 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -65.75 -0.68 2.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.046 0.387 . . . . 3.0600000000000001 112.046 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.9 t -128.18 142.08 51.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.685 0.624 . . . . 1.4099999999999999 112.685 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -69.15 158.84 85.5 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.848 -0.615 . . . . 1.96 109.497 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.539 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.9 Cg_exo -40.07 -56.69 1.37 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 123.188 2.592 . . . . 0.78000000000000003 116.446 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 12.5 pt-20 -71.45 -53.36 14.23 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.318 0.58 . . . . 1.8200000000000001 111.264 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.67 -5.03 22.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.126 -0.694 . . . . 1.9099999999999999 109.126 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.539 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -77.59 -46.98 20.51 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.683 -0.858 . . . . 2.0600000000000001 108.683 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -55.09 -42.57 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.378 -0.971 . . . . 1.8500000000000001 108.378 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 62' ' ' GLN . 13.0 tp -63.53 -63.48 1.17 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.537 -0.542 . . . . 1.6000000000000001 109.537 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.481 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 3.3 m-85 -51.13 -12.38 0.13 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.501 -0.772 . . . . 1.29 110.632 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -123.59 -126.21 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.587 -0.733 . . . . 1.8 111.239 -178.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.508 ' O ' ' O ' ' A' ' 62' ' ' GLN . 26.6 p 45.49 128.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.655 0.782 . . . . 1.4099999999999999 112.81 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.465 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -124.79 154.82 40.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.441 0.638 . . . . 2.0499999999999998 112.65 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.547 ' HD3' ' N ' ' A' ' 17' ' ' GLY . 18.2 mtp180 -123.3 -171.74 2.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.01 -0.995 . . . . 4.2800000000000002 110.281 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.4 -178.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 4.4699999999999998 111.043 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.98 163.25 39.32 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.434 -0.348 . . . . 5.1500000000000004 110.963 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.56 -93.76 0.06 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.504 -0.316 . . . . 3.1699999999999999 111.631 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -173.15 127.97 0.45 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.813 0.301 . . . . 2.3900000000000001 111.813 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.5 t 52.45 93.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.096 -0.502 . . . . 1.3200000000000001 111.976 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -160.58 161.44 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 1.77 110.588 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.07 177.56 39.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.978 -1.106 . . . . 0.98999999999999999 114.632 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.588 ' OH ' ' HB3' ' A' ' 16' ' ' ALA . 6.6 m-85 -100.89 161.73 13.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 1.1899999999999999 111.958 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -115.49 122.32 45.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.952 -1.022 . . . . 2.27 111.137 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.53 109.63 45.7 Favored Pre-proline 0 C--O 1.224 -0.251 0 CA-C-O 119.367 -0.349 . . . . 1.0700000000000001 111.179 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -81.85 130.43 6.67 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.297 1.142 . . . . 1.26 112.106 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.9 mt -121.78 148.41 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.847 0.356 . . . . 1.0900000000000001 111.324 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -139.41 -0.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 3.4399999999999999 111.039 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.426 ' HG3' ' HZ1' ' A' ' 174' ' ' LYS . 12.6 mm-40 -123.74 166.02 16.28 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.659 0.266 . . . . 2.1299999999999999 110.878 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -119.7 172.95 7.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.273 0.559 . . . . 0.37 111.175 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.04 -147.23 18.9 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.02 -1.232 . . . . 0.23000000000000001 110.02 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mt-10 -105.87 109.44 21.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.603 1.201 . . . . 2.0299999999999998 109.805 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -96.65 127.22 42.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.046 -0.724 . . . . 0.94999999999999996 109.046 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' ' 177' ' ' ALA . 17.3 t -113.36 117.06 54.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.383 -0.826 . . . . 1.21 111.48 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.21 104.79 16.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.79 111.312 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -105.3 137.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.918 -1.037 . . . . 1.95 108.976 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -156.14 135.42 12.2 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.501 -0.88 . . . . 2.0 112.368 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.678 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 3.5 mptt -97.38 127.47 43.36 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.918 -0.713 . . . . 3.3799999999999999 109.331 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.445 ' CD2' HD22 ' A' ' 115' ' ' LEU . 3.1 m-85 -106.94 137.12 45.6 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.217 -0.66 . . . . 0.34999999999999998 109.217 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 120.75 -0.38 . . . . 1.1499999999999999 110.35 179.591 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 26.7 mt-30 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.886 0.374 . . . . 3.6000000000000001 111.636 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.2 p -124.54 154.54 40.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 1.8899999999999999 111.755 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 47.22 29.2 1.14 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.767 -0.651 . . . . 2.6899999999999999 111.829 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -133.96 -48.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.259 -0.645 . . . . 3.0299999999999998 109.259 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -93.21 88.79 6.17 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 3.52 109.133 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.73 152.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.531 -0.759 . . . . 1.95 109.55 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -134.37 176.28 8.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.986 0.736 . . . . 0.80000000000000004 112.986 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -121.42 139.44 53.45 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.06 -0.518 . . . . 2.0099999999999998 111.206 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.68 130.6 42.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.641 -0.709 . . . . 1.1599999999999999 112.04 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -131.81 153.84 49.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.14 0.793 . . . . 2.1800000000000002 113.14 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 20.4 m -121.92 120.71 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.638 -1.165 . . . . 1.71 109.613 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.401 ' HA ' ' H ' ' A' ' 154' ' ' SER . 4.4 t-20 54.28 27.17 7.6 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.998 -0.741 . . . . 1.77 108.998 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.07 23.67 29.19 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.708 -1.133 . . . . 0.40999999999999998 112.914 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.6 m-70 -122.97 108.73 13.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.209 0.818 . . . . 0.58999999999999997 113.209 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.425 ' HG1' ' HZ2' ' A' ' 113' ' ' LYS . 5.4 p -62.48 115.9 4.64 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.91 0.386 . . . . 1.2 111.642 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 t -106.38 -36.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 1.3999999999999999 109.878 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.84 92.29 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.851 -0.426 . . . . 1.21 109.851 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.425 ' HZ2' ' HG1' ' A' ' 110' ' ' THR . 1.3 ptpt -105.8 76.99 1.22 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.715 1.245 . . . . 2.9199999999999999 111.983 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 155.71 27.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.221 -2.263 . . . . 2.5600000000000001 109.073 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.445 HD22 ' CD2' ' A' ' 89' ' ' PHE . 40.5 tp -60.88 102.17 0.18 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.628 0.728 . . . . 1.71 112.531 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 36.0 p-10 -112.06 89.43 3.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.528 -1.215 . . . . 1.99 108.406 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.0 -54.05 15.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 1.23 113.526 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 13.1 t80 -56.55 -40.07 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.88 0.326 . . . . 1.01 111.88 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.65 -28.81 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.124 0.416 . . . . 0.76000000000000001 112.124 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 120' ' ' ARG . 11.6 mmm180 -75.98 -58.69 3.13 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.511 0.56 . . . . 3.0299999999999998 112.511 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -87.1 -40.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.937 0.347 . . . . 2.0299999999999998 111.937 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.76 -94.93 0.75 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 1.0600000000000001 112.284 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.517 ' O ' HG23 ' A' ' 125' ' ' THR . 73.6 m80 -112.92 110.08 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.656 0.265 . . . . 4.29 111.286 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.2 m 56.05 -132.42 1.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.187 -0.46 . . . . 2.1099999999999999 111.245 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 123' ' ' HIS . 11.0 p 57.94 -171.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.303 0.241 . . . . 1.3300000000000001 111.006 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.28 139.5 49.37 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.591 0.96 . . . . 1.1200000000000001 113.591 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.61 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.4 t60 -100.31 150.86 22.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.55 -1.204 . . . . 0.45000000000000001 107.844 176.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.61 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 8.7 p-10 -145.37 122.33 11.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.26 -0.576 . . . . 2.0899999999999999 112.208 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -119.71 141.67 49.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.513 -0.767 . . . . 2.2799999999999998 109.512 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 mt -123.4 136.23 60.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.683 -0.69 . . . . 1.3799999999999999 111.229 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 131' ' ' ILE . 4.2 mp -134.29 89.5 27.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 2.0 111.631 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.01 144.07 92.18 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.72 1.613 . . . . 0.23999999999999999 111.305 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 134' ' ' SER . 21.5 mt -135.41 154.85 36.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.563 -0.29 . . . . 1.0600000000000001 111.181 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.434 ' N ' HG23 ' A' ' 133' ' ' ILE . 35.4 p -131.09 107.08 8.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 1.6599999999999999 110.635 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.9 mt -106.98 129.65 60.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.917 -0.583 . . . . 1.0700000000000001 110.55 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -147.88 140.5 24.61 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.798 0.332 . . . . 2.4300000000000002 110.814 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.68 ' HB2' ' HZ2' ' A' ' 137' ' ' LYS . 0.6 OUTLIER 55.66 28.51 12.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.554 0.692 . . . . 3.5600000000000001 110.06 -179.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.29 27.92 62.92 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.221 -0.899 . . . . 0.32000000000000001 112.703 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 62.4 mttp -121.89 146.87 46.69 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.919 0.359 . . . . 2.6800000000000002 110.797 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -107.67 131.31 54.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.146 0.498 . . . . 1.1100000000000001 112.197 -177.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.542 ' N ' HD22 ' A' ' 140' ' ' LEU . 32.3 t -121.32 110.36 16.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.53 -0.759 . . . . 1.3700000000000001 109.618 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 142' ' ' VAL . 7.1 p -103.66 108.28 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.321 0.582 . . . . 1.23 110.968 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 60.94 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.645 -0.707 . . . . 2.0499999999999998 112.022 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -137.92 12.45 3.64 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.47 -0.871 . . . . 0.59999999999999998 113.158 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -116.88 141.14 48.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.863 0.331 . . . . 2.02 110.263 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.46 136.95 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 1.8700000000000001 111.142 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.8 t -157.93 127.31 5.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.723 -0.672 . . . . 1.46 109.824 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.2 p -58.03 142.9 45.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.294 -0.412 . . . . 1.55 111.535 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -79.42 122.03 25.9 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.125 -0.694 . . . . 0.34000000000000002 109.125 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 t -111.18 91.36 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.156 -0.618 . . . . 2.02 112.6 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.04 -33.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 117.269 1.668 . . . . 0.77000000000000002 117.269 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.643 ' HZ2' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -160.87 154.97 22.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.501 1.651 . . . . 2.3199999999999998 113.868 -176.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.504 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -87.2 127.28 35.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.96 -1.126 . . . . 1.8600000000000001 107.96 176.19 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.401 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -118.11 114.2 22.72 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.382 0.882 . . . . 1.72 113.382 -176.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.83 103.29 14.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.44 -0.578 . . . . 1.27 109.44 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.545 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.4 mt-10 -107.67 139.44 42.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 2.48 111.447 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -136.11 138.44 42.06 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.011 -0.54 . . . . 1.9199999999999999 110.002 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.434 ' CG2' HH21 ' A' ' 105' ' ' ARG . 12.0 t -115.14 143.62 24.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.95 -1.023 . . . . 1.3899999999999999 111.466 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -63.74 148.16 49.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 2.48 110.931 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.43 -29.8 8.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 1.1200000000000001 111.721 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -145.53 -55.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.545 0.212 . . . . 3.8999999999999999 111.011 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -142.24 -83.21 0.19 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.588 -0.278 . . . . 4.0999999999999996 111.51 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.14 125.16 29.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 1.3999999999999999 111.52 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 166' ' ' LYS . 1.3 m-20 -59.98 171.14 0.95 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.323 -0.853 . . . . 2.0 110.32 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -28.89 -29.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 123.312 2.675 . . . . 3.1099999999999999 114.318 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ASN . 15.6 tptp 85.28 -75.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.619 0.575 . . . . 4.1100000000000003 112.364 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 63' ' ' THR . 3.5 t -96.34 135.08 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 120.606 -0.438 . . . . 1.5900000000000001 112.017 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.22 134.96 45.95 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.98 -0.555 . . . . 1.8600000000000001 112.425 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.521 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -124.4 35.43 4.81 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.228 -0.896 . . . . 1.04 112.769 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -37.48 138.99 0.29 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.15 0.5 . . . . 1.6799999999999999 111.888 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.496 ' N ' HD12 ' A' ' 170' ' ' LEU . 0.7 OUTLIER -157.71 100.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.47 -0.786 . . . . 0.38 110.24 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.606 ' O ' HD11 ' A' ' 11' ' ' ILE . 1.3 tt -106.26 125.35 61.95 Favored 'Isoleucine or valine' 0 C--O 1.264 1.867 0 CA-C-O 122.758 1.266 . . . . 1.3500000000000001 112.553 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.585 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.7 ppp? -115.14 162.38 17.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.988 -1.915 . . . . 1.26 109.525 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.426 ' HZ1' ' HG3' ' A' ' 79' ' ' GLU . 32.2 tttt -120.34 144.15 48.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 115.272 1.582 . . . . 2.3599999999999999 115.272 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.68 -36.8 4.1 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 112.397 -2.183 . . . . 0.23000000000000001 118.398 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.551 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.48 155.15 0.3 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.908 2.354 . . . . 1.1000000000000001 115.177 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.618 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -86.73 -24.61 25.08 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 114.566 -1.197 . . . . 1.1000000000000001 108.972 175.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-N 115.324 -0.853 . . . . 2.3100000000000001 110.657 -179.246 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 121.147 0.499 . . . . 1.1299999999999999 110.219 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -53.26 -20.4 4.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.362 -0.835 . . . . 1.1299999999999999 111.311 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.15 -27.8 38.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.407 0.521 . . . . 2.0899999999999999 112.407 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 37.4 mmtt -95.29 -22.75 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.717 -0.393 . . . . 2.5 111.49 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.485 HG11 ' O ' ' A' ' 7' ' ' ALA . 12.7 p -43.79 143.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 120.584 0.231 . . . . 1.05 111.615 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 11' ' ' ILE . 18.3 pt -136.91 -23.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.013 -0.675 . . . . 1.48 110.487 177.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.486 ' O ' HG21 ' A' ' 172' ' ' ILE . 73.3 t90 -172.74 140.94 1.03 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.049 -0.523 . . . . 0.33000000000000002 110.091 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -159.88 143.94 14.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.271 0.471 . . . . 1.05 112.271 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 13' ' ' ALA . 4.2 t -147.02 130.98 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 113.807 1.04 . . . . 1.3600000000000001 113.807 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 15.6 t-20 -114.43 95.25 5.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.887 -1.051 . . . . 1.8700000000000001 108.553 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.662 ' HB2' ' HH ' ' A' ' 73' ' ' TYR . . . -60.18 92.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.265 -1.013 . . . . 1.1100000000000001 108.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.598 ' HA3' ' OG1' ' A' ' 63' ' ' THR . . . -177.27 -95.34 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 O-C-N 124.582 1.176 . . . . 0.67000000000000004 114.55 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.445 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -66.47 -122.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.112 -0.566 . . . . 1.1200000000000001 114.039 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.761 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 1.5 tt0 -159.09 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.388 -0.406 . . . . 2.02 110.158 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.0 m 31.61 95.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.512 -0.767 . . . . 1.6499999999999999 112.68 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.643 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 22.8 t60 -123.59 139.96 53.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.787 -0.765 . . . . 0.41999999999999998 112.5 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.03 104.07 16.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.668 -0.696 . . . . 1.8200000000000001 110.582 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 157.03 29.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.194 -0.912 . . . . 1.1699999999999999 110.662 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -43.73 -47.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 O-C-N 124.367 1.042 . . . . 1.27 113.277 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -62.57 -20.18 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.318 0.58 . . . . 0.55000000000000004 110.386 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.34 34.89 3.25 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.208 -0.905 . . . . 0.32000000000000001 112.542 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.01 114.84 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 120.459 -0.496 . . . . 1.21 110.455 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.643 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.5 t60 -100.42 136.35 40.43 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.915 1.45 . . . . 0.68999999999999995 114.915 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.761 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -102.23 135.99 42.85 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.698 -1.137 . . . . 3.3199999999999998 108.753 177.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -86.29 106.99 17.75 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.796 0.685 . . . . 3.3999999999999999 112.303 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.614 ' NZ ' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -34.21 137.06 0.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.121 -0.945 . . . . 3.1600000000000001 113.296 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.49 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER 3.0 79.7 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 114.748 -1.115 . . . . 1.98 113.551 178.299 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 CA--C 1.537 0.638 0 C-N-CA 122.188 1.925 . . . . 1.53 114.095 179.533 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 108.537 -0.912 . . . . 1.45 108.537 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -54.55 26.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.579 -1.191 . . . . 2.29 114.103 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -74.62 28.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.53 0.937 . . . . 3.0600000000000001 113.53 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t -141.11 145.08 35.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.137 0.494 . . . . 1.4099999999999999 112.133 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.1 t30 -63.47 146.9 96.08 Favored Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 115.484 -0.78 . . . . 1.96 109.596 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.2 Cg_exo -40.81 -58.89 0.88 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 122.631 2.221 . . . . 0.78000000000000003 115.249 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -62.21 -54.37 41.91 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 122.298 1.047 . . . . 1.8200000000000001 110.76 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -69.83 -11.64 61.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.036 -0.983 . . . . 1.9099999999999999 110.215 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.614 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -64.45 -45.71 86.26 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.491 -1.67 . . . . 2.0600000000000001 106.491 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.8 t -54.19 -51.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.403 -1.271 . . . . 1.8500000000000001 109.352 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.54 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.9 tp -70.49 -7.2 41.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.586 -0.734 . . . . 1.6000000000000001 111.426 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.0 m-30 -120.08 16.03 12.42 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.478 -0.783 . . . . 1.29 109.719 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.537 ' HG2' ' N ' ' A' ' 63' ' ' THR . 30.6 tt0 -141.25 -109.92 0.14 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.305 -0.861 . . . . 1.8 110.596 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.598 ' OG1' ' HA3' ' A' ' 17' ' ' GLY . 69.2 p 37.26 -156.02 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 119.082 -0.485 . . . . 1.4099999999999999 110.298 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.494 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 12.6 pt-20 -174.86 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.593 1.701 . . . . 2.0499999999999998 115.593 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.49 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 7.9 mtp180 70.57 -172.79 0.17 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.062 0.392 . . . . 4.2800000000000002 110.056 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -87.25 178.83 6.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.519 -0.309 . . . . 4.4699999999999998 111.106 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -150.05 171.99 15.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.379 -0.373 . . . . 5.1500000000000004 111.121 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.41 -102.5 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.475 -0.33 . . . . 3.1699999999999999 111.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -169.85 131.68 1.08 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.646 0.26 . . . . 2.3900000000000001 111.028 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.511 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 21.7 t 53.21 93.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.252 -0.431 . . . . 1.3200000000000001 111.495 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -168.85 168.83 10.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 1.77 110.975 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.37 -146.2 5.15 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.248 -0.977 . . . . 0.98999999999999999 113.86 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.662 ' HH ' ' HB2' ' A' ' 16' ' ' ALA . 58.9 m-85 -135.87 172.72 12.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.719 0.771 . . . . 1.1899999999999999 112.908 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.06 135.76 53.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.068 -1.424 . . . . 2.27 110.17 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.466 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.7 mp -129.35 86.34 56.66 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 111.706 0.262 . . . . 1.0700000000000001 111.706 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.73 126.13 21.39 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.109 1.873 . . . . 1.26 112.512 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -121.05 149.89 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 1.0900000000000001 110.933 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.03 2.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 3.4399999999999999 111.425 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.622 ' HG2' ' NZ ' ' A' ' 174' ' ' LYS . 8.0 tp10 -132.11 165.99 22.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.835 0.35 . . . . 2.1299999999999999 110.092 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.522 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -116.41 178.85 4.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.37 111.642 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.87 -148.08 18.66 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 109.972 -1.251 . . . . 0.23000000000000001 109.972 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 11.1 mm-40 -105.97 110.53 22.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.701 1.251 . . . . 2.0299999999999998 109.235 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.28 126.36 41.44 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 108.954 -0.758 . . . . 0.94999999999999996 108.954 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.628 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.7 t -114.5 121.24 66.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.346 -0.843 . . . . 1.21 112.032 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.42 ' C ' HD21 ' A' ' 85' ' ' LEU . 6.5 tt -103.56 105.62 15.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.864 -1.062 . . . . 1.79 110.635 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.22 132.12 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.24 -0.891 . . . . 1.95 108.816 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -147.47 138.78 23.78 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.241 -0.984 . . . . 2.0 112.824 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.605 ' HZ3' ' HB1' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -98.95 126.61 44.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.097 -0.956 . . . . 3.3799999999999999 109.024 178.329 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.38 146.13 32.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.551 -0.75 . . . . 0.34999999999999998 110.548 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.4 0 CA-C-N 116.088 -0.506 . . . . 1.1499999999999999 109.832 178.274 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.745 0.307 . . . . 3.6000000000000001 111.019 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 99' ' ' GLN . 20.4 m -99.0 -88.4 0.33 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.686 0.624 . . . . 1.8899999999999999 112.686 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.86 36.22 0.17 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.903 0.383 . . . . 2.6899999999999999 111.558 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 97' ' ' SER . 1.8 mt-30 -133.79 -41.3 0.85 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.016 -0.538 . . . . 3.0299999999999998 109.697 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -94.39 75.86 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.293 -0.632 . . . . 3.52 109.293 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.33 154.33 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.707 -0.678 . . . . 1.95 109.851 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -139.64 173.85 11.11 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 111.968 0.359 . . . . 0.80000000000000004 111.968 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.92 137.08 54.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.589 -0.444 . . . . 2.0099999999999998 110.812 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.6 t -132.06 129.68 60.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 112.598 0.592 . . . . 1.1599999999999999 112.598 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 2.7 mtt180 -134.89 149.59 50.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.591 -0.731 . . . . 2.1800000000000002 112.82 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 14.0 m -119.28 120.8 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.313 -0.858 . . . . 1.71 109.99 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.488 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.11 27.23 9.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.42 0.628 . . . . 1.77 109.342 -176.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.5 21.33 41.08 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.016 -0.993 . . . . 0.40999999999999998 112.671 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -119.16 113.73 21.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.079 0.77 . . . . 0.58999999999999997 113.079 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -64.49 124.7 22.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.507 -0.477 . . . . 1.2 111.046 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.19 -32.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.833 -0.621 . . . . 1.3999999999999999 109.531 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.12 90.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.081 -0.509 . . . . 1.21 110.151 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 18.1 ptpt -104.19 137.85 41.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.033 -0.531 . . . . 2.9199999999999999 110.41 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 22.6 m-20 87.47 18.24 0.07 Allowed 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.025 -1.472 . . . . 2.5600000000000001 107.025 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 tp -45.78 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.983 -1.462 . . . . 1.71 111.763 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -102.89 90.41 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.162 -0.927 . . . . 1.99 109.317 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -52.15 -47.94 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 1.23 112.637 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.77 -44.61 96.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.936 0.347 . . . . 1.01 111.936 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.87 -27.73 63.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.159 0.429 . . . . 0.76000000000000001 112.159 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -70.9 -58.1 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.247 0.462 . . . . 3.0299999999999998 112.247 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -99.96 -40.29 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.073 0.398 . . . . 2.0299999999999998 112.073 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.77 -134.36 8.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.458 -0.877 . . . . 1.0600000000000001 112.568 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -83.79 120.46 26.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.585 0.231 . . . . 4.29 111.009 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.0 p 48.18 -121.96 1.47 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.095 -0.502 . . . . 2.1099999999999999 110.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.9 p 51.13 -167.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.672 0.272 . . . . 1.3300000000000001 111.635 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.605 ' HB1' ' HZ3' ' A' ' 88' ' ' LYS . . . -106.88 136.31 46.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.36 1.245 . . . . 1.1200000000000001 114.36 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.1 t60 -108.8 141.51 40.73 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.267 -1.383 . . . . 0.45000000000000001 107.267 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.29 119.33 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.772 0.656 . . . . 2.0899999999999999 112.772 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.88 136.66 52.83 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.82 -0.627 . . . . 2.2799999999999998 109.922 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.1 mt -112.51 133.33 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.44 -0.8 . . . . 1.3799999999999999 110.639 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.82 85.75 34.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.349 0.499 . . . . 2.0 112.349 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.18 146.57 90.7 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.876 1.717 . . . . 0.23999999999999999 111.784 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 134' ' ' SER . 23.7 mt -136.7 156.93 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 1.0600000000000001 110.854 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 133' ' ' ILE . 35.4 p -132.83 106.95 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 1.6599999999999999 110.836 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 25.7 mt -103.29 126.45 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.798 -0.637 . . . . 1.0700000000000001 109.609 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 88.0 mttt -148.08 138.15 22.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.878 -0.329 . . . . 2.4300000000000002 111.208 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 61.61 23.55 13.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 3.5600000000000001 110.572 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.09 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.041 -0.599 . . . . 0.32000000000000001 112.227 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 59.3 mttt -114.72 159.03 21.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.383 0.135 . . . . 2.6800000000000002 111.073 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 tt -121.09 124.15 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.076 0.465 . . . . 1.1100000000000001 111.288 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.4 ' HB3' ' OG ' ' A' ' 134' ' ' SER . 24.5 t -114.1 109.53 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.674 -0.694 . . . . 1.3700000000000001 110.014 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.57 106.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 1.23 111.031 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.95 -92.0 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.883 -0.599 . . . . 2.0499999999999998 111.814 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.87 37.6 2.28 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.596 -0.811 . . . . 0.59999999999999998 113.046 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.09 137.28 25.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.16 -0.311 . . . . 2.02 110.16 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.02 140.34 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.97 0.414 . . . . 1.8700000000000001 110.976 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -162.69 126.93 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.901 -0.59 . . . . 1.46 110.447 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 t -56.22 140.82 43.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.867 -0.606 . . . . 1.55 112.406 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -79.62 139.24 37.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.403 -0.817 . . . . 0.34000000000000002 109.284 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 36.0 p -136.11 95.88 3.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.223 0.823 . . . . 2.02 113.223 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.23 -60.7 1.46 Allowed Glycine 0 C--N 1.331 0.282 0 N-CA-C 115.549 0.98 . . . . 0.77000000000000002 115.549 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -148.68 176.44 10.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.061 0.931 . . . . 2.3199999999999998 112.978 -178.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.488 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.55 127.25 48.34 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.685 -1.228 . . . . 1.8600000000000001 107.685 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.3 t -115.18 115.93 27.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.421 -0.912 . . . . 1.72 113.433 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.78 97.54 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.249 -0.649 . . . . 1.27 109.249 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 tt0 -108.04 135.74 48.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 2.48 111.407 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -130.84 143.2 50.57 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.747 -0.66 . . . . 1.9199999999999999 109.729 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.6 t -122.66 144.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.421 -0.809 . . . . 1.3899999999999999 111.653 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 146.36 30.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.738 -0.664 . . . . 2.48 110.88 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.9 -17.24 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.868 -0.682 . . . . 1.1200000000000001 112.14 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -138.44 -61.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 3.8999999999999999 110.429 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -175.25 150.9 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.097 -0.501 . . . . 4.0999999999999996 110.877 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.18 89.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.194 -0.457 . . . . 1.3999999999999999 111.437 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 70' ' ' SER . 1.4 m-20 -54.76 169.35 0.41 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.017 -0.538 . . . . 2.0 109.792 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 164' ' ' ASN . 2.8 Cg_endo -36.4 105.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.321 2.014 . . . . 3.1099999999999999 111.63 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -60.53 -46.74 89.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.269 -0.878 . . . . 4.1100000000000003 112.34 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.1 t -116.1 135.02 57.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 112.807 0.669 . . . . 1.5900000000000001 112.807 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -137.54 137.41 38.57 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 113.389 0.885 . . . . 1.8600000000000001 113.389 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 60' ' ' LEU . . . -125.03 38.6 4.16 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.62 -1.173 . . . . 1.04 111.397 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.5 tp -50.11 127.05 15.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.737 -0.665 . . . . 1.6799999999999999 111.448 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.409 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -142.09 115.5 8.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.667 -0.697 . . . . 0.38 110.831 -178.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.486 HG21 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -115.99 129.63 72.03 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 CA-C-O 123.126 1.441 . . . . 1.3500000000000001 112.994 178.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.58 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.0 ppp? -124.24 168.4 13.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.957 -1.929 . . . . 1.26 109.834 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.622 ' NZ ' ' HG2' ' A' ' 79' ' ' GLU . 13.8 ptmt -120.45 156.05 32.26 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.167 1.543 . . . . 2.3599999999999999 115.167 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 86.46 -34.87 3.4 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 111.833 -2.439 . . . . 0.23000000000000001 118.082 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.546 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.62 158.55 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.209 2.004 . . . . 1.1000000000000001 114.249 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.628 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.44 -23.73 27.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.331 -0.849 . . . . 1.1000000000000001 110.425 177.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.692 -0.686 . . . . 2.3100000000000001 111.649 -178.598 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.143 0.497 . . . . 1.1299999999999999 109.812 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.502 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.95 -21.72 22.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.822 . . . . 1.1299999999999999 111.162 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.7 -19.78 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 2.0899999999999999 111.909 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -101.44 -23.39 14.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.949 -0.301 . . . . 2.5 111.282 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.1 p -45.71 141.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.735 0.303 . . . . 1.05 111.725 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.28 -21.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.324 -0.551 . . . . 1.48 110.355 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.531 ' O ' HG22 ' A' ' 172' ' ' ILE . 60.4 t90 -173.83 144.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.33000000000000002 109.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -164.31 144.91 8.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.628 0.603 . . . . 1.05 112.628 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.72 129.49 6.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 113.661 0.986 . . . . 1.3600000000000001 113.661 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 60' ' ' LEU . 49.1 t30 -111.52 87.1 2.47 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.934 -1.136 . . . . 1.8700000000000001 107.934 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.433 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -57.52 103.67 0.14 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.447 -1.251 . . . . 1.1100000000000001 109.983 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.587 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 154.2 -17.95 0.62 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 113.898 -1.501 . . . . 0.67000000000000004 115.576 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.7 -126.56 2.77 Favored Glycine 0 N--CA 1.459 0.191 0 C-N-CA 119.367 -1.396 . . . . 1.1200000000000001 113.529 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.566 ' HG3' ' HZ1' ' A' ' 31' ' ' LYS . 6.7 tt0 -165.67 120.23 1.23 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.905 0.383 . . . . 2.02 111.695 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.2 p 32.88 94.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.244 -0.889 . . . . 1.6499999999999999 112.882 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.3 t60 -128.9 137.61 51.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.826 -0.75 . . . . 0.41999999999999998 112.351 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 22' ' ' VAL . 6.0 p -113.68 105.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-O 121.387 0.613 . . . . 1.8200000000000001 111.462 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 156.53 36.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.513 -0.767 . . . . 1.1699999999999999 109.851 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 m -43.35 -46.72 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.761 1.023 . . . . 1.27 113.761 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -63.54 -13.91 45.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.55000000000000004 110.914 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.71 33.04 5.45 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.501 -0.772 . . . . 0.32000000000000001 112.527 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.407 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 23.3 mm -103.92 112.23 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.184 0.516 . . . . 1.21 110.497 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.2 t60 -98.64 136.24 39.0 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.447 1.277 . . . . 0.68999999999999995 114.447 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.89 132.32 43.58 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.73 -1.123 . . . . 3.3199999999999998 108.649 177.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 22.8 mtt-85 -84.04 103.75 13.53 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 124.27 0.981 . . . . 3.3999999999999999 112.685 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.566 ' HZ1' ' HG3' ' A' ' 19' ' ' GLU . 15.9 ttmm -14.61 124.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.003 1.112 . . . . 3.1600000000000001 114.003 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -13.84 81.5 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.912 1.285 . . . . 1.98 113.822 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.71 0 C-N-CA 123.188 2.592 . . . . 1.53 113.305 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 50' ' ' ILE . 1.2 mp . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.106 0.479 . . . . 1.45 110.567 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.28 -48.15 7.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.098 0.777 . . . . 2.29 113.098 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -76.44 36.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.046 0.758 . . . . 3.0600000000000001 113.046 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -151.45 145.01 24.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.075 0.464 . . . . 1.4099999999999999 111.776 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.9 t30 -58.96 144.84 81.39 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.543 -0.753 . . . . 1.96 110.822 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.648 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.98 -53.68 2.82 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.949 2.433 . . . . 0.78000000000000003 115.383 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -64.92 -55.28 20.23 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 122.474 1.131 . . . . 1.8200000000000001 110.442 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.51 -9.25 53.02 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.721 -1.127 . . . . 1.9099999999999999 109.733 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.648 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.1 tt0 -66.32 -49.68 66.18 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.834 -1.543 . . . . 2.0600000000000001 106.834 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.32 -46.01 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.985 -1.007 . . . . 1.8500000000000001 109.385 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.458 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.4 tp -72.29 -12.99 61.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.409 -0.814 . . . . 1.6000000000000001 111.376 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -120.71 20.61 11.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.6 -0.727 . . . . 1.29 111.494 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.462 ' O ' HG22 ' A' ' 167' ' ' VAL . 32.4 tt0 -137.86 -59.61 0.65 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.35 0.87 . . . . 1.8 113.35 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.509 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 82.8 p -39.53 143.87 0.19 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.213 0.82 . . . . 1.4099999999999999 113.213 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.587 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.6 OUTLIER -127.28 145.06 50.92 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.897 -0.592 . . . . 2.0499999999999998 111.51 -179.258 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -107.34 172.0 7.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.895 -0.593 . . . . 4.2800000000000002 110.015 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -57.72 174.97 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 4.4699999999999998 110.97 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.515 ' HB2' ' OD1' ' A' ' 164' ' ' ASN . 2.7 p-10 -150.26 167.48 26.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 5.1500000000000004 111.632 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.8 tp10 -163.02 -83.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.042 -0.526 . . . . 3.1699999999999999 111.311 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.485 ' HB2' ' HZ1' ' A' ' 159' ' ' LYS . 2.9 p30 -173.37 132.43 0.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.398 0.142 . . . . 2.3900000000000001 110.845 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t 43.4 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.426 -0.352 . . . . 1.3200000000000001 110.425 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.482 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 0.6 OUTLIER -149.3 158.22 44.0 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.8 -0.36 . . . . 1.77 111.569 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.45 -149.21 7.71 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.24 -0.981 . . . . 0.98999999999999999 114.367 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -129.71 168.84 15.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.543 0.687 . . . . 1.1899999999999999 112.536 -177.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.52 132.52 55.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.451 -1.25 . . . . 2.27 110.348 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 75' ' ' ILE . 4.4 mp -124.88 86.89 55.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.437 0.532 . . . . 1.0700000000000001 112.437 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -55.37 132.41 52.05 Favored 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 122.271 1.981 . . . . 1.26 112.325 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 77' ' ' ILE . 66.2 mt -127.93 151.31 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.231 -0.441 . . . . 1.0900000000000001 111.067 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -140.84 1.38 1.68 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.173 -0.467 . . . . 3.4399999999999999 111.193 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 11.3 mm-40 -124.34 172.98 8.7 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.592 0.234 . . . . 2.1299999999999999 110.819 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.24 165.37 19.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.379 0.609 . . . . 0.37 111.658 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.06 26.51 Favored Glycine 0 C--N 1.329 0.144 0 N-CA-C 109.874 -1.29 . . . . 0.23000000000000001 109.874 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.577 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -96.95 107.25 19.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.95 1.375 . . . . 2.0299999999999998 108.857 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.466 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 1.9 m-85 -95.39 127.46 41.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.573 0.702 . . . . 0.94999999999999996 109.189 -178.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.578 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.1 t -118.04 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.853 -1.067 . . . . 1.21 113.284 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.48 105.96 17.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.121 -0.945 . . . . 1.79 110.381 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.4 106.12 18.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.14 -0.689 . . . . 1.95 109.14 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.446 ' N ' HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.486 -0.486 . . . . 2.0 112.248 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.44 ' HZ3' ' HB2' ' A' ' 128' ' ' ASP . 10.6 tptp -106.59 115.89 30.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.272 -1.01 . . . . 3.3799999999999999 108.272 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 9.9 m-85 -104.77 143.64 32.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.535 -0.543 . . . . 0.34999999999999998 109.535 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.418 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 120.088 -0.645 . . . . 1.1499999999999999 111.001 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 2.4 pp0? . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.685 0.278 . . . . 3.6000000000000001 110.768 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.409 ' HB3' ' OD2' ' A' ' 119' ' ' ASP . 10.8 m -137.65 147.72 45.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 1.8899999999999999 111.708 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 54.03 24.75 4.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.868 -0.606 . . . . 2.6899999999999999 111.288 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -125.32 -56.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.602 -0.518 . . . . 3.0299999999999998 109.602 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -94.63 96.78 9.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.069 -0.715 . . . . 3.52 109.069 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.522 HG12 ' OD2' ' A' ' 116' ' ' ASP . 0.6 OUTLIER -109.2 148.99 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 1.95 110.553 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -120.35 -178.27 3.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.839 0.681 . . . . 0.80000000000000004 112.839 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -130.98 143.08 50.46 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 115.876 -0.602 . . . . 2.0099999999999998 112.131 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.22 132.68 46.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 112.151 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 12.9 ptt180 -134.35 151.65 51.35 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 115.318 -0.855 . . . . 2.1800000000000002 112.738 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 10.7 m -124.99 123.95 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.752 -1.113 . . . . 1.71 110.384 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 52.72 26.79 4.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.991 -0.744 . . . . 1.77 108.991 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.81 29.34 18.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.40999999999999998 112.666 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 80.3 m-70 -129.43 111.16 12.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.266 0.839 . . . . 0.58999999999999997 113.266 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -65.75 119.21 10.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.022 0.439 . . . . 1.2 111.259 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.52 -33.48 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.625 -0.716 . . . . 1.3999999999999999 110.015 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.58 90.54 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.214 -0.661 . . . . 1.21 109.214 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -103.39 77.1 1.48 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 122.295 1.045 . . . . 2.9199999999999999 111.406 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.5 p30 156.87 35.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.67 -1.605 . . . . 2.5600000000000001 109.152 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 93.81 0.14 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.292 0.568 . . . . 1.71 111.677 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.522 ' OD2' HG12 ' A' ' 101' ' ' VAL . 6.4 m-20 -104.58 81.12 1.75 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.766 -1.568 . . . . 1.99 106.766 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.3 mt -50.35 -38.29 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.972 -1.013 . . . . 1.23 112.821 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 14.1 t80 -71.09 -43.46 67.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.862 -0.335 . . . . 1.01 111.476 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.409 ' OD2' ' HB3' ' A' ' 97' ' ' SER . 9.4 t70 -66.12 -27.35 67.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.657 0.265 . . . . 0.76000000000000001 111.38 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -72.18 -58.6 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.488 0.551 . . . . 3.0299999999999998 112.488 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 m -96.33 -40.4 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.943 0.349 . . . . 2.0299999999999998 111.943 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.89 -98.85 1.89 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.721 . . . . 1.0600000000000001 112.046 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -68.56 159.43 31.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.026 -0.361 . . . . 4.29 110.026 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.4 p -57.4 94.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 2.1099999999999999 110.963 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.403 ' O ' HG13 ' A' ' 50' ' ' ILE . 23.8 p -140.75 -148.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 1.3300000000000001 110.029 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.439 ' HB2' ' HZ2' ' A' ' 88' ' ' LYS . . . -112.8 133.84 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.747 0.647 . . . . 1.1200000000000001 112.747 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.516 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.9 t60 -111.53 149.29 31.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.494 -0.928 . . . . 0.45000000000000001 108.494 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.516 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 19.5 t70 -141.73 132.07 25.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.31 0.576 . . . . 2.0899999999999999 112.517 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.96 114.36 16.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.137 -0.938 . . . . 2.2799999999999998 109.891 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.19 129.99 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 1.3799999999999999 110.55 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.4 89.52 47.19 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.417 -0.356 . . . . 2.0 111.933 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -64.05 150.57 88.08 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.056 1.837 . . . . 0.23999999999999999 112.011 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 134' ' ' SER . 34.2 mt -140.55 157.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.336 . . . . 1.0600000000000001 111.018 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.503 ' N ' HG22 ' A' ' 133' ' ' ILE . 35.4 p -133.53 106.41 7.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 1.6599999999999999 110.747 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 32.5 mt -105.5 126.51 60.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.761 -0.654 . . . . 1.0700000000000001 109.865 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.458 ' HZ2' ' HB2' ' A' ' 134' ' ' SER . 50.4 mttp -148.38 143.59 26.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.769 0.319 . . . . 2.4300000000000002 110.961 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt 57.69 13.89 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 3.5600000000000001 111.287 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.15 23.48 27.12 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.641 -0.79 . . . . 0.32000000000000001 113.075 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 1.3 mmmm -123.57 155.48 37.56 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.236 0.518 . . . . 2.6800000000000002 110.41 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -113.45 129.47 56.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.076 0.465 . . . . 1.1100000000000001 111.878 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.514 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.0 t -116.66 110.01 17.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 1.3700000000000001 109.472 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 142' ' ' VAL . 7.5 p -103.11 104.55 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.966 -0.561 . . . . 1.23 111.011 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 57.96 -91.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.965 -0.561 . . . . 2.0499999999999998 111.856 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.9 6.12 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.554 -0.831 . . . . 0.59999999999999998 113.414 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -127.79 136.08 50.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.056 -0.349 . . . . 2.02 110.056 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.15 136.96 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.049 0.452 . . . . 1.8700000000000001 111.141 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 m -155.93 175.3 14.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.761 -0.654 . . . . 1.46 109.26 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.29 141.78 32.67 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.604 -0.438 . . . . 1.55 111.757 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -77.63 129.99 36.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.477 -0.935 . . . . 0.34000000000000002 108.477 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 69.3 p -126.61 94.92 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.506 0.928 . . . . 2.02 113.506 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.03 -51.24 0.74 Allowed Glycine 0 CA--C 1.52 0.371 0 N-CA-C 116.328 1.291 . . . . 0.77000000000000002 116.328 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.512 ' HE2' ' N ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -156.37 164.31 38.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 118.443 1.121 . . . . 2.3199999999999998 112.618 -177.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -88.39 127.11 35.49 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.357 -1.349 . . . . 1.8600000000000001 107.357 177.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 t -113.42 112.91 24.42 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.698 -0.801 . . . . 1.72 112.988 -176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 104.06 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.277 -0.419 . . . . 1.27 110.344 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -125.11 156.94 37.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.226 0.536 . . . . 2.48 111.357 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.87 145.23 41.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.338 -0.846 . . . . 1.9199999999999999 110.065 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 t -115.31 143.92 24.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.414 -0.812 . . . . 1.3899999999999999 111.02 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.485 ' HZ1' ' HB2' ' A' ' 69' ' ' ASP . 24.3 pttm -75.92 144.59 40.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.483 -0.78 . . . . 2.48 111.116 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.62 -31.76 7.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.827 -0.701 . . . . 1.1200000000000001 111.745 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.42 -56.96 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.458 . . . . 3.8999999999999999 109.925 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -172.45 148.07 1.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.654 -0.703 . . . . 4.0999999999999996 110.372 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 65.42 71.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.277 0.56 . . . . 1.3999999999999999 111.07 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.515 ' OD1' ' HB2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -50.25 169.67 0.19 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 114.93 -1.032 . . . . 2.0 109.443 178.171 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -37.22 110.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 121.773 1.649 . . . . 3.1099999999999999 111.979 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -64.27 -69.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.091 -0.959 . . . . 4.1100000000000003 112.93 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 62' ' ' GLN . 91.9 t -87.27 132.1 33.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 112.044 0.386 . . . . 1.5900000000000001 112.044 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.58 123.41 21.29 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.759 0.662 . . . . 1.8600000000000001 112.669 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.423 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -118.84 40.46 3.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.748 -1.115 . . . . 1.04 112.985 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 tp -56.05 129.16 38.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.462 0.649 . . . . 1.6799999999999999 111.035 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -139.95 114.03 8.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.041 -0.982 . . . . 0.38 109.743 -178.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.531 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -111.23 126.78 68.64 Favored 'Isoleucine or valine' 0 C--O 1.258 1.513 0 CA-C-O 122.947 1.356 . . . . 1.3500000000000001 113.353 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.61 165.95 14.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.141 -1.845 . . . . 1.26 109.539 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 10.6 ptmt -120.36 142.9 48.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 114.886 1.439 . . . . 2.3599999999999999 114.886 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.4 -34.89 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 112.837 -1.983 . . . . 0.23000000000000001 117.737 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.557 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.27 158.26 0.47 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.393 2.096 . . . . 1.1000000000000001 114.26 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.578 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.18 -27.96 24.22 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 114.729 -1.123 . . . . 1.1000000000000001 110.034 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.6 -0.727 . . . . 2.3100000000000001 111.153 -179.193 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.4 tp . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.25 0.547 . . . . 1.1299999999999999 110.344 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.457 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -53.85 -21.54 7.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 1.1299999999999999 111.77 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.98 -23.41 41.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.637 0.606 . . . . 2.0899999999999999 112.637 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.57 -21.27 15.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.618 -0.433 . . . . 2.5 111.871 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 7' ' ' ALA . 12.6 p -44.37 144.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 121.146 -0.221 . . . . 1.05 111.245 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -135.86 -20.33 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 119.686 -0.806 . . . . 1.48 111.258 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.504 ' O ' HG21 ' A' ' 172' ' ' ILE . 23.5 t90 -174.07 139.54 0.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.765 -0.374 . . . . 0.33000000000000002 110.17 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.21 142.04 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.101 0.408 . . . . 1.05 112.101 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.9 t -147.52 129.29 6.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 114.567 1.321 . . . . 1.3600000000000001 114.567 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 15.6 t30 -115.23 96.72 5.81 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.089 0.471 . . . . 1.8700000000000001 110.385 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -68.16 114.19 6.45 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 115.683 -0.689 . . . . 1.1100000000000001 109.709 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' C ' ' HB ' ' A' ' 63' ' ' THR . . . 145.61 -36.06 1.37 Allowed Glycine 0 C--N 1.342 0.882 0 O-C-N 124.767 1.292 . . . . 0.67000000000000004 113.674 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.497 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -110.5 -132.37 6.2 Favored Glycine 0 N--CA 1.454 -0.102 0 C-N-CA 120.313 -0.946 . . . . 1.1200000000000001 113.36 -178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.31 120.75 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.588 0.233 . . . . 2.02 110.669 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 77.8 p 28.46 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.598 -0.728 . . . . 1.6499999999999999 112.672 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.573 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 75.8 t60 -119.11 151.6 38.0 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.921 -0.712 . . . . 0.41999999999999998 112.343 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.59 103.71 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.27 -0.877 . . . . 1.8200000000000001 109.969 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.83 153.19 42.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.074 -0.512 . . . . 1.1699999999999999 110.305 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.4 m -43.76 -51.26 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 124.17 0.919 . . . . 1.27 113.212 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -58.68 -17.92 26.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.134 0.492 . . . . 0.55000000000000004 110.532 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.11 35.51 3.92 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.32000000000000001 112.432 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 27' ' ' ILE . 35.7 mm -103.62 121.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.858 -0.423 . . . . 1.21 109.858 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.4 t60 -103.27 134.75 46.14 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.686 1.365 . . . . 0.68999999999999995 114.686 -176.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.23 132.52 44.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.055 -0.975 . . . . 3.3199999999999998 108.77 176.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 50.1 mtt180 -87.51 108.45 19.04 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.666 0.604 . . . . 3.3999999999999999 112.047 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 32' ' ' ASP . 39.0 tttt -23.57 135.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.947 0.899 . . . . 3.1600000000000001 112.97 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 31' ' ' LYS . 4.1 p-10 -11.41 84.04 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 124.228 0.955 . . . . 1.98 112.884 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 13.5 Cg_endo . . . . . 0 CA--C 1.536 0.583 0 C-N-CA 122.51 2.14 . . . . 1.53 114.856 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 61' ' ' TYR . 1.1 mp . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.825 0.345 . . . . 1.45 110.16 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -94.48 -51.75 4.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.176 0.806 . . . . 2.29 113.176 -177.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -74.25 36.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.205 0.817 . . . . 3.0600000000000001 113.205 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -150.32 149.48 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 1.4099999999999999 112.041 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 58' ' ' GLN . 44.1 t30 -64.29 147.07 97.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.511 -0.768 . . . . 1.96 109.925 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 20.8 Cg_exo -41.7 -50.62 4.79 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 122.366 2.044 . . . . 0.78000000000000003 114.218 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -55.36 14.26 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.934 0.873 . . . . 1.8200000000000001 110.978 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' HD21 ' A' ' 60' ' ' LEU . 14.2 t70 -67.96 -11.37 58.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.649 -0.705 . . . . 1.9099999999999999 109.387 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.647 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 20.9 tt0 -65.95 -49.23 68.64 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.007 -1.479 . . . . 2.0600000000000001 107.007 177.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -51.15 -47.51 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.011 -0.995 . . . . 1.8500000000000001 109.193 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 tp -71.52 -13.34 61.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.028 -0.987 . . . . 1.6000000000000001 111.787 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.0 m-30 -121.4 21.21 11.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.712 -0.676 . . . . 1.29 111.244 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.577 ' O ' HG22 ' A' ' 167' ' ' VAL . 31.0 tt0 -140.15 -59.75 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.569 0.951 . . . . 1.8 113.569 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.541 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 37.9 p -45.54 136.86 5.43 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.985 0.735 . . . . 1.4099999999999999 112.985 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.5 pt-20 -121.49 150.06 42.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.985 -0.552 . . . . 2.0499999999999998 111.417 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.491 ' HG3' HH11 ' A' ' 65' ' ' ARG . 12.7 ttt85 -117.66 147.76 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 4.2800000000000002 110.343 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -74.14 148.78 41.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 4.4699999999999998 111.778 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -153.38 -173.87 4.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.762 -0.654 . . . . 5.1500000000000004 110.276 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -122.7 -69.96 0.8 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.644 0.259 . . . . 3.1699999999999999 111.286 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -160.75 138.81 9.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.477 -0.329 . . . . 2.3900000000000001 110.28 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 54.32 87.97 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.814 -0.439 . . . . 1.3200000000000001 109.814 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.599 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 3.0 p90 -133.43 136.12 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.189 0.519 . . . . 1.77 111.1 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.25 -156.8 7.84 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.401 -0.818 . . . . 0.98999999999999999 113.594 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.3 163.89 31.28 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.163 0.506 . . . . 1.1899999999999999 111.213 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.04 114.11 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.21 -0.904 . . . . 2.27 110.667 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.7 mp -105.73 112.56 64.49 Favored Pre-proline 0 C--O 1.224 -0.258 0 CA-C-N 116.222 -0.444 . . . . 1.0700000000000001 111.548 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.01 141.44 11.83 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 120.219 1.114 . . . . 1.26 111.604 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 77' ' ' ILE . 57.0 mt -132.25 151.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.039 0.447 . . . . 1.0900000000000001 111.675 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -142.95 -4.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.837 -0.62 . . . . 3.4399999999999999 110.958 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.796 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 16.2 mm-40 -119.57 173.05 7.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.552 0.215 . . . . 2.1299999999999999 110.817 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -127.26 175.63 8.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.242 0.544 . . . . 0.37 111.425 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.3 -146.86 18.51 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 109.965 -1.254 . . . . 0.23000000000000001 109.965 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 19.2 mt-10 -104.68 109.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.722 1.261 . . . . 2.0299999999999998 109.433 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.796 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.1 m-85 -96.13 127.46 42.15 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.229 -0.656 . . . . 0.94999999999999996 109.229 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.606 HG22 ' N ' ' A' ' 177' ' ' ALA . 21.4 t -113.87 120.83 64.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.995 -1.002 . . . . 1.21 112.388 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -94.01 105.8 17.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.931 -1.032 . . . . 1.79 111.367 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 48.2 t -106.17 116.22 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.069 -0.969 . . . . 1.95 108.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 133.6 45.17 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.3 -0.56 . . . . 2.0 110.978 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HZ2' ' HB3' ' A' ' 126' ' ' ALA . 9.2 tptp -100.13 118.8 37.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 119.605 -0.838 . . . . 3.3799999999999999 109.16 177.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -105.94 136.62 45.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.14 -1.059 . . . . 0.34999999999999998 108.14 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 C-N-CA 119.42 -0.912 . . . . 1.1499999999999999 112.025 -179.858 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 120.712 0.292 . . . . 3.6000000000000001 110.449 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 98' ' ' GLN . 18.2 m -86.36 179.07 6.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.357 -0.383 . . . . 1.8899999999999999 111.941 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 97' ' ' SER . 84.1 mm-40 70.84 -68.55 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.421 -0.809 . . . . 2.6899999999999999 111.29 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -62.42 -17.61 59.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 3.0299999999999998 110.662 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 1.7 mptm? -110.43 52.23 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 3.52 110.305 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.59 133.95 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.295 -0.632 . . . . 1.95 109.295 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.414 ' CE1' ' HA ' ' A' ' 164' ' ' ASN . 61.2 m-85 -138.89 170.91 15.14 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.552 0.945 . . . . 0.80000000000000004 113.552 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 157' ' ' PHE . 5.1 m-20 -112.89 136.95 51.96 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.555 -0.458 . . . . 2.0099999999999998 110.444 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.02 128.98 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 111.997 0.369 . . . . 1.1599999999999999 111.997 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 15.7 ptt180 -133.63 147.55 51.47 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.351 0.871 . . . . 2.1800000000000002 113.351 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m -122.18 120.59 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 114.761 -1.108 . . . . 1.71 109.807 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.481 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.38 27.21 9.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.308 0.575 . . . . 1.77 109.49 -176.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.39 14.07 57.67 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.224 -0.898 . . . . 0.40999999999999998 112.938 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.0 m-70 -110.66 111.19 22.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.264 0.839 . . . . 0.58999999999999997 113.264 -178.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -69.25 112.6 5.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.004 0.43 . . . . 1.2 110.418 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.67 -37.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 1.3999999999999999 110.848 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.33 91.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.134 -0.626 . . . . 1.21 111.121 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 10.9 ptmm? -101.88 146.75 27.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.374 -0.83 . . . . 2.9199999999999999 109.706 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 5.4 m-20 77.24 33.27 0.43 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.865 -1.061 . . . . 2.5600000000000001 108.741 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 1.71 112.126 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 44.7 p-10 -101.52 84.21 2.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.151 -0.685 . . . . 1.99 109.151 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.2 pt -51.25 -37.24 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.648 -0.706 . . . . 1.23 112.231 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -57.08 -44.69 83.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.543 -0.298 . . . . 1.01 111.57 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.19 -28.18 63.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.83 0.308 . . . . 0.76000000000000001 111.83 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -72.25 -58.82 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.205 0.446 . . . . 3.0299999999999998 112.205 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.3 m -88.63 -40.41 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.846 0.313 . . . . 2.0299999999999998 111.846 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.73 -93.37 0.65 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.747 -0.739 . . . . 1.0600000000000001 111.94 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.457 ' O ' HG23 ' A' ' 125' ' ' THR . 61.0 m80 -115.08 110.4 19.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.517 0.198 . . . . 4.29 110.952 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.7 p 54.42 -144.84 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.269 -0.423 . . . . 2.1099999999999999 111.21 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.5 p 68.45 -172.67 0.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.987 0.515 . . . . 1.3300000000000001 111.743 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.617 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . . . -106.45 141.67 37.38 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.769 0.655 . . . . 1.1200000000000001 112.769 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.42 ' ND1' ' H ' ' A' ' 128' ' ' ASP . 15.7 t60 -101.88 157.4 16.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.606 -0.724 . . . . 0.45000000000000001 109.103 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.467 ' HB3' ' HZ1' ' A' ' 88' ' ' LYS . 7.1 p-10 -143.0 113.51 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.464 0.542 . . . . 2.0899999999999999 112.464 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -108.12 116.88 32.77 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.678 -0.692 . . . . 2.2799999999999998 110.078 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.7 mt -109.66 130.0 63.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.72 -0.673 . . . . 1.3799999999999999 110.109 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.71 89.53 25.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.34 0.496 . . . . 2.0 112.34 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -61.53 149.65 88.76 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.943 1.762 . . . . 0.23999999999999999 111.926 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 134' ' ' SER . 26.1 mt -140.06 156.71 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 1.0600000000000001 111.101 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.481 ' N ' HG23 ' A' ' 133' ' ' ILE . 39.9 t -130.6 107.24 9.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 1.6599999999999999 110.82 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.2 mt -107.6 129.03 62.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.811 -0.631 . . . . 1.0700000000000001 110.393 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -147.62 139.35 24.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 2.4300000000000002 110.771 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp 54.57 28.39 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 3.5600000000000001 110.646 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 28.37 58.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.32000000000000001 112.544 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.686 ' HB2' ' HZ2' ' A' ' 139' ' ' LYS . 4.4 ttmp? -121.89 146.04 47.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.386 -0.228 . . . . 2.6800000000000002 110.386 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.518 HD21 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -114.17 130.71 56.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.107 0.48 . . . . 1.1100000000000001 112.077 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.518 ' N ' HD21 ' A' ' 140' ' ' LEU . 22.2 t -127.07 110.01 12.48 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.617 -0.72 . . . . 1.3700000000000001 109.73 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 142' ' ' VAL . 3.2 p -102.94 131.34 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.337 -0.392 . . . . 1.23 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 46.96 -90.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.821 0.304 . . . . 2.0499999999999998 111.821 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -136.66 25.87 3.07 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.694 -0.765 . . . . 0.59999999999999998 113.346 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -124.03 142.68 50.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.69 -0.485 . . . . 2.02 109.69 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.49 145.97 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 1.8700000000000001 111.404 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.2 t -163.3 167.85 21.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.381 -0.6 . . . . 1.46 109.381 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.6 139.58 35.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.561 -0.456 . . . . 1.55 111.482 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.24 123.95 27.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.535 -1.283 . . . . 0.34000000000000002 107.535 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.1 m -129.24 94.23 3.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.418 -0.913 . . . . 2.02 112.874 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.32 -48.79 1.84 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 116.778 1.471 . . . . 0.77000000000000002 116.778 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.585 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -159.44 154.56 25.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.997 1.398 . . . . 2.3199999999999998 113.817 -176.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -86.58 131.77 34.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.352 -0.981 . . . . 1.8600000000000001 108.352 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.5 t -118.14 114.77 23.56 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.807 -0.757 . . . . 1.72 112.53 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.55 111.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.743 -0.383 . . . . 1.27 111.35 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.22 160.57 39.66 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.162 0.506 . . . . 2.48 111.302 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -132.96 140.45 47.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.459 -0.791 . . . . 1.9199999999999999 109.789 177.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.44 144.63 13.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.353 -0.839 . . . . 1.3899999999999999 111.989 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.628 ' HZ3' ' HB2' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -57.62 136.01 56.76 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.116 -0.947 . . . . 2.48 111.435 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.85 -32.16 2.52 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.869 -0.605 . . . . 1.1200000000000001 111.644 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -143.0 -65.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.696 0.284 . . . . 3.8999999999999999 110.26 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -176.86 152.2 0.93 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.128 -0.487 . . . . 4.0999999999999996 110.975 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 64.08 40.97 6.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.942 -0.572 . . . . 1.3999999999999999 112.406 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.71 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -60.4 -39.26 66.18 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-O 118.804 -0.617 . . . . 2.0 110.01 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.71 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 95.5 Cg_exo -23.51 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.415 2.744 . . . . 3.1099999999999999 111.786 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 10.3 ptmm? 32.35 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.603 -1.181 . . . . 4.1100000000000003 113.06 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 62' ' ' GLN . 46.0 t -96.16 133.62 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 121.045 -0.262 . . . . 1.5900000000000001 111.295 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -131.48 126.83 36.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.204 -0.598 . . . . 1.8600000000000001 111.689 -179.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 88' ' ' LYS . . . -122.37 37.03 4.49 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.957 1.095 . . . . 1.04 113.957 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -35.45 134.37 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.001 0.429 . . . . 1.6799999999999999 111.889 179.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.509 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -155.16 101.76 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.38 109.831 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.504 HG21 ' O ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -110.05 123.8 66.25 Favored 'Isoleucine or valine' 0 C--O 1.259 1.572 0 CA-C-O 123.037 1.398 . . . . 1.3500000000000001 112.93 179.33 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.19 160.55 18.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.256 -1.793 . . . . 1.26 108.768 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 175' ' ' GLY . 4.0 tmtt? -119.93 141.07 49.96 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.43 1.27 . . . . 2.3599999999999999 114.43 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 174' ' ' LYS . . . 104.97 -33.92 6.19 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 112.695 -2.048 . . . . 0.23000000000000001 117.639 175.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.534 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.29 156.33 0.41 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.2 2.0 . . . . 1.1000000000000001 114.601 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.606 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -86.26 -26.22 25.11 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 114.994 -1.003 . . . . 1.1000000000000001 110.277 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.913 -0.585 . . . . 2.3100000000000001 111.594 -178.961 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.228 0.537 . . . . 1.1299999999999999 110.333 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.62 -21.53 10.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.233 -0.894 . . . . 1.1299999999999999 111.371 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.527 ' HB3' ' HZ2' ' A' ' 9' ' ' LYS . 16.7 t70 -78.5 -23.4 46.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.012 0.375 . . . . 2.0899999999999999 112.012 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HZ2' ' HB3' ' A' ' 8' ' ' ASP . 25.6 mmtm -97.12 -23.09 16.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.761 -0.376 . . . . 2.5 111.375 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.0 p -44.86 145.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 120.623 0.249 . . . . 1.05 111.613 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.98 -32.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.123 -0.631 . . . . 1.48 110.848 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.424 ' O ' HG23 ' A' ' 172' ' ' ILE . 71.2 t90 -166.23 124.06 1.44 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.842 -0.343 . . . . 0.33000000000000002 110.304 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.15 141.97 28.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.489 -0.323 . . . . 1.05 111.785 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 170' ' ' LEU . 2.5 t -147.56 130.89 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 113.442 0.904 . . . . 1.3600000000000001 113.442 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 21.0 t-20 -110.14 89.44 3.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 107.865 -1.161 . . . . 1.8700000000000001 107.865 175.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HB1' ' OH ' ' A' ' 73' ' ' TYR . . . -58.33 99.07 0.04 OUTLIER 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.008 -0.996 . . . . 1.1100000000000001 109.605 -177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.72 -88.99 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.736 -1.12 . . . . 0.67000000000000004 114.355 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -78.56 -117.7 0.22 Allowed Glycine 0 CA--C 1.512 -0.127 0 C-N-CA 121.085 -0.579 . . . . 1.1200000000000001 113.419 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -145.04 148.52 33.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.635 -0.135 . . . . 2.02 110.635 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 64.6 m -12.36 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.171 0.804 . . . . 1.6499999999999999 113.171 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.485 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 29.0 t60 -139.09 150.42 45.7 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.095 0.474 . . . . 0.41999999999999998 111.915 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.57 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 1.8200000000000001 111.298 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 154.75 41.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.1699999999999999 110.472 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 m -44.35 -51.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 124.081 0.863 . . . . 1.27 113.147 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -58.16 -18.52 26.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.268 0.556 . . . . 0.55000000000000004 110.354 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 34.96 4.02 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.333 -0.849 . . . . 0.32000000000000001 112.232 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 27' ' ' ILE . 33.5 mm -103.64 121.34 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 1.21 110.084 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.7 t60 -101.08 135.82 41.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 114.271 1.211 . . . . 0.68999999999999995 114.271 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.642 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.86 136.78 42.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.975 -1.12 . . . . 3.3199999999999998 107.975 176.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 48.8 mtt180 -91.42 108.06 19.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.178 0.513 . . . . 3.3999999999999999 112.247 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 32' ' ' ASP . 63.5 tttm -25.1 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.724 -1.126 . . . . 3.1600000000000001 113.818 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.588 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 6.0 m-20 -7.31 80.27 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.875 1.27 . . . . 1.98 113.886 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 17.3 Cg_endo . . . . . 0 CA--C 1.537 0.632 0 C-N-CA 122.623 2.215 . . . . 1.53 113.826 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 125' ' ' THR . 2.8 mt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 1.45 108.316 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 51' ' ' LEU . 9.3 mp -96.1 -22.79 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.17 1.174 . . . . 2.29 114.17 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -103.77 36.57 2.28 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.226 -0.59 . . . . 3.0600000000000001 111.827 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.5 t -142.49 146.43 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.017 0.437 . . . . 1.4099999999999999 111.607 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.6 t30 -62.54 145.27 95.13 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 115.786 -0.643 . . . . 1.96 109.436 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.564 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 15.7 Cg_exo -39.95 -54.98 1.88 Allowed 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.687 2.258 . . . . 0.78000000000000003 114.984 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.591 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.9 mm-40 -64.95 -53.9 39.06 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.264 1.03 . . . . 1.8200000000000001 110.64 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -2.57 23.53 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.143 -0.935 . . . . 1.9099999999999999 110.549 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.564 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 32.9 tt0 -75.69 -56.75 4.38 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.509 -0.923 . . . . 2.0600000000000001 108.509 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 56' ' ' GLU . 7.2 p -52.84 -44.62 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.528 -0.916 . . . . 1.8500000000000001 108.528 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.63 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 10.0 tp -58.4 -67.18 0.38 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 119.738 -0.785 . . . . 1.6000000000000001 109.989 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.71 -8.55 0.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.611 -0.722 . . . . 1.29 111.757 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 60' ' ' LEU . 24.6 tt0 -115.74 -116.81 0.32 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 111.934 0.346 . . . . 1.8 111.934 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 59' ' ' VAL . 71.6 p 51.24 -173.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.125 0.17 . . . . 1.4099999999999999 110.925 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 63' ' ' THR . 0.8 OUTLIER 175.22 154.11 0.15 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.512 0.196 . . . . 2.0499999999999998 110.567 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.588 ' NH2' ' HB3' ' A' ' 32' ' ' ASP . 3.1 ptm180 -143.36 176.81 8.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.808 0.337 . . . . 4.2800000000000002 111.162 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.93 155.01 2.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.009 -0.541 . . . . 4.4699999999999998 111.927 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -133.16 158.1 43.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.703 -0.68 . . . . 5.1500000000000004 110.827 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 10.7 tp10 -133.48 -93.86 0.33 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.353 -0.385 . . . . 3.1699999999999999 110.971 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 2.9 p30 -172.76 125.37 0.47 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.603 0.239 . . . . 2.3900000000000001 110.796 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 t 49.8 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.181 -0.463 . . . . 1.3200000000000001 111.076 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -161.01 161.38 31.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.492 -0.483 . . . . 1.77 111.936 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.27 -160.52 20.0 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.527 -0.844 . . . . 0.98999999999999999 114.251 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.551 ' OH ' ' HB1' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -122.2 163.07 20.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.813 0.816 . . . . 1.1899999999999999 112.93 -177.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.524 ' CG ' ' HG3' ' A' ' 152' ' ' LYS . 3.5 t70 -113.54 105.5 13.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.91 -1.495 . . . . 2.27 110.331 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -96.1 106.5 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.58 -0.282 . . . . 1.0700000000000001 110.535 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.75 121.81 3.78 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 121.216 1.277 . . . . 1.26 113.121 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mt -135.98 151.76 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.458 0.647 . . . . 1.0900000000000001 111.327 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -144.79 37.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.5 -1.296 . . . . 3.4399999999999999 107.5 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 15.0 mm-40 -134.63 142.43 46.88 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.78 -1.1 . . . . 2.1299999999999999 110.374 -177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.27 149.64 29.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.464 0.65 . . . . 0.37 111.625 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.41 -154.58 25.61 Favored Glycine 0 CA--C 1.512 -0.129 0 N-CA-C 110.058 -1.217 . . . . 0.23000000000000001 110.058 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 20.2 mt-10 -102.39 109.66 21.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 118.979 1.39 . . . . 2.0299999999999998 109.667 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.446 ' OH ' ' HB2' ' A' ' 79' ' ' GLU . 44.4 m-85 -95.99 126.59 41.34 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.211 -1.033 . . . . 0.94999999999999996 108.211 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.633 HG23 ' N ' ' A' ' 177' ' ' ALA . 41.9 t -112.14 113.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.612 0.72 . . . . 1.21 111.728 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' C ' HD22 ' A' ' 85' ' ' LEU . 10.2 tt -98.57 104.35 16.38 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.481 -1.236 . . . . 1.79 110.194 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.95 137.27 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.253 -1.017 . . . . 1.95 108.253 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -149.25 139.26 22.07 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.45 -0.9 . . . . 2.0 112.77 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.563 ' HZ2' ' HB3' ' A' ' 128' ' ' ASP . 14.5 tptt -94.26 123.36 37.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.57 -1.195 . . . . 3.3799999999999999 109.708 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.5 143.03 35.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 0.34999999999999998 110.072 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.312 0 CA-C-N 116.444 -0.344 . . . . 1.1499999999999999 110.364 179.384 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.843 0.354 . . . . 3.6000000000000001 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 p -109.15 156.77 19.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.152 -0.476 . . . . 1.8899999999999999 111.506 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 48.47 34.9 5.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.871 -0.604 . . . . 2.6899999999999999 111.574 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.3 -46.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 3.0299999999999998 109.577 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.557 ' NZ ' ' HB3' ' A' ' 100' ' ' LYS . 1.2 mmmp? -101.23 85.89 2.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.787 . . . . 3.52 109.508 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.31 144.16 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.084 -0.507 . . . . 1.95 110.306 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -126.63 -175.04 3.28 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 116.278 -0.419 . . . . 0.80000000000000004 112.08 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.42 144.75 40.32 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 2.0099999999999998 110.861 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -134.19 138.14 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.939 -0.573 . . . . 1.1599999999999999 112.542 -177.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.479 HH21 HG22 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -142.85 148.99 37.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.611 0.967 . . . . 2.1800000000000002 113.611 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 22.2 m -113.01 121.66 65.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 CA-C-N 114.629 -1.169 . . . . 1.71 109.827 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.61 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 9.5 t30 51.58 26.95 3.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.245 -0.889 . . . . 1.77 110.124 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.15 21.97 21.28 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.545 -1.207 . . . . 0.40999999999999998 113.137 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 80.8 m-70 -122.86 109.38 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.175 0.806 . . . . 0.58999999999999997 113.175 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 21.8 p -60.34 120.52 10.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.054 0.454 . . . . 1.2 111.341 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.5 t -113.73 -29.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.647 -0.706 . . . . 1.3999999999999999 109.94 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.459 HG11 ' OE1' ' A' ' 129' ' ' GLU . 2.2 t -137.29 91.98 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 116.109 -0.496 . . . . 1.21 110.186 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 6.7 ptpp? -99.66 134.24 42.83 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.77 0.795 . . . . 2.9199999999999999 110.461 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 13.9 m-20 90.42 32.3 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.109 -1.859 . . . . 2.5600000000000001 109.52 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.42 HD23 ' OE2' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -54.7 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.922 -0.581 . . . . 1.71 111.43 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -98.67 81.96 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 1.99 107.992 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.0 mt -50.94 -48.62 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.97 -1.013 . . . . 1.23 112.5 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.14 -54.01 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.31 . . . . 1.01 111.327 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.35 -27.31 55.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.601 -0.272 . . . . 0.76000000000000001 111.705 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -72.46 -59.23 2.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.601 0.593 . . . . 3.0299999999999998 112.601 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 -41.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.541 0.571 . . . . 2.0299999999999998 112.541 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.34 -141.26 16.69 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.535 -0.84 . . . . 1.0600000000000001 113.174 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -53.48 110.31 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.677 0.275 . . . . 4.29 111.01 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.2 m 44.8 -97.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 2.1099999999999999 111.126 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.432 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 p 48.8 -178.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.039 0.447 . . . . 1.3300000000000001 111.466 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.02 130.41 53.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.406 -0.361 . . . . 1.1200000000000001 111.957 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -110.49 142.48 42.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.792 -0.818 . . . . 0.45000000000000001 108.792 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.563 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 4.6 p30 -135.31 131.51 36.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.055 0.761 . . . . 2.0899999999999999 113.055 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.459 ' OE1' HG11 ' A' ' 112' ' ' VAL . 22.8 mt-10 -132.15 121.13 23.25 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.315 -0.857 . . . . 2.2799999999999998 109.884 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.73 136.41 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.036 -0.529 . . . . 1.3799999999999999 111.066 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -135.85 86.58 26.86 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.888 0.699 . . . . 2.0 112.888 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -64.03 138.57 62.96 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.706 1.604 . . . . 0.23999999999999999 111.527 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -128.62 153.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.627 -0.261 . . . . 1.0600000000000001 110.572 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 67.1 p -132.52 108.39 9.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.379 . . . . 1.6599999999999999 111.707 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.0 mt -105.31 126.63 60.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.944 -0.571 . . . . 1.0700000000000001 110.032 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -148.09 144.52 27.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.394 -0.367 . . . . 2.4300000000000002 110.578 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.49 20.72 7.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 3.5600000000000001 110.218 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.8 28.45 50.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.862 -0.685 . . . . 0.32000000000000001 112.564 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 22.7 ttpt -131.17 142.41 50.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 2.6800000000000002 111.083 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.51 HD21 ' N ' ' A' ' 141' ' ' SER . 5.6 tt -96.06 133.43 40.32 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.847 -0.615 . . . . 1.1100000000000001 112.39 -177.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.51 ' N ' HD21 ' A' ' 140' ' ' LEU . 23.1 t -118.1 117.19 28.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.858 . . . . 1.3700000000000001 109.419 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.3 98.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.967 -0.56 . . . . 1.23 111.478 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.3 -97.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.859 -0.61 . . . . 2.0499999999999998 112.224 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -115.92 21.51 12.27 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.538 -0.839 . . . . 0.59999999999999998 113.485 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -137.76 145.95 43.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.934 -0.395 . . . . 2.02 109.934 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.31 148.65 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.838 0.352 . . . . 1.8700000000000001 111.663 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.6 m -162.25 135.87 6.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.002 -0.544 . . . . 1.46 110.609 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 50.2 p -54.03 136.4 41.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.087 -0.506 . . . . 1.55 111.53 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.17 123.47 27.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 0.34000000000000002 109.708 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 152' ' ' LYS . 2.1 t -110.08 90.21 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.922 -0.711 . . . . 2.02 111.98 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 44.36 -5.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 117.201 1.64 . . . . 0.77000000000000002 117.201 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.697 ' HB3' ' HZ3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -162.11 152.28 16.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.776 1.788 . . . . 2.3199999999999998 113.756 -178.049 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.473 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -98.38 124.51 43.09 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.453 -1.314 . . . . 1.8600000000000001 107.453 176.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -107.96 102.5 11.67 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.918 0.71 . . . . 1.72 112.918 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 56.2 t -100.36 117.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.418 -0.513 . . . . 1.27 110.605 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.78 42.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.348 -0.541 . . . . 2.48 111.521 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.06 148.99 51.06 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.273 -0.876 . . . . 1.9199999999999999 110.543 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.479 HG22 HH21 ' A' ' 105' ' ' ARG . 80.6 t -118.91 142.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.056 -0.975 . . . . 1.3899999999999999 110.585 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -81.48 146.55 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.726 -0.67 . . . . 2.48 111.483 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.24 -18.9 15.6 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.695 -0.684 . . . . 1.1200000000000001 111.509 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -147.19 -75.62 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.585 0.231 . . . . 3.8999999999999999 110.754 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -152.2 153.58 34.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.829 0.347 . . . . 4.0999999999999996 111.514 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 56.15 86.77 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.956 -0.566 . . . . 1.3999999999999999 111.958 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.7 169.96 0.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.118 -0.468 . . . . 2.0 109.913 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -40.35 104.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.573 1.516 . . . . 3.1099999999999999 111.515 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -55.23 -56.75 16.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.052 -0.977 . . . . 4.1100000000000003 112.645 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.38 133.89 49.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 112.534 0.568 . . . . 1.5900000000000001 112.534 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.7 t -135.56 131.79 36.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.847 0.684 . . . . 1.8600000000000001 112.847 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.583 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . . . -119.23 38.69 3.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.793 -1.094 . . . . 1.04 112.514 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 8.4 tp -48.43 127.29 12.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.374 0.669 . . . . 1.6799999999999999 111.786 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.3 OUTLIER -143.48 111.14 5.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.381 -0.827 . . . . 0.38 110.528 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -111.5 123.95 67.81 Favored 'Isoleucine or valine' 0 C--O 1.258 1.552 0 CA-C-O 122.758 1.266 . . . . 1.3500000000000001 112.175 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.72 166.87 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.75 -1.568 . . . . 1.26 109.807 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.704 ' HB2' ' HZ3' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -117.56 137.37 52.63 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.295 1.591 . . . . 2.3599999999999999 115.295 -176.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 99.19 -35.4 4.71 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 118.791 2.276 . . . . 0.23000000000000001 118.791 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.558 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.51 160.58 0.61 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.237 2.019 . . . . 1.1000000000000001 113.969 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.633 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -85.68 -23.51 27.4 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.11 -0.95 . . . . 1.1000000000000001 110.544 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 2.3100000000000001 111.645 -179.034 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.501 -0.24 . . . . 9.3900000000000006 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.26 109.68 0.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.351 . . . . 7.6799999999999997 110.986 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.1 ttt -120.38 -52.55 2.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 8.1699999999999999 110.797 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.0 m -58.6 161.2 4.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 4.25 110.947 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.44 33.43 3.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 1.8200000000000001 112.666 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.13 -46.51 14.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.359 0.6 . . . . 1.1299999999999999 110.188 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -56.24 -20.25 17.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.241 -0.891 . . . . 1.1299999999999999 110.972 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -74.07 -17.08 61.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 2.0899999999999999 111.914 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -111.58 -21.49 11.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.488 -0.485 . . . . 2.5 111.835 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 7' ' ' ALA . 11.1 p -43.83 147.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.889 -0.324 . . . . 1.05 111.46 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.4 pt -139.92 -22.96 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 119.782 -0.767 . . . . 1.48 111.623 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.532 ' O ' HG23 ' A' ' 172' ' ' ILE . 26.2 t90 -173.0 134.24 0.56 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 0.33000000000000002 110.24 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -152.29 144.36 23.82 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.443 -0.161 . . . . 1.05 111.211 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.97 126.73 4.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 N-CA-C 114.116 1.154 . . . . 1.3600000000000001 114.116 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 5.8 t30 -115.13 98.82 7.0 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.274 -0.571 . . . . 1.8700000000000001 110.566 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.88 109.3 3.35 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 109.3 -0.629 . . . . 1.1100000000000001 109.3 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.573 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 150.0 -44.55 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 114.806 -1.088 . . . . 0.67000000000000004 112.452 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.37 -140.16 11.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 1.1200000000000001 112.134 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -162.7 119.36 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.552 0.215 . . . . 2.02 110.801 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 62.6 p 33.19 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.607 -0.724 . . . . 1.6499999999999999 112.235 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 10.0 t60 -128.31 150.8 49.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.22 -0.592 . . . . 0.41999999999999998 112.072 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 5.9 p -120.61 109.94 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.374 0.607 . . . . 1.8200000000000001 111.89 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.26 155.58 39.42 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.435 -0.802 . . . . 1.1699999999999999 109.933 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 m -43.89 -52.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.545 0.942 . . . . 1.27 113.545 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -56.89 -20.3 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.226 0.536 . . . . 0.55000000000000004 110.579 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.85 34.83 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.357 -0.838 . . . . 0.32000000000000001 112.287 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.448 HG22 HD12 ' A' ' 27' ' ' ILE . 33.2 mm -103.52 109.45 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.978 0.418 . . . . 1.21 110.191 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 23.4 t60 -96.87 135.55 38.69 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 115.128 1.529 . . . . 0.68999999999999995 115.128 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.645 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.18 135.0 44.53 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 114.21 -1.359 . . . . 3.3199999999999998 107.854 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.4 ptm180 -95.51 112.42 24.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 3.3999999999999999 111.984 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.521 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 2.8 ttpm? -16.3 140.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.603 1.335 . . . . 3.1600000000000001 114.603 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.565 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 4.2 p-10 -18.71 90.02 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 CA-C-N 114.613 -1.176 . . . . 1.98 112.679 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -98.58 -2.57 1.02 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.598 2.198 . . . . 1.53 113.798 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 72' ' ' GLY . 0.5 OUTLIER -125.23 -24.57 3.95 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.52 -0.472 . . . . 2.3599999999999999 112.025 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -79.72 69.77 6.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.803 -0.443 . . . . 4.9500000000000002 109.803 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 75.78 -1.25 59.13 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.241 -1.144 . . . . 2.3300000000000001 110.241 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 43.46 24.89 0.06 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.247 0.619 . . . . 5.8700000000000001 111.233 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 36' ' ' GLY . 11.9 p -149.8 135.07 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.788 -0.642 . . . . 3.48 110.503 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.46 -161.13 23.23 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.414 -0.898 . . . . 2.5899999999999999 113.097 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -148.29 153.07 38.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.748 0.309 . . . . 7.3300000000000001 110.774 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.427 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -49.33 119.24 3.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.036 -0.529 . . . . 2.0099999999999998 111.38 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 t -69.84 -21.78 63.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 2.2999999999999998 110.06 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 37.27 54.32 1.31 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.843 -0.617 . . . . 2.23 111.296 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -90.4 -28.14 18.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 2.6000000000000001 110.928 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.3 27.83 8.27 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.567 -0.825 . . . . 2.6600000000000001 112.896 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.5 ttt -56.42 -27.76 57.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.217 0.532 . . . . 2.4300000000000002 109.934 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 48' ' ' LEU . 87.3 tttt -61.35 167.04 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.382 -0.826 . . . . 3.79 110.337 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER 69.2 64.54 0.54 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 3.23 110.346 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 84.8 Cg_exo -54.64 125.2 18.23 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.79 2.327 . . . . 1.9399999999999999 113.008 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 125' ' ' THR . 1.8 mt -57.04 136.53 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.699 -0.852 . . . . 1.45 108.699 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.21 -49.95 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.52 0.933 . . . . 2.29 113.52 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.82 36.42 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.564 0.579 . . . . 3.0600000000000001 112.564 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -150.54 134.75 17.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.992 0.425 . . . . 1.4099999999999999 111.666 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -63.62 148.41 94.19 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.076 -0.713 . . . . 1.96 109.076 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.535 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 5.1 Cg_exo -37.9 -42.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.047 2.498 . . . . 0.78000000000000003 116.112 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.569 ' O ' HG12 ' A' ' 59' ' ' VAL . 9.9 mm-40 -75.82 -55.84 5.24 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.846 0.832 . . . . 1.8200000000000001 110.811 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.4 p-10 -71.42 -0.45 10.33 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.229 -0.656 . . . . 1.9099999999999999 109.229 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.463 ' CD ' ' HB3' ' A' ' 49' ' ' PRO . 33.1 tt0 -77.4 -61.02 2.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.02 -0.991 . . . . 2.0600000000000001 108.972 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 56' ' ' GLU . 6.1 p -49.59 -39.13 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.1 -0.704 . . . . 1.8500000000000001 109.1 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 62' ' ' GLN . 9.4 tp -66.65 -66.64 0.53 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.412 -0.515 . . . . 1.6000000000000001 110.295 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -53.81 -7.03 0.1 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.154 -0.475 . . . . 1.29 111.101 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' A' ' 60' ' ' LEU . 4.8 tt0 -115.45 -130.65 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.93 -0.577 . . . . 1.8 110.667 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 167' ' ' VAL . 41.4 p 49.59 158.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.339 0.399 . . . . 1.4099999999999999 111.378 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.573 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -141.71 143.68 33.67 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.953 1.094 . . . . 2.0499999999999998 113.953 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.565 ' NE ' ' HB3' ' A' ' 32' ' ' ASP . 1.6 mtt85 -136.48 135.67 38.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.933 -1.031 . . . . 4.2800000000000002 109.654 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -116.51 131.7 56.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 4.4699999999999998 111.42 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.96 -75.35 0.63 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.013 -0.539 . . . . 5.1500000000000004 110.573 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 179.5 -58.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.33 0.493 . . . . 3.1699999999999999 112.33 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -175.98 145.08 0.63 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.575 -0.528 . . . . 2.3900000000000001 109.575 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.471 ' H ' HD22 ' A' ' 164' ' ' ASN . 20.9 t 46.31 76.09 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.604 -0.517 . . . . 1.3200000000000001 109.604 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.447 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -82.99 146.21 28.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.575 -1.268 . . . . 1.77 107.575 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -138.11 129.46 4.6 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 118.415 -1.85 . . . . 0.98999999999999999 115.204 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -108.73 146.59 33.28 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.948 -0.626 . . . . 1.1899999999999999 110.813 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.27 129.7 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 2.27 111.319 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.484 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.0 mp -124.46 87.42 54.23 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.356 -0.384 . . . . 1.0700000000000001 110.875 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.39 127.71 27.07 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.867 1.711 . . . . 1.26 111.868 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.43 151.76 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.947 0.404 . . . . 1.0900000000000001 111.4 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -143.61 4.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 3.4399999999999999 111.216 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -128.42 170.33 13.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.1299999999999999 110.796 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.33 172.28 9.23 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.255 0.55 . . . . 0.37 111.815 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.95 -155.25 22.26 Favored Glycine 0 N--CA 1.454 -0.152 0 N-CA-C 109.848 -1.301 . . . . 0.23000000000000001 109.848 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -98.2 108.61 21.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.009 1.404 . . . . 2.0299999999999998 108.869 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.0 125.99 40.05 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.911 -0.774 . . . . 0.94999999999999996 108.911 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 177' ' ' ALA . 14.2 t -113.27 116.29 52.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.828 -1.078 . . . . 1.21 111.535 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 85' ' ' LEU . 9.5 tt -96.5 105.15 17.2 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.69 -1.141 . . . . 1.79 110.583 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 20.3 t -110.79 132.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.917 -1.038 . . . . 1.95 108.52 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 87' ' ' LEU . 0.6 OUTLIER -142.13 146.22 35.1 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.236 -0.986 . . . . 2.0 111.88 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.705 ' HZ3' ' HB2' ' A' ' 128' ' ' ASP . 3.3 tptp -105.58 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 3.3799999999999999 110.356 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 10.0 m-85 -104.81 143.41 33.16 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.879 -1.156 . . . . 0.34999999999999998 107.879 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -155.09 157.32 37.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 119.543 -0.863 . . . . 1.1499999999999999 112.946 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 57.72 159.34 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.433 -0.803 . . . . 3.9700000000000002 111.834 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 p -172.25 -4.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 4.3099999999999996 111.465 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 67.04 140.04 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.238 -0.437 . . . . 3.0099999999999998 110.753 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 70.42 127.49 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.999 -0.546 . . . . 2.0 111.015 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.43 81.22 6.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.938 -0.574 . . . . 1.6599999999999999 110.859 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -133.29 152.07 51.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 3.6000000000000001 110.596 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.4 p -116.37 153.16 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.297 0.57 . . . . 1.8899999999999999 112.169 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 49.11 25.17 1.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.065 -0.971 . . . . 2.6899999999999999 112.497 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -119.09 -50.12 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.941 -0.392 . . . . 3.0299999999999998 109.941 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -85.76 77.96 9.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.286 -0.635 . . . . 3.52 109.286 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.45 142.59 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 1.95 110.112 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -130.81 -179.38 5.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.127 0.788 . . . . 0.80000000000000004 113.127 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -121.97 137.45 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.224 -0.443 . . . . 2.0099999999999998 111.564 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 t -129.73 127.26 64.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 115.869 -0.605 . . . . 1.1599999999999999 111.384 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 8.1 mtt180 -125.85 148.56 49.12 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.542 -0.753 . . . . 2.1800000000000002 112.502 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 40.7 t -120.21 117.23 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 114.632 -1.167 . . . . 1.71 109.695 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.51 26.48 7.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.634 -0.876 . . . . 1.77 108.634 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.98 22.63 29.83 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.656 -1.157 . . . . 0.40999999999999998 112.906 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.426 ' CG ' HG12 ' A' ' 142' ' ' VAL . 88.4 m-70 -121.55 111.49 17.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.558 0.947 . . . . 0.58999999999999997 113.558 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 p -64.71 117.33 7.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.681 -0.408 . . . . 1.2 110.868 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 109' ' ' HIS . 3.8 t -112.98 -30.34 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.904 -0.589 . . . . 1.3999999999999999 109.819 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.7 90.18 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.417 -0.586 . . . . 1.21 109.417 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 6.3 ptmm? -105.29 79.16 1.45 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.617 1.199 . . . . 2.9199999999999999 111.777 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.2 p30 156.49 35.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.032 -2.349 . . . . 2.5600000000000001 109.129 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.36 93.28 0.07 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.387 0.613 . . . . 1.71 112.149 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -109.83 85.99 2.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.791 -1.559 . . . . 1.99 106.791 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.9 mt -50.03 -40.98 17.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.138 -0.937 . . . . 1.23 112.405 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.73 -65.47 0.69 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.99 -0.284 . . . . 1.01 111.385 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -52.05 -27.18 12.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.12 0.415 . . . . 0.76000000000000001 112.12 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.64 -60.48 2.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.347 0.499 . . . . 3.0299999999999998 112.347 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 m -104.19 -40.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.405 0.52 . . . . 2.0299999999999998 112.405 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.7 -106.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.873 -0.891 . . . . 1.0600000000000001 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' SER . 37.9 m80 -64.31 170.19 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.651 -0.87 . . . . 4.29 108.651 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' HIS . 75.0 m -35.26 -80.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.05 0.219 . . . . 2.1099999999999999 110.9 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 50' ' ' ILE . 30.0 p 44.02 -164.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.808 0.337 . . . . 1.3300000000000001 111.328 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.568 ' HB1' ' HZ1' ' A' ' 88' ' ' LYS . . . -114.15 138.86 49.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.5 -0.318 . . . . 1.1200000000000001 110.804 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.535 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 2.1 t60 -111.78 147.5 35.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.45000000000000001 108.797 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.705 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 15.2 t70 -143.84 135.19 25.85 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.139 0.792 . . . . 2.0899999999999999 113.139 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -121.53 128.68 52.29 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.373 -0.83 . . . . 2.2799999999999998 109.127 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mt -111.0 120.41 61.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.668 -0.696 . . . . 1.3799999999999999 110.222 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.39 88.89 49.13 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.801 0.667 . . . . 2.0 112.801 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.2 145.9 93.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.927 1.751 . . . . 0.23999999999999999 111.854 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.432 HG21 ' N ' ' A' ' 134' ' ' SER . 11.6 mt -137.16 157.16 34.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.367 -0.379 . . . . 1.0600000000000001 110.604 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 34.6 p -133.31 110.21 9.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.126 0.489 . . . . 1.6599999999999999 111.244 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 19.6 mt -110.66 126.02 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.583 -0.735 . . . . 1.0700000000000001 109.851 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.488 ' HB3' ' HZ2' ' A' ' 137' ' ' LYS . 84.6 mttt -146.08 140.14 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 2.4300000000000002 110.767 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HZ2' ' HB3' ' A' ' 136' ' ' LYS . 1.2 mppt? 60.91 14.57 5.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 3.5600000000000001 111.116 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.69 12.35 58.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.658 -0.782 . . . . 0.32000000000000001 113.202 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 60.0 mttp -112.81 162.0 16.28 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 117.131 0.466 . . . . 2.6800000000000002 111.028 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.624 HD22 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -117.97 139.46 51.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.556 0.576 . . . . 1.1100000000000001 112.556 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.624 ' N ' HD22 ' A' ' 140' ' ' LEU . 28.6 t -128.93 109.61 11.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.765 . . . . 1.3700000000000001 109.678 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.426 HG12 ' CG ' ' A' ' 109' ' ' HIS . 12.1 p -105.46 114.7 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.165 0.507 . . . . 1.23 110.855 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 2.0499999999999998 112.115 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.49 22.03 3.38 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.619 -0.8 . . . . 0.59999999999999998 113.047 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -126.91 138.44 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.93 -0.396 . . . . 2.02 109.93 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.26 139.24 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.37 0.605 . . . . 1.8700000000000001 111.732 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 23.1 t -163.71 126.74 2.6 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.165 -0.925 . . . . 1.46 108.945 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.9 t -61.23 147.63 43.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.547 . . . . 1.55 112.263 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -78.78 142.94 36.55 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.389 -0.823 . . . . 0.34000000000000002 109.773 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.9 p -139.25 95.81 3.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.112 0.782 . . . . 2.02 113.112 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.23 -59.75 2.75 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.729 1.051 . . . . 0.77000000000000002 115.729 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.532 ' HZ2' ' HB2' ' A' ' 154' ' ' SER . 0.0 OUTLIER -153.34 169.12 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.914 0.857 . . . . 2.3199999999999998 112.726 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.79 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.965 -1.495 . . . . 1.8600000000000001 106.965 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.532 ' HB2' ' HZ2' ' A' ' 152' ' ' LYS . 5.0 t -125.52 113.43 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 118.657 -1.217 . . . . 1.72 113.177 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.5 OUTLIER -98.31 98.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.955 -0.566 . . . . 1.27 109.644 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.1 mt-10 -110.69 126.55 54.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.664 -0.698 . . . . 2.48 111.448 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -117.17 127.09 53.77 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 119.643 -0.823 . . . . 1.9199999999999999 110.264 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.512 HG22 HH21 ' A' ' 105' ' ' ARG . 10.8 t -97.2 143.99 11.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 114.185 -1.37 . . . . 1.3899999999999999 112.529 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -54.43 148.37 12.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 113.911 -1.495 . . . . 2.48 111.574 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.8 -53.09 0.17 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 111.843 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -148.64 61.04 1.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 3.8999999999999999 110.972 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 64.96 154.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.052 -0.522 . . . . 4.0999999999999996 111.876 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.37 77.83 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.651 -0.704 . . . . 1.3999999999999999 111.53 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.471 HD22 ' H ' ' A' ' 70' ' ' SER . 3.9 m-20 -50.82 155.52 1.96 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.815 -0.63 . . . . 2.0 109.974 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 164' ' ' ASN . 0.9 OUTLIER -29.86 103.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.467 2.111 . . . . 3.1099999999999999 112.346 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -53.0 -73.1 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.761 -1.108 . . . . 4.1100000000000003 112.649 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 63' ' ' THR . 89.8 t -93.25 133.51 34.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.184 0.438 . . . . 1.5900000000000001 112.184 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.9 130.52 45.27 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 123.928 0.768 . . . . 1.8600000000000001 110.803 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.471 ' HB2' ' H ' ' A' ' 88' ' ' LYS . . . -123.24 36.47 4.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.415 0.894 . . . . 1.04 113.415 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.52 129.86 0.28 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.871 0.367 . . . . 1.6799999999999999 111.834 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -149.27 104.73 3.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.208 -0.451 . . . . 0.38 110.053 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -113.49 126.35 70.92 Favored 'Isoleucine or valine' 0 C--O 1.261 1.708 0 CA-C-O 122.768 1.27 . . . . 1.3500000000000001 112.799 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 ptm -119.99 165.26 14.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.814 -1.539 . . . . 1.26 109.732 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -120.68 145.71 47.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.786 1.402 . . . . 2.3599999999999999 114.786 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.58 -36.05 4.56 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 112.38 -2.191 . . . . 0.23000000000000001 117.767 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.581 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.21 158.73 0.48 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.301 2.05 . . . . 1.1000000000000001 114.277 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.615 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.43 -24.81 25.54 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 114.893 -1.048 . . . . 1.1000000000000001 110.564 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.86 -34.18 72.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.828 -0.624 . . . . 2.3100000000000001 111.551 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.87 -43.75 77.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.454 -0.339 . . . . 2.3700000000000001 110.588 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 63.7 t -37.37 100.24 0.2 Allowed Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 116.052 -0.522 . . . . 3.0800000000000001 111.719 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -50.87 139.86 39.78 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.926 1.75 . . . . 2.4500000000000002 112.369 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.4 ttt -152.74 93.99 1.83 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 6.3700000000000001 110.826 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.2 mt -87.35 109.15 19.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 5.3499999999999996 110.729 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -60.92 141.19 93.45 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.359 -0.382 . . . . 8.5099999999999998 110.133 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -44.49 138.01 7.9 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.681 1.587 . . . . 9.6899999999999995 112.401 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.479 ' HD1' ' N ' ' A' ' 187' ' ' PRO . 3.2 t-80 -133.57 125.65 18.66 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.385 -0.371 . . . . 10.35 110.535 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.479 ' N ' ' HD1' ' A' ' 186' ' ' HIS . 9.4 Cg_endo -83.93 -158.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.152 1.901 . . . . 12.26 111.599 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 60.63 -161.55 22.29 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.437 -0.887 . . . . 12.619999999999999 112.703 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.4 mt -112.71 120.97 43.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.348 . . . . 14.65 110.83 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.241 -0.885 . . . . 15.699999999999999 110.771 179.931 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.502 -0.239 . . . . 9.3900000000000006 112.502 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.57 -20.17 2.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.797 0.332 . . . . 7.6799999999999997 110.92 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -99.22 -45.56 5.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 8.1699999999999999 110.86 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -106.72 141.83 37.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 4.25 110.693 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -146.86 32.94 1.41 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 1.8200000000000001 112.52 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 tp -68.56 -45.97 70.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 1.1299999999999999 110.3 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -60.24 -21.06 61.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.564 -0.744 . . . . 1.1299999999999999 111.178 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.93 -5.68 47.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 2.0899999999999999 111.579 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HE3' ' OD1' ' A' ' 179' ' ' ASP . 19.5 mttm -123.63 -22.07 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.505 -0.478 . . . . 2.5 111.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 7' ' ' ALA . 14.5 p -43.44 147.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 121.158 -0.217 . . . . 1.05 111.18 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 pt -134.82 -23.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 119.518 -0.873 . . . . 1.48 111.391 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -173.26 136.26 0.61 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.272 -0.571 . . . . 0.33000000000000002 110.769 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.09 145.43 22.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.771 0.286 . . . . 1.05 111.771 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.42 130.63 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 114.191 1.182 . . . . 1.3600000000000001 114.191 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 5.2 t-20 -115.77 88.55 2.91 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.414 -0.514 . . . . 1.8700000000000001 111.174 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.03 103.97 0.27 Allowed 'General case' 0 C--O 1.248 0.988 0 N-CA-C 108.709 -0.849 . . . . 1.1100000000000001 108.709 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.553 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 162.17 -47.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.707 0 O-C-N 124.505 1.128 . . . . 0.67000000000000004 113.227 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.54 -129.86 5.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 1.1200000000000001 112.573 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.031 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 14.8 tt0 -163.72 119.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.73 0.3 . . . . 2.02 110.947 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 8.4 t 38.73 96.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 1.6499999999999999 112.72 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 76.3 t60 -124.01 151.66 43.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 120.235 -0.586 . . . . 0.41999999999999998 112.293 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.8 t -121.05 104.14 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.159 -0.928 . . . . 1.8200000000000001 110.265 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -71.27 153.03 42.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 1.1699999999999999 110.688 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 m -43.85 -50.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.167 0.917 . . . . 1.27 113.065 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -56.42 -22.28 30.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.34 0.59 . . . . 0.55000000000000004 109.928 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . 104.33 35.35 3.38 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.032 -0.986 . . . . 0.32000000000000001 111.852 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.449 HG22 HD13 ' A' ' 27' ' ' ILE . 35.1 mm -103.12 122.29 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.602 -0.518 . . . . 1.21 109.602 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.3 t60 -104.77 134.57 47.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.538 1.31 . . . . 0.68999999999999995 114.538 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.031 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -101.01 134.16 44.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.149 -0.932 . . . . 3.3199999999999998 108.497 176.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -95.9 111.64 23.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.415 0.626 . . . . 3.3999999999999999 112.256 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' ASP . 51.6 tttm -15.47 139.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.176 1.547 . . . . 3.1600000000000001 115.176 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -15.54 89.22 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 114.138 -1.392 . . . . 1.98 112.471 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -98.47 -4.57 0.9 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.477 2.118 . . . . 1.53 115.845 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -142.91 -12.14 0.76 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 119.423 -0.911 . . . . 2.3599999999999999 112.542 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.542 ' N ' HD12 ' A' ' 34' ' ' LEU . 39.2 mp0 -79.06 67.01 4.65 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.069 -0.715 . . . . 4.9500000000000002 109.069 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -10.24 21.16 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.743 -0.943 . . . . 2.3300000000000001 110.743 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 35' ' ' GLU . 9.4 mtt180 49.0 36.17 8.03 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.132 0.492 . . . . 5.8700000000000001 110.997 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.34 121.41 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 115.468 -0.787 . . . . 3.48 110.549 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.17 -154.59 25.08 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.604 -0.808 . . . . 2.5899999999999999 112.927 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -144.55 -67.13 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 7.3300000000000001 111.14 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.79 86.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 2.0099999999999998 110.232 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 61.8 m -72.45 73.32 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 2.2999999999999998 110.589 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.56 36.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.763 -0.653 . . . . 2.23 110.281 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -58.42 108.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.908 -0.587 . . . . 2.6000000000000001 111.299 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.42 52.86 46.18 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.92 -0.657 . . . . 2.6600000000000001 113.192 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.441 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -79.34 2.16 22.54 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.992 -0.373 . . . . 2.4300000000000002 109.992 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -38.25 157.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.686 -0.688 . . . . 3.79 111.173 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 1.9 mt 66.66 62.28 0.89 Allowed Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.968 -0.56 . . . . 3.23 110.449 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HA ' ' CD ' ' A' ' 62' ' ' GLN . 45.4 Cg_exo -62.19 157.63 43.84 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.551 2.167 . . . . 1.9399999999999999 112.676 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.1 mp -58.41 141.6 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.242 -0.435 . . . . 1.45 110.174 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 124' ' ' SER . 4.3 mm? -86.03 -44.08 12.6 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.717 1.006 . . . . 2.29 113.717 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -82.66 32.66 0.42 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.677 0.621 . . . . 3.0600000000000001 112.677 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -146.36 141.89 27.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.334 0.494 . . . . 1.4099999999999999 112.334 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.524 ' OD1' ' HB3' ' A' ' 57' ' ' ASP . 5.8 p-10 -66.21 150.07 97.24 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.728 -0.669 . . . . 1.96 109.5 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.552 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 9.4 Cg_exo -39.84 -48.84 3.62 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.716 2.277 . . . . 0.78000000000000003 115.599 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -57.42 6.19 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.641 0.734 . . . . 1.8200000000000001 112.236 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.524 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -70.07 -13.72 62.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.515 -0.55 . . . . 1.9099999999999999 109.515 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 23.5 tt0 -62.94 -52.28 63.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.994 -1.113 . . . . 2.0600000000000001 107.994 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -51.61 -51.62 25.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.125 -0.943 . . . . 1.8500000000000001 109.187 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 4.2 tp -64.08 -15.87 60.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.809 . . . . 1.6000000000000001 111.353 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.418 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 6.6 m-30 -117.13 19.96 13.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.258 -0.883 . . . . 1.29 111.268 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.472 ' CD ' ' HA ' ' A' ' 49' ' ' PRO . 42.3 tt0 -142.96 -76.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.775 1.028 . . . . 1.8 113.775 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.446 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 1.2 p -28.75 144.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.502 0.927 . . . . 1.4099999999999999 113.502 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.539 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -135.88 150.57 49.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.318 -0.856 . . . . 2.0499999999999998 110.491 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.553 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 30.9 mtp180 -107.09 -177.3 3.32 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.162 -0.31 . . . . 4.2800000000000002 110.162 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -54.52 166.26 0.47 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 4.4699999999999998 110.848 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -133.14 137.54 46.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 5.1500000000000004 111.008 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 40.1 tt0 -123.44 -91.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 3.1699999999999999 110.442 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 68' ' ' GLU . 3.3 p30 -174.04 125.5 0.35 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.611 0.243 . . . . 2.3900000000000001 111.116 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t 50.06 100.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.117 -0.492 . . . . 1.3200000000000001 111.629 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.555 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 1.6 p90 -151.53 148.95 28.64 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.191 0.519 . . . . 1.77 111.346 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.67 -171.06 17.81 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.479 -0.867 . . . . 0.98999999999999999 114.651 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -126.91 153.64 45.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.907 -0.647 . . . . 1.1899999999999999 111.624 -178.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 122.94 47.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.039 -0.982 . . . . 2.27 110.151 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.492 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.2 mp -114.45 87.25 13.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.153 0.427 . . . . 1.0700000000000001 112.153 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -56.68 134.44 64.43 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.802 1.668 . . . . 1.26 112.359 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 78' ' ' LYS . 26.8 mt -124.82 155.56 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.994 0.426 . . . . 1.0900000000000001 111.115 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.444 ' N ' HG22 ' A' ' 77' ' ' ILE . 95.2 mttt -146.8 3.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.866 -0.606 . . . . 3.4399999999999999 110.839 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.73 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 13.7 mm-40 -130.9 173.08 11.32 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 120.707 0.289 . . . . 2.1299999999999999 111.078 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -129.35 168.7 15.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.237 0.541 . . . . 0.37 111.143 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.01 -151.32 22.06 Favored Glycine 0 CA--C 1.512 -0.113 0 N-CA-C 109.759 -1.337 . . . . 0.23000000000000001 109.759 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -99.95 109.36 21.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.103 1.451 . . . . 2.0299999999999998 108.863 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.73 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.7 m-85 -95.75 126.21 40.86 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.507 0.67 . . . . 0.94999999999999996 109.395 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 177' ' ' ALA . 26.3 t -111.35 117.56 55.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.726 -1.125 . . . . 1.21 111.741 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 tt -88.83 104.42 16.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.526 -1.216 . . . . 1.79 110.179 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 21.4 t -109.69 133.57 54.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.271 -0.877 . . . . 1.95 109.115 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -156.24 135.26 11.98 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.357 -0.937 . . . . 2.0 111.88 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.579 ' HZ3' ' HB3' ' A' ' 128' ' ' ASP . 17.3 tptt -95.64 120.61 36.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.875 . . . . 3.3799999999999999 110.187 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.41 142.44 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.906 -0.775 . . . . 0.34999999999999998 108.906 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.577 ' O ' HG13 ' A' ' 167' ' ' VAL . . . -149.18 168.58 22.86 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 120.57 -0.452 . . . . 1.1499999999999999 110.459 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.85 123.37 2.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 3.9700000000000002 110.553 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.6 p -127.91 70.05 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.631 0.729 . . . . 4.3099999999999996 110.873 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.537 ' HH ' ' HO4' ' A' ' 191' ' ' NGR . 4.4 m-85 -146.95 -67.98 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.649 -0.705 . . . . 3.0099999999999998 111.004 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -100.23 -179.13 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 2.0 110.68 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.45 82.5 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 1.6599999999999999 111.203 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -165.47 140.87 5.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 3.6000000000000001 111.274 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.1 t -91.59 163.34 14.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.801 -0.636 . . . . 1.8899999999999999 111.026 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 51.62 28.3 4.61 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.051 -0.522 . . . . 2.6899999999999999 111.12 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -134.11 -42.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 3.0299999999999998 109.853 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -108.76 82.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 3.52 109.485 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -109.5 150.22 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.704 -0.68 . . . . 1.95 110.202 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 114' ' ' ASP . 67.2 m-85 -133.38 -177.13 4.39 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 112.561 0.578 . . . . 0.80000000000000004 112.561 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -132.58 137.75 47.19 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.829 -0.348 . . . . 2.0099999999999998 111.005 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.8 t -131.37 129.76 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 112.758 0.651 . . . . 1.1599999999999999 112.758 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.535 HH21 HG23 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -139.14 149.42 44.46 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.95 0.722 . . . . 2.1800000000000002 112.95 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.9 p -116.15 121.05 66.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 115.211 -0.904 . . . . 1.71 110.566 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.659 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 2.3 t30 52.8 26.89 4.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.239 -0.891 . . . . 1.77 110.419 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.95 16.2 39.52 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 114.451 -1.249 . . . . 0.40999999999999998 113.128 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.2 m-70 -115.22 111.53 21.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.215 0.82 . . . . 0.58999999999999997 113.215 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -67.1 123.08 19.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.054 0.454 . . . . 1.2 111.118 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -39.81 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.572 -0.74 . . . . 1.3999999999999999 109.901 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.86 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.312 0.577 . . . . 1.21 109.933 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -98.94 154.71 17.85 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 2.9199999999999999 110.025 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 102' ' ' PHE . 12.7 m-20 66.91 32.06 6.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.135 -1.393 . . . . 2.5600000000000001 109.256 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 98.31 0.02 OUTLIER 'General case' 0 C--N 1.342 0.268 0 CA-C-O 120.96 0.41 . . . . 1.71 111.166 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 45.1 p-10 -100.72 79.28 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.298 -1.001 . . . . 1.99 108.298 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.91 -48.94 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.298 -0.865 . . . . 1.23 112.533 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.45 -39.99 77.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.711 0.263 . . . . 1.01 111.711 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.97 -27.7 62.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.97 0.359 . . . . 0.76000000000000001 111.97 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 34.5 mmt180 -70.0 -59.09 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.082 0.401 . . . . 3.0299999999999998 112.082 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.8 m -95.77 -40.47 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.228 0.455 . . . . 2.0299999999999998 112.228 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.57 -104.0 2.43 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.63 -0.795 . . . . 1.0600000000000001 112.22 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -63.95 164.78 9.82 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.347 -0.242 . . . . 4.29 110.347 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.458 ' O ' HD22 ' A' ' 51' ' ' LEU . 80.5 p -58.11 98.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.887 0.375 . . . . 2.1099999999999999 110.738 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -144.69 -157.79 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 1.3300000000000001 109.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.72 133.82 50.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.41 0.522 . . . . 1.1200000000000001 112.41 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -109.0 147.73 31.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.922 -0.77 . . . . 0.45000000000000001 108.922 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.579 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . 5.0 p-10 -140.39 124.86 17.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.546 0.573 . . . . 2.0899999999999999 112.546 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -116.81 135.75 53.5 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.467 -0.788 . . . . 2.2799999999999998 109.783 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.5 mt -128.8 133.58 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.85 -0.614 . . . . 1.3799999999999999 111.408 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.0 mp -135.17 92.36 18.18 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.457 -0.338 . . . . 2.0 111.883 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.03 140.1 76.93 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.388 1.392 . . . . 0.23999999999999999 111.193 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 134' ' ' SER . 14.8 mt -132.56 158.9 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.462 -0.336 . . . . 1.0600000000000001 110.992 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.448 ' N ' HG22 ' A' ' 133' ' ' ILE . 48.4 t -134.23 110.95 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.19 0.519 . . . . 1.6599999999999999 111.119 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 17.0 mt -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 115.406 -0.815 . . . . 1.0700000000000001 110.009 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -150.37 142.38 23.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.69 0.281 . . . . 2.4300000000000002 110.867 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm 61.19 19.0 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 3.5600000000000001 110.75 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.12 71.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 0.32000000000000001 113.206 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -111.16 164.77 12.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.891 0.345 . . . . 2.6800000000000002 110.523 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.5 tt -124.16 143.47 50.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.689 0.625 . . . . 1.1100000000000001 112.689 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.8 t -130.69 114.09 14.96 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.343 -0.844 . . . . 1.3700000000000001 109.723 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.432 ' O ' HG11 ' A' ' 142' ' ' VAL . 2.4 p -108.93 96.87 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.738 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 61.74 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 2.0499999999999998 111.752 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.36 6.65 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.464 -0.874 . . . . 0.59999999999999998 113.4 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.97 129.45 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.762 -0.458 . . . . 2.02 109.762 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.2 p -105.27 141.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.31 0.576 . . . . 1.8700000000000001 111.551 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.1 m -156.88 170.4 22.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.293 -0.867 . . . . 1.46 109.301 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.2 p -99.57 139.02 35.84 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.731 -0.388 . . . . 1.55 111.548 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -78.68 142.78 36.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.34000000000000002 109.69 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.1 t -147.27 96.12 2.66 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.038 0.755 . . . . 2.02 113.038 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.8 -65.5 4.05 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 115.511 0.964 . . . . 0.77000000000000002 115.511 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.58 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.56 -179.58 6.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 117.601 0.7 . . . . 2.3199999999999998 112.455 -177.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.43 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 1.3 tp -102.37 133.54 47.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.339 -1.356 . . . . 1.8600000000000001 107.339 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.659 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -111.31 101.07 9.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.555 0.946 . . . . 1.72 113.555 -175.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.63 98.32 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.58 -0.448 . . . . 1.27 109.905 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 155.29 42.42 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.986 -0.552 . . . . 2.48 111.629 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -130.91 146.9 52.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.431 -0.804 . . . . 1.9199999999999999 110.84 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.535 HG23 HH21 ' A' ' 105' ' ' ARG . 19.8 t -117.49 143.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 114.627 -1.17 . . . . 1.3899999999999999 110.705 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -86.6 147.59 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.902 -0.59 . . . . 2.48 110.993 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -88.66 -9.56 68.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 1.1200000000000001 112.606 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -153.35 -64.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.539 0.209 . . . . 3.8999999999999999 111.017 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -146.63 -64.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.844 0.354 . . . . 4.0999999999999996 111.017 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 13.7 m-20 -65.51 150.27 48.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.257 0.551 . . . . 1.3999999999999999 111.556 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.555 ' ND2' ' CE1' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -109.0 -179.0 0.61 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.635 -1.246 . . . . 2.0 107.635 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -11.01 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 CA-C-N 121.461 1.557 . . . . 3.1099999999999999 113.22 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.688 ' HZ1' ' HB2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER 74.92 -77.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 4.1100000000000003 111.32 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 90' ' ' ALA . 1.5 m -104.71 135.8 41.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 C-N-CA 119.398 -0.921 . . . . 1.5900000000000001 110.646 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 4.8 t -131.72 117.28 18.41 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.092 -0.958 . . . . 1.8600000000000001 112.362 -177.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.459 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -100.94 37.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.149 -0.932 . . . . 1.04 113.505 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.68 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.34 0.4 . . . . 1.6799999999999999 111.427 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -159.99 97.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.38 110.433 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.424 ' O ' HG21 ' A' ' 172' ' ' ILE . 0.7 OUTLIER -105.28 125.76 60.42 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 122.426 1.108 . . . . 1.3500000000000001 112.011 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.4 ptm -119.93 166.01 13.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.335 -1.302 . . . . 1.26 109.851 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 11.7 ptmt -120.82 152.5 38.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.899 1.444 . . . . 2.3599999999999999 114.899 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 94.5 -37.8 3.31 Favored Glycine 0 C--N 1.319 -0.401 0 CA-C-N 111.784 -2.462 . . . . 0.23000000000000001 117.058 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.59 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 176.92 166.15 0.52 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.451 1.625 . . . . 1.1000000000000001 112.528 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.625 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -84.78 -52.16 6.25 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.649 -0.705 . . . . 1.1000000000000001 109.538 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.55 4.58 17.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.166 -0.924 . . . . 2.3100000000000001 110.251 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.418 ' OD1' ' HE3' ' A' ' 9' ' ' LYS . 6.9 t0 -43.62 -50.14 7.46 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.037 -0.528 . . . . 2.3700000000000001 109.778 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.59 -64.69 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.613 -0.721 . . . . 3.0800000000000001 112.875 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.04 131.3 30.15 Favored 'Trans proline' 0 C--N 1.364 1.346 0 CA-C-N 121.313 1.505 . . . . 2.4500000000000002 111.942 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 182' ' ' MET . 2.0 mpt? -87.08 159.11 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 6.3700000000000001 110.631 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 82.1 mt -127.88 124.21 36.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 5.3499999999999996 110.582 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.43 142.52 90.64 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.037 -0.529 . . . . 8.5099999999999998 110.426 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -44.53 126.83 7.26 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 121.732 1.621 . . . . 9.6899999999999995 112.471 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.481 ' HD1' ' N ' ' A' ' 187' ' ' PRO . 3.1 t-80 -122.32 125.27 26.59 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.475 -0.329 . . . . 10.35 110.351 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.481 ' N ' ' HD1' ' A' ' 186' ' ' HIS . 12.3 Cg_endo -82.89 -158.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.058 1.839 . . . . 12.26 111.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 59.14 -114.25 5.95 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.394 -0.908 . . . . 12.619999999999999 112.811 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.434 HD13 ' N ' ' A' ' 189' ' ' LEU . 10.3 mp -79.97 156.33 27.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.717 0.294 . . . . 14.65 110.746 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.192 -0.908 . . . . 15.699999999999999 110.917 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . 0.537 ' HO4' ' HH ' ' A' ' 93' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.481 -0.248 . . . . 9.3900000000000006 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.15 122.16 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.735 0.303 . . . . 7.6799999999999997 110.853 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -141.62 20.26 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 8.1699999999999999 110.789 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 t 56.01 42.78 28.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.521 . . . . 4.25 110.947 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.8 42.87 1.79 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.666 -0.778 . . . . 1.8200000000000001 112.614 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp -74.53 -49.48 21.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.114 0.483 . . . . 1.1299999999999999 110.222 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -55.15 -21.52 13.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.422 -0.808 . . . . 1.1299999999999999 111.308 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.27 -20.97 46.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.159 0.429 . . . . 2.0899999999999999 112.159 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -101.67 -21.36 14.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.756 -0.377 . . . . 2.5 111.528 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 7' ' ' ALA . 10.1 p -45.08 145.6 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 120.577 0.227 . . . . 1.05 111.577 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.619 HG23 ' HZ3' ' A' ' 174' ' ' LYS . 3.4 pt -138.96 -23.52 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 120.142 -0.623 . . . . 1.48 111.181 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.511 ' O ' HG21 ' A' ' 172' ' ' ILE . 20.3 t90 -173.42 136.35 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.696 -0.402 . . . . 0.33000000000000002 110.126 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 28' ' ' HIS . . . -155.57 144.26 20.45 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.429 -0.169 . . . . 1.05 111.382 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -147.15 127.78 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 113.797 1.036 . . . . 1.3600000000000001 113.797 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -115.53 97.18 6.01 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 119.915 -0.714 . . . . 1.8700000000000001 110.997 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.6 100.29 0.87 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.037 -1.097 . . . . 1.1100000000000001 108.037 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.564 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 177.39 -58.0 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.502 -1.226 . . . . 0.67000000000000004 112.609 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.74 -126.26 4.77 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.644 -0.789 . . . . 1.1200000000000001 113.422 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG2' ' HZ1' ' A' ' 31' ' ' LYS . 26.0 mt-10 -151.81 119.51 6.12 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.44 0.296 . . . . 2.02 110.992 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.8 m 29.2 106.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.592 0.96 . . . . 1.6499999999999999 113.592 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 50.1 t60 -133.43 150.4 51.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 120.485 -0.486 . . . . 0.41999999999999998 112.036 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 p -122.81 104.94 15.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 121.4 0.619 . . . . 1.8200000000000001 111.405 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.95 155.45 34.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.425 -0.807 . . . . 1.1699999999999999 110.03 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 m -43.21 -50.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.48 0.919 . . . . 1.27 113.48 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -59.46 -18.3 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.118 0.485 . . . . 0.55000000000000004 110.646 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.94 35.24 3.77 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.487 -0.779 . . . . 0.32000000000000001 112.619 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.413 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 32.7 mm -103.42 111.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.003 0.43 . . . . 1.21 109.897 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 17.9 t60 -101.28 136.66 40.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.171 1.545 . . . . 0.68999999999999995 115.171 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.652 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.9 136.8 41.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.184 -1.371 . . . . 3.3199999999999998 108.189 177.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -97.38 109.98 22.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.415 0.626 . . . . 3.3999999999999999 112.402 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.539 ' H ' ' HG ' ' A' ' 20' ' ' SER . 11.5 tttm -12.22 137.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.62 1.568 . . . . 3.1600000000000001 114.934 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.519 ' OD1' ' HB2' ' A' ' 35' ' ' GLU . 27.9 t70 -13.36 88.95 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.01 -0.995 . . . . 1.98 113.01 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -99.84 -4.98 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.468 2.112 . . . . 1.53 115.818 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.513 HD23 ' C ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -142.87 -16.57 0.69 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.316 0.962 . . . . 2.3599999999999999 113.194 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.519 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 21.2 mm-40 -89.39 76.61 7.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 4.9500000000000002 109.804 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.52 -16.91 22.38 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.871 -0.892 . . . . 2.3300000000000001 110.871 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 49.56 54.67 10.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.357 0.598 . . . . 5.8700000000000001 110.827 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 m -141.58 176.72 4.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.301 -0.863 . . . . 3.48 110.529 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.15 120.44 6.35 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.707 -0.759 . . . . 2.5899999999999999 112.553 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -146.65 -75.06 0.2 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.418 0.151 . . . . 7.3300000000000001 111.183 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 65.67 124.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.994 0.426 . . . . 2.0099999999999998 111.486 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 t -99.86 -57.5 2.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.932 -0.576 . . . . 2.2999999999999998 110.135 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.26 30.66 3.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.032 0.444 . . . . 2.23 110.684 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -81.5 11.09 4.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.858 -0.61 . . . . 2.6000000000000001 110.095 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -102.05 17.31 54.51 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.879 -0.677 . . . . 2.6600000000000001 112.976 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.2 mtt -62.04 -26.07 68.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.31 0.576 . . . . 2.4300000000000002 109.962 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -85.37 -6.88 59.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.17 -0.923 . . . . 3.79 110.333 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mt -140.29 59.34 12.21 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.234 -0.894 . . . . 3.23 109.424 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -80.48 164.21 21.38 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.575 2.183 . . . . 1.9399999999999999 113.631 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.438 HD11 ' N ' ' A' ' 50' ' ' ILE . 1.1 mp -77.26 146.68 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.247 -0.888 . . . . 1.45 110.331 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.406 HD21 ' N ' ' A' ' 51' ' ' LEU . 4.3 mm? -95.6 -49.0 5.58 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.292 0.849 . . . . 2.29 113.292 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.95 31.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.939 0.718 . . . . 3.0600000000000001 112.939 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 51' ' ' LEU . 27.0 t -145.63 143.95 30.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.01 0.433 . . . . 1.4099999999999999 111.678 178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 58' ' ' GLN . 34.9 t30 -59.23 148.36 72.34 Favored Pre-proline 0 C--O 1.221 -0.403 0 CA-C-N 115.667 -0.697 . . . . 1.96 109.66 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.605 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.3 Cg_exo -42.0 -51.79 4.43 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.137 1.892 . . . . 0.78000000000000003 113.522 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -55.25 16.4 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.885 0.85 . . . . 1.8200000000000001 111.163 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.15 -12.67 61.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.759 -0.655 . . . . 1.9099999999999999 109.761 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 1.1 tt0 -66.0 -48.16 72.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.974 -1.491 . . . . 2.0600000000000001 106.974 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -50.47 -46.64 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.085 -0.961 . . . . 1.8500000000000001 109.153 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 tp -73.54 -13.12 60.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.975 -1.011 . . . . 1.6000000000000001 111.647 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.631 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 3.7 m-30 -121.06 23.41 10.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.565 -0.743 . . . . 1.29 111.132 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -142.11 -68.4 0.37 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.145 0.794 . . . . 1.8 113.145 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.496 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 74.9 p -29.19 148.85 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.224 0.824 . . . . 1.4099999999999999 113.224 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.564 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 3.1 pp20? -122.97 -22.54 5.21 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.256 1.206 . . . . 2.0499999999999998 114.256 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.517 ' N ' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mtp-105 69.62 -80.77 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.758 0.313 . . . . 4.2800000000000002 110.794 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -170.89 171.55 5.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.158 -0.474 . . . . 4.4699999999999998 110.564 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -97.88 166.88 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.333 -0.394 . . . . 5.1500000000000004 110.875 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -163.79 -120.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.528 -0.306 . . . . 3.1699999999999999 111.25 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -174.53 129.07 0.34 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.355 -0.216 . . . . 2.3900000000000001 110.421 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t 49.45 86.2 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.635 -0.505 . . . . 1.3200000000000001 109.635 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.517 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -92.39 130.3 38.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.628 . . . . 1.77 109.306 -178.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -128.2 129.16 6.2 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.521 -1.323 . . . . 0.98999999999999999 113.646 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 154' ' ' SER . 12.8 m-85 -112.9 144.69 42.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.401 . . . . 1.1899999999999999 110.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.91 126.98 55.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 2.27 111.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.458 HD13 ' N ' ' A' ' 75' ' ' ILE . 4.0 mp -123.21 86.49 51.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.615 -0.266 . . . . 1.0700000000000001 111.35 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.66 129.46 34.03 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.398 2.065 . . . . 1.26 112.764 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.58 149.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.043 -0.526 . . . . 1.0900000000000001 110.796 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -141.04 0.28 1.54 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 3.4399999999999999 111.387 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 80' ' ' GLU . 20.5 tt0 -131.07 167.19 19.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.827 0.346 . . . . 2.1299999999999999 110.32 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -115.84 176.86 4.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.354 0.597 . . . . 0.37 111.865 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.76 -151.13 19.89 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 109.933 -1.267 . . . . 0.23000000000000001 109.933 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.4 mt-10 -103.81 109.59 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.03 1.415 . . . . 2.0299999999999998 109.528 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.754 ' HH ' ' HZ2' ' A' ' 174' ' ' LYS . 3.3 m-85 -96.04 126.81 41.54 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.677 -0.86 . . . . 0.94999999999999996 108.677 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.609 HG22 ' N ' ' A' ' 177' ' ' ALA . 39.6 t -109.97 109.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.043 -0.981 . . . . 1.21 112.035 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.93 104.02 16.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.533 -1.212 . . . . 1.79 110.399 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 p -115.23 141.8 30.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.092 -0.958 . . . . 1.95 108.698 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 87' ' ' LEU . 2.0 pp -153.88 148.69 26.53 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.049 -0.66 . . . . 2.0 111.653 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.631 ' HZ2' ' HB3' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -107.71 127.08 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.82 -0.752 . . . . 3.3799999999999999 109.919 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-85 -109.39 148.51 30.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.353 -0.84 . . . . 0.34999999999999998 109.741 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.0 154.98 42.49 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.611 -0.268 . . . . 1.1499999999999999 110.566 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -179.04 136.77 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.179 -0.464 . . . . 3.9700000000000002 110.505 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.402 HG23 ' OG ' ' A' ' 124' ' ' SER . 7.6 p -168.08 125.05 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.153 0.501 . . . . 4.3099999999999996 111.85 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 178.07 -48.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.505 -0.77 . . . . 3.0099999999999998 110.128 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -117.21 82.28 1.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 2.0 110.01 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.77 106.52 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.901 -0.59 . . . . 1.6599999999999999 111.634 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.457 HE21 ' H ' ' A' ' 97' ' ' SER . 22.4 tp60 -175.89 140.25 0.42 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.152 -0.476 . . . . 3.6000000000000001 110.896 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.457 ' H ' HE21 ' A' ' 96' ' ' GLN . 40.9 t -99.25 165.57 11.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 1.8899999999999999 110.439 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 71.07 -64.74 0.37 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 2.6899999999999999 111.552 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -45.01 -43.79 9.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.495 -0.32 . . . . 3.0299999999999998 111.362 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 44.7 mtmt -92.01 71.46 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 3.52 110.752 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 t -109.8 132.57 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.35 -0.386 . . . . 1.95 109.971 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -123.04 179.01 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.362 0.504 . . . . 0.80000000000000004 112.362 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.412 ' OD2' HG21 ' A' ' 110' ' ' THR . 4.0 t70 -128.45 138.31 52.24 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 116.237 -0.438 . . . . 2.0099999999999998 112.005 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.44 132.26 64.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.644 -0.707 . . . . 1.1599999999999999 112.169 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 9.3 mtt180 -133.11 146.11 51.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 115.429 -0.805 . . . . 2.1800000000000002 112.611 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 11.8 m -117.53 119.75 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.428 -0.806 . . . . 1.71 109.538 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.465 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.71 26.75 9.76 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.826 -0.805 . . . . 1.77 108.826 -176.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.01 20.6 38.71 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.8 -1.091 . . . . 0.40999999999999998 112.897 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.5 m-70 -118.64 112.29 19.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.432 0.901 . . . . 0.58999999999999997 113.432 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.412 HG21 ' OD2' ' A' ' 103' ' ' ASP . 16.1 p -63.1 120.08 10.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.618 -0.433 . . . . 1.2 111.062 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.5 t -113.85 -32.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.371 -0.603 . . . . 1.3999999999999999 109.371 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.11 89.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.509 -0.552 . . . . 1.21 109.509 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.6 ptpp? -106.09 79.96 1.46 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.488 1.137 . . . . 2.9199999999999999 110.976 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.7 p-10 157.79 40.41 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.462 -2.154 . . . . 2.5600000000000001 108.445 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.91 84.39 0.95 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.238 0.829 . . . . 1.71 113.238 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 15.9 t70 -96.02 84.42 3.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.175 -1.417 . . . . 1.99 107.175 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.2 mt -50.46 -36.97 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.122 -0.945 . . . . 1.23 112.853 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.52 -47.97 79.46 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.73 0.271 . . . . 1.01 111.73 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.4 -27.58 67.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.973 0.36 . . . . 0.76000000000000001 111.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 38.9 mmt180 -67.85 -59.04 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.044 0.387 . . . . 3.0299999999999998 112.044 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.29 -39.39 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.879 0.326 . . . . 2.0299999999999998 111.879 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.22 -56.94 1.47 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.779 -0.724 . . . . 1.0600000000000001 111.999 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -114.6 158.12 22.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.979 -0.378 . . . . 4.29 109.979 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.402 ' OG ' HG23 ' A' ' 92' ' ' VAL . 68.5 m -55.58 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 2.1099999999999999 111.08 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 50' ' ' ILE . 28.7 p -143.7 -144.9 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 1.3300000000000001 110.355 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.547 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . . . -110.42 126.17 54.03 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.84 0.681 . . . . 1.1200000000000001 112.84 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.431 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 2.5 t60 -103.23 137.83 40.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.553 -0.906 . . . . 0.45000000000000001 108.553 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -144.29 128.37 17.59 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.569 0.581 . . . . 2.0899999999999999 112.569 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.55 134.72 55.03 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.247 -0.888 . . . . 2.2799999999999998 109.666 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.85 128.52 71.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.767 -0.651 . . . . 1.3799999999999999 110.397 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -126.04 84.85 60.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.508 0.558 . . . . 2.0 112.508 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.62 143.03 99.38 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.828 1.685 . . . . 0.23999999999999999 111.635 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 134' ' ' SER . 20.9 mt -135.93 156.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 1.0600000000000001 111.254 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.464 ' N ' HG23 ' A' ' 133' ' ' ILE . 46.3 t -132.62 107.16 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.067 0.46 . . . . 1.6599999999999999 111.147 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 23.6 mt -103.85 128.7 56.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.802 -0.635 . . . . 1.0700000000000001 110.001 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -147.92 143.23 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.866 0.365 . . . . 2.4300000000000002 111.378 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp 56.4 20.59 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 3.5600000000000001 110.817 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.01 24.45 41.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.76 -0.733 . . . . 0.32000000000000001 112.953 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 40.5 mtmt -125.21 152.42 44.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.185 0.492 . . . . 2.6800000000000002 110.943 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 141' ' ' SER . 6.0 tt -109.61 127.39 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 1.1100000000000001 111.84 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.401 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.6 t -117.5 109.5 16.81 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.56 -0.745 . . . . 1.3700000000000001 109.493 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.64 118.85 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 1.23 110.789 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 54.74 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 2.0499999999999998 111.556 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.92 27.84 3.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.794 -0.717 . . . . 0.59999999999999998 112.78 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.48 140.22 51.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.293 . . . . 2.02 110.265 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.44 138.65 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 1.8700000000000001 111.372 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.7 m -161.22 123.55 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 1.46 110.459 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.3 p -54.12 141.2 29.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 1.55 112.06 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -80.57 142.69 33.84 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.305 -0.628 . . . . 0.34000000000000002 109.305 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -140.79 96.35 3.0 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.168 0.803 . . . . 2.02 113.168 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.98 -63.17 2.45 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 115.4 0.92 . . . . 0.77000000000000002 115.4 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.589 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.7 178.5 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.804 0.802 . . . . 2.3199999999999998 112.543 -178.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.465 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.91 131.96 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.514 -1.291 . . . . 1.8600000000000001 107.514 177.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.9 t -120.21 112.02 18.55 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.016 -1.074 . . . . 1.72 113.531 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -94.11 99.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.042 -0.725 . . . . 1.27 109.042 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 37.0 mt-10 -109.04 124.69 51.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.525 -0.762 . . . . 2.48 111.324 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.61 132.92 55.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.894 -0.722 . . . . 1.9199999999999999 110.1 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.422 HG23 HH21 ' A' ' 105' ' ' ARG . 39.4 t -102.45 142.31 16.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.615 -1.175 . . . . 1.3899999999999999 111.851 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.74 148.43 51.28 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 115.4 -0.818 . . . . 2.48 111.106 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.63 -9.1 41.58 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 1.1200000000000001 112.374 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -155.73 -75.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.542 0.211 . . . . 3.8999999999999999 111.203 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -173.64 68.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.736 0.303 . . . . 4.0999999999999996 111.131 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -178.03 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.331 -0.395 . . . . 1.3999999999999999 110.897 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.25 159.12 0.12 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.479 -0.563 . . . . 2.0 109.479 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -40.07 100.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.632 1.555 . . . . 3.1099999999999999 111.371 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.98 -36.07 26.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 4.1100000000000003 112.322 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 79.5 t -126.7 135.3 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.566 0.58 . . . . 1.5900000000000001 112.566 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.7 t -130.47 131.53 45.2 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 123.836 0.71 . . . . 1.8600000000000001 111.653 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.412 ' HB1' ' H ' ' A' ' 88' ' ' LYS . . . -121.73 37.8 4.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.26 -0.882 . . . . 1.04 113.299 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.98 134.17 0.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.433 0.458 . . . . 1.6799999999999999 111.503 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -156.9 98.76 1.79 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.881 -0.145 . . . . 0.38 110.869 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.511 HG21 ' O ' ' A' ' 12' ' ' TRP . 16.5 tt -108.22 125.79 64.9 Favored 'Isoleucine or valine' 0 C--O 1.259 1.601 0 CA-C-O 122.784 1.278 . . . . 1.3500000000000001 112.486 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.16 167.17 11.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.798 -1.546 . . . . 1.26 109.035 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.754 ' HZ2' ' HH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -119.89 146.97 45.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.217 1.562 . . . . 2.3599999999999999 115.217 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.59 -35.99 4.04 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 112.008 -2.36 . . . . 0.23000000000000001 118.251 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.579 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.83 159.14 0.57 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.332 2.066 . . . . 1.1000000000000001 113.955 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.609 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -85.82 -20.05 29.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.079 -0.964 . . . . 1.1000000000000001 110.236 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -59.95 -33.58 72.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.756 -0.656 . . . . 2.3100000000000001 111.309 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -56.59 -44.92 81.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.514 -0.312 . . . . 2.3700000000000001 110.504 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.4 t -36.28 99.58 0.18 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 116.014 -0.539 . . . . 3.0800000000000001 111.901 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.12 140.39 32.84 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.139 1.893 . . . . 2.4500000000000002 112.44 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 92.5 mtp -86.97 93.66 9.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.267 -0.424 . . . . 6.3700000000000001 110.974 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 183' ' ' LEU . 3.7 mm? 59.25 175.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.0 -0.546 . . . . 5.3499999999999996 111.132 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -121.59 145.1 42.05 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.842 -0.617 . . . . 8.5099999999999998 110.023 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -44.71 124.51 5.61 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 121.579 1.52 . . . . 9.6899999999999995 111.918 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.504 ' HD1' ' N ' ' A' ' 187' ' ' PRO . 2.4 t-80 -125.71 124.22 24.87 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.954 -0.298 . . . . 10.35 110.809 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.504 ' N ' ' HD1' ' A' ' 186' ' ' HIS . 10.7 Cg_endo -83.68 -156.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.009 1.806 . . . . 12.26 111.387 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 160.96 123.93 0.7 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.358 -0.925 . . . . 12.619999999999999 112.682 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 189' ' ' LEU . 3.2 mm? -106.91 118.13 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.779 0.323 . . . . 14.65 110.485 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.296 -0.859 . . . . 15.699999999999999 110.77 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . 0.746 HO14 HO16 ' A' ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.505 -0.238 . . . . 9.3900000000000006 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.66 -33.62 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 7.6799999999999997 110.87 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -132.56 92.66 3.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 8.1699999999999999 110.771 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.0 p -102.42 172.64 6.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 4.25 110.677 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.05 45.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.853 -0.689 . . . . 1.8200000000000001 112.456 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.5 -44.23 62.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.387 0.613 . . . . 1.1299999999999999 110.482 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -55.82 -21.07 17.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 1.1299999999999999 111.198 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.05 -18.36 60.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 2.0899999999999999 111.859 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -103.9 -26.46 12.66 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.712 -0.395 . . . . 2.5 111.267 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 7' ' ' ALA . 8.3 p -43.37 144.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.849 0.315 . . . . 1.05 111.849 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -137.16 -24.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.422 -0.511 . . . . 1.48 110.758 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.544 ' O ' HG22 ' A' ' 172' ' ' ILE . 25.1 t90 -171.04 138.98 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.593 -0.521 . . . . 0.33000000000000002 109.593 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 28' ' ' HIS . . . -159.24 143.87 15.5 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.216 0.45 . . . . 1.05 112.216 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.01 131.3 8.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 114.224 1.194 . . . . 1.3600000000000001 114.224 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 8.4 t30 -114.67 88.63 2.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.265 -0.879 . . . . 1.8700000000000001 109.082 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB3' ' OH ' ' A' ' 73' ' ' TYR . . . -60.82 105.76 0.49 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.114 -0.948 . . . . 1.1100000000000001 110.192 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' N ' ' HD2' ' A' ' 65' ' ' ARG . . . 162.13 -48.05 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.867 -1.061 . . . . 0.67000000000000004 114.324 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.91 -130.89 6.92 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.654 -0.784 . . . . 1.1200000000000001 113.861 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -152.36 119.81 6.0 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 122.317 0.247 . . . . 2.02 111.086 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.5 m 24.14 101.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.358 0.873 . . . . 1.6499999999999999 113.358 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 13.2 t60 -126.44 150.52 48.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 119.971 -0.692 . . . . 0.41999999999999998 111.96 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.79 105.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 1.8200000000000001 110.807 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.8 154.39 42.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.434 -0.348 . . . . 1.1699999999999999 110.36 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 m -44.47 -50.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 124.117 0.885 . . . . 1.27 113.068 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -58.89 -17.22 22.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.261 0.553 . . . . 0.55000000000000004 110.307 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.49 34.76 4.62 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.32000000000000001 112.12 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 27' ' ' ILE . 31.1 mm -103.92 121.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 1.21 110.039 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.9 t60 -99.95 136.99 39.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.578 1.325 . . . . 0.68999999999999995 114.578 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.682 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.65 131.25 47.99 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.768 -1.106 . . . . 3.3199999999999998 108.311 176.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.456 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 14.6 mtt180 -89.63 109.62 20.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.584 0.553 . . . . 3.3999999999999999 112.282 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 30' ' ' ARG . 17.4 tttp -16.42 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.514 1.125 . . . . 3.1600000000000001 113.506 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -18.7 84.11 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.149 0.979 . . . . 1.98 113.165 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 5.3 Cg_endo -105.02 56.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.035 2.49 . . . . 1.53 112.933 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.4 tp -152.85 -78.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.818 0.303 . . . . 2.3599999999999999 111.818 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER -58.17 89.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.176 0.512 . . . . 4.9500000000000002 110.559 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.86 -13.08 5.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.783 -0.723 . . . . 2.3300000000000001 111.803 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.451 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER 46.13 31.5 1.19 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.934 0.397 . . . . 5.8700000000000001 111.126 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.2 p -148.56 144.14 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 3.48 110.572 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.79 -150.37 17.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.777 -0.725 . . . . 2.5899999999999999 112.343 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -130.09 -79.68 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.513 0.197 . . . . 7.3300000000000001 111.04 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.607 ' HA ' HH21 ' A' ' 65' ' ' ARG . . . -177.8 140.34 0.25 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.97 0.414 . . . . 2.0099999999999998 111.282 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 44' ' ' TYR . 74.1 m -90.05 45.98 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.512 -0.551 . . . . 2.2999999999999998 109.512 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.97 25.93 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.37 -0.832 . . . . 2.23 111.383 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.483 ' H ' ' C ' ' A' ' 42' ' ' SER . 90.1 t80 -52.75 -38.78 61.45 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.006 0.431 . . . . 2.6000000000000001 110.246 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -103.96 48.32 1.02 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.978 -0.63 . . . . 2.6600000000000001 112.019 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 32.0 ttm -58.48 -15.59 11.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.842 0.353 . . . . 2.4300000000000002 110.65 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -65.4 -165.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 3.79 110.594 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.41 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 17.5 mt 55.05 50.33 6.07 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 109.804 -0.443 . . . . 3.23 109.804 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 19.4 Cg_endo -53.95 115.6 2.45 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.563 2.175 . . . . 1.9399999999999999 112.828 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp -49.63 128.03 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.184 -0.673 . . . . 1.45 109.184 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 51' ' ' LEU . 7.8 mp -83.16 -32.06 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.385 0.884 . . . . 2.29 113.385 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -79.11 33.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.507 -0.477 . . . . 3.0600000000000001 111.681 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -165.97 142.22 5.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.359 -0.382 . . . . 1.4099999999999999 110.436 178.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -60.97 164.04 8.67 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.516 -0.311 . . . . 1.96 110.943 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 53.8 Cg_exo -47.21 -41.87 27.24 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.393 2.062 . . . . 0.78000000000000003 115.024 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.548 ' O ' HG13 ' A' ' 59' ' ' VAL . 11.3 mm-40 -73.26 -55.81 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.748 0.785 . . . . 1.8200000000000001 110.731 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 40.8 p30 -70.27 -3.02 15.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.701 -0.799 . . . . 1.9099999999999999 109.517 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.527 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -74.36 -60.73 2.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.425 -0.954 . . . . 2.0600000000000001 108.425 177.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 56' ' ' GLU . 7.2 p -49.63 -37.39 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.738 -0.467 . . . . 1.8500000000000001 109.738 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 62' ' ' GLN . 11.1 tp -69.15 -66.48 0.57 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.441 -0.504 . . . . 1.6000000000000001 110.245 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 8.1 m-30 -55.05 -2.71 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.198 0.523 . . . . 1.29 111.147 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.575 ' H ' ' C ' ' A' ' 60' ' ' LEU . 6.9 tt0 -116.67 -131.65 0.32 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 1.8 109.614 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 62' ' ' GLN . 12.3 p 44.23 131.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.444 0.905 . . . . 1.4099999999999999 113.444 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 -128.03 149.31 50.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.767 0.654 . . . . 2.0499999999999998 112.767 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.607 HH21 ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -80.4 -156.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.677 -0.692 . . . . 4.2800000000000002 109.616 177.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -87.12 -87.27 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 121.373 -0.131 . . . . 4.4699999999999998 111.165 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -179.89 155.77 0.63 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.592 0.235 . . . . 5.1500000000000004 110.957 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -176.43 -158.65 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.291 -0.413 . . . . 3.1699999999999999 110.61 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -152.83 135.86 15.58 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.502 -0.317 . . . . 2.3900000000000001 110.987 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t 50.54 79.21 0.09 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.483 -0.326 . . . . 1.3200000000000001 110.397 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -151.43 153.86 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.66 -0.416 . . . . 1.77 111.273 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -170.49 -160.43 18.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.621 -0.8 . . . . 0.98999999999999999 113.914 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.549 ' OH ' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -120.93 164.16 17.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.601 0.715 . . . . 1.1899999999999999 112.917 -177.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.46 125.08 50.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.483 -1.235 . . . . 2.27 109.539 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.498 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.1 mp -115.41 88.5 19.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.242 0.46 . . . . 1.0700000000000001 112.242 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -56.24 127.93 28.04 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.957 1.771 . . . . 1.26 112.16 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.4 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.3 mt -122.69 151.5 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.911 0.386 . . . . 1.0900000000000001 111.048 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -140.45 -0.39 1.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.1 -0.5 . . . . 3.4399999999999999 111.27 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.672 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 40.9 mt-10 -126.06 168.49 13.91 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.616 0.246 . . . . 2.1299999999999999 111.046 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -122.6 168.52 12.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.381 0.61 . . . . 0.37 111.55 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.33 -151.87 23.28 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.739 -1.345 . . . . 0.23000000000000001 109.739 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.41 107.6 18.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.066 1.433 . . . . 2.0299999999999998 108.84 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.672 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.1 m-85 -95.14 126.31 40.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.645 -0.822 . . . . 0.94999999999999996 109.162 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.603 HG23 ' N ' ' A' ' 177' ' ' ALA . 40.6 t -109.47 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.678 -1.146 . . . . 1.21 111.457 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 tp -99.28 105.06 17.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.365 -1.289 . . . . 1.79 110.729 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 p -113.56 135.25 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.774 -0.648 . . . . 1.95 109.929 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.06 135.19 45.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.59 . . . . 2.0 111.614 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.584 ' HZ3' ' HB3' ' A' ' 128' ' ' ASP . 17.9 tptt -102.93 114.83 29.44 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 3.3799999999999999 108.83 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -103.68 140.98 36.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.772 -0.825 . . . . 0.34999999999999998 108.772 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -154.63 170.55 21.25 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.475 0.917 . . . . 1.1499999999999999 113.475 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 66.18 149.9 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.67 -1.15 . . . . 3.9700000000000002 112.59 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.5 t -140.96 -37.21 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.378 -0.828 . . . . 4.3099999999999996 110.58 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 t80 64.42 14.47 8.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.659 -0.7 . . . . 3.0099999999999998 112.279 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.476 ' HB2' ' HZ2' ' A' ' 100' ' ' LYS . 11.7 m-85 -149.51 -38.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.468 0.175 . . . . 2.0 111.378 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 62.88 102.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.938 0.399 . . . . 1.6599999999999999 111.504 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -167.41 147.03 5.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 3.6000000000000001 110.238 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m -110.61 149.8 29.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.105 0.479 . . . . 1.8899999999999999 112.231 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 46.64 32.85 1.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.319 -0.855 . . . . 2.6899999999999999 111.823 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.42 -41.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.775 -0.454 . . . . 3.0299999999999998 109.775 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' A' ' 94' ' ' PHE . 39.1 mtpt -107.11 82.91 1.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.67 . . . . 3.52 109.696 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.506 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.9 OUTLIER -109.14 144.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 1.95 109.733 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.484 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 73.4 m-85 -128.1 -178.05 4.38 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.843 0.683 . . . . 0.80000000000000004 112.843 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -128.23 143.98 51.08 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.572 -0.451 . . . . 2.0099999999999998 112.083 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.2 t -139.15 131.98 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.78 -0.646 . . . . 1.1599999999999999 112.434 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -133.66 149.9 51.55 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 115.239 -0.891 . . . . 2.1800000000000002 112.612 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.9 m -118.7 117.6 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.705 -1.134 . . . . 1.71 109.749 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.405 ' HA ' ' H ' ' A' ' 154' ' ' SER . 3.8 t-20 55.85 26.32 9.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.758 0.789 . . . . 1.77 109.438 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.97 16.46 41.37 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.365 -1.289 . . . . 0.40999999999999998 113.278 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.7 m-70 -115.35 109.51 18.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.199 0.815 . . . . 0.58999999999999997 113.199 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.487 ' HG1' ' HZ1' ' A' ' 113' ' ' LYS . 11.0 p -67.22 113.69 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.115 0.483 . . . . 1.2 111.292 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.37 -30.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.511 -0.768 . . . . 1.3999999999999999 109.898 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.46 91.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.308 -0.405 . . . . 1.21 109.941 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.487 ' HZ1' ' HG1' ' A' ' 110' ' ' THR . 2.7 ptpp? -107.78 84.83 2.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 122.237 1.018 . . . . 2.9199999999999999 112.038 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.9 p-10 151.2 37.31 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.631 -2.077 . . . . 2.5600000000000001 108.79 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 92.36 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.326 0.584 . . . . 1.71 112.512 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.59 84.07 2.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.649 -1.612 . . . . 1.99 106.649 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 53.3 mt -50.21 -38.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.139 -0.937 . . . . 1.23 113.229 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.06 -52.95 52.76 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.217 0.451 . . . . 1.01 112.217 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.19 -27.62 64.65 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.045 0.387 . . . . 0.76000000000000001 112.045 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.15 -58.22 6.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.113 0.412 . . . . 3.0299999999999998 112.113 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.07 -40.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.175 0.435 . . . . 2.0299999999999998 112.175 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.45 -136.52 12.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.605 -0.807 . . . . 1.0600000000000001 112.601 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -56.65 169.54 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.551 0.215 . . . . 4.29 110.868 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -45.81 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.078 0.466 . . . . 2.1099999999999999 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.1 p -152.97 -175.1 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 1.3300000000000001 109.991 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.39 139.19 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 1.1200000000000001 112.161 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.486 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.7 t60 -111.69 148.88 32.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.869 -0.789 . . . . 0.45000000000000001 108.869 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.584 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . 4.1 p30 -141.87 135.1 29.2 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.712 0.634 . . . . 2.0899999999999999 112.712 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -129.85 112.6 13.73 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.151 -0.931 . . . . 2.2799999999999998 109.609 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -101.89 135.45 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.204 -0.453 . . . . 1.3799999999999999 111.043 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.499 HD11 ' N ' ' A' ' 131' ' ' ILE . 4.2 mp -134.89 86.32 32.97 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.888 0.329 . . . . 2.0 111.888 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -62.6 138.94 73.0 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.554 1.503 . . . . 0.23999999999999999 110.812 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 134' ' ' SER . 19.9 mt -130.13 155.73 41.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.769 0.319 . . . . 1.0600000000000001 111.59 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.446 ' N ' HG23 ' A' ' 133' ' ' ILE . 25.3 p -130.07 106.69 8.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.044 -0.525 . . . . 1.6599999999999999 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 26.6 mt -105.64 125.87 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.661 -0.699 . . . . 1.0700000000000001 109.918 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -146.66 144.08 29.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 2.4300000000000002 110.911 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm 60.29 10.88 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.984 -0.553 . . . . 3.5600000000000001 111.656 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.12 18.53 33.65 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.579 -0.82 . . . . 0.32000000000000001 113.067 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 147' ' ' SER . 33.7 mtmt -121.89 153.89 37.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.958 0.379 . . . . 2.6800000000000002 110.943 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -108.7 127.33 53.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 1.1100000000000001 111.739 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.463 ' N ' HD23 ' A' ' 140' ' ' LEU . 16.6 t -119.77 109.28 15.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 1.3700000000000001 110.176 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.489 ' O ' HG11 ' A' ' 142' ' ' VAL . 1.8 p -101.92 135.59 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.124 -0.489 . . . . 1.23 110.174 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 40.21 -91.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.91 0.337 . . . . 2.0499999999999998 111.91 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -135.59 47.28 0.99 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.033 -0.603 . . . . 0.59999999999999998 112.34 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.51 132.74 21.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.998 -0.371 . . . . 2.02 109.998 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.0 135.0 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.933 0.397 . . . . 1.8700000000000001 110.888 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 23.2 t -152.91 171.94 17.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 1.46 110.208 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.13 136.72 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.188 -0.46 . . . . 1.55 111.295 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 28.6 t80 -79.46 126.84 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.297 -1.001 . . . . 0.34000000000000002 108.297 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -124.0 94.86 4.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.086 0.772 . . . . 2.02 113.086 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.9 -52.82 1.31 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 116.056 1.182 . . . . 0.77000000000000002 116.056 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.498 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -154.75 170.94 20.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.272 1.036 . . . . 2.3199999999999998 113.007 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.33 124.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.027 -1.471 . . . . 1.8600000000000001 107.027 176.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.7 t -116.28 110.79 19.22 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.594 0.961 . . . . 1.72 113.594 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.445 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 15.2 t -99.14 114.96 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.871 -0.604 . . . . 1.27 110.363 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -124.46 136.52 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 2.48 111.659 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -118.3 131.71 56.32 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.743 -0.662 . . . . 1.9199999999999999 109.583 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.21 143.68 16.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.435 -0.802 . . . . 1.3899999999999999 111.469 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.71 148.33 39.15 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 114.816 -1.084 . . . . 2.48 111.728 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -126.15 -8.75 4.91 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.049 -0.82 . . . . 1.1200000000000001 111.049 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -151.77 -57.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.331 -0.435 . . . . 3.8999999999999999 110.265 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -174.33 -68.73 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.242 -0.436 . . . . 4.0999999999999996 111.146 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.29 90.65 4.97 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.008 0.433 . . . . 1.3999999999999999 111.281 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 165' ' ' PRO . 4.2 m-20 -48.03 153.18 1.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.414 -0.812 . . . . 2.0 109.35 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.484 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.57 99.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.191 1.927 . . . . 3.1099999999999999 112.226 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.533 ' NZ ' ' HB3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -51.97 -70.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.005 -0.998 . . . . 4.1100000000000003 111.774 -178.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 62' ' ' GLN . 25.0 t -84.95 131.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 119.455 -0.898 . . . . 1.5900000000000001 111.381 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.3 t -132.33 123.37 26.7 Favored 'General case' 0 C--N 1.338 0.095 0 O-C-N 124.136 0.897 . . . . 1.8600000000000001 109.721 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 88' ' ' LYS . . . -115.23 38.19 3.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.231 0.826 . . . . 1.04 113.231 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -40.22 135.21 1.46 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.974 0.416 . . . . 1.6799999999999999 110.431 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.528 ' N ' HD11 ' A' ' 170' ' ' LEU . 0.3 OUTLIER -152.82 102.36 2.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.837 -0.619 . . . . 0.38 110.072 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 12' ' ' TRP . 2.8 tt -105.1 123.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 CA-C-O 122.842 1.306 . . . . 1.3500000000000001 113.026 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.06 163.03 16.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.396 -1.729 . . . . 1.26 109.399 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.079 1.511 . . . . 2.3599999999999999 115.079 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.39 -35.34 5.03 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 112.327 -2.215 . . . . 0.23000000000000001 117.914 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.551 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.51 159.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 120.031 1.916 . . . . 1.1000000000000001 114.291 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.603 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.15 -18.2 32.89 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 115.116 -0.947 . . . . 1.1000000000000001 110.51 176.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -63.07 -16.46 60.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 2.3100000000000001 111.926 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -77.93 -61.11 2.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.658 -0.247 . . . . 2.3700000000000001 110.853 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 180' ' ' VAL . 5.1 p -50.32 104.5 0.43 Allowed Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.327 -0.397 . . . . 3.0800000000000001 111.407 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.16 110.22 0.39 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.808 1.672 . . . . 2.4500000000000002 112.466 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -132.64 162.64 30.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 6.3700000000000001 110.644 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 183' ' ' LEU . 9.5 mp -85.0 125.53 32.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 5.3499999999999996 110.736 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -57.11 150.25 41.6 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 8.5099999999999998 110.249 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.33 125.75 16.32 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.654 1.569 . . . . 9.6899999999999995 112.263 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.665 ' HD1' ' H ' ' A' ' 188' ' ' GLY . 26.6 t-80 -134.55 135.81 24.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.166 -0.47 . . . . 10.35 110.209 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.492 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 44.6 Cg_endo -76.14 5.34 4.61 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.212 1.941 . . . . 12.26 111.824 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.665 ' H ' ' HD1' ' A' ' 186' ' ' HIS . . . -50.37 141.95 15.81 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.752 -0.737 . . . . 12.619999999999999 112.7 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.9 pp -55.69 148.42 16.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.38 . . . . 14.65 110.989 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.113 -0.946 . . . . 15.699999999999999 110.721 179.948 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.467 -0.253 . . . . 9.3900000000000006 112.467 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.03 28.18 14.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.768 0.318 . . . . 7.6799999999999997 111.046 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 ttt -90.24 -49.19 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 8.1699999999999999 110.81 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -151.1 -0.46 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 4.25 110.922 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.79 31.68 70.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.855 -0.688 . . . . 1.8200000000000001 112.54 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.3 tp -76.11 -44.47 38.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.343 0.592 . . . . 1.1299999999999999 110.332 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.22 -21.08 8.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.181 -0.918 . . . . 1.1299999999999999 111.509 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.68 -23.06 53.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.139 0.422 . . . . 2.0899999999999999 112.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -98.11 -25.54 14.89 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.395 . . . . 2.5 111.436 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.8 p -44.0 145.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 120.648 0.261 . . . . 1.05 111.591 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -138.75 -23.24 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.096 -0.642 . . . . 1.48 111.012 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.517 ' O ' HG21 ' A' ' 172' ' ' ILE . 28.5 t90 -173.34 141.56 0.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.275 -0.42 . . . . 0.33000000000000002 109.944 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.39 150.15 17.78 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.343 -0.223 . . . . 1.05 111.531 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.78 129.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 114.19 1.182 . . . . 1.3600000000000001 114.19 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -115.17 87.2 2.6 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.726 -0.67 . . . . 1.8700000000000001 109.444 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.12 104.27 0.46 Allowed 'General case' 0 C--O 1.253 1.267 0 CA-C-N 115.414 -0.812 . . . . 1.1100000000000001 109.165 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.633 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 157.69 -20.48 0.38 Allowed Glycine 0 N--CA 1.44 -1.066 0 O-C-N 124.91 1.381 . . . . 0.67000000000000004 113.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.32 -133.27 3.13 Favored Glycine 0 C--N 1.329 0.191 0 C-N-CA 119.991 -1.1 . . . . 1.1200000000000001 113.455 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.958 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 35.1 mt-10 -152.65 120.13 5.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.44 0.162 . . . . 2.02 111.108 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.0 m 26.86 107.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.701 1.0 . . . . 1.6499999999999999 113.701 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.563 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 3.7 t60 -135.64 139.17 43.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 120.086 -0.645 . . . . 0.41999999999999998 112.571 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.486 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 4.9 p -110.08 102.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 115.45 -0.795 . . . . 1.8200000000000001 111.194 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.66 157.0 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.995 -1.002 . . . . 1.1699999999999999 110.301 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -43.55 -52.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.4 0.889 . . . . 1.27 113.4 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -56.82 -20.79 24.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.55000000000000004 110.318 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.4 34.98 3.46 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.22 -0.9 . . . . 0.32000000000000001 112.101 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 27' ' ' ILE . 34.7 mm -103.68 112.1 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.46 . . . . 1.21 110.351 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 13.2 t60 -97.93 132.63 43.34 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.981 1.104 . . . . 0.68999999999999995 113.981 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.958 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -97.42 135.27 39.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.804 -1.184 . . . . 3.3199999999999998 107.804 177.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.447 ' NH1' ' HA ' ' A' ' 12' ' ' TRP . 2.2 ptp85 -91.54 108.15 19.7 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.572 0.545 . . . . 3.3999999999999999 112.451 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -10.8 130.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.106 1.363 . . . . 3.1600000000000001 114.286 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.486 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 57.3 m-20 -16.52 85.86 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.632 1.173 . . . . 1.98 113.921 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -104.89 10.37 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.247 2.631 . . . . 1.53 111.763 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 72' ' ' GLY . 4.9 tp -59.13 -47.2 86.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.587 -0.733 . . . . 2.3599999999999999 112.291 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -150.15 46.1 0.91 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.939 0.718 . . . . 4.9500000000000002 112.939 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.43 0.64 58.62 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.276 -0.964 . . . . 2.3300000000000001 112.449 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HD3' ' NH2' ' A' ' 65' ' ' ARG . 15.0 mtt180 -70.11 62.95 0.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.929 0.492 . . . . 5.8700000000000001 111.287 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.55 122.07 58.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.069 0.462 . . . . 3.48 111.28 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.07 29.19 3.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.85 -0.69 . . . . 2.5899999999999999 112.721 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.581 ' HG3' HH12 ' A' ' 65' ' ' ARG . 17.0 ptm180 -162.77 170.93 17.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.034 0.445 . . . . 7.3300000000000001 111.205 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.57 99.78 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.776 -0.647 . . . . 2.0099999999999998 110.213 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 72.2 m -72.98 75.13 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 2.2999999999999998 110.739 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.55 38.75 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 2.23 110.668 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -50.44 121.55 5.84 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.124 -0.489 . . . . 2.6000000000000001 110.136 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.22 54.19 40.0 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.285 -0.96 . . . . 2.6600000000000001 111.284 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 16.4 ttt -52.3 -17.99 1.38 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.73 0.3 . . . . 2.4300000000000002 111.318 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -60.21 -172.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 3.79 110.598 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.567 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 11.2 mt 59.39 55.3 4.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 3.23 111.059 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 31.6 Cg_exo -64.75 145.6 86.82 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.341 2.027 . . . . 1.9399999999999999 111.774 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 50' ' ' ILE . 1.1 mp -59.29 141.27 16.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.798 -0.445 . . . . 1.45 109.798 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -48.3 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 2.29 112.231 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -77.49 37.16 0.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 3.0600000000000001 112.743 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -151.95 140.73 20.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.08 0.467 . . . . 1.4099999999999999 111.966 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.537 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.2 t30 -65.95 149.13 97.92 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.713 -0.676 . . . . 1.96 109.272 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.597 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 6.2 Cg_exo -38.73 -46.99 2.68 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.954 2.436 . . . . 0.78000000000000003 116.402 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.469 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 8.4 mm-40 -73.12 -56.68 4.78 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.856 0.836 . . . . 1.8200000000000001 111.113 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 -10.92 59.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.824 -0.806 . . . . 1.9099999999999999 108.824 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.597 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.7 tt0 -64.66 -47.29 79.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.56 -1.644 . . . . 2.0600000000000001 106.56 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.43 ' O ' HG21 ' A' ' 63' ' ' THR . 92.2 t -54.49 -57.77 5.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.838 -1.074 . . . . 1.8500000000000001 110.452 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.634 HD23 ' O ' ' A' ' 60' ' ' LEU . 4.2 tt -63.11 -14.64 50.94 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.711 -0.677 . . . . 1.6000000000000001 111.09 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.416 ' CE2' ' HD2' ' A' ' 88' ' ' LYS . 6.3 m-30 -110.81 5.79 20.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.101 -0.5 . . . . 1.29 111.11 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.61 ' HG2' ' N ' ' A' ' 63' ' ' THR . 35.6 tt0 -129.28 -104.95 0.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.49 . . . . 1.8 111.558 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.61 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 65.3 p 36.83 -154.7 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.088 -0.482 . . . . 1.4099999999999999 110.669 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.602 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.0 pt-20 168.85 130.68 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.468 0.576 . . . . 2.0499999999999998 112.026 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.633 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 14.9 mtp85 -107.35 -176.73 3.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.39 -0.368 . . . . 4.2800000000000002 110.284 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -168.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.21 -0.45 . . . . 4.4699999999999998 110.89 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -159.03 162.11 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 5.1500000000000004 111.167 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.419 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.4 tp10 -156.74 -92.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 3.1699999999999999 111.053 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.419 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 3.1 p30 -173.56 134.49 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.535 0.207 . . . . 2.3900000000000001 111.084 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.4 t 46.89 84.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.401 -0.363 . . . . 1.3200000000000001 110.693 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -155.92 155.64 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.578 -0.449 . . . . 1.77 111.995 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.486 ' O ' HD11 ' A' ' 34' ' ' LEU . . . -175.66 -161.38 24.93 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.601 -0.809 . . . . 0.98999999999999999 113.951 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.01 174.1 6.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.75 0.786 . . . . 1.1899999999999999 113.056 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -127.36 139.67 52.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.322 -1.308 . . . . 2.27 109.128 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.508 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -129.75 88.93 47.91 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.895 0.702 . . . . 1.0700000000000001 112.895 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.38 134.88 67.09 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.61 1.54 . . . . 1.26 111.433 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 77' ' ' ILE . 59.9 mt -126.52 155.14 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.859 0.361 . . . . 1.0900000000000001 111.266 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -147.35 4.11 0.79 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.021 -0.536 . . . . 3.4399999999999999 111.364 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.92 171.86 12.7 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.602 0.239 . . . . 2.1299999999999999 110.864 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.8 mp0 -127.4 173.29 9.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.37 111.419 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.92 -150.31 20.11 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 109.958 -1.257 . . . . 0.23000000000000001 109.958 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 28.4 mt-10 -100.98 108.13 19.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.826 1.313 . . . . 2.0299999999999998 109.038 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -94.81 126.32 40.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 119.772 -0.771 . . . . 0.94999999999999996 109.126 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.607 HG23 ' N ' ' A' ' 177' ' ' ALA . 21.2 t -110.78 109.09 27.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.951 -1.022 . . . . 1.21 111.319 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.4 105.45 17.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.848 -1.524 . . . . 1.79 110.45 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.6 t -110.33 143.39 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.171 -0.922 . . . . 1.95 110.31 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -136.77 133.79 36.38 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.591 -0.444 . . . . 2.0 111.414 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -103.47 110.41 22.43 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.64 -1.245 . . . . 3.3799999999999999 107.64 175.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -102.99 141.62 35.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.41 -0.959 . . . . 0.34999999999999998 108.41 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -159.4 172.09 18.57 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.248 1.203 . . . . 1.1499999999999999 114.248 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 54.86 167.74 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.025 -1.443 . . . . 3.9700000000000002 113.211 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p 179.19 135.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.548 -1.205 . . . . 4.3099999999999996 109.63 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -61.47 -66.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.341 . . . . 3.0099999999999998 111.375 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -86.03 144.51 27.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 2.0 111.307 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.2 99.52 9.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.987 -0.551 . . . . 1.6599999999999999 111.082 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -152.54 141.14 20.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 3.6000000000000001 110.695 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.7 p -97.74 153.17 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 1.8899999999999999 111.423 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 66.56 -71.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.726 -0.67 . . . . 2.6899999999999999 112.178 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -39.18 -44.88 1.26 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.298 -0.41 . . . . 3.0299999999999998 111.866 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -88.92 80.37 7.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.152 0.501 . . . . 3.52 110.939 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.44 142.6 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 1.95 109.934 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.46 177.65 5.8 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.769 0.655 . . . . 0.80000000000000004 112.769 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -125.65 141.43 52.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 115.977 -0.556 . . . . 2.0099999999999998 111.565 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.51 132.41 36.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 116.272 -0.422 . . . . 1.1599999999999999 111.717 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.5 OUTLIER -134.05 150.73 51.21 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.17 0.804 . . . . 2.1800000000000002 113.17 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 17.3 m -118.84 119.64 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.65 -1.159 . . . . 1.71 109.451 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.478 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.79 26.96 12.12 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.341 -0.614 . . . . 1.77 109.341 -176.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.1 53.11 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.40999999999999998 112.879 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.3 m-70 -114.27 109.46 18.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.292 0.849 . . . . 0.58999999999999997 113.292 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -67.36 109.67 3.25 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 1.2 111.168 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.05 -34.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.396 -0.82 . . . . 1.3999999999999999 109.85 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.91 90.36 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.599 -0.519 . . . . 1.21 109.599 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -109.36 81.83 1.5 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.304 1.049 . . . . 2.9199999999999999 111.201 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 157.67 37.16 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 112.462 -2.154 . . . . 2.5600000000000001 108.217 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.39 85.97 0.83 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.695 -0.684 . . . . 1.71 112.292 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 0.6 OUTLIER -100.16 83.64 2.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.597 -1.631 . . . . 1.99 106.597 175.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.2 mt -49.82 -41.57 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.358 -0.837 . . . . 1.23 112.112 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -61.54 -54.8 38.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.571 -0.286 . . . . 1.01 111.22 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.422 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 12.8 t70 -63.26 -27.53 69.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.871 0.323 . . . . 0.76000000000000001 111.871 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -63.69 -59.4 4.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.324 0.49 . . . . 3.0299999999999998 112.324 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.16 -41.39 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.204 -0.598 . . . . 2.0299999999999998 112.152 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.51 -112.13 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.586 -0.816 . . . . 1.0600000000000001 112.655 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -97.42 114.45 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.768 0.318 . . . . 4.29 111.377 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.8 t 54.63 -127.15 2.29 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.089 -0.505 . . . . 2.1099999999999999 111.192 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.7 p 56.15 174.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.946 0.403 . . . . 1.3300000000000001 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.55 139.32 34.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.329 0.585 . . . . 1.1200000000000001 112.134 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.609 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.6 t60 -107.78 149.22 28.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.108 -0.951 . . . . 0.45000000000000001 108.44 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.609 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 1.6 p30 -133.42 137.2 45.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.54 0.941 . . . . 2.0899999999999999 113.54 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -129.68 109.4 10.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.559 -1.2 . . . . 2.2799999999999998 109.464 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 mt -98.71 128.58 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.893 -0.594 . . . . 1.3799999999999999 110.27 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.91 84.33 38.12 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 113.076 0.769 . . . . 2.0 113.076 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.55 143.63 93.18 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.793 1.662 . . . . 0.23999999999999999 111.402 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 134' ' ' SER . 25.1 mt -136.36 159.43 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 1.0600000000000001 111.025 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.484 ' N ' HG23 ' A' ' 133' ' ' ILE . 53.6 p -134.4 107.13 7.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 1.6599999999999999 111.227 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 20.4 mt -105.55 127.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 115.72 -0.673 . . . . 1.0700000000000001 109.955 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -150.49 142.84 24.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.341 . . . . 2.4300000000000002 110.886 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt 60.53 11.83 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.017 -0.538 . . . . 3.5600000000000001 111.596 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.04 14.54 48.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.64 -0.79 . . . . 0.32000000000000001 113.134 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -116.78 153.47 32.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.861 0.33 . . . . 2.6800000000000002 110.907 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.414 HD21 ' N ' ' A' ' 141' ' ' SER . 6.5 tt -111.43 129.52 56.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 1.1100000000000001 111.727 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.414 ' N ' HD21 ' A' ' 140' ' ' LEU . 22.8 t -116.9 109.9 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 1.3700000000000001 109.678 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.06 110.79 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.125 -0.489 . . . . 1.23 111.007 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.14 -89.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.911 -0.586 . . . . 2.0499999999999998 111.769 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.92 22.33 4.3 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.528 -0.844 . . . . 0.59999999999999998 113.243 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -125.81 136.57 53.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 2.02 110.282 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -105.37 137.95 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 1.8700000000000001 111.129 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.1 m -152.67 170.61 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 1.46 110.124 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.44 135.46 38.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 1.55 111.277 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.7 137.79 37.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.928 -1.138 . . . . 0.34000000000000002 107.928 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.8 m -145.8 95.55 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.705 -0.798 . . . . 2.02 112.775 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.18 -65.75 3.97 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.366 -0.834 . . . . 0.77000000000000002 115.163 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.508 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.95 172.14 16.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 117.72 0.76 . . . . 2.3199999999999998 112.694 -178.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.478 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -95.29 125.22 39.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.909 -1.515 . . . . 1.8600000000000001 106.909 176.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 t -116.5 115.66 26.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.729 1.011 . . . . 1.72 113.729 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.469 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 11.7 t -101.46 121.37 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.579 . . . . 1.27 110.197 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 62.2 mm-40 -131.38 144.68 51.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.743 -0.662 . . . . 2.48 110.702 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -128.32 136.27 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 1.9199999999999999 109.782 178.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.73 143.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.226 -0.897 . . . . 1.3899999999999999 111.428 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.35 139.56 49.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.516 -0.765 . . . . 2.48 111.275 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.73 -21.02 27.26 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.856 -0.687 . . . . 1.1200000000000001 111.427 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -158.75 -51.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 3.8999999999999999 109.809 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -178.8 155.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.703 -0.68 . . . . 4.0999999999999996 110.152 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.88 75.65 0.4 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.477 -0.329 . . . . 1.3999999999999999 111.351 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.53 166.21 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.139 -0.482 . . . . 2.0 109.929 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -36.93 110.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.973 1.782 . . . . 3.1099999999999999 111.799 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -71.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.458 -0.792 . . . . 4.1100000000000003 112.268 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 63' ' ' THR . 22.3 t -87.02 132.77 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 120.185 -0.606 . . . . 1.5900000000000001 111.927 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.9 t -131.66 123.94 28.83 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 123.938 0.774 . . . . 1.8600000000000001 111.103 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.429 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -117.21 38.77 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.955 1.094 . . . . 1.04 113.955 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -33.14 141.99 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.872 0.368 . . . . 1.6799999999999999 111.038 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.474 ' N ' HD12 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -159.34 102.66 1.58 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 0.38 110.487 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.517 HG21 ' O ' ' A' ' 12' ' ' TRP . 2.3 tt -112.74 123.16 68.14 Favored 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-O 122.829 1.3 . . . . 1.3500000000000001 112.724 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.81 165.87 13.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.78 -1.555 . . . . 1.26 109.228 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -120.47 143.05 48.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.007 1.484 . . . . 2.3599999999999999 115.007 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.11 -35.27 5.06 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 112.382 -2.19 . . . . 0.23000000000000001 117.781 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.546 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.05 158.8 0.35 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.109 1.954 . . . . 1.1000000000000001 114.452 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.607 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.02 -16.79 37.09 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 115.114 -0.948 . . . . 1.1000000000000001 110.354 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.52 -22.83 67.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 2.3100000000000001 111.762 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -71.86 -62.95 1.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.728 -0.214 . . . . 2.3700000000000001 111.212 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 180' ' ' VAL . 4.3 p -46.98 103.32 0.35 Allowed Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.522 -0.308 . . . . 3.0800000000000001 111.404 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.19 133.03 35.13 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.073 1.849 . . . . 2.4500000000000002 112.798 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 25.8 ttt -152.3 106.19 3.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 6.3700000000000001 110.515 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.5 mt -92.8 124.49 36.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 5.3499999999999996 111.031 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -63.82 149.67 92.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 8.5099999999999998 110.204 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.47 125.21 14.57 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.629 1.553 . . . . 9.6899999999999995 112.254 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -134.18 131.73 20.84 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 10.35 110.299 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.38 -98.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.608 1.539 . . . . 12.26 111.739 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.29 156.87 22.73 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.808 -0.71 . . . . 12.619999999999999 112.775 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 189' ' ' LEU . 7.6 mp -102.1 159.1 15.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 14.65 110.714 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.244 -0.884 . . . . 15.699999999999999 110.615 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.384 -0.286 . . . . 9.3900000000000006 112.384 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.04 -5.08 45.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.766 0.317 . . . . 7.6799999999999997 110.928 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.6 ttp -104.33 77.51 1.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 8.1699999999999999 110.772 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.9 m -156.85 165.8 35.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 4.25 110.798 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.52 -44.53 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 1.8200000000000001 112.607 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.31 -45.27 16.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.341 0.591 . . . . 1.1299999999999999 110.287 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -54.6 -20.53 8.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.135 -0.939 . . . . 1.1299999999999999 111.515 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.75 -20.19 56.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.314 0.487 . . . . 2.0899999999999999 112.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.589 ' HZ3' ' HB2' ' A' ' 179' ' ' ASP . 61.4 mttt -105.96 -21.83 13.05 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.441 -0.504 . . . . 2.5 111.773 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 7' ' ' ALA . 12.1 p -43.93 145.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 121.03 -0.268 . . . . 1.05 111.465 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.7 pt -136.55 -23.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 119.689 -0.804 . . . . 1.48 110.998 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.518 ' O ' HG22 ' A' ' 172' ' ' ILE . 49.5 t90 -174.77 141.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.867 -0.419 . . . . 0.33000000000000002 109.867 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 14' ' ' VAL . . . -159.67 145.29 15.72 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.191 0.441 . . . . 1.05 112.191 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 13' ' ' ALA . 3.2 t -147.73 131.88 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 114.251 1.204 . . . . 1.3600000000000001 114.251 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 14.8 t30 -115.42 94.59 4.78 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 114.441 -1.254 . . . . 1.8700000000000001 109.71 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.627 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -61.34 96.04 0.05 Allowed 'General case' 0 C--O 1.252 1.222 0 N-CA-C 107.092 -1.447 . . . . 1.1100000000000001 107.092 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.563 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -178.49 -63.86 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.533 -1.667 . . . . 0.67000000000000004 113.746 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -105.17 -120.0 4.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.597 -0.811 . . . . 1.1200000000000001 112.105 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.847 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -172.31 128.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.25 0.548 . . . . 2.02 110.818 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.2 m 42.27 82.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.004 -0.998 . . . . 1.6499999999999999 112.445 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 67.1 t60 -112.77 151.97 29.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.072 -0.651 . . . . 0.41999999999999998 111.807 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.3 t -124.84 103.77 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.374 -0.83 . . . . 1.8200000000000001 110.108 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.58 151.99 39.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.385 -0.37 . . . . 1.1699999999999999 110.228 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 m -43.38 -48.23 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.777 1.029 . . . . 1.27 113.777 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.1 -18.52 47.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.274 0.559 . . . . 0.55000000000000004 110.422 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.09 34.62 3.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.318 -0.856 . . . . 0.32000000000000001 112.459 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 27' ' ' ILE . 28.9 mm -103.16 123.7 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.217 -0.66 . . . . 1.21 109.217 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.8 t60 -108.36 132.35 53.82 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.68999999999999995 114.151 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.847 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -97.25 132.66 42.78 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.232 -1.025 . . . . 3.3199999999999998 108.232 176.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' SER . 80.0 mtp180 -47.67 -109.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.229 1.196 . . . . 3.3999999999999999 114.229 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 179.47 99.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.166 -0.47 . . . . 3.1600000000000001 111.859 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.417 ' OD1' ' HD2' ' A' ' 65' ' ' ARG . 4.3 m-20 32.32 71.68 0.64 Allowed Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.507 0.558 . . . . 1.98 112.507 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.49 -71.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.679 2.253 . . . . 1.53 114.081 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -86.96 -11.8 49.47 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.558 0.577 . . . . 2.3599999999999999 112.558 -177.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.595 ' HB3' HH21 ' A' ' 65' ' ' ARG . 10.3 mm-40 -83.79 70.71 10.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 4.9500000000000002 111.394 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 78.41 -1.19 72.31 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.532 -0.842 . . . . 2.3300000000000001 111.694 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 38.66 43.59 0.71 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.078 0.466 . . . . 5.8700000000000001 111.37 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.4 m -147.83 176.54 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.705 -0.68 . . . . 3.48 110.361 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.45 136.83 16.02 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.663 -0.779 . . . . 2.5899999999999999 112.538 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.557 ' HB3' HH12 ' A' ' 65' ' ' ARG . 76.0 ttt180 -163.31 -67.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.69 0.281 . . . . 7.3300000000000001 110.808 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.543 ' H ' ' NH1' ' A' ' 65' ' ' ARG . . . 56.36 72.71 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.182 -0.463 . . . . 2.0099999999999998 111.435 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.9 m -82.12 80.74 8.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.329 -0.396 . . . . 2.2999999999999998 110.096 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.51 60.92 4.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.834 -0.621 . . . . 2.23 111.319 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -82.35 152.24 26.34 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.544 -0.539 . . . . 2.6000000000000001 109.544 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 47' ' ' LYS . . . 58.45 23.82 54.91 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.114 -1.041 . . . . 2.6600000000000001 110.93 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ttt -64.83 -0.51 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.247 -0.477 . . . . 2.4300000000000002 111.305 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.698 ' HZ1' ' HB3' ' A' ' 47' ' ' LYS . 3.1 ttpm? -80.58 55.97 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.285 0.564 . . . . 3.79 110.591 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.455 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 4.6 mt -155.34 61.38 2.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.599 -0.728 . . . . 3.23 109.972 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 71.8 Cg_exo -55.28 105.48 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.774 2.316 . . . . 1.9399999999999999 112.921 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 125' ' ' THR . 1.2 mp -52.76 129.59 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 120.81 0.338 . . . . 1.45 110.194 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.0 mp -86.41 -177.65 6.25 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.439 -0.949 . . . . 2.29 108.439 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 81.6 mtp180 70.01 -21.48 0.17 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.425 . . . . 3.0600000000000001 111.959 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 51' ' ' LEU . 2.7 t -105.39 172.7 6.65 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.065 0.46 . . . . 1.4099999999999999 111.229 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.5 t30 -90.24 148.57 39.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 109.051 -0.722 . . . . 1.96 109.051 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 18.0 Cg_exo -40.63 -51.41 3.54 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.179 1.919 . . . . 0.78000000000000003 114.065 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.449 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 10.4 mm-40 -63.68 -56.57 14.72 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.101 0.953 . . . . 1.8200000000000001 110.94 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' OD1' HD21 ' A' ' 60' ' ' LEU . 11.0 t0 -68.86 -12.06 61.16 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.694 -0.684 . . . . 1.9099999999999999 109.98 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.9 tt0 -63.51 -45.04 92.49 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.146 -1.798 . . . . 2.0600000000000001 106.146 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -53.21 -50.17 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 114.432 -1.258 . . . . 1.8500000000000001 109.186 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 7.1 tp -69.57 -11.33 60.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.087 -0.96 . . . . 1.6000000000000001 111.465 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.439 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.5 m-30 -121.51 20.06 11.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.833 -0.621 . . . . 1.29 111.246 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.494 ' NE2' ' HA ' ' A' ' 49' ' ' PRO . 6.9 tt0 -139.64 -59.58 0.56 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.448 0.907 . . . . 1.8 113.448 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 167' ' ' VAL . 77.6 p -43.15 150.78 0.17 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.584 -0.28 . . . . 1.4099999999999999 110.906 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.563 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -135.11 -30.49 1.05 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.913 1.449 . . . . 2.0499999999999998 114.913 -176.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.595 HH21 ' HB3' ' A' ' 35' ' ' GLU . 38.5 mtp85 68.57 -173.7 0.19 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.706 -0.479 . . . . 4.2800000000000002 109.706 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -77.37 156.06 31.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.721 0.296 . . . . 4.4699999999999998 110.373 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.417 ' ND2' ' HO3' ' A' ' 191' ' ' NGR . 2.5 p30 -134.0 149.02 51.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.415 -0.357 . . . . 5.1500000000000004 111.054 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -130.04 -101.22 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.27 -0.423 . . . . 3.1699999999999999 111.444 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.76 130.03 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.761 0.315 . . . . 2.3900000000000001 111.403 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.432 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 18.9 t 53.16 95.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.091 -0.504 . . . . 1.3200000000000001 111.507 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -162.66 164.73 26.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 1.77 111.235 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.561 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -164.69 -149.63 5.87 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.005 -1.093 . . . . 0.98999999999999999 114.605 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.532 ' OH ' ' HB1' ' A' ' 16' ' ' ALA . 2.2 m-85 -141.31 167.2 22.74 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.116 -0.542 . . . . 1.1899999999999999 111.455 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.33 134.35 55.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.144 -0.935 . . . . 2.27 110.892 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.485 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.5 mp -126.98 87.09 57.46 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.637 -0.256 . . . . 1.0700000000000001 111.48 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -57.56 119.79 7.28 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.875 1.717 . . . . 1.26 112.011 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.71 151.44 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 1.0900000000000001 111.191 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -144.49 3.99 1.17 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.209 -0.45 . . . . 3.4399999999999999 111.559 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 11.3 mm-40 -128.62 171.07 12.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.459 0.171 . . . . 2.1299999999999999 110.76 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -127.09 169.1 13.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.37 111.783 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.18 -155.74 24.1 Favored Glycine 0 CA--C 1.512 -0.133 0 N-CA-C 109.644 -1.382 . . . . 0.23000000000000001 109.644 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.7 mt-10 -96.51 108.5 21.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.048 1.424 . . . . 2.0299999999999998 108.657 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.516 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.8 m-85 -94.29 125.82 39.16 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.968 -0.753 . . . . 0.94999999999999996 108.968 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.629 HG23 ' N ' ' A' ' 177' ' ' ALA . 38.9 t -109.49 112.03 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 1.21 111.289 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -103.11 104.83 15.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.789 -1.551 . . . . 1.79 110.537 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.26 142.56 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.527 -0.761 . . . . 1.95 109.639 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.97 134.18 46.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.569 -0.452 . . . . 2.0 111.168 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HZ2' ' HB1' ' A' ' 126' ' ' ALA . 5.7 tptm -94.16 112.59 24.41 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.106 -1.442 . . . . 3.3799999999999999 107.106 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 14.7 m-85 -104.47 143.64 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.715 -0.476 . . . . 0.34999999999999998 109.715 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -149.76 161.09 42.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.117 -0.492 . . . . 1.1499999999999999 110.605 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 92' ' ' VAL . 38.5 tt0 -178.47 -102.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.383 0.135 . . . . 3.9700000000000002 111.119 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.404 ' N ' ' HG2' ' A' ' 91' ' ' GLU . 39.1 t 56.33 93.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.983 0.421 . . . . 4.3099999999999996 111.353 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -117.66 -34.39 4.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.901 -0.59 . . . . 3.0099999999999998 111.125 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.435 ' HD2' ' HZ3' ' A' ' 100' ' ' LYS . 71.7 m-85 -131.61 -1.89 3.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.469 -0.332 . . . . 2.0 111.138 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 59.34 94.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.056 -0.52 . . . . 1.6599999999999999 111.429 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -151.74 142.92 23.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.257 -0.428 . . . . 3.6000000000000001 110.976 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.5 m -113.05 156.92 22.25 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.569 0.581 . . . . 1.8899999999999999 112.569 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 48.09 27.15 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.145 -0.934 . . . . 2.6899999999999999 112.091 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -129.63 -42.91 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 3.0299999999999998 109.423 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.435 ' HZ3' ' HD2' ' A' ' 94' ' ' PHE . 93.0 mttt -92.47 78.02 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 3.52 109.256 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.54 145.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 1.95 109.705 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.17 178.03 7.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.601 0.593 . . . . 0.80000000000000004 112.601 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.46 137.76 54.73 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.262 -0.426 . . . . 2.0099999999999998 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.25 131.91 52.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.917 -0.583 . . . . 1.1599999999999999 112.323 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 6.7 mtt180 -133.48 146.79 51.44 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.997 0.74 . . . . 2.1800000000000002 112.997 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.8 m -117.14 114.26 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.074 -0.967 . . . . 1.71 109.373 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.503 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 60.62 27.14 16.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.199 -0.667 . . . . 1.77 109.199 -176.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.49 10.12 62.32 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.126 -0.943 . . . . 0.40999999999999998 112.767 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.484 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.7 m-70 -107.46 113.28 26.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.026 0.75 . . . . 0.58999999999999997 113.026 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -64.66 128.95 37.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.178 -0.609 . . . . 1.2 110.634 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.65 -30.87 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.198 -0.667 . . . . 1.3999999999999999 109.198 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.438 HG13 ' OE2' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -135.73 89.77 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.094 -0.706 . . . . 1.21 109.094 177.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.1 OUTLIER -105.33 76.66 1.24 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 122.508 1.147 . . . . 2.9199999999999999 111.146 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.7 p30 154.5 28.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.079 -1.873 . . . . 2.5600000000000001 108.35 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD23 ' CD2' ' A' ' 89' ' ' PHE . 16.6 tp -61.44 97.12 0.06 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.376 -0.829 . . . . 1.71 112.386 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.5 t70 -107.07 93.9 4.81 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 114.669 -1.151 . . . . 1.99 108.345 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.9 mt -51.86 -51.66 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 114.069 1.137 . . . . 1.23 114.069 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -53.51 -55.93 21.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.033 0.383 . . . . 1.01 112.033 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.78 -27.55 68.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.569 0.581 . . . . 0.76000000000000001 112.569 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -67.68 -58.56 4.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.872 0.693 . . . . 3.0299999999999998 112.872 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -106.08 -40.85 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.11 0.411 . . . . 2.0299999999999998 112.11 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.44 -138.9 13.22 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.539 -0.839 . . . . 1.0600000000000001 113.185 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -65.43 118.23 9.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.965 0.412 . . . . 4.29 111.607 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.4 m 39.13 -116.75 0.2 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.576 -0.738 . . . . 2.1099999999999999 112.066 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 50' ' ' ILE . 66.0 p 51.65 -166.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.661 0.267 . . . . 1.3300000000000001 110.953 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.406 ' HB1' ' HZ2' ' A' ' 88' ' ' LYS . . . -113.58 139.09 49.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.753 0.649 . . . . 1.1200000000000001 112.753 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.557 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.7 t60 -107.61 147.95 29.96 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.903 -0.777 . . . . 0.45000000000000001 108.903 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.557 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 4.5 p30 -143.03 131.06 21.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.558 0.577 . . . . 2.0899999999999999 112.558 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.438 ' OE2' HG13 ' A' ' 112' ' ' VAL . 57.8 mt-10 -124.23 109.8 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.508 -0.769 . . . . 2.2799999999999998 109.73 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.422 ' O ' HD13 ' A' ' 131' ' ' ILE . 15.5 mt -94.94 130.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.066 -0.516 . . . . 1.3799999999999999 110.839 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 130' ' ' ILE . 43.8 mm -131.53 85.88 51.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.375 -0.375 . . . . 2.0 111.902 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.59 144.62 97.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.694 1.596 . . . . 0.23999999999999999 111.447 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.496 HG23 ' N ' ' A' ' 134' ' ' SER . 28.3 mt -136.33 159.41 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 1.0600000000000001 110.674 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.496 ' N ' HG23 ' A' ' 133' ' ' ILE . 42.6 p -134.76 108.55 8.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 1.6599999999999999 111.132 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 26.6 mt -106.34 125.99 62.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.695 -0.684 . . . . 1.0700000000000001 109.979 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -150.97 144.04 24.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.699 0.285 . . . . 2.4300000000000002 110.802 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt 61.76 10.15 3.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 3.5600000000000001 111.468 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.01 37.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.621 -0.8 . . . . 0.32000000000000001 113.182 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -119.99 160.46 22.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.075 0.437 . . . . 2.6800000000000002 110.772 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.76 131.53 56.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.089 0.471 . . . . 1.1100000000000001 111.893 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.443 ' HB3' ' OG ' ' A' ' 134' ' ' SER . 22.9 t -116.54 116.64 27.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.631 -0.713 . . . . 1.3700000000000001 110.08 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.0 p -113.03 111.48 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.288 0.566 . . . . 1.23 111.551 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 50.27 -93.97 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.616 -0.72 . . . . 2.0499999999999998 112.441 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -123.94 34.79 3.46 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.544 -0.836 . . . . 0.59999999999999998 113.616 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -146.57 132.64 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.065 -0.346 . . . . 2.02 110.065 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.14 146.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.429 . . . . 1.8700000000000001 111.566 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.6 m -161.12 171.27 18.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.779 -0.646 . . . . 1.46 109.376 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 141.72 31.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.278 0.561 . . . . 1.55 111.496 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -78.66 140.74 38.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.136 -0.938 . . . . 0.34000000000000002 109.653 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.5 p -139.99 95.28 2.87 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.673 0.62 . . . . 2.02 112.673 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.96 -57.73 2.24 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.833 1.093 . . . . 0.77000000000000002 115.833 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.491 ' HB3' ' HZ3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -151.66 174.99 12.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.023 0.912 . . . . 2.3199999999999998 112.695 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.503 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 1.8 tt -101.9 129.03 48.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.407 -1.331 . . . . 1.8600000000000001 107.407 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.469 ' N ' HD22 ' A' ' 153' ' ' LEU . 1.6 t -116.51 114.37 24.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.696 -0.802 . . . . 1.72 112.851 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.407 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 43.7 t -93.1 105.09 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.039 -0.726 . . . . 1.27 109.039 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.1 tt0 -118.4 128.43 54.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 2.48 111.414 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -120.99 145.83 47.34 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.166 0.508 . . . . 1.9199999999999999 109.749 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 143.87 26.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 115.191 -0.913 . . . . 1.3899999999999999 111.261 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.468 ' O ' ' HD2' ' A' ' 159' ' ' LYS . 1.6 pptp? -83.89 148.48 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.471 -0.786 . . . . 2.48 111.394 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.68 0.51 55.41 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.923 -0.656 . . . . 1.1200000000000001 111.619 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -154.64 -76.25 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.847 -0.177 . . . . 3.8999999999999999 110.803 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -178.49 73.61 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.498 -0.319 . . . . 4.0999999999999996 110.713 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -174.37 -44.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.381 -0.372 . . . . 1.3999999999999999 111.165 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.432 ' ND2' ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 62.43 163.15 0.11 Allowed Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.545 -0.539 . . . . 2.0 109.545 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -44.47 103.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.325 1.35 . . . . 3.1099999999999999 111.272 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.488 ' HZ3' ' HO2' ' A' ' 191' ' ' NGR . 6.7 tppt? -53.3 -66.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.301 -0.863 . . . . 4.1100000000000003 112.088 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 63' ' ' THR . 45.5 t -94.45 132.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 120.547 -0.461 . . . . 1.5900000000000001 111.749 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -135.29 127.77 30.56 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 113.194 0.813 . . . . 1.8600000000000001 113.194 -178.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.41 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -122.24 38.56 4.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.697 -1.138 . . . . 1.04 112.647 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 171' ' ' PHE . 6.7 tp -46.79 130.38 11.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.094 0.473 . . . . 1.6799999999999999 110.398 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -142.86 114.47 8.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.75 -0.659 . . . . 0.38 110.373 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -113.92 123.88 70.02 Favored 'Isoleucine or valine' 0 C--O 1.263 1.77 0 CA-C-O 122.841 1.305 . . . . 1.3500000000000001 112.961 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -119.61 166.76 12.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.923 -1.49 . . . . 1.26 109.886 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 8.9 ptmt -120.71 144.67 48.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.008 1.484 . . . . 2.3599999999999999 115.008 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 100.64 -36.31 4.24 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 112.417 -2.174 . . . . 0.23000000000000001 118.181 174.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.576 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.87 158.44 0.43 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.57 2.185 . . . . 1.1000000000000001 114.324 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.629 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.34 -26.93 24.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.953 -1.022 . . . . 1.1000000000000001 110.37 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.33 -24.71 45.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.693 -0.685 . . . . 2.3100000000000001 111.149 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.589 ' HB2' ' HZ3' ' A' ' 9' ' ' LYS . 14.6 t70 -66.89 -45.42 78.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 2.3700000000000001 110.389 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.8 t -34.09 98.79 0.15 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 123.573 0.545 . . . . 3.0800000000000001 111.85 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -51.05 127.08 20.6 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.913 1.742 . . . . 2.4500000000000002 112.16 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -83.0 143.61 30.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.501 . . . . 6.3700000000000001 110.735 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.501 ' N ' HD13 ' A' ' 183' ' ' LEU . 7.5 mp -91.53 111.68 23.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 5.3499999999999996 110.253 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -52.94 142.54 34.59 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.186 -0.461 . . . . 8.5099999999999998 110.519 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -44.48 137.44 8.24 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 121.793 1.662 . . . . 9.6899999999999995 112.343 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.49 ' HD1' ' N ' ' A' ' 187' ' ' PRO . 2.8 t-80 -134.13 124.92 17.71 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.41 -0.359 . . . . 10.35 110.605 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.49 ' N ' ' HD1' ' A' ' 186' ' ' HIS . 9.2 Cg_endo -84.5 -157.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.185 1.923 . . . . 12.26 111.529 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.28 41.08 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.42 -0.895 . . . . 12.619999999999999 112.495 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.54 154.38 23.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.748 0.309 . . . . 14.65 110.697 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 15.699999999999999 110.885 179.848 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . 0.488 ' HO2' ' HZ3' ' A' ' 166' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.528 -0.229 . . . . 9.3900000000000006 112.528 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.99 81.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 7.6799999999999997 110.84 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 tpt -158.68 139.18 12.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 8.1699999999999999 110.692 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t 57.29 92.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.184 -0.462 . . . . 4.25 110.975 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.13 91.94 0.21 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.769 . . . . 1.8200000000000001 112.574 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.1 tp -68.63 -39.25 80.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.33 0.586 . . . . 1.1299999999999999 110.272 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.2 -19.87 9.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.262 -0.881 . . . . 1.1299999999999999 110.877 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.17 -20.06 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.058 0.392 . . . . 2.0899999999999999 112.058 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -103.5 -28.4 11.79 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.623 -0.431 . . . . 2.5 111.02 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -42.06 147.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.677 0.275 . . . . 1.05 111.601 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -139.6 -22.64 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.815 -0.754 . . . . 1.48 111.085 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.503 ' O ' HG23 ' A' ' 172' ' ' ILE . 32.7 t90 -173.39 139.71 0.78 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.626 -0.429 . . . . 0.33000000000000002 110.011 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.04 146.04 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.605 0.224 . . . . 1.05 111.605 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -146.99 126.7 4.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 114.255 1.206 . . . . 1.3600000000000001 114.255 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.563 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 7.3 t-20 -115.37 97.13 6.0 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.619 -0.718 . . . . 1.8700000000000001 110.146 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.436 ' HB3' ' OH ' ' A' ' 73' ' ' TYR . . . -69.51 107.33 3.33 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 120.552 -0.459 . . . . 1.1100000000000001 110.13 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.573 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 166.14 -74.75 0.15 Allowed Glycine 0 C--N 1.338 0.687 0 O-C-N 124.675 1.234 . . . . 0.67000000000000004 112.662 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.451 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -85.62 -125.13 1.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.883 -0.675 . . . . 1.1200000000000001 111.993 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.497 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -168.0 120.67 0.88 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.65 0.738 . . . . 2.02 111.214 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.705 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 47.61 95.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.319 -1.31 . . . . 1.6499999999999999 113.009 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.529 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 18.5 t60 -125.46 137.08 53.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 118.988 -1.085 . . . . 0.41999999999999998 113.069 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.0 t -107.43 101.59 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.588 -1.187 . . . . 1.8200000000000001 109.912 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.411 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -67.12 157.82 32.69 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.85 -0.613 . . . . 1.1699999999999999 110.627 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.26 -55.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 124.849 1.343 . . . . 1.27 112.828 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -55.53 -22.74 22.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.126 0.489 . . . . 0.55000000000000004 110.339 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.43 36.03 2.75 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.394 -0.821 . . . . 0.32000000000000001 112.165 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.436 HG21 HD11 ' A' ' 27' ' ' ILE . 35.9 mm -103.33 125.49 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.655 -0.498 . . . . 1.21 109.655 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.4 t60 -106.34 131.32 53.69 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.76 1.393 . . . . 0.68999999999999995 114.76 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.705 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.78 140.84 34.5 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.956 -1.128 . . . . 3.3199999999999998 107.956 175.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 20' ' ' SER . 77.2 mtp180 -63.31 -137.68 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.383 0.427 . . . . 3.3999999999999999 111.135 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.8 100.01 3.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.364 0.266 . . . . 3.1600000000000001 111.484 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 34.9 t70 35.59 69.78 1.09 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 111.985 0.365 . . . . 1.98 111.985 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -98.98 24.53 0.2 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.852 2.368 . . . . 1.53 114.496 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.414 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 45.1 tp -142.08 -66.34 0.4 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.564 -0.454 . . . . 2.3599999999999999 111.622 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' C ' ' H ' ' A' ' 37' ' ' ARG . 9.8 mm-40 -67.69 94.82 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 4.9500000000000002 110.454 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.54 -22.45 3.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.761 -0.733 . . . . 2.3300000000000001 111.603 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 5.8 mtp180 45.08 25.95 0.2 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.801 0.44 . . . . 5.8700000000000001 111.545 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.21 145.87 17.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 3.48 110.945 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.81 -164.93 12.31 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.695 -0.764 . . . . 2.5899999999999999 112.918 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -128.52 -171.04 2.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.648 0.261 . . . . 7.3300000000000001 110.731 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.82 167.3 0.59 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.19 0.519 . . . . 2.0099999999999998 111.194 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.409 ' N ' ' NH2' ' A' ' 65' ' ' ARG . 75.3 m -149.87 33.11 0.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.475 -0.784 . . . . 2.2999999999999998 109.527 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -43.41 93.74 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.138 -0.937 . . . . 2.23 111.449 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -112.28 -67.26 1.01 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 2.6000000000000001 110.268 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.85 33.58 3.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 2.6600000000000001 111.429 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.8 ttt -62.5 -8.73 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 2.4300000000000002 111.302 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 48' ' ' LEU . 87.9 tttt -53.96 163.33 0.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.355 -0.384 . . . . 3.79 110.523 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 3.6 mt 67.47 66.48 0.62 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 3.23 110.867 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 84.9 Cg_exo -54.92 124.86 17.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.633 2.222 . . . . 1.9399999999999999 112.061 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.74 124.68 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.333 0.587 . . . . 1.45 110.043 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 53' ' ' SER . 10.3 mp -76.89 -47.78 20.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.784 1.031 . . . . 2.29 113.784 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -70.06 26.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.268 0.84 . . . . 3.0600000000000001 113.268 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 51' ' ' LEU . 8.1 t -147.79 156.79 43.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.09 0.472 . . . . 1.4099999999999999 111.637 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 58' ' ' GLN . 7.9 t30 -71.95 148.22 91.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.729 -0.669 . . . . 1.96 109.878 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.584 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.16 -54.67 2.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.525 2.15 . . . . 0.78000000000000003 114.615 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 9.8 mm-40 -62.39 -57.95 9.44 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.88 0.848 . . . . 1.8200000000000001 110.994 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 23.8 t70 -69.04 -6.57 28.91 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.723 -0.671 . . . . 1.9099999999999999 109.623 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 12.5 tt0 -69.2 -42.44 75.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.61 -1.626 . . . . 2.0600000000000001 106.61 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.65 -57.61 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 114.329 -1.305 . . . . 1.8500000000000001 109.158 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.563 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.3 tt -54.31 -61.04 2.56 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.547 -0.751 . . . . 1.6000000000000001 109.345 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.544 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 2.3 m-85 -52.79 -15.14 0.66 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.585 -0.734 . . . . 1.29 111.097 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HG2' ' N ' ' A' ' 63' ' ' THR . 7.0 tt0 -119.63 -117.94 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.661 0.615 . . . . 1.8 112.661 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.584 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 2.7 p 36.44 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.623 0.769 . . . . 1.4099999999999999 112.669 -176.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.573 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.7 pt-20 -101.53 146.34 27.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.309 0.855 . . . . 2.0499999999999998 113.309 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.414 ' HD3' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -104.43 -144.43 0.37 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.723 -1.126 . . . . 4.2800000000000002 109.935 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.35 -175.51 2.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.496 0.189 . . . . 4.4699999999999998 110.543 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -138.63 160.05 40.58 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.82 0.343 . . . . 5.1500000000000004 111.482 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -154.6 -103.75 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.144 -0.48 . . . . 3.1699999999999999 111.024 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -174.41 124.85 0.31 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.495 0.188 . . . . 2.3900000000000001 110.803 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.468 ' H ' HD22 ' A' ' 164' ' ' ASN . 21.0 t 50.33 96.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.347 -0.388 . . . . 1.3200000000000001 111.699 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -166.31 167.09 16.26 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.217 -0.447 . . . . 1.77 111.105 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.28 -170.59 37.72 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.28 -0.962 . . . . 0.98999999999999999 114.045 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.436 ' OH ' ' HB3' ' A' ' 16' ' ' ALA . 7.4 m-85 -109.31 169.56 8.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.532 0.682 . . . . 1.1899999999999999 112.532 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.23 136.65 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.612 -1.176 . . . . 2.27 110.439 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 153' ' ' LEU . 4.4 mp -127.25 86.84 57.81 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 112.153 0.427 . . . . 1.0700000000000001 112.153 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -54.41 130.34 39.45 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.244 1.963 . . . . 1.26 112.418 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.406 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 74.2 mt -126.48 150.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.206 -0.452 . . . . 1.0900000000000001 111.294 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -142.86 0.75 1.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 3.4399999999999999 111.201 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.11 170.11 12.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.477 0.179 . . . . 2.1299999999999999 110.769 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.04 171.24 9.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.339 0.59 . . . . 0.37 111.912 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.44 -155.58 23.06 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 109.8 -1.32 . . . . 0.23000000000000001 109.8 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.1 mt-10 -97.41 108.38 21.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.128 1.464 . . . . 2.0299999999999998 109.107 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -95.57 126.47 40.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.926 -0.71 . . . . 0.94999999999999996 109.22 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.597 HG23 ' N ' ' A' ' 177' ' ' ALA . 16.1 t -112.68 113.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.906 -1.043 . . . . 1.21 111.386 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tt -95.67 104.02 15.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.566 -1.197 . . . . 1.79 110.445 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.15 126.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 114.507 -1.224 . . . . 1.95 108.705 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 87' ' ' LEU . 1.8 pp -135.67 141.15 44.95 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.569 -0.852 . . . . 2.0 111.04 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.695 ' HZ2' ' H ' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -107.13 124.29 49.48 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.282 -0.967 . . . . 3.3799999999999999 109.495 177.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.445 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 7.7 m-85 -105.73 142.36 35.6 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.398 -0.819 . . . . 0.34999999999999998 109.305 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.21 150.29 46.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.979 0.419 . . . . 1.1499999999999999 111.117 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.73 125.32 19.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 3.9700000000000002 110.048 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.0 m -142.28 60.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.786 0.327 . . . . 4.3099999999999996 111.84 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -149.49 -34.7 0.18 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.906 0.336 . . . . 3.0099999999999998 111.906 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -133.98 169.09 17.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.0 0.429 . . . . 2.0 111.22 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.67 98.86 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.879 -0.6 . . . . 1.6599999999999999 110.811 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.401 ' NE2' ' HG3' ' A' ' 100' ' ' LYS . 14.1 pt20 -161.22 140.65 10.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 3.6000000000000001 110.742 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.6 m -107.26 150.47 26.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.07 -0.514 . . . . 1.8899999999999999 112.277 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 47.24 39.93 9.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.518 -0.764 . . . . 2.6899999999999999 111.842 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -133.48 -48.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.751 -0.463 . . . . 3.0299999999999998 109.751 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.401 ' HG3' ' NE2' ' A' ' 96' ' ' GLN . 66.5 mttm -98.05 86.8 3.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.829 -0.623 . . . . 3.52 109.558 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.0 144.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 1.95 109.461 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -130.45 178.59 6.48 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.633 0.605 . . . . 0.80000000000000004 112.633 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -122.05 139.65 53.45 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.94 -0.304 . . . . 2.0099999999999998 111.154 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.1 132.05 52.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-N 116.084 -0.507 . . . . 1.1599999999999999 112.138 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.541 HH21 HG21 ' A' ' 158' ' ' VAL . 8.5 mtt180 -133.72 156.48 47.87 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 113.234 0.827 . . . . 2.1800000000000002 113.234 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 25.3 m -122.15 119.27 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 114.853 -1.067 . . . . 1.71 109.049 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' ' 153' ' ' LEU . 0.6 OUTLIER 56.27 26.39 10.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.922 -0.77 . . . . 1.77 108.922 -175.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.29 39.64 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.40999999999999998 112.784 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -117.83 112.11 19.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.943 0.72 . . . . 0.58999999999999997 112.943 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -61.84 127.67 32.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.634 -0.426 . . . . 1.2 111.24 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 t -123.64 -32.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.107 -0.701 . . . . 1.3999999999999999 109.107 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.99 90.18 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.078 -0.712 . . . . 1.21 109.078 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 16.1 ptpt -107.53 100.91 10.29 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.032 0.92 . . . . 2.9199999999999999 111.76 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 18.5 m-20 131.2 27.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.27 -2.241 . . . . 2.5600000000000001 108.037 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.438 HD21 ' CD2' ' A' ' 89' ' ' PHE . 45.4 tp -56.41 96.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.952 -1.022 . . . . 1.71 112.636 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -108.23 92.31 4.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.605 -1.18 . . . . 1.99 107.829 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 121' ' ' VAL . 43.3 mt -51.88 -35.95 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.47 0.915 . . . . 1.23 113.47 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -69.2 -54.64 13.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.304 0.483 . . . . 1.01 112.304 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.98 -27.28 66.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.545 0.572 . . . . 0.76000000000000001 112.545 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -72.66 -58.27 3.49 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.879 0.696 . . . . 3.0299999999999998 112.879 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 117' ' ' ILE . 8.5 p -97.48 -35.15 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.129 0.418 . . . . 2.0299999999999998 112.129 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.8 -129.2 8.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.651 -0.785 . . . . 1.0600000000000001 112.368 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -88.82 110.47 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.642 0.258 . . . . 4.29 110.619 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.3 t 51.46 -108.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 2.1099999999999999 110.529 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.4 p 48.46 -171.77 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.532 0.206 . . . . 1.3300000000000001 111.325 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.61 ' HA ' ' NZ ' ' A' ' 88' ' ' LYS . . . -102.85 121.95 43.54 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.305 0.854 . . . . 1.1200000000000001 113.305 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.695 ' H ' ' HZ2' ' A' ' 88' ' ' LYS . 2.1 t60 -100.35 135.35 41.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.816 -1.179 . . . . 0.45000000000000001 107.816 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -145.39 130.55 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.075 0.768 . . . . 2.0899999999999999 113.075 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -111.34 125.9 54.34 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.224 -0.898 . . . . 2.2799999999999998 109.403 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -105.86 110.1 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 1.3799999999999999 109.534 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.12 86.03 25.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.744 0.646 . . . . 2.0 112.744 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 140.03 75.57 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.875 1.717 . . . . 0.23999999999999999 111.622 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 134' ' ' SER . 22.0 mt -132.13 156.14 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 1.0600000000000001 110.631 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 19.4 p -130.73 106.76 8.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.121 0.486 . . . . 1.6599999999999999 110.719 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 24.0 mt -107.08 121.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.602 -0.726 . . . . 1.0700000000000001 109.867 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.422 ' HZ1' ' HB3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -145.53 141.22 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.577 -0.283 . . . . 2.4300000000000002 110.571 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm 60.72 20.7 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.56 . . . . 3.5600000000000001 110.984 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.02 60.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.32000000000000001 113.151 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 3.6 mmmm -117.83 155.52 29.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.864 0.332 . . . . 2.6800000000000002 110.32 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.488 HD21 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -115.22 131.36 56.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.077 0.465 . . . . 1.1100000000000001 112.12 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.488 ' N ' HD21 ' A' ' 140' ' ' LEU . 20.8 t -117.9 111.2 18.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.63 -0.714 . . . . 1.3700000000000001 109.5 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.427 ' O ' HG11 ' A' ' 142' ' ' VAL . 6.5 p -107.33 102.27 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.03 -0.532 . . . . 1.23 111.218 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.29 -92.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.904 -0.589 . . . . 2.0499999999999998 111.66 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.44 6.21 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.59999999999999998 113.18 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.4 132.26 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.203 -0.295 . . . . 2.02 110.203 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.5 p -105.48 140.69 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.198 0.523 . . . . 1.8700000000000001 111.658 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.1 m -154.03 173.01 16.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.421 -0.809 . . . . 1.46 109.621 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.28 136.66 38.92 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.86 -0.336 . . . . 1.55 111.163 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.406 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 40.3 t80 -79.72 136.68 36.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.117 -1.068 . . . . 0.34000000000000002 108.117 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.2 m -148.56 95.11 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.835 -0.746 . . . . 2.02 112.495 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.84 -70.0 1.87 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.121 0.809 . . . . 0.77000000000000002 115.121 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.608 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -149.98 178.17 9.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.776 0.788 . . . . 2.3199999999999998 112.945 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.498 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -103.0 128.07 49.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.416 -1.327 . . . . 1.8600000000000001 107.416 177.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.7 t -117.16 118.45 32.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.359 1.244 . . . . 1.72 114.359 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 86.9 t -93.96 99.29 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.471 -0.937 . . . . 1.27 108.471 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.7 tt0 -109.69 129.04 55.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.588 -0.733 . . . . 2.48 111.763 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -121.71 135.6 54.95 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.018 -0.537 . . . . 1.9199999999999999 110.004 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.541 HG21 HH21 ' A' ' 105' ' ' ARG . 11.0 t -109.98 143.87 19.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.043 -0.98 . . . . 1.3899999999999999 111.482 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -59.17 143.37 49.11 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.167 -0.924 . . . . 2.48 111.09 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -120.39 -16.01 4.84 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.951 -0.642 . . . . 1.1200000000000001 111.912 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -156.44 -61.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 3.8999999999999999 110.148 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -177.54 151.2 0.73 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.835 -0.621 . . . . 4.0999999999999996 110.188 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.95 82.09 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.73 0.3 . . . . 1.3999999999999999 110.857 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.468 HD22 ' H ' ' A' ' 70' ' ' SER . 2.9 m-20 -47.3 159.02 0.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 2.0 110.325 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 164' ' ' ASN . 2.8 Cg_exo -32.22 102.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.39 2.06 . . . . 3.1099999999999999 111.711 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.588 ' NZ ' ' HB2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -56.9 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.026 -0.988 . . . . 4.1100000000000003 113.19 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.6 t -91.62 134.45 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 120.246 -0.582 . . . . 1.5900000000000001 112.295 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 4.7 t -130.89 136.47 48.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.818 -0.628 . . . . 1.8600000000000001 112.102 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 88' ' ' LYS . . . -129.42 34.44 4.37 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.304 0.853 . . . . 1.04 113.304 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -36.53 136.76 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.563 0.579 . . . . 1.6799999999999999 112.563 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.466 ' N ' HD12 ' A' ' 170' ' ' LEU . 1.1 t80 -154.84 101.68 2.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.791 -0.641 . . . . 0.38 110.777 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -109.09 128.14 65.22 Favored 'Isoleucine or valine' 0 C--O 1.262 1.761 0 CA-C-O 122.874 1.321 . . . . 1.3500000000000001 112.428 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.427 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.3 ppp? -121.35 166.61 13.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.423 -1.717 . . . . 1.26 109.636 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -120.37 153.24 36.77 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 115.262 1.579 . . . . 2.3599999999999999 115.262 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 92.1 -35.06 4.13 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 111.93 -2.395 . . . . 0.23000000000000001 117.725 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.579 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.94 159.91 0.63 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.035 1.918 . . . . 1.1000000000000001 113.962 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.597 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -85.17 -36.9 20.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.368 -0.833 . . . . 1.1000000000000001 111.688 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -64.82 -15.26 61.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.42 . . . . 2.3100000000000001 111.966 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.94 -5.45 55.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.639 0.257 . . . . 2.3700000000000001 111.219 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.1 t -48.13 -57.94 9.19 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.706 0.632 . . . . 3.0800000000000001 112.706 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.71 161.87 41.88 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.408 1.406 . . . . 2.4500000000000002 112.59 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.1 ttt -101.31 94.8 6.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 6.3700000000000001 110.438 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.5 mt -78.64 142.0 37.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 5.3499999999999996 111.067 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -82.18 143.55 49.08 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.945 -0.571 . . . . 8.5099999999999998 110.213 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -44.9 135.5 10.28 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 121.707 1.605 . . . . 9.6899999999999995 112.221 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -134.4 133.29 21.47 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.765 -0.374 . . . . 10.35 110.643 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.03 -93.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.55 1.5 . . . . 12.26 111.675 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.63 110.74 1.13 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.953 -0.642 . . . . 12.619999999999999 112.616 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 189' ' ' LEU . 3.0 mm? -92.97 88.53 6.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 14.65 110.372 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.263 -0.875 . . . . 15.699999999999999 110.856 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 112.482 -0.247 . . . . 9.3900000000000006 112.482 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.22 -25.91 42.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.331 . . . . 7.6799999999999997 110.843 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' A' ' 3' ' ' MET . 1.8 mpt? -89.14 123.46 33.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 8.1699999999999999 110.599 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 t -149.06 -17.53 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.274 -0.421 . . . . 4.25 110.804 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.09 -44.61 1.35 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.77 -0.728 . . . . 1.8200000000000001 112.589 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.9 tp -83.36 -41.95 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.258 0.552 . . . . 1.1299999999999999 110.496 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -56.75 -20.89 24.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.4 -0.818 . . . . 1.1299999999999999 110.985 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.6 -15.74 61.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 2.0899999999999999 111.754 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 41.4 mmtt -107.92 -27.08 10.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.852 -0.339 . . . . 2.5 111.486 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.505 HG11 ' O ' ' A' ' 7' ' ' ALA . 9.0 p -42.87 145.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 111.883 0.327 . . . . 1.05 111.883 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.07 -23.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 119.981 -0.688 . . . . 1.48 111.352 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.543 ' O ' HG23 ' A' ' 172' ' ' ILE . 27.0 t90 -172.25 127.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.773 -0.371 . . . . 0.33000000000000002 110.124 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.21 143.65 29.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.816 -0.175 . . . . 1.05 110.871 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -146.6 126.44 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 114.36 1.244 . . . . 1.3600000000000001 114.36 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.497 HD22 ' HG1' ' A' ' 63' ' ' THR . 14.6 t30 -115.3 95.11 5.02 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.165 -0.614 . . . . 1.8700000000000001 110.454 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.606 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . . . -67.53 116.16 7.95 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.525 -0.761 . . . . 1.1100000000000001 109.64 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 63' ' ' THR . . . 145.35 -51.8 0.6 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.706 -1.588 . . . . 0.67000000000000004 112.157 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.01 -143.8 15.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.896 -0.669 . . . . 1.1200000000000001 112.211 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.16 119.41 5.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.604 0.202 . . . . 2.02 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 80.6 p 36.36 99.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.76 0.663 . . . . 1.6499999999999999 112.584 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 76.4 t60 -122.85 151.94 41.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.267 -0.573 . . . . 0.41999999999999998 112.47 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -122.32 103.5 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.224 -0.898 . . . . 1.8200000000000001 109.784 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.7 153.43 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 1.1699999999999999 110.523 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.8 m -43.31 -52.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 124.217 0.948 . . . . 1.27 113.382 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -57.99 -18.74 25.84 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.12 0.486 . . . . 0.55000000000000004 110.609 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.32 36.29 3.38 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.435 -0.802 . . . . 0.32000000000000001 112.334 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -103.3 122.5 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.401 -0.592 . . . . 1.21 109.401 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.539 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.5 t60 -105.71 133.05 51.07 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 114.456 1.28 . . . . 0.68999999999999995 114.456 -176.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.617 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.2 134.6 41.81 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.323 -0.991 . . . . 3.3199999999999998 108.323 176.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 15.9 ptm180 -96.33 114.11 25.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.362 0.601 . . . . 3.3999999999999999 112.255 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -12.05 139.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.234 1.568 . . . . 3.1600000000000001 115.234 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 65' ' ' ARG . 8.3 p-10 -22.68 89.23 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 114.066 -1.425 . . . . 1.98 113.67 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -101.65 19.86 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.909 2.406 . . . . 1.53 113.454 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.626 HD21 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -134.46 -37.82 0.85 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 122.251 -0.281 . . . . 2.3599999999999999 111.606 -179.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.626 ' N ' HD21 ' A' ' 34' ' ' LEU . 5.9 tt0 -76.55 71.17 3.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 4.9500000000000002 110.455 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 74.22 0.7 58.04 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.713 -1.355 . . . . 2.3300000000000001 109.713 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 47.77 23.14 0.41 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.552 -0.824 . . . . 5.8700000000000001 110.582 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.94 144.7 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.377 -0.829 . . . . 3.48 110.137 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.1 -166.54 28.95 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.32 -0.943 . . . . 2.5899999999999999 113.066 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -150.91 74.0 1.14 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.92 0.391 . . . . 7.3300000000000001 110.916 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.725 ' H ' HH22 ' A' ' 65' ' ' ARG . . . 58.18 179.82 0.06 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.328 0.585 . . . . 2.0099999999999998 111.836 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.0 p -170.61 23.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.313 -0.858 . . . . 2.2999999999999998 109.639 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -52.35 137.17 29.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.467 -0.788 . . . . 2.23 111.397 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -87.77 -15.88 35.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.812 -0.631 . . . . 2.6000000000000001 110.034 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.36 101.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.74 -0.664 . . . . 2.6600000000000001 112.204 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 50.4 mtt -58.85 -42.3 89.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.958 0.408 . . . . 2.4300000000000002 110.638 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -66.93 80.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.664 -0.698 . . . . 3.79 110.607 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.2 68.36 0.22 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.954 -0.566 . . . . 3.23 110.015 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.89 131.08 24.54 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.063 1.842 . . . . 1.9399999999999999 111.823 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.669 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.2 tp -54.45 -43.85 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.11 -0.495 . . . . 1.45 110.172 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' A' ' 50' ' ' ILE . 2.6 tt 130.67 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.869 1.667 . . . . 2.29 111.652 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.83 24.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.528 0.566 . . . . 3.0600000000000001 112.528 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -136.6 157.95 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.612 . . . . 1.4099999999999999 112.65 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLN . 35.8 t30 -70.86 153.16 94.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.05 -0.977 . . . . 1.96 108.788 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 59.7 Cg_exo -45.86 -59.53 1.16 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.499 1.466 . . . . 0.78000000000000003 112.872 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 1.3 pm0 -56.18 -54.84 40.39 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 122.174 0.988 . . . . 1.8200000000000001 111.026 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.407 ' OD1' HD22 ' A' ' 60' ' ' LEU . 19.4 t70 -69.51 -13.91 62.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.42 -0.809 . . . . 1.9099999999999999 110.958 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' ASN . 1.6 pt20 -65.27 -40.21 93.62 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.342 -1.725 . . . . 2.0600000000000001 106.342 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -56.16 -52.33 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.668 -1.151 . . . . 1.8500000000000001 109.145 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.4 tp -70.31 -9.14 55.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.209 -0.905 . . . . 1.6000000000000001 111.772 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.401 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 6.7 m-30 -119.7 15.08 12.71 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.458 0.646 . . . . 1.29 110.018 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.532 ' O ' ' O ' ' A' ' 63' ' ' THR . 7.8 tt0 -136.51 -105.37 0.2 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.911 -1.041 . . . . 1.8 110.249 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.57 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 37.4 p 4.6 121.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.485 0.92 . . . . 1.4099999999999999 113.485 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.472 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 9.5 pt-20 -111.59 150.74 29.63 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.067 0.765 . . . . 2.0499999999999998 113.067 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.725 HH22 ' H ' ' A' ' 41' ' ' ALA . 1.3 ttt85 -137.25 88.39 2.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.119 -0.946 . . . . 4.2800000000000002 109.809 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -84.48 145.74 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 4.4699999999999998 111.464 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -117.95 -78.99 0.59 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.894 -0.594 . . . . 5.1500000000000004 110.805 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -155.98 -89.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.449 -0.342 . . . . 3.1699999999999999 111.029 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -157.57 155.35 30.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.384 0.135 . . . . 2.3900000000000001 110.77 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t 47.87 86.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.91 0.386 . . . . 1.3200000000000001 110.313 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.454 ' CE2' ' ND2' ' A' ' 164' ' ' ASN . 2.0 p90 -156.13 166.21 34.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 1.77 111.441 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.609 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -176.36 -174.92 43.27 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.923 -1.132 . . . . 0.98999999999999999 114.213 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 16' ' ' ALA . 4.0 m-85 -110.2 173.13 6.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 1.1899999999999999 112.265 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.5 137.14 53.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.804 -1.089 . . . . 2.27 110.212 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.478 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -128.32 87.62 54.78 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.975 0.361 . . . . 1.0700000000000001 111.975 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.94 131.35 44.97 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 121.815 1.677 . . . . 1.26 111.711 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 77' ' ' ILE . 65.4 mt -123.2 153.74 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.883 0.373 . . . . 1.0900000000000001 111.643 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -143.44 -0.51 1.09 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.036 -0.529 . . . . 3.4399999999999999 111.597 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.594 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 37.0 mt-10 -124.77 167.95 13.9 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 120.77 0.319 . . . . 2.1299999999999999 111.2 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -123.99 164.05 20.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.232 0.539 . . . . 0.37 110.877 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.9 -146.43 17.24 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 109.729 -1.349 . . . . 0.23000000000000001 109.729 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 10.8 mm-40 -103.93 108.37 19.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.685 1.243 . . . . 2.0299999999999998 109.146 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.594 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 3.9 m-85 -94.44 126.42 39.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.94999999999999996 108.73 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.646 HG22 ' N ' ' A' ' 177' ' ' ALA . 23.0 t -112.45 110.97 34.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.096 -0.956 . . . . 1.21 111.323 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -97.51 103.65 15.6 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.571 -1.195 . . . . 1.79 110.684 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.42 139.58 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.507 -1.224 . . . . 1.95 108.473 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.447 HD11 ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.38 152.3 40.51 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.838 -0.745 . . . . 2.0 111.826 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.563 ' HZ2' ' HB3' ' A' ' 128' ' ' ASP . 15.3 tptt -108.41 117.74 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.06 -0.656 . . . . 3.3799999999999999 110.615 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.9 m-85 -105.23 145.07 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.169 -1.049 . . . . 0.34999999999999998 108.169 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -157.74 175.4 13.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 119.136 -1.025 . . . . 1.1499999999999999 113.53 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 65.59 147.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.675 -1.148 . . . . 3.9700000000000002 111.823 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 94' ' ' PHE . 8.1 t -141.09 -25.87 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.662 -0.699 . . . . 4.3099999999999996 110.789 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 68.82 -4.25 1.24 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.831 -0.622 . . . . 3.0099999999999998 110.718 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 92' ' ' VAL . 86.3 m-85 -145.26 -165.55 2.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.019 -0.537 . . . . 2.0 109.854 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.11 100.11 2.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.297 . . . . 1.6599999999999999 111.543 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.406 ' HG2' ' NE2' ' A' ' 99' ' ' GLN . 8.5 tp-100 -174.41 140.67 0.65 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.208 -0.451 . . . . 3.6000000000000001 110.982 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.8 m -97.18 153.97 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 1.8899999999999999 111.056 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 54.75 55.93 7.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.576 . . . . 2.6899999999999999 111.277 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.406 ' NE2' ' HG2' ' A' ' 96' ' ' GLN . 9.2 tt0 -151.16 -51.09 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.128 -0.693 . . . . 3.0299999999999998 109.128 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 30.2 mmtm -90.48 78.26 6.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.729 -0.841 . . . . 3.52 108.729 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.49 111.72 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.587 -0.733 . . . . 1.95 110.437 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.66 178.79 4.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.219 0.822 . . . . 0.80000000000000004 113.219 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.8 139.97 53.45 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 115.83 -0.623 . . . . 2.0099999999999998 111.618 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.4 133.2 33.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 115.99 -0.55 . . . . 1.1599999999999999 111.752 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.608 HH21 HG22 ' A' ' 158' ' ' VAL . 1.0 OUTLIER -133.69 152.26 51.84 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 112.94 0.719 . . . . 2.1800000000000002 112.94 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.6 m -118.17 117.57 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.864 -1.062 . . . . 1.71 109.224 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.452 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 58.55 27.05 15.12 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.043 -0.725 . . . . 1.77 109.043 -176.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.69 20.52 43.66 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.976 -1.011 . . . . 0.40999999999999998 112.734 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.0 m-70 -118.18 109.59 16.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.076 0.769 . . . . 0.58999999999999997 113.076 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.4 p -62.91 118.28 7.56 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.543 -0.463 . . . . 1.2 111.207 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.82 -32.77 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.044 -0.724 . . . . 1.3999999999999999 109.044 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.9 91.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.905 -0.589 . . . . 1.21 109.822 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 16.9 ttmt -107.17 82.34 1.66 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.771 0.796 . . . . 2.9199999999999999 110.283 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.8 p30 151.8 39.8 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.975 -1.92 . . . . 2.5600000000000001 108.594 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.16 88.13 0.17 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.066 0.765 . . . . 1.71 113.066 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -103.29 86.13 2.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.366 -1.346 . . . . 1.99 107.366 175.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 46.0 mt -50.52 -44.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.806 -0.634 . . . . 1.23 112.095 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.73 -58.66 6.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 1.01 111.247 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.97 -27.03 64.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 0.76000000000000001 112.034 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -64.61 -59.63 4.06 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.286 0.476 . . . . 3.0299999999999998 112.286 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.23 -40.81 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.108 0.411 . . . . 2.0299999999999998 112.108 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.92 -129.45 3.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.566 -0.826 . . . . 1.0600000000000001 112.65 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -94.34 110.92 22.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 4.29 110.971 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.491 ' HG ' ' H ' ' A' ' 125' ' ' THR . 12.8 t 63.28 -130.56 0.47 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.843 -0.617 . . . . 2.1099999999999999 111.195 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 4.4 p 58.83 -166.72 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.659 0.266 . . . . 1.3300000000000001 110.351 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.5 135.05 49.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.969 0.729 . . . . 1.1200000000000001 112.969 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.47 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 2.2 t60 -112.54 148.88 33.57 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.812 -0.81 . . . . 0.45000000000000001 108.812 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.563 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 2.5 p-10 -144.47 135.53 25.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.896 0.702 . . . . 2.0899999999999999 112.896 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -124.38 122.02 36.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.483 -0.78 . . . . 2.2799999999999998 108.973 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.36 126.33 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.078 -0.51 . . . . 1.3799999999999999 110.736 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.1 mp -128.83 85.89 58.98 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.279 0.474 . . . . 2.0 112.279 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -62.04 143.28 94.82 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.628 1.552 . . . . 0.23999999999999999 111.413 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.483 HG21 ' N ' ' A' ' 134' ' ' SER . 32.7 mt -136.97 159.22 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 1.0600000000000001 110.941 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.483 ' N ' HG21 ' A' ' 133' ' ' ILE . 41.2 p -134.24 110.22 9.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.6599999999999999 111.195 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 18.0 mt -108.4 128.37 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.793 -0.639 . . . . 1.0700000000000001 110.121 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -146.04 140.64 26.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.321 . . . . 2.4300000000000002 110.86 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt 58.74 14.57 3.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 3.5600000000000001 111.369 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.94 21.15 34.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.622 -0.799 . . . . 0.32000000000000001 112.747 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 96.9 mttt -118.52 152.29 36.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.609 0.205 . . . . 2.6800000000000002 110.659 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.513 HD21 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.24 132.96 54.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.274 0.559 . . . . 1.1100000000000001 112.145 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.513 ' N ' HD21 ' A' ' 140' ' ' LEU . 23.6 t -121.11 109.17 14.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.477 -0.783 . . . . 1.3700000000000001 109.782 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -103.78 112.58 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.272 0.558 . . . . 1.23 111.019 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 54.19 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.704 -0.68 . . . . 2.0499999999999998 112.262 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.43 27.43 3.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.51 -0.852 . . . . 0.59999999999999998 113.176 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -133.8 138.96 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.187 -0.301 . . . . 2.02 110.187 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.52 137.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.106 0.479 . . . . 1.8700000000000001 111.294 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.6 m -159.32 129.68 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 1.46 109.885 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.5 p -59.14 143.21 49.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.207 -0.451 . . . . 1.55 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -79.3 139.18 37.91 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.301 -0.629 . . . . 0.34000000000000002 109.301 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 t -135.37 95.29 3.25 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.078 0.77 . . . . 2.02 113.078 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.48 -59.16 1.2 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.675 1.03 . . . . 0.77000000000000002 115.675 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.478 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -152.64 168.61 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.035 0.918 . . . . 2.3199999999999998 112.68 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.452 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -92.02 126.32 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.833 -1.173 . . . . 1.8600000000000001 107.833 177.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.3 t -114.95 117.85 31.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.517 0.932 . . . . 1.72 113.517 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 92.1 t -93.02 97.89 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.049 -0.723 . . . . 1.27 109.049 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.8 tt0 -104.91 141.08 37.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.546 -0.752 . . . . 2.48 110.717 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -131.04 145.48 52.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 1.9199999999999999 109.844 178.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.608 HG22 HH21 ' A' ' 105' ' ' ARG . 11.5 t -116.74 140.86 37.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.642 -0.708 . . . . 1.3899999999999999 110.662 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.24 148.57 26.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.444 -0.798 . . . . 2.48 111.946 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -124.5 -27.26 1.33 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.487 -0.779 . . . . 1.1200000000000001 111.666 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -175.22 51.22 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.729 0.3 . . . . 3.8999999999999999 110.339 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 62.41 159.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.141 -0.481 . . . . 4.0999999999999996 111.214 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 54.43 91.88 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.588 0.709 . . . . 1.3999999999999999 110.723 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -50.98 174.95 0.08 OUTLIER Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 114.137 -1.392 . . . . 2.0 109.517 178.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -42.49 -16.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.79 1.66 . . . . 3.1099999999999999 112.56 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.615 ' HZ1' ' HB3' ' A' ' 166' ' ' LYS . 1.5 mtpm? 75.73 -76.7 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.736 0.814 . . . . 4.1100000000000003 111.554 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 62' ' ' GLN . 7.4 t -83.72 131.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 C-N-CA 119.451 -0.899 . . . . 1.5900000000000001 111.117 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -133.76 123.48 24.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.093 0.871 . . . . 1.8600000000000001 111.569 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.419 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -119.83 36.94 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.64 -1.164 . . . . 1.04 113.76 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.53 131.77 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.903 0.335 . . . . 1.6799999999999999 111.903 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.477 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -150.38 99.45 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.38 110.395 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -109.16 124.57 65.93 Favored 'Isoleucine or valine' 0 C--O 1.262 1.727 0 CA-C-O 122.763 1.268 . . . . 1.3500000000000001 112.547 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.2 ptm -115.71 164.05 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.102 -1.408 . . . . 1.26 109.441 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 175' ' ' GLY . 1.7 tptp -120.31 137.93 53.98 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.688 1.366 . . . . 2.3599999999999999 114.688 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.15 -34.54 5.71 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 118.198 2.039 . . . . 0.23000000000000001 118.198 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.563 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.79 156.03 0.45 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.732 2.266 . . . . 1.1000000000000001 114.447 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.646 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -85.34 -21.82 28.74 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.099 -0.955 . . . . 1.1000000000000001 110.336 177.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.71 -33.86 74.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.675 -0.693 . . . . 2.3100000000000001 111.434 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.91 -45.56 78.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.606 -0.27 . . . . 2.3700000000000001 110.536 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.1 t -40.55 100.28 0.22 Allowed Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 123.5 0.5 . . . . 3.0800000000000001 111.675 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -52.56 113.31 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.777 1.651 . . . . 2.4500000000000002 112.334 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.0 mmt -99.8 129.4 45.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 6.3700000000000001 110.667 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.8 mt 60.49 110.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 5.3499999999999996 111.042 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -50.75 151.49 4.21 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.019 -0.537 . . . . 8.5099999999999998 110.523 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -62.8 124.56 14.29 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.676 1.584 . . . . 9.6899999999999995 112.021 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.557 ' HD1' ' N ' ' A' ' 188' ' ' GLY . 62.6 t-80 -133.15 142.59 45.03 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.755 -0.657 . . . . 10.35 110.03 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 186' ' ' HIS . 95.5 Cg_endo -74.77 -36.49 2.72 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.901 1.734 . . . . 12.26 112.183 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.557 ' N ' ' HD1' ' A' ' 186' ' ' HIS . . . -111.29 -156.94 14.24 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.951 -0.642 . . . . 12.619999999999999 112.229 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.459 HD11 ' N ' ' A' ' 189' ' ' LEU . 8.5 mp -86.92 157.01 19.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.714 0.292 . . . . 14.65 110.556 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.128 -0.939 . . . . 15.699999999999999 110.902 -179.907 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.42 -0.272 . . . . 9.3900000000000006 112.42 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.06 -61.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.699 0.285 . . . . 7.6799999999999997 110.774 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.5 mtm 57.25 87.8 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.1 -0.5 . . . . 8.1699999999999999 110.944 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.0 m -63.34 163.44 10.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 4.25 110.95 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.4 72.8 0.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.73 . . . . 1.8200000000000001 112.428 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 tp -80.42 -41.98 23.55 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.284 0.564 . . . . 1.1299999999999999 110.43 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.555 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -56.38 -21.06 22.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.444 -0.798 . . . . 1.1299999999999999 110.585 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.33 -18.34 64.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.562 . . . . 2.0899999999999999 111.314 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.05 -28.4 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.916 -0.314 . . . . 2.5 111.549 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -44.54 145.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.839 -0.345 . . . . 1.05 111.683 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.7 pt -139.37 -23.44 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 120.222 -0.591 . . . . 1.48 111.137 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.506 ' O ' HG23 ' A' ' 172' ' ' ILE . 31.9 t90 -170.69 126.45 0.73 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.393 -0.523 . . . . 0.33000000000000002 110.355 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -144.41 141.07 29.41 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.675 -0.239 . . . . 1.05 111.275 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -147.18 126.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 114.028 1.122 . . . . 1.3600000000000001 114.028 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 22.2 t-20 -116.8 96.13 5.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.323 -0.551 . . . . 1.8700000000000001 110.933 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HB1' ' OH ' ' A' ' 73' ' ' TYR . . . -65.29 115.1 5.24 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 109.627 -0.508 . . . . 1.1100000000000001 109.627 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 162.62 -56.18 0.3 Allowed Glycine 0 N--CA 1.441 -0.992 0 O-C-N 124.093 0.871 . . . . 0.67000000000000004 113.855 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.51 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -115.19 -120.88 3.41 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.744 -0.741 . . . . 1.1200000000000001 112.946 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.77 ' N ' ' HH ' ' A' ' 29' ' ' TYR . 28.0 tt0 -154.74 120.28 5.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.89 0.33 . . . . 2.02 111.89 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 24.6 t 24.09 115.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.675 1.361 . . . . 1.6499999999999999 114.675 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.481 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 17.1 t60 -137.74 151.19 47.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.303 0.573 . . . . 0.41999999999999998 111.865 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.99 106.97 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.391 -0.822 . . . . 1.8200000000000001 111.507 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.09 153.96 42.13 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.292 -0.413 . . . . 1.1699999999999999 110.231 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.5 m -44.26 -53.07 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 113.445 0.905 . . . . 1.27 113.445 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -55.82 -19.88 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.194 0.521 . . . . 0.55000000000000004 110.565 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.38 35.01 3.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.407 -0.815 . . . . 0.32000000000000001 112.144 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.423 HG22 HD13 ' A' ' 27' ' ' ILE . 33.4 mm -102.75 120.52 52.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 1.21 109.454 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 10.3 t60 -103.52 129.12 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.335 1.235 . . . . 0.68999999999999995 114.335 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.77 ' HH ' ' N ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -100.82 139.44 36.51 Favored 'General case' 0 CA--C 1.524 -0.04 0 N-CA-C 107.468 -1.308 . . . . 3.3199999999999998 107.468 176.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 15.5 ptm180 -103.82 126.0 50.64 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.529 0.68 . . . . 3.3999999999999999 112.439 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.553 ' HZ1' ' HA2' ' A' ' 39' ' ' GLY . 4.5 tmmm? -20.32 141.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.445 1.498 . . . . 3.1600000000000001 114.708 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -27.86 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.072 -1.422 . . . . 1.98 112.467 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -102.17 1.99 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.939 2.426 . . . . 1.53 114.627 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -114.41 -29.77 6.77 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.399 0.518 . . . . 2.3599999999999999 112.399 -178.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.607 ' N ' HD23 ' A' ' 34' ' ' LEU . 60.1 mp0 -78.82 73.38 5.36 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.74 -0.384 . . . . 4.9500000000000002 110.085 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' C ' ' HG2' ' A' ' 37' ' ' ARG . . . 74.49 -0.22 56.01 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.158 -1.02 . . . . 2.3300000000000001 110.811 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER 42.41 63.76 1.32 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.289 0.566 . . . . 5.8700000000000001 110.517 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 p -146.49 146.79 18.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.293 -0.867 . . . . 3.48 110.502 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.553 ' HA2' ' HZ1' ' A' ' 31' ' ' LYS . . . -61.79 114.86 7.17 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.054 -0.593 . . . . 2.5899999999999999 113.173 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -150.78 -76.0 0.15 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.55 0.215 . . . . 7.3300000000000001 110.932 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.442 ' H ' HH21 ' A' ' 65' ' ' ARG . . . 57.78 90.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.411 -0.359 . . . . 2.0099999999999998 110.99 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -91.87 89.37 7.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 2.2999999999999998 110.838 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -74.44 94.8 2.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.026 -0.534 . . . . 2.23 110.4 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.442 ' C ' ' H ' ' A' ' 46' ' ' MET . 56.3 t80 -107.19 -71.43 0.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.943 -0.571 . . . . 2.6000000000000001 111.401 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.17 23.43 1.43 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.025 -0.607 . . . . 2.6600000000000001 113.027 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.442 ' H ' ' C ' ' A' ' 44' ' ' TYR . 7.7 ttt -66.06 -11.9 51.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.938 0.399 . . . . 2.4300000000000002 110.322 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' HD3' ' A' ' 49' ' ' PRO . 64.8 pttt -88.96 16.34 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.828 -0.624 . . . . 3.79 110.633 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.6 mt -127.21 65.82 66.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.888 -0.596 . . . . 3.23 109.908 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 84.9 Cg_exo -54.0 134.97 62.19 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.008 2.472 . . . . 1.9399999999999999 113.605 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.79 148.1 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.03 -0.73 . . . . 1.45 109.03 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' N ' HD11 ' A' ' 51' ' ' LEU . 10.0 mp -97.51 -37.46 9.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 2.29 112.897 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -82.36 38.94 0.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.594 0.59 . . . . 3.0600000000000001 112.594 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -153.3 165.97 34.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 1.4099999999999999 111.663 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.8 t30 -76.76 146.69 76.73 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.891 -0.595 . . . . 1.96 109.764 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.62 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.44 -55.62 1.83 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.466 2.111 . . . . 0.78000000000000003 114.272 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.627 ' O ' HG12 ' A' ' 59' ' ' VAL . 12.0 mm-40 -64.5 -56.76 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.721 0.772 . . . . 1.8200000000000001 111.167 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -70.58 -2.54 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.15 -0.62 . . . . 1.9099999999999999 110.304 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.62 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 14.5 tt0 -73.32 -56.15 5.45 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.701 -1.222 . . . . 2.0600000000000001 107.701 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 56' ' ' GLU . 11.0 p -52.46 -35.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.039 -1.097 . . . . 1.8500000000000001 108.039 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -65.18 -68.83 0.33 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.42 -0.512 . . . . 1.6000000000000001 110.1 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -54.12 -3.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.026 0.931 . . . . 1.29 111.9 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 63' ' ' THR . 26.7 tt0 -109.96 -113.92 0.31 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.585 -0.734 . . . . 1.8 110.351 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.577 ' O ' ' O ' ' A' ' 62' ' ' GLN . 57.2 p 29.87 123.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.699 1.37 . . . . 1.4099999999999999 114.699 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -127.26 147.44 50.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.868 -0.606 . . . . 2.0499999999999998 110.265 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.536 HH11 ' HG2' ' A' ' 35' ' ' GLU . 2.3 ptm180 -136.81 -173.25 3.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.686 0.279 . . . . 4.2800000000000002 110.45 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -49.21 148.95 2.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.371 0.508 . . . . 4.4699999999999998 112.371 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -135.43 -179.83 5.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 5.1500000000000004 110.525 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -156.6 -120.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.725 -0.216 . . . . 3.1699999999999999 111.106 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -153.29 129.33 10.33 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.468 0.175 . . . . 2.3900000000000001 110.823 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.621 ' H ' HD22 ' A' ' 164' ' ' ASN . 23.0 t 56.59 91.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.977 0.417 . . . . 1.3200000000000001 110.985 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -164.29 163.91 22.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.905 -0.588 . . . . 1.77 110.886 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.426 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -169.45 -174.27 37.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.15 -1.024 . . . . 0.98999999999999999 113.973 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.478 ' OH ' ' HB1' ' A' ' 16' ' ' ALA . 7.8 m-85 -108.51 165.98 11.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.44 0.638 . . . . 1.1899999999999999 112.138 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.74 126.97 51.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.824 -1.08 . . . . 2.27 110.218 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.495 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -118.43 87.53 31.01 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 111.835 0.309 . . . . 1.0700000000000001 111.835 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.12 133.62 58.9 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 121.929 1.753 . . . . 1.26 112.021 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 78' ' ' LYS . 24.1 mt -124.11 153.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.938 0.399 . . . . 1.0900000000000001 111.483 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 77' ' ' ILE . 59.0 mttp -140.85 0.98 1.64 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.888 -0.596 . . . . 3.4399999999999999 111.027 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.73 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 15.4 mm-40 -129.42 170.44 13.68 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.713 0.292 . . . . 2.1299999999999999 111.284 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -123.06 176.87 5.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.095 0.474 . . . . 0.37 111.242 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.36 -152.31 20.18 Favored Glycine 0 C--N 1.329 0.153 0 N-CA-C 109.868 -1.293 . . . . 0.23000000000000001 109.868 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.52 108.55 19.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.858 1.329 . . . . 2.0299999999999998 108.836 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.73 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.9 m-85 -95.01 126.95 40.7 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.578 0.704 . . . . 0.94999999999999996 109.677 -178.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.619 HG23 ' N ' ' A' ' 177' ' ' ALA . 13.9 t -113.6 118.49 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.787 -1.097 . . . . 1.21 111.831 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 105.37 17.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.521 -1.218 . . . . 1.79 111.572 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.64 126.47 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.78 -1.1 . . . . 1.95 108.966 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 129' ' ' GLU . 1.8 pt? -147.17 134.88 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.63 -0.828 . . . . 2.0 111.754 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.619 ' HZ2' ' HB3' ' A' ' 128' ' ' ASP . 5.3 tptp -98.02 120.74 38.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.317 -0.856 . . . . 3.3799999999999999 110.828 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.473 ' CD2' HD23 ' A' ' 115' ' ' LEU . 7.5 m-85 -105.09 136.54 44.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.757 -1.201 . . . . 0.34999999999999998 107.757 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -146.04 171.89 14.2 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.489 -0.884 . . . . 1.1499999999999999 113.074 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 59.45 176.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.296 -0.866 . . . . 3.9700000000000002 112.028 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 p -176.87 -18.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.839 -0.619 . . . . 4.3099999999999996 111.116 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.9 t80 73.65 -68.44 0.22 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.936 -0.575 . . . . 3.0099999999999998 110.582 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.48 138.68 31.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 2.0 110.856 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.97 99.1 12.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 1.6599999999999999 110.908 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.448 ' HB2' ' HZ2' ' A' ' 100' ' ' LYS . 16.7 mt-30 -142.01 145.11 34.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 3.6000000000000001 111.069 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 98' ' ' GLN . 73.9 m -119.1 134.4 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.8899999999999999 111.254 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 97' ' ' SER . 15.3 mm100 71.43 -60.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.772 -0.649 . . . . 2.6899999999999999 111.554 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -45.48 -38.29 6.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.409 -0.36 . . . . 3.0299999999999998 111.139 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.687 ' HZ3' ' HB2' ' A' ' 100' ' ' LYS . 4.7 ttmp? -101.95 82.55 2.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.305 0.574 . . . . 3.52 110.778 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.77 139.91 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.293 -0.867 . . . . 1.95 109.618 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.442 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 61.6 m-85 -119.92 176.85 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.756 0.65 . . . . 0.80000000000000004 112.756 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.41 ' OD2' HG22 ' A' ' 110' ' ' THR . 5.7 t70 -127.15 140.43 52.26 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.213 0.53 . . . . 2.0099999999999998 112.31 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.89 136.45 55.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.052 -0.977 . . . . 1.1599999999999999 112.008 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 5.1 mtt180 -135.5 156.68 48.5 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 113.264 0.839 . . . . 2.1800000000000002 113.264 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.586 HG11 ' ND2' ' A' ' 107' ' ' ASN . 39.5 t -122.9 123.34 67.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 114.558 -1.201 . . . . 1.71 109.298 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.599 ' ND2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 53.59 26.1 5.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.556 -0.905 . . . . 1.77 108.556 -175.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.83 17.15 57.03 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.278 -0.873 . . . . 0.40999999999999998 112.74 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 88.9 m-70 -112.37 112.89 24.79 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.895 0.702 . . . . 0.58999999999999997 112.895 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.41 HG22 ' OD2' ' A' ' 103' ' ' ASP . 11.6 p -62.77 127.17 30.0 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.864 -0.734 . . . . 1.2 110.454 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.06 -30.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 1.3999999999999999 109.316 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.37 88.97 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.804 -0.814 . . . . 1.21 108.804 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -106.6 77.72 1.21 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.515 1.15 . . . . 2.9199999999999999 110.773 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 p30 159.44 38.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.348 -1.751 . . . . 2.5600000000000001 108.499 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.473 HD23 ' CD2' ' A' ' 89' ' ' PHE . 20.5 tp -79.36 91.64 5.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.172 0.805 . . . . 1.71 113.172 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -106.48 91.14 3.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.869 -1.16 . . . . 1.99 107.869 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.25 -32.42 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.995 0.739 . . . . 1.23 112.995 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.97 -51.56 15.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.737 -0.385 . . . . 1.01 111.303 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.27 -27.13 65.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.76000000000000001 111.913 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HE ' ' CE1' ' A' ' 127' ' ' HIS . 23.8 mmm180 -77.65 -58.6 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.688 0.625 . . . . 3.0299999999999998 112.688 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.52 -41.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.383 0.512 . . . . 2.0299999999999998 112.383 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.65 -125.66 6.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.438 -0.887 . . . . 1.0600000000000001 112.889 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -72.42 110.34 6.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.382 . . . . 4.29 111.372 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 61.5 m 48.41 -109.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 2.1099999999999999 111.685 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.1 p 50.31 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 1.3300000000000001 110.988 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.61 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . . . -114.16 138.42 50.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.287 0.565 . . . . 1.1200000000000001 112.234 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.543 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.6 t60 -108.0 151.06 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.075 -0.966 . . . . 0.45000000000000001 108.416 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.619 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 4.6 p-10 -136.85 136.51 38.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.772 0.656 . . . . 2.0899999999999999 112.772 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.405 ' O ' HD21 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -127.76 123.86 36.34 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.05 -0.977 . . . . 2.2799999999999998 109.668 178.004 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 53.2 mt -119.08 124.05 72.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.917 -0.583 . . . . 1.3799999999999999 110.396 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.9 mm -131.6 95.5 23.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.122 0.415 . . . . 2.0 112.122 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.99 148.84 93.05 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.646 1.564 . . . . 0.23999999999999999 111.309 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 134' ' ' SER . 21.3 mt -139.64 155.96 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.336 . . . . 1.0600000000000001 110.961 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 29.2 p -131.57 111.2 11.53 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.008 0.432 . . . . 1.6599999999999999 111.168 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 20.3 mt -112.06 127.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.649 -0.705 . . . . 1.0700000000000001 110.217 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -149.32 137.97 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.518 -0.31 . . . . 2.4300000000000002 111.005 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.681 ' HZ1' ' HB2' ' A' ' 137' ' ' LYS . 9.4 mtmp? 62.5 13.4 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.998 -0.546 . . . . 3.5600000000000001 111.468 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.61 7.64 58.89 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.59 -0.814 . . . . 0.32000000000000001 112.986 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -108.12 167.06 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.883 0.341 . . . . 2.6800000000000002 110.645 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.553 HD21 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -127.96 146.36 50.67 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.739 0.644 . . . . 1.1100000000000001 112.739 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.553 ' N ' HD21 ' A' ' 140' ' ' LEU . 23.1 t -132.2 109.7 10.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.027 -0.988 . . . . 1.3700000000000001 109.335 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.71 111.51 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.082 -0.508 . . . . 1.23 110.349 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 61.89 -89.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 2.0499999999999998 111.579 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.07 15.13 4.02 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.712 -0.756 . . . . 0.59999999999999998 112.77 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.42 130.93 57.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.089 -0.337 . . . . 2.02 110.089 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.3 131.82 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.184 0.516 . . . . 1.8700000000000001 110.966 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -149.59 175.37 11.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.637 -0.711 . . . . 1.46 109.496 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.4 p -99.52 138.88 35.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.7 -0.4 . . . . 1.55 111.418 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.059 -0.719 . . . . 0.34000000000000002 109.059 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 t -139.6 95.86 2.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.175 0.805 . . . . 2.02 113.175 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.29 -51.02 3.22 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 115.819 1.087 . . . . 0.77000000000000002 115.819 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.495 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -158.66 174.94 14.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.385 1.093 . . . . 2.3199999999999998 113.543 -177.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.599 ' HG ' ' ND2' ' A' ' 107' ' ' ASN . 1.1 tp -97.69 124.69 42.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.035 -1.439 . . . . 1.8600000000000001 107.123 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.4 t -114.35 116.93 29.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 118.739 -1.184 . . . . 1.72 113.443 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 47.0 t -95.61 98.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.741 -0.837 . . . . 1.27 108.741 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.3 tt0 -109.13 134.63 51.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.658 -0.701 . . . . 2.48 111.207 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -126.33 134.56 51.06 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.276 0.56 . . . . 1.9199999999999999 110.345 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.476 HG23 HH21 ' A' ' 105' ' ' ARG . 99.1 t -105.8 142.04 19.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 114.73 -1.123 . . . . 1.3899999999999999 110.815 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 143.01 44.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.429 -0.805 . . . . 2.48 111.57 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.76 -14.13 16.45 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.458 -0.657 . . . . 1.1200000000000001 111.458 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -158.98 -64.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 3.8999999999999999 110.281 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -176.72 161.9 2.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 4.0999999999999996 110.783 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 57.22 71.24 0.59 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 1.3999999999999999 111.282 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.621 HD22 ' H ' ' A' ' 70' ' ' SER . 5.8 m-20 -49.98 153.31 2.34 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.537 -0.756 . . . . 2.0 109.503 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.442 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -28.71 105.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.381 2.054 . . . . 3.1099999999999999 112.343 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -58.14 -74.0 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.149 -0.932 . . . . 4.1100000000000003 112.584 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 4.8 t -79.1 133.13 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 119.858 -0.737 . . . . 1.5900000000000001 111.281 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 5.2 t -129.12 124.48 34.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.084 -0.962 . . . . 1.8600000000000001 109.817 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.554 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . . . -117.47 35.46 4.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.652 0.982 . . . . 1.04 113.652 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -35.74 131.06 0.54 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.175 0.512 . . . . 1.6799999999999999 111.649 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.455 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -152.46 96.71 2.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.38 109.542 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 12' ' ' TRP . 0.9 OUTLIER -104.82 126.81 59.66 Favored 'Isoleucine or valine' 0 C--O 1.263 1.805 0 CA-C-O 122.625 1.202 . . . . 1.3500000000000001 112.583 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ptm -118.29 162.52 18.13 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.57 -1.65 . . . . 1.26 109.254 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.97 146.45 46.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.818 1.414 . . . . 2.3599999999999999 114.818 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.97 -35.44 5.0 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 112.469 -2.15 . . . . 0.23000000000000001 117.837 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.569 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 153.87 0.36 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.396 2.098 . . . . 1.1000000000000001 115.298 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.619 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -87.75 -31.8 19.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.379 -1.282 . . . . 1.1000000000000001 110.465 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -56.12 -17.75 8.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.712 -0.677 . . . . 2.3100000000000001 111.63 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 180' ' ' VAL . 2.1 m-20 -73.26 -79.0 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.346 -0.388 . . . . 2.3700000000000001 110.608 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 177' ' ' ALA . 26.9 m 14.49 66.13 0.15 Allowed Pre-proline 0 N--CA 1.475 0.806 0 N-CA-C 113.308 0.855 . . . . 3.0800000000000001 113.308 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.93 124.3 15.93 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.507 2.138 . . . . 2.4500000000000002 112.453 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 59.4 mtt -92.18 120.31 32.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 6.3700000000000001 110.604 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.442 HD11 ' N ' ' A' ' 183' ' ' LEU . 10.1 mp 59.67 103.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.083 -0.508 . . . . 5.3499999999999996 110.979 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -54.26 146.41 31.6 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.041 -0.527 . . . . 8.5099999999999998 110.269 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -44.57 146.06 2.34 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.632 1.555 . . . . 9.6899999999999995 112.392 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.634 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 61.6 t60 -134.5 132.46 20.85 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.348 -0.387 . . . . 10.35 110.494 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.634 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 62.1 Cg_endo -74.05 -21.89 17.68 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.206 1.937 . . . . 12.26 112.469 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -50.1 151.3 4.68 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.778 -0.725 . . . . 12.619999999999999 112.658 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 189' ' ' LEU . 6.9 mp -106.26 137.27 44.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.704 0.287 . . . . 14.65 110.892 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.202 -0.904 . . . . 15.699999999999999 110.763 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.377 -0.289 . . . . 9.3900000000000006 112.377 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.72 -39.32 2.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 7.6799999999999997 110.963 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.7 mtt -104.04 10.83 35.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 8.1699999999999999 110.75 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.1 t -121.88 151.65 40.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 4.25 110.829 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.56 81.88 0.73 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.839 -0.696 . . . . 1.8200000000000001 112.636 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 180' ' ' VAL . 17.9 tp -73.58 -42.97 60.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.145 0.498 . . . . 1.1299999999999999 110.267 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.557 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -57.24 -20.67 28.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 1.1299999999999999 110.642 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.75 -18.29 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 2.0899999999999999 111.738 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HZ1' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -105.95 -27.04 11.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.776 -0.37 . . . . 2.5 111.091 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -45.43 146.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 120.979 -0.289 . . . . 1.05 111.311 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.24 -20.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 119.965 -0.694 . . . . 1.48 110.729 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.548 ' O ' HG21 ' A' ' 172' ' ' ILE . 13.1 t90 -173.51 129.33 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.028 -0.533 . . . . 0.33000000000000002 110.042 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.82 139.29 20.48 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 122.333 -0.229 . . . . 1.05 111.296 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.2 t -147.16 131.89 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 114.324 1.231 . . . . 1.3600000000000001 114.324 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 63.8 t30 -115.34 87.96 2.77 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 116.161 -0.472 . . . . 1.8700000000000001 110.822 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.483 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -57.97 112.21 1.43 Allowed 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.648 -0.706 . . . . 1.1100000000000001 110.046 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.518 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 143.97 -13.81 2.15 Favored Glycine 0 N--CA 1.442 -0.91 0 O-C-N 124.047 0.842 . . . . 0.67000000000000004 114.234 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.622 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -136.08 -131.06 2.97 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 119.961 -1.114 . . . . 1.1200000000000001 113.129 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.644 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 20.4 tt0 -160.99 120.01 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 2.02 111.45 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.6 m 26.4 104.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.921 -1.036 . . . . 1.6499999999999999 113.615 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.601 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.5 t60 -132.77 142.82 49.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 120.334 -0.546 . . . . 0.41999999999999998 112.404 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 22' ' ' VAL . 5.8 p -116.94 105.43 18.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 121.456 0.646 . . . . 1.8200000000000001 111.101 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.59 158.12 34.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.38 -0.827 . . . . 1.1699999999999999 110.512 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.2 m -42.95 -50.99 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.227 0.954 . . . . 1.27 113.261 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -57.33 -22.16 40.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.55000000000000004 110.42 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.54 34.72 3.5 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.228 -0.896 . . . . 0.32000000000000001 111.757 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 27' ' ' ILE . 26.5 mm -103.58 112.65 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.13 0.49 . . . . 1.21 110.403 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.1 t60 -97.59 139.01 34.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.485 1.291 . . . . 0.68999999999999995 114.485 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -104.76 138.02 41.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.458 -1.246 . . . . 3.3199999999999998 108.867 178.024 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 29.6 mtp180 -94.19 109.05 20.87 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.685 0.616 . . . . 3.3999999999999999 112.03 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 32' ' ' ASP . 81.2 tttt -24.05 132.16 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.176 1.176 . . . . 3.1600000000000001 114.176 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' LYS . 77.4 m-20 -2.41 80.11 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.701 1.2 . . . . 1.98 113.998 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -103.86 7.81 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.549 2.832 . . . . 1.53 112.561 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 72' ' ' GLY . 5.7 mt -52.18 -71.4 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.566 0.222 . . . . 2.3599999999999999 111.021 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -144.47 57.63 1.31 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.018 0.747 . . . . 4.9500000000000002 113.018 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.01 0.06 68.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.254 -0.974 . . . . 2.3300000000000001 114.066 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.562 ' HG3' ' CZ ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -69.93 59.98 0.17 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.257 0.529 . . . . 5.8700000000000001 111.507 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.8 m -106.72 136.09 42.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.835 0.35 . . . . 3.48 110.867 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.2 26.2 10.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 2.5899999999999999 112.625 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -137.87 -61.26 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.582 0.23 . . . . 7.3300000000000001 110.875 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 74.45 -44.52 0.56 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.815 -0.629 . . . . 2.0099999999999998 111.486 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.9 m 53.18 55.61 8.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.956 0.408 . . . . 2.2999999999999998 111.108 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -85.8 25.02 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 2.23 110.358 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -52.58 141.4 20.59 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.094 -0.503 . . . . 2.6000000000000001 110.292 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.66 40.11 78.14 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.378 -0.915 . . . . 2.6600000000000001 111.402 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ttt -57.46 -14.43 4.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.627 -0.286 . . . . 2.4300000000000002 111.552 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -60.68 -176.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.299 . . . . 3.79 110.874 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.506 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 11.8 mt 60.51 59.78 3.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 3.23 110.865 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 23.6 Cg_exo -69.78 157.36 60.6 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.534 2.156 . . . . 1.9399999999999999 112.59 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 50' ' ' ILE . 1.1 mp -66.23 145.79 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 116.124 -0.489 . . . . 1.45 109.779 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.439 ' N ' HD21 ' A' ' 51' ' ' LEU . 3.8 mm? -87.11 -60.46 1.97 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.796 1.036 . . . . 2.29 113.796 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -71.76 32.84 0.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.408 0.892 . . . . 3.0600000000000001 113.408 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 t -138.16 140.76 40.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.327 0.491 . . . . 1.4099999999999999 112.327 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.502 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 6.9 t30 -62.27 145.76 93.55 Favored Pre-proline 0 C--O 1.22 -0.451 0 CA-C-N 115.538 -0.755 . . . . 1.96 109.225 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.584 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 11.3 Cg_exo -39.57 -51.18 2.89 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.594 2.196 . . . . 0.78000000000000003 115.425 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.44 -56.19 12.15 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 122.407 1.098 . . . . 1.8200000000000001 110.911 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.58 59.94 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.866 -1.061 . . . . 1.9099999999999999 109.85 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 29.4 tt0 -64.49 -45.68 86.29 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.614 -1.625 . . . . 2.0600000000000001 106.614 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 63' ' ' THR . 96.7 t -57.1 -54.4 30.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.455 -1.248 . . . . 1.8500000000000001 109.99 177.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.9 tp -64.62 -12.75 48.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.9 -0.591 . . . . 1.6000000000000001 112.087 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.466 ' CZ ' ' HE2' ' A' ' 88' ' ' LYS . 4.1 m-30 -108.52 -2.0 19.26 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.916 -0.584 . . . . 1.29 110.21 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.606 ' HG2' ' N ' ' A' ' 63' ' ' THR . 36.7 tt0 -123.58 -107.61 0.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.539 -0.755 . . . . 1.8 112.033 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.606 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 48.2 p 42.08 -168.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.489 -0.323 . . . . 1.4099999999999999 110.994 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.518 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 177.71 128.4 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.977 0.417 . . . . 2.0499999999999998 111.77 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.562 ' CZ ' ' HG3' ' A' ' 37' ' ' ARG . 2.2 ttp85 -112.74 -170.97 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.103 -0.499 . . . . 4.2800000000000002 110.336 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -162.91 138.12 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.618 0.247 . . . . 4.4699999999999998 111.128 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.54 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 48.7 t-20 -130.8 -82.54 0.53 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.415 -0.357 . . . . 5.1500000000000004 110.944 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.91 -75.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.549 0.214 . . . . 3.1699999999999999 111.349 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -163.82 143.26 8.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.682 -0.235 . . . . 2.3900000000000001 110.69 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t 50.55 83.42 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.765 0.317 . . . . 1.3200000000000001 110.158 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.434 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 29.9 p90 -150.2 151.65 33.4 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.224 0.535 . . . . 1.77 111.632 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.488 ' O ' HD23 ' A' ' 34' ' ' LEU . . . -169.23 -169.37 32.49 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.268 -0.878 . . . . 0.98999999999999999 113.675 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.483 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 1.2 m-85 -102.15 177.73 4.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.578 0.955 . . . . 1.1899999999999999 113.578 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.68 120.89 21.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.661 -1.609 . . . . 2.27 109.663 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.42 HD13 ' N ' ' A' ' 75' ' ' ILE . 4.2 mp -110.99 90.66 11.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.241 0.46 . . . . 1.0700000000000001 112.241 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.7 141.28 90.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.097 1.198 . . . . 1.26 111.118 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.35 151.87 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 1.0900000000000001 111.32 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -144.63 2.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 3.4399999999999999 110.839 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HB2' ' HZ2' ' A' ' 174' ' ' LYS . 15.9 mm-40 -127.33 175.17 8.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.589 0.233 . . . . 2.1299999999999999 110.663 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -131.71 170.33 14.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.37 111.654 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.59 -154.64 22.65 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 109.569 -1.412 . . . . 0.23000000000000001 109.569 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -96.41 109.66 22.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.976 1.388 . . . . 2.0299999999999998 108.929 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.577 ' HH ' ' HZ2' ' A' ' 174' ' ' LYS . 2.1 m-85 -96.08 126.45 41.32 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.769 -0.826 . . . . 0.94999999999999996 108.769 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.611 ' HB ' ' SD ' ' A' ' 173' ' ' MET . 21.2 t -112.59 113.07 43.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.901 -1.045 . . . . 1.21 111.57 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.443 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.4 tt -89.78 103.75 16.37 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.641 -1.163 . . . . 1.79 109.66 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.62 134.44 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.404 -0.816 . . . . 1.95 108.859 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.488 HD11 ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -147.05 154.94 41.78 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.783 -0.767 . . . . 2.0 112.018 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.657 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.89 119.12 37.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.767 -0.652 . . . . 3.3799999999999999 110.172 178.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 7.7 m-85 -105.68 137.74 43.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.918 -0.583 . . . . 0.34999999999999998 109.531 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.537 ' O ' HG11 ' A' ' 167' ' ' VAL . . . -142.44 152.92 43.24 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.235 -0.283 . . . . 1.1499999999999999 110.235 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -171.19 130.34 0.75 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 3.9700000000000002 110.938 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 m -151.62 85.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.582 . . . . 4.3099999999999996 110.919 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -158.86 6.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 3.0099999999999998 110.937 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -140.81 -47.64 0.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 2.0 110.923 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.97 80.3 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 1.6599999999999999 111.005 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -173.34 140.54 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.18 -0.464 . . . . 3.6000000000000001 110.631 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -97.7 162.38 13.3 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.158 0.504 . . . . 1.8899999999999999 111.356 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.542 ' C ' ' H ' ' A' ' 100' ' ' LYS . 1.9 mp0 55.63 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.88 -1.054 . . . . 2.6899999999999999 110.818 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 71.33 -30.34 0.21 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.966 -1.016 . . . . 3.0299999999999998 110.602 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 98' ' ' GLN . 66.4 mmtt -108.52 63.1 0.61 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.537 -0.912 . . . . 3.52 108.537 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.4 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 1.1 m -109.11 150.78 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.262 -0.881 . . . . 1.95 110.532 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -118.62 178.32 4.51 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 112.843 0.683 . . . . 0.80000000000000004 112.843 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.67 137.67 52.57 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.062 -0.517 . . . . 2.0099999999999998 111.176 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.88 127.01 51.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 115.89 -0.595 . . . . 1.1599999999999999 111.952 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -128.31 141.44 51.44 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.141 -0.936 . . . . 2.1800000000000002 113.269 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.2 m -116.93 118.76 59.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 114.149 -1.387 . . . . 1.71 109.583 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 61.92 28.5 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.882 -0.784 . . . . 1.77 108.882 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.38 89.91 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.40999999999999998 111.369 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.691 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 58.6 m-70 -102.62 109.15 20.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.759 -0.721 . . . . 0.58999999999999997 112.209 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -68.44 133.42 48.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.477 0.656 . . . . 1.2 112.052 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -31.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.896 -1.047 . . . . 1.3999999999999999 109.636 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.25 91.03 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.197 -0.668 . . . . 1.21 109.197 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 3.3 ptpp? -109.18 77.28 1.05 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.692 1.234 . . . . 2.9199999999999999 112.24 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.1 p30 153.53 40.15 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.197 -2.274 . . . . 2.5600000000000001 109.353 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.18 94.42 0.07 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.247 0.546 . . . . 1.71 112.187 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -102.98 84.11 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.932 -1.507 . . . . 1.99 106.932 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.3 mt -50.32 -41.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.104 -0.953 . . . . 1.23 112.628 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.01 -45.73 87.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.667 0.27 . . . . 1.01 111.482 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.11 -28.82 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.211 0.449 . . . . 0.76000000000000001 112.211 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -68.35 -58.44 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.437 0.532 . . . . 3.0299999999999998 112.437 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.4 p -94.39 -37.1 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.867 0.321 . . . . 2.0299999999999998 111.867 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.16 -114.54 2.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.399 -0.905 . . . . 1.0600000000000001 112.878 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.468 ' O ' HG23 ' A' ' 125' ' ' THR . 57.3 t-80 -104.6 114.05 28.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.714 0.292 . . . . 4.29 111.172 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.3 p 53.3 -143.22 0.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.006 -0.543 . . . . 2.1099999999999999 111.316 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.0 p 64.36 -171.73 0.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.624 0.37 . . . . 1.3300000000000001 110.996 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -104.71 139.54 39.37 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.692 0.626 . . . . 1.1200000000000001 112.692 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.533 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.8 t60 -102.91 152.02 21.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.209 -0.905 . . . . 0.45000000000000001 109.075 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.533 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 1.6 p-10 -144.2 132.89 22.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.635 0.605 . . . . 2.0899999999999999 112.635 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -127.65 128.42 45.46 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 2.2799999999999998 109.893 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.4 mt -117.13 122.03 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.058 -0.519 . . . . 1.3799999999999999 110.496 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mm -124.93 89.71 52.15 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.392 -0.367 . . . . 2.0 111.928 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -60.52 143.12 99.42 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.928 1.752 . . . . 0.23999999999999999 111.918 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 134' ' ' SER . 24.1 mt -134.94 156.54 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 1.0600000000000001 110.367 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.442 ' N ' HG22 ' A' ' 133' ' ' ILE . 25.0 p -130.51 106.51 8.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.938 0.399 . . . . 1.6599999999999999 111.015 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 19.2 mt -107.7 122.98 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 1.0700000000000001 110.222 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.54 140.57 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 2.4300000000000002 110.804 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp 61.49 26.54 16.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.904 -0.589 . . . . 3.5600000000000001 110.82 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.72 27.75 60.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.898 -0.668 . . . . 0.32000000000000001 113.004 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 73.3 mttt -126.15 151.62 47.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.832 0.316 . . . . 2.6800000000000002 111.321 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.541 HD21 ' N ' ' A' ' 141' ' ' SER . 5.3 tt -111.24 129.52 55.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 1.1100000000000001 111.856 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.541 ' N ' HD21 ' A' ' 140' ' ' LEU . 18.3 m -117.35 109.41 16.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 1.3700000000000001 109.658 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.99 105.86 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.255 0.55 . . . . 1.23 111.173 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 56.63 -90.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.823 -0.626 . . . . 2.0499999999999998 111.976 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.77 24.95 4.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.468 -0.873 . . . . 0.59999999999999998 113.537 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -134.16 135.13 42.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.811 0.306 . . . . 2.02 110.178 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.33 139.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.093 0.473 . . . . 1.8700000000000001 111.132 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.2 t -161.35 127.83 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 1.46 109.993 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.6 p -53.69 143.72 19.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 1.55 111.68 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.31 124.81 28.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.914 -0.773 . . . . 0.34000000000000002 108.914 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 t -115.96 92.32 3.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.073 0.768 . . . . 2.02 113.073 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.06 -34.09 0.05 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 117.376 1.71 . . . . 0.77000000000000002 117.376 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.484 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.63 158.42 28.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.598 1.699 . . . . 2.3199999999999998 113.885 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.484 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -96.16 124.78 40.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.618 -1.253 . . . . 1.8600000000000001 107.618 176.089 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -108.09 142.34 38.43 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 113.904 1.075 . . . . 1.72 113.904 -176.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 64.6 t -129.67 97.8 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.54 . . . . 1.27 109.909 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 60.7 mm-40 -112.66 128.92 56.52 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.137 -0.938 . . . . 2.48 111.495 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -116.1 133.54 55.91 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.375 -0.602 . . . . 1.9199999999999999 109.375 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 t -108.79 142.86 20.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 115.303 -0.862 . . . . 1.3899999999999999 111.569 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -63.58 148.52 48.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.669 -1.151 . . . . 2.48 111.634 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -111.82 -10.34 19.0 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.744 -0.662 . . . . 1.1200000000000001 111.652 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -153.5 -51.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 3.8999999999999999 110.397 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -171.39 -64.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.151 -0.477 . . . . 4.0999999999999996 110.626 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.55 117.52 20.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.989 -0.551 . . . . 1.3999999999999999 110.809 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.452 ' C ' ' H ' ' A' ' 166' ' ' LYS . 2.1 m120 -60.09 -178.53 0.15 Allowed Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.211 -0.904 . . . . 2.0 109.506 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -48.18 -8.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.905 1.737 . . . . 3.1099999999999999 113.915 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 164' ' ' ASN . 27.6 tptt 76.64 -75.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.656 0.383 . . . . 4.1100000000000003 111.652 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.537 HG11 ' O ' ' A' ' 90' ' ' ALA . 2.0 m -111.95 137.1 45.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 C-N-CA 119.795 -0.762 . . . . 1.5900000000000001 111.562 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.8 t -131.88 122.54 25.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.738 -1.119 . . . . 1.8600000000000001 112.085 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.461 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -106.19 38.34 2.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.163 -0.926 . . . . 1.04 113.381 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -35.49 133.93 0.34 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.963 0.357 . . . . 1.6799999999999999 111.963 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.518 ' N ' HD13 ' A' ' 170' ' ' LEU . 0.6 OUTLIER -154.16 94.92 1.78 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.148 -0.478 . . . . 0.38 110.843 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.548 HG21 ' O ' ' A' ' 12' ' ' TRP . 6.1 tt -104.19 131.44 53.0 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 CA-C-O 122.643 1.211 . . . . 1.3500000000000001 112.547 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.611 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -122.15 166.6 14.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.858 -1.519 . . . . 1.26 110.416 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -116.1 150.57 37.13 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.959 1.466 . . . . 2.3599999999999999 114.959 -177.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 90.51 -34.49 4.16 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 112.105 -2.316 . . . . 0.23000000000000001 118.176 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.583 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.71 162.07 0.7 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.225 2.012 . . . . 1.1000000000000001 114.187 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.592 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -85.54 -23.58 27.63 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 115.029 -0.987 . . . . 1.1000000000000001 110.968 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.33 -18.69 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 2.3100000000000001 111.496 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.401 ' O ' HD13 ' A' ' 6' ' ' LEU . 14.4 m-20 -94.04 -7.09 43.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.544 -0.298 . . . . 2.3700000000000001 111.485 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 6' ' ' LEU . 2.1 t -42.95 -47.21 13.77 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.638 0.607 . . . . 3.0800000000000001 112.638 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.78 -167.09 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.318 1.345 . . . . 2.4500000000000002 111.603 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 61.2 ttp -137.88 138.99 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 6.3700000000000001 110.667 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.6 mt -108.69 134.5 51.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 5.3499999999999996 110.591 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -52.67 146.35 18.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.552 . . . . 8.5099999999999998 110.267 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.18 124.65 12.42 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.636 1.557 . . . . 9.6899999999999995 112.138 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -134.43 133.85 21.96 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.17 -0.468 . . . . 10.35 110.316 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.53 -95.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.575 1.516 . . . . 12.26 111.627 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 87.44 -146.34 20.1 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.879 -0.677 . . . . 12.619999999999999 112.51 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 189' ' ' LEU . 6.7 mp -93.8 141.44 28.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 14.65 110.653 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.1 -0.953 . . . . 15.699999999999999 110.736 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.466 -0.254 . . . . 9.3900000000000006 112.466 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.53 91.7 8.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 7.6799999999999997 110.885 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt -134.21 -54.16 0.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 8.1699999999999999 110.914 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.9 p -78.39 131.96 37.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 4.25 110.736 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.25 -78.47 0.22 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.748 -0.739 . . . . 1.8200000000000001 112.468 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 tp -67.34 -44.84 78.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 1.1299999999999999 110.402 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.52 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -56.7 -21.09 25.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.309 -0.859 . . . . 1.1299999999999999 111.466 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.24 -16.03 59.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.167 0.432 . . . . 2.0899999999999999 112.167 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -105.23 -28.62 10.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.665 -0.414 . . . . 2.5 111.002 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -40.1 144.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 111.772 0.286 . . . . 1.05 111.772 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.69 -23.75 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.071 -0.652 . . . . 1.48 111.073 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.479 ' O ' HG21 ' A' ' 172' ' ' ILE . 25.4 t90 -173.09 137.98 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.972 -0.381 . . . . 0.33000000000000002 109.972 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -157.27 145.95 19.66 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.343 -0.143 . . . . 1.05 111.121 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.9 t -147.35 124.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 114.075 1.139 . . . . 1.3600000000000001 114.075 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -115.4 101.23 8.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.457 -0.497 . . . . 1.8700000000000001 110.807 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.89 104.74 1.42 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 108.614 -0.884 . . . . 1.1100000000000001 108.614 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.62 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 165.68 -63.78 0.22 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 124.718 1.261 . . . . 0.67000000000000004 112.426 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.0 -131.07 5.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.859 -0.686 . . . . 1.1200000000000001 112.121 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -168.83 119.8 0.75 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.118 -0.327 . . . . 2.02 110.118 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 69.7 m 42.13 83.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.937 -0.574 . . . . 1.6499999999999999 111.068 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.576 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 26.3 t60 -116.89 143.78 45.29 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.036 -0.666 . . . . 0.41999999999999998 112.543 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.59 104.32 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.477 -0.783 . . . . 1.8200000000000001 110.151 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -71.85 157.09 38.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.346 -0.388 . . . . 1.1699999999999999 110.448 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 m -43.95 -51.02 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.255 0.972 . . . . 1.27 113.44 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -58.09 -20.09 37.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.314 0.578 . . . . 0.55000000000000004 110.104 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . 102.94 35.12 3.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.138 -0.937 . . . . 0.32000000000000001 111.987 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.439 HG23 HD11 ' A' ' 27' ' ' ILE . 28.4 mm -103.34 123.17 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.98 -0.378 . . . . 1.21 109.98 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.576 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.4 t60 -100.97 132.23 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.86 1.059 . . . . 0.68999999999999995 113.86 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.667 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 128.89 42.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.114 -1.069 . . . . 3.3199999999999998 108.114 177.228 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -82.72 110.31 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.833 0.708 . . . . 3.3999999999999999 112.12 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' C ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 tmmm? -22.96 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.83 1.252 . . . . 3.1600000000000001 113.708 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 35' ' ' GLU . 29.8 t70 -20.05 88.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 114.55 -1.205 . . . . 1.98 113.551 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -101.82 -2.76 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.714 2.276 . . . . 1.53 113.765 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 72' ' ' GLY . 0.6 OUTLIER -114.07 -40.02 3.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.406 0.521 . . . . 2.3599999999999999 112.406 -178.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' N ' HD23 ' A' ' 34' ' ' LEU . 5.6 mm-40 -73.38 71.34 1.27 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 121.036 -0.266 . . . . 4.9500000000000002 111.011 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 76.4 -0.59 63.67 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.252 -0.975 . . . . 2.3300000000000001 111.346 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 41.39 34.2 0.33 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.101 0.477 . . . . 5.8700000000000001 111.119 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 p -149.25 144.39 18.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.754 -0.657 . . . . 3.48 110.62 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.75 -168.85 15.49 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.665 -0.779 . . . . 2.5899999999999999 112.709 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -139.08 174.7 10.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.848 0.356 . . . . 7.3300000000000001 111.229 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.82 115.11 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.822 -0.626 . . . . 2.0099999999999998 111.295 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.9 t -77.22 -33.58 56.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.639 -0.504 . . . . 2.2999999999999998 109.639 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 36.76 54.28 1.13 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.347 -0.842 . . . . 2.23 112.043 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -81.46 98.45 8.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 2.6000000000000001 110.19 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 53.87 23.38 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.592 -0.813 . . . . 2.6600000000000001 111.958 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.446 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -69.1 2.48 2.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.342 0.115 . . . . 2.4300000000000002 111.179 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 10.6 ttmt -45.17 177.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.856 0.36 . . . . 3.79 111.298 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 4.4 mm? 68.46 63.33 0.64 Allowed Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 116.396 -0.365 . . . . 3.23 110.601 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 73.6 Cg_exo -58.25 135.34 67.55 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.018 2.479 . . . . 1.9399999999999999 113.085 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.414 ' N ' HD11 ' A' ' 50' ' ' ILE . 1.1 mp -63.05 120.24 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.183 -0.673 . . . . 1.45 109.183 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -54.3 -55.25 30.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.305 -0.861 . . . . 2.29 112.957 -177.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.42 31.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.81 0.67 . . . . 3.0600000000000001 112.81 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 51' ' ' LEU . 23.0 t -147.07 134.95 21.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 1.4099999999999999 111.707 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -69.51 159.76 82.23 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.358 -0.608 . . . . 1.96 109.358 178.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.445 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.8 Cg_exo -40.87 -39.5 3.24 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.532 2.155 . . . . 0.78000000000000003 115.408 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.51 -56.9 4.07 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.56 0.695 . . . . 1.8200000000000001 111.351 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 18.5 p-10 -69.48 -4.89 20.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.747 -0.781 . . . . 1.9099999999999999 109.057 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.512 ' CD ' ' HB3' ' A' ' 49' ' ' PRO . 14.3 tt0 -73.97 -64.04 1.09 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.281 -0.872 . . . . 2.0600000000000001 108.996 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.11 -35.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 1.8500000000000001 109.322 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 4.5 tp -69.04 -64.98 0.77 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.788 -0.819 . . . . 1.6000000000000001 108.788 176.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -69.55 22.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.673 -1.149 . . . . 1.29 113.177 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.446 ' NE2' ' O ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -143.94 -65.33 0.36 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.158 1.17 . . . . 1.8 114.158 -178.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -39.98 148.03 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.108 0.781 . . . . 1.4099999999999999 113.108 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -134.47 152.11 51.58 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.803 -0.635 . . . . 2.0499999999999998 111.101 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.62 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 35.9 mtp85 -105.16 -169.51 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.773 0.321 . . . . 4.2800000000000002 110.794 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -86.6 -171.47 3.55 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.159 -0.473 . . . . 4.4699999999999998 111.16 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.9 m120 64.53 156.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.283 -0.417 . . . . 5.1500000000000004 110.937 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.49 84.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.175 0.435 . . . . 3.1699999999999999 112.175 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -175.19 125.46 0.25 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.271 -0.171 . . . . 2.3900000000000001 111.182 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.1 t 37.83 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.415 0.447 . . . . 1.3200000000000001 110.963 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.523 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -90.36 104.76 17.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.203 -0.453 . . . . 1.77 109.817 -178.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.567 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -120.06 108.57 1.48 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 119.703 -1.237 . . . . 0.98999999999999999 115.355 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.0 154.7 18.73 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.069 0.461 . . . . 1.1899999999999999 110.817 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.27 134.35 54.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.38 -0.827 . . . . 2.27 110.831 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.523 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -127.94 86.96 56.88 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.514 -0.312 . . . . 1.0700000000000001 111.394 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -55.58 128.35 30.01 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.856 1.704 . . . . 1.26 112.357 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.403 HD11 HG23 ' A' ' 77' ' ' ILE . 63.2 mt -121.98 150.93 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.898 0.38 . . . . 1.0900000000000001 111.154 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.07 -1.42 1.38 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.034 -0.53 . . . . 3.4399999999999999 111.125 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.611 ' HB2' ' HZ3' ' A' ' 174' ' ' LYS . 43.1 mt-10 -125.85 169.38 12.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.783 0.325 . . . . 2.1299999999999999 110.924 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.1 mp0 -120.93 -180.0 4.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.37 111.103 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.67 -148.36 17.2 Favored Glycine 0 CA--C 1.509 -0.322 0 N-CA-C 110.062 -1.215 . . . . 0.23000000000000001 110.062 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.9 mm-40 -104.09 110.97 23.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.577 1.189 . . . . 2.0299999999999998 109.488 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.587 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 4.1 m-85 -95.97 126.79 41.46 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.506 -0.924 . . . . 0.94999999999999996 108.506 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.62 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.8 t -112.24 113.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.449 -0.796 . . . . 1.21 111.342 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -97.79 104.49 16.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.684 -1.144 . . . . 1.79 111.008 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 14.3 t -111.56 142.01 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.755 -1.111 . . . . 1.95 108.77 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -149.67 144.12 25.93 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.33 -0.948 . . . . 2.0 112.105 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.455 ' H ' ' HB2' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -101.72 121.95 43.0 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.082 -0.647 . . . . 3.3799999999999999 110.108 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.34 142.2 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.813 -0.81 . . . . 0.34999999999999998 108.813 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.46 163.29 39.32 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.474 -0.49 . . . . 1.1499999999999999 110.924 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.46 175.19 10.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.924 0.392 . . . . 3.9700000000000002 111.079 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.1 m -150.03 -31.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.999 -0.546 . . . . 4.3099999999999996 111.363 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -102.08 150.87 22.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.839 0.352 . . . . 3.0099999999999998 110.994 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 63.07 104.43 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.884 -0.598 . . . . 2.0 111.034 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.91 67.52 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 1.6599999999999999 110.941 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.412 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 49.9 tp60 -133.2 153.38 51.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.454 . . . . 3.6000000000000001 111.609 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -107.03 164.26 12.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.645 . . . . 1.8899999999999999 110.908 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 68.14 -70.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.998 -0.546 . . . . 2.6899999999999999 111.72 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -46.67 -32.08 3.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.692 0.282 . . . . 3.0299999999999998 111.313 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.685 ' HB3' ' HZ3' ' A' ' 100' ' ' LYS . 9.6 mtpm? -91.4 62.9 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 3.52 110.708 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.31 134.41 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.814 0.34 . . . . 1.95 110.206 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.448 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 78.6 m-85 -131.75 -179.28 5.3 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.565 0.58 . . . . 0.80000000000000004 112.565 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.426 ' OD2' HG21 ' A' ' 110' ' ' THR . 7.9 t70 -126.06 143.94 50.92 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.653 -0.419 . . . . 2.0099999999999998 112.123 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.0 OUTLIER -134.15 137.83 51.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 115.67 -0.695 . . . . 1.1599999999999999 111.824 -178.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.521 HH21 HG23 ' A' ' 158' ' ' VAL . 10.0 mtt180 -136.77 151.88 49.69 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 113.204 0.816 . . . . 2.1800000000000002 113.204 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 30.6 m -114.23 114.67 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 114.949 -1.023 . . . . 1.71 108.839 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.652 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 60.1 27.18 16.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.508 -0.769 . . . . 1.77 109.384 -176.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.22 20.18 39.59 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.605 -1.18 . . . . 0.40999999999999998 112.744 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.3 m-70 -119.42 109.56 15.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.925 0.713 . . . . 0.58999999999999997 112.925 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.426 HG21 ' OD2' ' A' ' 103' ' ' ASP . 31.4 p -56.19 135.82 53.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.219 0.533 . . . . 1.2 111.437 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.5 t -132.94 -29.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.276 -0.875 . . . . 1.3999999999999999 108.913 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.16 90.07 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.21 109.662 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 4.1 ptpp? -108.04 98.38 7.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.014 0.911 . . . . 2.9199999999999999 110.818 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 6.2 m-20 138.72 33.85 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.293 -2.231 . . . . 2.5600000000000001 108.198 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.08 89.47 0.06 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 112.852 0.686 . . . . 1.71 112.852 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.2 t70 -106.35 86.6 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.429 -1.323 . . . . 1.99 107.429 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.3 mt -50.96 -42.22 23.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.275 -0.875 . . . . 1.23 112.55 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -60.2 -49.27 78.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.85 0.315 . . . . 1.01 111.85 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.66 -27.52 65.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.869 0.322 . . . . 0.76000000000000001 111.869 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -64.69 -58.65 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.129 0.418 . . . . 3.0299999999999998 112.129 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.83 -40.53 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.054 0.391 . . . . 2.0299999999999998 112.054 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.76 -100.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 1.0600000000000001 111.793 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -114.69 110.76 20.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.728 0.299 . . . . 4.29 110.6 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.5 t 60.0 -124.84 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.16 -0.473 . . . . 2.1099999999999999 110.755 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.4 p 54.83 -175.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 1.3300000000000001 111.664 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -104.91 138.08 41.69 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.95 0.722 . . . . 1.1200000000000001 112.95 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.448 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.7 t60 -110.24 143.15 40.84 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.255 -1.017 . . . . 0.45000000000000001 108.255 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.448 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 5.2 p-10 -144.34 126.43 15.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.107 0.781 . . . . 2.0899999999999999 113.107 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.8 126.75 55.41 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.743 -0.662 . . . . 2.2799999999999998 109.41 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.37 117.86 54.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.584 -0.735 . . . . 1.3799999999999999 109.766 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.7 mt -127.14 87.78 55.76 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.186 0.81 . . . . 2.0 113.186 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -62.32 146.36 95.79 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.764 1.642 . . . . 0.23999999999999999 111.73 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 134' ' ' SER . 29.8 mt -137.34 157.84 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 1.0600000000000001 110.398 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.45 ' N ' HG22 ' A' ' 133' ' ' ILE . 58.6 p -134.09 109.39 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.059 0.457 . . . . 1.6599999999999999 111.513 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 14.2 mt -108.12 128.16 63.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 115.679 -0.692 . . . . 1.0700000000000001 109.82 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -148.59 142.81 26.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 2.4300000000000002 110.912 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm 60.38 15.73 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 3.5600000000000001 111.334 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.87 16.04 55.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.581 -0.818 . . . . 0.32000000000000001 113.204 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.4 ' HA ' ' H ' ' A' ' 149' ' ' PHE . 96.5 mttt -120.5 158.95 26.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.126 0.463 . . . . 2.6800000000000002 111.057 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.511 HD21 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.44 138.93 48.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.09 0.472 . . . . 1.1100000000000001 112.19 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.511 ' N ' HD21 ' A' ' 140' ' ' LEU . 23.1 t -125.32 114.96 19.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.576 -0.738 . . . . 1.3700000000000001 109.589 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 142' ' ' VAL . 3.4 p -111.93 99.8 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.402 0.62 . . . . 1.23 111.435 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 60.3 -86.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.537 -0.756 . . . . 2.0499999999999998 112.401 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.64 16.03 5.93 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.511 -0.852 . . . . 0.59999999999999998 113.088 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.57 134.27 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.785 0.326 . . . . 2.02 110.416 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.68 137.98 32.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.478 . . . . 1.8700000000000001 111.156 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 m -159.69 119.69 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 1.46 109.419 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.0 t -53.69 146.48 13.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.564 . . . . 1.55 112.042 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.4 ' H ' ' HA ' ' A' ' 139' ' ' LYS . 37.2 t80 -79.63 142.49 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.12 -0.946 . . . . 0.34000000000000002 110.031 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.3 p -139.38 95.94 3.01 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.967 0.728 . . . . 2.02 112.967 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.56 -60.5 2.43 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 115.66 1.024 . . . . 0.77000000000000002 115.66 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.97 164.78 36.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.943 0.872 . . . . 2.3199999999999998 112.553 -178.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.458 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -82.16 134.85 35.33 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.119 -1.437 . . . . 1.8600000000000001 107.119 177.084 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.652 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -121.78 103.92 9.21 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.502 1.297 . . . . 1.72 114.502 -174.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.437 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -93.53 126.32 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.96 -0.385 . . . . 1.27 109.96 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 42.0 mt-10 -137.41 127.43 25.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.112 0.412 . . . . 2.48 112.112 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.93 120.08 41.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.408 -0.96 . . . . 1.9199999999999999 108.408 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.521 HG23 HH21 ' A' ' 105' ' ' ARG . 9.7 t -91.09 143.6 10.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.324 0.583 . . . . 1.3899999999999999 111.532 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -57.31 147.96 24.19 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 114.728 -1.124 . . . . 2.48 111.501 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.21 -7.53 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.79 -0.641 . . . . 1.1200000000000001 111.918 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -151.59 -70.28 0.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.573 0.225 . . . . 3.8999999999999999 110.533 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -176.19 -64.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.362 -0.381 . . . . 4.0999999999999996 110.566 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.75 76.59 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 1.3999999999999999 110.89 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.425 ' HA ' ' CE1' ' A' ' 102' ' ' PHE . 5.8 m-20 -48.35 156.0 0.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.266 -0.879 . . . . 2.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.448 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.71 101.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.457 2.105 . . . . 3.1099999999999999 112.395 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -60.14 -45.57 92.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.623 -0.717 . . . . 4.1100000000000003 112.283 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.24 133.63 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 120.337 -0.545 . . . . 1.5900000000000001 111.841 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.8 t -131.92 136.78 47.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 115.945 -0.571 . . . . 1.8600000000000001 111.449 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 88' ' ' LYS . . . -127.55 35.67 4.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.382 0.882 . . . . 1.04 113.382 -178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.12 130.92 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.205 0.316 . . . . 1.6799999999999999 110.902 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 1.1 t80 -150.84 101.97 2.95 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.38 110.864 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.479 HG21 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -111.63 129.69 66.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.66 0 CA-C-O 122.815 1.293 . . . . 1.3500000000000001 112.854 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.538 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -123.24 168.19 12.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.546 -1.661 . . . . 1.26 109.965 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.656 ' HZ2' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -118.98 152.41 36.43 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.715 1.746 . . . . 2.3599999999999999 115.715 -176.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 88.17 -34.68 3.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 111.82 -2.446 . . . . 0.23000000000000001 118.193 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.549 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.63 158.98 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.209 2.004 . . . . 1.1000000000000001 114.252 -179.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.62 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.75 -10.31 55.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.376 -0.829 . . . . 1.1000000000000001 110.712 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.65 -43.35 84.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 2.3100000000000001 111.28 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.66 -43.04 97.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.343 -0.39 . . . . 2.3700000000000001 110.535 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.8 t -47.09 103.0 0.33 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.069 -0.514 . . . . 3.0800000000000001 111.031 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.05 146.3 17.59 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.029 1.819 . . . . 2.4500000000000002 112.527 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.6 ttt -130.89 103.76 6.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.058 -0.519 . . . . 6.3700000000000001 110.721 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 183' ' ' LEU . 6.8 mp -110.52 111.08 22.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 5.3499999999999996 110.627 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -61.95 145.27 93.02 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.096 -0.502 . . . . 8.5099999999999998 110.614 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -43.96 128.8 7.42 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.931 1.754 . . . . 9.6899999999999995 112.62 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.659 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 80.6 t60 -118.96 143.25 33.43 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.286 -0.416 . . . . 10.35 110.4 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.659 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 71.7 Cg_endo -68.95 -94.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.826 1.684 . . . . 12.26 112.034 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.67 23.91 34.72 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.004 -0.617 . . . . 12.619999999999999 112.388 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.499 HD11 ' N ' ' A' ' 189' ' ' LEU . 7.6 mp -100.88 140.36 35.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.728 0.299 . . . . 14.65 110.72 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.314 -0.85 . . . . 15.699999999999999 110.778 179.894 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 112.483 -0.247 . . . . 9.3900000000000006 112.483 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.29 -61.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.733 0.302 . . . . 7.6799999999999997 110.823 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.4 mmt 57.63 88.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 8.1699999999999999 110.94 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.1 m -134.82 119.23 17.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 4.25 111.114 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.71 55.35 0.91 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.854 -0.688 . . . . 1.8200000000000001 112.535 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 tp -66.49 -44.3 82.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.266 0.555 . . . . 1.1299999999999999 110.531 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.532 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -58.25 -21.11 47.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.373 -0.831 . . . . 1.1299999999999999 111.347 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.51 -16.29 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 2.0899999999999999 111.703 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -109.48 -26.15 10.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.661 -0.416 . . . . 2.5 111.657 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -42.5 145.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.69 0.256 . . . . 1.05 111.69 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.1 pt -140.14 -18.34 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 119.979 -0.689 . . . . 1.48 111.355 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.431 ' O ' HG22 ' A' ' 172' ' ' ILE . 32.2 t90 -173.0 136.67 0.67 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.803 -0.359 . . . . 0.33000000000000002 110.361 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.82 142.37 12.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.513 0.56 . . . . 1.05 112.513 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 15' ' ' ASN . 62.0 t -147.64 134.5 13.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 N-CA-C 114.32 1.23 . . . . 1.3600000000000001 114.32 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 26.6 t-20 -115.66 94.76 4.83 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.607 -0.437 . . . . 1.8700000000000001 110.537 175.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.25 105.46 1.42 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.765 -0.828 . . . . 1.1100000000000001 108.765 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.534 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 155.8 -40.99 0.59 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.115 -0.948 . . . . 0.67000000000000004 113.33 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -135.16 7.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.581 -0.819 . . . . 1.1200000000000001 113.203 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -160.95 119.52 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.537 0.208 . . . . 2.02 110.683 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 70.3 m 34.8 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.697 -0.683 . . . . 1.6499999999999999 112.536 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 67.9 t60 -116.57 151.89 35.26 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.254 0.549 . . . . 0.41999999999999998 112.237 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.27 103.22 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.17 -0.923 . . . . 1.8200000000000001 109.566 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 1.1699999999999999 110.227 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -43.67 -48.07 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 124.251 0.969 . . . . 1.27 113.267 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -59.26 -23.21 62.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.179 0.514 . . . . 0.55000000000000004 110.506 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.3 34.41 2.72 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.423 -0.808 . . . . 0.32000000000000001 112.377 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 27' ' ' ILE . 36.8 mm -103.15 125.34 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.188 -0.671 . . . . 1.21 109.188 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.7 t60 -110.45 131.4 55.09 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.721 1.378 . . . . 0.68999999999999995 114.721 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.636 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.22 134.4 40.58 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.3 -1.0 . . . . 3.3199999999999998 108.3 176.174 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -95.25 105.4 17.34 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.377 0.608 . . . . 3.3999999999999999 112.34 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 32' ' ' ASP . 31.2 ttpt -19.57 135.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.118 1.367 . . . . 3.1600000000000001 114.682 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' LYS . 1.2 m-20 -2.12 85.16 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.783 -1.099 . . . . 1.98 113.329 177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -102.87 -7.37 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.854 2.369 . . . . 1.53 115.911 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -117.52 -25.78 6.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.489 0.922 . . . . 2.3599999999999999 113.489 -177.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HG3' ' CZ ' ' A' ' 65' ' ' ARG . 1.5 pm0 -84.63 65.42 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.065 0.393 . . . . 4.9500000000000002 110.064 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 82.62 0.22 89.85 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.047 -1.073 . . . . 2.3300000000000001 110.812 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 41.51 70.43 0.27 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.421 0.629 . . . . 5.8700000000000001 111.247 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 36' ' ' GLY . 16.9 m -144.58 177.78 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.164 -0.926 . . . . 3.48 110.266 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.86 -151.54 0.04 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.77 -0.729 . . . . 2.5899999999999999 113.058 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 68.62 146.71 0.05 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.194 0.521 . . . . 7.3300000000000001 111.733 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.53 -20.65 1.35 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.58 -0.736 . . . . 2.0099999999999998 110.199 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.1 m 49.05 66.61 1.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.171 0.51 . . . . 2.2999999999999998 110.993 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -88.05 44.89 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.535 -0.757 . . . . 2.23 110.67 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -58.24 -60.61 3.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.322 -0.399 . . . . 2.6000000000000001 110.469 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.96 46.82 3.7 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 2.6600000000000001 111.713 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 13.8 ttt -60.36 -17.12 41.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.723 0.297 . . . . 2.4300000000000002 111.108 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -71.26 -174.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 3.79 110.651 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 17.1 tp 62.3 60.25 2.5 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.265 -0.425 . . . . 3.23 111.117 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 31.6 Cg_exo -64.24 130.49 27.23 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.184 1.923 . . . . 1.9399999999999999 112.068 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.1 143.13 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.912 0.387 . . . . 1.45 110.474 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 51' ' ' LEU . 2.9 mm? -94.42 -47.93 6.36 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.271 0.841 . . . . 2.29 113.271 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -73.44 34.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.232 0.827 . . . . 3.0600000000000001 113.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -150.05 163.34 38.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.19 0.519 . . . . 1.4099999999999999 112.105 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.1 t30 -78.26 148.4 74.31 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.452 -0.794 . . . . 1.96 109.372 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.572 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.83 -57.88 1.18 Allowed 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.383 2.055 . . . . 0.78000000000000003 114.424 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 13.4 mm-40 -58.77 -56.85 16.95 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.191 0.996 . . . . 1.8200000000000001 111.016 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' OD1' HD23 ' A' ' 60' ' ' LEU . 25.7 t70 -69.19 -10.38 57.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.512 -0.767 . . . . 1.9099999999999999 110.171 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.9 tt0 -63.17 -46.43 87.17 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.146 -1.798 . . . . 2.0600000000000001 106.146 176.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.26 -50.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.411 -1.268 . . . . 1.8500000000000001 109.053 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.538 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.8 tp -68.88 -9.68 52.89 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.451 -0.795 . . . . 1.6000000000000001 111.52 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 5.7 m-30 -122.34 17.94 10.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.868 -0.606 . . . . 1.29 111.204 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 49' ' ' PRO . 37.6 tt0 -140.46 -71.95 0.37 Allowed 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.714 1.005 . . . . 1.8 113.714 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 7.4 p -27.18 140.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.606 0.965 . . . . 1.4099999999999999 113.606 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.534 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -130.74 149.97 52.14 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.885 -0.598 . . . . 2.0499999999999998 110.916 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.59 HH12 ' HB2' ' A' ' 67' ' ' ASN . 3.7 ptm180 -136.86 138.66 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.835 0.35 . . . . 4.2800000000000002 110.359 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -78.15 142.92 37.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.048 -0.524 . . . . 4.4699999999999998 111.407 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.59 ' HB2' HH12 ' A' ' 65' ' ' ARG . 5.2 t30 -134.06 -89.88 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.246 -0.434 . . . . 5.1500000000000004 110.941 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.434 ' N ' HD21 ' A' ' 67' ' ' ASN . 41.4 tt0 -175.14 -95.84 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.339 0.126 . . . . 3.1699999999999999 111.339 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -156.27 151.44 26.49 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.483 -0.191 . . . . 2.3900000000000001 110.483 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t 48.06 81.53 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.783 0.325 . . . . 1.3200000000000001 110.132 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.427 ' HZ ' ' C ' ' A' ' 164' ' ' ASN . 2.8 p90 -136.77 152.44 50.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 1.77 110.754 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -163.09 -155.26 8.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.037 -1.078 . . . . 0.98999999999999999 114.36 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -135.78 154.81 51.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.726 0.639 . . . . 1.1899999999999999 112.726 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -118.49 106.48 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.664 -1.153 . . . . 2.27 110.223 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.35 110.68 64.63 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.909 0.337 . . . . 1.0700000000000001 111.909 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.01 133.81 10.23 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.502 1.468 . . . . 1.26 111.816 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 61.2 mt -120.75 148.83 23.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.43 . . . . 1.0900000000000001 111.496 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -139.75 -3.52 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.803 -0.635 . . . . 3.4399999999999999 110.84 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -121.77 173.93 7.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.582 0.23 . . . . 2.1299999999999999 110.583 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.77 177.31 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.37 111.545 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.18 -161.17 23.1 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.144 -1.582 . . . . 0.23000000000000001 109.144 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 0.1 OUTLIER -95.0 110.68 22.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 118.743 1.272 . . . . 2.0299999999999998 109.913 179.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.27 125.79 40.15 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.94999999999999996 109.577 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.583 HG23 ' C ' ' A' ' 176' ' ' THR . 10.2 t -113.07 116.87 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.477 -1.238 . . . . 1.21 111.939 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.89 104.57 16.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.668 -1.151 . . . . 1.79 110.778 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 58.8 t -103.22 119.39 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.124 -0.944 . . . . 1.95 108.897 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.9 134.22 42.41 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.282 -0.567 . . . . 2.0 111.186 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.614 ' HZ3' ' HB3' ' A' ' 128' ' ' ASP . 19.4 tptt -104.52 120.74 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.755 -0.778 . . . . 3.3799999999999999 109.732 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 8.1 m-85 -104.77 139.23 39.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.922 -1.14 . . . . 0.34999999999999998 107.922 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 91' ' ' GLU . . . -147.44 171.72 15.06 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.98 -0.688 . . . . 1.1499999999999999 112.534 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 10.0 tp10 81.12 138.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.832 -1.076 . . . . 3.9700000000000002 111.869 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.72 90.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.168 -0.924 . . . . 4.3099999999999996 110.376 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -52.48 -60.79 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 3.0099999999999998 111.706 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.439 ' HB2' ' HZ3' ' A' ' 100' ' ' LYS . 10.3 m-85 -102.81 142.83 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.392 -0.367 . . . . 2.0 110.812 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.98 81.29 8.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 1.6599999999999999 111.515 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -156.06 159.3 38.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 3.6000000000000001 110.907 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.6 p -97.27 -76.45 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.974 -0.557 . . . . 1.8899999999999999 111.781 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -78.13 64.11 3.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.04 0.447 . . . . 2.6899999999999999 111.57 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -145.66 -48.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.181 -0.674 . . . . 3.0299999999999998 109.181 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.439 ' HZ3' ' HB2' ' A' ' 94' ' ' PHE . 2.9 ptpp? -105.49 78.66 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.429 -0.805 . . . . 3.52 109.33 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.0 113.51 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.332 -0.849 . . . . 1.95 110.196 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -102.47 175.82 5.38 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.038 0.755 . . . . 0.80000000000000004 113.038 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -122.1 140.12 52.91 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.694 -0.685 . . . . 2.0099999999999998 111.09 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.12 123.76 44.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 115.996 -0.547 . . . . 1.1599999999999999 111.768 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.551 HH21 HG22 ' A' ' 158' ' ' VAL . 12.3 mtt180 -117.66 150.47 38.99 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 115.008 -0.996 . . . . 2.1800000000000002 112.401 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 84.4 t -126.2 109.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 114.652 -1.158 . . . . 1.71 109.392 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.426 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 57.02 25.99 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.432 -0.951 . . . . 1.77 108.432 -176.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.55 53.77 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.097 -0.956 . . . . 0.40999999999999998 112.674 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.434 ' CG ' HG13 ' A' ' 142' ' ' VAL . 92.1 m-70 -112.25 111.14 21.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.81 . . . . 0.58999999999999997 113.188 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -68.94 112.16 5.42 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 120.395 -0.522 . . . . 1.2 110.584 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.88 -28.71 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.594 -0.73 . . . . 1.3999999999999999 109.849 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.404 HG21 ' OE1' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -135.02 90.2 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 120.281 -0.568 . . . . 1.21 109.582 177.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.4 ptpp? -110.71 85.08 2.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.935 0.874 . . . . 2.9199999999999999 111.491 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.6 p-10 151.47 36.66 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 112.982 -1.917 . . . . 2.5600000000000001 108.325 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.62 90.15 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.327 0.862 . . . . 1.71 113.327 -177.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.77 83.91 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.351 -1.352 . . . . 1.99 107.351 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -50.44 -30.58 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.084 -0.507 . . . . 1.23 111.793 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -68.38 -43.76 76.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 1.01 111.237 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -69.54 -27.56 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.76000000000000001 111.867 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' NE2' ' A' ' 127' ' ' HIS . 29.7 mmt180 -71.88 -58.45 3.45 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.384 0.513 . . . . 3.0299999999999998 112.384 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.94 -40.66 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.217 0.451 . . . . 2.0299999999999998 112.217 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.53 -92.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.732 -0.747 . . . . 1.0600000000000001 111.784 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.457 ' O ' HG23 ' A' ' 125' ' ' THR . 45.4 t-80 -114.55 110.02 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 4.29 111.056 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.1 t 51.45 -128.23 2.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.083 -0.508 . . . . 2.1099999999999999 111.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 123' ' ' HIS . 26.7 p 58.08 -165.14 0.17 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.592 0.357 . . . . 1.3300000000000001 111.193 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.53 139.18 43.66 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.255 0.835 . . . . 1.1200000000000001 113.255 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.511 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 2.0 t60 -109.07 148.24 31.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.99 -0.744 . . . . 0.45000000000000001 108.99 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.614 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . 4.8 p-10 -143.81 127.12 16.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.674 0.62 . . . . 2.0899999999999999 112.674 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.404 ' OE1' HG21 ' A' ' 112' ' ' VAL . 24.4 mt-10 -120.65 115.67 23.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 2.2799999999999998 109.465 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.1 mt -105.58 126.85 60.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.516 -0.766 . . . . 1.3799999999999999 110.261 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.3 mm -126.12 86.45 57.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.218 0.451 . . . . 2.0 112.218 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -62.48 139.95 79.25 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.875 1.717 . . . . 0.23999999999999999 111.426 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 134' ' ' SER . 18.8 mt -132.86 155.07 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 1.0600000000000001 111.042 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.453 ' N ' HG21 ' A' ' 133' ' ' ILE . 23.8 p -126.21 107.9 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.942 0.401 . . . . 1.6599999999999999 110.859 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 25.6 mt -111.37 122.75 66.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.801 -0.636 . . . . 1.0700000000000001 109.881 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -147.38 143.16 27.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.37 -0.377 . . . . 2.4300000000000002 110.817 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt 62.92 7.81 2.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.098 -0.501 . . . . 3.5600000000000001 110.856 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.2 21.24 25.57 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.83 -0.7 . . . . 0.32000000000000001 112.933 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.641 ' HZ1' ' HB3' ' A' ' 139' ' ' LYS . 8.2 mtpm? -121.03 156.09 32.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.896 0.348 . . . . 2.6800000000000002 110.859 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -114.31 131.95 56.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.112 0.482 . . . . 1.1100000000000001 112.121 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.512 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.1 t -122.92 109.65 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 1.3700000000000001 109.642 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.434 HG13 ' CG ' ' A' ' 109' ' ' HIS . 7.5 p -102.35 108.06 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.198 0.523 . . . . 1.23 111.148 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 53.77 -91.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.765 -0.652 . . . . 2.0499999999999998 112.034 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.33 38.79 2.21 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.59999999999999998 113.516 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -146.61 137.11 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 2.02 110.297 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.3 135.7 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 1.8700000000000001 110.875 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -163.19 121.04 1.94 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.154 -0.684 . . . . 1.46 109.154 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.05 150.11 3.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.981 0.42 . . . . 1.55 111.328 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 t80 -77.55 122.85 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.34000000000000002 110.764 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -75.81 -170.8 1.42 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.955 -1.128 . . . . 2.02 107.955 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.56 -11.92 66.07 Favored Glycine 0 C--N 1.317 -0.503 0 C-N-CA 119.015 -1.564 . . . . 0.77000000000000002 112.93 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.551 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -160.82 151.8 18.72 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.168 0.484 . . . . 2.3199999999999998 112.105 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.626 HD21 ' N ' ' A' ' 154' ' ' SER . 3.5 tt -84.93 148.51 26.19 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.936 -1.135 . . . . 1.8600000000000001 107.936 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 153' ' ' LEU . 3.7 t -139.15 115.86 10.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 118.256 -1.378 . . . . 1.72 113.634 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 7.9 t -98.47 97.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.942 -0.762 . . . . 1.27 108.942 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 34.7 mt-10 -108.82 132.35 54.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.718 -0.674 . . . . 2.48 111.727 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.95 129.83 51.6 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.481 0.658 . . . . 1.9199999999999999 109.929 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.551 HG22 HH21 ' A' ' 105' ' ' ARG . 30.8 t -103.0 143.88 14.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.495 -1.23 . . . . 1.3899999999999999 111.678 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -50.88 148.14 4.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 114.988 -1.005 . . . . 2.48 111.445 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -118.99 -10.66 8.08 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.437 -0.665 . . . . 1.1200000000000001 111.437 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -163.64 -59.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.555 -0.322 . . . . 3.8999999999999999 110.344 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -176.84 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.061 -0.518 . . . . 4.0999999999999996 110.879 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -90.92 46.12 1.3 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.026 0.441 . . . . 1.3999999999999999 111.782 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.71 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 54.9 t30 -55.2 -42.07 93.98 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 115.46 -0.791 . . . . 2.0 109.048 176.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.71 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 36.9 Cg_endo -62.9 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.786 2.324 . . . . 3.1099999999999999 111.843 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 11.0 pttp -97.8 166.01 11.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.063 -0.717 . . . . 4.1100000000000003 109.063 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 62' ' ' GLN . 54.3 t -62.83 132.95 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 C-N-CA 119.533 -0.867 . . . . 1.5900000000000001 110.308 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -130.24 131.6 45.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.671 0.607 . . . . 1.8600000000000001 111.586 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -123.95 37.05 4.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 1.04 112.126 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -33.26 134.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.693 -0.685 . . . . 1.6799999999999999 110.404 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -159.56 95.81 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.533 -0.303 . . . . 0.38 110.813 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.458 ' C ' HD12 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -106.25 130.16 58.37 Favored 'Isoleucine or valine' 0 C--O 1.258 1.526 0 CA-C-O 122.96 1.362 . . . . 1.3500000000000001 112.719 178.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.573 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 ppp? -123.64 157.26 34.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.028 -1.896 . . . . 1.26 108.135 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.9 150.04 39.12 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.138 1.532 . . . . 2.3599999999999999 115.138 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.21 -33.91 6.2 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 112.448 -2.16 . . . . 0.23000000000000001 116.846 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.583 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 156.79 0.44 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.841 1.82 . . . . 1.1000000000000001 114.601 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.572 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.68 -23.37 25.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.161 -0.927 . . . . 1.1000000000000001 110.569 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.17 -37.71 86.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.864 -0.607 . . . . 2.3100000000000001 111.508 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.41 -40.66 71.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.438 -0.346 . . . . 2.3700000000000001 110.736 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 86.0 t -43.42 101.68 0.26 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.198 -0.455 . . . . 3.0800000000000001 111.189 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.61 144.68 24.8 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 121.904 1.736 . . . . 2.4500000000000002 112.411 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 mmt -136.8 93.75 2.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 6.3700000000000001 110.831 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.4 mt -136.81 116.09 12.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 5.3499999999999996 110.755 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -56.96 151.54 33.07 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.097 -0.502 . . . . 8.5099999999999998 110.314 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -64.89 124.6 13.35 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.593 1.529 . . . . 9.6899999999999995 112.069 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.402 ' HD1' ' N ' ' A' ' 187' ' ' PRO . 5.4 t-80 -132.55 128.73 21.13 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.07 -0.514 . . . . 10.35 110.492 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.402 ' N ' ' HD1' ' A' ' 186' ' ' HIS . 11.1 Cg_endo -83.39 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.197 1.932 . . . . 12.26 111.409 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 176.98 158.25 19.87 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.272 -0.966 . . . . 12.619999999999999 112.688 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.49 ' N ' HD21 ' A' ' 189' ' ' LEU . 3.3 mm? -92.35 148.69 21.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 14.65 110.669 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.179 -0.915 . . . . 15.699999999999999 110.785 179.83 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.496 -0.242 . . . . 9.3900000000000006 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.2 14.11 12.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.824 0.345 . . . . 7.6799999999999997 110.777 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtt -61.79 -59.49 5.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 8.1699999999999999 110.857 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.2 m 56.21 87.86 0.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.262 -0.427 . . . . 4.25 111.066 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.21 49.63 0.72 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.795 -0.716 . . . . 1.8200000000000001 112.588 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp -68.66 -48.5 63.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.517 . . . . 1.1299999999999999 110.259 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.71 -21.24 6.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.405 -0.816 . . . . 1.1299999999999999 111.314 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -79.29 -21.77 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 2.0899999999999999 112.121 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 34.9 mmtt -98.43 -26.52 14.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.937 -0.305 . . . . 2.5 111.475 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.9 p -44.47 146.82 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 111.961 0.356 . . . . 1.05 111.961 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.2 pt -139.48 -21.73 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.724 . . . . 1.48 111.103 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.524 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.9 t90 -173.7 133.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.55 -0.46 . . . . 0.33000000000000002 110.14 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -150.6 144.26 25.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.809 0.3 . . . . 1.05 111.809 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.2 t -147.63 126.66 4.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.495 1.295 . . . . 1.3600000000000001 114.495 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 11.5 t30 -114.6 100.86 8.59 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.533 -0.467 . . . . 1.8700000000000001 110.31 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.51 103.47 2.98 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 109.021 -0.733 . . . . 1.1100000000000001 109.021 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.57 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 167.9 -45.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.916 0 O-C-N 124.277 0.986 . . . . 0.67000000000000004 113.563 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.77 -123.6 3.48 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.586 -0.816 . . . . 1.1200000000000001 113.124 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.044 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 6.4 tt0 -164.1 120.3 1.62 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.871 0.367 . . . . 2.02 111.489 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.4 m 35.53 99.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.16 -0.927 . . . . 1.6499999999999999 113.231 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 56.3 t60 -130.65 140.16 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.729 -0.788 . . . . 0.41999999999999998 112.462 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 22' ' ' VAL . 4.4 p -114.64 103.91 16.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.637 0.732 . . . . 1.8200000000000001 110.787 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 156.3 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.036 -0.984 . . . . 1.1699999999999999 110.056 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.9 m -44.01 -49.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.175 0.922 . . . . 1.27 113.136 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -59.53 -18.17 38.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.294 0.569 . . . . 0.55000000000000004 110.567 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.72 35.2 3.84 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.34 -0.845 . . . . 0.32000000000000001 112.444 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.44 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 31.1 mm -103.88 111.95 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.026 0.441 . . . . 1.21 110.578 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 10.9 t60 -98.27 135.55 39.73 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.891 1.441 . . . . 0.68999999999999995 114.891 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.044 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -100.47 135.46 41.87 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.864 -1.062 . . . . 3.3199999999999998 108.619 177.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -88.04 111.42 21.51 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 124.001 0.813 . . . . 3.3999999999999999 112.252 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.663 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 5.3 ttpm? -23.44 135.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.349 1.06 . . . . 3.1600000000000001 113.723 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.641 ' HB3' HH11 ' A' ' 65' ' ' ARG . 2.5 m-20 -10.15 83.84 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 CA-C-N 114.2 -1.364 . . . . 1.98 113.708 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -103.71 15.01 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.166 2.577 . . . . 1.53 113.582 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.617 HD21 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -130.15 -38.21 1.42 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.041 0.386 . . . . 2.3599999999999999 112.041 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.617 ' N ' HD21 ' A' ' 34' ' ' LEU . 8.2 tp10 -87.39 92.37 9.06 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.675 -0.491 . . . . 4.9500000000000002 109.675 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.53 -1.42 51.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.494 -0.86 . . . . 2.3300000000000001 111.104 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.428 ' N ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER 41.68 49.45 3.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.208 0.528 . . . . 5.8700000000000001 110.992 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 m -144.29 176.08 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.629 -0.714 . . . . 3.48 110.229 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.67 118.79 5.55 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.571 -0.823 . . . . 2.5899999999999999 113.188 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -149.11 -50.23 0.15 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.515 0.198 . . . . 7.3300000000000001 110.844 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 72.08 -67.4 0.26 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.895 -0.593 . . . . 2.0099999999999998 111.545 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.3 t 62.32 56.82 2.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.95 0.405 . . . . 2.2999999999999998 110.744 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -78.93 74.39 5.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.004 -0.543 . . . . 2.23 110.534 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -66.01 85.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.02 -0.536 . . . . 2.6000000000000001 110.841 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.2 114.36 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.723 -0.751 . . . . 2.6600000000000001 112.813 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 30.9 mtt -82.54 -0.31 46.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.316 0.579 . . . . 2.4300000000000002 109.478 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -56.28 176.7 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.004 -0.998 . . . . 3.79 111.158 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.569 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 3.8 mm? 54.1 56.32 12.62 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.334 -0.393 . . . . 3.23 110.067 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 38.9 Cg_exo -66.31 134.49 36.4 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.806 2.337 . . . . 1.9399999999999999 112.868 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.24 128.15 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.347 -0.612 . . . . 1.45 109.347 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 53' ' ' SER . 4.2 mt -69.87 -49.19 54.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.911 1.449 . . . . 2.29 114.911 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -73.87 25.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.85 0.685 . . . . 3.0600000000000001 112.85 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 51' ' ' LEU . 8.5 t -146.19 144.57 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 1.4099999999999999 111.487 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 58' ' ' GLN . 1.8 p-10 -66.44 153.53 92.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.065 -0.516 . . . . 1.96 109.787 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HB2' ' OE2' ' A' ' 56' ' ' GLU . 14.6 Cg_exo -40.57 -59.14 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.47 2.113 . . . . 0.78000000000000003 114.626 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' OE2' ' HB2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -58.35 -55.43 35.13 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 121.901 0.858 . . . . 1.8200000000000001 111.246 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 11.2 t70 -69.38 -11.98 61.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.325 -0.55 . . . . 1.9099999999999999 110.439 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.671 HE22 HE21 ' A' ' 62' ' ' GLN . 0.9 OUTLIER -68.38 -39.83 81.59 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 106.523 -1.658 . . . . 2.0600000000000001 106.523 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' N ' ' HG3' ' A' ' 58' ' ' GLN . 62.4 t -54.37 -50.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.138 -1.06 . . . . 1.8500000000000001 108.138 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.8 tp -69.81 -13.76 62.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.907 -1.042 . . . . 1.6000000000000001 111.1 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.594 ' C ' ' HZ2' ' A' ' 88' ' ' LYS . 2.6 m-85 -121.89 27.71 7.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.182 -0.917 . . . . 1.29 111.679 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.671 HE21 HE22 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -151.46 -63.36 0.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.261 0.837 . . . . 1.8 113.261 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.53 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 13.7 p -34.13 147.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.815 0.672 . . . . 1.4099999999999999 112.815 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.557 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pp20? -137.52 148.05 45.68 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.691 0.626 . . . . 2.0499999999999998 112.691 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.641 HH11 ' HB3' ' A' ' 32' ' ' ASP . 19.3 mtp180 -114.27 -174.95 2.57 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.98 -0.554 . . . . 4.2800000000000002 109.858 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -66.32 172.0 4.33 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.531 -0.304 . . . . 4.4699999999999998 110.455 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -143.57 162.22 36.44 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.021 0.438 . . . . 5.1500000000000004 111.653 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -144.79 -118.16 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.876 -0.602 . . . . 3.1699999999999999 110.685 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.46 ' OD1' ' HD3' ' A' ' 159' ' ' LYS . 63.6 m-20 -156.62 134.4 10.97 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.44 -0.162 . . . . 2.3900000000000001 111.093 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 53.84 83.53 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.92 0.391 . . . . 1.3200000000000001 110.764 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -162.59 159.6 24.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 1.77 110.826 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.438 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -168.93 -168.15 30.56 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.437 -0.887 . . . . 0.98999999999999999 113.418 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.421 ' CD2' HD12 ' A' ' 34' ' ' LEU . 3.8 m-85 -108.36 165.12 11.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.294 0.569 . . . . 1.1899999999999999 111.763 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.03 140.53 49.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.91 -1.041 . . . . 2.27 110.825 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 75' ' ' ILE . 4.0 mp -135.27 109.87 10.56 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.142 -0.481 . . . . 1.0700000000000001 111.171 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.87 133.17 7.83 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.129 1.219 . . . . 1.26 112.045 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 78' ' ' LYS . 23.4 mt -121.32 155.2 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.985 0.421 . . . . 1.0900000000000001 111.577 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' HG23 ' A' ' 77' ' ' ILE . 99.5 mttt -143.19 -0.87 1.09 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.825 -0.625 . . . . 3.4399999999999999 110.995 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.702 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 23.3 mm-40 -127.46 169.03 14.08 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.826 0.345 . . . . 2.1299999999999999 111.562 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -117.48 -177.61 3.27 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.37 111.047 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.78 -151.04 18.05 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.997 -1.241 . . . . 0.23000000000000001 109.997 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 21.2 mt-10 -105.15 108.72 20.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.644 1.222 . . . . 2.0299999999999998 109.71 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.702 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.2 m-85 -95.34 129.68 42.39 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 119.719 -0.792 . . . . 0.94999999999999996 109.156 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 177' ' ' ALA . 22.0 t -116.92 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.686 -1.143 . . . . 1.21 111.806 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.94 105.7 17.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.726 -0.67 . . . . 1.79 110.126 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 38.1 t -101.4 119.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 107.945 -1.131 . . . . 1.95 107.945 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 135.92 23.83 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.671 -0.812 . . . . 2.0 112.437 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.786 ' HZ1' ' HB3' ' A' ' 90' ' ' ALA . 5.9 tmtt? -103.15 132.1 49.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.65 -0.82 . . . . 3.3799999999999999 109.952 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -111.44 149.32 31.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.609 -0.723 . . . . 0.34999999999999998 109.547 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.786 ' HB3' ' HZ1' ' A' ' 88' ' ' LYS . . . -145.56 157.4 43.99 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.073 0.464 . . . . 1.1499999999999999 111.323 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -144.97 131.31 19.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.621 -0.718 . . . . 3.9700000000000002 110.129 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.48 -65.2 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.434 . . . . 4.3099999999999996 111.653 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -92.61 -164.25 1.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 3.0099999999999998 110.987 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 63.0 64.71 0.84 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.929 -0.578 . . . . 2.0 110.723 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.52 79.51 8.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 1.6599999999999999 110.915 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -157.13 140.51 15.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 3.6000000000000001 111.153 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -103.8 157.15 17.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.951 -0.568 . . . . 1.8899999999999999 111.235 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 45.25 49.46 10.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.8 -0.636 . . . . 2.6899999999999999 111.647 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -153.47 -46.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.899 -0.778 . . . . 3.0299999999999998 108.899 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -96.89 82.04 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.271 -1.011 . . . . 3.52 108.271 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.434 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.7 OUTLIER -108.87 134.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 1.95 111.227 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -117.89 175.59 5.59 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.576 0.584 . . . . 0.80000000000000004 112.576 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.87 140.06 53.35 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 115.928 -0.578 . . . . 2.0099999999999998 111.459 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.06 131.65 41.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.075 -0.512 . . . . 1.1599999999999999 111.854 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.4 154.8 49.44 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.265 0.839 . . . . 2.1800000000000002 113.265 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 p -121.51 125.24 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.193 -1.367 . . . . 1.71 110.474 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.14 26.1 3.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.663 -0.866 . . . . 1.77 108.663 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.8 27.45 21.7 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 112.976 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 87.1 m-70 -127.35 110.5 12.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.164 0.801 . . . . 0.58999999999999997 113.164 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.0 p -67.24 115.56 7.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.245 0.545 . . . . 1.2 111.723 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.58 -34.71 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.215 -0.902 . . . . 1.3999999999999999 109.369 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.07 89.62 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.995 -0.548 . . . . 1.21 109.548 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.0 ptpp? -110.08 83.39 1.75 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.096 0.951 . . . . 2.9199999999999999 110.759 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 156.82 33.58 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 112.824 -1.989 . . . . 2.5600000000000001 108.557 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 85.92 0.08 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.595 0.591 . . . . 1.71 112.595 -177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 0.6 OUTLIER -98.47 80.42 2.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.714 -1.587 . . . . 1.99 106.714 175.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.7 mt -49.88 -38.48 14.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.516 -0.765 . . . . 1.23 112.291 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.28 -46.69 85.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.462 0.171 . . . . 1.01 111.462 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.407 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 37.1 t70 -70.33 -27.97 64.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.76000000000000001 111.514 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.519 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -61.33 -58.09 9.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.865 0.321 . . . . 3.0299999999999998 111.865 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.13 -40.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.033 0.383 . . . . 2.0299999999999998 112.033 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.93 -87.45 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.912 -0.661 . . . . 1.0600000000000001 112.487 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.478 ' O ' HG22 ' A' ' 125' ' ' THR . 48.6 m80 -112.87 110.46 20.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.641 0.257 . . . . 4.29 111.081 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.9 p 46.79 -116.85 0.72 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.019 -0.537 . . . . 2.1099999999999999 111.769 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 123' ' ' HIS . 41.8 p 50.91 -166.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.209 0.203 . . . . 1.3300000000000001 110.7 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.27 139.09 49.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.087 0.773 . . . . 1.1200000000000001 113.087 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.424 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.8 t60 -105.35 145.08 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.856 -1.164 . . . . 0.45000000000000001 107.856 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.424 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 17.8 t70 -143.75 126.94 16.58 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.056 -0.658 . . . . 2.0899999999999999 112.761 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -117.11 127.84 54.54 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.247 -0.888 . . . . 2.2799999999999998 110.096 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.1 mt -116.43 121.79 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.431 -0.804 . . . . 1.3799999999999999 109.817 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.76 90.09 51.47 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.723 0.638 . . . . 2.0 112.723 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.76 149.74 90.34 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.04 1.827 . . . . 0.23999999999999999 112.053 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 16.9 mt -144.16 156.89 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.452 -0.34 . . . . 1.0600000000000001 111.537 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.448 ' N ' HG21 ' A' ' 133' ' ' ILE . 32.7 t -133.07 110.23 10.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.026 0.441 . . . . 1.6599999999999999 111.077 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 21.8 mt -106.62 137.25 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.799 -0.637 . . . . 1.0700000000000001 110.337 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -145.35 130.36 18.34 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.997 -0.281 . . . . 2.4300000000000002 111.102 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 54.99 19.03 2.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.1 -0.5 . . . . 3.5600000000000001 110.8 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.5 16.14 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.688 -0.768 . . . . 0.32000000000000001 112.782 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -111.5 156.54 21.54 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.084 -0.339 . . . . 2.6800000000000002 110.084 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 141' ' ' SER . 5.1 tt -124.6 126.01 45.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.284 0.564 . . . . 1.1100000000000001 112.496 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.47 ' N ' HD21 ' A' ' 140' ' ' LEU . 9.5 t -115.81 109.23 17.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.302 -0.863 . . . . 1.3700000000000001 109.084 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -102.95 99.57 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.513 -0.767 . . . . 1.23 110.507 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.43 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 2.0499999999999998 111.626 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -132.33 29.58 3.29 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.44 -0.886 . . . . 0.59999999999999998 113.277 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.28 135.78 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.297 . . . . 2.02 110.526 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.83 135.46 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 1.8700000000000001 110.344 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 m -164.46 129.22 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 1.46 109.837 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -53.16 145.03 14.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.181 0.515 . . . . 1.55 112.238 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -78.72 121.67 25.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.516 -0.765 . . . . 0.34000000000000002 110.031 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.4 p -76.14 173.85 10.81 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.51 -0.922 . . . . 2.02 108.51 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.81 -8.8 1.48 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.948 -1.12 . . . . 0.77000000000000002 114.236 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.598 ' HB3' ' HZ3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -160.61 152.09 19.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.894 0.847 . . . . 2.3199999999999998 112.703 -179.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.578 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -80.9 129.63 34.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.794 -1.187 . . . . 1.8600000000000001 107.794 177.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.503 ' HB3' ' OE1' ' A' ' 156' ' ' GLU . 0.1 OUTLIER -121.88 120.71 35.3 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.96 1.096 . . . . 1.72 113.96 -176.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.412 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 96.6 t -106.11 101.13 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.741 -0.466 . . . . 1.27 109.741 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' A' ' 154' ' ' SER . 17.6 mp0 -116.64 150.5 38.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.369 0.604 . . . . 2.48 112.069 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.6 140.11 44.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.178 -0.919 . . . . 1.9199999999999999 110.148 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.67 144.06 24.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.058 -0.973 . . . . 1.3899999999999999 111.168 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.46 ' HD3' ' OD1' ' A' ' 69' ' ' ASP . 19.2 pttm -63.63 139.43 58.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.384 -0.825 . . . . 2.48 111.055 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -108.33 -4.79 32.75 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.116 -0.794 . . . . 1.1200000000000001 111.116 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -169.92 -54.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.327 -0.436 . . . . 3.8999999999999999 110.229 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -178.29 149.03 0.51 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.09 -0.505 . . . . 4.0999999999999996 110.64 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 55.84 87.5 0.05 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.855 0.36 . . . . 1.3999999999999999 111.681 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.41 166.37 0.56 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.848 -0.615 . . . . 2.0 109.886 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -35.78 104.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.015 1.81 . . . . 3.1099999999999999 111.731 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -58.21 -54.11 50.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 4.1100000000000003 113.133 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 63' ' ' THR . 6.8 t -103.55 134.72 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.961 0.726 . . . . 1.5900000000000001 112.961 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.42 138.85 49.26 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.964 -0.562 . . . . 1.8600000000000001 112.149 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 88' ' ' LYS . . . -129.75 35.94 4.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.183 -0.917 . . . . 1.04 112.915 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -36.96 136.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.232 0.539 . . . . 1.6799999999999999 112.404 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -156.62 96.11 1.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.305 -0.861 . . . . 0.38 109.33 178.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -99.93 127.67 52.6 Favored 'Isoleucine or valine' 0 C--O 1.266 1.942 0 CA-C-O 122.663 1.221 . . . . 1.3500000000000001 112.35 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.42 161.35 21.36 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.683 -1.599 . . . . 1.26 109.546 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 16.1 tttm -120.38 139.05 53.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.7 1.37 . . . . 2.3599999999999999 114.7 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.03 -35.05 5.3 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 118.123 2.009 . . . . 0.23000000000000001 118.123 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.551 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.55 158.06 0.5 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.436 2.118 . . . . 1.1000000000000001 114.105 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.59 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -85.34 -24.69 27.52 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.94 -1.027 . . . . 1.1000000000000001 109.858 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.03 -30.63 69.3 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.538 -0.756 . . . . 2.3100000000000001 111.132 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -53.7 -47.68 70.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.402 -0.363 . . . . 2.3700000000000001 110.217 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 35.3 t -39.68 100.48 0.22 Allowed Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.864 -0.607 . . . . 3.0800000000000001 111.587 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -51.26 139.38 44.37 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.002 1.802 . . . . 2.4500000000000002 112.397 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 86.3 mtp -133.09 141.57 48.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 6.3700000000000001 110.859 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.42 ' N ' HD21 ' A' ' 183' ' ' LEU . 4.0 mm? -74.75 118.1 17.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 5.3499999999999996 110.772 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -53.6 144.91 31.59 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.688 -0.486 . . . . 8.5099999999999998 109.688 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.22 124.12 12.52 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.398 1.399 . . . . 9.6899999999999995 112.407 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.579 ' HD1' ' H ' ' A' ' 188' ' ' GLY . 55.3 t-80 -135.01 135.14 22.45 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 10.35 110.41 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.58 -36.34 5.13 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.137 1.891 . . . . 12.26 112.6 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.579 ' H ' ' HD1' ' A' ' 186' ' ' HIS . . . -92.26 -163.15 37.71 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.968 -0.634 . . . . 12.619999999999999 112.632 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.29 152.57 24.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 14.65 110.812 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.407 -0.806 . . . . 15.699999999999999 110.975 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.535 -0.226 . . . . 9.3900000000000006 112.535 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.02 -57.78 2.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.357 . . . . 7.6799999999999997 111.003 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 tpt -97.27 96.8 8.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 8.1699999999999999 110.699 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -134.71 101.1 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 4.25 110.775 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.75 51.91 0.22 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 1.8200000000000001 112.445 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.1 tp -72.48 -50.06 28.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.354 0.597 . . . . 1.1299999999999999 110.052 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.02 -19.65 7.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.076 -0.966 . . . . 1.1299999999999999 111.652 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.75 -28.65 40.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.498 0.555 . . . . 2.0899999999999999 112.498 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 44.0 mttp -98.89 -18.08 18.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.325 -0.55 . . . . 2.5 112.065 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 7' ' ' ALA . 14.2 p -42.63 144.08 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 121.28 -0.168 . . . . 1.05 111.131 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 12' ' ' TRP . 4.1 pt -139.55 -21.7 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 C-N-CA 119.639 -0.824 . . . . 1.48 111.582 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.497 ' O ' HG23 ' A' ' 172' ' ' ILE . 50.5 t90 -175.99 130.79 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.478 -0.489 . . . . 0.33000000000000002 110.675 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -148.39 146.58 28.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.273 0.471 . . . . 1.05 112.273 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.3 t -147.5 126.77 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 114.229 1.196 . . . . 1.3600000000000001 114.229 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.601 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 18.4 t-20 -117.39 106.36 13.13 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.654 -0.703 . . . . 1.8700000000000001 110.133 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 113.54 15.14 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 120.68 -0.408 . . . . 1.1100000000000001 110.811 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.433 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 142.74 -29.74 2.1 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 114.649 -1.16 . . . . 0.67000000000000004 112.594 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -109.81 -144.75 10.51 Favored Glycine 0 CA--C 1.516 0.135 0 C-N-CA 121.138 -0.553 . . . . 1.1200000000000001 112.021 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' SER . 36.2 mt-10 -156.83 119.45 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.666 -0.124 . . . . 2.02 110.666 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.649 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.3 m 27.7 94.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.803 0.69 . . . . 1.6499999999999999 112.152 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 19.9 t60 -126.26 150.89 48.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 119.922 -0.711 . . . . 0.41999999999999998 112.416 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.56 105.32 18.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.133 -0.939 . . . . 1.8200000000000001 111.019 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 153.77 42.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.981 -0.377 . . . . 1.1699999999999999 109.981 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 m -44.44 -49.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.501 0.926 . . . . 1.27 113.501 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -58.44 -17.84 23.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.282 0.563 . . . . 0.55000000000000004 110.463 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.62 33.71 4.67 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.32000000000000001 112.149 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 27' ' ' ILE . 30.4 mm -103.23 120.72 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.904 -0.406 . . . . 1.21 109.904 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.499 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 12.8 t60 -102.97 132.91 48.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.191 1.182 . . . . 0.68999999999999995 114.191 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.5 134.19 43.82 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.935 -1.135 . . . . 3.3199999999999998 107.935 176.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -94.62 112.52 24.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.444 0.64 . . . . 3.3999999999999999 112.376 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HZ3' ' HA2' ' A' ' 39' ' ' GLY . 60.4 tttm -10.49 138.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.54 1.681 . . . . 3.1600000000000001 115.54 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.45 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 12.5 m-20 -22.54 89.67 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 113.722 -1.581 . . . . 1.98 114.219 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.39 -123.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.731 2.287 . . . . 1.53 113.309 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 72' ' ' GLY . 1.2 pt? -39.64 -32.97 0.15 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.026 0.75 . . . . 2.3599999999999999 113.026 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.474 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 9.7 mm-40 -62.61 85.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.922 0.392 . . . . 4.9500000000000002 110.257 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.68 -26.98 1.09 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.974 -0.631 . . . . 2.3300000000000001 112.497 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' H ' ' C ' ' A' ' 35' ' ' GLU . 6.3 mtp180 48.92 33.25 4.35 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.024 0.44 . . . . 5.8700000000000001 111.158 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.91 176.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.826 -0.625 . . . . 3.48 110.67 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' HA2' ' HZ3' ' A' ' 31' ' ' LYS . . . -67.56 102.26 0.79 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.805 -0.712 . . . . 2.5899999999999999 112.768 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.461 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 16.2 tpp180 -161.22 115.18 2.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.976 0.417 . . . . 7.3300000000000001 110.714 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.2 82.38 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 2.0099999999999998 110.434 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.9 m -64.06 81.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 2.2999999999999998 110.2 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.76 26.1 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.718 -0.673 . . . . 2.23 110.776 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -65.14 -48.66 72.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 2.6000000000000001 110.75 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.09 31.52 5.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 2.6600000000000001 112.411 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.5 ttt -67.02 -17.46 64.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.926 0.393 . . . . 2.4300000000000002 110.663 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -64.29 -179.48 0.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 3.79 110.278 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 11.0 mp 59.21 61.72 4.36 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.663 -0.244 . . . . 3.23 110.571 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.523 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 86.2 Cg_exo -54.74 124.26 15.76 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.275 1.983 . . . . 1.9399999999999999 111.975 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 50' ' ' ILE . 4.4 mt -59.94 121.22 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.264 -0.643 . . . . 1.45 109.264 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.68 -42.77 86.02 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.232 1.197 . . . . 2.29 114.232 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -80.25 25.14 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.705 -0.398 . . . . 3.0600000000000001 111.984 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.43 ' OG ' HG23 ' A' ' 50' ' ' ILE . 94.0 p -139.77 130.47 25.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.702 0.287 . . . . 1.4099999999999999 111.347 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 3.0 p-10 -59.73 152.73 56.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.857 -0.794 . . . . 1.96 108.857 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.463 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 7.6 Cg_exo -39.93 -39.52 2.3 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.341 2.027 . . . . 0.78000000000000003 115.251 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' HG11 ' A' ' 59' ' ' VAL . 7.5 mm-40 -75.43 -56.07 5.07 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.755 0.788 . . . . 1.8200000000000001 111.171 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.4 OUTLIER -70.79 -6.57 38.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.034 -0.666 . . . . 1.9099999999999999 109.256 -179.453 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.523 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 24.6 tt0 -70.54 -64.88 0.81 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.255 -0.884 . . . . 2.0600000000000001 108.661 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' O ' HG21 ' A' ' 63' ' ' THR . 2.6 p -48.41 -37.94 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.901 -0.591 . . . . 1.8500000000000001 109.79 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.601 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 4.9 tp -68.07 -68.19 0.41 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.84 -0.744 . . . . 1.6000000000000001 110.071 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -56.36 1.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.184 0.593 . . . . 1.29 111.932 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.599 ' H ' ' C ' ' A' ' 60' ' ' LEU . 1.8 tt0 -122.8 -126.02 0.26 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.115 -0.493 . . . . 1.8 111.734 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.448 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 47.6 p 49.08 -166.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.598 -0.273 . . . . 1.4099999999999999 110.725 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.2 pt-20 -179.3 140.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.628 0.252 . . . . 2.0499999999999998 111.1 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.474 ' NH1' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -123.13 177.15 5.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.012 0.434 . . . . 4.2800000000000002 111.601 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -57.63 169.8 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.718 -0.674 . . . . 4.4699999999999998 111.412 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -142.13 169.32 17.81 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.256 -0.429 . . . . 5.1500000000000004 111.077 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -154.57 -107.52 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.663 -0.244 . . . . 3.1699999999999999 111.446 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.68 125.71 1.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.429 -0.169 . . . . 2.3900000000000001 110.742 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 t 50.9 84.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.047 -0.353 . . . . 1.3200000000000001 110.047 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -159.09 164.72 35.09 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.593 -0.443 . . . . 1.77 111.223 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.52 ' O ' HD13 ' A' ' 34' ' ' LEU . . . 177.6 -167.8 39.0 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 119.066 -1.54 . . . . 0.98999999999999999 116.406 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.99 174.2 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.648 -1.276 . . . . 1.1899999999999999 113.147 -176.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.9 147.34 50.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.33 -1.305 . . . . 2.27 111.187 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.32 113.55 6.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.349 -0.387 . . . . 1.0700000000000001 111.167 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.62 140.25 13.09 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.198 1.266 . . . . 1.26 111.918 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mt -129.49 149.24 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 1.0900000000000001 111.652 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.84 8.45 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.633 -0.712 . . . . 3.4399999999999999 110.809 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.623 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 17.7 mt-10 -127.11 163.76 23.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.134 -0.321 . . . . 2.1299999999999999 110.134 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 2.5 mp0 -125.98 158.73 34.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.37 111.901 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.82 -144.3 11.63 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.793 -1.323 . . . . 0.23000000000000001 109.793 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -105.93 107.8 18.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.622 1.211 . . . . 2.0299999999999998 108.995 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.623 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.8 m-85 -95.26 126.21 40.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.715 -0.846 . . . . 0.94999999999999996 108.715 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.613 HG23 ' N ' ' A' ' 177' ' ' ALA . 12.7 t -114.36 120.75 64.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.007 -0.997 . . . . 1.21 111.915 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.472 ' C ' HD22 ' A' ' 85' ' ' LEU . 8.6 tt -101.46 104.97 15.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.918 -1.037 . . . . 1.79 110.617 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.93 135.93 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.184 -1.043 . . . . 1.95 108.184 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -147.97 150.08 33.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 118.861 -1.136 . . . . 2.0 112.952 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 127' ' ' HIS . 12.2 tptt -107.75 120.43 42.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.341 -0.845 . . . . 3.3799999999999999 110.099 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.79 145.89 31.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.558 -0.534 . . . . 0.34999999999999998 109.558 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.09 152.16 41.54 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.801 0.334 . . . . 1.1499999999999999 110.65 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -140.45 137.53 33.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 3.9700000000000002 110.534 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.9 m -144.59 172.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 4.3099999999999996 111.362 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 t80 63.38 12.88 6.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.842 -0.617 . . . . 3.0099999999999998 111.497 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -148.98 138.81 21.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.555 -0.293 . . . . 2.0 110.58 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.58 89.71 2.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 1.6599999999999999 111.078 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.518 ' NE2' ' HB2' ' A' ' 100' ' ' LYS . 17.7 pt20 -157.01 147.07 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 3.6000000000000001 110.707 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -126.78 153.42 45.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 1.8899999999999999 111.863 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 47.73 30.71 1.9 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.805 -0.634 . . . . 2.6899999999999999 111.574 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -131.56 -50.42 0.99 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 3.0299999999999998 109.879 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.518 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 22.3 tttp -97.92 90.47 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.087 -0.709 . . . . 3.52 109.087 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.49 147.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.95 110.435 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -121.22 -179.87 4.19 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.392 0.886 . . . . 0.80000000000000004 113.392 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.89 139.39 52.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 115.648 -0.706 . . . . 2.0099999999999998 111.162 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.1 t -135.01 133.47 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 116.152 -0.476 . . . . 1.1599999999999999 112.068 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 10.9 ptt180 -135.89 145.17 46.05 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.684 0.994 . . . . 2.1800000000000002 113.684 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.5 m -113.0 121.06 64.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.584 -1.189 . . . . 1.71 109.694 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.565 ' ND2' ' HA ' ' A' ' 153' ' ' LEU . 3.6 t-20 54.28 26.89 7.27 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.805 0.812 . . . . 1.77 109.332 -176.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 23.17 28.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.047 -1.433 . . . . 0.40999999999999998 112.977 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 81.5 m-70 -120.83 108.03 13.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.277 0.843 . . . . 0.58999999999999997 113.277 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 7.0 p -64.6 116.03 5.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.146 0.498 . . . . 1.2 111.407 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.55 -31.31 2.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.471 -0.786 . . . . 1.3999999999999999 109.99 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.18 91.49 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.351 -0.611 . . . . 1.21 109.351 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 4.2 ptpp? -106.6 77.96 1.23 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.584 1.183 . . . . 2.9199999999999999 112.517 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.1 p30 156.14 36.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.399 -2.182 . . . . 2.5600000000000001 109.453 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 91.78 0.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.352 0.596 . . . . 1.71 111.537 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 1.5 p30 -101.68 79.12 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.008 -1.479 . . . . 1.99 107.008 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.0 mt -50.4 -50.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.709 -1.132 . . . . 1.23 113.002 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -56.19 -51.45 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.83 0.307 . . . . 1.01 111.83 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.493 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 18.0 t70 -65.39 -29.59 70.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.369 0.507 . . . . 0.76000000000000001 112.369 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -64.02 -58.29 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.452 0.538 . . . . 3.0299999999999998 112.452 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 126' ' ' ALA . 10.9 m -103.53 -41.17 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.519 0.563 . . . . 2.0299999999999998 112.519 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.73 -131.23 10.26 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.524 -0.845 . . . . 1.0600000000000001 112.881 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.37 110.43 1.43 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.761 0.315 . . . . 4.29 111.083 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.424 ' OG ' HD23 ' A' ' 48' ' ' LEU . 53.8 m 45.27 -104.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.867 -0.606 . . . . 2.1099999999999999 111.161 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.405 ' OG1' ' HB ' ' A' ' 121' ' ' VAL . 23.0 p 50.07 178.24 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.084 0.469 . . . . 1.3300000000000001 111.914 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 121' ' ' VAL . . . -105.86 138.95 41.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 1.1200000000000001 111.786 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.486 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.8 t60 -112.57 144.8 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.918 -0.771 . . . . 0.45000000000000001 108.918 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.89 140.48 29.78 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.305 0.854 . . . . 2.0899999999999999 113.305 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.17 133.85 52.63 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.026 -0.988 . . . . 2.2799999999999998 109.092 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.4 mt -115.66 116.4 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.747 -0.66 . . . . 1.3799999999999999 110.187 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.9 mt -124.62 87.87 54.11 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.584 0.587 . . . . 2.0 112.584 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.6 141.82 74.8 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.81 1.674 . . . . 0.23999999999999999 111.602 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 134' ' ' SER . 21.2 mt -132.09 155.82 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 1.0600000000000001 110.505 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.444 ' N ' HG21 ' A' ' 133' ' ' ILE . 30.5 p -131.39 106.73 8.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 1.6599999999999999 110.732 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 23.8 mt -105.4 124.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.747 -0.66 . . . . 1.0700000000000001 109.911 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -146.97 142.1 27.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 2.4300000000000002 110.947 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp 58.91 19.13 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 3.5600000000000001 111.205 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.85 23.62 41.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 0.32000000000000001 113.396 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 25.9 mtmm -123.62 151.75 42.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.1 0.45 . . . . 2.6800000000000002 110.823 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -109.84 126.65 54.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.118 0.485 . . . . 1.1100000000000001 111.658 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.463 ' N ' HD22 ' A' ' 140' ' ' LEU . 24.2 t -114.55 110.99 20.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.723 -0.671 . . . . 1.3700000000000001 110.059 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.03 104.29 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.341 0.591 . . . . 1.23 111.286 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 58.22 -89.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.755 -0.657 . . . . 2.0499999999999998 112.085 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.96 23.41 4.97 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.437 -0.887 . . . . 0.59999999999999998 113.593 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -133.13 136.51 45.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.005 -0.368 . . . . 2.02 110.005 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.16 140.9 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.034 0.445 . . . . 1.8700000000000001 111.491 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.0 m -160.15 122.78 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.718 -0.674 . . . . 1.46 110.233 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.5 p -50.94 143.09 10.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.966 -0.561 . . . . 1.55 111.502 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -79.77 121.91 25.94 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.001 -0.741 . . . . 0.34000000000000002 109.001 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 t -111.19 91.44 3.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.819 0.674 . . . . 2.02 112.819 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.4 -36.73 0.03 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.255 1.662 . . . . 0.77000000000000002 117.255 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -159.75 151.98 20.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.335 1.567 . . . . 2.3199999999999998 113.466 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.565 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 1.3 tt -85.55 132.57 34.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.835 -1.172 . . . . 1.8600000000000001 107.835 176.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.413 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.5 t -122.79 117.7 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.817 -0.753 . . . . 1.72 112.493 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.13 115.62 47.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.864 0.364 . . . . 1.27 110.826 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 166.79 23.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.375 0.607 . . . . 2.48 111.23 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.84 151.24 45.54 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.027 -0.988 . . . . 1.9199999999999999 110.675 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -123.26 143.96 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.671 -1.15 . . . . 1.3899999999999999 110.029 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 145.03 24.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 2.48 111.594 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.56 -14.45 44.02 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.312 -0.715 . . . . 1.1200000000000001 111.312 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -141.55 -79.9 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.227 . . . . 3.8999999999999999 110.694 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -155.16 157.75 37.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.863 0.363 . . . . 4.0999999999999996 111.142 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 54.97 86.93 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.951 -0.568 . . . . 1.3999999999999999 111.861 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 170.96 0.4 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.82 -0.627 . . . . 2.0 110.01 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -41.22 103.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.588 1.525 . . . . 3.1099999999999999 111.159 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -58.55 -64.98 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.287 -0.869 . . . . 4.1100000000000003 113.088 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 63' ' ' THR . 11.9 t -91.71 134.26 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 120.14 -0.624 . . . . 1.5900000000000001 112.385 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.6 t -132.48 137.8 47.35 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.712 -0.676 . . . . 1.8600000000000001 112.616 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.546 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . . . -130.22 34.75 4.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.171 -0.922 . . . . 1.04 111.466 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.1 tp -44.93 128.28 6.92 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.801 -0.636 . . . . 1.6799999999999999 111.656 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.4 OUTLIER -143.15 115.69 8.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.94 -0.573 . . . . 0.38 110.831 -178.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -117.16 131.27 70.35 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-O 123.002 1.382 . . . . 1.3500000000000001 113.029 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -126.42 165.04 19.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.216 -1.811 . . . . 1.26 109.735 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 3.4 ptmm? -121.42 152.75 38.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.424 1.639 . . . . 2.3599999999999999 115.424 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.72 -34.85 4.62 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 112.044 -2.344 . . . . 0.23000000000000001 117.796 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.551 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.67 156.71 0.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.21 2.005 . . . . 1.1000000000000001 114.723 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.613 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -86.57 -10.5 53.84 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.167 -0.924 . . . . 1.1000000000000001 110.899 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.59 -44.87 95.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 2.3100000000000001 111.508 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -61.66 -43.37 98.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.426 -0.352 . . . . 2.3700000000000001 110.859 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 86.2 t -43.73 102.81 0.29 Allowed Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.023 -0.535 . . . . 3.0800000000000001 111.234 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -49.23 132.23 28.12 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.056 1.838 . . . . 2.4500000000000002 112.635 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 80.7 mtp -136.36 137.64 40.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.076 -0.511 . . . . 6.3700000000000001 110.787 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 85.9 mt -132.55 115.2 15.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 5.3499999999999996 110.751 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -61.49 144.13 92.63 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.209 -0.45 . . . . 8.5099999999999998 110.291 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -44.61 141.13 5.8 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.709 1.606 . . . . 9.6899999999999995 112.554 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -134.79 134.26 21.86 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.4 -0.363 . . . . 10.35 110.555 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.61 -95.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.898 1.732 . . . . 12.26 112.053 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.92 84.52 1.81 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.0 -0.619 . . . . 12.619999999999999 112.335 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 30.7 mt -84.73 146.65 27.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.384 . . . . 14.65 111.005 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.128 -0.939 . . . . 15.699999999999999 110.77 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.483 -0.247 . . . . 9.3900000000000006 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.26 -25.82 42.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.319 . . . . 7.6799999999999997 111.007 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -92.01 129.93 37.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 8.1699999999999999 110.705 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.2 m -141.48 116.71 10.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 4.25 110.915 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.31 -90.63 0.08 OUTLIER Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.782 -0.723 . . . . 1.8200000000000001 112.432 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.5 -36.74 83.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.306 0.574 . . . . 1.1299999999999999 110.322 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.578 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -55.39 -20.93 13.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.366 -0.834 . . . . 1.1299999999999999 111.184 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.11 -19.34 61.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 2.0899999999999999 111.856 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -102.05 -29.52 11.72 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.696 -0.401 . . . . 2.5 110.875 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 7' ' ' ALA . 9.9 p -45.38 146.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.796 0.332 . . . . 1.05 111.815 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.512 HG21 ' HZ2' ' A' ' 174' ' ' LYS . 10.2 pt -137.12 -22.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.224 -0.59 . . . . 1.48 110.649 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.501 ' O ' HG22 ' A' ' 172' ' ' ILE . 17.0 t90 -172.51 133.45 0.62 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.233 -0.439 . . . . 0.33000000000000002 109.912 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' HIS . . . -154.23 143.09 21.02 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.74 0.274 . . . . 1.05 111.74 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.409 HG21 ' C ' ' A' ' 13' ' ' ALA . 98.2 t -146.94 131.5 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.598 1.332 . . . . 1.3600000000000001 114.598 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.47 103.05 10.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.058 -0.519 . . . . 1.8700000000000001 110.621 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . -70.82 105.53 3.26 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.124 -0.63 . . . . 1.1100000000000001 109.367 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.08 -27.01 0.14 Allowed Glycine 0 N--CA 1.446 -0.659 0 O-C-N 124.016 0.823 . . . . 0.67000000000000004 114.074 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -138.44 -127.8 2.54 Favored Glycine 0 CA--C 1.511 -0.204 0 C-N-CA 119.98 -1.105 . . . . 1.1200000000000001 113.011 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.73 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 37.1 mt-10 -154.63 119.65 4.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.39 0.138 . . . . 2.02 111.2 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.5 m 29.59 100.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.251 0.834 . . . . 1.6499999999999999 113.251 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 22' ' ' VAL . 6.7 t60 -130.38 150.74 51.47 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 120.394 -0.522 . . . . 0.41999999999999998 111.767 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 55.1 t -115.64 109.54 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.678 -0.692 . . . . 1.8200000000000001 111.755 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.92 157.21 36.67 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.656 -0.247 . . . . 1.1699999999999999 110.424 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.0 m -44.31 -52.66 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.832 1.049 . . . . 1.27 113.832 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -58.38 -13.76 6.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.085 0.469 . . . . 0.55000000000000004 110.406 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.0 34.91 5.5 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.526 -0.761 . . . . 0.32000000000000001 112.299 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.46 HG22 HD12 ' A' ' 27' ' ' ILE . 32.9 mm -103.61 122.64 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.65 -0.5 . . . . 1.21 109.65 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 11.7 t60 -101.91 135.49 43.38 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.714 1.376 . . . . 0.68999999999999995 114.714 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.73 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -98.33 132.9 43.42 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.396 -0.965 . . . . 3.3199999999999998 108.396 176.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 6.9 mtp180 -92.43 112.69 24.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.787 0.662 . . . . 3.3999999999999999 112.787 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.598 ' HZ3' ' HB3' ' A' ' 19' ' ' GLU . 9.2 tttp -20.24 137.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.247 1.419 . . . . 3.1600000000000001 114.423 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -14.3 84.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.685 1.194 . . . . 1.98 113.807 177.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -73.11 -17.83 24.38 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.449 2.1 . . . . 1.53 115.234 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -128.08 -21.75 3.57 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.399 1.0 . . . . 2.3599999999999999 113.262 -178.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 37' ' ' ARG . 21.1 tt0 -82.28 82.64 7.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.435 0.636 . . . . 4.9500000000000002 109.363 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.11 -13.56 4.44 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.337 -0.847 . . . . 2.3300000000000001 111.15 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.495 ' H ' ' C ' ' A' ' 35' ' ' GLU . 5.3 ttt180 55.06 30.44 14.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.393 0.616 . . . . 5.8700000000000001 110.266 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -145.25 144.23 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 114.986 -1.006 . . . . 3.48 109.939 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.07 136.16 15.76 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.142 -0.551 . . . . 2.5899999999999999 113.264 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.29 -66.35 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.691 0.281 . . . . 7.3300000000000001 110.577 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 64.47 153.35 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.312 0.577 . . . . 2.0099999999999998 111.993 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.9 m -153.97 41.81 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.37 -0.832 . . . . 2.2999999999999998 109.579 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -43.75 -36.48 2.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.397 -0.819 . . . . 2.23 111.48 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.6 t80 57.31 13.82 1.89 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.153 0.501 . . . . 2.6000000000000001 110.047 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 47' ' ' LYS . . . 104.82 127.92 6.11 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.657 -0.701 . . . . 2.6600000000000001 112.049 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 47.3 mtt -68.77 -0.57 5.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.516 0.674 . . . . 2.4300000000000002 109.931 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 45' ' ' GLY . 57.4 pttt -53.82 157.13 2.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.789 -1.096 . . . . 3.79 109.684 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 7.9 mt 53.03 53.09 11.43 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 108.605 -0.887 . . . . 3.23 108.605 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HB2' ' NE2' ' A' ' 58' ' ' GLN . 75.7 Cg_endo -77.88 166.71 24.8 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.941 2.427 . . . . 1.9399999999999999 114.711 -177.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.435 HD11 ' N ' ' A' ' 50' ' ' ILE . 1.1 mp -67.24 143.04 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.974 -1.012 . . . . 1.45 108.667 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -48.87 8.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.679 0.992 . . . . 2.29 113.679 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -78.9 34.69 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.647 0.61 . . . . 3.0600000000000001 112.647 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -144.2 137.5 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 1.4099999999999999 111.293 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -67.55 161.75 62.76 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.493 -0.558 . . . . 1.96 109.493 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.6 Cg_exo -42.16 -46.89 7.16 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.764 2.31 . . . . 0.78000000000000003 116.141 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 59' ' ' VAL . 12.9 pt-20 -77.71 -53.16 7.87 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.248 0.547 . . . . 1.8200000000000001 111.649 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 8.7 p-10 -70.04 -2.3 12.36 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.717 -0.793 . . . . 1.9099999999999999 109.719 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.512 ' NE2' ' HB2' ' A' ' 49' ' ' PRO . 20.2 tt0 -80.36 -60.15 2.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.447 -0.797 . . . . 2.0600000000000001 109.218 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 56' ' ' GLU . 2.6 p -47.59 -35.57 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.457 -0.942 . . . . 1.8500000000000001 108.457 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 62' ' ' GLN . 10.2 tp -69.88 -64.52 0.87 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.465 0.65 . . . . 1.6000000000000001 109.41 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-30 -66.95 20.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.9 -1.046 . . . . 1.29 112.703 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.483 ' H ' ' C ' ' A' ' 60' ' ' LEU . 38.4 tt0 -137.54 -67.81 0.48 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.515 0.931 . . . . 1.8 113.515 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 21.0 p -30.6 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.554 0.946 . . . . 1.4099999999999999 113.554 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.552 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -131.98 151.63 51.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.686 -0.688 . . . . 2.0499999999999998 111.464 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.603 ' CZ ' ' HA ' ' A' ' 32' ' ' ASP . 30.2 mtt180 -105.2 -170.41 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.536 -0.542 . . . . 4.2800000000000002 109.536 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.81 -179.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 4.4699999999999998 111.069 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -117.12 164.85 14.14 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.184 -0.462 . . . . 5.1500000000000004 111.413 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -167.69 -150.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.844 -0.616 . . . . 3.1699999999999999 109.969 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 10.1 t70 -141.38 128.06 20.3 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.718 0.294 . . . . 2.3900000000000001 111.418 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 t 51.94 86.03 0.04 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.101 -0.5 . . . . 1.3200000000000001 111.238 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.07 160.5 43.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 1.77 110.909 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.17 -154.14 8.6 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.358 -0.925 . . . . 0.98999999999999999 113.998 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.88 167.84 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.478 0.656 . . . . 1.1899999999999999 112.046 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -120.22 135.62 54.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.638 -1.164 . . . . 2.27 110.047 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.417 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.9 mp -127.64 86.84 57.45 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 111.823 0.305 . . . . 1.0700000000000001 111.823 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -57.69 127.55 25.73 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.975 1.783 . . . . 1.26 112.059 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 78' ' ' LYS . 21.7 mt -119.25 153.69 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.966 0.412 . . . . 1.0900000000000001 111.138 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' N ' HG22 ' A' ' 77' ' ' ILE . 16.9 pttp -147.35 6.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.895 -0.593 . . . . 3.4399999999999999 110.823 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -130.77 171.0 13.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.822 -0.172 . . . . 2.1299999999999999 110.627 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.07 171.96 10.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.277 0.56 . . . . 0.37 111.577 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 -153.89 21.59 Favored Glycine 0 C--N 1.329 0.148 0 N-CA-C 109.901 -1.28 . . . . 0.23000000000000001 109.901 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.5 mm-40 -98.07 110.25 22.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.856 1.328 . . . . 2.0299999999999998 108.859 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.669 ' HH ' ' HZ1' ' A' ' 174' ' ' LYS . 4.1 m-85 -96.55 126.53 41.8 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.906 -0.776 . . . . 0.94999999999999996 108.906 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.634 HG22 ' N ' ' A' ' 177' ' ' ALA . 13.8 t -115.81 116.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.401 -0.818 . . . . 1.21 111.78 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.476 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.8 tt -94.06 105.15 17.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.761 -1.109 . . . . 1.79 111.029 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 42.9 t -108.07 135.59 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.163 -1.051 . . . . 1.95 108.163 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -150.05 148.8 29.46 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.952 -1.099 . . . . 2.0 112.365 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 2.2 tptm -104.59 118.82 37.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.457 -0.792 . . . . 3.3799999999999999 110.011 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -106.01 137.67 43.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.458 -0.941 . . . . 0.34999999999999998 108.458 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.424 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -150.63 175.8 11.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.026 -0.67 . . . . 1.1499999999999999 111.898 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -176.3 141.58 0.43 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.728 -0.669 . . . . 3.9700000000000002 110.626 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.4 m -144.26 52.24 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.295 -0.411 . . . . 4.3099999999999996 111.104 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -130.4 -29.17 2.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 3.0099999999999998 111.306 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -135.11 -176.86 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 2.0 111.145 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -158.4 88.47 0.93 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.15 -0.477 . . . . 1.6599999999999999 111.017 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -152.29 142.82 22.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 3.6000000000000001 111.183 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.9 m -115.01 153.38 30.75 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.0 -0.545 . . . . 1.8899999999999999 111.774 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 52.03 27.58 4.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.635 -0.711 . . . . 2.6899999999999999 112.144 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -134.27 -47.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 3.0299999999999998 109.636 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.99 86.52 3.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.719 -0.673 . . . . 3.52 109.541 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.17 150.32 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 1.95 109.892 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -127.13 179.04 5.63 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 113.065 0.765 . . . . 0.80000000000000004 113.065 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -123.6 137.58 54.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.124 -0.489 . . . . 2.0099999999999998 111.256 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.414 -0.357 . . . . 1.1599999999999999 111.922 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -130.35 151.2 51.11 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.825 0.676 . . . . 2.1800000000000002 112.825 -178.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 9.5 p -124.6 120.76 59.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 115.425 -0.807 . . . . 1.71 110.021 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.539 ' OD1' HD13 ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.68 25.85 10.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.524 -0.917 . . . . 1.77 108.524 -176.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.58 57.29 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.16 -0.927 . . . . 0.40999999999999998 112.987 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.482 ' CG ' HG13 ' A' ' 142' ' ' VAL . 89.1 m-70 -110.48 112.25 24.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.428 0.899 . . . . 0.58999999999999997 113.428 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 p -70.41 112.66 6.87 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.023 0.44 . . . . 1.2 111.221 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.34 -37.61 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 1.3999999999999999 110.124 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.87 90.31 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 109.337 -0.616 . . . . 1.21 109.337 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.3 ptpp? -108.25 84.58 1.96 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.165 0.983 . . . . 2.9199999999999999 112.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.6 p30 149.92 31.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.437 -2.165 . . . . 2.5600000000000001 108.142 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.32 98.87 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.146 0.498 . . . . 1.71 112.056 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -105.87 80.76 1.57 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.828 -1.175 . . . . 1.99 107.828 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.1 mt -51.0 -47.03 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.085 -0.962 . . . . 1.23 112.721 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.662 0.267 . . . . 1.01 111.671 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.29 -27.63 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.979 0.363 . . . . 0.76000000000000001 111.979 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -68.86 -58.54 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.069 0.396 . . . . 3.0299999999999998 112.069 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.5 m -90.54 -40.47 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.939 0.348 . . . . 2.0299999999999998 111.939 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.34 -82.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 1.0600000000000001 112.439 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -99.99 169.69 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.512 0.196 . . . . 4.29 110.782 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 m -49.88 97.91 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.36 -0.382 . . . . 2.1099999999999999 110.984 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.9 p -150.94 -170.12 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 1.3300000000000001 109.96 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . . . -96.6 131.11 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.741 0.645 . . . . 1.1200000000000001 112.741 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.403 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 2.1 t60 -106.32 147.08 29.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.572 -0.899 . . . . 0.45000000000000001 108.572 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.403 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 36.3 t70 -144.83 127.08 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.437 0.532 . . . . 2.0899999999999999 112.437 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -114.8 135.61 53.99 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.766 -0.652 . . . . 2.2799999999999998 109.568 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.54 120.86 66.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.4 -0.818 . . . . 1.3799999999999999 110.083 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.88 89.18 51.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.353 -0.385 . . . . 2.0 111.947 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.17 146.62 94.26 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.97 1.78 . . . . 0.23999999999999999 111.709 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 134' ' ' SER . 17.6 mt -138.6 156.86 29.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 1.0600000000000001 110.751 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.422 ' N ' HG22 ' A' ' 133' ' ' ILE . 29.1 p -133.53 108.56 8.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.068 0.461 . . . . 1.6599999999999999 111.349 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 18.3 mt -109.67 125.69 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-N 115.667 -0.697 . . . . 1.0700000000000001 110.224 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -149.12 141.69 24.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 2.4300000000000002 111.157 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt 61.36 14.24 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.9 -0.591 . . . . 3.5600000000000001 111.212 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.78 8.76 59.13 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.606 -0.807 . . . . 0.32000000000000001 113.402 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -112.34 165.2 12.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.34 0.57 . . . . 2.6800000000000002 110.669 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 141' ' ' SER . 8.2 tt -127.16 139.74 52.74 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.616 0.598 . . . . 1.1100000000000001 112.616 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.415 ' N ' HD22 ' A' ' 140' ' ' LEU . 36.1 t -126.44 116.03 20.51 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.626 -0.715 . . . . 1.3700000000000001 110.447 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.482 HG13 ' CG ' ' A' ' 109' ' ' HIS . 4.3 p -112.32 104.53 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.094 -0.957 . . . . 1.23 110.575 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.75 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 2.0499999999999998 112.009 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.17 9.87 4.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.352 -0.927 . . . . 0.59999999999999998 113.914 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -124.38 118.87 27.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.147 0.473 . . . . 2.02 110.019 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 140' ' ' LEU . 21.2 t -107.62 130.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.477 0.656 . . . . 1.8700000000000001 112.432 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 t -145.12 143.11 30.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 114.939 -1.028 . . . . 1.46 109.742 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.6 p -55.85 141.36 39.24 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.111 0.411 . . . . 1.55 112.111 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -79.09 143.15 35.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.168 -0.679 . . . . 0.34000000000000002 109.168 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.9 96.45 3.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.776 1.028 . . . . 2.02 113.776 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.66 -57.33 2.55 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.978 1.151 . . . . 0.77000000000000002 115.978 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -153.54 174.72 14.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.934 0.867 . . . . 2.3199999999999998 112.667 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.539 HD13 ' OD1' ' A' ' 107' ' ' ASN . 1.0 OUTLIER -97.06 130.79 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.964 -1.495 . . . . 1.8600000000000001 106.964 176.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.4 t -120.71 112.74 19.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.267 -0.973 . . . . 1.72 112.978 -175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 57.5 t -98.28 104.04 15.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 1.27 110.548 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 mt-10 -108.47 144.91 35.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.407 -0.815 . . . . 2.48 110.922 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.97 138.16 42.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.637 -0.505 . . . . 1.9199999999999999 109.637 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.6 t -112.25 143.59 21.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.22 -0.9 . . . . 1.3899999999999999 111.261 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.404 ' HD2' ' C ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -74.95 148.45 39.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.533 -0.758 . . . . 2.48 111.375 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.14 -9.2 28.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.943 -0.646 . . . . 1.1200000000000001 111.941 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.45 -61.89 0.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.616 0.246 . . . . 3.8999999999999999 110.489 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -172.69 -28.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 4.0999999999999996 111.048 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.73 90.54 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 1.3999999999999999 111.589 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -53.82 165.82 0.7 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.397 -0.594 . . . . 2.0 109.397 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -37.67 100.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.779 1.653 . . . . 3.1099999999999999 111.575 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -52.0 -57.0 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.975 . . . . 4.1100000000000003 112.384 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 61.3 t -103.04 133.69 46.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 120.495 -0.482 . . . . 1.5900000000000001 112.253 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -132.59 135.29 45.81 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 115.873 -0.603 . . . . 1.8600000000000001 111.065 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.444 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -126.23 35.57 4.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.806 . . . . 1.04 112.611 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -33.36 131.43 0.21 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.499 0.499 . . . . 1.6799999999999999 111.366 179.253 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.89 101.26 2.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.38 110.198 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -107.43 123.32 62.63 Favored 'Isoleucine or valine' 0 C--O 1.265 1.873 0 CA-C-O 122.858 1.313 . . . . 1.3500000000000001 112.587 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.9 ptm -114.76 165.24 13.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.507 -1.678 . . . . 1.26 110.045 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.669 ' HZ1' ' HH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -119.14 145.17 46.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 115.058 1.503 . . . . 2.3599999999999999 115.058 -177.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 101.81 -37.61 3.56 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 112.095 -2.32 . . . . 0.23000000000000001 118.749 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.57 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.06 157.48 0.32 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.883 2.341 . . . . 1.1000000000000001 114.358 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.634 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -86.12 -22.85 26.87 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.673 -1.149 . . . . 1.1000000000000001 108.861 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.53 -31.03 70.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.206 -0.906 . . . . 2.3100000000000001 110.86 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -49.78 -63.29 1.16 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.354 -0.61 . . . . 2.3700000000000001 109.354 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.7 t 62.2 130.53 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.716 -0.675 . . . . 3.0800000000000001 111.924 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -42.34 121.51 2.0 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.737 1.624 . . . . 2.4500000000000002 112.649 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 49.0 ttm -134.8 127.01 30.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 6.3700000000000001 110.696 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.0 159.91 38.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 5.3499999999999996 111.126 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -71.25 146.27 91.99 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.887 -0.597 . . . . 8.5099999999999998 109.747 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.1 125.86 15.39 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.451 1.434 . . . . 9.6899999999999995 112.482 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -134.6 135.02 22.81 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.997 -0.547 . . . . 10.35 110.226 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.52 -97.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.694 1.596 . . . . 12.26 112.017 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.09 39.92 15.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.928 -0.653 . . . . 12.619999999999999 112.646 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.83 90.21 5.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 14.65 110.387 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.324 -0.846 . . . . 15.699999999999999 110.8 179.904 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.472 -0.251 . . . . 9.3900000000000006 112.472 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.76 -11.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 7.6799999999999997 110.929 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -132.52 37.85 3.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 8.1699999999999999 110.667 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.467 ' HG ' ' N ' ' A' ' 5' ' ' GLY . 16.4 t 62.69 166.73 0.12 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.091 -0.504 . . . . 4.25 111.015 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.467 ' N ' ' HG ' ' A' ' 4' ' ' SER . . . -118.54 7.16 13.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.677 -0.773 . . . . 1.8200000000000001 112.703 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 tp -63.69 -41.39 98.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.4 0.619 . . . . 1.1299999999999999 109.669 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.575 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -59.83 -20.34 56.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.096 -0.956 . . . . 1.1299999999999999 110.599 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.09 -18.5 63.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 2.0899999999999999 111.35 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -107.7 -26.73 10.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.696 -0.401 . . . . 2.5 111.476 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -45.84 145.48 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.756 -0.378 . . . . 1.05 111.505 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.606 HD11 ' O ' ' A' ' 172' ' ' ILE . 0.2 OUTLIER -133.48 -18.86 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 119.861 -0.736 . . . . 1.48 110.345 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.512 ' O ' HG21 ' A' ' 172' ' ' ILE . 44.0 t90 -175.22 144.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.591 -0.444 . . . . 0.33000000000000002 110.311 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -162.05 142.82 10.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.667 0.247 . . . . 1.05 111.667 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.68 128.95 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.988 1.107 . . . . 1.3600000000000001 113.988 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.521 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 10.1 t30 -114.26 93.7 4.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.904 -0.776 . . . . 1.8700000000000001 108.904 176.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HB3' ' OH ' ' A' ' 73' ' ' TYR . . . -63.7 97.41 0.15 Allowed 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.442 -0.799 . . . . 1.1100000000000001 109.757 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.547 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . 176.93 -77.8 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.122 -1.399 . . . . 0.67000000000000004 113.196 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -77.16 -125.36 0.26 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.204 -0.522 . . . . 1.1200000000000001 112.759 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.95 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -162.72 121.48 2.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 120.858 0.361 . . . . 2.02 110.744 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.0 p 35.11 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.809 -0.632 . . . . 1.6499999999999999 112.289 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.542 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 55.9 t60 -117.78 152.47 35.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.157 -0.617 . . . . 0.41999999999999998 112.575 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.7 t -123.67 103.6 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.469 -0.787 . . . . 1.8200000000000001 110.427 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -68.45 151.29 47.03 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.275 -0.42 . . . . 1.1699999999999999 110.731 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 m -43.09 -48.69 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 124.367 1.042 . . . . 1.27 112.888 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -57.74 -29.73 65.0 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.319 0.58 . . . . 0.55000000000000004 110.069 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . 113.83 33.81 1.8 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.142 -0.935 . . . . 0.32000000000000001 111.666 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 27' ' ' ILE . 36.1 mm -103.39 123.5 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.607 -0.516 . . . . 1.21 109.607 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.6 t60 -104.38 134.97 46.69 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.614 1.338 . . . . 0.68999999999999995 114.614 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.95 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -97.72 129.31 44.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.564 -0.902 . . . . 3.3199999999999998 108.564 176.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -82.43 113.15 19.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.647 0.61 . . . . 3.3999999999999999 112.647 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -28.12 140.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.445 -1.252 . . . . 3.1600000000000001 113.499 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.511 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 1.6 m-20 -14.75 83.57 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.814 1.246 . . . . 1.98 114.079 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -102.46 -0.1 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.35 2.033 . . . . 1.53 113.783 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.455 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 30.4 tp -126.27 -60.76 1.25 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.404 0.52 . . . . 2.3599999999999999 112.404 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.498 ' HB2' HH21 ' A' ' 65' ' ' ARG . 51.8 mt-10 -72.2 90.45 1.23 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.061 0.457 . . . . 4.9500000000000002 110.081 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' HG22 ' A' ' 38' ' ' VAL . . . 90.22 -28.51 7.33 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.166 -0.774 . . . . 2.3300000000000001 111.166 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 45.15 36.48 2.12 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.915 0.486 . . . . 5.8700000000000001 111.258 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 36' ' ' GLY . 73.2 t -140.1 141.9 32.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.765 -0.652 . . . . 3.48 110.15 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.04 101.51 0.05 OUTLIER Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.067 -0.587 . . . . 2.5899999999999999 113.081 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -141.28 -78.82 0.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.45 0.166 . . . . 7.3300000000000001 110.64 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 61.12 113.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.984 0.421 . . . . 2.0099999999999998 111.409 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.1 m -73.03 -41.72 63.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 2.2999999999999998 110.677 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 38.74 43.54 0.72 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.171 -0.468 . . . . 2.23 111.408 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -105.41 32.72 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 2.6000000000000001 110.139 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.45 17.75 5.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.827 -0.702 . . . . 2.6600000000000001 112.823 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.9 mtt -52.14 -32.23 34.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.22 0.534 . . . . 2.4300000000000002 109.891 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 39.1 tptt -74.93 159.06 32.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.371 -0.831 . . . . 3.79 109.722 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 7.7 mt 64.81 62.23 1.27 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.591 0.234 . . . . 3.23 110.806 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 53.7 Cg_exo -59.68 129.17 29.68 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.425 2.084 . . . . 1.9399999999999999 112.229 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mt -63.2 111.67 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.758 0.789 . . . . 1.45 109.503 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mt -46.94 -52.48 14.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.171 -1.377 . . . . 2.29 113.937 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -65.75 -0.68 2.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.046 0.387 . . . . 3.0600000000000001 112.046 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.9 t -128.18 142.08 51.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.685 0.624 . . . . 1.4099999999999999 112.685 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -69.15 158.84 85.5 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.848 -0.615 . . . . 1.96 109.497 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.539 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.9 Cg_exo -40.07 -56.69 1.37 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 123.188 2.592 . . . . 0.78000000000000003 116.446 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 12.5 pt-20 -71.45 -53.36 14.23 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.318 0.58 . . . . 1.8200000000000001 111.264 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.67 -5.03 22.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.126 -0.694 . . . . 1.9099999999999999 109.126 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.539 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -77.59 -46.98 20.51 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.683 -0.858 . . . . 2.0600000000000001 108.683 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -55.09 -42.57 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.378 -0.971 . . . . 1.8500000000000001 108.378 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 62' ' ' GLN . 13.0 tp -63.53 -63.48 1.17 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.537 -0.542 . . . . 1.6000000000000001 109.537 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.481 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 3.3 m-85 -51.13 -12.38 0.13 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.501 -0.772 . . . . 1.29 110.632 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -123.59 -126.21 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.587 -0.733 . . . . 1.8 111.239 -178.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.508 ' O ' ' O ' ' A' ' 62' ' ' GLN . 26.6 p 45.49 128.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.655 0.782 . . . . 1.4099999999999999 112.81 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.465 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -124.79 154.82 40.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.441 0.638 . . . . 2.0499999999999998 112.65 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.547 ' HD3' ' N ' ' A' ' 17' ' ' GLY . 18.2 mtp180 -123.3 -171.74 2.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.01 -0.995 . . . . 4.2800000000000002 110.281 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.4 -178.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 4.4699999999999998 111.043 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.98 163.25 39.32 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.434 -0.348 . . . . 5.1500000000000004 110.963 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.56 -93.76 0.06 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.504 -0.316 . . . . 3.1699999999999999 111.631 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -173.15 127.97 0.45 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.813 0.301 . . . . 2.3900000000000001 111.813 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.5 t 52.45 93.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.096 -0.502 . . . . 1.3200000000000001 111.976 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -160.58 161.44 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 1.77 110.588 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.07 177.56 39.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.978 -1.106 . . . . 0.98999999999999999 114.632 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.588 ' OH ' ' HB3' ' A' ' 16' ' ' ALA . 6.6 m-85 -100.89 161.73 13.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 1.1899999999999999 111.958 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -115.49 122.32 45.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.952 -1.022 . . . . 2.27 111.137 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.53 109.63 45.7 Favored Pre-proline 0 C--O 1.224 -0.251 0 CA-C-O 119.367 -0.349 . . . . 1.0700000000000001 111.179 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -81.85 130.43 6.67 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.297 1.142 . . . . 1.26 112.106 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.9 mt -121.78 148.41 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.847 0.356 . . . . 1.0900000000000001 111.324 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -139.41 -0.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 3.4399999999999999 111.039 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.426 ' HG3' ' HZ1' ' A' ' 174' ' ' LYS . 12.6 mm-40 -123.74 166.02 16.28 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.659 0.266 . . . . 2.1299999999999999 110.878 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -119.7 172.95 7.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.273 0.559 . . . . 0.37 111.175 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.04 -147.23 18.9 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.02 -1.232 . . . . 0.23000000000000001 110.02 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mt-10 -105.87 109.44 21.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.603 1.201 . . . . 2.0299999999999998 109.805 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -96.65 127.22 42.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.046 -0.724 . . . . 0.94999999999999996 109.046 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' ' 177' ' ' ALA . 17.3 t -113.36 117.06 54.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.383 -0.826 . . . . 1.21 111.48 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.21 104.79 16.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.79 111.312 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -105.3 137.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.918 -1.037 . . . . 1.95 108.976 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -156.14 135.42 12.2 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.501 -0.88 . . . . 2.0 112.368 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.678 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 3.5 mptt -97.38 127.47 43.36 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.918 -0.713 . . . . 3.3799999999999999 109.331 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.445 ' CD2' HD22 ' A' ' 115' ' ' LEU . 3.1 m-85 -106.94 137.12 45.6 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.217 -0.66 . . . . 0.34999999999999998 109.217 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.51 153.16 52.08 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.75 -0.38 . . . . 1.1499999999999999 110.35 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -124.41 -75.59 0.6 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.469 -0.332 . . . . 3.9700000000000002 111.19 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 93' ' ' TYR . 36.9 t 66.3 160.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.482 -0.326 . . . . 4.3099999999999996 111.413 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.472 ' N ' HG12 ' A' ' 92' ' ' VAL . 0.3 OUTLIER 82.03 -64.59 0.13 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.256 0.623 . . . . 3.0099999999999998 111.902 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -86.6 158.16 19.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.976 0.417 . . . . 2.0 111.563 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HA ' ' CE1' ' A' ' 118' ' ' PHE . . . -134.66 84.36 2.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.9 -0.591 . . . . 1.6599999999999999 111.388 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 26.7 mt-30 -146.13 140.64 26.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.376 -0.375 . . . . 3.6000000000000001 111.636 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.2 p -124.54 154.54 40.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 1.8899999999999999 111.755 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 47.22 29.2 1.14 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.767 -0.651 . . . . 2.6899999999999999 111.829 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -133.96 -48.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.259 -0.645 . . . . 3.0299999999999998 109.259 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -93.21 88.79 6.17 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 3.52 109.133 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.73 152.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.531 -0.759 . . . . 1.95 109.55 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -134.37 176.28 8.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.986 0.736 . . . . 0.80000000000000004 112.986 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -121.42 139.44 53.45 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.06 -0.518 . . . . 2.0099999999999998 111.206 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.68 130.6 42.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.641 -0.709 . . . . 1.1599999999999999 112.04 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -131.81 153.84 49.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.14 0.793 . . . . 2.1800000000000002 113.14 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 20.4 m -121.92 120.71 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.638 -1.165 . . . . 1.71 109.613 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.401 ' HA ' ' H ' ' A' ' 154' ' ' SER . 4.4 t-20 54.28 27.17 7.6 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.998 -0.741 . . . . 1.77 108.998 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.07 23.67 29.19 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.708 -1.133 . . . . 0.40999999999999998 112.914 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.6 m-70 -122.97 108.73 13.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.209 0.818 . . . . 0.58999999999999997 113.209 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.425 ' HG1' ' HZ2' ' A' ' 113' ' ' LYS . 5.4 p -62.48 115.9 4.64 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.91 0.386 . . . . 1.2 111.642 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 t -106.38 -36.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 1.3999999999999999 109.878 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.84 92.29 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.851 -0.426 . . . . 1.21 109.851 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.425 ' HZ2' ' HG1' ' A' ' 110' ' ' THR . 1.3 ptpt -105.8 76.99 1.22 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.715 1.245 . . . . 2.9199999999999999 111.983 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 155.71 27.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.221 -2.263 . . . . 2.5600000000000001 109.073 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.445 HD22 ' CD2' ' A' ' 89' ' ' PHE . 40.5 tp -60.88 102.17 0.18 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.628 0.728 . . . . 1.71 112.531 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 36.0 p-10 -112.06 89.43 3.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.528 -1.215 . . . . 1.99 108.406 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.0 -54.05 15.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 1.23 113.526 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 13.1 t80 -56.55 -40.07 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.88 0.326 . . . . 1.01 111.88 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.65 -28.81 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.124 0.416 . . . . 0.76000000000000001 112.124 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 120' ' ' ARG . 11.6 mmm180 -75.98 -58.69 3.13 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.511 0.56 . . . . 3.0299999999999998 112.511 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -87.1 -40.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.937 0.347 . . . . 2.0299999999999998 111.937 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.76 -94.93 0.75 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 1.0600000000000001 112.284 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.517 ' O ' HG23 ' A' ' 125' ' ' THR . 73.6 m80 -112.92 110.08 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.656 0.265 . . . . 4.29 111.286 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.2 m 56.05 -132.42 1.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.187 -0.46 . . . . 2.1099999999999999 111.245 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 123' ' ' HIS . 11.0 p 57.94 -171.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.303 0.241 . . . . 1.3300000000000001 111.006 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.28 139.5 49.37 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.591 0.96 . . . . 1.1200000000000001 113.591 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.61 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.4 t60 -100.31 150.86 22.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.55 -1.204 . . . . 0.45000000000000001 107.844 176.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.61 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 8.7 p-10 -145.37 122.33 11.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.26 -0.576 . . . . 2.0899999999999999 112.208 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -119.71 141.67 49.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.513 -0.767 . . . . 2.2799999999999998 109.512 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 mt -123.4 136.23 60.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.683 -0.69 . . . . 1.3799999999999999 111.229 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 131' ' ' ILE . 4.2 mp -134.29 89.5 27.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 2.0 111.631 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.01 144.07 92.18 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.72 1.613 . . . . 0.23999999999999999 111.305 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 134' ' ' SER . 21.5 mt -135.41 154.85 36.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.563 -0.29 . . . . 1.0600000000000001 111.181 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.434 ' N ' HG23 ' A' ' 133' ' ' ILE . 35.4 p -131.09 107.08 8.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 1.6599999999999999 110.635 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.9 mt -106.98 129.65 60.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.917 -0.583 . . . . 1.0700000000000001 110.55 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -147.88 140.5 24.61 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.798 0.332 . . . . 2.4300000000000002 110.814 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.68 ' HB2' ' HZ2' ' A' ' 137' ' ' LYS . 0.6 OUTLIER 55.66 28.51 12.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.554 0.692 . . . . 3.5600000000000001 110.06 -179.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.29 27.92 62.92 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.221 -0.899 . . . . 0.32000000000000001 112.703 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 62.4 mttp -121.89 146.87 46.69 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.919 0.359 . . . . 2.6800000000000002 110.797 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -107.67 131.31 54.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.146 0.498 . . . . 1.1100000000000001 112.197 -177.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.542 ' N ' HD22 ' A' ' 140' ' ' LEU . 32.3 t -121.32 110.36 16.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.53 -0.759 . . . . 1.3700000000000001 109.618 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 142' ' ' VAL . 7.1 p -103.66 108.28 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.321 0.582 . . . . 1.23 110.968 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 60.94 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.645 -0.707 . . . . 2.0499999999999998 112.022 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -137.92 12.45 3.64 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.47 -0.871 . . . . 0.59999999999999998 113.158 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -116.88 141.14 48.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.863 0.331 . . . . 2.02 110.263 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.46 136.95 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 1.8700000000000001 111.142 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.8 t -157.93 127.31 5.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.723 -0.672 . . . . 1.46 109.824 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.2 p -58.03 142.9 45.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.294 -0.412 . . . . 1.55 111.535 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -79.42 122.03 25.9 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.125 -0.694 . . . . 0.34000000000000002 109.125 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 t -111.18 91.36 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.156 -0.618 . . . . 2.02 112.6 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.04 -33.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 117.269 1.668 . . . . 0.77000000000000002 117.269 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.643 ' HZ2' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -160.87 154.97 22.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.501 1.651 . . . . 2.3199999999999998 113.868 -176.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.504 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -87.2 127.28 35.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.96 -1.126 . . . . 1.8600000000000001 107.96 176.19 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.401 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -118.11 114.2 22.72 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.382 0.882 . . . . 1.72 113.382 -176.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.83 103.29 14.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.44 -0.578 . . . . 1.27 109.44 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.545 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.4 mt-10 -107.67 139.44 42.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 2.48 111.447 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -136.11 138.44 42.06 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.011 -0.54 . . . . 1.9199999999999999 110.002 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.434 ' CG2' HH21 ' A' ' 105' ' ' ARG . 12.0 t -115.14 143.62 24.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.95 -1.023 . . . . 1.3899999999999999 111.466 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -63.74 148.16 49.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 2.48 110.931 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.43 -29.8 8.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 1.1200000000000001 111.721 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -145.53 -55.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.545 0.212 . . . . 3.8999999999999999 111.011 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -142.24 -83.21 0.19 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.588 -0.278 . . . . 4.0999999999999996 111.51 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.14 125.16 29.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 1.3999999999999999 111.52 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 166' ' ' LYS . 1.3 m-20 -59.98 171.14 0.95 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.323 -0.853 . . . . 2.0 110.32 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -28.89 -29.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 123.312 2.675 . . . . 3.1099999999999999 114.318 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ASN . 15.6 tptp 85.28 -75.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.619 0.575 . . . . 4.1100000000000003 112.364 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 63' ' ' THR . 3.5 t -96.34 135.08 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 120.606 -0.438 . . . . 1.5900000000000001 112.017 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.22 134.96 45.95 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.98 -0.555 . . . . 1.8600000000000001 112.425 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.521 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -124.4 35.43 4.81 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.228 -0.896 . . . . 1.04 112.769 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -37.48 138.99 0.29 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.15 0.5 . . . . 1.6799999999999999 111.888 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.496 ' N ' HD12 ' A' ' 170' ' ' LEU . 0.7 OUTLIER -157.71 100.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.47 -0.786 . . . . 0.38 110.24 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.606 ' O ' HD11 ' A' ' 11' ' ' ILE . 1.3 tt -106.26 125.35 61.95 Favored 'Isoleucine or valine' 0 C--O 1.264 1.867 0 CA-C-O 122.758 1.266 . . . . 1.3500000000000001 112.553 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.585 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.7 ppp? -115.14 162.38 17.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.988 -1.915 . . . . 1.26 109.525 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.426 ' HZ1' ' HG3' ' A' ' 79' ' ' GLU . 32.2 tttt -120.34 144.15 48.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 115.272 1.582 . . . . 2.3599999999999999 115.272 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.68 -36.8 4.1 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 112.397 -2.183 . . . . 0.23000000000000001 118.398 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.551 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.48 155.15 0.3 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.908 2.354 . . . . 1.1000000000000001 115.177 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.618 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -86.73 -24.61 25.08 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 114.566 -1.197 . . . . 1.1000000000000001 108.972 175.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -57.11 -34.78 68.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.324 -0.853 . . . . 2.3100000000000001 110.657 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -52.9 -52.07 58.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.222 -0.658 . . . . 2.3700000000000001 109.222 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.8 t 62.85 120.71 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 115.482 -0.781 . . . . 3.0800000000000001 111.705 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -46.27 111.01 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.628 1.552 . . . . 2.4500000000000002 112.29 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -152.2 179.81 8.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.424 -0.353 . . . . 6.3700000000000001 110.953 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.499 ' N ' HD22 ' A' ' 183' ' ' LEU . 2.4 pt? -165.3 128.91 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 5.3499999999999996 110.679 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -62.67 144.89 95.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.419 -0.585 . . . . 8.5099999999999998 109.419 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.1 123.48 11.95 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.231 1.287 . . . . 9.6899999999999995 111.648 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.482 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 57.3 t-80 -134.73 143.95 48.59 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.883 -0.599 . . . . 10.35 110.124 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.482 ' HD2' ' CG ' ' A' ' 186' ' ' HIS . 89.0 Cg_endo -73.43 -39.99 1.78 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.813 1.675 . . . . 12.26 112.221 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.451 ' N ' ' HD1' ' A' ' 186' ' ' HIS . . . 46.38 74.23 0.25 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.895 -0.593 . . . . 12.619999999999999 112.775 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.6 mt -63.12 112.69 2.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 14.65 110.639 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.13 -0.938 . . . . 15.699999999999999 110.817 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.129 0 N-CA-C 112.474 -0.25 . . . . 9.3900000000000006 112.474 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.63 112.42 24.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 7.6799999999999997 110.81 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.7 mtt -87.01 -6.39 58.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 8.1699999999999999 110.769 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.1 m -146.38 138.7 25.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 4.25 110.902 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.47 75.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.984 -0.626 . . . . 1.8200000000000001 112.345 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.34 -50.32 54.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.147 0.499 . . . . 1.1299999999999999 110.219 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -53.26 -20.4 4.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.362 -0.835 . . . . 1.1299999999999999 111.311 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.15 -27.8 38.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.407 0.521 . . . . 2.0899999999999999 112.407 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 37.4 mmtt -95.29 -22.75 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.717 -0.393 . . . . 2.5 111.49 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.485 HG11 ' O ' ' A' ' 7' ' ' ALA . 12.7 p -43.79 143.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 120.584 0.231 . . . . 1.05 111.615 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 11' ' ' ILE . 18.3 pt -136.91 -23.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.013 -0.675 . . . . 1.48 110.487 177.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.486 ' O ' HG21 ' A' ' 172' ' ' ILE . 73.3 t90 -172.74 140.94 1.03 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.049 -0.523 . . . . 0.33000000000000002 110.091 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -159.88 143.94 14.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.271 0.471 . . . . 1.05 112.271 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 13' ' ' ALA . 4.2 t -147.02 130.98 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 113.807 1.04 . . . . 1.3600000000000001 113.807 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 15.6 t-20 -114.43 95.25 5.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.887 -1.051 . . . . 1.8700000000000001 108.553 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.662 ' HB2' ' HH ' ' A' ' 73' ' ' TYR . . . -60.18 92.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.265 -1.013 . . . . 1.1100000000000001 108.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.598 ' HA3' ' OG1' ' A' ' 63' ' ' THR . . . -177.27 -95.34 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 O-C-N 124.582 1.176 . . . . 0.67000000000000004 114.55 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.445 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -66.47 -122.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.112 -0.566 . . . . 1.1200000000000001 114.039 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.761 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 1.5 tt0 -159.09 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.388 -0.406 . . . . 2.02 110.158 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.0 m 31.61 95.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.512 -0.767 . . . . 1.6499999999999999 112.68 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.643 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 22.8 t60 -123.59 139.96 53.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.787 -0.765 . . . . 0.41999999999999998 112.5 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.03 104.07 16.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.668 -0.696 . . . . 1.8200000000000001 110.582 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 157.03 29.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.194 -0.912 . . . . 1.1699999999999999 110.662 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -43.73 -47.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 O-C-N 124.367 1.042 . . . . 1.27 113.277 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -62.57 -20.18 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.318 0.58 . . . . 0.55000000000000004 110.386 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.34 34.89 3.25 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.208 -0.905 . . . . 0.32000000000000001 112.542 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.01 114.84 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 120.459 -0.496 . . . . 1.21 110.455 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.643 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.5 t60 -100.42 136.35 40.43 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.915 1.45 . . . . 0.68999999999999995 114.915 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.761 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -102.23 135.99 42.85 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.698 -1.137 . . . . 3.3199999999999998 108.753 177.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -86.29 106.99 17.75 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.796 0.685 . . . . 3.3999999999999999 112.303 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.614 ' NZ ' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -34.21 137.06 0.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.121 -0.945 . . . . 3.1600000000000001 113.296 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER 3.0 79.7 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 114.748 -1.115 . . . . 1.98 113.551 178.299 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -96.82 -25.11 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.188 1.925 . . . . 1.53 114.095 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.564 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -112.58 -30.76 7.0 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.814 -0.354 . . . . 2.3599999999999999 110.976 -179.288 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -70.78 79.11 0.61 Allowed 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.229 -0.656 . . . . 4.9500000000000002 109.229 179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 74.64 -10.44 8.76 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.966 -1.254 . . . . 2.3300000000000001 109.966 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.528 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER 59.27 7.88 1.0 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.737 -0.732 . . . . 5.8700000000000001 111.231 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 36' ' ' GLY . 16.7 m -148.91 117.77 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 115.935 -0.575 . . . . 3.48 110.252 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.77 -139.03 2.6 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.555 -0.831 . . . . 2.5899999999999999 112.631 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -146.04 -69.22 0.27 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.447 0.165 . . . . 7.3300000000000001 111.27 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -177.75 -58.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.605 -0.27 . . . . 2.0099999999999998 111.283 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.6 t 63.02 41.07 8.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 2.2999999999999998 110.525 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' HB2' ' SD ' ' A' ' 46' ' ' MET . 7.0 p-10 -77.89 73.45 4.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.937 -0.574 . . . . 2.23 110.185 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -97.48 -17.1 19.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.833 -0.621 . . . . 2.6000000000000001 110.999 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.98 35.5 4.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.715 -0.755 . . . . 2.6600000000000001 112.645 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.455 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 74.6 mmm -86.34 -3.54 59.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.467 . . . . 2.4300000000000002 110.468 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -81.08 16.22 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.651 -0.704 . . . . 3.79 111.196 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.2 tp -148.39 62.01 6.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 3.23 110.216 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -50.06 124.22 12.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.985 2.457 . . . . 1.9399999999999999 113.736 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.01 109.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.537 -0.912 . . . . 1.45 108.537 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -54.55 26.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.579 -1.191 . . . . 2.29 114.103 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -74.62 28.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.53 0.937 . . . . 3.0600000000000001 113.53 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t -141.11 145.08 35.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.137 0.494 . . . . 1.4099999999999999 112.133 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.1 t30 -63.47 146.9 96.08 Favored Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 115.484 -0.78 . . . . 1.96 109.596 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.2 Cg_exo -40.81 -58.89 0.88 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 122.631 2.221 . . . . 0.78000000000000003 115.249 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -62.21 -54.37 41.91 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 122.298 1.047 . . . . 1.8200000000000001 110.76 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -69.83 -11.64 61.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.036 -0.983 . . . . 1.9099999999999999 110.215 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.614 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -64.45 -45.71 86.26 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.491 -1.67 . . . . 2.0600000000000001 106.491 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.8 t -54.19 -51.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.403 -1.271 . . . . 1.8500000000000001 109.352 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.54 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.9 tp -70.49 -7.2 41.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.586 -0.734 . . . . 1.6000000000000001 111.426 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.0 m-30 -120.08 16.03 12.42 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.478 -0.783 . . . . 1.29 109.719 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.537 ' HG2' ' N ' ' A' ' 63' ' ' THR . 30.6 tt0 -141.25 -109.92 0.14 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.305 -0.861 . . . . 1.8 110.596 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.598 ' OG1' ' HA3' ' A' ' 17' ' ' GLY . 69.2 p 37.26 -156.02 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 119.082 -0.485 . . . . 1.4099999999999999 110.298 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.494 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 12.6 pt-20 -174.86 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.593 1.701 . . . . 2.0499999999999998 115.593 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.544 ' NH2' ' HB2' ' A' ' 35' ' ' GLU . 7.9 mtp180 70.57 -172.79 0.17 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.062 0.392 . . . . 4.2800000000000002 110.056 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -87.25 178.83 6.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.519 -0.309 . . . . 4.4699999999999998 111.106 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -150.05 171.99 15.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.379 -0.373 . . . . 5.1500000000000004 111.121 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.41 -102.5 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.475 -0.33 . . . . 3.1699999999999999 111.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -169.85 131.68 1.08 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.646 0.26 . . . . 2.3900000000000001 111.028 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.511 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 21.7 t 53.21 93.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.252 -0.431 . . . . 1.3200000000000001 111.495 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -168.85 168.83 10.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 1.77 110.975 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -171.37 -146.2 5.15 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.248 -0.977 . . . . 0.98999999999999999 113.86 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.662 ' HH ' ' HB2' ' A' ' 16' ' ' ALA . 58.9 m-85 -135.87 172.72 12.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.719 0.771 . . . . 1.1899999999999999 112.908 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.06 135.76 53.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.068 -1.424 . . . . 2.27 110.17 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.466 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.7 mp -129.35 86.34 56.66 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 111.706 0.262 . . . . 1.0700000000000001 111.706 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.73 126.13 21.39 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.109 1.873 . . . . 1.26 112.512 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -121.05 149.89 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 1.0900000000000001 110.933 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.03 2.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 3.4399999999999999 111.425 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.622 ' HG2' ' NZ ' ' A' ' 174' ' ' LYS . 8.0 tp10 -132.11 165.99 22.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.835 0.35 . . . . 2.1299999999999999 110.092 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.522 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -116.41 178.85 4.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.37 111.642 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.87 -148.08 18.66 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 109.972 -1.251 . . . . 0.23000000000000001 109.972 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 11.1 mm-40 -105.97 110.53 22.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.701 1.251 . . . . 2.0299999999999998 109.235 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.28 126.36 41.44 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 108.954 -0.758 . . . . 0.94999999999999996 108.954 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.628 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.7 t -114.5 121.24 66.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.346 -0.843 . . . . 1.21 112.032 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.42 ' C ' HD21 ' A' ' 85' ' ' LEU . 6.5 tt -103.56 105.62 15.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.864 -1.062 . . . . 1.79 110.635 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.22 132.12 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.24 -0.891 . . . . 1.95 108.816 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -147.47 138.78 23.78 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.241 -0.984 . . . . 2.0 112.824 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.605 ' HZ3' ' HB1' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -98.95 126.61 44.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.097 -0.956 . . . . 3.3799999999999999 109.024 178.329 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.38 146.13 32.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.551 -0.75 . . . . 0.34999999999999998 110.548 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.84 146.36 34.06 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.088 -0.506 . . . . 1.1499999999999999 109.832 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' O ' HG23 ' A' ' 92' ' ' VAL . 32.2 tt0 -118.5 -56.08 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 3.9700000000000002 110.845 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 91' ' ' GLU . 8.4 m 47.95 177.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.62 -0.718 . . . . 4.3099999999999996 112.576 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 70.93 -69.23 0.19 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.567 -0.742 . . . . 3.0099999999999998 111.472 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -88.61 178.75 6.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.018 0.437 . . . . 2.0 111.266 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.96 82.21 1.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 1.6599999999999999 110.687 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -137.41 143.49 41.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 3.6000000000000001 111.019 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 99' ' ' GLN . 20.4 m -99.0 -88.4 0.33 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.686 0.624 . . . . 1.8899999999999999 112.686 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.86 36.22 0.17 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.903 0.383 . . . . 2.6899999999999999 111.558 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 97' ' ' SER . 1.8 mt-30 -133.79 -41.3 0.85 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.016 -0.538 . . . . 3.0299999999999998 109.697 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -94.39 75.86 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.293 -0.632 . . . . 3.52 109.293 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.33 154.33 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.707 -0.678 . . . . 1.95 109.851 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -139.64 173.85 11.11 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 111.968 0.359 . . . . 0.80000000000000004 111.968 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.92 137.08 54.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.589 -0.444 . . . . 2.0099999999999998 110.812 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.6 t -132.06 129.68 60.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 112.598 0.592 . . . . 1.1599999999999999 112.598 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 2.7 mtt180 -134.89 149.59 50.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.591 -0.731 . . . . 2.1800000000000002 112.82 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 14.0 m -119.28 120.8 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.313 -0.858 . . . . 1.71 109.99 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.488 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.11 27.23 9.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.42 0.628 . . . . 1.77 109.342 -176.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.5 21.33 41.08 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.016 -0.993 . . . . 0.40999999999999998 112.671 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -119.16 113.73 21.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.079 0.77 . . . . 0.58999999999999997 113.079 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -64.49 124.7 22.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.507 -0.477 . . . . 1.2 111.046 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.19 -32.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.833 -0.621 . . . . 1.3999999999999999 109.531 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.12 90.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.081 -0.509 . . . . 1.21 110.151 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 18.1 ptpt -104.19 137.85 41.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.033 -0.531 . . . . 2.9199999999999999 110.41 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 22.6 m-20 87.47 18.24 0.07 Allowed 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.025 -1.472 . . . . 2.5600000000000001 107.025 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 tp -45.78 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.983 -1.462 . . . . 1.71 111.763 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -102.89 90.41 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.162 -0.927 . . . . 1.99 109.317 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -52.15 -47.94 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 1.23 112.637 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.77 -44.61 96.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.936 0.347 . . . . 1.01 111.936 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.87 -27.73 63.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.159 0.429 . . . . 0.76000000000000001 112.159 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -70.9 -58.1 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.247 0.462 . . . . 3.0299999999999998 112.247 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -99.96 -40.29 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.073 0.398 . . . . 2.0299999999999998 112.073 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.77 -134.36 8.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.458 -0.877 . . . . 1.0600000000000001 112.568 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -83.79 120.46 26.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.585 0.231 . . . . 4.29 111.009 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.0 p 48.18 -121.96 1.47 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.095 -0.502 . . . . 2.1099999999999999 110.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.9 p 51.13 -167.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.672 0.272 . . . . 1.3300000000000001 111.635 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.605 ' HB1' ' HZ3' ' A' ' 88' ' ' LYS . . . -106.88 136.31 46.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.36 1.245 . . . . 1.1200000000000001 114.36 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.1 t60 -108.8 141.51 40.73 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.267 -1.383 . . . . 0.45000000000000001 107.267 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.29 119.33 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.772 0.656 . . . . 2.0899999999999999 112.772 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.88 136.66 52.83 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.82 -0.627 . . . . 2.2799999999999998 109.922 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.1 mt -112.51 133.33 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.44 -0.8 . . . . 1.3799999999999999 110.639 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.82 85.75 34.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.349 0.499 . . . . 2.0 112.349 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.18 146.57 90.7 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.876 1.717 . . . . 0.23999999999999999 111.784 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 134' ' ' SER . 23.7 mt -136.7 156.93 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 1.0600000000000001 110.854 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 133' ' ' ILE . 35.4 p -132.83 106.95 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 1.6599999999999999 110.836 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 25.7 mt -103.29 126.45 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.798 -0.637 . . . . 1.0700000000000001 109.609 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 88.0 mttt -148.08 138.15 22.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.878 -0.329 . . . . 2.4300000000000002 111.208 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 61.61 23.55 13.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 3.5600000000000001 110.572 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.09 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.041 -0.599 . . . . 0.32000000000000001 112.227 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 59.3 mttt -114.72 159.03 21.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.383 0.135 . . . . 2.6800000000000002 111.073 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 tt -121.09 124.15 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.076 0.465 . . . . 1.1100000000000001 111.288 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.4 ' HB3' ' OG ' ' A' ' 134' ' ' SER . 24.5 t -114.1 109.53 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.674 -0.694 . . . . 1.3700000000000001 110.014 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.57 106.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 1.23 111.031 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.95 -92.0 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.883 -0.599 . . . . 2.0499999999999998 111.814 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.87 37.6 2.28 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.596 -0.811 . . . . 0.59999999999999998 113.046 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.09 137.28 25.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.16 -0.311 . . . . 2.02 110.16 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.02 140.34 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.97 0.414 . . . . 1.8700000000000001 110.976 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -162.69 126.93 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.901 -0.59 . . . . 1.46 110.447 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 t -56.22 140.82 43.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.867 -0.606 . . . . 1.55 112.406 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -79.62 139.24 37.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.403 -0.817 . . . . 0.34000000000000002 109.284 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 36.0 p -136.11 95.88 3.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.223 0.823 . . . . 2.02 113.223 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.23 -60.7 1.46 Allowed Glycine 0 C--N 1.331 0.282 0 N-CA-C 115.549 0.98 . . . . 0.77000000000000002 115.549 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -148.68 176.44 10.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.061 0.931 . . . . 2.3199999999999998 112.978 -178.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.488 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.55 127.25 48.34 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.685 -1.228 . . . . 1.8600000000000001 107.685 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.3 t -115.18 115.93 27.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.421 -0.912 . . . . 1.72 113.433 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.78 97.54 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.249 -0.649 . . . . 1.27 109.249 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 tt0 -108.04 135.74 48.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 2.48 111.407 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -130.84 143.2 50.57 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.747 -0.66 . . . . 1.9199999999999999 109.729 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.6 t -122.66 144.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.421 -0.809 . . . . 1.3899999999999999 111.653 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 146.36 30.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.738 -0.664 . . . . 2.48 110.88 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.9 -17.24 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.868 -0.682 . . . . 1.1200000000000001 112.14 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -138.44 -61.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 3.8999999999999999 110.429 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -175.25 150.9 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.097 -0.501 . . . . 4.0999999999999996 110.877 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.18 89.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.194 -0.457 . . . . 1.3999999999999999 111.437 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 70' ' ' SER . 1.4 m-20 -54.76 169.35 0.41 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.017 -0.538 . . . . 2.0 109.792 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 164' ' ' ASN . 2.8 Cg_endo -36.4 105.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.321 2.014 . . . . 3.1099999999999999 111.63 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -60.53 -46.74 89.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.269 -0.878 . . . . 4.1100000000000003 112.34 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.1 t -116.1 135.02 57.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 112.807 0.669 . . . . 1.5900000000000001 112.807 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -137.54 137.41 38.57 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 113.389 0.885 . . . . 1.8600000000000001 113.389 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 60' ' ' LEU . . . -125.03 38.6 4.16 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.62 -1.173 . . . . 1.04 111.397 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.5 tp -50.11 127.05 15.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.737 -0.665 . . . . 1.6799999999999999 111.448 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.409 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -142.09 115.5 8.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.667 -0.697 . . . . 0.38 110.831 -178.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.486 HG21 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -115.99 129.63 72.03 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 CA-C-O 123.126 1.441 . . . . 1.3500000000000001 112.994 178.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.58 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.0 ppp? -124.24 168.4 13.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.957 -1.929 . . . . 1.26 109.834 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.622 ' NZ ' ' HG2' ' A' ' 79' ' ' GLU . 13.8 ptmt -120.45 156.05 32.26 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.167 1.543 . . . . 2.3599999999999999 115.167 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 86.46 -34.87 3.4 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 111.833 -2.439 . . . . 0.23000000000000001 118.082 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.546 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.62 158.55 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.209 2.004 . . . . 1.1000000000000001 114.249 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.628 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.44 -23.73 27.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.331 -0.849 . . . . 1.1000000000000001 110.425 177.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.59 -29.68 66.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.692 -0.686 . . . . 2.3100000000000001 111.649 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.14 -43.67 91.13 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.032 -0.267 . . . . 2.3700000000000001 110.538 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 94.8 t -44.01 101.34 0.25 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.879 -0.601 . . . . 3.0800000000000001 111.599 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.6 139.36 38.74 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.012 1.808 . . . . 2.4500000000000002 112.617 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.6 mmt -147.18 127.01 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.9 -0.591 . . . . 6.3700000000000001 110.692 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.24 122.23 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.029 -0.532 . . . . 5.3499999999999996 111.146 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -52.36 149.61 9.99 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.961 -0.563 . . . . 8.5099999999999998 110.313 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.64 124.36 12.27 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.653 1.569 . . . . 9.6899999999999995 112.037 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.669 ' HD1' ' H ' ' A' ' 188' ' ' GLY . 27.8 t-80 -134.68 132.92 20.88 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.241 -0.436 . . . . 10.35 110.48 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.49 -36.57 2.92 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.989 1.793 . . . . 12.26 112.444 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.669 ' H ' ' HD1' ' A' ' 186' ' ' HIS . . . -87.68 -101.33 0.89 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.934 -0.65 . . . . 12.619999999999999 112.618 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.9 104.24 1.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.731 0.301 . . . . 14.65 110.409 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 1.4 pm0 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.123 -0.941 . . . . 15.699999999999999 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.561 -0.216 . . . . 9.3900000000000006 112.561 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.27 83.7 1.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 7.6799999999999997 110.85 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.2 mtt 56.63 80.8 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 8.1699999999999999 110.983 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -98.92 -25.31 14.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 4.25 110.661 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.37 73.99 1.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.923 -0.656 . . . . 1.8200000000000001 112.833 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.1 tp -74.42 -49.54 22.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.143 0.497 . . . . 1.1299999999999999 109.812 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.502 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.95 -21.72 22.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.822 . . . . 1.1299999999999999 111.162 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.7 -19.78 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 2.0899999999999999 111.909 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -101.44 -23.39 14.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.949 -0.301 . . . . 2.5 111.282 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.1 p -45.71 141.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.735 0.303 . . . . 1.05 111.725 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.28 -21.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.324 -0.551 . . . . 1.48 110.355 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.531 ' O ' HG22 ' A' ' 172' ' ' ILE . 60.4 t90 -173.83 144.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.33000000000000002 109.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -164.31 144.91 8.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.628 0.603 . . . . 1.05 112.628 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.72 129.49 6.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 113.661 0.986 . . . . 1.3600000000000001 113.661 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 60' ' ' LEU . 49.1 t30 -111.52 87.1 2.47 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.934 -1.136 . . . . 1.8700000000000001 107.934 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.433 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -57.52 103.67 0.14 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.447 -1.251 . . . . 1.1100000000000001 109.983 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.587 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 154.2 -17.95 0.62 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 113.898 -1.501 . . . . 0.67000000000000004 115.576 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.7 -126.56 2.77 Favored Glycine 0 N--CA 1.459 0.191 0 C-N-CA 119.367 -1.396 . . . . 1.1200000000000001 113.529 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.566 ' HG3' ' HZ1' ' A' ' 31' ' ' LYS . 6.7 tt0 -165.67 120.23 1.23 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.905 0.383 . . . . 2.02 111.695 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.2 p 32.88 94.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.244 -0.889 . . . . 1.6499999999999999 112.882 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.3 t60 -128.9 137.61 51.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.826 -0.75 . . . . 0.41999999999999998 112.351 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 22' ' ' VAL . 6.0 p -113.68 105.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-O 121.387 0.613 . . . . 1.8200000000000001 111.462 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 156.53 36.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.513 -0.767 . . . . 1.1699999999999999 109.851 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 m -43.35 -46.72 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.761 1.023 . . . . 1.27 113.761 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -63.54 -13.91 45.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.55000000000000004 110.914 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.71 33.04 5.45 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.501 -0.772 . . . . 0.32000000000000001 112.527 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.407 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 23.3 mm -103.92 112.23 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.184 0.516 . . . . 1.21 110.497 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.2 t60 -98.64 136.24 39.0 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.447 1.277 . . . . 0.68999999999999995 114.447 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.89 132.32 43.58 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.73 -1.123 . . . . 3.3199999999999998 108.649 177.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 22.8 mtt-85 -84.04 103.75 13.53 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 124.27 0.981 . . . . 3.3999999999999999 112.685 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.566 ' HZ1' ' HG3' ' A' ' 19' ' ' GLU . 15.9 ttmm -14.61 124.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.003 1.112 . . . . 3.1600000000000001 114.003 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -13.84 81.5 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.912 1.285 . . . . 1.98 113.822 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -110.22 21.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.188 2.592 . . . . 1.53 113.305 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.745 ' H ' HH12 ' A' ' 65' ' ' ARG . 1.5 tt -58.52 -75.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.917 -0.313 . . . . 2.3599999999999999 110.461 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 34' ' ' LEU . 3.6 mt-10 177.44 107.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.678 0.621 . . . . 4.9500000000000002 112.678 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.12 -0.86 60.53 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.678 -0.773 . . . . 2.3300000000000001 112.439 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.717 ' HB2' HH21 ' A' ' 65' ' ' ARG . 1.0 OUTLIER -128.42 75.69 1.65 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.915 -0.314 . . . . 5.8700000000000001 110.78 -178.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.0 123.65 65.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 3.48 111.018 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.22 64.04 3.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.93 -0.652 . . . . 2.5899999999999999 112.85 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -145.17 -67.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.556 0.217 . . . . 7.3300000000000001 110.884 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 64.81 120.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.285 -0.416 . . . . 2.0099999999999998 111.118 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 9.2 t -96.42 57.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 2.2999999999999998 111.031 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.34 23.56 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.153 -0.476 . . . . 2.23 110.185 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' A' ' 42' ' ' SER . 58.5 t80 -54.4 102.71 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.7 -0.682 . . . . 2.6000000000000001 110.911 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.94 106.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.788 -0.72 . . . . 2.6600000000000001 112.653 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 41.9 mmm -84.83 -3.83 58.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 2.4300000000000002 110.189 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 162.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.813 -0.63 . . . . 3.79 110.027 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.51 53.63 6.31 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 109.645 -0.502 . . . . 3.23 109.645 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HB2' ' CD ' ' A' ' 58' ' ' GLN . 42.0 Cg_endo -82.14 168.48 15.17 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.509 2.139 . . . . 1.9399999999999999 112.728 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 50' ' ' ILE . 1.2 mp -70.88 137.56 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.119 -0.491 . . . . 1.45 110.567 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.28 -48.15 7.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.098 0.777 . . . . 2.29 113.098 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -76.44 36.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.046 0.758 . . . . 3.0600000000000001 113.046 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -151.45 145.01 24.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.075 0.464 . . . . 1.4099999999999999 111.776 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.9 t30 -58.96 144.84 81.39 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.543 -0.753 . . . . 1.96 110.822 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.648 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.98 -53.68 2.82 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.949 2.433 . . . . 0.78000000000000003 115.383 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -64.92 -55.28 20.23 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 122.474 1.131 . . . . 1.8200000000000001 110.442 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.51 -9.25 53.02 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.721 -1.127 . . . . 1.9099999999999999 109.733 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.648 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.1 tt0 -66.32 -49.68 66.18 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.834 -1.543 . . . . 2.0600000000000001 106.834 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.32 -46.01 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.985 -1.007 . . . . 1.8500000000000001 109.385 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.458 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.4 tp -72.29 -12.99 61.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.409 -0.814 . . . . 1.6000000000000001 111.376 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -120.71 20.61 11.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.6 -0.727 . . . . 1.29 111.494 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.462 ' O ' HG22 ' A' ' 167' ' ' VAL . 32.4 tt0 -137.86 -59.61 0.65 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.35 0.87 . . . . 1.8 113.35 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.509 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 82.8 p -39.53 143.87 0.19 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.213 0.82 . . . . 1.4099999999999999 113.213 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.587 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.6 OUTLIER -127.28 145.06 50.92 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.897 -0.592 . . . . 2.0499999999999998 111.51 -179.258 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.745 HH12 ' H ' ' A' ' 34' ' ' LEU . 47.6 ttt180 -107.34 172.0 7.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.895 -0.593 . . . . 4.2800000000000002 110.015 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -57.72 174.97 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 4.4699999999999998 110.97 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.515 ' HB2' ' OD1' ' A' ' 164' ' ' ASN . 2.7 p-10 -150.26 167.48 26.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 5.1500000000000004 111.632 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.8 tp10 -163.02 -83.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.042 -0.526 . . . . 3.1699999999999999 111.311 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.485 ' HB2' ' HZ1' ' A' ' 159' ' ' LYS . 2.9 p30 -173.37 132.43 0.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.398 0.142 . . . . 2.3900000000000001 110.845 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t 43.4 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.426 -0.352 . . . . 1.3200000000000001 110.425 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.482 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 0.6 OUTLIER -149.3 158.22 44.0 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.8 -0.36 . . . . 1.77 111.569 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.45 -149.21 7.71 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.24 -0.981 . . . . 0.98999999999999999 114.367 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -129.71 168.84 15.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.543 0.687 . . . . 1.1899999999999999 112.536 -177.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.52 132.52 55.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.451 -1.25 . . . . 2.27 110.348 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 75' ' ' ILE . 4.4 mp -124.88 86.89 55.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.437 0.532 . . . . 1.0700000000000001 112.437 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -55.37 132.41 52.05 Favored 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 122.271 1.981 . . . . 1.26 112.325 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 77' ' ' ILE . 66.2 mt -127.93 151.31 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.231 -0.441 . . . . 1.0900000000000001 111.067 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -140.84 1.38 1.68 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.173 -0.467 . . . . 3.4399999999999999 111.193 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 11.3 mm-40 -124.34 172.98 8.7 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.592 0.234 . . . . 2.1299999999999999 110.819 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.24 165.37 19.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.379 0.609 . . . . 0.37 111.658 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.06 26.51 Favored Glycine 0 C--N 1.329 0.144 0 N-CA-C 109.874 -1.29 . . . . 0.23000000000000001 109.874 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.577 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -96.95 107.25 19.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.95 1.375 . . . . 2.0299999999999998 108.857 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.466 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 1.9 m-85 -95.39 127.46 41.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.573 0.702 . . . . 0.94999999999999996 109.189 -178.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.578 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.1 t -118.04 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.853 -1.067 . . . . 1.21 113.284 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.48 105.96 17.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.121 -0.945 . . . . 1.79 110.381 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.4 106.12 18.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.14 -0.689 . . . . 1.95 109.14 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.446 ' N ' HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.486 -0.486 . . . . 2.0 112.248 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.44 ' HZ3' ' HB2' ' A' ' 128' ' ' ASP . 10.6 tptp -106.59 115.89 30.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.272 -1.01 . . . . 3.3799999999999999 108.272 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 9.9 m-85 -104.77 143.64 32.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.535 -0.543 . . . . 0.34999999999999998 109.535 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.418 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -149.63 155.62 40.55 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.088 -0.645 . . . . 1.1499999999999999 111.001 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -165.32 152.62 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.95 0.405 . . . . 3.9700000000000002 111.238 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.03 -21.83 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.75 -0.659 . . . . 4.3099999999999996 110.401 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.76 135.0 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 3.0099999999999998 111.057 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 61.39 97.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.075 -0.511 . . . . 2.0 110.871 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.53 79.07 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 1.6599999999999999 111.174 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 2.4 pp0? -135.25 157.22 47.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 3.6000000000000001 110.768 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.409 ' HB3' ' OD2' ' A' ' 119' ' ' ASP . 10.8 m -137.65 147.72 45.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 1.8899999999999999 111.708 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 54.03 24.75 4.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.868 -0.606 . . . . 2.6899999999999999 111.288 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -125.32 -56.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.602 -0.518 . . . . 3.0299999999999998 109.602 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -94.63 96.78 9.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.069 -0.715 . . . . 3.52 109.069 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.522 HG12 ' OD2' ' A' ' 116' ' ' ASP . 0.6 OUTLIER -109.2 148.99 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 1.95 110.553 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -120.35 -178.27 3.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.839 0.681 . . . . 0.80000000000000004 112.839 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -130.98 143.08 50.46 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 115.876 -0.602 . . . . 2.0099999999999998 112.131 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.22 132.68 46.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 112.151 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 12.9 ptt180 -134.35 151.65 51.35 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 115.318 -0.855 . . . . 2.1800000000000002 112.738 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 10.7 m -124.99 123.95 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.752 -1.113 . . . . 1.71 110.384 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 52.72 26.79 4.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.991 -0.744 . . . . 1.77 108.991 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.81 29.34 18.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.40999999999999998 112.666 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 80.3 m-70 -129.43 111.16 12.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.266 0.839 . . . . 0.58999999999999997 113.266 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -65.75 119.21 10.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.022 0.439 . . . . 1.2 111.259 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.52 -33.48 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.625 -0.716 . . . . 1.3999999999999999 110.015 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.58 90.54 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.214 -0.661 . . . . 1.21 109.214 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -103.39 77.1 1.48 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 122.295 1.045 . . . . 2.9199999999999999 111.406 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.5 p30 156.87 35.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.67 -1.605 . . . . 2.5600000000000001 109.152 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 93.81 0.14 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.292 0.568 . . . . 1.71 111.677 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.522 ' OD2' HG12 ' A' ' 101' ' ' VAL . 6.4 m-20 -104.58 81.12 1.75 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.766 -1.568 . . . . 1.99 106.766 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.3 mt -50.35 -38.29 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.972 -1.013 . . . . 1.23 112.821 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 14.1 t80 -71.09 -43.46 67.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.862 -0.335 . . . . 1.01 111.476 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.409 ' OD2' ' HB3' ' A' ' 97' ' ' SER . 9.4 t70 -66.12 -27.35 67.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.657 0.265 . . . . 0.76000000000000001 111.38 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -72.18 -58.6 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.488 0.551 . . . . 3.0299999999999998 112.488 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 m -96.33 -40.4 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.943 0.349 . . . . 2.0299999999999998 111.943 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.89 -98.85 1.89 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.721 . . . . 1.0600000000000001 112.046 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -68.56 159.43 31.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.026 -0.361 . . . . 4.29 110.026 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.4 p -57.4 94.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 2.1099999999999999 110.963 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.403 ' O ' HG13 ' A' ' 50' ' ' ILE . 23.8 p -140.75 -148.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 1.3300000000000001 110.029 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.439 ' HB2' ' HZ2' ' A' ' 88' ' ' LYS . . . -112.8 133.84 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.747 0.647 . . . . 1.1200000000000001 112.747 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.516 ' HD1' ' H ' ' A' ' 128' ' ' ASP . 1.9 t60 -111.53 149.29 31.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.494 -0.928 . . . . 0.45000000000000001 108.494 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.516 ' H ' ' HD1' ' A' ' 127' ' ' HIS . 19.5 t70 -141.73 132.07 25.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.31 0.576 . . . . 2.0899999999999999 112.517 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.96 114.36 16.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.137 -0.938 . . . . 2.2799999999999998 109.891 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.19 129.99 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 1.3799999999999999 110.55 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.4 89.52 47.19 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.417 -0.356 . . . . 2.0 111.933 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -64.05 150.57 88.08 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.056 1.837 . . . . 0.23999999999999999 112.011 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 134' ' ' SER . 34.2 mt -140.55 157.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.336 . . . . 1.0600000000000001 111.018 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.503 ' N ' HG22 ' A' ' 133' ' ' ILE . 35.4 p -133.53 106.41 7.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 1.6599999999999999 110.747 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 32.5 mt -105.5 126.51 60.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.761 -0.654 . . . . 1.0700000000000001 109.865 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.458 ' HZ2' ' HB2' ' A' ' 134' ' ' SER . 50.4 mttp -148.38 143.59 26.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.769 0.319 . . . . 2.4300000000000002 110.961 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt 57.69 13.89 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 3.5600000000000001 111.287 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.15 23.48 27.12 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.641 -0.79 . . . . 0.32000000000000001 113.075 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 1.3 mmmm -123.57 155.48 37.56 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.236 0.518 . . . . 2.6800000000000002 110.41 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -113.45 129.47 56.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.076 0.465 . . . . 1.1100000000000001 111.878 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.514 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.0 t -116.66 110.01 17.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 1.3700000000000001 109.472 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 142' ' ' VAL . 7.5 p -103.11 104.55 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.966 -0.561 . . . . 1.23 111.011 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 57.96 -91.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.965 -0.561 . . . . 2.0499999999999998 111.856 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.9 6.12 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.554 -0.831 . . . . 0.59999999999999998 113.414 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -127.79 136.08 50.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.056 -0.349 . . . . 2.02 110.056 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.15 136.96 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.049 0.452 . . . . 1.8700000000000001 111.141 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 m -155.93 175.3 14.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.761 -0.654 . . . . 1.46 109.26 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.29 141.78 32.67 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.604 -0.438 . . . . 1.55 111.757 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -77.63 129.99 36.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.477 -0.935 . . . . 0.34000000000000002 108.477 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 69.3 p -126.61 94.92 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.506 0.928 . . . . 2.02 113.506 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.03 -51.24 0.74 Allowed Glycine 0 CA--C 1.52 0.371 0 N-CA-C 116.328 1.291 . . . . 0.77000000000000002 116.328 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.512 ' HE2' ' N ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -156.37 164.31 38.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 118.443 1.121 . . . . 2.3199999999999998 112.618 -177.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -88.39 127.11 35.49 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.357 -1.349 . . . . 1.8600000000000001 107.357 177.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 t -113.42 112.91 24.42 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.698 -0.801 . . . . 1.72 112.988 -176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 104.06 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.277 -0.419 . . . . 1.27 110.344 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -125.11 156.94 37.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.226 0.536 . . . . 2.48 111.357 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.87 145.23 41.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.338 -0.846 . . . . 1.9199999999999999 110.065 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 t -115.31 143.92 24.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.414 -0.812 . . . . 1.3899999999999999 111.02 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.485 ' HZ1' ' HB2' ' A' ' 69' ' ' ASP . 24.3 pttm -75.92 144.59 40.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.483 -0.78 . . . . 2.48 111.116 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.62 -31.76 7.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.827 -0.701 . . . . 1.1200000000000001 111.745 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.42 -56.96 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.458 . . . . 3.8999999999999999 109.925 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -172.45 148.07 1.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.654 -0.703 . . . . 4.0999999999999996 110.372 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 65.42 71.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.277 0.56 . . . . 1.3999999999999999 111.07 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.515 ' OD1' ' HB2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -50.25 169.67 0.19 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 114.93 -1.032 . . . . 2.0 109.443 178.171 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -37.22 110.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 121.773 1.649 . . . . 3.1099999999999999 111.979 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.529 ' HZ3' ' HO3' ' A' ' 191' ' ' NGR . 12.0 tptp -64.27 -69.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.091 -0.959 . . . . 4.1100000000000003 112.93 -177.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 62' ' ' GLN . 91.9 t -87.27 132.1 33.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 112.044 0.386 . . . . 1.5900000000000001 112.044 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.58 123.41 21.29 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.759 0.662 . . . . 1.8600000000000001 112.669 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.423 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -118.84 40.46 3.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.748 -1.115 . . . . 1.04 112.985 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 tp -56.05 129.16 38.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.462 0.649 . . . . 1.6799999999999999 111.035 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -139.95 114.03 8.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.041 -0.982 . . . . 0.38 109.743 -178.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.531 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -111.23 126.78 68.64 Favored 'Isoleucine or valine' 0 C--O 1.258 1.513 0 CA-C-O 122.947 1.356 . . . . 1.3500000000000001 113.353 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.61 165.95 14.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.141 -1.845 . . . . 1.26 109.539 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 10.6 ptmt -120.36 142.9 48.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 114.886 1.439 . . . . 2.3599999999999999 114.886 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.4 -34.89 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 112.837 -1.983 . . . . 0.23000000000000001 117.737 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.557 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.27 158.26 0.47 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.393 2.096 . . . . 1.1000000000000001 114.26 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.578 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.18 -27.96 24.22 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 114.729 -1.123 . . . . 1.1000000000000001 110.034 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -59.23 -29.05 67.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.6 -0.727 . . . . 2.3100000000000001 111.153 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.9 -49.54 71.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.385 . . . . 2.3700000000000001 110.138 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 22.1 t -38.72 100.38 0.21 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 115.872 -0.603 . . . . 3.0800000000000001 111.588 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.47 115.05 1.71 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.039 1.826 . . . . 2.4500000000000002 112.602 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 67.9 mtt -109.84 149.06 30.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 6.3700000000000001 110.583 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.51 ' N ' HD22 ' A' ' 183' ' ' LEU . 1.9 pt? -154.24 128.92 9.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.002 0.43 . . . . 5.3499999999999996 110.938 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -62.77 148.04 92.25 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.878 -0.601 . . . . 8.5099999999999998 109.899 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.08 127.17 19.55 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.557 1.505 . . . . 9.6899999999999995 112.032 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.587 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 41.4 t60 -130.76 129.53 22.68 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.111 -0.495 . . . . 10.35 110.683 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.587 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 10.3 Cg_endo -84.52 -32.65 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.178 1.918 . . . . 12.26 112.906 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.439 ' N ' ' HG2' ' A' ' 187' ' ' PRO . . . 156.76 157.53 8.4 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.376 -0.916 . . . . 12.619999999999999 112.723 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.22 153.15 33.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 14.65 110.785 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.343 -0.837 . . . . 15.699999999999999 110.723 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . 0.529 ' HO3' ' HZ3' ' A' ' 166' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.507 -0.237 . . . . 9.3900000000000006 112.507 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.98 20.83 6.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.828 0.346 . . . . 7.6799999999999997 110.945 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 tpt -146.4 -55.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 8.1699999999999999 110.677 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.4 p -68.72 172.38 6.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 4.25 110.489 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.69 67.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 1.8200000000000001 112.484 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.4 tp -80.27 -47.23 14.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.25 0.547 . . . . 1.1299999999999999 110.344 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.457 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -53.85 -21.54 7.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 1.1299999999999999 111.77 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.98 -23.41 41.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.637 0.606 . . . . 2.0899999999999999 112.637 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.57 -21.27 15.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.618 -0.433 . . . . 2.5 111.871 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 7' ' ' ALA . 12.6 p -44.37 144.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 121.146 -0.221 . . . . 1.05 111.245 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -135.86 -20.33 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 119.686 -0.806 . . . . 1.48 111.258 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.504 ' O ' HG21 ' A' ' 172' ' ' ILE . 23.5 t90 -174.07 139.54 0.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.765 -0.374 . . . . 0.33000000000000002 110.17 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.21 142.04 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.101 0.408 . . . . 1.05 112.101 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.9 t -147.52 129.29 6.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 114.567 1.321 . . . . 1.3600000000000001 114.567 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 15.6 t30 -115.23 96.72 5.81 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.089 0.471 . . . . 1.8700000000000001 110.385 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -68.16 114.19 6.45 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 115.683 -0.689 . . . . 1.1100000000000001 109.709 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' C ' ' HB ' ' A' ' 63' ' ' THR . . . 145.61 -36.06 1.37 Allowed Glycine 0 C--N 1.342 0.882 0 O-C-N 124.767 1.292 . . . . 0.67000000000000004 113.674 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.497 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -110.5 -132.37 6.2 Favored Glycine 0 N--CA 1.454 -0.102 0 C-N-CA 120.313 -0.946 . . . . 1.1200000000000001 113.36 -178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.31 120.75 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.588 0.233 . . . . 2.02 110.669 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 77.8 p 28.46 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.598 -0.728 . . . . 1.6499999999999999 112.672 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.573 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 75.8 t60 -119.11 151.6 38.0 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.921 -0.712 . . . . 0.41999999999999998 112.343 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.59 103.71 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.27 -0.877 . . . . 1.8200000000000001 109.969 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.83 153.19 42.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.074 -0.512 . . . . 1.1699999999999999 110.305 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.4 m -43.76 -51.26 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 124.17 0.919 . . . . 1.27 113.212 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -58.68 -17.92 26.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.134 0.492 . . . . 0.55000000000000004 110.532 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.11 35.51 3.92 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.32000000000000001 112.432 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 27' ' ' ILE . 35.7 mm -103.62 121.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.858 -0.423 . . . . 1.21 109.858 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.4 t60 -103.27 134.75 46.14 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.686 1.365 . . . . 0.68999999999999995 114.686 -176.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.23 132.52 44.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.055 -0.975 . . . . 3.3199999999999998 108.77 176.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 50.1 mtt180 -87.51 108.45 19.04 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.666 0.604 . . . . 3.3999999999999999 112.047 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 32' ' ' ASP . 39.0 tttt -23.57 135.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.947 0.899 . . . . 3.1600000000000001 112.97 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 4.1 p-10 -11.41 84.04 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 124.228 0.955 . . . . 1.98 112.884 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 13.5 Cg_endo -97.65 -10.3 0.58 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.51 2.14 . . . . 1.53 114.856 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.508 ' C ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -114.58 -16.51 11.86 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.845 -0.742 . . . . 2.3599999999999999 112.809 -178.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.476 ' N ' HD11 ' A' ' 34' ' ' LEU . 12.6 mm-40 -96.14 72.92 2.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 4.9500000000000002 110.914 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.85 -2.99 47.11 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.601 -0.809 . . . . 2.3300000000000001 111.187 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 33.49 64.28 0.32 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.03 -0.585 . . . . 5.8700000000000001 111.527 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.59 141.28 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.585 -0.734 . . . . 3.48 110.626 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -42.72 101.99 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 CA-C-N 116.239 -0.437 . . . . 2.5899999999999999 113.437 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.705 ' HB3' HH22 ' A' ' 65' ' ' ARG . 58.4 ttt180 -175.11 148.4 0.99 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.732 0.301 . . . . 7.3300000000000001 110.563 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.24 -60.4 0.28 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.379 -0.373 . . . . 2.0099999999999998 110.964 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t 61.68 97.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 2.2999999999999998 111.317 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -95.73 -26.25 15.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.532 . . . . 2.23 110.31 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.9 t80 64.28 -75.52 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.768 -0.651 . . . . 2.6000000000000001 111.007 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.55 112.83 0.56 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.602 -0.808 . . . . 2.6600000000000001 112.693 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.1 mtt -81.33 -1.54 45.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.351 0.596 . . . . 2.4300000000000002 109.396 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -48.96 -22.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.892 -1.049 . . . . 3.79 112.102 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.51 73.72 4.16 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.156 -0.683 . . . . 3.23 109.156 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HB2' ' CD ' ' A' ' 58' ' ' GLN . 16.6 Cg_endo -90.39 170.46 3.84 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.674 2.249 . . . . 1.9399999999999999 114.322 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 61' ' ' TYR . 1.1 mp -75.4 148.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.095 -0.957 . . . . 1.45 110.16 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -94.48 -51.75 4.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.176 0.806 . . . . 2.29 113.176 -177.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -74.25 36.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.205 0.817 . . . . 3.0600000000000001 113.205 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -150.32 149.48 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 1.4099999999999999 112.041 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 58' ' ' GLN . 44.1 t30 -64.29 147.07 97.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.511 -0.768 . . . . 1.96 109.925 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 20.8 Cg_exo -41.7 -50.62 4.79 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 122.366 2.044 . . . . 0.78000000000000003 114.218 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -55.36 14.26 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.934 0.873 . . . . 1.8200000000000001 110.978 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' HD21 ' A' ' 60' ' ' LEU . 14.2 t70 -67.96 -11.37 58.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.649 -0.705 . . . . 1.9099999999999999 109.387 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.647 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 20.9 tt0 -65.95 -49.23 68.64 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.007 -1.479 . . . . 2.0600000000000001 107.007 177.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -51.15 -47.51 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.011 -0.995 . . . . 1.8500000000000001 109.193 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 tp -71.52 -13.34 61.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.028 -0.987 . . . . 1.6000000000000001 111.787 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.0 m-30 -121.4 21.21 11.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.712 -0.676 . . . . 1.29 111.244 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.577 ' O ' HG22 ' A' ' 167' ' ' VAL . 31.0 tt0 -140.15 -59.75 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.569 0.951 . . . . 1.8 113.569 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.541 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 37.9 p -45.54 136.86 5.43 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.985 0.735 . . . . 1.4099999999999999 112.985 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.5 pt-20 -121.49 150.06 42.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.985 -0.552 . . . . 2.0499999999999998 111.417 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.705 HH22 ' HB3' ' A' ' 40' ' ' ARG . 12.7 ttt85 -117.66 147.76 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 4.2800000000000002 110.343 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -74.14 148.78 41.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 4.4699999999999998 111.778 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -153.38 -173.87 4.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.762 -0.654 . . . . 5.1500000000000004 110.276 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -122.7 -69.96 0.8 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.644 0.259 . . . . 3.1699999999999999 111.286 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -160.75 138.81 9.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.477 -0.329 . . . . 2.3900000000000001 110.28 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 54.32 87.97 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.814 -0.439 . . . . 1.3200000000000001 109.814 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.599 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 3.0 p90 -133.43 136.12 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.189 0.519 . . . . 1.77 111.1 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -154.25 -156.8 7.84 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.401 -0.818 . . . . 0.98999999999999999 113.594 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.3 163.89 31.28 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.163 0.506 . . . . 1.1899999999999999 111.213 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.04 114.11 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.21 -0.904 . . . . 2.27 110.667 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.7 mp -105.73 112.56 64.49 Favored Pre-proline 0 C--O 1.224 -0.258 0 CA-C-N 116.222 -0.444 . . . . 1.0700000000000001 111.548 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.01 141.44 11.83 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 120.219 1.114 . . . . 1.26 111.604 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 77' ' ' ILE . 57.0 mt -132.25 151.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.039 0.447 . . . . 1.0900000000000001 111.675 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -142.95 -4.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.837 -0.62 . . . . 3.4399999999999999 110.958 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.796 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 16.2 mm-40 -119.57 173.05 7.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.552 0.215 . . . . 2.1299999999999999 110.817 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -127.26 175.63 8.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.242 0.544 . . . . 0.37 111.425 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.3 -146.86 18.51 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 109.965 -1.254 . . . . 0.23000000000000001 109.965 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 19.2 mt-10 -104.68 109.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.722 1.261 . . . . 2.0299999999999998 109.433 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.796 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.1 m-85 -96.13 127.46 42.15 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.229 -0.656 . . . . 0.94999999999999996 109.229 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.606 HG22 ' N ' ' A' ' 177' ' ' ALA . 21.4 t -113.87 120.83 64.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.995 -1.002 . . . . 1.21 112.388 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -94.01 105.8 17.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.931 -1.032 . . . . 1.79 111.367 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 48.2 t -106.17 116.22 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.069 -0.969 . . . . 1.95 108.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 133.6 45.17 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.3 -0.56 . . . . 2.0 110.978 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HZ2' ' HB3' ' A' ' 126' ' ' ALA . 9.2 tptp -100.13 118.8 37.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 119.605 -0.838 . . . . 3.3799999999999999 109.16 177.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -105.94 136.62 45.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.14 -1.059 . . . . 0.34999999999999998 108.14 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 91' ' ' GLU . . . -153.78 169.13 24.11 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.42 -0.912 . . . . 1.1499999999999999 112.025 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 21.4 tt0 175.08 137.71 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.807 -0.633 . . . . 3.9700000000000002 110.225 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.2 t -141.83 95.68 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.288 . . . . 4.3099999999999996 111.234 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -146.45 -77.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 3.0099999999999998 111.438 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.498 ' HB2' ' HZ2' ' A' ' 100' ' ' LYS . 73.2 m-85 -92.43 -33.75 14.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 2.0 110.808 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 56.71 92.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 1.6599999999999999 111.747 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -174.22 151.27 1.63 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.032 -0.531 . . . . 3.6000000000000001 110.449 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 98' ' ' GLN . 18.2 m -86.36 179.07 6.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.357 -0.383 . . . . 1.8899999999999999 111.941 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 97' ' ' SER . 84.1 mm-40 70.84 -68.55 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.421 -0.809 . . . . 2.6899999999999999 111.29 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -62.42 -17.61 59.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 3.0299999999999998 110.662 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.498 ' HZ2' ' HB2' ' A' ' 94' ' ' PHE . 1.7 mptm? -110.43 52.23 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 3.52 110.305 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.59 133.95 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.295 -0.632 . . . . 1.95 109.295 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.414 ' CE1' ' HA ' ' A' ' 164' ' ' ASN . 61.2 m-85 -138.89 170.91 15.14 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.552 0.945 . . . . 0.80000000000000004 113.552 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 157' ' ' PHE . 5.1 m-20 -112.89 136.95 51.96 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.555 -0.458 . . . . 2.0099999999999998 110.444 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.02 128.98 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 111.997 0.369 . . . . 1.1599999999999999 111.997 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 15.7 ptt180 -133.63 147.55 51.47 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.351 0.871 . . . . 2.1800000000000002 113.351 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m -122.18 120.59 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 114.761 -1.108 . . . . 1.71 109.807 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.481 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.38 27.21 9.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.308 0.575 . . . . 1.77 109.49 -176.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.39 14.07 57.67 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.224 -0.898 . . . . 0.40999999999999998 112.938 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.0 m-70 -110.66 111.19 22.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.264 0.839 . . . . 0.58999999999999997 113.264 -178.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -69.25 112.6 5.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.004 0.43 . . . . 1.2 110.418 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.67 -37.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 1.3999999999999999 110.848 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.33 91.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.134 -0.626 . . . . 1.21 111.121 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 10.9 ptmm? -101.88 146.75 27.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.374 -0.83 . . . . 2.9199999999999999 109.706 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 5.4 m-20 77.24 33.27 0.43 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.865 -1.061 . . . . 2.5600000000000001 108.741 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 1.71 112.126 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 44.7 p-10 -101.52 84.21 2.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.151 -0.685 . . . . 1.99 109.151 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.2 pt -51.25 -37.24 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.648 -0.706 . . . . 1.23 112.231 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -57.08 -44.69 83.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.543 -0.298 . . . . 1.01 111.57 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.19 -28.18 63.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.83 0.308 . . . . 0.76000000000000001 111.83 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -72.25 -58.82 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.205 0.446 . . . . 3.0299999999999998 112.205 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.3 m -88.63 -40.41 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.846 0.313 . . . . 2.0299999999999998 111.846 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.73 -93.37 0.65 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.747 -0.739 . . . . 1.0600000000000001 111.94 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.457 ' O ' HG23 ' A' ' 125' ' ' THR . 61.0 m80 -115.08 110.4 19.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.517 0.198 . . . . 4.29 110.952 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.7 p 54.42 -144.84 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.269 -0.423 . . . . 2.1099999999999999 111.21 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.5 p 68.45 -172.67 0.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.987 0.515 . . . . 1.3300000000000001 111.743 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.617 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . . . -106.45 141.67 37.38 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.769 0.655 . . . . 1.1200000000000001 112.769 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.42 ' ND1' ' H ' ' A' ' 128' ' ' ASP . 15.7 t60 -101.88 157.4 16.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.606 -0.724 . . . . 0.45000000000000001 109.103 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.467 ' HB3' ' HZ1' ' A' ' 88' ' ' LYS . 7.1 p-10 -143.0 113.51 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.464 0.542 . . . . 2.0899999999999999 112.464 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -108.12 116.88 32.77 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.678 -0.692 . . . . 2.2799999999999998 110.078 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.7 mt -109.66 130.0 63.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.72 -0.673 . . . . 1.3799999999999999 110.109 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.71 89.53 25.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.34 0.496 . . . . 2.0 112.34 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -61.53 149.65 88.76 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.943 1.762 . . . . 0.23999999999999999 111.926 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.481 HG23 ' N ' ' A' ' 134' ' ' SER . 26.1 mt -140.06 156.71 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 1.0600000000000001 111.101 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.481 ' N ' HG23 ' A' ' 133' ' ' ILE . 39.9 t -130.6 107.24 9.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 1.6599999999999999 110.82 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.2 mt -107.6 129.03 62.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.811 -0.631 . . . . 1.0700000000000001 110.393 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -147.62 139.35 24.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 2.4300000000000002 110.771 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp 54.57 28.39 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 3.5600000000000001 110.646 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 28.37 58.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.32000000000000001 112.544 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.686 ' HB2' ' HZ2' ' A' ' 139' ' ' LYS . 4.4 ttmp? -121.89 146.04 47.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.386 -0.228 . . . . 2.6800000000000002 110.386 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.518 HD21 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -114.17 130.71 56.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.107 0.48 . . . . 1.1100000000000001 112.077 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.518 ' N ' HD21 ' A' ' 140' ' ' LEU . 22.2 t -127.07 110.01 12.48 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.617 -0.72 . . . . 1.3700000000000001 109.73 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 142' ' ' VAL . 3.2 p -102.94 131.34 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.337 -0.392 . . . . 1.23 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 46.96 -90.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.821 0.304 . . . . 2.0499999999999998 111.821 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -136.66 25.87 3.07 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.694 -0.765 . . . . 0.59999999999999998 113.346 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -124.03 142.68 50.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.69 -0.485 . . . . 2.02 109.69 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.49 145.97 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 1.8700000000000001 111.404 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.2 t -163.3 167.85 21.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.381 -0.6 . . . . 1.46 109.381 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.6 139.58 35.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.561 -0.456 . . . . 1.55 111.482 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.24 123.95 27.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.535 -1.283 . . . . 0.34000000000000002 107.535 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.1 m -129.24 94.23 3.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.418 -0.913 . . . . 2.02 112.874 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.32 -48.79 1.84 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 116.778 1.471 . . . . 0.77000000000000002 116.778 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.585 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -159.44 154.56 25.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.997 1.398 . . . . 2.3199999999999998 113.817 -176.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -86.58 131.77 34.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.352 -0.981 . . . . 1.8600000000000001 108.352 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.5 t -118.14 114.77 23.56 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.807 -0.757 . . . . 1.72 112.53 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.55 111.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.743 -0.383 . . . . 1.27 111.35 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.22 160.57 39.66 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.162 0.506 . . . . 2.48 111.302 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -132.96 140.45 47.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.459 -0.791 . . . . 1.9199999999999999 109.789 177.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.44 144.63 13.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.353 -0.839 . . . . 1.3899999999999999 111.989 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.628 ' HZ3' ' HB2' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -57.62 136.01 56.76 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.116 -0.947 . . . . 2.48 111.435 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.85 -32.16 2.52 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.869 -0.605 . . . . 1.1200000000000001 111.644 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -143.0 -65.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.696 0.284 . . . . 3.8999999999999999 110.26 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -176.86 152.2 0.93 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.128 -0.487 . . . . 4.0999999999999996 110.975 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 64.08 40.97 6.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.942 -0.572 . . . . 1.3999999999999999 112.406 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.71 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -60.4 -39.26 66.18 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-O 118.804 -0.617 . . . . 2.0 110.01 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.71 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 95.5 Cg_exo -23.51 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.415 2.744 . . . . 3.1099999999999999 111.786 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 10.3 ptmm? 32.35 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.603 -1.181 . . . . 4.1100000000000003 113.06 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 62' ' ' GLN . 46.0 t -96.16 133.62 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 121.045 -0.262 . . . . 1.5900000000000001 111.295 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -131.48 126.83 36.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.204 -0.598 . . . . 1.8600000000000001 111.689 -179.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 88' ' ' LYS . . . -122.37 37.03 4.49 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.957 1.095 . . . . 1.04 113.957 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -35.45 134.37 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.001 0.429 . . . . 1.6799999999999999 111.889 179.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.509 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -155.16 101.76 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.38 109.831 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.504 HG21 ' O ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -110.05 123.8 66.25 Favored 'Isoleucine or valine' 0 C--O 1.259 1.572 0 CA-C-O 123.037 1.398 . . . . 1.3500000000000001 112.93 179.33 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.19 160.55 18.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.256 -1.793 . . . . 1.26 108.768 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 175' ' ' GLY . 4.0 tmtt? -119.93 141.07 49.96 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.43 1.27 . . . . 2.3599999999999999 114.43 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 174' ' ' LYS . . . 104.97 -33.92 6.19 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 112.695 -2.048 . . . . 0.23000000000000001 117.639 175.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.534 ' C ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.29 156.33 0.41 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.2 2.0 . . . . 1.1000000000000001 114.601 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.606 ' N ' HG22 ' A' ' 84' ' ' VAL . . . -86.26 -26.22 25.11 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 114.994 -1.003 . . . . 1.1000000000000001 110.277 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.77 -9.98 11.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.913 -0.585 . . . . 2.3100000000000001 111.594 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.47 -65.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.535 -0.302 . . . . 2.3700000000000001 111.012 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 180' ' ' VAL . 3.2 p -42.19 100.85 0.23 Allowed Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.383 0.427 . . . . 3.0800000000000001 111.318 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.88 114.92 1.57 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.815 1.676 . . . . 2.4500000000000002 112.575 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 41.9 tpp -131.25 146.28 52.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.952 -0.567 . . . . 6.3700000000000001 110.541 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.499 ' N ' HD22 ' A' ' 183' ' ' LEU . 3.4 mm? -98.09 121.93 40.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 5.3499999999999996 110.69 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -55.05 147.82 32.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 8.5099999999999998 110.172 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.87 126.92 17.49 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.59 1.526 . . . . 9.6899999999999995 112.207 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.614 ' HD1' ' H ' ' A' ' 188' ' ' GLY . 39.6 t-80 -134.05 133.27 21.85 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.113 -0.494 . . . . 10.35 110.098 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.5 -37.72 3.98 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.028 1.819 . . . . 12.26 112.48 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.614 ' H ' ' HD1' ' A' ' 186' ' ' HIS . . . -91.48 -171.98 42.74 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.913 -0.66 . . . . 12.619999999999999 112.392 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.5 mt -111.81 120.03 40.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 14.65 110.826 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.227 -0.892 . . . . 15.699999999999999 110.998 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.395 -0.282 . . . . 9.3900000000000006 112.395 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.79 28.79 14.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.316 . . . . 7.6799999999999997 111.077 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 ttt -83.1 103.47 12.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.273 -0.421 . . . . 8.1699999999999999 110.706 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.2 p -126.92 159.32 34.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 4.25 110.612 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.6 56.72 0.13 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.717 -0.754 . . . . 1.8200000000000001 112.472 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 tp -57.8 -43.85 85.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.228 0.537 . . . . 1.1299999999999999 110.333 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.62 -21.53 10.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.233 -0.894 . . . . 1.1299999999999999 111.371 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.527 ' HB3' ' HZ2' ' A' ' 9' ' ' LYS . 16.7 t70 -78.5 -23.4 46.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.012 0.375 . . . . 2.0899999999999999 112.012 -178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HZ2' ' HB3' ' A' ' 8' ' ' ASP . 25.6 mmtm -97.12 -23.09 16.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.761 -0.376 . . . . 2.5 111.375 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.0 p -44.86 145.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 120.623 0.249 . . . . 1.05 111.613 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.98 -32.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.123 -0.631 . . . . 1.48 110.848 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.424 ' O ' HG23 ' A' ' 172' ' ' ILE . 71.2 t90 -166.23 124.06 1.44 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.842 -0.343 . . . . 0.33000000000000002 110.304 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.15 141.97 28.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.489 -0.323 . . . . 1.05 111.785 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 170' ' ' LEU . 2.5 t -147.56 130.89 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 113.442 0.904 . . . . 1.3600000000000001 113.442 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 21.0 t-20 -110.14 89.44 3.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 107.865 -1.161 . . . . 1.8700000000000001 107.865 175.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HB1' ' OH ' ' A' ' 73' ' ' TYR . . . -58.33 99.07 0.04 OUTLIER 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.008 -0.996 . . . . 1.1100000000000001 109.605 -177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.72 -88.99 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.736 -1.12 . . . . 0.67000000000000004 114.355 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -78.56 -117.7 0.22 Allowed Glycine 0 CA--C 1.512 -0.127 0 C-N-CA 121.085 -0.579 . . . . 1.1200000000000001 113.419 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -145.04 148.52 33.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.635 -0.135 . . . . 2.02 110.635 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 64.6 m -12.36 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.171 0.804 . . . . 1.6499999999999999 113.171 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.485 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 29.0 t60 -139.09 150.42 45.7 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.095 0.474 . . . . 0.41999999999999998 111.915 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.57 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 1.8200000000000001 111.298 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 154.75 41.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.1699999999999999 110.472 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 m -44.35 -51.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 124.081 0.863 . . . . 1.27 113.147 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -58.16 -18.52 26.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.268 0.556 . . . . 0.55000000000000004 110.354 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 34.96 4.02 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.333 -0.849 . . . . 0.32000000000000001 112.232 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 27' ' ' ILE . 33.5 mm -103.64 121.34 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 1.21 110.084 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.7 t60 -101.08 135.82 41.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 114.271 1.211 . . . . 0.68999999999999995 114.271 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.642 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.86 136.78 42.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.975 -1.12 . . . . 3.3199999999999998 107.975 176.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 48.8 mtt180 -91.42 108.06 19.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.178 0.513 . . . . 3.3999999999999999 112.247 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.517 ' NZ ' ' HA2' ' A' ' 39' ' ' GLY . 63.5 tttm -25.1 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.724 -1.126 . . . . 3.1600000000000001 113.818 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.588 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 6.0 m-20 -7.31 80.27 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.875 1.27 . . . . 1.98 113.886 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 17.3 Cg_endo -101.22 12.71 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.623 2.215 . . . . 1.53 113.826 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 35' ' ' GLU . 7.9 tt -113.4 -62.91 1.52 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.895 0.331 . . . . 2.3599999999999999 111.895 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.588 ' N ' HD23 ' A' ' 34' ' ' LEU . 12.6 mm-40 -56.97 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.926 0.393 . . . . 4.9500000000000002 110.246 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.74 -2.28 41.39 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.685 -0.966 . . . . 2.3300000000000001 110.685 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 35' ' ' GLU . 1.9 mtm180 49.17 38.42 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.973 -0.613 . . . . 5.8700000000000001 110.942 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 m -143.36 177.48 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.559 -0.746 . . . . 3.48 110.335 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.517 ' HA2' ' NZ ' ' A' ' 31' ' ' LYS . . . -52.6 92.94 0.01 OUTLIER Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.947 -0.645 . . . . 2.5899999999999999 113.229 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 5.9 mmp_? -151.13 75.34 1.19 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.825 0.345 . . . . 7.3300000000000001 110.552 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.15 -54.49 4.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 2.0099999999999998 111.327 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.6 t 55.04 63.54 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 2.2999999999999998 110.251 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.31 50.88 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.664 -0.698 . . . . 2.23 110.689 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -71.34 -54.19 11.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.014 -0.539 . . . . 2.6000000000000001 111.003 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.99 36.43 2.71 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.709 -0.757 . . . . 2.6600000000000001 112.35 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.2 ttt -67.87 -17.8 64.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 2.4300000000000002 111.017 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.622 ' HZ1' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -71.22 -167.76 0.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.016 -0.538 . . . . 3.79 110.598 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.528 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 62.7 mt 50.04 57.28 17.85 Favored Pre-proline 0 C--N 1.333 -0.144 0 N-CA-C 110.227 -0.286 . . . . 3.23 110.227 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 84.2 Cg_exo -54.44 138.77 74.37 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.984 2.456 . . . . 1.9399999999999999 113.227 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 125' ' ' THR . 2.8 mt -57.99 145.0 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 1.45 108.316 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 51' ' ' LEU . 9.3 mp -96.1 -22.79 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.17 1.174 . . . . 2.29 114.17 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -103.77 36.57 2.28 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.226 -0.59 . . . . 3.0600000000000001 111.827 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.5 t -142.49 146.43 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.017 0.437 . . . . 1.4099999999999999 111.607 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.6 t30 -62.54 145.27 95.13 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 115.786 -0.643 . . . . 1.96 109.436 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.564 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 15.7 Cg_exo -39.95 -54.98 1.88 Allowed 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.687 2.258 . . . . 0.78000000000000003 114.984 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.591 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.9 mm-40 -64.95 -53.9 39.06 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.264 1.03 . . . . 1.8200000000000001 110.64 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -2.57 23.53 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.143 -0.935 . . . . 1.9099999999999999 110.549 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.564 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 32.9 tt0 -75.69 -56.75 4.38 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.509 -0.923 . . . . 2.0600000000000001 108.509 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 56' ' ' GLU . 7.2 p -52.84 -44.62 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.528 -0.916 . . . . 1.8500000000000001 108.528 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.63 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 10.0 tp -58.4 -67.18 0.38 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 119.738 -0.785 . . . . 1.6000000000000001 109.989 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.71 -8.55 0.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.611 -0.722 . . . . 1.29 111.757 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 60' ' ' LEU . 24.6 tt0 -115.74 -116.81 0.32 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 111.934 0.346 . . . . 1.8 111.934 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 59' ' ' VAL . 71.6 p 51.24 -173.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.125 0.17 . . . . 1.4099999999999999 110.925 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 63' ' ' THR . 0.8 OUTLIER 175.22 154.11 0.15 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.512 0.196 . . . . 2.0499999999999998 110.567 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.588 ' NH2' ' HB3' ' A' ' 32' ' ' ASP . 3.1 ptm180 -143.36 176.81 8.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.808 0.337 . . . . 4.2800000000000002 111.162 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.93 155.01 2.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.009 -0.541 . . . . 4.4699999999999998 111.927 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -133.16 158.1 43.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.703 -0.68 . . . . 5.1500000000000004 110.827 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 10.7 tp10 -133.48 -93.86 0.33 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.353 -0.385 . . . . 3.1699999999999999 110.971 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 2.9 p30 -172.76 125.37 0.47 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.603 0.239 . . . . 2.3900000000000001 110.796 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 t 49.8 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.181 -0.463 . . . . 1.3200000000000001 111.076 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -161.01 161.38 31.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.492 -0.483 . . . . 1.77 111.936 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' HD11 ' A' ' 34' ' ' LEU . . . -171.27 -160.52 20.0 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.527 -0.844 . . . . 0.98999999999999999 114.251 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.551 ' OH ' ' HB1' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -122.2 163.07 20.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.813 0.816 . . . . 1.1899999999999999 112.93 -177.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.524 ' CG ' ' HG3' ' A' ' 152' ' ' LYS . 3.5 t70 -113.54 105.5 13.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.91 -1.495 . . . . 2.27 110.331 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -96.1 106.5 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.58 -0.282 . . . . 1.0700000000000001 110.535 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.75 121.81 3.78 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 121.216 1.277 . . . . 1.26 113.121 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mt -135.98 151.76 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.458 0.647 . . . . 1.0900000000000001 111.327 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -144.79 37.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.5 -1.296 . . . . 3.4399999999999999 107.5 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 15.0 mm-40 -134.63 142.43 46.88 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.78 -1.1 . . . . 2.1299999999999999 110.374 -177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.27 149.64 29.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.464 0.65 . . . . 0.37 111.625 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.41 -154.58 25.61 Favored Glycine 0 CA--C 1.512 -0.129 0 N-CA-C 110.058 -1.217 . . . . 0.23000000000000001 110.058 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 20.2 mt-10 -102.39 109.66 21.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 118.979 1.39 . . . . 2.0299999999999998 109.667 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.446 ' OH ' ' HB2' ' A' ' 79' ' ' GLU . 44.4 m-85 -95.99 126.59 41.34 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.211 -1.033 . . . . 0.94999999999999996 108.211 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.633 HG23 ' N ' ' A' ' 177' ' ' ALA . 41.9 t -112.14 113.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.612 0.72 . . . . 1.21 111.728 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' C ' HD22 ' A' ' 85' ' ' LEU . 10.2 tt -98.57 104.35 16.38 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.481 -1.236 . . . . 1.79 110.194 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.95 137.27 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.253 -1.017 . . . . 1.95 108.253 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -149.25 139.26 22.07 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.45 -0.9 . . . . 2.0 112.77 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.563 ' HZ2' ' HB3' ' A' ' 128' ' ' ASP . 14.5 tptt -94.26 123.36 37.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.57 -1.195 . . . . 3.3799999999999999 109.708 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.5 143.03 35.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 0.34999999999999998 110.072 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.26 153.22 45.11 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.444 -0.344 . . . . 1.1499999999999999 110.364 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.82 141.24 29.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 3.9700000000000002 111.012 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.95 173.78 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 4.3099999999999996 110.844 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 63.0 9.81 4.02 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.046 -0.525 . . . . 3.0099999999999998 111.106 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -149.53 115.22 5.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 2.0 110.176 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.11 93.69 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 1.6599999999999999 111.526 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -169.91 149.87 3.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 3.6000000000000001 110.898 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 p -109.15 156.77 19.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.152 -0.476 . . . . 1.8899999999999999 111.506 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 48.47 34.9 5.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.871 -0.604 . . . . 2.6899999999999999 111.574 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.3 -46.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 3.0299999999999998 109.577 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.557 ' NZ ' ' HB3' ' A' ' 100' ' ' LYS . 1.2 mmmp? -101.23 85.89 2.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.787 . . . . 3.52 109.508 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.31 144.16 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.084 -0.507 . . . . 1.95 110.306 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -126.63 -175.04 3.28 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 116.278 -0.419 . . . . 0.80000000000000004 112.08 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.42 144.75 40.32 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 2.0099999999999998 110.861 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -134.19 138.14 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.939 -0.573 . . . . 1.1599999999999999 112.542 -177.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.479 HH21 HG22 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -142.85 148.99 37.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.611 0.967 . . . . 2.1800000000000002 113.611 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 22.2 m -113.01 121.66 65.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 CA-C-N 114.629 -1.169 . . . . 1.71 109.827 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.61 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 9.5 t30 51.58 26.95 3.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.245 -0.889 . . . . 1.77 110.124 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.15 21.97 21.28 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.545 -1.207 . . . . 0.40999999999999998 113.137 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 80.8 m-70 -122.86 109.38 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.175 0.806 . . . . 0.58999999999999997 113.175 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 21.8 p -60.34 120.52 10.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.054 0.454 . . . . 1.2 111.341 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.5 t -113.73 -29.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.647 -0.706 . . . . 1.3999999999999999 109.94 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.459 HG11 ' OE1' ' A' ' 129' ' ' GLU . 2.2 t -137.29 91.98 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 116.109 -0.496 . . . . 1.21 110.186 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 6.7 ptpp? -99.66 134.24 42.83 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.77 0.795 . . . . 2.9199999999999999 110.461 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 13.9 m-20 90.42 32.3 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.109 -1.859 . . . . 2.5600000000000001 109.52 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.42 HD23 ' OE2' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -54.7 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.922 -0.581 . . . . 1.71 111.43 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -98.67 81.96 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 1.99 107.992 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.0 mt -50.94 -48.62 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.97 -1.013 . . . . 1.23 112.5 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.14 -54.01 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.31 . . . . 1.01 111.327 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.35 -27.31 55.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.601 -0.272 . . . . 0.76000000000000001 111.705 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -72.46 -59.23 2.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.601 0.593 . . . . 3.0299999999999998 112.601 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 -41.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.541 0.571 . . . . 2.0299999999999998 112.541 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.34 -141.26 16.69 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.535 -0.84 . . . . 1.0600000000000001 113.174 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -53.48 110.31 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.677 0.275 . . . . 4.29 111.01 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.2 m 44.8 -97.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 2.1099999999999999 111.126 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.432 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 p 48.8 -178.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.039 0.447 . . . . 1.3300000000000001 111.466 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.02 130.41 53.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.406 -0.361 . . . . 1.1200000000000001 111.957 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -110.49 142.48 42.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.792 -0.818 . . . . 0.45000000000000001 108.792 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.563 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 4.6 p30 -135.31 131.51 36.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.055 0.761 . . . . 2.0899999999999999 113.055 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.459 ' OE1' HG11 ' A' ' 112' ' ' VAL . 22.8 mt-10 -132.15 121.13 23.25 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.315 -0.857 . . . . 2.2799999999999998 109.884 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.73 136.41 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.036 -0.529 . . . . 1.3799999999999999 111.066 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -135.85 86.58 26.86 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.888 0.699 . . . . 2.0 112.888 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -64.03 138.57 62.96 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.706 1.604 . . . . 0.23999999999999999 111.527 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -128.62 153.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.627 -0.261 . . . . 1.0600000000000001 110.572 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 67.1 p -132.52 108.39 9.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.379 . . . . 1.6599999999999999 111.707 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.0 mt -105.31 126.63 60.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.944 -0.571 . . . . 1.0700000000000001 110.032 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -148.09 144.52 27.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.394 -0.367 . . . . 2.4300000000000002 110.578 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.49 20.72 7.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 3.5600000000000001 110.218 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.8 28.45 50.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.862 -0.685 . . . . 0.32000000000000001 112.564 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 22.7 ttpt -131.17 142.41 50.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 2.6800000000000002 111.083 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.51 HD21 ' N ' ' A' ' 141' ' ' SER . 5.6 tt -96.06 133.43 40.32 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.847 -0.615 . . . . 1.1100000000000001 112.39 -177.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.51 ' N ' HD21 ' A' ' 140' ' ' LEU . 23.1 t -118.1 117.19 28.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.858 . . . . 1.3700000000000001 109.419 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.3 98.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.967 -0.56 . . . . 1.23 111.478 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.3 -97.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.859 -0.61 . . . . 2.0499999999999998 112.224 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -115.92 21.51 12.27 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.538 -0.839 . . . . 0.59999999999999998 113.485 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -137.76 145.95 43.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.934 -0.395 . . . . 2.02 109.934 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.31 148.65 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.838 0.352 . . . . 1.8700000000000001 111.663 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.6 m -162.25 135.87 6.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.002 -0.544 . . . . 1.46 110.609 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 50.2 p -54.03 136.4 41.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.087 -0.506 . . . . 1.55 111.53 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.17 123.47 27.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 0.34000000000000002 109.708 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 152' ' ' LYS . 2.1 t -110.08 90.21 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.922 -0.711 . . . . 2.02 111.98 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 44.36 -5.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 117.201 1.64 . . . . 0.77000000000000002 117.201 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.697 ' HB3' ' HZ3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -162.11 152.28 16.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.776 1.788 . . . . 2.3199999999999998 113.756 -178.049 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.473 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -98.38 124.51 43.09 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.453 -1.314 . . . . 1.8600000000000001 107.453 176.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -107.96 102.5 11.67 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.918 0.71 . . . . 1.72 112.918 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 56.2 t -100.36 117.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.418 -0.513 . . . . 1.27 110.605 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.78 42.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.348 -0.541 . . . . 2.48 111.521 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.06 148.99 51.06 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.273 -0.876 . . . . 1.9199999999999999 110.543 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.479 HG22 HH21 ' A' ' 105' ' ' ARG . 80.6 t -118.91 142.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.056 -0.975 . . . . 1.3899999999999999 110.585 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -81.48 146.55 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.726 -0.67 . . . . 2.48 111.483 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.24 -18.9 15.6 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.695 -0.684 . . . . 1.1200000000000001 111.509 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -147.19 -75.62 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.585 0.231 . . . . 3.8999999999999999 110.754 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -152.2 153.58 34.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.829 0.347 . . . . 4.0999999999999996 111.514 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 56.15 86.77 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.956 -0.566 . . . . 1.3999999999999999 111.958 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.7 169.96 0.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.118 -0.468 . . . . 2.0 109.913 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -40.35 104.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.573 1.516 . . . . 3.1099999999999999 111.515 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -55.23 -56.75 16.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.052 -0.977 . . . . 4.1100000000000003 112.645 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.38 133.89 49.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 112.534 0.568 . . . . 1.5900000000000001 112.534 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.7 t -135.56 131.79 36.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.847 0.684 . . . . 1.8600000000000001 112.847 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.583 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . . . -119.23 38.69 3.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.793 -1.094 . . . . 1.04 112.514 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 8.4 tp -48.43 127.29 12.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.374 0.669 . . . . 1.6799999999999999 111.786 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.3 OUTLIER -143.48 111.14 5.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.381 -0.827 . . . . 0.38 110.528 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -111.5 123.95 67.81 Favored 'Isoleucine or valine' 0 C--O 1.258 1.552 0 CA-C-O 122.758 1.266 . . . . 1.3500000000000001 112.175 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.72 166.87 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.75 -1.568 . . . . 1.26 109.807 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.704 ' HB2' ' HZ3' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -117.56 137.37 52.63 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.295 1.591 . . . . 2.3599999999999999 115.295 -176.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 99.19 -35.4 4.71 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 118.791 2.276 . . . . 0.23000000000000001 118.791 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.558 ' C ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.51 160.58 0.61 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.237 2.019 . . . . 1.1000000000000001 113.969 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.633 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -85.68 -23.51 27.4 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.11 -0.95 . . . . 1.1000000000000001 110.544 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -65.81 -5.32 8.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 2.3100000000000001 111.645 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -81.21 -63.7 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.64 -0.255 . . . . 2.3700000000000001 111.121 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 180' ' ' VAL . 2.7 p -42.0 101.06 0.23 Allowed Pre-proline 0 CA--C 1.54 0.594 0 O-C-N 123.454 0.471 . . . . 3.0800000000000001 111.627 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.86 137.11 35.64 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.05 1.834 . . . . 2.4500000000000002 112.652 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.6 ttt -140.23 112.91 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 6.3700000000000001 110.333 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.42 ' N ' HD21 ' A' ' 183' ' ' LEU . 2.4 pt? -50.66 144.26 8.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 5.3499999999999996 111.295 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -119.38 150.03 48.76 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.784 -0.644 . . . . 8.5099999999999998 110.015 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -44.26 124.43 5.05 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 121.635 1.557 . . . . 9.6899999999999995 112.418 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.691 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 79.3 t60 -130.91 137.78 31.53 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 116.218 -0.446 . . . . 10.35 110.613 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.691 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 68.6 Cg_endo -76.19 -38.08 1.25 Allowed 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.227 1.951 . . . . 12.26 112.56 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 52.26 84.4 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.996 -0.547 . . . . 12.619999999999999 112.758 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 69.7 mt -65.55 117.08 7.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.371 . . . . 14.65 110.71 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.348 -0.834 . . . . 15.699999999999999 110.713 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.359 0.6 . . . . 0.40999999999999998 110.188 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.584 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.24 -20.25 17.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.241 -0.891 . . . . 0.33000000000000002 110.972 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -74.07 -17.08 61.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 2.0899999999999999 111.914 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 33.9 mttm -111.58 -21.49 11.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.488 -0.485 . . . . 1.99 111.835 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 7' ' ' ALA . 11.1 p -43.83 147.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.889 -0.324 . . . . 0.20999999999999999 111.46 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.4 pt -139.92 -22.96 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 119.782 -0.767 . . . . 0.85999999999999999 111.623 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.609 ' O ' HG22 ' A' ' 172' ' ' ILE . 26.2 t90 -173.0 134.24 0.56 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 0.28000000000000003 110.24 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -152.29 144.36 23.82 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.443 -0.161 . . . . 0.20000000000000001 111.211 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.97 126.73 4.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 N-CA-C 114.116 1.154 . . . . 0.67000000000000004 114.116 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 5.8 t30 -115.13 98.82 7.0 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.274 -0.571 . . . . 1.27 110.566 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.88 109.3 3.35 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 109.3 -0.629 . . . . 0.37 109.3 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.6 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 150.0 -44.55 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 114.806 -1.088 . . . . 0.67000000000000004 112.452 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.37 -140.16 11.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 1.1200000000000001 112.134 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -162.7 119.36 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.552 0.215 . . . . 2.02 110.801 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 62.6 p 33.19 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.607 -0.724 . . . . 1.22 112.235 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 10.9 t-80 -128.31 150.8 49.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.22 -0.592 . . . . 0.34000000000000002 112.072 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.9 p -120.61 109.94 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.374 0.607 . . . . 1.1799999999999999 111.89 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.26 155.58 39.42 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.435 -0.802 . . . . 1.1699999999999999 109.933 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 25' ' ' HIS . 15.9 m -43.89 -52.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.545 0.942 . . . . 0.59999999999999998 113.545 -177.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.446 ' N ' HG23 ' A' ' 24' ' ' VAL . 78.2 m-70 -56.89 -20.3 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.226 0.536 . . . . 0.46000000000000002 110.579 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.85 34.83 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.357 -0.838 . . . . 0.28999999999999998 112.287 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.2 mm -103.52 109.45 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.978 0.418 . . . . 0.42999999999999999 110.191 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 23.4 t60 -96.87 135.55 38.69 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 115.128 1.529 . . . . 0.52000000000000002 115.128 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.18 135.0 44.53 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 114.21 -1.359 . . . . 3.0 107.854 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.4 ptm180 -95.51 112.42 24.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 2.8999999999999999 111.984 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.521 ' NZ ' ' HB3' ' A' ' 31' ' ' LYS . 2.8 ttpm? -16.3 140.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.603 1.335 . . . . 2.71 114.603 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.582 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 4.2 p-10 -18.71 90.02 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 CA-C-N 114.613 -1.176 . . . . 1.98 112.679 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.46 -0.466 0 C-N-CA 122.598 2.198 . . . . 1.53 113.798 -179.56 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.584 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.8 mt . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 108.699 -0.852 . . . . 0.82999999999999996 108.699 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.21 -49.95 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.52 0.933 . . . . 1.6899999999999999 113.52 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.82 36.42 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.564 0.579 . . . . 2.5600000000000001 112.564 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -150.54 134.75 17.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.992 0.425 . . . . 0.96999999999999997 111.666 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.533 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -63.62 148.41 94.19 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.076 -0.713 . . . . 1.96 109.076 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.533 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 5.1 Cg_exo -37.9 -42.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.047 2.498 . . . . 0.66000000000000003 116.112 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' O ' HG12 ' A' ' 59' ' ' VAL . 9.9 mm-40 -75.82 -55.84 5.24 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.846 0.832 . . . . 1.8200000000000001 110.811 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.4 p-10 -71.42 -0.45 10.33 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.229 -0.656 . . . . 1.9099999999999999 109.229 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 33.1 tt0 -77.4 -61.02 2.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.02 -0.991 . . . . 1.5 108.972 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 56' ' ' GLU . 6.1 p -49.59 -39.13 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.1 -0.704 . . . . 1.22 109.1 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 62' ' ' GLN . 9.4 tp -66.65 -66.64 0.53 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.412 -0.515 . . . . 1.05 110.295 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -53.81 -7.03 0.1 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.154 -0.475 . . . . 0.90000000000000002 111.101 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' A' ' 60' ' ' LEU . 4.8 tt0 -115.45 -130.65 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.93 -0.577 . . . . 1.8 110.667 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 59' ' ' VAL . 41.4 p 49.59 158.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.339 0.399 . . . . 1.05 111.378 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.6 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -141.71 143.68 33.67 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.953 1.094 . . . . 2.0499999999999998 113.953 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.582 ' NE ' ' HB3' ' A' ' 32' ' ' ASP . 1.6 mtt85 -136.48 135.67 38.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.933 -1.031 . . . . 3.5800000000000001 109.654 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -116.51 131.7 56.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 4.25 111.42 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.96 -75.35 0.63 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.013 -0.539 . . . . 4.3499999999999996 110.573 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 179.5 -58.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.33 0.493 . . . . 3.1699999999999999 112.33 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -175.98 145.08 0.63 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.575 -0.528 . . . . 2.3900000000000001 109.575 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.507 ' H ' HD21 ' A' ' 164' ' ' ASN . 20.9 t 46.31 76.09 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.604 -0.517 . . . . 0.98999999999999999 109.604 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.444 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -82.99 146.21 28.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.575 -1.268 . . . . 1.26 107.575 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -138.11 129.46 4.6 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 118.415 -1.85 . . . . 0.66000000000000003 115.204 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -108.73 146.59 33.28 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.948 -0.626 . . . . 0.82999999999999996 110.813 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.27 129.7 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 2.27 111.319 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.494 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.0 mp -124.46 87.42 54.23 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.356 -0.384 . . . . 0.34000000000000002 110.875 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.39 127.71 27.07 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.867 1.711 . . . . 0.80000000000000004 111.868 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.43 151.76 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.947 0.404 . . . . 0.38 111.4 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -143.61 4.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 2.96 111.216 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -128.42 170.33 13.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.1299999999999999 110.796 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.33 172.28 9.23 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.255 0.55 . . . . 0.37 111.815 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.95 -155.25 22.26 Favored Glycine 0 N--CA 1.454 -0.152 0 N-CA-C 109.848 -1.301 . . . . 0.20999999999999999 109.848 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -98.2 108.61 21.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.009 1.404 . . . . 2.0299999999999998 108.869 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.0 125.99 40.05 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.911 -0.774 . . . . 0.26000000000000001 108.911 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.634 HG21 ' N ' ' A' ' 177' ' ' ALA . 14.2 t -113.27 116.29 52.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.828 -1.078 . . . . 0.54000000000000004 111.535 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 tt -96.5 105.15 17.2 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.69 -1.141 . . . . 1.23 110.583 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 20.3 t -110.79 132.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.917 -1.038 . . . . 1.3100000000000001 108.52 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -142.13 146.22 35.1 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.236 -0.986 . . . . 1.3700000000000001 111.88 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 128' ' ' ASP . 3.3 tptp -105.58 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 2.9700000000000002 110.356 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 10.0 m-85 -104.81 143.41 33.16 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.879 -1.156 . . . . 0.29999999999999999 107.879 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.47 0.552 0 C-N-CA 119.543 -0.863 . . . . 0.40999999999999998 112.946 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.684 0.278 . . . . 2.96 110.596 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.4 p -116.37 153.16 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.297 0.57 . . . . 1.55 112.169 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 49.11 25.17 1.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.065 -0.971 . . . . 2.3300000000000001 112.497 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -119.09 -50.12 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.941 -0.392 . . . . 2.5099999999999998 109.941 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 14.0 mptt -85.76 77.96 9.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.286 -0.635 . . . . 3.1000000000000001 109.286 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.45 142.59 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 1.3100000000000001 110.112 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -130.81 -179.38 5.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.127 0.788 . . . . 0.68999999999999995 113.127 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -121.97 137.45 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.224 -0.443 . . . . 2.0099999999999998 111.564 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 t -129.73 127.26 64.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 115.869 -0.605 . . . . 0.46000000000000002 111.384 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 8.1 mtt180 -125.85 148.56 49.12 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.542 -0.753 . . . . 1.8500000000000001 112.502 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.21 117.23 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 114.632 -1.167 . . . . 1.1000000000000001 109.695 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.42 ' OD1' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER 54.51 26.48 7.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.634 -0.876 . . . . 1.77 108.634 -177.198 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.98 22.63 29.83 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.656 -1.157 . . . . 0.40999999999999998 112.906 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 88.4 m-70 -121.55 111.49 17.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.558 0.947 . . . . 0.46000000000000002 113.558 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 p -64.71 117.33 7.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.681 -0.408 . . . . 0.66000000000000003 110.868 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 109' ' ' HIS . 3.8 t -112.98 -30.34 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.904 -0.589 . . . . 0.80000000000000004 109.819 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.7 90.18 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.417 -0.586 . . . . 0.51000000000000001 109.417 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 6.3 ptmm? -105.29 79.16 1.45 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.617 1.199 . . . . 2.4399999999999999 111.777 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.2 p30 156.49 35.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.032 -2.349 . . . . 2.5600000000000001 109.129 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.36 93.28 0.07 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.387 0.613 . . . . 1.1000000000000001 112.149 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 11.7 t70 -109.83 85.99 2.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.791 -1.559 . . . . 1.99 106.791 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.9 mt -50.03 -40.98 17.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.138 -0.937 . . . . 0.63 112.405 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.73 -65.47 0.69 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.99 -0.284 . . . . 0.90000000000000002 111.385 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -52.05 -27.18 12.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.12 0.415 . . . . 0.76000000000000001 112.12 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.64 -60.48 2.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.347 0.499 . . . . 2.6800000000000002 112.347 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 m -104.19 -40.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.405 0.52 . . . . 1.4099999999999999 112.405 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.7 -106.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.873 -0.891 . . . . 1.0600000000000001 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' SER . 37.9 m80 -64.31 170.19 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.651 -0.87 . . . . 3.5099999999999998 108.651 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' HIS . 75.0 m -35.26 -80.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.05 0.219 . . . . 1.6799999999999999 110.9 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.499 ' O ' HG12 ' A' ' 50' ' ' ILE . 30.0 p 44.02 -164.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.808 0.337 . . . . 0.80000000000000004 111.328 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.15 138.86 49.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.5 -0.318 . . . . 0.44 110.804 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.502 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.1 t60 -111.78 147.5 35.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.38 108.797 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.541 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 15.2 t70 -143.84 135.19 25.85 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.139 0.792 . . . . 2.0899999999999999 113.139 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -121.53 128.68 52.29 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.373 -0.83 . . . . 2.2799999999999998 109.127 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mt -111.0 120.41 61.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.668 -0.696 . . . . 0.70999999999999996 110.222 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.39 88.89 49.13 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.801 0.667 . . . . 1.3799999999999999 112.801 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.2 145.9 93.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.927 1.751 . . . . 0.22 111.854 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.6 mt -137.16 157.16 34.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.367 -0.379 . . . . 0.20999999999999999 110.604 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 34.6 p -133.31 110.21 9.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.126 0.489 . . . . 1.1100000000000001 111.244 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 139' ' ' LYS . 19.6 mt -110.66 126.02 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.583 -0.735 . . . . 0.23000000000000001 109.851 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -146.08 140.14 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 1.9099999999999999 110.767 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 1.2 mppt? 60.91 14.57 5.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 3.1099999999999999 111.116 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.69 12.35 58.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.658 -0.782 . . . . 0.32000000000000001 113.202 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.604 ' O ' HG23 ' A' ' 135' ' ' ILE . 60.0 mttp -112.81 162.0 16.28 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 117.131 0.466 . . . . 2.1899999999999999 111.028 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -117.97 139.46 51.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.556 0.576 . . . . 0.37 112.556 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.661 ' N ' HD23 ' A' ' 140' ' ' LEU . 28.6 t -128.93 109.61 11.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.765 . . . . 0.90000000000000002 109.678 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 142' ' ' VAL . 12.1 p -105.46 114.7 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.165 0.507 . . . . 0.53000000000000003 110.855 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 2.0499999999999998 112.115 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.49 22.03 3.38 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.619 -0.8 . . . . 0.59999999999999998 113.047 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -126.91 138.44 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.93 -0.396 . . . . 2.02 109.93 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.26 139.24 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.37 0.605 . . . . 1.3 111.732 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 23.1 t -163.71 126.74 2.6 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.165 -0.925 . . . . 1.1200000000000001 108.945 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.9 t -61.23 147.63 43.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.547 . . . . 1.1100000000000001 112.263 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -78.78 142.94 36.55 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.389 -0.823 . . . . 0.28000000000000003 109.773 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.9 p -139.25 95.81 3.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.112 0.782 . . . . 1.55 113.112 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.23 -59.75 2.75 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.729 1.051 . . . . 0.46000000000000002 115.729 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -153.34 169.12 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.914 0.857 . . . . 1.8 112.726 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.42 HD12 ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -89.79 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.965 -1.495 . . . . 1.24 106.965 176.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 5.0 t -125.52 113.43 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 118.657 -1.217 . . . . 1.28 113.177 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.5 OUTLIER -98.31 98.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.955 -0.566 . . . . 0.58999999999999997 109.644 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.1 mt-10 -110.69 126.55 54.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.664 -0.698 . . . . 2.48 111.448 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -117.17 127.09 53.77 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 119.643 -0.823 . . . . 1.54 110.264 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.522 HG21 HH21 ' A' ' 105' ' ' ARG . 10.8 t -97.2 143.99 11.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 114.185 -1.37 . . . . 0.77000000000000002 112.529 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -54.43 148.37 12.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 113.911 -1.495 . . . . 1.97 111.574 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.8 -53.09 0.17 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 111.843 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -148.64 61.04 1.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 3.8100000000000001 110.972 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 64.96 154.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.052 -0.522 . . . . 3.8199999999999998 111.876 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.37 77.83 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.651 -0.704 . . . . 1.3999999999999999 111.53 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.507 HD21 ' H ' ' A' ' 70' ' ' SER . 3.9 m-20 -50.82 155.52 1.96 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.815 -0.63 . . . . 2.0 109.974 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 164' ' ' ASN . 0.9 OUTLIER -29.86 103.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.467 2.111 . . . . 2.5800000000000001 112.346 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -53.0 -73.1 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.761 -1.108 . . . . 3.71 112.649 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 89.8 t -93.25 133.51 34.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.184 0.438 . . . . 0.92000000000000004 112.184 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.9 130.52 45.27 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 123.928 0.768 . . . . 1.2 110.803 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.513 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -123.24 36.47 4.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.415 0.894 . . . . 0.22 113.415 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.52 129.86 0.28 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.871 0.367 . . . . 1.02 111.834 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -149.27 104.73 3.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.208 -0.451 . . . . 0.33000000000000002 110.053 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -113.49 126.35 70.92 Favored 'Isoleucine or valine' 0 C--O 1.261 1.708 0 CA-C-O 122.768 1.27 . . . . 0.68999999999999995 112.799 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 ptm -119.99 165.26 14.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.814 -1.539 . . . . 1.26 109.732 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 9.6 ptmt -120.68 145.71 47.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.786 1.402 . . . . 1.8200000000000001 114.786 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.58 -36.05 4.56 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 112.38 -2.191 . . . . 0.22 117.767 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.457 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.21 158.73 0.48 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.301 2.05 . . . . 0.28999999999999998 114.277 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.634 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.43 -24.81 25.54 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 114.893 -1.048 . . . . 0.56999999999999995 110.564 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 115.828 -0.624 . . . . 2.3100000000000001 111.551 -178.738 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 tp . . . . . 0 C--O 1.232 0.182 0 CA-C-O 121.126 0.489 . . . . 0.40999999999999998 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.547 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -60.24 -21.06 61.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.564 -0.744 . . . . 0.33000000000000002 111.178 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.93 -5.68 47.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 2.0899999999999999 111.579 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 19.5 mttm -123.63 -22.07 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.505 -0.478 . . . . 1.99 111.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 7' ' ' ALA . 14.5 p -43.44 147.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 121.158 -0.217 . . . . 0.20999999999999999 111.18 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 pt -134.82 -23.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 119.518 -0.873 . . . . 0.85999999999999999 111.391 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.426 ' O ' HG22 ' A' ' 172' ' ' ILE . 40.7 t90 -173.26 136.26 0.61 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.272 -0.571 . . . . 0.28000000000000003 110.769 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.09 145.43 22.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.771 0.286 . . . . 0.20000000000000001 111.771 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.42 130.63 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 114.191 1.182 . . . . 0.67000000000000004 114.191 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 5.2 t-20 -115.77 88.55 2.91 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.414 -0.514 . . . . 1.27 111.174 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.03 103.97 0.27 Allowed 'General case' 0 C--O 1.248 0.988 0 N-CA-C 108.709 -0.849 . . . . 0.37 108.709 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.562 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 162.17 -47.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.707 0 O-C-N 124.505 1.128 . . . . 0.67000000000000004 113.227 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.54 -129.86 5.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 1.1200000000000001 112.573 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.669 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 14.8 tt0 -163.72 119.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.73 0.3 . . . . 2.02 110.947 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 8.4 t 38.73 96.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 1.22 112.72 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 57.2 t-80 -124.01 151.66 43.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 120.235 -0.586 . . . . 0.34000000000000002 112.293 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.8 t -121.05 104.14 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.159 -0.928 . . . . 1.1799999999999999 110.265 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.27 153.03 42.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 1.1699999999999999 110.688 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 25' ' ' HIS . 16.1 m -43.85 -50.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.167 0.917 . . . . 0.59999999999999998 113.065 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 24' ' ' VAL . 78.6 m-70 -56.42 -22.28 30.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.34 0.59 . . . . 0.46000000000000002 109.928 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.33 35.35 3.38 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.032 -0.986 . . . . 0.28999999999999998 111.852 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -103.12 122.29 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.602 -0.518 . . . . 0.42999999999999999 109.602 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.3 t60 -104.77 134.57 47.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.538 1.31 . . . . 0.52000000000000002 114.538 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -101.01 134.16 44.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.149 -0.932 . . . . 3.0 108.497 176.461 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -95.9 111.64 23.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.415 0.626 . . . . 2.8999999999999999 112.256 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' ASP . 51.6 tttm -15.47 139.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.176 1.547 . . . . 2.71 115.176 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.495 ' OD1' ' HD2' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -15.54 89.22 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 114.138 -1.392 . . . . 1.98 112.471 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo . . . . . 0 CA--C 1.536 0.601 0 C-N-CA 122.477 2.118 . . . . 1.53 115.845 -178.824 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.955 0.407 . . . . 0.82999999999999996 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 124' ' ' SER . 4.3 mm? -86.03 -44.08 12.6 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.717 1.006 . . . . 1.6899999999999999 113.717 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -82.66 32.66 0.42 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.677 0.621 . . . . 2.5600000000000001 112.677 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -146.36 141.89 27.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.334 0.494 . . . . 0.96999999999999997 112.334 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' A' ' 57' ' ' ASP . 5.8 p-10 -66.21 150.07 97.24 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.728 -0.669 . . . . 1.96 109.5 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 9.4 Cg_exo -39.84 -48.84 3.62 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.716 2.277 . . . . 0.66000000000000003 115.599 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -57.42 6.19 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.641 0.734 . . . . 1.8200000000000001 112.236 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -70.07 -13.72 62.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.515 -0.55 . . . . 1.9099999999999999 109.515 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.563 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 23.5 tt0 -62.94 -52.28 63.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.994 -1.113 . . . . 1.5 107.994 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -51.61 -51.62 25.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.125 -0.943 . . . . 1.22 109.187 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 4.2 tp -64.08 -15.87 60.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.809 . . . . 1.05 111.353 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.409 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 6.6 m-30 -117.13 19.96 13.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.258 -0.883 . . . . 0.90000000000000002 111.268 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -142.96 -76.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.775 1.028 . . . . 1.8 113.775 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.472 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 1.2 p -28.75 144.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.502 0.927 . . . . 1.05 113.502 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.558 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -135.88 150.57 49.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.318 -0.856 . . . . 2.0499999999999998 110.491 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.562 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 30.9 mtp180 -107.09 -177.3 3.32 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.162 -0.31 . . . . 3.5800000000000001 110.162 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -54.52 166.26 0.47 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 4.25 110.848 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -133.14 137.54 46.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 4.3499999999999996 111.008 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.446 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 40.1 tt0 -123.44 -91.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 3.1699999999999999 110.442 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD2' ' HG2' ' A' ' 68' ' ' GLU . 3.3 p30 -174.04 125.5 0.35 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.611 0.243 . . . . 2.3900000000000001 111.116 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t 50.06 100.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.117 -0.492 . . . . 0.98999999999999999 111.629 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 1.6 p90 -151.53 148.95 28.64 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.191 0.519 . . . . 1.26 111.346 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.67 -171.06 17.81 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.479 -0.867 . . . . 0.66000000000000003 114.651 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -126.91 153.64 45.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.907 -0.647 . . . . 0.82999999999999996 111.624 -178.283 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 122.94 47.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.039 -0.982 . . . . 2.27 110.151 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.5 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.2 mp -114.45 87.25 13.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.153 0.427 . . . . 0.34000000000000002 112.153 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -56.68 134.44 64.43 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.802 1.668 . . . . 0.80000000000000004 112.359 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 78' ' ' LYS . 26.8 mt -124.82 155.56 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.994 0.426 . . . . 0.38 111.115 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 77' ' ' ILE . 95.2 mttt -146.8 3.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.866 -0.606 . . . . 2.96 110.839 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -130.9 173.08 11.32 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 120.707 0.289 . . . . 2.1299999999999999 111.078 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -129.35 168.7 15.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.237 0.541 . . . . 0.37 111.143 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.01 -151.32 22.06 Favored Glycine 0 CA--C 1.512 -0.113 0 N-CA-C 109.759 -1.337 . . . . 0.20999999999999999 109.759 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -99.95 109.36 21.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.103 1.451 . . . . 2.0299999999999998 108.863 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -95.75 126.21 40.86 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.507 0.67 . . . . 0.26000000000000001 109.395 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.656 HG21 ' N ' ' A' ' 177' ' ' ALA . 26.3 t -111.35 117.56 55.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.726 -1.125 . . . . 0.54000000000000004 111.741 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 tt -88.83 104.42 16.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.526 -1.216 . . . . 1.23 110.179 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 21.4 t -109.69 133.57 54.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.271 -0.877 . . . . 1.3100000000000001 109.115 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 87' ' ' LEU . 1.2 pt? -156.24 135.26 11.98 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.357 -0.937 . . . . 1.3700000000000001 111.88 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 17.3 tptt -95.64 120.61 36.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.875 . . . . 2.9700000000000002 110.187 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.41 142.44 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.906 -0.775 . . . . 0.29999999999999999 108.906 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.683 ' O ' HG13 ' A' ' 167' ' ' VAL . . . . . . . . 0 C--O 1.239 0.513 0 C-N-CA 120.57 -0.452 . . . . 0.40999999999999998 110.459 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.931 0.396 . . . . 2.96 111.274 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.1 t -91.59 163.34 14.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.801 -0.636 . . . . 1.55 111.026 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 51.62 28.3 4.61 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.051 -0.522 . . . . 2.3300000000000001 111.12 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -134.11 -42.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 2.5099999999999998 109.853 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -108.76 82.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 3.1000000000000001 109.485 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -109.5 150.22 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.704 -0.68 . . . . 1.3100000000000001 110.202 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 114' ' ' ASP . 67.2 m-85 -133.38 -177.13 4.39 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 112.561 0.578 . . . . 0.68999999999999995 112.561 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -132.58 137.75 47.19 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.829 -0.348 . . . . 2.0099999999999998 111.005 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.8 t -131.37 129.76 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 112.758 0.651 . . . . 0.46000000000000002 112.758 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.522 HH21 HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -139.14 149.42 44.46 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.95 0.722 . . . . 1.8500000000000001 112.95 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.9 p -116.15 121.05 66.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 115.211 -0.904 . . . . 1.1000000000000001 110.566 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.682 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 2.3 t30 52.8 26.89 4.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.239 -0.891 . . . . 1.77 110.419 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.95 16.2 39.52 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 114.451 -1.249 . . . . 0.40999999999999998 113.128 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.2 m-70 -115.22 111.53 21.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.215 0.82 . . . . 0.46000000000000002 113.215 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -67.1 123.08 19.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.054 0.454 . . . . 0.66000000000000003 111.118 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -39.81 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.572 -0.74 . . . . 0.80000000000000004 109.901 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.86 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.312 0.577 . . . . 0.51000000000000001 109.933 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -98.94 154.71 17.85 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 2.4399999999999999 110.025 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 102' ' ' PHE . 12.7 m-20 66.91 32.06 6.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.135 -1.393 . . . . 2.5600000000000001 109.256 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 98.31 0.02 OUTLIER 'General case' 0 C--N 1.342 0.268 0 CA-C-O 120.96 0.41 . . . . 1.1000000000000001 111.166 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 45.1 p-10 -100.72 79.28 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.298 -1.001 . . . . 1.99 108.298 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.91 -48.94 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.298 -0.865 . . . . 0.63 112.533 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.45 -39.99 77.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.711 0.263 . . . . 0.90000000000000002 111.711 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.97 -27.7 62.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.97 0.359 . . . . 0.76000000000000001 111.97 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 34.5 mmt180 -70.0 -59.09 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.082 0.401 . . . . 2.6800000000000002 112.082 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.8 m -95.77 -40.47 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.228 0.455 . . . . 1.4099999999999999 112.228 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.57 -104.0 2.43 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.63 -0.795 . . . . 1.0600000000000001 112.22 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -63.95 164.78 9.82 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.347 -0.242 . . . . 3.5099999999999998 110.347 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.456 ' O ' HD23 ' A' ' 51' ' ' LEU . 80.5 p -58.11 98.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.887 0.375 . . . . 1.6799999999999999 110.738 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -144.69 -157.79 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.80000000000000004 109.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.72 133.82 50.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.41 0.522 . . . . 0.44 112.41 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -109.0 147.73 31.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.922 -0.77 . . . . 0.38 108.922 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -140.39 124.86 17.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.546 0.573 . . . . 2.0899999999999999 112.546 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -116.81 135.75 53.5 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.467 -0.788 . . . . 2.2799999999999998 109.783 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 131' ' ' ILE . 38.5 mt -128.8 133.58 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.85 -0.614 . . . . 0.70999999999999996 111.408 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.0 mp -135.17 92.36 18.18 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.457 -0.338 . . . . 1.3799999999999999 111.883 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.03 140.1 76.93 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.388 1.392 . . . . 0.22 111.193 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 134' ' ' SER . 14.8 mt -132.56 158.9 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.462 -0.336 . . . . 0.20999999999999999 110.992 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 133' ' ' ILE . 48.4 t -134.23 110.95 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.19 0.519 . . . . 1.1100000000000001 111.119 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 139' ' ' LYS . 17.0 mt -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 115.406 -0.815 . . . . 0.23000000000000001 110.009 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -150.37 142.38 23.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.69 0.281 . . . . 1.9099999999999999 110.867 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm 61.19 19.0 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 3.1099999999999999 110.75 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.12 71.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 0.32000000000000001 113.206 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.605 ' O ' HG23 ' A' ' 135' ' ' ILE . 52.5 mtpt -111.16 164.77 12.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.891 0.345 . . . . 2.1899999999999999 110.523 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.496 ' CD1' HD11 ' A' ' 153' ' ' LEU . 5.5 tt -124.16 143.47 50.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.689 0.625 . . . . 0.37 112.689 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.8 t -130.69 114.09 14.96 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.343 -0.844 . . . . 0.90000000000000002 109.723 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 142' ' ' VAL . 2.4 p -108.93 96.87 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 115.99 -0.55 . . . . 0.53000000000000003 110.738 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 61.74 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 2.0499999999999998 111.752 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.36 6.65 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.464 -0.874 . . . . 0.59999999999999998 113.4 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.97 129.45 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.762 -0.458 . . . . 2.02 109.762 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.2 p -105.27 141.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.31 0.576 . . . . 1.3 111.551 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.1 m -156.88 170.4 22.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.293 -0.867 . . . . 1.1200000000000001 109.301 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.2 p -99.57 139.02 35.84 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.731 -0.388 . . . . 1.1100000000000001 111.548 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -78.68 142.78 36.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.28000000000000003 109.69 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 150' ' ' THR . 3.1 t -147.27 96.12 2.66 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.038 0.755 . . . . 1.55 113.038 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.8 -65.5 4.05 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 115.511 0.964 . . . . 0.46000000000000002 115.511 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.56 -179.58 6.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 117.601 0.7 . . . . 1.8 112.455 -177.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.496 HD11 ' CD1' ' A' ' 140' ' ' LEU . 1.3 tp -102.37 133.54 47.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.339 -1.356 . . . . 1.24 107.339 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -111.31 101.07 9.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.555 0.946 . . . . 1.28 113.555 -175.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.63 98.32 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.58 -0.448 . . . . 0.58999999999999997 109.905 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 155.29 42.42 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.986 -0.552 . . . . 2.48 111.629 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -130.91 146.9 52.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.431 -0.804 . . . . 1.54 110.84 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.522 HG21 HH21 ' A' ' 105' ' ' ARG . 19.8 t -117.49 143.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 114.627 -1.17 . . . . 0.77000000000000002 110.705 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -86.6 147.59 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.902 -0.59 . . . . 1.97 110.993 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -88.66 -9.56 68.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 1.1200000000000001 112.606 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -153.35 -64.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.539 0.209 . . . . 3.8100000000000001 111.017 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -146.63 -64.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.844 0.354 . . . . 3.8199999999999998 111.017 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 13.7 m-20 -65.51 150.27 48.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.257 0.551 . . . . 1.3999999999999999 111.556 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.561 ' ND2' ' HE1' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -109.0 -179.0 0.61 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.635 -1.246 . . . . 2.0 107.635 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -11.01 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 CA-C-N 121.461 1.557 . . . . 2.5800000000000001 113.22 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.601 ' NZ ' ' HB2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER 74.92 -77.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 3.71 111.32 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 90' ' ' ALA . 1.5 m -104.71 135.8 41.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 C-N-CA 119.398 -0.921 . . . . 0.92000000000000004 110.646 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 4.8 t -131.72 117.28 18.41 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.092 -0.958 . . . . 1.2 112.362 -177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.454 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -100.94 37.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.149 -0.932 . . . . 0.22 113.505 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.68 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.34 0.4 . . . . 1.02 111.427 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -159.99 97.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.33000000000000002 110.433 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.7 OUTLIER -105.28 125.76 60.42 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 122.426 1.108 . . . . 0.68999999999999995 112.011 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.4 ptm -119.93 166.01 13.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.335 -1.302 . . . . 1.26 109.851 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 11.7 ptmt -120.82 152.5 38.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.899 1.444 . . . . 1.8200000000000001 114.899 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 94.5 -37.8 3.31 Favored Glycine 0 C--N 1.319 -0.401 0 CA-C-N 111.784 -2.462 . . . . 0.22 117.058 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 176.92 166.15 0.52 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.451 1.625 . . . . 0.28999999999999998 112.528 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.656 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -84.78 -52.16 6.25 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.649 -0.705 . . . . 0.56999999999999995 109.538 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.166 -0.924 . . . . 2.3100000000000001 110.251 179.591 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.114 0.483 . . . . 0.40999999999999998 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.15 -21.52 13.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.422 -0.808 . . . . 0.33000000000000002 111.308 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.27 -20.97 46.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.159 0.429 . . . . 2.0899999999999999 112.159 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 18.6 mmtp -101.67 -21.36 14.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.756 -0.377 . . . . 1.99 111.528 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 7' ' ' ALA . 10.1 p -45.08 145.6 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 120.577 0.227 . . . . 0.20999999999999999 111.577 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.427 HD13 ' HZ2' ' A' ' 174' ' ' LYS . 3.4 pt -138.96 -23.52 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 120.142 -0.623 . . . . 0.85999999999999999 111.181 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.454 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.3 t90 -173.42 136.35 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.696 -0.402 . . . . 0.28000000000000003 110.126 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -155.57 144.26 20.45 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.429 -0.169 . . . . 0.20000000000000001 111.382 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -147.15 127.78 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 113.797 1.036 . . . . 0.67000000000000004 113.797 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -115.53 97.18 6.01 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 119.915 -0.714 . . . . 1.27 110.997 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.6 100.29 0.87 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.037 -1.097 . . . . 0.37 108.037 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.583 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 177.39 -58.0 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.502 -1.226 . . . . 0.67000000000000004 112.609 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.74 -126.26 4.77 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.644 -0.789 . . . . 1.1200000000000001 113.422 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 20' ' ' SER . 26.0 mt-10 -151.81 119.51 6.12 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.44 0.296 . . . . 2.02 110.992 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.8 m 29.2 106.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.592 0.96 . . . . 1.22 113.592 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 45.1 t-80 -133.43 150.4 51.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 120.485 -0.486 . . . . 0.34000000000000002 112.036 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.3 p -122.81 104.94 15.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 121.4 0.619 . . . . 1.1799999999999999 111.405 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.95 155.45 34.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.425 -0.807 . . . . 1.1699999999999999 110.03 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 m -43.21 -50.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.48 0.919 . . . . 0.59999999999999998 113.48 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -59.46 -18.3 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.118 0.485 . . . . 0.46000000000000002 110.646 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.94 35.24 3.77 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.487 -0.779 . . . . 0.28999999999999998 112.619 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.4 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 32.7 mm -103.42 111.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.003 0.43 . . . . 0.42999999999999999 109.897 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.605 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 17.9 t60 -101.28 136.66 40.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.171 1.545 . . . . 0.52000000000000002 115.171 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.9 136.8 41.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.184 -1.371 . . . . 3.0 108.189 177.159 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -97.38 109.98 22.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.415 0.626 . . . . 2.8999999999999999 112.402 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 32' ' ' ASP . 11.5 tttm -12.22 137.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.62 1.568 . . . . 2.71 114.934 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 31' ' ' LYS . 27.9 t70 -13.36 88.95 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.01 -0.995 . . . . 1.98 113.01 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo . . . . . 0 CA--C 1.539 0.74 0 C-N-CA 122.468 2.112 . . . . 1.53 115.818 -179.08 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 61' ' ' TYR . 1.1 mp . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.82999999999999996 110.331 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.6 -49.0 5.58 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.292 0.849 . . . . 1.6899999999999999 113.292 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.95 31.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.939 0.718 . . . . 2.5600000000000001 112.939 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.0 t -145.63 143.95 30.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.01 0.433 . . . . 0.96999999999999997 111.678 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 58' ' ' GLN . 34.9 t30 -59.23 148.36 72.34 Favored Pre-proline 0 C--O 1.221 -0.403 0 CA-C-N 115.667 -0.697 . . . . 1.96 109.66 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.3 Cg_exo -42.0 -51.79 4.43 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.137 1.892 . . . . 0.66000000000000003 113.522 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -55.25 16.4 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.885 0.85 . . . . 1.8200000000000001 111.163 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.15 -12.67 61.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.759 -0.655 . . . . 1.9099999999999999 109.761 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.609 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 10.1 tt0 -66.0 -48.16 72.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.974 -1.491 . . . . 1.5 106.974 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -50.47 -46.64 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.085 -0.961 . . . . 1.22 109.153 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 tp -73.54 -13.12 60.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.975 -1.011 . . . . 1.05 111.647 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . 3.7 m-30 -121.06 23.41 10.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.565 -0.743 . . . . 0.90000000000000002 111.132 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -142.11 -68.4 0.37 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.145 0.794 . . . . 1.8 113.145 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.492 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 74.9 p -29.19 148.85 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.224 0.824 . . . . 1.05 113.224 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.583 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 3.1 pp20? -122.97 -22.54 5.21 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.256 1.206 . . . . 2.0499999999999998 114.256 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.532 ' N ' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mtp-105 69.62 -80.77 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.758 0.313 . . . . 3.5800000000000001 110.794 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -170.89 171.55 5.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.158 -0.474 . . . . 4.25 110.564 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -97.88 166.88 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.333 -0.394 . . . . 4.3499999999999996 110.875 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 30.3 tt0 -163.79 -120.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.528 -0.306 . . . . 3.1699999999999999 111.25 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -174.53 129.07 0.34 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.355 -0.216 . . . . 2.3900000000000001 110.421 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t 49.45 86.2 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.635 -0.505 . . . . 0.98999999999999999 109.635 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.517 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -92.39 130.3 38.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.628 . . . . 1.26 109.306 -178.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -128.2 129.16 6.2 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.521 -1.323 . . . . 0.66000000000000003 113.646 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 154' ' ' SER . 12.8 m-85 -112.9 144.69 42.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.401 . . . . 0.82999999999999996 110.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.91 126.98 55.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 2.27 111.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.48 HG21 HG21 ' A' ' 172' ' ' ILE . 4.0 mp -123.21 86.49 51.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.615 -0.266 . . . . 0.34000000000000002 111.35 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.66 129.46 34.03 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.398 2.065 . . . . 0.80000000000000004 112.764 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.58 149.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.043 -0.526 . . . . 0.38 110.796 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -141.04 0.28 1.54 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 2.96 111.387 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 80' ' ' GLU . 20.5 tt0 -131.07 167.19 19.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.827 0.346 . . . . 2.1299999999999999 110.32 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -115.84 176.86 4.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.354 0.597 . . . . 0.37 111.865 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.76 -151.13 19.89 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 109.933 -1.267 . . . . 0.20999999999999999 109.933 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.4 mt-10 -103.81 109.59 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.03 1.415 . . . . 2.0299999999999998 109.528 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.04 126.81 41.54 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.677 -0.86 . . . . 0.26000000000000001 108.677 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 39.6 t -109.97 109.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.043 -0.981 . . . . 0.54000000000000004 112.035 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.93 104.02 16.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.533 -1.212 . . . . 1.23 110.399 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.413 HG13 ' CD2' ' A' ' 171' ' ' PHE . 1.5 p -115.23 141.8 30.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.092 -0.958 . . . . 1.3100000000000001 108.698 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 87' ' ' LEU . 2.0 pp -153.88 148.69 26.53 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.049 -0.66 . . . . 1.3700000000000001 111.653 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.614 ' HD3' ' C ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -107.71 127.08 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.82 -0.752 . . . . 2.9700000000000002 109.919 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-85 -109.39 148.51 30.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.353 -0.84 . . . . 0.29999999999999999 109.741 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 116.611 -0.268 . . . . 0.40999999999999998 110.566 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.911 0.386 . . . . 2.96 110.896 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.9 t -99.25 165.57 11.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 1.55 110.439 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 71.07 -64.74 0.37 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 2.3300000000000001 111.552 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -45.01 -43.79 9.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.495 -0.32 . . . . 2.5099999999999998 111.362 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 44.7 mtmt -92.01 71.46 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 3.1000000000000001 110.752 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 t -109.8 132.57 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.35 -0.386 . . . . 1.3100000000000001 109.971 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -123.04 179.01 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.362 0.504 . . . . 0.68999999999999995 112.362 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -128.45 138.31 52.24 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 116.237 -0.438 . . . . 2.0099999999999998 112.005 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.44 132.26 64.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.644 -0.707 . . . . 0.46000000000000002 112.169 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 9.3 mtt180 -133.11 146.11 51.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 115.429 -0.805 . . . . 1.8500000000000001 112.611 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 11.8 m -117.53 119.75 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.428 -0.806 . . . . 1.1000000000000001 109.538 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.479 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.71 26.75 9.76 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.826 -0.805 . . . . 1.77 108.826 -176.512 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.01 20.6 38.71 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.8 -1.091 . . . . 0.40999999999999998 112.897 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.5 m-70 -118.64 112.29 19.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.432 0.901 . . . . 0.46000000000000002 113.432 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -63.1 120.08 10.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.618 -0.433 . . . . 0.66000000000000003 111.062 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.5 t -113.85 -32.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.371 -0.603 . . . . 0.80000000000000004 109.371 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.11 89.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.509 -0.552 . . . . 0.51000000000000001 109.509 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.6 ptpp? -106.09 79.96 1.46 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.488 1.137 . . . . 2.4399999999999999 110.976 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.7 p-10 157.79 40.41 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.462 -2.154 . . . . 2.5600000000000001 108.445 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.91 84.39 0.95 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.238 0.829 . . . . 1.1000000000000001 113.238 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 15.9 t70 -96.02 84.42 3.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.175 -1.417 . . . . 1.99 107.175 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.2 mt -50.46 -36.97 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.122 -0.945 . . . . 0.63 112.853 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.52 -47.97 79.46 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.73 0.271 . . . . 0.90000000000000002 111.73 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.4 -27.58 67.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.973 0.36 . . . . 0.76000000000000001 111.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 38.9 mmt180 -67.85 -59.04 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.044 0.387 . . . . 2.6800000000000002 112.044 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.29 -39.39 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.879 0.326 . . . . 1.4099999999999999 111.879 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.22 -56.94 1.47 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.779 -0.724 . . . . 1.0600000000000001 111.999 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -114.6 158.12 22.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.979 -0.378 . . . . 3.5099999999999998 109.979 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.5 m -55.58 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 1.6799999999999999 111.08 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 50' ' ' ILE . 28.7 p -143.7 -144.9 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.80000000000000004 110.355 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HA ' ' HZ1' ' A' ' 88' ' ' LYS . . . -110.42 126.17 54.03 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.84 0.681 . . . . 0.44 112.84 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 2.5 t60 -103.23 137.83 40.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.553 -0.906 . . . . 0.38 108.553 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -144.29 128.37 17.59 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.569 0.581 . . . . 2.0899999999999999 112.569 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.55 134.72 55.03 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.247 -0.888 . . . . 2.2799999999999998 109.666 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.85 128.52 71.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.767 -0.651 . . . . 0.70999999999999996 110.397 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -126.04 84.85 60.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.508 0.558 . . . . 1.3799999999999999 112.508 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.62 143.03 99.38 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.828 1.685 . . . . 0.22 111.635 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 20.9 mt -135.93 156.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 0.20999999999999999 111.254 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 133' ' ' ILE . 46.3 t -132.62 107.16 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.067 0.46 . . . . 1.1100000000000001 111.147 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.512 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 23.6 mt -103.85 128.7 56.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.802 -0.635 . . . . 0.23000000000000001 110.001 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -147.92 143.23 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.866 0.365 . . . . 1.9099999999999999 111.378 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp 56.4 20.59 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 3.1099999999999999 110.817 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.01 24.45 41.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.76 -0.733 . . . . 0.32000000000000001 112.953 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 135' ' ' ILE . 40.5 mtmt -125.21 152.42 44.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.185 0.492 . . . . 2.1899999999999999 110.943 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 141' ' ' SER . 6.0 tt -109.61 127.39 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 0.37 111.84 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.438 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.6 t -117.5 109.5 16.81 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.56 -0.745 . . . . 0.90000000000000002 109.493 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.0 p -103.64 118.85 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 0.53000000000000003 110.789 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 54.74 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 2.0499999999999998 111.556 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.92 27.84 3.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.794 -0.717 . . . . 0.59999999999999998 112.78 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.48 140.22 51.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.293 . . . . 2.02 110.265 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.44 138.65 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 1.3 111.372 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.7 m -161.22 123.55 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 1.1200000000000001 110.459 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.3 p -54.12 141.2 29.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 1.1100000000000001 112.06 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -80.57 142.69 33.84 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.305 -0.628 . . . . 0.28000000000000003 109.305 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 150' ' ' THR . 2.9 t -140.79 96.35 3.0 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.168 0.803 . . . . 1.55 113.168 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.98 -63.17 2.45 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 115.4 0.92 . . . . 0.46000000000000002 115.4 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.608 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.7 178.5 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.804 0.802 . . . . 1.8 112.543 -178.46 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.479 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.91 131.96 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.514 -1.291 . . . . 1.24 107.514 177.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.461 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 t -120.21 112.02 18.55 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.016 -1.074 . . . . 1.28 113.531 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -94.11 99.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.042 -0.725 . . . . 0.58999999999999997 109.042 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 37.0 mt-10 -109.04 124.69 51.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.525 -0.762 . . . . 2.48 111.324 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.61 132.92 55.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.894 -0.722 . . . . 1.54 110.1 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.4 t -102.45 142.31 16.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.615 -1.175 . . . . 0.77000000000000002 111.851 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -67.74 148.43 51.28 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 115.4 -0.818 . . . . 1.97 111.106 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.63 -9.1 41.58 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 1.1200000000000001 112.374 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -155.73 -75.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.542 0.211 . . . . 3.8100000000000001 111.203 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -173.64 68.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.736 0.303 . . . . 3.8199999999999998 111.131 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -178.03 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.331 -0.395 . . . . 1.3999999999999999 110.897 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.25 159.12 0.12 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.479 -0.563 . . . . 2.0 109.479 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -40.07 100.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.632 1.555 . . . . 2.5800000000000001 111.371 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.98 -36.07 26.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 3.71 112.322 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 79.5 t -126.7 135.3 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.566 0.58 . . . . 0.92000000000000004 112.566 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.7 t -130.47 131.53 45.2 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 123.836 0.71 . . . . 1.2 111.653 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -121.73 37.8 4.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.26 -0.882 . . . . 0.22 113.299 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.98 134.17 0.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.433 0.458 . . . . 1.02 111.503 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -156.9 98.76 1.79 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.881 -0.145 . . . . 0.33000000000000002 110.869 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.48 HG21 HG21 ' A' ' 75' ' ' ILE . 16.5 tt -108.22 125.79 64.9 Favored 'Isoleucine or valine' 0 C--O 1.259 1.601 0 CA-C-O 122.784 1.278 . . . . 0.68999999999999995 112.486 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.16 167.17 11.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.798 -1.546 . . . . 1.26 109.035 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.431 ' CB ' ' HZ2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -119.89 146.97 45.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.217 1.562 . . . . 1.8200000000000001 115.217 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.59 -35.99 4.04 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 112.008 -2.36 . . . . 0.22 118.251 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.83 159.14 0.57 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.332 2.066 . . . . 0.28999999999999998 113.955 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.82 -20.05 29.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.079 -0.964 . . . . 0.56999999999999995 110.236 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.756 -0.656 . . . . 2.3100000000000001 111.309 -178.96 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp . . . . . 0 C--O 1.232 0.167 0 CA-C-O 121.387 0.613 . . . . 0.40999999999999998 110.482 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.632 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.82 -21.07 17.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 0.33000000000000002 111.198 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.05 -18.36 60.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 2.0899999999999999 111.859 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -103.9 -26.46 12.66 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.712 -0.395 . . . . 1.99 111.267 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.3 p -43.37 144.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.849 0.315 . . . . 0.20999999999999999 111.849 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -137.16 -24.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.422 -0.511 . . . . 0.85999999999999999 110.758 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.571 ' O ' HG22 ' A' ' 172' ' ' ILE . 25.1 t90 -171.04 138.98 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.593 -0.521 . . . . 0.28000000000000003 109.593 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -159.24 143.87 15.5 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.216 0.45 . . . . 0.20000000000000001 112.216 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.01 131.3 8.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 114.224 1.194 . . . . 0.67000000000000004 114.224 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 8.4 t30 -114.67 88.63 2.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.265 -0.879 . . . . 1.27 109.082 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 65' ' ' ARG . . . -60.82 105.76 0.49 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.114 -0.948 . . . . 0.37 110.192 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 65' ' ' ARG . . . 162.13 -48.05 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.867 -1.061 . . . . 0.67000000000000004 114.324 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.91 -130.89 6.92 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.654 -0.784 . . . . 1.1200000000000001 113.861 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -152.36 119.81 6.0 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 122.317 0.247 . . . . 2.02 111.086 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.697 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.5 m 24.14 101.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.358 0.873 . . . . 1.22 113.358 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 15.0 t-80 -126.44 150.52 48.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 119.971 -0.692 . . . . 0.34000000000000002 111.96 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.79 105.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 1.1799999999999999 110.807 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.8 154.39 42.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.434 -0.348 . . . . 1.1699999999999999 110.36 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 m -44.47 -50.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 124.117 0.885 . . . . 0.59999999999999998 113.068 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -58.89 -17.22 22.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.261 0.553 . . . . 0.46000000000000002 110.307 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.49 34.76 4.62 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.28999999999999998 112.12 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -103.92 121.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.42999999999999999 110.039 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.9 t60 -99.95 136.99 39.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.578 1.325 . . . . 0.52000000000000002 114.578 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.65 131.25 47.99 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.768 -1.106 . . . . 3.0 108.311 176.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.45 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 14.6 mtt180 -89.63 109.62 20.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.584 0.553 . . . . 2.8999999999999999 112.282 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 30' ' ' ARG . 17.4 tttp -16.42 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.514 1.125 . . . . 2.71 113.506 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -18.7 84.11 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.149 0.979 . . . . 1.98 113.165 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 5.3 Cg_endo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 123.035 2.49 . . . . 1.53 112.933 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.546 HD11 ' HB1' ' A' ' 90' ' ' ALA . 1.2 mp . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.184 -0.673 . . . . 0.82999999999999996 109.184 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.16 -32.06 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.385 0.884 . . . . 1.6899999999999999 113.385 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -79.11 33.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.507 -0.477 . . . . 2.5600000000000001 111.681 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.97 142.22 5.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.359 -0.382 . . . . 0.96999999999999997 110.436 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -60.97 164.04 8.67 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.516 -0.311 . . . . 1.96 110.943 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 53.8 Cg_exo -47.21 -41.87 27.24 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.393 2.062 . . . . 0.66000000000000003 115.024 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.613 ' O ' HG12 ' A' ' 59' ' ' VAL . 11.3 mm-40 -73.26 -55.81 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.748 0.785 . . . . 1.8200000000000001 110.731 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 40.8 p30 -70.27 -3.02 15.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.701 -0.799 . . . . 1.9099999999999999 109.517 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -74.36 -60.73 2.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.425 -0.954 . . . . 1.5 108.425 177.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 56' ' ' GLU . 7.2 p -49.63 -37.39 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.738 -0.467 . . . . 1.22 109.738 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 62' ' ' GLN . 11.1 tp -69.15 -66.48 0.57 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.441 -0.504 . . . . 1.05 110.245 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.426 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 8.1 m-30 -55.05 -2.71 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.198 0.523 . . . . 0.90000000000000002 111.147 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 60' ' ' LEU . 3.7 tt0 -116.67 -131.65 0.32 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 1.8 109.614 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 62' ' ' GLN . 12.3 p 44.23 131.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.444 0.905 . . . . 1.05 113.444 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 -128.03 149.31 50.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.767 0.654 . . . . 2.0499999999999998 112.767 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' HA ' ' NE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -80.4 -156.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.677 -0.692 . . . . 3.5800000000000001 109.616 177.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -87.12 -87.27 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 121.373 -0.131 . . . . 4.25 111.165 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -179.89 155.77 0.63 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.592 0.235 . . . . 4.3499999999999996 110.957 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 4.4 tt0 -176.43 -158.65 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.291 -0.413 . . . . 3.1699999999999999 110.61 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -152.83 135.86 15.58 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.502 -0.317 . . . . 2.3900000000000001 110.987 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t 50.54 79.21 0.09 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.483 -0.326 . . . . 0.98999999999999999 110.397 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -151.43 153.86 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.66 -0.416 . . . . 1.26 111.273 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -170.49 -160.43 18.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.621 -0.8 . . . . 0.66000000000000003 113.914 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.93 164.16 17.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.601 0.715 . . . . 0.82999999999999996 112.917 -177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.46 125.08 50.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.483 -1.235 . . . . 2.27 109.539 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.506 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.1 mp -115.41 88.5 19.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.242 0.46 . . . . 0.34000000000000002 112.242 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -56.24 127.93 28.04 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.957 1.771 . . . . 0.80000000000000004 112.16 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.406 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.3 mt -122.69 151.5 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.911 0.386 . . . . 0.38 111.048 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -140.45 -0.39 1.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.1 -0.5 . . . . 2.96 111.27 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -126.06 168.49 13.91 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.616 0.246 . . . . 2.1299999999999999 111.046 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -122.6 168.52 12.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.381 0.61 . . . . 0.37 111.55 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.33 -151.87 23.28 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.739 -1.345 . . . . 0.20999999999999999 109.739 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.41 107.6 18.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.066 1.433 . . . . 2.0299999999999998 108.84 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -95.14 126.31 40.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.645 -0.822 . . . . 0.26000000000000001 109.162 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 177' ' ' ALA . 40.6 t -109.47 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.678 -1.146 . . . . 0.54000000000000004 111.457 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 170' ' ' LEU . 8.7 tp -99.28 105.06 17.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.365 -1.289 . . . . 1.23 110.729 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.51 ' C ' HD23 ' A' ' 87' ' ' LEU . 1.1 p -113.56 135.25 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.774 -0.648 . . . . 1.3100000000000001 109.929 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -133.06 135.19 45.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.59 . . . . 1.3700000000000001 111.614 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.493 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 17.9 tptt -102.93 114.83 29.44 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 2.9700000000000002 108.83 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -103.68 140.98 36.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.772 -0.825 . . . . 0.29999999999999999 108.772 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 50' ' ' ILE . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 113.475 0.917 . . . . 0.40999999999999998 113.475 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 . . . . . 0 C--O 1.231 0.089 0 N-CA-C 110.238 -0.282 . . . . 2.96 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m -110.61 149.8 29.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.105 0.479 . . . . 1.55 112.231 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 46.64 32.85 1.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.319 -0.855 . . . . 2.3300000000000001 111.823 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.42 -41.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.775 -0.454 . . . . 2.5099999999999998 109.775 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -107.11 82.91 1.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.67 . . . . 3.1000000000000001 109.696 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.514 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.9 OUTLIER -109.14 144.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 1.3100000000000001 109.733 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.492 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 73.4 m-85 -128.1 -178.05 4.38 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.843 0.683 . . . . 0.68999999999999995 112.843 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -128.23 143.98 51.08 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.572 -0.451 . . . . 2.0099999999999998 112.083 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.2 t -139.15 131.98 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.78 -0.646 . . . . 0.46000000000000002 112.434 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -133.66 149.9 51.55 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 115.239 -0.891 . . . . 1.8500000000000001 112.612 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.9 m -118.7 117.6 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.705 -1.134 . . . . 1.1000000000000001 109.749 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.497 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 55.85 26.32 9.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.758 0.789 . . . . 1.77 109.438 -176.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.97 16.46 41.37 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.365 -1.289 . . . . 0.40999999999999998 113.278 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.7 m-70 -115.35 109.51 18.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.199 0.815 . . . . 0.46000000000000002 113.199 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.0 p -67.22 113.69 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.115 0.483 . . . . 0.66000000000000003 111.292 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.37 -30.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.511 -0.768 . . . . 0.80000000000000004 109.898 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.46 91.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.308 -0.405 . . . . 0.51000000000000001 109.941 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.7 ptpp? -107.78 84.83 2.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 122.237 1.018 . . . . 2.4399999999999999 112.038 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.9 p-10 151.2 37.31 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.631 -2.077 . . . . 2.5600000000000001 108.79 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 92.36 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.326 0.584 . . . . 1.1000000000000001 112.512 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.59 84.07 2.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.649 -1.612 . . . . 1.99 106.649 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 53.3 mt -50.21 -38.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.139 -0.937 . . . . 0.63 113.229 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.06 -52.95 52.76 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.217 0.451 . . . . 0.90000000000000002 112.217 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.19 -27.62 64.65 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.045 0.387 . . . . 0.76000000000000001 112.045 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.15 -58.22 6.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.113 0.412 . . . . 2.6800000000000002 112.113 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.07 -40.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.175 0.435 . . . . 1.4099999999999999 112.175 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.45 -136.52 12.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.605 -0.807 . . . . 1.0600000000000001 112.601 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -56.65 169.54 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.551 0.215 . . . . 3.5099999999999998 110.868 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -45.81 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.078 0.466 . . . . 1.6799999999999999 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.1 p -152.97 -175.1 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 0.80000000000000004 109.991 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.39 139.19 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 0.44 112.161 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -111.69 148.88 32.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.869 -0.789 . . . . 0.38 108.869 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -141.87 135.1 29.2 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.712 0.634 . . . . 2.0899999999999999 112.712 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -129.85 112.6 13.73 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.151 -0.931 . . . . 2.2799999999999998 109.609 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.435 ' C ' HD12 ' A' ' 131' ' ' ILE . 13.6 mt -101.89 135.45 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.204 -0.453 . . . . 0.70999999999999996 111.043 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.2 mp -134.89 86.32 32.97 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.888 0.329 . . . . 1.3799999999999999 111.888 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -62.6 138.94 73.0 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.554 1.503 . . . . 0.22 110.812 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.9 mt -130.13 155.73 41.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.769 0.319 . . . . 0.20999999999999999 111.59 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 133' ' ' ILE . 25.3 p -130.07 106.69 8.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.044 -0.525 . . . . 1.1100000000000001 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 139' ' ' LYS . 26.6 mt -105.64 125.87 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.661 -0.699 . . . . 0.23000000000000001 109.918 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -146.66 144.08 29.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 1.9099999999999999 110.911 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm 60.29 10.88 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.984 -0.553 . . . . 3.1099999999999999 111.656 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.12 18.53 33.65 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.579 -0.82 . . . . 0.32000000000000001 113.067 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 135' ' ' ILE . 33.7 mtmt -121.89 153.89 37.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.958 0.379 . . . . 2.1899999999999999 110.943 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -108.7 127.33 53.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.37 111.739 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.503 ' N ' HD23 ' A' ' 140' ' ' LEU . 16.6 t -119.77 109.28 15.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.90000000000000002 110.176 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 144' ' ' GLY . 1.8 p -101.92 135.59 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.124 -0.489 . . . . 0.53000000000000003 110.174 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 40.21 -91.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.91 0.337 . . . . 2.0499999999999998 111.91 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -135.59 47.28 0.99 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.033 -0.603 . . . . 0.59999999999999998 112.34 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.51 132.74 21.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.998 -0.371 . . . . 2.02 109.998 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.0 135.0 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.933 0.397 . . . . 1.3 110.888 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 23.2 t -152.91 171.94 17.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 1.1200000000000001 110.208 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.13 136.72 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.188 -0.46 . . . . 1.1100000000000001 111.295 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.406 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 28.6 t80 -79.46 126.84 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.297 -1.001 . . . . 0.28000000000000003 108.297 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -124.0 94.86 4.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.086 0.772 . . . . 1.55 113.086 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.9 -52.82 1.31 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 116.056 1.182 . . . . 0.46000000000000002 116.056 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.506 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -154.75 170.94 20.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.272 1.036 . . . . 1.8 113.007 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.33 124.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.027 -1.471 . . . . 1.24 107.027 176.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.497 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.7 t -116.28 110.79 19.22 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.594 0.961 . . . . 1.28 113.594 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.483 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 15.2 t -99.14 114.96 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.871 -0.604 . . . . 0.58999999999999997 110.363 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -124.46 136.52 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 2.48 111.659 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -118.3 131.71 56.32 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.743 -0.662 . . . . 1.54 109.583 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.21 143.68 16.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.435 -0.802 . . . . 0.77000000000000002 111.469 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.71 148.33 39.15 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 114.816 -1.084 . . . . 1.97 111.728 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -126.15 -8.75 4.91 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.049 -0.82 . . . . 1.1200000000000001 111.049 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -151.77 -57.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.331 -0.435 . . . . 3.8100000000000001 110.265 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -174.33 -68.73 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.242 -0.436 . . . . 3.8199999999999998 111.146 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.29 90.65 4.97 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.008 0.433 . . . . 1.3999999999999999 111.281 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 165' ' ' PRO . 4.2 m-20 -48.03 153.18 1.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.414 -0.812 . . . . 2.0 109.35 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.57 99.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.191 1.927 . . . . 2.5800000000000001 112.226 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.524 ' NZ ' ' HB3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -51.97 -70.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.005 -0.998 . . . . 3.71 111.774 -178.297 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 25.0 t -84.95 131.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 119.455 -0.898 . . . . 0.92000000000000004 111.381 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.3 t -132.33 123.37 26.7 Favored 'General case' 0 C--N 1.338 0.095 0 O-C-N 124.136 0.897 . . . . 1.2 109.721 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.493 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -115.23 38.19 3.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.231 0.826 . . . . 0.22 113.231 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.514 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -40.22 135.21 1.46 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.974 0.416 . . . . 1.02 110.431 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.514 ' H ' HD13 ' A' ' 170' ' ' LEU . 0.3 OUTLIER -152.82 102.36 2.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.837 -0.619 . . . . 0.33000000000000002 110.072 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 12' ' ' TRP . 2.8 tt -105.1 123.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 CA-C-O 122.842 1.306 . . . . 0.68999999999999995 113.026 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.06 163.03 16.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.396 -1.729 . . . . 1.26 109.399 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.079 1.511 . . . . 1.8200000000000001 115.079 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.39 -35.34 5.03 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 112.327 -2.215 . . . . 0.22 117.914 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.51 159.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 120.031 1.916 . . . . 0.28999999999999998 114.291 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.621 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.15 -18.2 32.89 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 115.116 -0.947 . . . . 0.56999999999999995 110.51 176.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 2.3100000000000001 111.926 -178.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HG ' HD11 ' A' ' 27' ' ' ILE . 24.3 tp . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.343 0.592 . . . . 0.40999999999999998 110.332 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.22 -21.08 8.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.181 -0.918 . . . . 0.33000000000000002 111.509 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.68 -23.06 53.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.139 0.422 . . . . 2.0899999999999999 112.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -98.11 -25.54 14.89 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.395 . . . . 1.99 111.436 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.8 p -44.0 145.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 120.648 0.261 . . . . 0.20999999999999999 111.591 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -138.75 -23.24 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.096 -0.642 . . . . 0.85999999999999999 111.012 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.52 ' O ' HG22 ' A' ' 172' ' ' ILE . 28.5 t90 -173.34 141.56 0.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.275 -0.42 . . . . 0.28000000000000003 109.944 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.39 150.15 17.78 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.343 -0.223 . . . . 0.20000000000000001 111.531 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.78 129.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 114.19 1.182 . . . . 0.67000000000000004 114.19 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -115.17 87.2 2.6 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.726 -0.67 . . . . 1.27 109.444 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -62.12 104.27 0.46 Allowed 'General case' 0 C--O 1.253 1.267 0 CA-C-N 115.414 -0.812 . . . . 0.37 109.165 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.643 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 157.69 -20.48 0.38 Allowed Glycine 0 N--CA 1.44 -1.066 0 O-C-N 124.91 1.381 . . . . 0.67000000000000004 113.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.32 -133.27 3.13 Favored Glycine 0 C--N 1.329 0.191 0 C-N-CA 119.991 -1.1 . . . . 1.1200000000000001 113.455 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 35.1 mt-10 -152.65 120.13 5.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.44 0.162 . . . . 2.02 111.108 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.647 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.0 m 26.86 107.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.701 1.0 . . . . 1.22 113.701 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 6.9 t-80 -135.64 139.17 43.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 120.086 -0.645 . . . . 0.34000000000000002 112.571 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.9 p -110.08 102.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 115.45 -0.795 . . . . 1.1799999999999999 111.194 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.66 157.0 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.995 -1.002 . . . . 1.1699999999999999 110.301 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 25' ' ' HIS . 21.8 m -43.55 -52.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.4 0.889 . . . . 0.59999999999999998 113.4 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.484 ' N ' HG23 ' A' ' 24' ' ' VAL . 75.1 m-70 -56.82 -20.79 24.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.46000000000000002 110.318 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.4 34.98 3.46 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.22 -0.9 . . . . 0.28999999999999998 112.101 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.413 HD11 ' HG ' ' A' ' 6' ' ' LEU . 34.7 mm -103.68 112.1 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.46 . . . . 0.42999999999999999 110.351 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 13.2 t60 -97.93 132.63 43.34 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.981 1.104 . . . . 0.52000000000000002 113.981 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.42 135.27 39.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.804 -1.184 . . . . 3.0 107.804 177.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.47 ' NH1' ' HA ' ' A' ' 12' ' ' TRP . 2.2 ptp85 -91.54 108.15 19.7 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.572 0.545 . . . . 2.8999999999999999 112.451 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -10.8 130.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.106 1.363 . . . . 2.71 114.286 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.5 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 57.3 m-20 -16.52 85.86 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.632 1.173 . . . . 1.98 113.921 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 123.247 2.631 . . . . 1.53 111.763 178.823 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp . . . . . 0 C--O 1.232 0.172 0 N-CA-C 109.798 -0.445 . . . . 0.82999999999999996 109.798 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -48.3 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 1.6899999999999999 112.231 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -77.49 37.16 0.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 2.5600000000000001 112.743 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -151.95 140.73 20.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.08 0.467 . . . . 0.96999999999999997 111.966 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.537 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.2 t30 -65.95 149.13 97.92 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.713 -0.676 . . . . 1.96 109.272 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.61 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 6.2 Cg_exo -38.73 -46.99 2.68 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.954 2.436 . . . . 0.66000000000000003 116.402 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.12 -56.68 4.78 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.856 0.836 . . . . 1.8200000000000001 111.113 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 -10.92 59.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.824 -0.806 . . . . 1.9099999999999999 108.824 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.7 tt0 -64.66 -47.29 79.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.56 -1.644 . . . . 1.5 106.56 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 63' ' ' THR . 92.2 t -54.49 -57.77 5.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.838 -1.074 . . . . 1.22 110.452 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 60' ' ' LEU . 4.2 tt -63.11 -14.64 50.94 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.711 -0.677 . . . . 1.05 111.09 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.43 ' CE2' ' HD2' ' A' ' 88' ' ' LYS . 6.3 m-30 -110.81 5.79 20.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.101 -0.5 . . . . 0.90000000000000002 111.11 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.608 ' HG2' ' N ' ' A' ' 63' ' ' THR . 35.6 tt0 -129.28 -104.95 0.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.49 . . . . 1.8 111.558 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.608 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 65.3 p 36.83 -154.7 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.088 -0.482 . . . . 1.05 110.669 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.624 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.0 pt-20 168.85 130.68 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.468 0.576 . . . . 2.0499999999999998 112.026 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.643 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 14.9 mtp85 -107.35 -176.73 3.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.39 -0.368 . . . . 3.5800000000000001 110.284 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -168.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.21 -0.45 . . . . 4.25 110.89 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -159.03 162.11 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 4.3499999999999996 111.167 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.4 tp10 -156.74 -92.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 3.1699999999999999 111.053 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 3.1 p30 -173.56 134.49 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.535 0.207 . . . . 2.3900000000000001 111.084 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.4 t 46.89 84.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.401 -0.363 . . . . 0.98999999999999999 110.693 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -155.92 155.64 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.578 -0.449 . . . . 1.26 111.995 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -175.66 -161.38 24.93 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.601 -0.809 . . . . 0.66000000000000003 113.951 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.01 174.1 6.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.75 0.786 . . . . 0.82999999999999996 113.056 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.436 ' OD2' ' HG3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -127.36 139.67 52.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.322 -1.308 . . . . 2.27 109.128 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.517 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -129.75 88.93 47.91 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.895 0.702 . . . . 0.34000000000000002 112.895 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.38 134.88 67.09 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.61 1.54 . . . . 0.80000000000000004 111.433 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 78' ' ' LYS . 59.9 mt -126.52 155.14 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.859 0.361 . . . . 0.38 111.266 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.426 ' N ' HG22 ' A' ' 77' ' ' ILE . 19.0 pttm -147.35 4.11 0.79 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.021 -0.536 . . . . 2.96 111.364 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.92 171.86 12.7 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.602 0.239 . . . . 2.1299999999999999 110.864 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.8 mp0 -127.4 173.29 9.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.37 111.419 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.92 -150.31 20.11 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 109.958 -1.257 . . . . 0.20999999999999999 109.958 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 28.4 mt-10 -100.98 108.13 19.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.826 1.313 . . . . 2.0299999999999998 109.038 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -94.81 126.32 40.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 119.772 -0.771 . . . . 0.26000000000000001 109.126 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.2 t -110.78 109.09 27.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.951 -1.022 . . . . 0.54000000000000004 111.319 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.4 105.45 17.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.848 -1.524 . . . . 1.23 110.45 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.6 t -110.33 143.39 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.171 -0.922 . . . . 1.3100000000000001 110.31 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -136.77 133.79 36.38 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.591 -0.444 . . . . 1.3700000000000001 111.414 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -103.47 110.41 22.43 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.64 -1.245 . . . . 2.9700000000000002 107.64 175.347 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -102.99 141.62 35.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.41 -0.959 . . . . 0.29999999999999999 108.41 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 114.248 1.203 . . . . 0.40999999999999998 114.248 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.796 0.331 . . . . 2.96 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.7 p -97.74 153.17 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 1.55 111.423 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 66.56 -71.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.726 -0.67 . . . . 2.3300000000000001 112.178 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -39.18 -44.88 1.26 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.298 -0.41 . . . . 2.5099999999999998 111.866 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -88.92 80.37 7.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.152 0.501 . . . . 3.1000000000000001 110.939 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.44 142.6 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 1.3100000000000001 109.934 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.46 177.65 5.8 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.769 0.655 . . . . 0.68999999999999995 112.769 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -125.65 141.43 52.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 115.977 -0.556 . . . . 2.0099999999999998 111.565 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.51 132.41 36.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 116.272 -0.422 . . . . 0.46000000000000002 111.717 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.5 OUTLIER -134.05 150.73 51.21 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.17 0.804 . . . . 1.8500000000000001 113.17 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 17.3 m -118.84 119.64 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.65 -1.159 . . . . 1.1000000000000001 109.451 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.494 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.79 26.96 12.12 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.341 -0.614 . . . . 1.77 109.341 -176.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.1 53.11 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.40999999999999998 112.879 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.3 m-70 -114.27 109.46 18.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.292 0.849 . . . . 0.46000000000000002 113.292 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -67.36 109.67 3.25 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 0.66000000000000003 111.168 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.05 -34.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.396 -0.82 . . . . 0.80000000000000004 109.85 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.91 90.36 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.599 -0.519 . . . . 0.51000000000000001 109.599 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -109.36 81.83 1.5 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.304 1.049 . . . . 2.4399999999999999 111.201 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 157.67 37.16 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 112.462 -2.154 . . . . 2.5600000000000001 108.217 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.39 85.97 0.83 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.695 -0.684 . . . . 1.1000000000000001 112.292 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 0.6 OUTLIER -100.16 83.64 2.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.597 -1.631 . . . . 1.99 106.597 175.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.2 mt -49.82 -41.57 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.358 -0.837 . . . . 0.63 112.112 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -61.54 -54.8 38.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.571 -0.286 . . . . 0.90000000000000002 111.22 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 12.8 t70 -63.26 -27.53 69.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.871 0.323 . . . . 0.76000000000000001 111.871 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -63.69 -59.4 4.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.324 0.49 . . . . 2.6800000000000002 112.324 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.16 -41.39 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.204 -0.598 . . . . 1.4099999999999999 112.152 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.51 -112.13 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.586 -0.816 . . . . 1.0600000000000001 112.655 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -97.42 114.45 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.768 0.318 . . . . 3.5099999999999998 111.377 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.8 t 54.63 -127.15 2.29 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.089 -0.505 . . . . 1.6799999999999999 111.192 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.7 p 56.15 174.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.946 0.403 . . . . 0.80000000000000004 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -98.55 139.32 34.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.329 0.585 . . . . 0.44 112.134 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.422 ' ND1' ' N ' ' A' ' 128' ' ' ASP . 1.6 t60 -107.78 149.22 28.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.108 -0.951 . . . . 0.38 108.44 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.422 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.6 p30 -133.42 137.2 45.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.54 0.941 . . . . 2.0899999999999999 113.54 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -129.68 109.4 10.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.559 -1.2 . . . . 2.2799999999999998 109.464 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 mt -98.71 128.58 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.893 -0.594 . . . . 0.70999999999999996 110.27 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.91 84.33 38.12 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 113.076 0.769 . . . . 1.3799999999999999 113.076 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.55 143.63 93.18 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.793 1.662 . . . . 0.22 111.402 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 134' ' ' SER . 25.1 mt -136.36 159.43 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 0.20999999999999999 111.025 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 133' ' ' ILE . 53.6 p -134.4 107.13 7.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 1.1100000000000001 111.227 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 20.4 mt -105.55 127.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 115.72 -0.673 . . . . 0.23000000000000001 109.955 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -150.49 142.84 24.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.341 . . . . 1.9099999999999999 110.886 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt 60.53 11.83 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.017 -0.538 . . . . 3.1099999999999999 111.596 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.04 14.54 48.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.64 -0.79 . . . . 0.32000000000000001 113.134 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 135' ' ' ILE . 63.6 mttp -116.78 153.47 32.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.861 0.33 . . . . 2.1899999999999999 110.907 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 141' ' ' SER . 6.5 tt -111.43 129.52 56.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.37 111.727 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.425 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.8 t -116.9 109.9 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 0.90000000000000002 109.678 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 142' ' ' VAL . 9.1 p -105.06 110.79 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.125 -0.489 . . . . 0.53000000000000003 111.007 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.14 -89.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.911 -0.586 . . . . 2.0499999999999998 111.769 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.92 22.33 4.3 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.528 -0.844 . . . . 0.59999999999999998 113.243 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -125.81 136.57 53.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 2.02 110.282 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -105.37 137.95 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 1.3 111.129 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.1 m -152.67 170.61 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 1.1200000000000001 110.124 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.44 135.46 38.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 1.1100000000000001 111.277 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.7 137.79 37.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.928 -1.138 . . . . 0.28000000000000003 107.928 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.8 m -145.8 95.55 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.705 -0.798 . . . . 1.55 112.775 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.18 -65.75 3.97 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.366 -0.834 . . . . 0.46000000000000002 115.163 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.517 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.95 172.14 16.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 117.72 0.76 . . . . 1.8 112.694 -178.036 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.494 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -95.29 125.22 39.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.909 -1.515 . . . . 1.24 106.909 176.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.471 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.8 t -116.5 115.66 26.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.729 1.011 . . . . 1.28 113.729 -175.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.491 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 11.7 t -101.46 121.37 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.579 . . . . 0.58999999999999997 110.197 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 62.2 mm-40 -131.38 144.68 51.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.743 -0.662 . . . . 2.48 110.702 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -128.32 136.27 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 1.54 109.782 178.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.73 143.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.226 -0.897 . . . . 0.77000000000000002 111.428 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.35 139.56 49.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.516 -0.765 . . . . 1.97 111.275 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.73 -21.02 27.26 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.856 -0.687 . . . . 1.1200000000000001 111.427 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -158.75 -51.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 3.8100000000000001 109.809 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -178.8 155.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.703 -0.68 . . . . 3.8199999999999998 110.152 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.88 75.65 0.4 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.477 -0.329 . . . . 1.3999999999999999 111.351 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.53 166.21 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.139 -0.482 . . . . 2.0 109.929 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -36.93 110.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.973 1.782 . . . . 2.5800000000000001 111.799 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -71.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.458 -0.792 . . . . 3.71 112.268 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 63' ' ' THR . 22.3 t -87.02 132.77 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 120.185 -0.606 . . . . 0.92000000000000004 111.927 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.9 t -131.66 123.94 28.83 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 123.938 0.774 . . . . 1.2 111.103 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -117.21 38.77 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.955 1.094 . . . . 0.22 113.955 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.604 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -33.14 141.99 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.872 0.368 . . . . 1.02 111.038 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.604 ' H ' HD13 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -159.34 102.66 1.58 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 0.33000000000000002 110.487 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 12' ' ' TRP . 2.3 tt -112.74 123.16 68.14 Favored 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-O 122.829 1.3 . . . . 0.68999999999999995 112.724 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.81 165.87 13.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.78 -1.555 . . . . 1.26 109.228 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -120.47 143.05 48.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.007 1.484 . . . . 1.8200000000000001 115.007 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.11 -35.27 5.06 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 112.382 -2.19 . . . . 0.22 117.781 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.05 158.8 0.35 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.109 1.954 . . . . 0.28999999999999998 114.452 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.02 -16.79 37.09 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 115.114 -0.948 . . . . 0.56999999999999995 110.354 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 2.3100000000000001 111.762 -178.903 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.341 0.591 . . . . 0.40999999999999998 110.287 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.598 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.6 -20.53 8.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.135 -0.939 . . . . 0.33000000000000002 111.515 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.75 -20.19 56.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.314 0.487 . . . . 2.0899999999999999 112.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 61.4 mttt -105.96 -21.83 13.05 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.441 -0.504 . . . . 1.99 111.773 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.1 p -43.93 145.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 121.03 -0.268 . . . . 0.20999999999999999 111.465 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.7 pt -136.55 -23.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 119.689 -0.804 . . . . 0.85999999999999999 110.998 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.553 ' O ' HG22 ' A' ' 172' ' ' ILE . 49.5 t90 -174.77 141.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.867 -0.419 . . . . 0.28000000000000003 109.867 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.67 145.29 15.72 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.191 0.441 . . . . 0.20000000000000001 112.191 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.73 131.88 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 114.251 1.204 . . . . 0.67000000000000004 114.251 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 14.8 t30 -115.42 94.59 4.78 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 114.441 -1.254 . . . . 1.27 109.71 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -61.34 96.04 0.05 Allowed 'General case' 0 C--O 1.252 1.222 0 N-CA-C 107.092 -1.447 . . . . 0.37 107.092 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -178.49 -63.86 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.533 -1.667 . . . . 0.67000000000000004 113.746 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.17 -120.0 4.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.597 -0.811 . . . . 1.1200000000000001 112.105 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.574 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -172.31 128.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.25 0.548 . . . . 2.02 110.818 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.2 m 42.27 82.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.004 -0.998 . . . . 1.22 112.445 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 56.5 t-80 -112.77 151.97 29.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.072 -0.651 . . . . 0.34000000000000002 111.807 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.3 t -124.84 103.77 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.374 -0.83 . . . . 1.1799999999999999 110.108 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.58 151.99 39.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.385 -0.37 . . . . 1.1699999999999999 110.228 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 m -43.38 -48.23 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.777 1.029 . . . . 0.59999999999999998 113.777 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.1 -18.52 47.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.274 0.559 . . . . 0.46000000000000002 110.422 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.09 34.62 3.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.318 -0.856 . . . . 0.28999999999999998 112.459 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.9 mm -103.16 123.7 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.217 -0.66 . . . . 0.42999999999999999 109.217 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.8 t60 -108.36 132.35 53.82 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.52000000000000002 114.151 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.25 132.66 42.78 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.232 -1.025 . . . . 3.0 108.232 176.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 20' ' ' SER . 80.0 mtp180 -47.67 -109.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.229 1.196 . . . . 2.8999999999999999 114.229 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 179.47 99.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.166 -0.47 . . . . 2.71 111.859 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.424 ' OD1' ' HD2' ' A' ' 65' ' ' ARG . 4.3 m-20 32.32 71.68 0.64 Allowed Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.507 0.558 . . . . 1.98 112.507 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo . . . . . 0 CA--C 1.532 0.424 0 C-N-CA 122.679 2.253 . . . . 1.53 114.081 -179.73 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 125' ' ' THR . 1.2 mp . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 120.81 0.338 . . . . 0.82999999999999996 110.194 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.0 mp -86.41 -177.65 6.25 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.439 -0.949 . . . . 1.6899999999999999 108.439 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 81.6 mtp180 70.01 -21.48 0.17 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.425 . . . . 2.5600000000000001 111.959 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 51' ' ' LEU . 2.7 t -105.39 172.7 6.65 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.065 0.46 . . . . 0.96999999999999997 111.229 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.5 t30 -90.24 148.57 39.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 109.051 -0.722 . . . . 1.96 109.051 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.638 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 18.0 Cg_exo -40.63 -51.41 3.54 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.179 1.919 . . . . 0.66000000000000003 114.065 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -63.68 -56.57 14.72 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.101 0.953 . . . . 1.8200000000000001 110.94 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -68.86 -12.06 61.16 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.694 -0.684 . . . . 1.9099999999999999 109.98 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.638 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.9 tt0 -63.51 -45.04 92.49 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.146 -1.798 . . . . 1.5 106.146 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -53.21 -50.17 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 114.432 -1.258 . . . . 1.22 109.186 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 7.1 tp -69.57 -11.33 60.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.087 -0.96 . . . . 1.05 111.465 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.44 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.5 m-30 -121.51 20.06 11.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.833 -0.621 . . . . 0.90000000000000002 111.246 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -139.64 -59.58 0.56 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.448 0.907 . . . . 1.8 113.448 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.52 ' O ' HG13 ' A' ' 167' ' ' VAL . 77.6 p -43.15 150.78 0.17 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.584 -0.28 . . . . 1.05 110.906 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.578 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -135.11 -30.49 1.05 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.913 1.449 . . . . 2.0499999999999998 114.913 -176.259 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 38.5 mtp85 68.57 -173.7 0.19 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.706 -0.479 . . . . 3.5800000000000001 109.706 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -77.37 156.06 31.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.721 0.296 . . . . 4.25 110.373 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -134.0 149.02 51.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.415 -0.357 . . . . 4.3499999999999996 111.054 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -130.04 -101.22 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.27 -0.423 . . . . 3.1699999999999999 111.444 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.76 130.03 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.761 0.315 . . . . 2.3900000000000001 111.403 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.466 ' H ' HD21 ' A' ' 164' ' ' ASN . 18.9 t 53.16 95.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.091 -0.504 . . . . 0.98999999999999999 111.507 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -162.66 164.73 26.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 1.26 111.235 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -164.69 -149.63 5.87 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.005 -1.093 . . . . 0.66000000000000003 114.605 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.534 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 2.2 m-85 -141.31 167.2 22.74 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.116 -0.542 . . . . 0.82999999999999996 111.455 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.33 134.35 55.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.144 -0.935 . . . . 2.27 110.892 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.49 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.5 mp -126.98 87.09 57.46 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.637 -0.256 . . . . 0.34000000000000002 111.48 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -57.56 119.79 7.28 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.875 1.717 . . . . 0.80000000000000004 112.011 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.71 151.44 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 0.38 111.191 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -144.49 3.99 1.17 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.209 -0.45 . . . . 2.96 111.559 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -128.62 171.07 12.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.459 0.171 . . . . 2.1299999999999999 110.76 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -127.09 169.1 13.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.37 111.783 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.18 -155.74 24.1 Favored Glycine 0 CA--C 1.512 -0.133 0 N-CA-C 109.644 -1.382 . . . . 0.20999999999999999 109.644 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.7 mt-10 -96.51 108.5 21.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.048 1.424 . . . . 2.0299999999999998 108.657 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.29 125.82 39.16 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.968 -0.753 . . . . 0.26000000000000001 108.968 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 177' ' ' ALA . 38.9 t -109.49 112.03 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 0.54000000000000004 111.289 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -103.11 104.83 15.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.789 -1.551 . . . . 1.23 110.537 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.26 142.56 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.527 -0.761 . . . . 1.3100000000000001 109.639 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.97 134.18 46.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.569 -0.452 . . . . 1.3700000000000001 111.168 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.622 ' HZ3' ' HB1' ' A' ' 126' ' ' ALA . 5.7 tptm -94.16 112.59 24.41 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.106 -1.442 . . . . 2.9700000000000002 107.106 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 14.7 m-85 -104.47 143.64 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.715 -0.476 . . . . 0.29999999999999999 109.715 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.117 -0.492 . . . . 0.40999999999999998 110.605 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.697 0.284 . . . . 2.96 110.976 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.455 ' HG ' ' HD2' ' A' ' 118' ' ' PHE . 32.5 m -113.05 156.92 22.25 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.569 0.581 . . . . 1.55 112.569 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 48.09 27.15 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.145 -0.934 . . . . 2.3300000000000001 112.091 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -129.63 -42.91 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 2.5099999999999998 109.423 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 93.0 mttt -92.47 78.02 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 3.1000000000000001 109.256 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.54 145.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 1.3100000000000001 109.705 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.17 178.03 7.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.601 0.593 . . . . 0.68999999999999995 112.601 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.46 137.76 54.73 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.262 -0.426 . . . . 2.0099999999999998 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.25 131.91 52.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.917 -0.583 . . . . 0.46000000000000002 112.323 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 6.7 mtt180 -133.48 146.79 51.44 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.997 0.74 . . . . 1.8500000000000001 112.997 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.8 m -117.14 114.26 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.074 -0.967 . . . . 1.1000000000000001 109.373 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.519 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 60.62 27.14 16.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.199 -0.667 . . . . 1.77 109.199 -176.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.49 10.12 62.32 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.126 -0.943 . . . . 0.40999999999999998 112.767 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.7 m-70 -107.46 113.28 26.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.026 0.75 . . . . 0.46000000000000002 113.026 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -64.66 128.95 37.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.178 -0.609 . . . . 0.66000000000000003 110.634 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.65 -30.87 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.198 -0.667 . . . . 0.80000000000000004 109.198 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.46 HG11 ' OE2' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -135.73 89.77 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.094 -0.706 . . . . 0.51000000000000001 109.094 177.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.1 OUTLIER -105.33 76.66 1.24 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 122.508 1.147 . . . . 2.4399999999999999 111.146 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.7 p30 154.5 28.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.079 -1.873 . . . . 2.5600000000000001 108.35 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 89' ' ' PHE . 16.6 tp -61.44 97.12 0.06 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.376 -0.829 . . . . 1.1000000000000001 112.386 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.5 t70 -107.07 93.9 4.81 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 114.669 -1.151 . . . . 1.99 108.345 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.9 mt -51.86 -51.66 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 114.069 1.137 . . . . 0.63 114.069 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.455 ' HD2' ' HG ' ' A' ' 97' ' ' SER . 87.9 t80 -53.51 -55.93 21.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.033 0.383 . . . . 0.90000000000000002 112.033 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.78 -27.55 68.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.569 0.581 . . . . 0.76000000000000001 112.569 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -67.68 -58.56 4.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.872 0.693 . . . . 2.6800000000000002 112.872 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -106.08 -40.85 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.11 0.411 . . . . 1.4099999999999999 112.11 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.44 -138.9 13.22 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.539 -0.839 . . . . 1.0600000000000001 113.185 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.567 ' O ' HG23 ' A' ' 125' ' ' THR . 17.2 p-80 -65.43 118.23 9.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.965 0.412 . . . . 3.5099999999999998 111.607 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.4 m 39.13 -116.75 0.2 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.576 -0.738 . . . . 1.6799999999999999 112.066 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 123' ' ' HIS . 66.0 p 51.65 -166.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.661 0.267 . . . . 0.80000000000000004 110.953 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.622 ' HB1' ' HZ3' ' A' ' 88' ' ' LYS . . . -113.58 139.09 49.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.753 0.649 . . . . 0.44 112.753 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.504 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.7 t60 -107.61 147.95 29.96 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.903 -0.777 . . . . 0.38 108.903 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -143.03 131.06 21.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.558 0.577 . . . . 2.0899999999999999 112.558 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.46 ' OE2' HG11 ' A' ' 112' ' ' VAL . 57.8 mt-10 -124.23 109.8 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.508 -0.769 . . . . 2.2799999999999998 109.73 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.538 ' O ' HD13 ' A' ' 131' ' ' ILE . 15.5 mt -94.94 130.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.066 -0.516 . . . . 0.70999999999999996 110.839 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 130' ' ' ILE . 43.8 mm -131.53 85.88 51.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.375 -0.375 . . . . 1.3799999999999999 111.902 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.59 144.62 97.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.694 1.596 . . . . 0.22 111.447 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 134' ' ' SER . 28.3 mt -136.33 159.41 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.20999999999999999 110.674 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 42.6 p -134.76 108.55 8.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 1.1100000000000001 111.132 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.515 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 26.6 mt -106.34 125.99 62.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.695 -0.684 . . . . 0.23000000000000001 109.979 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -150.97 144.04 24.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.699 0.285 . . . . 1.9099999999999999 110.802 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt 61.76 10.15 3.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 3.1099999999999999 111.468 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.01 37.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.621 -0.8 . . . . 0.32000000000000001 113.182 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 135' ' ' ILE . 59.6 mttp -119.99 160.46 22.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.075 0.437 . . . . 2.1899999999999999 110.772 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.76 131.53 56.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.089 0.471 . . . . 0.37 111.893 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.455 ' HB3' ' OG ' ' A' ' 134' ' ' SER . 22.9 t -116.54 116.64 27.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.631 -0.713 . . . . 0.90000000000000002 110.08 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 142' ' ' VAL . 8.0 p -113.03 111.48 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.288 0.566 . . . . 0.53000000000000003 111.551 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 50.27 -93.97 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.616 -0.72 . . . . 2.0499999999999998 112.441 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -123.94 34.79 3.46 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.544 -0.836 . . . . 0.59999999999999998 113.616 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -146.57 132.64 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.065 -0.346 . . . . 2.02 110.065 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.14 146.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.429 . . . . 1.3 111.566 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.6 m -161.12 171.27 18.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.779 -0.646 . . . . 1.1200000000000001 109.376 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 141.72 31.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.278 0.561 . . . . 1.1100000000000001 111.496 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -78.66 140.74 38.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.136 -0.938 . . . . 0.28000000000000003 109.653 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.5 p -139.99 95.28 2.87 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.673 0.62 . . . . 1.55 112.673 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.96 -57.73 2.24 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.833 1.093 . . . . 0.46000000000000002 115.833 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.66 174.99 12.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.023 0.912 . . . . 1.8 112.695 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.519 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 1.8 tt -101.9 129.03 48.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.407 -1.331 . . . . 1.24 107.407 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.506 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -116.51 114.37 24.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.696 -0.802 . . . . 1.28 112.851 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 43.7 t -93.1 105.09 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.039 -0.726 . . . . 0.58999999999999997 109.039 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.1 tt0 -118.4 128.43 54.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 2.48 111.414 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -120.99 145.83 47.34 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.166 0.508 . . . . 1.54 109.749 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 143.87 26.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 115.191 -0.913 . . . . 0.77000000000000002 111.261 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.459 ' O ' ' HD2' ' A' ' 159' ' ' LYS . 1.6 pptp? -83.89 148.48 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.471 -0.786 . . . . 1.97 111.394 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.68 0.51 55.41 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.923 -0.656 . . . . 1.1200000000000001 111.619 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -154.64 -76.25 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.847 -0.177 . . . . 3.8100000000000001 110.803 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -178.49 73.61 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.498 -0.319 . . . . 3.8199999999999998 110.713 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -174.37 -44.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.381 -0.372 . . . . 1.3999999999999999 111.165 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.466 HD21 ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 62.43 163.15 0.11 Allowed Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.545 -0.539 . . . . 2.0 109.545 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -44.47 103.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.325 1.35 . . . . 2.5800000000000001 111.272 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 6.7 tppt? -53.3 -66.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.301 -0.863 . . . . 3.71 112.088 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 64' ' ' GLU . 45.5 t -94.45 132.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 120.547 -0.461 . . . . 0.92000000000000004 111.749 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -135.29 127.77 30.56 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 113.194 0.813 . . . . 1.2 113.194 -178.554 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.41 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -122.24 38.56 4.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.697 -1.138 . . . . 0.22 112.647 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 171' ' ' PHE . 6.7 tp -46.79 130.38 11.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.094 0.473 . . . . 1.02 110.398 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -142.86 114.47 8.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.75 -0.659 . . . . 0.33000000000000002 110.373 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -113.92 123.88 70.02 Favored 'Isoleucine or valine' 0 C--O 1.263 1.77 0 CA-C-O 122.841 1.305 . . . . 0.68999999999999995 112.961 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -119.61 166.76 12.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.923 -1.49 . . . . 1.26 109.886 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 8.9 ptmt -120.71 144.67 48.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.008 1.484 . . . . 1.8200000000000001 115.008 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 100.64 -36.31 4.24 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 112.417 -2.174 . . . . 0.22 118.181 174.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.87 158.44 0.43 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.57 2.185 . . . . 0.28999999999999998 114.324 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.648 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.34 -26.93 24.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.953 -1.022 . . . . 0.56999999999999995 110.37 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.693 -0.685 . . . . 2.3100000000000001 111.149 -178.803 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.1 tp . . . . . 0 C--O 1.234 0.242 0 CA-C-O 121.33 0.586 . . . . 0.40999999999999998 110.272 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.695 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.2 -19.87 9.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.262 -0.881 . . . . 0.33000000000000002 110.877 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.17 -20.06 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.058 0.392 . . . . 2.0899999999999999 112.058 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -103.5 -28.4 11.79 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.623 -0.431 . . . . 1.99 111.02 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -42.06 147.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.677 0.275 . . . . 0.20999999999999999 111.601 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -139.6 -22.64 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.815 -0.754 . . . . 0.85999999999999999 111.085 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.501 ' O ' HG22 ' A' ' 172' ' ' ILE . 32.7 t90 -173.39 139.71 0.78 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.626 -0.429 . . . . 0.28000000000000003 110.011 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.04 146.04 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.605 0.224 . . . . 0.20000000000000001 111.605 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -146.99 126.7 4.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 114.255 1.206 . . . . 0.67000000000000004 114.255 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.522 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 5.8 t30 -115.37 97.13 6.0 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.619 -0.718 . . . . 1.27 110.146 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.51 107.33 3.33 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 120.552 -0.459 . . . . 0.37 110.13 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.6 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 166.14 -74.75 0.15 Allowed Glycine 0 C--N 1.338 0.687 0 O-C-N 124.675 1.234 . . . . 0.67000000000000004 112.662 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.458 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -85.62 -125.13 1.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.883 -0.675 . . . . 1.1200000000000001 111.993 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -168.0 120.67 0.88 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.65 0.738 . . . . 2.02 111.214 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.724 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 47.61 95.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.319 -1.31 . . . . 1.22 113.009 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 50.2 t-80 -125.46 137.08 53.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 118.988 -1.085 . . . . 0.34000000000000002 113.069 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.0 t -107.43 101.59 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.588 -1.187 . . . . 1.1799999999999999 109.912 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -67.12 157.82 32.69 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.85 -0.613 . . . . 1.1699999999999999 110.627 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.26 -55.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 124.849 1.343 . . . . 0.59999999999999998 112.828 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -55.53 -22.74 22.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.126 0.489 . . . . 0.46000000000000002 110.339 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.43 36.03 2.75 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.394 -0.821 . . . . 0.28999999999999998 112.165 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.442 HD11 ' HG ' ' A' ' 6' ' ' LEU . 35.9 mm -103.33 125.49 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.655 -0.498 . . . . 0.42999999999999999 109.655 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.4 t60 -106.34 131.32 53.69 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.76 1.393 . . . . 0.52000000000000002 114.76 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.78 140.84 34.5 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.956 -1.128 . . . . 3.0 107.956 175.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' SER . 77.2 mtp180 -63.31 -137.68 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.383 0.427 . . . . 2.8999999999999999 111.135 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.8 100.01 3.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.364 0.266 . . . . 2.71 111.484 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.422 ' OD1' ' HD3' ' A' ' 65' ' ' ARG . 34.9 t70 35.59 69.78 1.09 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 111.985 0.365 . . . . 1.98 111.985 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 C-N-CA 122.852 2.368 . . . . 1.53 114.496 -179.44 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 121.333 0.587 . . . . 0.82999999999999996 110.043 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 53' ' ' SER . 10.3 mp -76.89 -47.78 20.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.784 1.031 . . . . 1.6899999999999999 113.784 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -70.06 26.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.268 0.84 . . . . 2.5600000000000001 113.268 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 51' ' ' LEU . 8.1 t -147.79 156.79 43.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.09 0.472 . . . . 0.96999999999999997 111.637 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 58' ' ' GLN . 7.9 t30 -71.95 148.22 91.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.729 -0.669 . . . . 1.96 109.878 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.608 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.16 -54.67 2.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.525 2.15 . . . . 0.66000000000000003 114.615 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.39 -57.95 9.44 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.88 0.848 . . . . 1.8200000000000001 110.994 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 23.8 t70 -69.04 -6.57 28.91 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.723 -0.671 . . . . 1.9099999999999999 109.623 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 12.5 tt0 -69.2 -42.44 75.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.61 -1.626 . . . . 1.5 106.61 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.65 -57.61 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 114.329 -1.305 . . . . 1.22 109.158 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.41 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 6.3 tt -54.31 -61.04 2.56 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.547 -0.751 . . . . 1.05 109.345 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.551 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 2.3 m-85 -52.79 -15.14 0.66 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.585 -0.734 . . . . 0.90000000000000002 111.097 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 63' ' ' THR . 7.0 tt0 -119.63 -117.94 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.661 0.615 . . . . 1.8 112.661 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.572 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 2.7 p 36.44 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.623 0.769 . . . . 1.05 112.669 -176.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.6 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.7 pt-20 -101.53 146.34 27.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.309 0.855 . . . . 2.0499999999999998 113.309 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HD3' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -104.43 -144.43 0.37 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.723 -1.126 . . . . 3.5800000000000001 109.935 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.35 -175.51 2.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.496 0.189 . . . . 4.25 110.543 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -138.63 160.05 40.58 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.82 0.343 . . . . 4.3499999999999996 111.482 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -154.6 -103.75 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.144 -0.48 . . . . 3.1699999999999999 111.024 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -174.41 124.85 0.31 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.495 0.188 . . . . 2.3900000000000001 110.803 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.543 ' H ' HD21 ' A' ' 164' ' ' ASN . 21.0 t 50.33 96.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.347 -0.388 . . . . 0.98999999999999999 111.699 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -166.31 167.09 16.26 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.217 -0.447 . . . . 1.26 111.105 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -174.28 -170.59 37.72 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.28 -0.962 . . . . 0.66000000000000003 114.045 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -109.31 169.56 8.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.532 0.682 . . . . 0.82999999999999996 112.532 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.23 136.65 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.612 -1.176 . . . . 2.27 110.439 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.449 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.4 mp -127.25 86.84 57.81 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 112.153 0.427 . . . . 0.34000000000000002 112.153 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -54.41 130.34 39.45 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.244 1.963 . . . . 0.80000000000000004 112.418 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 74.2 mt -126.48 150.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.206 -0.452 . . . . 0.38 111.294 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -142.86 0.75 1.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 2.96 111.201 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.11 170.11 12.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.477 0.179 . . . . 2.1299999999999999 110.769 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.53 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.04 171.24 9.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.339 0.59 . . . . 0.37 111.912 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.44 -155.58 23.06 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 109.8 -1.32 . . . . 0.20999999999999999 109.8 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.1 mt-10 -97.41 108.38 21.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.128 1.464 . . . . 2.0299999999999998 109.107 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -95.57 126.47 40.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.926 -0.71 . . . . 0.26000000000000001 109.22 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 177' ' ' ALA . 16.1 t -112.68 113.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.906 -1.043 . . . . 0.54000000000000004 111.386 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tt -95.67 104.02 15.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.566 -1.197 . . . . 1.23 110.445 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.15 126.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 114.507 -1.224 . . . . 1.3100000000000001 108.705 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.753 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.8 pp -135.67 141.15 44.95 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.569 -0.852 . . . . 1.3700000000000001 111.04 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.735 ' HZ3' ' HA ' ' A' ' 126' ' ' ALA . 0.6 OUTLIER -107.13 124.29 49.48 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.282 -0.967 . . . . 2.9700000000000002 109.495 177.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CD2' HD21 ' A' ' 115' ' ' LEU . 7.7 m-85 -105.73 142.36 35.6 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.398 -0.819 . . . . 0.29999999999999999 109.305 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.979 0.419 . . . . 0.40999999999999998 111.117 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.875 0.369 . . . . 2.96 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.6 m -107.26 150.47 26.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.07 -0.514 . . . . 1.55 112.277 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 47.24 39.93 9.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.518 -0.764 . . . . 2.3300000000000001 111.842 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -133.48 -48.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.751 -0.463 . . . . 2.5099999999999998 109.751 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -98.05 86.8 3.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.829 -0.623 . . . . 3.1000000000000001 109.558 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.0 144.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 1.3100000000000001 109.461 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -130.45 178.59 6.48 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.633 0.605 . . . . 0.68999999999999995 112.633 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -122.05 139.65 53.45 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.94 -0.304 . . . . 2.0099999999999998 111.154 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.1 132.05 52.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-N 116.084 -0.507 . . . . 0.46000000000000002 112.138 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.54 HH21 HG21 ' A' ' 158' ' ' VAL . 8.5 mtt180 -133.72 156.48 47.87 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 113.234 0.827 . . . . 1.8500000000000001 113.234 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 25.3 m -122.15 119.27 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 114.853 -1.067 . . . . 1.1000000000000001 109.049 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.416 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 56.27 26.39 10.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.922 -0.77 . . . . 1.77 108.922 -175.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.29 39.64 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.40999999999999998 112.784 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -117.83 112.11 19.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.943 0.72 . . . . 0.46000000000000002 112.943 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -61.84 127.67 32.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.634 -0.426 . . . . 0.66000000000000003 111.24 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 t -123.64 -32.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.107 -0.701 . . . . 0.80000000000000004 109.107 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.99 90.18 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.078 -0.712 . . . . 0.51000000000000001 109.078 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 16.1 ptpt -107.53 100.91 10.29 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.032 0.92 . . . . 2.4399999999999999 111.76 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 18.5 m-20 131.2 27.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.27 -2.241 . . . . 2.5600000000000001 108.037 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 89' ' ' PHE . 45.4 tp -56.41 96.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.952 -1.022 . . . . 1.1000000000000001 112.636 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -108.23 92.31 4.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.605 -1.18 . . . . 1.99 107.829 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 121' ' ' VAL . 43.3 mt -51.88 -35.95 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.47 0.915 . . . . 0.63 113.47 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -69.2 -54.64 13.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.304 0.483 . . . . 0.90000000000000002 112.304 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.98 -27.28 66.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.545 0.572 . . . . 0.76000000000000001 112.545 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -72.66 -58.27 3.49 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.879 0.696 . . . . 2.6800000000000002 112.879 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 117' ' ' ILE . 8.5 p -97.48 -35.15 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.129 0.418 . . . . 1.4099999999999999 112.129 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.8 -129.2 8.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.651 -0.785 . . . . 1.0600000000000001 112.368 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -88.82 110.47 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.642 0.258 . . . . 3.5099999999999998 110.619 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.3 t 51.46 -108.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 1.6799999999999999 110.529 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.4 p 48.46 -171.77 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.532 0.206 . . . . 0.80000000000000004 111.325 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.735 ' HA ' ' HZ3' ' A' ' 88' ' ' LYS . . . -102.85 121.95 43.54 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.305 0.854 . . . . 0.44 113.305 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.568 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.1 t60 -100.35 135.35 41.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.816 -1.179 . . . . 0.38 107.816 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -145.39 130.55 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.075 0.768 . . . . 2.0899999999999999 113.075 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -111.34 125.9 54.34 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.224 -0.898 . . . . 2.2799999999999998 109.403 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -105.86 110.1 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.70999999999999996 109.534 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.12 86.03 25.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.744 0.646 . . . . 1.3799999999999999 112.744 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 140.03 75.57 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.875 1.717 . . . . 0.22 111.622 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.0 mt -132.13 156.14 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.20999999999999999 110.631 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 19.4 p -130.73 106.76 8.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.121 0.486 . . . . 1.1100000000000001 110.719 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 24.0 mt -107.08 121.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.602 -0.726 . . . . 0.23000000000000001 109.867 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -145.53 141.22 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.577 -0.283 . . . . 1.9099999999999999 110.571 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm 60.72 20.7 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.56 . . . . 3.1099999999999999 110.984 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.02 60.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.32000000000000001 113.151 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' HG23 ' A' ' 135' ' ' ILE . 3.6 mmmm -117.83 155.52 29.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.864 0.332 . . . . 2.1899999999999999 110.32 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -115.22 131.36 56.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.077 0.465 . . . . 0.37 112.12 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.507 ' N ' HD23 ' A' ' 140' ' ' LEU . 20.8 t -117.9 111.2 18.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.63 -0.714 . . . . 0.90000000000000002 109.5 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 142' ' ' VAL . 6.5 p -107.33 102.27 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.03 -0.532 . . . . 0.53000000000000003 111.218 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.29 -92.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.904 -0.589 . . . . 2.0499999999999998 111.66 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.44 6.21 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.59999999999999998 113.18 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.4 132.26 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.203 -0.295 . . . . 2.02 110.203 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.5 p -105.48 140.69 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.198 0.523 . . . . 1.3 111.658 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.1 m -154.03 173.01 16.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.421 -0.809 . . . . 1.1200000000000001 109.621 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.28 136.66 38.92 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.86 -0.336 . . . . 1.1100000000000001 111.163 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 40.3 t80 -79.72 136.68 36.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.117 -1.068 . . . . 0.28000000000000003 108.117 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.2 m -148.56 95.11 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.835 -0.746 . . . . 1.55 112.495 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.84 -70.0 1.87 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.121 0.809 . . . . 0.46000000000000002 115.121 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.623 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -149.98 178.17 9.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.776 0.788 . . . . 1.8 112.945 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.407 HD12 HD11 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -103.0 128.07 49.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.416 -1.327 . . . . 1.24 107.416 177.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.416 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 6.7 t -117.16 118.45 32.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.359 1.244 . . . . 1.28 114.359 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 86.9 t -93.96 99.29 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.471 -0.937 . . . . 0.58999999999999997 108.471 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.7 tt0 -109.69 129.04 55.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.588 -0.733 . . . . 2.48 111.763 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -121.71 135.6 54.95 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.018 -0.537 . . . . 1.54 110.004 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.54 HG21 HH21 ' A' ' 105' ' ' ARG . 11.0 t -109.98 143.87 19.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.043 -0.98 . . . . 0.77000000000000002 111.482 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -59.17 143.37 49.11 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.167 -0.924 . . . . 1.97 111.09 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -120.39 -16.01 4.84 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.951 -0.642 . . . . 1.1200000000000001 111.912 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -156.44 -61.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 3.8100000000000001 110.148 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -177.54 151.2 0.73 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.835 -0.621 . . . . 3.8199999999999998 110.188 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.95 82.09 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.73 0.3 . . . . 1.3999999999999999 110.857 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.543 HD21 ' H ' ' A' ' 70' ' ' SER . 2.9 m-20 -47.3 159.02 0.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 2.0 110.325 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 164' ' ' ASN . 2.8 Cg_exo -32.22 102.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.39 2.06 . . . . 2.5800000000000001 111.711 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.589 ' NZ ' ' HB2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -56.9 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.026 -0.988 . . . . 3.71 113.19 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 11.6 t -91.62 134.45 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 120.246 -0.582 . . . . 0.92000000000000004 112.295 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.7 t -130.89 136.47 48.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.818 -0.628 . . . . 1.2 112.102 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -129.42 34.44 4.37 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.304 0.853 . . . . 0.22 113.304 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -36.53 136.76 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.563 0.579 . . . . 1.02 112.563 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -154.84 101.68 2.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.791 -0.641 . . . . 0.33000000000000002 110.777 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -109.09 128.14 65.22 Favored 'Isoleucine or valine' 0 C--O 1.262 1.761 0 CA-C-O 122.874 1.321 . . . . 0.68999999999999995 112.428 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.419 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.3 ppp? -121.35 166.61 13.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.423 -1.717 . . . . 1.26 109.636 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -120.37 153.24 36.77 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 115.262 1.579 . . . . 1.8200000000000001 115.262 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 92.1 -35.06 4.13 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 111.93 -2.395 . . . . 0.22 117.725 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.94 159.91 0.63 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.035 1.918 . . . . 0.28999999999999998 113.962 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.63 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.17 -36.9 20.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.368 -0.833 . . . . 0.56999999999999995 111.688 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.42 . . . . 2.3100000000000001 111.966 -178.542 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.44 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.9 tp . . . . . 0 C--O 1.233 0.223 0 CA-C-O 121.258 0.552 . . . . 0.40999999999999998 110.496 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.613 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.75 -20.89 24.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.4 -0.818 . . . . 0.33000000000000002 110.985 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.6 -15.74 61.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 2.0899999999999999 111.754 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 41.4 mmtt -107.92 -27.08 10.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.852 -0.339 . . . . 1.99 111.486 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.0 p -42.87 145.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 111.883 0.327 . . . . 0.20999999999999999 111.883 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.07 -23.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 119.981 -0.688 . . . . 0.85999999999999999 111.352 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.639 ' O ' HG22 ' A' ' 172' ' ' ILE . 27.0 t90 -172.25 127.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.773 -0.371 . . . . 0.28000000000000003 110.124 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.21 143.65 29.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.816 -0.175 . . . . 0.20000000000000001 110.871 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -146.6 126.44 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 114.36 1.244 . . . . 0.67000000000000004 114.36 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -115.3 95.11 5.02 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.165 -0.614 . . . . 1.27 110.454 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.865 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -67.53 116.16 7.95 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.525 -0.761 . . . . 0.37 109.64 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.597 ' HA3' ' C ' ' A' ' 63' ' ' THR . . . 145.35 -51.8 0.6 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.706 -1.588 . . . . 0.67000000000000004 112.157 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.01 -143.8 15.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.896 -0.669 . . . . 1.1200000000000001 112.211 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.16 119.41 5.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.604 0.202 . . . . 2.02 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 80.6 p 36.36 99.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.76 0.663 . . . . 1.22 112.584 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.555 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 58.1 t-80 -122.85 151.94 41.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.267 -0.573 . . . . 0.34000000000000002 112.47 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -122.32 103.5 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.224 -0.898 . . . . 1.1799999999999999 109.784 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.7 153.43 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 1.1699999999999999 110.523 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 25' ' ' HIS . 17.8 m -43.31 -52.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 124.217 0.948 . . . . 0.59999999999999998 113.382 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.473 ' N ' HG23 ' A' ' 24' ' ' VAL . 82.6 m-70 -57.99 -18.74 25.84 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.12 0.486 . . . . 0.46000000000000002 110.609 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.32 36.29 3.38 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.435 -0.802 . . . . 0.28999999999999998 112.334 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.44 HD11 ' HG ' ' A' ' 6' ' ' LEU . 31.1 mm -103.3 122.5 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.401 -0.592 . . . . 0.42999999999999999 109.401 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.555 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.5 t60 -105.71 133.05 51.07 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 114.456 1.28 . . . . 0.52000000000000002 114.456 -176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.2 134.6 41.81 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.323 -0.991 . . . . 3.0 108.323 176.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 15.9 ptm180 -96.33 114.11 25.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.362 0.601 . . . . 2.8999999999999999 112.255 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -12.05 139.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.234 1.568 . . . . 2.71 115.234 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 65' ' ' ARG . 8.3 p-10 -22.68 89.23 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 114.066 -1.425 . . . . 1.98 113.67 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 CA--C 1.534 0.519 0 C-N-CA 122.909 2.406 . . . . 1.53 113.454 179.24 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.681 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.2 tp . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 110.172 -0.307 . . . . 0.82999999999999996 110.172 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.681 ' HB2' ' O ' ' A' ' 50' ' ' ILE . 2.6 tt 130.67 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.869 1.667 . . . . 1.6899999999999999 111.652 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.83 24.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.528 0.566 . . . . 2.5600000000000001 112.528 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -136.6 157.95 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.612 . . . . 0.96999999999999997 112.65 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLN . 35.8 t30 -70.86 153.16 94.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.05 -0.977 . . . . 1.96 108.788 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.454 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 59.7 Cg_exo -45.86 -59.53 1.16 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.499 1.466 . . . . 0.66000000000000003 112.872 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 1.3 pm0 -56.18 -54.84 40.39 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 122.174 0.988 . . . . 1.8200000000000001 111.026 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.51 -13.91 62.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.42 -0.809 . . . . 1.9099999999999999 110.958 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' ASN . 1.6 pt20 -65.27 -40.21 93.62 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.342 -1.725 . . . . 1.5 106.342 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -56.16 -52.33 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.668 -1.151 . . . . 1.22 109.145 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.4 tp -70.31 -9.14 55.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.209 -0.905 . . . . 1.05 111.772 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -119.7 15.08 12.71 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.458 0.646 . . . . 0.90000000000000002 110.018 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.559 ' O ' HG13 ' A' ' 167' ' ' VAL . 48.1 tt0 -136.51 -105.37 0.2 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.911 -1.041 . . . . 1.8 110.249 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.597 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 37.4 p 4.6 121.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.485 0.92 . . . . 1.05 113.485 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.493 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 9.5 pt-20 -111.59 150.74 29.63 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.067 0.765 . . . . 2.0499999999999998 113.067 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.481 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 1.3 ttt85 -137.25 88.39 2.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.119 -0.946 . . . . 3.5800000000000001 109.809 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -84.48 145.74 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 4.25 111.464 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -117.95 -78.99 0.59 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.894 -0.594 . . . . 4.3499999999999996 110.805 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -155.98 -89.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.449 -0.342 . . . . 3.1699999999999999 111.029 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -157.57 155.35 30.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.384 0.135 . . . . 2.3900000000000001 110.77 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t 47.87 86.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.98999999999999999 110.313 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.454 ' CE2' ' ND2' ' A' ' 164' ' ' ASN . 2.0 p90 -156.13 166.21 34.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 1.26 111.441 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.36 -174.92 43.27 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.923 -1.132 . . . . 0.66000000000000003 114.213 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.2 173.13 6.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 0.82999999999999996 112.265 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.5 137.14 53.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.804 -1.089 . . . . 2.27 110.212 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.486 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -128.32 87.62 54.78 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.975 0.361 . . . . 0.34000000000000002 111.975 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.94 131.35 44.97 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 121.815 1.677 . . . . 0.80000000000000004 111.711 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 78' ' ' LYS . 65.4 mt -123.2 153.74 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.883 0.373 . . . . 0.38 111.643 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' N ' HG22 ' A' ' 77' ' ' ILE . 26.4 mtmm -143.44 -0.51 1.09 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.036 -0.529 . . . . 2.96 111.597 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -124.77 167.95 13.9 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 120.77 0.319 . . . . 2.1299999999999999 111.2 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -123.99 164.05 20.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.232 0.539 . . . . 0.37 110.877 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.9 -146.43 17.24 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 109.729 -1.349 . . . . 0.20999999999999999 109.729 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 10.8 mm-40 -103.93 108.37 19.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.685 1.243 . . . . 2.0299999999999998 109.146 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.438 ' CZ ' ' HD3' ' A' ' 174' ' ' LYS . 3.9 m-85 -94.44 126.42 39.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.26000000000000001 108.73 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 177' ' ' ALA . 23.0 t -112.45 110.97 34.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.096 -0.956 . . . . 0.54000000000000004 111.323 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -97.51 103.65 15.6 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.571 -1.195 . . . . 1.23 110.684 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.42 139.58 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.507 -1.224 . . . . 1.3100000000000001 108.473 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.38 152.3 40.51 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.838 -0.745 . . . . 1.3700000000000001 111.826 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 15.3 tptt -108.41 117.74 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.06 -0.656 . . . . 2.9700000000000002 110.615 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.9 m-85 -105.23 145.07 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.169 -1.049 . . . . 0.29999999999999999 108.169 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.47 0.54 0 C-N-CA 119.136 -1.025 . . . . 0.40999999999999998 113.53 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.425 ' HG2' ' NE2' ' A' ' 99' ' ' GLN . 50.6 tp60 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.813 0.34 . . . . 2.96 110.982 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.8 m -97.18 153.97 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 1.55 111.056 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 54.75 55.93 7.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.576 . . . . 2.3300000000000001 111.277 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.425 ' NE2' ' HG2' ' A' ' 96' ' ' GLN . 9.2 tt0 -151.16 -51.09 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.128 -0.693 . . . . 2.5099999999999998 109.128 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 30.2 mmtm -90.48 78.26 6.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.729 -0.841 . . . . 3.1000000000000001 108.729 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.49 111.72 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.587 -0.733 . . . . 1.3100000000000001 110.437 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.66 178.79 4.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.219 0.822 . . . . 0.68999999999999995 113.219 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.8 139.97 53.45 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 115.83 -0.623 . . . . 2.0099999999999998 111.618 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.4 133.2 33.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 115.99 -0.55 . . . . 0.46000000000000002 111.752 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.629 HH21 HG21 ' A' ' 158' ' ' VAL . 1.0 OUTLIER -133.69 152.26 51.84 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 112.94 0.719 . . . . 1.8500000000000001 112.94 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.6 m -118.17 117.57 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.864 -1.062 . . . . 1.1000000000000001 109.224 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.467 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 58.55 27.05 15.12 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.043 -0.725 . . . . 1.77 109.043 -176.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.69 20.52 43.66 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.976 -1.011 . . . . 0.40999999999999998 112.734 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.0 m-70 -118.18 109.59 16.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.076 0.769 . . . . 0.46000000000000002 113.076 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.4 p -62.91 118.28 7.56 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.543 -0.463 . . . . 0.66000000000000003 111.207 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.82 -32.77 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.044 -0.724 . . . . 0.80000000000000004 109.044 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.405 HG11 ' OE2' ' A' ' 129' ' ' GLU . 0.9 OUTLIER -131.9 91.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.905 -0.589 . . . . 0.51000000000000001 109.822 178.522 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 16.9 ttmt -107.17 82.34 1.66 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.771 0.796 . . . . 2.4399999999999999 110.283 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.8 p30 151.8 39.8 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.975 -1.92 . . . . 2.5600000000000001 108.594 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.16 88.13 0.17 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.066 0.765 . . . . 1.1000000000000001 113.066 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -103.29 86.13 2.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.366 -1.346 . . . . 1.99 107.366 175.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 46.0 mt -50.52 -44.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.806 -0.634 . . . . 0.63 112.095 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.73 -58.66 6.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.90000000000000002 111.247 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.402 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 15.1 t70 -58.97 -27.03 64.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 0.76000000000000001 112.034 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -64.61 -59.63 4.06 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.286 0.476 . . . . 2.6800000000000002 112.286 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.23 -40.81 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.108 0.411 . . . . 1.4099999999999999 112.108 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.92 -129.45 3.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.566 -0.826 . . . . 1.0600000000000001 112.65 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' THR . 22.3 t-80 -94.34 110.92 22.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 3.5099999999999998 110.971 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.8 t 63.28 -130.56 0.47 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.843 -0.617 . . . . 1.6799999999999999 111.195 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 4.4 p 58.83 -166.72 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.659 0.266 . . . . 0.80000000000000004 110.351 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.5 135.05 49.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.969 0.729 . . . . 0.44 112.969 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.2 t60 -112.54 148.88 33.57 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -144.47 135.53 25.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.896 0.702 . . . . 2.0899999999999999 112.896 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.405 ' OE2' HG11 ' A' ' 112' ' ' VAL . 20.0 mt-10 -124.38 122.02 36.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.483 -0.78 . . . . 2.2799999999999998 108.973 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.36 126.33 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.078 -0.51 . . . . 0.70999999999999996 110.736 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.1 mp -128.83 85.89 58.98 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.279 0.474 . . . . 1.3799999999999999 112.279 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -62.04 143.28 94.82 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.628 1.552 . . . . 0.22 111.413 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 134' ' ' SER . 32.7 mt -136.97 159.22 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.20999999999999999 110.941 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 133' ' ' ILE . 41.2 p -134.24 110.22 9.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.1100000000000001 111.195 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 139' ' ' LYS . 18.0 mt -108.4 128.37 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.793 -0.639 . . . . 0.23000000000000001 110.121 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -146.04 140.64 26.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.321 . . . . 1.9099999999999999 110.86 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt 58.74 14.57 3.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 3.1099999999999999 111.369 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.94 21.15 34.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.622 -0.799 . . . . 0.32000000000000001 112.747 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 135' ' ' ILE . 96.9 mttt -118.52 152.29 36.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.609 0.205 . . . . 2.1899999999999999 110.659 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.24 132.96 54.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.274 0.559 . . . . 0.37 112.145 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.543 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.6 t -121.11 109.17 14.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.477 -0.783 . . . . 0.90000000000000002 109.782 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 142' ' ' VAL . 9.9 p -103.78 112.58 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.272 0.558 . . . . 0.53000000000000003 111.019 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 54.19 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.704 -0.68 . . . . 2.0499999999999998 112.262 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.43 27.43 3.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.51 -0.852 . . . . 0.59999999999999998 113.176 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -133.8 138.96 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.187 -0.301 . . . . 2.02 110.187 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.52 137.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.106 0.479 . . . . 1.3 111.294 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.6 m -159.32 129.68 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 1.1200000000000001 109.885 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.5 p -59.14 143.21 49.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.207 -0.451 . . . . 1.1100000000000001 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -79.3 139.18 37.91 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.301 -0.629 . . . . 0.28000000000000003 109.301 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 t -135.37 95.29 3.25 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.078 0.77 . . . . 1.55 113.078 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.48 -59.16 1.2 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.675 1.03 . . . . 0.46000000000000002 115.675 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.486 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -152.64 168.61 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.035 0.918 . . . . 1.8 112.68 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.467 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -92.02 126.32 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.833 -1.173 . . . . 1.24 107.833 177.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.448 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.3 t -114.95 117.85 31.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.517 0.932 . . . . 1.28 113.517 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.462 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 92.1 t -93.02 97.89 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.049 -0.723 . . . . 0.58999999999999997 109.049 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.8 tt0 -104.91 141.08 37.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.546 -0.752 . . . . 2.48 110.717 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -131.04 145.48 52.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 1.54 109.844 178.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.629 HG21 HH21 ' A' ' 105' ' ' ARG . 11.5 t -116.74 140.86 37.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.642 -0.708 . . . . 0.77000000000000002 110.662 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.24 148.57 26.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.444 -0.798 . . . . 1.97 111.946 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -124.5 -27.26 1.33 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.487 -0.779 . . . . 1.1200000000000001 111.666 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -175.22 51.22 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.729 0.3 . . . . 3.8100000000000001 110.339 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 62.41 159.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.141 -0.481 . . . . 3.8199999999999998 111.214 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 54.43 91.88 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.588 0.709 . . . . 1.3999999999999999 110.723 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -50.98 174.95 0.08 OUTLIER Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 114.137 -1.392 . . . . 2.0 109.517 178.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -42.49 -16.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.79 1.66 . . . . 2.5800000000000001 112.56 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.556 ' NZ ' ' HB3' ' A' ' 166' ' ' LYS . 1.5 mtpm? 75.73 -76.7 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.736 0.814 . . . . 3.71 111.554 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 62' ' ' GLN . 7.4 t -83.72 131.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 C-N-CA 119.451 -0.899 . . . . 0.92000000000000004 111.117 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.865 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -133.76 123.48 24.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.093 0.871 . . . . 1.2 111.569 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -119.83 36.94 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.64 -1.164 . . . . 0.22 113.76 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.53 131.77 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.903 0.335 . . . . 1.02 111.903 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.477 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -150.38 99.45 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.33000000000000002 110.395 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -109.16 124.57 65.93 Favored 'Isoleucine or valine' 0 C--O 1.262 1.727 0 CA-C-O 122.763 1.268 . . . . 0.68999999999999995 112.547 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.2 ptm -115.71 164.05 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.102 -1.408 . . . . 1.26 109.441 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 1.7 tptp -120.31 137.93 53.98 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.688 1.366 . . . . 1.8200000000000001 114.688 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.15 -34.54 5.71 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 118.198 2.039 . . . . 0.22 118.198 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.79 156.03 0.45 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.732 2.266 . . . . 0.28999999999999998 114.447 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.675 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.34 -21.82 28.74 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.099 -0.955 . . . . 0.56999999999999995 110.336 177.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.675 -0.693 . . . . 2.3100000000000001 111.434 -178.748 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.427 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.2 tp . . . . . 0 C--O 1.234 0.273 0 CA-C-O 121.284 0.564 . . . . 0.40999999999999998 110.43 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.658 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.38 -21.06 22.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.444 -0.798 . . . . 0.33000000000000002 110.585 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.33 -18.34 64.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.562 . . . . 2.0899999999999999 111.314 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.05 -28.4 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.916 -0.314 . . . . 1.99 111.549 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -44.54 145.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.839 -0.345 . . . . 0.20999999999999999 111.683 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.7 pt -139.37 -23.44 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 120.222 -0.591 . . . . 0.85999999999999999 111.137 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.594 ' O ' HG22 ' A' ' 172' ' ' ILE . 31.9 t90 -170.69 126.45 0.73 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.393 -0.523 . . . . 0.28000000000000003 110.355 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -144.41 141.07 29.41 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.675 -0.239 . . . . 0.20000000000000001 111.275 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -147.18 126.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 114.028 1.122 . . . . 0.67000000000000004 114.028 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 0.4 OUTLIER -116.8 96.13 5.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.323 -0.551 . . . . 1.27 110.933 177.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.29 115.1 5.24 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 109.627 -0.508 . . . . 0.37 109.627 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 162.62 -56.18 0.3 Allowed Glycine 0 N--CA 1.441 -0.992 0 O-C-N 124.093 0.871 . . . . 0.67000000000000004 113.855 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -115.19 -120.88 3.41 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.744 -0.741 . . . . 1.1200000000000001 112.946 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 20' ' ' SER . 28.0 tt0 -154.74 120.28 5.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.89 0.33 . . . . 2.02 111.89 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 24.6 t 24.09 115.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.675 1.361 . . . . 1.22 114.675 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -137.74 151.19 47.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.303 0.573 . . . . 0.34000000000000002 111.865 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.99 106.97 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.391 -0.822 . . . . 1.1799999999999999 111.507 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.09 153.96 42.13 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.292 -0.413 . . . . 1.1699999999999999 110.231 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 25' ' ' HIS . 12.5 m -44.26 -53.07 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 113.445 0.905 . . . . 0.59999999999999998 113.445 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.437 ' N ' HG23 ' A' ' 24' ' ' VAL . 82.6 m-70 -55.82 -19.88 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.194 0.521 . . . . 0.46000000000000002 110.565 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.38 35.01 3.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.407 -0.815 . . . . 0.28999999999999998 112.144 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.427 HD11 ' HG ' ' A' ' 6' ' ' LEU . 33.4 mm -102.75 120.52 52.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 0.42999999999999999 109.454 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 10.3 t60 -103.52 129.12 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.335 1.235 . . . . 0.52000000000000002 114.335 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.82 139.44 36.51 Favored 'General case' 0 CA--C 1.524 -0.04 0 N-CA-C 107.468 -1.308 . . . . 3.0 107.468 176.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.442 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 15.5 ptm180 -103.82 126.0 50.64 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.529 0.68 . . . . 2.8999999999999999 112.439 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 31' ' ' LYS . 4.5 tmmm? -20.32 141.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.445 1.498 . . . . 2.71 114.708 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -27.86 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.072 -1.422 . . . . 1.98 112.467 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 C--N 1.349 0.605 0 C-N-CA 122.939 2.426 . . . . 1.53 114.627 -179.351 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 109.03 -0.73 . . . . 0.82999999999999996 109.03 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 mp -97.51 -37.46 9.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 1.6899999999999999 112.897 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -82.36 38.94 0.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.594 0.59 . . . . 2.5600000000000001 112.594 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -153.3 165.97 34.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 0.96999999999999997 111.663 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.8 t30 -76.76 146.69 76.73 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.891 -0.595 . . . . 1.96 109.764 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.635 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.44 -55.62 1.83 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.466 2.111 . . . . 0.66000000000000003 114.272 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.718 ' O ' HG12 ' A' ' 59' ' ' VAL . 12.0 mm-40 -64.5 -56.76 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.721 0.772 . . . . 1.8200000000000001 111.167 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' OD1' HD13 ' A' ' 60' ' ' LEU . 47.2 t0 -70.58 -2.54 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.15 -0.62 . . . . 1.9099999999999999 110.304 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.635 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 22.6 tt0 -73.32 -56.15 5.45 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.701 -1.222 . . . . 1.5 107.701 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 56' ' ' GLU . 11.0 p -52.46 -35.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.039 -1.097 . . . . 1.22 108.039 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -65.18 -68.83 0.33 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.42 -0.512 . . . . 1.05 110.1 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -54.12 -3.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.026 0.931 . . . . 0.90000000000000002 111.9 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 63' ' ' THR . 26.7 tt0 -109.96 -113.92 0.31 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.585 -0.734 . . . . 1.8 110.351 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 59' ' ' VAL . 57.2 p 29.87 123.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.699 1.37 . . . . 1.05 114.699 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.483 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -127.26 147.44 50.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.868 -0.606 . . . . 2.0499999999999998 110.265 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.509 ' HG3' HH11 ' A' ' 65' ' ' ARG . 2.3 ptm180 -136.81 -173.25 3.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.686 0.279 . . . . 3.5800000000000001 110.45 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -49.21 148.95 2.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.371 0.508 . . . . 4.25 112.371 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -135.43 -179.83 5.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 4.3499999999999996 110.525 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -156.6 -120.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.725 -0.216 . . . . 3.1699999999999999 111.106 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -153.29 129.33 10.33 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.468 0.175 . . . . 2.3900000000000001 110.823 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.678 ' H ' HD21 ' A' ' 164' ' ' ASN . 23.0 t 56.59 91.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.977 0.417 . . . . 0.98999999999999999 110.985 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -164.29 163.91 22.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.905 -0.588 . . . . 1.26 110.886 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -169.45 -174.27 37.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.15 -1.024 . . . . 0.66000000000000003 113.973 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -108.51 165.98 11.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.44 0.638 . . . . 0.82999999999999996 112.138 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.74 126.97 51.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.824 -1.08 . . . . 2.27 110.218 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.501 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -118.43 87.53 31.01 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 111.835 0.309 . . . . 0.34000000000000002 111.835 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.12 133.62 58.9 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 121.929 1.753 . . . . 0.80000000000000004 112.021 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 78' ' ' LYS . 24.1 mt -124.11 153.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.938 0.399 . . . . 0.38 111.483 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' N ' HG22 ' A' ' 77' ' ' ILE . 59.0 mttp -140.85 0.98 1.64 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.888 -0.596 . . . . 2.96 111.027 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -129.42 170.44 13.68 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.713 0.292 . . . . 2.1299999999999999 111.284 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -123.06 176.87 5.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.095 0.474 . . . . 0.37 111.242 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.36 -152.31 20.18 Favored Glycine 0 C--N 1.329 0.153 0 N-CA-C 109.868 -1.293 . . . . 0.20999999999999999 109.868 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.52 108.55 19.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.858 1.329 . . . . 2.0299999999999998 108.836 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -95.01 126.95 40.7 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.578 0.704 . . . . 0.26000000000000001 109.677 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 177' ' ' ALA . 13.9 t -113.6 118.49 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.787 -1.097 . . . . 0.54000000000000004 111.831 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 105.37 17.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.521 -1.218 . . . . 1.23 111.572 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.64 126.47 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.78 -1.1 . . . . 1.3100000000000001 108.966 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 87' ' ' LEU . 1.8 pt? -147.17 134.88 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.63 -0.828 . . . . 1.3700000000000001 111.754 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.522 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 5.3 tptp -98.02 120.74 38.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.317 -0.856 . . . . 2.9700000000000002 110.828 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.579 ' CD2' HD21 ' A' ' 115' ' ' LEU . 7.5 m-85 -105.09 136.54 44.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.757 -1.201 . . . . 0.29999999999999999 107.757 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 119.489 -0.884 . . . . 0.40999999999999998 113.074 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.485 ' HB2' ' HZ2' ' A' ' 100' ' ' LYS . 40.6 mt-30 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 120.897 0.38 . . . . 2.96 111.069 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 73.9 m -119.1 134.4 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.55 111.254 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 71.43 -60.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.772 -0.649 . . . . 2.3300000000000001 111.554 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -45.48 -38.29 6.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.409 -0.36 . . . . 2.5099999999999998 111.139 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HZ2' ' HB2' ' A' ' 96' ' ' GLN . 4.7 ttmp? -101.95 82.55 2.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.305 0.574 . . . . 3.1000000000000001 110.778 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.77 139.91 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.293 -0.867 . . . . 1.3100000000000001 109.618 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.456 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 61.6 m-85 -119.92 176.85 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.756 0.65 . . . . 0.68999999999999995 112.756 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -127.15 140.43 52.26 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.213 0.53 . . . . 2.0099999999999998 112.31 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.89 136.45 55.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.052 -0.977 . . . . 0.46000000000000002 112.008 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 5.1 mtt180 -135.5 156.68 48.5 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 113.264 0.839 . . . . 1.8500000000000001 113.264 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 39.5 t -122.9 123.34 67.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 114.558 -1.201 . . . . 1.1000000000000001 109.298 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER 53.59 26.1 5.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.556 -0.905 . . . . 1.77 108.556 -175.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.83 17.15 57.03 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.278 -0.873 . . . . 0.40999999999999998 112.74 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 38.5 m80 -112.37 112.89 24.79 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.895 0.702 . . . . 0.46000000000000002 112.895 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 p -62.77 127.17 30.0 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.864 -0.734 . . . . 0.66000000000000003 110.454 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.06 -30.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 0.80000000000000004 109.316 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.37 88.97 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.804 -0.814 . . . . 0.51000000000000001 108.804 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -106.6 77.72 1.21 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.515 1.15 . . . . 2.4399999999999999 110.773 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 p30 159.44 38.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.348 -1.751 . . . . 2.5600000000000001 108.499 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.579 HD21 ' CD2' ' A' ' 89' ' ' PHE . 20.5 tp -79.36 91.64 5.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.172 0.805 . . . . 1.1000000000000001 113.172 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -106.48 91.14 3.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.869 -1.16 . . . . 1.99 107.869 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.25 -32.42 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.995 0.739 . . . . 0.63 112.995 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.97 -51.56 15.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.737 -0.385 . . . . 0.90000000000000002 111.303 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.27 -27.13 65.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.76000000000000001 111.913 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HE ' ' CE1' ' A' ' 127' ' ' HIS . 23.8 mmm180 -77.65 -58.6 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.688 0.625 . . . . 2.6800000000000002 112.688 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.52 -41.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.383 0.512 . . . . 1.4099999999999999 112.383 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.65 -125.66 6.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.438 -0.887 . . . . 1.0600000000000001 112.889 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.416 ' O ' HG23 ' A' ' 125' ' ' THR . 97.5 m-70 -72.42 110.34 6.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.382 . . . . 3.5099999999999998 111.372 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 61.5 m 48.41 -109.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 1.6799999999999999 111.685 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 123' ' ' HIS . 53.1 p 50.31 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 0.80000000000000004 110.988 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.16 138.42 50.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.287 0.565 . . . . 0.44 112.234 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.459 ' CE1' ' HE ' ' A' ' 120' ' ' ARG . 1.6 t60 -108.0 151.06 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.075 -0.966 . . . . 0.38 108.416 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.85 136.51 38.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.772 0.656 . . . . 2.0899999999999999 112.772 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' HD23 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -127.76 123.86 36.34 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.05 -0.977 . . . . 2.2799999999999998 109.668 178.004 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.461 ' O ' HD13 ' A' ' 131' ' ' ILE . 53.2 mt -119.08 124.05 72.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.917 -0.583 . . . . 0.70999999999999996 110.396 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 130' ' ' ILE . 50.9 mm -131.6 95.5 23.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.122 0.415 . . . . 1.3799999999999999 112.122 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.99 148.84 93.05 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.646 1.564 . . . . 0.22 111.309 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 134' ' ' SER . 21.3 mt -139.64 155.96 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.336 . . . . 0.20999999999999999 110.961 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 29.2 p -131.57 111.2 11.53 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.008 0.432 . . . . 1.1100000000000001 111.168 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LYS . 20.3 mt -112.06 127.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.649 -0.705 . . . . 0.23000000000000001 110.217 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -149.32 137.97 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.518 -0.31 . . . . 1.9099999999999999 111.005 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 137' ' ' LYS . 9.4 mtmp? 62.5 13.4 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.998 -0.546 . . . . 3.1099999999999999 111.468 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.61 7.64 58.89 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.59 -0.814 . . . . 0.32000000000000001 112.986 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.601 ' O ' HG23 ' A' ' 135' ' ' ILE . 53.1 mtpt -108.12 167.06 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.883 0.341 . . . . 2.1899999999999999 110.645 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -127.96 146.36 50.67 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.739 0.644 . . . . 0.37 112.739 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.568 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -132.2 109.7 10.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.027 -0.988 . . . . 0.90000000000000002 109.335 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.2 p -109.71 111.51 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.082 -0.508 . . . . 0.53000000000000003 110.349 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 61.89 -89.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 2.0499999999999998 111.579 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.07 15.13 4.02 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.712 -0.756 . . . . 0.59999999999999998 112.77 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.42 130.93 57.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.089 -0.337 . . . . 2.02 110.089 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.3 131.82 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.184 0.516 . . . . 1.3 110.966 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -149.59 175.37 11.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.637 -0.711 . . . . 1.1200000000000001 109.496 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.4 p -99.52 138.88 35.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.7 -0.4 . . . . 1.1100000000000001 111.418 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.059 -0.719 . . . . 0.28000000000000003 109.059 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 t -139.6 95.86 2.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.175 0.805 . . . . 1.55 113.175 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.29 -51.02 3.22 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 115.819 1.087 . . . . 0.46000000000000002 115.819 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.501 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -158.66 174.94 14.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.385 1.093 . . . . 1.8 113.543 -177.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.437 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 1.1 tp -97.69 124.69 42.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.035 -1.439 . . . . 1.24 107.123 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.4 t -114.35 116.93 29.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 118.739 -1.184 . . . . 1.28 113.443 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 47.0 t -95.61 98.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.741 -0.837 . . . . 0.58999999999999997 108.741 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.3 tt0 -109.13 134.63 51.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.658 -0.701 . . . . 2.48 111.207 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -126.33 134.56 51.06 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.276 0.56 . . . . 1.54 110.345 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.447 HG21 HH21 ' A' ' 105' ' ' ARG . 99.1 t -105.8 142.04 19.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 114.73 -1.123 . . . . 0.77000000000000002 110.815 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 143.01 44.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.429 -0.805 . . . . 1.97 111.57 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.76 -14.13 16.45 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.458 -0.657 . . . . 1.1200000000000001 111.458 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -158.98 -64.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 3.8100000000000001 110.281 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -176.72 161.9 2.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 3.8199999999999998 110.783 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 57.22 71.24 0.59 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 1.3999999999999999 111.282 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.678 HD21 ' H ' ' A' ' 70' ' ' SER . 5.8 m-20 -49.98 153.31 2.34 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.537 -0.756 . . . . 2.0 109.503 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.456 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -28.71 105.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.381 2.054 . . . . 2.5800000000000001 112.343 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -58.14 -74.0 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.149 -0.932 . . . . 3.71 112.584 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 4.8 t -79.1 133.13 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 119.858 -0.737 . . . . 0.92000000000000004 111.281 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 5.2 t -129.12 124.48 34.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.084 -0.962 . . . . 1.2 109.817 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.522 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -117.47 35.46 4.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.652 0.982 . . . . 0.22 113.652 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -35.74 131.06 0.54 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.175 0.512 . . . . 1.02 111.649 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.455 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -152.46 96.71 2.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.33000000000000002 109.542 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.9 OUTLIER -104.82 126.81 59.66 Favored 'Isoleucine or valine' 0 C--O 1.263 1.805 0 CA-C-O 122.625 1.202 . . . . 0.68999999999999995 112.583 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ptm -118.29 162.52 18.13 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.57 -1.65 . . . . 1.26 109.254 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.97 146.45 46.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.818 1.414 . . . . 1.8200000000000001 114.818 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.97 -35.44 5.0 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 112.469 -2.15 . . . . 0.22 117.837 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.463 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 153.87 0.36 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.396 2.098 . . . . 0.28999999999999998 115.298 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.648 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -87.75 -31.8 19.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.379 -1.282 . . . . 0.56999999999999995 110.465 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 115.712 -0.677 . . . . 2.3100000000000001 111.63 -178.556 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.145 0.498 . . . . 0.40999999999999998 110.267 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.67 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -57.24 -20.67 28.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 0.33000000000000002 110.642 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.75 -18.29 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 2.0899999999999999 111.738 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.578 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -105.95 -27.04 11.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.776 -0.37 . . . . 1.99 111.091 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -45.43 146.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 120.979 -0.289 . . . . 0.20999999999999999 111.311 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.24 -20.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 119.965 -0.694 . . . . 0.85999999999999999 110.729 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' O ' HG22 ' A' ' 172' ' ' ILE . 13.1 t90 -173.51 129.33 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.028 -0.533 . . . . 0.28000000000000003 110.042 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.82 139.29 20.48 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 122.333 -0.229 . . . . 0.20000000000000001 111.296 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.2 t -147.16 131.89 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 114.324 1.231 . . . . 0.67000000000000004 114.324 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 63.8 t30 -115.34 87.96 2.77 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 116.161 -0.472 . . . . 1.27 110.822 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.97 112.21 1.43 Allowed 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.648 -0.706 . . . . 0.37 110.046 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 143.97 -13.81 2.15 Favored Glycine 0 N--CA 1.442 -0.91 0 O-C-N 124.047 0.842 . . . . 0.67000000000000004 114.234 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.08 -131.06 2.97 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 119.961 -1.114 . . . . 1.1200000000000001 113.129 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -160.99 120.01 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 2.02 111.45 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.6 m 26.4 104.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.921 -1.036 . . . . 1.22 113.615 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.637 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 36.8 t-80 -132.77 142.82 49.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 120.334 -0.546 . . . . 0.34000000000000002 112.404 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.8 p -116.94 105.43 18.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 121.456 0.646 . . . . 1.1799999999999999 111.101 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.59 158.12 34.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.38 -0.827 . . . . 1.1699999999999999 110.512 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 25' ' ' HIS . 14.2 m -42.95 -50.99 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.227 0.954 . . . . 0.59999999999999998 113.261 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.433 ' N ' HG23 ' A' ' 24' ' ' VAL . 85.6 m-70 -57.33 -22.16 40.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.46000000000000002 110.42 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.54 34.72 3.5 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.228 -0.896 . . . . 0.28999999999999998 111.757 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.5 mm -103.58 112.65 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.13 0.49 . . . . 0.42999999999999999 110.403 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.637 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.1 t60 -97.59 139.01 34.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.485 1.291 . . . . 0.52000000000000002 114.485 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.675 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -104.76 138.02 41.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.458 -1.246 . . . . 3.0 108.867 178.024 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 29.6 mtp180 -94.19 109.05 20.87 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.685 0.616 . . . . 2.8999999999999999 112.03 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 32' ' ' ASP . 81.2 tttt -24.05 132.16 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.176 1.176 . . . . 2.71 114.176 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' LYS . 77.4 m-20 -2.41 80.11 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.701 1.2 . . . . 1.98 113.998 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.456 -0.685 0 C-N-CA 123.549 2.832 . . . . 1.53 112.561 179.26 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 109.779 -0.452 . . . . 0.82999999999999996 109.779 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.11 -60.46 1.97 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.796 1.036 . . . . 1.6899999999999999 113.796 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -71.76 32.84 0.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.408 0.892 . . . . 2.5600000000000001 113.408 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 t -138.16 140.76 40.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.327 0.491 . . . . 0.96999999999999997 112.327 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.505 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 6.9 t30 -62.27 145.76 93.55 Favored Pre-proline 0 C--O 1.22 -0.451 0 CA-C-N 115.538 -0.755 . . . . 1.96 109.225 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.602 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 11.3 Cg_exo -39.57 -51.18 2.89 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.594 2.196 . . . . 0.66000000000000003 115.425 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.44 -56.19 12.15 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 122.407 1.098 . . . . 1.8200000000000001 110.911 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.58 59.94 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.866 -1.061 . . . . 1.9099999999999999 109.85 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.602 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 29.4 tt0 -64.49 -45.68 86.29 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.614 -1.625 . . . . 1.5 106.614 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 63' ' ' THR . 96.7 t -57.1 -54.4 30.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.455 -1.248 . . . . 1.22 109.99 177.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.9 tp -64.62 -12.75 48.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.9 -0.591 . . . . 1.05 112.087 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.488 ' CZ ' ' HE2' ' A' ' 88' ' ' LYS . 4.1 m-30 -108.52 -2.0 19.26 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.916 -0.584 . . . . 0.90000000000000002 110.21 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.601 ' HG2' ' N ' ' A' ' 63' ' ' THR . 36.7 tt0 -123.58 -107.61 0.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.539 -0.755 . . . . 1.8 112.033 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 59' ' ' VAL . 48.2 p 42.08 -168.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.489 -0.323 . . . . 1.05 110.994 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 177.71 128.4 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.977 0.417 . . . . 2.0499999999999998 111.77 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.546 ' NH2' ' HB2' ' A' ' 67' ' ' ASN . 2.2 ttp85 -112.74 -170.97 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.103 -0.499 . . . . 3.5800000000000001 110.336 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -162.91 138.12 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.618 0.247 . . . . 4.25 111.128 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.546 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 48.7 t-20 -130.8 -82.54 0.53 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.415 -0.357 . . . . 4.3499999999999996 110.944 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.91 -75.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.549 0.214 . . . . 3.1699999999999999 111.349 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -163.82 143.26 8.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.682 -0.235 . . . . 2.3900000000000001 110.69 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t 50.55 83.42 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.98999999999999999 110.158 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.434 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 29.9 p90 -150.2 151.65 33.4 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.224 0.535 . . . . 1.26 111.632 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -169.23 -169.37 32.49 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.268 -0.878 . . . . 0.66000000000000003 113.675 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -102.15 177.73 4.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.578 0.955 . . . . 0.82999999999999996 113.578 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.68 120.89 21.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.661 -1.609 . . . . 2.27 109.663 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.99 90.66 11.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.241 0.46 . . . . 0.34000000000000002 112.241 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.7 141.28 90.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.097 1.198 . . . . 0.80000000000000004 111.118 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.35 151.87 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 0.38 111.32 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -144.63 2.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 2.96 110.839 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -127.33 175.17 8.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.589 0.233 . . . . 2.1299999999999999 110.663 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -131.71 170.33 14.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.37 111.654 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.59 -154.64 22.65 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 109.569 -1.412 . . . . 0.20999999999999999 109.569 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -96.41 109.66 22.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.976 1.388 . . . . 2.0299999999999998 108.929 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.08 126.45 41.32 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.769 -0.826 . . . . 0.26000000000000001 108.769 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.2 t -112.59 113.07 43.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.901 -1.045 . . . . 0.54000000000000004 111.57 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.78 103.75 16.37 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.641 -1.163 . . . . 1.23 109.66 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.62 134.44 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.404 -0.816 . . . . 1.3100000000000001 108.859 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -147.05 154.94 41.78 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.783 -0.767 . . . . 1.3700000000000001 112.018 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.89 119.12 37.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.767 -0.652 . . . . 2.9700000000000002 110.172 178.54 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 7.7 m-85 -105.68 137.74 43.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.918 -0.583 . . . . 0.29999999999999999 109.531 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.535 ' O ' HG13 ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.325 -0.477 0 N-CA-C 110.235 -0.283 . . . . 0.40999999999999998 110.235 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.687 0.279 . . . . 2.96 110.631 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -97.7 162.38 13.3 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.158 0.504 . . . . 1.55 111.356 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 100' ' ' LYS . 2.5 mp0 55.63 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.88 -1.054 . . . . 2.3300000000000001 110.818 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 71.33 -30.34 0.21 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.966 -1.016 . . . . 2.5099999999999998 110.602 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 98' ' ' GLN . 66.4 mmtt -108.52 63.1 0.61 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.537 -0.912 . . . . 3.1000000000000001 108.537 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.418 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 1.1 m -109.11 150.78 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.262 -0.881 . . . . 1.3100000000000001 110.532 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -118.62 178.32 4.51 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 112.843 0.683 . . . . 0.68999999999999995 112.843 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -127.67 137.67 52.57 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.062 -0.517 . . . . 2.0099999999999998 111.176 177.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.88 127.01 51.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 115.89 -0.595 . . . . 0.46000000000000002 111.952 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -128.31 141.44 51.44 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.141 -0.936 . . . . 1.8500000000000001 113.269 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.2 m -116.93 118.76 59.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 114.149 -1.387 . . . . 1.1000000000000001 109.583 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 61.92 28.5 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.882 -0.784 . . . . 1.77 108.882 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.38 89.91 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.40999999999999998 111.369 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 58.6 m-70 -102.62 109.15 20.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.759 -0.721 . . . . 0.46000000000000002 112.209 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -68.44 133.42 48.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.477 0.656 . . . . 0.66000000000000003 112.052 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -31.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.896 -1.047 . . . . 0.80000000000000004 109.636 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.25 91.03 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.197 -0.668 . . . . 0.51000000000000001 109.197 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 3.3 ptpp? -109.18 77.28 1.05 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.692 1.234 . . . . 2.4399999999999999 112.24 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.1 p30 153.53 40.15 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.197 -2.274 . . . . 2.5600000000000001 109.353 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.408 HD11 ' OE1' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -63.18 94.42 0.07 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.247 0.546 . . . . 1.1000000000000001 112.187 -178.454 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -102.98 84.11 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.932 -1.507 . . . . 1.99 106.932 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.3 mt -50.32 -41.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.104 -0.953 . . . . 0.63 112.628 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.01 -45.73 87.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.667 0.27 . . . . 0.90000000000000002 111.482 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.11 -28.82 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.211 0.449 . . . . 0.76000000000000001 112.211 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -68.35 -58.44 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.437 0.532 . . . . 2.6800000000000002 112.437 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.4 p -94.39 -37.1 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.867 0.321 . . . . 1.4099999999999999 111.867 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.16 -114.54 2.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.399 -0.905 . . . . 1.0600000000000001 112.878 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.486 ' O ' HG23 ' A' ' 125' ' ' THR . 57.3 t-80 -104.6 114.05 28.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.714 0.292 . . . . 3.5099999999999998 111.172 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.3 p 53.3 -143.22 0.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.006 -0.543 . . . . 1.6799999999999999 111.316 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.0 p 64.36 -171.73 0.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.624 0.37 . . . . 0.80000000000000004 110.996 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -104.71 139.54 39.37 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.692 0.626 . . . . 0.44 112.692 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.8 t60 -102.91 152.02 21.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.209 -0.905 . . . . 0.38 109.075 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -144.2 132.89 22.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.635 0.605 . . . . 2.0899999999999999 112.635 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.408 ' OE1' HD11 ' A' ' 115' ' ' LEU . 29.2 mt-10 -127.65 128.42 45.46 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 2.2799999999999998 109.893 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.4 mt -117.13 122.03 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.058 -0.519 . . . . 0.70999999999999996 110.496 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mm -124.93 89.71 52.15 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.392 -0.367 . . . . 1.3799999999999999 111.928 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -60.52 143.12 99.42 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.928 1.752 . . . . 0.22 111.918 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 24.1 mt -134.94 156.54 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.20999999999999999 110.367 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.0 p -130.51 106.51 8.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.938 0.399 . . . . 1.1100000000000001 111.015 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 139' ' ' LYS . 19.2 mt -107.7 122.98 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 0.23000000000000001 110.222 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.54 140.57 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 1.9099999999999999 110.804 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp 61.49 26.54 16.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.904 -0.589 . . . . 3.1099999999999999 110.82 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.72 27.75 60.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.898 -0.668 . . . . 0.32000000000000001 113.004 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.524 ' O ' HG23 ' A' ' 135' ' ' ILE . 73.3 mttt -126.15 151.62 47.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.832 0.316 . . . . 2.1899999999999999 111.321 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 141' ' ' SER . 5.3 tt -111.24 129.52 55.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 0.37 111.856 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 140' ' ' LEU . 18.3 m -117.35 109.41 16.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 0.90000000000000002 109.658 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -105.99 105.86 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.255 0.55 . . . . 0.53000000000000003 111.173 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 56.63 -90.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.823 -0.626 . . . . 2.0499999999999998 111.976 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.77 24.95 4.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.468 -0.873 . . . . 0.59999999999999998 113.537 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -134.16 135.13 42.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.811 0.306 . . . . 2.02 110.178 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.33 139.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.093 0.473 . . . . 1.3 111.132 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.2 t -161.35 127.83 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 1.1200000000000001 109.993 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.6 p -53.69 143.72 19.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 1.1100000000000001 111.68 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.31 124.81 28.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.914 -0.773 . . . . 0.28000000000000003 108.914 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 t -115.96 92.32 3.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.073 0.768 . . . . 1.55 113.073 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.06 -34.09 0.05 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 117.376 1.71 . . . . 0.46000000000000002 117.376 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.63 158.42 28.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.598 1.699 . . . . 1.8 113.885 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.47 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -96.16 124.78 40.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.618 -1.253 . . . . 1.24 107.618 176.089 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -108.09 142.34 38.43 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 113.904 1.075 . . . . 1.28 113.904 -176.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.511 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 64.6 t -129.67 97.8 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.54 . . . . 0.58999999999999997 109.909 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 60.7 mm-40 -112.66 128.92 56.52 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.137 -0.938 . . . . 2.48 111.495 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 17.7 p90 -116.1 133.54 55.91 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.375 -0.602 . . . . 1.54 109.375 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 t -108.79 142.86 20.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 115.303 -0.862 . . . . 0.77000000000000002 111.569 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -63.58 148.52 48.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.669 -1.151 . . . . 1.97 111.634 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -111.82 -10.34 19.0 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.744 -0.662 . . . . 1.1200000000000001 111.652 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -153.5 -51.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 3.8100000000000001 110.397 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -171.39 -64.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.151 -0.477 . . . . 3.8199999999999998 110.626 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.55 117.52 20.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.989 -0.551 . . . . 1.3999999999999999 110.809 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 166' ' ' LYS . 2.1 m120 -60.09 -178.53 0.15 Allowed Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.211 -0.904 . . . . 2.0 109.506 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -48.18 -8.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.905 1.737 . . . . 2.5800000000000001 113.915 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 164' ' ' ASN . 27.6 tptt 76.64 -75.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.656 0.383 . . . . 3.71 111.652 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 90' ' ' ALA . 2.0 m -111.95 137.1 45.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 C-N-CA 119.795 -0.762 . . . . 0.92000000000000004 111.562 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.8 t -131.88 122.54 25.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.738 -1.119 . . . . 1.2 112.085 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -106.19 38.34 2.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.163 -0.926 . . . . 0.22 113.381 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.402 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -35.49 133.93 0.34 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.963 0.357 . . . . 1.02 111.963 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.436 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -154.16 94.92 1.78 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.148 -0.478 . . . . 0.33000000000000002 110.843 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 12' ' ' TRP . 6.1 tt -104.19 131.44 53.0 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 CA-C-O 122.643 1.211 . . . . 0.68999999999999995 112.547 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.614 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -122.15 166.6 14.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.858 -1.519 . . . . 1.26 110.416 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.1 150.57 37.13 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.959 1.466 . . . . 1.8200000000000001 114.959 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 90.51 -34.49 4.16 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 112.105 -2.316 . . . . 0.22 118.176 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.71 162.07 0.7 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.225 2.012 . . . . 0.28999999999999998 114.187 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.621 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.54 -23.58 27.63 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 115.029 -0.987 . . . . 0.56999999999999995 110.968 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 2.3100000000000001 111.496 -179.047 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 tp . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.29 0.567 . . . . 0.40999999999999998 110.402 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.639 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.7 -21.09 25.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.309 -0.859 . . . . 0.33000000000000002 111.466 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.24 -16.03 59.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.167 0.432 . . . . 2.0899999999999999 112.167 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -105.23 -28.62 10.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.665 -0.414 . . . . 1.99 111.002 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -40.1 144.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 111.772 0.286 . . . . 0.20999999999999999 111.772 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.69 -23.75 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.071 -0.652 . . . . 0.85999999999999999 111.073 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.53 ' O ' HG22 ' A' ' 172' ' ' ILE . 25.4 t90 -173.09 137.98 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.972 -0.381 . . . . 0.28000000000000003 109.972 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -157.27 145.95 19.66 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.343 -0.143 . . . . 0.20000000000000001 111.121 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.9 t -147.35 124.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 114.075 1.139 . . . . 0.67000000000000004 114.075 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -115.4 101.23 8.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.457 -0.497 . . . . 1.27 110.807 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.89 104.74 1.42 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 108.614 -0.884 . . . . 0.37 108.614 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.64 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 165.68 -63.78 0.22 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 124.718 1.261 . . . . 0.67000000000000004 112.426 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.0 -131.07 5.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.859 -0.686 . . . . 1.1200000000000001 112.121 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -168.83 119.8 0.75 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.118 -0.327 . . . . 2.02 110.118 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 69.7 m 42.13 83.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.937 -0.574 . . . . 1.22 111.068 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 32.7 t-80 -116.89 143.78 45.29 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.036 -0.666 . . . . 0.34000000000000002 112.543 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.59 104.32 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.477 -0.783 . . . . 1.1799999999999999 110.151 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.85 157.09 38.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.346 -0.388 . . . . 1.1699999999999999 110.448 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 m -43.95 -51.02 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.255 0.972 . . . . 0.59999999999999998 113.44 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -58.09 -20.09 37.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.314 0.578 . . . . 0.46000000000000002 110.104 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.94 35.12 3.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.138 -0.937 . . . . 0.28999999999999998 111.987 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -103.34 123.17 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.98 -0.378 . . . . 0.42999999999999999 109.98 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.4 t60 -100.97 132.23 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.86 1.059 . . . . 0.52000000000000002 113.86 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 128.89 42.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.114 -1.069 . . . . 3.0 108.114 177.228 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -82.72 110.31 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.833 0.708 . . . . 2.8999999999999999 112.12 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 tmmm? -22.96 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.83 1.252 . . . . 2.71 113.708 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -20.05 88.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 114.55 -1.205 . . . . 1.98 113.551 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 CA--C 1.535 0.559 0 C-N-CA 122.714 2.276 . . . . 1.53 113.765 179.392 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.439 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 109.183 -0.673 . . . . 0.82999999999999996 109.183 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -55.25 30.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.305 -0.861 . . . . 1.6899999999999999 112.957 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.42 31.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.81 0.67 . . . . 2.5600000000000001 112.81 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -147.07 134.95 21.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 0.96999999999999997 111.707 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -69.51 159.76 82.23 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.358 -0.608 . . . . 1.96 109.358 178.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.8 Cg_exo -40.87 -39.5 3.24 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.532 2.155 . . . . 0.66000000000000003 115.408 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.51 -56.9 4.07 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.56 0.695 . . . . 1.8200000000000001 111.351 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 18.5 p-10 -69.48 -4.89 20.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.747 -0.781 . . . . 1.9099999999999999 109.057 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 2.2 tt0 -73.97 -64.04 1.09 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.281 -0.872 . . . . 1.5 108.996 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.11 -35.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 1.22 109.322 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.5 tp -69.04 -64.98 0.77 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.788 -0.819 . . . . 1.05 108.788 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -69.55 22.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.673 -1.149 . . . . 0.90000000000000002 113.177 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.94 -65.33 0.36 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.158 1.17 . . . . 1.8 114.158 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.408 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 6.9 m -39.98 148.03 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.108 0.781 . . . . 1.05 113.108 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HB3' HG22 ' A' ' 167' ' ' VAL . 1.0 OUTLIER -134.47 152.11 51.58 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.803 -0.635 . . . . 2.0499999999999998 111.101 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.64 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 35.9 mtp85 -105.16 -169.51 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.773 0.321 . . . . 3.5800000000000001 110.794 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -86.6 -171.47 3.55 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.159 -0.473 . . . . 4.25 111.16 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.9 m120 64.53 156.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.283 -0.417 . . . . 4.3499999999999996 110.937 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.49 84.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.175 0.435 . . . . 3.1699999999999999 112.175 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -175.19 125.46 0.25 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.271 -0.171 . . . . 2.3900000000000001 111.182 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 24.1 t 37.83 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.415 0.447 . . . . 0.98999999999999999 110.963 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.52 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -90.36 104.76 17.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.203 -0.453 . . . . 1.26 109.817 -178.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 155' ' ' VAL . . . -120.06 108.57 1.48 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 119.703 -1.237 . . . . 0.66000000000000003 115.355 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.0 154.7 18.73 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.069 0.461 . . . . 0.82999999999999996 110.817 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.27 134.35 54.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.38 -0.827 . . . . 2.27 110.831 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.531 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -127.94 86.96 56.88 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.514 -0.312 . . . . 0.34000000000000002 111.394 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -55.58 128.35 30.01 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.856 1.704 . . . . 0.80000000000000004 112.357 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 63.2 mt -121.98 150.93 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.898 0.38 . . . . 0.38 111.154 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.07 -1.42 1.38 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.034 -0.53 . . . . 2.96 111.125 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.85 169.38 12.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.783 0.325 . . . . 2.1299999999999999 110.924 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.1 mp0 -120.93 -180.0 4.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.37 111.103 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.67 -148.36 17.2 Favored Glycine 0 CA--C 1.509 -0.322 0 N-CA-C 110.062 -1.215 . . . . 0.20999999999999999 110.062 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.9 mm-40 -104.09 110.97 23.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.577 1.189 . . . . 2.0299999999999998 109.488 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -95.97 126.79 41.46 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.506 -0.924 . . . . 0.26000000000000001 108.506 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.647 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.8 t -112.24 113.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.449 -0.796 . . . . 0.54000000000000004 111.342 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -97.79 104.49 16.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.684 -1.144 . . . . 1.23 111.008 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 14.3 t -111.56 142.01 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.755 -1.111 . . . . 1.3100000000000001 108.77 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.684 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -149.67 144.12 25.93 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.33 -0.948 . . . . 1.3700000000000001 112.105 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.581 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -101.72 121.95 43.0 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.082 -0.647 . . . . 2.9700000000000002 110.108 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.34 142.2 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.813 -0.81 . . . . 0.29999999999999999 108.813 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 120.474 -0.49 . . . . 0.40999999999999998 110.924 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.422 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 49.9 tp60 . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 121.052 0.454 . . . . 2.96 111.609 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -107.03 164.26 12.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.645 . . . . 1.55 110.908 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 68.14 -70.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.998 -0.546 . . . . 2.3300000000000001 111.72 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -46.67 -32.08 3.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.692 0.282 . . . . 2.5099999999999998 111.313 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 9.6 mtpm? -91.4 62.9 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 3.1000000000000001 110.708 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.31 134.41 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.814 0.34 . . . . 1.3100000000000001 110.206 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.451 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 78.6 m-85 -131.75 -179.28 5.3 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.565 0.58 . . . . 0.68999999999999995 112.565 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 7.9 t70 -126.06 143.94 50.92 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.653 -0.419 . . . . 2.0099999999999998 112.123 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.15 137.83 51.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 115.67 -0.695 . . . . 0.46000000000000002 111.824 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.534 HH21 HG21 ' A' ' 158' ' ' VAL . 10.0 mtt180 -136.77 151.88 49.69 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 113.204 0.816 . . . . 1.8500000000000001 113.204 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 106' ' ' VAL . 30.6 m -114.23 114.67 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 114.949 -1.023 . . . . 1.1000000000000001 108.839 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.653 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 60.1 27.18 16.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.508 -0.769 . . . . 1.77 109.384 -176.55 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.22 20.18 39.59 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.605 -1.18 . . . . 0.40999999999999998 112.744 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.3 m-70 -119.42 109.56 15.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.925 0.713 . . . . 0.46000000000000002 112.925 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.4 p -56.19 135.82 53.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.219 0.533 . . . . 0.66000000000000003 111.437 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 109' ' ' HIS . 5.5 t -132.94 -29.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.276 -0.875 . . . . 0.80000000000000004 108.913 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.16 90.07 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 116.005 -0.543 . . . . 0.51000000000000001 109.662 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 4.1 ptpp? -108.04 98.38 7.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.014 0.911 . . . . 2.4399999999999999 110.818 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 6.2 m-20 138.72 33.85 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.293 -2.231 . . . . 2.5600000000000001 108.198 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.08 89.47 0.06 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 112.852 0.686 . . . . 1.1000000000000001 112.852 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.2 t70 -106.35 86.6 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.429 -1.323 . . . . 1.99 107.429 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.3 mt -50.96 -42.22 23.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.275 -0.875 . . . . 0.63 112.55 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -60.2 -49.27 78.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.85 0.315 . . . . 0.90000000000000002 111.85 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.66 -27.52 65.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.869 0.322 . . . . 0.76000000000000001 111.869 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -64.69 -58.65 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.129 0.418 . . . . 2.6800000000000002 112.129 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.83 -40.53 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.054 0.391 . . . . 1.4099999999999999 112.054 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.76 -100.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 1.0600000000000001 111.793 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -114.69 110.76 20.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.728 0.299 . . . . 3.5099999999999998 110.6 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.5 t 60.0 -124.84 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.16 -0.473 . . . . 1.6799999999999999 110.755 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.4 p 54.83 -175.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 0.80000000000000004 111.664 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.439 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -104.91 138.08 41.69 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.95 0.722 . . . . 0.44 112.95 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.7 t60 -110.24 143.15 40.84 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.255 -1.017 . . . . 0.38 108.255 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.34 126.43 15.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.107 0.781 . . . . 2.0899999999999999 113.107 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.8 126.75 55.41 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.743 -0.662 . . . . 2.2799999999999998 109.41 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.37 117.86 54.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.584 -0.735 . . . . 0.70999999999999996 109.766 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.7 mt -127.14 87.78 55.76 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.186 0.81 . . . . 1.3799999999999999 113.186 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -62.32 146.36 95.79 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.764 1.642 . . . . 0.22 111.73 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 134' ' ' SER . 29.8 mt -137.34 157.84 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.20999999999999999 110.398 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 58.6 p -134.09 109.39 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.059 0.457 . . . . 1.1100000000000001 111.513 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 139' ' ' LYS . 14.2 mt -108.12 128.16 63.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 115.679 -0.692 . . . . 0.23000000000000001 109.82 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -148.59 142.81 26.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 1.9099999999999999 110.912 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm 60.38 15.73 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 3.1099999999999999 111.334 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.87 16.04 55.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.581 -0.818 . . . . 0.32000000000000001 113.204 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 135' ' ' ILE . 96.5 mttt -120.5 158.95 26.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.126 0.463 . . . . 2.1899999999999999 111.057 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.44 138.93 48.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.09 0.472 . . . . 0.37 112.19 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.521 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -125.32 114.96 19.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.576 -0.738 . . . . 0.90000000000000002 109.589 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 142' ' ' VAL . 3.4 p -111.93 99.8 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.402 0.62 . . . . 0.53000000000000003 111.435 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 60.3 -86.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.537 -0.756 . . . . 2.0499999999999998 112.401 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.64 16.03 5.93 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.511 -0.852 . . . . 0.59999999999999998 113.088 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.57 134.27 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.785 0.326 . . . . 2.02 110.416 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.68 137.98 32.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.478 . . . . 1.3 111.156 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 m -159.69 119.69 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 1.1200000000000001 109.419 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.0 t -53.69 146.48 13.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.564 . . . . 1.1100000000000001 112.042 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.429 ' H ' ' HA ' ' A' ' 139' ' ' LYS . 37.2 t80 -79.63 142.49 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.12 -0.946 . . . . 0.28000000000000003 110.031 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.3 p -139.38 95.94 3.01 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.967 0.728 . . . . 1.55 112.967 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.56 -60.5 2.43 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 115.66 1.024 . . . . 0.46000000000000002 115.66 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.531 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.97 164.78 36.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.943 0.872 . . . . 1.8 112.553 -178.047 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -82.16 134.85 35.33 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.119 -1.437 . . . . 1.24 107.119 177.084 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.653 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -121.78 103.92 9.21 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.502 1.297 . . . . 1.28 114.502 -174.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.452 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -93.53 126.32 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.96 -0.385 . . . . 0.58999999999999997 109.96 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 42.0 mt-10 -137.41 127.43 25.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.112 0.412 . . . . 2.48 112.112 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.93 120.08 41.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.408 -0.96 . . . . 1.54 108.408 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.534 HG21 HH21 ' A' ' 105' ' ' ARG . 9.7 t -91.09 143.6 10.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.324 0.583 . . . . 0.77000000000000002 111.532 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -57.31 147.96 24.19 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 114.728 -1.124 . . . . 1.97 111.501 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.21 -7.53 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.79 -0.641 . . . . 1.1200000000000001 111.918 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -151.59 -70.28 0.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.573 0.225 . . . . 3.8100000000000001 110.533 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -176.19 -64.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.362 -0.381 . . . . 3.8199999999999998 110.566 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.75 76.59 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 1.3999999999999999 110.89 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 102' ' ' PHE . 5.8 m-20 -48.35 156.0 0.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.266 -0.879 . . . . 2.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.451 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.71 101.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.457 2.105 . . . . 2.5800000000000001 112.395 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -60.14 -45.57 92.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.623 -0.717 . . . . 3.71 112.283 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 64' ' ' GLU . 21.4 t -104.24 133.63 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 120.337 -0.545 . . . . 0.92000000000000004 111.841 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.8 t -131.92 136.78 47.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 115.945 -0.571 . . . . 1.2 111.449 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -127.55 35.67 4.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.382 0.882 . . . . 0.22 113.382 -178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.12 130.92 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.205 0.316 . . . . 1.02 110.902 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 1.1 t80 -150.84 101.97 2.95 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.33000000000000002 110.864 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -111.63 129.69 66.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.66 0 CA-C-O 122.815 1.293 . . . . 0.68999999999999995 112.854 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.53 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -123.24 168.19 12.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.546 -1.661 . . . . 1.26 109.965 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -118.98 152.41 36.43 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.715 1.746 . . . . 1.8200000000000001 115.715 -176.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 88.17 -34.68 3.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 111.82 -2.446 . . . . 0.22 118.193 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.63 158.98 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.209 2.004 . . . . 0.28999999999999998 114.252 -179.459 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.647 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.75 -10.31 55.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.376 -0.829 . . . . 0.56999999999999995 110.712 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 2.3100000000000001 111.28 -178.479 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 tp . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.266 0.555 . . . . 0.40999999999999998 110.531 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.623 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -58.25 -21.11 47.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.373 -0.831 . . . . 0.33000000000000002 111.347 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.51 -16.29 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 2.0899999999999999 111.703 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.528 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -109.48 -26.15 10.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.661 -0.416 . . . . 1.99 111.657 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -42.5 145.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.69 0.256 . . . . 0.20999999999999999 111.69 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.1 pt -140.14 -18.34 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 119.979 -0.689 . . . . 0.85999999999999999 111.355 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -173.0 136.67 0.67 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.803 -0.359 . . . . 0.28000000000000003 110.361 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.82 142.37 12.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.513 0.56 . . . . 0.20000000000000001 112.513 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.0 t -147.64 134.5 13.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 N-CA-C 114.32 1.23 . . . . 0.67000000000000004 114.32 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -115.66 94.76 4.83 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.607 -0.437 . . . . 1.27 110.537 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.414 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -66.25 105.46 1.42 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.765 -0.828 . . . . 0.37 108.765 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 155.8 -40.99 0.59 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.115 -0.948 . . . . 0.67000000000000004 113.33 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -135.16 7.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.581 -0.819 . . . . 1.1200000000000001 113.203 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -160.95 119.52 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.537 0.208 . . . . 2.02 110.683 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 70.3 m 34.8 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.697 -0.683 . . . . 1.22 112.536 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.543 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 58.6 t-80 -116.57 151.89 35.26 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.254 0.549 . . . . 0.34000000000000002 112.237 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.27 103.22 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.17 -0.923 . . . . 1.1799999999999999 109.566 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 1.1699999999999999 110.227 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -43.67 -48.07 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 124.251 0.969 . . . . 0.59999999999999998 113.267 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -59.26 -23.21 62.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.179 0.514 . . . . 0.46000000000000002 110.506 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.3 34.41 2.72 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.423 -0.808 . . . . 0.28999999999999998 112.377 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.8 mm -103.15 125.34 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.188 -0.671 . . . . 0.42999999999999999 109.188 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.7 t60 -110.45 131.4 55.09 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.721 1.378 . . . . 0.52000000000000002 114.721 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.657 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.22 134.4 40.58 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.3 -1.0 . . . . 3.0 108.3 176.174 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -95.25 105.4 17.34 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.377 0.608 . . . . 2.8999999999999999 112.34 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 32' ' ' ASP . 31.2 ttpt -19.57 135.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.118 1.367 . . . . 2.71 114.682 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' LYS . 1.2 m-20 -2.12 85.16 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.783 -1.099 . . . . 1.98 113.329 177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.938 0 C-N-CA 122.854 2.369 . . . . 1.53 115.911 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.912 0.387 . . . . 0.82999999999999996 110.474 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 51' ' ' LEU . 2.9 mm? -94.42 -47.93 6.36 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.271 0.841 . . . . 1.6899999999999999 113.271 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -73.44 34.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.232 0.827 . . . . 2.5600000000000001 113.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -150.05 163.34 38.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.19 0.519 . . . . 0.96999999999999997 112.105 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.1 t30 -78.26 148.4 74.31 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.452 -0.794 . . . . 1.96 109.372 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.595 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.83 -57.88 1.18 Allowed 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.383 2.055 . . . . 0.66000000000000003 114.424 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -58.77 -56.85 16.95 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.191 0.996 . . . . 1.8200000000000001 111.016 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.466 ' OD1' HD23 ' A' ' 60' ' ' LEU . 25.7 t70 -69.19 -10.38 57.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.512 -0.767 . . . . 1.9099999999999999 110.171 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.9 tt0 -63.17 -46.43 87.17 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.146 -1.798 . . . . 1.5 106.146 176.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.26 -50.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.411 -1.268 . . . . 1.22 109.053 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.8 tp -68.88 -9.68 52.89 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.451 -0.795 . . . . 1.05 111.52 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 5.7 m-30 -122.34 17.94 10.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.868 -0.606 . . . . 0.90000000000000002 111.204 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -140.46 -71.95 0.37 Allowed 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.714 1.005 . . . . 1.8 113.714 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 7.4 p -27.18 140.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.606 0.965 . . . . 1.05 113.606 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.548 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -130.74 149.97 52.14 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.885 -0.598 . . . . 2.0499999999999998 110.916 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.605 HH12 ' HB2' ' A' ' 67' ' ' ASN . 3.7 ptm180 -136.86 138.66 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.835 0.35 . . . . 3.5800000000000001 110.359 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -78.15 142.92 37.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.048 -0.524 . . . . 4.25 111.407 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.605 ' HB2' HH12 ' A' ' 65' ' ' ARG . 24.7 t-20 -134.06 -89.88 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.246 -0.434 . . . . 4.3499999999999996 110.941 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -175.14 -95.84 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.339 0.126 . . . . 3.1699999999999999 111.339 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -156.27 151.44 26.49 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.483 -0.191 . . . . 2.3900000000000001 110.483 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t 48.06 81.53 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.98999999999999999 110.132 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.429 ' HZ ' ' C ' ' A' ' 164' ' ' ASN . 2.8 p90 -136.77 152.44 50.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 1.26 110.754 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.09 -155.26 8.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.037 -1.078 . . . . 0.66000000000000003 114.36 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.414 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 80.3 m-85 -135.78 154.81 51.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.726 0.639 . . . . 0.82999999999999996 112.726 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -118.49 106.48 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.664 -1.153 . . . . 2.27 110.223 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.35 110.68 64.63 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.909 0.337 . . . . 0.34000000000000002 111.909 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.01 133.81 10.23 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.502 1.468 . . . . 0.80000000000000004 111.816 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 61.2 mt -120.75 148.83 23.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.43 . . . . 0.38 111.496 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -139.75 -3.52 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.803 -0.635 . . . . 2.96 110.84 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 23.9 mm-40 -121.77 173.93 7.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.582 0.23 . . . . 2.1299999999999999 110.583 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.77 177.31 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.37 111.545 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.18 -161.17 23.1 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.144 -1.582 . . . . 0.20999999999999999 109.144 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 0.1 OUTLIER -95.0 110.68 22.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 118.743 1.272 . . . . 2.0299999999999998 109.913 179.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.0 m-85 -95.27 125.79 40.15 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.26000000000000001 109.577 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.614 HG21 ' N ' ' A' ' 177' ' ' ALA . 10.2 t -113.07 116.87 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.477 -1.238 . . . . 0.54000000000000004 111.939 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.89 104.57 16.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.668 -1.151 . . . . 1.23 110.778 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 58.8 t -103.22 119.39 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.124 -0.944 . . . . 1.3100000000000001 108.897 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.9 134.22 42.41 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.282 -0.567 . . . . 1.3700000000000001 111.186 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.428 ' CB ' ' HB3' ' A' ' 169' ' ' ALA . 19.4 tptt -104.52 120.74 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.755 -0.778 . . . . 2.9700000000000002 109.732 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 8.1 m-85 -104.77 139.23 39.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.922 -1.14 . . . . 0.29999999999999999 107.922 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 119.98 -0.688 . . . . 0.40999999999999998 112.534 -178.674 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.836 0.351 . . . . 2.96 110.907 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.6 p -97.27 -76.45 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.974 -0.557 . . . . 1.55 111.781 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -78.13 64.11 3.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.04 0.447 . . . . 2.3300000000000001 111.57 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -145.66 -48.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.181 -0.674 . . . . 2.5099999999999998 109.181 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -105.49 78.66 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.429 -0.805 . . . . 3.1000000000000001 109.33 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.0 113.51 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.332 -0.849 . . . . 1.3100000000000001 110.196 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -102.47 175.82 5.38 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.038 0.755 . . . . 0.68999999999999995 113.038 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 5.4 m-20 -122.1 140.12 52.91 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.694 -0.685 . . . . 2.0099999999999998 111.09 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.12 123.76 44.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 115.996 -0.547 . . . . 0.46000000000000002 111.768 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 12.3 mtt180 -117.66 150.47 38.99 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 115.008 -0.996 . . . . 1.8500000000000001 112.401 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.519 HG13 HD21 ' A' ' 153' ' ' LEU . 84.4 t -126.2 109.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 114.652 -1.158 . . . . 1.1000000000000001 109.392 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.451 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 57.02 25.99 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.432 -0.951 . . . . 1.77 108.432 -176.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.55 53.77 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.097 -0.956 . . . . 0.40999999999999998 112.674 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 92.1 m-70 -112.25 111.14 21.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.81 . . . . 0.46000000000000002 113.188 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -68.94 112.16 5.42 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 120.395 -0.522 . . . . 0.66000000000000003 110.584 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.88 -28.71 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.594 -0.73 . . . . 0.80000000000000004 109.849 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.437 HG21 ' OE1' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -135.02 90.2 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 120.281 -0.568 . . . . 0.51000000000000001 109.582 177.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.4 ptpp? -110.71 85.08 2.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.935 0.874 . . . . 2.4399999999999999 111.491 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.6 p-10 151.47 36.66 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 112.982 -1.917 . . . . 2.5600000000000001 108.325 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.481 HD21 ' OE2' ' A' ' 129' ' ' GLU . 0.7 OUTLIER -62.62 90.15 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.327 0.862 . . . . 1.1000000000000001 113.327 -177.467 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.77 83.91 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.351 -1.352 . . . . 1.99 107.351 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -50.44 -30.58 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.63 111.793 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -68.38 -43.76 76.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 0.90000000000000002 111.237 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -69.54 -27.56 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.76000000000000001 111.867 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' NE2' ' A' ' 127' ' ' HIS . 29.7 mmt180 -71.88 -58.45 3.45 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.384 0.513 . . . . 2.6800000000000002 112.384 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.94 -40.66 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.217 0.451 . . . . 1.4099999999999999 112.217 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.53 -92.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.732 -0.747 . . . . 1.0600000000000001 111.784 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.512 ' O ' HG23 ' A' ' 125' ' ' THR . 45.4 t-80 -114.55 110.02 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 3.5099999999999998 111.056 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.1 t 51.45 -128.23 2.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.083 -0.508 . . . . 1.6799999999999999 111.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 123' ' ' HIS . 26.7 p 58.08 -165.14 0.17 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.592 0.357 . . . . 0.80000000000000004 111.193 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.53 139.18 43.66 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.255 0.835 . . . . 0.44 113.255 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.0 t60 -109.07 148.24 31.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.99 -0.744 . . . . 0.38 108.99 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 4.8 p-10 -143.81 127.12 16.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.674 0.62 . . . . 2.0899999999999999 112.674 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.481 ' OE2' HD21 ' A' ' 115' ' ' LEU . 24.4 mt-10 -120.65 115.67 23.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 2.2799999999999998 109.465 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.507 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.1 mt -105.58 126.85 60.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.516 -0.766 . . . . 0.70999999999999996 110.261 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 130' ' ' ILE . 28.3 mm -126.12 86.45 57.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.218 0.451 . . . . 1.3799999999999999 112.218 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -62.48 139.95 79.25 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.875 1.717 . . . . 0.22 111.426 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 18.8 mt -132.86 155.07 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.20999999999999999 111.042 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 23.8 p -126.21 107.9 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.942 0.401 . . . . 1.1100000000000001 110.859 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 139' ' ' LYS . 25.6 mt -111.37 122.75 66.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.801 -0.636 . . . . 0.23000000000000001 109.881 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -147.38 143.16 27.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.37 -0.377 . . . . 1.9099999999999999 110.817 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt 62.92 7.81 2.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.098 -0.501 . . . . 3.1099999999999999 110.856 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.2 21.24 25.57 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.83 -0.7 . . . . 0.32000000000000001 112.933 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 135' ' ' ILE . 8.2 mtpm? -121.03 156.09 32.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.896 0.348 . . . . 2.1899999999999999 110.859 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -114.31 131.95 56.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.112 0.482 . . . . 0.37 112.121 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.538 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.1 t -122.92 109.65 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 0.90000000000000002 109.642 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -102.35 108.06 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.198 0.523 . . . . 0.53000000000000003 111.148 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 53.77 -91.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.765 -0.652 . . . . 2.0499999999999998 112.034 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.33 38.79 2.21 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.59999999999999998 113.516 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -146.61 137.11 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 2.02 110.297 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.3 135.7 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 1.3 110.875 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -163.19 121.04 1.94 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.154 -0.684 . . . . 1.1200000000000001 109.154 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.05 150.11 3.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.981 0.42 . . . . 1.1100000000000001 111.328 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 t80 -77.55 122.85 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.28000000000000003 110.764 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -75.81 -170.8 1.42 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.955 -1.128 . . . . 1.55 107.955 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.56 -11.92 66.07 Favored Glycine 0 C--N 1.317 -0.503 0 C-N-CA 119.015 -1.564 . . . . 0.46000000000000002 112.93 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.82 151.8 18.72 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.168 0.484 . . . . 1.8 112.105 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.726 HD23 ' N ' ' A' ' 154' ' ' SER . 3.5 tt -84.93 148.51 26.19 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.936 -1.135 . . . . 1.24 107.936 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.726 ' N ' HD23 ' A' ' 153' ' ' LEU . 3.7 t -139.15 115.86 10.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 118.256 -1.378 . . . . 1.28 113.634 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 7.9 t -98.47 97.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.942 -0.762 . . . . 0.58999999999999997 108.942 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 34.7 mt-10 -108.82 132.35 54.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.718 -0.674 . . . . 2.48 111.727 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.95 129.83 51.6 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.481 0.658 . . . . 1.54 109.929 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.535 HG21 HH21 ' A' ' 105' ' ' ARG . 30.8 t -103.0 143.88 14.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.495 -1.23 . . . . 0.77000000000000002 111.678 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -50.88 148.14 4.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 114.988 -1.005 . . . . 1.97 111.445 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -118.99 -10.66 8.08 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.437 -0.665 . . . . 1.1200000000000001 111.437 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -163.64 -59.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.555 -0.322 . . . . 3.8100000000000001 110.344 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -176.84 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.061 -0.518 . . . . 3.8199999999999998 110.879 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -90.92 46.12 1.3 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.026 0.441 . . . . 1.3999999999999999 111.782 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.713 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 54.9 t30 -55.2 -42.07 93.98 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 115.46 -0.791 . . . . 2.0 109.048 176.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.713 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 36.9 Cg_endo -62.9 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.786 2.324 . . . . 2.5800000000000001 111.843 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 11.0 pttp -97.8 166.01 11.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.063 -0.717 . . . . 3.71 109.063 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.83 132.95 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 C-N-CA 119.533 -0.867 . . . . 0.92000000000000004 110.308 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -130.24 131.6 45.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.671 0.607 . . . . 1.2 111.586 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 88' ' ' LYS . . . -123.95 37.05 4.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.22 112.126 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -33.26 134.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.693 -0.685 . . . . 1.02 110.404 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -159.56 95.81 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.533 -0.303 . . . . 0.33000000000000002 110.813 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -106.25 130.16 58.37 Favored 'Isoleucine or valine' 0 C--O 1.258 1.526 0 CA-C-O 122.96 1.362 . . . . 0.68999999999999995 112.719 178.45 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 ppp? -123.64 157.26 34.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.028 -1.896 . . . . 1.26 108.135 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.9 150.04 39.12 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.138 1.532 . . . . 1.8200000000000001 115.138 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.21 -33.91 6.2 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 112.448 -2.16 . . . . 0.22 116.846 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.474 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 156.79 0.44 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.841 1.82 . . . . 0.28999999999999998 114.601 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.614 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.68 -23.37 25.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.161 -0.927 . . . . 0.56999999999999995 110.569 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.864 -0.607 . . . . 2.3100000000000001 111.508 -178.741 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 121.185 0.517 . . . . 0.40999999999999998 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.596 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.71 -21.24 6.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.405 -0.816 . . . . 0.33000000000000002 111.314 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -79.29 -21.77 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 2.0899999999999999 112.121 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 34.9 mmtt -98.43 -26.52 14.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.937 -0.305 . . . . 1.99 111.475 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.9 p -44.47 146.82 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 111.961 0.356 . . . . 0.20999999999999999 111.961 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.2 pt -139.48 -21.73 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.724 . . . . 0.85999999999999999 111.103 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.576 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.9 t90 -173.7 133.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.55 -0.46 . . . . 0.28000000000000003 110.14 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -150.6 144.26 25.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.809 0.3 . . . . 0.20000000000000001 111.809 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.2 t -147.63 126.66 4.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.495 1.295 . . . . 0.67000000000000004 114.495 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 11.5 t30 -114.6 100.86 8.59 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.533 -0.467 . . . . 1.27 110.31 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.51 103.47 2.98 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 109.021 -0.733 . . . . 0.37 109.021 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.581 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 167.9 -45.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.916 0 O-C-N 124.277 0.986 . . . . 0.67000000000000004 113.563 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.77 -123.6 3.48 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.586 -0.816 . . . . 1.1200000000000001 113.124 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.723 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 6.4 tt0 -164.1 120.3 1.62 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.871 0.367 . . . . 2.02 111.489 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.4 m 35.53 99.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.16 -0.927 . . . . 1.22 113.231 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.665 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 54.0 t-80 -130.65 140.16 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.729 -0.788 . . . . 0.34000000000000002 112.462 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 p -114.64 103.91 16.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.637 0.732 . . . . 1.1799999999999999 110.787 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 156.3 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.036 -0.984 . . . . 1.1699999999999999 110.056 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 25' ' ' HIS . 30.9 m -44.01 -49.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.175 0.922 . . . . 0.59999999999999998 113.136 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.464 ' N ' HG23 ' A' ' 24' ' ' VAL . 83.5 m-70 -59.53 -18.17 38.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.294 0.569 . . . . 0.46000000000000002 110.567 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.72 35.2 3.84 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.34 -0.845 . . . . 0.28999999999999998 112.444 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.428 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 31.1 mm -103.88 111.95 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.026 0.441 . . . . 0.42999999999999999 110.578 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.665 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 10.9 t60 -98.27 135.55 39.73 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.891 1.441 . . . . 0.52000000000000002 114.891 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.723 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -100.47 135.46 41.87 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.864 -1.062 . . . . 3.0 108.619 177.53 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -88.04 111.42 21.51 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 124.001 0.813 . . . . 2.8999999999999999 112.252 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 31' ' ' LYS . 5.3 ttpm? -23.44 135.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.349 1.06 . . . . 2.71 113.723 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.65 ' HB3' HH11 ' A' ' 65' ' ' ARG . 2.5 m-20 -10.15 83.84 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 CA-C-N 114.2 -1.364 . . . . 1.98 113.708 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 CA--C 1.535 0.531 0 C-N-CA 123.166 2.577 . . . . 1.53 113.582 179.736 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.2 mp . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 109.347 -0.612 . . . . 0.82999999999999996 109.347 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mt -69.87 -49.19 54.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.911 1.449 . . . . 1.6899999999999999 114.911 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -73.87 25.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.85 0.685 . . . . 2.5600000000000001 112.85 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -146.19 144.57 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.96999999999999997 111.487 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 58' ' ' GLN . 1.8 p-10 -66.44 153.53 92.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.065 -0.516 . . . . 1.96 109.787 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.423 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.57 -59.14 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.47 2.113 . . . . 0.66000000000000003 114.626 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -58.35 -55.43 35.13 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 121.901 0.858 . . . . 1.8200000000000001 111.246 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 11.2 t70 -69.38 -11.98 61.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.325 -0.55 . . . . 1.9099999999999999 110.439 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -68.38 -39.83 81.59 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 106.523 -1.658 . . . . 1.5 106.523 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.411 ' N ' ' HG3' ' A' ' 58' ' ' GLN . 62.4 t -54.37 -50.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.138 -1.06 . . . . 1.22 108.138 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.8 tp -69.81 -13.76 62.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.907 -1.042 . . . . 1.05 111.1 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.541 ' C ' ' HZ2' ' A' ' 88' ' ' LYS . 2.6 m-85 -121.89 27.71 7.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.182 -0.917 . . . . 0.90000000000000002 111.679 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -151.46 -63.36 0.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.261 0.837 . . . . 1.8 113.261 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 13.7 p -34.13 147.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.815 0.672 . . . . 1.05 112.815 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.577 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pp20? -137.52 148.05 45.68 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.691 0.626 . . . . 2.0499999999999998 112.691 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.65 HH11 ' HB3' ' A' ' 32' ' ' ASP . 19.3 mtp180 -114.27 -174.95 2.57 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.98 -0.554 . . . . 3.5800000000000001 109.858 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -66.32 172.0 4.33 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.531 -0.304 . . . . 4.25 110.455 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -143.57 162.22 36.44 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.021 0.438 . . . . 4.3499999999999996 111.653 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -144.79 -118.16 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.876 -0.602 . . . . 3.1699999999999999 110.685 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.459 ' OD1' ' HD3' ' A' ' 159' ' ' LYS . 63.6 m-20 -156.62 134.4 10.97 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.44 -0.162 . . . . 2.3900000000000001 111.093 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 53.84 83.53 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.92 0.391 . . . . 0.98999999999999999 110.764 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -162.59 159.6 24.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 1.26 110.826 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -168.93 -168.15 30.56 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.437 -0.887 . . . . 0.66000000000000003 113.418 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -108.36 165.12 11.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.294 0.569 . . . . 0.82999999999999996 111.763 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.03 140.53 49.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.91 -1.041 . . . . 2.27 110.825 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.27 109.87 10.56 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.142 -0.481 . . . . 0.34000000000000002 111.171 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.87 133.17 7.83 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.129 1.219 . . . . 0.80000000000000004 112.045 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 78' ' ' LYS . 23.4 mt -121.32 155.2 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.985 0.421 . . . . 0.38 111.577 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' N ' HG22 ' A' ' 77' ' ' ILE . 99.5 mttt -143.19 -0.87 1.09 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.825 -0.625 . . . . 2.96 110.995 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -127.46 169.03 14.08 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.826 0.345 . . . . 2.1299999999999999 111.562 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -117.48 -177.61 3.27 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.37 111.047 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.78 -151.04 18.05 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.997 -1.241 . . . . 0.20999999999999999 109.997 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 21.2 mt-10 -105.15 108.72 20.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.644 1.222 . . . . 2.0299999999999998 109.71 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -95.34 129.68 42.39 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 119.719 -0.792 . . . . 0.26000000000000001 109.156 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG21 ' N ' ' A' ' 177' ' ' ALA . 22.0 t -116.92 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.686 -1.143 . . . . 0.54000000000000004 111.806 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.94 105.7 17.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.726 -0.67 . . . . 1.23 110.126 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 38.1 t -101.4 119.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 107.945 -1.131 . . . . 1.3100000000000001 107.945 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 135.92 23.83 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.671 -0.812 . . . . 1.3700000000000001 112.437 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.711 ' NZ ' ' HB2' ' A' ' 90' ' ' ALA . 5.9 tmtt? -103.15 132.1 49.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.65 -0.82 . . . . 2.9700000000000002 109.952 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -111.44 149.32 31.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.609 -0.723 . . . . 0.29999999999999999 109.547 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.711 ' HB2' ' NZ ' ' A' ' 88' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 121.073 0.464 . . . . 0.40999999999999998 111.323 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.962 0.41 . . . . 2.96 111.153 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -103.8 157.15 17.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.951 -0.568 . . . . 1.55 111.235 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 45.25 49.46 10.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.8 -0.636 . . . . 2.3300000000000001 111.647 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -153.47 -46.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.899 -0.778 . . . . 2.5099999999999998 108.899 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -96.89 82.04 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.271 -1.011 . . . . 3.1000000000000001 108.271 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.437 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.7 OUTLIER -108.87 134.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 1.3100000000000001 111.227 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.403 ' CD1' ' HD3' ' A' ' 165' ' ' PRO . 69.9 m-85 -117.89 175.59 5.59 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.576 0.584 . . . . 0.68999999999999995 112.576 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.87 140.06 53.35 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 115.928 -0.578 . . . . 2.0099999999999998 111.459 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.06 131.65 41.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.075 -0.512 . . . . 0.46000000000000002 111.854 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.4 154.8 49.44 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.265 0.839 . . . . 1.8500000000000001 113.265 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 p -121.51 125.24 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.193 -1.367 . . . . 1.1000000000000001 110.474 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.14 26.1 3.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.663 -0.866 . . . . 1.77 108.663 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.8 27.45 21.7 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 112.976 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 87.1 m-70 -127.35 110.5 12.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.164 0.801 . . . . 0.46000000000000002 113.164 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.0 p -67.24 115.56 7.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.245 0.545 . . . . 0.66000000000000003 111.723 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.58 -34.71 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.215 -0.902 . . . . 0.80000000000000004 109.369 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.07 89.62 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.995 -0.548 . . . . 0.51000000000000001 109.548 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.0 ptpp? -110.08 83.39 1.75 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.096 0.951 . . . . 2.4399999999999999 110.759 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 156.82 33.58 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 112.824 -1.989 . . . . 2.5600000000000001 108.557 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 85.92 0.08 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.595 0.591 . . . . 1.1000000000000001 112.595 -177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 0.6 OUTLIER -98.47 80.42 2.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.714 -1.587 . . . . 1.99 106.714 175.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.7 mt -49.88 -38.48 14.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.516 -0.765 . . . . 0.63 112.291 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.28 -46.69 85.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.462 0.171 . . . . 0.90000000000000002 111.462 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.413 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 37.1 t70 -70.33 -27.97 64.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.76000000000000001 111.514 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -61.33 -58.09 9.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.865 0.321 . . . . 2.6800000000000002 111.865 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.13 -40.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.033 0.383 . . . . 1.4099999999999999 112.033 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.93 -87.45 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.912 -0.661 . . . . 1.0600000000000001 112.487 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.582 ' O ' HG23 ' A' ' 125' ' ' THR . 48.6 m80 -112.87 110.46 20.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.641 0.257 . . . . 3.5099999999999998 111.081 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.9 p 46.79 -116.85 0.72 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.019 -0.537 . . . . 1.6799999999999999 111.769 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 123' ' ' HIS . 41.8 p 50.91 -166.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.209 0.203 . . . . 0.80000000000000004 110.7 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.485 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.27 139.09 49.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.087 0.773 . . . . 0.44 113.087 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.409 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 1.8 t60 -105.35 145.08 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.856 -1.164 . . . . 0.38 107.856 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -143.75 126.94 16.58 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.056 -0.658 . . . . 2.0899999999999999 112.761 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -117.11 127.84 54.54 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.247 -0.888 . . . . 2.2799999999999998 110.096 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.1 mt -116.43 121.79 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.431 -0.804 . . . . 0.70999999999999996 109.817 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.76 90.09 51.47 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.723 0.638 . . . . 1.3799999999999999 112.723 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.76 149.74 90.34 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.04 1.827 . . . . 0.22 112.053 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 16.9 mt -144.16 156.89 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.452 -0.34 . . . . 0.20999999999999999 111.537 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 133' ' ' ILE . 32.7 t -133.07 110.23 10.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.026 0.441 . . . . 1.1100000000000001 111.077 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 139' ' ' LYS . 21.8 mt -106.62 137.25 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.799 -0.637 . . . . 0.23000000000000001 110.337 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -145.35 130.36 18.34 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.997 -0.281 . . . . 1.9099999999999999 111.102 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 54.99 19.03 2.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.1 -0.5 . . . . 3.1099999999999999 110.8 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.5 16.14 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.688 -0.768 . . . . 0.32000000000000001 112.782 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -111.5 156.54 21.54 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.084 -0.339 . . . . 2.1899999999999999 110.084 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 141' ' ' SER . 5.1 tt -124.6 126.01 45.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.284 0.564 . . . . 0.37 112.496 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.515 ' N ' HD23 ' A' ' 140' ' ' LEU . 9.5 t -115.81 109.23 17.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.302 -0.863 . . . . 0.90000000000000002 109.084 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -102.95 99.57 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.513 -0.767 . . . . 0.53000000000000003 110.507 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.43 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 2.0499999999999998 111.626 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -132.33 29.58 3.29 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.44 -0.886 . . . . 0.59999999999999998 113.277 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.28 135.78 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.297 . . . . 2.02 110.526 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.83 135.46 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 1.3 110.344 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 m -164.46 129.22 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 1.1200000000000001 109.837 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -53.16 145.03 14.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.181 0.515 . . . . 1.1100000000000001 112.238 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -78.72 121.67 25.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.516 -0.765 . . . . 0.28000000000000003 110.031 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.4 p -76.14 173.85 10.81 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.51 -0.922 . . . . 1.55 108.51 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.81 -8.8 1.48 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.948 -1.12 . . . . 0.46000000000000002 114.236 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.61 152.09 19.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.894 0.847 . . . . 1.8 112.703 -179.172 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -80.9 129.63 34.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.794 -1.187 . . . . 1.24 107.794 177.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.496 ' HB3' ' OE1' ' A' ' 156' ' ' GLU . 0.1 OUTLIER -121.88 120.71 35.3 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.96 1.096 . . . . 1.28 113.96 -176.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.436 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 96.6 t -106.11 101.13 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.741 -0.466 . . . . 0.58999999999999997 109.741 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.496 ' OE1' ' HB3' ' A' ' 154' ' ' SER . 17.6 mp0 -116.64 150.5 38.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.369 0.604 . . . . 2.48 112.069 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.6 140.11 44.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.178 -0.919 . . . . 1.54 110.148 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.67 144.06 24.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.058 -0.973 . . . . 0.77000000000000002 111.168 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.459 ' HD3' ' OD1' ' A' ' 69' ' ' ASP . 19.2 pttm -63.63 139.43 58.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.384 -0.825 . . . . 1.97 111.055 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -108.33 -4.79 32.75 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.116 -0.794 . . . . 1.1200000000000001 111.116 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -169.92 -54.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.327 -0.436 . . . . 3.8100000000000001 110.229 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -178.29 149.03 0.51 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.09 -0.505 . . . . 3.8199999999999998 110.64 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 55.84 87.5 0.05 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.855 0.36 . . . . 1.3999999999999999 111.681 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.41 166.37 0.56 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.848 -0.615 . . . . 2.0 109.886 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.403 ' HD3' ' CD1' ' A' ' 102' ' ' PHE . 7.0 Cg_exo -35.78 104.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.015 1.81 . . . . 2.5800000000000001 111.731 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -58.21 -54.11 50.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 3.71 113.133 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 64' ' ' GLU . 6.8 t -103.55 134.72 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.961 0.726 . . . . 0.92000000000000004 112.961 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.42 138.85 49.26 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.964 -0.562 . . . . 1.2 112.149 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -129.75 35.94 4.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.183 -0.917 . . . . 0.22 112.915 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -36.96 136.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.232 0.539 . . . . 1.02 112.404 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.528 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -156.62 96.11 1.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.305 -0.861 . . . . 0.33000000000000002 109.33 178.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -99.93 127.67 52.6 Favored 'Isoleucine or valine' 0 C--O 1.266 1.942 0 CA-C-O 122.663 1.221 . . . . 0.68999999999999995 112.35 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.42 161.35 21.36 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.683 -1.599 . . . . 1.26 109.546 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 16.1 tttm -120.38 139.05 53.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.7 1.37 . . . . 1.8200000000000001 114.7 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.03 -35.05 5.3 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 118.123 2.009 . . . . 0.22 118.123 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.55 158.06 0.5 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.436 2.118 . . . . 0.28999999999999998 114.105 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.618 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.34 -24.69 27.52 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.94 -1.027 . . . . 0.56999999999999995 109.858 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.538 -0.756 . . . . 2.3100000000000001 111.132 -179.459 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.1 tp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.354 0.597 . . . . 0.40999999999999998 110.052 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.543 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.02 -19.65 7.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.076 -0.966 . . . . 0.33000000000000002 111.652 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.75 -28.65 40.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.498 0.555 . . . . 2.0899999999999999 112.498 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 44.0 mttp -98.89 -18.08 18.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.325 -0.55 . . . . 1.99 112.065 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 7' ' ' ALA . 14.2 p -42.63 144.08 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 121.28 -0.168 . . . . 0.20999999999999999 111.131 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' TRP . 4.1 pt -139.55 -21.7 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 C-N-CA 119.639 -0.824 . . . . 0.85999999999999999 111.582 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.599 ' O ' HG22 ' A' ' 172' ' ' ILE . 50.5 t90 -175.99 130.79 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.478 -0.489 . . . . 0.28000000000000003 110.675 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -148.39 146.58 28.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.273 0.471 . . . . 0.20000000000000001 112.273 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.3 t -147.5 126.77 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 114.229 1.196 . . . . 0.67000000000000004 114.229 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -117.39 106.36 13.13 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.654 -0.703 . . . . 1.27 110.133 176.68 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 113.54 15.14 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 120.68 -0.408 . . . . 0.37 110.811 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.458 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 142.74 -29.74 2.1 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 114.649 -1.16 . . . . 0.67000000000000004 112.594 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -109.81 -144.75 10.51 Favored Glycine 0 CA--C 1.516 0.135 0 C-N-CA 121.138 -0.553 . . . . 1.1200000000000001 112.021 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 36.2 mt-10 -156.83 119.45 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.666 -0.124 . . . . 2.02 110.666 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.3 m 27.7 94.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.803 0.69 . . . . 1.22 112.152 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 21.7 t-80 -126.26 150.89 48.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 119.922 -0.711 . . . . 0.34000000000000002 112.416 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.56 105.32 18.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.133 -0.939 . . . . 1.1799999999999999 111.019 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 153.77 42.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.981 -0.377 . . . . 1.1699999999999999 109.981 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 25' ' ' HIS . 16.1 m -44.44 -49.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.501 0.926 . . . . 0.59999999999999998 113.501 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.419 ' N ' HG23 ' A' ' 24' ' ' VAL . 86.2 m-70 -58.44 -17.84 23.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.282 0.563 . . . . 0.46000000000000002 110.463 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.62 33.71 4.67 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.28999999999999998 112.149 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm -103.23 120.72 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.904 -0.406 . . . . 0.42999999999999999 109.904 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.511 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 12.8 t60 -102.97 132.91 48.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.191 1.182 . . . . 0.52000000000000002 114.191 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.667 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.5 134.19 43.82 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.935 -1.135 . . . . 3.0 107.935 176.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -94.62 112.52 24.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.444 0.64 . . . . 2.8999999999999999 112.376 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -10.49 138.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.54 1.681 . . . . 2.71 115.54 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.445 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 12.5 m-20 -22.54 89.67 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 113.722 -1.581 . . . . 1.98 114.219 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 CA--C 1.545 1.071 0 C-N-CA 122.731 2.287 . . . . 1.53 113.309 178.393 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' A' ' 126' ' ' ALA . 4.4 mt . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.264 -0.643 . . . . 0.82999999999999996 109.264 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.68 -42.77 86.02 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.232 1.197 . . . . 1.6899999999999999 114.232 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -80.25 25.14 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.705 -0.398 . . . . 2.5600000000000001 111.984 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.472 ' OG ' HG22 ' A' ' 50' ' ' ILE . 94.0 p -139.77 130.47 25.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.702 0.287 . . . . 0.96999999999999997 111.347 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 3.0 p-10 -59.73 152.73 56.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.857 -0.794 . . . . 1.96 108.857 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.48 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 7.6 Cg_exo -39.93 -39.52 2.3 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.341 2.027 . . . . 0.66000000000000003 115.251 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.5 mm-40 -75.43 -56.07 5.07 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.755 0.788 . . . . 1.8200000000000001 111.171 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.4 OUTLIER -70.79 -6.57 38.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.034 -0.666 . . . . 1.9099999999999999 109.256 -179.453 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 24.6 tt0 -70.54 -64.88 0.81 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.255 -0.884 . . . . 1.5 108.661 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 63' ' ' THR . 2.6 p -48.41 -37.94 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.901 -0.591 . . . . 1.22 109.79 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 62' ' ' GLN . 4.9 tp -68.07 -68.19 0.41 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.84 -0.744 . . . . 1.05 110.071 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -56.36 1.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.184 0.593 . . . . 0.90000000000000002 111.932 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 60' ' ' LEU . 2.1 tt0 -122.8 -126.02 0.26 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.115 -0.493 . . . . 1.8 111.734 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 59' ' ' VAL . 47.6 p 49.08 -166.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.598 -0.273 . . . . 1.05 110.725 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.458 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.2 pt-20 -179.3 140.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.628 0.252 . . . . 2.0499999999999998 111.1 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.445 ' NE ' ' HB3' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -123.13 177.15 5.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.012 0.434 . . . . 3.5800000000000001 111.601 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -57.63 169.8 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.718 -0.674 . . . . 4.25 111.412 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -142.13 169.32 17.81 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.256 -0.429 . . . . 4.3499999999999996 111.077 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -154.57 -107.52 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.663 -0.244 . . . . 3.1699999999999999 111.446 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.68 125.71 1.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.429 -0.169 . . . . 2.3900000000000001 110.742 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 t 50.9 84.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.047 -0.353 . . . . 0.98999999999999999 110.047 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -159.09 164.72 35.09 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.593 -0.443 . . . . 1.26 111.223 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.6 -167.8 39.0 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 119.066 -1.54 . . . . 0.66000000000000003 116.406 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.99 174.2 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.648 -1.276 . . . . 0.82999999999999996 113.147 -176.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.9 147.34 50.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.33 -1.305 . . . . 2.27 111.187 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.32 113.55 6.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.349 -0.387 . . . . 0.34000000000000002 111.167 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.62 140.25 13.09 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.198 1.266 . . . . 0.80000000000000004 111.918 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mt -129.49 149.24 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.38 111.652 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.84 8.45 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.633 -0.712 . . . . 2.96 110.809 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -127.11 163.76 23.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.134 -0.321 . . . . 2.1299999999999999 110.134 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 2.5 mp0 -125.98 158.73 34.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.37 111.901 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.82 -144.3 11.63 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.793 -1.323 . . . . 0.20999999999999999 109.793 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -105.93 107.8 18.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.622 1.211 . . . . 2.0299999999999998 108.995 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.26 126.21 40.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.715 -0.846 . . . . 0.26000000000000001 108.715 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.638 HG21 ' N ' ' A' ' 177' ' ' ALA . 12.7 t -114.36 120.75 64.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.007 -0.997 . . . . 0.54000000000000004 111.915 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.6 tt -101.46 104.97 15.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.918 -1.037 . . . . 1.23 110.617 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.93 135.93 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.184 -1.043 . . . . 1.3100000000000001 108.184 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.647 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -147.97 150.08 33.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 118.861 -1.136 . . . . 1.3700000000000001 112.952 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.564 ' O ' ' HB3' ' A' ' 169' ' ' ALA . 12.2 tptt -107.75 120.43 42.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.341 -0.845 . . . . 2.9700000000000002 110.099 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.79 145.89 31.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.558 -0.534 . . . . 0.29999999999999999 109.558 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.801 0.334 . . . . 0.40999999999999998 110.65 179.18 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.709 0.29 . . . . 2.96 110.707 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -126.78 153.42 45.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 1.55 111.863 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 47.73 30.71 1.9 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.805 -0.634 . . . . 2.3300000000000001 111.574 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -131.56 -50.42 0.99 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 2.5099999999999998 109.879 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.3 tttp -97.92 90.47 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.087 -0.709 . . . . 3.1000000000000001 109.087 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.49 147.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.3100000000000001 110.435 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -121.22 -179.87 4.19 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.392 0.886 . . . . 0.68999999999999995 113.392 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.89 139.39 52.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 115.648 -0.706 . . . . 2.0099999999999998 111.162 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.1 t -135.01 133.47 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 116.152 -0.476 . . . . 0.46000000000000002 112.068 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 10.9 ptt180 -135.89 145.17 46.05 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.684 0.994 . . . . 1.8500000000000001 113.684 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.5 m -113.0 121.06 64.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.584 -1.189 . . . . 1.1000000000000001 109.694 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.521 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 54.28 26.89 7.27 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.805 0.812 . . . . 1.77 109.332 -176.407 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 23.17 28.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.047 -1.433 . . . . 0.40999999999999998 112.977 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 81.5 m-70 -120.83 108.03 13.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.277 0.843 . . . . 0.46000000000000002 113.277 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 7.0 p -64.6 116.03 5.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.146 0.498 . . . . 0.66000000000000003 111.407 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.55 -31.31 2.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.471 -0.786 . . . . 0.80000000000000004 109.99 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.18 91.49 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.351 -0.611 . . . . 0.51000000000000001 109.351 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 4.2 ptpp? -106.6 77.96 1.23 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.584 1.183 . . . . 2.4399999999999999 112.517 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.1 p30 156.14 36.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.399 -2.182 . . . . 2.5600000000000001 109.453 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 91.78 0.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.352 0.596 . . . . 1.1000000000000001 111.537 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.506 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 1.5 p30 -101.68 79.12 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.008 -1.479 . . . . 1.99 107.008 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.0 mt -50.4 -50.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.709 -1.132 . . . . 0.63 113.002 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -56.19 -51.45 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.83 0.307 . . . . 0.90000000000000002 111.83 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.506 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 18.0 t70 -65.39 -29.59 70.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.369 0.507 . . . . 0.76000000000000001 112.369 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -64.02 -58.29 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.452 0.538 . . . . 2.6800000000000002 112.452 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 126' ' ' ALA . 10.9 m -103.53 -41.17 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.519 0.563 . . . . 1.4099999999999999 112.519 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.73 -131.23 10.26 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.524 -0.845 . . . . 1.0600000000000001 112.881 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.37 110.43 1.43 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.761 0.315 . . . . 3.5099999999999998 111.083 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.8 m 45.27 -104.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.867 -0.606 . . . . 1.6799999999999999 111.161 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.403 ' OG1' ' HB ' ' A' ' 121' ' ' VAL . 23.0 p 50.07 178.24 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.084 0.469 . . . . 0.80000000000000004 111.914 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -105.86 138.95 41.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.786 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.8 t60 -112.57 144.8 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.918 -0.771 . . . . 0.38 108.918 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.89 140.48 29.78 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.305 0.854 . . . . 2.0899999999999999 113.305 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.17 133.85 52.63 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.026 -0.988 . . . . 2.2799999999999998 109.092 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.4 mt -115.66 116.4 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.747 -0.66 . . . . 0.70999999999999996 110.187 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.9 mt -124.62 87.87 54.11 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.584 0.587 . . . . 1.3799999999999999 112.584 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.6 141.82 74.8 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.81 1.674 . . . . 0.22 111.602 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.2 mt -132.09 155.82 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 0.20999999999999999 110.505 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 30.5 p -131.39 106.73 8.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 1.1100000000000001 110.732 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 139' ' ' LYS . 23.8 mt -105.4 124.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.747 -0.66 . . . . 0.23000000000000001 109.911 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -146.97 142.1 27.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 1.9099999999999999 110.947 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp 58.91 19.13 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 3.1099999999999999 111.205 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.85 23.62 41.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 0.32000000000000001 113.396 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 135' ' ' ILE . 25.9 mtmm -123.62 151.75 42.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.1 0.45 . . . . 2.1899999999999999 110.823 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -109.84 126.65 54.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.118 0.485 . . . . 0.37 111.658 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.509 ' N ' HD23 ' A' ' 140' ' ' LEU . 24.2 t -114.55 110.99 20.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.723 -0.671 . . . . 0.90000000000000002 110.059 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.2 p -105.03 104.29 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.341 0.591 . . . . 0.53000000000000003 111.286 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 58.22 -89.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.755 -0.657 . . . . 2.0499999999999998 112.085 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.96 23.41 4.97 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.437 -0.887 . . . . 0.59999999999999998 113.593 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -133.13 136.51 45.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.005 -0.368 . . . . 2.02 110.005 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.16 140.9 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.034 0.445 . . . . 1.3 111.491 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.0 m -160.15 122.78 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.718 -0.674 . . . . 1.1200000000000001 110.233 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.5 p -50.94 143.09 10.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.966 -0.561 . . . . 1.1100000000000001 111.502 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -79.77 121.91 25.94 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.001 -0.741 . . . . 0.28000000000000003 109.001 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 t -111.19 91.44 3.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.819 0.674 . . . . 1.55 112.819 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.4 -36.73 0.03 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.255 1.662 . . . . 0.46000000000000002 117.255 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -159.75 151.98 20.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.335 1.567 . . . . 1.8 113.466 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.442 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 1.3 tt -85.55 132.57 34.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.835 -1.172 . . . . 1.24 107.835 176.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.521 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.5 t -122.79 117.7 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.817 -0.753 . . . . 1.28 112.493 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.13 115.62 47.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.864 0.364 . . . . 0.58999999999999997 110.826 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 166.79 23.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.375 0.607 . . . . 2.48 111.23 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.84 151.24 45.54 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.027 -0.988 . . . . 1.54 110.675 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -123.26 143.96 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.671 -1.15 . . . . 0.77000000000000002 110.029 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 145.03 24.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 1.97 111.594 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.56 -14.45 44.02 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.312 -0.715 . . . . 1.1200000000000001 111.312 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -141.55 -79.9 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.227 . . . . 3.8100000000000001 110.694 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -155.16 157.75 37.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.863 0.363 . . . . 3.8199999999999998 111.142 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 54.97 86.93 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.951 -0.568 . . . . 1.3999999999999999 111.861 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 170.96 0.4 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.82 -0.627 . . . . 2.0 110.01 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -41.22 103.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.588 1.525 . . . . 2.5800000000000001 111.159 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -58.55 -64.98 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.287 -0.869 . . . . 3.71 113.088 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 63' ' ' THR . 11.9 t -91.71 134.26 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 120.14 -0.624 . . . . 0.92000000000000004 112.385 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.6 t -132.48 137.8 47.35 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.712 -0.676 . . . . 1.2 112.616 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -130.22 34.75 4.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.171 -0.922 . . . . 0.22 111.466 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.1 tp -44.93 128.28 6.92 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.801 -0.636 . . . . 1.02 111.656 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.4 OUTLIER -143.15 115.69 8.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.94 -0.573 . . . . 0.33000000000000002 110.831 -178.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -117.16 131.27 70.35 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-O 123.002 1.382 . . . . 0.68999999999999995 113.029 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.558 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -126.42 165.04 19.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.216 -1.811 . . . . 1.26 109.735 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 3.4 ptmm? -121.42 152.75 38.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.424 1.639 . . . . 1.8200000000000001 115.424 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.72 -34.85 4.62 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 112.044 -2.344 . . . . 0.22 117.796 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.419 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.67 156.71 0.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.21 2.005 . . . . 0.28999999999999998 114.723 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.638 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.57 -10.5 53.84 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.167 -0.924 . . . . 0.56999999999999995 110.899 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 2.3100000000000001 111.508 -178.323 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.7 tp . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.306 0.574 . . . . 0.40999999999999998 110.322 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.682 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.39 -20.93 13.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.366 -0.834 . . . . 0.33000000000000002 111.184 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.11 -19.34 61.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 2.0899999999999999 111.856 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -102.05 -29.52 11.72 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.696 -0.401 . . . . 1.99 110.875 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.9 p -45.38 146.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.796 0.332 . . . . 0.20999999999999999 111.815 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.12 -22.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.224 -0.59 . . . . 0.85999999999999999 110.649 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.567 ' O ' HG22 ' A' ' 172' ' ' ILE . 17.0 t90 -172.51 133.45 0.62 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.233 -0.439 . . . . 0.28000000000000003 109.912 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -154.23 143.09 21.02 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.74 0.274 . . . . 0.20000000000000001 111.74 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.2 t -146.94 131.5 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.598 1.332 . . . . 0.67000000000000004 114.598 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.47 103.05 10.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.058 -0.519 . . . . 1.27 110.621 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . -70.82 105.53 3.26 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.124 -0.63 . . . . 0.37 109.367 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.576 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.08 -27.01 0.14 Allowed Glycine 0 N--CA 1.446 -0.659 0 O-C-N 124.016 0.823 . . . . 0.67000000000000004 114.074 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -138.44 -127.8 2.54 Favored Glycine 0 CA--C 1.511 -0.204 0 C-N-CA 119.98 -1.105 . . . . 1.1200000000000001 113.011 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 37.1 mt-10 -154.63 119.65 4.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.39 0.138 . . . . 2.02 111.2 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.5 m 29.59 100.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.251 0.834 . . . . 1.22 113.251 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 6.8 t-80 -130.38 150.74 51.47 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 120.394 -0.522 . . . . 0.34000000000000002 111.767 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.1 t -115.64 109.54 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.678 -0.692 . . . . 1.1799999999999999 111.755 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.92 157.21 36.67 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.656 -0.247 . . . . 1.1699999999999999 110.424 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 25' ' ' HIS . 13.0 m -44.31 -52.66 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.832 1.049 . . . . 0.59999999999999998 113.832 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.414 ' N ' HG23 ' A' ' 24' ' ' VAL . 40.9 m-70 -58.38 -13.76 6.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.085 0.469 . . . . 0.46000000000000002 110.406 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.0 34.91 5.5 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.526 -0.761 . . . . 0.28999999999999998 112.299 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.416 HD11 ' HG ' ' A' ' 6' ' ' LEU . 32.9 mm -103.61 122.64 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.65 -0.5 . . . . 0.42999999999999999 109.65 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 11.7 t60 -101.91 135.49 43.38 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.714 1.376 . . . . 0.52000000000000002 114.714 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -98.33 132.9 43.42 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.396 -0.965 . . . . 3.0 108.396 176.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.435 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 6.9 mtp180 -92.43 112.69 24.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.787 0.662 . . . . 2.8999999999999999 112.787 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -20.24 137.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.247 1.419 . . . . 2.71 114.423 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -14.3 84.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.685 1.194 . . . . 1.98 113.807 177.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo . . . . . 0 CA--C 1.542 0.876 0 C-N-CA 122.449 2.1 . . . . 1.53 115.234 179.375 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 108.667 -0.864 . . . . 0.82999999999999996 108.667 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -48.87 8.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.679 0.992 . . . . 1.6899999999999999 113.679 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -78.9 34.69 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.647 0.61 . . . . 2.5600000000000001 112.647 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -144.2 137.5 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.96999999999999997 111.293 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -67.55 161.75 62.76 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.493 -0.558 . . . . 1.96 109.493 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.435 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.6 Cg_exo -42.16 -46.89 7.16 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.764 2.31 . . . . 0.66000000000000003 116.141 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' O ' HG12 ' A' ' 59' ' ' VAL . 12.9 pt-20 -77.71 -53.16 7.87 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.248 0.547 . . . . 1.8200000000000001 111.649 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 8.7 p-10 -70.04 -2.3 12.36 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.717 -0.793 . . . . 1.9099999999999999 109.719 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 20.2 tt0 -80.36 -60.15 2.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.447 -0.797 . . . . 1.5 109.218 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 56' ' ' GLU . 2.6 p -47.59 -35.57 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.457 -0.942 . . . . 1.22 108.457 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 62' ' ' GLN . 10.2 tp -69.88 -64.52 0.87 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.465 0.65 . . . . 1.05 109.41 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.413 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-30 -66.95 20.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.9 -1.046 . . . . 0.90000000000000002 112.703 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 60' ' ' LEU . 38.4 tt0 -137.54 -67.81 0.48 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.515 0.931 . . . . 1.8 113.515 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 21.0 p -30.6 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.554 0.946 . . . . 1.05 113.554 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.576 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -131.98 151.63 51.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.686 -0.688 . . . . 2.0499999999999998 111.464 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.63 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 30.2 mtt180 -105.2 -170.41 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.536 -0.542 . . . . 3.5800000000000001 109.536 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.81 -179.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 4.25 111.069 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -117.12 164.85 14.14 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.184 -0.462 . . . . 4.3499999999999996 111.413 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -167.69 -150.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.844 -0.616 . . . . 3.1699999999999999 109.969 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 10.1 t70 -141.38 128.06 20.3 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.718 0.294 . . . . 2.3900000000000001 111.418 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 t 51.94 86.03 0.04 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.101 -0.5 . . . . 0.98999999999999999 111.238 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.07 160.5 43.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 1.26 110.909 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -168.17 -154.14 8.6 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.358 -0.925 . . . . 0.66000000000000003 113.998 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.88 167.84 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.478 0.656 . . . . 0.82999999999999996 112.046 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -120.22 135.62 54.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.638 -1.164 . . . . 2.27 110.047 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.423 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.9 mp -127.64 86.84 57.45 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 111.823 0.305 . . . . 0.34000000000000002 111.823 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -57.69 127.55 25.73 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.975 1.783 . . . . 0.80000000000000004 112.059 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 153' ' ' LEU . 21.7 mt -119.25 153.69 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.966 0.412 . . . . 0.38 111.138 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.432 ' N ' HG22 ' A' ' 77' ' ' ILE . 16.9 pttp -147.35 6.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.895 -0.593 . . . . 2.96 110.823 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -130.77 171.0 13.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.822 -0.172 . . . . 2.1299999999999999 110.627 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.07 171.96 10.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.277 0.56 . . . . 0.37 111.577 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 -153.89 21.59 Favored Glycine 0 C--N 1.329 0.148 0 N-CA-C 109.901 -1.28 . . . . 0.20999999999999999 109.901 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.5 mm-40 -98.07 110.25 22.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.856 1.328 . . . . 2.0299999999999998 108.859 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -96.55 126.53 41.8 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.906 -0.776 . . . . 0.26000000000000001 108.906 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.66 HG21 ' N ' ' A' ' 177' ' ' ALA . 13.8 t -115.81 116.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.401 -0.818 . . . . 0.54000000000000004 111.78 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.464 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.8 tt -94.06 105.15 17.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.761 -1.109 . . . . 1.23 111.029 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 42.9 t -108.07 135.59 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.163 -1.051 . . . . 1.3100000000000001 108.163 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -150.05 148.8 29.46 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.952 -1.099 . . . . 1.3700000000000001 112.365 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.585 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 2.2 tptm -104.59 118.82 37.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.457 -0.792 . . . . 2.9700000000000002 110.011 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 115' ' ' LEU . 4.9 m-85 -106.01 137.67 43.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.458 -0.941 . . . . 0.29999999999999999 108.458 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.428 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.337 0 C-N-CA 120.026 -0.67 . . . . 0.40999999999999998 111.898 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.977 0.418 . . . . 2.96 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.9 m -115.01 153.38 30.75 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.0 -0.545 . . . . 1.55 111.774 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 52.03 27.58 4.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.635 -0.711 . . . . 2.3300000000000001 112.144 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -134.27 -47.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 2.5099999999999998 109.636 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.99 86.52 3.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.719 -0.673 . . . . 3.1000000000000001 109.541 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.17 150.32 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 1.3100000000000001 109.892 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -127.13 179.04 5.63 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 113.065 0.765 . . . . 0.68999999999999995 113.065 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -123.6 137.58 54.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.124 -0.489 . . . . 2.0099999999999998 111.256 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.414 -0.357 . . . . 0.46000000000000002 111.922 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -130.35 151.2 51.11 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.825 0.676 . . . . 1.8500000000000001 112.825 -178.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 9.5 p -124.6 120.76 59.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 115.425 -0.807 . . . . 1.1000000000000001 110.021 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.475 ' OD1' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.68 25.85 10.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.524 -0.917 . . . . 1.77 108.524 -176.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.58 57.29 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.16 -0.927 . . . . 0.40999999999999998 112.987 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.454 ' CG ' HG11 ' A' ' 142' ' ' VAL . 89.1 m-70 -110.48 112.25 24.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.428 0.899 . . . . 0.46000000000000002 113.428 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 p -70.41 112.66 6.87 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.023 0.44 . . . . 0.66000000000000003 111.221 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.34 -37.61 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 0.80000000000000004 110.124 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.87 90.31 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 109.337 -0.616 . . . . 0.51000000000000001 109.337 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.3 ptpp? -108.25 84.58 1.96 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.165 0.983 . . . . 2.4399999999999999 112.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.6 p30 149.92 31.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.437 -2.165 . . . . 2.5600000000000001 108.142 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -56.32 98.87 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.146 0.498 . . . . 1.1000000000000001 112.056 -177.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -105.87 80.76 1.57 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.828 -1.175 . . . . 1.99 107.828 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.1 mt -51.0 -47.03 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.085 -0.962 . . . . 0.63 112.721 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.662 0.267 . . . . 0.90000000000000002 111.671 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.29 -27.63 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.979 0.363 . . . . 0.76000000000000001 111.979 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -68.86 -58.54 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.069 0.396 . . . . 2.6800000000000002 112.069 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.5 m -90.54 -40.47 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.939 0.348 . . . . 1.4099999999999999 111.939 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.34 -82.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 1.0600000000000001 112.439 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -99.99 169.69 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.512 0.196 . . . . 3.5099999999999998 110.782 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 m -49.88 97.91 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.36 -0.382 . . . . 1.6799999999999999 110.984 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.9 p -150.94 -170.12 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.80000000000000004 109.96 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.512 ' HB1' ' HZ3' ' A' ' 88' ' ' LYS . . . -96.6 131.11 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.741 0.645 . . . . 0.44 112.741 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -106.32 147.08 29.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.572 -0.899 . . . . 0.38 108.572 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -144.83 127.08 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.437 0.532 . . . . 2.0899999999999999 112.437 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -114.8 135.61 53.99 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.766 -0.652 . . . . 2.2799999999999998 109.568 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.54 120.86 66.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.4 -0.818 . . . . 0.70999999999999996 110.083 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.88 89.18 51.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.353 -0.385 . . . . 1.3799999999999999 111.947 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.17 146.62 94.26 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.97 1.78 . . . . 0.22 111.709 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.6 mt -138.6 156.86 29.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 0.20999999999999999 110.751 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 p -133.53 108.56 8.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.068 0.461 . . . . 1.1100000000000001 111.349 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 139' ' ' LYS . 18.3 mt -109.67 125.69 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-N 115.667 -0.697 . . . . 0.23000000000000001 110.224 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -149.12 141.69 24.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 1.9099999999999999 111.157 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt 61.36 14.24 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.9 -0.591 . . . . 3.1099999999999999 111.212 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.78 8.76 59.13 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.606 -0.807 . . . . 0.32000000000000001 113.402 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.595 ' O ' HG23 ' A' ' 135' ' ' ILE . 33.3 mtmt -112.34 165.2 12.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.34 0.57 . . . . 2.1899999999999999 110.669 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.507 ' CD1' HD11 ' A' ' 153' ' ' LEU . 8.2 tt -127.16 139.74 52.74 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.616 0.598 . . . . 0.37 112.616 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.448 ' OG ' HG22 ' A' ' 146' ' ' VAL . 36.1 t -126.44 116.03 20.51 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.626 -0.715 . . . . 0.90000000000000002 110.447 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 142' ' ' VAL . 4.3 p -112.32 104.53 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.094 -0.957 . . . . 0.53000000000000003 110.575 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.75 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 2.0499999999999998 112.009 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.17 9.87 4.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.352 -0.927 . . . . 0.59999999999999998 113.914 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -124.38 118.87 27.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.147 0.473 . . . . 2.02 110.019 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.448 HG22 ' OG ' ' A' ' 141' ' ' SER . 21.2 t -107.62 130.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.477 0.656 . . . . 1.3 112.432 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 t -145.12 143.11 30.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 114.939 -1.028 . . . . 1.1200000000000001 109.742 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.6 p -55.85 141.36 39.24 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.111 0.411 . . . . 1.1100000000000001 112.111 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -79.09 143.15 35.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.168 -0.679 . . . . 0.28000000000000003 109.168 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.9 96.45 3.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.776 1.028 . . . . 1.55 113.776 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.66 -57.33 2.55 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.978 1.151 . . . . 0.46000000000000002 115.978 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -153.54 174.72 14.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.934 0.867 . . . . 1.8 112.667 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.507 HD11 ' CD1' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -97.06 130.79 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.964 -1.495 . . . . 1.24 106.964 176.285 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.408 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.4 t -120.71 112.74 19.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.267 -0.973 . . . . 1.28 112.978 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 57.5 t -98.28 104.04 15.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 0.58999999999999997 110.548 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 mt-10 -108.47 144.91 35.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.407 -0.815 . . . . 2.48 110.922 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.97 138.16 42.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.637 -0.505 . . . . 1.54 109.637 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.6 t -112.25 143.59 21.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.22 -0.9 . . . . 0.77000000000000002 111.261 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -74.95 148.45 39.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.533 -0.758 . . . . 1.97 111.375 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.14 -9.2 28.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.943 -0.646 . . . . 1.1200000000000001 111.941 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.45 -61.89 0.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.616 0.246 . . . . 3.8100000000000001 110.489 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -172.69 -28.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 3.8199999999999998 111.048 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.73 90.54 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 1.3999999999999999 111.589 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -53.82 165.82 0.7 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.397 -0.594 . . . . 2.0 109.397 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -37.67 100.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.779 1.653 . . . . 2.5800000000000001 111.575 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -52.0 -57.0 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.975 . . . . 3.71 112.384 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 61.3 t -103.04 133.69 46.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 120.495 -0.482 . . . . 0.92000000000000004 112.253 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -132.59 135.29 45.81 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 115.873 -0.603 . . . . 1.2 111.065 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.585 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -126.23 35.57 4.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.806 . . . . 0.22 112.611 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.36 131.43 0.21 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.499 0.499 . . . . 1.02 111.366 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.458 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.89 101.26 2.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.33000000000000002 110.198 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -107.43 123.32 62.63 Favored 'Isoleucine or valine' 0 C--O 1.265 1.873 0 CA-C-O 122.858 1.313 . . . . 0.68999999999999995 112.587 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.9 ptm -114.76 165.24 13.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.507 -1.678 . . . . 1.26 110.045 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HZ2' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -119.14 145.17 46.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 115.058 1.503 . . . . 1.8200000000000001 115.058 -177.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 101.81 -37.61 3.56 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 112.095 -2.32 . . . . 0.22 118.749 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.482 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.06 157.48 0.32 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.883 2.341 . . . . 0.28999999999999998 114.358 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.66 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.12 -22.85 26.87 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.673 -1.149 . . . . 0.56999999999999995 108.861 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.232 0.137 0 CA-C-N 115.206 -0.906 . . . . 2.3100000000000001 110.86 -179.678 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 tp . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.4 0.619 . . . . 0.40999999999999998 109.669 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.691 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -59.83 -20.34 56.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.096 -0.956 . . . . 0.33000000000000002 110.599 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.09 -18.5 63.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 2.0899999999999999 111.35 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -107.7 -26.73 10.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.696 -0.401 . . . . 1.99 111.476 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -45.84 145.48 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.756 -0.378 . . . . 0.20999999999999999 111.505 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -133.48 -18.86 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 119.861 -0.736 . . . . 0.85999999999999999 110.345 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.493 ' O ' HG22 ' A' ' 172' ' ' ILE . 44.0 t90 -175.22 144.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.591 -0.444 . . . . 0.28000000000000003 110.311 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -162.05 142.82 10.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.667 0.247 . . . . 0.20000000000000001 111.667 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.68 128.95 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.988 1.107 . . . . 0.67000000000000004 113.988 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 10.1 t30 -114.26 93.7 4.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.904 -0.776 . . . . 1.27 108.904 176.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.556 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -63.7 97.41 0.15 Allowed 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.442 -0.799 . . . . 0.37 109.757 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.564 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . 176.93 -77.8 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.122 -1.399 . . . . 0.67000000000000004 113.196 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -77.16 -125.36 0.26 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.204 -0.522 . . . . 1.1200000000000001 112.759 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.548 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -162.72 121.48 2.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 120.858 0.361 . . . . 2.02 110.744 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.0 p 35.11 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.809 -0.632 . . . . 1.22 112.289 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.56 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 58.1 t-80 -117.78 152.47 35.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.157 -0.617 . . . . 0.34000000000000002 112.575 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.7 t -123.67 103.6 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.469 -0.787 . . . . 1.1799999999999999 110.427 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.45 151.29 47.03 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.275 -0.42 . . . . 1.1699999999999999 110.731 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 25' ' ' HIS . 14.7 m -43.09 -48.69 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 124.367 1.042 . . . . 0.59999999999999998 112.888 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.404 ' N ' HG23 ' A' ' 24' ' ' VAL . 46.3 m-70 -57.74 -29.73 65.0 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.319 0.58 . . . . 0.46000000000000002 110.069 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.83 33.81 1.8 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.142 -0.935 . . . . 0.28999999999999998 111.666 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.1 mm -103.39 123.5 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.607 -0.516 . . . . 0.42999999999999999 109.607 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.6 t60 -104.38 134.97 46.69 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.614 1.338 . . . . 0.52000000000000002 114.614 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CD1' ' C ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -97.72 129.31 44.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.564 -0.902 . . . . 3.0 108.564 176.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -82.43 113.15 19.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.647 0.61 . . . . 2.8999999999999999 112.647 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -28.12 140.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.445 -1.252 . . . . 2.71 113.499 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.499 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 1.6 m-20 -14.75 83.57 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.814 1.246 . . . . 1.98 114.079 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 C--N 1.351 0.682 0 C-N-CA 122.35 2.033 . . . . 1.53 113.783 178.638 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.725 HG21 ' HB2' ' A' ' 126' ' ' ALA . 2.0 mt . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.758 0.789 . . . . 0.82999999999999996 109.503 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mt -46.94 -52.48 14.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.171 -1.377 . . . . 1.6899999999999999 113.937 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -65.75 -0.68 2.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.046 0.387 . . . . 2.5600000000000001 112.046 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.9 t -128.18 142.08 51.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.685 0.624 . . . . 0.96999999999999997 112.685 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -69.15 158.84 85.5 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.848 -0.615 . . . . 1.96 109.497 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.9 Cg_exo -40.07 -56.69 1.37 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 123.188 2.592 . . . . 0.66000000000000003 116.446 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 12.5 pt-20 -71.45 -53.36 14.23 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.318 0.58 . . . . 1.8200000000000001 111.264 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.67 -5.03 22.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.126 -0.694 . . . . 1.9099999999999999 109.126 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -77.59 -46.98 20.51 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.683 -0.858 . . . . 1.5 108.683 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -55.09 -42.57 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.378 -0.971 . . . . 1.22 108.378 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.491 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 13.0 tp -63.53 -63.48 1.17 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.537 -0.542 . . . . 1.05 109.537 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.496 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 3.3 m-85 -51.13 -12.38 0.13 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.501 -0.772 . . . . 0.90000000000000002 110.632 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.508 ' O ' ' O ' ' A' ' 63' ' ' THR . 1.6 tt0 -123.59 -126.21 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.587 -0.733 . . . . 1.8 111.239 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 167' ' ' VAL . 26.6 p 45.49 128.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.655 0.782 . . . . 1.05 112.81 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 167' ' ' VAL . 0.0 OUTLIER -124.79 154.82 40.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.441 0.638 . . . . 2.0499999999999998 112.65 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.564 ' HD3' ' N ' ' A' ' 17' ' ' GLY . 18.2 mtp180 -123.3 -171.74 2.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.01 -0.995 . . . . 3.5800000000000001 110.281 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.4 -178.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 4.25 111.043 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.98 163.25 39.32 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.434 -0.348 . . . . 4.3499999999999996 110.963 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.56 -93.76 0.06 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.504 -0.316 . . . . 3.1699999999999999 111.631 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -173.15 127.97 0.45 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.813 0.301 . . . . 2.3900000000000001 111.813 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.5 t 52.45 93.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.096 -0.502 . . . . 0.98999999999999999 111.976 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -160.58 161.44 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 1.26 110.588 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.07 177.56 39.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.978 -1.106 . . . . 0.66000000000000003 114.632 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -100.89 161.73 13.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 0.82999999999999996 111.958 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -115.49 122.32 45.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.952 -1.022 . . . . 2.27 111.137 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.53 109.63 45.7 Favored Pre-proline 0 C--O 1.224 -0.251 0 CA-C-O 119.367 -0.349 . . . . 0.34000000000000002 111.179 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -81.85 130.43 6.67 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.297 1.142 . . . . 0.80000000000000004 112.106 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.9 mt -121.78 148.41 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.847 0.356 . . . . 0.38 111.324 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -139.41 -0.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 2.96 111.039 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.429 ' HG3' ' NZ ' ' A' ' 174' ' ' LYS . 12.6 mm-40 -123.74 166.02 16.28 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.659 0.266 . . . . 2.1299999999999999 110.878 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -119.7 172.95 7.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.273 0.559 . . . . 0.37 111.175 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.04 -147.23 18.9 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.02 -1.232 . . . . 0.20999999999999999 110.02 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mt-10 -105.87 109.44 21.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.603 1.201 . . . . 2.0299999999999998 109.805 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -96.65 127.22 42.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.046 -0.724 . . . . 0.26000000000000001 109.046 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.654 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.3 t -113.36 117.06 54.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.383 -0.826 . . . . 0.54000000000000004 111.48 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.21 104.79 16.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.23 111.312 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -105.3 137.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.918 -1.037 . . . . 1.3100000000000001 108.976 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -156.14 135.42 12.2 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.501 -0.88 . . . . 1.3700000000000001 112.368 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.698 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 3.5 mptt -97.38 127.47 43.36 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.918 -0.713 . . . . 2.9700000000000002 109.331 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CD2' HD21 ' A' ' 115' ' ' LEU . 3.1 m-85 -106.94 137.12 45.6 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.217 -0.66 . . . . 0.29999999999999999 109.217 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 120.75 -0.38 . . . . 0.40999999999999998 110.35 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.437 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 26.7 mt-30 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.886 0.374 . . . . 2.96 111.636 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 119' ' ' ASP . 33.2 p -124.54 154.54 40.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 1.55 111.755 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 47.22 29.2 1.14 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.767 -0.651 . . . . 2.3300000000000001 111.829 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -133.96 -48.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.259 -0.645 . . . . 2.5099999999999998 109.259 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -93.21 88.79 6.17 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 3.1000000000000001 109.133 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.73 152.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.531 -0.759 . . . . 1.3100000000000001 109.55 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -134.37 176.28 8.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.986 0.736 . . . . 0.68999999999999995 112.986 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -121.42 139.44 53.45 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.06 -0.518 . . . . 2.0099999999999998 111.206 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.68 130.6 42.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.641 -0.709 . . . . 0.46000000000000002 112.04 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -131.81 153.84 49.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.14 0.793 . . . . 1.8500000000000001 113.14 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 20.4 m -121.92 120.71 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.638 -1.165 . . . . 1.1000000000000001 109.613 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.502 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.2 OUTLIER 54.28 27.17 7.6 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.998 -0.741 . . . . 1.77 108.998 -176.609 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.07 23.67 29.19 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.708 -1.133 . . . . 0.40999999999999998 112.914 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.6 m-70 -122.97 108.73 13.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.209 0.818 . . . . 0.46000000000000002 113.209 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 p -62.48 115.9 4.64 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.91 0.386 . . . . 0.66000000000000003 111.642 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 t -106.38 -36.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.80000000000000004 109.878 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.458 HG11 ' OE2' ' A' ' 129' ' ' GLU . 2.1 t -127.84 92.29 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.851 -0.426 . . . . 0.51000000000000001 109.851 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 1.3 ptpt -105.8 76.99 1.22 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.715 1.245 . . . . 2.4399999999999999 111.983 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 155.71 27.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.221 -2.263 . . . . 2.5600000000000001 109.073 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 89' ' ' PHE . 40.5 tp -60.88 102.17 0.18 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.628 0.728 . . . . 1.1000000000000001 112.531 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 36.0 p-10 -112.06 89.43 3.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.528 -1.215 . . . . 1.99 108.406 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.0 -54.05 15.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 0.63 113.526 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 13.1 t80 -56.55 -40.07 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.88 0.326 . . . . 0.90000000000000002 111.88 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 97' ' ' SER . 19.4 t70 -67.65 -28.81 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.124 0.416 . . . . 0.76000000000000001 112.124 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 11.6 mmm180 -75.98 -58.69 3.13 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.511 0.56 . . . . 2.6800000000000002 112.511 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -87.1 -40.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.937 0.347 . . . . 1.4099999999999999 111.937 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.76 -94.93 0.75 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 1.0600000000000001 112.284 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 125' ' ' THR . 73.6 m80 -112.92 110.08 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.656 0.265 . . . . 3.5099999999999998 111.286 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.2 m 56.05 -132.42 1.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.187 -0.46 . . . . 1.6799999999999999 111.245 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 123' ' ' HIS . 11.0 p 57.94 -171.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.303 0.241 . . . . 0.80000000000000004 111.006 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.725 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.28 139.5 49.37 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.591 0.96 . . . . 0.44 113.591 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.4 t60 -100.31 150.86 22.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.55 -1.204 . . . . 0.38 107.844 176.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -145.37 122.33 11.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.26 -0.576 . . . . 2.0899999999999999 112.208 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.458 ' OE2' HG11 ' A' ' 112' ' ' VAL . 46.5 mt-10 -119.71 141.67 49.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.513 -0.767 . . . . 2.2799999999999998 109.512 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 mt -123.4 136.23 60.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.683 -0.69 . . . . 0.70999999999999996 111.229 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.2 mp -134.29 89.5 27.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 1.3799999999999999 111.631 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.01 144.07 92.18 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.72 1.613 . . . . 0.22 111.305 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 21.5 mt -135.41 154.85 36.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.563 -0.29 . . . . 0.20999999999999999 111.181 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -131.09 107.08 8.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 1.1100000000000001 110.635 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.9 mt -106.98 129.65 60.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.917 -0.583 . . . . 0.23000000000000001 110.55 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -147.88 140.5 24.61 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.798 0.332 . . . . 1.9099999999999999 110.814 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.434 ' NZ ' ' HB2' ' A' ' 137' ' ' LYS . 0.6 OUTLIER 55.66 28.51 12.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.554 0.692 . . . . 3.1099999999999999 110.06 -179.521 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.29 27.92 62.92 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.221 -0.899 . . . . 0.32000000000000001 112.703 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 62.4 mttp -121.89 146.87 46.69 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.919 0.359 . . . . 2.1899999999999999 110.797 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -107.67 131.31 54.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.146 0.498 . . . . 0.37 112.197 -177.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.592 ' N ' HD23 ' A' ' 140' ' ' LEU . 32.3 t -121.32 110.36 16.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.53 -0.759 . . . . 0.90000000000000002 109.618 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.1 p -103.66 108.28 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.321 0.582 . . . . 0.53000000000000003 110.968 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 60.94 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.645 -0.707 . . . . 2.0499999999999998 112.022 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -137.92 12.45 3.64 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.47 -0.871 . . . . 0.59999999999999998 113.158 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -116.88 141.14 48.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.863 0.331 . . . . 2.02 110.263 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.46 136.95 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 1.3 111.142 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.8 t -157.93 127.31 5.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.723 -0.672 . . . . 1.1200000000000001 109.824 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.2 p -58.03 142.9 45.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.294 -0.412 . . . . 1.1100000000000001 111.535 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -79.42 122.03 25.9 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.125 -0.694 . . . . 0.28000000000000003 109.125 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 t -111.18 91.36 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.156 -0.618 . . . . 1.55 112.6 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.04 -33.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 117.269 1.668 . . . . 0.46000000000000002 117.269 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -160.87 154.97 22.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.501 1.651 . . . . 1.8 113.868 -176.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.482 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -87.2 127.28 35.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.96 -1.126 . . . . 1.24 107.96 176.19 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.502 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -118.11 114.2 22.72 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.382 0.882 . . . . 1.28 113.382 -176.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.83 103.29 14.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.44 -0.578 . . . . 0.58999999999999997 109.44 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.4 mt-10 -107.67 139.44 42.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 2.48 111.447 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -136.11 138.44 42.06 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.011 -0.54 . . . . 1.54 110.002 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.453 ' CG2' HH21 ' A' ' 105' ' ' ARG . 12.0 t -115.14 143.62 24.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.95 -1.023 . . . . 0.77000000000000002 111.466 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -63.74 148.16 49.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 1.97 110.931 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.43 -29.8 8.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 1.1200000000000001 111.721 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -145.53 -55.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.545 0.212 . . . . 3.8100000000000001 111.011 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -142.24 -83.21 0.19 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.588 -0.278 . . . . 3.8199999999999998 111.51 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.14 125.16 29.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 1.3999999999999999 111.52 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 166' ' ' LYS . 1.3 m-20 -59.98 171.14 0.95 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.323 -0.853 . . . . 2.0 110.32 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -28.89 -29.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 123.312 2.675 . . . . 2.5800000000000001 114.318 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ASN . 15.6 tptp 85.28 -75.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.619 0.575 . . . . 3.71 112.364 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 64' ' ' GLU . 3.5 t -96.34 135.08 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 120.606 -0.438 . . . . 0.92000000000000004 112.017 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.22 134.96 45.95 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.98 -0.555 . . . . 1.2 112.425 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.513 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -124.4 35.43 4.81 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.228 -0.896 . . . . 0.22 112.769 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.424 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -37.48 138.99 0.29 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.15 0.5 . . . . 1.02 111.888 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.7 OUTLIER -157.71 100.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.47 -0.786 . . . . 0.33000000000000002 110.24 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -106.26 125.35 61.95 Favored 'Isoleucine or valine' 0 C--O 1.264 1.867 0 CA-C-O 122.758 1.266 . . . . 0.68999999999999995 112.553 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.583 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.7 ppp? -115.14 162.38 17.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.988 -1.915 . . . . 1.26 109.525 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.429 ' NZ ' ' HG3' ' A' ' 79' ' ' GLU . 32.2 tttt -120.34 144.15 48.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 115.272 1.582 . . . . 1.8200000000000001 115.272 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.68 -36.8 4.1 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 112.397 -2.183 . . . . 0.22 118.398 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.462 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.48 155.15 0.3 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.908 2.354 . . . . 0.28999999999999998 115.177 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.654 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.73 -24.61 25.08 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 114.566 -1.197 . . . . 0.56999999999999995 108.972 175.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-N 115.324 -0.853 . . . . 2.3100000000000001 110.657 -179.246 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 121.147 0.499 . . . . 0.40999999999999998 110.219 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.598 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.26 -20.4 4.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.362 -0.835 . . . . 0.33000000000000002 111.311 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.15 -27.8 38.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.407 0.521 . . . . 2.0899999999999999 112.407 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 37.4 mmtt -95.29 -22.75 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.717 -0.393 . . . . 1.99 111.49 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.7 p -43.79 143.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 120.584 0.231 . . . . 0.20999999999999999 111.615 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 pt -136.91 -23.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.013 -0.675 . . . . 0.85999999999999999 110.487 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.489 ' O ' HG22 ' A' ' 172' ' ' ILE . 73.3 t90 -172.74 140.94 1.03 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.049 -0.523 . . . . 0.28000000000000003 110.091 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -159.88 143.94 14.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.271 0.471 . . . . 0.20000000000000001 112.271 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.519 HG11 ' CE2' ' A' ' 73' ' ' TYR . 4.2 t -147.02 130.98 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 113.807 1.04 . . . . 0.67000000000000004 113.807 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.447 ' ND2' ' OG1' ' A' ' 63' ' ' THR . 2.7 t30 -114.43 95.25 5.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.887 -1.051 . . . . 1.27 108.553 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.681 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -60.18 92.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.265 -1.013 . . . . 0.37 108.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.62 ' HA3' ' OG1' ' A' ' 63' ' ' THR . . . -177.27 -95.34 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 O-C-N 124.582 1.176 . . . . 0.67000000000000004 114.55 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -66.47 -122.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.112 -0.566 . . . . 1.1200000000000001 114.039 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -159.09 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.388 -0.406 . . . . 2.02 110.158 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.716 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.0 m 31.61 95.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.512 -0.767 . . . . 1.22 112.68 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.683 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 43.5 t-80 -123.59 139.96 53.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.787 -0.765 . . . . 0.34000000000000002 112.5 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 22' ' ' VAL . 3.6 p -115.03 104.07 16.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.668 -0.696 . . . . 1.1799999999999999 110.582 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 157.03 29.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.194 -0.912 . . . . 1.1699999999999999 110.662 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -43.73 -47.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 O-C-N 124.367 1.042 . . . . 0.59999999999999998 113.277 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -62.57 -20.18 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.318 0.58 . . . . 0.46000000000000002 110.386 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.34 34.89 3.25 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.208 -0.905 . . . . 0.28999999999999998 112.542 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.01 114.84 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 120.459 -0.496 . . . . 0.42999999999999999 110.455 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.683 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.5 t60 -100.42 136.35 40.43 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.915 1.45 . . . . 0.52000000000000002 114.915 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.716 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.23 135.99 42.85 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.698 -1.137 . . . . 3.0 108.753 177.765 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -86.29 106.99 17.75 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.796 0.685 . . . . 2.8999999999999999 112.303 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.619 ' NZ ' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -34.21 137.06 0.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.121 -0.945 . . . . 2.71 113.296 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.496 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER 3.0 79.7 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 114.748 -1.115 . . . . 1.98 113.551 178.299 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 CA--C 1.537 0.638 0 C-N-CA 122.188 1.925 . . . . 1.53 114.095 179.533 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 108.537 -0.912 . . . . 0.82999999999999996 108.537 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -54.55 26.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.579 -1.191 . . . . 1.6899999999999999 114.103 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -74.62 28.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.53 0.937 . . . . 2.5600000000000001 113.53 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t -141.11 145.08 35.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.137 0.494 . . . . 0.96999999999999997 112.133 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.1 t30 -63.47 146.9 96.08 Favored Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 115.484 -0.78 . . . . 1.96 109.596 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.632 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.2 Cg_exo -40.81 -58.89 0.88 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 122.631 2.221 . . . . 0.66000000000000003 115.249 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -62.21 -54.37 41.91 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 122.298 1.047 . . . . 1.8200000000000001 110.76 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -69.83 -11.64 61.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.036 -0.983 . . . . 1.9099999999999999 110.215 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.632 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -64.45 -45.71 86.26 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.491 -1.67 . . . . 1.5 106.491 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' THR . 74.8 t -54.19 -51.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.403 -1.271 . . . . 1.22 109.352 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.9 tp -70.49 -7.2 41.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.586 -0.734 . . . . 1.05 111.426 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.0 m-30 -120.08 16.03 12.42 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.478 -0.783 . . . . 0.90000000000000002 109.719 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.548 ' HG2' ' N ' ' A' ' 63' ' ' THR . 30.6 tt0 -141.25 -109.92 0.14 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.305 -0.861 . . . . 1.8 110.596 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.62 ' OG1' ' HA3' ' A' ' 17' ' ' GLY . 69.2 p 37.26 -156.02 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 119.082 -0.485 . . . . 1.05 110.298 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.513 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 12.6 pt-20 -174.86 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.593 1.701 . . . . 2.0499999999999998 115.593 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 7.9 mtp180 70.57 -172.79 0.17 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.062 0.392 . . . . 3.5800000000000001 110.056 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -87.25 178.83 6.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.519 -0.309 . . . . 4.25 111.106 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -150.05 171.99 15.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.379 -0.373 . . . . 4.3499999999999996 111.121 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.41 -102.5 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.475 -0.33 . . . . 3.1699999999999999 111.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -169.85 131.68 1.08 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.646 0.26 . . . . 2.3900000000000001 111.028 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.541 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 21.7 t 53.21 93.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.252 -0.431 . . . . 0.98999999999999999 111.495 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -168.85 168.83 10.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 1.26 110.975 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -171.37 -146.2 5.15 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.248 -0.977 . . . . 0.66000000000000003 113.86 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.681 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 58.9 m-85 -135.87 172.72 12.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.719 0.771 . . . . 0.82999999999999996 112.908 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.06 135.76 53.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.068 -1.424 . . . . 2.27 110.17 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.474 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.7 mp -129.35 86.34 56.66 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 111.706 0.262 . . . . 0.34000000000000002 111.706 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.73 126.13 21.39 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.109 1.873 . . . . 0.80000000000000004 112.512 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -121.05 149.89 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.38 110.933 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.03 2.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 2.96 111.425 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.633 ' HG2' ' NZ ' ' A' ' 174' ' ' LYS . 8.0 tp10 -132.11 165.99 22.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.835 0.35 . . . . 2.1299999999999999 110.092 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -116.41 178.85 4.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.37 111.642 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.87 -148.08 18.66 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 109.972 -1.251 . . . . 0.20999999999999999 109.972 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 11.1 mm-40 -105.97 110.53 22.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.701 1.251 . . . . 2.0299999999999998 109.235 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.28 126.36 41.44 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 108.954 -0.758 . . . . 0.26000000000000001 108.954 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.653 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.7 t -114.5 121.24 66.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.346 -0.843 . . . . 0.54000000000000004 112.032 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.5 tt -103.56 105.62 15.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.864 -1.062 . . . . 1.23 110.635 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.22 132.12 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.24 -0.891 . . . . 1.3100000000000001 108.816 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -147.47 138.78 23.78 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.241 -0.984 . . . . 1.3700000000000001 112.824 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.61 ' HD3' ' C ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -98.95 126.61 44.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.097 -0.956 . . . . 2.9700000000000002 109.024 178.329 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.38 146.13 32.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.551 -0.75 . . . . 0.29999999999999999 110.548 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.558 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . . . . . . 0 C--O 1.237 0.4 0 CA-C-N 116.088 -0.506 . . . . 0.40999999999999998 109.832 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.745 0.307 . . . . 2.96 111.019 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 99' ' ' GLN . 20.4 m -99.0 -88.4 0.33 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.686 0.624 . . . . 1.55 112.686 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.86 36.22 0.17 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.903 0.383 . . . . 2.3300000000000001 111.558 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 97' ' ' SER . 1.8 mt-30 -133.79 -41.3 0.85 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.016 -0.538 . . . . 2.5099999999999998 109.697 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -94.39 75.86 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.293 -0.632 . . . . 3.1000000000000001 109.293 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.33 154.33 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.707 -0.678 . . . . 1.3100000000000001 109.851 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -139.64 173.85 11.11 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 111.968 0.359 . . . . 0.68999999999999995 111.968 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.92 137.08 54.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.589 -0.444 . . . . 2.0099999999999998 110.812 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.6 t -132.06 129.68 60.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 112.598 0.592 . . . . 0.46000000000000002 112.598 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 2.7 mtt180 -134.89 149.59 50.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.591 -0.731 . . . . 1.8500000000000001 112.82 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 14.0 m -119.28 120.8 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.313 -0.858 . . . . 1.1000000000000001 109.99 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.506 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.11 27.23 9.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.42 0.628 . . . . 1.77 109.342 -176.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.5 21.33 41.08 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.016 -0.993 . . . . 0.40999999999999998 112.671 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -119.16 113.73 21.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.079 0.77 . . . . 0.46000000000000002 113.079 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -64.49 124.7 22.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.507 -0.477 . . . . 0.66000000000000003 111.046 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.19 -32.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.833 -0.621 . . . . 0.80000000000000004 109.531 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.12 90.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.51000000000000001 110.151 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 18.1 ptpt -104.19 137.85 41.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.033 -0.531 . . . . 2.4399999999999999 110.41 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 22.6 m-20 87.47 18.24 0.07 Allowed 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.025 -1.472 . . . . 2.5600000000000001 107.025 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 tp -45.78 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.983 -1.462 . . . . 1.1000000000000001 111.763 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -102.89 90.41 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.162 -0.927 . . . . 1.99 109.317 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -52.15 -47.94 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 0.63 112.637 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.77 -44.61 96.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.936 0.347 . . . . 0.90000000000000002 111.936 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.87 -27.73 63.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.159 0.429 . . . . 0.76000000000000001 112.159 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -70.9 -58.1 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.247 0.462 . . . . 2.6800000000000002 112.247 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -99.96 -40.29 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.073 0.398 . . . . 1.4099999999999999 112.073 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.77 -134.36 8.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.458 -0.877 . . . . 1.0600000000000001 112.568 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -83.79 120.46 26.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.585 0.231 . . . . 3.5099999999999998 111.009 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.0 p 48.18 -121.96 1.47 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.095 -0.502 . . . . 1.6799999999999999 110.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.9 p 51.13 -167.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.672 0.272 . . . . 0.80000000000000004 111.635 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.416 ' HA ' ' HZ1' ' A' ' 88' ' ' LYS . . . -106.88 136.31 46.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.36 1.245 . . . . 0.44 114.36 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.1 t60 -108.8 141.51 40.73 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.267 -1.383 . . . . 0.38 107.267 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.29 119.33 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.772 0.656 . . . . 2.0899999999999999 112.772 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.88 136.66 52.83 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.82 -0.627 . . . . 2.2799999999999998 109.922 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.1 mt -112.51 133.33 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.44 -0.8 . . . . 0.70999999999999996 110.639 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.82 85.75 34.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.349 0.499 . . . . 1.3799999999999999 112.349 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.18 146.57 90.7 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.876 1.717 . . . . 0.22 111.784 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 134' ' ' SER . 23.7 mt -136.7 156.93 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 0.20999999999999999 110.854 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -132.83 106.95 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 1.1100000000000001 110.836 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 139' ' ' LYS . 25.7 mt -103.29 126.45 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.798 -0.637 . . . . 0.23000000000000001 109.609 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 88.0 mttt -148.08 138.15 22.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.878 -0.329 . . . . 1.9099999999999999 111.208 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 61.61 23.55 13.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 3.1099999999999999 110.572 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.09 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.041 -0.599 . . . . 0.32000000000000001 112.227 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.7 ' O ' HG23 ' A' ' 135' ' ' ILE . 59.3 mttt -114.72 159.03 21.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.383 0.135 . . . . 2.1899999999999999 111.073 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -121.09 124.15 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.076 0.465 . . . . 0.37 111.288 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 140' ' ' LEU . 24.5 t -114.1 109.53 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.674 -0.694 . . . . 0.90000000000000002 110.014 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.4 p -103.57 106.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 0.53000000000000003 111.031 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.95 -92.0 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.883 -0.599 . . . . 2.0499999999999998 111.814 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.87 37.6 2.28 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.596 -0.811 . . . . 0.59999999999999998 113.046 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.09 137.28 25.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.16 -0.311 . . . . 2.02 110.16 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.02 140.34 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.97 0.414 . . . . 1.3 110.976 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -162.69 126.93 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.901 -0.59 . . . . 1.1200000000000001 110.447 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 t -56.22 140.82 43.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.867 -0.606 . . . . 1.1100000000000001 112.406 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -79.62 139.24 37.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.403 -0.817 . . . . 0.28000000000000003 109.284 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 36.0 p -136.11 95.88 3.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.223 0.823 . . . . 1.55 113.223 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.23 -60.7 1.46 Allowed Glycine 0 C--N 1.331 0.282 0 N-CA-C 115.549 0.98 . . . . 0.46000000000000002 115.549 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.607 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -148.68 176.44 10.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.061 0.931 . . . . 1.8 112.978 -178.205 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.506 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.55 127.25 48.34 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.685 -1.228 . . . . 1.24 107.685 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.468 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.3 t -115.18 115.93 27.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.421 -0.912 . . . . 1.28 113.433 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.411 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 61.8 t -93.78 97.54 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.249 -0.649 . . . . 0.58999999999999997 109.249 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 tt0 -108.04 135.74 48.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 2.48 111.407 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -130.84 143.2 50.57 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.747 -0.66 . . . . 1.54 109.729 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.6 t -122.66 144.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.421 -0.809 . . . . 0.77000000000000002 111.653 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 146.36 30.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.738 -0.664 . . . . 1.97 110.88 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.9 -17.24 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.868 -0.682 . . . . 1.1200000000000001 112.14 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -138.44 -61.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 3.8100000000000001 110.429 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -175.25 150.9 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.097 -0.501 . . . . 3.8199999999999998 110.877 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.18 89.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.194 -0.457 . . . . 1.3999999999999999 111.437 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 70' ' ' SER . 1.4 m-20 -54.76 169.35 0.41 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.017 -0.538 . . . . 2.0 109.792 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.503 ' HD2' ' OD1' ' A' ' 164' ' ' ASN . 2.8 Cg_endo -36.4 105.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.321 2.014 . . . . 2.5800000000000001 111.63 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -60.53 -46.74 89.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.269 -0.878 . . . . 3.71 112.34 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 25.1 t -116.1 135.02 57.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 112.807 0.669 . . . . 0.92000000000000004 112.807 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -137.54 137.41 38.57 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 113.389 0.885 . . . . 1.2 113.389 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -125.03 38.6 4.16 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.62 -1.173 . . . . 0.22 111.397 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.5 tp -50.11 127.05 15.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.737 -0.665 . . . . 1.02 111.448 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.409 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -142.09 115.5 8.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.667 -0.697 . . . . 0.33000000000000002 110.831 -178.715 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -115.99 129.63 72.03 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 CA-C-O 123.126 1.441 . . . . 0.68999999999999995 112.994 178.547 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.575 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.0 ppp? -124.24 168.4 13.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.957 -1.929 . . . . 1.26 109.834 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.633 ' NZ ' ' HG2' ' A' ' 79' ' ' GLU . 13.8 ptmt -120.45 156.05 32.26 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.167 1.543 . . . . 1.8200000000000001 115.167 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 86.46 -34.87 3.4 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 111.833 -2.439 . . . . 0.22 118.082 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.62 158.55 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.209 2.004 . . . . 0.28999999999999998 114.249 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.653 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.44 -23.73 27.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.331 -0.849 . . . . 0.56999999999999995 110.425 177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.692 -0.686 . . . . 2.3100000000000001 111.649 -178.598 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.413 HD11 ' SD ' ' A' ' 173' ' ' MET . 22.1 tp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.143 0.497 . . . . 0.40999999999999998 109.812 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.635 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.95 -21.72 22.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.822 . . . . 0.33000000000000002 111.162 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.7 -19.78 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 2.0899999999999999 111.909 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -101.44 -23.39 14.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.949 -0.301 . . . . 1.99 111.282 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.1 p -45.71 141.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.735 0.303 . . . . 0.20999999999999999 111.725 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.28 -21.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.324 -0.551 . . . . 0.85999999999999999 110.355 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.487 ' O ' HG22 ' A' ' 172' ' ' ILE . 60.4 t90 -173.83 144.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.28000000000000003 109.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -164.31 144.91 8.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.628 0.603 . . . . 0.20000000000000001 112.628 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.72 129.49 6.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 113.661 0.986 . . . . 0.67000000000000004 113.661 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 60' ' ' LEU . 49.1 t30 -111.52 87.1 2.47 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.934 -1.136 . . . . 1.27 107.934 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.892 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -57.52 103.67 0.14 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.447 -1.251 . . . . 0.37 109.983 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.618 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 154.2 -17.95 0.62 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 113.898 -1.501 . . . . 0.67000000000000004 115.576 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.7 -126.56 2.77 Favored Glycine 0 N--CA 1.459 0.191 0 C-N-CA 119.367 -1.396 . . . . 1.1200000000000001 113.529 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -165.67 120.23 1.23 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.905 0.383 . . . . 2.02 111.695 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.2 p 32.88 94.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.244 -0.889 . . . . 1.22 112.882 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.664 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 36.5 t-80 -128.9 137.61 51.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.826 -0.75 . . . . 0.34000000000000002 112.351 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.0 p -113.68 105.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-O 121.387 0.613 . . . . 1.1799999999999999 111.462 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 156.53 36.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.513 -0.767 . . . . 1.1699999999999999 109.851 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 m -43.35 -46.72 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.761 1.023 . . . . 0.59999999999999998 113.761 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -63.54 -13.91 45.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.46000000000000002 110.914 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.71 33.04 5.45 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.501 -0.772 . . . . 0.28999999999999998 112.527 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 mm -103.92 112.23 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.184 0.516 . . . . 0.42999999999999999 110.497 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.2 t60 -98.64 136.24 39.0 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.447 1.277 . . . . 0.52000000000000002 114.447 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.637 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.89 132.32 43.58 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.73 -1.123 . . . . 3.0 108.649 177.72 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.516 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 22.8 mtt-85 -84.04 103.75 13.53 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 124.27 0.981 . . . . 2.8999999999999999 112.685 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 30' ' ' ARG . 15.9 ttmm -14.61 124.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.003 1.112 . . . . 2.71 114.003 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -13.84 81.5 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.912 1.285 . . . . 1.98 113.822 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.71 0 C-N-CA 123.188 2.592 . . . . 1.53 113.305 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 125' ' ' THR . 1.2 mp . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.106 0.479 . . . . 0.82999999999999996 110.567 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.28 -48.15 7.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.098 0.777 . . . . 1.6899999999999999 113.098 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -76.44 36.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.046 0.758 . . . . 2.5600000000000001 113.046 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -151.45 145.01 24.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.075 0.464 . . . . 0.96999999999999997 111.776 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.9 t30 -58.96 144.84 81.39 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.543 -0.753 . . . . 1.96 110.822 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.67 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.98 -53.68 2.82 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.949 2.433 . . . . 0.66000000000000003 115.383 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -64.92 -55.28 20.23 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 122.474 1.131 . . . . 1.8200000000000001 110.442 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.51 -9.25 53.02 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.721 -1.127 . . . . 1.9099999999999999 109.733 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.67 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.1 tt0 -66.32 -49.68 66.18 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.834 -1.543 . . . . 1.5 106.834 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.32 -46.01 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.985 -1.007 . . . . 1.22 109.385 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.475 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.4 tp -72.29 -12.99 61.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.409 -0.814 . . . . 1.05 111.376 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.403 ' O ' HG12 ' A' ' 50' ' ' ILE . 6.7 m-30 -120.71 20.61 11.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.6 -0.727 . . . . 0.90000000000000002 111.494 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -137.86 -59.61 0.65 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.35 0.87 . . . . 1.8 113.35 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 82.8 p -39.53 143.87 0.19 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.213 0.82 . . . . 1.05 113.213 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.618 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.6 OUTLIER -127.28 145.06 50.92 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.897 -0.592 . . . . 2.0499999999999998 111.51 -179.258 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -107.34 172.0 7.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.895 -0.593 . . . . 3.5800000000000001 110.015 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -57.72 174.97 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 4.25 110.97 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.526 ' HB2' ' OD1' ' A' ' 164' ' ' ASN . 2.7 p-10 -150.26 167.48 26.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 4.3499999999999996 111.632 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.45 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.8 tp10 -163.02 -83.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.042 -0.526 . . . . 3.1699999999999999 111.311 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 2.9 p30 -173.37 132.43 0.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.398 0.142 . . . . 2.3900000000000001 110.845 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t 43.4 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.426 -0.352 . . . . 0.98999999999999999 110.425 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.483 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 0.6 OUTLIER -149.3 158.22 44.0 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.8 -0.36 . . . . 1.26 111.569 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.45 -149.21 7.71 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.24 -0.981 . . . . 0.66000000000000003 114.367 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.463 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -129.71 168.84 15.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.543 0.687 . . . . 0.82999999999999996 112.536 -177.295 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.52 132.52 55.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.451 -1.25 . . . . 2.27 110.348 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.429 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.4 mp -124.88 86.89 55.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.437 0.532 . . . . 0.34000000000000002 112.437 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -55.37 132.41 52.05 Favored 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 122.271 1.981 . . . . 0.80000000000000004 112.325 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.93 151.31 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.231 -0.441 . . . . 0.38 111.067 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -140.84 1.38 1.68 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.173 -0.467 . . . . 2.96 111.193 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -124.34 172.98 8.7 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.592 0.234 . . . . 2.1299999999999999 110.819 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.24 165.37 19.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.379 0.609 . . . . 0.37 111.658 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.06 26.51 Favored Glycine 0 C--N 1.329 0.144 0 N-CA-C 109.874 -1.29 . . . . 0.20999999999999999 109.874 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -96.95 107.25 19.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.95 1.375 . . . . 2.0299999999999998 108.857 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 1.9 m-85 -95.39 127.46 41.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.573 0.702 . . . . 0.26000000000000001 109.189 -178.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.604 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.1 t -118.04 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.853 -1.067 . . . . 0.54000000000000004 113.284 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.48 105.96 17.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.121 -0.945 . . . . 1.23 110.381 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.4 106.12 18.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.14 -0.689 . . . . 1.3100000000000001 109.14 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.486 -0.486 . . . . 1.3700000000000001 112.248 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.535 ' NZ ' ' HB1' ' A' ' 126' ' ' ALA . 10.6 tptp -106.59 115.89 30.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.272 -1.01 . . . . 2.9700000000000002 108.272 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 9.9 m-85 -104.77 143.64 32.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.535 -0.543 . . . . 0.29999999999999999 109.535 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 120.088 -0.645 . . . . 0.40999999999999998 111.001 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 2.4 pp0? . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.685 0.278 . . . . 2.96 110.768 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.418 ' HB3' ' OD2' ' A' ' 119' ' ' ASP . 10.8 m -137.65 147.72 45.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 1.55 111.708 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 54.03 24.75 4.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.868 -0.606 . . . . 2.3300000000000001 111.288 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -125.32 -56.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.602 -0.518 . . . . 2.5099999999999998 109.602 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -94.63 96.78 9.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.069 -0.715 . . . . 3.1000000000000001 109.069 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.529 HG12 ' OD2' ' A' ' 116' ' ' ASP . 0.6 OUTLIER -109.2 148.99 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 1.3100000000000001 110.553 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -120.35 -178.27 3.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.839 0.681 . . . . 0.68999999999999995 112.839 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -130.98 143.08 50.46 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 115.876 -0.602 . . . . 2.0099999999999998 112.131 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.22 132.68 46.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.778 -0.646 . . . . 0.46000000000000002 112.151 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 12.9 ptt180 -134.35 151.65 51.35 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 115.318 -0.855 . . . . 1.8500000000000001 112.738 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 10.7 m -124.99 123.95 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.752 -1.113 . . . . 1.1000000000000001 110.384 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.464 ' HA ' ' H ' ' A' ' 154' ' ' SER . 7.0 t-20 52.72 26.79 4.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.991 -0.744 . . . . 1.77 108.991 -177.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.81 29.34 18.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.40999999999999998 112.666 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 80.3 m-70 -129.43 111.16 12.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.266 0.839 . . . . 0.46000000000000002 113.266 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -65.75 119.21 10.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.022 0.439 . . . . 0.66000000000000003 111.259 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.52 -33.48 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.625 -0.716 . . . . 0.80000000000000004 110.015 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.58 90.54 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.214 -0.661 . . . . 0.51000000000000001 109.214 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -103.39 77.1 1.48 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 122.295 1.045 . . . . 2.4399999999999999 111.406 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.5 p30 156.87 35.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.67 -1.605 . . . . 2.5600000000000001 109.152 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 93.81 0.14 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.292 0.568 . . . . 1.1000000000000001 111.677 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.529 ' OD2' HG12 ' A' ' 101' ' ' VAL . 6.4 m-20 -104.58 81.12 1.75 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.766 -1.568 . . . . 1.99 106.766 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.3 mt -50.35 -38.29 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.972 -1.013 . . . . 0.63 112.821 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 14.1 t80 -71.09 -43.46 67.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.862 -0.335 . . . . 0.90000000000000002 111.476 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 97' ' ' SER . 9.4 t70 -66.12 -27.35 67.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.657 0.265 . . . . 0.76000000000000001 111.38 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -72.18 -58.6 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.488 0.551 . . . . 2.6800000000000002 112.488 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 m -96.33 -40.4 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.943 0.349 . . . . 1.4099999999999999 111.943 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.89 -98.85 1.89 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.721 . . . . 1.0600000000000001 112.046 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -68.56 159.43 31.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.026 -0.361 . . . . 3.5099999999999998 110.026 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.4 p -57.4 94.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 1.6799999999999999 110.963 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 50' ' ' ILE . 23.8 p -140.75 -148.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 0.80000000000000004 110.029 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.535 ' HB1' ' NZ ' ' A' ' 88' ' ' LYS . . . -112.8 133.84 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.747 0.647 . . . . 0.44 112.747 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.522 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.9 t60 -111.53 149.29 31.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.494 -0.928 . . . . 0.38 108.494 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 19.5 t70 -141.73 132.07 25.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.31 0.576 . . . . 2.0899999999999999 112.517 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.96 114.36 16.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.137 -0.938 . . . . 2.2799999999999998 109.891 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.19 129.99 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 0.70999999999999996 110.55 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.4 89.52 47.19 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.417 -0.356 . . . . 1.3799999999999999 111.933 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -64.05 150.57 88.08 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.056 1.837 . . . . 0.22 112.011 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 134' ' ' SER . 34.2 mt -140.55 157.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.336 . . . . 0.20999999999999999 111.018 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -133.53 106.41 7.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 1.1100000000000001 110.747 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 139' ' ' LYS . 32.5 mt -105.5 126.51 60.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.761 -0.654 . . . . 0.23000000000000001 109.865 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' A' ' 134' ' ' SER . 50.4 mttp -148.38 143.59 26.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.769 0.319 . . . . 1.9099999999999999 110.961 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt 57.69 13.89 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 3.1099999999999999 111.287 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.15 23.48 27.12 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.641 -0.79 . . . . 0.32000000000000001 113.075 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.516 ' O ' HG23 ' A' ' 135' ' ' ILE . 1.3 mmmm -123.57 155.48 37.56 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.236 0.518 . . . . 2.1899999999999999 110.41 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -113.45 129.47 56.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.076 0.465 . . . . 0.37 111.878 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.566 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.0 t -116.66 110.01 17.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 0.90000000000000002 109.472 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -103.11 104.55 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.966 -0.561 . . . . 0.53000000000000003 111.011 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 57.96 -91.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.965 -0.561 . . . . 2.0499999999999998 111.856 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.9 6.12 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.554 -0.831 . . . . 0.59999999999999998 113.414 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -127.79 136.08 50.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.056 -0.349 . . . . 2.02 110.056 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.15 136.96 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.049 0.452 . . . . 1.3 111.141 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 m -155.93 175.3 14.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.761 -0.654 . . . . 1.1200000000000001 109.26 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.29 141.78 32.67 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.604 -0.438 . . . . 1.1100000000000001 111.757 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -77.63 129.99 36.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.477 -0.935 . . . . 0.28000000000000003 108.477 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 69.3 p -126.61 94.92 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.506 0.928 . . . . 1.55 113.506 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.03 -51.24 0.74 Allowed Glycine 0 CA--C 1.52 0.371 0 N-CA-C 116.328 1.291 . . . . 0.46000000000000002 116.328 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.539 ' HE2' ' N ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -156.37 164.31 38.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 118.443 1.121 . . . . 1.8 112.618 -177.519 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.39 127.11 35.49 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.357 -1.349 . . . . 1.24 107.357 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.464 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.7 t -113.42 112.91 24.42 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.698 -0.801 . . . . 1.28 112.988 -176.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 104.06 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.277 -0.419 . . . . 0.58999999999999997 110.344 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -125.11 156.94 37.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.226 0.536 . . . . 2.48 111.357 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.87 145.23 41.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.338 -0.846 . . . . 1.54 110.065 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 t -115.31 143.92 24.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.414 -0.812 . . . . 0.77000000000000002 111.02 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -75.92 144.59 40.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.483 -0.78 . . . . 1.97 111.116 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.62 -31.76 7.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.827 -0.701 . . . . 1.1200000000000001 111.745 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.42 -56.96 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.458 . . . . 3.8100000000000001 109.925 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -172.45 148.07 1.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.654 -0.703 . . . . 3.8199999999999998 110.372 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 65.42 71.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.277 0.56 . . . . 1.3999999999999999 111.07 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -50.25 169.67 0.19 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 114.93 -1.032 . . . . 2.0 109.443 178.171 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -37.22 110.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 121.773 1.649 . . . . 2.5800000000000001 111.979 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -64.27 -69.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.091 -0.959 . . . . 3.71 112.93 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 63' ' ' THR . 91.9 t -87.27 132.1 33.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 112.044 0.386 . . . . 0.92000000000000004 112.044 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.892 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.58 123.41 21.29 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.759 0.662 . . . . 1.2 112.669 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -118.84 40.46 3.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.748 -1.115 . . . . 0.22 112.985 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 tp -56.05 129.16 38.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.462 0.649 . . . . 1.02 111.035 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -139.95 114.03 8.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.041 -0.982 . . . . 0.33000000000000002 109.743 -178.192 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.648 HD13 ' N ' ' A' ' 173' ' ' MET . 0.2 OUTLIER -111.23 126.78 68.64 Favored 'Isoleucine or valine' 0 C--O 1.258 1.513 0 CA-C-O 122.947 1.356 . . . . 0.68999999999999995 113.353 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.648 ' N ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -121.61 165.95 14.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.141 -1.845 . . . . 1.26 109.539 -179.754 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 10.6 ptmt -120.36 142.9 48.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 114.886 1.439 . . . . 1.8200000000000001 114.886 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.4 -34.89 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 112.837 -1.983 . . . . 0.22 117.737 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.41 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.27 158.26 0.47 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.393 2.096 . . . . 0.28999999999999998 114.26 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.604 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.18 -27.96 24.22 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 114.729 -1.123 . . . . 0.56999999999999995 110.034 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.6 -0.727 . . . . 2.3100000000000001 111.153 -179.193 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.4 tp . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.25 0.547 . . . . 0.40999999999999998 110.344 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.546 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.85 -21.54 7.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 0.33000000000000002 111.77 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.98 -23.41 41.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.637 0.606 . . . . 2.0899999999999999 112.637 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.57 -21.27 15.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.618 -0.433 . . . . 1.99 111.871 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.6 p -44.37 144.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 121.146 -0.221 . . . . 0.20999999999999999 111.245 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -135.86 -20.33 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 119.686 -0.806 . . . . 0.85999999999999999 111.258 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.457 ' O ' HG22 ' A' ' 172' ' ' ILE . 23.5 t90 -174.07 139.54 0.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.765 -0.374 . . . . 0.28000000000000003 110.17 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -160.21 142.04 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.101 0.408 . . . . 0.20000000000000001 112.101 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.9 t -147.52 129.29 6.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 114.567 1.321 . . . . 0.67000000000000004 114.567 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 15.6 t30 -115.23 96.72 5.81 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.089 0.471 . . . . 1.27 110.385 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.905 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -68.16 114.19 6.45 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 115.683 -0.689 . . . . 0.37 109.709 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 145.61 -36.06 1.37 Allowed Glycine 0 C--N 1.342 0.882 0 O-C-N 124.767 1.292 . . . . 0.67000000000000004 113.674 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.5 -132.37 6.2 Favored Glycine 0 N--CA 1.454 -0.102 0 C-N-CA 120.313 -0.946 . . . . 1.1200000000000001 113.36 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.31 120.75 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.588 0.233 . . . . 2.02 110.669 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 77.8 p 28.46 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.598 -0.728 . . . . 1.22 112.672 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.591 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 58.3 t-80 -119.11 151.6 38.0 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.921 -0.712 . . . . 0.34000000000000002 112.343 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.59 103.71 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.27 -0.877 . . . . 1.1799999999999999 109.969 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.83 153.19 42.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.074 -0.512 . . . . 1.1699999999999999 110.305 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 25' ' ' HIS . 11.4 m -43.76 -51.26 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 124.17 0.919 . . . . 0.59999999999999998 113.212 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.4 ' N ' HG23 ' A' ' 24' ' ' VAL . 84.7 m-70 -58.68 -17.92 26.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.134 0.492 . . . . 0.46000000000000002 110.532 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.11 35.51 3.92 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.28999999999999998 112.432 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.7 mm -103.62 121.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.858 -0.423 . . . . 0.42999999999999999 109.858 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.4 t60 -103.27 134.75 46.14 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.686 1.365 . . . . 0.52000000000000002 114.686 -176.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.23 132.52 44.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.055 -0.975 . . . . 3.0 108.77 176.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.436 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 50.1 mtt180 -87.51 108.45 19.04 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.666 0.604 . . . . 2.8999999999999999 112.047 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 32' ' ' ASP . 39.0 tttt -23.57 135.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.947 0.899 . . . . 2.71 112.97 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 31' ' ' LYS . 4.1 p-10 -11.41 84.04 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 124.228 0.955 . . . . 1.98 112.884 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 13.5 Cg_endo . . . . . 0 CA--C 1.536 0.583 0 C-N-CA 122.51 2.14 . . . . 1.53 114.856 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 61' ' ' TYR . 1.1 mp . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.825 0.345 . . . . 0.82999999999999996 110.16 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.48 -51.75 4.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.176 0.806 . . . . 1.6899999999999999 113.176 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -74.25 36.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.205 0.817 . . . . 2.5600000000000001 113.205 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -150.32 149.48 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 0.96999999999999997 112.041 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 58' ' ' GLN . 44.1 t30 -64.29 147.07 97.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.511 -0.768 . . . . 1.96 109.925 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.666 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 20.8 Cg_exo -41.7 -50.62 4.79 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 122.366 2.044 . . . . 0.66000000000000003 114.218 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -55.36 14.26 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.934 0.873 . . . . 1.8200000000000001 110.978 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' OD1' HD23 ' A' ' 60' ' ' LEU . 14.2 t70 -67.96 -11.37 58.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.649 -0.705 . . . . 1.9099999999999999 109.387 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.666 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 20.9 tt0 -65.95 -49.23 68.64 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.007 -1.479 . . . . 1.5 107.007 177.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -51.15 -47.51 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.011 -0.995 . . . . 1.22 109.193 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 tp -71.52 -13.34 61.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.028 -0.987 . . . . 1.05 111.787 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.456 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.0 m-30 -121.4 21.21 11.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.712 -0.676 . . . . 0.90000000000000002 111.244 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -140.15 -59.75 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.569 0.951 . . . . 1.8 113.569 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.541 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 37.9 p -45.54 136.86 5.43 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.985 0.735 . . . . 1.05 112.985 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.557 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.5 pt-20 -121.49 150.06 42.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.985 -0.552 . . . . 2.0499999999999998 111.417 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.494 ' HG3' HH11 ' A' ' 65' ' ' ARG . 12.7 ttt85 -117.66 147.76 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 3.5800000000000001 110.343 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -74.14 148.78 41.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 4.25 111.778 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -153.38 -173.87 4.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.762 -0.654 . . . . 4.3499999999999996 110.276 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -122.7 -69.96 0.8 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.644 0.259 . . . . 3.1699999999999999 111.286 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -160.75 138.81 9.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.477 -0.329 . . . . 2.3900000000000001 110.28 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 54.32 87.97 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.814 -0.439 . . . . 0.98999999999999999 109.814 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.598 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 3.0 p90 -133.43 136.12 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.189 0.519 . . . . 1.26 111.1 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.403 ' HA3' ' CD ' ' A' ' 156' ' ' GLU . . . -154.25 -156.8 7.84 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.401 -0.818 . . . . 0.66000000000000003 113.594 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.4 ' CE1' HD23 ' A' ' 170' ' ' LEU . 0.7 OUTLIER -139.3 163.89 31.28 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.163 0.506 . . . . 0.82999999999999996 111.213 -178.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.04 114.11 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.21 -0.904 . . . . 2.27 110.667 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.7 mp -105.73 112.56 64.49 Favored Pre-proline 0 C--O 1.224 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.34000000000000002 111.548 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.01 141.44 11.83 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 120.219 1.114 . . . . 0.80000000000000004 111.604 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 78' ' ' LYS . 57.0 mt -132.25 151.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.039 0.447 . . . . 0.38 111.675 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' N ' HG22 ' A' ' 77' ' ' ILE . 99.6 mttt -142.95 -4.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.837 -0.62 . . . . 2.96 110.958 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -119.57 173.05 7.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.552 0.215 . . . . 2.1299999999999999 110.817 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -127.26 175.63 8.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.242 0.544 . . . . 0.37 111.425 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.3 -146.86 18.51 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 109.965 -1.254 . . . . 0.20999999999999999 109.965 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 19.2 mt-10 -104.68 109.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.722 1.261 . . . . 2.0299999999999998 109.433 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.13 127.46 42.15 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.229 -0.656 . . . . 0.26000000000000001 109.229 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.4 t -113.87 120.83 64.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.995 -1.002 . . . . 0.54000000000000004 112.388 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -94.01 105.8 17.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.931 -1.032 . . . . 1.23 111.367 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 48.2 t -106.17 116.22 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.069 -0.969 . . . . 1.3100000000000001 108.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 133.6 45.17 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.3 -0.56 . . . . 1.3700000000000001 110.978 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.459 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 9.2 tptp -100.13 118.8 37.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 119.605 -0.838 . . . . 2.9700000000000002 109.16 177.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 1.3 m-85 -105.94 136.62 45.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.14 -1.059 . . . . 0.29999999999999999 108.14 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 C-N-CA 119.42 -0.912 . . . . 0.40999999999999998 112.025 -179.858 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 120.712 0.292 . . . . 2.96 110.449 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 98' ' ' GLN . 18.2 m -86.36 179.07 6.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.357 -0.383 . . . . 1.55 111.941 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 97' ' ' SER . 84.1 mm-40 70.84 -68.55 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.421 -0.809 . . . . 2.3300000000000001 111.29 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -62.42 -17.61 59.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 2.5099999999999998 110.662 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 1.7 mptm? -110.43 52.23 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 3.1000000000000001 110.305 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.409 HG22 ' C ' ' A' ' 114' ' ' ASP . 0.8 OUTLIER -109.59 133.95 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.295 -0.632 . . . . 1.3100000000000001 109.295 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 164' ' ' ASN . 61.2 m-85 -138.89 170.91 15.14 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.552 0.945 . . . . 0.68999999999999995 113.552 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 157' ' ' PHE . 5.1 m-20 -112.89 136.95 51.96 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.555 -0.458 . . . . 2.0099999999999998 110.444 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.02 128.98 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 111.997 0.369 . . . . 0.46000000000000002 111.997 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 15.7 ptt180 -133.63 147.55 51.47 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.351 0.871 . . . . 1.8500000000000001 113.351 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m -122.18 120.59 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 114.761 -1.108 . . . . 1.1000000000000001 109.807 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.504 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.38 27.21 9.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.308 0.575 . . . . 1.77 109.49 -176.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.39 14.07 57.67 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.224 -0.898 . . . . 0.40999999999999998 112.938 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.0 m-70 -110.66 111.19 22.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.264 0.839 . . . . 0.46000000000000002 113.264 -178.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -69.25 112.6 5.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.004 0.43 . . . . 0.66000000000000003 110.418 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.67 -37.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 0.80000000000000004 110.848 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.33 91.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.134 -0.626 . . . . 0.51000000000000001 111.121 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 10.9 ptmm? -101.88 146.75 27.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.374 -0.83 . . . . 2.4399999999999999 109.706 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 5.4 m-20 77.24 33.27 0.43 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.865 -1.061 . . . . 2.5600000000000001 108.741 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 1.1000000000000001 112.126 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 44.7 p-10 -101.52 84.21 2.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.151 -0.685 . . . . 1.99 109.151 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.2 pt -51.25 -37.24 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.648 -0.706 . . . . 0.63 112.231 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -57.08 -44.69 83.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.543 -0.298 . . . . 0.90000000000000002 111.57 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.19 -28.18 63.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.83 0.308 . . . . 0.76000000000000001 111.83 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -72.25 -58.82 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.205 0.446 . . . . 2.6800000000000002 112.205 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.3 m -88.63 -40.41 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.846 0.313 . . . . 1.4099999999999999 111.846 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.73 -93.37 0.65 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.747 -0.739 . . . . 1.0600000000000001 111.94 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.472 ' O ' HG23 ' A' ' 125' ' ' THR . 61.0 m80 -115.08 110.4 19.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.517 0.198 . . . . 3.5099999999999998 110.952 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.7 p 54.42 -144.84 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.269 -0.423 . . . . 1.6799999999999999 111.21 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.5 p 68.45 -172.67 0.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.987 0.515 . . . . 0.80000000000000004 111.743 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.45 141.67 37.38 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.769 0.655 . . . . 0.44 112.769 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 15.7 t60 -101.88 157.4 16.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.606 -0.724 . . . . 0.38 109.103 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -143.0 113.51 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.464 0.542 . . . . 2.0899999999999999 112.464 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -108.12 116.88 32.77 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.678 -0.692 . . . . 2.2799999999999998 110.078 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.7 mt -109.66 130.0 63.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.72 -0.673 . . . . 0.70999999999999996 110.109 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.71 89.53 25.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.34 0.496 . . . . 1.3799999999999999 112.34 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -61.53 149.65 88.76 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.943 1.762 . . . . 0.22 111.926 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 26.1 mt -140.06 156.71 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.20999999999999999 111.101 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 133' ' ' ILE . 39.9 t -130.6 107.24 9.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 1.1100000000000001 110.82 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.2 mt -107.6 129.03 62.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.811 -0.631 . . . . 0.23000000000000001 110.393 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -147.62 139.35 24.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 1.9099999999999999 110.771 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp 54.57 28.39 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 3.1099999999999999 110.646 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 28.37 58.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.32000000000000001 112.544 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.548 ' HB2' ' NZ ' ' A' ' 139' ' ' LYS . 4.4 ttmp? -121.89 146.04 47.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.386 -0.228 . . . . 2.1899999999999999 110.386 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -114.17 130.71 56.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.107 0.48 . . . . 0.37 112.077 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.57 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.2 t -127.07 110.01 12.48 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.617 -0.72 . . . . 0.90000000000000002 109.73 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 144' ' ' GLY . 3.2 p -102.94 131.34 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.53000000000000003 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 46.96 -90.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.821 0.304 . . . . 2.0499999999999998 111.821 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -136.66 25.87 3.07 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.694 -0.765 . . . . 0.59999999999999998 113.346 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -124.03 142.68 50.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.69 -0.485 . . . . 2.02 109.69 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.49 145.97 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 1.3 111.404 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.2 t -163.3 167.85 21.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.381 -0.6 . . . . 1.1200000000000001 109.381 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.6 139.58 35.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.561 -0.456 . . . . 1.1100000000000001 111.482 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.24 123.95 27.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.535 -1.283 . . . . 0.28000000000000003 107.535 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.1 m -129.24 94.23 3.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.418 -0.913 . . . . 1.55 112.874 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.32 -48.79 1.84 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 116.778 1.471 . . . . 0.46000000000000002 116.778 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -159.44 154.56 25.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.997 1.398 . . . . 1.8 113.817 -176.388 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -86.58 131.77 34.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.352 -0.981 . . . . 1.24 108.352 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.443 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.5 t -118.14 114.77 23.56 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.807 -0.757 . . . . 1.28 112.53 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.55 111.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.743 -0.383 . . . . 0.58999999999999997 111.35 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' CD ' ' HA3' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -140.22 160.57 39.66 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.162 0.506 . . . . 2.48 111.302 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -132.96 140.45 47.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.459 -0.791 . . . . 1.54 109.789 177.654 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.44 144.63 13.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.353 -0.839 . . . . 0.77000000000000002 111.989 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.579 ' NZ ' ' HB2' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -57.62 136.01 56.76 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.116 -0.947 . . . . 1.97 111.435 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.85 -32.16 2.52 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.869 -0.605 . . . . 1.1200000000000001 111.644 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -143.0 -65.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.696 0.284 . . . . 3.8100000000000001 110.26 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -176.86 152.2 0.93 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.128 -0.487 . . . . 3.8199999999999998 110.975 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 64.08 40.97 6.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.942 -0.572 . . . . 1.3999999999999999 112.406 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.709 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -60.4 -39.26 66.18 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-O 118.804 -0.617 . . . . 2.0 110.01 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 95.5 Cg_exo -23.51 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.415 2.744 . . . . 2.5800000000000001 111.786 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 10.3 ptmm? 32.35 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.603 -1.181 . . . . 3.71 113.06 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 64' ' ' GLU . 46.0 t -96.16 133.62 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 121.045 -0.262 . . . . 0.92000000000000004 111.295 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.905 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -131.48 126.83 36.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.204 -0.598 . . . . 1.2 111.689 -179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.459 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -122.37 37.03 4.49 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.957 1.095 . . . . 0.22 113.957 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -35.45 134.37 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.001 0.429 . . . . 1.02 111.889 179.423 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.51 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -155.16 101.76 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.33000000000000002 109.831 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.501 HD13 ' N ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -110.05 123.8 66.25 Favored 'Isoleucine or valine' 0 C--O 1.259 1.572 0 CA-C-O 123.037 1.398 . . . . 0.68999999999999995 112.93 179.33 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.501 ' N ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -114.19 160.55 18.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.256 -1.793 . . . . 1.26 108.768 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.415 ' HG2' ' N ' ' A' ' 175' ' ' GLY . 4.0 tmtt? -119.93 141.07 49.96 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.43 1.27 . . . . 1.8200000000000001 114.43 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 174' ' ' LYS . . . 104.97 -33.92 6.19 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 112.695 -2.048 . . . . 0.22 117.639 175.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.29 156.33 0.41 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.2 2.0 . . . . 0.28999999999999998 114.601 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.26 -26.22 25.11 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 114.994 -1.003 . . . . 0.56999999999999995 110.277 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.913 -0.585 . . . . 2.3100000000000001 111.594 -178.961 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.228 0.537 . . . . 0.40999999999999998 110.333 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.62 -21.53 10.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.233 -0.894 . . . . 0.33000000000000002 111.371 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.5 -23.4 46.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.012 0.375 . . . . 2.0899999999999999 112.012 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -97.12 -23.09 16.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.761 -0.376 . . . . 1.99 111.375 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.0 p -44.86 145.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 120.623 0.249 . . . . 0.20999999999999999 111.613 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.98 -32.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.123 -0.631 . . . . 0.85999999999999999 110.848 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.492 ' O ' HG22 ' A' ' 172' ' ' ILE . 71.2 t90 -166.23 124.06 1.44 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.842 -0.343 . . . . 0.28000000000000003 110.304 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.15 141.97 28.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.489 -0.323 . . . . 0.20000000000000001 111.785 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 170' ' ' LEU . 2.5 t -147.56 130.89 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 113.442 0.904 . . . . 0.67000000000000004 113.442 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -110.14 89.44 3.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 107.865 -1.161 . . . . 1.27 107.865 175.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.674 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -58.33 99.07 0.04 OUTLIER 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.008 -0.996 . . . . 0.37 109.605 -177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.72 -88.99 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.736 -1.12 . . . . 0.67000000000000004 114.355 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -78.56 -117.7 0.22 Allowed Glycine 0 CA--C 1.512 -0.127 0 C-N-CA 121.085 -0.579 . . . . 1.1200000000000001 113.419 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -145.04 148.52 33.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.635 -0.135 . . . . 2.02 110.635 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 64.6 m -12.36 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.171 0.804 . . . . 1.22 113.171 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.2 t-80 -139.09 150.42 45.7 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.095 0.474 . . . . 0.34000000000000002 111.915 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.57 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 1.1799999999999999 111.298 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 154.75 41.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.1699999999999999 110.472 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 25' ' ' HIS . 12.0 m -44.35 -51.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 124.081 0.863 . . . . 0.59999999999999998 113.147 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.408 ' N ' HG23 ' A' ' 24' ' ' VAL . 80.3 m-70 -58.16 -18.52 26.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.268 0.556 . . . . 0.46000000000000002 110.354 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 34.96 4.02 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.333 -0.849 . . . . 0.28999999999999998 112.232 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -103.64 121.34 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 0.42999999999999999 110.084 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.7 t60 -101.08 135.82 41.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 114.271 1.211 . . . . 0.52000000000000002 114.271 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.86 136.78 42.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.975 -1.12 . . . . 3.0 107.975 176.561 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.435 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 48.8 mtt180 -91.42 108.06 19.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.178 0.513 . . . . 2.8999999999999999 112.247 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 32' ' ' ASP . 63.5 tttm -25.1 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.724 -1.126 . . . . 2.71 113.818 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.603 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 6.0 m-20 -7.31 80.27 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.875 1.27 . . . . 1.98 113.886 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 17.3 Cg_endo . . . . . 0 CA--C 1.537 0.632 0 C-N-CA 122.623 2.215 . . . . 1.53 113.826 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.467 HG21 ' HB2' ' A' ' 126' ' ' ALA . 2.8 mt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 0.82999999999999996 108.316 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.1 -22.79 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.17 1.174 . . . . 1.6899999999999999 114.17 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -103.77 36.57 2.28 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.226 -0.59 . . . . 2.5600000000000001 111.827 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.5 t -142.49 146.43 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.017 0.437 . . . . 0.96999999999999997 111.607 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.6 t30 -62.54 145.27 95.13 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 115.786 -0.643 . . . . 1.96 109.436 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.584 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 15.7 Cg_exo -39.95 -54.98 1.88 Allowed 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.687 2.258 . . . . 0.66000000000000003 114.984 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.9 mm-40 -64.95 -53.9 39.06 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.264 1.03 . . . . 1.8200000000000001 110.64 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -2.57 23.53 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.143 -0.935 . . . . 1.9099999999999999 110.549 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 32.9 tt0 -75.69 -56.75 4.38 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.509 -0.923 . . . . 1.5 108.509 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.835 ' O ' HG23 ' A' ' 63' ' ' THR . 7.2 p -52.84 -44.62 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.528 -0.916 . . . . 1.22 108.528 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.48 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 10.0 tp -58.4 -67.18 0.38 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 119.738 -0.785 . . . . 1.05 109.989 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.71 -8.55 0.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.611 -0.722 . . . . 0.90000000000000002 111.757 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.442 ' HG2' ' N ' ' A' ' 63' ' ' THR . 24.6 tt0 -115.74 -116.81 0.32 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 111.934 0.346 . . . . 1.8 111.934 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 59' ' ' VAL . 71.6 p 51.24 -173.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.125 0.17 . . . . 1.05 110.925 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 63' ' ' THR . 0.8 OUTLIER 175.22 154.11 0.15 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.512 0.196 . . . . 2.0499999999999998 110.567 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.603 ' NH2' ' HB3' ' A' ' 32' ' ' ASP . 3.1 ptm180 -143.36 176.81 8.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.808 0.337 . . . . 3.5800000000000001 111.162 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.93 155.01 2.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.009 -0.541 . . . . 4.25 111.927 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -133.16 158.1 43.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.703 -0.68 . . . . 4.3499999999999996 110.827 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.43 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 10.7 tp10 -133.48 -93.86 0.33 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.353 -0.385 . . . . 3.1699999999999999 110.971 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 2.9 p30 -172.76 125.37 0.47 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.603 0.239 . . . . 2.3900000000000001 110.796 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 t 49.8 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.98999999999999999 111.076 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -161.01 161.38 31.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.492 -0.483 . . . . 1.26 111.936 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.27 -160.52 20.0 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.527 -0.844 . . . . 0.66000000000000003 114.251 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.674 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -122.2 163.07 20.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.813 0.816 . . . . 0.82999999999999996 112.93 -177.528 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.531 ' CG ' ' HG3' ' A' ' 152' ' ' LYS . 3.5 t70 -113.54 105.5 13.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.91 -1.495 . . . . 2.27 110.331 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.562 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -96.1 106.5 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.58 -0.282 . . . . 0.34000000000000002 110.535 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.75 121.81 3.78 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 121.216 1.277 . . . . 0.80000000000000004 113.121 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.532 HG22 ' H ' ' A' ' 79' ' ' GLU . 3.7 mt -135.98 151.76 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.458 0.647 . . . . 0.38 111.327 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -144.79 37.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.5 -1.296 . . . . 2.96 107.5 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 77' ' ' ILE . 15.0 mm-40 -134.63 142.43 46.88 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.78 -1.1 . . . . 2.1299999999999999 110.374 -177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.27 149.64 29.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.464 0.65 . . . . 0.37 111.625 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.41 -154.58 25.61 Favored Glycine 0 CA--C 1.512 -0.129 0 N-CA-C 110.058 -1.217 . . . . 0.20999999999999999 110.058 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 20.2 mt-10 -102.39 109.66 21.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 118.979 1.39 . . . . 2.0299999999999998 109.667 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.456 ' OH ' ' HB2' ' A' ' 79' ' ' GLU . 44.4 m-85 -95.99 126.59 41.34 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.211 -1.033 . . . . 0.26000000000000001 108.211 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.65 HG21 ' N ' ' A' ' 177' ' ' ALA . 41.9 t -112.14 113.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.612 0.72 . . . . 0.54000000000000004 111.728 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 tt -98.57 104.35 16.38 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.481 -1.236 . . . . 1.23 110.194 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.95 137.27 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.253 -1.017 . . . . 1.3100000000000001 108.253 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -149.25 139.26 22.07 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.45 -0.9 . . . . 1.3700000000000001 112.77 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 14.5 tptt -94.26 123.36 37.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.57 -1.195 . . . . 2.9700000000000002 109.708 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.5 143.03 35.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 0.29999999999999999 110.072 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.425 ' HB3' HG11 ' A' ' 167' ' ' VAL . . . . . . . . 0 C--O 1.235 0.312 0 CA-C-N 116.444 -0.344 . . . . 0.40999999999999998 110.364 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.843 0.354 . . . . 2.96 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 p -109.15 156.77 19.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.152 -0.476 . . . . 1.55 111.506 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 48.47 34.9 5.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.871 -0.604 . . . . 2.3300000000000001 111.574 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.3 -46.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 2.5099999999999998 109.577 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.559 ' NZ ' ' HB3' ' A' ' 100' ' ' LYS . 1.2 mmmp? -101.23 85.89 2.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.787 . . . . 3.1000000000000001 109.508 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.31 144.16 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.084 -0.507 . . . . 1.3100000000000001 110.306 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -126.63 -175.04 3.28 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 116.278 -0.419 . . . . 0.68999999999999995 112.08 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.42 144.75 40.32 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 2.0099999999999998 110.861 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -134.19 138.14 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.939 -0.573 . . . . 0.46000000000000002 112.542 -177.32 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.423 HH21 HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -142.85 148.99 37.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.611 0.967 . . . . 1.8500000000000001 113.611 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 22.2 m -113.01 121.66 65.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 CA-C-N 114.629 -1.169 . . . . 1.1000000000000001 109.827 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.611 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 9.5 t30 51.58 26.95 3.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.245 -0.889 . . . . 1.77 110.124 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.15 21.97 21.28 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.545 -1.207 . . . . 0.40999999999999998 113.137 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 80.8 m-70 -122.86 109.38 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.175 0.806 . . . . 0.46000000000000002 113.175 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 21.8 p -60.34 120.52 10.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.054 0.454 . . . . 0.66000000000000003 111.341 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 109' ' ' HIS . 11.5 t -113.73 -29.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.647 -0.706 . . . . 0.80000000000000004 109.94 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.455 HG11 ' OE1' ' A' ' 129' ' ' GLU . 2.2 t -137.29 91.98 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 116.109 -0.496 . . . . 0.51000000000000001 110.186 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 6.7 ptpp? -99.66 134.24 42.83 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.77 0.795 . . . . 2.4399999999999999 110.461 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 13.9 m-20 90.42 32.3 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.109 -1.859 . . . . 2.5600000000000001 109.52 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.554 HD21 ' OE2' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -54.7 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.922 -0.581 . . . . 1.1000000000000001 111.43 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -98.67 81.96 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 1.99 107.992 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.0 mt -50.94 -48.62 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.97 -1.013 . . . . 0.63 112.5 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.14 -54.01 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.31 . . . . 0.90000000000000002 111.327 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.35 -27.31 55.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.601 -0.272 . . . . 0.76000000000000001 111.705 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -72.46 -59.23 2.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.601 0.593 . . . . 2.6800000000000002 112.601 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 -41.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.541 0.571 . . . . 1.4099999999999999 112.541 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.34 -141.26 16.69 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.535 -0.84 . . . . 1.0600000000000001 113.174 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 125' ' ' THR . 58.7 m-70 -53.48 110.31 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.677 0.275 . . . . 3.5099999999999998 111.01 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.2 m 44.8 -97.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 1.6799999999999999 111.126 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 p 48.8 -178.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.039 0.447 . . . . 0.80000000000000004 111.466 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.02 130.41 53.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.406 -0.361 . . . . 0.44 111.957 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -110.49 142.48 42.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.792 -0.818 . . . . 0.38 108.792 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -135.31 131.51 36.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.055 0.761 . . . . 2.0899999999999999 113.055 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.554 ' OE2' HD21 ' A' ' 115' ' ' LEU . 22.8 mt-10 -132.15 121.13 23.25 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.315 -0.857 . . . . 2.2799999999999998 109.884 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.73 136.41 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.036 -0.529 . . . . 0.70999999999999996 111.066 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -135.85 86.58 26.86 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.888 0.699 . . . . 1.3799999999999999 112.888 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -64.03 138.57 62.96 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.706 1.604 . . . . 0.22 111.527 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -128.62 153.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.627 -0.261 . . . . 0.20999999999999999 110.572 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 67.1 p -132.52 108.39 9.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.379 . . . . 1.1100000000000001 111.707 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.0 mt -105.31 126.63 60.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.944 -0.571 . . . . 0.23000000000000001 110.032 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -148.09 144.52 27.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.394 -0.367 . . . . 1.9099999999999999 110.578 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.49 20.72 7.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 3.1099999999999999 110.218 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.8 28.45 50.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.862 -0.685 . . . . 0.32000000000000001 112.564 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 22.7 ttpt -131.17 142.41 50.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 2.1899999999999999 111.083 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 141' ' ' SER . 5.6 tt -96.06 133.43 40.32 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.847 -0.615 . . . . 0.37 112.39 -177.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.604 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -118.1 117.19 28.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.858 . . . . 0.90000000000000002 109.419 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.3 98.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.967 -0.56 . . . . 0.53000000000000003 111.478 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.3 -97.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.859 -0.61 . . . . 2.0499999999999998 112.224 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -115.92 21.51 12.27 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.538 -0.839 . . . . 0.59999999999999998 113.485 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -137.76 145.95 43.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.934 -0.395 . . . . 2.02 109.934 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.31 148.65 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.838 0.352 . . . . 1.3 111.663 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.6 m -162.25 135.87 6.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.002 -0.544 . . . . 1.1200000000000001 110.609 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 50.2 p -54.03 136.4 41.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.087 -0.506 . . . . 1.1100000000000001 111.53 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.17 123.47 27.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 0.28000000000000003 109.708 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 152' ' ' LYS . 2.1 t -110.08 90.21 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.922 -0.711 . . . . 1.55 111.98 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 44.36 -5.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 117.201 1.64 . . . . 0.46000000000000002 117.201 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.592 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -162.11 152.28 16.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.776 1.788 . . . . 1.8 113.756 -178.049 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.456 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -98.38 124.51 43.09 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.453 -1.314 . . . . 1.24 107.453 176.233 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -107.96 102.5 11.67 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.918 0.71 . . . . 1.28 112.918 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 56.2 t -100.36 117.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.418 -0.513 . . . . 0.58999999999999997 110.605 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.78 42.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.348 -0.541 . . . . 2.48 111.521 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.06 148.99 51.06 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.273 -0.876 . . . . 1.54 110.543 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.423 HG21 HH21 ' A' ' 105' ' ' ARG . 80.6 t -118.91 142.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.056 -0.975 . . . . 0.77000000000000002 110.585 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -81.48 146.55 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.726 -0.67 . . . . 1.97 111.483 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.24 -18.9 15.6 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.695 -0.684 . . . . 1.1200000000000001 111.509 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -147.19 -75.62 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.585 0.231 . . . . 3.8100000000000001 110.754 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -152.2 153.58 34.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.829 0.347 . . . . 3.8199999999999998 111.514 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 56.15 86.77 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.956 -0.566 . . . . 1.3999999999999999 111.958 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.7 169.96 0.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.118 -0.468 . . . . 2.0 109.913 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -40.35 104.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.573 1.516 . . . . 2.5800000000000001 111.515 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -55.23 -56.75 16.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.052 -0.977 . . . . 3.71 112.645 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 63' ' ' THR . 21.3 t -106.38 133.89 49.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 112.534 0.568 . . . . 0.92000000000000004 112.534 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 3.7 t -135.56 131.79 36.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.847 0.684 . . . . 1.2 112.847 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.519 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -119.23 38.69 3.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.793 -1.094 . . . . 0.22 112.514 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 8.4 tp -48.43 127.29 12.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.374 0.669 . . . . 1.02 111.786 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.3 OUTLIER -143.48 111.14 5.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.381 -0.827 . . . . 0.33000000000000002 110.528 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -111.5 123.95 67.81 Favored 'Isoleucine or valine' 0 C--O 1.258 1.552 0 CA-C-O 122.758 1.266 . . . . 0.68999999999999995 112.175 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.72 166.87 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.75 -1.568 . . . . 1.26 109.807 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.46 ' NZ ' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -117.56 137.37 52.63 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.295 1.591 . . . . 1.8200000000000001 115.295 -176.258 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 99.19 -35.4 4.71 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 118.791 2.276 . . . . 0.22 118.791 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.51 160.58 0.61 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.237 2.019 . . . . 0.28999999999999998 113.969 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.65 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.68 -23.51 27.4 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.11 -0.95 . . . . 0.56999999999999995 110.544 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 2.3100000000000001 111.645 -179.034 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.501 -0.24 . . . . 9.1500000000000004 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.26 109.68 0.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.351 . . . . 7.3600000000000003 110.986 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.1 ttt -120.38 -52.55 2.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 7.7599999999999998 110.797 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.0 m -58.6 161.2 4.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 4.0199999999999996 110.947 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.44 33.43 3.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 1.28 112.666 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.402 ' HA ' ' OD2' ' A' ' 179' ' ' ASP . 15.5 tp -81.13 -46.51 14.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.359 0.6 . . . . 0.40999999999999998 110.188 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.584 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.24 -20.25 17.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.241 -0.891 . . . . 0.33000000000000002 110.972 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -74.07 -17.08 61.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 2.0899999999999999 111.914 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 33.9 mttm -111.58 -21.49 11.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.488 -0.485 . . . . 1.99 111.835 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 7' ' ' ALA . 11.1 p -43.83 147.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.889 -0.324 . . . . 0.20999999999999999 111.46 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.4 pt -139.92 -22.96 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 119.782 -0.767 . . . . 0.85999999999999999 111.623 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.609 ' O ' HG22 ' A' ' 172' ' ' ILE . 26.2 t90 -173.0 134.24 0.56 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 0.28000000000000003 110.24 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -152.29 144.36 23.82 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.443 -0.161 . . . . 0.20000000000000001 111.211 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.97 126.73 4.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 N-CA-C 114.116 1.154 . . . . 0.67000000000000004 114.116 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 5.8 t30 -115.13 98.82 7.0 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.274 -0.571 . . . . 1.27 110.566 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.88 109.3 3.35 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 109.3 -0.629 . . . . 0.37 109.3 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.6 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 150.0 -44.55 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 114.806 -1.088 . . . . 0.67000000000000004 112.452 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.37 -140.16 11.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 1.1200000000000001 112.134 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -162.7 119.36 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.552 0.215 . . . . 2.02 110.801 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 62.6 p 33.19 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.607 -0.724 . . . . 1.22 112.235 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 10.9 t-80 -128.31 150.8 49.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.22 -0.592 . . . . 0.34000000000000002 112.072 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.9 p -120.61 109.94 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.374 0.607 . . . . 1.1799999999999999 111.89 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.26 155.58 39.42 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.435 -0.802 . . . . 1.1699999999999999 109.933 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 25' ' ' HIS . 15.9 m -43.89 -52.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.545 0.942 . . . . 0.59999999999999998 113.545 -177.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.446 ' N ' HG23 ' A' ' 24' ' ' VAL . 78.2 m-70 -56.89 -20.3 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.226 0.536 . . . . 0.46000000000000002 110.579 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.85 34.83 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.357 -0.838 . . . . 0.28999999999999998 112.287 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.2 mm -103.52 109.45 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.978 0.418 . . . . 0.42999999999999999 110.191 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 23.4 t60 -96.87 135.55 38.69 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 115.128 1.529 . . . . 0.52000000000000002 115.128 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.18 135.0 44.53 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 114.21 -1.359 . . . . 3.0 107.854 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.4 ptm180 -95.51 112.42 24.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 2.8999999999999999 111.984 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.521 ' NZ ' ' HB3' ' A' ' 31' ' ' LYS . 2.8 ttpm? -16.3 140.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.603 1.335 . . . . 2.71 114.603 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.582 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 4.2 p-10 -18.71 90.02 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 CA-C-N 114.613 -1.176 . . . . 1.98 112.679 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -98.58 -2.57 1.02 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.598 2.198 . . . . 1.53 113.798 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 72' ' ' GLY . 0.5 OUTLIER -125.23 -24.57 3.95 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.52 -0.472 . . . . 1.8300000000000001 112.025 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' N ' HD23 ' A' ' 34' ' ' LEU . 9.0 tt0 -79.72 69.77 6.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.803 -0.443 . . . . 4.9500000000000002 109.803 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' HG12 ' A' ' 38' ' ' VAL . . . 75.78 -1.25 59.13 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.241 -1.144 . . . . 1.9399999999999999 110.241 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER 43.46 24.89 0.06 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.247 0.619 . . . . 5.3600000000000003 111.233 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 36' ' ' GLY . 11.9 p -149.8 135.07 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.788 -0.642 . . . . 2.9700000000000002 110.503 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.46 -161.13 23.23 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.414 -0.898 . . . . 1.99 113.097 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -148.29 153.07 38.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.748 0.309 . . . . 6.5899999999999999 110.774 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -49.33 119.24 3.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.036 -0.529 . . . . 2.0099999999999998 111.38 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 t -69.84 -21.78 63.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 2.02 110.06 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 37.27 54.32 1.31 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.843 -0.617 . . . . 2.23 111.296 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -90.4 -28.14 18.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 2.3300000000000001 110.928 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.3 27.83 8.27 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.567 -0.825 . . . . 2.2000000000000002 112.896 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.5 ttt -56.42 -27.76 57.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.217 0.532 . . . . 1.9299999999999999 109.934 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 48' ' ' LEU . 87.3 tttt -61.35 167.04 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.382 -0.826 . . . . 3.3500000000000001 110.337 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.47 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER 69.2 64.54 0.54 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 2.7599999999999998 110.346 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 84.8 Cg_exo -54.64 125.2 18.23 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.79 2.327 . . . . 1.46 113.008 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.584 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.8 mt -57.04 136.53 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.699 -0.852 . . . . 0.82999999999999996 108.699 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.21 -49.95 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.52 0.933 . . . . 1.6899999999999999 113.52 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.82 36.42 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.564 0.579 . . . . 2.5600000000000001 112.564 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -150.54 134.75 17.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.992 0.425 . . . . 0.96999999999999997 111.666 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.533 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -63.62 148.41 94.19 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.076 -0.713 . . . . 1.96 109.076 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.533 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 5.1 Cg_exo -37.9 -42.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.047 2.498 . . . . 0.66000000000000003 116.112 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' O ' HG12 ' A' ' 59' ' ' VAL . 9.9 mm-40 -75.82 -55.84 5.24 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.846 0.832 . . . . 1.8200000000000001 110.811 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.4 p-10 -71.42 -0.45 10.33 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.229 -0.656 . . . . 1.9099999999999999 109.229 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 33.1 tt0 -77.4 -61.02 2.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.02 -0.991 . . . . 1.5 108.972 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 56' ' ' GLU . 6.1 p -49.59 -39.13 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.1 -0.704 . . . . 1.22 109.1 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 62' ' ' GLN . 9.4 tp -66.65 -66.64 0.53 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.412 -0.515 . . . . 1.05 110.295 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -53.81 -7.03 0.1 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.154 -0.475 . . . . 0.90000000000000002 111.101 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' A' ' 60' ' ' LEU . 19.1 tt0 -115.45 -130.65 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.93 -0.577 . . . . 1.8 110.667 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 59' ' ' VAL . 41.4 p 49.59 158.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.339 0.399 . . . . 1.05 111.378 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.6 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -141.71 143.68 33.67 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.953 1.094 . . . . 2.0499999999999998 113.953 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.582 ' NE ' ' HB3' ' A' ' 32' ' ' ASP . 1.6 mtt85 -136.48 135.67 38.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.933 -1.031 . . . . 3.5800000000000001 109.654 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -116.51 131.7 56.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 4.25 111.42 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.96 -75.35 0.63 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.013 -0.539 . . . . 4.3499999999999996 110.573 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 179.5 -58.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.33 0.493 . . . . 3.1699999999999999 112.33 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -175.98 145.08 0.63 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.575 -0.528 . . . . 2.3900000000000001 109.575 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.507 ' H ' HD21 ' A' ' 164' ' ' ASN . 20.9 t 46.31 76.09 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.604 -0.517 . . . . 0.98999999999999999 109.604 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.444 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -82.99 146.21 28.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.575 -1.268 . . . . 1.26 107.575 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -138.11 129.46 4.6 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 118.415 -1.85 . . . . 0.66000000000000003 115.204 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -108.73 146.59 33.28 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.948 -0.626 . . . . 0.82999999999999996 110.813 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.27 129.7 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 2.27 111.319 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.494 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.0 mp -124.46 87.42 54.23 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.356 -0.384 . . . . 0.34000000000000002 110.875 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.39 127.71 27.07 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.867 1.711 . . . . 0.80000000000000004 111.868 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.43 151.76 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.947 0.404 . . . . 0.38 111.4 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -143.61 4.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 2.96 111.216 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -128.42 170.33 13.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.1299999999999999 110.796 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.33 172.28 9.23 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.255 0.55 . . . . 0.37 111.815 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.95 -155.25 22.26 Favored Glycine 0 N--CA 1.454 -0.152 0 N-CA-C 109.848 -1.301 . . . . 0.20999999999999999 109.848 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -98.2 108.61 21.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.009 1.404 . . . . 2.0299999999999998 108.869 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.0 125.99 40.05 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.911 -0.774 . . . . 0.26000000000000001 108.911 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.634 HG21 ' N ' ' A' ' 177' ' ' ALA . 14.2 t -113.27 116.29 52.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.828 -1.078 . . . . 0.54000000000000004 111.535 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 tt -96.5 105.15 17.2 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.69 -1.141 . . . . 1.23 110.583 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 20.3 t -110.79 132.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.917 -1.038 . . . . 1.3100000000000001 108.52 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -142.13 146.22 35.1 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.236 -0.986 . . . . 1.3700000000000001 111.88 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 128' ' ' ASP . 3.3 tptp -105.58 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 2.9700000000000002 110.356 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 10.0 m-85 -104.81 143.41 33.16 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.879 -1.156 . . . . 0.29999999999999999 107.879 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -155.09 157.32 37.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 119.543 -0.863 . . . . 0.40999999999999998 112.946 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 57.72 159.34 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.433 -0.803 . . . . 3.9700000000000002 111.834 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.412 ' H ' ' H ' ' A' ' 93' ' ' TYR . 5.0 p -172.25 -4.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 3.8100000000000001 111.465 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.412 ' H ' ' H ' ' A' ' 92' ' ' VAL . 0.6 OUTLIER 67.04 140.04 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.238 -0.437 . . . . 2.8900000000000001 110.753 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 70.42 127.49 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.999 -0.546 . . . . 2.0 111.015 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.43 81.22 6.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -133.29 152.07 51.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 2.96 110.596 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.4 p -116.37 153.16 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.297 0.57 . . . . 1.55 112.169 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 49.11 25.17 1.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.065 -0.971 . . . . 2.3300000000000001 112.497 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -119.09 -50.12 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.941 -0.392 . . . . 2.5099999999999998 109.941 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 14.0 mptt -85.76 77.96 9.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.286 -0.635 . . . . 3.1000000000000001 109.286 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.45 142.59 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 1.3100000000000001 110.112 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -130.81 -179.38 5.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.127 0.788 . . . . 0.68999999999999995 113.127 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -121.97 137.45 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.224 -0.443 . . . . 2.0099999999999998 111.564 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 t -129.73 127.26 64.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 115.869 -0.605 . . . . 0.46000000000000002 111.384 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 8.1 mtt180 -125.85 148.56 49.12 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.542 -0.753 . . . . 1.8500000000000001 112.502 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.21 117.23 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 114.632 -1.167 . . . . 1.1000000000000001 109.695 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.42 ' OD1' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER 54.51 26.48 7.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.634 -0.876 . . . . 1.77 108.634 -177.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.98 22.63 29.83 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.656 -1.157 . . . . 0.40999999999999998 112.906 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 88.4 m-70 -121.55 111.49 17.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.558 0.947 . . . . 0.46000000000000002 113.558 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 p -64.71 117.33 7.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.681 -0.408 . . . . 0.66000000000000003 110.868 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 109' ' ' HIS . 3.8 t -112.98 -30.34 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.904 -0.589 . . . . 0.80000000000000004 109.819 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.7 90.18 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.417 -0.586 . . . . 0.51000000000000001 109.417 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 6.3 ptmm? -105.29 79.16 1.45 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.617 1.199 . . . . 2.4399999999999999 111.777 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.2 p30 156.49 35.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.032 -2.349 . . . . 2.5600000000000001 109.129 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.36 93.28 0.07 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.387 0.613 . . . . 1.1000000000000001 112.149 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 11.7 t70 -109.83 85.99 2.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.791 -1.559 . . . . 1.99 106.791 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.9 mt -50.03 -40.98 17.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.138 -0.937 . . . . 0.63 112.405 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.73 -65.47 0.69 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.99 -0.284 . . . . 0.90000000000000002 111.385 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -52.05 -27.18 12.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.12 0.415 . . . . 0.76000000000000001 112.12 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.64 -60.48 2.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.347 0.499 . . . . 2.6800000000000002 112.347 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 m -104.19 -40.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.405 0.52 . . . . 1.4099999999999999 112.405 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.7 -106.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.873 -0.891 . . . . 1.0600000000000001 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' SER . 37.9 m80 -64.31 170.19 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.651 -0.87 . . . . 3.5099999999999998 108.651 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' HIS . 75.0 m -35.26 -80.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.05 0.219 . . . . 1.6799999999999999 110.9 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.499 ' O ' HG12 ' A' ' 50' ' ' ILE . 30.0 p 44.02 -164.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.808 0.337 . . . . 0.80000000000000004 111.328 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.15 138.86 49.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.5 -0.318 . . . . 0.44 110.804 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.502 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.1 t60 -111.78 147.5 35.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.38 108.797 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.541 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 15.2 t70 -143.84 135.19 25.85 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.139 0.792 . . . . 2.0899999999999999 113.139 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -121.53 128.68 52.29 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.373 -0.83 . . . . 2.2799999999999998 109.127 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mt -111.0 120.41 61.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.668 -0.696 . . . . 0.70999999999999996 110.222 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.39 88.89 49.13 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.801 0.667 . . . . 1.3799999999999999 112.801 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.2 145.9 93.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.927 1.751 . . . . 0.22 111.854 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.6 mt -137.16 157.16 34.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.367 -0.379 . . . . 0.20999999999999999 110.604 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 34.6 p -133.31 110.21 9.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.126 0.489 . . . . 1.1100000000000001 111.244 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 139' ' ' LYS . 19.6 mt -110.66 126.02 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.583 -0.735 . . . . 0.23000000000000001 109.851 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -146.08 140.14 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 1.9099999999999999 110.767 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 1.2 mppt? 60.91 14.57 5.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 3.1099999999999999 111.116 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.69 12.35 58.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.658 -0.782 . . . . 0.32000000000000001 113.202 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.604 ' O ' HG23 ' A' ' 135' ' ' ILE . 60.0 mttp -112.81 162.0 16.28 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 117.131 0.466 . . . . 2.1899999999999999 111.028 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -117.97 139.46 51.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.556 0.576 . . . . 0.37 112.556 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.661 ' N ' HD23 ' A' ' 140' ' ' LEU . 28.6 t -128.93 109.61 11.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.765 . . . . 0.90000000000000002 109.678 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 142' ' ' VAL . 12.1 p -105.46 114.7 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.165 0.507 . . . . 0.53000000000000003 110.855 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 2.0499999999999998 112.115 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.49 22.03 3.38 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.619 -0.8 . . . . 0.59999999999999998 113.047 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -126.91 138.44 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.93 -0.396 . . . . 2.02 109.93 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.26 139.24 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.37 0.605 . . . . 1.3 111.732 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 23.1 t -163.71 126.74 2.6 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.165 -0.925 . . . . 1.1200000000000001 108.945 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.9 t -61.23 147.63 43.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.547 . . . . 1.1100000000000001 112.263 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -78.78 142.94 36.55 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.389 -0.823 . . . . 0.28000000000000003 109.773 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.9 p -139.25 95.81 3.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.112 0.782 . . . . 1.55 113.112 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.23 -59.75 2.75 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.729 1.051 . . . . 0.46000000000000002 115.729 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -153.34 169.12 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.914 0.857 . . . . 1.8 112.726 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.42 HD12 ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -89.79 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.965 -1.495 . . . . 1.24 106.965 176.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 5.0 t -125.52 113.43 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 118.657 -1.217 . . . . 1.28 113.177 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.5 OUTLIER -98.31 98.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.955 -0.566 . . . . 0.58999999999999997 109.644 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.1 mt-10 -110.69 126.55 54.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.664 -0.698 . . . . 2.48 111.448 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -117.17 127.09 53.77 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 119.643 -0.823 . . . . 1.54 110.264 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.522 HG21 HH21 ' A' ' 105' ' ' ARG . 10.8 t -97.2 143.99 11.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 114.185 -1.37 . . . . 0.77000000000000002 112.529 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -54.43 148.37 12.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 113.911 -1.495 . . . . 1.97 111.574 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.8 -53.09 0.17 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 111.843 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -148.64 61.04 1.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 3.8100000000000001 110.972 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 64.96 154.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.052 -0.522 . . . . 3.8199999999999998 111.876 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.37 77.83 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.651 -0.704 . . . . 1.3999999999999999 111.53 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.507 HD21 ' H ' ' A' ' 70' ' ' SER . 3.9 m-20 -50.82 155.52 1.96 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.815 -0.63 . . . . 2.0 109.974 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 164' ' ' ASN . 0.9 OUTLIER -29.86 103.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.467 2.111 . . . . 2.5800000000000001 112.346 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -53.0 -73.1 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.761 -1.108 . . . . 3.71 112.649 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 89.8 t -93.25 133.51 34.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.184 0.438 . . . . 0.92000000000000004 112.184 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.9 130.52 45.27 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 123.928 0.768 . . . . 1.2 110.803 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.513 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -123.24 36.47 4.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.415 0.894 . . . . 0.22 113.415 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.52 129.86 0.28 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.871 0.367 . . . . 1.02 111.834 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -149.27 104.73 3.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.208 -0.451 . . . . 0.33000000000000002 110.053 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -113.49 126.35 70.92 Favored 'Isoleucine or valine' 0 C--O 1.261 1.708 0 CA-C-O 122.768 1.27 . . . . 0.68999999999999995 112.799 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 ptm -119.99 165.26 14.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.814 -1.539 . . . . 1.26 109.732 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 9.6 ptmt -120.68 145.71 47.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.786 1.402 . . . . 1.8200000000000001 114.786 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.58 -36.05 4.56 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 112.38 -2.191 . . . . 0.22 117.767 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.457 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.21 158.73 0.48 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.301 2.05 . . . . 0.28999999999999998 114.277 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.634 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.43 -24.81 25.54 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 114.893 -1.048 . . . . 0.56999999999999995 110.564 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.86 -34.18 72.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.828 -0.624 . . . . 2.3100000000000001 111.551 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 6' ' ' LEU . 21.4 t70 -55.87 -43.75 77.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.454 -0.339 . . . . 2.3700000000000001 110.588 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 63.7 t -37.37 100.24 0.2 Allowed Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 116.052 -0.522 . . . . 2.5699999999999998 111.719 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -50.87 139.86 39.78 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.926 1.75 . . . . 2.0800000000000001 112.369 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.4 ttt -152.74 93.99 1.83 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 6.04 110.826 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.2 mt -87.35 109.15 19.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 5.2999999999999998 110.729 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -60.92 141.19 93.45 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.359 -0.382 . . . . 8.0500000000000007 110.133 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -44.49 138.01 7.9 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.681 1.587 . . . . 9.1400000000000006 112.401 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -133.57 125.65 18.66 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.385 -0.371 . . . . 9.8699999999999992 110.535 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -83.93 -158.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.152 1.901 . . . . 11.69 111.599 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 60.63 -161.55 22.29 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.437 -0.887 . . . . 12.619999999999999 112.703 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.4 mt -112.71 120.97 43.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.348 . . . . 14.44 110.83 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.241 -0.885 . . . . 15.699999999999999 110.771 179.931 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.502 -0.239 . . . . 9.1500000000000004 112.502 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.57 -20.17 2.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.797 0.332 . . . . 7.3600000000000003 110.92 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -99.22 -45.56 5.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 7.7599999999999998 110.86 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -106.72 141.83 37.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 4.0199999999999996 110.693 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -146.86 32.94 1.41 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 1.28 112.52 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 tp -68.56 -45.97 70.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.40999999999999998 110.3 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.547 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -60.24 -21.06 61.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.564 -0.744 . . . . 0.33000000000000002 111.178 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.93 -5.68 47.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 2.0899999999999999 111.579 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HE3' ' OD1' ' A' ' 179' ' ' ASP . 19.5 mttm -123.63 -22.07 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.505 -0.478 . . . . 1.99 111.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 7' ' ' ALA . 14.5 p -43.44 147.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 121.158 -0.217 . . . . 0.20999999999999999 111.18 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 pt -134.82 -23.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 119.518 -0.873 . . . . 0.85999999999999999 111.391 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.426 ' O ' HG22 ' A' ' 172' ' ' ILE . 40.7 t90 -173.26 136.26 0.61 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.272 -0.571 . . . . 0.28000000000000003 110.769 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.09 145.43 22.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.771 0.286 . . . . 0.20000000000000001 111.771 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.42 130.63 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 114.191 1.182 . . . . 0.67000000000000004 114.191 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 5.2 t-20 -115.77 88.55 2.91 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.414 -0.514 . . . . 1.27 111.174 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.03 103.97 0.27 Allowed 'General case' 0 C--O 1.248 0.988 0 N-CA-C 108.709 -0.849 . . . . 0.37 108.709 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.562 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 162.17 -47.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.707 0 O-C-N 124.505 1.128 . . . . 0.67000000000000004 113.227 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.54 -129.86 5.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 1.1200000000000001 112.573 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.669 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 14.8 tt0 -163.72 119.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.73 0.3 . . . . 2.02 110.947 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 8.4 t 38.73 96.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 1.22 112.72 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 57.2 t-80 -124.01 151.66 43.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 120.235 -0.586 . . . . 0.34000000000000002 112.293 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.8 t -121.05 104.14 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.159 -0.928 . . . . 1.1799999999999999 110.265 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.27 153.03 42.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 1.1699999999999999 110.688 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 25' ' ' HIS . 16.1 m -43.85 -50.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.167 0.917 . . . . 0.59999999999999998 113.065 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 24' ' ' VAL . 78.6 m-70 -56.42 -22.28 30.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.34 0.59 . . . . 0.46000000000000002 109.928 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.33 35.35 3.38 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.032 -0.986 . . . . 0.28999999999999998 111.852 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -103.12 122.29 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.602 -0.518 . . . . 0.42999999999999999 109.602 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.3 t60 -104.77 134.57 47.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.538 1.31 . . . . 0.52000000000000002 114.538 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -101.01 134.16 44.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.149 -0.932 . . . . 3.0 108.497 176.461 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -95.9 111.64 23.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.415 0.626 . . . . 2.8999999999999999 112.256 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' ASP . 51.6 tttm -15.47 139.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.176 1.547 . . . . 2.71 115.176 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.495 ' OD1' ' HD2' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -15.54 89.22 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 114.138 -1.392 . . . . 1.98 112.471 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -98.47 -4.57 0.9 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.477 2.118 . . . . 1.53 115.845 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -142.91 -12.14 0.76 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 119.423 -0.911 . . . . 1.8300000000000001 112.542 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.548 ' HB2' HH11 ' A' ' 65' ' ' ARG . 39.2 mp0 -79.06 67.01 4.65 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.069 -0.715 . . . . 4.9500000000000002 109.069 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -10.24 21.16 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.743 -0.943 . . . . 1.9399999999999999 110.743 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 49.0 36.17 8.03 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.132 0.492 . . . . 5.3600000000000003 110.997 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.34 121.41 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 115.468 -0.787 . . . . 2.9700000000000002 110.549 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.17 -154.59 25.08 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.604 -0.808 . . . . 1.99 112.927 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -144.55 -67.13 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 6.5899999999999999 111.14 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.79 86.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 2.0099999999999998 110.232 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 61.8 m -72.45 73.32 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 2.02 110.589 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.56 36.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.763 -0.653 . . . . 2.23 110.281 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -58.42 108.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.908 -0.587 . . . . 2.3300000000000001 111.299 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.42 52.86 46.18 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.92 -0.657 . . . . 2.2000000000000002 113.192 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.441 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -79.34 2.16 22.54 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.992 -0.373 . . . . 1.9299999999999999 109.992 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -38.25 157.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.686 -0.688 . . . . 3.3500000000000001 111.173 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.449 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 1.9 mt 66.66 62.28 0.89 Allowed Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.968 -0.56 . . . . 2.7599999999999998 110.449 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HA ' ' CD ' ' A' ' 62' ' ' GLN . 45.4 Cg_exo -62.19 157.63 43.84 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.551 2.167 . . . . 1.46 112.676 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp -58.41 141.6 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.242 -0.435 . . . . 0.82999999999999996 110.174 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 124' ' ' SER . 4.3 mm? -86.03 -44.08 12.6 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.717 1.006 . . . . 1.6899999999999999 113.717 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -82.66 32.66 0.42 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.677 0.621 . . . . 2.5600000000000001 112.677 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -146.36 141.89 27.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.334 0.494 . . . . 0.96999999999999997 112.334 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' A' ' 57' ' ' ASP . 5.8 p-10 -66.21 150.07 97.24 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.728 -0.669 . . . . 1.96 109.5 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 9.4 Cg_exo -39.84 -48.84 3.62 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.716 2.277 . . . . 0.66000000000000003 115.599 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -57.42 6.19 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.641 0.734 . . . . 1.8200000000000001 112.236 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -70.07 -13.72 62.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.515 -0.55 . . . . 1.9099999999999999 109.515 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.563 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 23.5 tt0 -62.94 -52.28 63.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.994 -1.113 . . . . 1.5 107.994 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -51.61 -51.62 25.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.125 -0.943 . . . . 1.22 109.187 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 4.2 tp -64.08 -15.87 60.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.809 . . . . 1.05 111.353 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.409 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 6.6 m-30 -117.13 19.96 13.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.258 -0.883 . . . . 0.90000000000000002 111.268 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.451 ' CD ' ' HA ' ' A' ' 49' ' ' PRO . 42.3 tt0 -142.96 -76.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.775 1.028 . . . . 1.8 113.775 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.472 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 1.2 p -28.75 144.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.502 0.927 . . . . 1.05 113.502 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.558 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -135.88 150.57 49.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.318 -0.856 . . . . 2.0499999999999998 110.491 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.562 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 30.9 mtp180 -107.09 -177.3 3.32 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.162 -0.31 . . . . 3.5800000000000001 110.162 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -54.52 166.26 0.47 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 4.25 110.848 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -133.14 137.54 46.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 4.3499999999999996 111.008 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.446 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 40.1 tt0 -123.44 -91.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 3.1699999999999999 110.442 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD2' ' HG2' ' A' ' 68' ' ' GLU . 3.3 p30 -174.04 125.5 0.35 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.611 0.243 . . . . 2.3900000000000001 111.116 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t 50.06 100.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.117 -0.492 . . . . 0.98999999999999999 111.629 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 1.6 p90 -151.53 148.95 28.64 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.191 0.519 . . . . 1.26 111.346 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.67 -171.06 17.81 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.479 -0.867 . . . . 0.66000000000000003 114.651 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -126.91 153.64 45.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.907 -0.647 . . . . 0.82999999999999996 111.624 -178.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 122.94 47.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.039 -0.982 . . . . 2.27 110.151 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.5 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.2 mp -114.45 87.25 13.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.153 0.427 . . . . 0.34000000000000002 112.153 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -56.68 134.44 64.43 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.802 1.668 . . . . 0.80000000000000004 112.359 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 78' ' ' LYS . 26.8 mt -124.82 155.56 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.994 0.426 . . . . 0.38 111.115 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 77' ' ' ILE . 95.2 mttt -146.8 3.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.866 -0.606 . . . . 2.96 110.839 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -130.9 173.08 11.32 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 120.707 0.289 . . . . 2.1299999999999999 111.078 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -129.35 168.7 15.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.237 0.541 . . . . 0.37 111.143 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.01 -151.32 22.06 Favored Glycine 0 CA--C 1.512 -0.113 0 N-CA-C 109.759 -1.337 . . . . 0.20999999999999999 109.759 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -99.95 109.36 21.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.103 1.451 . . . . 2.0299999999999998 108.863 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -95.75 126.21 40.86 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.507 0.67 . . . . 0.26000000000000001 109.395 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.656 HG21 ' N ' ' A' ' 177' ' ' ALA . 26.3 t -111.35 117.56 55.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.726 -1.125 . . . . 0.54000000000000004 111.741 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 tt -88.83 104.42 16.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.526 -1.216 . . . . 1.23 110.179 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 21.4 t -109.69 133.57 54.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.271 -0.877 . . . . 1.3100000000000001 109.115 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 87' ' ' LEU . 1.2 pt? -156.24 135.26 11.98 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.357 -0.937 . . . . 1.3700000000000001 111.88 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 17.3 tptt -95.64 120.61 36.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.875 . . . . 2.9700000000000002 110.187 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.41 142.44 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.906 -0.775 . . . . 0.29999999999999999 108.906 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.683 ' O ' HG13 ' A' ' 167' ' ' VAL . . . -149.18 168.58 22.86 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 120.57 -0.452 . . . . 0.40999999999999998 110.459 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.85 123.37 2.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 3.9700000000000002 110.553 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.6 p -127.91 70.05 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.631 0.729 . . . . 3.8100000000000001 110.873 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -146.95 -67.98 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.649 -0.705 . . . . 2.8900000000000001 111.004 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -100.23 -179.13 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 2.0 110.68 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.45 82.5 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.203 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -165.47 140.87 5.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 2.96 111.274 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.1 t -91.59 163.34 14.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.801 -0.636 . . . . 1.55 111.026 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 51.62 28.3 4.61 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.051 -0.522 . . . . 2.3300000000000001 111.12 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -134.11 -42.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 2.5099999999999998 109.853 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -108.76 82.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 3.1000000000000001 109.485 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -109.5 150.22 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.704 -0.68 . . . . 1.3100000000000001 110.202 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 114' ' ' ASP . 67.2 m-85 -133.38 -177.13 4.39 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 112.561 0.578 . . . . 0.68999999999999995 112.561 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -132.58 137.75 47.19 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.829 -0.348 . . . . 2.0099999999999998 111.005 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.8 t -131.37 129.76 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 112.758 0.651 . . . . 0.46000000000000002 112.758 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.522 HH21 HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -139.14 149.42 44.46 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.95 0.722 . . . . 1.8500000000000001 112.95 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.9 p -116.15 121.05 66.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 115.211 -0.904 . . . . 1.1000000000000001 110.566 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.682 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 2.3 t30 52.8 26.89 4.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.239 -0.891 . . . . 1.77 110.419 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.95 16.2 39.52 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 114.451 -1.249 . . . . 0.40999999999999998 113.128 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.2 m-70 -115.22 111.53 21.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.215 0.82 . . . . 0.46000000000000002 113.215 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -67.1 123.08 19.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.054 0.454 . . . . 0.66000000000000003 111.118 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -39.81 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.572 -0.74 . . . . 0.80000000000000004 109.901 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.86 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.312 0.577 . . . . 0.51000000000000001 109.933 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -98.94 154.71 17.85 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 2.4399999999999999 110.025 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 102' ' ' PHE . 12.7 m-20 66.91 32.06 6.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.135 -1.393 . . . . 2.5600000000000001 109.256 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 98.31 0.02 OUTLIER 'General case' 0 C--N 1.342 0.268 0 CA-C-O 120.96 0.41 . . . . 1.1000000000000001 111.166 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 45.1 p-10 -100.72 79.28 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.298 -1.001 . . . . 1.99 108.298 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.91 -48.94 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.298 -0.865 . . . . 0.63 112.533 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.45 -39.99 77.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.711 0.263 . . . . 0.90000000000000002 111.711 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.97 -27.7 62.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.97 0.359 . . . . 0.76000000000000001 111.97 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 34.5 mmt180 -70.0 -59.09 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.082 0.401 . . . . 2.6800000000000002 112.082 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.8 m -95.77 -40.47 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.228 0.455 . . . . 1.4099999999999999 112.228 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.57 -104.0 2.43 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.63 -0.795 . . . . 1.0600000000000001 112.22 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -63.95 164.78 9.82 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.347 -0.242 . . . . 3.5099999999999998 110.347 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.456 ' O ' HD23 ' A' ' 51' ' ' LEU . 80.5 p -58.11 98.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.887 0.375 . . . . 1.6799999999999999 110.738 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -144.69 -157.79 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.80000000000000004 109.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.72 133.82 50.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.41 0.522 . . . . 0.44 112.41 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -109.0 147.73 31.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.922 -0.77 . . . . 0.38 108.922 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -140.39 124.86 17.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.546 0.573 . . . . 2.0899999999999999 112.546 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -116.81 135.75 53.5 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.467 -0.788 . . . . 2.2799999999999998 109.783 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 131' ' ' ILE . 38.5 mt -128.8 133.58 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.85 -0.614 . . . . 0.70999999999999996 111.408 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.0 mp -135.17 92.36 18.18 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.457 -0.338 . . . . 1.3799999999999999 111.883 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.03 140.1 76.93 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.388 1.392 . . . . 0.22 111.193 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 134' ' ' SER . 14.8 mt -132.56 158.9 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.462 -0.336 . . . . 0.20999999999999999 110.992 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 133' ' ' ILE . 48.4 t -134.23 110.95 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.19 0.519 . . . . 1.1100000000000001 111.119 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 139' ' ' LYS . 17.0 mt -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 115.406 -0.815 . . . . 0.23000000000000001 110.009 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -150.37 142.38 23.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.69 0.281 . . . . 1.9099999999999999 110.867 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm 61.19 19.0 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 3.1099999999999999 110.75 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.12 71.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 0.32000000000000001 113.206 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.605 ' O ' HG23 ' A' ' 135' ' ' ILE . 52.5 mtpt -111.16 164.77 12.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.891 0.345 . . . . 2.1899999999999999 110.523 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.496 ' CD1' HD11 ' A' ' 153' ' ' LEU . 5.5 tt -124.16 143.47 50.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.689 0.625 . . . . 0.37 112.689 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.8 t -130.69 114.09 14.96 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.343 -0.844 . . . . 0.90000000000000002 109.723 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 142' ' ' VAL . 2.4 p -108.93 96.87 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 115.99 -0.55 . . . . 0.53000000000000003 110.738 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 61.74 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 2.0499999999999998 111.752 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.36 6.65 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.464 -0.874 . . . . 0.59999999999999998 113.4 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.97 129.45 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.762 -0.458 . . . . 2.02 109.762 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.2 p -105.27 141.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.31 0.576 . . . . 1.3 111.551 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.1 m -156.88 170.4 22.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.293 -0.867 . . . . 1.1200000000000001 109.301 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.2 p -99.57 139.02 35.84 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.731 -0.388 . . . . 1.1100000000000001 111.548 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -78.68 142.78 36.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.28000000000000003 109.69 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 150' ' ' THR . 3.1 t -147.27 96.12 2.66 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.038 0.755 . . . . 1.55 113.038 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.8 -65.5 4.05 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 115.511 0.964 . . . . 0.46000000000000002 115.511 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.56 -179.58 6.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 117.601 0.7 . . . . 1.8 112.455 -177.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.496 HD11 ' CD1' ' A' ' 140' ' ' LEU . 1.3 tp -102.37 133.54 47.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.339 -1.356 . . . . 1.24 107.339 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -111.31 101.07 9.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.555 0.946 . . . . 1.28 113.555 -175.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.63 98.32 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.58 -0.448 . . . . 0.58999999999999997 109.905 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 155.29 42.42 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.986 -0.552 . . . . 2.48 111.629 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -130.91 146.9 52.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.431 -0.804 . . . . 1.54 110.84 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.522 HG21 HH21 ' A' ' 105' ' ' ARG . 19.8 t -117.49 143.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 114.627 -1.17 . . . . 0.77000000000000002 110.705 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -86.6 147.59 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.902 -0.59 . . . . 1.97 110.993 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -88.66 -9.56 68.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 1.1200000000000001 112.606 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -153.35 -64.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.539 0.209 . . . . 3.8100000000000001 111.017 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -146.63 -64.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.844 0.354 . . . . 3.8199999999999998 111.017 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 13.7 m-20 -65.51 150.27 48.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.257 0.551 . . . . 1.3999999999999999 111.556 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.561 ' ND2' ' HE1' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -109.0 -179.0 0.61 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.635 -1.246 . . . . 2.0 107.635 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -11.01 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 CA-C-N 121.461 1.557 . . . . 2.5800000000000001 113.22 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.601 ' NZ ' ' HB2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER 74.92 -77.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 3.71 111.32 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 90' ' ' ALA . 1.5 m -104.71 135.8 41.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 C-N-CA 119.398 -0.921 . . . . 0.92000000000000004 110.646 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 4.8 t -131.72 117.28 18.41 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.092 -0.958 . . . . 1.2 112.362 -177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.454 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -100.94 37.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.149 -0.932 . . . . 0.22 113.505 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.68 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.34 0.4 . . . . 1.02 111.427 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.464 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -159.99 97.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.33000000000000002 110.433 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.7 OUTLIER -105.28 125.76 60.42 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 122.426 1.108 . . . . 0.68999999999999995 112.011 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.4 ptm -119.93 166.01 13.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.335 -1.302 . . . . 1.26 109.851 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 11.7 ptmt -120.82 152.5 38.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.899 1.444 . . . . 1.8200000000000001 114.899 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 94.5 -37.8 3.31 Favored Glycine 0 C--N 1.319 -0.401 0 CA-C-N 111.784 -2.462 . . . . 0.22 117.058 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 176.92 166.15 0.52 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.451 1.625 . . . . 0.28999999999999998 112.528 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.656 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -84.78 -52.16 6.25 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.649 -0.705 . . . . 0.56999999999999995 109.538 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.55 4.58 17.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.166 -0.924 . . . . 2.3100000000000001 110.251 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.418 ' OD1' ' HE3' ' A' ' 9' ' ' LYS . 6.9 t0 -43.62 -50.14 7.46 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.037 -0.528 . . . . 2.3700000000000001 109.778 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.59 -64.69 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.613 -0.721 . . . . 2.5699999999999998 112.875 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.04 131.3 30.15 Favored 'Trans proline' 0 C--N 1.364 1.346 0 CA-C-N 121.313 1.505 . . . . 2.0800000000000001 111.942 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 182' ' ' MET . 2.0 mpt? -87.08 159.11 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 6.04 110.631 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 82.1 mt -127.88 124.21 36.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 5.2999999999999998 110.582 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.43 142.52 90.64 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.037 -0.529 . . . . 8.0500000000000007 110.426 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -44.53 126.83 7.26 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 121.732 1.621 . . . . 9.1400000000000006 112.471 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -122.32 125.27 26.59 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.475 -0.329 . . . . 9.8699999999999992 110.351 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -82.89 -158.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.058 1.839 . . . . 11.69 111.439 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 59.14 -114.25 5.95 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.394 -0.908 . . . . 12.619999999999999 112.811 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.97 156.33 27.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.717 0.294 . . . . 14.44 110.746 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.192 -0.908 . . . . 15.699999999999999 110.917 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.481 -0.248 . . . . 9.1500000000000004 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.15 122.16 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.735 0.303 . . . . 7.3600000000000003 110.853 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -141.62 20.26 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 7.7599999999999998 110.789 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 t 56.01 42.78 28.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.521 . . . . 4.0199999999999996 110.947 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.8 42.87 1.79 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.666 -0.778 . . . . 1.28 112.614 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp -74.53 -49.48 21.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.114 0.483 . . . . 0.40999999999999998 110.222 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.15 -21.52 13.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.422 -0.808 . . . . 0.33000000000000002 111.308 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.27 -20.97 46.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.159 0.429 . . . . 2.0899999999999999 112.159 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 18.6 mmtp -101.67 -21.36 14.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.756 -0.377 . . . . 1.99 111.528 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 7' ' ' ALA . 10.1 p -45.08 145.6 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 120.577 0.227 . . . . 0.20999999999999999 111.577 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.427 HD13 ' HZ2' ' A' ' 174' ' ' LYS . 3.4 pt -138.96 -23.52 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 120.142 -0.623 . . . . 0.85999999999999999 111.181 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.454 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.3 t90 -173.42 136.35 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.696 -0.402 . . . . 0.28000000000000003 110.126 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -155.57 144.26 20.45 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.429 -0.169 . . . . 0.20000000000000001 111.382 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -147.15 127.78 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 113.797 1.036 . . . . 0.67000000000000004 113.797 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -115.53 97.18 6.01 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 119.915 -0.714 . . . . 1.27 110.997 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.6 100.29 0.87 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.037 -1.097 . . . . 0.37 108.037 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.583 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 177.39 -58.0 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.502 -1.226 . . . . 0.67000000000000004 112.609 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.74 -126.26 4.77 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.644 -0.789 . . . . 1.1200000000000001 113.422 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 20' ' ' SER . 26.0 mt-10 -151.81 119.51 6.12 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.44 0.296 . . . . 2.02 110.992 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.8 m 29.2 106.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.592 0.96 . . . . 1.22 113.592 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 45.1 t-80 -133.43 150.4 51.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 120.485 -0.486 . . . . 0.34000000000000002 112.036 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.3 p -122.81 104.94 15.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 121.4 0.619 . . . . 1.1799999999999999 111.405 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.95 155.45 34.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.425 -0.807 . . . . 1.1699999999999999 110.03 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 m -43.21 -50.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.48 0.919 . . . . 0.59999999999999998 113.48 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -59.46 -18.3 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.118 0.485 . . . . 0.46000000000000002 110.646 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.94 35.24 3.77 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.487 -0.779 . . . . 0.28999999999999998 112.619 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.4 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 32.7 mm -103.42 111.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.003 0.43 . . . . 0.42999999999999999 109.897 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.605 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 17.9 t60 -101.28 136.66 40.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.171 1.545 . . . . 0.52000000000000002 115.171 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.9 136.8 41.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.184 -1.371 . . . . 3.0 108.189 177.159 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -97.38 109.98 22.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.415 0.626 . . . . 2.8999999999999999 112.402 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 32' ' ' ASP . 11.5 tttm -12.22 137.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.62 1.568 . . . . 2.71 114.934 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' HB2' ' A' ' 35' ' ' GLU . 27.9 t70 -13.36 88.95 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.01 -0.995 . . . . 1.98 113.01 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' C ' ' HG3' ' A' ' 37' ' ' ARG . 8.9 Cg_endo -99.84 -4.98 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.468 2.112 . . . . 1.53 115.818 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.489 ' C ' HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -142.87 -16.57 0.69 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.316 0.962 . . . . 1.8300000000000001 113.194 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.529 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 21.2 mm-40 -89.39 76.61 7.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 4.9500000000000002 109.804 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 82.52 -16.91 22.38 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.871 -0.892 . . . . 1.9399999999999999 110.871 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.407 ' HG3' ' C ' ' A' ' 33' ' ' PRO . 5.1 mtt180 49.56 54.67 10.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.357 0.598 . . . . 5.3600000000000003 110.827 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 36' ' ' GLY . 26.1 m -141.58 176.72 4.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.301 -0.863 . . . . 2.9700000000000002 110.529 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.15 120.44 6.35 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.707 -0.759 . . . . 1.99 112.553 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -146.65 -75.06 0.2 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.418 0.151 . . . . 6.5899999999999999 111.183 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 65.67 124.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.994 0.426 . . . . 2.0099999999999998 111.486 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 t -99.86 -57.5 2.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.932 -0.576 . . . . 2.02 110.135 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.26 30.66 3.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.032 0.444 . . . . 2.23 110.684 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -81.5 11.09 4.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.858 -0.61 . . . . 2.3300000000000001 110.095 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -102.05 17.31 54.51 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.879 -0.677 . . . . 2.2000000000000002 112.976 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.2 mtt -62.04 -26.07 68.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.31 0.576 . . . . 1.9299999999999999 109.962 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -85.37 -6.88 59.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.17 -0.923 . . . . 3.3500000000000001 110.333 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mt -140.29 59.34 12.21 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.234 -0.894 . . . . 2.7599999999999998 109.424 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -80.48 164.21 21.38 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.575 2.183 . . . . 1.46 113.631 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 61' ' ' TYR . 1.1 mp -77.26 146.68 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.247 -0.888 . . . . 0.82999999999999996 110.331 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.6 -49.0 5.58 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.292 0.849 . . . . 1.6899999999999999 113.292 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.95 31.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.939 0.718 . . . . 2.5600000000000001 112.939 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.0 t -145.63 143.95 30.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.01 0.433 . . . . 0.96999999999999997 111.678 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 58' ' ' GLN . 34.9 t30 -59.23 148.36 72.34 Favored Pre-proline 0 C--O 1.221 -0.403 0 CA-C-N 115.667 -0.697 . . . . 1.96 109.66 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.3 Cg_exo -42.0 -51.79 4.43 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.137 1.892 . . . . 0.66000000000000003 113.522 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -55.25 16.4 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.885 0.85 . . . . 1.8200000000000001 111.163 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.15 -12.67 61.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.759 -0.655 . . . . 1.9099999999999999 109.761 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.609 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 1.1 tt0 -66.0 -48.16 72.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.974 -1.491 . . . . 1.5 106.974 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -50.47 -46.64 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.085 -0.961 . . . . 1.22 109.153 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 tp -73.54 -13.12 60.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.975 -1.011 . . . . 1.05 111.647 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . 3.7 m-30 -121.06 23.41 10.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.565 -0.743 . . . . 0.90000000000000002 111.132 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -142.11 -68.4 0.37 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.145 0.794 . . . . 1.8 113.145 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.492 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 74.9 p -29.19 148.85 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.224 0.824 . . . . 1.05 113.224 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.583 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 3.1 pp20? -122.97 -22.54 5.21 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.256 1.206 . . . . 2.0499999999999998 114.256 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.532 ' N ' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mtp-105 69.62 -80.77 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.758 0.313 . . . . 3.5800000000000001 110.794 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -170.89 171.55 5.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.158 -0.474 . . . . 4.25 110.564 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -97.88 166.88 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.333 -0.394 . . . . 4.3499999999999996 110.875 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 30.3 tt0 -163.79 -120.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.528 -0.306 . . . . 3.1699999999999999 111.25 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -174.53 129.07 0.34 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.355 -0.216 . . . . 2.3900000000000001 110.421 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t 49.45 86.2 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.635 -0.505 . . . . 0.98999999999999999 109.635 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.517 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -92.39 130.3 38.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.628 . . . . 1.26 109.306 -178.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -128.2 129.16 6.2 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.521 -1.323 . . . . 0.66000000000000003 113.646 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 154' ' ' SER . 12.8 m-85 -112.9 144.69 42.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.401 . . . . 0.82999999999999996 110.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.91 126.98 55.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 2.27 111.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.48 HG21 HG21 ' A' ' 172' ' ' ILE . 4.0 mp -123.21 86.49 51.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.615 -0.266 . . . . 0.34000000000000002 111.35 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.66 129.46 34.03 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.398 2.065 . . . . 0.80000000000000004 112.764 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.58 149.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.043 -0.526 . . . . 0.38 110.796 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -141.04 0.28 1.54 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 2.96 111.387 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 80' ' ' GLU . 20.5 tt0 -131.07 167.19 19.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.827 0.346 . . . . 2.1299999999999999 110.32 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -115.84 176.86 4.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.354 0.597 . . . . 0.37 111.865 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.76 -151.13 19.89 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 109.933 -1.267 . . . . 0.20999999999999999 109.933 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.4 mt-10 -103.81 109.59 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.03 1.415 . . . . 2.0299999999999998 109.528 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.04 126.81 41.54 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.677 -0.86 . . . . 0.26000000000000001 108.677 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 39.6 t -109.97 109.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.043 -0.981 . . . . 0.54000000000000004 112.035 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.93 104.02 16.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.533 -1.212 . . . . 1.23 110.399 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.413 HG13 ' CD2' ' A' ' 171' ' ' PHE . 1.5 p -115.23 141.8 30.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.092 -0.958 . . . . 1.3100000000000001 108.698 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 87' ' ' LEU . 2.0 pp -153.88 148.69 26.53 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.049 -0.66 . . . . 1.3700000000000001 111.653 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.614 ' HD3' ' C ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -107.71 127.08 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.82 -0.752 . . . . 2.9700000000000002 109.919 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-85 -109.39 148.51 30.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.353 -0.84 . . . . 0.29999999999999999 109.741 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -146.0 154.98 42.49 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.611 -0.268 . . . . 0.40999999999999998 110.566 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -179.04 136.77 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.179 -0.464 . . . . 3.9700000000000002 110.505 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.467 HG21 ' OG ' ' A' ' 124' ' ' SER . 7.6 p -168.08 125.05 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.153 0.501 . . . . 3.8100000000000001 111.85 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 178.07 -48.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.505 -0.77 . . . . 2.8900000000000001 110.128 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -117.21 82.28 1.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 2.0 110.01 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.77 106.52 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.634 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -175.89 140.25 0.42 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.152 -0.476 . . . . 2.96 110.896 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.9 t -99.25 165.57 11.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 1.55 110.439 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 71.07 -64.74 0.37 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 2.3300000000000001 111.552 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -45.01 -43.79 9.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.495 -0.32 . . . . 2.5099999999999998 111.362 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 44.7 mtmt -92.01 71.46 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 3.1000000000000001 110.752 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 t -109.8 132.57 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.35 -0.386 . . . . 1.3100000000000001 109.971 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -123.04 179.01 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.362 0.504 . . . . 0.68999999999999995 112.362 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -128.45 138.31 52.24 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 116.237 -0.438 . . . . 2.0099999999999998 112.005 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.44 132.26 64.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.644 -0.707 . . . . 0.46000000000000002 112.169 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 9.3 mtt180 -133.11 146.11 51.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 115.429 -0.805 . . . . 1.8500000000000001 112.611 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 11.8 m -117.53 119.75 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.428 -0.806 . . . . 1.1000000000000001 109.538 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.479 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.71 26.75 9.76 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.826 -0.805 . . . . 1.77 108.826 -176.512 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.01 20.6 38.71 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.8 -1.091 . . . . 0.40999999999999998 112.897 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.5 m-70 -118.64 112.29 19.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.432 0.901 . . . . 0.46000000000000002 113.432 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -63.1 120.08 10.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.618 -0.433 . . . . 0.66000000000000003 111.062 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.5 t -113.85 -32.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.371 -0.603 . . . . 0.80000000000000004 109.371 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.11 89.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.509 -0.552 . . . . 0.51000000000000001 109.509 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.6 ptpp? -106.09 79.96 1.46 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.488 1.137 . . . . 2.4399999999999999 110.976 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.7 p-10 157.79 40.41 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.462 -2.154 . . . . 2.5600000000000001 108.445 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.91 84.39 0.95 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.238 0.829 . . . . 1.1000000000000001 113.238 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 15.9 t70 -96.02 84.42 3.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.175 -1.417 . . . . 1.99 107.175 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.2 mt -50.46 -36.97 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.122 -0.945 . . . . 0.63 112.853 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.52 -47.97 79.46 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.73 0.271 . . . . 0.90000000000000002 111.73 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.4 -27.58 67.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.973 0.36 . . . . 0.76000000000000001 111.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 38.9 mmt180 -67.85 -59.04 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.044 0.387 . . . . 2.6800000000000002 112.044 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.29 -39.39 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.879 0.326 . . . . 1.4099999999999999 111.879 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.22 -56.94 1.47 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.779 -0.724 . . . . 1.0600000000000001 111.999 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -114.6 158.12 22.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.979 -0.378 . . . . 3.5099999999999998 109.979 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.467 ' OG ' HG21 ' A' ' 92' ' ' VAL . 68.5 m -55.58 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 1.6799999999999999 111.08 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 50' ' ' ILE . 28.7 p -143.7 -144.9 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.80000000000000004 110.355 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HA ' ' HZ1' ' A' ' 88' ' ' LYS . . . -110.42 126.17 54.03 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.84 0.681 . . . . 0.44 112.84 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 2.5 t60 -103.23 137.83 40.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.553 -0.906 . . . . 0.38 108.553 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -144.29 128.37 17.59 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.569 0.581 . . . . 2.0899999999999999 112.569 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.55 134.72 55.03 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.247 -0.888 . . . . 2.2799999999999998 109.666 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.85 128.52 71.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.767 -0.651 . . . . 0.70999999999999996 110.397 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -126.04 84.85 60.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.508 0.558 . . . . 1.3799999999999999 112.508 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.62 143.03 99.38 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.828 1.685 . . . . 0.22 111.635 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 20.9 mt -135.93 156.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 0.20999999999999999 111.254 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 133' ' ' ILE . 46.3 t -132.62 107.16 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.067 0.46 . . . . 1.1100000000000001 111.147 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.512 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 23.6 mt -103.85 128.7 56.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.802 -0.635 . . . . 0.23000000000000001 110.001 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -147.92 143.23 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.866 0.365 . . . . 1.9099999999999999 111.378 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp 56.4 20.59 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 3.1099999999999999 110.817 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.01 24.45 41.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.76 -0.733 . . . . 0.32000000000000001 112.953 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 135' ' ' ILE . 40.5 mtmt -125.21 152.42 44.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.185 0.492 . . . . 2.1899999999999999 110.943 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 141' ' ' SER . 6.0 tt -109.61 127.39 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 0.37 111.84 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.438 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.6 t -117.5 109.5 16.81 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.56 -0.745 . . . . 0.90000000000000002 109.493 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.0 p -103.64 118.85 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 0.53000000000000003 110.789 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 54.74 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 2.0499999999999998 111.556 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.92 27.84 3.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.794 -0.717 . . . . 0.59999999999999998 112.78 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.48 140.22 51.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.293 . . . . 2.02 110.265 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.44 138.65 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 1.3 111.372 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.7 m -161.22 123.55 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 1.1200000000000001 110.459 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.3 p -54.12 141.2 29.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 1.1100000000000001 112.06 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -80.57 142.69 33.84 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.305 -0.628 . . . . 0.28000000000000003 109.305 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 150' ' ' THR . 2.9 t -140.79 96.35 3.0 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.168 0.803 . . . . 1.55 113.168 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.98 -63.17 2.45 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 115.4 0.92 . . . . 0.46000000000000002 115.4 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.608 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.7 178.5 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.804 0.802 . . . . 1.8 112.543 -178.46 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.479 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.91 131.96 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.514 -1.291 . . . . 1.24 107.514 177.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.461 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 t -120.21 112.02 18.55 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.016 -1.074 . . . . 1.28 113.531 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -94.11 99.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.042 -0.725 . . . . 0.58999999999999997 109.042 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 37.0 mt-10 -109.04 124.69 51.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.525 -0.762 . . . . 2.48 111.324 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.61 132.92 55.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.894 -0.722 . . . . 1.54 110.1 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.4 t -102.45 142.31 16.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.615 -1.175 . . . . 0.77000000000000002 111.851 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -67.74 148.43 51.28 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 115.4 -0.818 . . . . 1.97 111.106 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.63 -9.1 41.58 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 1.1200000000000001 112.374 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -155.73 -75.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.542 0.211 . . . . 3.8100000000000001 111.203 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -173.64 68.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.736 0.303 . . . . 3.8199999999999998 111.131 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -178.03 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.331 -0.395 . . . . 1.3999999999999999 110.897 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.25 159.12 0.12 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.479 -0.563 . . . . 2.0 109.479 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -40.07 100.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.632 1.555 . . . . 2.5800000000000001 111.371 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.98 -36.07 26.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 3.71 112.322 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 79.5 t -126.7 135.3 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.566 0.58 . . . . 0.92000000000000004 112.566 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.7 t -130.47 131.53 45.2 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 123.836 0.71 . . . . 1.2 111.653 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -121.73 37.8 4.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.26 -0.882 . . . . 0.22 113.299 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.98 134.17 0.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.433 0.458 . . . . 1.02 111.503 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -156.9 98.76 1.79 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.881 -0.145 . . . . 0.33000000000000002 110.869 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.48 HG21 HG21 ' A' ' 75' ' ' ILE . 16.5 tt -108.22 125.79 64.9 Favored 'Isoleucine or valine' 0 C--O 1.259 1.601 0 CA-C-O 122.784 1.278 . . . . 0.68999999999999995 112.486 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.16 167.17 11.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.798 -1.546 . . . . 1.26 109.035 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.431 ' CB ' ' HZ2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -119.89 146.97 45.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.217 1.562 . . . . 1.8200000000000001 115.217 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.59 -35.99 4.04 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 112.008 -2.36 . . . . 0.22 118.251 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.83 159.14 0.57 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.332 2.066 . . . . 0.28999999999999998 113.955 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.82 -20.05 29.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.079 -0.964 . . . . 0.56999999999999995 110.236 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -59.95 -33.58 72.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.756 -0.656 . . . . 2.3100000000000001 111.309 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -56.59 -44.92 81.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.514 -0.312 . . . . 2.3700000000000001 110.504 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.4 t -36.28 99.58 0.18 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 116.014 -0.539 . . . . 2.5699999999999998 111.901 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.12 140.39 32.84 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.139 1.893 . . . . 2.0800000000000001 112.44 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 92.5 mtp -86.97 93.66 9.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.267 -0.424 . . . . 6.04 110.974 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 59.25 175.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.0 -0.546 . . . . 5.2999999999999998 111.132 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -121.59 145.1 42.05 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.842 -0.617 . . . . 8.0500000000000007 110.023 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -44.71 124.51 5.61 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 121.579 1.52 . . . . 9.1400000000000006 111.918 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -125.71 124.22 24.87 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.954 -0.298 . . . . 9.8699999999999992 110.809 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -83.68 -156.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.009 1.806 . . . . 11.69 111.387 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 160.96 123.93 0.7 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.358 -0.925 . . . . 12.619999999999999 112.682 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.2 mm? -106.91 118.13 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.779 0.323 . . . . 14.44 110.485 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.296 -0.859 . . . . 15.699999999999999 110.77 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.505 -0.238 . . . . 9.1500000000000004 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.66 -33.62 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 7.3600000000000003 110.87 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -132.56 92.66 3.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 7.7599999999999998 110.771 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.0 p -102.42 172.64 6.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 4.0199999999999996 110.677 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.05 45.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.853 -0.689 . . . . 1.28 112.456 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.5 -44.23 62.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.387 0.613 . . . . 0.40999999999999998 110.482 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.632 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.82 -21.07 17.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 0.33000000000000002 111.198 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.05 -18.36 60.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 2.0899999999999999 111.859 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -103.9 -26.46 12.66 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.712 -0.395 . . . . 1.99 111.267 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.3 p -43.37 144.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.849 0.315 . . . . 0.20999999999999999 111.849 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -137.16 -24.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.422 -0.511 . . . . 0.85999999999999999 110.758 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.571 ' O ' HG22 ' A' ' 172' ' ' ILE . 25.1 t90 -171.04 138.98 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.593 -0.521 . . . . 0.28000000000000003 109.593 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -159.24 143.87 15.5 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.216 0.45 . . . . 0.20000000000000001 112.216 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.01 131.3 8.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 114.224 1.194 . . . . 0.67000000000000004 114.224 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 8.4 t30 -114.67 88.63 2.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.265 -0.879 . . . . 1.27 109.082 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 65' ' ' ARG . . . -60.82 105.76 0.49 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.114 -0.948 . . . . 0.37 110.192 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 65' ' ' ARG . . . 162.13 -48.05 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.867 -1.061 . . . . 0.67000000000000004 114.324 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.91 -130.89 6.92 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.654 -0.784 . . . . 1.1200000000000001 113.861 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -152.36 119.81 6.0 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 122.317 0.247 . . . . 2.02 111.086 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.697 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.5 m 24.14 101.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.358 0.873 . . . . 1.22 113.358 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 15.0 t-80 -126.44 150.52 48.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 119.971 -0.692 . . . . 0.34000000000000002 111.96 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.79 105.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 1.1799999999999999 110.807 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.8 154.39 42.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.434 -0.348 . . . . 1.1699999999999999 110.36 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 m -44.47 -50.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 124.117 0.885 . . . . 0.59999999999999998 113.068 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -58.89 -17.22 22.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.261 0.553 . . . . 0.46000000000000002 110.307 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.49 34.76 4.62 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.28999999999999998 112.12 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -103.92 121.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.42999999999999999 110.039 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.9 t60 -99.95 136.99 39.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.578 1.325 . . . . 0.52000000000000002 114.578 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.65 131.25 47.99 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.768 -1.106 . . . . 3.0 108.311 176.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.45 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 14.6 mtt180 -89.63 109.62 20.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.584 0.553 . . . . 2.8999999999999999 112.282 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 30' ' ' ARG . 17.4 tttp -16.42 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.514 1.125 . . . . 2.71 113.506 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -18.7 84.11 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.149 0.979 . . . . 1.98 113.165 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 5.3 Cg_endo -105.02 56.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.035 2.49 . . . . 1.53 112.933 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 72' ' ' GLY . 13.4 tp -152.85 -78.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.818 0.303 . . . . 1.8300000000000001 111.818 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER -58.17 89.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.176 0.512 . . . . 4.9500000000000002 110.559 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.86 -13.08 5.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.783 -0.723 . . . . 1.9399999999999999 111.803 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER 46.13 31.5 1.19 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.934 0.397 . . . . 5.3600000000000003 111.126 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.2 p -148.56 144.14 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 2.9700000000000002 110.572 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.79 -150.37 17.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.777 -0.725 . . . . 1.99 112.343 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -130.09 -79.68 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.513 0.197 . . . . 6.5899999999999999 111.04 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.625 ' HA ' HH21 ' A' ' 65' ' ' ARG . . . -177.8 140.34 0.25 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.97 0.414 . . . . 2.0099999999999998 111.282 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.447 ' C ' ' H ' ' A' ' 44' ' ' TYR . 74.1 m -90.05 45.98 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.512 -0.551 . . . . 2.02 109.512 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.97 25.93 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.37 -0.832 . . . . 2.23 111.383 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.447 ' H ' ' C ' ' A' ' 42' ' ' SER . 90.1 t80 -52.75 -38.78 61.45 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.006 0.431 . . . . 2.3300000000000001 110.246 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -103.96 48.32 1.02 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.978 -0.63 . . . . 2.2000000000000002 112.019 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 32.0 ttm -58.48 -15.59 11.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.842 0.353 . . . . 1.9299999999999999 110.65 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -65.4 -165.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 3.3500000000000001 110.594 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.41 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 17.5 mt 55.05 50.33 6.07 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 109.804 -0.443 . . . . 2.7599999999999998 109.804 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' O ' HD12 ' A' ' 51' ' ' LEU . 19.4 Cg_endo -53.95 115.6 2.45 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.563 2.175 . . . . 1.46 112.828 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.546 HD11 ' HB1' ' A' ' 90' ' ' ALA . 1.2 mp -49.63 128.03 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.184 -0.673 . . . . 0.82999999999999996 109.184 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 49' ' ' PRO . 7.8 mp -83.16 -32.06 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.385 0.884 . . . . 1.6899999999999999 113.385 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -79.11 33.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.507 -0.477 . . . . 2.5600000000000001 111.681 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.97 142.22 5.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.359 -0.382 . . . . 0.96999999999999997 110.436 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -60.97 164.04 8.67 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.516 -0.311 . . . . 1.96 110.943 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 53.8 Cg_exo -47.21 -41.87 27.24 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.393 2.062 . . . . 0.66000000000000003 115.024 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.613 ' O ' HG12 ' A' ' 59' ' ' VAL . 11.3 mm-40 -73.26 -55.81 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.748 0.785 . . . . 1.8200000000000001 110.731 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 40.8 p30 -70.27 -3.02 15.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.701 -0.799 . . . . 1.9099999999999999 109.517 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -74.36 -60.73 2.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.425 -0.954 . . . . 1.5 108.425 177.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 56' ' ' GLU . 7.2 p -49.63 -37.39 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.738 -0.467 . . . . 1.22 109.738 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 62' ' ' GLN . 11.1 tp -69.15 -66.48 0.57 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.441 -0.504 . . . . 1.05 110.245 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.426 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 8.1 m-30 -55.05 -2.71 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.198 0.523 . . . . 0.90000000000000002 111.147 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 60' ' ' LEU . 3.7 tt0 -116.67 -131.65 0.32 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 1.8 109.614 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 62' ' ' GLN . 12.3 p 44.23 131.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.444 0.905 . . . . 1.05 113.444 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 -128.03 149.31 50.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.767 0.654 . . . . 2.0499999999999998 112.767 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.625 HH21 ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -80.4 -156.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.677 -0.692 . . . . 3.5800000000000001 109.616 177.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -87.12 -87.27 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 121.373 -0.131 . . . . 4.25 111.165 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -179.89 155.77 0.63 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.592 0.235 . . . . 4.3499999999999996 110.957 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 4.4 tt0 -176.43 -158.65 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.291 -0.413 . . . . 3.1699999999999999 110.61 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -152.83 135.86 15.58 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.502 -0.317 . . . . 2.3900000000000001 110.987 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t 50.54 79.21 0.09 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.483 -0.326 . . . . 0.98999999999999999 110.397 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -151.43 153.86 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.66 -0.416 . . . . 1.26 111.273 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.523 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -170.49 -160.43 18.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.621 -0.8 . . . . 0.66000000000000003 113.914 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.93 164.16 17.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.601 0.715 . . . . 0.82999999999999996 112.917 -177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.46 125.08 50.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.483 -1.235 . . . . 2.27 109.539 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.506 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.1 mp -115.41 88.5 19.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.242 0.46 . . . . 0.34000000000000002 112.242 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -56.24 127.93 28.04 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.957 1.771 . . . . 0.80000000000000004 112.16 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.406 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.3 mt -122.69 151.5 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.911 0.386 . . . . 0.38 111.048 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -140.45 -0.39 1.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.1 -0.5 . . . . 2.96 111.27 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -126.06 168.49 13.91 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.616 0.246 . . . . 2.1299999999999999 111.046 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -122.6 168.52 12.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.381 0.61 . . . . 0.37 111.55 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.33 -151.87 23.28 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.739 -1.345 . . . . 0.20999999999999999 109.739 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.41 107.6 18.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.066 1.433 . . . . 2.0299999999999998 108.84 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -95.14 126.31 40.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.645 -0.822 . . . . 0.26000000000000001 109.162 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 177' ' ' ALA . 40.6 t -109.47 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.678 -1.146 . . . . 0.54000000000000004 111.457 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 170' ' ' LEU . 8.7 tp -99.28 105.06 17.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.365 -1.289 . . . . 1.23 110.729 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.51 ' C ' HD23 ' A' ' 87' ' ' LEU . 1.1 p -113.56 135.25 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.774 -0.648 . . . . 1.3100000000000001 109.929 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -133.06 135.19 45.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.59 . . . . 1.3700000000000001 111.614 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.493 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 17.9 tptt -102.93 114.83 29.44 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 2.9700000000000002 108.83 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -103.68 140.98 36.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.772 -0.825 . . . . 0.29999999999999999 108.772 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 50' ' ' ILE . . . -154.63 170.55 21.25 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.475 0.917 . . . . 0.40999999999999998 113.475 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 66.18 149.9 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.67 -1.15 . . . . 3.9700000000000002 112.59 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.5 t -140.96 -37.21 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.378 -0.828 . . . . 3.8100000000000001 110.58 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 t80 64.42 14.47 8.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.659 -0.7 . . . . 2.8900000000000001 112.279 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -149.51 -38.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.468 0.175 . . . . 2.0 111.378 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 62.88 102.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.938 0.399 . . . . 1.0 111.504 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -167.41 147.03 5.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 2.96 110.238 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m -110.61 149.8 29.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.105 0.479 . . . . 1.55 112.231 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 46.64 32.85 1.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.319 -0.855 . . . . 2.3300000000000001 111.823 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.42 -41.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.775 -0.454 . . . . 2.5099999999999998 109.775 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -107.11 82.91 1.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.67 . . . . 3.1000000000000001 109.696 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.514 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.9 OUTLIER -109.14 144.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 1.3100000000000001 109.733 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.492 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 73.4 m-85 -128.1 -178.05 4.38 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.843 0.683 . . . . 0.68999999999999995 112.843 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -128.23 143.98 51.08 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.572 -0.451 . . . . 2.0099999999999998 112.083 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.2 t -139.15 131.98 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.78 -0.646 . . . . 0.46000000000000002 112.434 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -133.66 149.9 51.55 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 115.239 -0.891 . . . . 1.8500000000000001 112.612 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.9 m -118.7 117.6 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.705 -1.134 . . . . 1.1000000000000001 109.749 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.497 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 55.85 26.32 9.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.758 0.789 . . . . 1.77 109.438 -176.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.97 16.46 41.37 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.365 -1.289 . . . . 0.40999999999999998 113.278 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.7 m-70 -115.35 109.51 18.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.199 0.815 . . . . 0.46000000000000002 113.199 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.0 p -67.22 113.69 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.115 0.483 . . . . 0.66000000000000003 111.292 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.37 -30.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.511 -0.768 . . . . 0.80000000000000004 109.898 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.46 91.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.308 -0.405 . . . . 0.51000000000000001 109.941 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.7 ptpp? -107.78 84.83 2.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 122.237 1.018 . . . . 2.4399999999999999 112.038 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.9 p-10 151.2 37.31 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.631 -2.077 . . . . 2.5600000000000001 108.79 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 92.36 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.326 0.584 . . . . 1.1000000000000001 112.512 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.59 84.07 2.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.649 -1.612 . . . . 1.99 106.649 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 53.3 mt -50.21 -38.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.139 -0.937 . . . . 0.63 113.229 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.06 -52.95 52.76 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.217 0.451 . . . . 0.90000000000000002 112.217 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.19 -27.62 64.65 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.045 0.387 . . . . 0.76000000000000001 112.045 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.15 -58.22 6.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.113 0.412 . . . . 2.6800000000000002 112.113 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.07 -40.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.175 0.435 . . . . 1.4099999999999999 112.175 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.45 -136.52 12.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.605 -0.807 . . . . 1.0600000000000001 112.601 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -56.65 169.54 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.551 0.215 . . . . 3.5099999999999998 110.868 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -45.81 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.078 0.466 . . . . 1.6799999999999999 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.1 p -152.97 -175.1 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 0.80000000000000004 109.991 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.39 139.19 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 0.44 112.161 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -111.69 148.88 32.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.869 -0.789 . . . . 0.38 108.869 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -141.87 135.1 29.2 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.712 0.634 . . . . 2.0899999999999999 112.712 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -129.85 112.6 13.73 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.151 -0.931 . . . . 2.2799999999999998 109.609 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.435 ' C ' HD12 ' A' ' 131' ' ' ILE . 13.6 mt -101.89 135.45 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.204 -0.453 . . . . 0.70999999999999996 111.043 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.2 mp -134.89 86.32 32.97 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.888 0.329 . . . . 1.3799999999999999 111.888 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -62.6 138.94 73.0 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.554 1.503 . . . . 0.22 110.812 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.9 mt -130.13 155.73 41.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.769 0.319 . . . . 0.20999999999999999 111.59 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 133' ' ' ILE . 25.3 p -130.07 106.69 8.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.044 -0.525 . . . . 1.1100000000000001 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 139' ' ' LYS . 26.6 mt -105.64 125.87 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.661 -0.699 . . . . 0.23000000000000001 109.918 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -146.66 144.08 29.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 1.9099999999999999 110.911 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm 60.29 10.88 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.984 -0.553 . . . . 3.1099999999999999 111.656 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.12 18.53 33.65 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.579 -0.82 . . . . 0.32000000000000001 113.067 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 135' ' ' ILE . 33.7 mtmt -121.89 153.89 37.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.958 0.379 . . . . 2.1899999999999999 110.943 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -108.7 127.33 53.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.37 111.739 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.503 ' N ' HD23 ' A' ' 140' ' ' LEU . 16.6 t -119.77 109.28 15.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.90000000000000002 110.176 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 144' ' ' GLY . 1.8 p -101.92 135.59 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.124 -0.489 . . . . 0.53000000000000003 110.174 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 40.21 -91.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.91 0.337 . . . . 2.0499999999999998 111.91 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -135.59 47.28 0.99 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.033 -0.603 . . . . 0.59999999999999998 112.34 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.51 132.74 21.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.998 -0.371 . . . . 2.02 109.998 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.0 135.0 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.933 0.397 . . . . 1.3 110.888 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 23.2 t -152.91 171.94 17.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 1.1200000000000001 110.208 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.13 136.72 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.188 -0.46 . . . . 1.1100000000000001 111.295 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.406 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 28.6 t80 -79.46 126.84 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.297 -1.001 . . . . 0.28000000000000003 108.297 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -124.0 94.86 4.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.086 0.772 . . . . 1.55 113.086 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.9 -52.82 1.31 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 116.056 1.182 . . . . 0.46000000000000002 116.056 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.506 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -154.75 170.94 20.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.272 1.036 . . . . 1.8 113.007 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.33 124.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.027 -1.471 . . . . 1.24 107.027 176.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.497 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.7 t -116.28 110.79 19.22 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.594 0.961 . . . . 1.28 113.594 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.483 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 15.2 t -99.14 114.96 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.871 -0.604 . . . . 0.58999999999999997 110.363 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -124.46 136.52 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 2.48 111.659 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -118.3 131.71 56.32 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.743 -0.662 . . . . 1.54 109.583 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.21 143.68 16.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.435 -0.802 . . . . 0.77000000000000002 111.469 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.71 148.33 39.15 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 114.816 -1.084 . . . . 1.97 111.728 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -126.15 -8.75 4.91 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.049 -0.82 . . . . 1.1200000000000001 111.049 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -151.77 -57.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.331 -0.435 . . . . 3.8100000000000001 110.265 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -174.33 -68.73 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.242 -0.436 . . . . 3.8199999999999998 111.146 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.29 90.65 4.97 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.008 0.433 . . . . 1.3999999999999999 111.281 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 165' ' ' PRO . 4.2 m-20 -48.03 153.18 1.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.414 -0.812 . . . . 2.0 109.35 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.57 99.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.191 1.927 . . . . 2.5800000000000001 112.226 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.524 ' NZ ' ' HB3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -51.97 -70.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.005 -0.998 . . . . 3.71 111.774 -178.297 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 25.0 t -84.95 131.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 119.455 -0.898 . . . . 0.92000000000000004 111.381 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.3 t -132.33 123.37 26.7 Favored 'General case' 0 C--N 1.338 0.095 0 O-C-N 124.136 0.897 . . . . 1.2 109.721 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.493 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -115.23 38.19 3.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.231 0.826 . . . . 0.22 113.231 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.514 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -40.22 135.21 1.46 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.974 0.416 . . . . 1.02 110.431 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.514 ' H ' HD13 ' A' ' 170' ' ' LEU . 0.3 OUTLIER -152.82 102.36 2.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.837 -0.619 . . . . 0.33000000000000002 110.072 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 12' ' ' TRP . 2.8 tt -105.1 123.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 CA-C-O 122.842 1.306 . . . . 0.68999999999999995 113.026 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.06 163.03 16.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.396 -1.729 . . . . 1.26 109.399 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.079 1.511 . . . . 1.8200000000000001 115.079 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.39 -35.34 5.03 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 112.327 -2.215 . . . . 0.22 117.914 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.51 159.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 120.031 1.916 . . . . 0.28999999999999998 114.291 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.621 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.15 -18.2 32.89 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 115.116 -0.947 . . . . 0.56999999999999995 110.51 176.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -63.07 -16.46 60.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 2.3100000000000001 111.926 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -77.93 -61.11 2.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.658 -0.247 . . . . 2.3700000000000001 110.853 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 180' ' ' VAL . 5.1 p -50.32 104.5 0.43 Allowed Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.327 -0.397 . . . . 2.5699999999999998 111.407 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.16 110.22 0.39 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.808 1.672 . . . . 2.0800000000000001 112.466 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -132.64 162.64 30.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 6.04 110.644 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.5 mp -85.0 125.53 32.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 5.2999999999999998 110.736 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -57.11 150.25 41.6 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 8.0500000000000007 110.249 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.33 125.75 16.32 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.654 1.569 . . . . 9.1400000000000006 112.263 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.482 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 26.6 t-80 -134.55 135.81 24.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.166 -0.47 . . . . 9.8699999999999992 110.209 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.482 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 44.6 Cg_endo -76.14 5.34 4.61 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.212 1.941 . . . . 11.69 111.824 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -50.37 141.95 15.81 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.752 -0.737 . . . . 12.619999999999999 112.7 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.9 pp -55.69 148.42 16.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.38 . . . . 14.44 110.989 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.113 -0.946 . . . . 15.699999999999999 110.721 179.948 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.467 -0.253 . . . . 9.1500000000000004 112.467 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.03 28.18 14.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.768 0.318 . . . . 7.3600000000000003 111.046 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 ttt -90.24 -49.19 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 7.7599999999999998 110.81 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -151.1 -0.46 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 4.0199999999999996 110.922 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.79 31.68 70.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.855 -0.688 . . . . 1.28 112.54 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HG ' HD11 ' A' ' 27' ' ' ILE . 24.3 tp -76.11 -44.47 38.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.343 0.592 . . . . 0.40999999999999998 110.332 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.22 -21.08 8.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.181 -0.918 . . . . 0.33000000000000002 111.509 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.68 -23.06 53.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.139 0.422 . . . . 2.0899999999999999 112.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -98.11 -25.54 14.89 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.395 . . . . 1.99 111.436 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.8 p -44.0 145.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 120.648 0.261 . . . . 0.20999999999999999 111.591 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -138.75 -23.24 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.096 -0.642 . . . . 0.85999999999999999 111.012 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.52 ' O ' HG22 ' A' ' 172' ' ' ILE . 28.5 t90 -173.34 141.56 0.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.275 -0.42 . . . . 0.28000000000000003 109.944 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.39 150.15 17.78 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.343 -0.223 . . . . 0.20000000000000001 111.531 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.78 129.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 114.19 1.182 . . . . 0.67000000000000004 114.19 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -115.17 87.2 2.6 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.726 -0.67 . . . . 1.27 109.444 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -62.12 104.27 0.46 Allowed 'General case' 0 C--O 1.253 1.267 0 CA-C-N 115.414 -0.812 . . . . 0.37 109.165 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.643 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 157.69 -20.48 0.38 Allowed Glycine 0 N--CA 1.44 -1.066 0 O-C-N 124.91 1.381 . . . . 0.67000000000000004 113.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.32 -133.27 3.13 Favored Glycine 0 C--N 1.329 0.191 0 C-N-CA 119.991 -1.1 . . . . 1.1200000000000001 113.455 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 35.1 mt-10 -152.65 120.13 5.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.44 0.162 . . . . 2.02 111.108 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.647 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.0 m 26.86 107.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.701 1.0 . . . . 1.22 113.701 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 6.9 t-80 -135.64 139.17 43.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 120.086 -0.645 . . . . 0.34000000000000002 112.571 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.9 p -110.08 102.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 115.45 -0.795 . . . . 1.1799999999999999 111.194 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.66 157.0 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.995 -1.002 . . . . 1.1699999999999999 110.301 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 25' ' ' HIS . 21.8 m -43.55 -52.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.4 0.889 . . . . 0.59999999999999998 113.4 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.484 ' N ' HG23 ' A' ' 24' ' ' VAL . 75.1 m-70 -56.82 -20.79 24.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.46000000000000002 110.318 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.4 34.98 3.46 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.22 -0.9 . . . . 0.28999999999999998 112.101 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.413 HD11 ' HG ' ' A' ' 6' ' ' LEU . 34.7 mm -103.68 112.1 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.46 . . . . 0.42999999999999999 110.351 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 13.2 t60 -97.93 132.63 43.34 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.981 1.104 . . . . 0.52000000000000002 113.981 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.42 135.27 39.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.804 -1.184 . . . . 3.0 107.804 177.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.47 ' NH1' ' HA ' ' A' ' 12' ' ' TRP . 2.2 ptp85 -91.54 108.15 19.7 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.572 0.545 . . . . 2.8999999999999999 112.451 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -10.8 130.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.106 1.363 . . . . 2.71 114.286 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.5 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 57.3 m-20 -16.52 85.86 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.632 1.173 . . . . 1.98 113.921 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -104.89 10.37 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.247 2.631 . . . . 1.53 111.763 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 72' ' ' GLY . 4.9 tp -59.13 -47.2 86.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.587 -0.733 . . . . 1.8300000000000001 112.291 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -150.15 46.1 0.91 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.939 0.718 . . . . 4.9500000000000002 112.939 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.43 0.64 58.62 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.276 -0.964 . . . . 1.9399999999999999 112.449 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HD3' ' NH2' ' A' ' 65' ' ' ARG . 15.0 mtt180 -70.11 62.95 0.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.929 0.492 . . . . 5.3600000000000003 111.287 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.55 122.07 58.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.069 0.462 . . . . 2.9700000000000002 111.28 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.07 29.19 3.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.85 -0.69 . . . . 1.99 112.721 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.615 ' HG3' HH12 ' A' ' 65' ' ' ARG . 17.0 ptm180 -162.77 170.93 17.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.034 0.445 . . . . 6.5899999999999999 111.205 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.57 99.78 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.776 -0.647 . . . . 2.0099999999999998 110.213 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 72.2 m -72.98 75.13 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 2.02 110.739 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.55 38.75 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 2.23 110.668 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -50.44 121.55 5.84 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.124 -0.489 . . . . 2.3300000000000001 110.136 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.22 54.19 40.0 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.285 -0.96 . . . . 2.2000000000000002 111.284 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 16.4 ttt -52.3 -17.99 1.38 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.73 0.3 . . . . 1.9299999999999999 111.318 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -60.21 -172.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 3.3500000000000001 110.598 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 11.2 mt 59.39 55.3 4.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 2.7599999999999998 111.059 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 31.6 Cg_exo -64.75 145.6 86.82 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.341 2.027 . . . . 1.46 111.774 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp -59.29 141.27 16.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.798 -0.445 . . . . 0.82999999999999996 109.798 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -48.3 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 1.6899999999999999 112.231 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -77.49 37.16 0.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 2.5600000000000001 112.743 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -151.95 140.73 20.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.08 0.467 . . . . 0.96999999999999997 111.966 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.537 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.2 t30 -65.95 149.13 97.92 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.713 -0.676 . . . . 1.96 109.272 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.61 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 6.2 Cg_exo -38.73 -46.99 2.68 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.954 2.436 . . . . 0.66000000000000003 116.402 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.12 -56.68 4.78 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.856 0.836 . . . . 1.8200000000000001 111.113 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 -10.92 59.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.824 -0.806 . . . . 1.9099999999999999 108.824 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.7 tt0 -64.66 -47.29 79.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.56 -1.644 . . . . 1.5 106.56 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 63' ' ' THR . 92.2 t -54.49 -57.77 5.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.838 -1.074 . . . . 1.22 110.452 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 60' ' ' LEU . 4.2 tt -63.11 -14.64 50.94 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.711 -0.677 . . . . 1.05 111.09 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.43 ' CE2' ' HD2' ' A' ' 88' ' ' LYS . 6.3 m-30 -110.81 5.79 20.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.101 -0.5 . . . . 0.90000000000000002 111.11 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.608 ' HG2' ' N ' ' A' ' 63' ' ' THR . 35.6 tt0 -129.28 -104.95 0.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.49 . . . . 1.8 111.558 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.608 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 65.3 p 36.83 -154.7 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.088 -0.482 . . . . 1.05 110.669 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.624 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.0 pt-20 168.85 130.68 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.468 0.576 . . . . 2.0499999999999998 112.026 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.643 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 14.9 mtp85 -107.35 -176.73 3.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.39 -0.368 . . . . 3.5800000000000001 110.284 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -168.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.21 -0.45 . . . . 4.25 110.89 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -159.03 162.11 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 4.3499999999999996 111.167 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.4 tp10 -156.74 -92.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 3.1699999999999999 111.053 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 3.1 p30 -173.56 134.49 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.535 0.207 . . . . 2.3900000000000001 111.084 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.4 t 46.89 84.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.401 -0.363 . . . . 0.98999999999999999 110.693 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -155.92 155.64 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.578 -0.449 . . . . 1.26 111.995 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.686 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -175.66 -161.38 24.93 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.601 -0.809 . . . . 0.66000000000000003 113.951 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.01 174.1 6.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.75 0.786 . . . . 0.82999999999999996 113.056 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.436 ' OD2' ' HG3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -127.36 139.67 52.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.322 -1.308 . . . . 2.27 109.128 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.517 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -129.75 88.93 47.91 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.895 0.702 . . . . 0.34000000000000002 112.895 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.38 134.88 67.09 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.61 1.54 . . . . 0.80000000000000004 111.433 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 78' ' ' LYS . 59.9 mt -126.52 155.14 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.859 0.361 . . . . 0.38 111.266 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.426 ' N ' HG22 ' A' ' 77' ' ' ILE . 19.0 pttm -147.35 4.11 0.79 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.021 -0.536 . . . . 2.96 111.364 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.92 171.86 12.7 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.602 0.239 . . . . 2.1299999999999999 110.864 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.8 mp0 -127.4 173.29 9.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.37 111.419 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.92 -150.31 20.11 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 109.958 -1.257 . . . . 0.20999999999999999 109.958 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 28.4 mt-10 -100.98 108.13 19.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.826 1.313 . . . . 2.0299999999999998 109.038 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -94.81 126.32 40.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 119.772 -0.771 . . . . 0.26000000000000001 109.126 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.2 t -110.78 109.09 27.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.951 -1.022 . . . . 0.54000000000000004 111.319 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.4 105.45 17.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.848 -1.524 . . . . 1.23 110.45 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.6 t -110.33 143.39 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.171 -0.922 . . . . 1.3100000000000001 110.31 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -136.77 133.79 36.38 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.591 -0.444 . . . . 1.3700000000000001 111.414 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -103.47 110.41 22.43 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.64 -1.245 . . . . 2.9700000000000002 107.64 175.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -102.99 141.62 35.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.41 -0.959 . . . . 0.29999999999999999 108.41 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -159.4 172.09 18.57 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.248 1.203 . . . . 0.40999999999999998 114.248 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 54.86 167.74 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.025 -1.443 . . . . 3.9700000000000002 113.211 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p 179.19 135.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.548 -1.205 . . . . 3.8100000000000001 109.63 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -61.47 -66.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.341 . . . . 2.8900000000000001 111.375 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -86.03 144.51 27.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 2.0 111.307 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.2 99.52 9.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.082 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -152.54 141.14 20.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 2.96 110.695 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.7 p -97.74 153.17 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 1.55 111.423 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 66.56 -71.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.726 -0.67 . . . . 2.3300000000000001 112.178 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -39.18 -44.88 1.26 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.298 -0.41 . . . . 2.5099999999999998 111.866 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -88.92 80.37 7.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.152 0.501 . . . . 3.1000000000000001 110.939 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.44 142.6 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 1.3100000000000001 109.934 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.46 177.65 5.8 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.769 0.655 . . . . 0.68999999999999995 112.769 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -125.65 141.43 52.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 115.977 -0.556 . . . . 2.0099999999999998 111.565 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.51 132.41 36.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 116.272 -0.422 . . . . 0.46000000000000002 111.717 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.5 OUTLIER -134.05 150.73 51.21 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.17 0.804 . . . . 1.8500000000000001 113.17 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 17.3 m -118.84 119.64 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.65 -1.159 . . . . 1.1000000000000001 109.451 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.494 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.79 26.96 12.12 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.341 -0.614 . . . . 1.77 109.341 -176.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.1 53.11 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.40999999999999998 112.879 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.3 m-70 -114.27 109.46 18.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.292 0.849 . . . . 0.46000000000000002 113.292 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -67.36 109.67 3.25 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 0.66000000000000003 111.168 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.05 -34.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.396 -0.82 . . . . 0.80000000000000004 109.85 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.91 90.36 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.599 -0.519 . . . . 0.51000000000000001 109.599 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -109.36 81.83 1.5 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.304 1.049 . . . . 2.4399999999999999 111.201 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 157.67 37.16 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 112.462 -2.154 . . . . 2.5600000000000001 108.217 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.39 85.97 0.83 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.695 -0.684 . . . . 1.1000000000000001 112.292 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 0.6 OUTLIER -100.16 83.64 2.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.597 -1.631 . . . . 1.99 106.597 175.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.2 mt -49.82 -41.57 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.358 -0.837 . . . . 0.63 112.112 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -61.54 -54.8 38.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.571 -0.286 . . . . 0.90000000000000002 111.22 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 12.8 t70 -63.26 -27.53 69.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.871 0.323 . . . . 0.76000000000000001 111.871 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -63.69 -59.4 4.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.324 0.49 . . . . 2.6800000000000002 112.324 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.16 -41.39 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.204 -0.598 . . . . 1.4099999999999999 112.152 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.51 -112.13 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.586 -0.816 . . . . 1.0600000000000001 112.655 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -97.42 114.45 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.768 0.318 . . . . 3.5099999999999998 111.377 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.8 t 54.63 -127.15 2.29 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.089 -0.505 . . . . 1.6799999999999999 111.192 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.7 p 56.15 174.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.946 0.403 . . . . 0.80000000000000004 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -98.55 139.32 34.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.329 0.585 . . . . 0.44 112.134 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.422 ' ND1' ' N ' ' A' ' 128' ' ' ASP . 1.6 t60 -107.78 149.22 28.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.108 -0.951 . . . . 0.38 108.44 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.422 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.6 p30 -133.42 137.2 45.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.54 0.941 . . . . 2.0899999999999999 113.54 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -129.68 109.4 10.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.559 -1.2 . . . . 2.2799999999999998 109.464 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 mt -98.71 128.58 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.893 -0.594 . . . . 0.70999999999999996 110.27 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.91 84.33 38.12 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 113.076 0.769 . . . . 1.3799999999999999 113.076 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.55 143.63 93.18 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.793 1.662 . . . . 0.22 111.402 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 134' ' ' SER . 25.1 mt -136.36 159.43 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 0.20999999999999999 111.025 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 133' ' ' ILE . 53.6 p -134.4 107.13 7.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 1.1100000000000001 111.227 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 20.4 mt -105.55 127.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 115.72 -0.673 . . . . 0.23000000000000001 109.955 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -150.49 142.84 24.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.341 . . . . 1.9099999999999999 110.886 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt 60.53 11.83 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.017 -0.538 . . . . 3.1099999999999999 111.596 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.04 14.54 48.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.64 -0.79 . . . . 0.32000000000000001 113.134 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 135' ' ' ILE . 63.6 mttp -116.78 153.47 32.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.861 0.33 . . . . 2.1899999999999999 110.907 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 141' ' ' SER . 6.5 tt -111.43 129.52 56.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.37 111.727 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.425 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.8 t -116.9 109.9 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 0.90000000000000002 109.678 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 142' ' ' VAL . 9.1 p -105.06 110.79 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.125 -0.489 . . . . 0.53000000000000003 111.007 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.14 -89.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.911 -0.586 . . . . 2.0499999999999998 111.769 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.92 22.33 4.3 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.528 -0.844 . . . . 0.59999999999999998 113.243 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -125.81 136.57 53.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 2.02 110.282 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -105.37 137.95 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 1.3 111.129 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.1 m -152.67 170.61 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 1.1200000000000001 110.124 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.44 135.46 38.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 1.1100000000000001 111.277 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.7 137.79 37.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.928 -1.138 . . . . 0.28000000000000003 107.928 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.8 m -145.8 95.55 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.705 -0.798 . . . . 1.55 112.775 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.18 -65.75 3.97 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.366 -0.834 . . . . 0.46000000000000002 115.163 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.517 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.95 172.14 16.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 117.72 0.76 . . . . 1.8 112.694 -178.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.494 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -95.29 125.22 39.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.909 -1.515 . . . . 1.24 106.909 176.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.471 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.8 t -116.5 115.66 26.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.729 1.011 . . . . 1.28 113.729 -175.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.491 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 11.7 t -101.46 121.37 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.579 . . . . 0.58999999999999997 110.197 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 62.2 mm-40 -131.38 144.68 51.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.743 -0.662 . . . . 2.48 110.702 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -128.32 136.27 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 1.54 109.782 178.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.73 143.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.226 -0.897 . . . . 0.77000000000000002 111.428 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.35 139.56 49.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.516 -0.765 . . . . 1.97 111.275 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.73 -21.02 27.26 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.856 -0.687 . . . . 1.1200000000000001 111.427 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -158.75 -51.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 3.8100000000000001 109.809 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -178.8 155.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.703 -0.68 . . . . 3.8199999999999998 110.152 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.88 75.65 0.4 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.477 -0.329 . . . . 1.3999999999999999 111.351 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.53 166.21 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.139 -0.482 . . . . 2.0 109.929 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -36.93 110.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.973 1.782 . . . . 2.5800000000000001 111.799 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -71.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.458 -0.792 . . . . 3.71 112.268 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 63' ' ' THR . 22.3 t -87.02 132.77 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 120.185 -0.606 . . . . 0.92000000000000004 111.927 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.9 t -131.66 123.94 28.83 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 123.938 0.774 . . . . 1.2 111.103 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -117.21 38.77 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.955 1.094 . . . . 0.22 113.955 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.604 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -33.14 141.99 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.872 0.368 . . . . 1.02 111.038 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.604 ' H ' HD13 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -159.34 102.66 1.58 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 0.33000000000000002 110.487 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 12' ' ' TRP . 2.3 tt -112.74 123.16 68.14 Favored 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-O 122.829 1.3 . . . . 0.68999999999999995 112.724 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.81 165.87 13.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.78 -1.555 . . . . 1.26 109.228 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -120.47 143.05 48.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.007 1.484 . . . . 1.8200000000000001 115.007 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.11 -35.27 5.06 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 112.382 -2.19 . . . . 0.22 117.781 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.05 158.8 0.35 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.109 1.954 . . . . 0.28999999999999998 114.452 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.02 -16.79 37.09 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 115.114 -0.948 . . . . 0.56999999999999995 110.354 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.52 -22.83 67.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 2.3100000000000001 111.762 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -71.86 -62.95 1.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.728 -0.214 . . . . 2.3700000000000001 111.212 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 180' ' ' VAL . 4.3 p -46.98 103.32 0.35 Allowed Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.522 -0.308 . . . . 2.5699999999999998 111.404 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.19 133.03 35.13 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.073 1.849 . . . . 2.0800000000000001 112.798 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 25.8 ttt -152.3 106.19 3.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 6.04 110.515 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.5 mt -92.8 124.49 36.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 5.2999999999999998 111.031 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -63.82 149.67 92.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 8.0500000000000007 110.204 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.47 125.21 14.57 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.629 1.553 . . . . 9.1400000000000006 112.254 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -134.18 131.73 20.84 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 9.8699999999999992 110.299 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.38 -98.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.608 1.539 . . . . 11.69 111.739 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.29 156.87 22.73 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.808 -0.71 . . . . 12.619999999999999 112.775 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 189' ' ' LEU . 7.6 mp -102.1 159.1 15.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 14.44 110.714 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.244 -0.884 . . . . 15.699999999999999 110.615 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.384 -0.286 . . . . 9.1500000000000004 112.384 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.04 -5.08 45.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.766 0.317 . . . . 7.3600000000000003 110.928 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.6 ttp -104.33 77.51 1.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 7.7599999999999998 110.772 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.9 m -156.85 165.8 35.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 4.0199999999999996 110.798 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.52 -44.53 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 1.28 112.607 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.31 -45.27 16.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.341 0.591 . . . . 0.40999999999999998 110.287 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.598 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.6 -20.53 8.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.135 -0.939 . . . . 0.33000000000000002 111.515 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.75 -20.19 56.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.314 0.487 . . . . 2.0899999999999999 112.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 61.4 mttt -105.96 -21.83 13.05 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.441 -0.504 . . . . 1.99 111.773 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.1 p -43.93 145.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 121.03 -0.268 . . . . 0.20999999999999999 111.465 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.7 pt -136.55 -23.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 119.689 -0.804 . . . . 0.85999999999999999 110.998 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.553 ' O ' HG22 ' A' ' 172' ' ' ILE . 49.5 t90 -174.77 141.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.867 -0.419 . . . . 0.28000000000000003 109.867 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.67 145.29 15.72 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.191 0.441 . . . . 0.20000000000000001 112.191 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.73 131.88 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 114.251 1.204 . . . . 0.67000000000000004 114.251 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 14.8 t30 -115.42 94.59 4.78 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 114.441 -1.254 . . . . 1.27 109.71 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -61.34 96.04 0.05 Allowed 'General case' 0 C--O 1.252 1.222 0 N-CA-C 107.092 -1.447 . . . . 0.37 107.092 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -178.49 -63.86 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.533 -1.667 . . . . 0.67000000000000004 113.746 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.17 -120.0 4.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.597 -0.811 . . . . 1.1200000000000001 112.105 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.574 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -172.31 128.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.25 0.548 . . . . 2.02 110.818 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.2 m 42.27 82.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.004 -0.998 . . . . 1.22 112.445 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 56.5 t-80 -112.77 151.97 29.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.072 -0.651 . . . . 0.34000000000000002 111.807 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.3 t -124.84 103.77 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.374 -0.83 . . . . 1.1799999999999999 110.108 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.58 151.99 39.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.385 -0.37 . . . . 1.1699999999999999 110.228 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 m -43.38 -48.23 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.777 1.029 . . . . 0.59999999999999998 113.777 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.1 -18.52 47.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.274 0.559 . . . . 0.46000000000000002 110.422 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.09 34.62 3.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.318 -0.856 . . . . 0.28999999999999998 112.459 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.9 mm -103.16 123.7 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.217 -0.66 . . . . 0.42999999999999999 109.217 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.8 t60 -108.36 132.35 53.82 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.52000000000000002 114.151 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.25 132.66 42.78 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.232 -1.025 . . . . 3.0 108.232 176.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 20' ' ' SER . 80.0 mtp180 -47.67 -109.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.229 1.196 . . . . 2.8999999999999999 114.229 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 179.47 99.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.166 -0.47 . . . . 2.71 111.859 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.424 ' OD1' ' HD2' ' A' ' 65' ' ' ARG . 4.3 m-20 32.32 71.68 0.64 Allowed Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.507 0.558 . . . . 1.98 112.507 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.49 -71.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.679 2.253 . . . . 1.53 114.081 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -86.96 -11.8 49.47 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.558 0.577 . . . . 1.8300000000000001 112.558 -177.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.621 ' HB3' HH21 ' A' ' 65' ' ' ARG . 10.3 mm-40 -83.79 70.71 10.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 4.9500000000000002 111.394 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 78.41 -1.19 72.31 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.532 -0.842 . . . . 1.9399999999999999 111.694 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 38.66 43.59 0.71 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.078 0.466 . . . . 5.3600000000000003 111.37 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 36' ' ' GLY . 18.4 m -147.83 176.54 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.705 -0.68 . . . . 2.9700000000000002 110.361 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.45 136.83 16.02 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.663 -0.779 . . . . 1.99 112.538 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.578 ' HB3' HH12 ' A' ' 65' ' ' ARG . 76.0 ttt180 -163.31 -67.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.69 0.281 . . . . 6.5899999999999999 110.808 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.598 ' H ' ' NH1' ' A' ' 65' ' ' ARG . . . 56.36 72.71 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.182 -0.463 . . . . 2.0099999999999998 111.435 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.9 m -82.12 80.74 8.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.329 -0.396 . . . . 2.02 110.096 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 46' ' ' MET . 7.6 m-20 -80.51 60.92 4.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.834 -0.621 . . . . 2.23 111.319 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -82.35 152.24 26.34 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.544 -0.539 . . . . 2.3300000000000001 109.544 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.45 23.82 54.91 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.114 -1.041 . . . . 2.2000000000000002 110.93 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 43' ' ' ASP . 19.7 ttt -64.83 -0.51 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.247 -0.477 . . . . 1.9299999999999999 111.305 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 3.1 ttpm? -80.58 55.97 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.285 0.564 . . . . 3.3500000000000001 110.591 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 4.6 mt -155.34 61.38 2.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.599 -0.728 . . . . 2.7599999999999998 109.972 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 71.8 Cg_exo -55.28 105.48 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.774 2.316 . . . . 1.46 112.921 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 125' ' ' THR . 1.2 mp -52.76 129.59 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 120.81 0.338 . . . . 0.82999999999999996 110.194 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.0 mp -86.41 -177.65 6.25 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.439 -0.949 . . . . 1.6899999999999999 108.439 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 81.6 mtp180 70.01 -21.48 0.17 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.425 . . . . 2.5600000000000001 111.959 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 51' ' ' LEU . 2.7 t -105.39 172.7 6.65 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.065 0.46 . . . . 0.96999999999999997 111.229 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.5 t30 -90.24 148.57 39.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 109.051 -0.722 . . . . 1.96 109.051 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.638 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 18.0 Cg_exo -40.63 -51.41 3.54 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.179 1.919 . . . . 0.66000000000000003 114.065 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -63.68 -56.57 14.72 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.101 0.953 . . . . 1.8200000000000001 110.94 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -68.86 -12.06 61.16 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.694 -0.684 . . . . 1.9099999999999999 109.98 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.638 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.9 tt0 -63.51 -45.04 92.49 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.146 -1.798 . . . . 1.5 106.146 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -53.21 -50.17 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 114.432 -1.258 . . . . 1.22 109.186 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 7.1 tp -69.57 -11.33 60.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.087 -0.96 . . . . 1.05 111.465 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.44 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.5 m-30 -121.51 20.06 11.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.833 -0.621 . . . . 0.90000000000000002 111.246 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -139.64 -59.58 0.56 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.448 0.907 . . . . 1.8 113.448 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.52 ' O ' HG13 ' A' ' 167' ' ' VAL . 77.6 p -43.15 150.78 0.17 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.584 -0.28 . . . . 1.05 110.906 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.578 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -135.11 -30.49 1.05 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.913 1.449 . . . . 2.0499999999999998 114.913 -176.259 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.621 HH21 ' HB3' ' A' ' 35' ' ' GLU . 38.5 mtp85 68.57 -173.7 0.19 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.706 -0.479 . . . . 3.5800000000000001 109.706 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -77.37 156.06 31.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.721 0.296 . . . . 4.25 110.373 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -134.0 149.02 51.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.415 -0.357 . . . . 4.3499999999999996 111.054 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -130.04 -101.22 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.27 -0.423 . . . . 3.1699999999999999 111.444 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.76 130.03 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.761 0.315 . . . . 2.3900000000000001 111.403 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.466 ' H ' HD21 ' A' ' 164' ' ' ASN . 18.9 t 53.16 95.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.091 -0.504 . . . . 0.98999999999999999 111.507 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -162.66 164.73 26.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 1.26 111.235 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.58 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -164.69 -149.63 5.87 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.005 -1.093 . . . . 0.66000000000000003 114.605 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.534 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 2.2 m-85 -141.31 167.2 22.74 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.116 -0.542 . . . . 0.82999999999999996 111.455 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.33 134.35 55.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.144 -0.935 . . . . 2.27 110.892 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.49 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.5 mp -126.98 87.09 57.46 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.637 -0.256 . . . . 0.34000000000000002 111.48 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -57.56 119.79 7.28 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.875 1.717 . . . . 0.80000000000000004 112.011 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.71 151.44 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 0.38 111.191 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -144.49 3.99 1.17 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.209 -0.45 . . . . 2.96 111.559 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -128.62 171.07 12.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.459 0.171 . . . . 2.1299999999999999 110.76 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -127.09 169.1 13.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.37 111.783 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.18 -155.74 24.1 Favored Glycine 0 CA--C 1.512 -0.133 0 N-CA-C 109.644 -1.382 . . . . 0.20999999999999999 109.644 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.7 mt-10 -96.51 108.5 21.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.048 1.424 . . . . 2.0299999999999998 108.657 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.29 125.82 39.16 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.968 -0.753 . . . . 0.26000000000000001 108.968 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 177' ' ' ALA . 38.9 t -109.49 112.03 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 0.54000000000000004 111.289 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -103.11 104.83 15.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.789 -1.551 . . . . 1.23 110.537 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.26 142.56 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.527 -0.761 . . . . 1.3100000000000001 109.639 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.97 134.18 46.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.569 -0.452 . . . . 1.3700000000000001 111.168 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.622 ' HZ3' ' HB1' ' A' ' 126' ' ' ALA . 5.7 tptm -94.16 112.59 24.41 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.106 -1.442 . . . . 2.9700000000000002 107.106 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 14.7 m-85 -104.47 143.64 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.715 -0.476 . . . . 0.29999999999999999 109.715 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -149.76 161.09 42.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.117 -0.492 . . . . 0.40999999999999998 110.605 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 92' ' ' VAL . 38.5 tt0 -178.47 -102.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.383 0.135 . . . . 3.9700000000000002 111.119 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.406 ' N ' ' HG2' ' A' ' 91' ' ' GLU . 39.1 t 56.33 93.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.983 0.421 . . . . 3.8100000000000001 111.353 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -117.66 -34.39 4.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.901 -0.59 . . . . 2.8900000000000001 111.125 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -131.61 -1.89 3.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.469 -0.332 . . . . 2.0 111.138 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 59.34 94.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.429 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -151.74 142.92 23.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.257 -0.428 . . . . 2.96 110.976 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.455 ' HG ' ' HD2' ' A' ' 118' ' ' PHE . 32.5 m -113.05 156.92 22.25 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.569 0.581 . . . . 1.55 112.569 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 48.09 27.15 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.145 -0.934 . . . . 2.3300000000000001 112.091 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -129.63 -42.91 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 2.5099999999999998 109.423 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 93.0 mttt -92.47 78.02 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 3.1000000000000001 109.256 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.54 145.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 1.3100000000000001 109.705 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.17 178.03 7.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.601 0.593 . . . . 0.68999999999999995 112.601 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.46 137.76 54.73 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.262 -0.426 . . . . 2.0099999999999998 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.25 131.91 52.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.917 -0.583 . . . . 0.46000000000000002 112.323 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 6.7 mtt180 -133.48 146.79 51.44 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.997 0.74 . . . . 1.8500000000000001 112.997 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.8 m -117.14 114.26 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.074 -0.967 . . . . 1.1000000000000001 109.373 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.519 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 60.62 27.14 16.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.199 -0.667 . . . . 1.77 109.199 -176.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.49 10.12 62.32 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.126 -0.943 . . . . 0.40999999999999998 112.767 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.7 m-70 -107.46 113.28 26.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.026 0.75 . . . . 0.46000000000000002 113.026 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -64.66 128.95 37.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.178 -0.609 . . . . 0.66000000000000003 110.634 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.65 -30.87 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.198 -0.667 . . . . 0.80000000000000004 109.198 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.46 HG11 ' OE2' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -135.73 89.77 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.094 -0.706 . . . . 0.51000000000000001 109.094 177.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.1 OUTLIER -105.33 76.66 1.24 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 122.508 1.147 . . . . 2.4399999999999999 111.146 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.7 p30 154.5 28.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.079 -1.873 . . . . 2.5600000000000001 108.35 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 89' ' ' PHE . 16.6 tp -61.44 97.12 0.06 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.376 -0.829 . . . . 1.1000000000000001 112.386 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.5 t70 -107.07 93.9 4.81 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 114.669 -1.151 . . . . 1.99 108.345 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.9 mt -51.86 -51.66 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 114.069 1.137 . . . . 0.63 114.069 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.455 ' HD2' ' HG ' ' A' ' 97' ' ' SER . 87.9 t80 -53.51 -55.93 21.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.033 0.383 . . . . 0.90000000000000002 112.033 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.78 -27.55 68.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.569 0.581 . . . . 0.76000000000000001 112.569 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -67.68 -58.56 4.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.872 0.693 . . . . 2.6800000000000002 112.872 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -106.08 -40.85 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.11 0.411 . . . . 1.4099999999999999 112.11 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.44 -138.9 13.22 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.539 -0.839 . . . . 1.0600000000000001 113.185 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.567 ' O ' HG23 ' A' ' 125' ' ' THR . 17.2 p-80 -65.43 118.23 9.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.965 0.412 . . . . 3.5099999999999998 111.607 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.4 m 39.13 -116.75 0.2 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.576 -0.738 . . . . 1.6799999999999999 112.066 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 123' ' ' HIS . 66.0 p 51.65 -166.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.661 0.267 . . . . 0.80000000000000004 110.953 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.622 ' HB1' ' HZ3' ' A' ' 88' ' ' LYS . . . -113.58 139.09 49.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.753 0.649 . . . . 0.44 112.753 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.504 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.7 t60 -107.61 147.95 29.96 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.903 -0.777 . . . . 0.38 108.903 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -143.03 131.06 21.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.558 0.577 . . . . 2.0899999999999999 112.558 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.46 ' OE2' HG11 ' A' ' 112' ' ' VAL . 57.8 mt-10 -124.23 109.8 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.508 -0.769 . . . . 2.2799999999999998 109.73 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.538 ' O ' HD13 ' A' ' 131' ' ' ILE . 15.5 mt -94.94 130.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.066 -0.516 . . . . 0.70999999999999996 110.839 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 130' ' ' ILE . 43.8 mm -131.53 85.88 51.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.375 -0.375 . . . . 1.3799999999999999 111.902 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.59 144.62 97.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.694 1.596 . . . . 0.22 111.447 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 134' ' ' SER . 28.3 mt -136.33 159.41 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.20999999999999999 110.674 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 42.6 p -134.76 108.55 8.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 1.1100000000000001 111.132 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.515 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 26.6 mt -106.34 125.99 62.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.695 -0.684 . . . . 0.23000000000000001 109.979 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -150.97 144.04 24.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.699 0.285 . . . . 1.9099999999999999 110.802 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt 61.76 10.15 3.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 3.1099999999999999 111.468 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.01 37.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.621 -0.8 . . . . 0.32000000000000001 113.182 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 135' ' ' ILE . 59.6 mttp -119.99 160.46 22.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.075 0.437 . . . . 2.1899999999999999 110.772 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.76 131.53 56.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.089 0.471 . . . . 0.37 111.893 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.455 ' HB3' ' OG ' ' A' ' 134' ' ' SER . 22.9 t -116.54 116.64 27.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.631 -0.713 . . . . 0.90000000000000002 110.08 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 142' ' ' VAL . 8.0 p -113.03 111.48 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.288 0.566 . . . . 0.53000000000000003 111.551 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 50.27 -93.97 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.616 -0.72 . . . . 2.0499999999999998 112.441 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -123.94 34.79 3.46 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.544 -0.836 . . . . 0.59999999999999998 113.616 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -146.57 132.64 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.065 -0.346 . . . . 2.02 110.065 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.14 146.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.429 . . . . 1.3 111.566 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.6 m -161.12 171.27 18.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.779 -0.646 . . . . 1.1200000000000001 109.376 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 141.72 31.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.278 0.561 . . . . 1.1100000000000001 111.496 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -78.66 140.74 38.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.136 -0.938 . . . . 0.28000000000000003 109.653 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.5 p -139.99 95.28 2.87 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.673 0.62 . . . . 1.55 112.673 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.96 -57.73 2.24 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.833 1.093 . . . . 0.46000000000000002 115.833 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.66 174.99 12.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.023 0.912 . . . . 1.8 112.695 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.519 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 1.8 tt -101.9 129.03 48.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.407 -1.331 . . . . 1.24 107.407 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.506 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -116.51 114.37 24.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.696 -0.802 . . . . 1.28 112.851 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 43.7 t -93.1 105.09 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.039 -0.726 . . . . 0.58999999999999997 109.039 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.1 tt0 -118.4 128.43 54.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 2.48 111.414 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -120.99 145.83 47.34 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.166 0.508 . . . . 1.54 109.749 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 143.87 26.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 115.191 -0.913 . . . . 0.77000000000000002 111.261 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.459 ' O ' ' HD2' ' A' ' 159' ' ' LYS . 1.6 pptp? -83.89 148.48 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.471 -0.786 . . . . 1.97 111.394 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.68 0.51 55.41 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.923 -0.656 . . . . 1.1200000000000001 111.619 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -154.64 -76.25 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.847 -0.177 . . . . 3.8100000000000001 110.803 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -178.49 73.61 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.498 -0.319 . . . . 3.8199999999999998 110.713 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -174.37 -44.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.381 -0.372 . . . . 1.3999999999999999 111.165 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.466 HD21 ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 62.43 163.15 0.11 Allowed Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.545 -0.539 . . . . 2.0 109.545 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -44.47 103.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.325 1.35 . . . . 2.5800000000000001 111.272 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 6.7 tppt? -53.3 -66.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.301 -0.863 . . . . 3.71 112.088 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 64' ' ' GLU . 45.5 t -94.45 132.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 120.547 -0.461 . . . . 0.92000000000000004 111.749 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -135.29 127.77 30.56 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 113.194 0.813 . . . . 1.2 113.194 -178.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.41 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -122.24 38.56 4.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.697 -1.138 . . . . 0.22 112.647 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 171' ' ' PHE . 6.7 tp -46.79 130.38 11.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.094 0.473 . . . . 1.02 110.398 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -142.86 114.47 8.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.75 -0.659 . . . . 0.33000000000000002 110.373 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -113.92 123.88 70.02 Favored 'Isoleucine or valine' 0 C--O 1.263 1.77 0 CA-C-O 122.841 1.305 . . . . 0.68999999999999995 112.961 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -119.61 166.76 12.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.923 -1.49 . . . . 1.26 109.886 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 8.9 ptmt -120.71 144.67 48.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.008 1.484 . . . . 1.8200000000000001 115.008 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 100.64 -36.31 4.24 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 112.417 -2.174 . . . . 0.22 118.181 174.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.87 158.44 0.43 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.57 2.185 . . . . 0.28999999999999998 114.324 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.648 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.34 -26.93 24.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.953 -1.022 . . . . 0.56999999999999995 110.37 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.33 -24.71 45.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.693 -0.685 . . . . 2.3100000000000001 111.149 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.89 -45.42 78.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 2.3700000000000001 110.389 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.8 t -34.09 98.79 0.15 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 123.573 0.545 . . . . 2.5699999999999998 111.85 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -51.05 127.08 20.6 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.913 1.742 . . . . 2.0800000000000001 112.16 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -83.0 143.61 30.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.501 . . . . 6.04 110.735 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 183' ' ' LEU . 7.5 mp -91.53 111.68 23.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 5.2999999999999998 110.253 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -52.94 142.54 34.59 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.186 -0.461 . . . . 8.0500000000000007 110.519 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -44.48 137.44 8.24 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 121.793 1.662 . . . . 9.1400000000000006 112.343 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -134.13 124.92 17.71 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.41 -0.359 . . . . 9.8699999999999992 110.605 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -84.5 -157.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.185 1.923 . . . . 11.69 111.529 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.28 41.08 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.42 -0.895 . . . . 12.619999999999999 112.495 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.54 154.38 23.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.748 0.309 . . . . 14.44 110.697 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 15.699999999999999 110.885 179.848 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.528 -0.229 . . . . 9.1500000000000004 112.528 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.99 81.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 7.3600000000000003 110.84 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 tpt -158.68 139.18 12.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 7.7599999999999998 110.692 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t 57.29 92.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.184 -0.462 . . . . 4.0199999999999996 110.975 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.13 91.94 0.21 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.769 . . . . 1.28 112.574 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 180' ' ' VAL . 19.1 tp -68.63 -39.25 80.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.33 0.586 . . . . 0.40999999999999998 110.272 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.2 -19.87 9.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.262 -0.881 . . . . 0.33000000000000002 110.877 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.17 -20.06 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.058 0.392 . . . . 2.0899999999999999 112.058 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -103.5 -28.4 11.79 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.623 -0.431 . . . . 1.99 111.02 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -42.06 147.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.677 0.275 . . . . 0.20999999999999999 111.601 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -139.6 -22.64 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.815 -0.754 . . . . 0.85999999999999999 111.085 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.501 ' O ' HG22 ' A' ' 172' ' ' ILE . 32.7 t90 -173.39 139.71 0.78 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.626 -0.429 . . . . 0.28000000000000003 110.011 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.04 146.04 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.605 0.224 . . . . 0.20000000000000001 111.605 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -146.99 126.7 4.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 114.255 1.206 . . . . 0.67000000000000004 114.255 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.522 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 5.8 t30 -115.37 97.13 6.0 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.619 -0.718 . . . . 1.27 110.146 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.51 107.33 3.33 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 120.552 -0.459 . . . . 0.37 110.13 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.6 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 166.14 -74.75 0.15 Allowed Glycine 0 C--N 1.338 0.687 0 O-C-N 124.675 1.234 . . . . 0.67000000000000004 112.662 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.458 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -85.62 -125.13 1.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.883 -0.675 . . . . 1.1200000000000001 111.993 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -168.0 120.67 0.88 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.65 0.738 . . . . 2.02 111.214 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.724 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 47.61 95.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.319 -1.31 . . . . 1.22 113.009 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 50.2 t-80 -125.46 137.08 53.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 118.988 -1.085 . . . . 0.34000000000000002 113.069 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.0 t -107.43 101.59 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.588 -1.187 . . . . 1.1799999999999999 109.912 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -67.12 157.82 32.69 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.85 -0.613 . . . . 1.1699999999999999 110.627 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.26 -55.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 124.849 1.343 . . . . 0.59999999999999998 112.828 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -55.53 -22.74 22.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.126 0.489 . . . . 0.46000000000000002 110.339 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.43 36.03 2.75 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.394 -0.821 . . . . 0.28999999999999998 112.165 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.442 HD11 ' HG ' ' A' ' 6' ' ' LEU . 35.9 mm -103.33 125.49 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.655 -0.498 . . . . 0.42999999999999999 109.655 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.4 t60 -106.34 131.32 53.69 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.76 1.393 . . . . 0.52000000000000002 114.76 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.78 140.84 34.5 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.956 -1.128 . . . . 3.0 107.956 175.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' SER . 77.2 mtp180 -63.31 -137.68 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.383 0.427 . . . . 2.8999999999999999 111.135 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.8 100.01 3.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.364 0.266 . . . . 2.71 111.484 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 34.9 t70 35.59 69.78 1.09 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 111.985 0.365 . . . . 1.98 111.985 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -98.98 24.53 0.2 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.852 2.368 . . . . 1.53 114.496 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 72' ' ' GLY . 45.1 tp -142.08 -66.34 0.4 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.564 -0.454 . . . . 1.8300000000000001 111.622 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 37' ' ' ARG . 9.8 mm-40 -67.69 94.82 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 4.9500000000000002 110.454 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.54 -22.45 3.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.761 -0.733 . . . . 1.9399999999999999 111.603 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 5.8 mtp180 45.08 25.95 0.2 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.801 0.44 . . . . 5.3600000000000003 111.545 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.21 145.87 17.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 2.9700000000000002 110.945 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.81 -164.93 12.31 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.695 -0.764 . . . . 1.99 112.918 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -128.52 -171.04 2.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.648 0.261 . . . . 6.5899999999999999 110.731 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.82 167.3 0.59 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.19 0.519 . . . . 2.0099999999999998 111.194 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.409 ' N ' ' NH2' ' A' ' 65' ' ' ARG . 75.3 m -149.87 33.11 0.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.475 -0.784 . . . . 2.02 109.527 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -43.41 93.74 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.138 -0.937 . . . . 2.23 111.449 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -112.28 -67.26 1.01 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 2.3300000000000001 110.268 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.85 33.58 3.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 2.2000000000000002 111.429 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.8 ttt -62.5 -8.73 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 1.9299999999999999 111.302 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 48' ' ' LEU . 87.9 tttt -53.96 163.33 0.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.355 -0.384 . . . . 3.3500000000000001 110.523 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.465 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 3.6 mt 67.47 66.48 0.62 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 2.7599999999999998 110.867 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' O ' HD12 ' A' ' 51' ' ' LEU . 84.9 Cg_exo -54.92 124.86 17.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.633 2.222 . . . . 1.46 112.061 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.74 124.68 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.333 0.587 . . . . 0.82999999999999996 110.043 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 49' ' ' PRO . 10.3 mp -76.89 -47.78 20.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.784 1.031 . . . . 1.6899999999999999 113.784 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -70.06 26.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.268 0.84 . . . . 2.5600000000000001 113.268 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 51' ' ' LEU . 8.1 t -147.79 156.79 43.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.09 0.472 . . . . 0.96999999999999997 111.637 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 58' ' ' GLN . 7.9 t30 -71.95 148.22 91.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.729 -0.669 . . . . 1.96 109.878 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.608 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.16 -54.67 2.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.525 2.15 . . . . 0.66000000000000003 114.615 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.39 -57.95 9.44 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.88 0.848 . . . . 1.8200000000000001 110.994 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 23.8 t70 -69.04 -6.57 28.91 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.723 -0.671 . . . . 1.9099999999999999 109.623 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 12.5 tt0 -69.2 -42.44 75.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.61 -1.626 . . . . 1.5 106.61 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.65 -57.61 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 114.329 -1.305 . . . . 1.22 109.158 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.41 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 6.3 tt -54.31 -61.04 2.56 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.547 -0.751 . . . . 1.05 109.345 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.551 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 2.3 m-85 -52.79 -15.14 0.66 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.585 -0.734 . . . . 0.90000000000000002 111.097 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 63' ' ' THR . 7.0 tt0 -119.63 -117.94 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.661 0.615 . . . . 1.8 112.661 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.572 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 2.7 p 36.44 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.623 0.769 . . . . 1.05 112.669 -176.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.6 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.7 pt-20 -101.53 146.34 27.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.309 0.855 . . . . 2.0499999999999998 113.309 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HD3' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -104.43 -144.43 0.37 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.723 -1.126 . . . . 3.5800000000000001 109.935 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.35 -175.51 2.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.496 0.189 . . . . 4.25 110.543 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -138.63 160.05 40.58 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.82 0.343 . . . . 4.3499999999999996 111.482 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -154.6 -103.75 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.144 -0.48 . . . . 3.1699999999999999 111.024 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -174.41 124.85 0.31 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.495 0.188 . . . . 2.3900000000000001 110.803 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.543 ' H ' HD21 ' A' ' 164' ' ' ASN . 21.0 t 50.33 96.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.347 -0.388 . . . . 0.98999999999999999 111.699 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -166.31 167.09 16.26 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.217 -0.447 . . . . 1.26 111.105 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.45 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -174.28 -170.59 37.72 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.28 -0.962 . . . . 0.66000000000000003 114.045 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -109.31 169.56 8.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.532 0.682 . . . . 0.82999999999999996 112.532 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.23 136.65 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.612 -1.176 . . . . 2.27 110.439 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.449 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.4 mp -127.25 86.84 57.81 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 112.153 0.427 . . . . 0.34000000000000002 112.153 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -54.41 130.34 39.45 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.244 1.963 . . . . 0.80000000000000004 112.418 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 74.2 mt -126.48 150.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.206 -0.452 . . . . 0.38 111.294 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -142.86 0.75 1.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 2.96 111.201 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.11 170.11 12.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.477 0.179 . . . . 2.1299999999999999 110.769 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.53 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.04 171.24 9.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.339 0.59 . . . . 0.37 111.912 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.44 -155.58 23.06 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 109.8 -1.32 . . . . 0.20999999999999999 109.8 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.1 mt-10 -97.41 108.38 21.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.128 1.464 . . . . 2.0299999999999998 109.107 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -95.57 126.47 40.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.926 -0.71 . . . . 0.26000000000000001 109.22 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 177' ' ' ALA . 16.1 t -112.68 113.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.906 -1.043 . . . . 0.54000000000000004 111.386 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tt -95.67 104.02 15.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.566 -1.197 . . . . 1.23 110.445 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.15 126.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 114.507 -1.224 . . . . 1.3100000000000001 108.705 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.753 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.8 pp -135.67 141.15 44.95 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.569 -0.852 . . . . 1.3700000000000001 111.04 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.735 ' HZ3' ' HA ' ' A' ' 126' ' ' ALA . 0.6 OUTLIER -107.13 124.29 49.48 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.282 -0.967 . . . . 2.9700000000000002 109.495 177.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CD2' HD21 ' A' ' 115' ' ' LEU . 7.7 m-85 -105.73 142.36 35.6 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.398 -0.819 . . . . 0.29999999999999999 109.305 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -138.21 150.29 46.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.979 0.419 . . . . 0.40999999999999998 111.117 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.73 125.32 19.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 3.9700000000000002 110.048 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.0 m -142.28 60.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.786 0.327 . . . . 3.8100000000000001 111.84 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -149.49 -34.7 0.18 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.906 0.336 . . . . 2.8900000000000001 111.906 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -133.98 169.09 17.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.0 0.429 . . . . 2.0 111.22 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.67 98.86 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.811 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -161.22 140.65 10.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 2.96 110.742 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.6 m -107.26 150.47 26.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.07 -0.514 . . . . 1.55 112.277 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 47.24 39.93 9.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.518 -0.764 . . . . 2.3300000000000001 111.842 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -133.48 -48.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.751 -0.463 . . . . 2.5099999999999998 109.751 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -98.05 86.8 3.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.829 -0.623 . . . . 3.1000000000000001 109.558 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.0 144.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 1.3100000000000001 109.461 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -130.45 178.59 6.48 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.633 0.605 . . . . 0.68999999999999995 112.633 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -122.05 139.65 53.45 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.94 -0.304 . . . . 2.0099999999999998 111.154 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.1 132.05 52.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-N 116.084 -0.507 . . . . 0.46000000000000002 112.138 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.54 HH21 HG21 ' A' ' 158' ' ' VAL . 8.5 mtt180 -133.72 156.48 47.87 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 113.234 0.827 . . . . 1.8500000000000001 113.234 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 25.3 m -122.15 119.27 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 114.853 -1.067 . . . . 1.1000000000000001 109.049 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.416 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 56.27 26.39 10.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.922 -0.77 . . . . 1.77 108.922 -175.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.29 39.64 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.40999999999999998 112.784 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -117.83 112.11 19.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.943 0.72 . . . . 0.46000000000000002 112.943 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -61.84 127.67 32.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.634 -0.426 . . . . 0.66000000000000003 111.24 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 t -123.64 -32.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.107 -0.701 . . . . 0.80000000000000004 109.107 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.99 90.18 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.078 -0.712 . . . . 0.51000000000000001 109.078 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 16.1 ptpt -107.53 100.91 10.29 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.032 0.92 . . . . 2.4399999999999999 111.76 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 18.5 m-20 131.2 27.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.27 -2.241 . . . . 2.5600000000000001 108.037 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 89' ' ' PHE . 45.4 tp -56.41 96.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.952 -1.022 . . . . 1.1000000000000001 112.636 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -108.23 92.31 4.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.605 -1.18 . . . . 1.99 107.829 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 121' ' ' VAL . 43.3 mt -51.88 -35.95 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.47 0.915 . . . . 0.63 113.47 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -69.2 -54.64 13.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.304 0.483 . . . . 0.90000000000000002 112.304 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.98 -27.28 66.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.545 0.572 . . . . 0.76000000000000001 112.545 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -72.66 -58.27 3.49 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.879 0.696 . . . . 2.6800000000000002 112.879 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 117' ' ' ILE . 8.5 p -97.48 -35.15 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.129 0.418 . . . . 1.4099999999999999 112.129 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.8 -129.2 8.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.651 -0.785 . . . . 1.0600000000000001 112.368 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -88.82 110.47 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.642 0.258 . . . . 3.5099999999999998 110.619 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.3 t 51.46 -108.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 1.6799999999999999 110.529 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.4 p 48.46 -171.77 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.532 0.206 . . . . 0.80000000000000004 111.325 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.735 ' HA ' ' HZ3' ' A' ' 88' ' ' LYS . . . -102.85 121.95 43.54 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.305 0.854 . . . . 0.44 113.305 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.568 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.1 t60 -100.35 135.35 41.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.816 -1.179 . . . . 0.38 107.816 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -145.39 130.55 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.075 0.768 . . . . 2.0899999999999999 113.075 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -111.34 125.9 54.34 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.224 -0.898 . . . . 2.2799999999999998 109.403 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -105.86 110.1 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.70999999999999996 109.534 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.12 86.03 25.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.744 0.646 . . . . 1.3799999999999999 112.744 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 140.03 75.57 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.875 1.717 . . . . 0.22 111.622 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.0 mt -132.13 156.14 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.20999999999999999 110.631 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 19.4 p -130.73 106.76 8.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.121 0.486 . . . . 1.1100000000000001 110.719 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 24.0 mt -107.08 121.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.602 -0.726 . . . . 0.23000000000000001 109.867 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -145.53 141.22 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.577 -0.283 . . . . 1.9099999999999999 110.571 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm 60.72 20.7 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.56 . . . . 3.1099999999999999 110.984 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.02 60.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.32000000000000001 113.151 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' HG23 ' A' ' 135' ' ' ILE . 3.6 mmmm -117.83 155.52 29.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.864 0.332 . . . . 2.1899999999999999 110.32 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -115.22 131.36 56.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.077 0.465 . . . . 0.37 112.12 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.507 ' N ' HD23 ' A' ' 140' ' ' LEU . 20.8 t -117.9 111.2 18.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.63 -0.714 . . . . 0.90000000000000002 109.5 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 142' ' ' VAL . 6.5 p -107.33 102.27 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.03 -0.532 . . . . 0.53000000000000003 111.218 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.29 -92.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.904 -0.589 . . . . 2.0499999999999998 111.66 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.44 6.21 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.59999999999999998 113.18 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.4 132.26 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.203 -0.295 . . . . 2.02 110.203 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.5 p -105.48 140.69 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.198 0.523 . . . . 1.3 111.658 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.1 m -154.03 173.01 16.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.421 -0.809 . . . . 1.1200000000000001 109.621 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.28 136.66 38.92 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.86 -0.336 . . . . 1.1100000000000001 111.163 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 40.3 t80 -79.72 136.68 36.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.117 -1.068 . . . . 0.28000000000000003 108.117 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.2 m -148.56 95.11 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.835 -0.746 . . . . 1.55 112.495 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.84 -70.0 1.87 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.121 0.809 . . . . 0.46000000000000002 115.121 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.623 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -149.98 178.17 9.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.776 0.788 . . . . 1.8 112.945 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.407 HD12 HD11 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -103.0 128.07 49.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.416 -1.327 . . . . 1.24 107.416 177.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.416 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 6.7 t -117.16 118.45 32.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.359 1.244 . . . . 1.28 114.359 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 86.9 t -93.96 99.29 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.471 -0.937 . . . . 0.58999999999999997 108.471 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.7 tt0 -109.69 129.04 55.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.588 -0.733 . . . . 2.48 111.763 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -121.71 135.6 54.95 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.018 -0.537 . . . . 1.54 110.004 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.54 HG21 HH21 ' A' ' 105' ' ' ARG . 11.0 t -109.98 143.87 19.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.043 -0.98 . . . . 0.77000000000000002 111.482 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -59.17 143.37 49.11 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.167 -0.924 . . . . 1.97 111.09 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -120.39 -16.01 4.84 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.951 -0.642 . . . . 1.1200000000000001 111.912 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -156.44 -61.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 3.8100000000000001 110.148 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -177.54 151.2 0.73 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.835 -0.621 . . . . 3.8199999999999998 110.188 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.95 82.09 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.73 0.3 . . . . 1.3999999999999999 110.857 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.543 HD21 ' H ' ' A' ' 70' ' ' SER . 2.9 m-20 -47.3 159.02 0.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 2.0 110.325 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 164' ' ' ASN . 2.8 Cg_exo -32.22 102.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.39 2.06 . . . . 2.5800000000000001 111.711 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.589 ' NZ ' ' HB2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -56.9 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.026 -0.988 . . . . 3.71 113.19 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 11.6 t -91.62 134.45 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 120.246 -0.582 . . . . 0.92000000000000004 112.295 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.7 t -130.89 136.47 48.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.818 -0.628 . . . . 1.2 112.102 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -129.42 34.44 4.37 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.304 0.853 . . . . 0.22 113.304 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -36.53 136.76 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.563 0.579 . . . . 1.02 112.563 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -154.84 101.68 2.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.791 -0.641 . . . . 0.33000000000000002 110.777 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -109.09 128.14 65.22 Favored 'Isoleucine or valine' 0 C--O 1.262 1.761 0 CA-C-O 122.874 1.321 . . . . 0.68999999999999995 112.428 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.419 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.3 ppp? -121.35 166.61 13.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.423 -1.717 . . . . 1.26 109.636 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -120.37 153.24 36.77 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 115.262 1.579 . . . . 1.8200000000000001 115.262 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 92.1 -35.06 4.13 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 111.93 -2.395 . . . . 0.22 117.725 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.94 159.91 0.63 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.035 1.918 . . . . 0.28999999999999998 113.962 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.63 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.17 -36.9 20.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.368 -0.833 . . . . 0.56999999999999995 111.688 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -64.82 -15.26 61.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.42 . . . . 2.3100000000000001 111.966 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.94 -5.45 55.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.639 0.257 . . . . 2.3700000000000001 111.219 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.757 ' O ' HD22 ' A' ' 6' ' ' LEU . 4.1 t -48.13 -57.94 9.19 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.706 0.632 . . . . 2.5699999999999998 112.706 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.71 161.87 41.88 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.408 1.406 . . . . 2.0800000000000001 112.59 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.1 ttt -101.31 94.8 6.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 6.04 110.438 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.5 mt -78.64 142.0 37.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 5.2999999999999998 111.067 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -82.18 143.55 49.08 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.945 -0.571 . . . . 8.0500000000000007 110.213 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -44.9 135.5 10.28 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 121.707 1.605 . . . . 9.1400000000000006 112.221 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -134.4 133.29 21.47 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.765 -0.374 . . . . 9.8699999999999992 110.643 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.03 -93.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.55 1.5 . . . . 11.69 111.675 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.63 110.74 1.13 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.953 -0.642 . . . . 12.619999999999999 112.616 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.0 mm? -92.97 88.53 6.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 14.44 110.372 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.263 -0.875 . . . . 15.699999999999999 110.856 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 112.482 -0.247 . . . . 9.1500000000000004 112.482 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.22 -25.91 42.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.331 . . . . 7.3600000000000003 110.843 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' A' ' 3' ' ' MET . 1.8 mpt? -89.14 123.46 33.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 7.7599999999999998 110.599 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 t -149.06 -17.53 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.274 -0.421 . . . . 4.0199999999999996 110.804 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.09 -44.61 1.35 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.77 -0.728 . . . . 1.28 112.589 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.44 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.9 tp -83.36 -41.95 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.258 0.552 . . . . 0.40999999999999998 110.496 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.613 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.75 -20.89 24.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.4 -0.818 . . . . 0.33000000000000002 110.985 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.6 -15.74 61.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 2.0899999999999999 111.754 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 41.4 mmtt -107.92 -27.08 10.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.852 -0.339 . . . . 1.99 111.486 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.0 p -42.87 145.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 111.883 0.327 . . . . 0.20999999999999999 111.883 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.07 -23.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 119.981 -0.688 . . . . 0.85999999999999999 111.352 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.639 ' O ' HG22 ' A' ' 172' ' ' ILE . 27.0 t90 -172.25 127.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.773 -0.371 . . . . 0.28000000000000003 110.124 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.21 143.65 29.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.816 -0.175 . . . . 0.20000000000000001 110.871 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -146.6 126.44 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 114.36 1.244 . . . . 0.67000000000000004 114.36 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -115.3 95.11 5.02 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.165 -0.614 . . . . 1.27 110.454 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.865 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -67.53 116.16 7.95 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.525 -0.761 . . . . 0.37 109.64 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.597 ' HA3' ' C ' ' A' ' 63' ' ' THR . . . 145.35 -51.8 0.6 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.706 -1.588 . . . . 0.67000000000000004 112.157 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.01 -143.8 15.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.896 -0.669 . . . . 1.1200000000000001 112.211 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.16 119.41 5.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.604 0.202 . . . . 2.02 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 80.6 p 36.36 99.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.76 0.663 . . . . 1.22 112.584 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.555 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 58.1 t-80 -122.85 151.94 41.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.267 -0.573 . . . . 0.34000000000000002 112.47 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -122.32 103.5 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.224 -0.898 . . . . 1.1799999999999999 109.784 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.7 153.43 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 1.1699999999999999 110.523 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 25' ' ' HIS . 17.8 m -43.31 -52.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 124.217 0.948 . . . . 0.59999999999999998 113.382 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.473 ' N ' HG23 ' A' ' 24' ' ' VAL . 82.6 m-70 -57.99 -18.74 25.84 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.12 0.486 . . . . 0.46000000000000002 110.609 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.32 36.29 3.38 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.435 -0.802 . . . . 0.28999999999999998 112.334 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.44 HD11 ' HG ' ' A' ' 6' ' ' LEU . 31.1 mm -103.3 122.5 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.401 -0.592 . . . . 0.42999999999999999 109.401 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.555 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.5 t60 -105.71 133.05 51.07 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 114.456 1.28 . . . . 0.52000000000000002 114.456 -176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.2 134.6 41.81 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.323 -0.991 . . . . 3.0 108.323 176.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 15.9 ptm180 -96.33 114.11 25.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.362 0.601 . . . . 2.8999999999999999 112.255 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -12.05 139.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.234 1.568 . . . . 2.71 115.234 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 65' ' ' ARG . 8.3 p-10 -22.68 89.23 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 114.066 -1.425 . . . . 1.98 113.67 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -101.65 19.86 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.909 2.406 . . . . 1.53 113.454 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -134.46 -37.82 0.85 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 122.251 -0.281 . . . . 1.8300000000000001 111.606 -179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.634 ' N ' HD23 ' A' ' 34' ' ' LEU . 5.9 tt0 -76.55 71.17 3.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 4.9500000000000002 110.455 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 74.22 0.7 58.04 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.713 -1.355 . . . . 1.9399999999999999 109.713 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 47.77 23.14 0.41 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.552 -0.824 . . . . 5.3600000000000003 110.582 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.94 144.7 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.377 -0.829 . . . . 2.9700000000000002 110.137 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.1 -166.54 28.95 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.32 -0.943 . . . . 1.99 113.066 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -150.91 74.0 1.14 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.92 0.391 . . . . 6.5899999999999999 110.916 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.799 ' H ' HH22 ' A' ' 65' ' ' ARG . . . 58.18 179.82 0.06 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.328 0.585 . . . . 2.0099999999999998 111.836 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.0 p -170.61 23.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.313 -0.858 . . . . 2.02 109.639 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -52.35 137.17 29.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.467 -0.788 . . . . 2.23 111.397 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -87.77 -15.88 35.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.812 -0.631 . . . . 2.3300000000000001 110.034 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.36 101.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.74 -0.664 . . . . 2.2000000000000002 112.204 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 50.4 mtt -58.85 -42.3 89.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.958 0.408 . . . . 1.9299999999999999 110.638 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -66.93 80.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.664 -0.698 . . . . 3.3500000000000001 110.607 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.2 68.36 0.22 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.954 -0.566 . . . . 2.7599999999999998 110.015 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.89 131.08 24.54 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.063 1.842 . . . . 1.46 111.823 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.681 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.2 tp -54.45 -43.85 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.11 -0.495 . . . . 0.82999999999999996 110.172 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.681 ' HB2' ' O ' ' A' ' 50' ' ' ILE . 2.6 tt 130.67 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.869 1.667 . . . . 1.6899999999999999 111.652 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.83 24.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.528 0.566 . . . . 2.5600000000000001 112.528 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -136.6 157.95 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.612 . . . . 0.96999999999999997 112.65 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLN . 35.8 t30 -70.86 153.16 94.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.05 -0.977 . . . . 1.96 108.788 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.454 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 59.7 Cg_exo -45.86 -59.53 1.16 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.499 1.466 . . . . 0.66000000000000003 112.872 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 1.3 pm0 -56.18 -54.84 40.39 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 122.174 0.988 . . . . 1.8200000000000001 111.026 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.51 -13.91 62.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.42 -0.809 . . . . 1.9099999999999999 110.958 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' ASN . 1.6 pt20 -65.27 -40.21 93.62 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.342 -1.725 . . . . 1.5 106.342 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -56.16 -52.33 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.668 -1.151 . . . . 1.22 109.145 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.4 tp -70.31 -9.14 55.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.209 -0.905 . . . . 1.05 111.772 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -119.7 15.08 12.71 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.458 0.646 . . . . 0.90000000000000002 110.018 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.559 ' O ' HG13 ' A' ' 167' ' ' VAL . 48.1 tt0 -136.51 -105.37 0.2 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.911 -1.041 . . . . 1.8 110.249 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.597 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 37.4 p 4.6 121.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.485 0.92 . . . . 1.05 113.485 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.493 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 9.5 pt-20 -111.59 150.74 29.63 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.067 0.765 . . . . 2.0499999999999998 113.067 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.799 HH22 ' H ' ' A' ' 41' ' ' ALA . 1.3 ttt85 -137.25 88.39 2.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.119 -0.946 . . . . 3.5800000000000001 109.809 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -84.48 145.74 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 4.25 111.464 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -117.95 -78.99 0.59 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.894 -0.594 . . . . 4.3499999999999996 110.805 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -155.98 -89.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.449 -0.342 . . . . 3.1699999999999999 111.029 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -157.57 155.35 30.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.384 0.135 . . . . 2.3900000000000001 110.77 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t 47.87 86.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.98999999999999999 110.313 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.454 ' CE2' ' ND2' ' A' ' 164' ' ' ASN . 2.0 p90 -156.13 166.21 34.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 1.26 111.441 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.659 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -176.36 -174.92 43.27 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.923 -1.132 . . . . 0.66000000000000003 114.213 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.2 173.13 6.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 0.82999999999999996 112.265 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.5 137.14 53.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.804 -1.089 . . . . 2.27 110.212 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.486 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -128.32 87.62 54.78 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.975 0.361 . . . . 0.34000000000000002 111.975 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.94 131.35 44.97 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 121.815 1.677 . . . . 0.80000000000000004 111.711 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 78' ' ' LYS . 65.4 mt -123.2 153.74 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.883 0.373 . . . . 0.38 111.643 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' N ' HG22 ' A' ' 77' ' ' ILE . 26.4 mtmm -143.44 -0.51 1.09 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.036 -0.529 . . . . 2.96 111.597 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -124.77 167.95 13.9 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 120.77 0.319 . . . . 2.1299999999999999 111.2 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -123.99 164.05 20.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.232 0.539 . . . . 0.37 110.877 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.9 -146.43 17.24 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 109.729 -1.349 . . . . 0.20999999999999999 109.729 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 10.8 mm-40 -103.93 108.37 19.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.685 1.243 . . . . 2.0299999999999998 109.146 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.438 ' CZ ' ' HD3' ' A' ' 174' ' ' LYS . 3.9 m-85 -94.44 126.42 39.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.26000000000000001 108.73 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 177' ' ' ALA . 23.0 t -112.45 110.97 34.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.096 -0.956 . . . . 0.54000000000000004 111.323 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -97.51 103.65 15.6 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.571 -1.195 . . . . 1.23 110.684 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.42 139.58 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.507 -1.224 . . . . 1.3100000000000001 108.473 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.38 152.3 40.51 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.838 -0.745 . . . . 1.3700000000000001 111.826 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 15.3 tptt -108.41 117.74 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.06 -0.656 . . . . 2.9700000000000002 110.615 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.9 m-85 -105.23 145.07 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.169 -1.049 . . . . 0.29999999999999999 108.169 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -157.74 175.4 13.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 119.136 -1.025 . . . . 0.40999999999999998 113.53 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 65.59 147.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.675 -1.148 . . . . 3.9700000000000002 111.823 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.403 ' C ' ' H ' ' A' ' 94' ' ' PHE . 8.1 t -141.09 -25.87 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.662 -0.699 . . . . 3.8100000000000001 110.789 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 68.82 -4.25 1.24 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.831 -0.622 . . . . 2.8900000000000001 110.718 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 92' ' ' VAL . 86.3 m-85 -145.26 -165.55 2.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.019 -0.537 . . . . 2.0 109.854 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.11 100.11 2.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.297 . . . . 1.0 111.543 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.425 ' HG2' ' NE2' ' A' ' 99' ' ' GLN . 50.6 tp60 -174.41 140.67 0.65 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.208 -0.451 . . . . 2.96 110.982 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.8 m -97.18 153.97 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 1.55 111.056 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 54.75 55.93 7.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.576 . . . . 2.3300000000000001 111.277 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.425 ' NE2' ' HG2' ' A' ' 96' ' ' GLN . 9.2 tt0 -151.16 -51.09 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.128 -0.693 . . . . 2.5099999999999998 109.128 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 30.2 mmtm -90.48 78.26 6.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.729 -0.841 . . . . 3.1000000000000001 108.729 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.49 111.72 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.587 -0.733 . . . . 1.3100000000000001 110.437 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.66 178.79 4.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.219 0.822 . . . . 0.68999999999999995 113.219 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.8 139.97 53.45 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 115.83 -0.623 . . . . 2.0099999999999998 111.618 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.4 133.2 33.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 115.99 -0.55 . . . . 0.46000000000000002 111.752 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.629 HH21 HG21 ' A' ' 158' ' ' VAL . 1.0 OUTLIER -133.69 152.26 51.84 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 112.94 0.719 . . . . 1.8500000000000001 112.94 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.6 m -118.17 117.57 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.864 -1.062 . . . . 1.1000000000000001 109.224 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.467 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 58.55 27.05 15.12 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.043 -0.725 . . . . 1.77 109.043 -176.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.69 20.52 43.66 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.976 -1.011 . . . . 0.40999999999999998 112.734 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.0 m-70 -118.18 109.59 16.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.076 0.769 . . . . 0.46000000000000002 113.076 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.4 p -62.91 118.28 7.56 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.543 -0.463 . . . . 0.66000000000000003 111.207 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.82 -32.77 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.044 -0.724 . . . . 0.80000000000000004 109.044 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.405 HG11 ' OE2' ' A' ' 129' ' ' GLU . 0.9 OUTLIER -131.9 91.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.905 -0.589 . . . . 0.51000000000000001 109.822 178.522 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 16.9 ttmt -107.17 82.34 1.66 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.771 0.796 . . . . 2.4399999999999999 110.283 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.8 p30 151.8 39.8 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.975 -1.92 . . . . 2.5600000000000001 108.594 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.16 88.13 0.17 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.066 0.765 . . . . 1.1000000000000001 113.066 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -103.29 86.13 2.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.366 -1.346 . . . . 1.99 107.366 175.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 46.0 mt -50.52 -44.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.806 -0.634 . . . . 0.63 112.095 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.73 -58.66 6.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.90000000000000002 111.247 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.402 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 15.1 t70 -58.97 -27.03 64.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 0.76000000000000001 112.034 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -64.61 -59.63 4.06 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.286 0.476 . . . . 2.6800000000000002 112.286 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.23 -40.81 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.108 0.411 . . . . 1.4099999999999999 112.108 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.92 -129.45 3.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.566 -0.826 . . . . 1.0600000000000001 112.65 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' THR . 22.3 t-80 -94.34 110.92 22.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 3.5099999999999998 110.971 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.8 t 63.28 -130.56 0.47 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.843 -0.617 . . . . 1.6799999999999999 111.195 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 4.4 p 58.83 -166.72 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.659 0.266 . . . . 0.80000000000000004 110.351 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.5 135.05 49.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.969 0.729 . . . . 0.44 112.969 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.2 t60 -112.54 148.88 33.57 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -144.47 135.53 25.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.896 0.702 . . . . 2.0899999999999999 112.896 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.405 ' OE2' HG11 ' A' ' 112' ' ' VAL . 20.0 mt-10 -124.38 122.02 36.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.483 -0.78 . . . . 2.2799999999999998 108.973 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.36 126.33 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.078 -0.51 . . . . 0.70999999999999996 110.736 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.1 mp -128.83 85.89 58.98 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.279 0.474 . . . . 1.3799999999999999 112.279 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -62.04 143.28 94.82 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.628 1.552 . . . . 0.22 111.413 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 134' ' ' SER . 32.7 mt -136.97 159.22 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.20999999999999999 110.941 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 133' ' ' ILE . 41.2 p -134.24 110.22 9.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.1100000000000001 111.195 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 139' ' ' LYS . 18.0 mt -108.4 128.37 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.793 -0.639 . . . . 0.23000000000000001 110.121 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -146.04 140.64 26.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.321 . . . . 1.9099999999999999 110.86 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt 58.74 14.57 3.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 3.1099999999999999 111.369 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.94 21.15 34.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.622 -0.799 . . . . 0.32000000000000001 112.747 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 135' ' ' ILE . 96.9 mttt -118.52 152.29 36.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.609 0.205 . . . . 2.1899999999999999 110.659 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.24 132.96 54.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.274 0.559 . . . . 0.37 112.145 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.543 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.6 t -121.11 109.17 14.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.477 -0.783 . . . . 0.90000000000000002 109.782 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 142' ' ' VAL . 9.9 p -103.78 112.58 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.272 0.558 . . . . 0.53000000000000003 111.019 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 54.19 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.704 -0.68 . . . . 2.0499999999999998 112.262 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.43 27.43 3.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.51 -0.852 . . . . 0.59999999999999998 113.176 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -133.8 138.96 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.187 -0.301 . . . . 2.02 110.187 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.52 137.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.106 0.479 . . . . 1.3 111.294 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.6 m -159.32 129.68 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 1.1200000000000001 109.885 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.5 p -59.14 143.21 49.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.207 -0.451 . . . . 1.1100000000000001 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -79.3 139.18 37.91 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.301 -0.629 . . . . 0.28000000000000003 109.301 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 t -135.37 95.29 3.25 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.078 0.77 . . . . 1.55 113.078 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.48 -59.16 1.2 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.675 1.03 . . . . 0.46000000000000002 115.675 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.486 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -152.64 168.61 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.035 0.918 . . . . 1.8 112.68 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.467 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -92.02 126.32 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.833 -1.173 . . . . 1.24 107.833 177.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.448 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.3 t -114.95 117.85 31.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.517 0.932 . . . . 1.28 113.517 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.462 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 92.1 t -93.02 97.89 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.049 -0.723 . . . . 0.58999999999999997 109.049 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.8 tt0 -104.91 141.08 37.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.546 -0.752 . . . . 2.48 110.717 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -131.04 145.48 52.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 1.54 109.844 178.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.629 HG21 HH21 ' A' ' 105' ' ' ARG . 11.5 t -116.74 140.86 37.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.642 -0.708 . . . . 0.77000000000000002 110.662 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.24 148.57 26.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.444 -0.798 . . . . 1.97 111.946 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -124.5 -27.26 1.33 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.487 -0.779 . . . . 1.1200000000000001 111.666 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -175.22 51.22 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.729 0.3 . . . . 3.8100000000000001 110.339 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 62.41 159.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.141 -0.481 . . . . 3.8199999999999998 111.214 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 54.43 91.88 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.588 0.709 . . . . 1.3999999999999999 110.723 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -50.98 174.95 0.08 OUTLIER Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 114.137 -1.392 . . . . 2.0 109.517 178.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -42.49 -16.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.79 1.66 . . . . 2.5800000000000001 112.56 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.556 ' NZ ' ' HB3' ' A' ' 166' ' ' LYS . 1.5 mtpm? 75.73 -76.7 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.736 0.814 . . . . 3.71 111.554 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 62' ' ' GLN . 7.4 t -83.72 131.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 C-N-CA 119.451 -0.899 . . . . 0.92000000000000004 111.117 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.865 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -133.76 123.48 24.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.093 0.871 . . . . 1.2 111.569 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -119.83 36.94 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.64 -1.164 . . . . 0.22 113.76 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.53 131.77 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.903 0.335 . . . . 1.02 111.903 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.477 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -150.38 99.45 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.33000000000000002 110.395 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -109.16 124.57 65.93 Favored 'Isoleucine or valine' 0 C--O 1.262 1.727 0 CA-C-O 122.763 1.268 . . . . 0.68999999999999995 112.547 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.2 ptm -115.71 164.05 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.102 -1.408 . . . . 1.26 109.441 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 1.7 tptp -120.31 137.93 53.98 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.688 1.366 . . . . 1.8200000000000001 114.688 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.15 -34.54 5.71 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 118.198 2.039 . . . . 0.22 118.198 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.79 156.03 0.45 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.732 2.266 . . . . 0.28999999999999998 114.447 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.675 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.34 -21.82 28.74 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.099 -0.955 . . . . 0.56999999999999995 110.336 177.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.71 -33.86 74.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.675 -0.693 . . . . 2.3100000000000001 111.434 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.91 -45.56 78.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.606 -0.27 . . . . 2.3700000000000001 110.536 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.1 t -40.55 100.28 0.22 Allowed Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 123.5 0.5 . . . . 2.5699999999999998 111.675 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -52.56 113.31 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.777 1.651 . . . . 2.0800000000000001 112.334 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.0 mmt -99.8 129.4 45.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 6.04 110.667 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.8 mt 60.49 110.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 5.2999999999999998 111.042 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -50.75 151.49 4.21 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.019 -0.537 . . . . 8.0500000000000007 110.523 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -62.8 124.56 14.29 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.676 1.584 . . . . 9.1400000000000006 112.021 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 62.6 t-80 -133.15 142.59 45.03 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.755 -0.657 . . . . 9.8699999999999992 110.03 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 186' ' ' HIS . 95.5 Cg_endo -74.77 -36.49 2.72 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.901 1.734 . . . . 11.69 112.183 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.29 -156.94 14.24 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.951 -0.642 . . . . 12.619999999999999 112.229 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.5 mp -86.92 157.01 19.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.714 0.292 . . . . 14.44 110.556 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.128 -0.939 . . . . 15.699999999999999 110.902 -179.907 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.42 -0.272 . . . . 9.1500000000000004 112.42 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.06 -61.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.699 0.285 . . . . 7.3600000000000003 110.774 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.5 mtm 57.25 87.8 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.1 -0.5 . . . . 7.7599999999999998 110.944 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.0 m -63.34 163.44 10.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 4.0199999999999996 110.95 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.4 72.8 0.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.73 . . . . 1.28 112.428 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.2 tp -80.42 -41.98 23.55 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.284 0.564 . . . . 0.40999999999999998 110.43 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.658 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.38 -21.06 22.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.444 -0.798 . . . . 0.33000000000000002 110.585 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.33 -18.34 64.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.562 . . . . 2.0899999999999999 111.314 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.05 -28.4 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.916 -0.314 . . . . 1.99 111.549 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -44.54 145.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.839 -0.345 . . . . 0.20999999999999999 111.683 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.7 pt -139.37 -23.44 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 120.222 -0.591 . . . . 0.85999999999999999 111.137 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.594 ' O ' HG22 ' A' ' 172' ' ' ILE . 31.9 t90 -170.69 126.45 0.73 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.393 -0.523 . . . . 0.28000000000000003 110.355 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -144.41 141.07 29.41 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.675 -0.239 . . . . 0.20000000000000001 111.275 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -147.18 126.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 114.028 1.122 . . . . 0.67000000000000004 114.028 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 0.4 OUTLIER -116.8 96.13 5.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.323 -0.551 . . . . 1.27 110.933 177.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.29 115.1 5.24 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 109.627 -0.508 . . . . 0.37 109.627 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 162.62 -56.18 0.3 Allowed Glycine 0 N--CA 1.441 -0.992 0 O-C-N 124.093 0.871 . . . . 0.67000000000000004 113.855 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -115.19 -120.88 3.41 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.744 -0.741 . . . . 1.1200000000000001 112.946 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 20' ' ' SER . 28.0 tt0 -154.74 120.28 5.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.89 0.33 . . . . 2.02 111.89 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 24.6 t 24.09 115.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.675 1.361 . . . . 1.22 114.675 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -137.74 151.19 47.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.303 0.573 . . . . 0.34000000000000002 111.865 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.99 106.97 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.391 -0.822 . . . . 1.1799999999999999 111.507 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.09 153.96 42.13 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.292 -0.413 . . . . 1.1699999999999999 110.231 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 25' ' ' HIS . 12.5 m -44.26 -53.07 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 113.445 0.905 . . . . 0.59999999999999998 113.445 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.437 ' N ' HG23 ' A' ' 24' ' ' VAL . 82.6 m-70 -55.82 -19.88 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.194 0.521 . . . . 0.46000000000000002 110.565 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.38 35.01 3.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.407 -0.815 . . . . 0.28999999999999998 112.144 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.427 HD11 ' HG ' ' A' ' 6' ' ' LEU . 33.4 mm -102.75 120.52 52.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 0.42999999999999999 109.454 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 10.3 t60 -103.52 129.12 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.335 1.235 . . . . 0.52000000000000002 114.335 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.82 139.44 36.51 Favored 'General case' 0 CA--C 1.524 -0.04 0 N-CA-C 107.468 -1.308 . . . . 3.0 107.468 176.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.442 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 15.5 ptm180 -103.82 126.0 50.64 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.529 0.68 . . . . 2.8999999999999999 112.439 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 31' ' ' LYS . 4.5 tmmm? -20.32 141.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.445 1.498 . . . . 2.71 114.708 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -27.86 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.072 -1.422 . . . . 1.98 112.467 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -102.17 1.99 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.939 2.426 . . . . 1.53 114.627 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.41 -29.77 6.77 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.399 0.518 . . . . 1.8300000000000001 112.399 -178.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.657 ' N ' HD23 ' A' ' 34' ' ' LEU . 60.1 mp0 -78.82 73.38 5.36 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.74 -0.384 . . . . 4.9500000000000002 110.085 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.49 -0.22 56.01 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.158 -1.02 . . . . 1.9399999999999999 110.811 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER 42.41 63.76 1.32 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.289 0.566 . . . . 5.3600000000000003 110.517 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 p -146.49 146.79 18.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.293 -0.867 . . . . 2.9700000000000002 110.502 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.79 114.86 7.17 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.054 -0.593 . . . . 1.99 113.173 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -150.78 -76.0 0.15 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.55 0.215 . . . . 6.5899999999999999 110.932 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.503 ' H ' HH21 ' A' ' 65' ' ' ARG . . . 57.78 90.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.411 -0.359 . . . . 2.0099999999999998 110.99 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -91.87 89.37 7.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 2.02 110.838 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -74.44 94.8 2.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.026 -0.534 . . . . 2.23 110.4 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.408 ' C ' ' H ' ' A' ' 46' ' ' MET . 56.3 t80 -107.19 -71.43 0.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.943 -0.571 . . . . 2.3300000000000001 111.401 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.17 23.43 1.43 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.025 -0.607 . . . . 2.2000000000000002 113.027 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.408 ' H ' ' C ' ' A' ' 44' ' ' TYR . 7.7 ttt -66.06 -11.9 51.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.938 0.399 . . . . 1.9299999999999999 110.322 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' C ' ' HD3' ' A' ' 49' ' ' PRO . 64.8 pttt -88.96 16.34 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.828 -0.624 . . . . 3.3500000000000001 110.633 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.6 mt -127.21 65.82 66.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.888 -0.596 . . . . 2.7599999999999998 109.908 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 47' ' ' LYS . 84.9 Cg_exo -54.0 134.97 62.19 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.008 2.472 . . . . 1.46 113.605 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.79 148.1 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.03 -0.73 . . . . 0.82999999999999996 109.03 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 mp -97.51 -37.46 9.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 1.6899999999999999 112.897 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -82.36 38.94 0.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.594 0.59 . . . . 2.5600000000000001 112.594 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -153.3 165.97 34.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 0.96999999999999997 111.663 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.8 t30 -76.76 146.69 76.73 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.891 -0.595 . . . . 1.96 109.764 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.635 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.44 -55.62 1.83 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.466 2.111 . . . . 0.66000000000000003 114.272 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.718 ' O ' HG12 ' A' ' 59' ' ' VAL . 12.0 mm-40 -64.5 -56.76 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.721 0.772 . . . . 1.8200000000000001 111.167 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' OD1' HD13 ' A' ' 60' ' ' LEU . 47.2 t0 -70.58 -2.54 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.15 -0.62 . . . . 1.9099999999999999 110.304 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.635 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 22.6 tt0 -73.32 -56.15 5.45 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.701 -1.222 . . . . 1.5 107.701 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 56' ' ' GLU . 11.0 p -52.46 -35.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.039 -1.097 . . . . 1.22 108.039 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -65.18 -68.83 0.33 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.42 -0.512 . . . . 1.05 110.1 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -54.12 -3.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.026 0.931 . . . . 0.90000000000000002 111.9 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 63' ' ' THR . 26.7 tt0 -109.96 -113.92 0.31 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.585 -0.734 . . . . 1.8 110.351 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 59' ' ' VAL . 57.2 p 29.87 123.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.699 1.37 . . . . 1.05 114.699 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -127.26 147.44 50.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.868 -0.606 . . . . 2.0499999999999998 110.265 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.529 HH11 ' HG2' ' A' ' 35' ' ' GLU . 2.3 ptm180 -136.81 -173.25 3.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.686 0.279 . . . . 3.5800000000000001 110.45 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -49.21 148.95 2.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.371 0.508 . . . . 4.25 112.371 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -135.43 -179.83 5.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 4.3499999999999996 110.525 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -156.6 -120.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.725 -0.216 . . . . 3.1699999999999999 111.106 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -153.29 129.33 10.33 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.468 0.175 . . . . 2.3900000000000001 110.823 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.678 ' H ' HD21 ' A' ' 164' ' ' ASN . 23.0 t 56.59 91.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.977 0.417 . . . . 0.98999999999999999 110.985 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -164.29 163.91 22.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.905 -0.588 . . . . 1.26 110.886 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.732 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -169.45 -174.27 37.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.15 -1.024 . . . . 0.66000000000000003 113.973 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.403 ' CE2' HD13 ' A' ' 34' ' ' LEU . 7.8 m-85 -108.51 165.98 11.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.44 0.638 . . . . 0.82999999999999996 112.138 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.74 126.97 51.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.824 -1.08 . . . . 2.27 110.218 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.501 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -118.43 87.53 31.01 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 111.835 0.309 . . . . 0.34000000000000002 111.835 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.12 133.62 58.9 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 121.929 1.753 . . . . 0.80000000000000004 112.021 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 78' ' ' LYS . 24.1 mt -124.11 153.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.938 0.399 . . . . 0.38 111.483 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' N ' HG22 ' A' ' 77' ' ' ILE . 59.0 mttp -140.85 0.98 1.64 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.888 -0.596 . . . . 2.96 111.027 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -129.42 170.44 13.68 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.713 0.292 . . . . 2.1299999999999999 111.284 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -123.06 176.87 5.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.095 0.474 . . . . 0.37 111.242 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.36 -152.31 20.18 Favored Glycine 0 C--N 1.329 0.153 0 N-CA-C 109.868 -1.293 . . . . 0.20999999999999999 109.868 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.52 108.55 19.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.858 1.329 . . . . 2.0299999999999998 108.836 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -95.01 126.95 40.7 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.578 0.704 . . . . 0.26000000000000001 109.677 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 177' ' ' ALA . 13.9 t -113.6 118.49 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.787 -1.097 . . . . 0.54000000000000004 111.831 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 105.37 17.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.521 -1.218 . . . . 1.23 111.572 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.64 126.47 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.78 -1.1 . . . . 1.3100000000000001 108.966 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 87' ' ' LEU . 1.8 pt? -147.17 134.88 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.63 -0.828 . . . . 1.3700000000000001 111.754 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.522 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 5.3 tptp -98.02 120.74 38.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.317 -0.856 . . . . 2.9700000000000002 110.828 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.579 ' CD2' HD21 ' A' ' 115' ' ' LEU . 7.5 m-85 -105.09 136.54 44.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.757 -1.201 . . . . 0.29999999999999999 107.757 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -146.04 171.89 14.2 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.489 -0.884 . . . . 0.40999999999999998 113.074 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 59.45 176.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.296 -0.866 . . . . 3.9700000000000002 112.028 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 p -176.87 -18.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.839 -0.619 . . . . 3.8100000000000001 111.116 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.9 t80 73.65 -68.44 0.22 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.936 -0.575 . . . . 2.8900000000000001 110.582 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.48 138.68 31.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 2.0 110.856 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.97 99.1 12.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.485 ' HB2' ' HZ2' ' A' ' 100' ' ' LYS . 40.6 mt-30 -142.01 145.11 34.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 2.96 111.069 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 73.9 m -119.1 134.4 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.55 111.254 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 71.43 -60.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.772 -0.649 . . . . 2.3300000000000001 111.554 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -45.48 -38.29 6.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.409 -0.36 . . . . 2.5099999999999998 111.139 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HZ2' ' HB2' ' A' ' 96' ' ' GLN . 4.7 ttmp? -101.95 82.55 2.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.305 0.574 . . . . 3.1000000000000001 110.778 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.77 139.91 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.293 -0.867 . . . . 1.3100000000000001 109.618 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.456 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 61.6 m-85 -119.92 176.85 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.756 0.65 . . . . 0.68999999999999995 112.756 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -127.15 140.43 52.26 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.213 0.53 . . . . 2.0099999999999998 112.31 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.89 136.45 55.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.052 -0.977 . . . . 0.46000000000000002 112.008 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 5.1 mtt180 -135.5 156.68 48.5 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 113.264 0.839 . . . . 1.8500000000000001 113.264 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 39.5 t -122.9 123.34 67.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 114.558 -1.201 . . . . 1.1000000000000001 109.298 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER 53.59 26.1 5.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.556 -0.905 . . . . 1.77 108.556 -175.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.83 17.15 57.03 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.278 -0.873 . . . . 0.40999999999999998 112.74 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 38.5 m80 -112.37 112.89 24.79 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.895 0.702 . . . . 0.46000000000000002 112.895 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 p -62.77 127.17 30.0 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.864 -0.734 . . . . 0.66000000000000003 110.454 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.06 -30.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 0.80000000000000004 109.316 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.37 88.97 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.804 -0.814 . . . . 0.51000000000000001 108.804 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -106.6 77.72 1.21 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.515 1.15 . . . . 2.4399999999999999 110.773 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 p30 159.44 38.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.348 -1.751 . . . . 2.5600000000000001 108.499 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.579 HD21 ' CD2' ' A' ' 89' ' ' PHE . 20.5 tp -79.36 91.64 5.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.172 0.805 . . . . 1.1000000000000001 113.172 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -106.48 91.14 3.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.869 -1.16 . . . . 1.99 107.869 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.25 -32.42 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.995 0.739 . . . . 0.63 112.995 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.97 -51.56 15.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.737 -0.385 . . . . 0.90000000000000002 111.303 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.27 -27.13 65.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.76000000000000001 111.913 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HE ' ' CE1' ' A' ' 127' ' ' HIS . 23.8 mmm180 -77.65 -58.6 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.688 0.625 . . . . 2.6800000000000002 112.688 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.52 -41.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.383 0.512 . . . . 1.4099999999999999 112.383 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.65 -125.66 6.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.438 -0.887 . . . . 1.0600000000000001 112.889 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.416 ' O ' HG23 ' A' ' 125' ' ' THR . 97.5 m-70 -72.42 110.34 6.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.382 . . . . 3.5099999999999998 111.372 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 61.5 m 48.41 -109.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 1.6799999999999999 111.685 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 123' ' ' HIS . 53.1 p 50.31 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 0.80000000000000004 110.988 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.16 138.42 50.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.287 0.565 . . . . 0.44 112.234 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.459 ' CE1' ' HE ' ' A' ' 120' ' ' ARG . 1.6 t60 -108.0 151.06 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.075 -0.966 . . . . 0.38 108.416 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.85 136.51 38.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.772 0.656 . . . . 2.0899999999999999 112.772 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' HD23 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -127.76 123.86 36.34 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.05 -0.977 . . . . 2.2799999999999998 109.668 178.004 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.461 ' O ' HD13 ' A' ' 131' ' ' ILE . 53.2 mt -119.08 124.05 72.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.917 -0.583 . . . . 0.70999999999999996 110.396 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 130' ' ' ILE . 50.9 mm -131.6 95.5 23.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.122 0.415 . . . . 1.3799999999999999 112.122 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.99 148.84 93.05 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.646 1.564 . . . . 0.22 111.309 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 134' ' ' SER . 21.3 mt -139.64 155.96 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.336 . . . . 0.20999999999999999 110.961 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 29.2 p -131.57 111.2 11.53 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.008 0.432 . . . . 1.1100000000000001 111.168 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LYS . 20.3 mt -112.06 127.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.649 -0.705 . . . . 0.23000000000000001 110.217 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -149.32 137.97 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.518 -0.31 . . . . 1.9099999999999999 111.005 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 137' ' ' LYS . 9.4 mtmp? 62.5 13.4 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.998 -0.546 . . . . 3.1099999999999999 111.468 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.61 7.64 58.89 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.59 -0.814 . . . . 0.32000000000000001 112.986 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.601 ' O ' HG23 ' A' ' 135' ' ' ILE . 53.1 mtpt -108.12 167.06 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.883 0.341 . . . . 2.1899999999999999 110.645 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -127.96 146.36 50.67 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.739 0.644 . . . . 0.37 112.739 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.568 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -132.2 109.7 10.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.027 -0.988 . . . . 0.90000000000000002 109.335 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.2 p -109.71 111.51 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.082 -0.508 . . . . 0.53000000000000003 110.349 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 61.89 -89.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 2.0499999999999998 111.579 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.07 15.13 4.02 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.712 -0.756 . . . . 0.59999999999999998 112.77 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.42 130.93 57.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.089 -0.337 . . . . 2.02 110.089 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.3 131.82 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.184 0.516 . . . . 1.3 110.966 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -149.59 175.37 11.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.637 -0.711 . . . . 1.1200000000000001 109.496 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.4 p -99.52 138.88 35.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.7 -0.4 . . . . 1.1100000000000001 111.418 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.059 -0.719 . . . . 0.28000000000000003 109.059 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 t -139.6 95.86 2.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.175 0.805 . . . . 1.55 113.175 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.29 -51.02 3.22 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 115.819 1.087 . . . . 0.46000000000000002 115.819 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.501 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -158.66 174.94 14.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.385 1.093 . . . . 1.8 113.543 -177.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.437 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 1.1 tp -97.69 124.69 42.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.035 -1.439 . . . . 1.24 107.123 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.4 t -114.35 116.93 29.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 118.739 -1.184 . . . . 1.28 113.443 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 47.0 t -95.61 98.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.741 -0.837 . . . . 0.58999999999999997 108.741 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.3 tt0 -109.13 134.63 51.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.658 -0.701 . . . . 2.48 111.207 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -126.33 134.56 51.06 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.276 0.56 . . . . 1.54 110.345 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.447 HG21 HH21 ' A' ' 105' ' ' ARG . 99.1 t -105.8 142.04 19.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 114.73 -1.123 . . . . 0.77000000000000002 110.815 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 143.01 44.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.429 -0.805 . . . . 1.97 111.57 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.76 -14.13 16.45 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.458 -0.657 . . . . 1.1200000000000001 111.458 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -158.98 -64.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 3.8100000000000001 110.281 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -176.72 161.9 2.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 3.8199999999999998 110.783 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 57.22 71.24 0.59 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 1.3999999999999999 111.282 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.678 HD21 ' H ' ' A' ' 70' ' ' SER . 5.8 m-20 -49.98 153.31 2.34 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.537 -0.756 . . . . 2.0 109.503 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.456 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -28.71 105.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.381 2.054 . . . . 2.5800000000000001 112.343 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -58.14 -74.0 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.149 -0.932 . . . . 3.71 112.584 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 4.8 t -79.1 133.13 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 119.858 -0.737 . . . . 0.92000000000000004 111.281 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 5.2 t -129.12 124.48 34.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.084 -0.962 . . . . 1.2 109.817 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.522 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -117.47 35.46 4.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.652 0.982 . . . . 0.22 113.652 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -35.74 131.06 0.54 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.175 0.512 . . . . 1.02 111.649 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.455 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -152.46 96.71 2.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.33000000000000002 109.542 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.9 OUTLIER -104.82 126.81 59.66 Favored 'Isoleucine or valine' 0 C--O 1.263 1.805 0 CA-C-O 122.625 1.202 . . . . 0.68999999999999995 112.583 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ptm -118.29 162.52 18.13 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.57 -1.65 . . . . 1.26 109.254 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.97 146.45 46.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.818 1.414 . . . . 1.8200000000000001 114.818 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.97 -35.44 5.0 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 112.469 -2.15 . . . . 0.22 117.837 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.463 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 153.87 0.36 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.396 2.098 . . . . 0.28999999999999998 115.298 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.648 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -87.75 -31.8 19.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.379 -1.282 . . . . 0.56999999999999995 110.465 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -56.12 -17.75 8.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.712 -0.677 . . . . 2.3100000000000001 111.63 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 180' ' ' VAL . 2.1 m-20 -73.26 -79.0 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.346 -0.388 . . . . 2.3700000000000001 110.608 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 177' ' ' ALA . 26.9 m 14.49 66.13 0.15 Allowed Pre-proline 0 N--CA 1.475 0.806 0 N-CA-C 113.308 0.855 . . . . 2.5699999999999998 113.308 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.93 124.3 15.93 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.507 2.138 . . . . 2.0800000000000001 112.453 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 59.4 mtt -92.18 120.31 32.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 6.04 110.604 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 10.1 mp 59.67 103.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.083 -0.508 . . . . 5.2999999999999998 110.979 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -54.26 146.41 31.6 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.041 -0.527 . . . . 8.0500000000000007 110.269 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -44.57 146.06 2.34 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.632 1.555 . . . . 9.1400000000000006 112.392 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.642 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 61.6 t60 -134.5 132.46 20.85 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.348 -0.387 . . . . 9.8699999999999992 110.494 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.642 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 62.1 Cg_endo -74.05 -21.89 17.68 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.206 1.937 . . . . 11.69 112.469 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -50.1 151.3 4.68 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.778 -0.725 . . . . 12.619999999999999 112.658 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 189' ' ' LEU . 6.9 mp -106.26 137.27 44.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.704 0.287 . . . . 14.44 110.892 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.202 -0.904 . . . . 15.699999999999999 110.763 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.377 -0.289 . . . . 9.1500000000000004 112.377 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.72 -39.32 2.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 7.3600000000000003 110.963 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.7 mtt -104.04 10.83 35.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 7.7599999999999998 110.75 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.1 t -121.88 151.65 40.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 4.0199999999999996 110.829 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.56 81.88 0.73 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.839 -0.696 . . . . 1.28 112.636 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.495 HD22 ' O ' ' A' ' 180' ' ' VAL . 17.9 tp -73.58 -42.97 60.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.145 0.498 . . . . 0.40999999999999998 110.267 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.67 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -57.24 -20.67 28.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 0.33000000000000002 110.642 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.75 -18.29 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 2.0899999999999999 111.738 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.578 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -105.95 -27.04 11.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.776 -0.37 . . . . 1.99 111.091 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -45.43 146.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 120.979 -0.289 . . . . 0.20999999999999999 111.311 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.24 -20.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 119.965 -0.694 . . . . 0.85999999999999999 110.729 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' O ' HG22 ' A' ' 172' ' ' ILE . 13.1 t90 -173.51 129.33 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.028 -0.533 . . . . 0.28000000000000003 110.042 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.82 139.29 20.48 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 122.333 -0.229 . . . . 0.20000000000000001 111.296 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.2 t -147.16 131.89 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 114.324 1.231 . . . . 0.67000000000000004 114.324 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 63.8 t30 -115.34 87.96 2.77 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 116.161 -0.472 . . . . 1.27 110.822 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.97 112.21 1.43 Allowed 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.648 -0.706 . . . . 0.37 110.046 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 143.97 -13.81 2.15 Favored Glycine 0 N--CA 1.442 -0.91 0 O-C-N 124.047 0.842 . . . . 0.67000000000000004 114.234 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.08 -131.06 2.97 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 119.961 -1.114 . . . . 1.1200000000000001 113.129 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -160.99 120.01 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 2.02 111.45 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.6 m 26.4 104.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.921 -1.036 . . . . 1.22 113.615 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.637 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 36.8 t-80 -132.77 142.82 49.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 120.334 -0.546 . . . . 0.34000000000000002 112.404 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.8 p -116.94 105.43 18.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 121.456 0.646 . . . . 1.1799999999999999 111.101 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.59 158.12 34.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.38 -0.827 . . . . 1.1699999999999999 110.512 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 25' ' ' HIS . 14.2 m -42.95 -50.99 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.227 0.954 . . . . 0.59999999999999998 113.261 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.433 ' N ' HG23 ' A' ' 24' ' ' VAL . 85.6 m-70 -57.33 -22.16 40.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.46000000000000002 110.42 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.54 34.72 3.5 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.228 -0.896 . . . . 0.28999999999999998 111.757 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.5 mm -103.58 112.65 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.13 0.49 . . . . 0.42999999999999999 110.403 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.637 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.1 t60 -97.59 139.01 34.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.485 1.291 . . . . 0.52000000000000002 114.485 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.675 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -104.76 138.02 41.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.458 -1.246 . . . . 3.0 108.867 178.024 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 29.6 mtp180 -94.19 109.05 20.87 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.685 0.616 . . . . 2.8999999999999999 112.03 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 32' ' ' ASP . 81.2 tttt -24.05 132.16 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.176 1.176 . . . . 2.71 114.176 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' LYS . 77.4 m-20 -2.41 80.11 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.701 1.2 . . . . 1.98 113.998 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -103.86 7.81 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.549 2.832 . . . . 1.53 112.561 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD23 ' C ' ' A' ' 72' ' ' GLY . 5.7 mt -52.18 -71.4 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.566 0.222 . . . . 1.8300000000000001 111.021 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -144.47 57.63 1.31 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.018 0.747 . . . . 4.9500000000000002 113.018 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.01 0.06 68.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.254 -0.974 . . . . 1.9399999999999999 114.066 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.55 ' HG3' ' CZ ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -69.93 59.98 0.17 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.257 0.529 . . . . 5.3600000000000003 111.507 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.8 m -106.72 136.09 42.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.835 0.35 . . . . 2.9700000000000002 110.867 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.2 26.2 10.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 1.99 112.625 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 97.1 mtt180 -137.87 -61.26 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.582 0.23 . . . . 6.5899999999999999 110.875 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 40' ' ' ARG . . . 74.45 -44.52 0.56 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.815 -0.629 . . . . 2.0099999999999998 111.486 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.9 m 53.18 55.61 8.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.956 0.408 . . . . 2.02 111.108 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -85.8 25.02 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 2.23 110.358 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -52.58 141.4 20.59 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.094 -0.503 . . . . 2.3300000000000001 110.292 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.66 40.11 78.14 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.378 -0.915 . . . . 2.2000000000000002 111.402 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ttt -57.46 -14.43 4.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.627 -0.286 . . . . 1.9299999999999999 111.552 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -60.68 -176.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.299 . . . . 3.3500000000000001 110.874 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.498 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 11.8 mt 60.51 59.78 3.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 2.7599999999999998 110.865 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 23.6 Cg_exo -69.78 157.36 60.6 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.534 2.156 . . . . 1.46 112.59 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp -66.23 145.79 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 116.124 -0.489 . . . . 0.82999999999999996 109.779 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.11 -60.46 1.97 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.796 1.036 . . . . 1.6899999999999999 113.796 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -71.76 32.84 0.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.408 0.892 . . . . 2.5600000000000001 113.408 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 t -138.16 140.76 40.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.327 0.491 . . . . 0.96999999999999997 112.327 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.505 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 6.9 t30 -62.27 145.76 93.55 Favored Pre-proline 0 C--O 1.22 -0.451 0 CA-C-N 115.538 -0.755 . . . . 1.96 109.225 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.602 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 11.3 Cg_exo -39.57 -51.18 2.89 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.594 2.196 . . . . 0.66000000000000003 115.425 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.44 -56.19 12.15 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 122.407 1.098 . . . . 1.8200000000000001 110.911 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.58 59.94 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.866 -1.061 . . . . 1.9099999999999999 109.85 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.602 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 29.4 tt0 -64.49 -45.68 86.29 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.614 -1.625 . . . . 1.5 106.614 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 63' ' ' THR . 96.7 t -57.1 -54.4 30.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.455 -1.248 . . . . 1.22 109.99 177.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.9 tp -64.62 -12.75 48.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.9 -0.591 . . . . 1.05 112.087 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.488 ' CZ ' ' HE2' ' A' ' 88' ' ' LYS . 4.1 m-30 -108.52 -2.0 19.26 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.916 -0.584 . . . . 0.90000000000000002 110.21 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.601 ' HG2' ' N ' ' A' ' 63' ' ' THR . 36.7 tt0 -123.58 -107.61 0.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.539 -0.755 . . . . 1.8 112.033 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 59' ' ' VAL . 48.2 p 42.08 -168.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.489 -0.323 . . . . 1.05 110.994 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 177.71 128.4 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.977 0.417 . . . . 2.0499999999999998 111.77 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.55 ' CZ ' ' HG3' ' A' ' 37' ' ' ARG . 2.2 ttp85 -112.74 -170.97 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.103 -0.499 . . . . 3.5800000000000001 110.336 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -162.91 138.12 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.618 0.247 . . . . 4.25 111.128 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.546 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 48.7 t-20 -130.8 -82.54 0.53 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.415 -0.357 . . . . 4.3499999999999996 110.944 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.91 -75.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.549 0.214 . . . . 3.1699999999999999 111.349 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -163.82 143.26 8.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.682 -0.235 . . . . 2.3900000000000001 110.69 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t 50.55 83.42 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.98999999999999999 110.158 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.434 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 29.9 p90 -150.2 151.65 33.4 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.224 0.535 . . . . 1.26 111.632 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -169.23 -169.37 32.49 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.268 -0.878 . . . . 0.66000000000000003 113.675 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -102.15 177.73 4.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.578 0.955 . . . . 0.82999999999999996 113.578 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.68 120.89 21.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.661 -1.609 . . . . 2.27 109.663 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.99 90.66 11.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.241 0.46 . . . . 0.34000000000000002 112.241 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.7 141.28 90.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.097 1.198 . . . . 0.80000000000000004 111.118 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.35 151.87 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 0.38 111.32 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -144.63 2.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 2.96 110.839 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -127.33 175.17 8.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.589 0.233 . . . . 2.1299999999999999 110.663 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -131.71 170.33 14.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.37 111.654 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.59 -154.64 22.65 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 109.569 -1.412 . . . . 0.20999999999999999 109.569 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -96.41 109.66 22.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.976 1.388 . . . . 2.0299999999999998 108.929 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.08 126.45 41.32 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.769 -0.826 . . . . 0.26000000000000001 108.769 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.2 t -112.59 113.07 43.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.901 -1.045 . . . . 0.54000000000000004 111.57 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.78 103.75 16.37 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.641 -1.163 . . . . 1.23 109.66 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.62 134.44 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.404 -0.816 . . . . 1.3100000000000001 108.859 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -147.05 154.94 41.78 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.783 -0.767 . . . . 1.3700000000000001 112.018 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.89 119.12 37.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.767 -0.652 . . . . 2.9700000000000002 110.172 178.54 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 7.7 m-85 -105.68 137.74 43.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.918 -0.583 . . . . 0.29999999999999999 109.531 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.535 ' O ' HG13 ' A' ' 167' ' ' VAL . . . -142.44 152.92 43.24 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.235 -0.283 . . . . 0.40999999999999998 110.235 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -171.19 130.34 0.75 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 3.9700000000000002 110.938 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 m -151.62 85.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.582 . . . . 3.8100000000000001 110.919 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -158.86 6.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 2.8900000000000001 110.937 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -140.81 -47.64 0.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 2.0 110.923 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.97 80.3 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.005 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -173.34 140.54 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.18 -0.464 . . . . 2.96 110.631 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -97.7 162.38 13.3 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.158 0.504 . . . . 1.55 111.356 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 100' ' ' LYS . 2.5 mp0 55.63 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.88 -1.054 . . . . 2.3300000000000001 110.818 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 71.33 -30.34 0.21 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.966 -1.016 . . . . 2.5099999999999998 110.602 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 98' ' ' GLN . 66.4 mmtt -108.52 63.1 0.61 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.537 -0.912 . . . . 3.1000000000000001 108.537 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.418 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 1.1 m -109.11 150.78 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.262 -0.881 . . . . 1.3100000000000001 110.532 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -118.62 178.32 4.51 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 112.843 0.683 . . . . 0.68999999999999995 112.843 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -127.67 137.67 52.57 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.062 -0.517 . . . . 2.0099999999999998 111.176 177.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.88 127.01 51.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 115.89 -0.595 . . . . 0.46000000000000002 111.952 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -128.31 141.44 51.44 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.141 -0.936 . . . . 1.8500000000000001 113.269 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.2 m -116.93 118.76 59.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 114.149 -1.387 . . . . 1.1000000000000001 109.583 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 61.92 28.5 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.882 -0.784 . . . . 1.77 108.882 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.38 89.91 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.40999999999999998 111.369 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 58.6 m-70 -102.62 109.15 20.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.759 -0.721 . . . . 0.46000000000000002 112.209 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -68.44 133.42 48.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.477 0.656 . . . . 0.66000000000000003 112.052 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -31.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.896 -1.047 . . . . 0.80000000000000004 109.636 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.25 91.03 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.197 -0.668 . . . . 0.51000000000000001 109.197 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 3.3 ptpp? -109.18 77.28 1.05 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.692 1.234 . . . . 2.4399999999999999 112.24 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.1 p30 153.53 40.15 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.197 -2.274 . . . . 2.5600000000000001 109.353 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.408 HD11 ' OE1' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -63.18 94.42 0.07 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.247 0.546 . . . . 1.1000000000000001 112.187 -178.454 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -102.98 84.11 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.932 -1.507 . . . . 1.99 106.932 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.3 mt -50.32 -41.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.104 -0.953 . . . . 0.63 112.628 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.01 -45.73 87.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.667 0.27 . . . . 0.90000000000000002 111.482 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.11 -28.82 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.211 0.449 . . . . 0.76000000000000001 112.211 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -68.35 -58.44 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.437 0.532 . . . . 2.6800000000000002 112.437 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.4 p -94.39 -37.1 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.867 0.321 . . . . 1.4099999999999999 111.867 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.16 -114.54 2.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.399 -0.905 . . . . 1.0600000000000001 112.878 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.486 ' O ' HG23 ' A' ' 125' ' ' THR . 57.3 t-80 -104.6 114.05 28.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.714 0.292 . . . . 3.5099999999999998 111.172 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.3 p 53.3 -143.22 0.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.006 -0.543 . . . . 1.6799999999999999 111.316 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.0 p 64.36 -171.73 0.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.624 0.37 . . . . 0.80000000000000004 110.996 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -104.71 139.54 39.37 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.692 0.626 . . . . 0.44 112.692 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.8 t60 -102.91 152.02 21.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.209 -0.905 . . . . 0.38 109.075 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -144.2 132.89 22.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.635 0.605 . . . . 2.0899999999999999 112.635 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.408 ' OE1' HD11 ' A' ' 115' ' ' LEU . 29.2 mt-10 -127.65 128.42 45.46 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 2.2799999999999998 109.893 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.4 mt -117.13 122.03 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.058 -0.519 . . . . 0.70999999999999996 110.496 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mm -124.93 89.71 52.15 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.392 -0.367 . . . . 1.3799999999999999 111.928 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -60.52 143.12 99.42 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.928 1.752 . . . . 0.22 111.918 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 24.1 mt -134.94 156.54 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.20999999999999999 110.367 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.0 p -130.51 106.51 8.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.938 0.399 . . . . 1.1100000000000001 111.015 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 139' ' ' LYS . 19.2 mt -107.7 122.98 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 0.23000000000000001 110.222 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.54 140.57 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 1.9099999999999999 110.804 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp 61.49 26.54 16.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.904 -0.589 . . . . 3.1099999999999999 110.82 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.72 27.75 60.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.898 -0.668 . . . . 0.32000000000000001 113.004 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.524 ' O ' HG23 ' A' ' 135' ' ' ILE . 73.3 mttt -126.15 151.62 47.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.832 0.316 . . . . 2.1899999999999999 111.321 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 141' ' ' SER . 5.3 tt -111.24 129.52 55.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 0.37 111.856 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 140' ' ' LEU . 18.3 m -117.35 109.41 16.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 0.90000000000000002 109.658 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -105.99 105.86 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.255 0.55 . . . . 0.53000000000000003 111.173 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 56.63 -90.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.823 -0.626 . . . . 2.0499999999999998 111.976 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.77 24.95 4.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.468 -0.873 . . . . 0.59999999999999998 113.537 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -134.16 135.13 42.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.811 0.306 . . . . 2.02 110.178 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.33 139.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.093 0.473 . . . . 1.3 111.132 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.2 t -161.35 127.83 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 1.1200000000000001 109.993 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.6 p -53.69 143.72 19.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 1.1100000000000001 111.68 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.31 124.81 28.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.914 -0.773 . . . . 0.28000000000000003 108.914 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 t -115.96 92.32 3.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.073 0.768 . . . . 1.55 113.073 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.06 -34.09 0.05 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 117.376 1.71 . . . . 0.46000000000000002 117.376 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.63 158.42 28.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.598 1.699 . . . . 1.8 113.885 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.47 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -96.16 124.78 40.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.618 -1.253 . . . . 1.24 107.618 176.089 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -108.09 142.34 38.43 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 113.904 1.075 . . . . 1.28 113.904 -176.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.511 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 64.6 t -129.67 97.8 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.54 . . . . 0.58999999999999997 109.909 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 60.7 mm-40 -112.66 128.92 56.52 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.137 -0.938 . . . . 2.48 111.495 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 17.7 p90 -116.1 133.54 55.91 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.375 -0.602 . . . . 1.54 109.375 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 t -108.79 142.86 20.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 115.303 -0.862 . . . . 0.77000000000000002 111.569 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -63.58 148.52 48.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.669 -1.151 . . . . 1.97 111.634 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -111.82 -10.34 19.0 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.744 -0.662 . . . . 1.1200000000000001 111.652 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -153.5 -51.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 3.8100000000000001 110.397 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -171.39 -64.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.151 -0.477 . . . . 3.8199999999999998 110.626 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.55 117.52 20.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.989 -0.551 . . . . 1.3999999999999999 110.809 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 166' ' ' LYS . 2.1 m120 -60.09 -178.53 0.15 Allowed Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.211 -0.904 . . . . 2.0 109.506 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -48.18 -8.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.905 1.737 . . . . 2.5800000000000001 113.915 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 164' ' ' ASN . 27.6 tptt 76.64 -75.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.656 0.383 . . . . 3.71 111.652 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 90' ' ' ALA . 2.0 m -111.95 137.1 45.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 C-N-CA 119.795 -0.762 . . . . 0.92000000000000004 111.562 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.8 t -131.88 122.54 25.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.738 -1.119 . . . . 1.2 112.085 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -106.19 38.34 2.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.163 -0.926 . . . . 0.22 113.381 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.402 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -35.49 133.93 0.34 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.963 0.357 . . . . 1.02 111.963 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.436 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -154.16 94.92 1.78 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.148 -0.478 . . . . 0.33000000000000002 110.843 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 12' ' ' TRP . 6.1 tt -104.19 131.44 53.0 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 CA-C-O 122.643 1.211 . . . . 0.68999999999999995 112.547 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.614 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -122.15 166.6 14.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.858 -1.519 . . . . 1.26 110.416 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.1 150.57 37.13 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.959 1.466 . . . . 1.8200000000000001 114.959 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 90.51 -34.49 4.16 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 112.105 -2.316 . . . . 0.22 118.176 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.71 162.07 0.7 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.225 2.012 . . . . 0.28999999999999998 114.187 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.621 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.54 -23.58 27.63 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 115.029 -0.987 . . . . 0.56999999999999995 110.968 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.33 -18.69 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 2.3100000000000001 111.496 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.481 ' O ' HD13 ' A' ' 6' ' ' LEU . 14.4 m-20 -94.04 -7.09 43.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.544 -0.298 . . . . 2.3700000000000001 111.485 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.495 ' O ' HD22 ' A' ' 6' ' ' LEU . 2.1 t -42.95 -47.21 13.77 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.638 0.607 . . . . 2.5699999999999998 112.638 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.78 -167.09 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.318 1.345 . . . . 2.0800000000000001 111.603 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 61.2 ttp -137.88 138.99 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 6.04 110.667 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.6 mt -108.69 134.5 51.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 5.2999999999999998 110.591 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -52.67 146.35 18.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.552 . . . . 8.0500000000000007 110.267 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.18 124.65 12.42 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.636 1.557 . . . . 9.1400000000000006 112.138 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -134.43 133.85 21.96 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.17 -0.468 . . . . 9.8699999999999992 110.316 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.53 -95.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.575 1.516 . . . . 11.69 111.627 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 87.44 -146.34 20.1 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.879 -0.677 . . . . 12.619999999999999 112.51 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 189' ' ' LEU . 6.7 mp -93.8 141.44 28.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 14.44 110.653 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.1 -0.953 . . . . 15.699999999999999 110.736 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.466 -0.254 . . . . 9.1500000000000004 112.466 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.53 91.7 8.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 7.3600000000000003 110.885 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt -134.21 -54.16 0.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 7.7599999999999998 110.914 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.9 p -78.39 131.96 37.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 4.0199999999999996 110.736 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.408 ' O ' ' HE2' ' A' ' 9' ' ' LYS . . . 150.25 -78.47 0.22 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.748 -0.739 . . . . 1.28 112.468 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 tp -67.34 -44.84 78.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.40999999999999998 110.402 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.639 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.7 -21.09 25.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.309 -0.859 . . . . 0.33000000000000002 111.466 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.24 -16.03 59.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.167 0.432 . . . . 2.0899999999999999 112.167 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 5' ' ' GLY . 20.1 mmtt -105.23 -28.62 10.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.665 -0.414 . . . . 1.99 111.002 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -40.1 144.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 111.772 0.286 . . . . 0.20999999999999999 111.772 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.69 -23.75 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.071 -0.652 . . . . 0.85999999999999999 111.073 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.53 ' O ' HG22 ' A' ' 172' ' ' ILE . 25.4 t90 -173.09 137.98 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.972 -0.381 . . . . 0.28000000000000003 109.972 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -157.27 145.95 19.66 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.343 -0.143 . . . . 0.20000000000000001 111.121 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.9 t -147.35 124.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 114.075 1.139 . . . . 0.67000000000000004 114.075 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -115.4 101.23 8.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.457 -0.497 . . . . 1.27 110.807 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.89 104.74 1.42 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 108.614 -0.884 . . . . 0.37 108.614 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.64 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 165.68 -63.78 0.22 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 124.718 1.261 . . . . 0.67000000000000004 112.426 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.0 -131.07 5.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.859 -0.686 . . . . 1.1200000000000001 112.121 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -168.83 119.8 0.75 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.118 -0.327 . . . . 2.02 110.118 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 69.7 m 42.13 83.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.937 -0.574 . . . . 1.22 111.068 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 32.7 t-80 -116.89 143.78 45.29 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.036 -0.666 . . . . 0.34000000000000002 112.543 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.59 104.32 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.477 -0.783 . . . . 1.1799999999999999 110.151 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.85 157.09 38.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.346 -0.388 . . . . 1.1699999999999999 110.448 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 m -43.95 -51.02 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.255 0.972 . . . . 0.59999999999999998 113.44 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -58.09 -20.09 37.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.314 0.578 . . . . 0.46000000000000002 110.104 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.94 35.12 3.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.138 -0.937 . . . . 0.28999999999999998 111.987 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -103.34 123.17 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.98 -0.378 . . . . 0.42999999999999999 109.98 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.4 t60 -100.97 132.23 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.86 1.059 . . . . 0.52000000000000002 113.86 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 128.89 42.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.114 -1.069 . . . . 3.0 108.114 177.228 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -82.72 110.31 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.833 0.708 . . . . 2.8999999999999999 112.12 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 tmmm? -22.96 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.83 1.252 . . . . 2.71 113.708 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 35' ' ' GLU . 29.8 t70 -20.05 88.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 114.55 -1.205 . . . . 1.98 113.551 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -101.82 -2.76 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.714 2.276 . . . . 1.53 113.765 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 72' ' ' GLY . 0.6 OUTLIER -114.07 -40.02 3.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.406 0.521 . . . . 1.8300000000000001 112.406 -178.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 5.6 mm-40 -73.38 71.34 1.27 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 121.036 -0.266 . . . . 4.9500000000000002 111.011 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 76.4 -0.59 63.67 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.252 -0.975 . . . . 1.9399999999999999 111.346 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 41.39 34.2 0.33 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.101 0.477 . . . . 5.3600000000000003 111.119 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 p -149.25 144.39 18.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.754 -0.657 . . . . 2.9700000000000002 110.62 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.75 -168.85 15.49 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.665 -0.779 . . . . 1.99 112.709 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -139.08 174.7 10.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.848 0.356 . . . . 6.5899999999999999 111.229 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.82 115.11 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.822 -0.626 . . . . 2.0099999999999998 111.295 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.9 t -77.22 -33.58 56.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.639 -0.504 . . . . 2.02 109.639 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 36.76 54.28 1.13 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.347 -0.842 . . . . 2.23 112.043 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -81.46 98.45 8.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 2.3300000000000001 110.19 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 53.87 23.38 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.592 -0.813 . . . . 2.2000000000000002 111.958 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.446 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -69.1 2.48 2.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.342 0.115 . . . . 1.9299999999999999 111.179 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 10.6 ttmt -45.17 177.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.856 0.36 . . . . 3.3500000000000001 111.298 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 4.4 mm? 68.46 63.33 0.64 Allowed Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 116.396 -0.365 . . . . 2.7599999999999998 110.601 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 73.6 Cg_exo -58.25 135.34 67.55 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.018 2.479 . . . . 1.46 113.085 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.439 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp -63.05 120.24 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.183 -0.673 . . . . 0.82999999999999996 109.183 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -55.25 30.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.305 -0.861 . . . . 1.6899999999999999 112.957 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.42 31.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.81 0.67 . . . . 2.5600000000000001 112.81 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -147.07 134.95 21.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 0.96999999999999997 111.707 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -69.51 159.76 82.23 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.358 -0.608 . . . . 1.96 109.358 178.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.8 Cg_exo -40.87 -39.5 3.24 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.532 2.155 . . . . 0.66000000000000003 115.408 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.51 -56.9 4.07 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.56 0.695 . . . . 1.8200000000000001 111.351 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 18.5 p-10 -69.48 -4.89 20.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.747 -0.781 . . . . 1.9099999999999999 109.057 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.517 ' CD ' ' HB3' ' A' ' 49' ' ' PRO . 14.3 tt0 -73.97 -64.04 1.09 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.281 -0.872 . . . . 1.5 108.996 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.11 -35.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 1.22 109.322 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.5 tp -69.04 -64.98 0.77 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.788 -0.819 . . . . 1.05 108.788 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -69.55 22.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.673 -1.149 . . . . 0.90000000000000002 113.177 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.446 ' NE2' ' O ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -143.94 -65.33 0.36 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.158 1.17 . . . . 1.8 114.158 -178.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.408 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 6.9 m -39.98 148.03 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.108 0.781 . . . . 1.05 113.108 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HB3' HG22 ' A' ' 167' ' ' VAL . 1.0 OUTLIER -134.47 152.11 51.58 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.803 -0.635 . . . . 2.0499999999999998 111.101 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.64 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 35.9 mtp85 -105.16 -169.51 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.773 0.321 . . . . 3.5800000000000001 110.794 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -86.6 -171.47 3.55 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.159 -0.473 . . . . 4.25 111.16 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.9 m120 64.53 156.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.283 -0.417 . . . . 4.3499999999999996 110.937 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.49 84.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.175 0.435 . . . . 3.1699999999999999 112.175 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -175.19 125.46 0.25 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.271 -0.171 . . . . 2.3900000000000001 111.182 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 24.1 t 37.83 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.415 0.447 . . . . 0.98999999999999999 110.963 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.52 ' N ' ' HD1' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -90.36 104.76 17.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.203 -0.453 . . . . 1.26 109.817 -178.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.524 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -120.06 108.57 1.48 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 119.703 -1.237 . . . . 0.66000000000000003 115.355 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.0 154.7 18.73 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.069 0.461 . . . . 0.82999999999999996 110.817 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.27 134.35 54.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.38 -0.827 . . . . 2.27 110.831 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.531 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -127.94 86.96 56.88 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.514 -0.312 . . . . 0.34000000000000002 111.394 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -55.58 128.35 30.01 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.856 1.704 . . . . 0.80000000000000004 112.357 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 63.2 mt -121.98 150.93 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.898 0.38 . . . . 0.38 111.154 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.07 -1.42 1.38 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.034 -0.53 . . . . 2.96 111.125 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.85 169.38 12.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.783 0.325 . . . . 2.1299999999999999 110.924 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.1 mp0 -120.93 -180.0 4.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.37 111.103 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.67 -148.36 17.2 Favored Glycine 0 CA--C 1.509 -0.322 0 N-CA-C 110.062 -1.215 . . . . 0.20999999999999999 110.062 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.9 mm-40 -104.09 110.97 23.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.577 1.189 . . . . 2.0299999999999998 109.488 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -95.97 126.79 41.46 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.506 -0.924 . . . . 0.26000000000000001 108.506 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.647 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.8 t -112.24 113.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.449 -0.796 . . . . 0.54000000000000004 111.342 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -97.79 104.49 16.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.684 -1.144 . . . . 1.23 111.008 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 14.3 t -111.56 142.01 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.755 -1.111 . . . . 1.3100000000000001 108.77 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.684 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -149.67 144.12 25.93 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.33 -0.948 . . . . 1.3700000000000001 112.105 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.581 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -101.72 121.95 43.0 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.082 -0.647 . . . . 2.9700000000000002 110.108 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.34 142.2 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.813 -0.81 . . . . 0.29999999999999999 108.813 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.46 163.29 39.32 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.474 -0.49 . . . . 0.40999999999999998 110.924 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.46 175.19 10.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.924 0.392 . . . . 3.9700000000000002 111.079 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.1 m -150.03 -31.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.999 -0.546 . . . . 3.8100000000000001 111.363 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -102.08 150.87 22.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.839 0.352 . . . . 2.8900000000000001 110.994 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 63.07 104.43 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.884 -0.598 . . . . 2.0 111.034 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.91 67.52 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.941 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.422 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 49.9 tp60 -133.2 153.38 51.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.454 . . . . 2.96 111.609 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -107.03 164.26 12.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.645 . . . . 1.55 110.908 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 68.14 -70.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.998 -0.546 . . . . 2.3300000000000001 111.72 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -46.67 -32.08 3.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.692 0.282 . . . . 2.5099999999999998 111.313 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 9.6 mtpm? -91.4 62.9 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 3.1000000000000001 110.708 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.31 134.41 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.814 0.34 . . . . 1.3100000000000001 110.206 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.451 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 78.6 m-85 -131.75 -179.28 5.3 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.565 0.58 . . . . 0.68999999999999995 112.565 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 7.9 t70 -126.06 143.94 50.92 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.653 -0.419 . . . . 2.0099999999999998 112.123 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.15 137.83 51.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 115.67 -0.695 . . . . 0.46000000000000002 111.824 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.534 HH21 HG21 ' A' ' 158' ' ' VAL . 10.0 mtt180 -136.77 151.88 49.69 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 113.204 0.816 . . . . 1.8500000000000001 113.204 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 106' ' ' VAL . 30.6 m -114.23 114.67 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 114.949 -1.023 . . . . 1.1000000000000001 108.839 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.653 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 60.1 27.18 16.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.508 -0.769 . . . . 1.77 109.384 -176.55 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.22 20.18 39.59 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.605 -1.18 . . . . 0.40999999999999998 112.744 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.3 m-70 -119.42 109.56 15.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.925 0.713 . . . . 0.46000000000000002 112.925 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.4 p -56.19 135.82 53.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.219 0.533 . . . . 0.66000000000000003 111.437 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 109' ' ' HIS . 5.5 t -132.94 -29.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.276 -0.875 . . . . 0.80000000000000004 108.913 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.16 90.07 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 116.005 -0.543 . . . . 0.51000000000000001 109.662 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 113' ' ' LYS . 4.1 ptpp? -108.04 98.38 7.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.014 0.911 . . . . 2.4399999999999999 110.818 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 6.2 m-20 138.72 33.85 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.293 -2.231 . . . . 2.5600000000000001 108.198 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.08 89.47 0.06 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 112.852 0.686 . . . . 1.1000000000000001 112.852 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.2 t70 -106.35 86.6 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.429 -1.323 . . . . 1.99 107.429 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.3 mt -50.96 -42.22 23.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.275 -0.875 . . . . 0.63 112.55 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -60.2 -49.27 78.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.85 0.315 . . . . 0.90000000000000002 111.85 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.66 -27.52 65.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.869 0.322 . . . . 0.76000000000000001 111.869 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -64.69 -58.65 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.129 0.418 . . . . 2.6800000000000002 112.129 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.83 -40.53 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.054 0.391 . . . . 1.4099999999999999 112.054 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.76 -100.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 1.0600000000000001 111.793 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -114.69 110.76 20.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.728 0.299 . . . . 3.5099999999999998 110.6 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.5 t 60.0 -124.84 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.16 -0.473 . . . . 1.6799999999999999 110.755 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.4 p 54.83 -175.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 0.80000000000000004 111.664 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.439 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -104.91 138.08 41.69 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.95 0.722 . . . . 0.44 112.95 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.7 t60 -110.24 143.15 40.84 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.255 -1.017 . . . . 0.38 108.255 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.34 126.43 15.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.107 0.781 . . . . 2.0899999999999999 113.107 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.8 126.75 55.41 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.743 -0.662 . . . . 2.2799999999999998 109.41 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.37 117.86 54.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.584 -0.735 . . . . 0.70999999999999996 109.766 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.7 mt -127.14 87.78 55.76 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.186 0.81 . . . . 1.3799999999999999 113.186 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -62.32 146.36 95.79 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.764 1.642 . . . . 0.22 111.73 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 134' ' ' SER . 29.8 mt -137.34 157.84 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.20999999999999999 110.398 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 58.6 p -134.09 109.39 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.059 0.457 . . . . 1.1100000000000001 111.513 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 139' ' ' LYS . 14.2 mt -108.12 128.16 63.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 115.679 -0.692 . . . . 0.23000000000000001 109.82 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -148.59 142.81 26.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 1.9099999999999999 110.912 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm 60.38 15.73 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 3.1099999999999999 111.334 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.87 16.04 55.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.581 -0.818 . . . . 0.32000000000000001 113.204 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 135' ' ' ILE . 96.5 mttt -120.5 158.95 26.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.126 0.463 . . . . 2.1899999999999999 111.057 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.44 138.93 48.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.09 0.472 . . . . 0.37 112.19 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.521 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -125.32 114.96 19.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.576 -0.738 . . . . 0.90000000000000002 109.589 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 142' ' ' VAL . 3.4 p -111.93 99.8 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.402 0.62 . . . . 0.53000000000000003 111.435 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 60.3 -86.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.537 -0.756 . . . . 2.0499999999999998 112.401 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.64 16.03 5.93 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.511 -0.852 . . . . 0.59999999999999998 113.088 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.57 134.27 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.785 0.326 . . . . 2.02 110.416 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.68 137.98 32.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.478 . . . . 1.3 111.156 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 m -159.69 119.69 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 1.1200000000000001 109.419 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.0 t -53.69 146.48 13.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.564 . . . . 1.1100000000000001 112.042 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.429 ' H ' ' HA ' ' A' ' 139' ' ' LYS . 37.2 t80 -79.63 142.49 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.12 -0.946 . . . . 0.28000000000000003 110.031 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.3 p -139.38 95.94 3.01 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.967 0.728 . . . . 1.55 112.967 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.56 -60.5 2.43 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 115.66 1.024 . . . . 0.46000000000000002 115.66 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.531 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.97 164.78 36.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.943 0.872 . . . . 1.8 112.553 -178.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -82.16 134.85 35.33 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.119 -1.437 . . . . 1.24 107.119 177.084 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.653 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -121.78 103.92 9.21 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.502 1.297 . . . . 1.28 114.502 -174.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.452 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -93.53 126.32 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.96 -0.385 . . . . 0.58999999999999997 109.96 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 42.0 mt-10 -137.41 127.43 25.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.112 0.412 . . . . 2.48 112.112 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.93 120.08 41.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.408 -0.96 . . . . 1.54 108.408 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.534 HG21 HH21 ' A' ' 105' ' ' ARG . 9.7 t -91.09 143.6 10.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.324 0.583 . . . . 0.77000000000000002 111.532 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -57.31 147.96 24.19 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 114.728 -1.124 . . . . 1.97 111.501 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.21 -7.53 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.79 -0.641 . . . . 1.1200000000000001 111.918 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -151.59 -70.28 0.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.573 0.225 . . . . 3.8100000000000001 110.533 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -176.19 -64.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.362 -0.381 . . . . 3.8199999999999998 110.566 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.75 76.59 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 1.3999999999999999 110.89 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 102' ' ' PHE . 5.8 m-20 -48.35 156.0 0.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.266 -0.879 . . . . 2.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.451 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.71 101.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.457 2.105 . . . . 2.5800000000000001 112.395 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -60.14 -45.57 92.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.623 -0.717 . . . . 3.71 112.283 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 64' ' ' GLU . 21.4 t -104.24 133.63 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 120.337 -0.545 . . . . 0.92000000000000004 111.841 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.8 t -131.92 136.78 47.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 115.945 -0.571 . . . . 1.2 111.449 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -127.55 35.67 4.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.382 0.882 . . . . 0.22 113.382 -178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.12 130.92 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.205 0.316 . . . . 1.02 110.902 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 1.1 t80 -150.84 101.97 2.95 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.33000000000000002 110.864 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -111.63 129.69 66.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.66 0 CA-C-O 122.815 1.293 . . . . 0.68999999999999995 112.854 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.53 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -123.24 168.19 12.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.546 -1.661 . . . . 1.26 109.965 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -118.98 152.41 36.43 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.715 1.746 . . . . 1.8200000000000001 115.715 -176.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 88.17 -34.68 3.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 111.82 -2.446 . . . . 0.22 118.193 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.63 158.98 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.209 2.004 . . . . 0.28999999999999998 114.252 -179.459 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.647 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.75 -10.31 55.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.376 -0.829 . . . . 0.56999999999999995 110.712 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.65 -43.35 84.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 2.3100000000000001 111.28 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.66 -43.04 97.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.343 -0.39 . . . . 2.3700000000000001 110.535 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.8 t -47.09 103.0 0.33 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.069 -0.514 . . . . 2.5699999999999998 111.031 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.05 146.3 17.59 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.029 1.819 . . . . 2.0800000000000001 112.527 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.6 ttt -130.89 103.76 6.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.058 -0.519 . . . . 6.04 110.721 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 183' ' ' LEU . 6.8 mp -110.52 111.08 22.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 5.2999999999999998 110.627 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -61.95 145.27 93.02 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.096 -0.502 . . . . 8.0500000000000007 110.614 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -43.96 128.8 7.42 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.931 1.754 . . . . 9.1400000000000006 112.62 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.662 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 80.6 t60 -118.96 143.25 33.43 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.286 -0.416 . . . . 9.8699999999999992 110.4 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.662 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 71.7 Cg_endo -68.95 -94.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.826 1.684 . . . . 11.69 112.034 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.67 23.91 34.72 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.004 -0.617 . . . . 12.619999999999999 112.388 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 189' ' ' LEU . 7.6 mp -100.88 140.36 35.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.728 0.299 . . . . 14.44 110.72 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.314 -0.85 . . . . 15.699999999999999 110.778 179.894 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 112.483 -0.247 . . . . 9.1500000000000004 112.483 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.29 -61.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.733 0.302 . . . . 7.3600000000000003 110.823 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.4 mmt 57.63 88.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 7.7599999999999998 110.94 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.1 m -134.82 119.23 17.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 4.0199999999999996 111.114 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.71 55.35 0.91 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.854 -0.688 . . . . 1.28 112.535 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 tp -66.49 -44.3 82.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.266 0.555 . . . . 0.40999999999999998 110.531 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.623 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -58.25 -21.11 47.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.373 -0.831 . . . . 0.33000000000000002 111.347 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.51 -16.29 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 2.0899999999999999 111.703 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.528 ' HB3' ' NZ ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -109.48 -26.15 10.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.661 -0.416 . . . . 1.99 111.657 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -42.5 145.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.69 0.256 . . . . 0.20999999999999999 111.69 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.1 pt -140.14 -18.34 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 119.979 -0.689 . . . . 0.85999999999999999 111.355 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -173.0 136.67 0.67 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.803 -0.359 . . . . 0.28000000000000003 110.361 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.82 142.37 12.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.513 0.56 . . . . 0.20000000000000001 112.513 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.0 t -147.64 134.5 13.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 N-CA-C 114.32 1.23 . . . . 0.67000000000000004 114.32 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -115.66 94.76 4.83 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.607 -0.437 . . . . 1.27 110.537 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.414 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -66.25 105.46 1.42 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.765 -0.828 . . . . 0.37 108.765 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 155.8 -40.99 0.59 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.115 -0.948 . . . . 0.67000000000000004 113.33 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -135.16 7.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.581 -0.819 . . . . 1.1200000000000001 113.203 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -160.95 119.52 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.537 0.208 . . . . 2.02 110.683 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 70.3 m 34.8 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.697 -0.683 . . . . 1.22 112.536 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.543 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 58.6 t-80 -116.57 151.89 35.26 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.254 0.549 . . . . 0.34000000000000002 112.237 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.27 103.22 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.17 -0.923 . . . . 1.1799999999999999 109.566 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 1.1699999999999999 110.227 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -43.67 -48.07 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 124.251 0.969 . . . . 0.59999999999999998 113.267 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -59.26 -23.21 62.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.179 0.514 . . . . 0.46000000000000002 110.506 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.3 34.41 2.72 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.423 -0.808 . . . . 0.28999999999999998 112.377 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.8 mm -103.15 125.34 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.188 -0.671 . . . . 0.42999999999999999 109.188 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.7 t60 -110.45 131.4 55.09 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.721 1.378 . . . . 0.52000000000000002 114.721 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.657 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.22 134.4 40.58 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.3 -1.0 . . . . 3.0 108.3 176.174 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -95.25 105.4 17.34 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.377 0.608 . . . . 2.8999999999999999 112.34 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 32' ' ' ASP . 31.2 ttpt -19.57 135.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.118 1.367 . . . . 2.71 114.682 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' LYS . 1.2 m-20 -2.12 85.16 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.783 -1.099 . . . . 1.98 113.329 177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -102.87 -7.37 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.854 2.369 . . . . 1.53 115.911 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.754 HD13 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -117.52 -25.78 6.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.489 0.922 . . . . 1.8300000000000001 113.489 -177.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.754 ' N ' HD13 ' A' ' 34' ' ' LEU . 1.5 pm0 -84.63 65.42 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.065 0.393 . . . . 4.9500000000000002 110.064 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 82.62 0.22 89.85 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.047 -1.073 . . . . 1.9399999999999999 110.812 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 41.51 70.43 0.27 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.421 0.629 . . . . 5.3600000000000003 111.247 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 36' ' ' GLY . 16.9 m -144.58 177.78 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.164 -0.926 . . . . 2.9700000000000002 110.266 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.86 -151.54 0.04 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.77 -0.729 . . . . 1.99 113.058 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 68.62 146.71 0.05 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.194 0.521 . . . . 6.5899999999999999 111.733 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.53 -20.65 1.35 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.58 -0.736 . . . . 2.0099999999999998 110.199 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.1 m 49.05 66.61 1.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.171 0.51 . . . . 2.02 110.993 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -88.05 44.89 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.535 -0.757 . . . . 2.23 110.67 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -58.24 -60.61 3.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.322 -0.399 . . . . 2.3300000000000001 110.469 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.96 46.82 3.7 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 2.2000000000000002 111.713 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 13.8 ttt -60.36 -17.12 41.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.723 0.297 . . . . 1.9299999999999999 111.108 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -71.26 -174.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 3.3500000000000001 110.651 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 17.1 tp 62.3 60.25 2.5 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.265 -0.425 . . . . 2.7599999999999998 111.117 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 31.6 Cg_exo -64.24 130.49 27.23 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.184 1.923 . . . . 1.46 112.068 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.1 143.13 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.912 0.387 . . . . 0.82999999999999996 110.474 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 51' ' ' LEU . 2.9 mm? -94.42 -47.93 6.36 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.271 0.841 . . . . 1.6899999999999999 113.271 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -73.44 34.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.232 0.827 . . . . 2.5600000000000001 113.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -150.05 163.34 38.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.19 0.519 . . . . 0.96999999999999997 112.105 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.1 t30 -78.26 148.4 74.31 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.452 -0.794 . . . . 1.96 109.372 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.595 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.83 -57.88 1.18 Allowed 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.383 2.055 . . . . 0.66000000000000003 114.424 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -58.77 -56.85 16.95 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.191 0.996 . . . . 1.8200000000000001 111.016 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.466 ' OD1' HD23 ' A' ' 60' ' ' LEU . 25.7 t70 -69.19 -10.38 57.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.512 -0.767 . . . . 1.9099999999999999 110.171 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.9 tt0 -63.17 -46.43 87.17 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.146 -1.798 . . . . 1.5 106.146 176.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.26 -50.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.411 -1.268 . . . . 1.22 109.053 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.8 tp -68.88 -9.68 52.89 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.451 -0.795 . . . . 1.05 111.52 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 5.7 m-30 -122.34 17.94 10.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.868 -0.606 . . . . 0.90000000000000002 111.204 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.435 ' OE1' ' HA ' ' A' ' 49' ' ' PRO . 37.6 tt0 -140.46 -71.95 0.37 Allowed 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.714 1.005 . . . . 1.8 113.714 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 7.4 p -27.18 140.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.606 0.965 . . . . 1.05 113.606 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.548 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -130.74 149.97 52.14 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.885 -0.598 . . . . 2.0499999999999998 110.916 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.605 HH12 ' HB2' ' A' ' 67' ' ' ASN . 3.7 ptm180 -136.86 138.66 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.835 0.35 . . . . 3.5800000000000001 110.359 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -78.15 142.92 37.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.048 -0.524 . . . . 4.25 111.407 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.605 ' HB2' HH12 ' A' ' 65' ' ' ARG . 5.2 t30 -134.06 -89.88 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.246 -0.434 . . . . 4.3499999999999996 110.941 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' N ' HD22 ' A' ' 67' ' ' ASN . 41.4 tt0 -175.14 -95.84 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.339 0.126 . . . . 3.1699999999999999 111.339 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -156.27 151.44 26.49 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.483 -0.191 . . . . 2.3900000000000001 110.483 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t 48.06 81.53 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.98999999999999999 110.132 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.429 ' HZ ' ' C ' ' A' ' 164' ' ' ASN . 2.8 p90 -136.77 152.44 50.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 1.26 110.754 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -163.09 -155.26 8.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.037 -1.078 . . . . 0.66000000000000003 114.36 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.414 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 80.3 m-85 -135.78 154.81 51.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.726 0.639 . . . . 0.82999999999999996 112.726 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -118.49 106.48 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.664 -1.153 . . . . 2.27 110.223 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.35 110.68 64.63 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.909 0.337 . . . . 0.34000000000000002 111.909 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.01 133.81 10.23 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.502 1.468 . . . . 0.80000000000000004 111.816 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 61.2 mt -120.75 148.83 23.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.43 . . . . 0.38 111.496 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -139.75 -3.52 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.803 -0.635 . . . . 2.96 110.84 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 23.9 mm-40 -121.77 173.93 7.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.582 0.23 . . . . 2.1299999999999999 110.583 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.77 177.31 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.37 111.545 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.18 -161.17 23.1 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.144 -1.582 . . . . 0.20999999999999999 109.144 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 0.1 OUTLIER -95.0 110.68 22.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 118.743 1.272 . . . . 2.0299999999999998 109.913 179.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.0 m-85 -95.27 125.79 40.15 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.26000000000000001 109.577 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.614 HG21 ' N ' ' A' ' 177' ' ' ALA . 10.2 t -113.07 116.87 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.477 -1.238 . . . . 0.54000000000000004 111.939 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.89 104.57 16.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.668 -1.151 . . . . 1.23 110.778 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 58.8 t -103.22 119.39 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.124 -0.944 . . . . 1.3100000000000001 108.897 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.9 134.22 42.41 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.282 -0.567 . . . . 1.3700000000000001 111.186 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.428 ' CB ' ' HB3' ' A' ' 169' ' ' ALA . 19.4 tptt -104.52 120.74 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.755 -0.778 . . . . 2.9700000000000002 109.732 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 8.1 m-85 -104.77 139.23 39.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.922 -1.14 . . . . 0.29999999999999999 107.922 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 91' ' ' GLU . . . -147.44 171.72 15.06 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.98 -0.688 . . . . 0.40999999999999998 112.534 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 10.0 tp10 81.12 138.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.832 -1.076 . . . . 3.9700000000000002 111.869 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.72 90.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.168 -0.924 . . . . 3.8100000000000001 110.376 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -52.48 -60.79 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 2.8900000000000001 111.706 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -102.81 142.83 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.392 -0.367 . . . . 2.0 110.812 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.98 81.29 8.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.515 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -156.06 159.3 38.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 2.96 110.907 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.6 p -97.27 -76.45 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.974 -0.557 . . . . 1.55 111.781 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -78.13 64.11 3.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.04 0.447 . . . . 2.3300000000000001 111.57 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -145.66 -48.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.181 -0.674 . . . . 2.5099999999999998 109.181 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -105.49 78.66 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.429 -0.805 . . . . 3.1000000000000001 109.33 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.0 113.51 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.332 -0.849 . . . . 1.3100000000000001 110.196 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -102.47 175.82 5.38 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.038 0.755 . . . . 0.68999999999999995 113.038 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 5.4 m-20 -122.1 140.12 52.91 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.694 -0.685 . . . . 2.0099999999999998 111.09 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.12 123.76 44.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 115.996 -0.547 . . . . 0.46000000000000002 111.768 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 12.3 mtt180 -117.66 150.47 38.99 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 115.008 -0.996 . . . . 1.8500000000000001 112.401 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.519 HG13 HD21 ' A' ' 153' ' ' LEU . 84.4 t -126.2 109.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 114.652 -1.158 . . . . 1.1000000000000001 109.392 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.451 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 57.02 25.99 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.432 -0.951 . . . . 1.77 108.432 -176.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.55 53.77 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.097 -0.956 . . . . 0.40999999999999998 112.674 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 92.1 m-70 -112.25 111.14 21.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.81 . . . . 0.46000000000000002 113.188 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -68.94 112.16 5.42 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 120.395 -0.522 . . . . 0.66000000000000003 110.584 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.88 -28.71 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.594 -0.73 . . . . 0.80000000000000004 109.849 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.437 HG21 ' OE1' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -135.02 90.2 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 120.281 -0.568 . . . . 0.51000000000000001 109.582 177.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.4 ptpp? -110.71 85.08 2.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.935 0.874 . . . . 2.4399999999999999 111.491 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.6 p-10 151.47 36.66 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 112.982 -1.917 . . . . 2.5600000000000001 108.325 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.481 HD21 ' OE2' ' A' ' 129' ' ' GLU . 0.7 OUTLIER -62.62 90.15 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.327 0.862 . . . . 1.1000000000000001 113.327 -177.467 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.77 83.91 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.351 -1.352 . . . . 1.99 107.351 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -50.44 -30.58 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.63 111.793 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -68.38 -43.76 76.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 0.90000000000000002 111.237 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -69.54 -27.56 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.76000000000000001 111.867 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' NE2' ' A' ' 127' ' ' HIS . 29.7 mmt180 -71.88 -58.45 3.45 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.384 0.513 . . . . 2.6800000000000002 112.384 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.94 -40.66 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.217 0.451 . . . . 1.4099999999999999 112.217 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.53 -92.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.732 -0.747 . . . . 1.0600000000000001 111.784 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.512 ' O ' HG23 ' A' ' 125' ' ' THR . 45.4 t-80 -114.55 110.02 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 3.5099999999999998 111.056 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.1 t 51.45 -128.23 2.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.083 -0.508 . . . . 1.6799999999999999 111.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 123' ' ' HIS . 26.7 p 58.08 -165.14 0.17 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.592 0.357 . . . . 0.80000000000000004 111.193 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.53 139.18 43.66 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.255 0.835 . . . . 0.44 113.255 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.0 t60 -109.07 148.24 31.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.99 -0.744 . . . . 0.38 108.99 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 4.8 p-10 -143.81 127.12 16.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.674 0.62 . . . . 2.0899999999999999 112.674 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.481 ' OE2' HD21 ' A' ' 115' ' ' LEU . 24.4 mt-10 -120.65 115.67 23.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 2.2799999999999998 109.465 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.507 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.1 mt -105.58 126.85 60.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.516 -0.766 . . . . 0.70999999999999996 110.261 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 130' ' ' ILE . 28.3 mm -126.12 86.45 57.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.218 0.451 . . . . 1.3799999999999999 112.218 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -62.48 139.95 79.25 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.875 1.717 . . . . 0.22 111.426 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 18.8 mt -132.86 155.07 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.20999999999999999 111.042 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 23.8 p -126.21 107.9 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.942 0.401 . . . . 1.1100000000000001 110.859 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 139' ' ' LYS . 25.6 mt -111.37 122.75 66.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.801 -0.636 . . . . 0.23000000000000001 109.881 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -147.38 143.16 27.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.37 -0.377 . . . . 1.9099999999999999 110.817 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt 62.92 7.81 2.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.098 -0.501 . . . . 3.1099999999999999 110.856 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.2 21.24 25.57 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.83 -0.7 . . . . 0.32000000000000001 112.933 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 135' ' ' ILE . 8.2 mtpm? -121.03 156.09 32.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.896 0.348 . . . . 2.1899999999999999 110.859 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -114.31 131.95 56.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.112 0.482 . . . . 0.37 112.121 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.538 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.1 t -122.92 109.65 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 0.90000000000000002 109.642 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -102.35 108.06 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.198 0.523 . . . . 0.53000000000000003 111.148 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 53.77 -91.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.765 -0.652 . . . . 2.0499999999999998 112.034 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.33 38.79 2.21 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.59999999999999998 113.516 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -146.61 137.11 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 2.02 110.297 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.3 135.7 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 1.3 110.875 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -163.19 121.04 1.94 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.154 -0.684 . . . . 1.1200000000000001 109.154 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.05 150.11 3.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.981 0.42 . . . . 1.1100000000000001 111.328 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 t80 -77.55 122.85 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.28000000000000003 110.764 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -75.81 -170.8 1.42 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.955 -1.128 . . . . 1.55 107.955 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.56 -11.92 66.07 Favored Glycine 0 C--N 1.317 -0.503 0 C-N-CA 119.015 -1.564 . . . . 0.46000000000000002 112.93 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.82 151.8 18.72 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.168 0.484 . . . . 1.8 112.105 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.726 HD23 ' N ' ' A' ' 154' ' ' SER . 3.5 tt -84.93 148.51 26.19 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.936 -1.135 . . . . 1.24 107.936 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.726 ' N ' HD23 ' A' ' 153' ' ' LEU . 3.7 t -139.15 115.86 10.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 118.256 -1.378 . . . . 1.28 113.634 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 7.9 t -98.47 97.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.942 -0.762 . . . . 0.58999999999999997 108.942 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 34.7 mt-10 -108.82 132.35 54.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.718 -0.674 . . . . 2.48 111.727 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.95 129.83 51.6 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.481 0.658 . . . . 1.54 109.929 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.535 HG21 HH21 ' A' ' 105' ' ' ARG . 30.8 t -103.0 143.88 14.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.495 -1.23 . . . . 0.77000000000000002 111.678 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -50.88 148.14 4.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 114.988 -1.005 . . . . 1.97 111.445 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -118.99 -10.66 8.08 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.437 -0.665 . . . . 1.1200000000000001 111.437 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -163.64 -59.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.555 -0.322 . . . . 3.8100000000000001 110.344 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -176.84 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.061 -0.518 . . . . 3.8199999999999998 110.879 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -90.92 46.12 1.3 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.026 0.441 . . . . 1.3999999999999999 111.782 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.713 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 54.9 t30 -55.2 -42.07 93.98 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 115.46 -0.791 . . . . 2.0 109.048 176.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.713 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 36.9 Cg_endo -62.9 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.786 2.324 . . . . 2.5800000000000001 111.843 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 11.0 pttp -97.8 166.01 11.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.063 -0.717 . . . . 3.71 109.063 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.83 132.95 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 C-N-CA 119.533 -0.867 . . . . 0.92000000000000004 110.308 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -130.24 131.6 45.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.671 0.607 . . . . 1.2 111.586 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 88' ' ' LYS . . . -123.95 37.05 4.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.22 112.126 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -33.26 134.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.693 -0.685 . . . . 1.02 110.404 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -159.56 95.81 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.533 -0.303 . . . . 0.33000000000000002 110.813 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -106.25 130.16 58.37 Favored 'Isoleucine or valine' 0 C--O 1.258 1.526 0 CA-C-O 122.96 1.362 . . . . 0.68999999999999995 112.719 178.45 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 ppp? -123.64 157.26 34.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.028 -1.896 . . . . 1.26 108.135 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.9 150.04 39.12 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.138 1.532 . . . . 1.8200000000000001 115.138 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.21 -33.91 6.2 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 112.448 -2.16 . . . . 0.22 116.846 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.474 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 156.79 0.44 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.841 1.82 . . . . 0.28999999999999998 114.601 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.614 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.68 -23.37 25.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.161 -0.927 . . . . 0.56999999999999995 110.569 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.17 -37.71 86.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.864 -0.607 . . . . 2.3100000000000001 111.508 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.41 -40.66 71.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.438 -0.346 . . . . 2.3700000000000001 110.736 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 86.0 t -43.42 101.68 0.26 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.198 -0.455 . . . . 2.5699999999999998 111.189 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.61 144.68 24.8 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 121.904 1.736 . . . . 2.0800000000000001 112.411 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 mmt -136.8 93.75 2.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 6.04 110.831 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.4 mt -136.81 116.09 12.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 5.2999999999999998 110.755 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -56.96 151.54 33.07 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.097 -0.502 . . . . 8.0500000000000007 110.314 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -64.89 124.6 13.35 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.593 1.529 . . . . 9.1400000000000006 112.069 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -132.55 128.73 21.13 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.07 -0.514 . . . . 9.8699999999999992 110.492 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -83.39 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.197 1.932 . . . . 11.69 111.409 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 176.98 158.25 19.87 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.272 -0.966 . . . . 12.619999999999999 112.688 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.3 mm? -92.35 148.69 21.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 14.44 110.669 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.179 -0.915 . . . . 15.699999999999999 110.785 179.83 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.496 -0.242 . . . . 9.1500000000000004 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.2 14.11 12.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.824 0.345 . . . . 7.3600000000000003 110.777 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtt -61.79 -59.49 5.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 7.7599999999999998 110.857 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.2 m 56.21 87.86 0.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.262 -0.427 . . . . 4.0199999999999996 111.066 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.21 49.63 0.72 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.795 -0.716 . . . . 1.28 112.588 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp -68.66 -48.5 63.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.517 . . . . 0.40999999999999998 110.259 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.596 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.71 -21.24 6.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.405 -0.816 . . . . 0.33000000000000002 111.314 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -79.29 -21.77 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 2.0899999999999999 112.121 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 34.9 mmtt -98.43 -26.52 14.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.937 -0.305 . . . . 1.99 111.475 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.9 p -44.47 146.82 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 111.961 0.356 . . . . 0.20999999999999999 111.961 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.2 pt -139.48 -21.73 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.724 . . . . 0.85999999999999999 111.103 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.576 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.9 t90 -173.7 133.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.55 -0.46 . . . . 0.28000000000000003 110.14 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -150.6 144.26 25.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.809 0.3 . . . . 0.20000000000000001 111.809 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.2 t -147.63 126.66 4.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.495 1.295 . . . . 0.67000000000000004 114.495 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 11.5 t30 -114.6 100.86 8.59 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.533 -0.467 . . . . 1.27 110.31 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.51 103.47 2.98 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 109.021 -0.733 . . . . 0.37 109.021 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.581 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 167.9 -45.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.916 0 O-C-N 124.277 0.986 . . . . 0.67000000000000004 113.563 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.77 -123.6 3.48 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.586 -0.816 . . . . 1.1200000000000001 113.124 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.723 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 6.4 tt0 -164.1 120.3 1.62 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.871 0.367 . . . . 2.02 111.489 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.4 m 35.53 99.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.16 -0.927 . . . . 1.22 113.231 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.665 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 54.0 t-80 -130.65 140.16 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.729 -0.788 . . . . 0.34000000000000002 112.462 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 p -114.64 103.91 16.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.637 0.732 . . . . 1.1799999999999999 110.787 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 156.3 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.036 -0.984 . . . . 1.1699999999999999 110.056 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 25' ' ' HIS . 30.9 m -44.01 -49.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.175 0.922 . . . . 0.59999999999999998 113.136 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.464 ' N ' HG23 ' A' ' 24' ' ' VAL . 83.5 m-70 -59.53 -18.17 38.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.294 0.569 . . . . 0.46000000000000002 110.567 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.72 35.2 3.84 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.34 -0.845 . . . . 0.28999999999999998 112.444 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.428 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 31.1 mm -103.88 111.95 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.026 0.441 . . . . 0.42999999999999999 110.578 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.665 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 10.9 t60 -98.27 135.55 39.73 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.891 1.441 . . . . 0.52000000000000002 114.891 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.723 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -100.47 135.46 41.87 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.864 -1.062 . . . . 3.0 108.619 177.53 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -88.04 111.42 21.51 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 124.001 0.813 . . . . 2.8999999999999999 112.252 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 31' ' ' LYS . 5.3 ttpm? -23.44 135.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.349 1.06 . . . . 2.71 113.723 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.65 ' HB3' HH11 ' A' ' 65' ' ' ARG . 2.5 m-20 -10.15 83.84 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 CA-C-N 114.2 -1.364 . . . . 1.98 113.708 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -103.71 15.01 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.166 2.577 . . . . 1.53 113.582 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -130.15 -38.21 1.42 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.041 0.386 . . . . 1.8300000000000001 112.041 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.661 ' N ' HD23 ' A' ' 34' ' ' LEU . 8.2 tp10 -87.39 92.37 9.06 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.675 -0.491 . . . . 4.9500000000000002 109.675 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.53 -1.42 51.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.494 -0.86 . . . . 1.9399999999999999 111.104 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.424 ' N ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER 41.68 49.45 3.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.208 0.528 . . . . 5.3600000000000003 110.992 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 m -144.29 176.08 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.629 -0.714 . . . . 2.9700000000000002 110.229 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.67 118.79 5.55 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.571 -0.823 . . . . 1.99 113.188 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 98.0 mtt180 -149.11 -50.23 0.15 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.515 0.198 . . . . 6.5899999999999999 110.844 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 40' ' ' ARG . . . 72.08 -67.4 0.26 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.895 -0.593 . . . . 2.0099999999999998 111.545 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.3 t 62.32 56.82 2.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.95 0.405 . . . . 2.02 110.744 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -78.93 74.39 5.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.004 -0.543 . . . . 2.23 110.534 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -66.01 85.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.02 -0.536 . . . . 2.3300000000000001 110.841 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.2 114.36 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.723 -0.751 . . . . 2.2000000000000002 112.813 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 30.9 mtt -82.54 -0.31 46.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.316 0.579 . . . . 1.9299999999999999 109.478 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -56.28 176.7 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.004 -0.998 . . . . 3.3500000000000001 111.158 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.57 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 3.8 mm? 54.1 56.32 12.62 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.334 -0.393 . . . . 2.7599999999999998 110.067 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 38.9 Cg_exo -66.31 134.49 36.4 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.806 2.337 . . . . 1.46 112.868 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.2 mp -60.24 128.15 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.347 -0.612 . . . . 0.82999999999999996 109.347 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mt -69.87 -49.19 54.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.911 1.449 . . . . 1.6899999999999999 114.911 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -73.87 25.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.85 0.685 . . . . 2.5600000000000001 112.85 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -146.19 144.57 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.96999999999999997 111.487 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 58' ' ' GLN . 1.8 p-10 -66.44 153.53 92.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.065 -0.516 . . . . 1.96 109.787 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.423 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.57 -59.14 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.47 2.113 . . . . 0.66000000000000003 114.626 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -58.35 -55.43 35.13 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 121.901 0.858 . . . . 1.8200000000000001 111.246 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 11.2 t70 -69.38 -11.98 61.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.325 -0.55 . . . . 1.9099999999999999 110.439 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -68.38 -39.83 81.59 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 106.523 -1.658 . . . . 1.5 106.523 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.411 ' N ' ' HG3' ' A' ' 58' ' ' GLN . 62.4 t -54.37 -50.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.138 -1.06 . . . . 1.22 108.138 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.8 tp -69.81 -13.76 62.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.907 -1.042 . . . . 1.05 111.1 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.541 ' C ' ' HZ2' ' A' ' 88' ' ' LYS . 2.6 m-85 -121.89 27.71 7.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.182 -0.917 . . . . 0.90000000000000002 111.679 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -151.46 -63.36 0.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.261 0.837 . . . . 1.8 113.261 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 13.7 p -34.13 147.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.815 0.672 . . . . 1.05 112.815 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.577 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pp20? -137.52 148.05 45.68 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.691 0.626 . . . . 2.0499999999999998 112.691 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.65 HH11 ' HB3' ' A' ' 32' ' ' ASP . 19.3 mtp180 -114.27 -174.95 2.57 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.98 -0.554 . . . . 3.5800000000000001 109.858 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -66.32 172.0 4.33 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.531 -0.304 . . . . 4.25 110.455 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -143.57 162.22 36.44 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.021 0.438 . . . . 4.3499999999999996 111.653 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -144.79 -118.16 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.876 -0.602 . . . . 3.1699999999999999 110.685 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.459 ' OD1' ' HD3' ' A' ' 159' ' ' LYS . 63.6 m-20 -156.62 134.4 10.97 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.44 -0.162 . . . . 2.3900000000000001 111.093 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 53.84 83.53 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.92 0.391 . . . . 0.98999999999999999 110.764 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -162.59 159.6 24.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 1.26 110.826 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.691 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -168.93 -168.15 30.56 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.437 -0.887 . . . . 0.66000000000000003 113.418 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.437 ' CE2' HD13 ' A' ' 34' ' ' LEU . 3.8 m-85 -108.36 165.12 11.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.294 0.569 . . . . 0.82999999999999996 111.763 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.03 140.53 49.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.91 -1.041 . . . . 2.27 110.825 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.27 109.87 10.56 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.142 -0.481 . . . . 0.34000000000000002 111.171 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.87 133.17 7.83 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.129 1.219 . . . . 0.80000000000000004 112.045 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 78' ' ' LYS . 23.4 mt -121.32 155.2 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.985 0.421 . . . . 0.38 111.577 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' N ' HG22 ' A' ' 77' ' ' ILE . 99.5 mttt -143.19 -0.87 1.09 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.825 -0.625 . . . . 2.96 110.995 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -127.46 169.03 14.08 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.826 0.345 . . . . 2.1299999999999999 111.562 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -117.48 -177.61 3.27 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.37 111.047 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.78 -151.04 18.05 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.997 -1.241 . . . . 0.20999999999999999 109.997 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 21.2 mt-10 -105.15 108.72 20.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.644 1.222 . . . . 2.0299999999999998 109.71 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -95.34 129.68 42.39 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 119.719 -0.792 . . . . 0.26000000000000001 109.156 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG21 ' N ' ' A' ' 177' ' ' ALA . 22.0 t -116.92 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.686 -1.143 . . . . 0.54000000000000004 111.806 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.94 105.7 17.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.726 -0.67 . . . . 1.23 110.126 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 38.1 t -101.4 119.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 107.945 -1.131 . . . . 1.3100000000000001 107.945 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 135.92 23.83 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.671 -0.812 . . . . 1.3700000000000001 112.437 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.711 ' NZ ' ' HB2' ' A' ' 90' ' ' ALA . 5.9 tmtt? -103.15 132.1 49.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.65 -0.82 . . . . 2.9700000000000002 109.952 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -111.44 149.32 31.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.609 -0.723 . . . . 0.29999999999999999 109.547 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.711 ' HB2' ' NZ ' ' A' ' 88' ' ' LYS . . . -145.56 157.4 43.99 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.073 0.464 . . . . 0.40999999999999998 111.323 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -144.97 131.31 19.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.621 -0.718 . . . . 3.9700000000000002 110.129 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.48 -65.2 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.434 . . . . 3.8100000000000001 111.653 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -92.61 -164.25 1.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 2.8900000000000001 110.987 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 63.0 64.71 0.84 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.929 -0.578 . . . . 2.0 110.723 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.52 79.51 8.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -157.13 140.51 15.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 2.96 111.153 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -103.8 157.15 17.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.951 -0.568 . . . . 1.55 111.235 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 45.25 49.46 10.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.8 -0.636 . . . . 2.3300000000000001 111.647 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -153.47 -46.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.899 -0.778 . . . . 2.5099999999999998 108.899 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -96.89 82.04 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.271 -1.011 . . . . 3.1000000000000001 108.271 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.437 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.7 OUTLIER -108.87 134.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 1.3100000000000001 111.227 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.403 ' CD1' ' HD3' ' A' ' 165' ' ' PRO . 69.9 m-85 -117.89 175.59 5.59 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.576 0.584 . . . . 0.68999999999999995 112.576 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.87 140.06 53.35 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 115.928 -0.578 . . . . 2.0099999999999998 111.459 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.06 131.65 41.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.075 -0.512 . . . . 0.46000000000000002 111.854 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.4 154.8 49.44 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.265 0.839 . . . . 1.8500000000000001 113.265 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 p -121.51 125.24 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.193 -1.367 . . . . 1.1000000000000001 110.474 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.14 26.1 3.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.663 -0.866 . . . . 1.77 108.663 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.8 27.45 21.7 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 112.976 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 87.1 m-70 -127.35 110.5 12.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.164 0.801 . . . . 0.46000000000000002 113.164 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.0 p -67.24 115.56 7.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.245 0.545 . . . . 0.66000000000000003 111.723 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.58 -34.71 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.215 -0.902 . . . . 0.80000000000000004 109.369 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.07 89.62 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.995 -0.548 . . . . 0.51000000000000001 109.548 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.0 ptpp? -110.08 83.39 1.75 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.096 0.951 . . . . 2.4399999999999999 110.759 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 156.82 33.58 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 112.824 -1.989 . . . . 2.5600000000000001 108.557 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 85.92 0.08 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.595 0.591 . . . . 1.1000000000000001 112.595 -177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 0.6 OUTLIER -98.47 80.42 2.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.714 -1.587 . . . . 1.99 106.714 175.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.7 mt -49.88 -38.48 14.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.516 -0.765 . . . . 0.63 112.291 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.28 -46.69 85.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.462 0.171 . . . . 0.90000000000000002 111.462 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.413 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 37.1 t70 -70.33 -27.97 64.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.76000000000000001 111.514 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -61.33 -58.09 9.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.865 0.321 . . . . 2.6800000000000002 111.865 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.13 -40.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.033 0.383 . . . . 1.4099999999999999 112.033 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.93 -87.45 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.912 -0.661 . . . . 1.0600000000000001 112.487 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.582 ' O ' HG23 ' A' ' 125' ' ' THR . 48.6 m80 -112.87 110.46 20.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.641 0.257 . . . . 3.5099999999999998 111.081 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.9 p 46.79 -116.85 0.72 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.019 -0.537 . . . . 1.6799999999999999 111.769 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 123' ' ' HIS . 41.8 p 50.91 -166.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.209 0.203 . . . . 0.80000000000000004 110.7 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.485 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.27 139.09 49.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.087 0.773 . . . . 0.44 113.087 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.409 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 1.8 t60 -105.35 145.08 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.856 -1.164 . . . . 0.38 107.856 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -143.75 126.94 16.58 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.056 -0.658 . . . . 2.0899999999999999 112.761 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -117.11 127.84 54.54 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.247 -0.888 . . . . 2.2799999999999998 110.096 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.1 mt -116.43 121.79 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.431 -0.804 . . . . 0.70999999999999996 109.817 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.76 90.09 51.47 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.723 0.638 . . . . 1.3799999999999999 112.723 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.76 149.74 90.34 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.04 1.827 . . . . 0.22 112.053 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 16.9 mt -144.16 156.89 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.452 -0.34 . . . . 0.20999999999999999 111.537 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 133' ' ' ILE . 32.7 t -133.07 110.23 10.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.026 0.441 . . . . 1.1100000000000001 111.077 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 139' ' ' LYS . 21.8 mt -106.62 137.25 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.799 -0.637 . . . . 0.23000000000000001 110.337 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -145.35 130.36 18.34 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.997 -0.281 . . . . 1.9099999999999999 111.102 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 54.99 19.03 2.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.1 -0.5 . . . . 3.1099999999999999 110.8 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.5 16.14 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.688 -0.768 . . . . 0.32000000000000001 112.782 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -111.5 156.54 21.54 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.084 -0.339 . . . . 2.1899999999999999 110.084 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 141' ' ' SER . 5.1 tt -124.6 126.01 45.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.284 0.564 . . . . 0.37 112.496 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.515 ' N ' HD23 ' A' ' 140' ' ' LEU . 9.5 t -115.81 109.23 17.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.302 -0.863 . . . . 0.90000000000000002 109.084 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -102.95 99.57 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.513 -0.767 . . . . 0.53000000000000003 110.507 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.43 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 2.0499999999999998 111.626 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -132.33 29.58 3.29 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.44 -0.886 . . . . 0.59999999999999998 113.277 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.28 135.78 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.297 . . . . 2.02 110.526 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.83 135.46 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 1.3 110.344 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 m -164.46 129.22 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 1.1200000000000001 109.837 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -53.16 145.03 14.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.181 0.515 . . . . 1.1100000000000001 112.238 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -78.72 121.67 25.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.516 -0.765 . . . . 0.28000000000000003 110.031 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.4 p -76.14 173.85 10.81 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.51 -0.922 . . . . 1.55 108.51 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.81 -8.8 1.48 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.948 -1.12 . . . . 0.46000000000000002 114.236 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.61 152.09 19.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.894 0.847 . . . . 1.8 112.703 -179.172 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -80.9 129.63 34.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.794 -1.187 . . . . 1.24 107.794 177.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.496 ' HB3' ' OE1' ' A' ' 156' ' ' GLU . 0.1 OUTLIER -121.88 120.71 35.3 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.96 1.096 . . . . 1.28 113.96 -176.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.436 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 96.6 t -106.11 101.13 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.741 -0.466 . . . . 0.58999999999999997 109.741 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.496 ' OE1' ' HB3' ' A' ' 154' ' ' SER . 17.6 mp0 -116.64 150.5 38.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.369 0.604 . . . . 2.48 112.069 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.6 140.11 44.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.178 -0.919 . . . . 1.54 110.148 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.67 144.06 24.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.058 -0.973 . . . . 0.77000000000000002 111.168 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.459 ' HD3' ' OD1' ' A' ' 69' ' ' ASP . 19.2 pttm -63.63 139.43 58.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.384 -0.825 . . . . 1.97 111.055 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -108.33 -4.79 32.75 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.116 -0.794 . . . . 1.1200000000000001 111.116 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -169.92 -54.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.327 -0.436 . . . . 3.8100000000000001 110.229 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -178.29 149.03 0.51 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.09 -0.505 . . . . 3.8199999999999998 110.64 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 55.84 87.5 0.05 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.855 0.36 . . . . 1.3999999999999999 111.681 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.41 166.37 0.56 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.848 -0.615 . . . . 2.0 109.886 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.403 ' HD3' ' CD1' ' A' ' 102' ' ' PHE . 7.0 Cg_exo -35.78 104.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.015 1.81 . . . . 2.5800000000000001 111.731 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -58.21 -54.11 50.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 3.71 113.133 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 64' ' ' GLU . 6.8 t -103.55 134.72 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.961 0.726 . . . . 0.92000000000000004 112.961 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.42 138.85 49.26 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.964 -0.562 . . . . 1.2 112.149 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -129.75 35.94 4.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.183 -0.917 . . . . 0.22 112.915 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -36.96 136.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.232 0.539 . . . . 1.02 112.404 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.528 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -156.62 96.11 1.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.305 -0.861 . . . . 0.33000000000000002 109.33 178.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -99.93 127.67 52.6 Favored 'Isoleucine or valine' 0 C--O 1.266 1.942 0 CA-C-O 122.663 1.221 . . . . 0.68999999999999995 112.35 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.42 161.35 21.36 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.683 -1.599 . . . . 1.26 109.546 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 16.1 tttm -120.38 139.05 53.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.7 1.37 . . . . 1.8200000000000001 114.7 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.03 -35.05 5.3 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 118.123 2.009 . . . . 0.22 118.123 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.55 158.06 0.5 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.436 2.118 . . . . 0.28999999999999998 114.105 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.618 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.34 -24.69 27.52 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.94 -1.027 . . . . 0.56999999999999995 109.858 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.03 -30.63 69.3 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.538 -0.756 . . . . 2.3100000000000001 111.132 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -53.7 -47.68 70.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.402 -0.363 . . . . 2.3700000000000001 110.217 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 35.3 t -39.68 100.48 0.22 Allowed Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.864 -0.607 . . . . 2.5699999999999998 111.587 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -51.26 139.38 44.37 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.002 1.802 . . . . 2.0800000000000001 112.397 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 86.3 mtp -133.09 141.57 48.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 6.04 110.859 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.75 118.1 17.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 5.2999999999999998 110.772 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -53.6 144.91 31.59 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.688 -0.486 . . . . 8.0500000000000007 109.688 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.22 124.12 12.52 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.398 1.399 . . . . 9.1400000000000006 112.407 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -135.01 135.14 22.45 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 9.8699999999999992 110.41 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.58 -36.34 5.13 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.137 1.891 . . . . 11.69 112.6 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.26 -163.15 37.71 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.968 -0.634 . . . . 12.619999999999999 112.632 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.29 152.57 24.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 14.44 110.812 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.407 -0.806 . . . . 15.699999999999999 110.975 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.535 -0.226 . . . . 9.1500000000000004 112.535 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.02 -57.78 2.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.357 . . . . 7.3600000000000003 111.003 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 tpt -97.27 96.8 8.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 7.7599999999999998 110.699 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -134.71 101.1 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 4.0199999999999996 110.775 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.75 51.91 0.22 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 1.28 112.445 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.1 tp -72.48 -50.06 28.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.354 0.597 . . . . 0.40999999999999998 110.052 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.543 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.02 -19.65 7.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.076 -0.966 . . . . 0.33000000000000002 111.652 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.75 -28.65 40.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.498 0.555 . . . . 2.0899999999999999 112.498 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 44.0 mttp -98.89 -18.08 18.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.325 -0.55 . . . . 1.99 112.065 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 7' ' ' ALA . 14.2 p -42.63 144.08 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 121.28 -0.168 . . . . 0.20999999999999999 111.131 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' TRP . 4.1 pt -139.55 -21.7 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 C-N-CA 119.639 -0.824 . . . . 0.85999999999999999 111.582 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.599 ' O ' HG22 ' A' ' 172' ' ' ILE . 50.5 t90 -175.99 130.79 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.478 -0.489 . . . . 0.28000000000000003 110.675 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -148.39 146.58 28.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.273 0.471 . . . . 0.20000000000000001 112.273 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.3 t -147.5 126.77 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 114.229 1.196 . . . . 0.67000000000000004 114.229 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -117.39 106.36 13.13 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.654 -0.703 . . . . 1.27 110.133 176.68 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 113.54 15.14 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 120.68 -0.408 . . . . 0.37 110.811 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.458 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 142.74 -29.74 2.1 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 114.649 -1.16 . . . . 0.67000000000000004 112.594 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -109.81 -144.75 10.51 Favored Glycine 0 CA--C 1.516 0.135 0 C-N-CA 121.138 -0.553 . . . . 1.1200000000000001 112.021 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 36.2 mt-10 -156.83 119.45 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.666 -0.124 . . . . 2.02 110.666 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.3 m 27.7 94.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.803 0.69 . . . . 1.22 112.152 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 21.7 t-80 -126.26 150.89 48.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 119.922 -0.711 . . . . 0.34000000000000002 112.416 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.56 105.32 18.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.133 -0.939 . . . . 1.1799999999999999 111.019 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 153.77 42.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.981 -0.377 . . . . 1.1699999999999999 109.981 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 25' ' ' HIS . 16.1 m -44.44 -49.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.501 0.926 . . . . 0.59999999999999998 113.501 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.419 ' N ' HG23 ' A' ' 24' ' ' VAL . 86.2 m-70 -58.44 -17.84 23.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.282 0.563 . . . . 0.46000000000000002 110.463 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.62 33.71 4.67 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.28999999999999998 112.149 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm -103.23 120.72 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.904 -0.406 . . . . 0.42999999999999999 109.904 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.511 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 12.8 t60 -102.97 132.91 48.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.191 1.182 . . . . 0.52000000000000002 114.191 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.667 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.5 134.19 43.82 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.935 -1.135 . . . . 3.0 107.935 176.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -94.62 112.52 24.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.444 0.64 . . . . 2.8999999999999999 112.376 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -10.49 138.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.54 1.681 . . . . 2.71 115.54 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.445 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 12.5 m-20 -22.54 89.67 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 113.722 -1.581 . . . . 1.98 114.219 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.39 -123.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.731 2.287 . . . . 1.53 113.309 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.787 HD13 ' O ' ' A' ' 72' ' ' GLY . 1.2 pt? -39.64 -32.97 0.15 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.026 0.75 . . . . 1.8300000000000001 113.026 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.491 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 9.7 mm-40 -62.61 85.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.922 0.392 . . . . 4.9500000000000002 110.257 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.68 -26.98 1.09 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.974 -0.631 . . . . 1.9399999999999999 112.497 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 35' ' ' GLU . 6.3 mtp180 48.92 33.25 4.35 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.024 0.44 . . . . 5.3600000000000003 111.158 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.91 176.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.826 -0.625 . . . . 2.9700000000000002 110.67 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.56 102.26 0.79 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.805 -0.712 . . . . 1.99 112.768 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.467 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 16.2 tpp180 -161.22 115.18 2.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.976 0.417 . . . . 6.5899999999999999 110.714 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.2 82.38 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 2.0099999999999998 110.434 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.9 m -64.06 81.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 2.02 110.2 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.76 26.1 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.718 -0.673 . . . . 2.23 110.776 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -65.14 -48.66 72.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 2.3300000000000001 110.75 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.09 31.52 5.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 2.2000000000000002 112.411 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.5 ttt -67.02 -17.46 64.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.926 0.393 . . . . 1.9299999999999999 110.663 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -64.29 -179.48 0.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 3.3500000000000001 110.278 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD23 ' OG ' ' A' ' 124' ' ' SER . 11.0 mp 59.21 61.72 4.36 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.663 -0.244 . . . . 2.7599999999999998 110.571 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 86.2 Cg_exo -54.74 124.26 15.76 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.275 1.983 . . . . 1.46 111.975 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' A' ' 126' ' ' ALA . 4.4 mt -59.94 121.22 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.264 -0.643 . . . . 0.82999999999999996 109.264 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.68 -42.77 86.02 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.232 1.197 . . . . 1.6899999999999999 114.232 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -80.25 25.14 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.705 -0.398 . . . . 2.5600000000000001 111.984 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.472 ' OG ' HG22 ' A' ' 50' ' ' ILE . 94.0 p -139.77 130.47 25.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.702 0.287 . . . . 0.96999999999999997 111.347 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 3.0 p-10 -59.73 152.73 56.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.857 -0.794 . . . . 1.96 108.857 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.48 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 7.6 Cg_exo -39.93 -39.52 2.3 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.341 2.027 . . . . 0.66000000000000003 115.251 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.5 mm-40 -75.43 -56.07 5.07 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.755 0.788 . . . . 1.8200000000000001 111.171 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.4 OUTLIER -70.79 -6.57 38.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.034 -0.666 . . . . 1.9099999999999999 109.256 -179.453 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 4.5 tt0 -70.54 -64.88 0.81 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.255 -0.884 . . . . 1.5 108.661 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 63' ' ' THR . 2.6 p -48.41 -37.94 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.901 -0.591 . . . . 1.22 109.79 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 62' ' ' GLN . 4.9 tp -68.07 -68.19 0.41 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.84 -0.744 . . . . 1.05 110.071 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -56.36 1.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.184 0.593 . . . . 0.90000000000000002 111.932 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 60' ' ' LEU . 1.8 tt0 -122.8 -126.02 0.26 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.115 -0.493 . . . . 1.8 111.734 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 59' ' ' VAL . 47.6 p 49.08 -166.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.598 -0.273 . . . . 1.05 110.725 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.2 pt-20 -179.3 140.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.628 0.252 . . . . 2.0499999999999998 111.1 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.491 ' NH1' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -123.13 177.15 5.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.012 0.434 . . . . 3.5800000000000001 111.601 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -57.63 169.8 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.718 -0.674 . . . . 4.25 111.412 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -142.13 169.32 17.81 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.256 -0.429 . . . . 4.3499999999999996 111.077 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -154.57 -107.52 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.663 -0.244 . . . . 3.1699999999999999 111.446 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.68 125.71 1.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.429 -0.169 . . . . 2.3900000000000001 110.742 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 t 50.9 84.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.047 -0.353 . . . . 0.98999999999999999 110.047 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -159.09 164.72 35.09 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.593 -0.443 . . . . 1.26 111.223 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.787 ' O ' HD13 ' A' ' 34' ' ' LEU . . . 177.6 -167.8 39.0 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 119.066 -1.54 . . . . 0.66000000000000003 116.406 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.99 174.2 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.648 -1.276 . . . . 0.82999999999999996 113.147 -176.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.9 147.34 50.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.33 -1.305 . . . . 2.27 111.187 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.32 113.55 6.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.349 -0.387 . . . . 0.34000000000000002 111.167 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.62 140.25 13.09 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.198 1.266 . . . . 0.80000000000000004 111.918 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mt -129.49 149.24 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.38 111.652 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.84 8.45 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.633 -0.712 . . . . 2.96 110.809 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -127.11 163.76 23.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.134 -0.321 . . . . 2.1299999999999999 110.134 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 2.5 mp0 -125.98 158.73 34.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.37 111.901 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.82 -144.3 11.63 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.793 -1.323 . . . . 0.20999999999999999 109.793 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -105.93 107.8 18.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.622 1.211 . . . . 2.0299999999999998 108.995 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.26 126.21 40.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.715 -0.846 . . . . 0.26000000000000001 108.715 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.638 HG21 ' N ' ' A' ' 177' ' ' ALA . 12.7 t -114.36 120.75 64.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.007 -0.997 . . . . 0.54000000000000004 111.915 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.6 tt -101.46 104.97 15.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.918 -1.037 . . . . 1.23 110.617 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.93 135.93 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.184 -1.043 . . . . 1.3100000000000001 108.184 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.647 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -147.97 150.08 33.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 118.861 -1.136 . . . . 1.3700000000000001 112.952 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.564 ' O ' ' HB3' ' A' ' 169' ' ' ALA . 12.2 tptt -107.75 120.43 42.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.341 -0.845 . . . . 2.9700000000000002 110.099 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.79 145.89 31.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.558 -0.534 . . . . 0.29999999999999999 109.558 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.09 152.16 41.54 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.801 0.334 . . . . 0.40999999999999998 110.65 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -140.45 137.53 33.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 3.9700000000000002 110.534 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.9 m -144.59 172.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 3.8100000000000001 111.362 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 t80 63.38 12.88 6.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.842 -0.617 . . . . 2.8900000000000001 111.497 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -148.98 138.81 21.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.555 -0.293 . . . . 2.0 110.58 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.58 89.71 2.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 1.0 111.078 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -157.01 147.07 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 2.96 110.707 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -126.78 153.42 45.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 1.55 111.863 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 47.73 30.71 1.9 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.805 -0.634 . . . . 2.3300000000000001 111.574 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -131.56 -50.42 0.99 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 2.5099999999999998 109.879 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.3 tttp -97.92 90.47 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.087 -0.709 . . . . 3.1000000000000001 109.087 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.49 147.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.3100000000000001 110.435 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -121.22 -179.87 4.19 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.392 0.886 . . . . 0.68999999999999995 113.392 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.89 139.39 52.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 115.648 -0.706 . . . . 2.0099999999999998 111.162 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.1 t -135.01 133.47 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 116.152 -0.476 . . . . 0.46000000000000002 112.068 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 10.9 ptt180 -135.89 145.17 46.05 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.684 0.994 . . . . 1.8500000000000001 113.684 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.5 m -113.0 121.06 64.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.584 -1.189 . . . . 1.1000000000000001 109.694 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.521 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 54.28 26.89 7.27 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.805 0.812 . . . . 1.77 109.332 -176.407 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 23.17 28.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.047 -1.433 . . . . 0.40999999999999998 112.977 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 81.5 m-70 -120.83 108.03 13.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.277 0.843 . . . . 0.46000000000000002 113.277 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 7.0 p -64.6 116.03 5.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.146 0.498 . . . . 0.66000000000000003 111.407 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.55 -31.31 2.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.471 -0.786 . . . . 0.80000000000000004 109.99 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.18 91.49 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.351 -0.611 . . . . 0.51000000000000001 109.351 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 4.2 ptpp? -106.6 77.96 1.23 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.584 1.183 . . . . 2.4399999999999999 112.517 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.1 p30 156.14 36.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.399 -2.182 . . . . 2.5600000000000001 109.453 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 91.78 0.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.352 0.596 . . . . 1.1000000000000001 111.537 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.506 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 1.5 p30 -101.68 79.12 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.008 -1.479 . . . . 1.99 107.008 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.0 mt -50.4 -50.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.709 -1.132 . . . . 0.63 113.002 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -56.19 -51.45 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.83 0.307 . . . . 0.90000000000000002 111.83 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.506 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 18.0 t70 -65.39 -29.59 70.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.369 0.507 . . . . 0.76000000000000001 112.369 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -64.02 -58.29 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.452 0.538 . . . . 2.6800000000000002 112.452 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 126' ' ' ALA . 10.9 m -103.53 -41.17 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.519 0.563 . . . . 1.4099999999999999 112.519 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.73 -131.23 10.26 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.524 -0.845 . . . . 1.0600000000000001 112.881 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.37 110.43 1.43 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.761 0.315 . . . . 3.5099999999999998 111.083 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.445 ' OG ' HD23 ' A' ' 48' ' ' LEU . 53.8 m 45.27 -104.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.867 -0.606 . . . . 1.6799999999999999 111.161 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.403 ' OG1' ' HB ' ' A' ' 121' ' ' VAL . 23.0 p 50.07 178.24 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.084 0.469 . . . . 0.80000000000000004 111.914 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -105.86 138.95 41.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.786 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.8 t60 -112.57 144.8 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.918 -0.771 . . . . 0.38 108.918 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.89 140.48 29.78 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.305 0.854 . . . . 2.0899999999999999 113.305 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.17 133.85 52.63 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.026 -0.988 . . . . 2.2799999999999998 109.092 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.4 mt -115.66 116.4 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.747 -0.66 . . . . 0.70999999999999996 110.187 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.9 mt -124.62 87.87 54.11 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.584 0.587 . . . . 1.3799999999999999 112.584 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.6 141.82 74.8 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.81 1.674 . . . . 0.22 111.602 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.2 mt -132.09 155.82 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 0.20999999999999999 110.505 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 30.5 p -131.39 106.73 8.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 1.1100000000000001 110.732 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 139' ' ' LYS . 23.8 mt -105.4 124.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.747 -0.66 . . . . 0.23000000000000001 109.911 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -146.97 142.1 27.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 1.9099999999999999 110.947 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp 58.91 19.13 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 3.1099999999999999 111.205 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.85 23.62 41.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 0.32000000000000001 113.396 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 135' ' ' ILE . 25.9 mtmm -123.62 151.75 42.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.1 0.45 . . . . 2.1899999999999999 110.823 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -109.84 126.65 54.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.118 0.485 . . . . 0.37 111.658 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.509 ' N ' HD23 ' A' ' 140' ' ' LEU . 24.2 t -114.55 110.99 20.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.723 -0.671 . . . . 0.90000000000000002 110.059 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.2 p -105.03 104.29 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.341 0.591 . . . . 0.53000000000000003 111.286 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 58.22 -89.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.755 -0.657 . . . . 2.0499999999999998 112.085 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.96 23.41 4.97 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.437 -0.887 . . . . 0.59999999999999998 113.593 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -133.13 136.51 45.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.005 -0.368 . . . . 2.02 110.005 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.16 140.9 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.034 0.445 . . . . 1.3 111.491 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.0 m -160.15 122.78 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.718 -0.674 . . . . 1.1200000000000001 110.233 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.5 p -50.94 143.09 10.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.966 -0.561 . . . . 1.1100000000000001 111.502 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -79.77 121.91 25.94 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.001 -0.741 . . . . 0.28000000000000003 109.001 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 t -111.19 91.44 3.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.819 0.674 . . . . 1.55 112.819 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.4 -36.73 0.03 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.255 1.662 . . . . 0.46000000000000002 117.255 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -159.75 151.98 20.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.335 1.567 . . . . 1.8 113.466 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.442 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 1.3 tt -85.55 132.57 34.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.835 -1.172 . . . . 1.24 107.835 176.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.521 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.5 t -122.79 117.7 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.817 -0.753 . . . . 1.28 112.493 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.13 115.62 47.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.864 0.364 . . . . 0.58999999999999997 110.826 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 166.79 23.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.375 0.607 . . . . 2.48 111.23 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.84 151.24 45.54 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.027 -0.988 . . . . 1.54 110.675 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -123.26 143.96 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.671 -1.15 . . . . 0.77000000000000002 110.029 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 145.03 24.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 1.97 111.594 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.56 -14.45 44.02 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.312 -0.715 . . . . 1.1200000000000001 111.312 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -141.55 -79.9 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.227 . . . . 3.8100000000000001 110.694 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -155.16 157.75 37.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.863 0.363 . . . . 3.8199999999999998 111.142 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 54.97 86.93 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.951 -0.568 . . . . 1.3999999999999999 111.861 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 170.96 0.4 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.82 -0.627 . . . . 2.0 110.01 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -41.22 103.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.588 1.525 . . . . 2.5800000000000001 111.159 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -58.55 -64.98 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.287 -0.869 . . . . 3.71 113.088 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 63' ' ' THR . 11.9 t -91.71 134.26 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 120.14 -0.624 . . . . 0.92000000000000004 112.385 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.6 t -132.48 137.8 47.35 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.712 -0.676 . . . . 1.2 112.616 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -130.22 34.75 4.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.171 -0.922 . . . . 0.22 111.466 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.1 tp -44.93 128.28 6.92 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.801 -0.636 . . . . 1.02 111.656 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.4 OUTLIER -143.15 115.69 8.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.94 -0.573 . . . . 0.33000000000000002 110.831 -178.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -117.16 131.27 70.35 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-O 123.002 1.382 . . . . 0.68999999999999995 113.029 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.558 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -126.42 165.04 19.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.216 -1.811 . . . . 1.26 109.735 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 3.4 ptmm? -121.42 152.75 38.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.424 1.639 . . . . 1.8200000000000001 115.424 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.72 -34.85 4.62 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 112.044 -2.344 . . . . 0.22 117.796 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.419 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.67 156.71 0.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.21 2.005 . . . . 0.28999999999999998 114.723 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.638 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.57 -10.5 53.84 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.167 -0.924 . . . . 0.56999999999999995 110.899 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.59 -44.87 95.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 2.3100000000000001 111.508 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -61.66 -43.37 98.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.426 -0.352 . . . . 2.3700000000000001 110.859 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 86.2 t -43.73 102.81 0.29 Allowed Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.023 -0.535 . . . . 2.5699999999999998 111.234 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -49.23 132.23 28.12 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.056 1.838 . . . . 2.0800000000000001 112.635 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 80.7 mtp -136.36 137.64 40.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.076 -0.511 . . . . 6.04 110.787 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 85.9 mt -132.55 115.2 15.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 5.2999999999999998 110.751 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -61.49 144.13 92.63 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.209 -0.45 . . . . 8.0500000000000007 110.291 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -44.61 141.13 5.8 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.709 1.606 . . . . 9.1400000000000006 112.554 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -134.79 134.26 21.86 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.4 -0.363 . . . . 9.8699999999999992 110.555 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.61 -95.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.898 1.732 . . . . 11.69 112.053 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.92 84.52 1.81 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.0 -0.619 . . . . 12.619999999999999 112.335 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 30.7 mt -84.73 146.65 27.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.384 . . . . 14.44 111.005 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.128 -0.939 . . . . 15.699999999999999 110.77 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.483 -0.247 . . . . 9.1500000000000004 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.26 -25.82 42.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.319 . . . . 7.3600000000000003 111.007 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -92.01 129.93 37.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 7.7599999999999998 110.705 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.2 m -141.48 116.71 10.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 4.0199999999999996 110.915 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.31 -90.63 0.08 OUTLIER Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.782 -0.723 . . . . 1.28 112.432 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.7 tp -62.5 -36.74 83.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.306 0.574 . . . . 0.40999999999999998 110.322 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.682 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.39 -20.93 13.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.366 -0.834 . . . . 0.33000000000000002 111.184 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.11 -19.34 61.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 2.0899999999999999 111.856 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -102.05 -29.52 11.72 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.696 -0.401 . . . . 1.99 110.875 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.9 p -45.38 146.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.796 0.332 . . . . 0.20999999999999999 111.815 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.12 -22.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.224 -0.59 . . . . 0.85999999999999999 110.649 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.567 ' O ' HG22 ' A' ' 172' ' ' ILE . 17.0 t90 -172.51 133.45 0.62 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.233 -0.439 . . . . 0.28000000000000003 109.912 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -154.23 143.09 21.02 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.74 0.274 . . . . 0.20000000000000001 111.74 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.2 t -146.94 131.5 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.598 1.332 . . . . 0.67000000000000004 114.598 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.47 103.05 10.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.058 -0.519 . . . . 1.27 110.621 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . -70.82 105.53 3.26 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.124 -0.63 . . . . 0.37 109.367 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.576 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.08 -27.01 0.14 Allowed Glycine 0 N--CA 1.446 -0.659 0 O-C-N 124.016 0.823 . . . . 0.67000000000000004 114.074 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -138.44 -127.8 2.54 Favored Glycine 0 CA--C 1.511 -0.204 0 C-N-CA 119.98 -1.105 . . . . 1.1200000000000001 113.011 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 37.1 mt-10 -154.63 119.65 4.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.39 0.138 . . . . 2.02 111.2 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.5 m 29.59 100.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.251 0.834 . . . . 1.22 113.251 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 6.8 t-80 -130.38 150.74 51.47 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 120.394 -0.522 . . . . 0.34000000000000002 111.767 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.1 t -115.64 109.54 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.678 -0.692 . . . . 1.1799999999999999 111.755 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.92 157.21 36.67 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.656 -0.247 . . . . 1.1699999999999999 110.424 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 25' ' ' HIS . 13.0 m -44.31 -52.66 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.832 1.049 . . . . 0.59999999999999998 113.832 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.414 ' N ' HG23 ' A' ' 24' ' ' VAL . 40.9 m-70 -58.38 -13.76 6.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.085 0.469 . . . . 0.46000000000000002 110.406 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.0 34.91 5.5 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.526 -0.761 . . . . 0.28999999999999998 112.299 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.416 HD11 ' HG ' ' A' ' 6' ' ' LEU . 32.9 mm -103.61 122.64 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.65 -0.5 . . . . 0.42999999999999999 109.65 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 11.7 t60 -101.91 135.49 43.38 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.714 1.376 . . . . 0.52000000000000002 114.714 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -98.33 132.9 43.42 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.396 -0.965 . . . . 3.0 108.396 176.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.435 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 6.9 mtp180 -92.43 112.69 24.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.787 0.662 . . . . 2.8999999999999999 112.787 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -20.24 137.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.247 1.419 . . . . 2.71 114.423 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -14.3 84.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.685 1.194 . . . . 1.98 113.807 177.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -73.11 -17.83 24.38 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.449 2.1 . . . . 1.53 115.234 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.649 HD22 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -128.08 -21.75 3.57 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.399 1.0 . . . . 1.8300000000000001 113.262 -178.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.649 ' N ' HD22 ' A' ' 34' ' ' LEU . 21.1 tt0 -82.28 82.64 7.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.435 0.636 . . . . 4.9500000000000002 109.363 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.11 -13.56 4.44 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.337 -0.847 . . . . 1.9399999999999999 111.15 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' A' ' 35' ' ' GLU . 5.3 ttt180 55.06 30.44 14.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.393 0.616 . . . . 5.3600000000000003 110.266 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -145.25 144.23 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 114.986 -1.006 . . . . 2.9700000000000002 109.939 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.07 136.16 15.76 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.142 -0.551 . . . . 1.99 113.264 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.29 -66.35 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.691 0.281 . . . . 6.5899999999999999 110.577 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 64.47 153.35 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.312 0.577 . . . . 2.0099999999999998 111.993 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.9 m -153.97 41.81 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.37 -0.832 . . . . 2.02 109.579 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -43.75 -36.48 2.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.397 -0.819 . . . . 2.23 111.48 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.6 t80 57.31 13.82 1.89 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.153 0.501 . . . . 2.3300000000000001 110.047 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 47' ' ' LYS . . . 104.82 127.92 6.11 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.657 -0.701 . . . . 2.2000000000000002 112.049 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 47.3 mtt -68.77 -0.57 5.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.516 0.674 . . . . 1.9299999999999999 109.931 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 45' ' ' GLY . 57.4 pttt -53.82 157.13 2.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.789 -1.096 . . . . 3.3500000000000001 109.684 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 7.9 mt 53.03 53.09 11.43 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 108.605 -0.887 . . . . 2.7599999999999998 108.605 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HB2' ' CD ' ' A' ' 58' ' ' GLN . 75.7 Cg_endo -77.88 166.71 24.8 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.941 2.427 . . . . 1.46 114.711 -177.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.24 143.04 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.974 -1.012 . . . . 0.82999999999999996 108.667 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -48.87 8.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.679 0.992 . . . . 1.6899999999999999 113.679 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -78.9 34.69 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.647 0.61 . . . . 2.5600000000000001 112.647 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -144.2 137.5 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.96999999999999997 111.293 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -67.55 161.75 62.76 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.493 -0.558 . . . . 1.96 109.493 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.435 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.6 Cg_exo -42.16 -46.89 7.16 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.764 2.31 . . . . 0.66000000000000003 116.141 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' O ' HG12 ' A' ' 59' ' ' VAL . 12.9 pt-20 -77.71 -53.16 7.87 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.248 0.547 . . . . 1.8200000000000001 111.649 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 8.7 p-10 -70.04 -2.3 12.36 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.717 -0.793 . . . . 1.9099999999999999 109.719 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.452 ' CD ' ' HB2' ' A' ' 49' ' ' PRO . 17.2 tt0 -80.36 -60.15 2.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.447 -0.797 . . . . 1.5 109.218 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 56' ' ' GLU . 2.6 p -47.59 -35.57 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.457 -0.942 . . . . 1.22 108.457 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 62' ' ' GLN . 10.2 tp -69.88 -64.52 0.87 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.465 0.65 . . . . 1.05 109.41 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.413 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-30 -66.95 20.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.9 -1.046 . . . . 0.90000000000000002 112.703 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 60' ' ' LEU . 38.4 tt0 -137.54 -67.81 0.48 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.515 0.931 . . . . 1.8 113.515 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 21.0 p -30.6 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.554 0.946 . . . . 1.05 113.554 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.576 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -131.98 151.63 51.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.686 -0.688 . . . . 2.0499999999999998 111.464 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.63 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 30.2 mtt180 -105.2 -170.41 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.536 -0.542 . . . . 3.5800000000000001 109.536 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.81 -179.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 4.25 111.069 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -117.12 164.85 14.14 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.184 -0.462 . . . . 4.3499999999999996 111.413 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -167.69 -150.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.844 -0.616 . . . . 3.1699999999999999 109.969 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 10.1 t70 -141.38 128.06 20.3 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.718 0.294 . . . . 2.3900000000000001 111.418 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 t 51.94 86.03 0.04 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.101 -0.5 . . . . 0.98999999999999999 111.238 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.07 160.5 43.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 1.26 110.909 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -168.17 -154.14 8.6 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.358 -0.925 . . . . 0.66000000000000003 113.998 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.88 167.84 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.478 0.656 . . . . 0.82999999999999996 112.046 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -120.22 135.62 54.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.638 -1.164 . . . . 2.27 110.047 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.423 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.9 mp -127.64 86.84 57.45 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 111.823 0.305 . . . . 0.34000000000000002 111.823 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -57.69 127.55 25.73 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.975 1.783 . . . . 0.80000000000000004 112.059 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 153' ' ' LEU . 21.7 mt -119.25 153.69 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.966 0.412 . . . . 0.38 111.138 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.432 ' N ' HG22 ' A' ' 77' ' ' ILE . 16.9 pttp -147.35 6.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.895 -0.593 . . . . 2.96 110.823 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -130.77 171.0 13.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.822 -0.172 . . . . 2.1299999999999999 110.627 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.07 171.96 10.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.277 0.56 . . . . 0.37 111.577 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 -153.89 21.59 Favored Glycine 0 C--N 1.329 0.148 0 N-CA-C 109.901 -1.28 . . . . 0.20999999999999999 109.901 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.5 mm-40 -98.07 110.25 22.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.856 1.328 . . . . 2.0299999999999998 108.859 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -96.55 126.53 41.8 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.906 -0.776 . . . . 0.26000000000000001 108.906 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.66 HG21 ' N ' ' A' ' 177' ' ' ALA . 13.8 t -115.81 116.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.401 -0.818 . . . . 0.54000000000000004 111.78 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.464 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.8 tt -94.06 105.15 17.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.761 -1.109 . . . . 1.23 111.029 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 42.9 t -108.07 135.59 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.163 -1.051 . . . . 1.3100000000000001 108.163 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -150.05 148.8 29.46 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.952 -1.099 . . . . 1.3700000000000001 112.365 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.585 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 2.2 tptm -104.59 118.82 37.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.457 -0.792 . . . . 2.9700000000000002 110.011 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 115' ' ' LEU . 4.9 m-85 -106.01 137.67 43.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.458 -0.941 . . . . 0.29999999999999999 108.458 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.428 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -150.63 175.8 11.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.026 -0.67 . . . . 0.40999999999999998 111.898 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -176.3 141.58 0.43 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.728 -0.669 . . . . 3.9700000000000002 110.626 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.4 m -144.26 52.24 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.295 -0.411 . . . . 3.8100000000000001 111.104 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -130.4 -29.17 2.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 2.8900000000000001 111.306 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -135.11 -176.86 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 2.0 111.145 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -158.4 88.47 0.93 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.017 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -152.29 142.82 22.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 2.96 111.183 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.9 m -115.01 153.38 30.75 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.0 -0.545 . . . . 1.55 111.774 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 52.03 27.58 4.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.635 -0.711 . . . . 2.3300000000000001 112.144 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -134.27 -47.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 2.5099999999999998 109.636 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.99 86.52 3.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.719 -0.673 . . . . 3.1000000000000001 109.541 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.17 150.32 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 1.3100000000000001 109.892 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -127.13 179.04 5.63 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 113.065 0.765 . . . . 0.68999999999999995 113.065 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -123.6 137.58 54.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.124 -0.489 . . . . 2.0099999999999998 111.256 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.414 -0.357 . . . . 0.46000000000000002 111.922 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -130.35 151.2 51.11 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.825 0.676 . . . . 1.8500000000000001 112.825 -178.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 9.5 p -124.6 120.76 59.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 115.425 -0.807 . . . . 1.1000000000000001 110.021 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.475 ' OD1' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.68 25.85 10.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.524 -0.917 . . . . 1.77 108.524 -176.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.58 57.29 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.16 -0.927 . . . . 0.40999999999999998 112.987 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.454 ' CG ' HG11 ' A' ' 142' ' ' VAL . 89.1 m-70 -110.48 112.25 24.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.428 0.899 . . . . 0.46000000000000002 113.428 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 p -70.41 112.66 6.87 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.023 0.44 . . . . 0.66000000000000003 111.221 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.34 -37.61 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 0.80000000000000004 110.124 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.87 90.31 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 109.337 -0.616 . . . . 0.51000000000000001 109.337 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.3 ptpp? -108.25 84.58 1.96 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.165 0.983 . . . . 2.4399999999999999 112.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.6 p30 149.92 31.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.437 -2.165 . . . . 2.5600000000000001 108.142 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -56.32 98.87 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.146 0.498 . . . . 1.1000000000000001 112.056 -177.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -105.87 80.76 1.57 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.828 -1.175 . . . . 1.99 107.828 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.1 mt -51.0 -47.03 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.085 -0.962 . . . . 0.63 112.721 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.662 0.267 . . . . 0.90000000000000002 111.671 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.29 -27.63 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.979 0.363 . . . . 0.76000000000000001 111.979 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -68.86 -58.54 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.069 0.396 . . . . 2.6800000000000002 112.069 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.5 m -90.54 -40.47 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.939 0.348 . . . . 1.4099999999999999 111.939 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.34 -82.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 1.0600000000000001 112.439 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -99.99 169.69 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.512 0.196 . . . . 3.5099999999999998 110.782 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 m -49.88 97.91 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.36 -0.382 . . . . 1.6799999999999999 110.984 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.9 p -150.94 -170.12 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.80000000000000004 109.96 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.512 ' HB1' ' HZ3' ' A' ' 88' ' ' LYS . . . -96.6 131.11 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.741 0.645 . . . . 0.44 112.741 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -106.32 147.08 29.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.572 -0.899 . . . . 0.38 108.572 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -144.83 127.08 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.437 0.532 . . . . 2.0899999999999999 112.437 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -114.8 135.61 53.99 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.766 -0.652 . . . . 2.2799999999999998 109.568 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.54 120.86 66.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.4 -0.818 . . . . 0.70999999999999996 110.083 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.88 89.18 51.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.353 -0.385 . . . . 1.3799999999999999 111.947 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.17 146.62 94.26 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.97 1.78 . . . . 0.22 111.709 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.6 mt -138.6 156.86 29.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 0.20999999999999999 110.751 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 p -133.53 108.56 8.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.068 0.461 . . . . 1.1100000000000001 111.349 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 139' ' ' LYS . 18.3 mt -109.67 125.69 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-N 115.667 -0.697 . . . . 0.23000000000000001 110.224 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -149.12 141.69 24.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 1.9099999999999999 111.157 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt 61.36 14.24 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.9 -0.591 . . . . 3.1099999999999999 111.212 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.78 8.76 59.13 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.606 -0.807 . . . . 0.32000000000000001 113.402 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.595 ' O ' HG23 ' A' ' 135' ' ' ILE . 33.3 mtmt -112.34 165.2 12.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.34 0.57 . . . . 2.1899999999999999 110.669 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.507 ' CD1' HD11 ' A' ' 153' ' ' LEU . 8.2 tt -127.16 139.74 52.74 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.616 0.598 . . . . 0.37 112.616 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.448 ' OG ' HG22 ' A' ' 146' ' ' VAL . 36.1 t -126.44 116.03 20.51 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.626 -0.715 . . . . 0.90000000000000002 110.447 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 142' ' ' VAL . 4.3 p -112.32 104.53 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.094 -0.957 . . . . 0.53000000000000003 110.575 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.75 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 2.0499999999999998 112.009 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.17 9.87 4.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.352 -0.927 . . . . 0.59999999999999998 113.914 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -124.38 118.87 27.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.147 0.473 . . . . 2.02 110.019 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.448 HG22 ' OG ' ' A' ' 141' ' ' SER . 21.2 t -107.62 130.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.477 0.656 . . . . 1.3 112.432 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 t -145.12 143.11 30.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 114.939 -1.028 . . . . 1.1200000000000001 109.742 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.6 p -55.85 141.36 39.24 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.111 0.411 . . . . 1.1100000000000001 112.111 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -79.09 143.15 35.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.168 -0.679 . . . . 0.28000000000000003 109.168 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.9 96.45 3.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.776 1.028 . . . . 1.55 113.776 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.66 -57.33 2.55 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.978 1.151 . . . . 0.46000000000000002 115.978 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -153.54 174.72 14.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.934 0.867 . . . . 1.8 112.667 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.507 HD11 ' CD1' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -97.06 130.79 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.964 -1.495 . . . . 1.24 106.964 176.285 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.408 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.4 t -120.71 112.74 19.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.267 -0.973 . . . . 1.28 112.978 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 57.5 t -98.28 104.04 15.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 0.58999999999999997 110.548 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 mt-10 -108.47 144.91 35.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.407 -0.815 . . . . 2.48 110.922 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.97 138.16 42.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.637 -0.505 . . . . 1.54 109.637 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.6 t -112.25 143.59 21.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.22 -0.9 . . . . 0.77000000000000002 111.261 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -74.95 148.45 39.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.533 -0.758 . . . . 1.97 111.375 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.14 -9.2 28.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.943 -0.646 . . . . 1.1200000000000001 111.941 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.45 -61.89 0.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.616 0.246 . . . . 3.8100000000000001 110.489 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -172.69 -28.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 3.8199999999999998 111.048 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.73 90.54 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 1.3999999999999999 111.589 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -53.82 165.82 0.7 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.397 -0.594 . . . . 2.0 109.397 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -37.67 100.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.779 1.653 . . . . 2.5800000000000001 111.575 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -52.0 -57.0 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.975 . . . . 3.71 112.384 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 61.3 t -103.04 133.69 46.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 120.495 -0.482 . . . . 0.92000000000000004 112.253 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -132.59 135.29 45.81 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 115.873 -0.603 . . . . 1.2 111.065 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.585 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -126.23 35.57 4.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.806 . . . . 0.22 112.611 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.36 131.43 0.21 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.499 0.499 . . . . 1.02 111.366 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.458 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.89 101.26 2.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.33000000000000002 110.198 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -107.43 123.32 62.63 Favored 'Isoleucine or valine' 0 C--O 1.265 1.873 0 CA-C-O 122.858 1.313 . . . . 0.68999999999999995 112.587 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.9 ptm -114.76 165.24 13.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.507 -1.678 . . . . 1.26 110.045 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HZ2' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -119.14 145.17 46.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 115.058 1.503 . . . . 1.8200000000000001 115.058 -177.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 101.81 -37.61 3.56 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 112.095 -2.32 . . . . 0.22 118.749 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.482 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.06 157.48 0.32 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.883 2.341 . . . . 0.28999999999999998 114.358 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.66 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.12 -22.85 26.87 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.673 -1.149 . . . . 0.56999999999999995 108.861 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.53 -31.03 70.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.206 -0.906 . . . . 2.3100000000000001 110.86 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -49.78 -63.29 1.16 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.354 -0.61 . . . . 2.3700000000000001 109.354 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.7 t 62.2 130.53 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.716 -0.675 . . . . 2.5699999999999998 111.924 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -42.34 121.51 2.0 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.737 1.624 . . . . 2.0800000000000001 112.649 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 49.0 ttm -134.8 127.01 30.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 6.04 110.696 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.0 159.91 38.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 5.2999999999999998 111.126 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -71.25 146.27 91.99 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.887 -0.597 . . . . 8.0500000000000007 109.747 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.1 125.86 15.39 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.451 1.434 . . . . 9.1400000000000006 112.482 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -134.6 135.02 22.81 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.997 -0.547 . . . . 9.8699999999999992 110.226 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.52 -97.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.694 1.596 . . . . 11.69 112.017 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.09 39.92 15.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.928 -0.653 . . . . 12.619999999999999 112.646 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.83 90.21 5.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 14.44 110.387 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.324 -0.846 . . . . 15.699999999999999 110.8 179.904 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.472 -0.251 . . . . 9.1500000000000004 112.472 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.76 -11.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 7.3600000000000003 110.929 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -132.52 37.85 3.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 7.7599999999999998 110.667 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.4 t 62.69 166.73 0.12 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.091 -0.504 . . . . 4.0199999999999996 111.015 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -118.54 7.16 13.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.677 -0.773 . . . . 1.28 112.703 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 tp -63.69 -41.39 98.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.4 0.619 . . . . 0.40999999999999998 109.669 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.691 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -59.83 -20.34 56.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.096 -0.956 . . . . 0.33000000000000002 110.599 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.09 -18.5 63.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 2.0899999999999999 111.35 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -107.7 -26.73 10.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.696 -0.401 . . . . 1.99 111.476 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -45.84 145.48 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.756 -0.378 . . . . 0.20999999999999999 111.505 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -133.48 -18.86 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 119.861 -0.736 . . . . 0.85999999999999999 110.345 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.493 ' O ' HG22 ' A' ' 172' ' ' ILE . 44.0 t90 -175.22 144.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.591 -0.444 . . . . 0.28000000000000003 110.311 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -162.05 142.82 10.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.667 0.247 . . . . 0.20000000000000001 111.667 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.68 128.95 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.988 1.107 . . . . 0.67000000000000004 113.988 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 10.1 t30 -114.26 93.7 4.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.904 -0.776 . . . . 1.27 108.904 176.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.556 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -63.7 97.41 0.15 Allowed 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.442 -0.799 . . . . 0.37 109.757 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.564 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . 176.93 -77.8 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.122 -1.399 . . . . 0.67000000000000004 113.196 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -77.16 -125.36 0.26 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.204 -0.522 . . . . 1.1200000000000001 112.759 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.548 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -162.72 121.48 2.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 120.858 0.361 . . . . 2.02 110.744 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.0 p 35.11 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.809 -0.632 . . . . 1.22 112.289 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.56 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 58.1 t-80 -117.78 152.47 35.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.157 -0.617 . . . . 0.34000000000000002 112.575 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.7 t -123.67 103.6 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.469 -0.787 . . . . 1.1799999999999999 110.427 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.45 151.29 47.03 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.275 -0.42 . . . . 1.1699999999999999 110.731 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 25' ' ' HIS . 14.7 m -43.09 -48.69 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 124.367 1.042 . . . . 0.59999999999999998 112.888 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.404 ' N ' HG23 ' A' ' 24' ' ' VAL . 46.3 m-70 -57.74 -29.73 65.0 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.319 0.58 . . . . 0.46000000000000002 110.069 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.83 33.81 1.8 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.142 -0.935 . . . . 0.28999999999999998 111.666 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.1 mm -103.39 123.5 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.607 -0.516 . . . . 0.42999999999999999 109.607 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.6 t60 -104.38 134.97 46.69 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.614 1.338 . . . . 0.52000000000000002 114.614 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CD1' ' C ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -97.72 129.31 44.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.564 -0.902 . . . . 3.0 108.564 176.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -82.43 113.15 19.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.647 0.61 . . . . 2.8999999999999999 112.647 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -28.12 140.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.445 -1.252 . . . . 2.71 113.499 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.499 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 1.6 m-20 -14.75 83.57 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.814 1.246 . . . . 1.98 114.079 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -102.46 -0.1 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.35 2.033 . . . . 1.53 113.783 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.549 HD22 ' C ' ' A' ' 72' ' ' GLY . 30.4 tp -126.27 -60.76 1.25 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.404 0.52 . . . . 1.8300000000000001 112.404 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' H ' ' NH2' ' A' ' 65' ' ' ARG . 51.8 mt-10 -72.2 90.45 1.23 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.061 0.457 . . . . 4.9500000000000002 110.081 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 90.22 -28.51 7.33 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.166 -0.774 . . . . 1.9399999999999999 111.166 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 45.15 36.48 2.12 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.915 0.486 . . . . 5.3600000000000003 111.258 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 36' ' ' GLY . 73.2 t -140.1 141.9 32.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.765 -0.652 . . . . 2.9700000000000002 110.15 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.04 101.51 0.05 OUTLIER Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.067 -0.587 . . . . 1.99 113.081 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -141.28 -78.82 0.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.45 0.166 . . . . 6.5899999999999999 110.64 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 61.12 113.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.984 0.421 . . . . 2.0099999999999998 111.409 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.1 m -73.03 -41.72 63.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 2.02 110.677 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 38.74 43.54 0.72 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.171 -0.468 . . . . 2.23 111.408 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -105.41 32.72 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 2.3300000000000001 110.139 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.45 17.75 5.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.827 -0.702 . . . . 2.2000000000000002 112.823 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.9 mtt -52.14 -32.23 34.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.22 0.534 . . . . 1.9299999999999999 109.891 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 39.1 tptt -74.93 159.06 32.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.371 -0.831 . . . . 3.3500000000000001 109.722 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 7.7 mt 64.81 62.23 1.27 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.591 0.234 . . . . 2.7599999999999998 110.806 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 53.7 Cg_exo -59.68 129.17 29.68 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.425 2.084 . . . . 1.46 112.229 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.725 HG21 ' HB2' ' A' ' 126' ' ' ALA . 2.0 mt -63.2 111.67 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.758 0.789 . . . . 0.82999999999999996 109.503 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mt -46.94 -52.48 14.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.171 -1.377 . . . . 1.6899999999999999 113.937 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -65.75 -0.68 2.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.046 0.387 . . . . 2.5600000000000001 112.046 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.9 t -128.18 142.08 51.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.685 0.624 . . . . 0.96999999999999997 112.685 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -69.15 158.84 85.5 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.848 -0.615 . . . . 1.96 109.497 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.9 Cg_exo -40.07 -56.69 1.37 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 123.188 2.592 . . . . 0.66000000000000003 116.446 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 12.5 pt-20 -71.45 -53.36 14.23 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.318 0.58 . . . . 1.8200000000000001 111.264 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.67 -5.03 22.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.126 -0.694 . . . . 1.9099999999999999 109.126 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -77.59 -46.98 20.51 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.683 -0.858 . . . . 1.5 108.683 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -55.09 -42.57 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.378 -0.971 . . . . 1.22 108.378 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.491 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 13.0 tp -63.53 -63.48 1.17 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.537 -0.542 . . . . 1.05 109.537 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.496 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 3.3 m-85 -51.13 -12.38 0.13 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.501 -0.772 . . . . 0.90000000000000002 110.632 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.508 ' O ' ' O ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -123.59 -126.21 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.587 -0.733 . . . . 1.8 111.239 -178.643 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 167' ' ' VAL . 26.6 p 45.49 128.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.655 0.782 . . . . 1.05 112.81 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 167' ' ' VAL . 0.0 OUTLIER -124.79 154.82 40.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.441 0.638 . . . . 2.0499999999999998 112.65 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.564 ' HD3' ' N ' ' A' ' 17' ' ' GLY . 18.2 mtp180 -123.3 -171.74 2.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.01 -0.995 . . . . 3.5800000000000001 110.281 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.4 -178.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 4.25 111.043 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.98 163.25 39.32 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.434 -0.348 . . . . 4.3499999999999996 110.963 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.56 -93.76 0.06 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.504 -0.316 . . . . 3.1699999999999999 111.631 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -173.15 127.97 0.45 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.813 0.301 . . . . 2.3900000000000001 111.813 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.5 t 52.45 93.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.096 -0.502 . . . . 0.98999999999999999 111.976 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -160.58 161.44 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 1.26 110.588 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' C ' HD22 ' A' ' 34' ' ' LEU . . . -164.07 177.56 39.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.978 -1.106 . . . . 0.66000000000000003 114.632 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -100.89 161.73 13.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 0.82999999999999996 111.958 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -115.49 122.32 45.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.952 -1.022 . . . . 2.27 111.137 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.53 109.63 45.7 Favored Pre-proline 0 C--O 1.224 -0.251 0 CA-C-O 119.367 -0.349 . . . . 0.34000000000000002 111.179 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -81.85 130.43 6.67 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.297 1.142 . . . . 0.80000000000000004 112.106 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.9 mt -121.78 148.41 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.847 0.356 . . . . 0.38 111.324 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -139.41 -0.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 2.96 111.039 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.429 ' HG3' ' NZ ' ' A' ' 174' ' ' LYS . 12.6 mm-40 -123.74 166.02 16.28 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.659 0.266 . . . . 2.1299999999999999 110.878 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -119.7 172.95 7.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.273 0.559 . . . . 0.37 111.175 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.04 -147.23 18.9 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.02 -1.232 . . . . 0.20999999999999999 110.02 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mt-10 -105.87 109.44 21.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.603 1.201 . . . . 2.0299999999999998 109.805 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -96.65 127.22 42.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.046 -0.724 . . . . 0.26000000000000001 109.046 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.654 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.3 t -113.36 117.06 54.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.383 -0.826 . . . . 0.54000000000000004 111.48 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.21 104.79 16.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.23 111.312 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -105.3 137.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.918 -1.037 . . . . 1.3100000000000001 108.976 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -156.14 135.42 12.2 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.501 -0.88 . . . . 1.3700000000000001 112.368 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.698 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 3.5 mptt -97.38 127.47 43.36 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.918 -0.713 . . . . 2.9700000000000002 109.331 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CD2' HD21 ' A' ' 115' ' ' LEU . 3.1 m-85 -106.94 137.12 45.6 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.217 -0.66 . . . . 0.29999999999999999 109.217 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -134.51 153.16 52.08 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.75 -0.38 . . . . 0.40999999999999998 110.35 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -124.41 -75.59 0.6 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.469 -0.332 . . . . 3.9700000000000002 111.19 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 93' ' ' TYR . 36.9 t 66.3 160.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.482 -0.326 . . . . 3.8100000000000001 111.413 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.468 ' N ' HG12 ' A' ' 92' ' ' VAL . 0.3 OUTLIER 82.03 -64.59 0.13 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.256 0.623 . . . . 2.8900000000000001 111.902 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -86.6 158.16 19.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.976 0.417 . . . . 2.0 111.563 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.418 ' HA ' ' CE1' ' A' ' 118' ' ' PHE . . . -134.66 84.36 2.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.388 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.437 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 26.7 mt-30 -146.13 140.64 26.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.376 -0.375 . . . . 2.96 111.636 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 119' ' ' ASP . 33.2 p -124.54 154.54 40.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 1.55 111.755 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 47.22 29.2 1.14 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.767 -0.651 . . . . 2.3300000000000001 111.829 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -133.96 -48.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.259 -0.645 . . . . 2.5099999999999998 109.259 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -93.21 88.79 6.17 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 3.1000000000000001 109.133 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.73 152.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.531 -0.759 . . . . 1.3100000000000001 109.55 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -134.37 176.28 8.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.986 0.736 . . . . 0.68999999999999995 112.986 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -121.42 139.44 53.45 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.06 -0.518 . . . . 2.0099999999999998 111.206 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.68 130.6 42.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.641 -0.709 . . . . 0.46000000000000002 112.04 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -131.81 153.84 49.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.14 0.793 . . . . 1.8500000000000001 113.14 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 20.4 m -121.92 120.71 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.638 -1.165 . . . . 1.1000000000000001 109.613 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.502 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.2 OUTLIER 54.28 27.17 7.6 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.998 -0.741 . . . . 1.77 108.998 -176.609 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.07 23.67 29.19 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.708 -1.133 . . . . 0.40999999999999998 112.914 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.6 m-70 -122.97 108.73 13.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.209 0.818 . . . . 0.46000000000000002 113.209 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 p -62.48 115.9 4.64 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.91 0.386 . . . . 0.66000000000000003 111.642 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 t -106.38 -36.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.80000000000000004 109.878 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.458 HG11 ' OE2' ' A' ' 129' ' ' GLU . 2.1 t -127.84 92.29 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.851 -0.426 . . . . 0.51000000000000001 109.851 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 1.3 ptpt -105.8 76.99 1.22 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.715 1.245 . . . . 2.4399999999999999 111.983 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 155.71 27.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.221 -2.263 . . . . 2.5600000000000001 109.073 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 89' ' ' PHE . 40.5 tp -60.88 102.17 0.18 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.628 0.728 . . . . 1.1000000000000001 112.531 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 36.0 p-10 -112.06 89.43 3.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.528 -1.215 . . . . 1.99 108.406 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.0 -54.05 15.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 0.63 113.526 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 13.1 t80 -56.55 -40.07 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.88 0.326 . . . . 0.90000000000000002 111.88 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 97' ' ' SER . 19.4 t70 -67.65 -28.81 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.124 0.416 . . . . 0.76000000000000001 112.124 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 11.6 mmm180 -75.98 -58.69 3.13 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.511 0.56 . . . . 2.6800000000000002 112.511 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -87.1 -40.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.937 0.347 . . . . 1.4099999999999999 111.937 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.76 -94.93 0.75 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 1.0600000000000001 112.284 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 125' ' ' THR . 73.6 m80 -112.92 110.08 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.656 0.265 . . . . 3.5099999999999998 111.286 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.2 m 56.05 -132.42 1.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.187 -0.46 . . . . 1.6799999999999999 111.245 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 123' ' ' HIS . 11.0 p 57.94 -171.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.303 0.241 . . . . 0.80000000000000004 111.006 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.725 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.28 139.5 49.37 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.591 0.96 . . . . 0.44 113.591 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.4 t60 -100.31 150.86 22.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.55 -1.204 . . . . 0.38 107.844 176.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -145.37 122.33 11.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.26 -0.576 . . . . 2.0899999999999999 112.208 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.458 ' OE2' HG11 ' A' ' 112' ' ' VAL . 46.5 mt-10 -119.71 141.67 49.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.513 -0.767 . . . . 2.2799999999999998 109.512 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 mt -123.4 136.23 60.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.683 -0.69 . . . . 0.70999999999999996 111.229 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.2 mp -134.29 89.5 27.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 1.3799999999999999 111.631 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.01 144.07 92.18 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.72 1.613 . . . . 0.22 111.305 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 21.5 mt -135.41 154.85 36.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.563 -0.29 . . . . 0.20999999999999999 111.181 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -131.09 107.08 8.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 1.1100000000000001 110.635 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.9 mt -106.98 129.65 60.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.917 -0.583 . . . . 0.23000000000000001 110.55 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -147.88 140.5 24.61 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.798 0.332 . . . . 1.9099999999999999 110.814 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.434 ' NZ ' ' HB2' ' A' ' 137' ' ' LYS . 0.6 OUTLIER 55.66 28.51 12.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.554 0.692 . . . . 3.1099999999999999 110.06 -179.521 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.29 27.92 62.92 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.221 -0.899 . . . . 0.32000000000000001 112.703 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 62.4 mttp -121.89 146.87 46.69 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.919 0.359 . . . . 2.1899999999999999 110.797 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -107.67 131.31 54.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.146 0.498 . . . . 0.37 112.197 -177.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.592 ' N ' HD23 ' A' ' 140' ' ' LEU . 32.3 t -121.32 110.36 16.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.53 -0.759 . . . . 0.90000000000000002 109.618 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.1 p -103.66 108.28 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.321 0.582 . . . . 0.53000000000000003 110.968 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 60.94 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.645 -0.707 . . . . 2.0499999999999998 112.022 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -137.92 12.45 3.64 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.47 -0.871 . . . . 0.59999999999999998 113.158 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -116.88 141.14 48.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.863 0.331 . . . . 2.02 110.263 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.46 136.95 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 1.3 111.142 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.8 t -157.93 127.31 5.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.723 -0.672 . . . . 1.1200000000000001 109.824 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.2 p -58.03 142.9 45.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.294 -0.412 . . . . 1.1100000000000001 111.535 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -79.42 122.03 25.9 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.125 -0.694 . . . . 0.28000000000000003 109.125 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 t -111.18 91.36 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.156 -0.618 . . . . 1.55 112.6 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.04 -33.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 117.269 1.668 . . . . 0.46000000000000002 117.269 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -160.87 154.97 22.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.501 1.651 . . . . 1.8 113.868 -176.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.482 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -87.2 127.28 35.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.96 -1.126 . . . . 1.24 107.96 176.19 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.502 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -118.11 114.2 22.72 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.382 0.882 . . . . 1.28 113.382 -176.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.83 103.29 14.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.44 -0.578 . . . . 0.58999999999999997 109.44 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.4 mt-10 -107.67 139.44 42.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 2.48 111.447 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -136.11 138.44 42.06 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.011 -0.54 . . . . 1.54 110.002 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.453 ' CG2' HH21 ' A' ' 105' ' ' ARG . 12.0 t -115.14 143.62 24.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.95 -1.023 . . . . 0.77000000000000002 111.466 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -63.74 148.16 49.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 1.97 110.931 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.43 -29.8 8.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 1.1200000000000001 111.721 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -145.53 -55.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.545 0.212 . . . . 3.8100000000000001 111.011 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -142.24 -83.21 0.19 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.588 -0.278 . . . . 3.8199999999999998 111.51 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.14 125.16 29.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 1.3999999999999999 111.52 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 166' ' ' LYS . 1.3 m-20 -59.98 171.14 0.95 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.323 -0.853 . . . . 2.0 110.32 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -28.89 -29.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 123.312 2.675 . . . . 2.5800000000000001 114.318 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ASN . 15.6 tptp 85.28 -75.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.619 0.575 . . . . 3.71 112.364 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 64' ' ' GLU . 3.5 t -96.34 135.08 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 120.606 -0.438 . . . . 0.92000000000000004 112.017 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.22 134.96 45.95 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.98 -0.555 . . . . 1.2 112.425 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.513 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -124.4 35.43 4.81 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.228 -0.896 . . . . 0.22 112.769 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.424 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -37.48 138.99 0.29 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.15 0.5 . . . . 1.02 111.888 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.7 OUTLIER -157.71 100.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.47 -0.786 . . . . 0.33000000000000002 110.24 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -106.26 125.35 61.95 Favored 'Isoleucine or valine' 0 C--O 1.264 1.867 0 CA-C-O 122.758 1.266 . . . . 0.68999999999999995 112.553 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.583 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.7 ppp? -115.14 162.38 17.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.988 -1.915 . . . . 1.26 109.525 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.429 ' NZ ' ' HG3' ' A' ' 79' ' ' GLU . 32.2 tttt -120.34 144.15 48.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 115.272 1.582 . . . . 1.8200000000000001 115.272 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.68 -36.8 4.1 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 112.397 -2.183 . . . . 0.22 118.398 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.462 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.48 155.15 0.3 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.908 2.354 . . . . 0.28999999999999998 115.177 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.654 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.73 -24.61 25.08 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 114.566 -1.197 . . . . 0.56999999999999995 108.972 175.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 180' ' ' VAL . 19.8 m-20 -57.11 -34.78 68.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.324 -0.853 . . . . 2.3100000000000001 110.657 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -52.9 -52.07 58.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.222 -0.658 . . . . 2.3700000000000001 109.222 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 178' ' ' ASP . 57.8 t 62.85 120.71 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 115.482 -0.781 . . . . 2.5699999999999998 111.705 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -46.27 111.01 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.628 1.552 . . . . 2.0800000000000001 112.29 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -152.2 179.81 8.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.424 -0.353 . . . . 6.04 110.953 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 183' ' ' LEU . 2.4 pt? -165.3 128.91 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 5.2999999999999998 110.679 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -62.67 144.89 95.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.419 -0.585 . . . . 8.0500000000000007 109.419 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.1 123.48 11.95 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.231 1.287 . . . . 9.1400000000000006 111.648 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.485 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 57.3 t-80 -134.73 143.95 48.59 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.883 -0.599 . . . . 9.8699999999999992 110.124 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 186' ' ' HIS . 89.0 Cg_endo -73.43 -39.99 1.78 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.813 1.675 . . . . 11.69 112.221 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 46.38 74.23 0.25 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.895 -0.593 . . . . 12.619999999999999 112.775 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.6 mt -63.12 112.69 2.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 14.44 110.639 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.13 -0.938 . . . . 15.699999999999999 110.817 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.129 0 N-CA-C 112.474 -0.25 . . . . 9.1500000000000004 112.474 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.63 112.42 24.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 7.3600000000000003 110.81 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.7 mtt -87.01 -6.39 58.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 7.7599999999999998 110.769 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.1 m -146.38 138.7 25.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 4.0199999999999996 110.902 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.47 75.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.984 -0.626 . . . . 1.28 112.345 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.34 -50.32 54.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.147 0.499 . . . . 0.40999999999999998 110.219 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.598 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.26 -20.4 4.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.362 -0.835 . . . . 0.33000000000000002 111.311 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.15 -27.8 38.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.407 0.521 . . . . 2.0899999999999999 112.407 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 37.4 mmtt -95.29 -22.75 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.717 -0.393 . . . . 1.99 111.49 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.7 p -43.79 143.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 120.584 0.231 . . . . 0.20999999999999999 111.615 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 pt -136.91 -23.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.013 -0.675 . . . . 0.85999999999999999 110.487 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.489 ' O ' HG22 ' A' ' 172' ' ' ILE . 73.3 t90 -172.74 140.94 1.03 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.049 -0.523 . . . . 0.28000000000000003 110.091 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -159.88 143.94 14.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.271 0.471 . . . . 0.20000000000000001 112.271 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG11 ' CE2' ' A' ' 73' ' ' TYR . 4.2 t -147.02 130.98 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 113.807 1.04 . . . . 0.67000000000000004 113.807 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.447 ' ND2' ' OG1' ' A' ' 63' ' ' THR . 2.7 t30 -114.43 95.25 5.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.887 -1.051 . . . . 1.27 108.553 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.681 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -60.18 92.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.265 -1.013 . . . . 0.37 108.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.62 ' HA3' ' OG1' ' A' ' 63' ' ' THR . . . -177.27 -95.34 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 O-C-N 124.582 1.176 . . . . 0.67000000000000004 114.55 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -66.47 -122.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.112 -0.566 . . . . 1.1200000000000001 114.039 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -159.09 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.388 -0.406 . . . . 2.02 110.158 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.716 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.0 m 31.61 95.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.512 -0.767 . . . . 1.22 112.68 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.683 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 43.5 t-80 -123.59 139.96 53.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.787 -0.765 . . . . 0.34000000000000002 112.5 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 22' ' ' VAL . 3.6 p -115.03 104.07 16.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.668 -0.696 . . . . 1.1799999999999999 110.582 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 157.03 29.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.194 -0.912 . . . . 1.1699999999999999 110.662 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -43.73 -47.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 O-C-N 124.367 1.042 . . . . 0.59999999999999998 113.277 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -62.57 -20.18 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.318 0.58 . . . . 0.46000000000000002 110.386 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.34 34.89 3.25 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.208 -0.905 . . . . 0.28999999999999998 112.542 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.01 114.84 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 120.459 -0.496 . . . . 0.42999999999999999 110.455 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.683 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.5 t60 -100.42 136.35 40.43 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.915 1.45 . . . . 0.52000000000000002 114.915 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.716 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.23 135.99 42.85 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.698 -1.137 . . . . 3.0 108.753 177.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -86.29 106.99 17.75 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.796 0.685 . . . . 2.8999999999999999 112.303 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.619 ' NZ ' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -34.21 137.06 0.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.121 -0.945 . . . . 2.71 113.296 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.496 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER 3.0 79.7 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 114.748 -1.115 . . . . 1.98 113.551 178.299 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -96.82 -25.11 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.188 1.925 . . . . 1.53 114.095 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -112.58 -30.76 7.0 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.814 -0.354 . . . . 1.8300000000000001 110.976 -179.288 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.872 ' N ' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -70.78 79.11 0.61 Allowed 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.229 -0.656 . . . . 4.9500000000000002 109.229 179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 38' ' ' VAL . . . 74.64 -10.44 8.76 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.966 -1.254 . . . . 1.9399999999999999 109.966 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER 59.27 7.88 1.0 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.737 -0.732 . . . . 5.3600000000000003 111.231 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 36' ' ' GLY . 16.7 m -148.91 117.77 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 115.935 -0.575 . . . . 2.9700000000000002 110.252 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.77 -139.03 2.6 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.555 -0.831 . . . . 1.99 112.631 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -146.04 -69.22 0.27 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.447 0.165 . . . . 6.5899999999999999 111.27 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -177.75 -58.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.605 -0.27 . . . . 2.0099999999999998 111.283 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.6 t 63.02 41.07 8.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 2.02 110.525 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' HB2' ' SD ' ' A' ' 46' ' ' MET . 7.0 p-10 -77.89 73.45 4.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.937 -0.574 . . . . 2.23 110.185 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -97.48 -17.1 19.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.833 -0.621 . . . . 2.3300000000000001 110.999 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.98 35.5 4.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.715 -0.755 . . . . 2.2000000000000002 112.645 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.466 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 74.6 mmm -86.34 -3.54 59.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.467 . . . . 1.9299999999999999 110.468 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -81.08 16.22 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.651 -0.704 . . . . 3.3500000000000001 111.196 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.2 tp -148.39 62.01 6.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 2.7599999999999998 110.216 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 85.1 Cg_exo -50.06 124.22 12.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.985 2.457 . . . . 1.46 113.736 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.01 109.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.537 -0.912 . . . . 0.82999999999999996 108.537 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -54.55 26.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.579 -1.191 . . . . 1.6899999999999999 114.103 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -74.62 28.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.53 0.937 . . . . 2.5600000000000001 113.53 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t -141.11 145.08 35.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.137 0.494 . . . . 0.96999999999999997 112.133 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.1 t30 -63.47 146.9 96.08 Favored Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 115.484 -0.78 . . . . 1.96 109.596 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.632 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.2 Cg_exo -40.81 -58.89 0.88 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 122.631 2.221 . . . . 0.66000000000000003 115.249 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -62.21 -54.37 41.91 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 122.298 1.047 . . . . 1.8200000000000001 110.76 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -69.83 -11.64 61.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.036 -0.983 . . . . 1.9099999999999999 110.215 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.632 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -64.45 -45.71 86.26 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.491 -1.67 . . . . 1.5 106.491 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' THR . 74.8 t -54.19 -51.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.403 -1.271 . . . . 1.22 109.352 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.9 tp -70.49 -7.2 41.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.586 -0.734 . . . . 1.05 111.426 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.0 m-30 -120.08 16.03 12.42 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.478 -0.783 . . . . 0.90000000000000002 109.719 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.548 ' HG2' ' N ' ' A' ' 63' ' ' THR . 30.6 tt0 -141.25 -109.92 0.14 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.305 -0.861 . . . . 1.8 110.596 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.62 ' OG1' ' HA3' ' A' ' 17' ' ' GLY . 69.2 p 37.26 -156.02 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 119.082 -0.485 . . . . 1.05 110.298 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 12.6 pt-20 -174.86 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.593 1.701 . . . . 2.0499999999999998 115.593 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.551 ' NH2' ' HB2' ' A' ' 35' ' ' GLU . 7.9 mtp180 70.57 -172.79 0.17 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.062 0.392 . . . . 3.5800000000000001 110.056 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -87.25 178.83 6.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.519 -0.309 . . . . 4.25 111.106 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -150.05 171.99 15.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.379 -0.373 . . . . 4.3499999999999996 111.121 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.41 -102.5 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.475 -0.33 . . . . 3.1699999999999999 111.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -169.85 131.68 1.08 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.646 0.26 . . . . 2.3900000000000001 111.028 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.541 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 21.7 t 53.21 93.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.252 -0.431 . . . . 0.98999999999999999 111.495 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -168.85 168.83 10.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 1.26 110.975 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -171.37 -146.2 5.15 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.248 -0.977 . . . . 0.66000000000000003 113.86 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.681 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 58.9 m-85 -135.87 172.72 12.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.719 0.771 . . . . 0.82999999999999996 112.908 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.06 135.76 53.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.068 -1.424 . . . . 2.27 110.17 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.474 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.7 mp -129.35 86.34 56.66 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 111.706 0.262 . . . . 0.34000000000000002 111.706 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.73 126.13 21.39 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.109 1.873 . . . . 0.80000000000000004 112.512 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -121.05 149.89 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.38 110.933 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.03 2.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 2.96 111.425 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.633 ' HG2' ' NZ ' ' A' ' 174' ' ' LYS . 8.0 tp10 -132.11 165.99 22.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.835 0.35 . . . . 2.1299999999999999 110.092 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -116.41 178.85 4.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.37 111.642 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.87 -148.08 18.66 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 109.972 -1.251 . . . . 0.20999999999999999 109.972 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 11.1 mm-40 -105.97 110.53 22.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.701 1.251 . . . . 2.0299999999999998 109.235 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.28 126.36 41.44 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 108.954 -0.758 . . . . 0.26000000000000001 108.954 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.653 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.7 t -114.5 121.24 66.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.346 -0.843 . . . . 0.54000000000000004 112.032 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.5 tt -103.56 105.62 15.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.864 -1.062 . . . . 1.23 110.635 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.22 132.12 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.24 -0.891 . . . . 1.3100000000000001 108.816 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -147.47 138.78 23.78 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.241 -0.984 . . . . 1.3700000000000001 112.824 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.61 ' HD3' ' C ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -98.95 126.61 44.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.097 -0.956 . . . . 2.9700000000000002 109.024 178.329 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.38 146.13 32.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.551 -0.75 . . . . 0.29999999999999999 110.548 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.558 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -142.84 146.36 34.06 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.088 -0.506 . . . . 0.40999999999999998 109.832 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 92' ' ' VAL . 32.2 tt0 -118.5 -56.08 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 3.9700000000000002 110.845 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 91' ' ' GLU . 8.4 m 47.95 177.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.62 -0.718 . . . . 3.8100000000000001 112.576 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 70.93 -69.23 0.19 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.567 -0.742 . . . . 2.8900000000000001 111.472 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -88.61 178.75 6.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.018 0.437 . . . . 2.0 111.266 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.96 82.21 1.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.687 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -137.41 143.49 41.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 2.96 111.019 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 99' ' ' GLN . 20.4 m -99.0 -88.4 0.33 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.686 0.624 . . . . 1.55 112.686 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.86 36.22 0.17 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.903 0.383 . . . . 2.3300000000000001 111.558 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 97' ' ' SER . 1.8 mt-30 -133.79 -41.3 0.85 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.016 -0.538 . . . . 2.5099999999999998 109.697 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -94.39 75.86 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.293 -0.632 . . . . 3.1000000000000001 109.293 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.33 154.33 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.707 -0.678 . . . . 1.3100000000000001 109.851 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -139.64 173.85 11.11 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 111.968 0.359 . . . . 0.68999999999999995 111.968 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.92 137.08 54.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.589 -0.444 . . . . 2.0099999999999998 110.812 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.6 t -132.06 129.68 60.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 112.598 0.592 . . . . 0.46000000000000002 112.598 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 2.7 mtt180 -134.89 149.59 50.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.591 -0.731 . . . . 1.8500000000000001 112.82 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 14.0 m -119.28 120.8 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.313 -0.858 . . . . 1.1000000000000001 109.99 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.506 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.11 27.23 9.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.42 0.628 . . . . 1.77 109.342 -176.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.5 21.33 41.08 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.016 -0.993 . . . . 0.40999999999999998 112.671 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -119.16 113.73 21.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.079 0.77 . . . . 0.46000000000000002 113.079 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -64.49 124.7 22.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.507 -0.477 . . . . 0.66000000000000003 111.046 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.19 -32.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.833 -0.621 . . . . 0.80000000000000004 109.531 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.12 90.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.51000000000000001 110.151 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 18.1 ptpt -104.19 137.85 41.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.033 -0.531 . . . . 2.4399999999999999 110.41 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 22.6 m-20 87.47 18.24 0.07 Allowed 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.025 -1.472 . . . . 2.5600000000000001 107.025 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 tp -45.78 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.983 -1.462 . . . . 1.1000000000000001 111.763 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -102.89 90.41 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.162 -0.927 . . . . 1.99 109.317 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -52.15 -47.94 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 0.63 112.637 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.77 -44.61 96.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.936 0.347 . . . . 0.90000000000000002 111.936 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.87 -27.73 63.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.159 0.429 . . . . 0.76000000000000001 112.159 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -70.9 -58.1 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.247 0.462 . . . . 2.6800000000000002 112.247 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -99.96 -40.29 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.073 0.398 . . . . 1.4099999999999999 112.073 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.77 -134.36 8.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.458 -0.877 . . . . 1.0600000000000001 112.568 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -83.79 120.46 26.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.585 0.231 . . . . 3.5099999999999998 111.009 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.0 p 48.18 -121.96 1.47 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.095 -0.502 . . . . 1.6799999999999999 110.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.9 p 51.13 -167.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.672 0.272 . . . . 0.80000000000000004 111.635 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.416 ' HA ' ' HZ1' ' A' ' 88' ' ' LYS . . . -106.88 136.31 46.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.36 1.245 . . . . 0.44 114.36 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.1 t60 -108.8 141.51 40.73 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.267 -1.383 . . . . 0.38 107.267 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.29 119.33 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.772 0.656 . . . . 2.0899999999999999 112.772 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.88 136.66 52.83 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.82 -0.627 . . . . 2.2799999999999998 109.922 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.1 mt -112.51 133.33 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.44 -0.8 . . . . 0.70999999999999996 110.639 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.82 85.75 34.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.349 0.499 . . . . 1.3799999999999999 112.349 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.18 146.57 90.7 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.876 1.717 . . . . 0.22 111.784 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 134' ' ' SER . 23.7 mt -136.7 156.93 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 0.20999999999999999 110.854 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -132.83 106.95 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 1.1100000000000001 110.836 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 139' ' ' LYS . 25.7 mt -103.29 126.45 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.798 -0.637 . . . . 0.23000000000000001 109.609 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 88.0 mttt -148.08 138.15 22.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.878 -0.329 . . . . 1.9099999999999999 111.208 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 61.61 23.55 13.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 3.1099999999999999 110.572 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.09 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.041 -0.599 . . . . 0.32000000000000001 112.227 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.7 ' O ' HG23 ' A' ' 135' ' ' ILE . 59.3 mttt -114.72 159.03 21.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.383 0.135 . . . . 2.1899999999999999 111.073 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -121.09 124.15 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.076 0.465 . . . . 0.37 111.288 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 140' ' ' LEU . 24.5 t -114.1 109.53 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.674 -0.694 . . . . 0.90000000000000002 110.014 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.4 p -103.57 106.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 0.53000000000000003 111.031 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.95 -92.0 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.883 -0.599 . . . . 2.0499999999999998 111.814 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.87 37.6 2.28 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.596 -0.811 . . . . 0.59999999999999998 113.046 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.09 137.28 25.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.16 -0.311 . . . . 2.02 110.16 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.02 140.34 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.97 0.414 . . . . 1.3 110.976 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -162.69 126.93 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.901 -0.59 . . . . 1.1200000000000001 110.447 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 t -56.22 140.82 43.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.867 -0.606 . . . . 1.1100000000000001 112.406 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -79.62 139.24 37.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.403 -0.817 . . . . 0.28000000000000003 109.284 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 36.0 p -136.11 95.88 3.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.223 0.823 . . . . 1.55 113.223 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.23 -60.7 1.46 Allowed Glycine 0 C--N 1.331 0.282 0 N-CA-C 115.549 0.98 . . . . 0.46000000000000002 115.549 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.607 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -148.68 176.44 10.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.061 0.931 . . . . 1.8 112.978 -178.205 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.506 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.55 127.25 48.34 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.685 -1.228 . . . . 1.24 107.685 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.468 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.3 t -115.18 115.93 27.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.421 -0.912 . . . . 1.28 113.433 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.411 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 61.8 t -93.78 97.54 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.249 -0.649 . . . . 0.58999999999999997 109.249 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 tt0 -108.04 135.74 48.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 2.48 111.407 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -130.84 143.2 50.57 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.747 -0.66 . . . . 1.54 109.729 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.6 t -122.66 144.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.421 -0.809 . . . . 0.77000000000000002 111.653 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 146.36 30.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.738 -0.664 . . . . 1.97 110.88 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.9 -17.24 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.868 -0.682 . . . . 1.1200000000000001 112.14 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -138.44 -61.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 3.8100000000000001 110.429 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -175.25 150.9 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.097 -0.501 . . . . 3.8199999999999998 110.877 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.18 89.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.194 -0.457 . . . . 1.3999999999999999 111.437 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 70' ' ' SER . 1.4 m-20 -54.76 169.35 0.41 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.017 -0.538 . . . . 2.0 109.792 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.503 ' HD2' ' OD1' ' A' ' 164' ' ' ASN . 2.8 Cg_endo -36.4 105.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.321 2.014 . . . . 2.5800000000000001 111.63 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -60.53 -46.74 89.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.269 -0.878 . . . . 3.71 112.34 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 25.1 t -116.1 135.02 57.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 112.807 0.669 . . . . 0.92000000000000004 112.807 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -137.54 137.41 38.57 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 113.389 0.885 . . . . 1.2 113.389 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -125.03 38.6 4.16 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.62 -1.173 . . . . 0.22 111.397 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.5 tp -50.11 127.05 15.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.737 -0.665 . . . . 1.02 111.448 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.409 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -142.09 115.5 8.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.667 -0.697 . . . . 0.33000000000000002 110.831 -178.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -115.99 129.63 72.03 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 CA-C-O 123.126 1.441 . . . . 0.68999999999999995 112.994 178.547 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.575 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.0 ppp? -124.24 168.4 13.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.957 -1.929 . . . . 1.26 109.834 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.633 ' NZ ' ' HG2' ' A' ' 79' ' ' GLU . 13.8 ptmt -120.45 156.05 32.26 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.167 1.543 . . . . 1.8200000000000001 115.167 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 86.46 -34.87 3.4 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 111.833 -2.439 . . . . 0.22 118.082 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.62 158.55 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.209 2.004 . . . . 0.28999999999999998 114.249 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.653 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.44 -23.73 27.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.331 -0.849 . . . . 0.56999999999999995 110.425 177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.59 -29.68 66.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.692 -0.686 . . . . 2.3100000000000001 111.649 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.14 -43.67 91.13 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.032 -0.267 . . . . 2.3700000000000001 110.538 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 94.8 t -44.01 101.34 0.25 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.879 -0.601 . . . . 2.5699999999999998 111.599 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.6 139.36 38.74 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.012 1.808 . . . . 2.0800000000000001 112.617 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.6 mmt -147.18 127.01 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.9 -0.591 . . . . 6.04 110.692 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.24 122.23 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.029 -0.532 . . . . 5.2999999999999998 111.146 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -52.36 149.61 9.99 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.961 -0.563 . . . . 8.0500000000000007 110.313 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.64 124.36 12.27 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.653 1.569 . . . . 9.1400000000000006 112.037 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -134.68 132.92 20.88 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.241 -0.436 . . . . 9.8699999999999992 110.48 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.49 -36.57 2.92 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.989 1.793 . . . . 11.69 112.444 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -87.68 -101.33 0.89 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.934 -0.65 . . . . 12.619999999999999 112.618 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.9 104.24 1.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.731 0.301 . . . . 14.44 110.409 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 1.4 pm0 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.123 -0.941 . . . . 15.699999999999999 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.561 -0.216 . . . . 9.1500000000000004 112.561 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.27 83.7 1.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 7.3600000000000003 110.85 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.2 mtt 56.63 80.8 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 7.7599999999999998 110.983 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -98.92 -25.31 14.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 4.0199999999999996 110.661 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.37 73.99 1.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.923 -0.656 . . . . 1.28 112.833 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.413 HD11 ' SD ' ' A' ' 173' ' ' MET . 22.1 tp -74.42 -49.54 22.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.143 0.497 . . . . 0.40999999999999998 109.812 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.635 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.95 -21.72 22.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.822 . . . . 0.33000000000000002 111.162 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.7 -19.78 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 2.0899999999999999 111.909 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -101.44 -23.39 14.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.949 -0.301 . . . . 1.99 111.282 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.1 p -45.71 141.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.735 0.303 . . . . 0.20999999999999999 111.725 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.28 -21.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.324 -0.551 . . . . 0.85999999999999999 110.355 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.487 ' O ' HG22 ' A' ' 172' ' ' ILE . 60.4 t90 -173.83 144.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.28000000000000003 109.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -164.31 144.91 8.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.628 0.603 . . . . 0.20000000000000001 112.628 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.72 129.49 6.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 113.661 0.986 . . . . 0.67000000000000004 113.661 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 60' ' ' LEU . 49.1 t30 -111.52 87.1 2.47 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.934 -1.136 . . . . 1.27 107.934 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.892 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -57.52 103.67 0.14 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.447 -1.251 . . . . 0.37 109.983 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.618 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 154.2 -17.95 0.62 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 113.898 -1.501 . . . . 0.67000000000000004 115.576 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.7 -126.56 2.77 Favored Glycine 0 N--CA 1.459 0.191 0 C-N-CA 119.367 -1.396 . . . . 1.1200000000000001 113.529 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -165.67 120.23 1.23 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.905 0.383 . . . . 2.02 111.695 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.2 p 32.88 94.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.244 -0.889 . . . . 1.22 112.882 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.664 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 36.5 t-80 -128.9 137.61 51.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.826 -0.75 . . . . 0.34000000000000002 112.351 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.0 p -113.68 105.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-O 121.387 0.613 . . . . 1.1799999999999999 111.462 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 156.53 36.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.513 -0.767 . . . . 1.1699999999999999 109.851 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 m -43.35 -46.72 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.761 1.023 . . . . 0.59999999999999998 113.761 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -63.54 -13.91 45.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.46000000000000002 110.914 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.71 33.04 5.45 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.501 -0.772 . . . . 0.28999999999999998 112.527 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 mm -103.92 112.23 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.184 0.516 . . . . 0.42999999999999999 110.497 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.2 t60 -98.64 136.24 39.0 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.447 1.277 . . . . 0.52000000000000002 114.447 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.637 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.89 132.32 43.58 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.73 -1.123 . . . . 3.0 108.649 177.72 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.516 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 22.8 mtt-85 -84.04 103.75 13.53 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 124.27 0.981 . . . . 2.8999999999999999 112.685 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 30' ' ' ARG . 15.9 ttmm -14.61 124.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.003 1.112 . . . . 2.71 114.003 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -13.84 81.5 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.912 1.285 . . . . 1.98 113.822 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -110.22 21.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.188 2.592 . . . . 1.53 113.305 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.799 ' H ' HH12 ' A' ' 65' ' ' ARG . 1.5 tt -58.52 -75.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.917 -0.313 . . . . 1.8300000000000001 110.461 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 34' ' ' LEU . 3.6 mt-10 177.44 107.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.678 0.621 . . . . 4.9500000000000002 112.678 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.12 -0.86 60.53 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.678 -0.773 . . . . 1.9399999999999999 112.439 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.722 ' HB2' HH21 ' A' ' 65' ' ' ARG . 1.0 OUTLIER -128.42 75.69 1.65 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.915 -0.314 . . . . 5.3600000000000003 110.78 -178.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.0 123.65 65.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 2.9700000000000002 111.018 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.22 64.04 3.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.93 -0.652 . . . . 1.99 112.85 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -145.17 -67.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.556 0.217 . . . . 6.5899999999999999 110.884 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 64.81 120.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.285 -0.416 . . . . 2.0099999999999998 111.118 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 9.2 t -96.42 57.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 2.02 111.031 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.34 23.56 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.153 -0.476 . . . . 2.23 110.185 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -54.4 102.71 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.7 -0.682 . . . . 2.3300000000000001 110.911 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.94 106.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.788 -0.72 . . . . 2.2000000000000002 112.653 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 41.9 mmm -84.83 -3.83 58.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 1.9299999999999999 110.189 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 162.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.813 -0.63 . . . . 3.3500000000000001 110.027 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.51 53.63 6.31 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 109.645 -0.502 . . . . 2.7599999999999998 109.645 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HB2' ' CD ' ' A' ' 58' ' ' GLN . 42.0 Cg_endo -82.14 168.48 15.17 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.509 2.139 . . . . 1.46 112.728 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 125' ' ' THR . 1.2 mp -70.88 137.56 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.82999999999999996 110.567 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.28 -48.15 7.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.098 0.777 . . . . 1.6899999999999999 113.098 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -76.44 36.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.046 0.758 . . . . 2.5600000000000001 113.046 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -151.45 145.01 24.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.075 0.464 . . . . 0.96999999999999997 111.776 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.9 t30 -58.96 144.84 81.39 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.543 -0.753 . . . . 1.96 110.822 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.67 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.98 -53.68 2.82 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.949 2.433 . . . . 0.66000000000000003 115.383 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -64.92 -55.28 20.23 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 122.474 1.131 . . . . 1.8200000000000001 110.442 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.51 -9.25 53.02 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.721 -1.127 . . . . 1.9099999999999999 109.733 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.67 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.1 tt0 -66.32 -49.68 66.18 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.834 -1.543 . . . . 1.5 106.834 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.32 -46.01 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.985 -1.007 . . . . 1.22 109.385 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.475 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.4 tp -72.29 -12.99 61.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.409 -0.814 . . . . 1.05 111.376 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.403 ' O ' HG12 ' A' ' 50' ' ' ILE . 6.7 m-30 -120.71 20.61 11.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.6 -0.727 . . . . 0.90000000000000002 111.494 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -137.86 -59.61 0.65 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.35 0.87 . . . . 1.8 113.35 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 82.8 p -39.53 143.87 0.19 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.213 0.82 . . . . 1.05 113.213 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.618 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.6 OUTLIER -127.28 145.06 50.92 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.897 -0.592 . . . . 2.0499999999999998 111.51 -179.258 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.799 HH12 ' H ' ' A' ' 34' ' ' LEU . 47.6 ttt180 -107.34 172.0 7.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.895 -0.593 . . . . 3.5800000000000001 110.015 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -57.72 174.97 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 4.25 110.97 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.526 ' HB2' ' OD1' ' A' ' 164' ' ' ASN . 2.7 p-10 -150.26 167.48 26.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 4.3499999999999996 111.632 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.45 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.8 tp10 -163.02 -83.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.042 -0.526 . . . . 3.1699999999999999 111.311 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 2.9 p30 -173.37 132.43 0.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.398 0.142 . . . . 2.3900000000000001 110.845 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t 43.4 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.426 -0.352 . . . . 0.98999999999999999 110.425 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.483 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 0.6 OUTLIER -149.3 158.22 44.0 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.8 -0.36 . . . . 1.26 111.569 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.45 -149.21 7.71 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.24 -0.981 . . . . 0.66000000000000003 114.367 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.463 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -129.71 168.84 15.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.543 0.687 . . . . 0.82999999999999996 112.536 -177.295 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.52 132.52 55.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.451 -1.25 . . . . 2.27 110.348 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.429 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.4 mp -124.88 86.89 55.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.437 0.532 . . . . 0.34000000000000002 112.437 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -55.37 132.41 52.05 Favored 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 122.271 1.981 . . . . 0.80000000000000004 112.325 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.93 151.31 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.231 -0.441 . . . . 0.38 111.067 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -140.84 1.38 1.68 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.173 -0.467 . . . . 2.96 111.193 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -124.34 172.98 8.7 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.592 0.234 . . . . 2.1299999999999999 110.819 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.24 165.37 19.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.379 0.609 . . . . 0.37 111.658 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.06 26.51 Favored Glycine 0 C--N 1.329 0.144 0 N-CA-C 109.874 -1.29 . . . . 0.20999999999999999 109.874 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -96.95 107.25 19.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.95 1.375 . . . . 2.0299999999999998 108.857 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 1.9 m-85 -95.39 127.46 41.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.573 0.702 . . . . 0.26000000000000001 109.189 -178.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.604 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.1 t -118.04 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.853 -1.067 . . . . 0.54000000000000004 113.284 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.48 105.96 17.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.121 -0.945 . . . . 1.23 110.381 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.4 106.12 18.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.14 -0.689 . . . . 1.3100000000000001 109.14 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.475 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.486 -0.486 . . . . 1.3700000000000001 112.248 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.535 ' NZ ' ' HB1' ' A' ' 126' ' ' ALA . 10.6 tptp -106.59 115.89 30.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.272 -1.01 . . . . 2.9700000000000002 108.272 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 9.9 m-85 -104.77 143.64 32.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.535 -0.543 . . . . 0.29999999999999999 109.535 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -149.63 155.62 40.55 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.088 -0.645 . . . . 0.40999999999999998 111.001 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -165.32 152.62 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.95 0.405 . . . . 3.9700000000000002 111.238 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.03 -21.83 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.75 -0.659 . . . . 3.8100000000000001 110.401 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.76 135.0 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 2.8900000000000001 111.057 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 61.39 97.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.075 -0.511 . . . . 2.0 110.871 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.53 79.07 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.174 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 2.4 pp0? -135.25 157.22 47.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 2.96 110.768 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.418 ' HB3' ' OD2' ' A' ' 119' ' ' ASP . 10.8 m -137.65 147.72 45.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 1.55 111.708 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 54.03 24.75 4.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.868 -0.606 . . . . 2.3300000000000001 111.288 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -125.32 -56.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.602 -0.518 . . . . 2.5099999999999998 109.602 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -94.63 96.78 9.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.069 -0.715 . . . . 3.1000000000000001 109.069 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.529 HG12 ' OD2' ' A' ' 116' ' ' ASP . 0.6 OUTLIER -109.2 148.99 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 1.3100000000000001 110.553 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -120.35 -178.27 3.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.839 0.681 . . . . 0.68999999999999995 112.839 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -130.98 143.08 50.46 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 115.876 -0.602 . . . . 2.0099999999999998 112.131 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.22 132.68 46.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.778 -0.646 . . . . 0.46000000000000002 112.151 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 12.9 ptt180 -134.35 151.65 51.35 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 115.318 -0.855 . . . . 1.8500000000000001 112.738 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 10.7 m -124.99 123.95 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.752 -1.113 . . . . 1.1000000000000001 110.384 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.464 ' HA ' ' H ' ' A' ' 154' ' ' SER . 7.0 t-20 52.72 26.79 4.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.991 -0.744 . . . . 1.77 108.991 -177.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.81 29.34 18.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.40999999999999998 112.666 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 80.3 m-70 -129.43 111.16 12.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.266 0.839 . . . . 0.46000000000000002 113.266 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -65.75 119.21 10.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.022 0.439 . . . . 0.66000000000000003 111.259 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.52 -33.48 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.625 -0.716 . . . . 0.80000000000000004 110.015 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.58 90.54 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.214 -0.661 . . . . 0.51000000000000001 109.214 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -103.39 77.1 1.48 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 122.295 1.045 . . . . 2.4399999999999999 111.406 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.5 p30 156.87 35.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.67 -1.605 . . . . 2.5600000000000001 109.152 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 93.81 0.14 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.292 0.568 . . . . 1.1000000000000001 111.677 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.529 ' OD2' HG12 ' A' ' 101' ' ' VAL . 6.4 m-20 -104.58 81.12 1.75 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.766 -1.568 . . . . 1.99 106.766 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.3 mt -50.35 -38.29 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.972 -1.013 . . . . 0.63 112.821 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 14.1 t80 -71.09 -43.46 67.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.862 -0.335 . . . . 0.90000000000000002 111.476 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 97' ' ' SER . 9.4 t70 -66.12 -27.35 67.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.657 0.265 . . . . 0.76000000000000001 111.38 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -72.18 -58.6 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.488 0.551 . . . . 2.6800000000000002 112.488 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 m -96.33 -40.4 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.943 0.349 . . . . 1.4099999999999999 111.943 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.89 -98.85 1.89 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.721 . . . . 1.0600000000000001 112.046 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -68.56 159.43 31.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.026 -0.361 . . . . 3.5099999999999998 110.026 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.4 p -57.4 94.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 1.6799999999999999 110.963 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 50' ' ' ILE . 23.8 p -140.75 -148.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 0.80000000000000004 110.029 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.535 ' HB1' ' NZ ' ' A' ' 88' ' ' LYS . . . -112.8 133.84 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.747 0.647 . . . . 0.44 112.747 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.522 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.9 t60 -111.53 149.29 31.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.494 -0.928 . . . . 0.38 108.494 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 19.5 t70 -141.73 132.07 25.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.31 0.576 . . . . 2.0899999999999999 112.517 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.96 114.36 16.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.137 -0.938 . . . . 2.2799999999999998 109.891 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.19 129.99 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 0.70999999999999996 110.55 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.4 89.52 47.19 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.417 -0.356 . . . . 1.3799999999999999 111.933 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -64.05 150.57 88.08 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.056 1.837 . . . . 0.22 112.011 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 134' ' ' SER . 34.2 mt -140.55 157.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.336 . . . . 0.20999999999999999 111.018 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -133.53 106.41 7.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 1.1100000000000001 110.747 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 139' ' ' LYS . 32.5 mt -105.5 126.51 60.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.761 -0.654 . . . . 0.23000000000000001 109.865 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' A' ' 134' ' ' SER . 50.4 mttp -148.38 143.59 26.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.769 0.319 . . . . 1.9099999999999999 110.961 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt 57.69 13.89 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 3.1099999999999999 111.287 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.15 23.48 27.12 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.641 -0.79 . . . . 0.32000000000000001 113.075 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.516 ' O ' HG23 ' A' ' 135' ' ' ILE . 1.3 mmmm -123.57 155.48 37.56 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.236 0.518 . . . . 2.1899999999999999 110.41 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -113.45 129.47 56.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.076 0.465 . . . . 0.37 111.878 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.566 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.0 t -116.66 110.01 17.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 0.90000000000000002 109.472 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -103.11 104.55 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.966 -0.561 . . . . 0.53000000000000003 111.011 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 57.96 -91.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.965 -0.561 . . . . 2.0499999999999998 111.856 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.9 6.12 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.554 -0.831 . . . . 0.59999999999999998 113.414 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -127.79 136.08 50.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.056 -0.349 . . . . 2.02 110.056 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.15 136.96 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.049 0.452 . . . . 1.3 111.141 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 m -155.93 175.3 14.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.761 -0.654 . . . . 1.1200000000000001 109.26 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.29 141.78 32.67 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.604 -0.438 . . . . 1.1100000000000001 111.757 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -77.63 129.99 36.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.477 -0.935 . . . . 0.28000000000000003 108.477 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 69.3 p -126.61 94.92 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.506 0.928 . . . . 1.55 113.506 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.03 -51.24 0.74 Allowed Glycine 0 CA--C 1.52 0.371 0 N-CA-C 116.328 1.291 . . . . 0.46000000000000002 116.328 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.539 ' HE2' ' N ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -156.37 164.31 38.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 118.443 1.121 . . . . 1.8 112.618 -177.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.39 127.11 35.49 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.357 -1.349 . . . . 1.24 107.357 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.464 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.7 t -113.42 112.91 24.42 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.698 -0.801 . . . . 1.28 112.988 -176.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 104.06 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.277 -0.419 . . . . 0.58999999999999997 110.344 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -125.11 156.94 37.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.226 0.536 . . . . 2.48 111.357 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.87 145.23 41.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.338 -0.846 . . . . 1.54 110.065 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 t -115.31 143.92 24.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.414 -0.812 . . . . 0.77000000000000002 111.02 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -75.92 144.59 40.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.483 -0.78 . . . . 1.97 111.116 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.62 -31.76 7.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.827 -0.701 . . . . 1.1200000000000001 111.745 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.42 -56.96 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.458 . . . . 3.8100000000000001 109.925 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -172.45 148.07 1.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.654 -0.703 . . . . 3.8199999999999998 110.372 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 65.42 71.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.277 0.56 . . . . 1.3999999999999999 111.07 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -50.25 169.67 0.19 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 114.93 -1.032 . . . . 2.0 109.443 178.171 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -37.22 110.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 121.773 1.649 . . . . 2.5800000000000001 111.979 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -64.27 -69.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.091 -0.959 . . . . 3.71 112.93 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 63' ' ' THR . 91.9 t -87.27 132.1 33.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 112.044 0.386 . . . . 0.92000000000000004 112.044 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.892 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.58 123.41 21.29 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.759 0.662 . . . . 1.2 112.669 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -118.84 40.46 3.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.748 -1.115 . . . . 0.22 112.985 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 tp -56.05 129.16 38.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.462 0.649 . . . . 1.02 111.035 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -139.95 114.03 8.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.041 -0.982 . . . . 0.33000000000000002 109.743 -178.192 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.648 HD13 ' N ' ' A' ' 173' ' ' MET . 0.2 OUTLIER -111.23 126.78 68.64 Favored 'Isoleucine or valine' 0 C--O 1.258 1.513 0 CA-C-O 122.947 1.356 . . . . 0.68999999999999995 113.353 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.648 ' N ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -121.61 165.95 14.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.141 -1.845 . . . . 1.26 109.539 -179.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 10.6 ptmt -120.36 142.9 48.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 114.886 1.439 . . . . 1.8200000000000001 114.886 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.4 -34.89 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 112.837 -1.983 . . . . 0.22 117.737 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.41 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.27 158.26 0.47 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.393 2.096 . . . . 0.28999999999999998 114.26 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.604 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.18 -27.96 24.22 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 114.729 -1.123 . . . . 0.56999999999999995 110.034 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -59.23 -29.05 67.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.6 -0.727 . . . . 2.3100000000000001 111.153 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.9 -49.54 71.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.385 . . . . 2.3700000000000001 110.138 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 22.1 t -38.72 100.38 0.21 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 115.872 -0.603 . . . . 2.5699999999999998 111.588 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.47 115.05 1.71 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.039 1.826 . . . . 2.0800000000000001 112.602 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 67.9 mtt -109.84 149.06 30.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 6.04 110.583 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 183' ' ' LEU . 1.9 pt? -154.24 128.92 9.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.002 0.43 . . . . 5.2999999999999998 110.938 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -62.77 148.04 92.25 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.878 -0.601 . . . . 8.0500000000000007 109.899 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.08 127.17 19.55 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.557 1.505 . . . . 9.1400000000000006 112.032 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.601 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 41.4 t60 -130.76 129.53 22.68 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.111 -0.495 . . . . 9.8699999999999992 110.683 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.601 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 10.3 Cg_endo -84.52 -32.65 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.178 1.918 . . . . 11.69 112.906 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.76 157.53 8.4 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.376 -0.916 . . . . 12.619999999999999 112.723 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.22 153.15 33.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 14.44 110.785 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.343 -0.837 . . . . 15.699999999999999 110.723 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.507 -0.237 . . . . 9.1500000000000004 112.507 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.98 20.83 6.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.828 0.346 . . . . 7.3600000000000003 110.945 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 tpt -146.4 -55.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 7.7599999999999998 110.677 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.4 p -68.72 172.38 6.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 4.0199999999999996 110.489 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.69 67.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 1.28 112.484 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.4 tp -80.27 -47.23 14.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.25 0.547 . . . . 0.40999999999999998 110.344 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.546 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.85 -21.54 7.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 0.33000000000000002 111.77 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.98 -23.41 41.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.637 0.606 . . . . 2.0899999999999999 112.637 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.57 -21.27 15.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.618 -0.433 . . . . 1.99 111.871 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.6 p -44.37 144.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 121.146 -0.221 . . . . 0.20999999999999999 111.245 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -135.86 -20.33 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 119.686 -0.806 . . . . 0.85999999999999999 111.258 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.457 ' O ' HG22 ' A' ' 172' ' ' ILE . 23.5 t90 -174.07 139.54 0.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.765 -0.374 . . . . 0.28000000000000003 110.17 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -160.21 142.04 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.101 0.408 . . . . 0.20000000000000001 112.101 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.9 t -147.52 129.29 6.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 114.567 1.321 . . . . 0.67000000000000004 114.567 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 15.6 t30 -115.23 96.72 5.81 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.089 0.471 . . . . 1.27 110.385 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.905 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -68.16 114.19 6.45 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 115.683 -0.689 . . . . 0.37 109.709 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 145.61 -36.06 1.37 Allowed Glycine 0 C--N 1.342 0.882 0 O-C-N 124.767 1.292 . . . . 0.67000000000000004 113.674 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.5 -132.37 6.2 Favored Glycine 0 N--CA 1.454 -0.102 0 C-N-CA 120.313 -0.946 . . . . 1.1200000000000001 113.36 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.31 120.75 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.588 0.233 . . . . 2.02 110.669 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 77.8 p 28.46 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.598 -0.728 . . . . 1.22 112.672 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.591 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 58.3 t-80 -119.11 151.6 38.0 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.921 -0.712 . . . . 0.34000000000000002 112.343 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.59 103.71 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.27 -0.877 . . . . 1.1799999999999999 109.969 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.83 153.19 42.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.074 -0.512 . . . . 1.1699999999999999 110.305 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 25' ' ' HIS . 11.4 m -43.76 -51.26 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 124.17 0.919 . . . . 0.59999999999999998 113.212 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.4 ' N ' HG23 ' A' ' 24' ' ' VAL . 84.7 m-70 -58.68 -17.92 26.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.134 0.492 . . . . 0.46000000000000002 110.532 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.11 35.51 3.92 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.28999999999999998 112.432 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.7 mm -103.62 121.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.858 -0.423 . . . . 0.42999999999999999 109.858 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.4 t60 -103.27 134.75 46.14 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.686 1.365 . . . . 0.52000000000000002 114.686 -176.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.23 132.52 44.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.055 -0.975 . . . . 3.0 108.77 176.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.436 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 50.1 mtt180 -87.51 108.45 19.04 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.666 0.604 . . . . 2.8999999999999999 112.047 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 32' ' ' ASP . 39.0 tttt -23.57 135.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.947 0.899 . . . . 2.71 112.97 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 4.1 p-10 -11.41 84.04 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 124.228 0.955 . . . . 1.98 112.884 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 13.5 Cg_endo -97.65 -10.3 0.58 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.51 2.14 . . . . 1.53 114.856 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -114.58 -16.51 11.86 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.845 -0.742 . . . . 1.8300000000000001 112.809 -178.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.496 ' N ' HD13 ' A' ' 34' ' ' LEU . 12.6 mm-40 -96.14 72.92 2.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 4.9500000000000002 110.914 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.85 -2.99 47.11 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.601 -0.809 . . . . 1.9399999999999999 111.187 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 33.49 64.28 0.32 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.03 -0.585 . . . . 5.3600000000000003 111.527 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.59 141.28 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.585 -0.734 . . . . 2.9700000000000002 110.626 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -42.72 101.99 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 CA-C-N 116.239 -0.437 . . . . 1.99 113.437 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.732 ' HB3' HH22 ' A' ' 65' ' ' ARG . 58.4 ttt180 -175.11 148.4 0.99 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.732 0.301 . . . . 6.5899999999999999 110.563 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.24 -60.4 0.28 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.379 -0.373 . . . . 2.0099999999999998 110.964 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t 61.68 97.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 2.02 111.317 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -95.73 -26.25 15.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.532 . . . . 2.23 110.31 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.9 t80 64.28 -75.52 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.768 -0.651 . . . . 2.3300000000000001 111.007 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.55 112.83 0.56 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.602 -0.808 . . . . 2.2000000000000002 112.693 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.1 mtt -81.33 -1.54 45.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.351 0.596 . . . . 1.9299999999999999 109.396 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -48.96 -22.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.892 -1.049 . . . . 3.3500000000000001 112.102 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.51 73.72 4.16 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.156 -0.683 . . . . 2.7599999999999998 109.156 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HB2' ' CD ' ' A' ' 58' ' ' GLN . 16.6 Cg_endo -90.39 170.46 3.84 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.674 2.249 . . . . 1.46 114.322 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 61' ' ' TYR . 1.1 mp -75.4 148.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.095 -0.957 . . . . 0.82999999999999996 110.16 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.48 -51.75 4.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.176 0.806 . . . . 1.6899999999999999 113.176 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -74.25 36.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.205 0.817 . . . . 2.5600000000000001 113.205 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -150.32 149.48 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 0.96999999999999997 112.041 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 58' ' ' GLN . 44.1 t30 -64.29 147.07 97.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.511 -0.768 . . . . 1.96 109.925 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.666 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 20.8 Cg_exo -41.7 -50.62 4.79 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 122.366 2.044 . . . . 0.66000000000000003 114.218 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -55.36 14.26 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.934 0.873 . . . . 1.8200000000000001 110.978 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' OD1' HD23 ' A' ' 60' ' ' LEU . 14.2 t70 -67.96 -11.37 58.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.649 -0.705 . . . . 1.9099999999999999 109.387 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.666 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 20.9 tt0 -65.95 -49.23 68.64 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.007 -1.479 . . . . 1.5 107.007 177.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -51.15 -47.51 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.011 -0.995 . . . . 1.22 109.193 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 tp -71.52 -13.34 61.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.028 -0.987 . . . . 1.05 111.787 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.456 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.0 m-30 -121.4 21.21 11.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.712 -0.676 . . . . 0.90000000000000002 111.244 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -140.15 -59.75 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.569 0.951 . . . . 1.8 113.569 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.541 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 37.9 p -45.54 136.86 5.43 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.985 0.735 . . . . 1.05 112.985 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.557 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.5 pt-20 -121.49 150.06 42.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.985 -0.552 . . . . 2.0499999999999998 111.417 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.732 HH22 ' HB3' ' A' ' 40' ' ' ARG . 12.7 ttt85 -117.66 147.76 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 3.5800000000000001 110.343 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -74.14 148.78 41.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 4.25 111.778 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -153.38 -173.87 4.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.762 -0.654 . . . . 4.3499999999999996 110.276 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -122.7 -69.96 0.8 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.644 0.259 . . . . 3.1699999999999999 111.286 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -160.75 138.81 9.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.477 -0.329 . . . . 2.3900000000000001 110.28 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 54.32 87.97 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.814 -0.439 . . . . 0.98999999999999999 109.814 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.598 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 3.0 p90 -133.43 136.12 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.189 0.519 . . . . 1.26 111.1 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.44 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -154.25 -156.8 7.84 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.401 -0.818 . . . . 0.66000000000000003 113.594 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.4 ' CE1' HD23 ' A' ' 170' ' ' LEU . 0.7 OUTLIER -139.3 163.89 31.28 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.163 0.506 . . . . 0.82999999999999996 111.213 -178.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.04 114.11 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.21 -0.904 . . . . 2.27 110.667 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.7 mp -105.73 112.56 64.49 Favored Pre-proline 0 C--O 1.224 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.34000000000000002 111.548 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.01 141.44 11.83 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 120.219 1.114 . . . . 0.80000000000000004 111.604 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 78' ' ' LYS . 57.0 mt -132.25 151.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.039 0.447 . . . . 0.38 111.675 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' N ' HG22 ' A' ' 77' ' ' ILE . 99.6 mttt -142.95 -4.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.837 -0.62 . . . . 2.96 110.958 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -119.57 173.05 7.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.552 0.215 . . . . 2.1299999999999999 110.817 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -127.26 175.63 8.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.242 0.544 . . . . 0.37 111.425 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.3 -146.86 18.51 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 109.965 -1.254 . . . . 0.20999999999999999 109.965 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 19.2 mt-10 -104.68 109.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.722 1.261 . . . . 2.0299999999999998 109.433 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.13 127.46 42.15 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.229 -0.656 . . . . 0.26000000000000001 109.229 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.4 t -113.87 120.83 64.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.995 -1.002 . . . . 0.54000000000000004 112.388 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -94.01 105.8 17.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.931 -1.032 . . . . 1.23 111.367 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 48.2 t -106.17 116.22 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.069 -0.969 . . . . 1.3100000000000001 108.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 133.6 45.17 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.3 -0.56 . . . . 1.3700000000000001 110.978 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.459 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 9.2 tptp -100.13 118.8 37.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 119.605 -0.838 . . . . 2.9700000000000002 109.16 177.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 1.3 m-85 -105.94 136.62 45.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.14 -1.059 . . . . 0.29999999999999999 108.14 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 91' ' ' GLU . . . -153.78 169.13 24.11 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.42 -0.912 . . . . 0.40999999999999998 112.025 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 21.4 tt0 175.08 137.71 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.807 -0.633 . . . . 3.9700000000000002 110.225 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.2 t -141.83 95.68 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.288 . . . . 3.8100000000000001 111.234 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -146.45 -77.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 2.8900000000000001 111.438 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -92.43 -33.75 14.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 2.0 110.808 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 56.71 92.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.747 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -174.22 151.27 1.63 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.032 -0.531 . . . . 2.96 110.449 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 98' ' ' GLN . 18.2 m -86.36 179.07 6.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.357 -0.383 . . . . 1.55 111.941 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 97' ' ' SER . 84.1 mm-40 70.84 -68.55 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.421 -0.809 . . . . 2.3300000000000001 111.29 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -62.42 -17.61 59.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 2.5099999999999998 110.662 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 1.7 mptm? -110.43 52.23 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 3.1000000000000001 110.305 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.409 HG22 ' C ' ' A' ' 114' ' ' ASP . 0.8 OUTLIER -109.59 133.95 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.295 -0.632 . . . . 1.3100000000000001 109.295 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 164' ' ' ASN . 61.2 m-85 -138.89 170.91 15.14 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.552 0.945 . . . . 0.68999999999999995 113.552 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 157' ' ' PHE . 5.1 m-20 -112.89 136.95 51.96 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.555 -0.458 . . . . 2.0099999999999998 110.444 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.02 128.98 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 111.997 0.369 . . . . 0.46000000000000002 111.997 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 15.7 ptt180 -133.63 147.55 51.47 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.351 0.871 . . . . 1.8500000000000001 113.351 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m -122.18 120.59 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 114.761 -1.108 . . . . 1.1000000000000001 109.807 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.504 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.38 27.21 9.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.308 0.575 . . . . 1.77 109.49 -176.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.39 14.07 57.67 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.224 -0.898 . . . . 0.40999999999999998 112.938 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.0 m-70 -110.66 111.19 22.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.264 0.839 . . . . 0.46000000000000002 113.264 -178.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -69.25 112.6 5.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.004 0.43 . . . . 0.66000000000000003 110.418 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.67 -37.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 0.80000000000000004 110.848 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.33 91.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.134 -0.626 . . . . 0.51000000000000001 111.121 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 10.9 ptmm? -101.88 146.75 27.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.374 -0.83 . . . . 2.4399999999999999 109.706 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 5.4 m-20 77.24 33.27 0.43 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.865 -1.061 . . . . 2.5600000000000001 108.741 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 1.1000000000000001 112.126 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 44.7 p-10 -101.52 84.21 2.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.151 -0.685 . . . . 1.99 109.151 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.2 pt -51.25 -37.24 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.648 -0.706 . . . . 0.63 112.231 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -57.08 -44.69 83.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.543 -0.298 . . . . 0.90000000000000002 111.57 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.19 -28.18 63.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.83 0.308 . . . . 0.76000000000000001 111.83 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -72.25 -58.82 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.205 0.446 . . . . 2.6800000000000002 112.205 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.3 m -88.63 -40.41 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.846 0.313 . . . . 1.4099999999999999 111.846 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.73 -93.37 0.65 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.747 -0.739 . . . . 1.0600000000000001 111.94 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.472 ' O ' HG23 ' A' ' 125' ' ' THR . 61.0 m80 -115.08 110.4 19.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.517 0.198 . . . . 3.5099999999999998 110.952 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.7 p 54.42 -144.84 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.269 -0.423 . . . . 1.6799999999999999 111.21 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.5 p 68.45 -172.67 0.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.987 0.515 . . . . 0.80000000000000004 111.743 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.45 141.67 37.38 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.769 0.655 . . . . 0.44 112.769 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 15.7 t60 -101.88 157.4 16.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.606 -0.724 . . . . 0.38 109.103 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -143.0 113.51 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.464 0.542 . . . . 2.0899999999999999 112.464 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -108.12 116.88 32.77 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.678 -0.692 . . . . 2.2799999999999998 110.078 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.7 mt -109.66 130.0 63.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.72 -0.673 . . . . 0.70999999999999996 110.109 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.71 89.53 25.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.34 0.496 . . . . 1.3799999999999999 112.34 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -61.53 149.65 88.76 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.943 1.762 . . . . 0.22 111.926 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 26.1 mt -140.06 156.71 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.20999999999999999 111.101 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 133' ' ' ILE . 39.9 t -130.6 107.24 9.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 1.1100000000000001 110.82 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.2 mt -107.6 129.03 62.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.811 -0.631 . . . . 0.23000000000000001 110.393 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -147.62 139.35 24.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 1.9099999999999999 110.771 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp 54.57 28.39 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 3.1099999999999999 110.646 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 28.37 58.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.32000000000000001 112.544 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.548 ' HB2' ' NZ ' ' A' ' 139' ' ' LYS . 4.4 ttmp? -121.89 146.04 47.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.386 -0.228 . . . . 2.1899999999999999 110.386 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -114.17 130.71 56.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.107 0.48 . . . . 0.37 112.077 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.57 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.2 t -127.07 110.01 12.48 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.617 -0.72 . . . . 0.90000000000000002 109.73 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 144' ' ' GLY . 3.2 p -102.94 131.34 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.53000000000000003 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 46.96 -90.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.821 0.304 . . . . 2.0499999999999998 111.821 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -136.66 25.87 3.07 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.694 -0.765 . . . . 0.59999999999999998 113.346 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -124.03 142.68 50.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.69 -0.485 . . . . 2.02 109.69 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.49 145.97 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 1.3 111.404 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.2 t -163.3 167.85 21.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.381 -0.6 . . . . 1.1200000000000001 109.381 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.6 139.58 35.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.561 -0.456 . . . . 1.1100000000000001 111.482 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.24 123.95 27.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.535 -1.283 . . . . 0.28000000000000003 107.535 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.1 m -129.24 94.23 3.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.418 -0.913 . . . . 1.55 112.874 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.32 -48.79 1.84 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 116.778 1.471 . . . . 0.46000000000000002 116.778 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -159.44 154.56 25.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.997 1.398 . . . . 1.8 113.817 -176.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -86.58 131.77 34.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.352 -0.981 . . . . 1.24 108.352 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.443 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.5 t -118.14 114.77 23.56 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.807 -0.757 . . . . 1.28 112.53 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.55 111.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.743 -0.383 . . . . 0.58999999999999997 111.35 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' CD ' ' HA3' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -140.22 160.57 39.66 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.162 0.506 . . . . 2.48 111.302 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -132.96 140.45 47.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.459 -0.791 . . . . 1.54 109.789 177.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.44 144.63 13.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.353 -0.839 . . . . 0.77000000000000002 111.989 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.579 ' NZ ' ' HB2' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -57.62 136.01 56.76 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.116 -0.947 . . . . 1.97 111.435 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.85 -32.16 2.52 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.869 -0.605 . . . . 1.1200000000000001 111.644 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -143.0 -65.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.696 0.284 . . . . 3.8100000000000001 110.26 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -176.86 152.2 0.93 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.128 -0.487 . . . . 3.8199999999999998 110.975 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 64.08 40.97 6.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.942 -0.572 . . . . 1.3999999999999999 112.406 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.709 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -60.4 -39.26 66.18 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-O 118.804 -0.617 . . . . 2.0 110.01 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 95.5 Cg_exo -23.51 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.415 2.744 . . . . 2.5800000000000001 111.786 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 10.3 ptmm? 32.35 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.603 -1.181 . . . . 3.71 113.06 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 64' ' ' GLU . 46.0 t -96.16 133.62 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 121.045 -0.262 . . . . 0.92000000000000004 111.295 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.905 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -131.48 126.83 36.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.204 -0.598 . . . . 1.2 111.689 -179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.459 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -122.37 37.03 4.49 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.957 1.095 . . . . 0.22 113.957 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -35.45 134.37 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.001 0.429 . . . . 1.02 111.889 179.423 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.51 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -155.16 101.76 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.33000000000000002 109.831 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.501 HD13 ' N ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -110.05 123.8 66.25 Favored 'Isoleucine or valine' 0 C--O 1.259 1.572 0 CA-C-O 123.037 1.398 . . . . 0.68999999999999995 112.93 179.33 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.501 ' N ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -114.19 160.55 18.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.256 -1.793 . . . . 1.26 108.768 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.415 ' HG2' ' N ' ' A' ' 175' ' ' GLY . 4.0 tmtt? -119.93 141.07 49.96 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.43 1.27 . . . . 1.8200000000000001 114.43 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 174' ' ' LYS . . . 104.97 -33.92 6.19 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 112.695 -2.048 . . . . 0.22 117.639 175.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.29 156.33 0.41 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.2 2.0 . . . . 0.28999999999999998 114.601 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.26 -26.22 25.11 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 114.994 -1.003 . . . . 0.56999999999999995 110.277 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.77 -9.98 11.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.913 -0.585 . . . . 2.3100000000000001 111.594 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.47 -65.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.535 -0.302 . . . . 2.3700000000000001 111.012 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 180' ' ' VAL . 3.2 p -42.19 100.85 0.23 Allowed Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.383 0.427 . . . . 2.5699999999999998 111.318 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.88 114.92 1.57 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.815 1.676 . . . . 2.0800000000000001 112.575 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 41.9 tpp -131.25 146.28 52.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.952 -0.567 . . . . 6.04 110.541 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 183' ' ' LEU . 3.4 mm? -98.09 121.93 40.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 5.2999999999999998 110.69 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -55.05 147.82 32.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 8.0500000000000007 110.172 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.87 126.92 17.49 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.59 1.526 . . . . 9.1400000000000006 112.207 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -134.05 133.27 21.85 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.113 -0.494 . . . . 9.8699999999999992 110.098 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.5 -37.72 3.98 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.028 1.819 . . . . 11.69 112.48 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.48 -171.98 42.74 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.913 -0.66 . . . . 12.619999999999999 112.392 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.5 mt -111.81 120.03 40.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 14.44 110.826 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.227 -0.892 . . . . 15.699999999999999 110.998 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.395 -0.282 . . . . 9.1500000000000004 112.395 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.79 28.79 14.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.316 . . . . 7.3600000000000003 111.077 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 ttt -83.1 103.47 12.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.273 -0.421 . . . . 7.7599999999999998 110.706 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.2 p -126.92 159.32 34.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 4.0199999999999996 110.612 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.6 56.72 0.13 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.717 -0.754 . . . . 1.28 112.472 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 tp -57.8 -43.85 85.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.228 0.537 . . . . 0.40999999999999998 110.333 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.62 -21.53 10.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.233 -0.894 . . . . 0.33000000000000002 111.371 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.5 -23.4 46.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.012 0.375 . . . . 2.0899999999999999 112.012 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -97.12 -23.09 16.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.761 -0.376 . . . . 1.99 111.375 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.0 p -44.86 145.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 120.623 0.249 . . . . 0.20999999999999999 111.613 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.98 -32.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.123 -0.631 . . . . 0.85999999999999999 110.848 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.492 ' O ' HG22 ' A' ' 172' ' ' ILE . 71.2 t90 -166.23 124.06 1.44 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.842 -0.343 . . . . 0.28000000000000003 110.304 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.15 141.97 28.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.489 -0.323 . . . . 0.20000000000000001 111.785 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 170' ' ' LEU . 2.5 t -147.56 130.89 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 113.442 0.904 . . . . 0.67000000000000004 113.442 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -110.14 89.44 3.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 107.865 -1.161 . . . . 1.27 107.865 175.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.674 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -58.33 99.07 0.04 OUTLIER 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.008 -0.996 . . . . 0.37 109.605 -177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.72 -88.99 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.736 -1.12 . . . . 0.67000000000000004 114.355 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -78.56 -117.7 0.22 Allowed Glycine 0 CA--C 1.512 -0.127 0 C-N-CA 121.085 -0.579 . . . . 1.1200000000000001 113.419 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -145.04 148.52 33.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.635 -0.135 . . . . 2.02 110.635 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 64.6 m -12.36 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.171 0.804 . . . . 1.22 113.171 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.2 t-80 -139.09 150.42 45.7 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.095 0.474 . . . . 0.34000000000000002 111.915 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.57 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 1.1799999999999999 111.298 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 154.75 41.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.1699999999999999 110.472 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 25' ' ' HIS . 12.0 m -44.35 -51.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 124.081 0.863 . . . . 0.59999999999999998 113.147 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.408 ' N ' HG23 ' A' ' 24' ' ' VAL . 80.3 m-70 -58.16 -18.52 26.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.268 0.556 . . . . 0.46000000000000002 110.354 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 34.96 4.02 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.333 -0.849 . . . . 0.28999999999999998 112.232 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -103.64 121.34 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 0.42999999999999999 110.084 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.7 t60 -101.08 135.82 41.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 114.271 1.211 . . . . 0.52000000000000002 114.271 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.86 136.78 42.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.975 -1.12 . . . . 3.0 107.975 176.561 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.435 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 48.8 mtt180 -91.42 108.06 19.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.178 0.513 . . . . 2.8999999999999999 112.247 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' NZ ' ' HA2' ' A' ' 39' ' ' GLY . 63.5 tttm -25.1 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.724 -1.126 . . . . 2.71 113.818 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.603 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 6.0 m-20 -7.31 80.27 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.875 1.27 . . . . 1.98 113.886 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 17.3 Cg_endo -101.22 12.71 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.623 2.215 . . . . 1.53 113.826 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 35' ' ' GLU . 7.9 tt -113.4 -62.91 1.52 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.895 0.331 . . . . 1.8300000000000001 111.895 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.595 ' H ' ' NH2' ' A' ' 65' ' ' ARG . 12.6 mm-40 -56.97 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.926 0.393 . . . . 4.9500000000000002 110.246 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.74 -2.28 41.39 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.685 -0.966 . . . . 1.9399999999999999 110.685 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 49.17 38.42 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.973 -0.613 . . . . 5.3600000000000003 110.942 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 m -143.36 177.48 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.559 -0.746 . . . . 2.9700000000000002 110.335 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.533 ' HA2' ' NZ ' ' A' ' 31' ' ' LYS . . . -52.6 92.94 0.01 OUTLIER Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.947 -0.645 . . . . 1.99 113.229 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.542 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 5.9 mmp_? -151.13 75.34 1.19 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.825 0.345 . . . . 6.5899999999999999 110.552 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.15 -54.49 4.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 2.0099999999999998 111.327 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.6 t 55.04 63.54 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 2.02 110.251 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.31 50.88 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.664 -0.698 . . . . 2.23 110.689 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -71.34 -54.19 11.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.014 -0.539 . . . . 2.3300000000000001 111.003 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.99 36.43 2.71 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.709 -0.757 . . . . 2.2000000000000002 112.35 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.2 ttt -67.87 -17.8 64.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 1.9299999999999999 111.017 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.573 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -71.22 -167.76 0.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.016 -0.538 . . . . 3.3500000000000001 110.598 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.528 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 62.7 mt 50.04 57.28 17.85 Favored Pre-proline 0 C--N 1.333 -0.144 0 N-CA-C 110.227 -0.286 . . . . 2.7599999999999998 110.227 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 84.2 Cg_exo -54.44 138.77 74.37 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.984 2.456 . . . . 1.46 113.227 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.467 HG21 ' HB2' ' A' ' 126' ' ' ALA . 2.8 mt -57.99 145.0 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 0.82999999999999996 108.316 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.1 -22.79 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.17 1.174 . . . . 1.6899999999999999 114.17 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -103.77 36.57 2.28 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.226 -0.59 . . . . 2.5600000000000001 111.827 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.5 t -142.49 146.43 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.017 0.437 . . . . 0.96999999999999997 111.607 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.6 t30 -62.54 145.27 95.13 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 115.786 -0.643 . . . . 1.96 109.436 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.584 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 15.7 Cg_exo -39.95 -54.98 1.88 Allowed 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.687 2.258 . . . . 0.66000000000000003 114.984 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.9 mm-40 -64.95 -53.9 39.06 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.264 1.03 . . . . 1.8200000000000001 110.64 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -2.57 23.53 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.143 -0.935 . . . . 1.9099999999999999 110.549 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 32.9 tt0 -75.69 -56.75 4.38 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.509 -0.923 . . . . 1.5 108.509 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.835 ' O ' HG23 ' A' ' 63' ' ' THR . 7.2 p -52.84 -44.62 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.528 -0.916 . . . . 1.22 108.528 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.48 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 10.0 tp -58.4 -67.18 0.38 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 119.738 -0.785 . . . . 1.05 109.989 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.71 -8.55 0.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.611 -0.722 . . . . 0.90000000000000002 111.757 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 49' ' ' PRO . 24.6 tt0 -115.74 -116.81 0.32 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 111.934 0.346 . . . . 1.8 111.934 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 59' ' ' VAL . 71.6 p 51.24 -173.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.125 0.17 . . . . 1.05 110.925 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 63' ' ' THR . 0.8 OUTLIER 175.22 154.11 0.15 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.512 0.196 . . . . 2.0499999999999998 110.567 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.603 ' NH2' ' HB3' ' A' ' 32' ' ' ASP . 3.1 ptm180 -143.36 176.81 8.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.808 0.337 . . . . 3.5800000000000001 111.162 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.93 155.01 2.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.009 -0.541 . . . . 4.25 111.927 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -133.16 158.1 43.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.703 -0.68 . . . . 4.3499999999999996 110.827 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.43 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 10.7 tp10 -133.48 -93.86 0.33 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.353 -0.385 . . . . 3.1699999999999999 110.971 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 2.9 p30 -172.76 125.37 0.47 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.603 0.239 . . . . 2.3900000000000001 110.796 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 t 49.8 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.98999999999999999 111.076 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -161.01 161.38 31.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.492 -0.483 . . . . 1.26 111.936 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.27 -160.52 20.0 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.527 -0.844 . . . . 0.66000000000000003 114.251 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.674 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -122.2 163.07 20.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.813 0.816 . . . . 0.82999999999999996 112.93 -177.528 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.531 ' CG ' ' HG3' ' A' ' 152' ' ' LYS . 3.5 t70 -113.54 105.5 13.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.91 -1.495 . . . . 2.27 110.331 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.562 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -96.1 106.5 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.58 -0.282 . . . . 0.34000000000000002 110.535 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.75 121.81 3.78 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 121.216 1.277 . . . . 0.80000000000000004 113.121 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.532 HG22 ' H ' ' A' ' 79' ' ' GLU . 3.7 mt -135.98 151.76 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.458 0.647 . . . . 0.38 111.327 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -144.79 37.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.5 -1.296 . . . . 2.96 107.5 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 77' ' ' ILE . 15.0 mm-40 -134.63 142.43 46.88 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.78 -1.1 . . . . 2.1299999999999999 110.374 -177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.27 149.64 29.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.464 0.65 . . . . 0.37 111.625 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.41 -154.58 25.61 Favored Glycine 0 CA--C 1.512 -0.129 0 N-CA-C 110.058 -1.217 . . . . 0.20999999999999999 110.058 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 20.2 mt-10 -102.39 109.66 21.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 118.979 1.39 . . . . 2.0299999999999998 109.667 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.456 ' OH ' ' HB2' ' A' ' 79' ' ' GLU . 44.4 m-85 -95.99 126.59 41.34 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.211 -1.033 . . . . 0.26000000000000001 108.211 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.65 HG21 ' N ' ' A' ' 177' ' ' ALA . 41.9 t -112.14 113.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.612 0.72 . . . . 0.54000000000000004 111.728 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 tt -98.57 104.35 16.38 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.481 -1.236 . . . . 1.23 110.194 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.95 137.27 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.253 -1.017 . . . . 1.3100000000000001 108.253 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -149.25 139.26 22.07 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.45 -0.9 . . . . 1.3700000000000001 112.77 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 14.5 tptt -94.26 123.36 37.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.57 -1.195 . . . . 2.9700000000000002 109.708 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.5 143.03 35.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 0.29999999999999999 110.072 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.425 ' HB3' HG11 ' A' ' 167' ' ' VAL . . . -141.26 153.22 45.11 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.444 -0.344 . . . . 0.40999999999999998 110.364 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.82 141.24 29.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 3.9700000000000002 111.012 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.95 173.78 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 3.8100000000000001 110.844 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 63.0 9.81 4.02 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.046 -0.525 . . . . 2.8900000000000001 111.106 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -149.53 115.22 5.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 2.0 110.176 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.11 93.69 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 1.0 111.526 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -169.91 149.87 3.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 2.96 110.898 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 p -109.15 156.77 19.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.152 -0.476 . . . . 1.55 111.506 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 48.47 34.9 5.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.871 -0.604 . . . . 2.3300000000000001 111.574 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.3 -46.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 2.5099999999999998 109.577 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.559 ' NZ ' ' HB3' ' A' ' 100' ' ' LYS . 1.2 mmmp? -101.23 85.89 2.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.787 . . . . 3.1000000000000001 109.508 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.31 144.16 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.084 -0.507 . . . . 1.3100000000000001 110.306 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -126.63 -175.04 3.28 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 116.278 -0.419 . . . . 0.68999999999999995 112.08 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.42 144.75 40.32 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 2.0099999999999998 110.861 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -134.19 138.14 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.939 -0.573 . . . . 0.46000000000000002 112.542 -177.32 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.423 HH21 HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -142.85 148.99 37.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.611 0.967 . . . . 1.8500000000000001 113.611 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 22.2 m -113.01 121.66 65.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 CA-C-N 114.629 -1.169 . . . . 1.1000000000000001 109.827 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.611 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 9.5 t30 51.58 26.95 3.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.245 -0.889 . . . . 1.77 110.124 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.15 21.97 21.28 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.545 -1.207 . . . . 0.40999999999999998 113.137 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 80.8 m-70 -122.86 109.38 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.175 0.806 . . . . 0.46000000000000002 113.175 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 21.8 p -60.34 120.52 10.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.054 0.454 . . . . 0.66000000000000003 111.341 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 109' ' ' HIS . 11.5 t -113.73 -29.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.647 -0.706 . . . . 0.80000000000000004 109.94 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.455 HG11 ' OE1' ' A' ' 129' ' ' GLU . 2.2 t -137.29 91.98 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 116.109 -0.496 . . . . 0.51000000000000001 110.186 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 6.7 ptpp? -99.66 134.24 42.83 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.77 0.795 . . . . 2.4399999999999999 110.461 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 13.9 m-20 90.42 32.3 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.109 -1.859 . . . . 2.5600000000000001 109.52 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.554 HD21 ' OE2' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -54.7 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.922 -0.581 . . . . 1.1000000000000001 111.43 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -98.67 81.96 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 1.99 107.992 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.0 mt -50.94 -48.62 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.97 -1.013 . . . . 0.63 112.5 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.14 -54.01 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.31 . . . . 0.90000000000000002 111.327 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.35 -27.31 55.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.601 -0.272 . . . . 0.76000000000000001 111.705 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -72.46 -59.23 2.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.601 0.593 . . . . 2.6800000000000002 112.601 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 -41.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.541 0.571 . . . . 1.4099999999999999 112.541 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.34 -141.26 16.69 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.535 -0.84 . . . . 1.0600000000000001 113.174 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 125' ' ' THR . 58.7 m-70 -53.48 110.31 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.677 0.275 . . . . 3.5099999999999998 111.01 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.2 m 44.8 -97.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 1.6799999999999999 111.126 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 p 48.8 -178.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.039 0.447 . . . . 0.80000000000000004 111.466 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.02 130.41 53.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.406 -0.361 . . . . 0.44 111.957 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -110.49 142.48 42.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.792 -0.818 . . . . 0.38 108.792 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -135.31 131.51 36.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.055 0.761 . . . . 2.0899999999999999 113.055 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.554 ' OE2' HD21 ' A' ' 115' ' ' LEU . 22.8 mt-10 -132.15 121.13 23.25 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.315 -0.857 . . . . 2.2799999999999998 109.884 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.73 136.41 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.036 -0.529 . . . . 0.70999999999999996 111.066 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -135.85 86.58 26.86 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.888 0.699 . . . . 1.3799999999999999 112.888 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -64.03 138.57 62.96 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.706 1.604 . . . . 0.22 111.527 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -128.62 153.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.627 -0.261 . . . . 0.20999999999999999 110.572 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 67.1 p -132.52 108.39 9.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.379 . . . . 1.1100000000000001 111.707 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.0 mt -105.31 126.63 60.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.944 -0.571 . . . . 0.23000000000000001 110.032 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -148.09 144.52 27.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.394 -0.367 . . . . 1.9099999999999999 110.578 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.49 20.72 7.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 3.1099999999999999 110.218 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.8 28.45 50.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.862 -0.685 . . . . 0.32000000000000001 112.564 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 22.7 ttpt -131.17 142.41 50.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 2.1899999999999999 111.083 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 141' ' ' SER . 5.6 tt -96.06 133.43 40.32 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.847 -0.615 . . . . 0.37 112.39 -177.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.604 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -118.1 117.19 28.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.858 . . . . 0.90000000000000002 109.419 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.3 98.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.967 -0.56 . . . . 0.53000000000000003 111.478 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.3 -97.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.859 -0.61 . . . . 2.0499999999999998 112.224 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -115.92 21.51 12.27 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.538 -0.839 . . . . 0.59999999999999998 113.485 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -137.76 145.95 43.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.934 -0.395 . . . . 2.02 109.934 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.31 148.65 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.838 0.352 . . . . 1.3 111.663 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.6 m -162.25 135.87 6.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.002 -0.544 . . . . 1.1200000000000001 110.609 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 50.2 p -54.03 136.4 41.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.087 -0.506 . . . . 1.1100000000000001 111.53 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.17 123.47 27.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 0.28000000000000003 109.708 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 152' ' ' LYS . 2.1 t -110.08 90.21 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.922 -0.711 . . . . 1.55 111.98 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 44.36 -5.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 117.201 1.64 . . . . 0.46000000000000002 117.201 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.592 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -162.11 152.28 16.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.776 1.788 . . . . 1.8 113.756 -178.049 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.456 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -98.38 124.51 43.09 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.453 -1.314 . . . . 1.24 107.453 176.233 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -107.96 102.5 11.67 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.918 0.71 . . . . 1.28 112.918 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 56.2 t -100.36 117.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.418 -0.513 . . . . 0.58999999999999997 110.605 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.78 42.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.348 -0.541 . . . . 2.48 111.521 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.06 148.99 51.06 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.273 -0.876 . . . . 1.54 110.543 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.423 HG21 HH21 ' A' ' 105' ' ' ARG . 80.6 t -118.91 142.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.056 -0.975 . . . . 0.77000000000000002 110.585 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -81.48 146.55 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.726 -0.67 . . . . 1.97 111.483 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.24 -18.9 15.6 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.695 -0.684 . . . . 1.1200000000000001 111.509 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -147.19 -75.62 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.585 0.231 . . . . 3.8100000000000001 110.754 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -152.2 153.58 34.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.829 0.347 . . . . 3.8199999999999998 111.514 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 56.15 86.77 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.956 -0.566 . . . . 1.3999999999999999 111.958 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.7 169.96 0.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.118 -0.468 . . . . 2.0 109.913 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -40.35 104.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.573 1.516 . . . . 2.5800000000000001 111.515 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -55.23 -56.75 16.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.052 -0.977 . . . . 3.71 112.645 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 63' ' ' THR . 21.3 t -106.38 133.89 49.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 112.534 0.568 . . . . 0.92000000000000004 112.534 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 3.7 t -135.56 131.79 36.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.847 0.684 . . . . 1.2 112.847 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.519 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -119.23 38.69 3.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.793 -1.094 . . . . 0.22 112.514 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 8.4 tp -48.43 127.29 12.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.374 0.669 . . . . 1.02 111.786 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 171' ' ' PHE . 0.3 OUTLIER -143.48 111.14 5.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.381 -0.827 . . . . 0.33000000000000002 110.528 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -111.5 123.95 67.81 Favored 'Isoleucine or valine' 0 C--O 1.258 1.552 0 CA-C-O 122.758 1.266 . . . . 0.68999999999999995 112.175 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.72 166.87 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.75 -1.568 . . . . 1.26 109.807 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.46 ' NZ ' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -117.56 137.37 52.63 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.295 1.591 . . . . 1.8200000000000001 115.295 -176.258 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 99.19 -35.4 4.71 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 118.791 2.276 . . . . 0.22 118.791 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.51 160.58 0.61 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.237 2.019 . . . . 0.28999999999999998 113.969 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.65 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.68 -23.51 27.4 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.11 -0.95 . . . . 0.56999999999999995 110.544 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -65.81 -5.32 8.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 2.3100000000000001 111.645 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -81.21 -63.7 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.64 -0.255 . . . . 2.3700000000000001 111.121 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 180' ' ' VAL . 2.7 p -42.0 101.06 0.23 Allowed Pre-proline 0 CA--C 1.54 0.594 0 O-C-N 123.454 0.471 . . . . 2.5699999999999998 111.627 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.86 137.11 35.64 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.05 1.834 . . . . 2.0800000000000001 112.652 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.6 ttt -140.23 112.91 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 6.04 110.333 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.66 144.26 8.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 5.2999999999999998 111.295 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -119.38 150.03 48.76 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.784 -0.644 . . . . 8.0500000000000007 110.015 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -44.26 124.43 5.05 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 121.635 1.557 . . . . 9.1400000000000006 112.418 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.699 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 79.3 t60 -130.91 137.78 31.53 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 116.218 -0.446 . . . . 9.8699999999999992 110.613 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.699 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 68.6 Cg_endo -76.19 -38.08 1.25 Allowed 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.227 1.951 . . . . 11.69 112.56 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 52.26 84.4 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.996 -0.547 . . . . 12.619999999999999 112.758 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 69.7 mt -65.55 117.08 7.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.371 . . . . 14.44 110.71 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.348 -0.834 . . . . 15.699999999999999 110.713 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.359 0.6 . . . . 0.41 110.188 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.584 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.24 -20.25 17.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.241 -0.891 . . . . 0.33 110.972 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -74.07 -17.08 61.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 2.09 111.914 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 33.9 mttm -111.58 -21.49 11.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.488 -0.485 . . . . 1.99 111.835 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 7' ' ' ALA . 11.1 p -43.83 147.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.889 -0.324 . . . . 0.21 111.46 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.4 pt -139.92 -22.96 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 119.782 -0.767 . . . . 0.86 111.623 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.609 ' O ' HG22 ' A' ' 172' ' ' ILE . 26.2 t90 -173.0 134.24 0.56 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 0.28 110.24 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -152.29 144.36 23.82 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.443 -0.161 . . . . 0.2 111.211 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.97 126.73 4.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 N-CA-C 114.116 1.154 . . . . 0.67 114.116 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 5.8 t30 -115.13 98.82 7.0 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.274 -0.571 . . . . 1.27 110.566 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.88 109.3 3.35 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 109.3 -0.629 . . . . 0.37 109.3 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.6 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 150.0 -44.55 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 114.806 -1.088 . . . . 0.67 112.452 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.37 -140.16 11.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 1.12 112.134 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -162.7 119.36 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.552 0.215 . . . . 2.02 110.801 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 62.6 p 33.19 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.607 -0.724 . . . . 1.22 112.235 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 10.0 t60 -128.31 150.8 49.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.22 -0.592 . . . . 0.34 112.072 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.9 p -120.61 109.94 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.374 0.607 . . . . 1.18 111.89 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.26 155.58 39.42 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.435 -0.802 . . . . 1.17 109.933 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 25' ' ' HIS . 15.9 m -43.89 -52.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.545 0.942 . . . . 0.6 113.545 -177.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.446 ' N ' HG23 ' A' ' 24' ' ' VAL . 78.2 m-70 -56.89 -20.3 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.226 0.536 . . . . 0.46 110.579 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.85 34.83 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.357 -0.838 . . . . 0.29 112.287 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.2 mm -103.52 109.45 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.978 0.418 . . . . 0.43 110.191 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 23.4 t60 -96.87 135.55 38.69 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 115.128 1.529 . . . . 0.52 115.128 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.18 135.0 44.53 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 114.21 -1.359 . . . . 3.0 107.854 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.4 ptm180 -95.51 112.42 24.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 2.9 111.984 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.521 ' HB3' ' NZ ' ' A' ' 31' ' ' LYS . 2.8 ttpm? -16.3 140.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.603 1.335 . . . . 2.71 114.603 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.582 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 4.2 p-10 -18.71 90.02 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 CA-C-N 114.613 -1.176 . . . . 1.98 112.679 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.46 -0.466 0 C-N-CA 122.598 2.198 . . . . 1.53 113.798 -179.56 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.584 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.8 mt . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 108.699 -0.852 . . . . 0.83 108.699 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.21 -49.95 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.52 0.933 . . . . 1.69 113.52 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.82 36.42 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.564 0.579 . . . . 2.56 112.564 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -150.54 134.75 17.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.992 0.425 . . . . 0.97 111.666 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.533 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -63.62 148.41 94.19 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.076 -0.713 . . . . 1.96 109.076 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.533 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 5.1 Cg_exo -37.9 -42.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.047 2.498 . . . . 0.66 116.112 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' O ' HG12 ' A' ' 59' ' ' VAL . 9.9 mm-40 -75.82 -55.84 5.24 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.846 0.832 . . . . 1.82 110.811 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.4 p-10 -71.42 -0.45 10.33 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.229 -0.656 . . . . 1.91 109.229 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 33.1 tt0 -77.4 -61.02 2.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.02 -0.991 . . . . 1.5 108.972 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 56' ' ' GLU . 6.1 p -49.59 -39.13 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.1 -0.704 . . . . 1.22 109.1 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 62' ' ' GLN . 9.4 tp -66.65 -66.64 0.53 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.412 -0.515 . . . . 1.05 110.295 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -53.81 -7.03 0.1 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.154 -0.475 . . . . 0.9 111.101 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' A' ' 60' ' ' LEU . 4.8 tt0 -115.45 -130.65 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.93 -0.577 . . . . 1.8 110.667 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 59' ' ' VAL . 41.4 p 49.59 158.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.339 0.399 . . . . 1.05 111.378 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.6 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -141.71 143.68 33.67 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.953 1.094 . . . . 2.05 113.953 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.582 ' NE ' ' HB3' ' A' ' 32' ' ' ASP . 1.6 mtt85 -136.48 135.67 38.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.933 -1.031 . . . . 3.58 109.654 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -116.51 131.7 56.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 4.25 111.42 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.96 -75.35 0.63 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.013 -0.539 . . . . 4.35 110.573 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 179.5 -58.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.33 0.493 . . . . 3.17 112.33 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -175.98 145.08 0.63 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.575 -0.528 . . . . 2.39 109.575 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.507 ' H ' HD21 ' A' ' 164' ' ' ASN . 20.9 t 46.31 76.09 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.604 -0.517 . . . . 0.99 109.604 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.444 ' HD1' ' N ' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -82.99 146.21 28.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.575 -1.268 . . . . 1.26 107.575 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -138.11 129.46 4.6 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 118.415 -1.85 . . . . 0.66 115.204 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -108.73 146.59 33.28 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.948 -0.626 . . . . 0.83 110.813 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.27 129.7 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 2.27 111.319 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.494 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.0 mp -124.46 87.42 54.23 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.356 -0.384 . . . . 0.34 110.875 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.39 127.71 27.07 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.867 1.711 . . . . 0.8 111.868 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.43 151.76 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.947 0.404 . . . . 0.38 111.4 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -143.61 4.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 2.96 111.216 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -128.42 170.33 13.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.13 110.796 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.33 172.28 9.23 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.255 0.55 . . . . 0.37 111.815 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.95 -155.25 22.26 Favored Glycine 0 N--CA 1.454 -0.152 0 N-CA-C 109.848 -1.301 . . . . 0.21 109.848 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -98.2 108.61 21.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.009 1.404 . . . . 2.03 108.869 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.0 125.99 40.05 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.911 -0.774 . . . . 0.26 108.911 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.634 HG21 ' N ' ' A' ' 177' ' ' ALA . 14.2 t -113.27 116.29 52.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.828 -1.078 . . . . 0.54 111.535 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 tt -96.5 105.15 17.2 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.69 -1.141 . . . . 1.23 110.583 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 20.3 t -110.79 132.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.917 -1.038 . . . . 1.31 108.52 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -142.13 146.22 35.1 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.236 -0.986 . . . . 1.37 111.88 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 128' ' ' ASP . 3.3 tptp -105.58 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 2.97 110.356 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 10.0 m-85 -104.81 143.41 33.16 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.879 -1.156 . . . . 0.3 107.879 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.47 0.552 0 C-N-CA 119.543 -0.863 . . . . 0.41 112.946 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.684 0.278 . . . . 2.96 110.596 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.4 p -116.37 153.16 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.297 0.57 . . . . 1.55 112.169 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 49.11 25.17 1.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.065 -0.971 . . . . 2.33 112.497 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -119.09 -50.12 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.941 -0.392 . . . . 2.51 109.941 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 14.0 mptt -85.76 77.96 9.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.286 -0.635 . . . . 3.1 109.286 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.45 142.59 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 1.31 110.112 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -130.81 -179.38 5.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.127 0.788 . . . . 0.69 113.127 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -121.97 137.45 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.224 -0.443 . . . . 2.01 111.564 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 t -129.73 127.26 64.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 115.869 -0.605 . . . . 0.46 111.384 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 8.1 mtt180 -125.85 148.56 49.12 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.542 -0.753 . . . . 1.85 112.502 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.21 117.23 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 114.632 -1.167 . . . . 1.1 109.695 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.42 ' OD1' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER 54.51 26.48 7.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.634 -0.876 . . . . 1.77 108.634 -177.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.98 22.63 29.83 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.656 -1.157 . . . . 0.41 112.906 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 88.4 m-70 -121.55 111.49 17.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.558 0.947 . . . . 0.46 113.558 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 p -64.71 117.33 7.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.681 -0.408 . . . . 0.66 110.868 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 109' ' ' HIS . 3.8 t -112.98 -30.34 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.904 -0.589 . . . . 0.8 109.819 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.7 90.18 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.417 -0.586 . . . . 0.51 109.417 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 6.3 ptmm? -105.29 79.16 1.45 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.617 1.199 . . . . 2.44 111.777 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.2 p30 156.49 35.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.032 -2.349 . . . . 2.56 109.129 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.36 93.28 0.07 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.387 0.613 . . . . 1.1 112.149 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 11.7 t70 -109.83 85.99 2.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.791 -1.559 . . . . 1.99 106.791 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.9 mt -50.03 -40.98 17.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.138 -0.937 . . . . 0.63 112.405 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.73 -65.47 0.69 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.99 -0.284 . . . . 0.9 111.385 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -52.05 -27.18 12.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.12 0.415 . . . . 0.76 112.12 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.64 -60.48 2.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.347 0.499 . . . . 2.68 112.347 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 m -104.19 -40.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.405 0.52 . . . . 1.41 112.405 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.7 -106.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.873 -0.891 . . . . 1.06 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' SER . 37.9 m80 -64.31 170.19 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.651 -0.87 . . . . 3.51 108.651 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' HIS . 75.0 m -35.26 -80.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.05 0.219 . . . . 1.68 110.9 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.499 ' O ' HG12 ' A' ' 50' ' ' ILE . 30.0 p 44.02 -164.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.808 0.337 . . . . 0.8 111.328 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.15 138.86 49.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.5 -0.318 . . . . 0.44 110.804 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.502 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.1 t60 -111.78 147.5 35.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.38 108.797 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.541 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 15.2 t70 -143.84 135.19 25.85 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.139 0.792 . . . . 2.09 113.139 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -121.53 128.68 52.29 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.373 -0.83 . . . . 2.28 109.127 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mt -111.0 120.41 61.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.668 -0.696 . . . . 0.71 110.222 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.39 88.89 49.13 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.801 0.667 . . . . 1.38 112.801 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.2 145.9 93.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.927 1.751 . . . . 0.22 111.854 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.6 mt -137.16 157.16 34.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.367 -0.379 . . . . 0.21 110.604 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 34.6 p -133.31 110.21 9.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.126 0.489 . . . . 1.11 111.244 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 139' ' ' LYS . 19.6 mt -110.66 126.02 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.583 -0.735 . . . . 0.23 109.851 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -146.08 140.14 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 1.91 110.767 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 1.2 mppt? 60.91 14.57 5.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 3.11 111.116 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.69 12.35 58.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.658 -0.782 . . . . 0.32 113.202 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.604 ' O ' HG23 ' A' ' 135' ' ' ILE . 60.0 mttp -112.81 162.0 16.28 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 117.131 0.466 . . . . 2.19 111.028 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -117.97 139.46 51.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.556 0.576 . . . . 0.37 112.556 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.661 ' N ' HD23 ' A' ' 140' ' ' LEU . 28.6 t -128.93 109.61 11.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.765 . . . . 0.9 109.678 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 142' ' ' VAL . 12.1 p -105.46 114.7 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.165 0.507 . . . . 0.53 110.855 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 2.05 112.115 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.49 22.03 3.38 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.619 -0.8 . . . . 0.6 113.047 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -126.91 138.44 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.93 -0.396 . . . . 2.02 109.93 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.26 139.24 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.37 0.605 . . . . 1.3 111.732 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 23.1 t -163.71 126.74 2.6 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.165 -0.925 . . . . 1.12 108.945 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.9 t -61.23 147.63 43.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.547 . . . . 1.11 112.263 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -78.78 142.94 36.55 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.389 -0.823 . . . . 0.28 109.773 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.9 p -139.25 95.81 3.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.112 0.782 . . . . 1.55 113.112 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.23 -59.75 2.75 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.729 1.051 . . . . 0.46 115.729 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -153.34 169.12 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.914 0.857 . . . . 1.8 112.726 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.42 HD12 ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -89.79 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.965 -1.495 . . . . 1.24 106.965 176.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 5.0 t -125.52 113.43 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 118.657 -1.217 . . . . 1.28 113.177 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.5 OUTLIER -98.31 98.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.955 -0.566 . . . . 0.59 109.644 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.1 mt-10 -110.69 126.55 54.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.664 -0.698 . . . . 2.48 111.448 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -117.17 127.09 53.77 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 119.643 -0.823 . . . . 1.54 110.264 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.522 HG21 HH21 ' A' ' 105' ' ' ARG . 10.8 t -97.2 143.99 11.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 114.185 -1.37 . . . . 0.77 112.529 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -54.43 148.37 12.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 113.911 -1.495 . . . . 1.97 111.574 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.8 -53.09 0.17 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.636 -0.711 . . . . 1.12 111.843 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -148.64 61.04 1.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 3.81 110.972 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 64.96 154.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.052 -0.522 . . . . 3.82 111.876 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.37 77.83 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.651 -0.704 . . . . 1.4 111.53 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.507 HD21 ' H ' ' A' ' 70' ' ' SER . 3.9 m-20 -50.82 155.52 1.96 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.815 -0.63 . . . . 2.0 109.974 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 164' ' ' ASN . 0.9 OUTLIER -29.86 103.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.467 2.111 . . . . 2.58 112.346 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -53.0 -73.1 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.761 -1.108 . . . . 3.71 112.649 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 89.8 t -93.25 133.51 34.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.184 0.438 . . . . 0.92 112.184 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.9 130.52 45.27 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 123.928 0.768 . . . . 1.2 110.803 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.513 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -123.24 36.47 4.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.415 0.894 . . . . 0.22 113.415 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.52 129.86 0.28 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.871 0.367 . . . . 1.02 111.834 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -149.27 104.73 3.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.208 -0.451 . . . . 0.33 110.053 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -113.49 126.35 70.92 Favored 'Isoleucine or valine' 0 C--O 1.261 1.708 0 CA-C-O 122.768 1.27 . . . . 0.69 112.799 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 ptm -119.99 165.26 14.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.814 -1.539 . . . . 1.26 109.732 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 9.6 ptmt -120.68 145.71 47.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.786 1.402 . . . . 1.82 114.786 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.58 -36.05 4.56 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 112.38 -2.191 . . . . 0.22 117.767 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.457 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.21 158.73 0.48 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.301 2.05 . . . . 0.29 114.277 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.634 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.43 -24.81 25.54 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 114.893 -1.048 . . . . 0.57 110.564 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 115.828 -0.624 . . . . 2.31 111.551 -178.738 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 tp . . . . . 0 C--O 1.232 0.182 0 CA-C-O 121.126 0.489 . . . . 0.41 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.547 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -60.24 -21.06 61.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.564 -0.744 . . . . 0.33 111.178 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.93 -5.68 47.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 2.09 111.579 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 19.5 mttm -123.63 -22.07 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.505 -0.478 . . . . 1.99 111.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 7' ' ' ALA . 14.5 p -43.44 147.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 121.158 -0.217 . . . . 0.21 111.18 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 pt -134.82 -23.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 119.518 -0.873 . . . . 0.86 111.391 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.426 ' O ' HG22 ' A' ' 172' ' ' ILE . 40.7 t90 -173.26 136.26 0.61 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.272 -0.571 . . . . 0.28 110.769 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.09 145.43 22.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.771 0.286 . . . . 0.2 111.771 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.42 130.63 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 114.191 1.182 . . . . 0.67 114.191 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 5.2 t-20 -115.77 88.55 2.91 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.414 -0.514 . . . . 1.27 111.174 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.03 103.97 0.27 Allowed 'General case' 0 C--O 1.248 0.988 0 N-CA-C 108.709 -0.849 . . . . 0.37 108.709 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.562 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 162.17 -47.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.707 0 O-C-N 124.505 1.128 . . . . 0.67 113.227 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.54 -129.86 5.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 1.12 112.573 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.669 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 14.8 tt0 -163.72 119.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.73 0.3 . . . . 2.02 110.947 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 8.4 t 38.73 96.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 1.22 112.72 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 76.3 t60 -124.01 151.66 43.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 120.235 -0.586 . . . . 0.34 112.293 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.8 t -121.05 104.14 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.159 -0.928 . . . . 1.18 110.265 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.27 153.03 42.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 1.17 110.688 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 25' ' ' HIS . 16.1 m -43.85 -50.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.167 0.917 . . . . 0.6 113.065 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 24' ' ' VAL . 78.6 m-70 -56.42 -22.28 30.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.34 0.59 . . . . 0.46 109.928 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.33 35.35 3.38 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.032 -0.986 . . . . 0.29 111.852 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -103.12 122.29 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.602 -0.518 . . . . 0.43 109.602 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.3 t60 -104.77 134.57 47.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.538 1.31 . . . . 0.52 114.538 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -101.01 134.16 44.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.149 -0.932 . . . . 3.0 108.497 176.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -95.9 111.64 23.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.415 0.626 . . . . 2.9 112.256 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' ASP . 51.6 tttm -15.47 139.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.176 1.547 . . . . 2.71 115.176 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.495 ' OD1' ' HD2' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -15.54 89.22 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 114.138 -1.392 . . . . 1.98 112.471 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo . . . . . 0 CA--C 1.536 0.601 0 C-N-CA 122.477 2.118 . . . . 1.53 115.845 -178.824 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.955 0.407 . . . . 0.83 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 124' ' ' SER . 4.3 mm? -86.03 -44.08 12.6 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.717 1.006 . . . . 1.69 113.717 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -82.66 32.66 0.42 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.677 0.621 . . . . 2.56 112.677 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -146.36 141.89 27.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.334 0.494 . . . . 0.97 112.334 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' A' ' 57' ' ' ASP . 5.8 p-10 -66.21 150.07 97.24 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.728 -0.669 . . . . 1.96 109.5 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 9.4 Cg_exo -39.84 -48.84 3.62 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.716 2.277 . . . . 0.66 115.599 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -57.42 6.19 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.641 0.734 . . . . 1.82 112.236 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -70.07 -13.72 62.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.515 -0.55 . . . . 1.91 109.515 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.563 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 23.5 tt0 -62.94 -52.28 63.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.994 -1.113 . . . . 1.5 107.994 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -51.61 -51.62 25.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.125 -0.943 . . . . 1.22 109.187 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 4.2 tp -64.08 -15.87 60.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.809 . . . . 1.05 111.353 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.409 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 6.6 m-30 -117.13 19.96 13.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.258 -0.883 . . . . 0.9 111.268 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -142.96 -76.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.775 1.028 . . . . 1.8 113.775 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.472 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 1.2 p -28.75 144.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.502 0.927 . . . . 1.05 113.502 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.558 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -135.88 150.57 49.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.318 -0.856 . . . . 2.05 110.491 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.562 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 30.9 mtp180 -107.09 -177.3 3.32 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.162 -0.31 . . . . 3.58 110.162 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -54.52 166.26 0.47 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 4.25 110.848 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -133.14 137.54 46.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 4.35 111.008 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.446 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 40.1 tt0 -123.44 -91.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 3.17 110.442 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD2' ' HG2' ' A' ' 68' ' ' GLU . 3.3 p30 -174.04 125.5 0.35 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.611 0.243 . . . . 2.39 111.116 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t 50.06 100.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.117 -0.492 . . . . 0.99 111.629 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 1.6 p90 -151.53 148.95 28.64 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.191 0.519 . . . . 1.26 111.346 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.67 -171.06 17.81 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.479 -0.867 . . . . 0.66 114.651 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -126.91 153.64 45.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.907 -0.647 . . . . 0.83 111.624 -178.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 122.94 47.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.039 -0.982 . . . . 2.27 110.151 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.5 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.2 mp -114.45 87.25 13.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.153 0.427 . . . . 0.34 112.153 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -56.68 134.44 64.43 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.802 1.668 . . . . 0.8 112.359 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 78' ' ' LYS . 26.8 mt -124.82 155.56 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.994 0.426 . . . . 0.38 111.115 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 77' ' ' ILE . 95.2 mttt -146.8 3.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.866 -0.606 . . . . 2.96 110.839 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -130.9 173.08 11.32 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 120.707 0.289 . . . . 2.13 111.078 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -129.35 168.7 15.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.237 0.541 . . . . 0.37 111.143 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.01 -151.32 22.06 Favored Glycine 0 CA--C 1.512 -0.113 0 N-CA-C 109.759 -1.337 . . . . 0.21 109.759 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -99.95 109.36 21.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.103 1.451 . . . . 2.03 108.863 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -95.75 126.21 40.86 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.507 0.67 . . . . 0.26 109.395 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.656 HG21 ' N ' ' A' ' 177' ' ' ALA . 26.3 t -111.35 117.56 55.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.726 -1.125 . . . . 0.54 111.741 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 tt -88.83 104.42 16.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.526 -1.216 . . . . 1.23 110.179 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 21.4 t -109.69 133.57 54.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.271 -0.877 . . . . 1.31 109.115 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.474 ' N ' HD23 ' A' ' 87' ' ' LEU . 1.2 pt? -156.24 135.26 11.98 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.357 -0.937 . . . . 1.37 111.88 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 17.3 tptt -95.64 120.61 36.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.875 . . . . 2.97 110.187 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.41 142.44 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.906 -0.775 . . . . 0.3 108.906 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.683 ' O ' HG13 ' A' ' 167' ' ' VAL . . . . . . . . 0 C--O 1.239 0.513 0 C-N-CA 120.57 -0.452 . . . . 0.41 110.459 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.931 0.396 . . . . 2.96 111.274 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.1 t -91.59 163.34 14.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.801 -0.636 . . . . 1.55 111.026 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 51.62 28.3 4.61 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.051 -0.522 . . . . 2.33 111.12 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -134.11 -42.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 2.51 109.853 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -108.76 82.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 3.1 109.485 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -109.5 150.22 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.704 -0.68 . . . . 1.31 110.202 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 114' ' ' ASP . 67.2 m-85 -133.38 -177.13 4.39 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 112.561 0.578 . . . . 0.69 112.561 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -132.58 137.75 47.19 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.829 -0.348 . . . . 2.01 111.005 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.8 t -131.37 129.76 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 112.758 0.651 . . . . 0.46 112.758 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.522 HH21 HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -139.14 149.42 44.46 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.95 0.722 . . . . 1.85 112.95 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.9 p -116.15 121.05 66.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 115.211 -0.904 . . . . 1.1 110.566 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.682 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 2.3 t30 52.8 26.89 4.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.239 -0.891 . . . . 1.77 110.419 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.95 16.2 39.52 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 114.451 -1.249 . . . . 0.41 113.128 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.2 m-70 -115.22 111.53 21.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.215 0.82 . . . . 0.46 113.215 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -67.1 123.08 19.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.054 0.454 . . . . 0.66 111.118 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -39.81 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.572 -0.74 . . . . 0.8 109.901 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.86 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.312 0.577 . . . . 0.51 109.933 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -98.94 154.71 17.85 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 2.44 110.025 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 102' ' ' PHE . 12.7 m-20 66.91 32.06 6.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.135 -1.393 . . . . 2.56 109.256 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 98.31 0.02 OUTLIER 'General case' 0 C--N 1.342 0.268 0 CA-C-O 120.96 0.41 . . . . 1.1 111.166 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 45.1 p-10 -100.72 79.28 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.298 -1.001 . . . . 1.99 108.298 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.91 -48.94 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.298 -0.865 . . . . 0.63 112.533 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.45 -39.99 77.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.711 0.263 . . . . 0.9 111.711 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.97 -27.7 62.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.97 0.359 . . . . 0.76 111.97 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 34.5 mmt180 -70.0 -59.09 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.082 0.401 . . . . 2.68 112.082 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.8 m -95.77 -40.47 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.228 0.455 . . . . 1.41 112.228 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.57 -104.0 2.43 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.63 -0.795 . . . . 1.06 112.22 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -63.95 164.78 9.82 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.347 -0.242 . . . . 3.51 110.347 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.456 ' O ' HD23 ' A' ' 51' ' ' LEU . 80.5 p -58.11 98.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.887 0.375 . . . . 1.68 110.738 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -144.69 -157.79 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.8 109.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.72 133.82 50.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.41 0.522 . . . . 0.44 112.41 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -109.0 147.73 31.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.922 -0.77 . . . . 0.38 108.922 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -140.39 124.86 17.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.546 0.573 . . . . 2.09 112.546 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -116.81 135.75 53.5 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.467 -0.788 . . . . 2.28 109.783 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 131' ' ' ILE . 38.5 mt -128.8 133.58 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.85 -0.614 . . . . 0.71 111.408 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.0 mp -135.17 92.36 18.18 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.457 -0.338 . . . . 1.38 111.883 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.03 140.1 76.93 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.388 1.392 . . . . 0.22 111.193 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 134' ' ' SER . 14.8 mt -132.56 158.9 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.462 -0.336 . . . . 0.21 110.992 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 133' ' ' ILE . 48.4 t -134.23 110.95 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.19 0.519 . . . . 1.11 111.119 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 139' ' ' LYS . 17.0 mt -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 115.406 -0.815 . . . . 0.23 110.009 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -150.37 142.38 23.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.69 0.281 . . . . 1.91 110.867 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm 61.19 19.0 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 3.11 110.75 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.12 71.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 0.32 113.206 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.605 ' O ' HG23 ' A' ' 135' ' ' ILE . 52.5 mtpt -111.16 164.77 12.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.891 0.345 . . . . 2.19 110.523 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.496 ' CD1' HD11 ' A' ' 153' ' ' LEU . 5.5 tt -124.16 143.47 50.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.689 0.625 . . . . 0.37 112.689 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.8 t -130.69 114.09 14.96 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.343 -0.844 . . . . 0.9 109.723 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 142' ' ' VAL . 2.4 p -108.93 96.87 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 115.99 -0.55 . . . . 0.53 110.738 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 61.74 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 2.05 111.752 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.36 6.65 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.464 -0.874 . . . . 0.6 113.4 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.97 129.45 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.762 -0.458 . . . . 2.02 109.762 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.2 p -105.27 141.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.31 0.576 . . . . 1.3 111.551 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.1 m -156.88 170.4 22.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.293 -0.867 . . . . 1.12 109.301 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.2 p -99.57 139.02 35.84 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.731 -0.388 . . . . 1.11 111.548 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -78.68 142.78 36.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.28 109.69 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 150' ' ' THR . 3.1 t -147.27 96.12 2.66 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.038 0.755 . . . . 1.55 113.038 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.8 -65.5 4.05 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 115.511 0.964 . . . . 0.46 115.511 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.56 -179.58 6.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 117.601 0.7 . . . . 1.8 112.455 -177.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.496 HD11 ' CD1' ' A' ' 140' ' ' LEU . 1.3 tp -102.37 133.54 47.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.339 -1.356 . . . . 1.24 107.339 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -111.31 101.07 9.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.555 0.946 . . . . 1.28 113.555 -175.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.63 98.32 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.58 -0.448 . . . . 0.59 109.905 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 155.29 42.42 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.986 -0.552 . . . . 2.48 111.629 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -130.91 146.9 52.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.431 -0.804 . . . . 1.54 110.84 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.522 HG21 HH21 ' A' ' 105' ' ' ARG . 19.8 t -117.49 143.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 114.627 -1.17 . . . . 0.77 110.705 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -86.6 147.59 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.902 -0.59 . . . . 1.97 110.993 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -88.66 -9.56 68.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 1.12 112.606 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -153.35 -64.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.539 0.209 . . . . 3.81 111.017 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -146.63 -64.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.844 0.354 . . . . 3.82 111.017 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 13.7 m-20 -65.51 150.27 48.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.257 0.551 . . . . 1.4 111.556 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.561 ' ND2' ' HE1' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -109.0 -179.0 0.61 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.635 -1.246 . . . . 2.0 107.635 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -11.01 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 CA-C-N 121.461 1.557 . . . . 2.58 113.22 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.601 ' HB2' ' NZ ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER 74.92 -77.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 3.71 111.32 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 90' ' ' ALA . 1.5 m -104.71 135.8 41.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 C-N-CA 119.398 -0.921 . . . . 0.92 110.646 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 4.8 t -131.72 117.28 18.41 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.092 -0.958 . . . . 1.2 112.362 -177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.454 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -100.94 37.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.149 -0.932 . . . . 0.22 113.505 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.68 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.34 0.4 . . . . 1.02 111.427 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -159.99 97.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.33 110.433 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.7 OUTLIER -105.28 125.76 60.42 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 122.426 1.108 . . . . 0.69 112.011 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.4 ptm -119.93 166.01 13.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.335 -1.302 . . . . 1.26 109.851 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 11.7 ptmt -120.82 152.5 38.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.899 1.444 . . . . 1.82 114.899 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 94.5 -37.8 3.31 Favored Glycine 0 C--N 1.319 -0.401 0 CA-C-N 111.784 -2.462 . . . . 0.22 117.058 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 176.92 166.15 0.52 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.451 1.625 . . . . 0.29 112.528 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.656 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -84.78 -52.16 6.25 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.649 -0.705 . . . . 0.57 109.538 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.166 -0.924 . . . . 2.31 110.251 179.591 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.114 0.483 . . . . 0.41 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.15 -21.52 13.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.422 -0.808 . . . . 0.33 111.308 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.27 -20.97 46.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.159 0.429 . . . . 2.09 112.159 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 18.6 mmtp -101.67 -21.36 14.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.756 -0.377 . . . . 1.99 111.528 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 7' ' ' ALA . 10.1 p -45.08 145.6 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 120.577 0.227 . . . . 0.21 111.577 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.427 HD13 ' HZ2' ' A' ' 174' ' ' LYS . 3.4 pt -138.96 -23.52 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 120.142 -0.623 . . . . 0.86 111.181 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.454 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.3 t90 -173.42 136.35 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.696 -0.402 . . . . 0.28 110.126 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -155.57 144.26 20.45 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.429 -0.169 . . . . 0.2 111.382 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -147.15 127.78 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 113.797 1.036 . . . . 0.67 113.797 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -115.53 97.18 6.01 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 119.915 -0.714 . . . . 1.27 110.997 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.6 100.29 0.87 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.037 -1.097 . . . . 0.37 108.037 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.583 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 177.39 -58.0 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.502 -1.226 . . . . 0.67 112.609 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.74 -126.26 4.77 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.644 -0.789 . . . . 1.12 113.422 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 20' ' ' SER . 26.0 mt-10 -151.81 119.51 6.12 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.44 0.296 . . . . 2.02 110.992 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.8 m 29.2 106.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.592 0.96 . . . . 1.22 113.592 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 50.1 t60 -133.43 150.4 51.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 120.485 -0.486 . . . . 0.34 112.036 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.3 p -122.81 104.94 15.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 121.4 0.619 . . . . 1.18 111.405 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.95 155.45 34.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.425 -0.807 . . . . 1.17 110.03 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 m -43.21 -50.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.48 0.919 . . . . 0.6 113.48 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -59.46 -18.3 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.118 0.485 . . . . 0.46 110.646 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.94 35.24 3.77 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.487 -0.779 . . . . 0.29 112.619 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.4 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 32.7 mm -103.42 111.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.003 0.43 . . . . 0.43 109.897 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.605 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 17.9 t60 -101.28 136.66 40.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.171 1.545 . . . . 0.52 115.171 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.9 136.8 41.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.184 -1.371 . . . . 3.0 108.189 177.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -97.38 109.98 22.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.415 0.626 . . . . 2.9 112.402 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 32' ' ' ASP . 11.5 tttm -12.22 137.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.62 1.568 . . . . 2.71 114.934 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 31' ' ' LYS . 27.9 t70 -13.36 88.95 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.01 -0.995 . . . . 1.98 113.01 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo . . . . . 0 CA--C 1.539 0.74 0 C-N-CA 122.468 2.112 . . . . 1.53 115.818 -179.08 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 61' ' ' TYR . 1.1 mp . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.83 110.331 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.6 -49.0 5.58 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.292 0.849 . . . . 1.69 113.292 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.95 31.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.939 0.718 . . . . 2.56 112.939 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.0 t -145.63 143.95 30.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.01 0.433 . . . . 0.97 111.678 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 58' ' ' GLN . 34.9 t30 -59.23 148.36 72.34 Favored Pre-proline 0 C--O 1.221 -0.403 0 CA-C-N 115.667 -0.697 . . . . 1.96 109.66 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.3 Cg_exo -42.0 -51.79 4.43 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.137 1.892 . . . . 0.66 113.522 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -55.25 16.4 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.885 0.85 . . . . 1.82 111.163 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.15 -12.67 61.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.759 -0.655 . . . . 1.91 109.761 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.609 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 1.1 tt0 -66.0 -48.16 72.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.974 -1.491 . . . . 1.5 106.974 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -50.47 -46.64 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.085 -0.961 . . . . 1.22 109.153 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 tp -73.54 -13.12 60.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.975 -1.011 . . . . 1.05 111.647 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . 3.7 m-30 -121.06 23.41 10.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.565 -0.743 . . . . 0.9 111.132 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -142.11 -68.4 0.37 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.145 0.794 . . . . 1.8 113.145 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.492 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 74.9 p -29.19 148.85 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.224 0.824 . . . . 1.05 113.224 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.583 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 3.1 pp20? -122.97 -22.54 5.21 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.256 1.206 . . . . 2.05 114.256 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.532 ' N ' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mtp-105 69.62 -80.77 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.758 0.313 . . . . 3.58 110.794 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -170.89 171.55 5.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.158 -0.474 . . . . 4.25 110.564 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -97.88 166.88 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.333 -0.394 . . . . 4.35 110.875 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 30.3 tt0 -163.79 -120.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.528 -0.306 . . . . 3.17 111.25 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -174.53 129.07 0.34 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.355 -0.216 . . . . 2.39 110.421 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t 49.45 86.2 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.635 -0.505 . . . . 0.99 109.635 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.517 ' HD1' ' N ' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -92.39 130.3 38.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.628 . . . . 1.26 109.306 -178.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -128.2 129.16 6.2 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.521 -1.323 . . . . 0.66 113.646 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 154' ' ' SER . 12.8 m-85 -112.9 144.69 42.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.401 . . . . 0.83 110.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.91 126.98 55.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 2.27 111.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.48 HG21 HG21 ' A' ' 172' ' ' ILE . 4.0 mp -123.21 86.49 51.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.615 -0.266 . . . . 0.34 111.35 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.66 129.46 34.03 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.398 2.065 . . . . 0.8 112.764 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.58 149.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.043 -0.526 . . . . 0.38 110.796 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -141.04 0.28 1.54 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 2.96 111.387 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 80' ' ' GLU . 20.5 tt0 -131.07 167.19 19.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.827 0.346 . . . . 2.13 110.32 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -115.84 176.86 4.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.354 0.597 . . . . 0.37 111.865 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.76 -151.13 19.89 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 109.933 -1.267 . . . . 0.21 109.933 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.4 mt-10 -103.81 109.59 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.03 1.415 . . . . 2.03 109.528 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.04 126.81 41.54 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.677 -0.86 . . . . 0.26 108.677 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 39.6 t -109.97 109.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.043 -0.981 . . . . 0.54 112.035 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.93 104.02 16.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.533 -1.212 . . . . 1.23 110.399 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.413 HG13 ' CD2' ' A' ' 171' ' ' PHE . 1.5 p -115.23 141.8 30.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.092 -0.958 . . . . 1.31 108.698 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 87' ' ' LEU . 2.0 pp -153.88 148.69 26.53 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.049 -0.66 . . . . 1.37 111.653 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.614 ' C ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -107.71 127.08 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.82 -0.752 . . . . 2.97 109.919 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-85 -109.39 148.51 30.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.353 -0.84 . . . . 0.3 109.741 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 116.611 -0.268 . . . . 0.41 110.566 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.492 HE21 ' H ' ' A' ' 97' ' ' SER . 22.4 tp60 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.911 0.386 . . . . 2.96 110.896 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.492 ' H ' HE21 ' A' ' 96' ' ' GLN . 40.9 t -99.25 165.57 11.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 1.55 110.439 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 71.07 -64.74 0.37 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 2.33 111.552 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -45.01 -43.79 9.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.495 -0.32 . . . . 2.51 111.362 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 44.7 mtmt -92.01 71.46 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 3.1 110.752 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 t -109.8 132.57 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.35 -0.386 . . . . 1.31 109.971 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -123.04 179.01 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.362 0.504 . . . . 0.69 112.362 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -128.45 138.31 52.24 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 116.237 -0.438 . . . . 2.01 112.005 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.44 132.26 64.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.644 -0.707 . . . . 0.46 112.169 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 9.3 mtt180 -133.11 146.11 51.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 115.429 -0.805 . . . . 1.85 112.611 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 11.8 m -117.53 119.75 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.428 -0.806 . . . . 1.1 109.538 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.479 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.71 26.75 9.76 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.826 -0.805 . . . . 1.77 108.826 -176.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.01 20.6 38.71 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.8 -1.091 . . . . 0.41 112.897 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.5 m-70 -118.64 112.29 19.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.432 0.901 . . . . 0.46 113.432 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -63.1 120.08 10.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.618 -0.433 . . . . 0.66 111.062 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.5 t -113.85 -32.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.371 -0.603 . . . . 0.8 109.371 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.11 89.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.509 -0.552 . . . . 0.51 109.509 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.6 ptpp? -106.09 79.96 1.46 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.488 1.137 . . . . 2.44 110.976 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.7 p-10 157.79 40.41 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.462 -2.154 . . . . 2.56 108.445 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.91 84.39 0.95 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.238 0.829 . . . . 1.1 113.238 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 15.9 t70 -96.02 84.42 3.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.175 -1.417 . . . . 1.99 107.175 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.2 mt -50.46 -36.97 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.122 -0.945 . . . . 0.63 112.853 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.52 -47.97 79.46 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.73 0.271 . . . . 0.9 111.73 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.4 -27.58 67.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.973 0.36 . . . . 0.76 111.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 38.9 mmt180 -67.85 -59.04 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.044 0.387 . . . . 2.68 112.044 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.29 -39.39 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.879 0.326 . . . . 1.41 111.879 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.22 -56.94 1.47 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.779 -0.724 . . . . 1.06 111.999 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -114.6 158.12 22.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.979 -0.378 . . . . 3.51 109.979 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.5 m -55.58 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 1.68 111.08 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 50' ' ' ILE . 28.7 p -143.7 -144.9 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.8 110.355 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HA ' ' HZ1' ' A' ' 88' ' ' LYS . . . -110.42 126.17 54.03 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.84 0.681 . . . . 0.44 112.84 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 2.5 t60 -103.23 137.83 40.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.553 -0.906 . . . . 0.38 108.553 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -144.29 128.37 17.59 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.569 0.581 . . . . 2.09 112.569 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.55 134.72 55.03 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.247 -0.888 . . . . 2.28 109.666 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.85 128.52 71.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.767 -0.651 . . . . 0.71 110.397 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -126.04 84.85 60.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.508 0.558 . . . . 1.38 112.508 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.62 143.03 99.38 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.828 1.685 . . . . 0.22 111.635 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 20.9 mt -135.93 156.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 0.21 111.254 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 133' ' ' ILE . 46.3 t -132.62 107.16 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.067 0.46 . . . . 1.11 111.147 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.512 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 23.6 mt -103.85 128.7 56.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.802 -0.635 . . . . 0.23 110.001 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -147.92 143.23 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.866 0.365 . . . . 1.91 111.378 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp 56.4 20.59 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 3.11 110.817 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.01 24.45 41.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.76 -0.733 . . . . 0.32 112.953 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 135' ' ' ILE . 40.5 mtmt -125.21 152.42 44.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.185 0.492 . . . . 2.19 110.943 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 141' ' ' SER . 6.0 tt -109.61 127.39 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 0.37 111.84 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.438 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.6 t -117.5 109.5 16.81 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.56 -0.745 . . . . 0.9 109.493 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.0 p -103.64 118.85 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 0.53 110.789 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 54.74 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 2.05 111.556 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.92 27.84 3.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.794 -0.717 . . . . 0.6 112.78 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.48 140.22 51.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.293 . . . . 2.02 110.265 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.44 138.65 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 1.3 111.372 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.7 m -161.22 123.55 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 1.12 110.459 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.3 p -54.12 141.2 29.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 1.11 112.06 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -80.57 142.69 33.84 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.305 -0.628 . . . . 0.28 109.305 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 150' ' ' THR . 2.9 t -140.79 96.35 3.0 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.168 0.803 . . . . 1.55 113.168 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.98 -63.17 2.45 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 115.4 0.92 . . . . 0.46 115.4 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.608 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.7 178.5 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.804 0.802 . . . . 1.8 112.543 -178.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.479 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.91 131.96 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.514 -1.291 . . . . 1.24 107.514 177.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.461 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 t -120.21 112.02 18.55 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.016 -1.074 . . . . 1.28 113.531 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -94.11 99.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.042 -0.725 . . . . 0.59 109.042 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 37.0 mt-10 -109.04 124.69 51.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.525 -0.762 . . . . 2.48 111.324 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.61 132.92 55.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.894 -0.722 . . . . 1.54 110.1 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.4 t -102.45 142.31 16.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.615 -1.175 . . . . 0.77 111.851 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.415 ' H ' ' HD3' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -67.74 148.43 51.28 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 115.4 -0.818 . . . . 1.97 111.106 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.63 -9.1 41.58 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 1.12 112.374 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -155.73 -75.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.542 0.211 . . . . 3.81 111.203 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -173.64 68.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.736 0.303 . . . . 3.82 111.131 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -178.03 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.331 -0.395 . . . . 1.4 110.897 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.25 159.12 0.12 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.479 -0.563 . . . . 2.0 109.479 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -40.07 100.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.632 1.555 . . . . 2.58 111.371 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.98 -36.07 26.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 3.71 112.322 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 79.5 t -126.7 135.3 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.566 0.58 . . . . 0.92 112.566 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.7 t -130.47 131.53 45.2 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 123.836 0.71 . . . . 1.2 111.653 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -121.73 37.8 4.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.26 -0.882 . . . . 0.22 113.299 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.98 134.17 0.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.433 0.458 . . . . 1.02 111.503 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -156.9 98.76 1.79 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.881 -0.145 . . . . 0.33 110.869 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.48 HG21 HG21 ' A' ' 75' ' ' ILE . 16.5 tt -108.22 125.79 64.9 Favored 'Isoleucine or valine' 0 C--O 1.259 1.601 0 CA-C-O 122.784 1.278 . . . . 0.69 112.486 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.16 167.17 11.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.798 -1.546 . . . . 1.26 109.035 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.431 ' HZ2' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -119.89 146.97 45.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.217 1.562 . . . . 1.82 115.217 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.59 -35.99 4.04 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 112.008 -2.36 . . . . 0.22 118.251 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.83 159.14 0.57 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.332 2.066 . . . . 0.29 113.955 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.82 -20.05 29.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.079 -0.964 . . . . 0.57 110.236 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.756 -0.656 . . . . 2.31 111.309 -178.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp . . . . . 0 C--O 1.232 0.167 0 CA-C-O 121.387 0.613 . . . . 0.41 110.482 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.632 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.82 -21.07 17.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 0.33 111.198 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.05 -18.36 60.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 2.09 111.859 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -103.9 -26.46 12.66 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.712 -0.395 . . . . 1.99 111.267 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.3 p -43.37 144.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.849 0.315 . . . . 0.21 111.849 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -137.16 -24.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.422 -0.511 . . . . 0.86 110.758 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.571 ' O ' HG22 ' A' ' 172' ' ' ILE . 25.1 t90 -171.04 138.98 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.593 -0.521 . . . . 0.28 109.593 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -159.24 143.87 15.5 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.216 0.45 . . . . 0.2 112.216 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.01 131.3 8.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 114.224 1.194 . . . . 0.67 114.224 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 8.4 t30 -114.67 88.63 2.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.265 -0.879 . . . . 1.27 109.082 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 65' ' ' ARG . . . -60.82 105.76 0.49 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.114 -0.948 . . . . 0.37 110.192 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 65' ' ' ARG . . . 162.13 -48.05 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.867 -1.061 . . . . 0.67 114.324 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.91 -130.89 6.92 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.654 -0.784 . . . . 1.12 113.861 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -152.36 119.81 6.0 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 122.317 0.247 . . . . 2.02 111.086 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.697 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.5 m 24.14 101.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.358 0.873 . . . . 1.22 113.358 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 13.2 t60 -126.44 150.52 48.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 119.971 -0.692 . . . . 0.34 111.96 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.79 105.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 1.18 110.807 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.8 154.39 42.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.434 -0.348 . . . . 1.17 110.36 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 m -44.47 -50.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 124.117 0.885 . . . . 0.6 113.068 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -58.89 -17.22 22.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.261 0.553 . . . . 0.46 110.307 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.49 34.76 4.62 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.29 112.12 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -103.92 121.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.43 110.039 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.9 t60 -99.95 136.99 39.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.578 1.325 . . . . 0.52 114.578 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.65 131.25 47.99 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.768 -1.106 . . . . 3.0 108.311 176.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.45 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 14.6 mtt180 -89.63 109.62 20.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.584 0.553 . . . . 2.9 112.282 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 30' ' ' ARG . 17.4 tttp -16.42 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.514 1.125 . . . . 2.71 113.506 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -18.7 84.11 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.149 0.979 . . . . 1.98 113.165 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 5.3 Cg_endo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 123.035 2.49 . . . . 1.53 112.933 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.546 HD11 ' HB1' ' A' ' 90' ' ' ALA . 1.2 mp . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.184 -0.673 . . . . 0.83 109.184 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.16 -32.06 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.385 0.884 . . . . 1.69 113.385 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -79.11 33.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.507 -0.477 . . . . 2.56 111.681 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.97 142.22 5.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.359 -0.382 . . . . 0.97 110.436 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -60.97 164.04 8.67 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.516 -0.311 . . . . 1.96 110.943 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 53.8 Cg_exo -47.21 -41.87 27.24 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.393 2.062 . . . . 0.66 115.024 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.613 ' O ' HG12 ' A' ' 59' ' ' VAL . 11.3 mm-40 -73.26 -55.81 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.748 0.785 . . . . 1.82 110.731 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 40.8 p30 -70.27 -3.02 15.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.701 -0.799 . . . . 1.91 109.517 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -74.36 -60.73 2.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.425 -0.954 . . . . 1.5 108.425 177.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 56' ' ' GLU . 7.2 p -49.63 -37.39 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.738 -0.467 . . . . 1.22 109.738 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 62' ' ' GLN . 11.1 tp -69.15 -66.48 0.57 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.441 -0.504 . . . . 1.05 110.245 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.426 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 8.1 m-30 -55.05 -2.71 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.198 0.523 . . . . 0.9 111.147 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 60' ' ' LEU . 6.9 tt0 -116.67 -131.65 0.32 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 1.8 109.614 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 62' ' ' GLN . 12.3 p 44.23 131.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.444 0.905 . . . . 1.05 113.444 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 -128.03 149.31 50.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.767 0.654 . . . . 2.05 112.767 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -80.4 -156.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.677 -0.692 . . . . 3.58 109.616 177.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -87.12 -87.27 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 121.373 -0.131 . . . . 4.25 111.165 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -179.89 155.77 0.63 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.592 0.235 . . . . 4.35 110.957 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 4.4 tt0 -176.43 -158.65 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.291 -0.413 . . . . 3.17 110.61 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -152.83 135.86 15.58 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.502 -0.317 . . . . 2.39 110.987 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t 50.54 79.21 0.09 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.483 -0.326 . . . . 0.99 110.397 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -151.43 153.86 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.66 -0.416 . . . . 1.26 111.273 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -170.49 -160.43 18.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.621 -0.8 . . . . 0.66 113.914 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.93 164.16 17.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.601 0.715 . . . . 0.83 112.917 -177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.46 125.08 50.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.483 -1.235 . . . . 2.27 109.539 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.506 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.1 mp -115.41 88.5 19.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.242 0.46 . . . . 0.34 112.242 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -56.24 127.93 28.04 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.957 1.771 . . . . 0.8 112.16 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.406 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.3 mt -122.69 151.5 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.911 0.386 . . . . 0.38 111.048 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -140.45 -0.39 1.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.1 -0.5 . . . . 2.96 111.27 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -126.06 168.49 13.91 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.616 0.246 . . . . 2.13 111.046 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -122.6 168.52 12.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.381 0.61 . . . . 0.37 111.55 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.33 -151.87 23.28 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.739 -1.345 . . . . 0.21 109.739 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.41 107.6 18.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.066 1.433 . . . . 2.03 108.84 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -95.14 126.31 40.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.645 -0.822 . . . . 0.26 109.162 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 177' ' ' ALA . 40.6 t -109.47 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.678 -1.146 . . . . 0.54 111.457 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 170' ' ' LEU . 8.7 tp -99.28 105.06 17.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.365 -1.289 . . . . 1.23 110.729 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.51 ' C ' HD23 ' A' ' 87' ' ' LEU . 1.1 p -113.56 135.25 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.774 -0.648 . . . . 1.31 109.929 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -133.06 135.19 45.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.59 . . . . 1.37 111.614 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.493 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 17.9 tptt -102.93 114.83 29.44 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 2.97 108.83 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -103.68 140.98 36.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.772 -0.825 . . . . 0.3 108.772 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 50' ' ' ILE . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 113.475 0.917 . . . . 0.41 113.475 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 . . . . . 0 C--O 1.231 0.089 0 N-CA-C 110.238 -0.282 . . . . 2.96 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m -110.61 149.8 29.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.105 0.479 . . . . 1.55 112.231 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 46.64 32.85 1.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.319 -0.855 . . . . 2.33 111.823 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.42 -41.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.775 -0.454 . . . . 2.51 109.775 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -107.11 82.91 1.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.67 . . . . 3.1 109.696 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.514 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.9 OUTLIER -109.14 144.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 1.31 109.733 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.492 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 73.4 m-85 -128.1 -178.05 4.38 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.843 0.683 . . . . 0.69 112.843 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -128.23 143.98 51.08 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.572 -0.451 . . . . 2.01 112.083 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.2 t -139.15 131.98 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.78 -0.646 . . . . 0.46 112.434 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -133.66 149.9 51.55 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 115.239 -0.891 . . . . 1.85 112.612 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.9 m -118.7 117.6 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.705 -1.134 . . . . 1.1 109.749 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.497 ' HA ' ' H ' ' A' ' 154' ' ' SER . 3.8 t-20 55.85 26.32 9.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.758 0.789 . . . . 1.77 109.438 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.97 16.46 41.37 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.365 -1.289 . . . . 0.41 113.278 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.7 m-70 -115.35 109.51 18.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.199 0.815 . . . . 0.46 113.199 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.0 p -67.22 113.69 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.115 0.483 . . . . 0.66 111.292 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.37 -30.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.511 -0.768 . . . . 0.8 109.898 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.46 91.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.308 -0.405 . . . . 0.51 109.941 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.7 ptpp? -107.78 84.83 2.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 122.237 1.018 . . . . 2.44 112.038 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.9 p-10 151.2 37.31 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.631 -2.077 . . . . 2.56 108.79 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 92.36 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.326 0.584 . . . . 1.1 112.512 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.59 84.07 2.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.649 -1.612 . . . . 1.99 106.649 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 53.3 mt -50.21 -38.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.139 -0.937 . . . . 0.63 113.229 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.06 -52.95 52.76 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.217 0.451 . . . . 0.9 112.217 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.19 -27.62 64.65 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.045 0.387 . . . . 0.76 112.045 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.15 -58.22 6.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.113 0.412 . . . . 2.68 112.113 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.07 -40.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.175 0.435 . . . . 1.41 112.175 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.45 -136.52 12.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.605 -0.807 . . . . 1.06 112.601 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -56.65 169.54 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.551 0.215 . . . . 3.51 110.868 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -45.81 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.078 0.466 . . . . 1.68 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.1 p -152.97 -175.1 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 0.8 109.991 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.39 139.19 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 0.44 112.161 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -111.69 148.88 32.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.869 -0.789 . . . . 0.38 108.869 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -141.87 135.1 29.2 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.712 0.634 . . . . 2.09 112.712 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -129.85 112.6 13.73 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.151 -0.931 . . . . 2.28 109.609 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.435 ' C ' HD12 ' A' ' 131' ' ' ILE . 13.6 mt -101.89 135.45 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.204 -0.453 . . . . 0.71 111.043 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.2 mp -134.89 86.32 32.97 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.888 0.329 . . . . 1.38 111.888 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -62.6 138.94 73.0 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.554 1.503 . . . . 0.22 110.812 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.9 mt -130.13 155.73 41.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.769 0.319 . . . . 0.21 111.59 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 133' ' ' ILE . 25.3 p -130.07 106.69 8.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.044 -0.525 . . . . 1.11 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 139' ' ' LYS . 26.6 mt -105.64 125.87 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.661 -0.699 . . . . 0.23 109.918 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -146.66 144.08 29.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 1.91 110.911 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm 60.29 10.88 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.984 -0.553 . . . . 3.11 111.656 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.12 18.53 33.65 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.579 -0.82 . . . . 0.32 113.067 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 135' ' ' ILE . 33.7 mtmt -121.89 153.89 37.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.958 0.379 . . . . 2.19 110.943 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -108.7 127.33 53.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.37 111.739 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.503 ' N ' HD23 ' A' ' 140' ' ' LEU . 16.6 t -119.77 109.28 15.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.9 110.176 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 144' ' ' GLY . 1.8 p -101.92 135.59 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.124 -0.489 . . . . 0.53 110.174 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 40.21 -91.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.91 0.337 . . . . 2.05 111.91 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -135.59 47.28 0.99 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.033 -0.603 . . . . 0.6 112.34 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.51 132.74 21.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.998 -0.371 . . . . 2.02 109.998 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.0 135.0 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.933 0.397 . . . . 1.3 110.888 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 23.2 t -152.91 171.94 17.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 1.12 110.208 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.13 136.72 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.188 -0.46 . . . . 1.11 111.295 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.406 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 28.6 t80 -79.46 126.84 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.297 -1.001 . . . . 0.28 108.297 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -124.0 94.86 4.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.086 0.772 . . . . 1.55 113.086 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.9 -52.82 1.31 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 116.056 1.182 . . . . 0.46 116.056 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.506 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -154.75 170.94 20.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.272 1.036 . . . . 1.8 113.007 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.33 124.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.027 -1.471 . . . . 1.24 107.027 176.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.497 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.7 t -116.28 110.79 19.22 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.594 0.961 . . . . 1.28 113.594 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.483 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 15.2 t -99.14 114.96 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.871 -0.604 . . . . 0.59 110.363 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -124.46 136.52 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 2.48 111.659 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -118.3 131.71 56.32 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.743 -0.662 . . . . 1.54 109.583 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.21 143.68 16.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.435 -0.802 . . . . 0.77 111.469 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.71 148.33 39.15 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 114.816 -1.084 . . . . 1.97 111.728 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -126.15 -8.75 4.91 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.049 -0.82 . . . . 1.12 111.049 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -151.77 -57.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.331 -0.435 . . . . 3.81 110.265 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -174.33 -68.73 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.242 -0.436 . . . . 3.82 111.146 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.29 90.65 4.97 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.008 0.433 . . . . 1.4 111.281 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 165' ' ' PRO . 4.2 m-20 -48.03 153.18 1.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.414 -0.812 . . . . 2.0 109.35 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.57 99.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.191 1.927 . . . . 2.58 112.226 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.524 ' NZ ' ' HB3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -51.97 -70.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.005 -0.998 . . . . 3.71 111.774 -178.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 25.0 t -84.95 131.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 119.455 -0.898 . . . . 0.92 111.381 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.3 t -132.33 123.37 26.7 Favored 'General case' 0 C--N 1.338 0.095 0 O-C-N 124.136 0.897 . . . . 1.2 109.721 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.493 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -115.23 38.19 3.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.231 0.826 . . . . 0.22 113.231 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.514 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -40.22 135.21 1.46 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.974 0.416 . . . . 1.02 110.431 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.514 ' H ' HD13 ' A' ' 170' ' ' LEU . 0.3 OUTLIER -152.82 102.36 2.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.837 -0.619 . . . . 0.33 110.072 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 12' ' ' TRP . 2.8 tt -105.1 123.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 CA-C-O 122.842 1.306 . . . . 0.69 113.026 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.06 163.03 16.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.396 -1.729 . . . . 1.26 109.399 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.079 1.511 . . . . 1.82 115.079 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.39 -35.34 5.03 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 112.327 -2.215 . . . . 0.22 117.914 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.51 159.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 120.031 1.916 . . . . 0.29 114.291 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.621 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.15 -18.2 32.89 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 115.116 -0.947 . . . . 0.57 110.51 176.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 2.31 111.926 -178.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HG ' HD11 ' A' ' 27' ' ' ILE . 24.3 tp . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.343 0.592 . . . . 0.41 110.332 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.22 -21.08 8.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.181 -0.918 . . . . 0.33 111.509 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.68 -23.06 53.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.139 0.422 . . . . 2.09 112.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -98.11 -25.54 14.89 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.395 . . . . 1.99 111.436 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.8 p -44.0 145.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 120.648 0.261 . . . . 0.21 111.591 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -138.75 -23.24 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.096 -0.642 . . . . 0.86 111.012 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.52 ' O ' HG22 ' A' ' 172' ' ' ILE . 28.5 t90 -173.34 141.56 0.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.275 -0.42 . . . . 0.28 109.944 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.39 150.15 17.78 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.343 -0.223 . . . . 0.2 111.531 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.78 129.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 114.19 1.182 . . . . 0.67 114.19 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -115.17 87.2 2.6 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.726 -0.67 . . . . 1.27 109.444 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -62.12 104.27 0.46 Allowed 'General case' 0 C--O 1.253 1.267 0 CA-C-N 115.414 -0.812 . . . . 0.37 109.165 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.643 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 157.69 -20.48 0.38 Allowed Glycine 0 N--CA 1.44 -1.066 0 O-C-N 124.91 1.381 . . . . 0.67 113.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.32 -133.27 3.13 Favored Glycine 0 C--N 1.329 0.191 0 C-N-CA 119.991 -1.1 . . . . 1.12 113.455 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 35.1 mt-10 -152.65 120.13 5.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.44 0.162 . . . . 2.02 111.108 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.647 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.0 m 26.86 107.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.701 1.0 . . . . 1.22 113.701 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 3.7 t60 -135.64 139.17 43.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 120.086 -0.645 . . . . 0.34 112.571 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.486 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 4.9 p -110.08 102.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 115.45 -0.795 . . . . 1.18 111.194 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.66 157.0 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.995 -1.002 . . . . 1.17 110.301 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 25' ' ' HIS . 21.8 m -43.55 -52.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.4 0.889 . . . . 0.6 113.4 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.484 ' N ' HG23 ' A' ' 24' ' ' VAL . 75.1 m-70 -56.82 -20.79 24.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.46 110.318 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.4 34.98 3.46 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.22 -0.9 . . . . 0.29 112.101 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.413 HD11 ' HG ' ' A' ' 6' ' ' LEU . 34.7 mm -103.68 112.1 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.46 . . . . 0.43 110.351 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 13.2 t60 -97.93 132.63 43.34 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.981 1.104 . . . . 0.52 113.981 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.42 135.27 39.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.804 -1.184 . . . . 3.0 107.804 177.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.47 ' NH1' ' HA ' ' A' ' 12' ' ' TRP . 2.2 ptp85 -91.54 108.15 19.7 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.572 0.545 . . . . 2.9 112.451 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -10.8 130.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.106 1.363 . . . . 2.71 114.286 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.5 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 57.3 m-20 -16.52 85.86 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.632 1.173 . . . . 1.98 113.921 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 123.247 2.631 . . . . 1.53 111.763 178.823 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp . . . . . 0 C--O 1.232 0.172 0 N-CA-C 109.798 -0.445 . . . . 0.83 109.798 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -48.3 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 1.69 112.231 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -77.49 37.16 0.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 2.56 112.743 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -151.95 140.73 20.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.08 0.467 . . . . 0.97 111.966 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.537 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.2 t30 -65.95 149.13 97.92 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.713 -0.676 . . . . 1.96 109.272 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.61 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 6.2 Cg_exo -38.73 -46.99 2.68 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.954 2.436 . . . . 0.66 116.402 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.469 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 8.4 mm-40 -73.12 -56.68 4.78 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.856 0.836 . . . . 1.82 111.113 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 -10.92 59.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.824 -0.806 . . . . 1.91 108.824 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.7 tt0 -64.66 -47.29 79.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.56 -1.644 . . . . 1.5 106.56 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 63' ' ' THR . 92.2 t -54.49 -57.77 5.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.838 -1.074 . . . . 1.22 110.452 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 60' ' ' LEU . 4.2 tt -63.11 -14.64 50.94 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.711 -0.677 . . . . 1.05 111.09 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.43 ' CE2' ' HD2' ' A' ' 88' ' ' LYS . 6.3 m-30 -110.81 5.79 20.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.101 -0.5 . . . . 0.9 111.11 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.608 ' HG2' ' N ' ' A' ' 63' ' ' THR . 35.6 tt0 -129.28 -104.95 0.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.49 . . . . 1.8 111.558 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.608 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 65.3 p 36.83 -154.7 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.088 -0.482 . . . . 1.05 110.669 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.624 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.0 pt-20 168.85 130.68 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.468 0.576 . . . . 2.05 112.026 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.643 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 14.9 mtp85 -107.35 -176.73 3.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.39 -0.368 . . . . 3.58 110.284 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -168.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.21 -0.45 . . . . 4.25 110.89 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -159.03 162.11 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 4.35 111.167 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.4 tp10 -156.74 -92.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 3.17 111.053 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 3.1 p30 -173.56 134.49 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.535 0.207 . . . . 2.39 111.084 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.4 t 46.89 84.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.401 -0.363 . . . . 0.99 110.693 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -155.92 155.64 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.578 -0.449 . . . . 1.26 111.995 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -175.66 -161.38 24.93 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.601 -0.809 . . . . 0.66 113.951 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.01 174.1 6.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.75 0.786 . . . . 0.83 113.056 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.436 ' OD2' ' HG3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -127.36 139.67 52.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.322 -1.308 . . . . 2.27 109.128 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.517 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -129.75 88.93 47.91 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.895 0.702 . . . . 0.34 112.895 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.38 134.88 67.09 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.61 1.54 . . . . 0.8 111.433 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 78' ' ' LYS . 59.9 mt -126.52 155.14 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.859 0.361 . . . . 0.38 111.266 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.426 ' N ' HG22 ' A' ' 77' ' ' ILE . 19.0 pttm -147.35 4.11 0.79 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.021 -0.536 . . . . 2.96 111.364 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.92 171.86 12.7 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.602 0.239 . . . . 2.13 110.864 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.8 mp0 -127.4 173.29 9.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.37 111.419 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.92 -150.31 20.11 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 109.958 -1.257 . . . . 0.21 109.958 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 28.4 mt-10 -100.98 108.13 19.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.826 1.313 . . . . 2.03 109.038 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -94.81 126.32 40.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 119.772 -0.771 . . . . 0.26 109.126 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.2 t -110.78 109.09 27.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.951 -1.022 . . . . 0.54 111.319 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.4 105.45 17.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.848 -1.524 . . . . 1.23 110.45 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.6 t -110.33 143.39 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.171 -0.922 . . . . 1.31 110.31 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -136.77 133.79 36.38 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.591 -0.444 . . . . 1.37 111.414 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -103.47 110.41 22.43 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.64 -1.245 . . . . 2.97 107.64 175.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -102.99 141.62 35.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.41 -0.959 . . . . 0.3 108.41 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 114.248 1.203 . . . . 0.41 114.248 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.796 0.331 . . . . 2.96 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.7 p -97.74 153.17 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 1.55 111.423 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 66.56 -71.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.726 -0.67 . . . . 2.33 112.178 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -39.18 -44.88 1.26 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.298 -0.41 . . . . 2.51 111.866 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -88.92 80.37 7.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.152 0.501 . . . . 3.1 110.939 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.44 142.6 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 1.31 109.934 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.46 177.65 5.8 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.769 0.655 . . . . 0.69 112.769 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -125.65 141.43 52.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 115.977 -0.556 . . . . 2.01 111.565 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.51 132.41 36.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 116.272 -0.422 . . . . 0.46 111.717 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.5 OUTLIER -134.05 150.73 51.21 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.17 0.804 . . . . 1.85 113.17 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 17.3 m -118.84 119.64 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.65 -1.159 . . . . 1.1 109.451 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.494 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.79 26.96 12.12 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.341 -0.614 . . . . 1.77 109.341 -176.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.1 53.11 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.41 112.879 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.3 m-70 -114.27 109.46 18.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.292 0.849 . . . . 0.46 113.292 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -67.36 109.67 3.25 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 0.66 111.168 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.05 -34.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.396 -0.82 . . . . 0.8 109.85 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.91 90.36 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.599 -0.519 . . . . 0.51 109.599 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -109.36 81.83 1.5 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.304 1.049 . . . . 2.44 111.201 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 157.67 37.16 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 112.462 -2.154 . . . . 2.56 108.217 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.39 85.97 0.83 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.695 -0.684 . . . . 1.1 112.292 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 0.6 OUTLIER -100.16 83.64 2.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.597 -1.631 . . . . 1.99 106.597 175.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.2 mt -49.82 -41.57 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.358 -0.837 . . . . 0.63 112.112 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -61.54 -54.8 38.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.571 -0.286 . . . . 0.9 111.22 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 12.8 t70 -63.26 -27.53 69.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.871 0.323 . . . . 0.76 111.871 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -63.69 -59.4 4.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.324 0.49 . . . . 2.68 112.324 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.16 -41.39 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.204 -0.598 . . . . 1.41 112.152 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.51 -112.13 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.586 -0.816 . . . . 1.06 112.655 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -97.42 114.45 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.768 0.318 . . . . 3.51 111.377 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.8 t 54.63 -127.15 2.29 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.089 -0.505 . . . . 1.68 111.192 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.7 p 56.15 174.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.946 0.403 . . . . 0.8 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -98.55 139.32 34.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.329 0.585 . . . . 0.44 112.134 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.422 ' ND1' ' N ' ' A' ' 128' ' ' ASP . 1.6 t60 -107.78 149.22 28.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.108 -0.951 . . . . 0.38 108.44 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.422 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.6 p30 -133.42 137.2 45.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.54 0.941 . . . . 2.09 113.54 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -129.68 109.4 10.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.559 -1.2 . . . . 2.28 109.464 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 mt -98.71 128.58 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.893 -0.594 . . . . 0.71 110.27 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.91 84.33 38.12 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 113.076 0.769 . . . . 1.38 113.076 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.55 143.63 93.18 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.793 1.662 . . . . 0.22 111.402 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 134' ' ' SER . 25.1 mt -136.36 159.43 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 0.21 111.025 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 133' ' ' ILE . 53.6 p -134.4 107.13 7.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 1.11 111.227 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 20.4 mt -105.55 127.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 115.72 -0.673 . . . . 0.23 109.955 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -150.49 142.84 24.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.341 . . . . 1.91 110.886 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt 60.53 11.83 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.017 -0.538 . . . . 3.11 111.596 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.04 14.54 48.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.64 -0.79 . . . . 0.32 113.134 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 135' ' ' ILE . 63.6 mttp -116.78 153.47 32.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.861 0.33 . . . . 2.19 110.907 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 141' ' ' SER . 6.5 tt -111.43 129.52 56.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.37 111.727 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.425 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.8 t -116.9 109.9 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 0.9 109.678 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 142' ' ' VAL . 9.1 p -105.06 110.79 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.125 -0.489 . . . . 0.53 111.007 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.14 -89.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.911 -0.586 . . . . 2.05 111.769 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.92 22.33 4.3 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.528 -0.844 . . . . 0.6 113.243 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -125.81 136.57 53.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 2.02 110.282 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -105.37 137.95 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 1.3 111.129 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.1 m -152.67 170.61 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 1.12 110.124 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.44 135.46 38.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 1.11 111.277 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.7 137.79 37.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.928 -1.138 . . . . 0.28 107.928 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.8 m -145.8 95.55 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.705 -0.798 . . . . 1.55 112.775 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.18 -65.75 3.97 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.366 -0.834 . . . . 0.46 115.163 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.517 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.95 172.14 16.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 117.72 0.76 . . . . 1.8 112.694 -178.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.494 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -95.29 125.22 39.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.909 -1.515 . . . . 1.24 106.909 176.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.471 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.8 t -116.5 115.66 26.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.729 1.011 . . . . 1.28 113.729 -175.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.491 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 11.7 t -101.46 121.37 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.579 . . . . 0.59 110.197 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 62.2 mm-40 -131.38 144.68 51.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.743 -0.662 . . . . 2.48 110.702 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -128.32 136.27 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 1.54 109.782 178.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.73 143.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.226 -0.897 . . . . 0.77 111.428 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.35 139.56 49.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.516 -0.765 . . . . 1.97 111.275 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.73 -21.02 27.26 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.856 -0.687 . . . . 1.12 111.427 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -158.75 -51.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 3.81 109.809 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -178.8 155.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.703 -0.68 . . . . 3.82 110.152 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.88 75.65 0.4 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.477 -0.329 . . . . 1.4 111.351 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.53 166.21 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.139 -0.482 . . . . 2.0 109.929 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -36.93 110.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.973 1.782 . . . . 2.58 111.799 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -71.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.458 -0.792 . . . . 3.71 112.268 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 63' ' ' THR . 22.3 t -87.02 132.77 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 120.185 -0.606 . . . . 0.92 111.927 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.9 t -131.66 123.94 28.83 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 123.938 0.774 . . . . 1.2 111.103 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -117.21 38.77 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.955 1.094 . . . . 0.22 113.955 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.604 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -33.14 141.99 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.872 0.368 . . . . 1.02 111.038 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.604 ' H ' HD13 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -159.34 102.66 1.58 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 0.33 110.487 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 12' ' ' TRP . 2.3 tt -112.74 123.16 68.14 Favored 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-O 122.829 1.3 . . . . 0.69 112.724 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.81 165.87 13.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.78 -1.555 . . . . 1.26 109.228 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -120.47 143.05 48.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.007 1.484 . . . . 1.82 115.007 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.11 -35.27 5.06 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 112.382 -2.19 . . . . 0.22 117.781 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.05 158.8 0.35 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.109 1.954 . . . . 0.29 114.452 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.02 -16.79 37.09 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 115.114 -0.948 . . . . 0.57 110.354 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 2.31 111.762 -178.903 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.341 0.591 . . . . 0.41 110.287 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.598 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.6 -20.53 8.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.135 -0.939 . . . . 0.33 111.515 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.75 -20.19 56.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.314 0.487 . . . . 2.09 112.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 61.4 mttt -105.96 -21.83 13.05 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.441 -0.504 . . . . 1.99 111.773 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.1 p -43.93 145.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 121.03 -0.268 . . . . 0.21 111.465 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.7 pt -136.55 -23.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 119.689 -0.804 . . . . 0.86 110.998 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.553 ' O ' HG22 ' A' ' 172' ' ' ILE . 49.5 t90 -174.77 141.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.867 -0.419 . . . . 0.28 109.867 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.67 145.29 15.72 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.191 0.441 . . . . 0.2 112.191 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.73 131.88 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 114.251 1.204 . . . . 0.67 114.251 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 14.8 t30 -115.42 94.59 4.78 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 114.441 -1.254 . . . . 1.27 109.71 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -61.34 96.04 0.05 Allowed 'General case' 0 C--O 1.252 1.222 0 N-CA-C 107.092 -1.447 . . . . 0.37 107.092 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -178.49 -63.86 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.533 -1.667 . . . . 0.67 113.746 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.17 -120.0 4.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.597 -0.811 . . . . 1.12 112.105 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.574 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -172.31 128.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.25 0.548 . . . . 2.02 110.818 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.2 m 42.27 82.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.004 -0.998 . . . . 1.22 112.445 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 67.1 t60 -112.77 151.97 29.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.072 -0.651 . . . . 0.34 111.807 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.3 t -124.84 103.77 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.374 -0.83 . . . . 1.18 110.108 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.58 151.99 39.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.385 -0.37 . . . . 1.17 110.228 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 m -43.38 -48.23 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.777 1.029 . . . . 0.6 113.777 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.1 -18.52 47.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.274 0.559 . . . . 0.46 110.422 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.09 34.62 3.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.318 -0.856 . . . . 0.29 112.459 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.9 mm -103.16 123.7 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.217 -0.66 . . . . 0.43 109.217 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.8 t60 -108.36 132.35 53.82 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.52 114.151 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.25 132.66 42.78 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.232 -1.025 . . . . 3.0 108.232 176.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 20' ' ' SER . 80.0 mtp180 -47.67 -109.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.229 1.196 . . . . 2.9 114.229 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 179.47 99.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.166 -0.47 . . . . 2.71 111.859 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.424 ' OD1' ' HD2' ' A' ' 65' ' ' ARG . 4.3 m-20 32.32 71.68 0.64 Allowed Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.507 0.558 . . . . 1.98 112.507 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo . . . . . 0 CA--C 1.532 0.424 0 C-N-CA 122.679 2.253 . . . . 1.53 114.081 -179.73 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 125' ' ' THR . 1.2 mp . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 120.81 0.338 . . . . 0.83 110.194 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.0 mp -86.41 -177.65 6.25 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.439 -0.949 . . . . 1.69 108.439 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 81.6 mtp180 70.01 -21.48 0.17 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.425 . . . . 2.56 111.959 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 51' ' ' LEU . 2.7 t -105.39 172.7 6.65 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.065 0.46 . . . . 0.97 111.229 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.5 t30 -90.24 148.57 39.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 109.051 -0.722 . . . . 1.96 109.051 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.638 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 18.0 Cg_exo -40.63 -51.41 3.54 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.179 1.919 . . . . 0.66 114.065 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.449 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 10.4 mm-40 -63.68 -56.57 14.72 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.101 0.953 . . . . 1.82 110.94 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -68.86 -12.06 61.16 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.694 -0.684 . . . . 1.91 109.98 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.638 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.9 tt0 -63.51 -45.04 92.49 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.146 -1.798 . . . . 1.5 106.146 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -53.21 -50.17 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 114.432 -1.258 . . . . 1.22 109.186 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 7.1 tp -69.57 -11.33 60.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.087 -0.96 . . . . 1.05 111.465 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.44 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.5 m-30 -121.51 20.06 11.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.833 -0.621 . . . . 0.9 111.246 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -139.64 -59.58 0.56 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.448 0.907 . . . . 1.8 113.448 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.52 ' O ' HG13 ' A' ' 167' ' ' VAL . 77.6 p -43.15 150.78 0.17 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.584 -0.28 . . . . 1.05 110.906 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.578 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -135.11 -30.49 1.05 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.913 1.449 . . . . 2.05 114.913 -176.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 38.5 mtp85 68.57 -173.7 0.19 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.706 -0.479 . . . . 3.58 109.706 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -77.37 156.06 31.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.721 0.296 . . . . 4.25 110.373 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -134.0 149.02 51.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.415 -0.357 . . . . 4.35 111.054 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -130.04 -101.22 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.27 -0.423 . . . . 3.17 111.444 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.76 130.03 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.761 0.315 . . . . 2.39 111.403 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.466 ' H ' HD21 ' A' ' 164' ' ' ASN . 18.9 t 53.16 95.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.091 -0.504 . . . . 0.99 111.507 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -162.66 164.73 26.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 1.26 111.235 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -164.69 -149.63 5.87 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.005 -1.093 . . . . 0.66 114.605 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.534 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 2.2 m-85 -141.31 167.2 22.74 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.116 -0.542 . . . . 0.83 111.455 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.33 134.35 55.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.144 -0.935 . . . . 2.27 110.892 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.49 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.5 mp -126.98 87.09 57.46 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.637 -0.256 . . . . 0.34 111.48 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -57.56 119.79 7.28 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.875 1.717 . . . . 0.8 112.011 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.71 151.44 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 0.38 111.191 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -144.49 3.99 1.17 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.209 -0.45 . . . . 2.96 111.559 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -128.62 171.07 12.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.459 0.171 . . . . 2.13 110.76 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -127.09 169.1 13.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.37 111.783 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.18 -155.74 24.1 Favored Glycine 0 CA--C 1.512 -0.133 0 N-CA-C 109.644 -1.382 . . . . 0.21 109.644 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.7 mt-10 -96.51 108.5 21.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.048 1.424 . . . . 2.03 108.657 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.29 125.82 39.16 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.968 -0.753 . . . . 0.26 108.968 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 177' ' ' ALA . 38.9 t -109.49 112.03 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 0.54 111.289 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -103.11 104.83 15.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.789 -1.551 . . . . 1.23 110.537 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.26 142.56 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.527 -0.761 . . . . 1.31 109.639 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.97 134.18 46.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.569 -0.452 . . . . 1.37 111.168 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.622 ' HZ3' ' HB1' ' A' ' 126' ' ' ALA . 5.7 tptm -94.16 112.59 24.41 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.106 -1.442 . . . . 2.97 107.106 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 14.7 m-85 -104.47 143.64 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.715 -0.476 . . . . 0.3 109.715 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.117 -0.492 . . . . 0.41 110.605 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.697 0.284 . . . . 2.96 110.976 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.455 ' HG ' ' HD2' ' A' ' 118' ' ' PHE . 32.5 m -113.05 156.92 22.25 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.569 0.581 . . . . 1.55 112.569 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 48.09 27.15 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.145 -0.934 . . . . 2.33 112.091 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -129.63 -42.91 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 2.51 109.423 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 93.0 mttt -92.47 78.02 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 3.1 109.256 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.54 145.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 1.31 109.705 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.17 178.03 7.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.601 0.593 . . . . 0.69 112.601 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.46 137.76 54.73 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.262 -0.426 . . . . 2.01 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.25 131.91 52.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.917 -0.583 . . . . 0.46 112.323 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 6.7 mtt180 -133.48 146.79 51.44 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.997 0.74 . . . . 1.85 112.997 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.8 m -117.14 114.26 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.074 -0.967 . . . . 1.1 109.373 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.519 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 60.62 27.14 16.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.199 -0.667 . . . . 1.77 109.199 -176.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.49 10.12 62.32 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.126 -0.943 . . . . 0.41 112.767 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.7 m-70 -107.46 113.28 26.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.026 0.75 . . . . 0.46 113.026 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -64.66 128.95 37.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.178 -0.609 . . . . 0.66 110.634 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.65 -30.87 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.198 -0.667 . . . . 0.8 109.198 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.46 HG11 ' OE2' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -135.73 89.77 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.094 -0.706 . . . . 0.51 109.094 177.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.1 OUTLIER -105.33 76.66 1.24 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 122.508 1.147 . . . . 2.44 111.146 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.7 p30 154.5 28.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.079 -1.873 . . . . 2.56 108.35 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 89' ' ' PHE . 16.6 tp -61.44 97.12 0.06 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.376 -0.829 . . . . 1.1 112.386 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.5 t70 -107.07 93.9 4.81 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 114.669 -1.151 . . . . 1.99 108.345 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.9 mt -51.86 -51.66 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 114.069 1.137 . . . . 0.63 114.069 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.455 ' HD2' ' HG ' ' A' ' 97' ' ' SER . 87.9 t80 -53.51 -55.93 21.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.033 0.383 . . . . 0.9 112.033 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.78 -27.55 68.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.569 0.581 . . . . 0.76 112.569 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -67.68 -58.56 4.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.872 0.693 . . . . 2.68 112.872 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -106.08 -40.85 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.11 0.411 . . . . 1.41 112.11 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.44 -138.9 13.22 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.539 -0.839 . . . . 1.06 113.185 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.567 ' O ' HG23 ' A' ' 125' ' ' THR . 17.2 p-80 -65.43 118.23 9.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.965 0.412 . . . . 3.51 111.607 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.4 m 39.13 -116.75 0.2 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.576 -0.738 . . . . 1.68 112.066 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 123' ' ' HIS . 66.0 p 51.65 -166.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.661 0.267 . . . . 0.8 110.953 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.622 ' HB1' ' HZ3' ' A' ' 88' ' ' LYS . . . -113.58 139.09 49.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.753 0.649 . . . . 0.44 112.753 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.504 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.7 t60 -107.61 147.95 29.96 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.903 -0.777 . . . . 0.38 108.903 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -143.03 131.06 21.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.558 0.577 . . . . 2.09 112.558 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.46 ' OE2' HG11 ' A' ' 112' ' ' VAL . 57.8 mt-10 -124.23 109.8 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.508 -0.769 . . . . 2.28 109.73 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.538 ' O ' HD13 ' A' ' 131' ' ' ILE . 15.5 mt -94.94 130.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.066 -0.516 . . . . 0.71 110.839 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 130' ' ' ILE . 43.8 mm -131.53 85.88 51.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.375 -0.375 . . . . 1.38 111.902 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.59 144.62 97.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.694 1.596 . . . . 0.22 111.447 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 134' ' ' SER . 28.3 mt -136.33 159.41 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.21 110.674 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 42.6 p -134.76 108.55 8.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 1.11 111.132 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.515 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 26.6 mt -106.34 125.99 62.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.695 -0.684 . . . . 0.23 109.979 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -150.97 144.04 24.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.699 0.285 . . . . 1.91 110.802 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt 61.76 10.15 3.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 3.11 111.468 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.01 37.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.621 -0.8 . . . . 0.32 113.182 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 135' ' ' ILE . 59.6 mttp -119.99 160.46 22.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.075 0.437 . . . . 2.19 110.772 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.76 131.53 56.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.089 0.471 . . . . 0.37 111.893 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.455 ' HB3' ' OG ' ' A' ' 134' ' ' SER . 22.9 t -116.54 116.64 27.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.631 -0.713 . . . . 0.9 110.08 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 142' ' ' VAL . 8.0 p -113.03 111.48 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.288 0.566 . . . . 0.53 111.551 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 50.27 -93.97 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.616 -0.72 . . . . 2.05 112.441 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -123.94 34.79 3.46 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.544 -0.836 . . . . 0.6 113.616 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -146.57 132.64 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.065 -0.346 . . . . 2.02 110.065 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.14 146.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.429 . . . . 1.3 111.566 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.6 m -161.12 171.27 18.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.779 -0.646 . . . . 1.12 109.376 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 141.72 31.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.278 0.561 . . . . 1.11 111.496 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -78.66 140.74 38.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.136 -0.938 . . . . 0.28 109.653 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.5 p -139.99 95.28 2.87 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.673 0.62 . . . . 1.55 112.673 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.96 -57.73 2.24 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.833 1.093 . . . . 0.46 115.833 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.66 174.99 12.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.023 0.912 . . . . 1.8 112.695 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.519 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 1.8 tt -101.9 129.03 48.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.407 -1.331 . . . . 1.24 107.407 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.506 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -116.51 114.37 24.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.696 -0.802 . . . . 1.28 112.851 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 43.7 t -93.1 105.09 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.039 -0.726 . . . . 0.59 109.039 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.1 tt0 -118.4 128.43 54.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 2.48 111.414 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -120.99 145.83 47.34 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.166 0.508 . . . . 1.54 109.749 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 143.87 26.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 115.191 -0.913 . . . . 0.77 111.261 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 159' ' ' LYS . 1.6 pptp? -83.89 148.48 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.471 -0.786 . . . . 1.97 111.394 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.68 0.51 55.41 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.923 -0.656 . . . . 1.12 111.619 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -154.64 -76.25 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.847 -0.177 . . . . 3.81 110.803 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -178.49 73.61 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.498 -0.319 . . . . 3.82 110.713 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -174.37 -44.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.381 -0.372 . . . . 1.4 111.165 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.466 HD21 ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 62.43 163.15 0.11 Allowed Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.545 -0.539 . . . . 2.0 109.545 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -44.47 103.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.325 1.35 . . . . 2.58 111.272 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 6.7 tppt? -53.3 -66.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.301 -0.863 . . . . 3.71 112.088 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 64' ' ' GLU . 45.5 t -94.45 132.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 120.547 -0.461 . . . . 0.92 111.749 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -135.29 127.77 30.56 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 113.194 0.813 . . . . 1.2 113.194 -178.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.41 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -122.24 38.56 4.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.697 -1.138 . . . . 0.22 112.647 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 171' ' ' PHE . 6.7 tp -46.79 130.38 11.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.094 0.473 . . . . 1.02 110.398 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -142.86 114.47 8.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.75 -0.659 . . . . 0.33 110.373 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -113.92 123.88 70.02 Favored 'Isoleucine or valine' 0 C--O 1.263 1.77 0 CA-C-O 122.841 1.305 . . . . 0.69 112.961 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -119.61 166.76 12.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.923 -1.49 . . . . 1.26 109.886 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 8.9 ptmt -120.71 144.67 48.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.008 1.484 . . . . 1.82 115.008 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 100.64 -36.31 4.24 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 112.417 -2.174 . . . . 0.22 118.181 174.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.87 158.44 0.43 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.57 2.185 . . . . 0.29 114.324 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.648 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.34 -26.93 24.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.953 -1.022 . . . . 0.57 110.37 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.693 -0.685 . . . . 2.31 111.149 -178.803 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.1 tp . . . . . 0 C--O 1.234 0.242 0 CA-C-O 121.33 0.586 . . . . 0.41 110.272 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.695 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.2 -19.87 9.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.262 -0.881 . . . . 0.33 110.877 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.17 -20.06 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.058 0.392 . . . . 2.09 112.058 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -103.5 -28.4 11.79 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.623 -0.431 . . . . 1.99 111.02 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -42.06 147.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.677 0.275 . . . . 0.21 111.601 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -139.6 -22.64 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.815 -0.754 . . . . 0.86 111.085 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.501 ' O ' HG22 ' A' ' 172' ' ' ILE . 32.7 t90 -173.39 139.71 0.78 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.626 -0.429 . . . . 0.28 110.011 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.04 146.04 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.605 0.224 . . . . 0.2 111.605 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -146.99 126.7 4.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 114.255 1.206 . . . . 0.67 114.255 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.563 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 7.3 t-20 -115.37 97.13 6.0 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.619 -0.718 . . . . 1.27 110.146 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.51 107.33 3.33 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 120.552 -0.459 . . . . 0.37 110.13 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.6 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 166.14 -74.75 0.15 Allowed Glycine 0 C--N 1.338 0.687 0 O-C-N 124.675 1.234 . . . . 0.67 112.662 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.458 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -85.62 -125.13 1.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.883 -0.675 . . . . 1.12 111.993 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -168.0 120.67 0.88 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.65 0.738 . . . . 2.02 111.214 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.724 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 47.61 95.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.319 -1.31 . . . . 1.22 113.009 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.546 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 18.5 t60 -125.46 137.08 53.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 118.988 -1.085 . . . . 0.34 113.069 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.0 t -107.43 101.59 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.588 -1.187 . . . . 1.18 109.912 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -67.12 157.82 32.69 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.85 -0.613 . . . . 1.17 110.627 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.26 -55.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 124.849 1.343 . . . . 0.6 112.828 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -55.53 -22.74 22.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.126 0.489 . . . . 0.46 110.339 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.43 36.03 2.75 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.394 -0.821 . . . . 0.29 112.165 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.442 HD11 ' HG ' ' A' ' 6' ' ' LEU . 35.9 mm -103.33 125.49 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.655 -0.498 . . . . 0.43 109.655 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.4 t60 -106.34 131.32 53.69 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.76 1.393 . . . . 0.52 114.76 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.78 140.84 34.5 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.956 -1.128 . . . . 3.0 107.956 175.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' SER . 77.2 mtp180 -63.31 -137.68 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.383 0.427 . . . . 2.9 111.135 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.8 100.01 3.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.364 0.266 . . . . 2.71 111.484 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.422 ' OD1' ' HD3' ' A' ' 65' ' ' ARG . 34.9 t70 35.59 69.78 1.09 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 111.985 0.365 . . . . 1.98 111.985 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 C-N-CA 122.852 2.368 . . . . 1.53 114.496 -179.44 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 121.333 0.587 . . . . 0.83 110.043 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 53' ' ' SER . 10.3 mp -76.89 -47.78 20.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.784 1.031 . . . . 1.69 113.784 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -70.06 26.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.268 0.84 . . . . 2.56 113.268 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 51' ' ' LEU . 8.1 t -147.79 156.79 43.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.09 0.472 . . . . 0.97 111.637 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 58' ' ' GLN . 7.9 t30 -71.95 148.22 91.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.729 -0.669 . . . . 1.96 109.878 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.608 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.16 -54.67 2.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.525 2.15 . . . . 0.66 114.615 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 9.8 mm-40 -62.39 -57.95 9.44 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.88 0.848 . . . . 1.82 110.994 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 23.8 t70 -69.04 -6.57 28.91 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.723 -0.671 . . . . 1.91 109.623 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 12.5 tt0 -69.2 -42.44 75.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.61 -1.626 . . . . 1.5 106.61 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.65 -57.61 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 114.329 -1.305 . . . . 1.22 109.158 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.563 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.3 tt -54.31 -61.04 2.56 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.547 -0.751 . . . . 1.05 109.345 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.551 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 2.3 m-85 -52.79 -15.14 0.66 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.585 -0.734 . . . . 0.9 111.097 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 63' ' ' THR . 7.0 tt0 -119.63 -117.94 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.661 0.615 . . . . 1.8 112.661 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.572 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 2.7 p 36.44 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.623 0.769 . . . . 1.05 112.669 -176.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.6 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.7 pt-20 -101.53 146.34 27.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.309 0.855 . . . . 2.05 113.309 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HD3' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -104.43 -144.43 0.37 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.723 -1.126 . . . . 3.58 109.935 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.35 -175.51 2.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.496 0.189 . . . . 4.25 110.543 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -138.63 160.05 40.58 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.82 0.343 . . . . 4.35 111.482 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -154.6 -103.75 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.144 -0.48 . . . . 3.17 111.024 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -174.41 124.85 0.31 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.495 0.188 . . . . 2.39 110.803 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.543 ' H ' HD21 ' A' ' 164' ' ' ASN . 21.0 t 50.33 96.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.347 -0.388 . . . . 0.99 111.699 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -166.31 167.09 16.26 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.217 -0.447 . . . . 1.26 111.105 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -174.28 -170.59 37.72 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.28 -0.962 . . . . 0.66 114.045 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -109.31 169.56 8.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.532 0.682 . . . . 0.83 112.532 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.23 136.65 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.612 -1.176 . . . . 2.27 110.439 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.449 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.4 mp -127.25 86.84 57.81 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 112.153 0.427 . . . . 0.34 112.153 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -54.41 130.34 39.45 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.244 1.963 . . . . 0.8 112.418 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 74.2 mt -126.48 150.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.206 -0.452 . . . . 0.38 111.294 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -142.86 0.75 1.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 2.96 111.201 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.11 170.11 12.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.477 0.179 . . . . 2.13 110.769 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.53 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.04 171.24 9.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.339 0.59 . . . . 0.37 111.912 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.44 -155.58 23.06 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 109.8 -1.32 . . . . 0.21 109.8 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.1 mt-10 -97.41 108.38 21.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.128 1.464 . . . . 2.03 109.107 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -95.57 126.47 40.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.926 -0.71 . . . . 0.26 109.22 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 177' ' ' ALA . 16.1 t -112.68 113.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.906 -1.043 . . . . 0.54 111.386 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tt -95.67 104.02 15.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.566 -1.197 . . . . 1.23 110.445 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.15 126.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 114.507 -1.224 . . . . 1.31 108.705 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.753 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.8 pp -135.67 141.15 44.95 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.569 -0.852 . . . . 1.37 111.04 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.735 ' HZ3' ' HA ' ' A' ' 126' ' ' ALA . 0.6 OUTLIER -107.13 124.29 49.48 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.282 -0.967 . . . . 2.97 109.495 177.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CD2' HD21 ' A' ' 115' ' ' LEU . 7.7 m-85 -105.73 142.36 35.6 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.398 -0.819 . . . . 0.3 109.305 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.979 0.419 . . . . 0.41 111.117 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.407 ' NE2' ' HG3' ' A' ' 100' ' ' LYS . 14.1 pt20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.875 0.369 . . . . 2.96 110.742 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.6 m -107.26 150.47 26.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.07 -0.514 . . . . 1.55 112.277 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 47.24 39.93 9.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.518 -0.764 . . . . 2.33 111.842 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -133.48 -48.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.751 -0.463 . . . . 2.51 109.751 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HG3' ' NE2' ' A' ' 96' ' ' GLN . 66.5 mttm -98.05 86.8 3.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.829 -0.623 . . . . 3.1 109.558 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.0 144.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 1.31 109.461 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -130.45 178.59 6.48 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.633 0.605 . . . . 0.69 112.633 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -122.05 139.65 53.45 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.94 -0.304 . . . . 2.01 111.154 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.1 132.05 52.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-N 116.084 -0.507 . . . . 0.46 112.138 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.54 HH21 HG21 ' A' ' 158' ' ' VAL . 8.5 mtt180 -133.72 156.48 47.87 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 113.234 0.827 . . . . 1.85 113.234 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 25.3 m -122.15 119.27 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 114.853 -1.067 . . . . 1.1 109.049 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.552 ' ND2' ' HA ' ' A' ' 153' ' ' LEU . 0.6 OUTLIER 56.27 26.39 10.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.922 -0.77 . . . . 1.77 108.922 -175.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.29 39.64 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.41 112.784 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -117.83 112.11 19.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.943 0.72 . . . . 0.46 112.943 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -61.84 127.67 32.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.634 -0.426 . . . . 0.66 111.24 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 t -123.64 -32.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.107 -0.701 . . . . 0.8 109.107 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.99 90.18 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.078 -0.712 . . . . 0.51 109.078 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 113' ' ' LYS . 16.1 ptpt -107.53 100.91 10.29 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.032 0.92 . . . . 2.44 111.76 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 18.5 m-20 131.2 27.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.27 -2.241 . . . . 2.56 108.037 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 89' ' ' PHE . 45.4 tp -56.41 96.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.952 -1.022 . . . . 1.1 112.636 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -108.23 92.31 4.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.605 -1.18 . . . . 1.99 107.829 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 121' ' ' VAL . 43.3 mt -51.88 -35.95 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.47 0.915 . . . . 0.63 113.47 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -69.2 -54.64 13.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.304 0.483 . . . . 0.9 112.304 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.98 -27.28 66.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.545 0.572 . . . . 0.76 112.545 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -72.66 -58.27 3.49 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.879 0.696 . . . . 2.68 112.879 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 117' ' ' ILE . 8.5 p -97.48 -35.15 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.129 0.418 . . . . 1.41 112.129 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.8 -129.2 8.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.651 -0.785 . . . . 1.06 112.368 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -88.82 110.47 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.642 0.258 . . . . 3.51 110.619 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.3 t 51.46 -108.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 1.68 110.529 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.4 p 48.46 -171.77 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.532 0.206 . . . . 0.8 111.325 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.735 ' HA ' ' HZ3' ' A' ' 88' ' ' LYS . . . -102.85 121.95 43.54 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.305 0.854 . . . . 0.44 113.305 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.568 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.1 t60 -100.35 135.35 41.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.816 -1.179 . . . . 0.38 107.816 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -145.39 130.55 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.075 0.768 . . . . 2.09 113.075 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -111.34 125.9 54.34 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.224 -0.898 . . . . 2.28 109.403 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -105.86 110.1 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.71 109.534 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.12 86.03 25.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.744 0.646 . . . . 1.38 112.744 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 140.03 75.57 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.875 1.717 . . . . 0.22 111.622 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.0 mt -132.13 156.14 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.21 110.631 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 19.4 p -130.73 106.76 8.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.121 0.486 . . . . 1.11 110.719 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 24.0 mt -107.08 121.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.602 -0.726 . . . . 0.23 109.867 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -145.53 141.22 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.577 -0.283 . . . . 1.91 110.571 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm 60.72 20.7 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.56 . . . . 3.11 110.984 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.02 60.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.32 113.151 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' HG23 ' A' ' 135' ' ' ILE . 3.6 mmmm -117.83 155.52 29.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.864 0.332 . . . . 2.19 110.32 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -115.22 131.36 56.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.077 0.465 . . . . 0.37 112.12 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.507 ' N ' HD23 ' A' ' 140' ' ' LEU . 20.8 t -117.9 111.2 18.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.63 -0.714 . . . . 0.9 109.5 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 142' ' ' VAL . 6.5 p -107.33 102.27 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.03 -0.532 . . . . 0.53 111.218 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.29 -92.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.904 -0.589 . . . . 2.05 111.66 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.44 6.21 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.6 113.18 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.4 132.26 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.203 -0.295 . . . . 2.02 110.203 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.5 p -105.48 140.69 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.198 0.523 . . . . 1.3 111.658 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.1 m -154.03 173.01 16.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.421 -0.809 . . . . 1.12 109.621 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.28 136.66 38.92 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.86 -0.336 . . . . 1.11 111.163 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 40.3 t80 -79.72 136.68 36.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.117 -1.068 . . . . 0.28 108.117 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.2 m -148.56 95.11 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.835 -0.746 . . . . 1.55 112.495 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.84 -70.0 1.87 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.121 0.809 . . . . 0.46 115.121 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.623 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -149.98 178.17 9.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.776 0.788 . . . . 1.8 112.945 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -103.0 128.07 49.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.416 -1.327 . . . . 1.24 107.416 177.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.416 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 6.7 t -117.16 118.45 32.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.359 1.244 . . . . 1.28 114.359 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 86.9 t -93.96 99.29 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.471 -0.937 . . . . 0.59 108.471 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.7 tt0 -109.69 129.04 55.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.588 -0.733 . . . . 2.48 111.763 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -121.71 135.6 54.95 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.018 -0.537 . . . . 1.54 110.004 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.54 HG21 HH21 ' A' ' 105' ' ' ARG . 11.0 t -109.98 143.87 19.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.043 -0.98 . . . . 0.77 111.482 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -59.17 143.37 49.11 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.167 -0.924 . . . . 1.97 111.09 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -120.39 -16.01 4.84 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.951 -0.642 . . . . 1.12 111.912 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -156.44 -61.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 3.81 110.148 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -177.54 151.2 0.73 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.835 -0.621 . . . . 3.82 110.188 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.95 82.09 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.73 0.3 . . . . 1.4 110.857 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.543 HD21 ' H ' ' A' ' 70' ' ' SER . 2.9 m-20 -47.3 159.02 0.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 2.0 110.325 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 164' ' ' ASN . 2.8 Cg_exo -32.22 102.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.39 2.06 . . . . 2.58 111.711 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.589 ' HB2' ' NZ ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -56.9 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.026 -0.988 . . . . 3.71 113.19 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 11.6 t -91.62 134.45 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 120.246 -0.582 . . . . 0.92 112.295 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 4.7 t -130.89 136.47 48.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.818 -0.628 . . . . 1.2 112.102 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -129.42 34.44 4.37 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.304 0.853 . . . . 0.22 113.304 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -36.53 136.76 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.563 0.579 . . . . 1.02 112.563 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -154.84 101.68 2.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.791 -0.641 . . . . 0.33 110.777 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -109.09 128.14 65.22 Favored 'Isoleucine or valine' 0 C--O 1.262 1.761 0 CA-C-O 122.874 1.321 . . . . 0.69 112.428 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.419 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.3 ppp? -121.35 166.61 13.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.423 -1.717 . . . . 1.26 109.636 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -120.37 153.24 36.77 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 115.262 1.579 . . . . 1.82 115.262 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 92.1 -35.06 4.13 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 111.93 -2.395 . . . . 0.22 117.725 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.94 159.91 0.63 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.035 1.918 . . . . 0.29 113.962 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.63 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.17 -36.9 20.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.368 -0.833 . . . . 0.57 111.688 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.42 . . . . 2.31 111.966 -178.542 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.44 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.9 tp . . . . . 0 C--O 1.233 0.223 0 CA-C-O 121.258 0.552 . . . . 0.41 110.496 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.613 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.75 -20.89 24.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.4 -0.818 . . . . 0.33 110.985 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.6 -15.74 61.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 2.09 111.754 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 41.4 mmtt -107.92 -27.08 10.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.852 -0.339 . . . . 1.99 111.486 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.0 p -42.87 145.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 111.883 0.327 . . . . 0.21 111.883 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.07 -23.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 119.981 -0.688 . . . . 0.86 111.352 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.639 ' O ' HG22 ' A' ' 172' ' ' ILE . 27.0 t90 -172.25 127.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.773 -0.371 . . . . 0.28 110.124 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.21 143.65 29.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.816 -0.175 . . . . 0.2 110.871 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -146.6 126.44 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 114.36 1.244 . . . . 0.67 114.36 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -115.3 95.11 5.02 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.165 -0.614 . . . . 1.27 110.454 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.865 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -67.53 116.16 7.95 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.525 -0.761 . . . . 0.37 109.64 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.597 ' HA3' ' C ' ' A' ' 63' ' ' THR . . . 145.35 -51.8 0.6 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.706 -1.588 . . . . 0.67 112.157 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.01 -143.8 15.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.896 -0.669 . . . . 1.12 112.211 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.16 119.41 5.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.604 0.202 . . . . 2.02 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 80.6 p 36.36 99.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.76 0.663 . . . . 1.22 112.584 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.555 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 76.4 t60 -122.85 151.94 41.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.267 -0.573 . . . . 0.34 112.47 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -122.32 103.5 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.224 -0.898 . . . . 1.18 109.784 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.7 153.43 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 1.17 110.523 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 25' ' ' HIS . 17.8 m -43.31 -52.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 124.217 0.948 . . . . 0.6 113.382 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.473 ' N ' HG23 ' A' ' 24' ' ' VAL . 82.6 m-70 -57.99 -18.74 25.84 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.12 0.486 . . . . 0.46 110.609 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.32 36.29 3.38 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.435 -0.802 . . . . 0.29 112.334 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.44 HD11 ' HG ' ' A' ' 6' ' ' LEU . 31.1 mm -103.3 122.5 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.401 -0.592 . . . . 0.43 109.401 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.555 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.5 t60 -105.71 133.05 51.07 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 114.456 1.28 . . . . 0.52 114.456 -176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.2 134.6 41.81 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.323 -0.991 . . . . 3.0 108.323 176.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 15.9 ptm180 -96.33 114.11 25.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.362 0.601 . . . . 2.9 112.255 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -12.05 139.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.234 1.568 . . . . 2.71 115.234 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 65' ' ' ARG . 8.3 p-10 -22.68 89.23 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 114.066 -1.425 . . . . 1.98 113.67 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 CA--C 1.534 0.519 0 C-N-CA 122.909 2.406 . . . . 1.53 113.454 179.24 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.681 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.2 tp . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 110.172 -0.307 . . . . 0.83 110.172 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.681 ' HB2' ' O ' ' A' ' 50' ' ' ILE . 2.6 tt 130.67 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.869 1.667 . . . . 1.69 111.652 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.83 24.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.528 0.566 . . . . 2.56 112.528 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -136.6 157.95 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.612 . . . . 0.97 112.65 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLN . 35.8 t30 -70.86 153.16 94.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.05 -0.977 . . . . 1.96 108.788 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.454 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 59.7 Cg_exo -45.86 -59.53 1.16 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.499 1.466 . . . . 0.66 112.872 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 1.3 pm0 -56.18 -54.84 40.39 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 122.174 0.988 . . . . 1.82 111.026 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.51 -13.91 62.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.42 -0.809 . . . . 1.91 110.958 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' ASN . 1.6 pt20 -65.27 -40.21 93.62 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.342 -1.725 . . . . 1.5 106.342 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -56.16 -52.33 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.668 -1.151 . . . . 1.22 109.145 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.4 tp -70.31 -9.14 55.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.209 -0.905 . . . . 1.05 111.772 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -119.7 15.08 12.71 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.458 0.646 . . . . 0.9 110.018 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.559 ' O ' HG13 ' A' ' 167' ' ' VAL . 7.8 tt0 -136.51 -105.37 0.2 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.911 -1.041 . . . . 1.8 110.249 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.597 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 37.4 p 4.6 121.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.485 0.92 . . . . 1.05 113.485 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.493 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 9.5 pt-20 -111.59 150.74 29.63 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.067 0.765 . . . . 2.05 113.067 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.481 ' HB2' ' N ' ' A' ' 17' ' ' GLY . 1.3 ttt85 -137.25 88.39 2.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.119 -0.946 . . . . 3.58 109.809 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -84.48 145.74 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 4.25 111.464 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -117.95 -78.99 0.59 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.894 -0.594 . . . . 4.35 110.805 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -155.98 -89.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.449 -0.342 . . . . 3.17 111.029 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -157.57 155.35 30.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.384 0.135 . . . . 2.39 110.77 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t 47.87 86.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.99 110.313 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.454 ' CE2' ' ND2' ' A' ' 164' ' ' ASN . 2.0 p90 -156.13 166.21 34.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 1.26 111.441 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.36 -174.92 43.27 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.923 -1.132 . . . . 0.66 114.213 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.2 173.13 6.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 0.83 112.265 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.5 137.14 53.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.804 -1.089 . . . . 2.27 110.212 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.486 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -128.32 87.62 54.78 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.975 0.361 . . . . 0.34 111.975 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.94 131.35 44.97 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 121.815 1.677 . . . . 0.8 111.711 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 78' ' ' LYS . 65.4 mt -123.2 153.74 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.883 0.373 . . . . 0.38 111.643 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' N ' HG22 ' A' ' 77' ' ' ILE . 26.4 mtmm -143.44 -0.51 1.09 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.036 -0.529 . . . . 2.96 111.597 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -124.77 167.95 13.9 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 120.77 0.319 . . . . 2.13 111.2 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -123.99 164.05 20.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.232 0.539 . . . . 0.37 110.877 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.9 -146.43 17.24 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 109.729 -1.349 . . . . 0.21 109.729 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 10.8 mm-40 -103.93 108.37 19.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.685 1.243 . . . . 2.03 109.146 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.438 ' CZ ' ' HD3' ' A' ' 174' ' ' LYS . 3.9 m-85 -94.44 126.42 39.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.26 108.73 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 177' ' ' ALA . 23.0 t -112.45 110.97 34.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.096 -0.956 . . . . 0.54 111.323 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -97.51 103.65 15.6 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.571 -1.195 . . . . 1.23 110.684 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.42 139.58 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.507 -1.224 . . . . 1.31 108.473 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.38 152.3 40.51 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.838 -0.745 . . . . 1.37 111.826 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 15.3 tptt -108.41 117.74 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.06 -0.656 . . . . 2.97 110.615 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.9 m-85 -105.23 145.07 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.169 -1.049 . . . . 0.3 108.169 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.47 0.54 0 C-N-CA 119.136 -1.025 . . . . 0.41 113.53 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.425 ' HG2' ' NE2' ' A' ' 99' ' ' GLN . 8.5 tp-100 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.813 0.34 . . . . 2.96 110.982 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.8 m -97.18 153.97 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 1.55 111.056 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 54.75 55.93 7.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.576 . . . . 2.33 111.277 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.425 ' NE2' ' HG2' ' A' ' 96' ' ' GLN . 9.2 tt0 -151.16 -51.09 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.128 -0.693 . . . . 2.51 109.128 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 30.2 mmtm -90.48 78.26 6.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.729 -0.841 . . . . 3.1 108.729 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.49 111.72 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.587 -0.733 . . . . 1.31 110.437 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.66 178.79 4.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.219 0.822 . . . . 0.69 113.219 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.8 139.97 53.45 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 115.83 -0.623 . . . . 2.01 111.618 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.4 133.2 33.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 115.99 -0.55 . . . . 0.46 111.752 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.629 HH21 HG21 ' A' ' 158' ' ' VAL . 1.0 OUTLIER -133.69 152.26 51.84 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 112.94 0.719 . . . . 1.85 112.94 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.6 m -118.17 117.57 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.864 -1.062 . . . . 1.1 109.224 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.467 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 58.55 27.05 15.12 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.043 -0.725 . . . . 1.77 109.043 -176.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.69 20.52 43.66 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.976 -1.011 . . . . 0.41 112.734 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.0 m-70 -118.18 109.59 16.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.076 0.769 . . . . 0.46 113.076 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.4 p -62.91 118.28 7.56 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.543 -0.463 . . . . 0.66 111.207 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.82 -32.77 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.044 -0.724 . . . . 0.8 109.044 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.405 HG11 ' OE2' ' A' ' 129' ' ' GLU . 0.9 OUTLIER -131.9 91.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.905 -0.589 . . . . 0.51 109.822 178.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 16.9 ttmt -107.17 82.34 1.66 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.771 0.796 . . . . 2.44 110.283 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.8 p30 151.8 39.8 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.975 -1.92 . . . . 2.56 108.594 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.16 88.13 0.17 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.066 0.765 . . . . 1.1 113.066 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -103.29 86.13 2.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.366 -1.346 . . . . 1.99 107.366 175.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 46.0 mt -50.52 -44.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.806 -0.634 . . . . 0.63 112.095 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.73 -58.66 6.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.9 111.247 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.402 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 15.1 t70 -58.97 -27.03 64.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 0.76 112.034 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.528 ' NE ' ' HA ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -64.61 -59.63 4.06 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.286 0.476 . . . . 2.68 112.286 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.23 -40.81 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.108 0.411 . . . . 1.41 112.108 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.92 -129.45 3.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.566 -0.826 . . . . 1.06 112.65 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' THR . 22.3 t-80 -94.34 110.92 22.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 3.51 110.971 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.8 t 63.28 -130.56 0.47 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.843 -0.617 . . . . 1.68 111.195 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 4.4 p 58.83 -166.72 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.659 0.266 . . . . 0.8 110.351 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.5 135.05 49.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.969 0.729 . . . . 0.44 112.969 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.2 t60 -112.54 148.88 33.57 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -144.47 135.53 25.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.896 0.702 . . . . 2.09 112.896 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.405 ' OE2' HG11 ' A' ' 112' ' ' VAL . 20.0 mt-10 -124.38 122.02 36.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.483 -0.78 . . . . 2.28 108.973 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.36 126.33 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.078 -0.51 . . . . 0.71 110.736 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.1 mp -128.83 85.89 58.98 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.279 0.474 . . . . 1.38 112.279 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -62.04 143.28 94.82 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.628 1.552 . . . . 0.22 111.413 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 134' ' ' SER . 32.7 mt -136.97 159.22 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.21 110.941 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 133' ' ' ILE . 41.2 p -134.24 110.22 9.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.11 111.195 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 139' ' ' LYS . 18.0 mt -108.4 128.37 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.793 -0.639 . . . . 0.23 110.121 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -146.04 140.64 26.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.321 . . . . 1.91 110.86 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt 58.74 14.57 3.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 3.11 111.369 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.94 21.15 34.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.622 -0.799 . . . . 0.32 112.747 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 135' ' ' ILE . 96.9 mttt -118.52 152.29 36.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.609 0.205 . . . . 2.19 110.659 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.24 132.96 54.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.274 0.559 . . . . 0.37 112.145 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.543 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.6 t -121.11 109.17 14.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.477 -0.783 . . . . 0.9 109.782 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 142' ' ' VAL . 9.9 p -103.78 112.58 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.272 0.558 . . . . 0.53 111.019 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 54.19 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.704 -0.68 . . . . 2.05 112.262 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.43 27.43 3.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.51 -0.852 . . . . 0.6 113.176 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -133.8 138.96 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.187 -0.301 . . . . 2.02 110.187 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.52 137.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.106 0.479 . . . . 1.3 111.294 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.6 m -159.32 129.68 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 1.12 109.885 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.5 p -59.14 143.21 49.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.207 -0.451 . . . . 1.11 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -79.3 139.18 37.91 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.301 -0.629 . . . . 0.28 109.301 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 t -135.37 95.29 3.25 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.078 0.77 . . . . 1.55 113.078 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.48 -59.16 1.2 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.675 1.03 . . . . 0.46 115.675 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.486 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -152.64 168.61 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.035 0.918 . . . . 1.8 112.68 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.467 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -92.02 126.32 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.833 -1.173 . . . . 1.24 107.833 177.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.448 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.3 t -114.95 117.85 31.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.517 0.932 . . . . 1.28 113.517 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.462 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 92.1 t -93.02 97.89 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.049 -0.723 . . . . 0.59 109.049 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.8 tt0 -104.91 141.08 37.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.546 -0.752 . . . . 2.48 110.717 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -131.04 145.48 52.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 1.54 109.844 178.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.629 HG21 HH21 ' A' ' 105' ' ' ARG . 11.5 t -116.74 140.86 37.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.642 -0.708 . . . . 0.77 110.662 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.24 148.57 26.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.444 -0.798 . . . . 1.97 111.946 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -124.5 -27.26 1.33 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.487 -0.779 . . . . 1.12 111.666 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -175.22 51.22 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.729 0.3 . . . . 3.81 110.339 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 62.41 159.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.141 -0.481 . . . . 3.82 111.214 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 54.43 91.88 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.588 0.709 . . . . 1.4 110.723 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -50.98 174.95 0.08 OUTLIER Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 114.137 -1.392 . . . . 2.0 109.517 178.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -42.49 -16.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.79 1.66 . . . . 2.58 112.56 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.556 ' NZ ' ' HB3' ' A' ' 166' ' ' LYS . 1.5 mtpm? 75.73 -76.7 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.736 0.814 . . . . 3.71 111.554 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 62' ' ' GLN . 7.4 t -83.72 131.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 C-N-CA 119.451 -0.899 . . . . 0.92 111.117 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.865 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -133.76 123.48 24.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.093 0.871 . . . . 1.2 111.569 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -119.83 36.94 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.64 -1.164 . . . . 0.22 113.76 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.53 131.77 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.903 0.335 . . . . 1.02 111.903 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.477 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -150.38 99.45 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.33 110.395 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -109.16 124.57 65.93 Favored 'Isoleucine or valine' 0 C--O 1.262 1.727 0 CA-C-O 122.763 1.268 . . . . 0.69 112.547 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.2 ptm -115.71 164.05 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.102 -1.408 . . . . 1.26 109.441 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 1.7 tptp -120.31 137.93 53.98 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.688 1.366 . . . . 1.82 114.688 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.15 -34.54 5.71 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 118.198 2.039 . . . . 0.22 118.198 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.79 156.03 0.45 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.732 2.266 . . . . 0.29 114.447 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.675 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.34 -21.82 28.74 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.099 -0.955 . . . . 0.57 110.336 177.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.675 -0.693 . . . . 2.31 111.434 -178.748 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.427 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.2 tp . . . . . 0 C--O 1.234 0.273 0 CA-C-O 121.284 0.564 . . . . 0.41 110.43 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.658 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.38 -21.06 22.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.444 -0.798 . . . . 0.33 110.585 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.33 -18.34 64.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.562 . . . . 2.09 111.314 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.05 -28.4 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.916 -0.314 . . . . 1.99 111.549 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -44.54 145.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.839 -0.345 . . . . 0.21 111.683 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.7 pt -139.37 -23.44 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 120.222 -0.591 . . . . 0.86 111.137 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.594 ' O ' HG22 ' A' ' 172' ' ' ILE . 31.9 t90 -170.69 126.45 0.73 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.393 -0.523 . . . . 0.28 110.355 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -144.41 141.07 29.41 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.675 -0.239 . . . . 0.2 111.275 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -147.18 126.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 114.028 1.122 . . . . 0.67 114.028 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 22.2 t-20 -116.8 96.13 5.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.323 -0.551 . . . . 1.27 110.933 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.29 115.1 5.24 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 109.627 -0.508 . . . . 0.37 109.627 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 162.62 -56.18 0.3 Allowed Glycine 0 N--CA 1.441 -0.992 0 O-C-N 124.093 0.871 . . . . 0.67 113.855 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -115.19 -120.88 3.41 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.744 -0.741 . . . . 1.12 112.946 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 20' ' ' SER . 28.0 tt0 -154.74 120.28 5.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.89 0.33 . . . . 2.02 111.89 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 24.6 t 24.09 115.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.675 1.361 . . . . 1.22 114.675 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.494 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 17.1 t60 -137.74 151.19 47.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.303 0.573 . . . . 0.34 111.865 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.99 106.97 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.391 -0.822 . . . . 1.18 111.507 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.09 153.96 42.13 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.292 -0.413 . . . . 1.17 110.231 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 25' ' ' HIS . 12.5 m -44.26 -53.07 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 113.445 0.905 . . . . 0.6 113.445 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.437 ' N ' HG23 ' A' ' 24' ' ' VAL . 82.6 m-70 -55.82 -19.88 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.194 0.521 . . . . 0.46 110.565 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.38 35.01 3.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.407 -0.815 . . . . 0.29 112.144 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.427 HD11 ' HG ' ' A' ' 6' ' ' LEU . 33.4 mm -102.75 120.52 52.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 0.43 109.454 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 10.3 t60 -103.52 129.12 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.335 1.235 . . . . 0.52 114.335 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.82 139.44 36.51 Favored 'General case' 0 CA--C 1.524 -0.04 0 N-CA-C 107.468 -1.308 . . . . 3.0 107.468 176.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.442 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 15.5 ptm180 -103.82 126.0 50.64 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.529 0.68 . . . . 2.9 112.439 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 31' ' ' LYS . 4.5 tmmm? -20.32 141.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.445 1.498 . . . . 2.71 114.708 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -27.86 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.072 -1.422 . . . . 1.98 112.467 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 C--N 1.349 0.605 0 C-N-CA 122.939 2.426 . . . . 1.53 114.627 -179.351 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 109.03 -0.73 . . . . 0.83 109.03 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 mp -97.51 -37.46 9.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 1.69 112.897 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -82.36 38.94 0.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.594 0.59 . . . . 2.56 112.594 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -153.3 165.97 34.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 0.97 111.663 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.8 t30 -76.76 146.69 76.73 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.891 -0.595 . . . . 1.96 109.764 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.635 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.44 -55.62 1.83 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.466 2.111 . . . . 0.66 114.272 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.718 ' O ' HG12 ' A' ' 59' ' ' VAL . 12.0 mm-40 -64.5 -56.76 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.721 0.772 . . . . 1.82 111.167 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' OD1' HD13 ' A' ' 60' ' ' LEU . 47.2 t0 -70.58 -2.54 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.15 -0.62 . . . . 1.91 110.304 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.635 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 14.5 tt0 -73.32 -56.15 5.45 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.701 -1.222 . . . . 1.5 107.701 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 56' ' ' GLU . 11.0 p -52.46 -35.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.039 -1.097 . . . . 1.22 108.039 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -65.18 -68.83 0.33 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.42 -0.512 . . . . 1.05 110.1 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -54.12 -3.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.026 0.931 . . . . 0.9 111.9 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 63' ' ' THR . 26.7 tt0 -109.96 -113.92 0.31 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.585 -0.734 . . . . 1.8 110.351 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 59' ' ' VAL . 57.2 p 29.87 123.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.699 1.37 . . . . 1.05 114.699 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.483 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -127.26 147.44 50.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.868 -0.606 . . . . 2.05 110.265 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.509 HH11 ' HG3' ' A' ' 65' ' ' ARG . 2.3 ptm180 -136.81 -173.25 3.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.686 0.279 . . . . 3.58 110.45 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -49.21 148.95 2.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.371 0.508 . . . . 4.25 112.371 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -135.43 -179.83 5.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 4.35 110.525 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -156.6 -120.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.725 -0.216 . . . . 3.17 111.106 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -153.29 129.33 10.33 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.468 0.175 . . . . 2.39 110.823 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.678 ' H ' HD21 ' A' ' 164' ' ' ASN . 23.0 t 56.59 91.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.977 0.417 . . . . 0.99 110.985 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -164.29 163.91 22.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.905 -0.588 . . . . 1.26 110.886 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -169.45 -174.27 37.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.15 -1.024 . . . . 0.66 113.973 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -108.51 165.98 11.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.44 0.638 . . . . 0.83 112.138 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.74 126.97 51.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.824 -1.08 . . . . 2.27 110.218 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.501 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -118.43 87.53 31.01 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 111.835 0.309 . . . . 0.34 111.835 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.12 133.62 58.9 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 121.929 1.753 . . . . 0.8 112.021 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 78' ' ' LYS . 24.1 mt -124.11 153.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.938 0.399 . . . . 0.38 111.483 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' N ' HG22 ' A' ' 77' ' ' ILE . 59.0 mttp -140.85 0.98 1.64 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.888 -0.596 . . . . 2.96 111.027 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -129.42 170.44 13.68 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.713 0.292 . . . . 2.13 111.284 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -123.06 176.87 5.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.095 0.474 . . . . 0.37 111.242 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.36 -152.31 20.18 Favored Glycine 0 C--N 1.329 0.153 0 N-CA-C 109.868 -1.293 . . . . 0.21 109.868 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.52 108.55 19.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.858 1.329 . . . . 2.03 108.836 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -95.01 126.95 40.7 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.578 0.704 . . . . 0.26 109.677 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 177' ' ' ALA . 13.9 t -113.6 118.49 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.787 -1.097 . . . . 0.54 111.831 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 105.37 17.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.521 -1.218 . . . . 1.23 111.572 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.64 126.47 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.78 -1.1 . . . . 1.31 108.966 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.48 ' N ' HD23 ' A' ' 87' ' ' LEU . 1.8 pt? -147.17 134.88 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.63 -0.828 . . . . 1.37 111.754 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.522 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 5.3 tptp -98.02 120.74 38.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.317 -0.856 . . . . 2.97 110.828 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.579 ' CD2' HD21 ' A' ' 115' ' ' LEU . 7.5 m-85 -105.09 136.54 44.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.757 -1.201 . . . . 0.3 107.757 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 119.489 -0.884 . . . . 0.41 113.074 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 120.897 0.38 . . . . 2.96 111.069 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 73.9 m -119.1 134.4 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.55 111.254 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 71.43 -60.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.772 -0.649 . . . . 2.33 111.554 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -45.48 -38.29 6.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.409 -0.36 . . . . 2.51 111.139 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.836 ' HZ2' ' HB2' ' A' ' 100' ' ' LYS . 4.7 ttmp? -101.95 82.55 2.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.305 0.574 . . . . 3.1 110.778 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.77 139.91 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.293 -0.867 . . . . 1.31 109.618 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.456 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 61.6 m-85 -119.92 176.85 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.756 0.65 . . . . 0.69 112.756 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -127.15 140.43 52.26 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.213 0.53 . . . . 2.01 112.31 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.89 136.45 55.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.052 -0.977 . . . . 0.46 112.008 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 5.1 mtt180 -135.5 156.68 48.5 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 113.264 0.839 . . . . 1.85 113.264 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' ND2' ' A' ' 107' ' ' ASN . 39.5 t -122.9 123.34 67.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 114.558 -1.201 . . . . 1.1 109.298 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.6 ' ND2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 53.59 26.1 5.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.556 -0.905 . . . . 1.77 108.556 -175.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.83 17.15 57.03 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.278 -0.873 . . . . 0.41 112.74 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 88.9 m-70 -112.37 112.89 24.79 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.895 0.702 . . . . 0.46 112.895 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 p -62.77 127.17 30.0 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.864 -0.734 . . . . 0.66 110.454 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.06 -30.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 0.8 109.316 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.37 88.97 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.804 -0.814 . . . . 0.51 108.804 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -106.6 77.72 1.21 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.515 1.15 . . . . 2.44 110.773 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 p30 159.44 38.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.348 -1.751 . . . . 2.56 108.499 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.579 HD21 ' CD2' ' A' ' 89' ' ' PHE . 20.5 tp -79.36 91.64 5.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.172 0.805 . . . . 1.1 113.172 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -106.48 91.14 3.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.869 -1.16 . . . . 1.99 107.869 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.25 -32.42 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.995 0.739 . . . . 0.63 112.995 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.97 -51.56 15.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.737 -0.385 . . . . 0.9 111.303 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.27 -27.13 65.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.76 111.913 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HE ' ' CE1' ' A' ' 127' ' ' HIS . 23.8 mmm180 -77.65 -58.6 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.688 0.625 . . . . 2.68 112.688 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.52 -41.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.383 0.512 . . . . 1.41 112.383 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.65 -125.66 6.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.438 -0.887 . . . . 1.06 112.889 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.416 ' O ' HG23 ' A' ' 125' ' ' THR . 97.5 m-70 -72.42 110.34 6.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.382 . . . . 3.51 111.372 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 61.5 m 48.41 -109.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 1.68 111.685 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 123' ' ' HIS . 53.1 p 50.31 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 0.8 110.988 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.16 138.42 50.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.287 0.565 . . . . 0.44 112.234 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.459 ' CE1' ' HE ' ' A' ' 120' ' ' ARG . 1.6 t60 -108.0 151.06 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.075 -0.966 . . . . 0.38 108.416 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.85 136.51 38.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.772 0.656 . . . . 2.09 112.772 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' HD23 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -127.76 123.86 36.34 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.05 -0.977 . . . . 2.28 109.668 178.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.461 ' O ' HD13 ' A' ' 131' ' ' ILE . 53.2 mt -119.08 124.05 72.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.917 -0.583 . . . . 0.71 110.396 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 130' ' ' ILE . 50.9 mm -131.6 95.5 23.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.122 0.415 . . . . 1.38 112.122 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.99 148.84 93.05 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.646 1.564 . . . . 0.22 111.309 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 134' ' ' SER . 21.3 mt -139.64 155.96 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.336 . . . . 0.21 110.961 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 29.2 p -131.57 111.2 11.53 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.008 0.432 . . . . 1.11 111.168 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LYS . 20.3 mt -112.06 127.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.649 -0.705 . . . . 0.23 110.217 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -149.32 137.97 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.518 -0.31 . . . . 1.91 111.005 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 137' ' ' LYS . 9.4 mtmp? 62.5 13.4 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.998 -0.546 . . . . 3.11 111.468 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.61 7.64 58.89 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.59 -0.814 . . . . 0.32 112.986 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.601 ' O ' HG23 ' A' ' 135' ' ' ILE . 53.1 mtpt -108.12 167.06 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.883 0.341 . . . . 2.19 110.645 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -127.96 146.36 50.67 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.739 0.644 . . . . 0.37 112.739 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.568 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -132.2 109.7 10.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.027 -0.988 . . . . 0.9 109.335 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.2 p -109.71 111.51 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.082 -0.508 . . . . 0.53 110.349 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 61.89 -89.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 2.05 111.579 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.07 15.13 4.02 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.712 -0.756 . . . . 0.6 112.77 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.42 130.93 57.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.089 -0.337 . . . . 2.02 110.089 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.3 131.82 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.184 0.516 . . . . 1.3 110.966 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -149.59 175.37 11.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.637 -0.711 . . . . 1.12 109.496 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.4 p -99.52 138.88 35.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.7 -0.4 . . . . 1.11 111.418 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.059 -0.719 . . . . 0.28 109.059 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 t -139.6 95.86 2.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.175 0.805 . . . . 1.55 113.175 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.29 -51.02 3.22 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 115.819 1.087 . . . . 0.46 115.819 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.501 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -158.66 174.94 14.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.385 1.093 . . . . 1.8 113.543 -177.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.6 ' HG ' ' ND2' ' A' ' 107' ' ' ASN . 1.1 tp -97.69 124.69 42.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.035 -1.439 . . . . 1.24 107.123 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.4 t -114.35 116.93 29.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 118.739 -1.184 . . . . 1.28 113.443 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 47.0 t -95.61 98.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.741 -0.837 . . . . 0.59 108.741 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.3 tt0 -109.13 134.63 51.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.658 -0.701 . . . . 2.48 111.207 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -126.33 134.56 51.06 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.276 0.56 . . . . 1.54 110.345 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.447 HG21 HH21 ' A' ' 105' ' ' ARG . 99.1 t -105.8 142.04 19.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 114.73 -1.123 . . . . 0.77 110.815 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 143.01 44.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.429 -0.805 . . . . 1.97 111.57 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.76 -14.13 16.45 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.458 -0.657 . . . . 1.12 111.458 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -158.98 -64.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 3.81 110.281 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -176.72 161.9 2.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 3.82 110.783 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 57.22 71.24 0.59 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 1.4 111.282 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.678 HD21 ' H ' ' A' ' 70' ' ' SER . 5.8 m-20 -49.98 153.31 2.34 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.537 -0.756 . . . . 2.0 109.503 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.456 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -28.71 105.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.381 2.054 . . . . 2.58 112.343 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -58.14 -74.0 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.149 -0.932 . . . . 3.71 112.584 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 4.8 t -79.1 133.13 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 119.858 -0.737 . . . . 0.92 111.281 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 5.2 t -129.12 124.48 34.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.084 -0.962 . . . . 1.2 109.817 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . . . -117.47 35.46 4.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.652 0.982 . . . . 0.22 113.652 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -35.74 131.06 0.54 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.175 0.512 . . . . 1.02 111.649 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.455 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -152.46 96.71 2.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.33 109.542 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.9 OUTLIER -104.82 126.81 59.66 Favored 'Isoleucine or valine' 0 C--O 1.263 1.805 0 CA-C-O 122.625 1.202 . . . . 0.69 112.583 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ptm -118.29 162.52 18.13 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.57 -1.65 . . . . 1.26 109.254 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.97 146.45 46.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.818 1.414 . . . . 1.82 114.818 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.97 -35.44 5.0 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 112.469 -2.15 . . . . 0.22 117.837 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.463 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 153.87 0.36 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.396 2.098 . . . . 0.29 115.298 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.648 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -87.75 -31.8 19.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.379 -1.282 . . . . 0.57 110.465 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 115.712 -0.677 . . . . 2.31 111.63 -178.556 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.145 0.498 . . . . 0.41 110.267 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.67 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -57.24 -20.67 28.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 0.33 110.642 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.75 -18.29 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 2.09 111.738 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.578 ' NZ ' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -105.95 -27.04 11.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.776 -0.37 . . . . 1.99 111.091 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -45.43 146.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 120.979 -0.289 . . . . 0.21 111.311 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.24 -20.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 119.965 -0.694 . . . . 0.86 110.729 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' O ' HG22 ' A' ' 172' ' ' ILE . 13.1 t90 -173.51 129.33 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.028 -0.533 . . . . 0.28 110.042 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.82 139.29 20.48 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 122.333 -0.229 . . . . 0.2 111.296 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.2 t -147.16 131.89 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 114.324 1.231 . . . . 0.67 114.324 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 63.8 t30 -115.34 87.96 2.77 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 116.161 -0.472 . . . . 1.27 110.822 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.97 112.21 1.43 Allowed 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.648 -0.706 . . . . 0.37 110.046 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 143.97 -13.81 2.15 Favored Glycine 0 N--CA 1.442 -0.91 0 O-C-N 124.047 0.842 . . . . 0.67 114.234 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.08 -131.06 2.97 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 119.961 -1.114 . . . . 1.12 113.129 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -160.99 120.01 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 2.02 111.45 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.6 m 26.4 104.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.921 -1.036 . . . . 1.22 113.615 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.637 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.5 t60 -132.77 142.82 49.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 120.334 -0.546 . . . . 0.34 112.404 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.8 p -116.94 105.43 18.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 121.456 0.646 . . . . 1.18 111.101 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.59 158.12 34.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.38 -0.827 . . . . 1.17 110.512 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 25' ' ' HIS . 14.2 m -42.95 -50.99 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.227 0.954 . . . . 0.6 113.261 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.433 ' N ' HG23 ' A' ' 24' ' ' VAL . 85.6 m-70 -57.33 -22.16 40.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.46 110.42 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.54 34.72 3.5 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.228 -0.896 . . . . 0.29 111.757 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.5 mm -103.58 112.65 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.13 0.49 . . . . 0.43 110.403 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.637 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.1 t60 -97.59 139.01 34.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.485 1.291 . . . . 0.52 114.485 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.675 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -104.76 138.02 41.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.458 -1.246 . . . . 3.0 108.867 178.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 29.6 mtp180 -94.19 109.05 20.87 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.685 0.616 . . . . 2.9 112.03 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 32' ' ' ASP . 81.2 tttt -24.05 132.16 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.176 1.176 . . . . 2.71 114.176 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' LYS . 77.4 m-20 -2.41 80.11 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.701 1.2 . . . . 1.98 113.998 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.456 -0.685 0 C-N-CA 123.549 2.832 . . . . 1.53 112.561 179.26 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 109.779 -0.452 . . . . 0.83 109.779 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.11 -60.46 1.97 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.796 1.036 . . . . 1.69 113.796 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -71.76 32.84 0.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.408 0.892 . . . . 2.56 113.408 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 t -138.16 140.76 40.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.327 0.491 . . . . 0.97 112.327 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.505 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 6.9 t30 -62.27 145.76 93.55 Favored Pre-proline 0 C--O 1.22 -0.451 0 CA-C-N 115.538 -0.755 . . . . 1.96 109.225 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.602 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 11.3 Cg_exo -39.57 -51.18 2.89 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.594 2.196 . . . . 0.66 115.425 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.44 -56.19 12.15 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 122.407 1.098 . . . . 1.82 110.911 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.58 59.94 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.866 -1.061 . . . . 1.91 109.85 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.602 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 29.4 tt0 -64.49 -45.68 86.29 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.614 -1.625 . . . . 1.5 106.614 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 63' ' ' THR . 96.7 t -57.1 -54.4 30.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.455 -1.248 . . . . 1.22 109.99 177.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.9 tp -64.62 -12.75 48.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.9 -0.591 . . . . 1.05 112.087 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.488 ' CZ ' ' HE2' ' A' ' 88' ' ' LYS . 4.1 m-30 -108.52 -2.0 19.26 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.916 -0.584 . . . . 0.9 110.21 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.601 ' HG2' ' N ' ' A' ' 63' ' ' THR . 36.7 tt0 -123.58 -107.61 0.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.539 -0.755 . . . . 1.8 112.033 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 59' ' ' VAL . 48.2 p 42.08 -168.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.489 -0.323 . . . . 1.05 110.994 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 177.71 128.4 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.977 0.417 . . . . 2.05 111.77 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.546 ' NH2' ' HB2' ' A' ' 67' ' ' ASN . 2.2 ttp85 -112.74 -170.97 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.103 -0.499 . . . . 3.58 110.336 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -162.91 138.12 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.618 0.247 . . . . 4.25 111.128 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.546 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 48.7 t-20 -130.8 -82.54 0.53 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.415 -0.357 . . . . 4.35 110.944 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.91 -75.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.549 0.214 . . . . 3.17 111.349 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -163.82 143.26 8.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.682 -0.235 . . . . 2.39 110.69 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t 50.55 83.42 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.99 110.158 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.434 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 29.9 p90 -150.2 151.65 33.4 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.224 0.535 . . . . 1.26 111.632 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -169.23 -169.37 32.49 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.268 -0.878 . . . . 0.66 113.675 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -102.15 177.73 4.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.578 0.955 . . . . 0.83 113.578 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.68 120.89 21.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.661 -1.609 . . . . 2.27 109.663 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.99 90.66 11.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.241 0.46 . . . . 0.34 112.241 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.7 141.28 90.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.097 1.198 . . . . 0.8 111.118 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.35 151.87 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 0.38 111.32 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -144.63 2.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 2.96 110.839 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -127.33 175.17 8.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.589 0.233 . . . . 2.13 110.663 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -131.71 170.33 14.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.37 111.654 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.59 -154.64 22.65 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 109.569 -1.412 . . . . 0.21 109.569 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -96.41 109.66 22.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.976 1.388 . . . . 2.03 108.929 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.08 126.45 41.32 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.769 -0.826 . . . . 0.26 108.769 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.2 t -112.59 113.07 43.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.901 -1.045 . . . . 0.54 111.57 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.78 103.75 16.37 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.641 -1.163 . . . . 1.23 109.66 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.62 134.44 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.404 -0.816 . . . . 1.31 108.859 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -147.05 154.94 41.78 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.783 -0.767 . . . . 1.37 112.018 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HZ3' ' HB2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.89 119.12 37.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.767 -0.652 . . . . 2.97 110.172 178.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 7.7 m-85 -105.68 137.74 43.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.918 -0.583 . . . . 0.3 109.531 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.535 ' O ' HG13 ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.325 -0.477 0 N-CA-C 110.235 -0.283 . . . . 0.41 110.235 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.687 0.279 . . . . 2.96 110.631 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -97.7 162.38 13.3 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.158 0.504 . . . . 1.55 111.356 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 100' ' ' LYS . 1.9 mp0 55.63 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.88 -1.054 . . . . 2.33 110.818 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 71.33 -30.34 0.21 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.966 -1.016 . . . . 2.51 110.602 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 98' ' ' GLN . 66.4 mmtt -108.52 63.1 0.61 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.537 -0.912 . . . . 3.1 108.537 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.418 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 1.1 m -109.11 150.78 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.262 -0.881 . . . . 1.31 110.532 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -118.62 178.32 4.51 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 112.843 0.683 . . . . 0.69 112.843 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -127.67 137.67 52.57 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.062 -0.517 . . . . 2.01 111.176 177.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.88 127.01 51.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 115.89 -0.595 . . . . 0.46 111.952 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -128.31 141.44 51.44 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.141 -0.936 . . . . 1.85 113.269 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.2 m -116.93 118.76 59.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 114.149 -1.387 . . . . 1.1 109.583 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 61.92 28.5 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.882 -0.784 . . . . 1.77 108.882 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.38 89.91 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.41 111.369 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 58.6 m-70 -102.62 109.15 20.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.759 -0.721 . . . . 0.46 112.209 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -68.44 133.42 48.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.477 0.656 . . . . 0.66 112.052 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -31.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.896 -1.047 . . . . 0.8 109.636 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.25 91.03 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.197 -0.668 . . . . 0.51 109.197 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 3.3 ptpp? -109.18 77.28 1.05 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.692 1.234 . . . . 2.44 112.24 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.1 p30 153.53 40.15 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.197 -2.274 . . . . 2.56 109.353 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.408 HD11 ' OE1' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -63.18 94.42 0.07 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.247 0.546 . . . . 1.1 112.187 -178.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -102.98 84.11 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.932 -1.507 . . . . 1.99 106.932 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.3 mt -50.32 -41.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.104 -0.953 . . . . 0.63 112.628 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.01 -45.73 87.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.667 0.27 . . . . 0.9 111.482 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.11 -28.82 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.211 0.449 . . . . 0.76 112.211 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -68.35 -58.44 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.437 0.532 . . . . 2.68 112.437 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.4 p -94.39 -37.1 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.867 0.321 . . . . 1.41 111.867 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.16 -114.54 2.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.399 -0.905 . . . . 1.06 112.878 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.486 ' O ' HG23 ' A' ' 125' ' ' THR . 57.3 t-80 -104.6 114.05 28.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.714 0.292 . . . . 3.51 111.172 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.3 p 53.3 -143.22 0.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.006 -0.543 . . . . 1.68 111.316 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.0 p 64.36 -171.73 0.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.624 0.37 . . . . 0.8 110.996 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -104.71 139.54 39.37 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.692 0.626 . . . . 0.44 112.692 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.8 t60 -102.91 152.02 21.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.209 -0.905 . . . . 0.38 109.075 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -144.2 132.89 22.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.635 0.605 . . . . 2.09 112.635 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.408 ' OE1' HD11 ' A' ' 115' ' ' LEU . 29.2 mt-10 -127.65 128.42 45.46 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 2.28 109.893 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.4 mt -117.13 122.03 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.058 -0.519 . . . . 0.71 110.496 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mm -124.93 89.71 52.15 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.392 -0.367 . . . . 1.38 111.928 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -60.52 143.12 99.42 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.928 1.752 . . . . 0.22 111.918 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 24.1 mt -134.94 156.54 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.21 110.367 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.0 p -130.51 106.51 8.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.938 0.399 . . . . 1.11 111.015 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 139' ' ' LYS . 19.2 mt -107.7 122.98 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 0.23 110.222 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.54 140.57 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 1.91 110.804 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp 61.49 26.54 16.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.904 -0.589 . . . . 3.11 110.82 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.72 27.75 60.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.898 -0.668 . . . . 0.32 113.004 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.524 ' O ' HG23 ' A' ' 135' ' ' ILE . 73.3 mttt -126.15 151.62 47.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.832 0.316 . . . . 2.19 111.321 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 141' ' ' SER . 5.3 tt -111.24 129.52 55.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 0.37 111.856 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 140' ' ' LEU . 18.3 m -117.35 109.41 16.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 0.9 109.658 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -105.99 105.86 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.255 0.55 . . . . 0.53 111.173 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 56.63 -90.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.823 -0.626 . . . . 2.05 111.976 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.77 24.95 4.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.468 -0.873 . . . . 0.6 113.537 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -134.16 135.13 42.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.811 0.306 . . . . 2.02 110.178 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.33 139.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.093 0.473 . . . . 1.3 111.132 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.2 t -161.35 127.83 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 1.12 109.993 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.6 p -53.69 143.72 19.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 1.11 111.68 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.31 124.81 28.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.914 -0.773 . . . . 0.28 108.914 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 t -115.96 92.32 3.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.073 0.768 . . . . 1.55 113.073 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.06 -34.09 0.05 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 117.376 1.71 . . . . 0.46 117.376 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.63 158.42 28.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.598 1.699 . . . . 1.8 113.885 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.47 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -96.16 124.78 40.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.618 -1.253 . . . . 1.24 107.618 176.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -108.09 142.34 38.43 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 113.904 1.075 . . . . 1.28 113.904 -176.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.511 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 64.6 t -129.67 97.8 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.54 . . . . 0.59 109.909 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 60.7 mm-40 -112.66 128.92 56.52 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.137 -0.938 . . . . 2.48 111.495 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 17.7 p90 -116.1 133.54 55.91 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.375 -0.602 . . . . 1.54 109.375 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 t -108.79 142.86 20.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 115.303 -0.862 . . . . 0.77 111.569 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -63.58 148.52 48.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.669 -1.151 . . . . 1.97 111.634 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -111.82 -10.34 19.0 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.744 -0.662 . . . . 1.12 111.652 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -153.5 -51.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 3.81 110.397 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -171.39 -64.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.151 -0.477 . . . . 3.82 110.626 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.55 117.52 20.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.989 -0.551 . . . . 1.4 110.809 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 166' ' ' LYS . 2.1 m120 -60.09 -178.53 0.15 Allowed Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.211 -0.904 . . . . 2.0 109.506 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -48.18 -8.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.905 1.737 . . . . 2.58 113.915 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 164' ' ' ASN . 27.6 tptt 76.64 -75.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.656 0.383 . . . . 3.71 111.652 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 90' ' ' ALA . 2.0 m -111.95 137.1 45.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 C-N-CA 119.795 -0.762 . . . . 0.92 111.562 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.8 t -131.88 122.54 25.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.738 -1.119 . . . . 1.2 112.085 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -106.19 38.34 2.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.163 -0.926 . . . . 0.22 113.381 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.402 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -35.49 133.93 0.34 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.963 0.357 . . . . 1.02 111.963 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -154.16 94.92 1.78 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.148 -0.478 . . . . 0.33 110.843 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 12' ' ' TRP . 6.1 tt -104.19 131.44 53.0 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 CA-C-O 122.643 1.211 . . . . 0.69 112.547 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.614 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -122.15 166.6 14.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.858 -1.519 . . . . 1.26 110.416 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.1 150.57 37.13 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.959 1.466 . . . . 1.82 114.959 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 90.51 -34.49 4.16 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 112.105 -2.316 . . . . 0.22 118.176 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.71 162.07 0.7 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.225 2.012 . . . . 0.29 114.187 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.621 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.54 -23.58 27.63 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 115.029 -0.987 . . . . 0.57 110.968 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 2.31 111.496 -179.047 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 tp . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.29 0.567 . . . . 0.41 110.402 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.639 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.7 -21.09 25.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.309 -0.859 . . . . 0.33 111.466 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.24 -16.03 59.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.167 0.432 . . . . 2.09 112.167 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 mmtt -105.23 -28.62 10.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.665 -0.414 . . . . 1.99 111.002 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -40.1 144.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 111.772 0.286 . . . . 0.21 111.772 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.69 -23.75 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.071 -0.652 . . . . 0.86 111.073 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.53 ' O ' HG22 ' A' ' 172' ' ' ILE . 25.4 t90 -173.09 137.98 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.972 -0.381 . . . . 0.28 109.972 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -157.27 145.95 19.66 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.343 -0.143 . . . . 0.2 111.121 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.9 t -147.35 124.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 114.075 1.139 . . . . 0.67 114.075 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -115.4 101.23 8.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.457 -0.497 . . . . 1.27 110.807 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.89 104.74 1.42 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 108.614 -0.884 . . . . 0.37 108.614 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.64 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 165.68 -63.78 0.22 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 124.718 1.261 . . . . 0.67 112.426 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.0 -131.07 5.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.859 -0.686 . . . . 1.12 112.121 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -168.83 119.8 0.75 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.118 -0.327 . . . . 2.02 110.118 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 69.7 m 42.13 83.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.937 -0.574 . . . . 1.22 111.068 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 26.3 t60 -116.89 143.78 45.29 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.036 -0.666 . . . . 0.34 112.543 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.59 104.32 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.477 -0.783 . . . . 1.18 110.151 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.85 157.09 38.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.346 -0.388 . . . . 1.17 110.448 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 m -43.95 -51.02 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.255 0.972 . . . . 0.6 113.44 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -58.09 -20.09 37.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.314 0.578 . . . . 0.46 110.104 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.94 35.12 3.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.138 -0.937 . . . . 0.29 111.987 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -103.34 123.17 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.98 -0.378 . . . . 0.43 109.98 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.4 t60 -100.97 132.23 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.86 1.059 . . . . 0.52 113.86 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 128.89 42.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.114 -1.069 . . . . 3.0 108.114 177.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -82.72 110.31 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.833 0.708 . . . . 2.9 112.12 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 tmmm? -22.96 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.83 1.252 . . . . 2.71 113.708 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -20.05 88.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 114.55 -1.205 . . . . 1.98 113.551 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 CA--C 1.535 0.559 0 C-N-CA 122.714 2.276 . . . . 1.53 113.765 179.392 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.439 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 109.183 -0.673 . . . . 0.83 109.183 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -55.25 30.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.305 -0.861 . . . . 1.69 112.957 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.42 31.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.81 0.67 . . . . 2.56 112.81 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -147.07 134.95 21.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 0.97 111.707 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -69.51 159.76 82.23 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.358 -0.608 . . . . 1.96 109.358 178.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.8 Cg_exo -40.87 -39.5 3.24 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.532 2.155 . . . . 0.66 115.408 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.51 -56.9 4.07 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.56 0.695 . . . . 1.82 111.351 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 18.5 p-10 -69.48 -4.89 20.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.747 -0.781 . . . . 1.91 109.057 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 14.3 tt0 -73.97 -64.04 1.09 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.281 -0.872 . . . . 1.5 108.996 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.11 -35.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 1.22 109.322 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 4.5 tp -69.04 -64.98 0.77 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.788 -0.819 . . . . 1.05 108.788 176.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -69.55 22.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.673 -1.149 . . . . 0.9 113.177 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.94 -65.33 0.36 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.158 1.17 . . . . 1.8 114.158 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.408 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 6.9 m -39.98 148.03 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.108 0.781 . . . . 1.05 113.108 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HB3' HG22 ' A' ' 167' ' ' VAL . 1.0 OUTLIER -134.47 152.11 51.58 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.803 -0.635 . . . . 2.05 111.101 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.64 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 35.9 mtp85 -105.16 -169.51 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.773 0.321 . . . . 3.58 110.794 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -86.6 -171.47 3.55 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.159 -0.473 . . . . 4.25 111.16 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.9 m120 64.53 156.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.283 -0.417 . . . . 4.35 110.937 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.49 84.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.175 0.435 . . . . 3.17 112.175 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -175.19 125.46 0.25 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.271 -0.171 . . . . 2.39 111.182 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 24.1 t 37.83 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.415 0.447 . . . . 0.99 110.963 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.52 ' HD1' ' N ' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -90.36 104.76 17.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.203 -0.453 . . . . 1.26 109.817 -178.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 155' ' ' VAL . . . -120.06 108.57 1.48 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 119.703 -1.237 . . . . 0.66 115.355 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.0 154.7 18.73 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.069 0.461 . . . . 0.83 110.817 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.27 134.35 54.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.38 -0.827 . . . . 2.27 110.831 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.531 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -127.94 86.96 56.88 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.514 -0.312 . . . . 0.34 111.394 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -55.58 128.35 30.01 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.856 1.704 . . . . 0.8 112.357 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 63.2 mt -121.98 150.93 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.898 0.38 . . . . 0.38 111.154 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.07 -1.42 1.38 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.034 -0.53 . . . . 2.96 111.125 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.85 169.38 12.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.783 0.325 . . . . 2.13 110.924 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.1 mp0 -120.93 -180.0 4.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.37 111.103 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.67 -148.36 17.2 Favored Glycine 0 CA--C 1.509 -0.322 0 N-CA-C 110.062 -1.215 . . . . 0.21 110.062 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.9 mm-40 -104.09 110.97 23.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.577 1.189 . . . . 2.03 109.488 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -95.97 126.79 41.46 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.506 -0.924 . . . . 0.26 108.506 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.647 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.8 t -112.24 113.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.449 -0.796 . . . . 0.54 111.342 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -97.79 104.49 16.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.684 -1.144 . . . . 1.23 111.008 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 14.3 t -111.56 142.01 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.755 -1.111 . . . . 1.31 108.77 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.684 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -149.67 144.12 25.93 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.33 -0.948 . . . . 1.37 112.105 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.581 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -101.72 121.95 43.0 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.082 -0.647 . . . . 2.97 110.108 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.34 142.2 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.813 -0.81 . . . . 0.3 108.813 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 120.474 -0.49 . . . . 0.41 110.924 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.422 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 49.9 tp60 . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 121.052 0.454 . . . . 2.96 111.609 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -107.03 164.26 12.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.645 . . . . 1.55 110.908 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 68.14 -70.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.998 -0.546 . . . . 2.33 111.72 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -46.67 -32.08 3.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.692 0.282 . . . . 2.51 111.313 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 9.6 mtpm? -91.4 62.9 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 3.1 110.708 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.31 134.41 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.814 0.34 . . . . 1.31 110.206 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.451 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 78.6 m-85 -131.75 -179.28 5.3 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.565 0.58 . . . . 0.69 112.565 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 7.9 t70 -126.06 143.94 50.92 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.653 -0.419 . . . . 2.01 112.123 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.15 137.83 51.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 115.67 -0.695 . . . . 0.46 111.824 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.534 HH21 HG21 ' A' ' 158' ' ' VAL . 10.0 mtt180 -136.77 151.88 49.69 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 113.204 0.816 . . . . 1.85 113.204 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 106' ' ' VAL . 30.6 m -114.23 114.67 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 114.949 -1.023 . . . . 1.1 108.839 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.653 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 60.1 27.18 16.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.508 -0.769 . . . . 1.77 109.384 -176.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.22 20.18 39.59 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.605 -1.18 . . . . 0.41 112.744 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.3 m-70 -119.42 109.56 15.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.925 0.713 . . . . 0.46 112.925 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.4 p -56.19 135.82 53.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.219 0.533 . . . . 0.66 111.437 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 109' ' ' HIS . 5.5 t -132.94 -29.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.276 -0.875 . . . . 0.8 108.913 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.16 90.07 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 116.005 -0.543 . . . . 0.51 109.662 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 113' ' ' LYS . 4.1 ptpp? -108.04 98.38 7.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.014 0.911 . . . . 2.44 110.818 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 6.2 m-20 138.72 33.85 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.293 -2.231 . . . . 2.56 108.198 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.08 89.47 0.06 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 112.852 0.686 . . . . 1.1 112.852 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.2 t70 -106.35 86.6 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.429 -1.323 . . . . 1.99 107.429 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.3 mt -50.96 -42.22 23.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.275 -0.875 . . . . 0.63 112.55 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -60.2 -49.27 78.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.85 0.315 . . . . 0.9 111.85 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.66 -27.52 65.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.869 0.322 . . . . 0.76 111.869 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -64.69 -58.65 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.129 0.418 . . . . 2.68 112.129 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.83 -40.53 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.054 0.391 . . . . 1.41 112.054 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.76 -100.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 1.06 111.793 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -114.69 110.76 20.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.728 0.299 . . . . 3.51 110.6 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.5 t 60.0 -124.84 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.16 -0.473 . . . . 1.68 110.755 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.4 p 54.83 -175.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 0.8 111.664 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.439 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -104.91 138.08 41.69 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.95 0.722 . . . . 0.44 112.95 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.7 t60 -110.24 143.15 40.84 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.255 -1.017 . . . . 0.38 108.255 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.34 126.43 15.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.107 0.781 . . . . 2.09 113.107 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.8 126.75 55.41 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.743 -0.662 . . . . 2.28 109.41 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.37 117.86 54.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.584 -0.735 . . . . 0.71 109.766 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.7 mt -127.14 87.78 55.76 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.186 0.81 . . . . 1.38 113.186 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -62.32 146.36 95.79 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.764 1.642 . . . . 0.22 111.73 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 134' ' ' SER . 29.8 mt -137.34 157.84 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.21 110.398 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 58.6 p -134.09 109.39 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.059 0.457 . . . . 1.11 111.513 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 139' ' ' LYS . 14.2 mt -108.12 128.16 63.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 115.679 -0.692 . . . . 0.23 109.82 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -148.59 142.81 26.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 1.91 110.912 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm 60.38 15.73 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 3.11 111.334 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.87 16.04 55.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.581 -0.818 . . . . 0.32 113.204 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 135' ' ' ILE . 96.5 mttt -120.5 158.95 26.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.126 0.463 . . . . 2.19 111.057 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.44 138.93 48.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.09 0.472 . . . . 0.37 112.19 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.521 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -125.32 114.96 19.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.576 -0.738 . . . . 0.9 109.589 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 142' ' ' VAL . 3.4 p -111.93 99.8 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.402 0.62 . . . . 0.53 111.435 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 60.3 -86.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.537 -0.756 . . . . 2.05 112.401 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.64 16.03 5.93 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.511 -0.852 . . . . 0.6 113.088 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.57 134.27 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.785 0.326 . . . . 2.02 110.416 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.68 137.98 32.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.478 . . . . 1.3 111.156 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 m -159.69 119.69 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 1.12 109.419 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.0 t -53.69 146.48 13.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.564 . . . . 1.11 112.042 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.429 ' H ' ' HA ' ' A' ' 139' ' ' LYS . 37.2 t80 -79.63 142.49 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.12 -0.946 . . . . 0.28 110.031 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.3 p -139.38 95.94 3.01 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.967 0.728 . . . . 1.55 112.967 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.56 -60.5 2.43 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 115.66 1.024 . . . . 0.46 115.66 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.531 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.97 164.78 36.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.943 0.872 . . . . 1.8 112.553 -178.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -82.16 134.85 35.33 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.119 -1.437 . . . . 1.24 107.119 177.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.653 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -121.78 103.92 9.21 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.502 1.297 . . . . 1.28 114.502 -174.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.452 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -93.53 126.32 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.96 -0.385 . . . . 0.59 109.96 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 42.0 mt-10 -137.41 127.43 25.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.112 0.412 . . . . 2.48 112.112 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.93 120.08 41.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.408 -0.96 . . . . 1.54 108.408 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.534 HG21 HH21 ' A' ' 105' ' ' ARG . 9.7 t -91.09 143.6 10.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.324 0.583 . . . . 0.77 111.532 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -57.31 147.96 24.19 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 114.728 -1.124 . . . . 1.97 111.501 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.21 -7.53 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.79 -0.641 . . . . 1.12 111.918 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -151.59 -70.28 0.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.573 0.225 . . . . 3.81 110.533 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -176.19 -64.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.362 -0.381 . . . . 3.82 110.566 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.75 76.59 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 1.4 110.89 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 102' ' ' PHE . 5.8 m-20 -48.35 156.0 0.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.266 -0.879 . . . . 2.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.451 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.71 101.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.457 2.105 . . . . 2.58 112.395 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -60.14 -45.57 92.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.623 -0.717 . . . . 3.71 112.283 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 64' ' ' GLU . 21.4 t -104.24 133.63 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 120.337 -0.545 . . . . 0.92 111.841 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.8 t -131.92 136.78 47.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 115.945 -0.571 . . . . 1.2 111.449 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -127.55 35.67 4.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.382 0.882 . . . . 0.22 113.382 -178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.12 130.92 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.205 0.316 . . . . 1.02 110.902 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 1.1 t80 -150.84 101.97 2.95 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.33 110.864 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -111.63 129.69 66.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.66 0 CA-C-O 122.815 1.293 . . . . 0.69 112.854 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.53 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -123.24 168.19 12.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.546 -1.661 . . . . 1.26 109.965 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -118.98 152.41 36.43 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.715 1.746 . . . . 1.82 115.715 -176.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 88.17 -34.68 3.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 111.82 -2.446 . . . . 0.22 118.193 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.63 158.98 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.209 2.004 . . . . 0.29 114.252 -179.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.647 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.75 -10.31 55.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.376 -0.829 . . . . 0.57 110.712 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 2.31 111.28 -178.479 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 tp . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.266 0.555 . . . . 0.41 110.531 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.623 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -58.25 -21.11 47.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.373 -0.831 . . . . 0.33 111.347 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.51 -16.29 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 2.09 111.703 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.528 ' NZ ' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -109.48 -26.15 10.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.661 -0.416 . . . . 1.99 111.657 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -42.5 145.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.69 0.256 . . . . 0.21 111.69 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.1 pt -140.14 -18.34 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 119.979 -0.689 . . . . 0.86 111.355 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -173.0 136.67 0.67 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.803 -0.359 . . . . 0.28 110.361 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.82 142.37 12.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.513 0.56 . . . . 0.2 112.513 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.0 t -147.64 134.5 13.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 N-CA-C 114.32 1.23 . . . . 0.67 114.32 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 26.6 t-20 -115.66 94.76 4.83 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.607 -0.437 . . . . 1.27 110.537 175.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.414 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -66.25 105.46 1.42 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.765 -0.828 . . . . 0.37 108.765 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 155.8 -40.99 0.59 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.115 -0.948 . . . . 0.67 113.33 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -135.16 7.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.581 -0.819 . . . . 1.12 113.203 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -160.95 119.52 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.537 0.208 . . . . 2.02 110.683 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 70.3 m 34.8 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.697 -0.683 . . . . 1.22 112.536 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.543 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 67.9 t60 -116.57 151.89 35.26 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.254 0.549 . . . . 0.34 112.237 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.27 103.22 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.17 -0.923 . . . . 1.18 109.566 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 1.17 110.227 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -43.67 -48.07 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 124.251 0.969 . . . . 0.6 113.267 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -59.26 -23.21 62.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.179 0.514 . . . . 0.46 110.506 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.3 34.41 2.72 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.423 -0.808 . . . . 0.29 112.377 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.8 mm -103.15 125.34 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.188 -0.671 . . . . 0.43 109.188 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.7 t60 -110.45 131.4 55.09 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.721 1.378 . . . . 0.52 114.721 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.657 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.22 134.4 40.58 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.3 -1.0 . . . . 3.0 108.3 176.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -95.25 105.4 17.34 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.377 0.608 . . . . 2.9 112.34 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 32' ' ' ASP . 31.2 ttpt -19.57 135.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.118 1.367 . . . . 2.71 114.682 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' LYS . 1.2 m-20 -2.12 85.16 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.783 -1.099 . . . . 1.98 113.329 177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.938 0 C-N-CA 122.854 2.369 . . . . 1.53 115.911 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.912 0.387 . . . . 0.83 110.474 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 51' ' ' LEU . 2.9 mm? -94.42 -47.93 6.36 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.271 0.841 . . . . 1.69 113.271 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -73.44 34.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.232 0.827 . . . . 2.56 113.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -150.05 163.34 38.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.19 0.519 . . . . 0.97 112.105 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.1 t30 -78.26 148.4 74.31 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.452 -0.794 . . . . 1.96 109.372 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.595 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.83 -57.88 1.18 Allowed 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.383 2.055 . . . . 0.66 114.424 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 13.4 mm-40 -58.77 -56.85 16.95 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.191 0.996 . . . . 1.82 111.016 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.466 ' OD1' HD23 ' A' ' 60' ' ' LEU . 25.7 t70 -69.19 -10.38 57.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.512 -0.767 . . . . 1.91 110.171 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.9 tt0 -63.17 -46.43 87.17 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.146 -1.798 . . . . 1.5 106.146 176.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.26 -50.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.411 -1.268 . . . . 1.22 109.053 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.538 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.8 tp -68.88 -9.68 52.89 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.451 -0.795 . . . . 1.05 111.52 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 5.7 m-30 -122.34 17.94 10.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.868 -0.606 . . . . 0.9 111.204 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -140.46 -71.95 0.37 Allowed 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.714 1.005 . . . . 1.8 113.714 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 7.4 p -27.18 140.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.606 0.965 . . . . 1.05 113.606 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.548 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -130.74 149.97 52.14 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.885 -0.598 . . . . 2.05 110.916 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.605 HH12 ' HB2' ' A' ' 67' ' ' ASN . 3.7 ptm180 -136.86 138.66 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.835 0.35 . . . . 3.58 110.359 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -78.15 142.92 37.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.048 -0.524 . . . . 4.25 111.407 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.605 ' HB2' HH12 ' A' ' 65' ' ' ARG . 5.2 t30 -134.06 -89.88 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.246 -0.434 . . . . 4.35 110.941 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.439 ' N ' HD22 ' A' ' 67' ' ' ASN . 41.4 tt0 -175.14 -95.84 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.339 0.126 . . . . 3.17 111.339 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -156.27 151.44 26.49 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.483 -0.191 . . . . 2.39 110.483 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t 48.06 81.53 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.99 110.132 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.429 ' HZ ' ' C ' ' A' ' 164' ' ' ASN . 2.8 p90 -136.77 152.44 50.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 1.26 110.754 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.09 -155.26 8.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.037 -1.078 . . . . 0.66 114.36 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.414 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 80.3 m-85 -135.78 154.81 51.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.726 0.639 . . . . 0.83 112.726 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -118.49 106.48 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.664 -1.153 . . . . 2.27 110.223 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.35 110.68 64.63 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.909 0.337 . . . . 0.34 111.909 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.01 133.81 10.23 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.502 1.468 . . . . 0.8 111.816 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 61.2 mt -120.75 148.83 23.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.43 . . . . 0.38 111.496 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -139.75 -3.52 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.803 -0.635 . . . . 2.96 110.84 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 23.9 mm-40 -121.77 173.93 7.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.582 0.23 . . . . 2.13 110.583 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.77 177.31 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.37 111.545 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.18 -161.17 23.1 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.144 -1.582 . . . . 0.21 109.144 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 0.1 OUTLIER -95.0 110.68 22.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 118.743 1.272 . . . . 2.03 109.913 179.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.0 m-85 -95.27 125.79 40.15 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.26 109.577 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.614 HG21 ' N ' ' A' ' 177' ' ' ALA . 10.2 t -113.07 116.87 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.477 -1.238 . . . . 0.54 111.939 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.89 104.57 16.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.668 -1.151 . . . . 1.23 110.778 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 58.8 t -103.22 119.39 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.124 -0.944 . . . . 1.31 108.897 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.9 134.22 42.41 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.282 -0.567 . . . . 1.37 111.186 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.428 ' CB ' ' HB3' ' A' ' 169' ' ' ALA . 19.4 tptt -104.52 120.74 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.755 -0.778 . . . . 2.97 109.732 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 8.1 m-85 -104.77 139.23 39.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.922 -1.14 . . . . 0.3 107.922 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 119.98 -0.688 . . . . 0.41 112.534 -178.674 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.836 0.351 . . . . 2.96 110.907 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.6 p -97.27 -76.45 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.974 -0.557 . . . . 1.55 111.781 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -78.13 64.11 3.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.04 0.447 . . . . 2.33 111.57 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -145.66 -48.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.181 -0.674 . . . . 2.51 109.181 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -105.49 78.66 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.429 -0.805 . . . . 3.1 109.33 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.0 113.51 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.332 -0.849 . . . . 1.31 110.196 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -102.47 175.82 5.38 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.038 0.755 . . . . 0.69 113.038 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 5.4 m-20 -122.1 140.12 52.91 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.694 -0.685 . . . . 2.01 111.09 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.12 123.76 44.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 115.996 -0.547 . . . . 0.46 111.768 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 12.3 mtt180 -117.66 150.47 38.99 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 115.008 -0.996 . . . . 1.85 112.401 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.519 HG13 HD21 ' A' ' 153' ' ' LEU . 84.4 t -126.2 109.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 114.652 -1.158 . . . . 1.1 109.392 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.451 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 57.02 25.99 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.432 -0.951 . . . . 1.77 108.432 -176.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.55 53.77 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.097 -0.956 . . . . 0.41 112.674 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 92.1 m-70 -112.25 111.14 21.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.81 . . . . 0.46 113.188 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -68.94 112.16 5.42 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 120.395 -0.522 . . . . 0.66 110.584 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.88 -28.71 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.594 -0.73 . . . . 0.8 109.849 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.437 HG21 ' OE1' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -135.02 90.2 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 120.281 -0.568 . . . . 0.51 109.582 177.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.4 ptpp? -110.71 85.08 2.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.935 0.874 . . . . 2.44 111.491 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.6 p-10 151.47 36.66 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 112.982 -1.917 . . . . 2.56 108.325 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.481 HD21 ' OE2' ' A' ' 129' ' ' GLU . 0.7 OUTLIER -62.62 90.15 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.327 0.862 . . . . 1.1 113.327 -177.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.77 83.91 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.351 -1.352 . . . . 1.99 107.351 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -50.44 -30.58 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.63 111.793 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -68.38 -43.76 76.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 0.9 111.237 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -69.54 -27.56 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.76 111.867 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' NE2' ' A' ' 127' ' ' HIS . 29.7 mmt180 -71.88 -58.45 3.45 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.384 0.513 . . . . 2.68 112.384 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.94 -40.66 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.217 0.451 . . . . 1.41 112.217 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.53 -92.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.732 -0.747 . . . . 1.06 111.784 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.512 ' O ' HG23 ' A' ' 125' ' ' THR . 45.4 t-80 -114.55 110.02 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 3.51 111.056 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.1 t 51.45 -128.23 2.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.083 -0.508 . . . . 1.68 111.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 123' ' ' HIS . 26.7 p 58.08 -165.14 0.17 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.592 0.357 . . . . 0.8 111.193 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.53 139.18 43.66 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.255 0.835 . . . . 0.44 113.255 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.0 t60 -109.07 148.24 31.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.99 -0.744 . . . . 0.38 108.99 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 4.8 p-10 -143.81 127.12 16.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.674 0.62 . . . . 2.09 112.674 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.481 ' OE2' HD21 ' A' ' 115' ' ' LEU . 24.4 mt-10 -120.65 115.67 23.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 2.28 109.465 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.507 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.1 mt -105.58 126.85 60.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.516 -0.766 . . . . 0.71 110.261 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 130' ' ' ILE . 28.3 mm -126.12 86.45 57.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.218 0.451 . . . . 1.38 112.218 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -62.48 139.95 79.25 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.875 1.717 . . . . 0.22 111.426 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 18.8 mt -132.86 155.07 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.21 111.042 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 23.8 p -126.21 107.9 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.942 0.401 . . . . 1.11 110.859 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 139' ' ' LYS . 25.6 mt -111.37 122.75 66.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.801 -0.636 . . . . 0.23 109.881 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -147.38 143.16 27.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.37 -0.377 . . . . 1.91 110.817 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt 62.92 7.81 2.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.098 -0.501 . . . . 3.11 110.856 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.2 21.24 25.57 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.83 -0.7 . . . . 0.32 112.933 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 135' ' ' ILE . 8.2 mtpm? -121.03 156.09 32.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.896 0.348 . . . . 2.19 110.859 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -114.31 131.95 56.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.112 0.482 . . . . 0.37 112.121 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.538 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.1 t -122.92 109.65 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 0.9 109.642 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -102.35 108.06 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.198 0.523 . . . . 0.53 111.148 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 53.77 -91.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.765 -0.652 . . . . 2.05 112.034 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.33 38.79 2.21 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.6 113.516 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -146.61 137.11 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 2.02 110.297 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.3 135.7 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 1.3 110.875 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -163.19 121.04 1.94 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.154 -0.684 . . . . 1.12 109.154 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.05 150.11 3.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.981 0.42 . . . . 1.11 111.328 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 t80 -77.55 122.85 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.28 110.764 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -75.81 -170.8 1.42 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.955 -1.128 . . . . 1.55 107.955 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.56 -11.92 66.07 Favored Glycine 0 C--N 1.317 -0.503 0 C-N-CA 119.015 -1.564 . . . . 0.46 112.93 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.82 151.8 18.72 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.168 0.484 . . . . 1.8 112.105 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.726 HD23 ' N ' ' A' ' 154' ' ' SER . 3.5 tt -84.93 148.51 26.19 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.936 -1.135 . . . . 1.24 107.936 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.726 ' N ' HD23 ' A' ' 153' ' ' LEU . 3.7 t -139.15 115.86 10.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 118.256 -1.378 . . . . 1.28 113.634 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 7.9 t -98.47 97.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.942 -0.762 . . . . 0.59 108.942 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 34.7 mt-10 -108.82 132.35 54.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.718 -0.674 . . . . 2.48 111.727 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.95 129.83 51.6 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.481 0.658 . . . . 1.54 109.929 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.535 HG21 HH21 ' A' ' 105' ' ' ARG . 30.8 t -103.0 143.88 14.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.495 -1.23 . . . . 0.77 111.678 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -50.88 148.14 4.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 114.988 -1.005 . . . . 1.97 111.445 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -118.99 -10.66 8.08 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.437 -0.665 . . . . 1.12 111.437 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -163.64 -59.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.555 -0.322 . . . . 3.81 110.344 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -176.84 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.061 -0.518 . . . . 3.82 110.879 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -90.92 46.12 1.3 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.026 0.441 . . . . 1.4 111.782 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.713 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 54.9 t30 -55.2 -42.07 93.98 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 115.46 -0.791 . . . . 2.0 109.048 176.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.713 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 36.9 Cg_endo -62.9 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.786 2.324 . . . . 2.58 111.843 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 11.0 pttp -97.8 166.01 11.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.063 -0.717 . . . . 3.71 109.063 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.83 132.95 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 C-N-CA 119.533 -0.867 . . . . 0.92 110.308 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -130.24 131.6 45.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.671 0.607 . . . . 1.2 111.586 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 88' ' ' LYS . . . -123.95 37.05 4.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.22 112.126 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -33.26 134.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.693 -0.685 . . . . 1.02 110.404 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -159.56 95.81 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.533 -0.303 . . . . 0.33 110.813 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -106.25 130.16 58.37 Favored 'Isoleucine or valine' 0 C--O 1.258 1.526 0 CA-C-O 122.96 1.362 . . . . 0.69 112.719 178.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 ppp? -123.64 157.26 34.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.028 -1.896 . . . . 1.26 108.135 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.9 150.04 39.12 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.138 1.532 . . . . 1.82 115.138 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.21 -33.91 6.2 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 112.448 -2.16 . . . . 0.22 116.846 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.474 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 156.79 0.44 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.841 1.82 . . . . 0.29 114.601 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.614 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.68 -23.37 25.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.161 -0.927 . . . . 0.57 110.569 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.864 -0.607 . . . . 2.31 111.508 -178.741 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 121.185 0.517 . . . . 0.41 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.596 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.71 -21.24 6.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.405 -0.816 . . . . 0.33 111.314 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -79.29 -21.77 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 2.09 112.121 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 34.9 mmtt -98.43 -26.52 14.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.937 -0.305 . . . . 1.99 111.475 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.9 p -44.47 146.82 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 111.961 0.356 . . . . 0.21 111.961 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.2 pt -139.48 -21.73 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.724 . . . . 0.86 111.103 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.576 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.9 t90 -173.7 133.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.55 -0.46 . . . . 0.28 110.14 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -150.6 144.26 25.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.809 0.3 . . . . 0.2 111.809 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.2 t -147.63 126.66 4.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.495 1.295 . . . . 0.67 114.495 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 11.5 t30 -114.6 100.86 8.59 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.533 -0.467 . . . . 1.27 110.31 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.51 103.47 2.98 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 109.021 -0.733 . . . . 0.37 109.021 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.581 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 167.9 -45.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.916 0 O-C-N 124.277 0.986 . . . . 0.67 113.563 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.77 -123.6 3.48 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.586 -0.816 . . . . 1.12 113.124 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.723 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 6.4 tt0 -164.1 120.3 1.62 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.871 0.367 . . . . 2.02 111.489 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.4 m 35.53 99.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.16 -0.927 . . . . 1.22 113.231 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.665 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 56.3 t60 -130.65 140.16 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.729 -0.788 . . . . 0.34 112.462 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 p -114.64 103.91 16.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.637 0.732 . . . . 1.18 110.787 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 156.3 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.036 -0.984 . . . . 1.17 110.056 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 25' ' ' HIS . 30.9 m -44.01 -49.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.175 0.922 . . . . 0.6 113.136 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.464 ' N ' HG23 ' A' ' 24' ' ' VAL . 83.5 m-70 -59.53 -18.17 38.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.294 0.569 . . . . 0.46 110.567 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.72 35.2 3.84 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.34 -0.845 . . . . 0.29 112.444 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.428 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 31.1 mm -103.88 111.95 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.026 0.441 . . . . 0.43 110.578 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.665 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 10.9 t60 -98.27 135.55 39.73 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.891 1.441 . . . . 0.52 114.891 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.723 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -100.47 135.46 41.87 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.864 -1.062 . . . . 3.0 108.619 177.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -88.04 111.42 21.51 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 124.001 0.813 . . . . 2.9 112.252 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HB3' ' NZ ' ' A' ' 31' ' ' LYS . 5.3 ttpm? -23.44 135.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.349 1.06 . . . . 2.71 113.723 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.65 ' HB3' HH11 ' A' ' 65' ' ' ARG . 2.5 m-20 -10.15 83.84 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 CA-C-N 114.2 -1.364 . . . . 1.98 113.708 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 CA--C 1.535 0.531 0 C-N-CA 123.166 2.577 . . . . 1.53 113.582 179.736 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.2 mp . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 109.347 -0.612 . . . . 0.83 109.347 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mt -69.87 -49.19 54.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.911 1.449 . . . . 1.69 114.911 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -73.87 25.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.85 0.685 . . . . 2.56 112.85 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -146.19 144.57 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.97 111.487 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 58' ' ' GLN . 1.8 p-10 -66.44 153.53 92.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.065 -0.516 . . . . 1.96 109.787 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.423 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.57 -59.14 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.47 2.113 . . . . 0.66 114.626 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -58.35 -55.43 35.13 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 121.901 0.858 . . . . 1.82 111.246 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 11.2 t70 -69.38 -11.98 61.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.325 -0.55 . . . . 1.91 110.439 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.713 HE22 ' NE2' ' A' ' 62' ' ' GLN . 0.9 OUTLIER -68.38 -39.83 81.59 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 106.523 -1.658 . . . . 1.5 106.523 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.411 ' N ' ' HG3' ' A' ' 58' ' ' GLN . 62.4 t -54.37 -50.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.138 -1.06 . . . . 1.22 108.138 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.8 tp -69.81 -13.76 62.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.907 -1.042 . . . . 1.05 111.1 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.541 ' C ' ' HZ2' ' A' ' 88' ' ' LYS . 2.6 m-85 -121.89 27.71 7.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.182 -0.917 . . . . 0.9 111.679 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.713 ' NE2' HE22 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -151.46 -63.36 0.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.261 0.837 . . . . 1.8 113.261 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 13.7 p -34.13 147.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.815 0.672 . . . . 1.05 112.815 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.577 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pp20? -137.52 148.05 45.68 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.691 0.626 . . . . 2.05 112.691 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.65 HH11 ' HB3' ' A' ' 32' ' ' ASP . 19.3 mtp180 -114.27 -174.95 2.57 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.98 -0.554 . . . . 3.58 109.858 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -66.32 172.0 4.33 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.531 -0.304 . . . . 4.25 110.455 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -143.57 162.22 36.44 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.021 0.438 . . . . 4.35 111.653 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -144.79 -118.16 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.876 -0.602 . . . . 3.17 110.685 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.459 ' OD1' ' HD3' ' A' ' 159' ' ' LYS . 63.6 m-20 -156.62 134.4 10.97 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.44 -0.162 . . . . 2.39 111.093 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 53.84 83.53 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.92 0.391 . . . . 0.99 110.764 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -162.59 159.6 24.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 1.26 110.826 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -168.93 -168.15 30.56 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.437 -0.887 . . . . 0.66 113.418 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -108.36 165.12 11.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.294 0.569 . . . . 0.83 111.763 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.03 140.53 49.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.91 -1.041 . . . . 2.27 110.825 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.27 109.87 10.56 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.142 -0.481 . . . . 0.34 111.171 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.87 133.17 7.83 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.129 1.219 . . . . 0.8 112.045 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 78' ' ' LYS . 23.4 mt -121.32 155.2 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.985 0.421 . . . . 0.38 111.577 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' N ' HG22 ' A' ' 77' ' ' ILE . 99.5 mttt -143.19 -0.87 1.09 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.825 -0.625 . . . . 2.96 110.995 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -127.46 169.03 14.08 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.826 0.345 . . . . 2.13 111.562 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -117.48 -177.61 3.27 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.37 111.047 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.78 -151.04 18.05 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.997 -1.241 . . . . 0.21 109.997 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 21.2 mt-10 -105.15 108.72 20.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.644 1.222 . . . . 2.03 109.71 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -95.34 129.68 42.39 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 119.719 -0.792 . . . . 0.26 109.156 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG21 ' N ' ' A' ' 177' ' ' ALA . 22.0 t -116.92 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.686 -1.143 . . . . 0.54 111.806 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.94 105.7 17.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.726 -0.67 . . . . 1.23 110.126 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 38.1 t -101.4 119.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 107.945 -1.131 . . . . 1.31 107.945 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 135.92 23.83 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.671 -0.812 . . . . 1.37 112.437 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.711 ' NZ ' ' HB2' ' A' ' 90' ' ' ALA . 5.9 tmtt? -103.15 132.1 49.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.65 -0.82 . . . . 2.97 109.952 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -111.44 149.32 31.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.609 -0.723 . . . . 0.3 109.547 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.711 ' HB2' ' NZ ' ' A' ' 88' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 121.073 0.464 . . . . 0.41 111.323 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.962 0.41 . . . . 2.96 111.153 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -103.8 157.15 17.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.951 -0.568 . . . . 1.55 111.235 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 45.25 49.46 10.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.8 -0.636 . . . . 2.33 111.647 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -153.47 -46.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.899 -0.778 . . . . 2.51 108.899 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -96.89 82.04 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.271 -1.011 . . . . 3.1 108.271 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.437 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.7 OUTLIER -108.87 134.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 1.31 111.227 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.403 ' CD1' ' HD3' ' A' ' 165' ' ' PRO . 69.9 m-85 -117.89 175.59 5.59 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.576 0.584 . . . . 0.69 112.576 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.87 140.06 53.35 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 115.928 -0.578 . . . . 2.01 111.459 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.06 131.65 41.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.075 -0.512 . . . . 0.46 111.854 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.4 154.8 49.44 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.265 0.839 . . . . 1.85 113.265 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 p -121.51 125.24 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.193 -1.367 . . . . 1.1 110.474 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.14 26.1 3.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.663 -0.866 . . . . 1.77 108.663 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.8 27.45 21.7 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.729 -1.123 . . . . 0.41 112.976 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 87.1 m-70 -127.35 110.5 12.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.164 0.801 . . . . 0.46 113.164 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.0 p -67.24 115.56 7.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.245 0.545 . . . . 0.66 111.723 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.58 -34.71 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.215 -0.902 . . . . 0.8 109.369 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.07 89.62 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.995 -0.548 . . . . 0.51 109.548 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.0 ptpp? -110.08 83.39 1.75 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.096 0.951 . . . . 2.44 110.759 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 156.82 33.58 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 112.824 -1.989 . . . . 2.56 108.557 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 85.92 0.08 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.595 0.591 . . . . 1.1 112.595 -177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 0.6 OUTLIER -98.47 80.42 2.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.714 -1.587 . . . . 1.99 106.714 175.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.7 mt -49.88 -38.48 14.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.516 -0.765 . . . . 0.63 112.291 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.28 -46.69 85.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.462 0.171 . . . . 0.9 111.462 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.413 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 37.1 t70 -70.33 -27.97 64.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.76 111.514 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -61.33 -58.09 9.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.865 0.321 . . . . 2.68 111.865 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.13 -40.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.033 0.383 . . . . 1.41 112.033 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.93 -87.45 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.912 -0.661 . . . . 1.06 112.487 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.582 ' O ' HG23 ' A' ' 125' ' ' THR . 48.6 m80 -112.87 110.46 20.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.641 0.257 . . . . 3.51 111.081 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.9 p 46.79 -116.85 0.72 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.019 -0.537 . . . . 1.68 111.769 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 123' ' ' HIS . 41.8 p 50.91 -166.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.209 0.203 . . . . 0.8 110.7 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.485 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.27 139.09 49.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.087 0.773 . . . . 0.44 113.087 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.409 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 1.8 t60 -105.35 145.08 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.856 -1.164 . . . . 0.38 107.856 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -143.75 126.94 16.58 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.056 -0.658 . . . . 2.09 112.761 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -117.11 127.84 54.54 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.247 -0.888 . . . . 2.28 110.096 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.1 mt -116.43 121.79 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.431 -0.804 . . . . 0.71 109.817 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.76 90.09 51.47 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.723 0.638 . . . . 1.38 112.723 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.76 149.74 90.34 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.04 1.827 . . . . 0.22 112.053 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 16.9 mt -144.16 156.89 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.452 -0.34 . . . . 0.21 111.537 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 133' ' ' ILE . 32.7 t -133.07 110.23 10.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.026 0.441 . . . . 1.11 111.077 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 139' ' ' LYS . 21.8 mt -106.62 137.25 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.799 -0.637 . . . . 0.23 110.337 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -145.35 130.36 18.34 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.997 -0.281 . . . . 1.91 111.102 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 54.99 19.03 2.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.1 -0.5 . . . . 3.11 110.8 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.5 16.14 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.688 -0.768 . . . . 0.32 112.782 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -111.5 156.54 21.54 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.084 -0.339 . . . . 2.19 110.084 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 141' ' ' SER . 5.1 tt -124.6 126.01 45.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.284 0.564 . . . . 0.37 112.496 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.515 ' N ' HD23 ' A' ' 140' ' ' LEU . 9.5 t -115.81 109.23 17.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.302 -0.863 . . . . 0.9 109.084 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -102.95 99.57 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.513 -0.767 . . . . 0.53 110.507 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.43 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 2.05 111.626 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -132.33 29.58 3.29 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.44 -0.886 . . . . 0.6 113.277 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.28 135.78 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.297 . . . . 2.02 110.526 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.83 135.46 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 1.3 110.344 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 m -164.46 129.22 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 1.12 109.837 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -53.16 145.03 14.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.181 0.515 . . . . 1.11 112.238 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -78.72 121.67 25.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.516 -0.765 . . . . 0.28 110.031 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.4 p -76.14 173.85 10.81 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.51 -0.922 . . . . 1.55 108.51 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.81 -8.8 1.48 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.948 -1.12 . . . . 0.46 114.236 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.61 152.09 19.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.894 0.847 . . . . 1.8 112.703 -179.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -80.9 129.63 34.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.794 -1.187 . . . . 1.24 107.794 177.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.496 ' HB3' ' OE1' ' A' ' 156' ' ' GLU . 0.1 OUTLIER -121.88 120.71 35.3 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.96 1.096 . . . . 1.28 113.96 -176.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.436 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 96.6 t -106.11 101.13 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.741 -0.466 . . . . 0.59 109.741 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.496 ' OE1' ' HB3' ' A' ' 154' ' ' SER . 17.6 mp0 -116.64 150.5 38.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.369 0.604 . . . . 2.48 112.069 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.6 140.11 44.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.178 -0.919 . . . . 1.54 110.148 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.67 144.06 24.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.058 -0.973 . . . . 0.77 111.168 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.459 ' HD3' ' OD1' ' A' ' 69' ' ' ASP . 19.2 pttm -63.63 139.43 58.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.384 -0.825 . . . . 1.97 111.055 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -108.33 -4.79 32.75 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.116 -0.794 . . . . 1.12 111.116 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -169.92 -54.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.327 -0.436 . . . . 3.81 110.229 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -178.29 149.03 0.51 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.09 -0.505 . . . . 3.82 110.64 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 55.84 87.5 0.05 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.855 0.36 . . . . 1.4 111.681 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.41 166.37 0.56 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.848 -0.615 . . . . 2.0 109.886 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.403 ' HD3' ' CD1' ' A' ' 102' ' ' PHE . 7.0 Cg_exo -35.78 104.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.015 1.81 . . . . 2.58 111.731 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -58.21 -54.11 50.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 3.71 113.133 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 64' ' ' GLU . 6.8 t -103.55 134.72 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.961 0.726 . . . . 0.92 112.961 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.42 138.85 49.26 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.964 -0.562 . . . . 1.2 112.149 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -129.75 35.94 4.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.183 -0.917 . . . . 0.22 112.915 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -36.96 136.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.232 0.539 . . . . 1.02 112.404 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.528 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -156.62 96.11 1.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.305 -0.861 . . . . 0.33 109.33 178.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -99.93 127.67 52.6 Favored 'Isoleucine or valine' 0 C--O 1.266 1.942 0 CA-C-O 122.663 1.221 . . . . 0.69 112.35 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.42 161.35 21.36 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.683 -1.599 . . . . 1.26 109.546 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 16.1 tttm -120.38 139.05 53.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.7 1.37 . . . . 1.82 114.7 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.03 -35.05 5.3 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 118.123 2.009 . . . . 0.22 118.123 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.55 158.06 0.5 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.436 2.118 . . . . 0.29 114.105 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.618 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.34 -24.69 27.52 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.94 -1.027 . . . . 0.57 109.858 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.538 -0.756 . . . . 2.31 111.132 -179.459 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.1 tp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.354 0.597 . . . . 0.41 110.052 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.543 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.02 -19.65 7.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.076 -0.966 . . . . 0.33 111.652 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.75 -28.65 40.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.498 0.555 . . . . 2.09 112.498 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 44.0 mttp -98.89 -18.08 18.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.325 -0.55 . . . . 1.99 112.065 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 7' ' ' ALA . 14.2 p -42.63 144.08 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 121.28 -0.168 . . . . 0.21 111.131 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' TRP . 4.1 pt -139.55 -21.7 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 C-N-CA 119.639 -0.824 . . . . 0.86 111.582 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.599 ' O ' HG22 ' A' ' 172' ' ' ILE . 50.5 t90 -175.99 130.79 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.478 -0.489 . . . . 0.28 110.675 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -148.39 146.58 28.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.273 0.471 . . . . 0.2 112.273 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.3 t -147.5 126.77 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 114.229 1.196 . . . . 0.67 114.229 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.601 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 18.4 t-20 -117.39 106.36 13.13 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.654 -0.703 . . . . 1.27 110.133 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 113.54 15.14 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 120.68 -0.408 . . . . 0.37 110.811 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.458 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 142.74 -29.74 2.1 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 114.649 -1.16 . . . . 0.67 112.594 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -109.81 -144.75 10.51 Favored Glycine 0 CA--C 1.516 0.135 0 C-N-CA 121.138 -0.553 . . . . 1.12 112.021 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 36.2 mt-10 -156.83 119.45 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.666 -0.124 . . . . 2.02 110.666 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.3 m 27.7 94.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.803 0.69 . . . . 1.22 112.152 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 19.9 t60 -126.26 150.89 48.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 119.922 -0.711 . . . . 0.34 112.416 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.56 105.32 18.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.133 -0.939 . . . . 1.18 111.019 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 153.77 42.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.981 -0.377 . . . . 1.17 109.981 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 25' ' ' HIS . 16.1 m -44.44 -49.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.501 0.926 . . . . 0.6 113.501 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.419 ' N ' HG23 ' A' ' 24' ' ' VAL . 86.2 m-70 -58.44 -17.84 23.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.282 0.563 . . . . 0.46 110.463 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.62 33.71 4.67 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.29 112.149 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm -103.23 120.72 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.904 -0.406 . . . . 0.43 109.904 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.511 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 12.8 t60 -102.97 132.91 48.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.191 1.182 . . . . 0.52 114.191 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.667 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.5 134.19 43.82 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.935 -1.135 . . . . 3.0 107.935 176.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -94.62 112.52 24.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.444 0.64 . . . . 2.9 112.376 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -10.49 138.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.54 1.681 . . . . 2.71 115.54 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.445 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 12.5 m-20 -22.54 89.67 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 113.722 -1.581 . . . . 1.98 114.219 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 CA--C 1.545 1.071 0 C-N-CA 122.731 2.287 . . . . 1.53 113.309 178.393 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' A' ' 126' ' ' ALA . 4.4 mt . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.264 -0.643 . . . . 0.83 109.264 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.68 -42.77 86.02 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.232 1.197 . . . . 1.69 114.232 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -80.25 25.14 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.705 -0.398 . . . . 2.56 111.984 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.472 ' OG ' HG22 ' A' ' 50' ' ' ILE . 94.0 p -139.77 130.47 25.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.702 0.287 . . . . 0.97 111.347 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 3.0 p-10 -59.73 152.73 56.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.857 -0.794 . . . . 1.96 108.857 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.48 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 7.6 Cg_exo -39.93 -39.52 2.3 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.341 2.027 . . . . 0.66 115.251 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.5 mm-40 -75.43 -56.07 5.07 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.755 0.788 . . . . 1.82 111.171 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.4 OUTLIER -70.79 -6.57 38.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.034 -0.666 . . . . 1.91 109.256 -179.453 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 24.6 tt0 -70.54 -64.88 0.81 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.255 -0.884 . . . . 1.5 108.661 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 63' ' ' THR . 2.6 p -48.41 -37.94 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.901 -0.591 . . . . 1.22 109.79 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.601 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 4.9 tp -68.07 -68.19 0.41 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.84 -0.744 . . . . 1.05 110.071 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -56.36 1.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.184 0.593 . . . . 0.9 111.932 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 60' ' ' LEU . 1.8 tt0 -122.8 -126.02 0.26 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.115 -0.493 . . . . 1.8 111.734 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 59' ' ' VAL . 47.6 p 49.08 -166.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.598 -0.273 . . . . 1.05 110.725 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.458 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.2 pt-20 -179.3 140.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.628 0.252 . . . . 2.05 111.1 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.445 ' NE ' ' HB3' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -123.13 177.15 5.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.012 0.434 . . . . 3.58 111.601 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -57.63 169.8 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.718 -0.674 . . . . 4.25 111.412 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -142.13 169.32 17.81 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.256 -0.429 . . . . 4.35 111.077 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -154.57 -107.52 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.663 -0.244 . . . . 3.17 111.446 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.68 125.71 1.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.429 -0.169 . . . . 2.39 110.742 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 t 50.9 84.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.047 -0.353 . . . . 0.99 110.047 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -159.09 164.72 35.09 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.593 -0.443 . . . . 1.26 111.223 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.6 -167.8 39.0 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 119.066 -1.54 . . . . 0.66 116.406 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.99 174.2 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.648 -1.276 . . . . 0.83 113.147 -176.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.9 147.34 50.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.33 -1.305 . . . . 2.27 111.187 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.32 113.55 6.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.349 -0.387 . . . . 0.34 111.167 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.62 140.25 13.09 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.198 1.266 . . . . 0.8 111.918 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mt -129.49 149.24 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.38 111.652 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.84 8.45 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.633 -0.712 . . . . 2.96 110.809 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -127.11 163.76 23.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.134 -0.321 . . . . 2.13 110.134 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 2.5 mp0 -125.98 158.73 34.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.37 111.901 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.82 -144.3 11.63 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.793 -1.323 . . . . 0.21 109.793 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -105.93 107.8 18.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.622 1.211 . . . . 2.03 108.995 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.26 126.21 40.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.715 -0.846 . . . . 0.26 108.715 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.638 HG21 ' N ' ' A' ' 177' ' ' ALA . 12.7 t -114.36 120.75 64.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.007 -0.997 . . . . 0.54 111.915 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.6 tt -101.46 104.97 15.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.918 -1.037 . . . . 1.23 110.617 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.93 135.93 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.184 -1.043 . . . . 1.31 108.184 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.647 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -147.97 150.08 33.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 118.861 -1.136 . . . . 1.37 112.952 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.564 ' O ' ' HB3' ' A' ' 169' ' ' ALA . 12.2 tptt -107.75 120.43 42.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.341 -0.845 . . . . 2.97 110.099 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.79 145.89 31.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.558 -0.534 . . . . 0.3 109.558 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.801 0.334 . . . . 0.41 110.65 179.18 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 100' ' ' LYS . 17.7 pt20 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.709 0.29 . . . . 2.96 110.707 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -126.78 153.42 45.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 1.55 111.863 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 47.73 30.71 1.9 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.805 -0.634 . . . . 2.33 111.574 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -131.56 -50.42 0.99 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 2.51 109.879 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.52 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 22.3 tttp -97.92 90.47 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.087 -0.709 . . . . 3.1 109.087 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.49 147.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.31 110.435 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -121.22 -179.87 4.19 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.392 0.886 . . . . 0.69 113.392 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.89 139.39 52.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 115.648 -0.706 . . . . 2.01 111.162 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.1 t -135.01 133.47 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 116.152 -0.476 . . . . 0.46 112.068 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 10.9 ptt180 -135.89 145.17 46.05 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.684 0.994 . . . . 1.85 113.684 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.5 m -113.0 121.06 64.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.584 -1.189 . . . . 1.1 109.694 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.589 ' ND2' ' HA ' ' A' ' 153' ' ' LEU . 3.6 t-20 54.28 26.89 7.27 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.805 0.812 . . . . 1.77 109.332 -176.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 23.17 28.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.047 -1.433 . . . . 0.41 112.977 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 81.5 m-70 -120.83 108.03 13.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.277 0.843 . . . . 0.46 113.277 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 7.0 p -64.6 116.03 5.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.146 0.498 . . . . 0.66 111.407 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.55 -31.31 2.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.471 -0.786 . . . . 0.8 109.99 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.18 91.49 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.351 -0.611 . . . . 0.51 109.351 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 4.2 ptpp? -106.6 77.96 1.23 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.584 1.183 . . . . 2.44 112.517 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.1 p30 156.14 36.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.399 -2.182 . . . . 2.56 109.453 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 91.78 0.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.352 0.596 . . . . 1.1 111.537 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.506 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 1.5 p30 -101.68 79.12 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.008 -1.479 . . . . 1.99 107.008 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.0 mt -50.4 -50.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.709 -1.132 . . . . 0.63 113.002 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -56.19 -51.45 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.83 0.307 . . . . 0.9 111.83 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.506 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 18.0 t70 -65.39 -29.59 70.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.369 0.507 . . . . 0.76 112.369 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -64.02 -58.29 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.452 0.538 . . . . 2.68 112.452 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 126' ' ' ALA . 10.9 m -103.53 -41.17 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.519 0.563 . . . . 1.41 112.519 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.73 -131.23 10.26 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.524 -0.845 . . . . 1.06 112.881 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.37 110.43 1.43 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.761 0.315 . . . . 3.51 111.083 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.8 m 45.27 -104.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.867 -0.606 . . . . 1.68 111.161 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.403 ' OG1' ' HB ' ' A' ' 121' ' ' VAL . 23.0 p 50.07 178.24 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.084 0.469 . . . . 0.8 111.914 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -105.86 138.95 41.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.786 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.8 t60 -112.57 144.8 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.918 -0.771 . . . . 0.38 108.918 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.89 140.48 29.78 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.305 0.854 . . . . 2.09 113.305 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.17 133.85 52.63 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.026 -0.988 . . . . 2.28 109.092 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.4 mt -115.66 116.4 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.747 -0.66 . . . . 0.71 110.187 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.9 mt -124.62 87.87 54.11 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.584 0.587 . . . . 1.38 112.584 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.6 141.82 74.8 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.81 1.674 . . . . 0.22 111.602 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.2 mt -132.09 155.82 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 0.21 110.505 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 30.5 p -131.39 106.73 8.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 1.11 110.732 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 139' ' ' LYS . 23.8 mt -105.4 124.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.747 -0.66 . . . . 0.23 109.911 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -146.97 142.1 27.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 1.91 110.947 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp 58.91 19.13 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 3.11 111.205 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.85 23.62 41.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 0.32 113.396 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 135' ' ' ILE . 25.9 mtmm -123.62 151.75 42.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.1 0.45 . . . . 2.19 110.823 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -109.84 126.65 54.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.118 0.485 . . . . 0.37 111.658 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.509 ' N ' HD23 ' A' ' 140' ' ' LEU . 24.2 t -114.55 110.99 20.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.723 -0.671 . . . . 0.9 110.059 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.2 p -105.03 104.29 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.341 0.591 . . . . 0.53 111.286 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 58.22 -89.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.755 -0.657 . . . . 2.05 112.085 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.96 23.41 4.97 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.437 -0.887 . . . . 0.6 113.593 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -133.13 136.51 45.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.005 -0.368 . . . . 2.02 110.005 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.16 140.9 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.034 0.445 . . . . 1.3 111.491 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.0 m -160.15 122.78 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.718 -0.674 . . . . 1.12 110.233 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.5 p -50.94 143.09 10.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.966 -0.561 . . . . 1.11 111.502 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -79.77 121.91 25.94 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.001 -0.741 . . . . 0.28 109.001 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 t -111.19 91.44 3.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.819 0.674 . . . . 1.55 112.819 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.4 -36.73 0.03 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.255 1.662 . . . . 0.46 117.255 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -159.75 151.98 20.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.335 1.567 . . . . 1.8 113.466 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.589 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 1.3 tt -85.55 132.57 34.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.835 -1.172 . . . . 1.24 107.835 176.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.521 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.5 t -122.79 117.7 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.817 -0.753 . . . . 1.28 112.493 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.13 115.62 47.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.864 0.364 . . . . 0.59 110.826 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 166.79 23.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.375 0.607 . . . . 2.48 111.23 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.84 151.24 45.54 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.027 -0.988 . . . . 1.54 110.675 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -123.26 143.96 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.671 -1.15 . . . . 0.77 110.029 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 145.03 24.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 1.97 111.594 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.56 -14.45 44.02 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.312 -0.715 . . . . 1.12 111.312 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -141.55 -79.9 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.227 . . . . 3.81 110.694 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -155.16 157.75 37.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.863 0.363 . . . . 3.82 111.142 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 54.97 86.93 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.951 -0.568 . . . . 1.4 111.861 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 170.96 0.4 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.82 -0.627 . . . . 2.0 110.01 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -41.22 103.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.588 1.525 . . . . 2.58 111.159 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -58.55 -64.98 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.287 -0.869 . . . . 3.71 113.088 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 63' ' ' THR . 11.9 t -91.71 134.26 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 120.14 -0.624 . . . . 0.92 112.385 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.6 t -132.48 137.8 47.35 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.712 -0.676 . . . . 1.2 112.616 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -130.22 34.75 4.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.171 -0.922 . . . . 0.22 111.466 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.1 tp -44.93 128.28 6.92 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.801 -0.636 . . . . 1.02 111.656 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.4 OUTLIER -143.15 115.69 8.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.94 -0.573 . . . . 0.33 110.831 -178.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -117.16 131.27 70.35 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-O 123.002 1.382 . . . . 0.69 113.029 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.558 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -126.42 165.04 19.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.216 -1.811 . . . . 1.26 109.735 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 3.4 ptmm? -121.42 152.75 38.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.424 1.639 . . . . 1.82 115.424 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.72 -34.85 4.62 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 112.044 -2.344 . . . . 0.22 117.796 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.419 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.67 156.71 0.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.21 2.005 . . . . 0.29 114.723 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.638 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.57 -10.5 53.84 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.167 -0.924 . . . . 0.57 110.899 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 2.31 111.508 -178.323 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.7 tp . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.306 0.574 . . . . 0.41 110.322 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.682 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.39 -20.93 13.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.366 -0.834 . . . . 0.33 111.184 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.11 -19.34 61.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 2.09 111.856 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -102.05 -29.52 11.72 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.696 -0.401 . . . . 1.99 110.875 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.9 p -45.38 146.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.796 0.332 . . . . 0.21 111.815 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.12 -22.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.224 -0.59 . . . . 0.86 110.649 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.567 ' O ' HG22 ' A' ' 172' ' ' ILE . 17.0 t90 -172.51 133.45 0.62 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.233 -0.439 . . . . 0.28 109.912 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -154.23 143.09 21.02 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.74 0.274 . . . . 0.2 111.74 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.2 t -146.94 131.5 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.598 1.332 . . . . 0.67 114.598 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.47 103.05 10.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.058 -0.519 . . . . 1.27 110.621 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . -70.82 105.53 3.26 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.124 -0.63 . . . . 0.37 109.367 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.576 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.08 -27.01 0.14 Allowed Glycine 0 N--CA 1.446 -0.659 0 O-C-N 124.016 0.823 . . . . 0.67 114.074 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -138.44 -127.8 2.54 Favored Glycine 0 CA--C 1.511 -0.204 0 C-N-CA 119.98 -1.105 . . . . 1.12 113.011 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 37.1 mt-10 -154.63 119.65 4.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.39 0.138 . . . . 2.02 111.2 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.5 m 29.59 100.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.251 0.834 . . . . 1.22 113.251 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 22' ' ' VAL . 6.7 t60 -130.38 150.74 51.47 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 120.394 -0.522 . . . . 0.34 111.767 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 55.1 t -115.64 109.54 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.678 -0.692 . . . . 1.18 111.755 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.92 157.21 36.67 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.656 -0.247 . . . . 1.17 110.424 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 25' ' ' HIS . 13.0 m -44.31 -52.66 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.832 1.049 . . . . 0.6 113.832 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.414 ' N ' HG23 ' A' ' 24' ' ' VAL . 40.9 m-70 -58.38 -13.76 6.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.085 0.469 . . . . 0.46 110.406 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.0 34.91 5.5 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.526 -0.761 . . . . 0.29 112.299 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.416 HD11 ' HG ' ' A' ' 6' ' ' LEU . 32.9 mm -103.61 122.64 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.65 -0.5 . . . . 0.43 109.65 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 11.7 t60 -101.91 135.49 43.38 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.714 1.376 . . . . 0.52 114.714 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -98.33 132.9 43.42 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.396 -0.965 . . . . 3.0 108.396 176.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.435 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 6.9 mtp180 -92.43 112.69 24.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.787 0.662 . . . . 2.9 112.787 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -20.24 137.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.247 1.419 . . . . 2.71 114.423 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -14.3 84.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.685 1.194 . . . . 1.98 113.807 177.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo . . . . . 0 CA--C 1.542 0.876 0 C-N-CA 122.449 2.1 . . . . 1.53 115.234 179.375 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 108.667 -0.864 . . . . 0.83 108.667 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -48.87 8.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.679 0.992 . . . . 1.69 113.679 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -78.9 34.69 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.647 0.61 . . . . 2.56 112.647 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -144.2 137.5 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.97 111.293 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -67.55 161.75 62.76 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.493 -0.558 . . . . 1.96 109.493 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.435 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.6 Cg_exo -42.16 -46.89 7.16 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.764 2.31 . . . . 0.66 116.141 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' O ' HG12 ' A' ' 59' ' ' VAL . 12.9 pt-20 -77.71 -53.16 7.87 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.248 0.547 . . . . 1.82 111.649 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 8.7 p-10 -70.04 -2.3 12.36 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.717 -0.793 . . . . 1.91 109.719 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 20.2 tt0 -80.36 -60.15 2.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.447 -0.797 . . . . 1.5 109.218 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 56' ' ' GLU . 2.6 p -47.59 -35.57 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.457 -0.942 . . . . 1.22 108.457 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 62' ' ' GLN . 10.2 tp -69.88 -64.52 0.87 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.465 0.65 . . . . 1.05 109.41 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.413 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-30 -66.95 20.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.9 -1.046 . . . . 0.9 112.703 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 60' ' ' LEU . 38.4 tt0 -137.54 -67.81 0.48 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.515 0.931 . . . . 1.8 113.515 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 21.0 p -30.6 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.554 0.946 . . . . 1.05 113.554 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.576 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -131.98 151.63 51.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.686 -0.688 . . . . 2.05 111.464 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.63 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 30.2 mtt180 -105.2 -170.41 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.536 -0.542 . . . . 3.58 109.536 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.81 -179.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 4.25 111.069 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -117.12 164.85 14.14 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.184 -0.462 . . . . 4.35 111.413 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -167.69 -150.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.844 -0.616 . . . . 3.17 109.969 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 10.1 t70 -141.38 128.06 20.3 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.718 0.294 . . . . 2.39 111.418 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 t 51.94 86.03 0.04 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.101 -0.5 . . . . 0.99 111.238 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.07 160.5 43.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 1.26 110.909 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -168.17 -154.14 8.6 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.358 -0.925 . . . . 0.66 113.998 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.88 167.84 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.478 0.656 . . . . 0.83 112.046 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -120.22 135.62 54.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.638 -1.164 . . . . 2.27 110.047 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.423 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.9 mp -127.64 86.84 57.45 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 111.823 0.305 . . . . 0.34 111.823 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -57.69 127.55 25.73 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.975 1.783 . . . . 0.8 112.059 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 153' ' ' LEU . 21.7 mt -119.25 153.69 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.966 0.412 . . . . 0.38 111.138 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.432 ' N ' HG22 ' A' ' 77' ' ' ILE . 16.9 pttp -147.35 6.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.895 -0.593 . . . . 2.96 110.823 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -130.77 171.0 13.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.822 -0.172 . . . . 2.13 110.627 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.07 171.96 10.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.277 0.56 . . . . 0.37 111.577 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 -153.89 21.59 Favored Glycine 0 C--N 1.329 0.148 0 N-CA-C 109.901 -1.28 . . . . 0.21 109.901 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.5 mm-40 -98.07 110.25 22.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.856 1.328 . . . . 2.03 108.859 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -96.55 126.53 41.8 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.906 -0.776 . . . . 0.26 108.906 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.66 HG21 ' N ' ' A' ' 177' ' ' ALA . 13.8 t -115.81 116.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.401 -0.818 . . . . 0.54 111.78 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.464 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.8 tt -94.06 105.15 17.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.761 -1.109 . . . . 1.23 111.029 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 42.9 t -108.07 135.59 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.163 -1.051 . . . . 1.31 108.163 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -150.05 148.8 29.46 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.952 -1.099 . . . . 1.37 112.365 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.585 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 2.2 tptm -104.59 118.82 37.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.457 -0.792 . . . . 2.97 110.011 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 115' ' ' LEU . 4.9 m-85 -106.01 137.67 43.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.458 -0.941 . . . . 0.3 108.458 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.428 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.337 0 C-N-CA 120.026 -0.67 . . . . 0.41 111.898 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.977 0.418 . . . . 2.96 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.9 m -115.01 153.38 30.75 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.0 -0.545 . . . . 1.55 111.774 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 52.03 27.58 4.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.635 -0.711 . . . . 2.33 112.144 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -134.27 -47.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 2.51 109.636 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.99 86.52 3.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.719 -0.673 . . . . 3.1 109.541 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.17 150.32 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 1.31 109.892 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -127.13 179.04 5.63 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 113.065 0.765 . . . . 0.69 113.065 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -123.6 137.58 54.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.124 -0.489 . . . . 2.01 111.256 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.414 -0.357 . . . . 0.46 111.922 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -130.35 151.2 51.11 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.825 0.676 . . . . 1.85 112.825 -178.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 9.5 p -124.6 120.76 59.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 115.425 -0.807 . . . . 1.1 110.021 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.475 ' OD1' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.68 25.85 10.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.524 -0.917 . . . . 1.77 108.524 -176.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.58 57.29 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.16 -0.927 . . . . 0.41 112.987 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.454 ' CG ' HG11 ' A' ' 142' ' ' VAL . 89.1 m-70 -110.48 112.25 24.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.428 0.899 . . . . 0.46 113.428 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 p -70.41 112.66 6.87 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.023 0.44 . . . . 0.66 111.221 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.34 -37.61 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 0.8 110.124 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.87 90.31 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 109.337 -0.616 . . . . 0.51 109.337 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.3 ptpp? -108.25 84.58 1.96 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.165 0.983 . . . . 2.44 112.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.6 p30 149.92 31.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.437 -2.165 . . . . 2.56 108.142 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -56.32 98.87 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.146 0.498 . . . . 1.1 112.056 -177.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -105.87 80.76 1.57 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.828 -1.175 . . . . 1.99 107.828 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.1 mt -51.0 -47.03 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.085 -0.962 . . . . 0.63 112.721 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.662 0.267 . . . . 0.9 111.671 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.29 -27.63 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.979 0.363 . . . . 0.76 111.979 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -68.86 -58.54 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.069 0.396 . . . . 2.68 112.069 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.5 m -90.54 -40.47 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.939 0.348 . . . . 1.41 111.939 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.34 -82.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 1.06 112.439 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -99.99 169.69 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.512 0.196 . . . . 3.51 110.782 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 m -49.88 97.91 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.36 -0.382 . . . . 1.68 110.984 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.9 p -150.94 -170.12 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.8 109.96 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.512 ' HB1' ' HZ3' ' A' ' 88' ' ' LYS . . . -96.6 131.11 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.741 0.645 . . . . 0.44 112.741 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -106.32 147.08 29.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.572 -0.899 . . . . 0.38 108.572 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -144.83 127.08 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.437 0.532 . . . . 2.09 112.437 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -114.8 135.61 53.99 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.766 -0.652 . . . . 2.28 109.568 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.54 120.86 66.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.4 -0.818 . . . . 0.71 110.083 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.88 89.18 51.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.353 -0.385 . . . . 1.38 111.947 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.17 146.62 94.26 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.97 1.78 . . . . 0.22 111.709 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.6 mt -138.6 156.86 29.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 0.21 110.751 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 p -133.53 108.56 8.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.068 0.461 . . . . 1.11 111.349 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 139' ' ' LYS . 18.3 mt -109.67 125.69 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-N 115.667 -0.697 . . . . 0.23 110.224 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -149.12 141.69 24.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 1.91 111.157 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt 61.36 14.24 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.9 -0.591 . . . . 3.11 111.212 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.78 8.76 59.13 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.606 -0.807 . . . . 0.32 113.402 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.595 ' O ' HG23 ' A' ' 135' ' ' ILE . 33.3 mtmt -112.34 165.2 12.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.34 0.57 . . . . 2.19 110.669 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.507 ' CD1' HD11 ' A' ' 153' ' ' LEU . 8.2 tt -127.16 139.74 52.74 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.616 0.598 . . . . 0.37 112.616 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.448 ' OG ' HG22 ' A' ' 146' ' ' VAL . 36.1 t -126.44 116.03 20.51 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.626 -0.715 . . . . 0.9 110.447 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 142' ' ' VAL . 4.3 p -112.32 104.53 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.094 -0.957 . . . . 0.53 110.575 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.75 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 2.05 112.009 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.17 9.87 4.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.352 -0.927 . . . . 0.6 113.914 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -124.38 118.87 27.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.147 0.473 . . . . 2.02 110.019 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.448 HG22 ' OG ' ' A' ' 141' ' ' SER . 21.2 t -107.62 130.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.477 0.656 . . . . 1.3 112.432 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 t -145.12 143.11 30.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 114.939 -1.028 . . . . 1.12 109.742 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.6 p -55.85 141.36 39.24 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.111 0.411 . . . . 1.11 112.111 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -79.09 143.15 35.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.168 -0.679 . . . . 0.28 109.168 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.9 96.45 3.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.776 1.028 . . . . 1.55 113.776 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.66 -57.33 2.55 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.978 1.151 . . . . 0.46 115.978 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -153.54 174.72 14.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.934 0.867 . . . . 1.8 112.667 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.507 HD11 ' CD1' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -97.06 130.79 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.964 -1.495 . . . . 1.24 106.964 176.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.408 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.4 t -120.71 112.74 19.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.267 -0.973 . . . . 1.28 112.978 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 57.5 t -98.28 104.04 15.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 0.59 110.548 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 mt-10 -108.47 144.91 35.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.407 -0.815 . . . . 2.48 110.922 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.97 138.16 42.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.637 -0.505 . . . . 1.54 109.637 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.6 t -112.25 143.59 21.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.22 -0.9 . . . . 0.77 111.261 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -74.95 148.45 39.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.533 -0.758 . . . . 1.97 111.375 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.14 -9.2 28.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.943 -0.646 . . . . 1.12 111.941 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.45 -61.89 0.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.616 0.246 . . . . 3.81 110.489 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -172.69 -28.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 3.82 111.048 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.73 90.54 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 1.4 111.589 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -53.82 165.82 0.7 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.397 -0.594 . . . . 2.0 109.397 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -37.67 100.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.779 1.653 . . . . 2.58 111.575 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -52.0 -57.0 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.975 . . . . 3.71 112.384 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 61.3 t -103.04 133.69 46.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 120.495 -0.482 . . . . 0.92 112.253 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -132.59 135.29 45.81 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 115.873 -0.603 . . . . 1.2 111.065 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.585 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -126.23 35.57 4.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.806 . . . . 0.22 112.611 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.36 131.43 0.21 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.499 0.499 . . . . 1.02 111.366 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.458 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.89 101.26 2.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.33 110.198 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -107.43 123.32 62.63 Favored 'Isoleucine or valine' 0 C--O 1.265 1.873 0 CA-C-O 122.858 1.313 . . . . 0.69 112.587 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.9 ptm -114.76 165.24 13.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.507 -1.678 . . . . 1.26 110.045 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HZ2' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -119.14 145.17 46.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 115.058 1.503 . . . . 1.82 115.058 -177.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 101.81 -37.61 3.56 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 112.095 -2.32 . . . . 0.22 118.749 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.482 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.06 157.48 0.32 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.883 2.341 . . . . 0.29 114.358 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.66 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.12 -22.85 26.87 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.673 -1.149 . . . . 0.57 108.861 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.232 0.137 0 CA-C-N 115.206 -0.906 . . . . 2.31 110.86 -179.678 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 tp . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.4 0.619 . . . . 0.41 109.669 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.691 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -59.83 -20.34 56.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.096 -0.956 . . . . 0.33 110.599 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.09 -18.5 63.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 2.09 111.35 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -107.7 -26.73 10.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.696 -0.401 . . . . 1.99 111.476 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -45.84 145.48 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.756 -0.378 . . . . 0.21 111.505 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -133.48 -18.86 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 119.861 -0.736 . . . . 0.86 110.345 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.493 ' O ' HG22 ' A' ' 172' ' ' ILE . 44.0 t90 -175.22 144.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.591 -0.444 . . . . 0.28 110.311 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -162.05 142.82 10.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.667 0.247 . . . . 0.2 111.667 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.68 128.95 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.988 1.107 . . . . 0.67 113.988 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 10.1 t30 -114.26 93.7 4.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.904 -0.776 . . . . 1.27 108.904 176.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.556 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -63.7 97.41 0.15 Allowed 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.442 -0.799 . . . . 0.37 109.757 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.564 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . 176.93 -77.8 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.122 -1.399 . . . . 0.67 113.196 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -77.16 -125.36 0.26 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.204 -0.522 . . . . 1.12 112.759 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.548 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -162.72 121.48 2.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 120.858 0.361 . . . . 2.02 110.744 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.0 p 35.11 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.809 -0.632 . . . . 1.22 112.289 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.56 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 55.9 t60 -117.78 152.47 35.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.157 -0.617 . . . . 0.34 112.575 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.7 t -123.67 103.6 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.469 -0.787 . . . . 1.18 110.427 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.45 151.29 47.03 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.275 -0.42 . . . . 1.17 110.731 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 25' ' ' HIS . 14.7 m -43.09 -48.69 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 124.367 1.042 . . . . 0.6 112.888 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.404 ' N ' HG23 ' A' ' 24' ' ' VAL . 46.3 m-70 -57.74 -29.73 65.0 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.319 0.58 . . . . 0.46 110.069 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.83 33.81 1.8 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.142 -0.935 . . . . 0.29 111.666 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.1 mm -103.39 123.5 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.607 -0.516 . . . . 0.43 109.607 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.6 t60 -104.38 134.97 46.69 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.614 1.338 . . . . 0.52 114.614 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CD1' ' C ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -97.72 129.31 44.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.564 -0.902 . . . . 3.0 108.564 176.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -82.43 113.15 19.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.647 0.61 . . . . 2.9 112.647 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -28.12 140.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.445 -1.252 . . . . 2.71 113.499 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.499 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 1.6 m-20 -14.75 83.57 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.814 1.246 . . . . 1.98 114.079 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 C--N 1.351 0.682 0 C-N-CA 122.35 2.033 . . . . 1.53 113.783 178.638 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.725 HG21 ' HB2' ' A' ' 126' ' ' ALA . 2.0 mt . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.758 0.789 . . . . 0.83 109.503 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mt -46.94 -52.48 14.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.171 -1.377 . . . . 1.69 113.937 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -65.75 -0.68 2.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.046 0.387 . . . . 2.56 112.046 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.9 t -128.18 142.08 51.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.685 0.624 . . . . 0.97 112.685 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -69.15 158.84 85.5 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.848 -0.615 . . . . 1.96 109.497 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.9 Cg_exo -40.07 -56.69 1.37 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 123.188 2.592 . . . . 0.66 116.446 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 12.5 pt-20 -71.45 -53.36 14.23 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.318 0.58 . . . . 1.82 111.264 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.67 -5.03 22.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.126 -0.694 . . . . 1.91 109.126 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -77.59 -46.98 20.51 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.683 -0.858 . . . . 1.5 108.683 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -55.09 -42.57 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.378 -0.971 . . . . 1.22 108.378 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.491 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 13.0 tp -63.53 -63.48 1.17 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.537 -0.542 . . . . 1.05 109.537 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.496 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 3.3 m-85 -51.13 -12.38 0.13 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.501 -0.772 . . . . 0.9 110.632 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.508 ' O ' ' O ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -123.59 -126.21 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.587 -0.733 . . . . 1.8 111.239 -178.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 167' ' ' VAL . 26.6 p 45.49 128.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.655 0.782 . . . . 1.05 112.81 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 167' ' ' VAL . 0.0 OUTLIER -124.79 154.82 40.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.441 0.638 . . . . 2.05 112.65 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.564 ' HD3' ' N ' ' A' ' 17' ' ' GLY . 18.2 mtp180 -123.3 -171.74 2.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.01 -0.995 . . . . 3.58 110.281 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.4 -178.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 4.25 111.043 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.98 163.25 39.32 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.434 -0.348 . . . . 4.35 110.963 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.56 -93.76 0.06 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.504 -0.316 . . . . 3.17 111.631 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -173.15 127.97 0.45 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.813 0.301 . . . . 2.39 111.813 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.5 t 52.45 93.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.096 -0.502 . . . . 0.99 111.976 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -160.58 161.44 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 1.26 110.588 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.07 177.56 39.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.978 -1.106 . . . . 0.66 114.632 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -100.89 161.73 13.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 0.83 111.958 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -115.49 122.32 45.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.952 -1.022 . . . . 2.27 111.137 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.53 109.63 45.7 Favored Pre-proline 0 C--O 1.224 -0.251 0 CA-C-O 119.367 -0.349 . . . . 0.34 111.179 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -81.85 130.43 6.67 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.297 1.142 . . . . 0.8 112.106 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.9 mt -121.78 148.41 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.847 0.356 . . . . 0.38 111.324 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -139.41 -0.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 2.96 111.039 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.429 ' HG3' ' NZ ' ' A' ' 174' ' ' LYS . 12.6 mm-40 -123.74 166.02 16.28 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.659 0.266 . . . . 2.13 110.878 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -119.7 172.95 7.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.273 0.559 . . . . 0.37 111.175 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.04 -147.23 18.9 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.02 -1.232 . . . . 0.21 110.02 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mt-10 -105.87 109.44 21.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.603 1.201 . . . . 2.03 109.805 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -96.65 127.22 42.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.046 -0.724 . . . . 0.26 109.046 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.654 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.3 t -113.36 117.06 54.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.383 -0.826 . . . . 0.54 111.48 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.21 104.79 16.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.23 111.312 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -105.3 137.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.918 -1.037 . . . . 1.31 108.976 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.488 ' N ' HD23 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -156.14 135.42 12.2 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.501 -0.88 . . . . 1.37 112.368 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.698 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 3.5 mptt -97.38 127.47 43.36 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.918 -0.713 . . . . 2.97 109.331 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CD2' HD21 ' A' ' 115' ' ' LEU . 3.1 m-85 -106.94 137.12 45.6 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.217 -0.66 . . . . 0.3 109.217 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 120.75 -0.38 . . . . 0.41 110.35 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.437 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 26.7 mt-30 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.886 0.374 . . . . 2.96 111.636 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 119' ' ' ASP . 33.2 p -124.54 154.54 40.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 1.55 111.755 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 47.22 29.2 1.14 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.767 -0.651 . . . . 2.33 111.829 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -133.96 -48.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.259 -0.645 . . . . 2.51 109.259 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -93.21 88.79 6.17 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 3.1 109.133 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.73 152.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.531 -0.759 . . . . 1.31 109.55 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -134.37 176.28 8.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.986 0.736 . . . . 0.69 112.986 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -121.42 139.44 53.45 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.06 -0.518 . . . . 2.01 111.206 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.68 130.6 42.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.641 -0.709 . . . . 0.46 112.04 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -131.81 153.84 49.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.14 0.793 . . . . 1.85 113.14 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 20.4 m -121.92 120.71 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.638 -1.165 . . . . 1.1 109.613 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.502 ' HA ' ' H ' ' A' ' 154' ' ' SER . 4.4 t-20 54.28 27.17 7.6 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.998 -0.741 . . . . 1.77 108.998 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.07 23.67 29.19 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.708 -1.133 . . . . 0.41 112.914 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.6 m-70 -122.97 108.73 13.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.209 0.818 . . . . 0.46 113.209 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 p -62.48 115.9 4.64 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.91 0.386 . . . . 0.66 111.642 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 t -106.38 -36.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.8 109.878 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.458 HG11 ' OE2' ' A' ' 129' ' ' GLU . 2.1 t -127.84 92.29 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.851 -0.426 . . . . 0.51 109.851 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 1.3 ptpt -105.8 76.99 1.22 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.715 1.245 . . . . 2.44 111.983 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 155.71 27.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.221 -2.263 . . . . 2.56 109.073 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 89' ' ' PHE . 40.5 tp -60.88 102.17 0.18 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.628 0.728 . . . . 1.1 112.531 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 36.0 p-10 -112.06 89.43 3.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.528 -1.215 . . . . 1.99 108.406 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.0 -54.05 15.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 0.63 113.526 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 13.1 t80 -56.55 -40.07 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.88 0.326 . . . . 0.9 111.88 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 97' ' ' SER . 19.4 t70 -67.65 -28.81 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.124 0.416 . . . . 0.76 112.124 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 11.6 mmm180 -75.98 -58.69 3.13 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.511 0.56 . . . . 2.68 112.511 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -87.1 -40.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.937 0.347 . . . . 1.41 111.937 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.76 -94.93 0.75 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 1.06 112.284 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 125' ' ' THR . 73.6 m80 -112.92 110.08 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.656 0.265 . . . . 3.51 111.286 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.2 m 56.05 -132.42 1.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.187 -0.46 . . . . 1.68 111.245 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 123' ' ' HIS . 11.0 p 57.94 -171.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.303 0.241 . . . . 0.8 111.006 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.725 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.28 139.5 49.37 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.591 0.96 . . . . 0.44 113.591 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.4 t60 -100.31 150.86 22.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.55 -1.204 . . . . 0.38 107.844 176.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -145.37 122.33 11.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.26 -0.576 . . . . 2.09 112.208 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.458 ' OE2' HG11 ' A' ' 112' ' ' VAL . 46.5 mt-10 -119.71 141.67 49.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.513 -0.767 . . . . 2.28 109.512 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 mt -123.4 136.23 60.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.683 -0.69 . . . . 0.71 111.229 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.2 mp -134.29 89.5 27.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 1.38 111.631 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.01 144.07 92.18 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.72 1.613 . . . . 0.22 111.305 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 21.5 mt -135.41 154.85 36.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.563 -0.29 . . . . 0.21 111.181 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -131.09 107.08 8.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 1.11 110.635 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.9 mt -106.98 129.65 60.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.917 -0.583 . . . . 0.23 110.55 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -147.88 140.5 24.61 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.798 0.332 . . . . 1.91 110.814 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.434 ' NZ ' ' HB2' ' A' ' 137' ' ' LYS . 0.6 OUTLIER 55.66 28.51 12.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.554 0.692 . . . . 3.11 110.06 -179.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.29 27.92 62.92 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.221 -0.899 . . . . 0.32 112.703 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 62.4 mttp -121.89 146.87 46.69 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.919 0.359 . . . . 2.19 110.797 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -107.67 131.31 54.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.146 0.498 . . . . 0.37 112.197 -177.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.592 ' N ' HD23 ' A' ' 140' ' ' LEU . 32.3 t -121.32 110.36 16.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.53 -0.759 . . . . 0.9 109.618 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.1 p -103.66 108.28 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.321 0.582 . . . . 0.53 110.968 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 60.94 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.645 -0.707 . . . . 2.05 112.022 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -137.92 12.45 3.64 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.47 -0.871 . . . . 0.6 113.158 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -116.88 141.14 48.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.863 0.331 . . . . 2.02 110.263 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.46 136.95 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 1.3 111.142 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.8 t -157.93 127.31 5.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.723 -0.672 . . . . 1.12 109.824 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.2 p -58.03 142.9 45.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.294 -0.412 . . . . 1.11 111.535 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -79.42 122.03 25.9 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.125 -0.694 . . . . 0.28 109.125 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 t -111.18 91.36 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.156 -0.618 . . . . 1.55 112.6 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.04 -33.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 117.269 1.668 . . . . 0.46 117.269 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -160.87 154.97 22.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.501 1.651 . . . . 1.8 113.868 -176.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.482 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -87.2 127.28 35.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.96 -1.126 . . . . 1.24 107.96 176.19 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.502 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -118.11 114.2 22.72 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.382 0.882 . . . . 1.28 113.382 -176.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.83 103.29 14.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.44 -0.578 . . . . 0.59 109.44 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.4 mt-10 -107.67 139.44 42.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 2.48 111.447 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -136.11 138.44 42.06 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.011 -0.54 . . . . 1.54 110.002 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.453 ' CG2' HH21 ' A' ' 105' ' ' ARG . 12.0 t -115.14 143.62 24.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.95 -1.023 . . . . 0.77 111.466 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -63.74 148.16 49.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 1.97 110.931 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.43 -29.8 8.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 1.12 111.721 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -145.53 -55.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.545 0.212 . . . . 3.81 111.011 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -142.24 -83.21 0.19 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.588 -0.278 . . . . 3.82 111.51 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.14 125.16 29.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 1.4 111.52 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 166' ' ' LYS . 1.3 m-20 -59.98 171.14 0.95 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.323 -0.853 . . . . 2.0 110.32 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -28.89 -29.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 123.312 2.675 . . . . 2.58 114.318 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ASN . 15.6 tptp 85.28 -75.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.619 0.575 . . . . 3.71 112.364 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 64' ' ' GLU . 3.5 t -96.34 135.08 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 120.606 -0.438 . . . . 0.92 112.017 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.22 134.96 45.95 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.98 -0.555 . . . . 1.2 112.425 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.513 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -124.4 35.43 4.81 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.228 -0.896 . . . . 0.22 112.769 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.424 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -37.48 138.99 0.29 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.15 0.5 . . . . 1.02 111.888 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.7 OUTLIER -157.71 100.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.47 -0.786 . . . . 0.33 110.24 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -106.26 125.35 61.95 Favored 'Isoleucine or valine' 0 C--O 1.264 1.867 0 CA-C-O 122.758 1.266 . . . . 0.69 112.553 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.583 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.7 ppp? -115.14 162.38 17.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.988 -1.915 . . . . 1.26 109.525 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.429 ' NZ ' ' HG3' ' A' ' 79' ' ' GLU . 32.2 tttt -120.34 144.15 48.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 115.272 1.582 . . . . 1.82 115.272 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.68 -36.8 4.1 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 112.397 -2.183 . . . . 0.22 118.398 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.462 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.48 155.15 0.3 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.908 2.354 . . . . 0.29 115.177 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.654 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.73 -24.61 25.08 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 114.566 -1.197 . . . . 0.57 108.972 175.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-N 115.324 -0.853 . . . . 2.31 110.657 -179.246 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 121.147 0.499 . . . . 0.41 110.219 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.598 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.26 -20.4 4.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.362 -0.835 . . . . 0.33 111.311 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.15 -27.8 38.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.407 0.521 . . . . 2.09 112.407 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 37.4 mmtt -95.29 -22.75 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.717 -0.393 . . . . 1.99 111.49 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.7 p -43.79 143.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 120.584 0.231 . . . . 0.21 111.615 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 pt -136.91 -23.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.013 -0.675 . . . . 0.86 110.487 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.489 ' O ' HG22 ' A' ' 172' ' ' ILE . 73.3 t90 -172.74 140.94 1.03 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.049 -0.523 . . . . 0.28 110.091 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -159.88 143.94 14.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.271 0.471 . . . . 0.2 112.271 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.519 HG11 ' CE2' ' A' ' 73' ' ' TYR . 4.2 t -147.02 130.98 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 113.807 1.04 . . . . 0.67 113.807 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 15.6 t-20 -114.43 95.25 5.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.887 -1.051 . . . . 1.27 108.553 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.681 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -60.18 92.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.265 -1.013 . . . . 0.37 108.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.62 ' HA3' ' OG1' ' A' ' 63' ' ' THR . . . -177.27 -95.34 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 O-C-N 124.582 1.176 . . . . 0.67 114.55 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -66.47 -122.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.112 -0.566 . . . . 1.12 114.039 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -159.09 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.388 -0.406 . . . . 2.02 110.158 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.716 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.0 m 31.61 95.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.512 -0.767 . . . . 1.22 112.68 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.683 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 22.8 t60 -123.59 139.96 53.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.787 -0.765 . . . . 0.34 112.5 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 22' ' ' VAL . 3.6 p -115.03 104.07 16.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.668 -0.696 . . . . 1.18 110.582 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 157.03 29.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.194 -0.912 . . . . 1.17 110.662 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -43.73 -47.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 O-C-N 124.367 1.042 . . . . 0.6 113.277 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -62.57 -20.18 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.318 0.58 . . . . 0.46 110.386 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.34 34.89 3.25 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.208 -0.905 . . . . 0.29 112.542 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.01 114.84 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 120.459 -0.496 . . . . 0.43 110.455 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.683 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.5 t60 -100.42 136.35 40.43 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.915 1.45 . . . . 0.52 114.915 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.716 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.23 135.99 42.85 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.698 -1.137 . . . . 3.0 108.753 177.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -86.29 106.99 17.75 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.796 0.685 . . . . 2.9 112.303 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.619 ' HB3' ' NZ ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -34.21 137.06 0.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.121 -0.945 . . . . 2.71 113.296 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.496 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER 3.0 79.7 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 114.748 -1.115 . . . . 1.98 113.551 178.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 CA--C 1.537 0.638 0 C-N-CA 122.188 1.925 . . . . 1.53 114.095 179.533 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 108.537 -0.912 . . . . 0.83 108.537 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -54.55 26.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.579 -1.191 . . . . 1.69 114.103 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -74.62 28.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.53 0.937 . . . . 2.56 113.53 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t -141.11 145.08 35.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.137 0.494 . . . . 0.97 112.133 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.1 t30 -63.47 146.9 96.08 Favored Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 115.484 -0.78 . . . . 1.96 109.596 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.632 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.2 Cg_exo -40.81 -58.89 0.88 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 122.631 2.221 . . . . 0.66 115.249 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -62.21 -54.37 41.91 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 122.298 1.047 . . . . 1.82 110.76 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -69.83 -11.64 61.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.036 -0.983 . . . . 1.91 110.215 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.632 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -64.45 -45.71 86.26 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.491 -1.67 . . . . 1.5 106.491 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' THR . 74.8 t -54.19 -51.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.403 -1.271 . . . . 1.22 109.352 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.9 tp -70.49 -7.2 41.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.586 -0.734 . . . . 1.05 111.426 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.0 m-30 -120.08 16.03 12.42 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.478 -0.783 . . . . 0.9 109.719 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.548 ' HG2' ' N ' ' A' ' 63' ' ' THR . 30.6 tt0 -141.25 -109.92 0.14 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.305 -0.861 . . . . 1.8 110.596 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.62 ' OG1' ' HA3' ' A' ' 17' ' ' GLY . 69.2 p 37.26 -156.02 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 119.082 -0.485 . . . . 1.05 110.298 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.513 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 12.6 pt-20 -174.86 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.593 1.701 . . . . 2.05 115.593 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 7.9 mtp180 70.57 -172.79 0.17 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.062 0.392 . . . . 3.58 110.056 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -87.25 178.83 6.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.519 -0.309 . . . . 4.25 111.106 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -150.05 171.99 15.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.379 -0.373 . . . . 4.35 111.121 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.41 -102.5 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.475 -0.33 . . . . 3.17 111.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -169.85 131.68 1.08 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.646 0.26 . . . . 2.39 111.028 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.541 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 21.7 t 53.21 93.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.252 -0.431 . . . . 0.99 111.495 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -168.85 168.83 10.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 1.26 110.975 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -171.37 -146.2 5.15 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.248 -0.977 . . . . 0.66 113.86 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.681 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 58.9 m-85 -135.87 172.72 12.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.719 0.771 . . . . 0.83 112.908 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.06 135.76 53.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.068 -1.424 . . . . 2.27 110.17 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.474 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.7 mp -129.35 86.34 56.66 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 111.706 0.262 . . . . 0.34 111.706 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.73 126.13 21.39 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.109 1.873 . . . . 0.8 112.512 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -121.05 149.89 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.38 110.933 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.03 2.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 2.96 111.425 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.633 ' HG2' ' NZ ' ' A' ' 174' ' ' LYS . 8.0 tp10 -132.11 165.99 22.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.835 0.35 . . . . 2.13 110.092 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -116.41 178.85 4.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.37 111.642 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.87 -148.08 18.66 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 109.972 -1.251 . . . . 0.21 109.972 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 11.1 mm-40 -105.97 110.53 22.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.701 1.251 . . . . 2.03 109.235 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.28 126.36 41.44 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 108.954 -0.758 . . . . 0.26 108.954 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.653 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.7 t -114.5 121.24 66.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.346 -0.843 . . . . 0.54 112.032 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.5 tt -103.56 105.62 15.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.864 -1.062 . . . . 1.23 110.635 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.22 132.12 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.24 -0.891 . . . . 1.31 108.816 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -147.47 138.78 23.78 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.241 -0.984 . . . . 1.37 112.824 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.61 ' C ' ' HD3' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -98.95 126.61 44.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.097 -0.956 . . . . 2.97 109.024 178.329 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.38 146.13 32.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.551 -0.75 . . . . 0.3 110.548 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.558 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . . . . . . 0 C--O 1.237 0.4 0 CA-C-N 116.088 -0.506 . . . . 0.41 109.832 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.745 0.307 . . . . 2.96 111.019 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 99' ' ' GLN . 20.4 m -99.0 -88.4 0.33 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.686 0.624 . . . . 1.55 112.686 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.86 36.22 0.17 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.903 0.383 . . . . 2.33 111.558 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 97' ' ' SER . 1.8 mt-30 -133.79 -41.3 0.85 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.016 -0.538 . . . . 2.51 109.697 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -94.39 75.86 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.293 -0.632 . . . . 3.1 109.293 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.33 154.33 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.707 -0.678 . . . . 1.31 109.851 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -139.64 173.85 11.11 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 111.968 0.359 . . . . 0.69 111.968 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.92 137.08 54.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.589 -0.444 . . . . 2.01 110.812 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.6 t -132.06 129.68 60.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 112.598 0.592 . . . . 0.46 112.598 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 2.7 mtt180 -134.89 149.59 50.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.591 -0.731 . . . . 1.85 112.82 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 14.0 m -119.28 120.8 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.313 -0.858 . . . . 1.1 109.99 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.506 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.11 27.23 9.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.42 0.628 . . . . 1.77 109.342 -176.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.5 21.33 41.08 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.016 -0.993 . . . . 0.41 112.671 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -119.16 113.73 21.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.079 0.77 . . . . 0.46 113.079 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -64.49 124.7 22.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.507 -0.477 . . . . 0.66 111.046 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.19 -32.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.833 -0.621 . . . . 0.8 109.531 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.12 90.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.51 110.151 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 18.1 ptpt -104.19 137.85 41.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.033 -0.531 . . . . 2.44 110.41 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 22.6 m-20 87.47 18.24 0.07 Allowed 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.025 -1.472 . . . . 2.56 107.025 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 tp -45.78 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.983 -1.462 . . . . 1.1 111.763 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -102.89 90.41 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.162 -0.927 . . . . 1.99 109.317 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -52.15 -47.94 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 0.63 112.637 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.77 -44.61 96.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.936 0.347 . . . . 0.9 111.936 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.87 -27.73 63.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.159 0.429 . . . . 0.76 112.159 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -70.9 -58.1 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.247 0.462 . . . . 2.68 112.247 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -99.96 -40.29 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.073 0.398 . . . . 1.41 112.073 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.77 -134.36 8.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.458 -0.877 . . . . 1.06 112.568 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -83.79 120.46 26.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.585 0.231 . . . . 3.51 111.009 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.0 p 48.18 -121.96 1.47 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.095 -0.502 . . . . 1.68 110.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.9 p 51.13 -167.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.672 0.272 . . . . 0.8 111.635 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.416 ' HA ' ' HZ1' ' A' ' 88' ' ' LYS . . . -106.88 136.31 46.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.36 1.245 . . . . 0.44 114.36 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.1 t60 -108.8 141.51 40.73 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.267 -1.383 . . . . 0.38 107.267 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.29 119.33 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.772 0.656 . . . . 2.09 112.772 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.88 136.66 52.83 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.82 -0.627 . . . . 2.28 109.922 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.1 mt -112.51 133.33 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.44 -0.8 . . . . 0.71 110.639 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.82 85.75 34.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.349 0.499 . . . . 1.38 112.349 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.18 146.57 90.7 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.876 1.717 . . . . 0.22 111.784 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 134' ' ' SER . 23.7 mt -136.7 156.93 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 0.21 110.854 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -132.83 106.95 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 1.11 110.836 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 139' ' ' LYS . 25.7 mt -103.29 126.45 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.798 -0.637 . . . . 0.23 109.609 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 88.0 mttt -148.08 138.15 22.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.878 -0.329 . . . . 1.91 111.208 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 61.61 23.55 13.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 3.11 110.572 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.09 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.041 -0.599 . . . . 0.32 112.227 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.7 ' O ' HG23 ' A' ' 135' ' ' ILE . 59.3 mttt -114.72 159.03 21.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.383 0.135 . . . . 2.19 111.073 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -121.09 124.15 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.076 0.465 . . . . 0.37 111.288 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 140' ' ' LEU . 24.5 t -114.1 109.53 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.674 -0.694 . . . . 0.9 110.014 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.4 p -103.57 106.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 0.53 111.031 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.95 -92.0 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.883 -0.599 . . . . 2.05 111.814 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.87 37.6 2.28 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.596 -0.811 . . . . 0.6 113.046 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.09 137.28 25.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.16 -0.311 . . . . 2.02 110.16 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.02 140.34 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.97 0.414 . . . . 1.3 110.976 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -162.69 126.93 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.901 -0.59 . . . . 1.12 110.447 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 t -56.22 140.82 43.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.867 -0.606 . . . . 1.11 112.406 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -79.62 139.24 37.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.403 -0.817 . . . . 0.28 109.284 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 36.0 p -136.11 95.88 3.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.223 0.823 . . . . 1.55 113.223 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.23 -60.7 1.46 Allowed Glycine 0 C--N 1.331 0.282 0 N-CA-C 115.549 0.98 . . . . 0.46 115.549 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.607 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -148.68 176.44 10.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.061 0.931 . . . . 1.8 112.978 -178.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.506 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.55 127.25 48.34 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.685 -1.228 . . . . 1.24 107.685 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.468 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.3 t -115.18 115.93 27.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.421 -0.912 . . . . 1.28 113.433 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.411 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 61.8 t -93.78 97.54 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.249 -0.649 . . . . 0.59 109.249 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 tt0 -108.04 135.74 48.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 2.48 111.407 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -130.84 143.2 50.57 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.747 -0.66 . . . . 1.54 109.729 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.6 t -122.66 144.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.421 -0.809 . . . . 0.77 111.653 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 146.36 30.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.738 -0.664 . . . . 1.97 110.88 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.9 -17.24 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.868 -0.682 . . . . 1.12 112.14 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -138.44 -61.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 3.81 110.429 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -175.25 150.9 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.097 -0.501 . . . . 3.82 110.877 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.18 89.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.194 -0.457 . . . . 1.4 111.437 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 70' ' ' SER . 1.4 m-20 -54.76 169.35 0.41 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.017 -0.538 . . . . 2.0 109.792 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.503 ' HD2' ' OD1' ' A' ' 164' ' ' ASN . 2.8 Cg_endo -36.4 105.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.321 2.014 . . . . 2.58 111.63 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -60.53 -46.74 89.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.269 -0.878 . . . . 3.71 112.34 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 25.1 t -116.1 135.02 57.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 112.807 0.669 . . . . 0.92 112.807 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -137.54 137.41 38.57 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 113.389 0.885 . . . . 1.2 113.389 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 15' ' ' ASN . . . -125.03 38.6 4.16 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.62 -1.173 . . . . 0.22 111.397 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.5 tp -50.11 127.05 15.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.737 -0.665 . . . . 1.02 111.448 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -142.09 115.5 8.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.667 -0.697 . . . . 0.33 110.831 -178.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -115.99 129.63 72.03 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 CA-C-O 123.126 1.441 . . . . 0.69 112.994 178.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.575 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.0 ppp? -124.24 168.4 13.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.957 -1.929 . . . . 1.26 109.834 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.633 ' NZ ' ' HG2' ' A' ' 79' ' ' GLU . 13.8 ptmt -120.45 156.05 32.26 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.167 1.543 . . . . 1.82 115.167 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 86.46 -34.87 3.4 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 111.833 -2.439 . . . . 0.22 118.082 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.62 158.55 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.209 2.004 . . . . 0.29 114.249 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.653 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.44 -23.73 27.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.331 -0.849 . . . . 0.57 110.425 177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.692 -0.686 . . . . 2.31 111.649 -178.598 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.413 HD11 ' SD ' ' A' ' 173' ' ' MET . 22.1 tp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.143 0.497 . . . . 0.41 109.812 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.635 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.95 -21.72 22.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.822 . . . . 0.33 111.162 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.7 -19.78 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 2.09 111.909 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -101.44 -23.39 14.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.949 -0.301 . . . . 1.99 111.282 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.1 p -45.71 141.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.735 0.303 . . . . 0.21 111.725 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.28 -21.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.324 -0.551 . . . . 0.86 110.355 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.487 ' O ' HG22 ' A' ' 172' ' ' ILE . 60.4 t90 -173.83 144.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.28 109.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -164.31 144.91 8.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.628 0.603 . . . . 0.2 112.628 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.72 129.49 6.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 113.661 0.986 . . . . 0.67 113.661 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 60' ' ' LEU . 49.1 t30 -111.52 87.1 2.47 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.934 -1.136 . . . . 1.27 107.934 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.892 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -57.52 103.67 0.14 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.447 -1.251 . . . . 0.37 109.983 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.618 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 154.2 -17.95 0.62 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 113.898 -1.501 . . . . 0.67 115.576 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.7 -126.56 2.77 Favored Glycine 0 N--CA 1.459 0.191 0 C-N-CA 119.367 -1.396 . . . . 1.12 113.529 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -165.67 120.23 1.23 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.905 0.383 . . . . 2.02 111.695 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.2 p 32.88 94.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.244 -0.889 . . . . 1.22 112.882 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.664 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.3 t60 -128.9 137.61 51.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.826 -0.75 . . . . 0.34 112.351 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.0 p -113.68 105.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-O 121.387 0.613 . . . . 1.18 111.462 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 156.53 36.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.513 -0.767 . . . . 1.17 109.851 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 m -43.35 -46.72 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.761 1.023 . . . . 0.6 113.761 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -63.54 -13.91 45.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.46 110.914 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.71 33.04 5.45 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.501 -0.772 . . . . 0.29 112.527 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 mm -103.92 112.23 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.184 0.516 . . . . 0.43 110.497 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.2 t60 -98.64 136.24 39.0 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.447 1.277 . . . . 0.52 114.447 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.637 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.89 132.32 43.58 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.73 -1.123 . . . . 3.0 108.649 177.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.516 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 22.8 mtt-85 -84.04 103.75 13.53 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 124.27 0.981 . . . . 2.9 112.685 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 30' ' ' ARG . 15.9 ttmm -14.61 124.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.003 1.112 . . . . 2.71 114.003 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -13.84 81.5 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.912 1.285 . . . . 1.98 113.822 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.71 0 C-N-CA 123.188 2.592 . . . . 1.53 113.305 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 125' ' ' THR . 1.2 mp . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.106 0.479 . . . . 0.83 110.567 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.28 -48.15 7.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.098 0.777 . . . . 1.69 113.098 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -76.44 36.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.046 0.758 . . . . 2.56 113.046 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -151.45 145.01 24.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.075 0.464 . . . . 0.97 111.776 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.9 t30 -58.96 144.84 81.39 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.543 -0.753 . . . . 1.96 110.822 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.67 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.98 -53.68 2.82 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.949 2.433 . . . . 0.66 115.383 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -64.92 -55.28 20.23 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 122.474 1.131 . . . . 1.82 110.442 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.51 -9.25 53.02 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.721 -1.127 . . . . 1.91 109.733 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.67 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.1 tt0 -66.32 -49.68 66.18 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.834 -1.543 . . . . 1.5 106.834 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.32 -46.01 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.985 -1.007 . . . . 1.22 109.385 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.475 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.4 tp -72.29 -12.99 61.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.409 -0.814 . . . . 1.05 111.376 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.403 ' O ' HG12 ' A' ' 50' ' ' ILE . 6.7 m-30 -120.71 20.61 11.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.6 -0.727 . . . . 0.9 111.494 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -137.86 -59.61 0.65 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.35 0.87 . . . . 1.8 113.35 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 82.8 p -39.53 143.87 0.19 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.213 0.82 . . . . 1.05 113.213 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.618 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.6 OUTLIER -127.28 145.06 50.92 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.897 -0.592 . . . . 2.05 111.51 -179.258 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -107.34 172.0 7.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.895 -0.593 . . . . 3.58 110.015 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -57.72 174.97 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 4.25 110.97 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.526 ' HB2' ' OD1' ' A' ' 164' ' ' ASN . 2.7 p-10 -150.26 167.48 26.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 4.35 111.632 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.45 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.8 tp10 -163.02 -83.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.042 -0.526 . . . . 3.17 111.311 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 2.9 p30 -173.37 132.43 0.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.398 0.142 . . . . 2.39 110.845 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t 43.4 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.426 -0.352 . . . . 0.99 110.425 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.483 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 0.6 OUTLIER -149.3 158.22 44.0 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.8 -0.36 . . . . 1.26 111.569 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.45 -149.21 7.71 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.24 -0.981 . . . . 0.66 114.367 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.463 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -129.71 168.84 15.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.543 0.687 . . . . 0.83 112.536 -177.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.52 132.52 55.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.451 -1.25 . . . . 2.27 110.348 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.429 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.4 mp -124.88 86.89 55.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.437 0.532 . . . . 0.34 112.437 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -55.37 132.41 52.05 Favored 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 122.271 1.981 . . . . 0.8 112.325 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.93 151.31 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.231 -0.441 . . . . 0.38 111.067 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -140.84 1.38 1.68 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.173 -0.467 . . . . 2.96 111.193 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -124.34 172.98 8.7 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.592 0.234 . . . . 2.13 110.819 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.24 165.37 19.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.379 0.609 . . . . 0.37 111.658 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.06 26.51 Favored Glycine 0 C--N 1.329 0.144 0 N-CA-C 109.874 -1.29 . . . . 0.21 109.874 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -96.95 107.25 19.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.95 1.375 . . . . 2.03 108.857 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 1.9 m-85 -95.39 127.46 41.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.573 0.702 . . . . 0.26 109.189 -178.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.604 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.1 t -118.04 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.853 -1.067 . . . . 0.54 113.284 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.48 105.96 17.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.121 -0.945 . . . . 1.23 110.381 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.4 106.12 18.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.14 -0.689 . . . . 1.31 109.14 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.475 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.486 -0.486 . . . . 1.37 112.248 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.535 ' NZ ' ' HB1' ' A' ' 126' ' ' ALA . 10.6 tptp -106.59 115.89 30.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.272 -1.01 . . . . 2.97 108.272 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 9.9 m-85 -104.77 143.64 32.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.535 -0.543 . . . . 0.3 109.535 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 120.088 -0.645 . . . . 0.41 111.001 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 2.4 pp0? . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.685 0.278 . . . . 2.96 110.768 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.418 ' HB3' ' OD2' ' A' ' 119' ' ' ASP . 10.8 m -137.65 147.72 45.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 1.55 111.708 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 54.03 24.75 4.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.868 -0.606 . . . . 2.33 111.288 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -125.32 -56.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.602 -0.518 . . . . 2.51 109.602 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -94.63 96.78 9.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.069 -0.715 . . . . 3.1 109.069 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.529 HG12 ' OD2' ' A' ' 116' ' ' ASP . 0.6 OUTLIER -109.2 148.99 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 1.31 110.553 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -120.35 -178.27 3.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.839 0.681 . . . . 0.69 112.839 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -130.98 143.08 50.46 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 115.876 -0.602 . . . . 2.01 112.131 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.22 132.68 46.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.778 -0.646 . . . . 0.46 112.151 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 12.9 ptt180 -134.35 151.65 51.35 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 115.318 -0.855 . . . . 1.85 112.738 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 10.7 m -124.99 123.95 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.752 -1.113 . . . . 1.1 110.384 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.464 ' HA ' ' H ' ' A' ' 154' ' ' SER . 7.0 t-20 52.72 26.79 4.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.991 -0.744 . . . . 1.77 108.991 -177.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.81 29.34 18.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.41 112.666 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 80.3 m-70 -129.43 111.16 12.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.266 0.839 . . . . 0.46 113.266 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -65.75 119.21 10.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.022 0.439 . . . . 0.66 111.259 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.52 -33.48 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.625 -0.716 . . . . 0.8 110.015 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.58 90.54 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.214 -0.661 . . . . 0.51 109.214 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -103.39 77.1 1.48 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 122.295 1.045 . . . . 2.44 111.406 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.5 p30 156.87 35.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.67 -1.605 . . . . 2.56 109.152 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 93.81 0.14 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.292 0.568 . . . . 1.1 111.677 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.529 ' OD2' HG12 ' A' ' 101' ' ' VAL . 6.4 m-20 -104.58 81.12 1.75 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.766 -1.568 . . . . 1.99 106.766 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.3 mt -50.35 -38.29 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.972 -1.013 . . . . 0.63 112.821 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 14.1 t80 -71.09 -43.46 67.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.862 -0.335 . . . . 0.9 111.476 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 97' ' ' SER . 9.4 t70 -66.12 -27.35 67.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.657 0.265 . . . . 0.76 111.38 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -72.18 -58.6 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.488 0.551 . . . . 2.68 112.488 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 m -96.33 -40.4 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.943 0.349 . . . . 1.41 111.943 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.89 -98.85 1.89 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.721 . . . . 1.06 112.046 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -68.56 159.43 31.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.026 -0.361 . . . . 3.51 110.026 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.4 p -57.4 94.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 1.68 110.963 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 50' ' ' ILE . 23.8 p -140.75 -148.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 0.8 110.029 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.535 ' HB1' ' NZ ' ' A' ' 88' ' ' LYS . . . -112.8 133.84 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.747 0.647 . . . . 0.44 112.747 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.522 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.9 t60 -111.53 149.29 31.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.494 -0.928 . . . . 0.38 108.494 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 19.5 t70 -141.73 132.07 25.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.31 0.576 . . . . 2.09 112.517 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.96 114.36 16.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.137 -0.938 . . . . 2.28 109.891 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.19 129.99 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 0.71 110.55 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.4 89.52 47.19 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.417 -0.356 . . . . 1.38 111.933 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -64.05 150.57 88.08 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.056 1.837 . . . . 0.22 112.011 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 134' ' ' SER . 34.2 mt -140.55 157.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.336 . . . . 0.21 111.018 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -133.53 106.41 7.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 1.11 110.747 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 139' ' ' LYS . 32.5 mt -105.5 126.51 60.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.761 -0.654 . . . . 0.23 109.865 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' A' ' 134' ' ' SER . 50.4 mttp -148.38 143.59 26.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.769 0.319 . . . . 1.91 110.961 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt 57.69 13.89 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 3.11 111.287 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.15 23.48 27.12 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.641 -0.79 . . . . 0.32 113.075 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.516 ' O ' HG23 ' A' ' 135' ' ' ILE . 1.3 mmmm -123.57 155.48 37.56 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.236 0.518 . . . . 2.19 110.41 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -113.45 129.47 56.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.076 0.465 . . . . 0.37 111.878 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.566 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.0 t -116.66 110.01 17.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 0.9 109.472 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -103.11 104.55 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.966 -0.561 . . . . 0.53 111.011 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 57.96 -91.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.965 -0.561 . . . . 2.05 111.856 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.9 6.12 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.554 -0.831 . . . . 0.6 113.414 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -127.79 136.08 50.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.056 -0.349 . . . . 2.02 110.056 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.15 136.96 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.049 0.452 . . . . 1.3 111.141 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 m -155.93 175.3 14.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.761 -0.654 . . . . 1.12 109.26 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.29 141.78 32.67 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.604 -0.438 . . . . 1.11 111.757 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -77.63 129.99 36.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.477 -0.935 . . . . 0.28 108.477 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 69.3 p -126.61 94.92 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.506 0.928 . . . . 1.55 113.506 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.03 -51.24 0.74 Allowed Glycine 0 CA--C 1.52 0.371 0 N-CA-C 116.328 1.291 . . . . 0.46 116.328 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.539 ' N ' ' HE2' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -156.37 164.31 38.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 118.443 1.121 . . . . 1.8 112.618 -177.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.39 127.11 35.49 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.357 -1.349 . . . . 1.24 107.357 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.464 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.7 t -113.42 112.91 24.42 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.698 -0.801 . . . . 1.28 112.988 -176.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 104.06 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.277 -0.419 . . . . 0.59 110.344 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -125.11 156.94 37.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.226 0.536 . . . . 2.48 111.357 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.87 145.23 41.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.338 -0.846 . . . . 1.54 110.065 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 t -115.31 143.92 24.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.414 -0.812 . . . . 0.77 111.02 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -75.92 144.59 40.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.483 -0.78 . . . . 1.97 111.116 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.62 -31.76 7.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.827 -0.701 . . . . 1.12 111.745 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.42 -56.96 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.458 . . . . 3.81 109.925 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -172.45 148.07 1.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.654 -0.703 . . . . 3.82 110.372 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 65.42 71.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.277 0.56 . . . . 1.4 111.07 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -50.25 169.67 0.19 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 114.93 -1.032 . . . . 2.0 109.443 178.171 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -37.22 110.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 121.773 1.649 . . . . 2.58 111.979 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -64.27 -69.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.091 -0.959 . . . . 3.71 112.93 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 63' ' ' THR . 91.9 t -87.27 132.1 33.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 112.044 0.386 . . . . 0.92 112.044 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.892 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.58 123.41 21.29 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.759 0.662 . . . . 1.2 112.669 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -118.84 40.46 3.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.748 -1.115 . . . . 0.22 112.985 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 tp -56.05 129.16 38.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.462 0.649 . . . . 1.02 111.035 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -139.95 114.03 8.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.041 -0.982 . . . . 0.33 109.743 -178.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.648 HD13 ' N ' ' A' ' 173' ' ' MET . 0.2 OUTLIER -111.23 126.78 68.64 Favored 'Isoleucine or valine' 0 C--O 1.258 1.513 0 CA-C-O 122.947 1.356 . . . . 0.69 113.353 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.648 ' N ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -121.61 165.95 14.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.141 -1.845 . . . . 1.26 109.539 -179.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 10.6 ptmt -120.36 142.9 48.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 114.886 1.439 . . . . 1.82 114.886 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.4 -34.89 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 112.837 -1.983 . . . . 0.22 117.737 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.41 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.27 158.26 0.47 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.393 2.096 . . . . 0.29 114.26 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.604 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.18 -27.96 24.22 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 114.729 -1.123 . . . . 0.57 110.034 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 115.6 -0.727 . . . . 2.31 111.153 -179.193 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.4 tp . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.25 0.547 . . . . 0.41 110.344 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.546 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.85 -21.54 7.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 0.33 111.77 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.98 -23.41 41.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.637 0.606 . . . . 2.09 112.637 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.57 -21.27 15.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.618 -0.433 . . . . 1.99 111.871 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.6 p -44.37 144.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 121.146 -0.221 . . . . 0.21 111.245 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -135.86 -20.33 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 119.686 -0.806 . . . . 0.86 111.258 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.457 ' O ' HG22 ' A' ' 172' ' ' ILE . 23.5 t90 -174.07 139.54 0.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.765 -0.374 . . . . 0.28 110.17 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -160.21 142.04 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.101 0.408 . . . . 0.2 112.101 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.9 t -147.52 129.29 6.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 114.567 1.321 . . . . 0.67 114.567 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 15.6 t30 -115.23 96.72 5.81 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.089 0.471 . . . . 1.27 110.385 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.905 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -68.16 114.19 6.45 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 115.683 -0.689 . . . . 0.37 109.709 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 145.61 -36.06 1.37 Allowed Glycine 0 C--N 1.342 0.882 0 O-C-N 124.767 1.292 . . . . 0.67 113.674 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.5 -132.37 6.2 Favored Glycine 0 N--CA 1.454 -0.102 0 C-N-CA 120.313 -0.946 . . . . 1.12 113.36 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.31 120.75 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.588 0.233 . . . . 2.02 110.669 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 77.8 p 28.46 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.598 -0.728 . . . . 1.22 112.672 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.591 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 75.8 t60 -119.11 151.6 38.0 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.921 -0.712 . . . . 0.34 112.343 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.59 103.71 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.27 -0.877 . . . . 1.18 109.969 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.83 153.19 42.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.074 -0.512 . . . . 1.17 110.305 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 25' ' ' HIS . 11.4 m -43.76 -51.26 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 124.17 0.919 . . . . 0.6 113.212 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.4 ' N ' HG23 ' A' ' 24' ' ' VAL . 84.7 m-70 -58.68 -17.92 26.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.134 0.492 . . . . 0.46 110.532 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.11 35.51 3.92 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.29 112.432 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.7 mm -103.62 121.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.858 -0.423 . . . . 0.43 109.858 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.4 t60 -103.27 134.75 46.14 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.686 1.365 . . . . 0.52 114.686 -176.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.23 132.52 44.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.055 -0.975 . . . . 3.0 108.77 176.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.436 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 50.1 mtt180 -87.51 108.45 19.04 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.666 0.604 . . . . 2.9 112.047 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 32' ' ' ASP . 39.0 tttt -23.57 135.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.947 0.899 . . . . 2.71 112.97 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 31' ' ' LYS . 4.1 p-10 -11.41 84.04 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 124.228 0.955 . . . . 1.98 112.884 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 13.5 Cg_endo . . . . . 0 CA--C 1.536 0.583 0 C-N-CA 122.51 2.14 . . . . 1.53 114.856 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 61' ' ' TYR . 1.1 mp . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.825 0.345 . . . . 0.83 110.16 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.48 -51.75 4.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.176 0.806 . . . . 1.69 113.176 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -74.25 36.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.205 0.817 . . . . 2.56 113.205 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -150.32 149.48 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 0.97 112.041 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 58' ' ' GLN . 44.1 t30 -64.29 147.07 97.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.511 -0.768 . . . . 1.96 109.925 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.666 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 20.8 Cg_exo -41.7 -50.62 4.79 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 122.366 2.044 . . . . 0.66 114.218 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -55.36 14.26 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.934 0.873 . . . . 1.82 110.978 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' OD1' HD23 ' A' ' 60' ' ' LEU . 14.2 t70 -67.96 -11.37 58.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.649 -0.705 . . . . 1.91 109.387 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.666 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 20.9 tt0 -65.95 -49.23 68.64 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.007 -1.479 . . . . 1.5 107.007 177.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -51.15 -47.51 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.011 -0.995 . . . . 1.22 109.193 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 tp -71.52 -13.34 61.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.028 -0.987 . . . . 1.05 111.787 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.456 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.0 m-30 -121.4 21.21 11.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.712 -0.676 . . . . 0.9 111.244 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -140.15 -59.75 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.569 0.951 . . . . 1.8 113.569 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.541 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 37.9 p -45.54 136.86 5.43 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.985 0.735 . . . . 1.05 112.985 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.557 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.5 pt-20 -121.49 150.06 42.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.985 -0.552 . . . . 2.05 111.417 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.494 HH11 ' HG3' ' A' ' 65' ' ' ARG . 12.7 ttt85 -117.66 147.76 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 3.58 110.343 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -74.14 148.78 41.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 4.25 111.778 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -153.38 -173.87 4.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.762 -0.654 . . . . 4.35 110.276 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -122.7 -69.96 0.8 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.644 0.259 . . . . 3.17 111.286 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -160.75 138.81 9.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.477 -0.329 . . . . 2.39 110.28 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 54.32 87.97 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.814 -0.439 . . . . 0.99 109.814 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.598 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 3.0 p90 -133.43 136.12 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.189 0.519 . . . . 1.26 111.1 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.403 ' HA3' ' CD ' ' A' ' 156' ' ' GLU . . . -154.25 -156.8 7.84 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.401 -0.818 . . . . 0.66 113.594 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.4 ' CE1' HD23 ' A' ' 170' ' ' LEU . 0.7 OUTLIER -139.3 163.89 31.28 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.163 0.506 . . . . 0.83 111.213 -178.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.04 114.11 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.21 -0.904 . . . . 2.27 110.667 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.7 mp -105.73 112.56 64.49 Favored Pre-proline 0 C--O 1.224 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.34 111.548 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.01 141.44 11.83 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 120.219 1.114 . . . . 0.8 111.604 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 78' ' ' LYS . 57.0 mt -132.25 151.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.039 0.447 . . . . 0.38 111.675 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' N ' HG22 ' A' ' 77' ' ' ILE . 99.6 mttt -142.95 -4.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.837 -0.62 . . . . 2.96 110.958 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -119.57 173.05 7.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.552 0.215 . . . . 2.13 110.817 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -127.26 175.63 8.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.242 0.544 . . . . 0.37 111.425 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.3 -146.86 18.51 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 109.965 -1.254 . . . . 0.21 109.965 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 19.2 mt-10 -104.68 109.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.722 1.261 . . . . 2.03 109.433 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.13 127.46 42.15 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.229 -0.656 . . . . 0.26 109.229 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.4 t -113.87 120.83 64.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.995 -1.002 . . . . 0.54 112.388 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -94.01 105.8 17.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.931 -1.032 . . . . 1.23 111.367 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 48.2 t -106.17 116.22 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.069 -0.969 . . . . 1.31 108.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 133.6 45.17 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.3 -0.56 . . . . 1.37 110.978 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.459 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 9.2 tptp -100.13 118.8 37.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 119.605 -0.838 . . . . 2.97 109.16 177.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 1.3 m-85 -105.94 136.62 45.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.14 -1.059 . . . . 0.3 108.14 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 C-N-CA 119.42 -0.912 . . . . 0.41 112.025 -179.858 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 120.712 0.292 . . . . 2.96 110.449 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 98' ' ' GLN . 18.2 m -86.36 179.07 6.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.357 -0.383 . . . . 1.55 111.941 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 97' ' ' SER . 84.1 mm-40 70.84 -68.55 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.421 -0.809 . . . . 2.33 111.29 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -62.42 -17.61 59.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 2.51 110.662 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 1.7 mptm? -110.43 52.23 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 3.1 110.305 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.409 HG22 ' C ' ' A' ' 114' ' ' ASP . 0.8 OUTLIER -109.59 133.95 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.295 -0.632 . . . . 1.31 109.295 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 164' ' ' ASN . 61.2 m-85 -138.89 170.91 15.14 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.552 0.945 . . . . 0.69 113.552 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 157' ' ' PHE . 5.1 m-20 -112.89 136.95 51.96 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.555 -0.458 . . . . 2.01 110.444 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.02 128.98 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 111.997 0.369 . . . . 0.46 111.997 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 15.7 ptt180 -133.63 147.55 51.47 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.351 0.871 . . . . 1.85 113.351 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m -122.18 120.59 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 114.761 -1.108 . . . . 1.1 109.807 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.504 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.38 27.21 9.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.308 0.575 . . . . 1.77 109.49 -176.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.39 14.07 57.67 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.224 -0.898 . . . . 0.41 112.938 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.0 m-70 -110.66 111.19 22.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.264 0.839 . . . . 0.46 113.264 -178.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -69.25 112.6 5.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.004 0.43 . . . . 0.66 110.418 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.67 -37.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 0.8 110.848 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.33 91.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.134 -0.626 . . . . 0.51 111.121 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 10.9 ptmm? -101.88 146.75 27.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.374 -0.83 . . . . 2.44 109.706 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 5.4 m-20 77.24 33.27 0.43 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.865 -1.061 . . . . 2.56 108.741 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 1.1 112.126 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 44.7 p-10 -101.52 84.21 2.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.151 -0.685 . . . . 1.99 109.151 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.2 pt -51.25 -37.24 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.648 -0.706 . . . . 0.63 112.231 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -57.08 -44.69 83.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.543 -0.298 . . . . 0.9 111.57 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.19 -28.18 63.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.83 0.308 . . . . 0.76 111.83 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -72.25 -58.82 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.205 0.446 . . . . 2.68 112.205 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.3 m -88.63 -40.41 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.846 0.313 . . . . 1.41 111.846 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.73 -93.37 0.65 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.747 -0.739 . . . . 1.06 111.94 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.472 ' O ' HG23 ' A' ' 125' ' ' THR . 61.0 m80 -115.08 110.4 19.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.517 0.198 . . . . 3.51 110.952 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.7 p 54.42 -144.84 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.269 -0.423 . . . . 1.68 111.21 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.5 p 68.45 -172.67 0.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.987 0.515 . . . . 0.8 111.743 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.45 141.67 37.38 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.769 0.655 . . . . 0.44 112.769 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 15.7 t60 -101.88 157.4 16.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.606 -0.724 . . . . 0.38 109.103 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -143.0 113.51 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.464 0.542 . . . . 2.09 112.464 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -108.12 116.88 32.77 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.678 -0.692 . . . . 2.28 110.078 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.7 mt -109.66 130.0 63.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.72 -0.673 . . . . 0.71 110.109 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.71 89.53 25.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.34 0.496 . . . . 1.38 112.34 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -61.53 149.65 88.76 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.943 1.762 . . . . 0.22 111.926 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 26.1 mt -140.06 156.71 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.21 111.101 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 133' ' ' ILE . 39.9 t -130.6 107.24 9.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 1.11 110.82 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.2 mt -107.6 129.03 62.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.811 -0.631 . . . . 0.23 110.393 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -147.62 139.35 24.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 1.91 110.771 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp 54.57 28.39 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 3.11 110.646 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 28.37 58.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.32 112.544 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.548 ' NZ ' ' HB2' ' A' ' 139' ' ' LYS . 4.4 ttmp? -121.89 146.04 47.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.386 -0.228 . . . . 2.19 110.386 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -114.17 130.71 56.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.107 0.48 . . . . 0.37 112.077 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.57 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.2 t -127.07 110.01 12.48 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.617 -0.72 . . . . 0.9 109.73 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 144' ' ' GLY . 3.2 p -102.94 131.34 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.53 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 46.96 -90.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.821 0.304 . . . . 2.05 111.821 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -136.66 25.87 3.07 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.694 -0.765 . . . . 0.6 113.346 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -124.03 142.68 50.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.69 -0.485 . . . . 2.02 109.69 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.49 145.97 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 1.3 111.404 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.2 t -163.3 167.85 21.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.381 -0.6 . . . . 1.12 109.381 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.6 139.58 35.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.561 -0.456 . . . . 1.11 111.482 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.24 123.95 27.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.535 -1.283 . . . . 0.28 107.535 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.1 m -129.24 94.23 3.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.418 -0.913 . . . . 1.55 112.874 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.32 -48.79 1.84 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 116.778 1.471 . . . . 0.46 116.778 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -159.44 154.56 25.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.997 1.398 . . . . 1.8 113.817 -176.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -86.58 131.77 34.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.352 -0.981 . . . . 1.24 108.352 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.443 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.5 t -118.14 114.77 23.56 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.807 -0.757 . . . . 1.28 112.53 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.55 111.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.743 -0.383 . . . . 0.59 111.35 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' CD ' ' HA3' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -140.22 160.57 39.66 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.162 0.506 . . . . 2.48 111.302 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -132.96 140.45 47.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.459 -0.791 . . . . 1.54 109.789 177.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.44 144.63 13.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.353 -0.839 . . . . 0.77 111.989 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.579 ' NZ ' ' HB2' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -57.62 136.01 56.76 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.116 -0.947 . . . . 1.97 111.435 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.85 -32.16 2.52 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.869 -0.605 . . . . 1.12 111.644 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -143.0 -65.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.696 0.284 . . . . 3.81 110.26 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -176.86 152.2 0.93 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.128 -0.487 . . . . 3.82 110.975 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 64.08 40.97 6.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.942 -0.572 . . . . 1.4 112.406 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.709 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -60.4 -39.26 66.18 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-O 118.804 -0.617 . . . . 2.0 110.01 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 95.5 Cg_exo -23.51 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.415 2.744 . . . . 2.58 111.786 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 10.3 ptmm? 32.35 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.603 -1.181 . . . . 3.71 113.06 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 64' ' ' GLU . 46.0 t -96.16 133.62 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 121.045 -0.262 . . . . 0.92 111.295 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.905 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -131.48 126.83 36.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.204 -0.598 . . . . 1.2 111.689 -179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.459 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -122.37 37.03 4.49 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.957 1.095 . . . . 0.22 113.957 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -35.45 134.37 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.001 0.429 . . . . 1.02 111.889 179.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.51 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -155.16 101.76 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.33 109.831 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.501 HD13 ' N ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -110.05 123.8 66.25 Favored 'Isoleucine or valine' 0 C--O 1.259 1.572 0 CA-C-O 123.037 1.398 . . . . 0.69 112.93 179.33 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.501 ' N ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -114.19 160.55 18.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.256 -1.793 . . . . 1.26 108.768 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.415 ' HG2' ' N ' ' A' ' 175' ' ' GLY . 4.0 tmtt? -119.93 141.07 49.96 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.43 1.27 . . . . 1.82 114.43 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 174' ' ' LYS . . . 104.97 -33.92 6.19 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 112.695 -2.048 . . . . 0.22 117.639 175.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.29 156.33 0.41 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.2 2.0 . . . . 0.29 114.601 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.26 -26.22 25.11 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 114.994 -1.003 . . . . 0.57 110.277 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.913 -0.585 . . . . 2.31 111.594 -178.961 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.228 0.537 . . . . 0.41 110.333 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.62 -21.53 10.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.233 -0.894 . . . . 0.33 111.371 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.5 -23.4 46.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.012 0.375 . . . . 2.09 112.012 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -97.12 -23.09 16.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.761 -0.376 . . . . 1.99 111.375 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.0 p -44.86 145.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 120.623 0.249 . . . . 0.21 111.613 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.98 -32.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.123 -0.631 . . . . 0.86 110.848 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.492 ' O ' HG22 ' A' ' 172' ' ' ILE . 71.2 t90 -166.23 124.06 1.44 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.842 -0.343 . . . . 0.28 110.304 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.15 141.97 28.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.489 -0.323 . . . . 0.2 111.785 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 170' ' ' LEU . 2.5 t -147.56 130.89 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 113.442 0.904 . . . . 0.67 113.442 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 21.0 t-20 -110.14 89.44 3.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 107.865 -1.161 . . . . 1.27 107.865 175.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.674 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -58.33 99.07 0.04 OUTLIER 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.008 -0.996 . . . . 0.37 109.605 -177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.72 -88.99 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.736 -1.12 . . . . 0.67 114.355 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -78.56 -117.7 0.22 Allowed Glycine 0 CA--C 1.512 -0.127 0 C-N-CA 121.085 -0.579 . . . . 1.12 113.419 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -145.04 148.52 33.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.635 -0.135 . . . . 2.02 110.635 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 64.6 m -12.36 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.171 0.804 . . . . 1.22 113.171 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 29.0 t60 -139.09 150.42 45.7 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.095 0.474 . . . . 0.34 111.915 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.57 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 1.18 111.298 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 154.75 41.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.17 110.472 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 25' ' ' HIS . 12.0 m -44.35 -51.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 124.081 0.863 . . . . 0.6 113.147 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.408 ' N ' HG23 ' A' ' 24' ' ' VAL . 80.3 m-70 -58.16 -18.52 26.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.268 0.556 . . . . 0.46 110.354 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 34.96 4.02 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.333 -0.849 . . . . 0.29 112.232 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -103.64 121.34 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 0.43 110.084 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.7 t60 -101.08 135.82 41.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 114.271 1.211 . . . . 0.52 114.271 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.86 136.78 42.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.975 -1.12 . . . . 3.0 107.975 176.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.435 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 48.8 mtt180 -91.42 108.06 19.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.178 0.513 . . . . 2.9 112.247 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 32' ' ' ASP . 63.5 tttm -25.1 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.724 -1.126 . . . . 2.71 113.818 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.603 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 6.0 m-20 -7.31 80.27 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.875 1.27 . . . . 1.98 113.886 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 17.3 Cg_endo . . . . . 0 CA--C 1.537 0.632 0 C-N-CA 122.623 2.215 . . . . 1.53 113.826 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.467 HG21 ' HB2' ' A' ' 126' ' ' ALA . 2.8 mt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 0.83 108.316 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.1 -22.79 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.17 1.174 . . . . 1.69 114.17 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -103.77 36.57 2.28 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.226 -0.59 . . . . 2.56 111.827 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.5 t -142.49 146.43 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.017 0.437 . . . . 0.97 111.607 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.6 t30 -62.54 145.27 95.13 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 115.786 -0.643 . . . . 1.96 109.436 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.584 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 15.7 Cg_exo -39.95 -54.98 1.88 Allowed 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.687 2.258 . . . . 0.66 114.984 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.9 mm-40 -64.95 -53.9 39.06 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.264 1.03 . . . . 1.82 110.64 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -2.57 23.53 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.143 -0.935 . . . . 1.91 110.549 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 32.9 tt0 -75.69 -56.75 4.38 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.509 -0.923 . . . . 1.5 108.509 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.835 ' O ' HG23 ' A' ' 63' ' ' THR . 7.2 p -52.84 -44.62 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.528 -0.916 . . . . 1.22 108.528 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.63 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 10.0 tp -58.4 -67.18 0.38 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 119.738 -0.785 . . . . 1.05 109.989 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.71 -8.55 0.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.611 -0.722 . . . . 0.9 111.757 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.442 ' HG2' ' N ' ' A' ' 63' ' ' THR . 24.6 tt0 -115.74 -116.81 0.32 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 111.934 0.346 . . . . 1.8 111.934 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 59' ' ' VAL . 71.6 p 51.24 -173.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.125 0.17 . . . . 1.05 110.925 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 63' ' ' THR . 0.8 OUTLIER 175.22 154.11 0.15 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.512 0.196 . . . . 2.05 110.567 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.603 ' NH2' ' HB3' ' A' ' 32' ' ' ASP . 3.1 ptm180 -143.36 176.81 8.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.808 0.337 . . . . 3.58 111.162 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.93 155.01 2.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.009 -0.541 . . . . 4.25 111.927 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -133.16 158.1 43.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.703 -0.68 . . . . 4.35 110.827 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.43 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 10.7 tp10 -133.48 -93.86 0.33 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.353 -0.385 . . . . 3.17 110.971 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 2.9 p30 -172.76 125.37 0.47 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.603 0.239 . . . . 2.39 110.796 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 t 49.8 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.99 111.076 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -161.01 161.38 31.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.492 -0.483 . . . . 1.26 111.936 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.27 -160.52 20.0 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.527 -0.844 . . . . 0.66 114.251 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.674 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -122.2 163.07 20.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.813 0.816 . . . . 0.83 112.93 -177.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.531 ' CG ' ' HG3' ' A' ' 152' ' ' LYS . 3.5 t70 -113.54 105.5 13.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.91 -1.495 . . . . 2.27 110.331 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.562 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -96.1 106.5 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.58 -0.282 . . . . 0.34 110.535 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.75 121.81 3.78 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 121.216 1.277 . . . . 0.8 113.121 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.532 HG22 ' H ' ' A' ' 79' ' ' GLU . 3.7 mt -135.98 151.76 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.458 0.647 . . . . 0.38 111.327 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -144.79 37.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.5 -1.296 . . . . 2.96 107.5 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 77' ' ' ILE . 15.0 mm-40 -134.63 142.43 46.88 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.78 -1.1 . . . . 2.13 110.374 -177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.27 149.64 29.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.464 0.65 . . . . 0.37 111.625 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.41 -154.58 25.61 Favored Glycine 0 CA--C 1.512 -0.129 0 N-CA-C 110.058 -1.217 . . . . 0.21 110.058 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 20.2 mt-10 -102.39 109.66 21.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 118.979 1.39 . . . . 2.03 109.667 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.456 ' OH ' ' HB2' ' A' ' 79' ' ' GLU . 44.4 m-85 -95.99 126.59 41.34 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.211 -1.033 . . . . 0.26 108.211 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.65 HG21 ' N ' ' A' ' 177' ' ' ALA . 41.9 t -112.14 113.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.612 0.72 . . . . 0.54 111.728 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 tt -98.57 104.35 16.38 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.481 -1.236 . . . . 1.23 110.194 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.95 137.27 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.253 -1.017 . . . . 1.31 108.253 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -149.25 139.26 22.07 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.45 -0.9 . . . . 1.37 112.77 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 14.5 tptt -94.26 123.36 37.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.57 -1.195 . . . . 2.97 109.708 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.5 143.03 35.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 0.3 110.072 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.425 ' HB3' HG11 ' A' ' 167' ' ' VAL . . . . . . . . 0 C--O 1.235 0.312 0 CA-C-N 116.444 -0.344 . . . . 0.41 110.364 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.843 0.354 . . . . 2.96 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 p -109.15 156.77 19.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.152 -0.476 . . . . 1.55 111.506 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 48.47 34.9 5.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.871 -0.604 . . . . 2.33 111.574 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.3 -46.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 2.51 109.577 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.559 ' NZ ' ' HB3' ' A' ' 100' ' ' LYS . 1.2 mmmp? -101.23 85.89 2.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.787 . . . . 3.1 109.508 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.31 144.16 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.084 -0.507 . . . . 1.31 110.306 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -126.63 -175.04 3.28 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 116.278 -0.419 . . . . 0.69 112.08 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.42 144.75 40.32 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 2.01 110.861 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -134.19 138.14 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.939 -0.573 . . . . 0.46 112.542 -177.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.423 HH21 HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -142.85 148.99 37.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.611 0.967 . . . . 1.85 113.611 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 22.2 m -113.01 121.66 65.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 CA-C-N 114.629 -1.169 . . . . 1.1 109.827 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.611 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 9.5 t30 51.58 26.95 3.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.245 -0.889 . . . . 1.77 110.124 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.15 21.97 21.28 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.545 -1.207 . . . . 0.41 113.137 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 80.8 m-70 -122.86 109.38 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.175 0.806 . . . . 0.46 113.175 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 21.8 p -60.34 120.52 10.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.054 0.454 . . . . 0.66 111.341 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 109' ' ' HIS . 11.5 t -113.73 -29.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.647 -0.706 . . . . 0.8 109.94 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.455 HG11 ' OE1' ' A' ' 129' ' ' GLU . 2.2 t -137.29 91.98 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 116.109 -0.496 . . . . 0.51 110.186 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 6.7 ptpp? -99.66 134.24 42.83 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.77 0.795 . . . . 2.44 110.461 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 13.9 m-20 90.42 32.3 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.109 -1.859 . . . . 2.56 109.52 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.554 HD21 ' OE2' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -54.7 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.922 -0.581 . . . . 1.1 111.43 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -98.67 81.96 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 1.99 107.992 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.0 mt -50.94 -48.62 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.97 -1.013 . . . . 0.63 112.5 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.14 -54.01 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.31 . . . . 0.9 111.327 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.35 -27.31 55.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.601 -0.272 . . . . 0.76 111.705 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -72.46 -59.23 2.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.601 0.593 . . . . 2.68 112.601 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 -41.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.541 0.571 . . . . 1.41 112.541 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.34 -141.26 16.69 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.535 -0.84 . . . . 1.06 113.174 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 125' ' ' THR . 58.7 m-70 -53.48 110.31 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.677 0.275 . . . . 3.51 111.01 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.2 m 44.8 -97.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 1.68 111.126 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 p 48.8 -178.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.039 0.447 . . . . 0.8 111.466 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.02 130.41 53.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.406 -0.361 . . . . 0.44 111.957 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -110.49 142.48 42.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.792 -0.818 . . . . 0.38 108.792 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -135.31 131.51 36.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.055 0.761 . . . . 2.09 113.055 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.554 ' OE2' HD21 ' A' ' 115' ' ' LEU . 22.8 mt-10 -132.15 121.13 23.25 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.315 -0.857 . . . . 2.28 109.884 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.73 136.41 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.036 -0.529 . . . . 0.71 111.066 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -135.85 86.58 26.86 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.888 0.699 . . . . 1.38 112.888 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -64.03 138.57 62.96 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.706 1.604 . . . . 0.22 111.527 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -128.62 153.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.627 -0.261 . . . . 0.21 110.572 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 67.1 p -132.52 108.39 9.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.379 . . . . 1.11 111.707 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.0 mt -105.31 126.63 60.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.944 -0.571 . . . . 0.23 110.032 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -148.09 144.52 27.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.394 -0.367 . . . . 1.91 110.578 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.49 20.72 7.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 3.11 110.218 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.8 28.45 50.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.862 -0.685 . . . . 0.32 112.564 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 22.7 ttpt -131.17 142.41 50.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 2.19 111.083 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 141' ' ' SER . 5.6 tt -96.06 133.43 40.32 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.847 -0.615 . . . . 0.37 112.39 -177.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.604 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -118.1 117.19 28.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.858 . . . . 0.9 109.419 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.3 98.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.967 -0.56 . . . . 0.53 111.478 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.3 -97.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.859 -0.61 . . . . 2.05 112.224 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -115.92 21.51 12.27 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.538 -0.839 . . . . 0.6 113.485 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -137.76 145.95 43.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.934 -0.395 . . . . 2.02 109.934 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.31 148.65 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.838 0.352 . . . . 1.3 111.663 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.6 m -162.25 135.87 6.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.002 -0.544 . . . . 1.12 110.609 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 50.2 p -54.03 136.4 41.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.087 -0.506 . . . . 1.11 111.53 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.17 123.47 27.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 0.28 109.708 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 152' ' ' LYS . 2.1 t -110.08 90.21 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.922 -0.711 . . . . 1.55 111.98 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 44.36 -5.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 117.201 1.64 . . . . 0.46 117.201 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.592 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -162.11 152.28 16.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.776 1.788 . . . . 1.8 113.756 -178.049 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.456 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -98.38 124.51 43.09 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.453 -1.314 . . . . 1.24 107.453 176.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -107.96 102.5 11.67 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.918 0.71 . . . . 1.28 112.918 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 56.2 t -100.36 117.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.418 -0.513 . . . . 0.59 110.605 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.78 42.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.348 -0.541 . . . . 2.48 111.521 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.06 148.99 51.06 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.273 -0.876 . . . . 1.54 110.543 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.423 HG21 HH21 ' A' ' 105' ' ' ARG . 80.6 t -118.91 142.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.056 -0.975 . . . . 0.77 110.585 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -81.48 146.55 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.726 -0.67 . . . . 1.97 111.483 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.24 -18.9 15.6 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.695 -0.684 . . . . 1.12 111.509 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -147.19 -75.62 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.585 0.231 . . . . 3.81 110.754 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -152.2 153.58 34.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.829 0.347 . . . . 3.82 111.514 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 56.15 86.77 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.956 -0.566 . . . . 1.4 111.958 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.7 169.96 0.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.118 -0.468 . . . . 2.0 109.913 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -40.35 104.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.573 1.516 . . . . 2.58 111.515 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -55.23 -56.75 16.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.052 -0.977 . . . . 3.71 112.645 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 63' ' ' THR . 21.3 t -106.38 133.89 49.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 112.534 0.568 . . . . 0.92 112.534 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 3.7 t -135.56 131.79 36.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.847 0.684 . . . . 1.2 112.847 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.574 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . . . -119.23 38.69 3.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.793 -1.094 . . . . 0.22 112.514 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 8.4 tp -48.43 127.29 12.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.374 0.669 . . . . 1.02 111.786 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.3 OUTLIER -143.48 111.14 5.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.381 -0.827 . . . . 0.33 110.528 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -111.5 123.95 67.81 Favored 'Isoleucine or valine' 0 C--O 1.258 1.552 0 CA-C-O 122.758 1.266 . . . . 0.69 112.175 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.72 166.87 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.75 -1.568 . . . . 1.26 109.807 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.46 ' NZ ' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -117.56 137.37 52.63 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.295 1.591 . . . . 1.82 115.295 -176.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 99.19 -35.4 4.71 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 118.791 2.276 . . . . 0.22 118.791 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.51 160.58 0.61 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.237 2.019 . . . . 0.29 113.969 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.65 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.68 -23.51 27.4 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.11 -0.95 . . . . 0.57 110.544 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 2.31 111.645 -179.034 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.501 -0.24 . . . . 9.15 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.26 109.68 0.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.351 . . . . 7.36 110.986 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.1 ttt -120.38 -52.55 2.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 7.76 110.797 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.0 m -58.6 161.2 4.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 4.02 110.947 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.44 33.43 3.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 1.28 112.666 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.402 ' HA ' ' OD2' ' A' ' 179' ' ' ASP . 15.5 tp -81.13 -46.51 14.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.359 0.6 . . . . 0.41 110.188 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.584 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.24 -20.25 17.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.241 -0.891 . . . . 0.33 110.972 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -74.07 -17.08 61.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 2.09 111.914 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 33.9 mttm -111.58 -21.49 11.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.488 -0.485 . . . . 1.99 111.835 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 7' ' ' ALA . 11.1 p -43.83 147.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.889 -0.324 . . . . 0.21 111.46 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.4 pt -139.92 -22.96 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 119.782 -0.767 . . . . 0.86 111.623 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.609 ' O ' HG22 ' A' ' 172' ' ' ILE . 26.2 t90 -173.0 134.24 0.56 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 0.28 110.24 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -152.29 144.36 23.82 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.443 -0.161 . . . . 0.2 111.211 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.97 126.73 4.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 N-CA-C 114.116 1.154 . . . . 0.67 114.116 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 5.8 t30 -115.13 98.82 7.0 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.274 -0.571 . . . . 1.27 110.566 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.88 109.3 3.35 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 109.3 -0.629 . . . . 0.37 109.3 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.6 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 150.0 -44.55 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 114.806 -1.088 . . . . 0.67 112.452 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.37 -140.16 11.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 1.12 112.134 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -162.7 119.36 1.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.552 0.215 . . . . 2.02 110.801 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 62.6 p 33.19 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.607 -0.724 . . . . 1.22 112.235 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 10.0 t60 -128.31 150.8 49.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 120.22 -0.592 . . . . 0.34 112.072 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.9 p -120.61 109.94 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 121.374 0.607 . . . . 1.18 111.89 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.26 155.58 39.42 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.435 -0.802 . . . . 1.17 109.933 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 25' ' ' HIS . 15.9 m -43.89 -52.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.545 0.942 . . . . 0.6 113.545 -177.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.446 ' N ' HG23 ' A' ' 24' ' ' VAL . 78.2 m-70 -56.89 -20.3 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.226 0.536 . . . . 0.46 110.579 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.85 34.83 3.39 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.357 -0.838 . . . . 0.29 112.287 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.2 mm -103.52 109.45 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.978 0.418 . . . . 0.43 110.191 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 23.4 t60 -96.87 135.55 38.69 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 115.128 1.529 . . . . 0.52 115.128 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.18 135.0 44.53 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 114.21 -1.359 . . . . 3.0 107.854 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.4 ptm180 -95.51 112.42 24.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 2.9 111.984 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.521 ' HB3' ' NZ ' ' A' ' 31' ' ' LYS . 2.8 ttpm? -16.3 140.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.603 1.335 . . . . 2.71 114.603 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.582 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 4.2 p-10 -18.71 90.02 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 CA-C-N 114.613 -1.176 . . . . 1.98 112.679 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -98.58 -2.57 1.02 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.598 2.198 . . . . 1.53 113.798 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 72' ' ' GLY . 0.5 OUTLIER -125.23 -24.57 3.95 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.52 -0.472 . . . . 1.83 112.025 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' N ' HD23 ' A' ' 34' ' ' LEU . 9.0 tt0 -79.72 69.77 6.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.803 -0.443 . . . . 4.95 109.803 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' HG12 ' A' ' 38' ' ' VAL . . . 75.78 -1.25 59.13 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.241 -1.144 . . . . 1.94 110.241 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER 43.46 24.89 0.06 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.247 0.619 . . . . 5.36 111.233 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 36' ' ' GLY . 11.9 p -149.8 135.07 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.788 -0.642 . . . . 2.97 110.503 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.46 -161.13 23.23 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.414 -0.898 . . . . 1.99 113.097 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -148.29 153.07 38.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.748 0.309 . . . . 6.59 110.774 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -49.33 119.24 3.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.036 -0.529 . . . . 2.01 111.38 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 t -69.84 -21.78 63.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 2.02 110.06 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 37.27 54.32 1.31 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.843 -0.617 . . . . 2.23 111.296 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -90.4 -28.14 18.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 2.33 110.928 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.3 27.83 8.27 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.567 -0.825 . . . . 2.2 112.896 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.5 ttt -56.42 -27.76 57.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.217 0.532 . . . . 1.93 109.934 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 48' ' ' LEU . 87.3 tttt -61.35 167.04 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.382 -0.826 . . . . 3.35 110.337 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.47 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER 69.2 64.54 0.54 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 2.76 110.346 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 84.8 Cg_exo -54.64 125.2 18.23 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.79 2.327 . . . . 1.46 113.008 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.584 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.8 mt -57.04 136.53 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.699 -0.852 . . . . 0.83 108.699 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.21 -49.95 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.52 0.933 . . . . 1.69 113.52 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.82 36.42 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.564 0.579 . . . . 2.56 112.564 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -150.54 134.75 17.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.992 0.425 . . . . 0.97 111.666 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.533 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -63.62 148.41 94.19 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.076 -0.713 . . . . 1.96 109.076 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.533 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 5.1 Cg_exo -37.9 -42.62 1.4 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.047 2.498 . . . . 0.66 116.112 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' O ' HG12 ' A' ' 59' ' ' VAL . 9.9 mm-40 -75.82 -55.84 5.24 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.846 0.832 . . . . 1.82 110.811 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.4 p-10 -71.42 -0.45 10.33 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.229 -0.656 . . . . 1.91 109.229 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 33.1 tt0 -77.4 -61.02 2.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.02 -0.991 . . . . 1.5 108.972 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 56' ' ' GLU . 6.1 p -49.59 -39.13 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.1 -0.704 . . . . 1.22 109.1 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 62' ' ' GLN . 9.4 tp -66.65 -66.64 0.53 Allowed 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.412 -0.515 . . . . 1.05 110.295 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -53.81 -7.03 0.1 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.154 -0.475 . . . . 0.9 111.101 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' A' ' 60' ' ' LEU . 4.8 tt0 -115.45 -130.65 0.31 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.93 -0.577 . . . . 1.8 110.667 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 59' ' ' VAL . 41.4 p 49.59 158.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.339 0.399 . . . . 1.05 111.378 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.6 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -141.71 143.68 33.67 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.953 1.094 . . . . 2.05 113.953 -178.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.582 ' NE ' ' HB3' ' A' ' 32' ' ' ASP . 1.6 mtt85 -136.48 135.67 38.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.933 -1.031 . . . . 3.58 109.654 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -116.51 131.7 56.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 4.25 111.42 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -104.96 -75.35 0.63 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.013 -0.539 . . . . 4.35 110.573 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 179.5 -58.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.33 0.493 . . . . 3.17 112.33 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -175.98 145.08 0.63 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.575 -0.528 . . . . 2.39 109.575 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.507 ' H ' HD21 ' A' ' 164' ' ' ASN . 20.9 t 46.31 76.09 0.11 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.604 -0.517 . . . . 0.99 109.604 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.444 ' HD1' ' N ' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -82.99 146.21 28.9 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.575 -1.268 . . . . 1.26 107.575 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -138.11 129.46 4.6 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 118.415 -1.85 . . . . 0.66 115.204 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -108.73 146.59 33.28 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.948 -0.626 . . . . 0.83 110.813 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.27 129.7 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 2.27 111.319 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.494 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.0 mp -124.46 87.42 54.23 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.356 -0.384 . . . . 0.34 110.875 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.39 127.71 27.07 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.867 1.711 . . . . 0.8 111.868 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.43 151.76 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.947 0.404 . . . . 0.38 111.4 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -143.61 4.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.962 -0.563 . . . . 2.96 111.216 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -128.42 170.33 13.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.13 110.796 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.33 172.28 9.23 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.255 0.55 . . . . 0.37 111.815 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.95 -155.25 22.26 Favored Glycine 0 N--CA 1.454 -0.152 0 N-CA-C 109.848 -1.301 . . . . 0.21 109.848 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -98.2 108.61 21.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.009 1.404 . . . . 2.03 108.869 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.0 125.99 40.05 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.911 -0.774 . . . . 0.26 108.911 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.634 HG21 ' N ' ' A' ' 177' ' ' ALA . 14.2 t -113.27 116.29 52.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.828 -1.078 . . . . 0.54 111.535 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 tt -96.5 105.15 17.2 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.69 -1.141 . . . . 1.23 110.583 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 20.3 t -110.79 132.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 114.917 -1.038 . . . . 1.31 108.52 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -142.13 146.22 35.1 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.236 -0.986 . . . . 1.37 111.88 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 128' ' ' ASP . 3.3 tptp -105.58 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.649 -0.705 . . . . 2.97 110.356 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 10.0 m-85 -104.81 143.41 33.16 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 107.879 -1.156 . . . . 0.3 107.879 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -155.09 157.32 37.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 119.543 -0.863 . . . . 0.41 112.946 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 57.72 159.34 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.433 -0.803 . . . . 3.97 111.834 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.412 ' H ' ' H ' ' A' ' 93' ' ' TYR . 5.0 p -172.25 -4.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 3.81 111.465 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.412 ' H ' ' H ' ' A' ' 92' ' ' VAL . 0.6 OUTLIER 67.04 140.04 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.238 -0.437 . . . . 2.89 110.753 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 70.42 127.49 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.999 -0.546 . . . . 2.0 111.015 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.43 81.22 6.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -133.29 152.07 51.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 2.96 110.596 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.4 p -116.37 153.16 32.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.297 0.57 . . . . 1.55 112.169 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 49.11 25.17 1.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.065 -0.971 . . . . 2.33 112.497 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -119.09 -50.12 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.941 -0.392 . . . . 2.51 109.941 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 14.0 mptt -85.76 77.96 9.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.286 -0.635 . . . . 3.1 109.286 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.45 142.59 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 1.31 110.112 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -130.81 -179.38 5.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.127 0.788 . . . . 0.69 113.127 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -121.97 137.45 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.224 -0.443 . . . . 2.01 111.564 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 t -129.73 127.26 64.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 115.869 -0.605 . . . . 0.46 111.384 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 8.1 mtt180 -125.85 148.56 49.12 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.542 -0.753 . . . . 1.85 112.502 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.21 117.23 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 114.632 -1.167 . . . . 1.1 109.695 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.42 ' OD1' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER 54.51 26.48 7.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.634 -0.876 . . . . 1.77 108.634 -177.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.98 22.63 29.83 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.656 -1.157 . . . . 0.41 112.906 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 88.4 m-70 -121.55 111.49 17.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.558 0.947 . . . . 0.46 113.558 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 p -64.71 117.33 7.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.681 -0.408 . . . . 0.66 110.868 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 109' ' ' HIS . 3.8 t -112.98 -30.34 2.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.904 -0.589 . . . . 0.8 109.819 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.7 90.18 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.417 -0.586 . . . . 0.51 109.417 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 6.3 ptmm? -105.29 79.16 1.45 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.617 1.199 . . . . 2.44 111.777 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.2 p30 156.49 35.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.032 -2.349 . . . . 2.56 109.129 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.36 93.28 0.07 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.387 0.613 . . . . 1.1 112.149 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 11.7 t70 -109.83 85.99 2.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.791 -1.559 . . . . 1.99 106.791 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.9 mt -50.03 -40.98 17.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.138 -0.937 . . . . 0.63 112.405 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.73 -65.47 0.69 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.99 -0.284 . . . . 0.9 111.385 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -52.05 -27.18 12.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.12 0.415 . . . . 0.76 112.12 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.64 -60.48 2.87 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.347 0.499 . . . . 2.68 112.347 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 m -104.19 -40.45 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.405 0.52 . . . . 1.41 112.405 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.7 -106.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.873 -0.891 . . . . 1.06 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' SER . 37.9 m80 -64.31 170.19 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.651 -0.87 . . . . 3.51 108.651 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' HIS . 75.0 m -35.26 -80.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.05 0.219 . . . . 1.68 110.9 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.499 ' O ' HG12 ' A' ' 50' ' ' ILE . 30.0 p 44.02 -164.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.808 0.337 . . . . 0.8 111.328 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.15 138.86 49.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.5 -0.318 . . . . 0.44 110.804 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.502 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.1 t60 -111.78 147.5 35.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.38 108.797 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.541 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 15.2 t70 -143.84 135.19 25.85 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.139 0.792 . . . . 2.09 113.139 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -121.53 128.68 52.29 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.373 -0.83 . . . . 2.28 109.127 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mt -111.0 120.41 61.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.668 -0.696 . . . . 0.71 110.222 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.39 88.89 49.13 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.801 0.667 . . . . 1.38 112.801 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.2 145.9 93.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.927 1.751 . . . . 0.22 111.854 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.6 mt -137.16 157.16 34.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.367 -0.379 . . . . 0.21 110.604 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 34.6 p -133.31 110.21 9.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.126 0.489 . . . . 1.11 111.244 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 139' ' ' LYS . 19.6 mt -110.66 126.02 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.583 -0.735 . . . . 0.23 109.851 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -146.08 140.14 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 1.91 110.767 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 1.2 mppt? 60.91 14.57 5.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 3.11 111.116 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.69 12.35 58.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.658 -0.782 . . . . 0.32 113.202 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.604 ' O ' HG23 ' A' ' 135' ' ' ILE . 60.0 mttp -112.81 162.0 16.28 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 117.131 0.466 . . . . 2.19 111.028 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -117.97 139.46 51.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.556 0.576 . . . . 0.37 112.556 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.661 ' N ' HD23 ' A' ' 140' ' ' LEU . 28.6 t -128.93 109.61 11.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.518 -0.765 . . . . 0.9 109.678 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 142' ' ' VAL . 12.1 p -105.46 114.7 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.165 0.507 . . . . 0.53 110.855 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 55.06 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 2.05 112.115 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.49 22.03 3.38 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.619 -0.8 . . . . 0.6 113.047 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -126.91 138.44 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.93 -0.396 . . . . 2.02 109.93 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.26 139.24 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.37 0.605 . . . . 1.3 111.732 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 140' ' ' LEU . 23.1 t -163.71 126.74 2.6 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.165 -0.925 . . . . 1.12 108.945 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.9 t -61.23 147.63 43.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.547 . . . . 1.11 112.263 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -78.78 142.94 36.55 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.389 -0.823 . . . . 0.28 109.773 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.9 p -139.25 95.81 3.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.112 0.782 . . . . 1.55 113.112 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.23 -59.75 2.75 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.729 1.051 . . . . 0.46 115.729 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -153.34 169.12 23.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.914 0.857 . . . . 1.8 112.726 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.42 HD12 ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -89.79 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.965 -1.495 . . . . 1.24 106.965 176.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 5.0 t -125.52 113.43 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 118.657 -1.217 . . . . 1.28 113.177 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.5 OUTLIER -98.31 98.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.955 -0.566 . . . . 0.59 109.644 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.1 mt-10 -110.69 126.55 54.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.664 -0.698 . . . . 2.48 111.448 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -117.17 127.09 53.77 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 119.643 -0.823 . . . . 1.54 110.264 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.522 HG21 HH21 ' A' ' 105' ' ' ARG . 10.8 t -97.2 143.99 11.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 114.185 -1.37 . . . . 0.77 112.529 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -54.43 148.37 12.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 113.911 -1.495 . . . . 1.97 111.574 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.8 -53.09 0.17 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.636 -0.711 . . . . 1.12 111.843 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -148.64 61.04 1.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.732 0.301 . . . . 3.81 110.972 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 64.96 154.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.052 -0.522 . . . . 3.82 111.876 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.37 77.83 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.651 -0.704 . . . . 1.4 111.53 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.507 HD21 ' H ' ' A' ' 70' ' ' SER . 3.9 m-20 -50.82 155.52 1.96 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.815 -0.63 . . . . 2.0 109.974 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 164' ' ' ASN . 0.9 OUTLIER -29.86 103.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.467 2.111 . . . . 2.58 112.346 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -53.0 -73.1 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.761 -1.108 . . . . 3.71 112.649 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 89.8 t -93.25 133.51 34.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.184 0.438 . . . . 0.92 112.184 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.9 130.52 45.27 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 123.928 0.768 . . . . 1.2 110.803 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.513 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -123.24 36.47 4.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.415 0.894 . . . . 0.22 113.415 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.52 129.86 0.28 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.871 0.367 . . . . 1.02 111.834 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -149.27 104.73 3.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.208 -0.451 . . . . 0.33 110.053 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -113.49 126.35 70.92 Favored 'Isoleucine or valine' 0 C--O 1.261 1.708 0 CA-C-O 122.768 1.27 . . . . 0.69 112.799 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 ptm -119.99 165.26 14.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.814 -1.539 . . . . 1.26 109.732 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 9.6 ptmt -120.68 145.71 47.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.786 1.402 . . . . 1.82 114.786 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.58 -36.05 4.56 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 112.38 -2.191 . . . . 0.22 117.767 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.457 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.21 158.73 0.48 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 120.301 2.05 . . . . 0.29 114.277 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.634 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.43 -24.81 25.54 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 114.893 -1.048 . . . . 0.57 110.564 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.86 -34.18 72.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.828 -0.624 . . . . 2.31 111.551 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 6' ' ' LEU . 21.4 t70 -55.87 -43.75 77.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.454 -0.339 . . . . 2.37 110.588 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 63.7 t -37.37 100.24 0.2 Allowed Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 116.052 -0.522 . . . . 2.57 111.719 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -50.87 139.86 39.78 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.926 1.75 . . . . 2.08 112.369 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.4 ttt -152.74 93.99 1.83 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 6.04 110.826 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.2 mt -87.35 109.15 19.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 5.3 110.729 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -60.92 141.19 93.45 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.359 -0.382 . . . . 8.05 110.133 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -44.49 138.01 7.9 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.681 1.587 . . . . 9.14 112.401 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -133.57 125.65 18.66 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.385 -0.371 . . . . 9.87 110.535 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -83.93 -158.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.152 1.901 . . . . 11.69 111.599 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 60.63 -161.55 22.29 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.437 -0.887 . . . . 12.62 112.703 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.4 mt -112.71 120.97 43.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.348 . . . . 14.44 110.83 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.241 -0.885 . . . . 15.7 110.771 179.931 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.502 -0.239 . . . . 9.15 112.502 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.57 -20.17 2.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.797 0.332 . . . . 7.36 110.92 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -99.22 -45.56 5.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 7.76 110.86 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -106.72 141.83 37.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 4.02 110.693 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -146.86 32.94 1.41 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 1.28 112.52 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 tp -68.56 -45.97 70.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.41 110.3 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.547 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -60.24 -21.06 61.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.564 -0.744 . . . . 0.33 111.178 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.93 -5.68 47.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 2.09 111.579 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HE3' ' OD1' ' A' ' 179' ' ' ASP . 19.5 mttm -123.63 -22.07 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.505 -0.478 . . . . 1.99 111.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 7' ' ' ALA . 14.5 p -43.44 147.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 121.158 -0.217 . . . . 0.21 111.18 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 pt -134.82 -23.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 119.518 -0.873 . . . . 0.86 111.391 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.426 ' O ' HG22 ' A' ' 172' ' ' ILE . 40.7 t90 -173.26 136.26 0.61 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.272 -0.571 . . . . 0.28 110.769 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.09 145.43 22.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.771 0.286 . . . . 0.2 111.771 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.42 130.63 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 114.191 1.182 . . . . 0.67 114.191 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 5.2 t-20 -115.77 88.55 2.91 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.414 -0.514 . . . . 1.27 111.174 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.03 103.97 0.27 Allowed 'General case' 0 C--O 1.248 0.988 0 N-CA-C 108.709 -0.849 . . . . 0.37 108.709 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.562 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 162.17 -47.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.707 0 O-C-N 124.505 1.128 . . . . 0.67 113.227 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.54 -129.86 5.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 1.12 112.573 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.669 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 14.8 tt0 -163.72 119.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.73 0.3 . . . . 2.02 110.947 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 8.4 t 38.73 96.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 1.22 112.72 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 76.3 t60 -124.01 151.66 43.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 120.235 -0.586 . . . . 0.34 112.293 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.8 t -121.05 104.14 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.159 -0.928 . . . . 1.18 110.265 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.27 153.03 42.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 1.17 110.688 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 25' ' ' HIS . 16.1 m -43.85 -50.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.167 0.917 . . . . 0.6 113.065 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 24' ' ' VAL . 78.6 m-70 -56.42 -22.28 30.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.34 0.59 . . . . 0.46 109.928 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.33 35.35 3.38 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.032 -0.986 . . . . 0.29 111.852 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -103.12 122.29 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.602 -0.518 . . . . 0.43 109.602 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.3 t60 -104.77 134.57 47.68 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.538 1.31 . . . . 0.52 114.538 -175.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -101.01 134.16 44.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.149 -0.932 . . . . 3.0 108.497 176.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -95.9 111.64 23.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.415 0.626 . . . . 2.9 112.256 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' ASP . 51.6 tttm -15.47 139.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.176 1.547 . . . . 2.71 115.176 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.495 ' OD1' ' HD2' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -15.54 89.22 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 114.138 -1.392 . . . . 1.98 112.471 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -98.47 -4.57 0.9 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.477 2.118 . . . . 1.53 115.845 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -142.91 -12.14 0.76 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 119.423 -0.911 . . . . 1.83 112.542 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.548 ' HB2' HH11 ' A' ' 65' ' ' ARG . 39.2 mp0 -79.06 67.01 4.65 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.069 -0.715 . . . . 4.95 109.069 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -10.24 21.16 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.743 -0.943 . . . . 1.94 110.743 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 49.0 36.17 8.03 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.132 0.492 . . . . 5.36 110.997 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.34 121.41 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 115.468 -0.787 . . . . 2.97 110.549 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.17 -154.59 25.08 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.604 -0.808 . . . . 1.99 112.927 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -144.55 -67.13 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 6.59 111.14 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.79 86.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 2.01 110.232 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 61.8 m -72.45 73.32 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 2.02 110.589 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.56 36.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.763 -0.653 . . . . 2.23 110.281 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -58.42 108.08 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.908 -0.587 . . . . 2.33 111.299 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.42 52.86 46.18 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.92 -0.657 . . . . 2.2 113.192 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.441 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -79.34 2.16 22.54 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.992 -0.373 . . . . 1.93 109.992 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -38.25 157.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.686 -0.688 . . . . 3.35 111.173 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.449 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 1.9 mt 66.66 62.28 0.89 Allowed Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.968 -0.56 . . . . 2.76 110.449 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HA ' ' CD ' ' A' ' 62' ' ' GLN . 45.4 Cg_exo -62.19 157.63 43.84 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.551 2.167 . . . . 1.46 112.676 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp -58.41 141.6 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.242 -0.435 . . . . 0.83 110.174 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 124' ' ' SER . 4.3 mm? -86.03 -44.08 12.6 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.717 1.006 . . . . 1.69 113.717 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -82.66 32.66 0.42 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.677 0.621 . . . . 2.56 112.677 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -146.36 141.89 27.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.334 0.494 . . . . 0.97 112.334 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' A' ' 57' ' ' ASP . 5.8 p-10 -66.21 150.07 97.24 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.728 -0.669 . . . . 1.96 109.5 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 9.4 Cg_exo -39.84 -48.84 3.62 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.716 2.277 . . . . 0.66 115.599 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -57.42 6.19 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.641 0.734 . . . . 1.82 112.236 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -70.07 -13.72 62.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.515 -0.55 . . . . 1.91 109.515 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.563 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 23.5 tt0 -62.94 -52.28 63.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.994 -1.113 . . . . 1.5 107.994 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -51.61 -51.62 25.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.125 -0.943 . . . . 1.22 109.187 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 4.2 tp -64.08 -15.87 60.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.809 . . . . 1.05 111.353 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.409 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 6.6 m-30 -117.13 19.96 13.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.258 -0.883 . . . . 0.9 111.268 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.451 ' CD ' ' HA ' ' A' ' 49' ' ' PRO . 42.3 tt0 -142.96 -76.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.775 1.028 . . . . 1.8 113.775 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.472 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 1.2 p -28.75 144.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.502 0.927 . . . . 1.05 113.502 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.558 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -135.88 150.57 49.41 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.318 -0.856 . . . . 2.05 110.491 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.562 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 30.9 mtp180 -107.09 -177.3 3.32 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.162 -0.31 . . . . 3.58 110.162 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -54.52 166.26 0.47 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 4.25 110.848 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -133.14 137.54 46.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 4.35 111.008 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.446 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 40.1 tt0 -123.44 -91.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 3.17 110.442 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD2' ' HG2' ' A' ' 68' ' ' GLU . 3.3 p30 -174.04 125.5 0.35 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.611 0.243 . . . . 2.39 111.116 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 t 50.06 100.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.117 -0.492 . . . . 0.99 111.629 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 1.6 p90 -151.53 148.95 28.64 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.191 0.519 . . . . 1.26 111.346 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.67 -171.06 17.81 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.479 -0.867 . . . . 0.66 114.651 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -126.91 153.64 45.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.907 -0.647 . . . . 0.83 111.624 -178.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 122.94 47.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.039 -0.982 . . . . 2.27 110.151 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.5 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.2 mp -114.45 87.25 13.59 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.153 0.427 . . . . 0.34 112.153 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -56.68 134.44 64.43 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.802 1.668 . . . . 0.8 112.359 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 78' ' ' LYS . 26.8 mt -124.82 155.56 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.994 0.426 . . . . 0.38 111.115 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 77' ' ' ILE . 95.2 mttt -146.8 3.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.866 -0.606 . . . . 2.96 110.839 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -130.9 173.08 11.32 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 120.707 0.289 . . . . 2.13 111.078 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -129.35 168.7 15.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.237 0.541 . . . . 0.37 111.143 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.01 -151.32 22.06 Favored Glycine 0 CA--C 1.512 -0.113 0 N-CA-C 109.759 -1.337 . . . . 0.21 109.759 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -99.95 109.36 21.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.103 1.451 . . . . 2.03 108.863 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -95.75 126.21 40.86 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.507 0.67 . . . . 0.26 109.395 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.656 HG21 ' N ' ' A' ' 177' ' ' ALA . 26.3 t -111.35 117.56 55.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.726 -1.125 . . . . 0.54 111.741 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 tt -88.83 104.42 16.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.526 -1.216 . . . . 1.23 110.179 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 21.4 t -109.69 133.57 54.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.271 -0.877 . . . . 1.31 109.115 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.474 ' N ' HD23 ' A' ' 87' ' ' LEU . 1.2 pt? -156.24 135.26 11.98 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.357 -0.937 . . . . 1.37 111.88 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 17.3 tptt -95.64 120.61 36.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.276 -0.875 . . . . 2.97 110.187 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.41 142.44 35.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.906 -0.775 . . . . 0.3 108.906 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.683 ' O ' HG13 ' A' ' 167' ' ' VAL . . . -149.18 168.58 22.86 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 120.57 -0.452 . . . . 0.41 110.459 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.85 123.37 2.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 3.97 110.553 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.6 p -127.91 70.05 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.631 0.729 . . . . 3.81 110.873 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -146.95 -67.98 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.649 -0.705 . . . . 2.89 111.004 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -100.23 -179.13 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 2.0 110.68 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.45 82.5 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.203 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -165.47 140.87 5.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 2.96 111.274 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.1 t -91.59 163.34 14.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.801 -0.636 . . . . 1.55 111.026 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 51.62 28.3 4.61 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.051 -0.522 . . . . 2.33 111.12 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -134.11 -42.56 0.8 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 2.51 109.853 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -108.76 82.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.853 -0.612 . . . . 3.1 109.485 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -109.5 150.22 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.704 -0.68 . . . . 1.31 110.202 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 114' ' ' ASP . 67.2 m-85 -133.38 -177.13 4.39 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 112.561 0.578 . . . . 0.69 112.561 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -132.58 137.75 47.19 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.829 -0.348 . . . . 2.01 111.005 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.8 t -131.37 129.76 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 112.758 0.651 . . . . 0.46 112.758 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.522 HH21 HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -139.14 149.42 44.46 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.95 0.722 . . . . 1.85 112.95 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.9 p -116.15 121.05 66.65 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 115.211 -0.904 . . . . 1.1 110.566 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.682 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 2.3 t30 52.8 26.89 4.86 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.239 -0.891 . . . . 1.77 110.419 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.95 16.2 39.52 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 114.451 -1.249 . . . . 0.41 113.128 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.2 m-70 -115.22 111.53 21.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.215 0.82 . . . . 0.46 113.215 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -67.1 123.08 19.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.054 0.454 . . . . 0.66 111.118 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -39.81 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.572 -0.74 . . . . 0.8 109.901 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.86 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.312 0.577 . . . . 0.51 109.933 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -98.94 154.71 17.85 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 2.44 110.025 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 102' ' ' PHE . 12.7 m-20 66.91 32.06 6.76 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.135 -1.393 . . . . 2.56 109.256 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.71 98.31 0.02 OUTLIER 'General case' 0 C--N 1.342 0.268 0 CA-C-O 120.96 0.41 . . . . 1.1 111.166 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 45.1 p-10 -100.72 79.28 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.298 -1.001 . . . . 1.99 108.298 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.91 -48.94 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.298 -0.865 . . . . 0.63 112.533 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.45 -39.99 77.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.711 0.263 . . . . 0.9 111.711 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.97 -27.7 62.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.97 0.359 . . . . 0.76 111.97 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 34.5 mmt180 -70.0 -59.09 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.082 0.401 . . . . 2.68 112.082 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.8 m -95.77 -40.47 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.228 0.455 . . . . 1.41 112.228 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.57 -104.0 2.43 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.63 -0.795 . . . . 1.06 112.22 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -63.95 164.78 9.82 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.347 -0.242 . . . . 3.51 110.347 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.456 ' O ' HD23 ' A' ' 51' ' ' LEU . 80.5 p -58.11 98.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.887 0.375 . . . . 1.68 110.738 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -144.69 -157.79 0.82 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.8 109.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.72 133.82 50.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.41 0.522 . . . . 0.44 112.41 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -109.0 147.73 31.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.922 -0.77 . . . . 0.38 108.922 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -140.39 124.86 17.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.546 0.573 . . . . 2.09 112.546 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -116.81 135.75 53.5 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.467 -0.788 . . . . 2.28 109.783 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 131' ' ' ILE . 38.5 mt -128.8 133.58 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.85 -0.614 . . . . 0.71 111.408 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.0 mp -135.17 92.36 18.18 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.457 -0.338 . . . . 1.38 111.883 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.03 140.1 76.93 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.388 1.392 . . . . 0.22 111.193 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 134' ' ' SER . 14.8 mt -132.56 158.9 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.462 -0.336 . . . . 0.21 110.992 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 133' ' ' ILE . 48.4 t -134.23 110.95 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.19 0.519 . . . . 1.11 111.119 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 139' ' ' LYS . 17.0 mt -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 115.406 -0.815 . . . . 0.23 110.009 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -150.37 142.38 23.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.69 0.281 . . . . 1.91 110.867 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm 61.19 19.0 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.469 . . . . 3.11 110.75 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.12 71.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 0.32 113.206 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.605 ' O ' HG23 ' A' ' 135' ' ' ILE . 52.5 mtpt -111.16 164.77 12.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.891 0.345 . . . . 2.19 110.523 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.496 ' CD1' HD11 ' A' ' 153' ' ' LEU . 5.5 tt -124.16 143.47 50.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.689 0.625 . . . . 0.37 112.689 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.8 t -130.69 114.09 14.96 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.343 -0.844 . . . . 0.9 109.723 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 142' ' ' VAL . 2.4 p -108.93 96.87 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 115.99 -0.55 . . . . 0.53 110.738 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 61.74 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 2.05 111.752 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.36 6.65 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.464 -0.874 . . . . 0.6 113.4 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.97 129.45 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.762 -0.458 . . . . 2.02 109.762 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.2 p -105.27 141.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.31 0.576 . . . . 1.3 111.551 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.1 m -156.88 170.4 22.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.293 -0.867 . . . . 1.12 109.301 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.2 p -99.57 139.02 35.84 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.731 -0.388 . . . . 1.11 111.548 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -78.68 142.78 36.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.28 109.69 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 150' ' ' THR . 3.1 t -147.27 96.12 2.66 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.038 0.755 . . . . 1.55 113.038 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.8 -65.5 4.05 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 115.511 0.964 . . . . 0.46 115.511 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.56 -179.58 6.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 117.601 0.7 . . . . 1.8 112.455 -177.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.496 HD11 ' CD1' ' A' ' 140' ' ' LEU . 1.3 tp -102.37 133.54 47.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.339 -1.356 . . . . 1.24 107.339 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -111.31 101.07 9.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.555 0.946 . . . . 1.28 113.555 -175.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.63 98.32 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.58 -0.448 . . . . 0.59 109.905 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 155.29 42.42 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.986 -0.552 . . . . 2.48 111.629 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -130.91 146.9 52.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.431 -0.804 . . . . 1.54 110.84 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.522 HG21 HH21 ' A' ' 105' ' ' ARG . 19.8 t -117.49 143.69 27.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 114.627 -1.17 . . . . 0.77 110.705 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -86.6 147.59 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.902 -0.59 . . . . 1.97 110.993 -179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -88.66 -9.56 68.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 1.12 112.606 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -153.35 -64.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.539 0.209 . . . . 3.81 111.017 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -146.63 -64.72 0.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.844 0.354 . . . . 3.82 111.017 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 13.7 m-20 -65.51 150.27 48.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.257 0.551 . . . . 1.4 111.556 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.561 ' ND2' ' HE1' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -109.0 -179.0 0.61 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.635 -1.246 . . . . 2.0 107.635 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.35 -11.01 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 CA-C-N 121.461 1.557 . . . . 2.58 113.22 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.601 ' HB2' ' NZ ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER 74.92 -77.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 3.71 111.32 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 90' ' ' ALA . 1.5 m -104.71 135.8 41.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 C-N-CA 119.398 -0.921 . . . . 0.92 110.646 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 4.8 t -131.72 117.28 18.41 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.092 -0.958 . . . . 1.2 112.362 -177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.454 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -100.94 37.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.149 -0.932 . . . . 0.22 113.505 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.68 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.34 0.4 . . . . 1.02 111.427 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -159.99 97.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.33 110.433 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.7 OUTLIER -105.28 125.76 60.42 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 122.426 1.108 . . . . 0.69 112.011 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.4 ptm -119.93 166.01 13.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.335 -1.302 . . . . 1.26 109.851 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 11.7 ptmt -120.82 152.5 38.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.899 1.444 . . . . 1.82 114.899 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 94.5 -37.8 3.31 Favored Glycine 0 C--N 1.319 -0.401 0 CA-C-N 111.784 -2.462 . . . . 0.22 117.058 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 176.92 166.15 0.52 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.451 1.625 . . . . 0.29 112.528 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.656 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -84.78 -52.16 6.25 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.649 -0.705 . . . . 0.57 109.538 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.55 4.58 17.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.166 -0.924 . . . . 2.31 110.251 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.418 ' OD1' ' HE3' ' A' ' 9' ' ' LYS . 6.9 t0 -43.62 -50.14 7.46 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.037 -0.528 . . . . 2.37 109.778 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.59 -64.69 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.613 -0.721 . . . . 2.57 112.875 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.04 131.3 30.15 Favored 'Trans proline' 0 C--N 1.364 1.346 0 CA-C-N 121.313 1.505 . . . . 2.08 111.942 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 182' ' ' MET . 2.0 mpt? -87.08 159.11 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 6.04 110.631 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 82.1 mt -127.88 124.21 36.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 5.3 110.582 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.43 142.52 90.64 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.037 -0.529 . . . . 8.05 110.426 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -44.53 126.83 7.26 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 121.732 1.621 . . . . 9.14 112.471 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -122.32 125.27 26.59 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.475 -0.329 . . . . 9.87 110.351 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -82.89 -158.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.058 1.839 . . . . 11.69 111.439 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 59.14 -114.25 5.95 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.394 -0.908 . . . . 12.62 112.811 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.97 156.33 27.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.717 0.294 . . . . 14.44 110.746 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.192 -0.908 . . . . 15.7 110.917 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.481 -0.248 . . . . 9.15 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.15 122.16 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.735 0.303 . . . . 7.36 110.853 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -141.62 20.26 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 7.76 110.789 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 t 56.01 42.78 28.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.521 . . . . 4.02 110.947 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.8 42.87 1.79 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.666 -0.778 . . . . 1.28 112.614 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp -74.53 -49.48 21.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.114 0.483 . . . . 0.41 110.222 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.15 -21.52 13.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.422 -0.808 . . . . 0.33 111.308 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.27 -20.97 46.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.159 0.429 . . . . 2.09 112.159 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 18.6 mmtp -101.67 -21.36 14.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.756 -0.377 . . . . 1.99 111.528 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 7' ' ' ALA . 10.1 p -45.08 145.6 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 120.577 0.227 . . . . 0.21 111.577 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.427 HD13 ' HZ2' ' A' ' 174' ' ' LYS . 3.4 pt -138.96 -23.52 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 C-N-CA 120.142 -0.623 . . . . 0.86 111.181 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.454 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.3 t90 -173.42 136.35 0.6 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.696 -0.402 . . . . 0.28 110.126 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -155.57 144.26 20.45 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.429 -0.169 . . . . 0.2 111.382 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -147.15 127.78 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 113.797 1.036 . . . . 0.67 113.797 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -115.53 97.18 6.01 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 119.915 -0.714 . . . . 1.27 110.997 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.6 100.29 0.87 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.037 -1.097 . . . . 0.37 108.037 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.583 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 177.39 -58.0 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.502 -1.226 . . . . 0.67 112.609 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.74 -126.26 4.77 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.644 -0.789 . . . . 1.12 113.422 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 20' ' ' SER . 26.0 mt-10 -151.81 119.51 6.12 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.44 0.296 . . . . 2.02 110.992 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.8 m 29.2 106.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.592 0.96 . . . . 1.22 113.592 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 50.1 t60 -133.43 150.4 51.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 120.485 -0.486 . . . . 0.34 112.036 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.3 p -122.81 104.94 15.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 121.4 0.619 . . . . 1.18 111.405 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.95 155.45 34.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.425 -0.807 . . . . 1.17 110.03 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 m -43.21 -50.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.48 0.919 . . . . 0.6 113.48 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -59.46 -18.3 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.118 0.485 . . . . 0.46 110.646 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.94 35.24 3.77 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.487 -0.779 . . . . 0.29 112.619 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.4 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 32.7 mm -103.42 111.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.003 0.43 . . . . 0.43 109.897 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.605 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 17.9 t60 -101.28 136.66 40.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 115.171 1.545 . . . . 0.52 115.171 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.9 136.8 41.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.184 -1.371 . . . . 3.0 108.189 177.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -97.38 109.98 22.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.415 0.626 . . . . 2.9 112.402 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 32' ' ' ASP . 11.5 tttm -12.22 137.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.62 1.568 . . . . 2.71 114.934 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' HB2' ' A' ' 35' ' ' GLU . 27.9 t70 -13.36 88.95 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.01 -0.995 . . . . 1.98 113.01 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' C ' ' HG3' ' A' ' 37' ' ' ARG . 8.9 Cg_endo -99.84 -4.98 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.468 2.112 . . . . 1.53 115.818 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.489 HD22 ' C ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -142.87 -16.57 0.69 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.316 0.962 . . . . 1.83 113.194 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.529 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 21.2 mm-40 -89.39 76.61 7.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 4.95 109.804 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 82.52 -16.91 22.38 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.871 -0.892 . . . . 1.94 110.871 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.407 ' HG3' ' C ' ' A' ' 33' ' ' PRO . 5.1 mtt180 49.56 54.67 10.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.357 0.598 . . . . 5.36 110.827 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 36' ' ' GLY . 26.1 m -141.58 176.72 4.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.301 -0.863 . . . . 2.97 110.529 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.15 120.44 6.35 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.707 -0.759 . . . . 1.99 112.553 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -146.65 -75.06 0.2 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.418 0.151 . . . . 6.59 111.183 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 65.67 124.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.994 0.426 . . . . 2.01 111.486 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 t -99.86 -57.5 2.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.932 -0.576 . . . . 2.02 110.135 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.26 30.66 3.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.032 0.444 . . . . 2.23 110.684 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -81.5 11.09 4.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.858 -0.61 . . . . 2.33 110.095 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -102.05 17.31 54.51 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.879 -0.677 . . . . 2.2 112.976 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.2 mtt -62.04 -26.07 68.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.31 0.576 . . . . 1.93 109.962 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -85.37 -6.88 59.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.17 -0.923 . . . . 3.35 110.333 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mt -140.29 59.34 12.21 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.234 -0.894 . . . . 2.76 109.424 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -80.48 164.21 21.38 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.575 2.183 . . . . 1.46 113.631 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 61' ' ' TYR . 1.1 mp -77.26 146.68 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.247 -0.888 . . . . 0.83 110.331 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.6 -49.0 5.58 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.292 0.849 . . . . 1.69 113.292 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.95 31.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.939 0.718 . . . . 2.56 112.939 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.0 t -145.63 143.95 30.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.01 0.433 . . . . 0.97 111.678 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 58' ' ' GLN . 34.9 t30 -59.23 148.36 72.34 Favored Pre-proline 0 C--O 1.221 -0.403 0 CA-C-N 115.667 -0.697 . . . . 1.96 109.66 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.3 Cg_exo -42.0 -51.79 4.43 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.137 1.892 . . . . 0.66 113.522 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.53 -55.25 16.4 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.885 0.85 . . . . 1.82 111.163 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.15 -12.67 61.32 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.759 -0.655 . . . . 1.91 109.761 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.609 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 1.1 tt0 -66.0 -48.16 72.11 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.974 -1.491 . . . . 1.5 106.974 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -50.47 -46.64 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.085 -0.961 . . . . 1.22 109.153 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 tp -73.54 -13.12 60.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.975 -1.011 . . . . 1.05 111.647 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HB3' ' HZ3' ' A' ' 88' ' ' LYS . 3.7 m-30 -121.06 23.41 10.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.565 -0.743 . . . . 0.9 111.132 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -142.11 -68.4 0.37 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.145 0.794 . . . . 1.8 113.145 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.492 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 74.9 p -29.19 148.85 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.224 0.824 . . . . 1.05 113.224 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.583 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 3.1 pp20? -122.97 -22.54 5.21 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.256 1.206 . . . . 2.05 114.256 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.532 ' N ' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mtp-105 69.62 -80.77 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.758 0.313 . . . . 3.58 110.794 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -170.89 171.55 5.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.158 -0.474 . . . . 4.25 110.564 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -97.88 166.88 11.25 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.333 -0.394 . . . . 4.35 110.875 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 30.3 tt0 -163.79 -120.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.528 -0.306 . . . . 3.17 111.25 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -174.53 129.07 0.34 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 122.355 -0.216 . . . . 2.39 110.421 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t 49.45 86.2 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.635 -0.505 . . . . 0.99 109.635 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.517 ' HD1' ' N ' ' A' ' 71' ' ' PHE . 0.4 OUTLIER -92.39 130.3 38.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.628 . . . . 1.26 109.306 -178.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -128.2 129.16 6.2 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 119.521 -1.323 . . . . 0.66 113.646 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 154' ' ' SER . 12.8 m-85 -112.9 144.69 42.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.401 . . . . 0.83 110.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.91 126.98 55.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 2.27 111.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.48 HG21 HG21 ' A' ' 172' ' ' ILE . 4.0 mp -123.21 86.49 51.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.615 -0.266 . . . . 0.34 111.35 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.66 129.46 34.03 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.398 2.065 . . . . 0.8 112.764 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.58 149.46 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.043 -0.526 . . . . 0.38 110.796 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -141.04 0.28 1.54 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 2.96 111.387 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 80' ' ' GLU . 20.5 tt0 -131.07 167.19 19.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.827 0.346 . . . . 2.13 110.32 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -115.84 176.86 4.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.354 0.597 . . . . 0.37 111.865 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.76 -151.13 19.89 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 109.933 -1.267 . . . . 0.21 109.933 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.4 mt-10 -103.81 109.59 21.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.03 1.415 . . . . 2.03 109.528 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.04 126.81 41.54 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.677 -0.86 . . . . 0.26 108.677 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 39.6 t -109.97 109.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.043 -0.981 . . . . 0.54 112.035 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.93 104.02 16.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.533 -1.212 . . . . 1.23 110.399 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.413 HG13 ' CD2' ' A' ' 171' ' ' PHE . 1.5 p -115.23 141.8 30.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.092 -0.958 . . . . 1.31 108.698 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 87' ' ' LEU . 2.0 pp -153.88 148.69 26.53 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.049 -0.66 . . . . 1.37 111.653 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.614 ' C ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -107.71 127.08 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.82 -0.752 . . . . 2.97 109.919 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' N ' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-85 -109.39 148.51 30.98 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.353 -0.84 . . . . 0.3 109.741 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -146.0 154.98 42.49 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.611 -0.268 . . . . 0.41 110.566 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -179.04 136.77 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.179 -0.464 . . . . 3.97 110.505 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.467 HG21 ' OG ' ' A' ' 124' ' ' SER . 7.6 p -168.08 125.05 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.153 0.501 . . . . 3.81 111.85 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 178.07 -48.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.505 -0.77 . . . . 2.89 110.128 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -117.21 82.28 1.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 2.0 110.01 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.77 106.52 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.634 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.492 HE21 ' H ' ' A' ' 97' ' ' SER . 22.4 tp60 -175.89 140.25 0.42 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.152 -0.476 . . . . 2.96 110.896 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.492 ' H ' HE21 ' A' ' 96' ' ' GLN . 40.9 t -99.25 165.57 11.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 1.55 110.439 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 71.07 -64.74 0.37 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 2.33 111.552 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -45.01 -43.79 9.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.495 -0.32 . . . . 2.51 111.362 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 44.7 mtmt -92.01 71.46 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 3.1 110.752 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 t -109.8 132.57 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.35 -0.386 . . . . 1.31 109.971 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -123.04 179.01 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.362 0.504 . . . . 0.69 112.362 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -128.45 138.31 52.24 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 116.237 -0.438 . . . . 2.01 112.005 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.44 132.26 64.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 115.644 -0.707 . . . . 0.46 112.169 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 9.3 mtt180 -133.11 146.11 51.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 115.429 -0.805 . . . . 1.85 112.611 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 11.8 m -117.53 119.75 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.428 -0.806 . . . . 1.1 109.538 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.479 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.71 26.75 9.76 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.826 -0.805 . . . . 1.77 108.826 -176.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.01 20.6 38.71 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.8 -1.091 . . . . 0.41 112.897 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.5 m-70 -118.64 112.29 19.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.432 0.901 . . . . 0.46 113.432 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -63.1 120.08 10.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.618 -0.433 . . . . 0.66 111.062 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.5 t -113.85 -32.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.371 -0.603 . . . . 0.8 109.371 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.11 89.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.509 -0.552 . . . . 0.51 109.509 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.6 ptpp? -106.09 79.96 1.46 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.488 1.137 . . . . 2.44 110.976 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.7 p-10 157.79 40.41 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.462 -2.154 . . . . 2.56 108.445 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.91 84.39 0.95 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.238 0.829 . . . . 1.1 113.238 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 15.9 t70 -96.02 84.42 3.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.175 -1.417 . . . . 1.99 107.175 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.2 mt -50.46 -36.97 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.122 -0.945 . . . . 0.63 112.853 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.52 -47.97 79.46 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.73 0.271 . . . . 0.9 111.73 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.4 -27.58 67.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.973 0.36 . . . . 0.76 111.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 38.9 mmt180 -67.85 -59.04 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.044 0.387 . . . . 2.68 112.044 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.29 -39.39 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.879 0.326 . . . . 1.41 111.879 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 96.22 -56.94 1.47 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.779 -0.724 . . . . 1.06 111.999 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -114.6 158.12 22.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.979 -0.378 . . . . 3.51 109.979 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.467 ' OG ' HG21 ' A' ' 92' ' ' VAL . 68.5 m -55.58 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.392 -0.367 . . . . 1.68 111.08 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 50' ' ' ILE . 28.7 p -143.7 -144.9 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.8 110.355 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HA ' ' HZ1' ' A' ' 88' ' ' LYS . . . -110.42 126.17 54.03 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.84 0.681 . . . . 0.44 112.84 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 2.5 t60 -103.23 137.83 40.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.553 -0.906 . . . . 0.38 108.553 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -144.29 128.37 17.59 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.569 0.581 . . . . 2.09 112.569 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.55 134.72 55.03 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.247 -0.888 . . . . 2.28 109.666 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -114.85 128.52 71.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.767 -0.651 . . . . 0.71 110.397 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -126.04 84.85 60.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.508 0.558 . . . . 1.38 112.508 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.62 143.03 99.38 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.828 1.685 . . . . 0.22 111.635 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 20.9 mt -135.93 156.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.419 -0.355 . . . . 0.21 111.254 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 133' ' ' ILE . 46.3 t -132.62 107.16 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.067 0.46 . . . . 1.11 111.147 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.512 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 23.6 mt -103.85 128.7 56.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.802 -0.635 . . . . 0.23 110.001 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -147.92 143.23 27.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.866 0.365 . . . . 1.91 111.378 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp 56.4 20.59 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 3.11 110.817 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.01 24.45 41.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.76 -0.733 . . . . 0.32 112.953 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 135' ' ' ILE . 40.5 mtmt -125.21 152.42 44.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.185 0.492 . . . . 2.19 110.943 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 141' ' ' SER . 6.0 tt -109.61 127.39 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.098 0.475 . . . . 0.37 111.84 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.438 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.6 t -117.5 109.5 16.81 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.56 -0.745 . . . . 0.9 109.493 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.0 p -103.64 118.85 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 0.53 110.789 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 54.74 -90.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 2.05 111.556 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.92 27.84 3.01 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.794 -0.717 . . . . 0.6 112.78 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -129.48 140.22 51.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.293 . . . . 2.02 110.265 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.44 138.65 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 1.3 111.372 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.7 m -161.22 123.55 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.78 -0.645 . . . . 1.12 110.459 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.3 p -54.12 141.2 29.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 1.11 112.06 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -80.57 142.69 33.84 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.305 -0.628 . . . . 0.28 109.305 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 150' ' ' THR . 2.9 t -140.79 96.35 3.0 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.168 0.803 . . . . 1.55 113.168 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.98 -63.17 2.45 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 115.4 0.92 . . . . 0.46 115.4 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.608 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -147.7 178.5 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.804 0.802 . . . . 1.8 112.543 -178.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.479 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.91 131.96 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.514 -1.291 . . . . 1.24 107.514 177.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.461 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 t -120.21 112.02 18.55 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.016 -1.074 . . . . 1.28 113.531 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -94.11 99.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.042 -0.725 . . . . 0.59 109.042 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 37.0 mt-10 -109.04 124.69 51.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.525 -0.762 . . . . 2.48 111.324 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.61 132.92 55.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.894 -0.722 . . . . 1.54 110.1 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.4 t -102.45 142.31 16.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.615 -1.175 . . . . 0.77 111.851 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.415 ' H ' ' HD3' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -67.74 148.43 51.28 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 115.4 -0.818 . . . . 1.97 111.106 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.63 -9.1 41.58 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.894 -0.669 . . . . 1.12 112.374 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -155.73 -75.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.542 0.211 . . . . 3.81 111.203 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -173.64 68.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.736 0.303 . . . . 3.82 111.131 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -178.03 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.331 -0.395 . . . . 1.4 110.897 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.25 159.12 0.12 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.479 -0.563 . . . . 2.0 109.479 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -40.07 100.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.632 1.555 . . . . 2.58 111.371 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.98 -36.07 26.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 3.71 112.322 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 79.5 t -126.7 135.3 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.566 0.58 . . . . 0.92 112.566 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.7 t -130.47 131.53 45.2 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 123.836 0.71 . . . . 1.2 111.653 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -121.73 37.8 4.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.26 -0.882 . . . . 0.22 113.299 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -30.98 134.17 0.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.433 0.458 . . . . 1.02 111.503 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -156.9 98.76 1.79 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.881 -0.145 . . . . 0.33 110.869 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.48 HG21 HG21 ' A' ' 75' ' ' ILE . 16.5 tt -108.22 125.79 64.9 Favored 'Isoleucine or valine' 0 C--O 1.259 1.601 0 CA-C-O 122.784 1.278 . . . . 0.69 112.486 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.16 167.17 11.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.798 -1.546 . . . . 1.26 109.035 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.431 ' HZ2' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -119.89 146.97 45.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 115.217 1.562 . . . . 1.82 115.217 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.59 -35.99 4.04 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 112.008 -2.36 . . . . 0.22 118.251 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.83 159.14 0.57 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.332 2.066 . . . . 0.29 113.955 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.82 -20.05 29.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.079 -0.964 . . . . 0.57 110.236 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -59.95 -33.58 72.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.756 -0.656 . . . . 2.31 111.309 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -56.59 -44.92 81.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.514 -0.312 . . . . 2.37 110.504 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.4 t -36.28 99.58 0.18 Allowed Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 116.014 -0.539 . . . . 2.57 111.901 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.12 140.39 32.84 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.139 1.893 . . . . 2.08 112.44 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 92.5 mtp -86.97 93.66 9.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.267 -0.424 . . . . 6.04 110.974 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 59.25 175.79 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.0 -0.546 . . . . 5.3 111.132 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -121.59 145.1 42.05 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.842 -0.617 . . . . 8.05 110.023 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -44.71 124.51 5.61 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 121.579 1.52 . . . . 9.14 111.918 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -125.71 124.22 24.87 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.954 -0.298 . . . . 9.87 110.809 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -83.68 -156.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.009 1.806 . . . . 11.69 111.387 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 160.96 123.93 0.7 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.358 -0.925 . . . . 12.62 112.682 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.2 mm? -106.91 118.13 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.779 0.323 . . . . 14.44 110.485 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.296 -0.859 . . . . 15.7 110.77 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.505 -0.238 . . . . 9.15 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.66 -33.62 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 7.36 110.87 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -132.56 92.66 3.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 7.76 110.771 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.0 p -102.42 172.64 6.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 4.02 110.677 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.05 45.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.853 -0.689 . . . . 1.28 112.456 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp -72.5 -44.23 62.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.387 0.613 . . . . 0.41 110.482 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.632 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.82 -21.07 17.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 0.33 111.198 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.05 -18.36 60.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 2.09 111.859 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -103.9 -26.46 12.66 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.712 -0.395 . . . . 1.99 111.267 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.3 p -43.37 144.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 111.849 0.315 . . . . 0.21 111.849 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -137.16 -24.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.422 -0.511 . . . . 0.86 110.758 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.571 ' O ' HG22 ' A' ' 172' ' ' ILE . 25.1 t90 -171.04 138.98 1.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.593 -0.521 . . . . 0.28 109.593 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -159.24 143.87 15.5 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.216 0.45 . . . . 0.2 112.216 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.01 131.3 8.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 114.224 1.194 . . . . 0.67 114.224 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 8.4 t30 -114.67 88.63 2.91 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.265 -0.879 . . . . 1.27 109.082 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 65' ' ' ARG . . . -60.82 105.76 0.49 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.114 -0.948 . . . . 0.37 110.192 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 65' ' ' ARG . . . 162.13 -48.05 0.35 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.867 -1.061 . . . . 0.67 114.324 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.91 -130.89 6.92 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.654 -0.784 . . . . 1.12 113.861 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -152.36 119.81 6.0 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 122.317 0.247 . . . . 2.02 111.086 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.697 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.5 m 24.14 101.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.358 0.873 . . . . 1.22 113.358 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 13.2 t60 -126.44 150.52 48.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 119.971 -0.692 . . . . 0.34 111.96 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.79 105.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 1.18 110.807 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.8 154.39 42.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.434 -0.348 . . . . 1.17 110.36 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 m -44.47 -50.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 124.117 0.885 . . . . 0.6 113.068 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -58.89 -17.22 22.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.261 0.553 . . . . 0.46 110.307 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.49 34.76 4.62 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.29 112.12 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.1 mm -103.92 121.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.43 110.039 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.9 t60 -99.95 136.99 39.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.578 1.325 . . . . 0.52 114.578 -176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -101.65 131.25 47.99 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.768 -1.106 . . . . 3.0 108.311 176.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.45 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 14.6 mtt180 -89.63 109.62 20.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.584 0.553 . . . . 2.9 112.282 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 30' ' ' ARG . 17.4 tttp -16.42 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.514 1.125 . . . . 2.71 113.506 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -18.7 84.11 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 124.149 0.979 . . . . 1.98 113.165 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 5.3 Cg_endo -105.02 56.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.035 2.49 . . . . 1.53 112.933 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 72' ' ' GLY . 13.4 tp -152.85 -78.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.818 0.303 . . . . 1.83 111.818 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER -58.17 89.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.176 0.512 . . . . 4.95 110.559 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.86 -13.08 5.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.783 -0.723 . . . . 1.94 111.803 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER 46.13 31.5 1.19 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.934 0.397 . . . . 5.36 111.126 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.2 p -148.56 144.14 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 2.97 110.572 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.79 -150.37 17.87 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.777 -0.725 . . . . 1.99 112.343 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -130.09 -79.68 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.513 0.197 . . . . 6.59 111.04 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.625 ' HA ' HH21 ' A' ' 65' ' ' ARG . . . -177.8 140.34 0.25 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.97 0.414 . . . . 2.01 111.282 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.447 ' C ' ' H ' ' A' ' 44' ' ' TYR . 74.1 m -90.05 45.98 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.512 -0.551 . . . . 2.02 109.512 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.97 25.93 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.37 -0.832 . . . . 2.23 111.383 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.447 ' H ' ' C ' ' A' ' 42' ' ' SER . 90.1 t80 -52.75 -38.78 61.45 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.006 0.431 . . . . 2.33 110.246 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -103.96 48.32 1.02 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.978 -0.63 . . . . 2.2 112.019 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 32.0 ttm -58.48 -15.59 11.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.842 0.353 . . . . 1.93 110.65 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -65.4 -165.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 3.35 110.594 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.41 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 17.5 mt 55.05 50.33 6.07 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 109.804 -0.443 . . . . 2.76 109.804 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' O ' HD12 ' A' ' 51' ' ' LEU . 19.4 Cg_endo -53.95 115.6 2.45 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.563 2.175 . . . . 1.46 112.828 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.546 HD11 ' HB1' ' A' ' 90' ' ' ALA . 1.2 mp -49.63 128.03 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.184 -0.673 . . . . 0.83 109.184 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 49' ' ' PRO . 7.8 mp -83.16 -32.06 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.385 0.884 . . . . 1.69 113.385 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -79.11 33.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.507 -0.477 . . . . 2.56 111.681 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.97 142.22 5.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.359 -0.382 . . . . 0.97 110.436 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -60.97 164.04 8.67 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.516 -0.311 . . . . 1.96 110.943 -179.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 53.8 Cg_exo -47.21 -41.87 27.24 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.393 2.062 . . . . 0.66 115.024 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.613 ' O ' HG12 ' A' ' 59' ' ' VAL . 11.3 mm-40 -73.26 -55.81 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.748 0.785 . . . . 1.82 110.731 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 40.8 p30 -70.27 -3.02 15.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.701 -0.799 . . . . 1.91 109.517 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -74.36 -60.73 2.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.425 -0.954 . . . . 1.5 108.425 177.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 56' ' ' GLU . 7.2 p -49.63 -37.39 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.738 -0.467 . . . . 1.22 109.738 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 62' ' ' GLN . 11.1 tp -69.15 -66.48 0.57 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.441 -0.504 . . . . 1.05 110.245 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.426 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 8.1 m-30 -55.05 -2.71 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.198 0.523 . . . . 0.9 111.147 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 60' ' ' LEU . 6.9 tt0 -116.67 -131.65 0.32 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 1.8 109.614 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 62' ' ' GLN . 12.3 p 44.23 131.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.444 0.905 . . . . 1.05 113.444 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 -128.03 149.31 50.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.767 0.654 . . . . 2.05 112.767 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.625 HH21 ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -80.4 -156.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.677 -0.692 . . . . 3.58 109.616 177.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -87.12 -87.27 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 121.373 -0.131 . . . . 4.25 111.165 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -179.89 155.77 0.63 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.592 0.235 . . . . 4.35 110.957 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 4.4 tt0 -176.43 -158.65 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.291 -0.413 . . . . 3.17 110.61 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -152.83 135.86 15.58 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.502 -0.317 . . . . 2.39 110.987 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t 50.54 79.21 0.09 Allowed 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.483 -0.326 . . . . 0.99 110.397 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -151.43 153.86 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.66 -0.416 . . . . 1.26 111.273 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.523 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -170.49 -160.43 18.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.621 -0.8 . . . . 0.66 113.914 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.93 164.16 17.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.601 0.715 . . . . 0.83 112.917 -177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.46 125.08 50.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.483 -1.235 . . . . 2.27 109.539 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.506 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.1 mp -115.41 88.5 19.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 112.242 0.46 . . . . 0.34 112.242 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -56.24 127.93 28.04 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.957 1.771 . . . . 0.8 112.16 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.406 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.3 mt -122.69 151.5 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.911 0.386 . . . . 0.38 111.048 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -140.45 -0.39 1.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.1 -0.5 . . . . 2.96 111.27 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -126.06 168.49 13.91 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.616 0.246 . . . . 2.13 111.046 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -122.6 168.52 12.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.381 0.61 . . . . 0.37 111.55 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.33 -151.87 23.28 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.739 -1.345 . . . . 0.21 109.739 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.41 107.6 18.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.066 1.433 . . . . 2.03 108.84 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -95.14 126.31 40.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.645 -0.822 . . . . 0.26 109.162 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 177' ' ' ALA . 40.6 t -109.47 113.12 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.678 -1.146 . . . . 0.54 111.457 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 170' ' ' LEU . 8.7 tp -99.28 105.06 17.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.365 -1.289 . . . . 1.23 110.729 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.51 ' C ' HD23 ' A' ' 87' ' ' LEU . 1.1 p -113.56 135.25 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.774 -0.648 . . . . 1.31 109.929 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -133.06 135.19 45.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.59 . . . . 1.37 111.614 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.493 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 17.9 tptt -102.93 114.83 29.44 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.83 -0.804 . . . . 2.97 108.83 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -103.68 140.98 36.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.772 -0.825 . . . . 0.3 108.772 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 50' ' ' ILE . . . -154.63 170.55 21.25 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.475 0.917 . . . . 0.41 113.475 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 66.18 149.9 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.67 -1.15 . . . . 3.97 112.59 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.5 t -140.96 -37.21 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.378 -0.828 . . . . 3.81 110.58 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 t80 64.42 14.47 8.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.659 -0.7 . . . . 2.89 112.279 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -149.51 -38.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.468 0.175 . . . . 2.0 111.378 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 62.88 102.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.938 0.399 . . . . 1.0 111.504 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -167.41 147.03 5.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 2.96 110.238 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m -110.61 149.8 29.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.105 0.479 . . . . 1.55 112.231 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 46.64 32.85 1.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.319 -0.855 . . . . 2.33 111.823 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.42 -41.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.775 -0.454 . . . . 2.51 109.775 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -107.11 82.91 1.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.67 . . . . 3.1 109.696 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.514 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.9 OUTLIER -109.14 144.71 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 1.31 109.733 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.492 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 73.4 m-85 -128.1 -178.05 4.38 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.843 0.683 . . . . 0.69 112.843 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -128.23 143.98 51.08 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.572 -0.451 . . . . 2.01 112.083 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.2 t -139.15 131.98 37.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.78 -0.646 . . . . 0.46 112.434 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -133.66 149.9 51.55 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 115.239 -0.891 . . . . 1.85 112.612 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.9 m -118.7 117.6 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 114.705 -1.134 . . . . 1.1 109.749 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.497 ' HA ' ' H ' ' A' ' 154' ' ' SER . 3.8 t-20 55.85 26.32 9.53 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.758 0.789 . . . . 1.77 109.438 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.97 16.46 41.37 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.365 -1.289 . . . . 0.41 113.278 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.7 m-70 -115.35 109.51 18.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.199 0.815 . . . . 0.46 113.199 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.0 p -67.22 113.69 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.115 0.483 . . . . 0.66 111.292 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.37 -30.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.511 -0.768 . . . . 0.8 109.898 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.46 91.54 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.308 -0.405 . . . . 0.51 109.941 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.7 ptpp? -107.78 84.83 2.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 122.237 1.018 . . . . 2.44 112.038 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.9 p-10 151.2 37.31 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.631 -2.077 . . . . 2.56 108.79 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 92.36 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.326 0.584 . . . . 1.1 112.512 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.59 84.07 2.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.649 -1.612 . . . . 1.99 106.649 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 53.3 mt -50.21 -38.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.139 -0.937 . . . . 0.63 113.229 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.06 -52.95 52.76 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.217 0.451 . . . . 0.9 112.217 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.19 -27.62 64.65 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.045 0.387 . . . . 0.76 112.045 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.15 -58.22 6.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.113 0.412 . . . . 2.68 112.113 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.07 -40.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.175 0.435 . . . . 1.41 112.175 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.45 -136.52 12.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.605 -0.807 . . . . 1.06 112.601 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -56.65 169.54 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.551 0.215 . . . . 3.51 110.868 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -45.81 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.078 0.466 . . . . 1.68 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.1 p -152.97 -175.1 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 0.8 109.991 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.39 139.19 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 0.44 112.161 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -111.69 148.88 32.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.869 -0.789 . . . . 0.38 108.869 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -141.87 135.1 29.2 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.712 0.634 . . . . 2.09 112.712 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -129.85 112.6 13.73 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.151 -0.931 . . . . 2.28 109.609 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.435 ' C ' HD12 ' A' ' 131' ' ' ILE . 13.6 mt -101.89 135.45 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.204 -0.453 . . . . 0.71 111.043 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.2 mp -134.89 86.32 32.97 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.888 0.329 . . . . 1.38 111.888 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -62.6 138.94 73.0 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.554 1.503 . . . . 0.22 110.812 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.9 mt -130.13 155.73 41.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.769 0.319 . . . . 0.21 111.59 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 133' ' ' ILE . 25.3 p -130.07 106.69 8.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.044 -0.525 . . . . 1.11 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 139' ' ' LYS . 26.6 mt -105.64 125.87 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.661 -0.699 . . . . 0.23 109.918 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -146.66 144.08 29.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 1.91 110.911 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm 60.29 10.88 2.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.984 -0.553 . . . . 3.11 111.656 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.12 18.53 33.65 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.579 -0.82 . . . . 0.32 113.067 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 135' ' ' ILE . 33.7 mtmt -121.89 153.89 37.83 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.958 0.379 . . . . 2.19 110.943 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -108.7 127.33 53.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.37 111.739 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.503 ' N ' HD23 ' A' ' 140' ' ' LEU . 16.6 t -119.77 109.28 15.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.9 110.176 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 144' ' ' GLY . 1.8 p -101.92 135.59 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.124 -0.489 . . . . 0.53 110.174 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 40.21 -91.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.91 0.337 . . . . 2.05 111.91 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -135.59 47.28 0.99 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.033 -0.603 . . . . 0.6 112.34 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.51 132.74 21.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.998 -0.371 . . . . 2.02 109.998 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.0 135.0 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.933 0.397 . . . . 1.3 110.888 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 23.2 t -152.91 171.94 17.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 1.12 110.208 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.13 136.72 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.188 -0.46 . . . . 1.11 111.295 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.406 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 28.6 t80 -79.46 126.84 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.297 -1.001 . . . . 0.28 108.297 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -124.0 94.86 4.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.086 0.772 . . . . 1.55 113.086 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.9 -52.82 1.31 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 116.056 1.182 . . . . 0.46 116.056 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.506 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -154.75 170.94 20.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.272 1.036 . . . . 1.8 113.007 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.33 124.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.027 -1.471 . . . . 1.24 107.027 176.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.497 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.7 t -116.28 110.79 19.22 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.594 0.961 . . . . 1.28 113.594 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.483 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 15.2 t -99.14 114.96 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.871 -0.604 . . . . 0.59 110.363 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -124.46 136.52 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 2.48 111.659 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -118.3 131.71 56.32 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.743 -0.662 . . . . 1.54 109.583 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.21 143.68 16.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.435 -0.802 . . . . 0.77 111.469 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.71 148.33 39.15 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 114.816 -1.084 . . . . 1.97 111.728 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -126.15 -8.75 4.91 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.049 -0.82 . . . . 1.12 111.049 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -151.77 -57.49 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.331 -0.435 . . . . 3.81 110.265 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -174.33 -68.73 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.242 -0.436 . . . . 3.82 111.146 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.29 90.65 4.97 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.008 0.433 . . . . 1.4 111.281 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 165' ' ' PRO . 4.2 m-20 -48.03 153.18 1.24 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.414 -0.812 . . . . 2.0 109.35 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.57 99.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.191 1.927 . . . . 2.58 112.226 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.524 ' NZ ' ' HB3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -51.97 -70.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.005 -0.998 . . . . 3.71 111.774 -178.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 25.0 t -84.95 131.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 C-N-CA 119.455 -0.898 . . . . 0.92 111.381 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.3 t -132.33 123.37 26.7 Favored 'General case' 0 C--N 1.338 0.095 0 O-C-N 124.136 0.897 . . . . 1.2 109.721 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.493 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -115.23 38.19 3.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.231 0.826 . . . . 0.22 113.231 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.514 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -40.22 135.21 1.46 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.974 0.416 . . . . 1.02 110.431 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.514 ' H ' HD13 ' A' ' 170' ' ' LEU . 0.3 OUTLIER -152.82 102.36 2.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.837 -0.619 . . . . 0.33 110.072 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 12' ' ' TRP . 2.8 tt -105.1 123.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.262 1.746 0 CA-C-O 122.842 1.306 . . . . 0.69 113.026 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.06 163.03 16.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.396 -1.729 . . . . 1.26 109.399 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.079 1.511 . . . . 1.82 115.079 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.39 -35.34 5.03 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 112.327 -2.215 . . . . 0.22 117.914 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.51 159.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 120.031 1.916 . . . . 0.29 114.291 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.621 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.15 -18.2 32.89 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 115.116 -0.947 . . . . 0.57 110.51 176.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -63.07 -16.46 60.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 2.31 111.926 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -77.93 -61.11 2.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.658 -0.247 . . . . 2.37 110.853 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 180' ' ' VAL . 5.1 p -50.32 104.5 0.43 Allowed Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.327 -0.397 . . . . 2.57 111.407 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.16 110.22 0.39 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.808 1.672 . . . . 2.08 112.466 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -132.64 162.64 30.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 6.04 110.644 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.5 mp -85.0 125.53 32.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 5.3 110.736 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -57.11 150.25 41.6 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 8.05 110.249 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.33 125.75 16.32 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.654 1.569 . . . . 9.14 112.263 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.482 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 26.6 t-80 -134.55 135.81 24.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.166 -0.47 . . . . 9.87 110.209 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.482 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 44.6 Cg_endo -76.14 5.34 4.61 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.212 1.941 . . . . 11.69 111.824 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -50.37 141.95 15.81 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.752 -0.737 . . . . 12.62 112.7 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.9 pp -55.69 148.42 16.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.38 . . . . 14.44 110.989 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.113 -0.946 . . . . 15.7 110.721 179.948 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.467 -0.253 . . . . 9.15 112.467 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.03 28.18 14.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.768 0.318 . . . . 7.36 111.046 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 ttt -90.24 -49.19 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 7.76 110.81 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -151.1 -0.46 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 4.02 110.922 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.79 31.68 70.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.855 -0.688 . . . . 1.28 112.54 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HG ' HD11 ' A' ' 27' ' ' ILE . 24.3 tp -76.11 -44.47 38.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.343 0.592 . . . . 0.41 110.332 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.22 -21.08 8.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.181 -0.918 . . . . 0.33 111.509 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.68 -23.06 53.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.139 0.422 . . . . 2.09 112.139 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -98.11 -25.54 14.89 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.714 -0.395 . . . . 1.99 111.436 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.8 p -44.0 145.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 120.648 0.261 . . . . 0.21 111.591 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -138.75 -23.24 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.096 -0.642 . . . . 0.86 111.012 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.52 ' O ' HG22 ' A' ' 172' ' ' ILE . 28.5 t90 -173.34 141.56 0.92 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.275 -0.42 . . . . 0.28 109.944 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.39 150.15 17.78 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.343 -0.223 . . . . 0.2 111.531 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.78 129.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 114.19 1.182 . . . . 0.67 114.19 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -115.17 87.2 2.6 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.726 -0.67 . . . . 1.27 109.444 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -62.12 104.27 0.46 Allowed 'General case' 0 C--O 1.253 1.267 0 CA-C-N 115.414 -0.812 . . . . 0.37 109.165 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.643 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 157.69 -20.48 0.38 Allowed Glycine 0 N--CA 1.44 -1.066 0 O-C-N 124.91 1.381 . . . . 0.67 113.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.32 -133.27 3.13 Favored Glycine 0 C--N 1.329 0.191 0 C-N-CA 119.991 -1.1 . . . . 1.12 113.455 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 35.1 mt-10 -152.65 120.13 5.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.44 0.162 . . . . 2.02 111.108 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.647 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.0 m 26.86 107.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.701 1.0 . . . . 1.22 113.701 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 3.7 t60 -135.64 139.17 43.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 120.086 -0.645 . . . . 0.34 112.571 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.486 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 4.9 p -110.08 102.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 115.45 -0.795 . . . . 1.18 111.194 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.66 157.0 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.995 -1.002 . . . . 1.17 110.301 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 25' ' ' HIS . 21.8 m -43.55 -52.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.4 0.889 . . . . 0.6 113.4 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.484 ' N ' HG23 ' A' ' 24' ' ' VAL . 75.1 m-70 -56.82 -20.79 24.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.46 110.318 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.4 34.98 3.46 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.22 -0.9 . . . . 0.29 112.101 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.413 HD11 ' HG ' ' A' ' 6' ' ' LEU . 34.7 mm -103.68 112.1 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.46 . . . . 0.43 110.351 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 13.2 t60 -97.93 132.63 43.34 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.981 1.104 . . . . 0.52 113.981 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.42 135.27 39.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.804 -1.184 . . . . 3.0 107.804 177.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.47 ' NH1' ' HA ' ' A' ' 12' ' ' TRP . 2.2 ptp85 -91.54 108.15 19.7 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.572 0.545 . . . . 2.9 112.451 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -10.8 130.4 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.106 1.363 . . . . 2.71 114.286 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.5 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 57.3 m-20 -16.52 85.86 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.632 1.173 . . . . 1.98 113.921 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -104.89 10.37 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.247 2.631 . . . . 1.53 111.763 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 72' ' ' GLY . 4.9 tp -59.13 -47.2 86.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.587 -0.733 . . . . 1.83 112.291 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -150.15 46.1 0.91 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.939 0.718 . . . . 4.95 112.939 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.43 0.64 58.62 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.276 -0.964 . . . . 1.94 112.449 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HD3' ' NH2' ' A' ' 65' ' ' ARG . 15.0 mtt180 -70.11 62.95 0.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.929 0.492 . . . . 5.36 111.287 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.55 122.07 58.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.069 0.462 . . . . 2.97 111.28 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.07 29.19 3.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.85 -0.69 . . . . 1.99 112.721 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.615 ' HG3' HH12 ' A' ' 65' ' ' ARG . 17.0 ptm180 -162.77 170.93 17.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.034 0.445 . . . . 6.59 111.205 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.57 99.78 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.776 -0.647 . . . . 2.01 110.213 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 72.2 m -72.98 75.13 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 2.02 110.739 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.55 38.75 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 2.23 110.668 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -50.44 121.55 5.84 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.124 -0.489 . . . . 2.33 110.136 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.22 54.19 40.0 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.285 -0.96 . . . . 2.2 111.284 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 16.4 ttt -52.3 -17.99 1.38 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.73 0.3 . . . . 1.93 111.318 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -60.21 -172.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 3.35 110.598 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 11.2 mt 59.39 55.3 4.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 2.76 111.059 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 31.6 Cg_exo -64.75 145.6 86.82 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.341 2.027 . . . . 1.46 111.774 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp -59.29 141.27 16.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.798 -0.445 . . . . 0.83 109.798 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -48.3 8.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 1.69 112.231 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -77.49 37.16 0.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 2.56 112.743 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -151.95 140.73 20.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.08 0.467 . . . . 0.97 111.966 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.537 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.2 t30 -65.95 149.13 97.92 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.713 -0.676 . . . . 1.96 109.272 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.61 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 6.2 Cg_exo -38.73 -46.99 2.68 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.954 2.436 . . . . 0.66 116.402 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.469 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 8.4 mm-40 -73.12 -56.68 4.78 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.856 0.836 . . . . 1.82 111.113 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 -10.92 59.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.824 -0.806 . . . . 1.91 108.824 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.7 tt0 -64.66 -47.29 79.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.56 -1.644 . . . . 1.5 106.56 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 63' ' ' THR . 92.2 t -54.49 -57.77 5.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.838 -1.074 . . . . 1.22 110.452 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 60' ' ' LEU . 4.2 tt -63.11 -14.64 50.94 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.711 -0.677 . . . . 1.05 111.09 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.43 ' CE2' ' HD2' ' A' ' 88' ' ' LYS . 6.3 m-30 -110.81 5.79 20.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.101 -0.5 . . . . 0.9 111.11 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.608 ' HG2' ' N ' ' A' ' 63' ' ' THR . 35.6 tt0 -129.28 -104.95 0.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.49 . . . . 1.8 111.558 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.608 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 65.3 p 36.83 -154.7 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.088 -0.482 . . . . 1.05 110.669 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.624 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.0 pt-20 168.85 130.68 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.468 0.576 . . . . 2.05 112.026 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.643 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 14.9 mtp85 -107.35 -176.73 3.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.39 -0.368 . . . . 3.58 110.284 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -168.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.21 -0.45 . . . . 4.25 110.89 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -159.03 162.11 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 4.35 111.167 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.4 tp10 -156.74 -92.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.973 -0.558 . . . . 3.17 111.053 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 3.1 p30 -173.56 134.49 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.535 0.207 . . . . 2.39 111.084 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.4 t 46.89 84.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.401 -0.363 . . . . 0.99 110.693 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -155.92 155.64 33.18 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.578 -0.449 . . . . 1.26 111.995 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.686 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -175.66 -161.38 24.93 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.601 -0.809 . . . . 0.66 113.951 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.01 174.1 6.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.75 0.786 . . . . 0.83 113.056 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.436 ' OD2' ' HG3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -127.36 139.67 52.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.322 -1.308 . . . . 2.27 109.128 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.517 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -129.75 88.93 47.91 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.895 0.702 . . . . 0.34 112.895 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.38 134.88 67.09 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.61 1.54 . . . . 0.8 111.433 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 78' ' ' LYS . 59.9 mt -126.52 155.14 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.859 0.361 . . . . 0.38 111.266 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.426 ' N ' HG22 ' A' ' 77' ' ' ILE . 19.0 pttm -147.35 4.11 0.79 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.021 -0.536 . . . . 2.96 111.364 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.92 171.86 12.7 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.602 0.239 . . . . 2.13 110.864 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.8 mp0 -127.4 173.29 9.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.37 111.419 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.92 -150.31 20.11 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 109.958 -1.257 . . . . 0.21 109.958 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 28.4 mt-10 -100.98 108.13 19.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.826 1.313 . . . . 2.03 109.038 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -94.81 126.32 40.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 119.772 -0.771 . . . . 0.26 109.126 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.2 t -110.78 109.09 27.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.951 -1.022 . . . . 0.54 111.319 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.4 105.45 17.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 113.848 -1.524 . . . . 1.23 110.45 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.6 t -110.33 143.39 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.171 -0.922 . . . . 1.31 110.31 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -136.77 133.79 36.38 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.591 -0.444 . . . . 1.37 111.414 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -103.47 110.41 22.43 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.64 -1.245 . . . . 2.97 107.64 175.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -102.99 141.62 35.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.41 -0.959 . . . . 0.3 108.41 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -159.4 172.09 18.57 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.248 1.203 . . . . 0.41 114.248 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 54.86 167.74 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.025 -1.443 . . . . 3.97 113.211 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p 179.19 135.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.548 -1.205 . . . . 3.81 109.63 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -61.47 -66.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.341 . . . . 2.89 111.375 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -86.03 144.51 27.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 2.0 111.307 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.2 99.52 9.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.082 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -152.54 141.14 20.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 2.96 110.695 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.7 p -97.74 153.17 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 1.55 111.423 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 66.56 -71.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.726 -0.67 . . . . 2.33 112.178 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -39.18 -44.88 1.26 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.298 -0.41 . . . . 2.51 111.866 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -88.92 80.37 7.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.152 0.501 . . . . 3.1 110.939 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.44 142.6 24.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 1.31 109.934 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -124.46 177.65 5.8 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.769 0.655 . . . . 0.69 112.769 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -125.65 141.43 52.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 115.977 -0.556 . . . . 2.01 111.565 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.51 132.41 36.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 116.272 -0.422 . . . . 0.46 111.717 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.5 OUTLIER -134.05 150.73 51.21 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.17 0.804 . . . . 1.85 113.17 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 17.3 m -118.84 119.64 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.65 -1.159 . . . . 1.1 109.451 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.494 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.79 26.96 12.12 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.341 -0.614 . . . . 1.77 109.341 -176.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.64 16.1 53.11 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.096 -0.956 . . . . 0.41 112.879 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.3 m-70 -114.27 109.46 18.41 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.292 0.849 . . . . 0.46 113.292 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -67.36 109.67 3.25 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 0.66 111.168 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.05 -34.19 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.396 -0.82 . . . . 0.8 109.85 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.91 90.36 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.599 -0.519 . . . . 0.51 109.599 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -109.36 81.83 1.5 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.304 1.049 . . . . 2.44 111.201 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 157.67 37.16 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 112.462 -2.154 . . . . 2.56 108.217 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.39 85.97 0.83 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.695 -0.684 . . . . 1.1 112.292 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 0.6 OUTLIER -100.16 83.64 2.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.597 -1.631 . . . . 1.99 106.597 175.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.2 mt -49.82 -41.57 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.358 -0.837 . . . . 0.63 112.112 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -61.54 -54.8 38.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.571 -0.286 . . . . 0.9 111.22 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 12.8 t70 -63.26 -27.53 69.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.871 0.323 . . . . 0.76 111.871 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -63.69 -59.4 4.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.324 0.49 . . . . 2.68 112.324 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.16 -41.39 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.204 -0.598 . . . . 1.41 112.152 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.51 -112.13 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.586 -0.816 . . . . 1.06 112.655 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -97.42 114.45 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.768 0.318 . . . . 3.51 111.377 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.8 t 54.63 -127.15 2.29 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.089 -0.505 . . . . 1.68 111.192 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.7 p 56.15 174.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.946 0.403 . . . . 0.8 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -98.55 139.32 34.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.329 0.585 . . . . 0.44 112.134 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.422 ' ND1' ' N ' ' A' ' 128' ' ' ASP . 1.6 t60 -107.78 149.22 28.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.108 -0.951 . . . . 0.38 108.44 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.422 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.6 p30 -133.42 137.2 45.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.54 0.941 . . . . 2.09 113.54 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -129.68 109.4 10.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.559 -1.2 . . . . 2.28 109.464 177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 mt -98.71 128.58 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.893 -0.594 . . . . 0.71 110.27 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.91 84.33 38.12 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 113.076 0.769 . . . . 1.38 113.076 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -62.55 143.63 93.18 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.793 1.662 . . . . 0.22 111.402 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 134' ' ' SER . 25.1 mt -136.36 159.43 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 0.21 111.025 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 133' ' ' ILE . 53.6 p -134.4 107.13 7.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 1.11 111.227 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 20.4 mt -105.55 127.87 60.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 115.72 -0.673 . . . . 0.23 109.955 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -150.49 142.84 24.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.341 . . . . 1.91 110.886 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt 60.53 11.83 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.017 -0.538 . . . . 3.11 111.596 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.04 14.54 48.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.64 -0.79 . . . . 0.32 113.134 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 135' ' ' ILE . 63.6 mttp -116.78 153.47 32.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.861 0.33 . . . . 2.19 110.907 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 141' ' ' SER . 6.5 tt -111.43 129.52 56.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.37 111.727 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.425 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.8 t -116.9 109.9 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 0.9 109.678 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 142' ' ' VAL . 9.1 p -105.06 110.79 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.125 -0.489 . . . . 0.53 111.007 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.14 -89.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.911 -0.586 . . . . 2.05 111.769 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.92 22.33 4.3 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.528 -0.844 . . . . 0.6 113.243 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -125.81 136.57 53.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 2.02 110.282 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -105.37 137.95 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 1.3 111.129 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.1 m -152.67 170.61 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 1.12 110.124 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.44 135.46 38.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 1.11 111.277 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -79.7 137.79 37.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.928 -1.138 . . . . 0.28 107.928 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.8 m -145.8 95.55 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.705 -0.798 . . . . 1.55 112.775 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.18 -65.75 3.97 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.366 -0.834 . . . . 0.46 115.163 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.517 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.95 172.14 16.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 117.72 0.76 . . . . 1.8 112.694 -178.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.494 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -95.29 125.22 39.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.909 -1.515 . . . . 1.24 106.909 176.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.471 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.8 t -116.5 115.66 26.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.729 1.011 . . . . 1.28 113.729 -175.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.491 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 11.7 t -101.46 121.37 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.579 . . . . 0.59 110.197 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 62.2 mm-40 -131.38 144.68 51.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.743 -0.662 . . . . 2.48 110.702 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -128.32 136.27 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 1.54 109.782 178.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.73 143.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.226 -0.897 . . . . 0.77 111.428 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -71.35 139.56 49.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.516 -0.765 . . . . 1.97 111.275 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.73 -21.02 27.26 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.856 -0.687 . . . . 1.12 111.427 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -158.75 -51.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 3.81 109.809 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -178.8 155.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.703 -0.68 . . . . 3.82 110.152 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.88 75.65 0.4 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.477 -0.329 . . . . 1.4 111.351 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.53 166.21 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.139 -0.482 . . . . 2.0 109.929 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -36.93 110.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.973 1.782 . . . . 2.58 111.799 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -71.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.458 -0.792 . . . . 3.71 112.268 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 63' ' ' THR . 22.3 t -87.02 132.77 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 120.185 -0.606 . . . . 0.92 111.927 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.9 t -131.66 123.94 28.83 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 123.938 0.774 . . . . 1.2 111.103 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -117.21 38.77 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.955 1.094 . . . . 0.22 113.955 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.604 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -33.14 141.99 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.872 0.368 . . . . 1.02 111.038 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.604 ' H ' HD13 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -159.34 102.66 1.58 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.194 -0.457 . . . . 0.33 110.487 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 12' ' ' TRP . 2.3 tt -112.74 123.16 68.14 Favored 'Isoleucine or valine' 0 C--O 1.26 1.631 0 CA-C-O 122.829 1.3 . . . . 0.69 112.724 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.81 165.87 13.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.78 -1.555 . . . . 1.26 109.228 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -120.47 143.05 48.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.007 1.484 . . . . 1.82 115.007 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.11 -35.27 5.06 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 112.382 -2.19 . . . . 0.22 117.781 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.05 158.8 0.35 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 120.109 1.954 . . . . 0.29 114.452 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.02 -16.79 37.09 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 115.114 -0.948 . . . . 0.57 110.354 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.52 -22.83 67.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 2.31 111.762 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -71.86 -62.95 1.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.728 -0.214 . . . . 2.37 111.212 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 180' ' ' VAL . 4.3 p -46.98 103.32 0.35 Allowed Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.522 -0.308 . . . . 2.57 111.404 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.19 133.03 35.13 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.073 1.849 . . . . 2.08 112.798 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 25.8 ttt -152.3 106.19 3.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.907 -0.588 . . . . 6.04 110.515 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.5 mt -92.8 124.49 36.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 5.3 111.031 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -63.82 149.67 92.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 8.05 110.204 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -64.47 125.21 14.57 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.629 1.553 . . . . 9.14 112.254 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -134.18 131.73 20.84 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 9.87 110.299 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.38 -98.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.608 1.539 . . . . 11.69 111.739 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.29 156.87 22.73 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.808 -0.71 . . . . 12.62 112.775 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 189' ' ' LEU . 7.6 mp -102.1 159.1 15.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 14.44 110.714 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.244 -0.884 . . . . 15.7 110.615 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.384 -0.286 . . . . 9.15 112.384 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.04 -5.08 45.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.766 0.317 . . . . 7.36 110.928 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.6 ttp -104.33 77.51 1.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 7.76 110.772 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.9 m -156.85 165.8 35.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 4.02 110.798 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.52 -44.53 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 1.28 112.607 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.31 -45.27 16.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.341 0.591 . . . . 0.41 110.287 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.598 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.6 -20.53 8.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.135 -0.939 . . . . 0.33 111.515 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.75 -20.19 56.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.314 0.487 . . . . 2.09 112.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 61.4 mttt -105.96 -21.83 13.05 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.441 -0.504 . . . . 1.99 111.773 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.1 p -43.93 145.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 121.03 -0.268 . . . . 0.21 111.465 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.7 pt -136.55 -23.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 119.689 -0.804 . . . . 0.86 110.998 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.553 ' O ' HG22 ' A' ' 172' ' ' ILE . 49.5 t90 -174.77 141.66 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.867 -0.419 . . . . 0.28 109.867 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.67 145.29 15.72 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.191 0.441 . . . . 0.2 112.191 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.73 131.88 9.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 114.251 1.204 . . . . 0.67 114.251 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 14.8 t30 -115.42 94.59 4.78 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 114.441 -1.254 . . . . 1.27 109.71 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -61.34 96.04 0.05 Allowed 'General case' 0 C--O 1.252 1.222 0 N-CA-C 107.092 -1.447 . . . . 0.37 107.092 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -178.49 -63.86 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.533 -1.667 . . . . 0.67 113.746 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.17 -120.0 4.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.597 -0.811 . . . . 1.12 112.105 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.574 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -172.31 128.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.25 0.548 . . . . 2.02 110.818 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.2 m 42.27 82.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.004 -0.998 . . . . 1.22 112.445 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 67.1 t60 -112.77 151.97 29.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.072 -0.651 . . . . 0.34 111.807 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.3 t -124.84 103.77 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.374 -0.83 . . . . 1.18 110.108 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.58 151.99 39.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.385 -0.37 . . . . 1.17 110.228 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 m -43.38 -48.23 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 113.777 1.029 . . . . 0.6 113.777 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.1 -18.52 47.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.274 0.559 . . . . 0.46 110.422 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.09 34.62 3.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.318 -0.856 . . . . 0.29 112.459 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.9 mm -103.16 123.7 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.217 -0.66 . . . . 0.43 109.217 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.8 t60 -108.36 132.35 53.82 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.52 114.151 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.25 132.66 42.78 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.232 -1.025 . . . . 3.0 108.232 176.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 20' ' ' SER . 80.0 mtp180 -47.67 -109.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.229 1.196 . . . . 2.9 114.229 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 179.47 99.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.166 -0.47 . . . . 2.71 111.859 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.424 ' OD1' ' HD2' ' A' ' 65' ' ' ARG . 4.3 m-20 32.32 71.68 0.64 Allowed Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.507 0.558 . . . . 1.98 112.507 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.49 -71.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.679 2.253 . . . . 1.53 114.081 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -86.96 -11.8 49.47 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.558 0.577 . . . . 1.83 112.558 -177.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.621 ' HB3' HH21 ' A' ' 65' ' ' ARG . 10.3 mm-40 -83.79 70.71 10.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 4.95 111.394 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 78.41 -1.19 72.31 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.532 -0.842 . . . . 1.94 111.694 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 38.66 43.59 0.71 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.078 0.466 . . . . 5.36 111.37 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 36' ' ' GLY . 18.4 m -147.83 176.54 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.705 -0.68 . . . . 2.97 110.361 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.45 136.83 16.02 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.663 -0.779 . . . . 1.99 112.538 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.578 ' HB3' HH12 ' A' ' 65' ' ' ARG . 76.0 ttt180 -163.31 -67.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.69 0.281 . . . . 6.59 110.808 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.598 ' H ' ' NH1' ' A' ' 65' ' ' ARG . . . 56.36 72.71 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.182 -0.463 . . . . 2.01 111.435 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.9 m -82.12 80.74 8.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.329 -0.396 . . . . 2.02 110.096 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 46' ' ' MET . 7.6 m-20 -80.51 60.92 4.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.834 -0.621 . . . . 2.23 111.319 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -82.35 152.24 26.34 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.544 -0.539 . . . . 2.33 109.544 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.45 23.82 54.91 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.114 -1.041 . . . . 2.2 110.93 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 43' ' ' ASP . 19.7 ttt -64.83 -0.51 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.247 -0.477 . . . . 1.93 111.305 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' NZ ' ' HB3' ' A' ' 47' ' ' LYS . 3.1 ttpm? -80.58 55.97 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.285 0.564 . . . . 3.35 110.591 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 4.6 mt -155.34 61.38 2.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.599 -0.728 . . . . 2.76 109.972 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.514 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 71.8 Cg_exo -55.28 105.48 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.774 2.316 . . . . 1.46 112.921 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 125' ' ' THR . 1.2 mp -52.76 129.59 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 120.81 0.338 . . . . 0.83 110.194 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.0 mp -86.41 -177.65 6.25 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.439 -0.949 . . . . 1.69 108.439 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 81.6 mtp180 70.01 -21.48 0.17 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.425 . . . . 2.56 111.959 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 51' ' ' LEU . 2.7 t -105.39 172.7 6.65 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.065 0.46 . . . . 0.97 111.229 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.5 t30 -90.24 148.57 39.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 109.051 -0.722 . . . . 1.96 109.051 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.638 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 18.0 Cg_exo -40.63 -51.41 3.54 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.179 1.919 . . . . 0.66 114.065 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.449 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 10.4 mm-40 -63.68 -56.57 14.72 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.101 0.953 . . . . 1.82 110.94 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -68.86 -12.06 61.16 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.694 -0.684 . . . . 1.91 109.98 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.638 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 25.9 tt0 -63.51 -45.04 92.49 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.146 -1.798 . . . . 1.5 106.146 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.8 t -53.21 -50.17 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 114.432 -1.258 . . . . 1.22 109.186 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 7.1 tp -69.57 -11.33 60.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.087 -0.96 . . . . 1.05 111.465 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.44 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.5 m-30 -121.51 20.06 11.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.833 -0.621 . . . . 0.9 111.246 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 49' ' ' PRO . 6.9 tt0 -139.64 -59.58 0.56 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.448 0.907 . . . . 1.8 113.448 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.52 ' O ' HG13 ' A' ' 167' ' ' VAL . 77.6 p -43.15 150.78 0.17 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.584 -0.28 . . . . 1.05 110.906 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.578 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -135.11 -30.49 1.05 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.913 1.449 . . . . 2.05 114.913 -176.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.621 HH21 ' HB3' ' A' ' 35' ' ' GLU . 38.5 mtp85 68.57 -173.7 0.19 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.706 -0.479 . . . . 3.58 109.706 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -77.37 156.06 31.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.721 0.296 . . . . 4.25 110.373 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -134.0 149.02 51.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.415 -0.357 . . . . 4.35 111.054 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -130.04 -101.22 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.27 -0.423 . . . . 3.17 111.444 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.76 130.03 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.761 0.315 . . . . 2.39 111.403 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.466 ' H ' HD21 ' A' ' 164' ' ' ASN . 18.9 t 53.16 95.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.091 -0.504 . . . . 0.99 111.507 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -162.66 164.73 26.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 1.26 111.235 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.58 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -164.69 -149.63 5.87 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.005 -1.093 . . . . 0.66 114.605 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.534 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 2.2 m-85 -141.31 167.2 22.74 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.116 -0.542 . . . . 0.83 111.455 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.33 134.35 55.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.144 -0.935 . . . . 2.27 110.892 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.49 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.5 mp -126.98 87.09 57.46 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.637 -0.256 . . . . 0.34 111.48 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -57.56 119.79 7.28 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.875 1.717 . . . . 0.8 112.011 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.71 151.44 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 0.38 111.191 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -144.49 3.99 1.17 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.209 -0.45 . . . . 2.96 111.559 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -128.62 171.07 12.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.459 0.171 . . . . 2.13 110.76 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -127.09 169.1 13.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.37 111.783 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.18 -155.74 24.1 Favored Glycine 0 CA--C 1.512 -0.133 0 N-CA-C 109.644 -1.382 . . . . 0.21 109.644 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.7 mt-10 -96.51 108.5 21.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.048 1.424 . . . . 2.03 108.657 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.29 125.82 39.16 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.968 -0.753 . . . . 0.26 108.968 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 177' ' ' ALA . 38.9 t -109.49 112.03 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 0.54 111.289 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -103.11 104.83 15.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.789 -1.551 . . . . 1.23 110.537 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.26 142.56 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.527 -0.761 . . . . 1.31 109.639 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.97 134.18 46.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.569 -0.452 . . . . 1.37 111.168 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.622 ' HZ3' ' HB1' ' A' ' 126' ' ' ALA . 5.7 tptm -94.16 112.59 24.41 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.106 -1.442 . . . . 2.97 107.106 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 14.7 m-85 -104.47 143.64 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.715 -0.476 . . . . 0.3 109.715 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -149.76 161.09 42.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.117 -0.492 . . . . 0.41 110.605 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 92' ' ' VAL . 38.5 tt0 -178.47 -102.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.383 0.135 . . . . 3.97 111.119 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.406 ' N ' ' HG2' ' A' ' 91' ' ' GLU . 39.1 t 56.33 93.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.983 0.421 . . . . 3.81 111.353 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -117.66 -34.39 4.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.901 -0.59 . . . . 2.89 111.125 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -131.61 -1.89 3.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.469 -0.332 . . . . 2.0 111.138 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 59.34 94.01 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.429 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -151.74 142.92 23.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.257 -0.428 . . . . 2.96 110.976 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.455 ' HG ' ' HD2' ' A' ' 118' ' ' PHE . 32.5 m -113.05 156.92 22.25 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.569 0.581 . . . . 1.55 112.569 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 48.09 27.15 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.145 -0.934 . . . . 2.33 112.091 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -129.63 -42.91 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 2.51 109.423 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 93.0 mttt -92.47 78.02 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 3.1 109.256 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.54 145.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 1.31 109.705 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.17 178.03 7.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.601 0.593 . . . . 0.69 112.601 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.46 137.76 54.73 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.262 -0.426 . . . . 2.01 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.25 131.91 52.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.917 -0.583 . . . . 0.46 112.323 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 6.7 mtt180 -133.48 146.79 51.44 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.997 0.74 . . . . 1.85 112.997 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.8 m -117.14 114.26 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.074 -0.967 . . . . 1.1 109.373 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.519 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 60.62 27.14 16.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.199 -0.667 . . . . 1.77 109.199 -176.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.49 10.12 62.32 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.126 -0.943 . . . . 0.41 112.767 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.7 m-70 -107.46 113.28 26.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.026 0.75 . . . . 0.46 113.026 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -64.66 128.95 37.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.178 -0.609 . . . . 0.66 110.634 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.65 -30.87 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.198 -0.667 . . . . 0.8 109.198 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.46 HG11 ' OE2' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -135.73 89.77 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.094 -0.706 . . . . 0.51 109.094 177.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.1 OUTLIER -105.33 76.66 1.24 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 122.508 1.147 . . . . 2.44 111.146 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.7 p30 154.5 28.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.079 -1.873 . . . . 2.56 108.35 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 89' ' ' PHE . 16.6 tp -61.44 97.12 0.06 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.376 -0.829 . . . . 1.1 112.386 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.5 t70 -107.07 93.9 4.81 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 114.669 -1.151 . . . . 1.99 108.345 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.9 mt -51.86 -51.66 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 114.069 1.137 . . . . 0.63 114.069 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.455 ' HD2' ' HG ' ' A' ' 97' ' ' SER . 87.9 t80 -53.51 -55.93 21.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.033 0.383 . . . . 0.9 112.033 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.78 -27.55 68.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.569 0.581 . . . . 0.76 112.569 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -67.68 -58.56 4.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.872 0.693 . . . . 2.68 112.872 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -106.08 -40.85 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.11 0.411 . . . . 1.41 112.11 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.44 -138.9 13.22 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.539 -0.839 . . . . 1.06 113.185 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.567 ' O ' HG23 ' A' ' 125' ' ' THR . 17.2 p-80 -65.43 118.23 9.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.965 0.412 . . . . 3.51 111.607 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.4 m 39.13 -116.75 0.2 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.576 -0.738 . . . . 1.68 112.066 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 123' ' ' HIS . 66.0 p 51.65 -166.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.661 0.267 . . . . 0.8 110.953 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.622 ' HB1' ' HZ3' ' A' ' 88' ' ' LYS . . . -113.58 139.09 49.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.753 0.649 . . . . 0.44 112.753 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.504 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.7 t60 -107.61 147.95 29.96 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.903 -0.777 . . . . 0.38 108.903 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -143.03 131.06 21.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.558 0.577 . . . . 2.09 112.558 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.46 ' OE2' HG11 ' A' ' 112' ' ' VAL . 57.8 mt-10 -124.23 109.8 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.508 -0.769 . . . . 2.28 109.73 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.538 ' O ' HD13 ' A' ' 131' ' ' ILE . 15.5 mt -94.94 130.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 116.066 -0.516 . . . . 0.71 110.839 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 130' ' ' ILE . 43.8 mm -131.53 85.88 51.19 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.375 -0.375 . . . . 1.38 111.902 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.59 144.62 97.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.694 1.596 . . . . 0.22 111.447 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 134' ' ' SER . 28.3 mt -136.33 159.41 38.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.21 110.674 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 42.6 p -134.76 108.55 8.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 1.11 111.132 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.515 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 26.6 mt -106.34 125.99 62.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.695 -0.684 . . . . 0.23 109.979 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -150.97 144.04 24.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.699 0.285 . . . . 1.91 110.802 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt 61.76 10.15 3.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 3.11 111.468 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.6 17.01 37.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.621 -0.8 . . . . 0.32 113.182 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 135' ' ' ILE . 59.6 mttp -119.99 160.46 22.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.075 0.437 . . . . 2.19 110.772 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.76 131.53 56.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.089 0.471 . . . . 0.37 111.893 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.455 ' HB3' ' OG ' ' A' ' 134' ' ' SER . 22.9 t -116.54 116.64 27.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.631 -0.713 . . . . 0.9 110.08 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 142' ' ' VAL . 8.0 p -113.03 111.48 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.288 0.566 . . . . 0.53 111.551 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 50.27 -93.97 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.616 -0.72 . . . . 2.05 112.441 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -123.94 34.79 3.46 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.544 -0.836 . . . . 0.6 113.616 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -146.57 132.64 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.065 -0.346 . . . . 2.02 110.065 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.14 146.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.002 0.429 . . . . 1.3 111.566 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.6 m -161.12 171.27 18.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.779 -0.646 . . . . 1.12 109.376 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 141.72 31.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.278 0.561 . . . . 1.11 111.496 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -78.66 140.74 38.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.136 -0.938 . . . . 0.28 109.653 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.5 p -139.99 95.28 2.87 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.673 0.62 . . . . 1.55 112.673 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.96 -57.73 2.24 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 115.833 1.093 . . . . 0.46 115.833 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.66 174.99 12.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.023 0.912 . . . . 1.8 112.695 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.519 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 1.8 tt -101.9 129.03 48.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.407 -1.331 . . . . 1.24 107.407 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.506 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -116.51 114.37 24.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.696 -0.802 . . . . 1.28 112.851 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 43.7 t -93.1 105.09 16.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.039 -0.726 . . . . 0.59 109.039 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.1 tt0 -118.4 128.43 54.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.882 -0.599 . . . . 2.48 111.414 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -120.99 145.83 47.34 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.166 0.508 . . . . 1.54 109.749 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 143.87 26.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 115.191 -0.913 . . . . 0.77 111.261 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 159' ' ' LYS . 1.6 pptp? -83.89 148.48 26.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.471 -0.786 . . . . 1.97 111.394 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.68 0.51 55.41 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.923 -0.656 . . . . 1.12 111.619 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -154.64 -76.25 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.847 -0.177 . . . . 3.81 110.803 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -178.49 73.61 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.498 -0.319 . . . . 3.82 110.713 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -174.37 -44.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.381 -0.372 . . . . 1.4 111.165 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.466 HD21 ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 62.43 163.15 0.11 Allowed Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 109.545 -0.539 . . . . 2.0 109.545 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -44.47 103.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.325 1.35 . . . . 2.58 111.272 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 6.7 tppt? -53.3 -66.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.301 -0.863 . . . . 3.71 112.088 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 64' ' ' GLU . 45.5 t -94.45 132.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 120.547 -0.461 . . . . 0.92 111.749 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -135.29 127.77 30.56 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 113.194 0.813 . . . . 1.2 113.194 -178.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.41 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -122.24 38.56 4.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.697 -1.138 . . . . 0.22 112.647 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 171' ' ' PHE . 6.7 tp -46.79 130.38 11.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.094 0.473 . . . . 1.02 110.398 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -142.86 114.47 8.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.75 -0.659 . . . . 0.33 110.373 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -113.92 123.88 70.02 Favored 'Isoleucine or valine' 0 C--O 1.263 1.77 0 CA-C-O 122.841 1.305 . . . . 0.69 112.961 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -119.61 166.76 12.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.923 -1.49 . . . . 1.26 109.886 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 8.9 ptmt -120.71 144.67 48.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.008 1.484 . . . . 1.82 115.008 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 100.64 -36.31 4.24 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 112.417 -2.174 . . . . 0.22 118.181 174.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.87 158.44 0.43 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.57 2.185 . . . . 0.29 114.324 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.648 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.34 -26.93 24.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 114.953 -1.022 . . . . 0.57 110.37 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.33 -24.71 45.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.693 -0.685 . . . . 2.31 111.149 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.89 -45.42 78.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 2.37 110.389 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.8 t -34.09 98.79 0.15 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 123.573 0.545 . . . . 2.57 111.85 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -51.05 127.08 20.6 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.913 1.742 . . . . 2.08 112.16 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -83.0 143.61 30.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.501 . . . . 6.04 110.735 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 183' ' ' LEU . 7.5 mp -91.53 111.68 23.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 5.3 110.253 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -52.94 142.54 34.59 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.186 -0.461 . . . . 8.05 110.519 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -44.48 137.44 8.24 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 121.793 1.662 . . . . 9.14 112.343 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -134.13 124.92 17.71 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.41 -0.359 . . . . 9.87 110.605 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -84.5 -157.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.185 1.923 . . . . 11.69 111.529 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.28 41.08 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.42 -0.895 . . . . 12.62 112.495 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.54 154.38 23.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.748 0.309 . . . . 14.44 110.697 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 15.7 110.885 179.848 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.528 -0.229 . . . . 9.15 112.528 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.99 81.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 7.36 110.84 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 tpt -158.68 139.18 12.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 7.76 110.692 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t 57.29 92.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.184 -0.462 . . . . 4.02 110.975 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.13 91.94 0.21 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.769 . . . . 1.28 112.574 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 180' ' ' VAL . 19.1 tp -68.63 -39.25 80.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.33 0.586 . . . . 0.41 110.272 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.2 -19.87 9.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.262 -0.881 . . . . 0.33 110.877 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.17 -20.06 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.058 0.392 . . . . 2.09 112.058 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -103.5 -28.4 11.79 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.623 -0.431 . . . . 1.99 111.02 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -42.06 147.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.677 0.275 . . . . 0.21 111.601 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -139.6 -22.64 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.815 -0.754 . . . . 0.86 111.085 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.501 ' O ' HG22 ' A' ' 172' ' ' ILE . 32.7 t90 -173.39 139.71 0.78 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.626 -0.429 . . . . 0.28 110.011 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.04 146.04 18.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.605 0.224 . . . . 0.2 111.605 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -146.99 126.7 4.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 114.255 1.206 . . . . 0.67 114.255 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.563 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 7.3 t-20 -115.37 97.13 6.0 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.619 -0.718 . . . . 1.27 110.146 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.51 107.33 3.33 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 120.552 -0.459 . . . . 0.37 110.13 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.6 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 166.14 -74.75 0.15 Allowed Glycine 0 C--N 1.338 0.687 0 O-C-N 124.675 1.234 . . . . 0.67 112.662 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.458 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -85.62 -125.13 1.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.883 -0.675 . . . . 1.12 111.993 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -168.0 120.67 0.88 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.65 0.738 . . . . 2.02 111.214 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.724 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 47.61 95.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.319 -1.31 . . . . 1.22 113.009 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.546 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 18.5 t60 -125.46 137.08 53.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 118.988 -1.085 . . . . 0.34 113.069 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.0 t -107.43 101.59 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.588 -1.187 . . . . 1.18 109.912 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -67.12 157.82 32.69 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.85 -0.613 . . . . 1.17 110.627 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.26 -55.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 124.849 1.343 . . . . 0.6 112.828 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -55.53 -22.74 22.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.126 0.489 . . . . 0.46 110.339 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.43 36.03 2.75 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.394 -0.821 . . . . 0.29 112.165 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.442 HD11 ' HG ' ' A' ' 6' ' ' LEU . 35.9 mm -103.33 125.49 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.655 -0.498 . . . . 0.43 109.655 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.4 t60 -106.34 131.32 53.69 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.76 1.393 . . . . 0.52 114.76 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.78 140.84 34.5 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.956 -1.128 . . . . 3.0 107.956 175.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' SER . 77.2 mtp180 -63.31 -137.68 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.383 0.427 . . . . 2.9 111.135 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.8 100.01 3.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.364 0.266 . . . . 2.71 111.484 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 34.9 t70 35.59 69.78 1.09 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 111.985 0.365 . . . . 1.98 111.985 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -98.98 24.53 0.2 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.852 2.368 . . . . 1.53 114.496 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 72' ' ' GLY . 45.1 tp -142.08 -66.34 0.4 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.564 -0.454 . . . . 1.83 111.622 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 37' ' ' ARG . 9.8 mm-40 -67.69 94.82 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 4.95 110.454 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.54 -22.45 3.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.761 -0.733 . . . . 1.94 111.603 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 5.8 mtp180 45.08 25.95 0.2 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.801 0.44 . . . . 5.36 111.545 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.21 145.87 17.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 2.97 110.945 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.81 -164.93 12.31 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.695 -0.764 . . . . 1.99 112.918 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -128.52 -171.04 2.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.648 0.261 . . . . 6.59 110.731 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.82 167.3 0.59 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.19 0.519 . . . . 2.01 111.194 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.409 ' N ' ' NH2' ' A' ' 65' ' ' ARG . 75.3 m -149.87 33.11 0.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.475 -0.784 . . . . 2.02 109.527 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -43.41 93.74 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.138 -0.937 . . . . 2.23 111.449 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -112.28 -67.26 1.01 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 2.33 110.268 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.85 33.58 3.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 2.2 111.429 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.8 ttt -62.5 -8.73 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 1.93 111.302 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 48' ' ' LEU . 87.9 tttt -53.96 163.33 0.77 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.355 -0.384 . . . . 3.35 110.523 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.465 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 3.6 mt 67.47 66.48 0.62 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 2.76 110.867 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' O ' HD12 ' A' ' 51' ' ' LEU . 84.9 Cg_exo -54.92 124.86 17.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.633 2.222 . . . . 1.46 112.061 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.74 124.68 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.333 0.587 . . . . 0.83 110.043 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 49' ' ' PRO . 10.3 mp -76.89 -47.78 20.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.784 1.031 . . . . 1.69 113.784 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -70.06 26.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.268 0.84 . . . . 2.56 113.268 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 51' ' ' LEU . 8.1 t -147.79 156.79 43.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.09 0.472 . . . . 0.97 111.637 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 58' ' ' GLN . 7.9 t30 -71.95 148.22 91.79 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.729 -0.669 . . . . 1.96 109.878 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.608 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.16 -54.67 2.07 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.525 2.15 . . . . 0.66 114.615 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 9.8 mm-40 -62.39 -57.95 9.44 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.88 0.848 . . . . 1.82 110.994 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 23.8 t70 -69.04 -6.57 28.91 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.723 -0.671 . . . . 1.91 109.623 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 12.5 tt0 -69.2 -42.44 75.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.61 -1.626 . . . . 1.5 106.61 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.65 -57.61 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 114.329 -1.305 . . . . 1.22 109.158 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.563 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.3 tt -54.31 -61.04 2.56 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.547 -0.751 . . . . 1.05 109.345 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.551 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 2.3 m-85 -52.79 -15.14 0.66 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.585 -0.734 . . . . 0.9 111.097 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 63' ' ' THR . 7.0 tt0 -119.63 -117.94 0.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.661 0.615 . . . . 1.8 112.661 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.572 ' N ' ' HG2' ' A' ' 62' ' ' GLN . 2.7 p 36.44 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.623 0.769 . . . . 1.05 112.669 -176.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.6 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 10.7 pt-20 -101.53 146.34 27.79 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.309 0.855 . . . . 2.05 113.309 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HD3' ' OD1' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -104.43 -144.43 0.37 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.723 -1.126 . . . . 3.58 109.935 178.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.35 -175.51 2.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.496 0.189 . . . . 4.25 110.543 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -138.63 160.05 40.58 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.82 0.343 . . . . 4.35 111.482 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -154.6 -103.75 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.144 -0.48 . . . . 3.17 111.024 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -174.41 124.85 0.31 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.495 0.188 . . . . 2.39 110.803 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.543 ' H ' HD21 ' A' ' 164' ' ' ASN . 21.0 t 50.33 96.48 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.347 -0.388 . . . . 0.99 111.699 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -166.31 167.09 16.26 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.217 -0.447 . . . . 1.26 111.105 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.45 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -174.28 -170.59 37.72 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.28 -0.962 . . . . 0.66 114.045 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -109.31 169.56 8.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.532 0.682 . . . . 0.83 112.532 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.23 136.65 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.612 -1.176 . . . . 2.27 110.439 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.449 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.4 mp -127.25 86.84 57.81 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 112.153 0.427 . . . . 0.34 112.153 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -54.41 130.34 39.45 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.244 1.963 . . . . 0.8 112.418 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 74.2 mt -126.48 150.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.206 -0.452 . . . . 0.38 111.294 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -142.86 0.75 1.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.041 -0.527 . . . . 2.96 111.201 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.11 170.11 12.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.477 0.179 . . . . 2.13 110.769 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.53 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -124.04 171.24 9.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.339 0.59 . . . . 0.37 111.912 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.44 -155.58 23.06 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 109.8 -1.32 . . . . 0.21 109.8 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.1 mt-10 -97.41 108.38 21.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.128 1.464 . . . . 2.03 109.107 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -95.57 126.47 40.88 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 119.926 -0.71 . . . . 0.26 109.22 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 177' ' ' ALA . 16.1 t -112.68 113.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.906 -1.043 . . . . 0.54 111.386 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tt -95.67 104.02 15.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.566 -1.197 . . . . 1.23 110.445 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.15 126.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 114.507 -1.224 . . . . 1.31 108.705 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.753 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.8 pp -135.67 141.15 44.95 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.569 -0.852 . . . . 1.37 111.04 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.735 ' HZ3' ' HA ' ' A' ' 126' ' ' ALA . 0.6 OUTLIER -107.13 124.29 49.48 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.282 -0.967 . . . . 2.97 109.495 177.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CD2' HD21 ' A' ' 115' ' ' LEU . 7.7 m-85 -105.73 142.36 35.6 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.398 -0.819 . . . . 0.3 109.305 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -138.21 150.29 46.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.979 0.419 . . . . 0.41 111.117 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.73 125.32 19.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 3.97 110.048 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.0 m -142.28 60.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.786 0.327 . . . . 3.81 111.84 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -149.49 -34.7 0.18 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.906 0.336 . . . . 2.89 111.906 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -133.98 169.09 17.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.0 0.429 . . . . 2.0 111.22 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.67 98.86 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.811 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.407 ' NE2' ' HG3' ' A' ' 100' ' ' LYS . 14.1 pt20 -161.22 140.65 10.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 2.96 110.742 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.6 m -107.26 150.47 26.62 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.07 -0.514 . . . . 1.55 112.277 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 47.24 39.93 9.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.518 -0.764 . . . . 2.33 111.842 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -133.48 -48.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.751 -0.463 . . . . 2.51 109.751 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HG3' ' NE2' ' A' ' 96' ' ' GLN . 66.5 mttm -98.05 86.8 3.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.829 -0.623 . . . . 3.1 109.558 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.0 144.95 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 1.31 109.461 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -130.45 178.59 6.48 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.633 0.605 . . . . 0.69 112.633 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -122.05 139.65 53.45 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.94 -0.304 . . . . 2.01 111.154 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.1 132.05 52.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-N 116.084 -0.507 . . . . 0.46 112.138 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.54 HH21 HG21 ' A' ' 158' ' ' VAL . 8.5 mtt180 -133.72 156.48 47.87 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 113.234 0.827 . . . . 1.85 113.234 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 25.3 m -122.15 119.27 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 114.853 -1.067 . . . . 1.1 109.049 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.552 ' ND2' ' HA ' ' A' ' 153' ' ' LEU . 0.6 OUTLIER 56.27 26.39 10.42 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.922 -0.77 . . . . 1.77 108.922 -175.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.29 39.64 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.41 112.784 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -117.83 112.11 19.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.943 0.72 . . . . 0.46 112.943 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -61.84 127.67 32.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.634 -0.426 . . . . 0.66 111.24 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 t -123.64 -32.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.107 -0.701 . . . . 0.8 109.107 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.99 90.18 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.078 -0.712 . . . . 0.51 109.078 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 113' ' ' LYS . 16.1 ptpt -107.53 100.91 10.29 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.032 0.92 . . . . 2.44 111.76 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 18.5 m-20 131.2 27.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.27 -2.241 . . . . 2.56 108.037 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.528 HD21 ' CD2' ' A' ' 89' ' ' PHE . 45.4 tp -56.41 96.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.952 -1.022 . . . . 1.1 112.636 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -108.23 92.31 4.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.605 -1.18 . . . . 1.99 107.829 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 121' ' ' VAL . 43.3 mt -51.88 -35.95 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.47 0.915 . . . . 0.63 113.47 -176.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -69.2 -54.64 13.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.304 0.483 . . . . 0.9 112.304 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.98 -27.28 66.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.545 0.572 . . . . 0.76 112.545 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -72.66 -58.27 3.49 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.879 0.696 . . . . 2.68 112.879 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 117' ' ' ILE . 8.5 p -97.48 -35.15 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.129 0.418 . . . . 1.41 112.129 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.8 -129.2 8.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.651 -0.785 . . . . 1.06 112.368 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -88.82 110.47 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.642 0.258 . . . . 3.51 110.619 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.3 t 51.46 -108.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 1.68 110.529 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.4 p 48.46 -171.77 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.532 0.206 . . . . 0.8 111.325 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.735 ' HA ' ' HZ3' ' A' ' 88' ' ' LYS . . . -102.85 121.95 43.54 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.305 0.854 . . . . 0.44 113.305 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.568 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.1 t60 -100.35 135.35 41.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.816 -1.179 . . . . 0.38 107.816 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -145.39 130.55 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.075 0.768 . . . . 2.09 113.075 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -111.34 125.9 54.34 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.224 -0.898 . . . . 2.28 109.403 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -105.86 110.1 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.71 109.534 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.12 86.03 25.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.744 0.646 . . . . 1.38 112.744 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 140.03 75.57 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.875 1.717 . . . . 0.22 111.622 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.0 mt -132.13 156.14 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.21 110.631 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 19.4 p -130.73 106.76 8.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.121 0.486 . . . . 1.11 110.719 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 24.0 mt -107.08 121.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.602 -0.726 . . . . 0.23 109.867 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -145.53 141.22 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.577 -0.283 . . . . 1.91 110.571 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm 60.72 20.7 10.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.277 0.56 . . . . 3.11 110.984 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.02 60.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.32 113.151 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' HG23 ' A' ' 135' ' ' ILE . 3.6 mmmm -117.83 155.52 29.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.864 0.332 . . . . 2.19 110.32 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -115.22 131.36 56.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.077 0.465 . . . . 0.37 112.12 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.507 ' N ' HD23 ' A' ' 140' ' ' LEU . 20.8 t -117.9 111.2 18.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.63 -0.714 . . . . 0.9 109.5 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 142' ' ' VAL . 6.5 p -107.33 102.27 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.03 -0.532 . . . . 0.53 111.218 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.29 -92.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.904 -0.589 . . . . 2.05 111.66 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.44 6.21 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.6 113.18 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.4 132.26 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.203 -0.295 . . . . 2.02 110.203 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.5 p -105.48 140.69 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.198 0.523 . . . . 1.3 111.658 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.1 m -154.03 173.01 16.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.421 -0.809 . . . . 1.12 109.621 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.28 136.66 38.92 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.86 -0.336 . . . . 1.11 111.163 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 40.3 t80 -79.72 136.68 36.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.117 -1.068 . . . . 0.28 108.117 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.2 m -148.56 95.11 2.39 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.835 -0.746 . . . . 1.55 112.495 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.84 -70.0 1.87 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.121 0.809 . . . . 0.46 115.121 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.623 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -149.98 178.17 9.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.776 0.788 . . . . 1.8 112.945 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -103.0 128.07 49.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.416 -1.327 . . . . 1.24 107.416 177.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.416 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 6.7 t -117.16 118.45 32.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.359 1.244 . . . . 1.28 114.359 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 86.9 t -93.96 99.29 9.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.471 -0.937 . . . . 0.59 108.471 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.7 tt0 -109.69 129.04 55.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.588 -0.733 . . . . 2.48 111.763 -177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -121.71 135.6 54.95 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.018 -0.537 . . . . 1.54 110.004 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.54 HG21 HH21 ' A' ' 105' ' ' ARG . 11.0 t -109.98 143.87 19.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.043 -0.98 . . . . 0.77 111.482 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -59.17 143.37 49.11 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.167 -0.924 . . . . 1.97 111.09 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -120.39 -16.01 4.84 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.951 -0.642 . . . . 1.12 111.912 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -156.44 -61.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 3.81 110.148 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -177.54 151.2 0.73 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.835 -0.621 . . . . 3.82 110.188 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.95 82.09 0.12 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.73 0.3 . . . . 1.4 110.857 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.543 HD21 ' H ' ' A' ' 70' ' ' SER . 2.9 m-20 -47.3 159.02 0.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 2.0 110.325 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 164' ' ' ASN . 2.8 Cg_exo -32.22 102.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.39 2.06 . . . . 2.58 111.711 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.589 ' HB2' ' NZ ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -56.9 -66.87 0.37 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.026 -0.988 . . . . 3.71 113.19 -177.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 11.6 t -91.62 134.45 29.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 120.246 -0.582 . . . . 0.92 112.295 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 4.7 t -130.89 136.47 48.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.818 -0.628 . . . . 1.2 112.102 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -129.42 34.44 4.37 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.304 0.853 . . . . 0.22 113.304 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -36.53 136.76 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.563 0.579 . . . . 1.02 112.563 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -154.84 101.68 2.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.791 -0.641 . . . . 0.33 110.777 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -109.09 128.14 65.22 Favored 'Isoleucine or valine' 0 C--O 1.262 1.761 0 CA-C-O 122.874 1.321 . . . . 0.69 112.428 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.419 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.3 ppp? -121.35 166.61 13.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.423 -1.717 . . . . 1.26 109.636 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -120.37 153.24 36.77 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 115.262 1.579 . . . . 1.82 115.262 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 92.1 -35.06 4.13 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 111.93 -2.395 . . . . 0.22 117.725 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.94 159.91 0.63 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.035 1.918 . . . . 0.29 113.962 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.63 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.17 -36.9 20.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.368 -0.833 . . . . 0.57 111.688 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -64.82 -15.26 61.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.42 . . . . 2.31 111.966 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.94 -5.45 55.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.639 0.257 . . . . 2.37 111.219 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.757 ' O ' HD22 ' A' ' 6' ' ' LEU . 4.1 t -48.13 -57.94 9.19 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.706 0.632 . . . . 2.57 112.706 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.71 161.87 41.88 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.408 1.406 . . . . 2.08 112.59 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.1 ttt -101.31 94.8 6.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 6.04 110.438 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.5 mt -78.64 142.0 37.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 5.3 111.067 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -82.18 143.55 49.08 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.945 -0.571 . . . . 8.05 110.213 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -44.9 135.5 10.28 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 121.707 1.605 . . . . 9.14 112.221 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -134.4 133.29 21.47 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.765 -0.374 . . . . 9.87 110.643 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.03 -93.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.55 1.5 . . . . 11.69 111.675 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.63 110.74 1.13 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.953 -0.642 . . . . 12.62 112.616 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.0 mm? -92.97 88.53 6.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 14.44 110.372 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.263 -0.875 . . . . 15.7 110.856 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 112.482 -0.247 . . . . 9.15 112.482 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.22 -25.91 42.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.331 . . . . 7.36 110.843 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' A' ' 3' ' ' MET . 1.8 mpt? -89.14 123.46 33.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 7.76 110.599 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 t -149.06 -17.53 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.274 -0.421 . . . . 4.02 110.804 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.09 -44.61 1.35 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.77 -0.728 . . . . 1.28 112.589 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.44 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.9 tp -83.36 -41.95 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.258 0.552 . . . . 0.41 110.496 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.613 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.75 -20.89 24.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.4 -0.818 . . . . 0.33 110.985 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.6 -15.74 61.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 2.09 111.754 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 41.4 mmtt -107.92 -27.08 10.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.852 -0.339 . . . . 1.99 111.486 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.0 p -42.87 145.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 111.883 0.327 . . . . 0.21 111.883 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -140.07 -23.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 119.981 -0.688 . . . . 0.86 111.352 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.639 ' O ' HG22 ' A' ' 172' ' ' ILE . 27.0 t90 -172.25 127.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.773 -0.371 . . . . 0.28 110.124 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.21 143.65 29.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.816 -0.175 . . . . 0.2 110.871 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -146.6 126.44 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 114.36 1.244 . . . . 0.67 114.36 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -115.3 95.11 5.02 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.165 -0.614 . . . . 1.27 110.454 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.865 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -67.53 116.16 7.95 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.525 -0.761 . . . . 0.37 109.64 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.597 ' HA3' ' C ' ' A' ' 63' ' ' THR . . . 145.35 -51.8 0.6 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.706 -1.588 . . . . 0.67 112.157 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.01 -143.8 15.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.896 -0.669 . . . . 1.12 112.211 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.16 119.41 5.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.604 0.202 . . . . 2.02 110.989 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 80.6 p 36.36 99.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.76 0.663 . . . . 1.22 112.584 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.555 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 76.4 t60 -122.85 151.94 41.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.267 -0.573 . . . . 0.34 112.47 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -122.32 103.5 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.224 -0.898 . . . . 1.18 109.784 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.7 153.43 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 1.17 110.523 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 25' ' ' HIS . 17.8 m -43.31 -52.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 124.217 0.948 . . . . 0.6 113.382 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.473 ' N ' HG23 ' A' ' 24' ' ' VAL . 82.6 m-70 -57.99 -18.74 25.84 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.12 0.486 . . . . 0.46 110.609 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.32 36.29 3.38 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.435 -0.802 . . . . 0.29 112.334 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.44 HD11 ' HG ' ' A' ' 6' ' ' LEU . 31.1 mm -103.3 122.5 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.401 -0.592 . . . . 0.43 109.401 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.555 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.5 t60 -105.71 133.05 51.07 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 114.456 1.28 . . . . 0.52 114.456 -176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.2 134.6 41.81 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.323 -0.991 . . . . 3.0 108.323 176.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 15.9 ptm180 -96.33 114.11 25.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.362 0.601 . . . . 2.9 112.255 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -12.05 139.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.234 1.568 . . . . 2.71 115.234 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 65' ' ' ARG . 8.3 p-10 -22.68 89.23 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 114.066 -1.425 . . . . 1.98 113.67 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -101.65 19.86 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.909 2.406 . . . . 1.53 113.454 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -134.46 -37.82 0.85 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 122.251 -0.281 . . . . 1.83 111.606 -179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.634 ' N ' HD23 ' A' ' 34' ' ' LEU . 5.9 tt0 -76.55 71.17 3.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 4.95 110.455 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 74.22 0.7 58.04 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.713 -1.355 . . . . 1.94 109.713 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 47.77 23.14 0.41 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.552 -0.824 . . . . 5.36 110.582 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.94 144.7 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.377 -0.829 . . . . 2.97 110.137 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.1 -166.54 28.95 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.32 -0.943 . . . . 1.99 113.066 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -150.91 74.0 1.14 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.92 0.391 . . . . 6.59 110.916 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.799 ' H ' HH22 ' A' ' 65' ' ' ARG . . . 58.18 179.82 0.06 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.328 0.585 . . . . 2.01 111.836 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.0 p -170.61 23.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.313 -0.858 . . . . 2.02 109.639 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -52.35 137.17 29.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.467 -0.788 . . . . 2.23 111.397 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -87.77 -15.88 35.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.812 -0.631 . . . . 2.33 110.034 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.36 101.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.74 -0.664 . . . . 2.2 112.204 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 50.4 mtt -58.85 -42.3 89.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.958 0.408 . . . . 1.93 110.638 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -66.93 80.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.664 -0.698 . . . . 3.35 110.607 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.2 68.36 0.22 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.954 -0.566 . . . . 2.76 110.015 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.89 131.08 24.54 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.063 1.842 . . . . 1.46 111.823 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.681 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.2 tp -54.45 -43.85 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.11 -0.495 . . . . 0.83 110.172 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.681 ' HB2' ' O ' ' A' ' 50' ' ' ILE . 2.6 tt 130.67 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.869 1.667 . . . . 1.69 111.652 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.83 24.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.528 0.566 . . . . 2.56 112.528 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -136.6 157.95 45.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.384 0.612 . . . . 0.97 112.65 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLN . 35.8 t30 -70.86 153.16 94.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.05 -0.977 . . . . 1.96 108.788 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.454 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 59.7 Cg_exo -45.86 -59.53 1.16 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.499 1.466 . . . . 0.66 112.872 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 1.3 pm0 -56.18 -54.84 40.39 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 122.174 0.988 . . . . 1.82 111.026 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.51 -13.91 62.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.42 -0.809 . . . . 1.91 110.958 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' ASN . 1.6 pt20 -65.27 -40.21 93.62 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.342 -1.725 . . . . 1.5 106.342 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -56.16 -52.33 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.668 -1.151 . . . . 1.22 109.145 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.4 tp -70.31 -9.14 55.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.209 -0.905 . . . . 1.05 111.772 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -119.7 15.08 12.71 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.458 0.646 . . . . 0.9 110.018 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.559 ' O ' HG13 ' A' ' 167' ' ' VAL . 7.8 tt0 -136.51 -105.37 0.2 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.911 -1.041 . . . . 1.8 110.249 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.597 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 37.4 p 4.6 121.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.485 0.92 . . . . 1.05 113.485 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.493 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 9.5 pt-20 -111.59 150.74 29.63 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.067 0.765 . . . . 2.05 113.067 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.799 HH22 ' H ' ' A' ' 41' ' ' ALA . 1.3 ttt85 -137.25 88.39 2.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.119 -0.946 . . . . 3.58 109.809 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -84.48 145.74 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 4.25 111.464 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -117.95 -78.99 0.59 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.894 -0.594 . . . . 4.35 110.805 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -155.98 -89.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.449 -0.342 . . . . 3.17 111.029 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -157.57 155.35 30.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.384 0.135 . . . . 2.39 110.77 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t 47.87 86.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.99 110.313 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.454 ' CE2' ' ND2' ' A' ' 164' ' ' ASN . 2.0 p90 -156.13 166.21 34.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 1.26 111.441 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.659 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -176.36 -174.92 43.27 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.923 -1.132 . . . . 0.66 114.213 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.2 173.13 6.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 0.83 112.265 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.5 137.14 53.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.804 -1.089 . . . . 2.27 110.212 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.486 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -128.32 87.62 54.78 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.975 0.361 . . . . 0.34 111.975 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -56.94 131.35 44.97 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 121.815 1.677 . . . . 0.8 111.711 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 78' ' ' LYS . 65.4 mt -123.2 153.74 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.883 0.373 . . . . 0.38 111.643 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' N ' HG22 ' A' ' 77' ' ' ILE . 26.4 mtmm -143.44 -0.51 1.09 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.036 -0.529 . . . . 2.96 111.597 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -124.77 167.95 13.9 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 120.77 0.319 . . . . 2.13 111.2 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -123.99 164.05 20.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.232 0.539 . . . . 0.37 110.877 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.9 -146.43 17.24 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 109.729 -1.349 . . . . 0.21 109.729 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 10.8 mm-40 -103.93 108.37 19.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.685 1.243 . . . . 2.03 109.146 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.438 ' CZ ' ' HD3' ' A' ' 174' ' ' LYS . 3.9 m-85 -94.44 126.42 39.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.73 -0.841 . . . . 0.26 108.73 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 177' ' ' ALA . 23.0 t -112.45 110.97 34.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.096 -0.956 . . . . 0.54 111.323 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 tt -97.51 103.65 15.6 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.571 -1.195 . . . . 1.23 110.684 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.42 139.58 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 114.507 -1.224 . . . . 1.31 108.473 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.38 152.3 40.51 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.838 -0.745 . . . . 1.37 111.826 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 15.3 tptt -108.41 117.74 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.06 -0.656 . . . . 2.97 110.615 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.9 m-85 -105.23 145.07 31.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.169 -1.049 . . . . 0.3 108.169 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -157.74 175.4 13.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 119.136 -1.025 . . . . 0.41 113.53 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 65.59 147.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.675 -1.148 . . . . 3.97 111.823 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.403 ' C ' ' H ' ' A' ' 94' ' ' PHE . 8.1 t -141.09 -25.87 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.662 -0.699 . . . . 3.81 110.789 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 68.82 -4.25 1.24 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.831 -0.622 . . . . 2.89 110.718 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 92' ' ' VAL . 86.3 m-85 -145.26 -165.55 2.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.019 -0.537 . . . . 2.0 109.854 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.11 100.11 2.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.297 . . . . 1.0 111.543 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.425 ' HG2' ' NE2' ' A' ' 99' ' ' GLN . 8.5 tp-100 -174.41 140.67 0.65 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.208 -0.451 . . . . 2.96 110.982 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.8 m -97.18 153.97 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 1.55 111.056 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 54.75 55.93 7.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.576 . . . . 2.33 111.277 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.425 ' NE2' ' HG2' ' A' ' 96' ' ' GLN . 9.2 tt0 -151.16 -51.09 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.128 -0.693 . . . . 2.51 109.128 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 30.2 mmtm -90.48 78.26 6.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.729 -0.841 . . . . 3.1 108.729 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.49 111.72 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.587 -0.733 . . . . 1.31 110.437 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.66 178.79 4.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.219 0.822 . . . . 0.69 113.219 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.8 139.97 53.45 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 115.83 -0.623 . . . . 2.01 111.618 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.4 133.2 33.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 115.99 -0.55 . . . . 0.46 111.752 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.629 HH21 HG21 ' A' ' 158' ' ' VAL . 1.0 OUTLIER -133.69 152.26 51.84 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 112.94 0.719 . . . . 1.85 112.94 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.6 m -118.17 117.57 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.864 -1.062 . . . . 1.1 109.224 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.467 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 58.55 27.05 15.12 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.043 -0.725 . . . . 1.77 109.043 -176.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.69 20.52 43.66 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.976 -1.011 . . . . 0.41 112.734 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 85.0 m-70 -118.18 109.59 16.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.076 0.769 . . . . 0.46 113.076 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.4 p -62.91 118.28 7.56 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.543 -0.463 . . . . 0.66 111.207 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.82 -32.77 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.044 -0.724 . . . . 0.8 109.044 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.405 HG11 ' OE2' ' A' ' 129' ' ' GLU . 0.9 OUTLIER -131.9 91.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.905 -0.589 . . . . 0.51 109.822 178.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 16.9 ttmt -107.17 82.34 1.66 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.771 0.796 . . . . 2.44 110.283 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.8 p30 151.8 39.8 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.975 -1.92 . . . . 2.56 108.594 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.16 88.13 0.17 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.066 0.765 . . . . 1.1 113.066 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -103.29 86.13 2.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.366 -1.346 . . . . 1.99 107.366 175.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 46.0 mt -50.52 -44.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.806 -0.634 . . . . 0.63 112.095 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.73 -58.66 6.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.9 111.247 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.402 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 15.1 t70 -58.97 -27.03 64.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 0.76 112.034 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.528 ' NE ' ' HA ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -64.61 -59.63 4.06 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.286 0.476 . . . . 2.68 112.286 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.23 -40.81 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.108 0.411 . . . . 1.41 112.108 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.92 -129.45 3.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.566 -0.826 . . . . 1.06 112.65 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.443 ' O ' HG23 ' A' ' 125' ' ' THR . 22.3 t-80 -94.34 110.92 22.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 3.51 110.971 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.8 t 63.28 -130.56 0.47 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.843 -0.617 . . . . 1.68 111.195 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 4.4 p 58.83 -166.72 0.16 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.659 0.266 . . . . 0.8 110.351 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.5 135.05 49.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.969 0.729 . . . . 0.44 112.969 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.2 t60 -112.54 148.88 33.57 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -144.47 135.53 25.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.896 0.702 . . . . 2.09 112.896 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.405 ' OE2' HG11 ' A' ' 112' ' ' VAL . 20.0 mt-10 -124.38 122.02 36.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.483 -0.78 . . . . 2.28 108.973 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.5 mt -106.36 126.33 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.078 -0.51 . . . . 0.71 110.736 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.1 mp -128.83 85.89 58.98 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.279 0.474 . . . . 1.38 112.279 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -62.04 143.28 94.82 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.628 1.552 . . . . 0.22 111.413 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 134' ' ' SER . 32.7 mt -136.97 159.22 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.21 110.941 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 133' ' ' ILE . 41.2 p -134.24 110.22 9.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.11 111.195 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 139' ' ' LYS . 18.0 mt -108.4 128.37 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-N 115.793 -0.639 . . . . 0.23 110.121 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -146.04 140.64 26.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.321 . . . . 1.91 110.86 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt 58.74 14.57 3.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 3.11 111.369 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.94 21.15 34.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.622 -0.799 . . . . 0.32 112.747 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 135' ' ' ILE . 96.9 mttt -118.52 152.29 36.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.609 0.205 . . . . 2.19 110.659 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.24 132.96 54.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.274 0.559 . . . . 0.37 112.145 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.543 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.6 t -121.11 109.17 14.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.477 -0.783 . . . . 0.9 109.782 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 142' ' ' VAL . 9.9 p -103.78 112.58 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.272 0.558 . . . . 0.53 111.019 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 54.19 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.704 -0.68 . . . . 2.05 112.262 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.43 27.43 3.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.51 -0.852 . . . . 0.6 113.176 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -133.8 138.96 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.187 -0.301 . . . . 2.02 110.187 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.52 137.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.106 0.479 . . . . 1.3 111.294 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.6 m -159.32 129.68 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 1.12 109.885 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.5 p -59.14 143.21 49.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.207 -0.451 . . . . 1.11 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -79.3 139.18 37.91 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.301 -0.629 . . . . 0.28 109.301 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 t -135.37 95.29 3.25 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.078 0.77 . . . . 1.55 113.078 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.48 -59.16 1.2 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.675 1.03 . . . . 0.46 115.675 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.486 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -152.64 168.61 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.035 0.918 . . . . 1.8 112.68 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.467 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -92.02 126.32 37.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.833 -1.173 . . . . 1.24 107.833 177.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.448 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.3 t -114.95 117.85 31.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.517 0.932 . . . . 1.28 113.517 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.462 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 92.1 t -93.02 97.89 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.049 -0.723 . . . . 0.59 109.049 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.8 tt0 -104.91 141.08 37.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.546 -0.752 . . . . 2.48 110.717 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -131.04 145.48 52.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 1.54 109.844 178.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.629 HG21 HH21 ' A' ' 105' ' ' ARG . 11.5 t -116.74 140.86 37.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.642 -0.708 . . . . 0.77 110.662 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.24 148.57 26.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.444 -0.798 . . . . 1.97 111.946 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -124.5 -27.26 1.33 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.487 -0.779 . . . . 1.12 111.666 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -175.22 51.22 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.729 0.3 . . . . 3.81 110.339 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 62.41 159.57 0.07 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.141 -0.481 . . . . 3.82 111.214 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 54.43 91.88 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.588 0.709 . . . . 1.4 110.723 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -50.98 174.95 0.08 OUTLIER Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 114.137 -1.392 . . . . 2.0 109.517 178.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -42.49 -16.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.79 1.66 . . . . 2.58 112.56 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.556 ' NZ ' ' HB3' ' A' ' 166' ' ' LYS . 1.5 mtpm? 75.73 -76.7 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.736 0.814 . . . . 3.71 111.554 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 62' ' ' GLN . 7.4 t -83.72 131.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 C-N-CA 119.451 -0.899 . . . . 0.92 111.117 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.865 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -133.76 123.48 24.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 124.093 0.871 . . . . 1.2 111.569 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -119.83 36.94 4.35 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.64 -1.164 . . . . 0.22 113.76 -177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.53 131.77 0.22 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.903 0.335 . . . . 1.02 111.903 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.477 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -150.38 99.45 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.33 110.395 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -109.16 124.57 65.93 Favored 'Isoleucine or valine' 0 C--O 1.262 1.727 0 CA-C-O 122.763 1.268 . . . . 0.69 112.547 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.2 ptm -115.71 164.05 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.102 -1.408 . . . . 1.26 109.441 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 1.7 tptp -120.31 137.93 53.98 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.688 1.366 . . . . 1.82 114.688 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.15 -34.54 5.71 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 118.198 2.039 . . . . 0.22 118.198 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.79 156.03 0.45 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.732 2.266 . . . . 0.29 114.447 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.675 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.34 -21.82 28.74 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 115.099 -0.955 . . . . 0.57 110.336 177.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.71 -33.86 74.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.675 -0.693 . . . . 2.31 111.434 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.91 -45.56 78.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.606 -0.27 . . . . 2.37 110.536 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.1 t -40.55 100.28 0.22 Allowed Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 123.5 0.5 . . . . 2.57 111.675 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -52.56 113.31 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.777 1.651 . . . . 2.08 112.334 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.0 mmt -99.8 129.4 45.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 6.04 110.667 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.8 mt 60.49 110.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 5.3 111.042 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -50.75 151.49 4.21 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.019 -0.537 . . . . 8.05 110.523 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -62.8 124.56 14.29 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.676 1.584 . . . . 9.14 112.021 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 62.6 t-80 -133.15 142.59 45.03 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.755 -0.657 . . . . 9.87 110.03 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 186' ' ' HIS . 95.5 Cg_endo -74.77 -36.49 2.72 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.901 1.734 . . . . 11.69 112.183 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.29 -156.94 14.24 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.951 -0.642 . . . . 12.62 112.229 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.5 mp -86.92 157.01 19.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.714 0.292 . . . . 14.44 110.556 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.128 -0.939 . . . . 15.7 110.902 -179.907 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.42 -0.272 . . . . 9.15 112.42 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.06 -61.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.699 0.285 . . . . 7.36 110.774 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.5 mtm 57.25 87.8 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.1 -0.5 . . . . 7.76 110.944 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.0 m -63.34 163.44 10.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 4.02 110.95 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.4 72.8 0.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.73 . . . . 1.28 112.428 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.2 tp -80.42 -41.98 23.55 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.284 0.564 . . . . 0.41 110.43 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.658 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.38 -21.06 22.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.444 -0.798 . . . . 0.33 110.585 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -68.33 -18.34 64.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.562 . . . . 2.09 111.314 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.05 -28.4 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.916 -0.314 . . . . 1.99 111.549 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -44.54 145.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.839 -0.345 . . . . 0.21 111.683 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.7 pt -139.37 -23.44 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 120.222 -0.591 . . . . 0.86 111.137 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.594 ' O ' HG22 ' A' ' 172' ' ' ILE . 31.9 t90 -170.69 126.45 0.73 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.393 -0.523 . . . . 0.28 110.355 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -144.41 141.07 29.41 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.675 -0.239 . . . . 0.2 111.275 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -147.18 126.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 114.028 1.122 . . . . 0.67 114.028 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 22.2 t-20 -116.8 96.13 5.34 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.323 -0.551 . . . . 1.27 110.933 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.29 115.1 5.24 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 109.627 -0.508 . . . . 0.37 109.627 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 162.62 -56.18 0.3 Allowed Glycine 0 N--CA 1.441 -0.992 0 O-C-N 124.093 0.871 . . . . 0.67 113.855 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -115.19 -120.88 3.41 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.744 -0.741 . . . . 1.12 112.946 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 20' ' ' SER . 28.0 tt0 -154.74 120.28 5.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.89 0.33 . . . . 2.02 111.89 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 24.6 t 24.09 115.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.675 1.361 . . . . 1.22 114.675 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.494 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 17.1 t60 -137.74 151.19 47.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.303 0.573 . . . . 0.34 111.865 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.99 106.97 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.391 -0.822 . . . . 1.18 111.507 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.09 153.96 42.13 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.292 -0.413 . . . . 1.17 110.231 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 25' ' ' HIS . 12.5 m -44.26 -53.07 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 113.445 0.905 . . . . 0.6 113.445 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.437 ' N ' HG23 ' A' ' 24' ' ' VAL . 82.6 m-70 -55.82 -19.88 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.194 0.521 . . . . 0.46 110.565 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.38 35.01 3.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.407 -0.815 . . . . 0.29 112.144 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.427 HD11 ' HG ' ' A' ' 6' ' ' LEU . 33.4 mm -102.75 120.52 52.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.454 -0.573 . . . . 0.43 109.454 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 10.3 t60 -103.52 129.12 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.335 1.235 . . . . 0.52 114.335 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.82 139.44 36.51 Favored 'General case' 0 CA--C 1.524 -0.04 0 N-CA-C 107.468 -1.308 . . . . 3.0 107.468 176.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.442 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 15.5 ptm180 -103.82 126.0 50.64 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.529 0.68 . . . . 2.9 112.439 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 31' ' ' LYS . 4.5 tmmm? -20.32 141.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.445 1.498 . . . . 2.71 114.708 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -27.86 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.072 -1.422 . . . . 1.98 112.467 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -102.17 1.99 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.939 2.426 . . . . 1.53 114.627 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.41 -29.77 6.77 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.399 0.518 . . . . 1.83 112.399 -178.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.657 ' N ' HD23 ' A' ' 34' ' ' LEU . 60.1 mp0 -78.82 73.38 5.36 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.74 -0.384 . . . . 4.95 110.085 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.49 -0.22 56.01 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.158 -1.02 . . . . 1.94 110.811 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER 42.41 63.76 1.32 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.289 0.566 . . . . 5.36 110.517 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 p -146.49 146.79 18.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.293 -0.867 . . . . 2.97 110.502 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.79 114.86 7.17 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.054 -0.593 . . . . 1.99 113.173 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -150.78 -76.0 0.15 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.55 0.215 . . . . 6.59 110.932 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.503 ' H ' HH21 ' A' ' 65' ' ' ARG . . . 57.78 90.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.411 -0.359 . . . . 2.01 110.99 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -91.87 89.37 7.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 2.02 110.838 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -74.44 94.8 2.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.026 -0.534 . . . . 2.23 110.4 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.408 ' C ' ' H ' ' A' ' 46' ' ' MET . 56.3 t80 -107.19 -71.43 0.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.943 -0.571 . . . . 2.33 111.401 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.17 23.43 1.43 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.025 -0.607 . . . . 2.2 113.027 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.408 ' H ' ' C ' ' A' ' 44' ' ' TYR . 7.7 ttt -66.06 -11.9 51.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.938 0.399 . . . . 1.93 110.322 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' C ' ' HD3' ' A' ' 49' ' ' PRO . 64.8 pttt -88.96 16.34 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.828 -0.624 . . . . 3.35 110.633 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.6 mt -127.21 65.82 66.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.888 -0.596 . . . . 2.76 109.908 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 84.9 Cg_exo -54.0 134.97 62.19 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.008 2.472 . . . . 1.46 113.605 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.79 148.1 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.03 -0.73 . . . . 0.83 109.03 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 mp -97.51 -37.46 9.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 1.69 112.897 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -82.36 38.94 0.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.594 0.59 . . . . 2.56 112.594 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -153.3 165.97 34.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 0.97 111.663 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.8 t30 -76.76 146.69 76.73 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.891 -0.595 . . . . 1.96 109.764 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.635 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.44 -55.62 1.83 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.466 2.111 . . . . 0.66 114.272 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.718 ' O ' HG12 ' A' ' 59' ' ' VAL . 12.0 mm-40 -64.5 -56.76 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.721 0.772 . . . . 1.82 111.167 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' OD1' HD13 ' A' ' 60' ' ' LEU . 47.2 t0 -70.58 -2.54 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.15 -0.62 . . . . 1.91 110.304 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.635 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 14.5 tt0 -73.32 -56.15 5.45 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.701 -1.222 . . . . 1.5 107.701 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.718 HG12 ' O ' ' A' ' 56' ' ' GLU . 11.0 p -52.46 -35.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.039 -1.097 . . . . 1.22 108.039 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -65.18 -68.83 0.33 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.42 -0.512 . . . . 1.05 110.1 178.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -54.12 -3.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.026 0.931 . . . . 0.9 111.9 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 63' ' ' THR . 26.7 tt0 -109.96 -113.92 0.31 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.585 -0.734 . . . . 1.8 110.351 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 59' ' ' VAL . 57.2 p 29.87 123.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.699 1.37 . . . . 1.05 114.699 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -127.26 147.44 50.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.868 -0.606 . . . . 2.05 110.265 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.529 HH11 ' HG2' ' A' ' 35' ' ' GLU . 2.3 ptm180 -136.81 -173.25 3.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.686 0.279 . . . . 3.58 110.45 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -49.21 148.95 2.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.371 0.508 . . . . 4.25 112.371 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -135.43 -179.83 5.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.451 -0.795 . . . . 4.35 110.525 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -156.6 -120.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.725 -0.216 . . . . 3.17 111.106 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -153.29 129.33 10.33 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.468 0.175 . . . . 2.39 110.823 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.678 ' H ' HD21 ' A' ' 164' ' ' ASN . 23.0 t 56.59 91.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.977 0.417 . . . . 0.99 110.985 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -164.29 163.91 22.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.905 -0.588 . . . . 1.26 110.886 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.732 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -169.45 -174.27 37.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.15 -1.024 . . . . 0.66 113.973 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.403 ' CE2' HD13 ' A' ' 34' ' ' LEU . 7.8 m-85 -108.51 165.98 11.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.44 0.638 . . . . 0.83 112.138 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.74 126.97 51.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.824 -1.08 . . . . 2.27 110.218 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.501 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.3 mp -118.43 87.53 31.01 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 111.835 0.309 . . . . 0.34 111.835 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.12 133.62 58.9 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 121.929 1.753 . . . . 0.8 112.021 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 78' ' ' LYS . 24.1 mt -124.11 153.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.938 0.399 . . . . 0.38 111.483 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' N ' HG22 ' A' ' 77' ' ' ILE . 59.0 mttp -140.85 0.98 1.64 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.888 -0.596 . . . . 2.96 111.027 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -129.42 170.44 13.68 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.713 0.292 . . . . 2.13 111.284 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -123.06 176.87 5.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.095 0.474 . . . . 0.37 111.242 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.36 -152.31 20.18 Favored Glycine 0 C--N 1.329 0.153 0 N-CA-C 109.868 -1.293 . . . . 0.21 109.868 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 22.6 mt-10 -102.52 108.55 19.88 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.858 1.329 . . . . 2.03 108.836 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -95.01 126.95 40.7 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.578 0.704 . . . . 0.26 109.677 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 177' ' ' ALA . 13.9 t -113.6 118.49 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.787 -1.097 . . . . 0.54 111.831 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 105.37 17.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.521 -1.218 . . . . 1.23 111.572 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.64 126.47 65.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.78 -1.1 . . . . 1.31 108.966 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.48 ' N ' HD23 ' A' ' 87' ' ' LEU . 1.8 pt? -147.17 134.88 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.63 -0.828 . . . . 1.37 111.754 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.522 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 5.3 tptp -98.02 120.74 38.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.317 -0.856 . . . . 2.97 110.828 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.579 ' CD2' HD21 ' A' ' 115' ' ' LEU . 7.5 m-85 -105.09 136.54 44.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.757 -1.201 . . . . 0.3 107.757 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -146.04 171.89 14.2 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.489 -0.884 . . . . 0.41 113.074 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 59.45 176.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.296 -0.866 . . . . 3.97 112.028 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 p -176.87 -18.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.839 -0.619 . . . . 3.81 111.116 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.9 t80 73.65 -68.44 0.22 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.936 -0.575 . . . . 2.89 110.582 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.48 138.68 31.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 2.0 110.856 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.97 99.1 12.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -142.01 145.11 34.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 2.96 111.069 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 73.9 m -119.1 134.4 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.55 111.254 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 71.43 -60.45 0.52 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.772 -0.649 . . . . 2.33 111.554 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -45.48 -38.29 6.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.409 -0.36 . . . . 2.51 111.139 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.836 ' HZ2' ' HB2' ' A' ' 100' ' ' LYS . 4.7 ttmp? -101.95 82.55 2.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.305 0.574 . . . . 3.1 110.778 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.77 139.91 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.293 -0.867 . . . . 1.31 109.618 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.456 ' CG ' ' HD3' ' A' ' 165' ' ' PRO . 61.6 m-85 -119.92 176.85 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.756 0.65 . . . . 0.69 112.756 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -127.15 140.43 52.26 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.213 0.53 . . . . 2.01 112.31 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.89 136.45 55.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.052 -0.977 . . . . 0.46 112.008 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 5.1 mtt180 -135.5 156.68 48.5 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 113.264 0.839 . . . . 1.85 113.264 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' ND2' ' A' ' 107' ' ' ASN . 39.5 t -122.9 123.34 67.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 114.558 -1.201 . . . . 1.1 109.298 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.6 ' ND2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 53.59 26.1 5.43 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.556 -0.905 . . . . 1.77 108.556 -175.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.83 17.15 57.03 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.278 -0.873 . . . . 0.41 112.74 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 88.9 m-70 -112.37 112.89 24.79 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.895 0.702 . . . . 0.46 112.895 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 p -62.77 127.17 30.0 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 119.864 -0.734 . . . . 0.66 110.454 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.06 -30.21 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.792 -0.64 . . . . 0.8 109.316 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.37 88.97 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.804 -0.814 . . . . 0.51 108.804 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -106.6 77.72 1.21 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.515 1.15 . . . . 2.44 110.773 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 p30 159.44 38.0 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.348 -1.751 . . . . 2.56 108.499 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.579 HD21 ' CD2' ' A' ' 89' ' ' PHE . 20.5 tp -79.36 91.64 5.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 113.172 0.805 . . . . 1.1 113.172 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -106.48 91.14 3.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.869 -1.16 . . . . 1.99 107.869 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.3 mt -51.25 -32.42 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.995 0.739 . . . . 0.63 112.995 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.97 -51.56 15.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.737 -0.385 . . . . 0.9 111.303 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.27 -27.13 65.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.76 111.913 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HE ' ' CE1' ' A' ' 127' ' ' HIS . 23.8 mmm180 -77.65 -58.6 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.688 0.625 . . . . 2.68 112.688 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.52 -41.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.383 0.512 . . . . 1.41 112.383 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.65 -125.66 6.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.438 -0.887 . . . . 1.06 112.889 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.416 ' O ' HG23 ' A' ' 125' ' ' THR . 97.5 m-70 -72.42 110.34 6.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.382 . . . . 3.51 111.372 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 61.5 m 48.41 -109.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 1.68 111.685 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 123' ' ' HIS . 53.1 p 50.31 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 0.8 110.988 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.16 138.42 50.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.287 0.565 . . . . 0.44 112.234 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.459 ' CE1' ' HE ' ' A' ' 120' ' ' ARG . 1.6 t60 -108.0 151.06 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.075 -0.966 . . . . 0.38 108.416 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.85 136.51 38.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.772 0.656 . . . . 2.09 112.772 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' HD23 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -127.76 123.86 36.34 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.05 -0.977 . . . . 2.28 109.668 178.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.461 ' O ' HD13 ' A' ' 131' ' ' ILE . 53.2 mt -119.08 124.05 72.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.917 -0.583 . . . . 0.71 110.396 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 130' ' ' ILE . 50.9 mm -131.6 95.5 23.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.122 0.415 . . . . 1.38 112.122 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.99 148.84 93.05 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.646 1.564 . . . . 0.22 111.309 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 134' ' ' SER . 21.3 mt -139.64 155.96 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.336 . . . . 0.21 110.961 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 29.2 p -131.57 111.2 11.53 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.008 0.432 . . . . 1.11 111.168 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LYS . 20.3 mt -112.06 127.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.649 -0.705 . . . . 0.23 110.217 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -149.32 137.97 21.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.518 -0.31 . . . . 1.91 111.005 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 137' ' ' LYS . 9.4 mtmp? 62.5 13.4 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.998 -0.546 . . . . 3.11 111.468 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.61 7.64 58.89 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.59 -0.814 . . . . 0.32 112.986 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.601 ' O ' HG23 ' A' ' 135' ' ' ILE . 53.1 mtpt -108.12 167.06 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.883 0.341 . . . . 2.19 110.645 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 141' ' ' SER . 5.5 tt -127.96 146.36 50.67 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.739 0.644 . . . . 0.37 112.739 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.568 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -132.2 109.7 10.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.027 -0.988 . . . . 0.9 109.335 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.2 p -109.71 111.51 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.082 -0.508 . . . . 0.53 110.349 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 61.89 -89.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 2.05 111.579 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.07 15.13 4.02 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.712 -0.756 . . . . 0.6 112.77 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.42 130.93 57.03 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.089 -0.337 . . . . 2.02 110.089 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.3 131.82 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.184 0.516 . . . . 1.3 110.966 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 60.0 m -149.59 175.37 11.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.637 -0.711 . . . . 1.12 109.496 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.4 p -99.52 138.88 35.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.7 -0.4 . . . . 1.11 111.418 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -78.23 139.17 38.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.059 -0.719 . . . . 0.28 109.059 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 t -139.6 95.86 2.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.175 0.805 . . . . 1.55 113.175 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.29 -51.02 3.22 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 115.819 1.087 . . . . 0.46 115.819 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.501 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -158.66 174.94 14.28 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.385 1.093 . . . . 1.8 113.543 -177.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.6 ' HG ' ' ND2' ' A' ' 107' ' ' ASN . 1.1 tp -97.69 124.69 42.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.035 -1.439 . . . . 1.24 107.123 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.4 t -114.35 116.93 29.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 118.739 -1.184 . . . . 1.28 113.443 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 47.0 t -95.61 98.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.741 -0.837 . . . . 0.59 108.741 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.3 tt0 -109.13 134.63 51.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.658 -0.701 . . . . 2.48 111.207 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -126.33 134.56 51.06 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.276 0.56 . . . . 1.54 110.345 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.447 HG21 HH21 ' A' ' 105' ' ' ARG . 99.1 t -105.8 142.04 19.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 114.73 -1.123 . . . . 0.77 110.815 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.65 143.01 44.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.429 -0.805 . . . . 1.97 111.57 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.76 -14.13 16.45 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.458 -0.657 . . . . 1.12 111.458 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -158.98 -64.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 3.81 110.281 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -176.72 161.9 2.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 3.82 110.783 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 57.22 71.24 0.59 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.272 -0.422 . . . . 1.4 111.282 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.678 HD21 ' H ' ' A' ' 70' ' ' SER . 5.8 m-20 -49.98 153.31 2.34 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.537 -0.756 . . . . 2.0 109.503 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.456 ' HD3' ' CG ' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -28.71 105.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.381 2.054 . . . . 2.58 112.343 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -58.14 -74.0 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.149 -0.932 . . . . 3.71 112.584 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 4.8 t -79.1 133.13 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 119.858 -0.737 . . . . 0.92 111.281 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 5.2 t -129.12 124.48 34.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.084 -0.962 . . . . 1.2 109.817 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . . . -117.47 35.46 4.67 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.652 0.982 . . . . 0.22 113.652 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -35.74 131.06 0.54 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.175 0.512 . . . . 1.02 111.649 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.455 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.5 OUTLIER -152.46 96.71 2.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.33 109.542 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.9 OUTLIER -104.82 126.81 59.66 Favored 'Isoleucine or valine' 0 C--O 1.263 1.805 0 CA-C-O 122.625 1.202 . . . . 0.69 112.583 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ptm -118.29 162.52 18.13 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.57 -1.65 . . . . 1.26 109.254 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -120.97 146.45 46.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.818 1.414 . . . . 1.82 114.818 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 102.97 -35.44 5.0 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 112.469 -2.15 . . . . 0.22 117.837 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.463 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 153.87 0.36 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.396 2.098 . . . . 0.29 115.298 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.648 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -87.75 -31.8 19.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 114.379 -1.282 . . . . 0.57 110.465 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -56.12 -17.75 8.02 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.712 -0.677 . . . . 2.31 111.63 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 180' ' ' VAL . 2.1 m-20 -73.26 -79.0 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.346 -0.388 . . . . 2.37 110.608 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 177' ' ' ALA . 26.9 m 14.49 66.13 0.15 Allowed Pre-proline 0 N--CA 1.475 0.806 0 N-CA-C 113.308 0.855 . . . . 2.57 113.308 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.93 124.3 15.93 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.507 2.138 . . . . 2.08 112.453 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 59.4 mtt -92.18 120.31 32.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 6.04 110.604 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 10.1 mp 59.67 103.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.083 -0.508 . . . . 5.3 110.979 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -54.26 146.41 31.6 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.041 -0.527 . . . . 8.05 110.269 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -44.57 146.06 2.34 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.632 1.555 . . . . 9.14 112.392 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.642 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 61.6 t60 -134.5 132.46 20.85 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.348 -0.387 . . . . 9.87 110.494 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.642 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 62.1 Cg_endo -74.05 -21.89 17.68 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.206 1.937 . . . . 11.69 112.469 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -50.1 151.3 4.68 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.778 -0.725 . . . . 12.62 112.658 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 189' ' ' LEU . 6.9 mp -106.26 137.27 44.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.704 0.287 . . . . 14.44 110.892 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.202 -0.904 . . . . 15.7 110.763 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.377 -0.289 . . . . 9.15 112.377 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.72 -39.32 2.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 7.36 110.963 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.7 mtt -104.04 10.83 35.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 7.76 110.75 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.1 t -121.88 151.65 40.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 4.02 110.829 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.56 81.88 0.73 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.839 -0.696 . . . . 1.28 112.636 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.495 HD22 ' O ' ' A' ' 180' ' ' VAL . 17.9 tp -73.58 -42.97 60.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.145 0.498 . . . . 0.41 110.267 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.67 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -57.24 -20.67 28.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 0.33 110.642 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.75 -18.29 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 2.09 111.738 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.578 ' NZ ' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -105.95 -27.04 11.43 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.776 -0.37 . . . . 1.99 111.091 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.5 p -45.43 146.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 120.979 -0.289 . . . . 0.21 111.311 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.24 -20.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 119.965 -0.694 . . . . 0.86 110.729 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' O ' HG22 ' A' ' 172' ' ' ILE . 13.1 t90 -173.51 129.33 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.028 -0.533 . . . . 0.28 110.042 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.82 139.29 20.48 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 122.333 -0.229 . . . . 0.2 111.296 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.2 t -147.16 131.89 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 114.324 1.231 . . . . 0.67 114.324 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 63.8 t30 -115.34 87.96 2.77 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 116.161 -0.472 . . . . 1.27 110.822 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.97 112.21 1.43 Allowed 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.648 -0.706 . . . . 0.37 110.046 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 143.97 -13.81 2.15 Favored Glycine 0 N--CA 1.442 -0.91 0 O-C-N 124.047 0.842 . . . . 0.67 114.234 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.08 -131.06 2.97 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 119.961 -1.114 . . . . 1.12 113.129 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -160.99 120.01 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 2.02 111.45 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 71.6 m 26.4 104.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.921 -1.036 . . . . 1.22 113.615 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.637 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.5 t60 -132.77 142.82 49.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 120.334 -0.546 . . . . 0.34 112.404 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.8 p -116.94 105.43 18.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 121.456 0.646 . . . . 1.18 111.101 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.59 158.12 34.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.38 -0.827 . . . . 1.17 110.512 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 25' ' ' HIS . 14.2 m -42.95 -50.99 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.227 0.954 . . . . 0.6 113.261 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.433 ' N ' HG23 ' A' ' 24' ' ' VAL . 85.6 m-70 -57.33 -22.16 40.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.46 110.42 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.54 34.72 3.5 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.228 -0.896 . . . . 0.29 111.757 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.5 mm -103.58 112.65 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.13 0.49 . . . . 0.43 110.403 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.637 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.1 t60 -97.59 139.01 34.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.485 1.291 . . . . 0.52 114.485 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.675 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -104.76 138.02 41.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.458 -1.246 . . . . 3.0 108.867 178.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 29.6 mtp180 -94.19 109.05 20.87 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.685 0.616 . . . . 2.9 112.03 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 32' ' ' ASP . 81.2 tttt -24.05 132.16 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.176 1.176 . . . . 2.71 114.176 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' LYS . 77.4 m-20 -2.41 80.11 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.701 1.2 . . . . 1.98 113.998 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -103.86 7.81 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.549 2.832 . . . . 1.53 112.561 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD23 ' C ' ' A' ' 72' ' ' GLY . 5.7 mt -52.18 -71.4 0.07 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.566 0.222 . . . . 1.83 111.021 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -144.47 57.63 1.31 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.018 0.747 . . . . 4.95 113.018 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.01 0.06 68.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.254 -0.974 . . . . 1.94 114.066 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.55 ' HG3' ' CZ ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -69.93 59.98 0.17 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.257 0.529 . . . . 5.36 111.507 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.8 m -106.72 136.09 42.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.835 0.35 . . . . 2.97 110.867 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.2 26.2 10.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 1.99 112.625 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 97.1 mtt180 -137.87 -61.26 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.582 0.23 . . . . 6.59 110.875 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 40' ' ' ARG . . . 74.45 -44.52 0.56 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.815 -0.629 . . . . 2.01 111.486 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.9 m 53.18 55.61 8.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.956 0.408 . . . . 2.02 111.108 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -85.8 25.02 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 2.23 110.358 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -52.58 141.4 20.59 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.094 -0.503 . . . . 2.33 110.292 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.66 40.11 78.14 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.378 -0.915 . . . . 2.2 111.402 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ttt -57.46 -14.43 4.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.627 -0.286 . . . . 1.93 111.552 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -60.68 -176.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.299 . . . . 3.35 110.874 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.498 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 11.8 mt 60.51 59.78 3.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 2.76 110.865 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 23.6 Cg_exo -69.78 157.36 60.6 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.534 2.156 . . . . 1.46 112.59 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp -66.23 145.79 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 116.124 -0.489 . . . . 0.83 109.779 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.11 -60.46 1.97 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.796 1.036 . . . . 1.69 113.796 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -71.76 32.84 0.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.408 0.892 . . . . 2.56 113.408 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 t -138.16 140.76 40.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.327 0.491 . . . . 0.97 112.327 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.505 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 6.9 t30 -62.27 145.76 93.55 Favored Pre-proline 0 C--O 1.22 -0.451 0 CA-C-N 115.538 -0.755 . . . . 1.96 109.225 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.602 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 11.3 Cg_exo -39.57 -51.18 2.89 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.594 2.196 . . . . 0.66 115.425 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.44 -56.19 12.15 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 122.407 1.098 . . . . 1.82 110.911 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.58 59.94 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.866 -1.061 . . . . 1.91 109.85 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.602 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 29.4 tt0 -64.49 -45.68 86.29 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.614 -1.625 . . . . 1.5 106.614 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 63' ' ' THR . 96.7 t -57.1 -54.4 30.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.455 -1.248 . . . . 1.22 109.99 177.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.9 tp -64.62 -12.75 48.94 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.9 -0.591 . . . . 1.05 112.087 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.488 ' CZ ' ' HE2' ' A' ' 88' ' ' LYS . 4.1 m-30 -108.52 -2.0 19.26 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.916 -0.584 . . . . 0.9 110.21 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.601 ' HG2' ' N ' ' A' ' 63' ' ' THR . 36.7 tt0 -123.58 -107.61 0.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.539 -0.755 . . . . 1.8 112.033 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 59' ' ' VAL . 48.2 p 42.08 -168.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.489 -0.323 . . . . 1.05 110.994 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.3 pt-20 177.71 128.4 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.977 0.417 . . . . 2.05 111.77 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.55 ' CZ ' ' HG3' ' A' ' 37' ' ' ARG . 2.2 ttp85 -112.74 -170.97 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.103 -0.499 . . . . 3.58 110.336 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -162.91 138.12 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.618 0.247 . . . . 4.25 111.128 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.546 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 48.7 t-20 -130.8 -82.54 0.53 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.415 -0.357 . . . . 4.35 110.944 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.91 -75.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.549 0.214 . . . . 3.17 111.349 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -163.82 143.26 8.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.682 -0.235 . . . . 2.39 110.69 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 t 50.55 83.42 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.99 110.158 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.434 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 29.9 p90 -150.2 151.65 33.4 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.224 0.535 . . . . 1.26 111.632 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -169.23 -169.37 32.49 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.268 -0.878 . . . . 0.66 113.675 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -102.15 177.73 4.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.578 0.955 . . . . 0.83 113.578 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.68 120.89 21.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.661 -1.609 . . . . 2.27 109.663 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.99 90.66 11.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 112.241 0.46 . . . . 0.34 112.241 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.7 141.28 90.22 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 121.097 1.198 . . . . 0.8 111.118 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.35 151.87 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 0.38 111.32 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -144.63 2.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 2.96 110.839 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -127.33 175.17 8.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.589 0.233 . . . . 2.13 110.663 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -131.71 170.33 14.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.37 111.654 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.59 -154.64 22.65 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 109.569 -1.412 . . . . 0.21 109.569 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -96.41 109.66 22.15 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.976 1.388 . . . . 2.03 108.929 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.08 126.45 41.32 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.769 -0.826 . . . . 0.26 108.769 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.2 t -112.59 113.07 43.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.901 -1.045 . . . . 0.54 111.57 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.78 103.75 16.37 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.641 -1.163 . . . . 1.23 109.66 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.62 134.44 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.404 -0.816 . . . . 1.31 108.859 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -147.05 154.94 41.78 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.783 -0.767 . . . . 1.37 112.018 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HZ3' ' HB2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.89 119.12 37.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.767 -0.652 . . . . 2.97 110.172 178.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 7.7 m-85 -105.68 137.74 43.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.918 -0.583 . . . . 0.3 109.531 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.535 ' O ' HG13 ' A' ' 167' ' ' VAL . . . -142.44 152.92 43.24 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.235 -0.283 . . . . 0.41 110.235 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -171.19 130.34 0.75 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 3.97 110.938 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 m -151.62 85.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.582 . . . . 3.81 110.919 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -158.86 6.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 2.89 110.937 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -140.81 -47.64 0.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 2.0 110.923 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.97 80.3 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.005 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -173.34 140.54 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.18 -0.464 . . . . 2.96 110.631 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 p -97.7 162.38 13.3 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.158 0.504 . . . . 1.55 111.356 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 100' ' ' LYS . 1.9 mp0 55.63 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.88 -1.054 . . . . 2.33 110.818 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 71.33 -30.34 0.21 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.966 -1.016 . . . . 2.51 110.602 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 98' ' ' GLN . 66.4 mmtt -108.52 63.1 0.61 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.537 -0.912 . . . . 3.1 108.537 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.418 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 1.1 m -109.11 150.78 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.262 -0.881 . . . . 1.31 110.532 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -118.62 178.32 4.51 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 112.843 0.683 . . . . 0.69 112.843 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -127.67 137.67 52.57 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.062 -0.517 . . . . 2.01 111.176 177.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.88 127.01 51.54 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-N 115.89 -0.595 . . . . 0.46 111.952 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -128.31 141.44 51.44 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.141 -0.936 . . . . 1.85 113.269 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 4.2 m -116.93 118.76 59.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 114.149 -1.387 . . . . 1.1 109.583 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 61.92 28.5 17.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.882 -0.784 . . . . 1.77 108.882 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.38 89.91 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.41 111.369 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 58.6 m-70 -102.62 109.15 20.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.759 -0.721 . . . . 0.46 112.209 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.0 p -68.44 133.42 48.62 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.477 0.656 . . . . 0.66 112.052 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -31.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.896 -1.047 . . . . 0.8 109.636 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.25 91.03 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.197 -0.668 . . . . 0.51 109.197 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 3.3 ptpp? -109.18 77.28 1.05 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.692 1.234 . . . . 2.44 112.24 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.1 p30 153.53 40.15 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.197 -2.274 . . . . 2.56 109.353 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.408 HD11 ' OE1' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -63.18 94.42 0.07 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.247 0.546 . . . . 1.1 112.187 -178.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -102.98 84.11 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.932 -1.507 . . . . 1.99 106.932 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.3 mt -50.32 -41.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.104 -0.953 . . . . 0.63 112.628 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.01 -45.73 87.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.667 0.27 . . . . 0.9 111.482 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.11 -28.82 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.211 0.449 . . . . 0.76 112.211 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -68.35 -58.44 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.437 0.532 . . . . 2.68 112.437 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.4 p -94.39 -37.1 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.867 0.321 . . . . 1.41 111.867 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.16 -114.54 2.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.399 -0.905 . . . . 1.06 112.878 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.486 ' O ' HG23 ' A' ' 125' ' ' THR . 57.3 t-80 -104.6 114.05 28.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.714 0.292 . . . . 3.51 111.172 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.3 p 53.3 -143.22 0.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.006 -0.543 . . . . 1.68 111.316 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.0 p 64.36 -171.73 0.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.624 0.37 . . . . 0.8 110.996 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -104.71 139.54 39.37 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.692 0.626 . . . . 0.44 112.692 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.8 t60 -102.91 152.02 21.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.209 -0.905 . . . . 0.38 109.075 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -144.2 132.89 22.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.635 0.605 . . . . 2.09 112.635 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.408 ' OE1' HD11 ' A' ' 115' ' ' LEU . 29.2 mt-10 -127.65 128.42 45.46 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 2.28 109.893 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.4 mt -117.13 122.03 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.058 -0.519 . . . . 0.71 110.496 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mm -124.93 89.71 52.15 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.392 -0.367 . . . . 1.38 111.928 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -60.52 143.12 99.42 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.928 1.752 . . . . 0.22 111.918 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 24.1 mt -134.94 156.54 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.21 110.367 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.0 p -130.51 106.51 8.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.938 0.399 . . . . 1.11 111.015 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 139' ' ' LYS . 19.2 mt -107.7 122.98 62.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 0.23 110.222 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.54 140.57 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 1.91 110.804 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp 61.49 26.54 16.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.904 -0.589 . . . . 3.11 110.82 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.72 27.75 60.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.898 -0.668 . . . . 0.32 113.004 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.524 ' O ' HG23 ' A' ' 135' ' ' ILE . 73.3 mttt -126.15 151.62 47.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.832 0.316 . . . . 2.19 111.321 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 141' ' ' SER . 5.3 tt -111.24 129.52 55.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 0.37 111.856 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 140' ' ' LEU . 18.3 m -117.35 109.41 16.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 0.9 109.658 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -105.99 105.86 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.255 0.55 . . . . 0.53 111.173 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 56.63 -90.03 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.823 -0.626 . . . . 2.05 111.976 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.77 24.95 4.78 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.468 -0.873 . . . . 0.6 113.537 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -134.16 135.13 42.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.811 0.306 . . . . 2.02 110.178 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -105.33 139.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.093 0.473 . . . . 1.3 111.132 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.2 t -161.35 127.83 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 1.12 109.993 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.6 p -53.69 143.72 19.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 1.11 111.68 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.31 124.81 28.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.914 -0.773 . . . . 0.28 108.914 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 t -115.96 92.32 3.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.073 0.768 . . . . 1.55 113.073 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.06 -34.09 0.05 OUTLIER Glycine 0 CA--C 1.527 0.84 0 N-CA-C 117.376 1.71 . . . . 0.46 117.376 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.63 158.42 28.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.598 1.699 . . . . 1.8 113.885 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.47 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -96.16 124.78 40.29 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.618 -1.253 . . . . 1.24 107.618 176.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -108.09 142.34 38.43 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 113.904 1.075 . . . . 1.28 113.904 -176.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.511 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 64.6 t -129.67 97.8 3.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.54 . . . . 0.59 109.909 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 60.7 mm-40 -112.66 128.92 56.52 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.137 -0.938 . . . . 2.48 111.495 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 17.7 p90 -116.1 133.54 55.91 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.375 -0.602 . . . . 1.54 109.375 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 t -108.79 142.86 20.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 115.303 -0.862 . . . . 0.77 111.569 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -63.58 148.52 48.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.669 -1.151 . . . . 1.97 111.634 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -111.82 -10.34 19.0 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.744 -0.662 . . . . 1.12 111.652 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -153.5 -51.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 3.81 110.397 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -171.39 -64.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.151 -0.477 . . . . 3.82 110.626 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.55 117.52 20.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.989 -0.551 . . . . 1.4 110.809 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 166' ' ' LYS . 2.1 m120 -60.09 -178.53 0.15 Allowed Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.211 -0.904 . . . . 2.0 109.506 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -48.18 -8.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.905 1.737 . . . . 2.58 113.915 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 164' ' ' ASN . 27.6 tptt 76.64 -75.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.656 0.383 . . . . 3.71 111.652 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 90' ' ' ALA . 2.0 m -111.95 137.1 45.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 C-N-CA 119.795 -0.762 . . . . 0.92 111.562 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 9.8 t -131.88 122.54 25.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.738 -1.119 . . . . 1.2 112.085 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -106.19 38.34 2.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.163 -0.926 . . . . 0.22 113.381 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.402 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -35.49 133.93 0.34 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.963 0.357 . . . . 1.02 111.963 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -154.16 94.92 1.78 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.148 -0.478 . . . . 0.33 110.843 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 12' ' ' TRP . 6.1 tt -104.19 131.44 53.0 Favored 'Isoleucine or valine' 0 C--O 1.26 1.619 0 CA-C-O 122.643 1.211 . . . . 0.69 112.547 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.614 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -122.15 166.6 14.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.858 -1.519 . . . . 1.26 110.416 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.1 150.57 37.13 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.959 1.466 . . . . 1.82 114.959 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 90.51 -34.49 4.16 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 112.105 -2.316 . . . . 0.22 118.176 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.71 162.07 0.7 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.225 2.012 . . . . 0.29 114.187 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.621 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.54 -23.58 27.63 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 115.029 -0.987 . . . . 0.57 110.968 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.33 -18.69 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 2.31 111.496 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.481 ' O ' HD13 ' A' ' 6' ' ' LEU . 14.4 m-20 -94.04 -7.09 43.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.544 -0.298 . . . . 2.37 111.485 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.495 ' O ' HD22 ' A' ' 6' ' ' LEU . 2.1 t -42.95 -47.21 13.77 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.638 0.607 . . . . 2.57 112.638 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -81.78 -167.09 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.318 1.345 . . . . 2.08 111.603 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 61.2 ttp -137.88 138.99 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 6.04 110.667 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.6 mt -108.69 134.5 51.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 5.3 110.591 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -52.67 146.35 18.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.552 . . . . 8.05 110.267 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.18 124.65 12.42 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.636 1.557 . . . . 9.14 112.138 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -134.43 133.85 21.96 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.17 -0.468 . . . . 9.87 110.316 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.53 -95.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.575 1.516 . . . . 11.69 111.627 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 87.44 -146.34 20.1 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.879 -0.677 . . . . 12.62 112.51 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 189' ' ' LEU . 6.7 mp -93.8 141.44 28.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 14.44 110.653 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.1 -0.953 . . . . 15.7 110.736 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.466 -0.254 . . . . 9.15 112.466 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.53 91.7 8.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 7.36 110.885 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt -134.21 -54.16 0.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 7.76 110.914 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.9 p -78.39 131.96 37.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 4.02 110.736 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.408 ' O ' ' HE2' ' A' ' 9' ' ' LYS . . . 150.25 -78.47 0.22 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.748 -0.739 . . . . 1.28 112.468 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 tp -67.34 -44.84 78.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.41 110.402 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.639 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -56.7 -21.09 25.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.309 -0.859 . . . . 0.33 111.466 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.24 -16.03 59.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.167 0.432 . . . . 2.09 112.167 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 5' ' ' GLY . 20.1 mmtt -105.23 -28.62 10.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.665 -0.414 . . . . 1.99 111.002 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -40.1 144.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 111.772 0.286 . . . . 0.21 111.772 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.69 -23.75 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.071 -0.652 . . . . 0.86 111.073 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.53 ' O ' HG22 ' A' ' 172' ' ' ILE . 25.4 t90 -173.09 137.98 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.972 -0.381 . . . . 0.28 109.972 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -157.27 145.95 19.66 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.343 -0.143 . . . . 0.2 111.121 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.9 t -147.35 124.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 114.075 1.139 . . . . 0.67 114.075 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -115.4 101.23 8.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.457 -0.497 . . . . 1.27 110.807 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.89 104.74 1.42 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 108.614 -0.884 . . . . 0.37 108.614 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.64 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 165.68 -63.78 0.22 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 124.718 1.261 . . . . 0.67 112.426 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.0 -131.07 5.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.859 -0.686 . . . . 1.12 112.121 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -168.83 119.8 0.75 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.118 -0.327 . . . . 2.02 110.118 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 69.7 m 42.13 83.22 0.02 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.937 -0.574 . . . . 1.22 111.068 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 26.3 t60 -116.89 143.78 45.29 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.036 -0.666 . . . . 0.34 112.543 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.59 104.32 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.477 -0.783 . . . . 1.18 110.151 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.85 157.09 38.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.346 -0.388 . . . . 1.17 110.448 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 m -43.95 -51.02 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.255 0.972 . . . . 0.6 113.44 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -58.09 -20.09 37.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.314 0.578 . . . . 0.46 110.104 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.94 35.12 3.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.138 -0.937 . . . . 0.29 111.987 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -103.34 123.17 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.98 -0.378 . . . . 0.43 109.98 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.4 t60 -100.97 132.23 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.86 1.059 . . . . 0.52 113.86 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 128.89 42.7 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.114 -1.069 . . . . 3.0 108.114 177.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -82.72 110.31 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.833 0.708 . . . . 2.9 112.12 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 tmmm? -22.96 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.83 1.252 . . . . 2.71 113.708 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 35' ' ' GLU . 29.8 t70 -20.05 88.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 114.55 -1.205 . . . . 1.98 113.551 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -101.82 -2.76 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.714 2.276 . . . . 1.53 113.765 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 72' ' ' GLY . 0.6 OUTLIER -114.07 -40.02 3.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.406 0.521 . . . . 1.83 112.406 -178.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 5.6 mm-40 -73.38 71.34 1.27 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 121.036 -0.266 . . . . 4.95 111.011 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 76.4 -0.59 63.67 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.252 -0.975 . . . . 1.94 111.346 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 41.39 34.2 0.33 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.101 0.477 . . . . 5.36 111.119 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 p -149.25 144.39 18.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.754 -0.657 . . . . 2.97 110.62 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.75 -168.85 15.49 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.665 -0.779 . . . . 1.99 112.709 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -139.08 174.7 10.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.848 0.356 . . . . 6.59 111.229 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.82 115.11 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.822 -0.626 . . . . 2.01 111.295 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.9 t -77.22 -33.58 56.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.639 -0.504 . . . . 2.02 109.639 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 36.76 54.28 1.13 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.347 -0.842 . . . . 2.23 112.043 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -81.46 98.45 8.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 2.33 110.19 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.27 53.87 23.38 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.592 -0.813 . . . . 2.2 111.958 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.446 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -69.1 2.48 2.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.342 0.115 . . . . 1.93 111.179 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 10.6 ttmt -45.17 177.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.856 0.36 . . . . 3.35 111.298 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 4.4 mm? 68.46 63.33 0.64 Allowed Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 116.396 -0.365 . . . . 2.76 110.601 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 73.6 Cg_exo -58.25 135.34 67.55 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.018 2.479 . . . . 1.46 113.085 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.439 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.1 mp -63.05 120.24 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.183 -0.673 . . . . 0.83 109.183 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -55.25 30.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.305 -0.861 . . . . 1.69 112.957 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.42 31.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.81 0.67 . . . . 2.56 112.81 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -147.07 134.95 21.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 0.97 111.707 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -69.51 159.76 82.23 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.358 -0.608 . . . . 1.96 109.358 178.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.8 Cg_exo -40.87 -39.5 3.24 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.532 2.155 . . . . 0.66 115.408 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.51 -56.9 4.07 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.56 0.695 . . . . 1.82 111.351 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 18.5 p-10 -69.48 -4.89 20.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.747 -0.781 . . . . 1.91 109.057 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.517 ' CD ' ' HB3' ' A' ' 49' ' ' PRO . 14.3 tt0 -73.97 -64.04 1.09 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.281 -0.872 . . . . 1.5 108.996 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.11 -35.57 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 1.22 109.322 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 4.5 tp -69.04 -64.98 0.77 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.788 -0.819 . . . . 1.05 108.788 176.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -69.55 22.07 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.673 -1.149 . . . . 0.9 113.177 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.446 ' NE2' ' O ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -143.94 -65.33 0.36 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.158 1.17 . . . . 1.8 114.158 -178.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.408 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 6.9 m -39.98 148.03 0.08 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.108 0.781 . . . . 1.05 113.108 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HB3' HG22 ' A' ' 167' ' ' VAL . 1.0 OUTLIER -134.47 152.11 51.58 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.803 -0.635 . . . . 2.05 111.101 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.64 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 35.9 mtp85 -105.16 -169.51 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.773 0.321 . . . . 3.58 110.794 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -86.6 -171.47 3.55 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.159 -0.473 . . . . 4.25 111.16 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.9 m120 64.53 156.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.283 -0.417 . . . . 4.35 110.937 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.49 84.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.175 0.435 . . . . 3.17 112.175 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -175.19 125.46 0.25 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.271 -0.171 . . . . 2.39 111.182 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 24.1 t 37.83 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.415 0.447 . . . . 0.99 110.963 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.52 ' HD1' ' N ' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -90.36 104.76 17.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.203 -0.453 . . . . 1.26 109.817 -178.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.524 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -120.06 108.57 1.48 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 119.703 -1.237 . . . . 0.66 115.355 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.0 154.7 18.73 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.069 0.461 . . . . 0.83 110.817 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.27 134.35 54.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.38 -0.827 . . . . 2.27 110.831 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.531 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.6 mp -127.94 86.96 56.88 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.514 -0.312 . . . . 0.34 111.394 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -55.58 128.35 30.01 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.856 1.704 . . . . 0.8 112.357 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 63.2 mt -121.98 150.93 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.898 0.38 . . . . 0.38 111.154 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -141.07 -1.42 1.38 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.034 -0.53 . . . . 2.96 111.125 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.85 169.38 12.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.783 0.325 . . . . 2.13 110.924 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.1 mp0 -120.93 -180.0 4.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.37 111.103 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.67 -148.36 17.2 Favored Glycine 0 CA--C 1.509 -0.322 0 N-CA-C 110.062 -1.215 . . . . 0.21 110.062 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.9 mm-40 -104.09 110.97 23.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 118.577 1.189 . . . . 2.03 109.488 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -95.97 126.79 41.46 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.506 -0.924 . . . . 0.26 108.506 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.647 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.8 t -112.24 113.55 44.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.449 -0.796 . . . . 0.54 111.342 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -97.79 104.49 16.52 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.684 -1.144 . . . . 1.23 111.008 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 14.3 t -111.56 142.01 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.755 -1.111 . . . . 1.31 108.77 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.684 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -149.67 144.12 25.93 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.33 -0.948 . . . . 1.37 112.105 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.581 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -101.72 121.95 43.0 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.082 -0.647 . . . . 2.97 110.108 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.34 142.2 37.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.813 -0.81 . . . . 0.3 108.813 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.46 163.29 39.32 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.474 -0.49 . . . . 0.41 110.924 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.46 175.19 10.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.924 0.392 . . . . 3.97 111.079 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.1 m -150.03 -31.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.999 -0.546 . . . . 3.81 111.363 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -102.08 150.87 22.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.839 0.352 . . . . 2.89 110.994 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 63.07 104.43 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.884 -0.598 . . . . 2.0 111.034 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.91 67.52 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.941 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.422 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 49.9 tp60 -133.2 153.38 51.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.454 . . . . 2.96 111.609 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -107.03 164.26 12.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.645 . . . . 1.55 110.908 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 68.14 -70.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.998 -0.546 . . . . 2.33 111.72 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -46.67 -32.08 3.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.692 0.282 . . . . 2.51 111.313 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 9.6 mtpm? -91.4 62.9 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 3.1 110.708 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.31 134.41 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.814 0.34 . . . . 1.31 110.206 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.451 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 78.6 m-85 -131.75 -179.28 5.3 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.565 0.58 . . . . 0.69 112.565 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 7.9 t70 -126.06 143.94 50.92 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.653 -0.419 . . . . 2.01 112.123 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.15 137.83 51.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-N 115.67 -0.695 . . . . 0.46 111.824 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.534 HH21 HG21 ' A' ' 158' ' ' VAL . 10.0 mtt180 -136.77 151.88 49.69 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 113.204 0.816 . . . . 1.85 113.204 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 106' ' ' VAL . 30.6 m -114.23 114.67 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 114.949 -1.023 . . . . 1.1 108.839 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.653 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 0.1 OUTLIER 60.1 27.18 16.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.508 -0.769 . . . . 1.77 109.384 -176.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.22 20.18 39.59 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.605 -1.18 . . . . 0.41 112.744 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.3 m-70 -119.42 109.56 15.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.925 0.713 . . . . 0.46 112.925 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.4 p -56.19 135.82 53.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.219 0.533 . . . . 0.66 111.437 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 109' ' ' HIS . 5.5 t -132.94 -29.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 115.276 -0.875 . . . . 0.8 108.913 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.16 90.07 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 116.005 -0.543 . . . . 0.51 109.662 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 113' ' ' LYS . 4.1 ptpp? -108.04 98.38 7.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.014 0.911 . . . . 2.44 110.818 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 113' ' ' LYS . 6.2 m-20 138.72 33.85 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.293 -2.231 . . . . 2.56 108.198 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.08 89.47 0.06 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 112.852 0.686 . . . . 1.1 112.852 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 12.2 t70 -106.35 86.6 2.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.429 -1.323 . . . . 1.99 107.429 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.3 mt -50.96 -42.22 23.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.275 -0.875 . . . . 0.63 112.55 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -60.2 -49.27 78.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.85 0.315 . . . . 0.9 111.85 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.66 -27.52 65.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.869 0.322 . . . . 0.76 111.869 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -64.69 -58.65 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.129 0.418 . . . . 2.68 112.129 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.83 -40.53 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.054 0.391 . . . . 1.41 112.054 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.76 -100.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 1.06 111.793 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -114.69 110.76 20.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.728 0.299 . . . . 3.51 110.6 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.5 t 60.0 -124.84 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.16 -0.473 . . . . 1.68 110.755 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.4 p 54.83 -175.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 0.8 111.664 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.439 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -104.91 138.08 41.69 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.95 0.722 . . . . 0.44 112.95 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.7 t60 -110.24 143.15 40.84 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.255 -1.017 . . . . 0.38 108.255 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.34 126.43 15.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.107 0.781 . . . . 2.09 113.107 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.8 126.75 55.41 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.743 -0.662 . . . . 2.28 109.41 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.6 mt -108.37 117.86 54.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.584 -0.735 . . . . 0.71 109.766 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.7 mt -127.14 87.78 55.76 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.186 0.81 . . . . 1.38 113.186 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -62.32 146.36 95.79 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.764 1.642 . . . . 0.22 111.73 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 134' ' ' SER . 29.8 mt -137.34 157.84 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.21 110.398 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 58.6 p -134.09 109.39 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.059 0.457 . . . . 1.11 111.513 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 139' ' ' LYS . 14.2 mt -108.12 128.16 63.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 115.679 -0.692 . . . . 0.23 109.82 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -148.59 142.81 26.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.718 0.294 . . . . 1.91 110.912 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm 60.38 15.73 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 3.11 111.334 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.87 16.04 55.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.581 -0.818 . . . . 0.32 113.204 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 135' ' ' ILE . 96.5 mttt -120.5 158.95 26.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.126 0.463 . . . . 2.19 111.057 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -112.44 138.93 48.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.09 0.472 . . . . 0.37 112.19 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.521 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -125.32 114.96 19.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.576 -0.738 . . . . 0.9 109.589 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 142' ' ' VAL . 3.4 p -111.93 99.8 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.402 0.62 . . . . 0.53 111.435 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 60.3 -86.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.537 -0.756 . . . . 2.05 112.401 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.64 16.03 5.93 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.511 -0.852 . . . . 0.6 113.088 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.57 134.27 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.785 0.326 . . . . 2.02 110.416 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.68 137.98 32.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.147 -0.478 . . . . 1.3 111.156 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 m -159.69 119.69 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 1.12 109.419 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.0 t -53.69 146.48 13.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.564 . . . . 1.11 112.042 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.429 ' H ' ' HA ' ' A' ' 139' ' ' LYS . 37.2 t80 -79.63 142.49 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.12 -0.946 . . . . 0.28 110.031 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 50.3 p -139.38 95.94 3.01 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.967 0.728 . . . . 1.55 112.967 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.56 -60.5 2.43 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 115.66 1.024 . . . . 0.46 115.66 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.531 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.97 164.78 36.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.943 0.872 . . . . 1.8 112.553 -178.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -82.16 134.85 35.33 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.119 -1.437 . . . . 1.24 107.119 177.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.653 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -121.78 103.92 9.21 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.502 1.297 . . . . 1.28 114.502 -174.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.452 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -93.53 126.32 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.96 -0.385 . . . . 0.59 109.96 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 42.0 mt-10 -137.41 127.43 25.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.112 0.412 . . . . 2.48 112.112 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -110.93 120.08 41.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.408 -0.96 . . . . 1.54 108.408 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.534 HG21 HH21 ' A' ' 105' ' ' ARG . 9.7 t -91.09 143.6 10.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.324 0.583 . . . . 0.77 111.532 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -57.31 147.96 24.19 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 114.728 -1.124 . . . . 1.97 111.501 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.21 -7.53 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.79 -0.641 . . . . 1.12 111.918 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -151.59 -70.28 0.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.573 0.225 . . . . 3.81 110.533 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -176.19 -64.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.362 -0.381 . . . . 3.82 110.566 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.75 76.59 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 1.4 110.89 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 102' ' ' PHE . 5.8 m-20 -48.35 156.0 0.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.266 -0.879 . . . . 2.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.451 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -30.71 101.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.457 2.105 . . . . 2.58 112.395 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -60.14 -45.57 92.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.623 -0.717 . . . . 3.71 112.283 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 64' ' ' GLU . 21.4 t -104.24 133.63 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 120.337 -0.545 . . . . 0.92 111.841 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.8 t -131.92 136.78 47.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 115.945 -0.571 . . . . 1.2 111.449 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -127.55 35.67 4.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.382 0.882 . . . . 0.22 113.382 -178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.12 130.92 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.205 0.316 . . . . 1.02 110.902 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 1.1 t80 -150.84 101.97 2.95 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.33 110.864 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -111.63 129.69 66.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.66 0 CA-C-O 122.815 1.293 . . . . 0.69 112.854 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.53 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -123.24 168.19 12.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.546 -1.661 . . . . 1.26 109.965 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -118.98 152.41 36.43 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.715 1.746 . . . . 1.82 115.715 -176.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 88.17 -34.68 3.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 111.82 -2.446 . . . . 0.22 118.193 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.63 158.98 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 120.209 2.004 . . . . 0.29 114.252 -179.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.647 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.75 -10.31 55.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.376 -0.829 . . . . 0.57 110.712 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.65 -43.35 84.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 2.31 111.28 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.66 -43.04 97.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.343 -0.39 . . . . 2.37 110.535 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.8 t -47.09 103.0 0.33 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.069 -0.514 . . . . 2.57 111.031 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.05 146.3 17.59 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.029 1.819 . . . . 2.08 112.527 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.6 ttt -130.89 103.76 6.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.058 -0.519 . . . . 6.04 110.721 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 183' ' ' LEU . 6.8 mp -110.52 111.08 22.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 5.3 110.627 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -61.95 145.27 93.02 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.096 -0.502 . . . . 8.05 110.614 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -43.96 128.8 7.42 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.931 1.754 . . . . 9.14 112.62 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.662 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 80.6 t60 -118.96 143.25 33.43 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.286 -0.416 . . . . 9.87 110.4 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.662 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 71.7 Cg_endo -68.95 -94.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.826 1.684 . . . . 11.69 112.034 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.67 23.91 34.72 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.004 -0.617 . . . . 12.62 112.388 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 189' ' ' LEU . 7.6 mp -100.88 140.36 35.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.728 0.299 . . . . 14.44 110.72 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.314 -0.85 . . . . 15.7 110.778 179.894 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 112.483 -0.247 . . . . 9.15 112.483 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.29 -61.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.733 0.302 . . . . 7.36 110.823 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.4 mmt 57.63 88.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 7.76 110.94 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.1 m -134.82 119.23 17.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 4.02 111.114 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.71 55.35 0.91 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.854 -0.688 . . . . 1.28 112.535 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 tp -66.49 -44.3 82.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.266 0.555 . . . . 0.41 110.531 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.623 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -58.25 -21.11 47.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.373 -0.831 . . . . 0.33 111.347 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.51 -16.29 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 2.09 111.703 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.528 ' NZ ' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -109.48 -26.15 10.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.661 -0.416 . . . . 1.99 111.657 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.3 p -42.5 145.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.69 0.256 . . . . 0.21 111.69 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.1 pt -140.14 -18.34 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 119.979 -0.689 . . . . 0.86 111.355 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -173.0 136.67 0.67 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 120.803 -0.359 . . . . 0.28 110.361 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.82 142.37 12.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.513 0.56 . . . . 0.2 112.513 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.0 t -147.64 134.5 13.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 N-CA-C 114.32 1.23 . . . . 0.67 114.32 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 26.6 t-20 -115.66 94.76 4.83 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.607 -0.437 . . . . 1.27 110.537 175.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.414 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -66.25 105.46 1.42 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.765 -0.828 . . . . 0.37 108.765 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 155.8 -40.99 0.59 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.115 -0.948 . . . . 0.67 113.33 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -135.16 7.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.581 -0.819 . . . . 1.12 113.203 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -160.95 119.52 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.537 0.208 . . . . 2.02 110.683 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 70.3 m 34.8 94.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.697 -0.683 . . . . 1.22 112.536 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.543 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 67.9 t60 -116.57 151.89 35.26 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.254 0.549 . . . . 0.34 112.237 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.27 103.22 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.17 -0.923 . . . . 1.18 109.566 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 1.17 110.227 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -43.67 -48.07 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 124.251 0.969 . . . . 0.6 113.267 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -59.26 -23.21 62.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.179 0.514 . . . . 0.46 110.506 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.3 34.41 2.72 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.423 -0.808 . . . . 0.29 112.377 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.8 mm -103.15 125.34 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.188 -0.671 . . . . 0.43 109.188 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.7 t60 -110.45 131.4 55.09 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.721 1.378 . . . . 0.52 114.721 -175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.657 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.22 134.4 40.58 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.3 -1.0 . . . . 3.0 108.3 176.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -95.25 105.4 17.34 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.377 0.608 . . . . 2.9 112.34 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 32' ' ' ASP . 31.2 ttpt -19.57 135.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.118 1.367 . . . . 2.71 114.682 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' LYS . 1.2 m-20 -2.12 85.16 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.783 -1.099 . . . . 1.98 113.329 177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -102.87 -7.37 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.854 2.369 . . . . 1.53 115.911 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.754 HD13 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -117.52 -25.78 6.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.489 0.922 . . . . 1.83 113.489 -177.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.754 ' N ' HD13 ' A' ' 34' ' ' LEU . 1.5 pm0 -84.63 65.42 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.065 0.393 . . . . 4.95 110.064 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 82.62 0.22 89.85 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.047 -1.073 . . . . 1.94 110.812 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 41.51 70.43 0.27 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.421 0.629 . . . . 5.36 111.247 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 36' ' ' GLY . 16.9 m -144.58 177.78 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.164 -0.926 . . . . 2.97 110.266 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.86 -151.54 0.04 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.77 -0.729 . . . . 1.99 113.058 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 68.62 146.71 0.05 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.194 0.521 . . . . 6.59 111.733 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.53 -20.65 1.35 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.58 -0.736 . . . . 2.01 110.199 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.1 m 49.05 66.61 1.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.171 0.51 . . . . 2.02 110.993 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -88.05 44.89 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.535 -0.757 . . . . 2.23 110.67 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -58.24 -60.61 3.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.322 -0.399 . . . . 2.33 110.469 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.96 46.82 3.7 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 2.2 111.713 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 13.8 ttt -60.36 -17.12 41.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.723 0.297 . . . . 1.93 111.108 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -71.26 -174.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 3.35 110.651 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 17.1 tp 62.3 60.25 2.5 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.265 -0.425 . . . . 2.76 111.117 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 31.6 Cg_exo -64.24 130.49 27.23 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.184 1.923 . . . . 1.46 112.068 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.1 143.13 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.912 0.387 . . . . 0.83 110.474 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 51' ' ' LEU . 2.9 mm? -94.42 -47.93 6.36 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.271 0.841 . . . . 1.69 113.271 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -73.44 34.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.232 0.827 . . . . 2.56 113.232 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -150.05 163.34 38.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.19 0.519 . . . . 0.97 112.105 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.1 t30 -78.26 148.4 74.31 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.452 -0.794 . . . . 1.96 109.372 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.595 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 17.2 Cg_exo -40.83 -57.88 1.18 Allowed 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.383 2.055 . . . . 0.66 114.424 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 13.4 mm-40 -58.77 -56.85 16.95 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.191 0.996 . . . . 1.82 111.016 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.466 ' OD1' HD23 ' A' ' 60' ' ' LEU . 25.7 t70 -69.19 -10.38 57.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.512 -0.767 . . . . 1.91 110.171 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.9 tt0 -63.17 -46.43 87.17 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.146 -1.798 . . . . 1.5 106.146 176.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.26 -50.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.411 -1.268 . . . . 1.22 109.053 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.538 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.8 tp -68.88 -9.68 52.89 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.451 -0.795 . . . . 1.05 111.52 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 5.7 m-30 -122.34 17.94 10.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.868 -0.606 . . . . 0.9 111.204 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.435 ' OE1' ' HA ' ' A' ' 49' ' ' PRO . 37.6 tt0 -140.46 -71.95 0.37 Allowed 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.714 1.005 . . . . 1.8 113.714 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 7.4 p -27.18 140.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.606 0.965 . . . . 1.05 113.606 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.548 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -130.74 149.97 52.14 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.885 -0.598 . . . . 2.05 110.916 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.605 HH12 ' HB2' ' A' ' 67' ' ' ASN . 3.7 ptm180 -136.86 138.66 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.835 0.35 . . . . 3.58 110.359 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -78.15 142.92 37.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.048 -0.524 . . . . 4.25 111.407 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.605 ' HB2' HH12 ' A' ' 65' ' ' ARG . 5.2 t30 -134.06 -89.88 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.246 -0.434 . . . . 4.35 110.941 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' N ' HD22 ' A' ' 67' ' ' ASN . 41.4 tt0 -175.14 -95.84 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.339 0.126 . . . . 3.17 111.339 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -156.27 151.44 26.49 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.483 -0.191 . . . . 2.39 110.483 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t 48.06 81.53 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.99 110.132 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.429 ' HZ ' ' C ' ' A' ' 164' ' ' ASN . 2.8 p90 -136.77 152.44 50.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 1.26 110.754 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -163.09 -155.26 8.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.037 -1.078 . . . . 0.66 114.36 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.414 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 80.3 m-85 -135.78 154.81 51.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.726 0.639 . . . . 0.83 112.726 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -118.49 106.48 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.664 -1.153 . . . . 2.27 110.223 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.35 110.68 64.63 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.909 0.337 . . . . 0.34 111.909 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.01 133.81 10.23 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.502 1.468 . . . . 0.8 111.816 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 61.2 mt -120.75 148.83 23.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.43 . . . . 0.38 111.496 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -139.75 -3.52 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.803 -0.635 . . . . 2.96 110.84 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' C ' ' HH ' ' A' ' 83' ' ' TYR . 23.9 mm-40 -121.77 173.93 7.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.582 0.23 . . . . 2.13 110.583 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.77 177.31 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.37 111.545 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.18 -161.17 23.1 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.144 -1.582 . . . . 0.21 109.144 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 0.1 OUTLIER -95.0 110.68 22.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 118.743 1.272 . . . . 2.03 109.913 179.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' HH ' ' C ' ' A' ' 79' ' ' GLU . 2.0 m-85 -95.27 125.79 40.15 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.26 109.577 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.614 HG21 ' N ' ' A' ' 177' ' ' ALA . 10.2 t -113.07 116.87 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.477 -1.238 . . . . 0.54 111.939 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.89 104.57 16.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.668 -1.151 . . . . 1.23 110.778 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 58.8 t -103.22 119.39 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.124 -0.944 . . . . 1.31 108.897 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.9 134.22 42.41 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.282 -0.567 . . . . 1.37 111.186 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.428 ' CB ' ' HB3' ' A' ' 169' ' ' ALA . 19.4 tptt -104.52 120.74 41.96 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.755 -0.778 . . . . 2.97 109.732 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 8.1 m-85 -104.77 139.23 39.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.922 -1.14 . . . . 0.3 107.922 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 91' ' ' GLU . . . -147.44 171.72 15.06 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.98 -0.688 . . . . 0.41 112.534 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 10.0 tp10 81.12 138.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.832 -1.076 . . . . 3.97 111.869 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.72 90.46 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.168 -0.924 . . . . 3.81 110.376 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -52.48 -60.79 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 2.89 111.706 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -102.81 142.83 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.392 -0.367 . . . . 2.0 110.812 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.98 81.29 8.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.515 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -156.06 159.3 38.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 2.96 110.907 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.6 p -97.27 -76.45 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.974 -0.557 . . . . 1.55 111.781 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -78.13 64.11 3.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.04 0.447 . . . . 2.33 111.57 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -145.66 -48.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.181 -0.674 . . . . 2.51 109.181 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -105.49 78.66 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.429 -0.805 . . . . 3.1 109.33 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.0 113.51 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.332 -0.849 . . . . 1.31 110.196 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -102.47 175.82 5.38 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.038 0.755 . . . . 0.69 113.038 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 5.4 m-20 -122.1 140.12 52.91 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.694 -0.685 . . . . 2.01 111.09 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.12 123.76 44.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 CA-C-N 115.996 -0.547 . . . . 0.46 111.768 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 12.3 mtt180 -117.66 150.47 38.99 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 115.008 -0.996 . . . . 1.85 112.401 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.519 HG13 HD21 ' A' ' 153' ' ' LEU . 84.4 t -126.2 109.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 114.652 -1.158 . . . . 1.1 109.392 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.451 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 57.02 25.99 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.432 -0.951 . . . . 1.77 108.432 -176.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 13.55 53.77 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.097 -0.956 . . . . 0.41 112.674 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 92.1 m-70 -112.25 111.14 21.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.81 . . . . 0.46 113.188 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 p -68.94 112.16 5.42 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 120.395 -0.522 . . . . 0.66 110.584 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.88 -28.71 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.594 -0.73 . . . . 0.8 109.849 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.437 HG21 ' OE1' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -135.02 90.2 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 120.281 -0.568 . . . . 0.51 109.582 177.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.4 ptpp? -110.71 85.08 2.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.935 0.874 . . . . 2.44 111.491 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 4.6 p-10 151.47 36.66 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 112.982 -1.917 . . . . 2.56 108.325 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.481 HD21 ' OE2' ' A' ' 129' ' ' GLU . 0.7 OUTLIER -62.62 90.15 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 113.327 0.862 . . . . 1.1 113.327 -177.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.77 83.91 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.351 -1.352 . . . . 1.99 107.351 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -50.44 -30.58 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.084 -0.507 . . . . 0.63 111.793 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -68.38 -43.76 76.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 0.9 111.237 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -69.54 -27.56 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.76 111.867 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' NE2' ' A' ' 127' ' ' HIS . 29.7 mmt180 -71.88 -58.45 3.45 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.384 0.513 . . . . 2.68 112.384 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.94 -40.66 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.217 0.451 . . . . 1.41 112.217 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.53 -92.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.732 -0.747 . . . . 1.06 111.784 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.512 ' O ' HG23 ' A' ' 125' ' ' THR . 45.4 t-80 -114.55 110.02 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 3.51 111.056 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.1 t 51.45 -128.23 2.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.083 -0.508 . . . . 1.68 111.69 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 123' ' ' HIS . 26.7 p 58.08 -165.14 0.17 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.592 0.357 . . . . 0.8 111.193 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.53 139.18 43.66 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.255 0.835 . . . . 0.44 113.255 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 2.0 t60 -109.07 148.24 31.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.99 -0.744 . . . . 0.38 108.99 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 4.8 p-10 -143.81 127.12 16.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.674 0.62 . . . . 2.09 112.674 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.481 ' OE2' HD21 ' A' ' 115' ' ' LEU . 24.4 mt-10 -120.65 115.67 23.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 2.28 109.465 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.507 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.1 mt -105.58 126.85 60.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.516 -0.766 . . . . 0.71 110.261 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 130' ' ' ILE . 28.3 mm -126.12 86.45 57.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 112.218 0.451 . . . . 1.38 112.218 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -62.48 139.95 79.25 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.875 1.717 . . . . 0.22 111.426 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 18.8 mt -132.86 155.07 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.21 111.042 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 23.8 p -126.21 107.9 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.942 0.401 . . . . 1.11 110.859 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 139' ' ' LYS . 25.6 mt -111.37 122.75 66.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.801 -0.636 . . . . 0.23 109.881 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -147.38 143.16 27.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.37 -0.377 . . . . 1.91 110.817 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt 62.92 7.81 2.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.098 -0.501 . . . . 3.11 110.856 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.2 21.24 25.57 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.83 -0.7 . . . . 0.32 112.933 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 135' ' ' ILE . 8.2 mtpm? -121.03 156.09 32.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.896 0.348 . . . . 2.19 110.859 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.538 HD23 ' N ' ' A' ' 141' ' ' SER . 5.8 tt -114.31 131.95 56.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.112 0.482 . . . . 0.37 112.121 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.538 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.1 t -122.92 109.65 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 0.9 109.642 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -102.35 108.06 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.198 0.523 . . . . 0.53 111.148 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 53.77 -91.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.765 -0.652 . . . . 2.05 112.034 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.33 38.79 2.21 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.6 113.516 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -146.61 137.11 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.332 . . . . 2.02 110.297 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.3 135.7 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 1.3 110.875 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -163.19 121.04 1.94 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.154 -0.684 . . . . 1.12 109.154 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.05 150.11 3.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.981 0.42 . . . . 1.11 111.328 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 t80 -77.55 122.85 25.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.28 110.764 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -75.81 -170.8 1.42 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 107.955 -1.128 . . . . 1.55 107.955 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.56 -11.92 66.07 Favored Glycine 0 C--N 1.317 -0.503 0 C-N-CA 119.015 -1.564 . . . . 0.46 112.93 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.82 151.8 18.72 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.168 0.484 . . . . 1.8 112.105 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.726 HD23 ' N ' ' A' ' 154' ' ' SER . 3.5 tt -84.93 148.51 26.19 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.936 -1.135 . . . . 1.24 107.936 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.726 ' N ' HD23 ' A' ' 153' ' ' LEU . 3.7 t -139.15 115.86 10.73 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 118.256 -1.378 . . . . 1.28 113.634 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 7.9 t -98.47 97.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.942 -0.762 . . . . 0.59 108.942 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 34.7 mt-10 -108.82 132.35 54.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.718 -0.674 . . . . 2.48 111.727 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.95 129.83 51.6 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.481 0.658 . . . . 1.54 109.929 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.535 HG21 HH21 ' A' ' 105' ' ' ARG . 30.8 t -103.0 143.88 14.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.495 -1.23 . . . . 0.77 111.678 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -50.88 148.14 4.41 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 114.988 -1.005 . . . . 1.97 111.445 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -118.99 -10.66 8.08 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.437 -0.665 . . . . 1.12 111.437 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -163.64 -59.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.555 -0.322 . . . . 3.81 110.344 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -176.84 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.061 -0.518 . . . . 3.82 110.879 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -90.92 46.12 1.3 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.026 0.441 . . . . 1.4 111.782 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.713 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 54.9 t30 -55.2 -42.07 93.98 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 115.46 -0.791 . . . . 2.0 109.048 176.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.713 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 36.9 Cg_endo -62.9 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.786 2.324 . . . . 2.58 111.843 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 11.0 pttp -97.8 166.01 11.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.063 -0.717 . . . . 3.71 109.063 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.83 132.95 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 C-N-CA 119.533 -0.867 . . . . 0.92 110.308 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -130.24 131.6 45.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.671 0.607 . . . . 1.2 111.586 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 88' ' ' LYS . . . -123.95 37.05 4.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.22 112.126 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -33.26 134.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.693 -0.685 . . . . 1.02 110.404 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -159.56 95.81 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.533 -0.303 . . . . 0.33 110.813 -179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -106.25 130.16 58.37 Favored 'Isoleucine or valine' 0 C--O 1.258 1.526 0 CA-C-O 122.96 1.362 . . . . 0.69 112.719 178.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.6 ppp? -123.64 157.26 34.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.028 -1.896 . . . . 1.26 108.135 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.9 150.04 39.12 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 115.138 1.532 . . . . 1.82 115.138 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.21 -33.91 6.2 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 112.448 -2.16 . . . . 0.22 116.846 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.474 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.46 156.79 0.44 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.841 1.82 . . . . 0.29 114.601 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.614 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.68 -23.37 25.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.161 -0.927 . . . . 0.57 110.569 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.17 -37.71 86.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.864 -0.607 . . . . 2.31 111.508 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.41 -40.66 71.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.438 -0.346 . . . . 2.37 110.736 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 86.0 t -43.42 101.68 0.26 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.198 -0.455 . . . . 2.57 111.189 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.61 144.68 24.8 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 121.904 1.736 . . . . 2.08 112.411 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.5 mmt -136.8 93.75 2.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 6.04 110.831 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 56.4 mt -136.81 116.09 12.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 5.3 110.755 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -56.96 151.54 33.07 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.097 -0.502 . . . . 8.05 110.314 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -64.89 124.6 13.35 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.593 1.529 . . . . 9.14 112.069 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -132.55 128.73 21.13 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.07 -0.514 . . . . 9.87 110.492 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -83.39 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.197 1.932 . . . . 11.69 111.409 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 176.98 158.25 19.87 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.272 -0.966 . . . . 12.62 112.688 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.3 mm? -92.35 148.69 21.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 14.44 110.669 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.179 -0.915 . . . . 15.7 110.785 179.83 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.496 -0.242 . . . . 9.15 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.2 14.11 12.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.824 0.345 . . . . 7.36 110.777 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtt -61.79 -59.49 5.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 7.76 110.857 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.2 m 56.21 87.86 0.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.262 -0.427 . . . . 4.02 111.066 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.21 49.63 0.72 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.795 -0.716 . . . . 1.28 112.588 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.8 tp -68.66 -48.5 63.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.517 . . . . 0.41 110.259 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.596 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.71 -21.24 6.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.405 -0.816 . . . . 0.33 111.314 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -79.29 -21.77 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.283 -0.417 . . . . 2.09 112.121 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 34.9 mmtt -98.43 -26.52 14.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.937 -0.305 . . . . 1.99 111.475 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 7' ' ' ALA . 8.9 p -44.47 146.82 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 111.961 0.356 . . . . 0.21 111.961 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.2 pt -139.48 -21.73 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 C-N-CA 119.891 -0.724 . . . . 0.86 111.103 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.576 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.9 t90 -173.7 133.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.55 -0.46 . . . . 0.28 110.14 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -150.6 144.26 25.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.809 0.3 . . . . 0.2 111.809 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.2 t -147.63 126.66 4.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.495 1.295 . . . . 0.67 114.495 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 11.5 t30 -114.6 100.86 8.59 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.533 -0.467 . . . . 1.27 110.31 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.51 103.47 2.98 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 109.021 -0.733 . . . . 0.37 109.021 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.581 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 167.9 -45.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.916 0 O-C-N 124.277 0.986 . . . . 0.67 113.563 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.77 -123.6 3.48 Favored Glycine 0 C--O 1.231 -0.063 0 C-N-CA 120.586 -0.816 . . . . 1.12 113.124 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.723 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 6.4 tt0 -164.1 120.3 1.62 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.871 0.367 . . . . 2.02 111.489 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 66.4 m 35.53 99.96 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.16 -0.927 . . . . 1.22 113.231 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.665 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 56.3 t60 -130.65 140.16 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.729 -0.788 . . . . 0.34 112.462 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 p -114.64 103.91 16.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.637 0.732 . . . . 1.18 110.787 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 156.3 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.036 -0.984 . . . . 1.17 110.056 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 25' ' ' HIS . 30.9 m -44.01 -49.97 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 124.175 0.922 . . . . 0.6 113.136 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.464 ' N ' HG23 ' A' ' 24' ' ' VAL . 83.5 m-70 -59.53 -18.17 38.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.294 0.569 . . . . 0.46 110.567 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.72 35.2 3.84 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.34 -0.845 . . . . 0.29 112.444 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.428 HG13 ' CZ ' ' A' ' 171' ' ' PHE . 31.1 mm -103.88 111.95 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.026 0.441 . . . . 0.43 110.578 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.665 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 10.9 t60 -98.27 135.55 39.73 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.891 1.441 . . . . 0.52 114.891 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.723 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -100.47 135.46 41.87 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.864 -1.062 . . . . 3.0 108.619 177.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -88.04 111.42 21.51 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 124.001 0.813 . . . . 2.9 112.252 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HB3' ' NZ ' ' A' ' 31' ' ' LYS . 5.3 ttpm? -23.44 135.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.349 1.06 . . . . 2.71 113.723 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.65 ' HB3' HH11 ' A' ' 65' ' ' ARG . 2.5 m-20 -10.15 83.84 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 CA-C-N 114.2 -1.364 . . . . 1.98 113.708 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -103.71 15.01 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.166 2.577 . . . . 1.53 113.582 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -130.15 -38.21 1.42 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.041 0.386 . . . . 1.83 112.041 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.661 ' N ' HD23 ' A' ' 34' ' ' LEU . 8.2 tp10 -87.39 92.37 9.06 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.675 -0.491 . . . . 4.95 109.675 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.53 -1.42 51.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.494 -0.86 . . . . 1.94 111.104 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER 41.68 49.45 3.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.208 0.528 . . . . 5.36 110.992 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 m -144.29 176.08 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.629 -0.714 . . . . 2.97 110.229 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.67 118.79 5.55 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.571 -0.823 . . . . 1.99 113.188 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 98.0 mtt180 -149.11 -50.23 0.15 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.515 0.198 . . . . 6.59 110.844 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 40' ' ' ARG . . . 72.08 -67.4 0.26 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.895 -0.593 . . . . 2.01 111.545 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.3 t 62.32 56.82 2.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.95 0.405 . . . . 2.02 110.744 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -78.93 74.39 5.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.004 -0.543 . . . . 2.23 110.534 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -66.01 85.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.02 -0.536 . . . . 2.33 110.841 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.2 114.36 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.723 -0.751 . . . . 2.2 112.813 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 30.9 mtt -82.54 -0.31 46.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.316 0.579 . . . . 1.93 109.478 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -56.28 176.7 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.004 -0.998 . . . . 3.35 111.158 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.57 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 3.8 mm? 54.1 56.32 12.62 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.334 -0.393 . . . . 2.76 110.067 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 38.9 Cg_exo -66.31 134.49 36.4 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.806 2.337 . . . . 1.46 112.868 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.2 mp -60.24 128.15 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.347 -0.612 . . . . 0.83 109.347 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mt -69.87 -49.19 54.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.911 1.449 . . . . 1.69 114.911 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -73.87 25.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.85 0.685 . . . . 2.56 112.85 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -146.19 144.57 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.97 111.487 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 58' ' ' GLN . 1.8 p-10 -66.44 153.53 92.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.065 -0.516 . . . . 1.96 109.787 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.423 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.57 -59.14 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.47 2.113 . . . . 0.66 114.626 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -58.35 -55.43 35.13 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 121.901 0.858 . . . . 1.82 111.246 -178.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 11.2 t70 -69.38 -11.98 61.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.325 -0.55 . . . . 1.91 110.439 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.713 HE22 ' NE2' ' A' ' 62' ' ' GLN . 0.9 OUTLIER -68.38 -39.83 81.59 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 106.523 -1.658 . . . . 1.5 106.523 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.411 ' N ' ' HG3' ' A' ' 58' ' ' GLN . 62.4 t -54.37 -50.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.138 -1.06 . . . . 1.22 108.138 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.8 tp -69.81 -13.76 62.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.907 -1.042 . . . . 1.05 111.1 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.541 ' C ' ' HZ2' ' A' ' 88' ' ' LYS . 2.6 m-85 -121.89 27.71 7.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.182 -0.917 . . . . 0.9 111.679 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.713 ' NE2' HE22 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -151.46 -63.36 0.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.261 0.837 . . . . 1.8 113.261 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 13.7 p -34.13 147.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.815 0.672 . . . . 1.05 112.815 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.577 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pp20? -137.52 148.05 45.68 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.691 0.626 . . . . 2.05 112.691 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.65 HH11 ' HB3' ' A' ' 32' ' ' ASP . 19.3 mtp180 -114.27 -174.95 2.57 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.98 -0.554 . . . . 3.58 109.858 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -66.32 172.0 4.33 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.531 -0.304 . . . . 4.25 110.455 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -143.57 162.22 36.44 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.021 0.438 . . . . 4.35 111.653 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -144.79 -118.16 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.876 -0.602 . . . . 3.17 110.685 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.459 ' OD1' ' HD3' ' A' ' 159' ' ' LYS . 63.6 m-20 -156.62 134.4 10.97 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 122.44 -0.162 . . . . 2.39 111.093 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 53.84 83.53 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.92 0.391 . . . . 0.99 110.764 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -162.59 159.6 24.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 1.26 110.826 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.691 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -168.93 -168.15 30.56 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.437 -0.887 . . . . 0.66 113.418 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.437 ' CE2' HD13 ' A' ' 34' ' ' LEU . 3.8 m-85 -108.36 165.12 11.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.294 0.569 . . . . 0.83 111.763 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.03 140.53 49.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.91 -1.041 . . . . 2.27 110.825 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.27 109.87 10.56 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.142 -0.481 . . . . 0.34 111.171 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.87 133.17 7.83 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.129 1.219 . . . . 0.8 112.045 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 78' ' ' LYS . 23.4 mt -121.32 155.2 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.985 0.421 . . . . 0.38 111.577 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' N ' HG22 ' A' ' 77' ' ' ILE . 99.5 mttt -143.19 -0.87 1.09 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.825 -0.625 . . . . 2.96 110.995 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -127.46 169.03 14.08 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.826 0.345 . . . . 2.13 111.562 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -117.48 -177.61 3.27 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.37 111.047 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 126.78 -151.04 18.05 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.997 -1.241 . . . . 0.21 109.997 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 21.2 mt-10 -105.15 108.72 20.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.644 1.222 . . . . 2.03 109.71 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -95.34 129.68 42.39 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 119.719 -0.792 . . . . 0.26 109.156 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG21 ' N ' ' A' ' 177' ' ' ALA . 22.0 t -116.92 117.11 54.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.686 -1.143 . . . . 0.54 111.806 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.94 105.7 17.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.726 -0.67 . . . . 1.23 110.126 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 38.1 t -101.4 119.12 49.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 107.945 -1.131 . . . . 1.31 107.945 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 135.92 23.83 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.671 -0.812 . . . . 1.37 112.437 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.711 ' NZ ' ' HB2' ' A' ' 90' ' ' ALA . 5.9 tmtt? -103.15 132.1 49.67 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 119.65 -0.82 . . . . 2.97 109.952 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -111.44 149.32 31.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.609 -0.723 . . . . 0.3 109.547 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.711 ' HB2' ' NZ ' ' A' ' 88' ' ' LYS . . . -145.56 157.4 43.99 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.073 0.464 . . . . 0.41 111.323 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -144.97 131.31 19.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.621 -0.718 . . . . 3.97 110.129 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.48 -65.2 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.434 . . . . 3.81 111.653 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -92.61 -164.25 1.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 2.89 110.987 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 63.0 64.71 0.84 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.929 -0.578 . . . . 2.0 110.723 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.52 79.51 8.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -157.13 140.51 15.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 2.96 111.153 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -103.8 157.15 17.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.951 -0.568 . . . . 1.55 111.235 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 45.25 49.46 10.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.8 -0.636 . . . . 2.33 111.647 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -153.47 -46.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.899 -0.778 . . . . 2.51 108.899 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -96.89 82.04 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.271 -1.011 . . . . 3.1 108.271 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.437 ' O ' ' HA3' ' A' ' 160' ' ' GLY . 0.7 OUTLIER -108.87 134.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 1.31 111.227 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.403 ' CD1' ' HD3' ' A' ' 165' ' ' PRO . 69.9 m-85 -117.89 175.59 5.59 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.576 0.584 . . . . 0.69 112.576 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.87 140.06 53.35 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 115.928 -0.578 . . . . 2.01 111.459 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.06 131.65 41.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.075 -0.512 . . . . 0.46 111.854 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.4 154.8 49.44 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.265 0.839 . . . . 1.85 113.265 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 p -121.51 125.24 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.193 -1.367 . . . . 1.1 110.474 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.14 26.1 3.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.663 -0.866 . . . . 1.77 108.663 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.8 27.45 21.7 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.729 -1.123 . . . . 0.41 112.976 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 87.1 m-70 -127.35 110.5 12.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.164 0.801 . . . . 0.46 113.164 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.0 p -67.24 115.56 7.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.245 0.545 . . . . 0.66 111.723 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.58 -34.71 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.215 -0.902 . . . . 0.8 109.369 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.07 89.62 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.995 -0.548 . . . . 0.51 109.548 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.0 ptpp? -110.08 83.39 1.75 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.096 0.951 . . . . 2.44 110.759 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 156.82 33.58 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 112.824 -1.989 . . . . 2.56 108.557 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 85.92 0.08 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.595 0.591 . . . . 1.1 112.595 -177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 0.6 OUTLIER -98.47 80.42 2.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.714 -1.587 . . . . 1.99 106.714 175.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.7 mt -49.88 -38.48 14.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.516 -0.765 . . . . 0.63 112.291 -176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -63.28 -46.69 85.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.462 0.171 . . . . 0.9 111.462 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.413 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 37.1 t70 -70.33 -27.97 64.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.76 111.514 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 120' ' ' ARG . 4.7 mmp_? -61.33 -58.09 9.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.865 0.321 . . . . 2.68 111.865 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.13 -40.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.033 0.383 . . . . 1.41 112.033 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.93 -87.45 0.44 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.912 -0.661 . . . . 1.06 112.487 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.582 ' O ' HG23 ' A' ' 125' ' ' THR . 48.6 m80 -112.87 110.46 20.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.641 0.257 . . . . 3.51 111.081 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.9 p 46.79 -116.85 0.72 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.019 -0.537 . . . . 1.68 111.769 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 123' ' ' HIS . 41.8 p 50.91 -166.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.209 0.203 . . . . 0.8 110.7 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.485 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.27 139.09 49.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.087 0.773 . . . . 0.44 113.087 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.409 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 1.8 t60 -105.35 145.08 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.856 -1.164 . . . . 0.38 107.856 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -143.75 126.94 16.58 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.056 -0.658 . . . . 2.09 112.761 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -117.11 127.84 54.54 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.247 -0.888 . . . . 2.28 110.096 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.1 mt -116.43 121.79 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.431 -0.804 . . . . 0.71 109.817 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.76 90.09 51.47 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.723 0.638 . . . . 1.38 112.723 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.76 149.74 90.34 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.04 1.827 . . . . 0.22 112.053 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 16.9 mt -144.16 156.89 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.452 -0.34 . . . . 0.21 111.537 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 133' ' ' ILE . 32.7 t -133.07 110.23 10.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.026 0.441 . . . . 1.11 111.077 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 139' ' ' LYS . 21.8 mt -106.62 137.25 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.799 -0.637 . . . . 0.23 110.337 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -145.35 130.36 18.34 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.997 -0.281 . . . . 1.91 111.102 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 54.99 19.03 2.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.1 -0.5 . . . . 3.11 110.8 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.5 16.14 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.688 -0.768 . . . . 0.32 112.782 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -111.5 156.54 21.54 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 110.084 -0.339 . . . . 2.19 110.084 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 141' ' ' SER . 5.1 tt -124.6 126.01 45.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.284 0.564 . . . . 0.37 112.496 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.515 ' N ' HD23 ' A' ' 140' ' ' LEU . 9.5 t -115.81 109.23 17.36 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.302 -0.863 . . . . 0.9 109.084 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 p -102.95 99.57 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.513 -0.767 . . . . 0.53 110.507 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.43 -84.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 2.05 111.626 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -132.33 29.58 3.29 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.44 -0.886 . . . . 0.6 113.277 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.28 135.78 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.297 . . . . 2.02 110.526 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.83 135.46 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 1.3 110.344 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 m -164.46 129.22 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 1.12 109.837 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -53.16 145.03 14.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.181 0.515 . . . . 1.11 112.238 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -78.72 121.67 25.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.516 -0.765 . . . . 0.28 110.031 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.4 p -76.14 173.85 10.81 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.51 -0.922 . . . . 1.55 108.51 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.81 -8.8 1.48 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.948 -1.12 . . . . 0.46 114.236 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -160.61 152.09 19.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.894 0.847 . . . . 1.8 112.703 -179.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -80.9 129.63 34.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.794 -1.187 . . . . 1.24 107.794 177.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.496 ' HB3' ' OE1' ' A' ' 156' ' ' GLU . 0.1 OUTLIER -121.88 120.71 35.3 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.96 1.096 . . . . 1.28 113.96 -176.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.436 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 96.6 t -106.11 101.13 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.741 -0.466 . . . . 0.59 109.741 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.496 ' OE1' ' HB3' ' A' ' 154' ' ' SER . 17.6 mp0 -116.64 150.5 38.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.369 0.604 . . . . 2.48 112.069 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.6 140.11 44.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.178 -0.919 . . . . 1.54 110.148 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.67 144.06 24.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.058 -0.973 . . . . 0.77 111.168 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.459 ' HD3' ' OD1' ' A' ' 69' ' ' ASP . 19.2 pttm -63.63 139.43 58.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.384 -0.825 . . . . 1.97 111.055 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -108.33 -4.79 32.75 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.116 -0.794 . . . . 1.12 111.116 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -169.92 -54.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.327 -0.436 . . . . 3.81 110.229 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -178.29 149.03 0.51 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.09 -0.505 . . . . 3.82 110.64 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 55.84 87.5 0.05 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.855 0.36 . . . . 1.4 111.681 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -53.41 166.37 0.56 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.848 -0.615 . . . . 2.0 109.886 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.403 ' HD3' ' CD1' ' A' ' 102' ' ' PHE . 7.0 Cg_exo -35.78 104.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.015 1.81 . . . . 2.58 111.731 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -58.21 -54.11 50.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 3.71 113.133 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 64' ' ' GLU . 6.8 t -103.55 134.72 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.961 0.726 . . . . 0.92 112.961 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.42 138.85 49.26 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 115.964 -0.562 . . . . 1.2 112.149 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -129.75 35.94 4.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.183 -0.917 . . . . 0.22 112.915 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -36.96 136.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.232 0.539 . . . . 1.02 112.404 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.528 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -156.62 96.11 1.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.305 -0.861 . . . . 0.33 109.33 178.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -99.93 127.67 52.6 Favored 'Isoleucine or valine' 0 C--O 1.266 1.942 0 CA-C-O 122.663 1.221 . . . . 0.69 112.35 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.42 161.35 21.36 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.683 -1.599 . . . . 1.26 109.546 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 16.1 tttm -120.38 139.05 53.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.7 1.37 . . . . 1.82 114.7 -176.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.03 -35.05 5.3 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 118.123 2.009 . . . . 0.22 118.123 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.55 158.06 0.5 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.436 2.118 . . . . 0.29 114.105 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.618 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.34 -24.69 27.52 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.94 -1.027 . . . . 0.57 109.858 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.03 -30.63 69.3 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.538 -0.756 . . . . 2.31 111.132 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -53.7 -47.68 70.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.402 -0.363 . . . . 2.37 110.217 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 35.3 t -39.68 100.48 0.22 Allowed Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.864 -0.607 . . . . 2.57 111.587 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -51.26 139.38 44.37 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.002 1.802 . . . . 2.08 112.397 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 86.3 mtp -133.09 141.57 48.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 6.04 110.859 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.75 118.1 17.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 5.3 110.772 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -53.6 144.91 31.59 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.688 -0.486 . . . . 8.05 109.688 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.22 124.12 12.52 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.398 1.399 . . . . 9.14 112.407 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -135.01 135.14 22.45 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 9.87 110.41 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.58 -36.34 5.13 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.137 1.891 . . . . 11.69 112.6 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.26 -163.15 37.71 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.968 -0.634 . . . . 12.62 112.632 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.29 152.57 24.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 14.44 110.812 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.407 -0.806 . . . . 15.7 110.975 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.535 -0.226 . . . . 9.15 112.535 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.02 -57.78 2.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.357 . . . . 7.36 111.003 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 tpt -97.27 96.8 8.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 7.76 110.699 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -134.71 101.1 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 4.02 110.775 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.75 51.91 0.22 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 1.28 112.445 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.1 tp -72.48 -50.06 28.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.354 0.597 . . . . 0.41 110.052 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.543 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.02 -19.65 7.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.076 -0.966 . . . . 0.33 111.652 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.75 -28.65 40.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.498 0.555 . . . . 2.09 112.498 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 44.0 mttp -98.89 -18.08 18.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.325 -0.55 . . . . 1.99 112.065 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 7' ' ' ALA . 14.2 p -42.63 144.08 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 121.28 -0.168 . . . . 0.21 111.131 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' TRP . 4.1 pt -139.55 -21.7 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 C-N-CA 119.639 -0.824 . . . . 0.86 111.582 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.599 ' O ' HG22 ' A' ' 172' ' ' ILE . 50.5 t90 -175.99 130.79 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.478 -0.489 . . . . 0.28 110.675 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -148.39 146.58 28.54 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.273 0.471 . . . . 0.2 112.273 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.3 t -147.5 126.77 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 114.229 1.196 . . . . 0.67 114.229 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.601 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 18.4 t-20 -117.39 106.36 13.13 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.654 -0.703 . . . . 1.27 110.133 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 113.54 15.14 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 120.68 -0.408 . . . . 0.37 110.811 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.458 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 142.74 -29.74 2.1 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 114.649 -1.16 . . . . 0.67 112.594 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -109.81 -144.75 10.51 Favored Glycine 0 CA--C 1.516 0.135 0 C-N-CA 121.138 -0.553 . . . . 1.12 112.021 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 36.2 mt-10 -156.83 119.45 4.0 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.666 -0.124 . . . . 2.02 110.666 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.3 m 27.7 94.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.803 0.69 . . . . 1.22 112.152 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 19.9 t60 -126.26 150.89 48.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 119.922 -0.711 . . . . 0.34 112.416 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.56 105.32 18.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.133 -0.939 . . . . 1.18 111.019 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 153.77 42.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.981 -0.377 . . . . 1.17 109.981 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 25' ' ' HIS . 16.1 m -44.44 -49.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.501 0.926 . . . . 0.6 113.501 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.419 ' N ' HG23 ' A' ' 24' ' ' VAL . 86.2 m-70 -58.44 -17.84 23.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.282 0.563 . . . . 0.46 110.463 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.62 33.71 4.67 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.305 -0.861 . . . . 0.29 112.149 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm -103.23 120.72 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.904 -0.406 . . . . 0.43 109.904 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.511 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 12.8 t60 -102.97 132.91 48.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.191 1.182 . . . . 0.52 114.191 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.667 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -100.5 134.19 43.82 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.935 -1.135 . . . . 3.0 107.935 176.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -94.62 112.52 24.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.444 0.64 . . . . 2.9 112.376 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -10.49 138.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.54 1.681 . . . . 2.71 115.54 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.445 ' HB3' ' NE ' ' A' ' 65' ' ' ARG . 12.5 m-20 -22.54 89.67 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 113.722 -1.581 . . . . 1.98 114.219 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.39 -123.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.731 2.287 . . . . 1.53 113.309 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.787 HD13 ' O ' ' A' ' 72' ' ' GLY . 1.2 pt? -39.64 -32.97 0.15 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.026 0.75 . . . . 1.83 113.026 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.491 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 9.7 mm-40 -62.61 85.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.922 0.392 . . . . 4.95 110.257 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.68 -26.98 1.09 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.974 -0.631 . . . . 1.94 112.497 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 35' ' ' GLU . 6.3 mtp180 48.92 33.25 4.35 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.024 0.44 . . . . 5.36 111.158 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.91 176.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.826 -0.625 . . . . 2.97 110.67 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.56 102.26 0.79 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.805 -0.712 . . . . 1.99 112.768 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.467 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 16.2 tpp180 -161.22 115.18 2.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.976 0.417 . . . . 6.59 110.714 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.2 82.38 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 2.01 110.434 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.9 m -64.06 81.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 2.02 110.2 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -86.76 26.1 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.718 -0.673 . . . . 2.23 110.776 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -65.14 -48.66 72.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 2.33 110.75 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.09 31.52 5.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 2.2 112.411 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.5 ttt -67.02 -17.46 64.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.926 0.393 . . . . 1.93 110.663 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -64.29 -179.48 0.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 3.35 110.278 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD23 ' OG ' ' A' ' 124' ' ' SER . 11.0 mp 59.21 61.72 4.36 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.663 -0.244 . . . . 2.76 110.571 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.516 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 86.2 Cg_exo -54.74 124.26 15.76 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.275 1.983 . . . . 1.46 111.975 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' A' ' 126' ' ' ALA . 4.4 mt -59.94 121.22 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.264 -0.643 . . . . 0.83 109.264 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.68 -42.77 86.02 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.232 1.197 . . . . 1.69 114.232 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -80.25 25.14 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.705 -0.398 . . . . 2.56 111.984 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.472 ' OG ' HG22 ' A' ' 50' ' ' ILE . 94.0 p -139.77 130.47 25.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.702 0.287 . . . . 0.97 111.347 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 3.0 p-10 -59.73 152.73 56.43 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.857 -0.794 . . . . 1.96 108.857 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.48 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 7.6 Cg_exo -39.93 -39.52 2.3 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.341 2.027 . . . . 0.66 115.251 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.5 mm-40 -75.43 -56.07 5.07 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.755 0.788 . . . . 1.82 111.171 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.4 OUTLIER -70.79 -6.57 38.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.034 -0.666 . . . . 1.91 109.256 -179.453 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.516 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 24.6 tt0 -70.54 -64.88 0.81 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.255 -0.884 . . . . 1.5 108.661 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 63' ' ' THR . 2.6 p -48.41 -37.94 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.901 -0.591 . . . . 1.22 109.79 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.601 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 4.9 tp -68.07 -68.19 0.41 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.84 -0.744 . . . . 1.05 110.071 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -56.36 1.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.184 0.593 . . . . 0.9 111.932 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 60' ' ' LEU . 1.8 tt0 -122.8 -126.02 0.26 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.115 -0.493 . . . . 1.8 111.734 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 59' ' ' VAL . 47.6 p 49.08 -166.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.598 -0.273 . . . . 1.05 110.725 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 13.2 pt-20 -179.3 140.74 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.628 0.252 . . . . 2.05 111.1 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.491 ' NH1' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -123.13 177.15 5.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.012 0.434 . . . . 3.58 111.601 179.091 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -57.63 169.8 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.718 -0.674 . . . . 4.25 111.412 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -142.13 169.32 17.81 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.256 -0.429 . . . . 4.35 111.077 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -154.57 -107.52 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.663 -0.244 . . . . 3.17 111.446 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.68 125.71 1.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 122.429 -0.169 . . . . 2.39 110.742 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 t 50.9 84.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.047 -0.353 . . . . 0.99 110.047 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -159.09 164.72 35.09 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.593 -0.443 . . . . 1.26 111.223 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.787 ' O ' HD13 ' A' ' 34' ' ' LEU . . . 177.6 -167.8 39.0 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 119.066 -1.54 . . . . 0.66 116.406 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.99 174.2 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.648 -1.276 . . . . 0.83 113.147 -176.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.9 147.34 50.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.33 -1.305 . . . . 2.27 111.187 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.32 113.55 6.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.349 -0.387 . . . . 0.34 111.167 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.62 140.25 13.09 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.198 1.266 . . . . 0.8 111.918 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mt -129.49 149.24 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.38 111.652 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.84 8.45 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.633 -0.712 . . . . 2.96 110.809 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -127.11 163.76 23.08 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.134 -0.321 . . . . 2.13 110.134 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 2.5 mp0 -125.98 158.73 34.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.37 111.901 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.82 -144.3 11.63 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.793 -1.323 . . . . 0.21 109.793 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.1 mt-10 -105.93 107.8 18.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.622 1.211 . . . . 2.03 108.995 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.26 126.21 40.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.715 -0.846 . . . . 0.26 108.715 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.638 HG21 ' N ' ' A' ' 177' ' ' ALA . 12.7 t -114.36 120.75 64.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.007 -0.997 . . . . 0.54 111.915 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.6 tt -101.46 104.97 15.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.918 -1.037 . . . . 1.23 110.617 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.93 135.93 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.184 -1.043 . . . . 1.31 108.184 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.647 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -147.97 150.08 33.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 118.861 -1.136 . . . . 1.37 112.952 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.564 ' O ' ' HB3' ' A' ' 169' ' ' ALA . 12.2 tptt -107.75 120.43 42.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.341 -0.845 . . . . 2.97 110.099 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.79 145.89 31.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.558 -0.534 . . . . 0.3 109.558 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.09 152.16 41.54 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.801 0.334 . . . . 0.41 110.65 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -140.45 137.53 33.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 3.97 110.534 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.9 m -144.59 172.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 3.81 111.362 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 t80 63.38 12.88 6.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.842 -0.617 . . . . 2.89 111.497 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -148.98 138.81 21.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.555 -0.293 . . . . 2.0 110.58 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.58 89.71 2.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 1.0 111.078 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 100' ' ' LYS . 17.7 pt20 -157.01 147.07 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 2.96 110.707 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -126.78 153.42 45.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 1.55 111.863 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 47.73 30.71 1.9 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.805 -0.634 . . . . 2.33 111.574 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -131.56 -50.42 0.99 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.117 -0.492 . . . . 2.51 109.879 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.52 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 22.3 tttp -97.92 90.47 4.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.087 -0.709 . . . . 3.1 109.087 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.49 147.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.31 110.435 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -121.22 -179.87 4.19 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.392 0.886 . . . . 0.69 113.392 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.89 139.39 52.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 115.648 -0.706 . . . . 2.01 111.162 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.1 t -135.01 133.47 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 116.152 -0.476 . . . . 0.46 112.068 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 10.9 ptt180 -135.89 145.17 46.05 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.684 0.994 . . . . 1.85 113.684 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 18.5 m -113.0 121.06 64.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.584 -1.189 . . . . 1.1 109.694 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.589 ' ND2' ' HA ' ' A' ' 153' ' ' LEU . 3.6 t-20 54.28 26.89 7.27 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.805 0.812 . . . . 1.77 109.332 -176.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 23.17 28.06 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.047 -1.433 . . . . 0.41 112.977 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 81.5 m-70 -120.83 108.03 13.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.277 0.843 . . . . 0.46 113.277 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 7.0 p -64.6 116.03 5.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.146 0.498 . . . . 0.66 111.407 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.55 -31.31 2.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.471 -0.786 . . . . 0.8 109.99 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.18 91.49 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.351 -0.611 . . . . 0.51 109.351 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 4.2 ptpp? -106.6 77.96 1.23 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.584 1.183 . . . . 2.44 112.517 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.1 p30 156.14 36.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.399 -2.182 . . . . 2.56 109.453 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 91.78 0.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.352 0.596 . . . . 1.1 111.537 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.506 ' OD1' ' HB3' ' A' ' 119' ' ' ASP . 1.5 p30 -101.68 79.12 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.008 -1.479 . . . . 1.99 107.008 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.0 mt -50.4 -50.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.709 -1.132 . . . . 0.63 113.002 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -56.19 -51.45 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.83 0.307 . . . . 0.9 111.83 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.506 ' HB3' ' OD1' ' A' ' 116' ' ' ASP . 18.0 t70 -65.39 -29.59 70.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.369 0.507 . . . . 0.76 112.369 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -64.02 -58.29 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.452 0.538 . . . . 2.68 112.452 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 126' ' ' ALA . 10.9 m -103.53 -41.17 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.519 0.563 . . . . 1.41 112.519 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.73 -131.23 10.26 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.524 -0.845 . . . . 1.06 112.881 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -61.37 110.43 1.43 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.761 0.315 . . . . 3.51 111.083 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.445 ' OG ' HD23 ' A' ' 48' ' ' LEU . 53.8 m 45.27 -104.15 0.08 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.867 -0.606 . . . . 1.68 111.161 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.403 ' OG1' ' HB ' ' A' ' 121' ' ' VAL . 23.0 p 50.07 178.24 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.084 0.469 . . . . 0.8 111.914 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -105.86 138.95 41.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.786 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.8 t60 -112.57 144.8 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.918 -0.771 . . . . 0.38 108.918 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.89 140.48 29.78 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.305 0.854 . . . . 2.09 113.305 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.17 133.85 52.63 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.026 -0.988 . . . . 2.28 109.092 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.4 mt -115.66 116.4 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.747 -0.66 . . . . 0.71 110.187 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.9 mt -124.62 87.87 54.11 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.584 0.587 . . . . 1.38 112.584 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.6 141.82 74.8 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.81 1.674 . . . . 0.22 111.602 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.2 mt -132.09 155.82 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 0.21 110.505 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 30.5 p -131.39 106.73 8.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 1.11 110.732 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 139' ' ' LYS . 23.8 mt -105.4 124.53 60.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.747 -0.66 . . . . 0.23 109.911 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -146.97 142.1 27.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 1.91 110.947 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp 58.91 19.13 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 3.11 111.205 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.85 23.62 41.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 0.32 113.396 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 135' ' ' ILE . 25.9 mtmm -123.62 151.75 42.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.1 0.45 . . . . 2.19 110.823 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -109.84 126.65 54.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.118 0.485 . . . . 0.37 111.658 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.509 ' N ' HD23 ' A' ' 140' ' ' LEU . 24.2 t -114.55 110.99 20.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.723 -0.671 . . . . 0.9 110.059 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.2 p -105.03 104.29 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.341 0.591 . . . . 0.53 111.286 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 58.22 -89.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.755 -0.657 . . . . 2.05 112.085 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.96 23.41 4.97 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.437 -0.887 . . . . 0.6 113.593 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -133.13 136.51 45.84 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.005 -0.368 . . . . 2.02 110.005 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.3 p -105.16 140.9 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.034 0.445 . . . . 1.3 111.491 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.0 m -160.15 122.78 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.718 -0.674 . . . . 1.12 110.233 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.5 p -50.94 143.09 10.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.966 -0.561 . . . . 1.11 111.502 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -79.77 121.91 25.94 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.001 -0.741 . . . . 0.28 109.001 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 t -111.19 91.44 3.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.819 0.674 . . . . 1.55 112.819 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.4 -36.73 0.03 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.255 1.662 . . . . 0.46 117.255 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -159.75 151.98 20.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.335 1.567 . . . . 1.8 113.466 -177.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.589 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 1.3 tt -85.55 132.57 34.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.835 -1.172 . . . . 1.24 107.835 176.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.521 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.5 t -122.79 117.7 26.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.817 -0.753 . . . . 1.28 112.493 -177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.13 115.62 47.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.864 0.364 . . . . 0.59 110.826 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 166.79 23.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.375 0.607 . . . . 2.48 111.23 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.84 151.24 45.54 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.027 -0.988 . . . . 1.54 110.675 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -123.26 143.96 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.671 -1.15 . . . . 0.77 110.029 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 145.03 24.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 1.97 111.594 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.56 -14.45 44.02 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.312 -0.715 . . . . 1.12 111.312 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -141.55 -79.9 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.227 . . . . 3.81 110.694 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -155.16 157.75 37.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.863 0.363 . . . . 3.82 111.142 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 54.97 86.93 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.951 -0.568 . . . . 1.4 111.861 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 170.96 0.4 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.82 -0.627 . . . . 2.0 110.01 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -41.22 103.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.588 1.525 . . . . 2.58 111.159 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -58.55 -64.98 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.287 -0.869 . . . . 3.71 113.088 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 63' ' ' THR . 11.9 t -91.71 134.26 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 C-N-CA 120.14 -0.624 . . . . 0.92 112.385 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.6 t -132.48 137.8 47.35 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.712 -0.676 . . . . 1.2 112.616 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -130.22 34.75 4.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.171 -0.922 . . . . 0.22 111.466 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.1 tp -44.93 128.28 6.92 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.801 -0.636 . . . . 1.02 111.656 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.4 OUTLIER -143.15 115.69 8.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.94 -0.573 . . . . 0.33 110.831 -178.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.1 tt -117.16 131.27 70.35 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-O 123.002 1.382 . . . . 0.69 113.029 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.558 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.6 ppp? -126.42 165.04 19.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.216 -1.811 . . . . 1.26 109.735 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 3.4 ptmm? -121.42 152.75 38.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 115.424 1.639 . . . . 1.82 115.424 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 95.72 -34.85 4.62 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 112.044 -2.344 . . . . 0.22 117.796 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.419 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.67 156.71 0.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.21 2.005 . . . . 0.29 114.723 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.638 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.57 -10.5 53.84 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.167 -0.924 . . . . 0.57 110.899 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.59 -44.87 95.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 2.31 111.508 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -61.66 -43.37 98.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.426 -0.352 . . . . 2.37 110.859 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 86.2 t -43.73 102.81 0.29 Allowed Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.023 -0.535 . . . . 2.57 111.234 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -49.23 132.23 28.12 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.056 1.838 . . . . 2.08 112.635 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 80.7 mtp -136.36 137.64 40.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.076 -0.511 . . . . 6.04 110.787 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 85.9 mt -132.55 115.2 15.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 5.3 110.751 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -61.49 144.13 92.63 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.209 -0.45 . . . . 8.05 110.291 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -44.61 141.13 5.8 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.709 1.606 . . . . 9.14 112.554 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -134.79 134.26 21.86 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.4 -0.363 . . . . 9.87 110.555 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.61 -95.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.898 1.732 . . . . 11.69 112.053 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.92 84.52 1.81 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.0 -0.619 . . . . 12.62 112.335 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 30.7 mt -84.73 146.65 27.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.384 . . . . 14.44 111.005 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.128 -0.939 . . . . 15.7 110.77 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.483 -0.247 . . . . 9.15 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.26 -25.82 42.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.319 . . . . 7.36 111.007 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -92.01 129.93 37.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 7.76 110.705 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.2 m -141.48 116.71 10.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 4.02 110.915 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.31 -90.63 0.08 OUTLIER Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.782 -0.723 . . . . 1.28 112.432 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.7 tp -62.5 -36.74 83.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.306 0.574 . . . . 0.41 110.322 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.682 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.39 -20.93 13.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.366 -0.834 . . . . 0.33 111.184 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.11 -19.34 61.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 2.09 111.856 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -102.05 -29.52 11.72 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.696 -0.401 . . . . 1.99 110.875 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 7' ' ' ALA . 9.9 p -45.38 146.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.796 0.332 . . . . 0.21 111.815 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.12 -22.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.224 -0.59 . . . . 0.86 110.649 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.567 ' O ' HG22 ' A' ' 172' ' ' ILE . 17.0 t90 -172.51 133.45 0.62 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.233 -0.439 . . . . 0.28 109.912 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -154.23 143.09 21.02 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.74 0.274 . . . . 0.2 111.74 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.2 t -146.94 131.5 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.598 1.332 . . . . 0.67 114.598 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -116.47 103.05 10.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.058 -0.519 . . . . 1.27 110.621 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . -70.82 105.53 3.26 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.124 -0.63 . . . . 0.37 109.367 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.576 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.08 -27.01 0.14 Allowed Glycine 0 N--CA 1.446 -0.659 0 O-C-N 124.016 0.823 . . . . 0.67 114.074 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -138.44 -127.8 2.54 Favored Glycine 0 CA--C 1.511 -0.204 0 C-N-CA 119.98 -1.105 . . . . 1.12 113.011 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 37.1 mt-10 -154.63 119.65 4.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.39 0.138 . . . . 2.02 111.2 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 63.5 m 29.59 100.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.251 0.834 . . . . 1.22 113.251 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 22' ' ' VAL . 6.7 t60 -130.38 150.74 51.47 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 120.394 -0.522 . . . . 0.34 111.767 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 55.1 t -115.64 109.54 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.678 -0.692 . . . . 1.18 111.755 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.92 157.21 36.67 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.656 -0.247 . . . . 1.17 110.424 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 25' ' ' HIS . 13.0 m -44.31 -52.66 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.832 1.049 . . . . 0.6 113.832 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.414 ' N ' HG23 ' A' ' 24' ' ' VAL . 40.9 m-70 -58.38 -13.76 6.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.085 0.469 . . . . 0.46 110.406 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.0 34.91 5.5 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.526 -0.761 . . . . 0.29 112.299 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.416 HD11 ' HG ' ' A' ' 6' ' ' LEU . 32.9 mm -103.61 122.64 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.65 -0.5 . . . . 0.43 109.65 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 11.7 t60 -101.91 135.49 43.38 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.714 1.376 . . . . 0.52 114.714 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -98.33 132.9 43.42 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.396 -0.965 . . . . 3.0 108.396 176.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.435 ' N ' ' HD1' ' A' ' 29' ' ' TYR . 6.9 mtp180 -92.43 112.69 24.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.787 0.662 . . . . 2.9 112.787 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -20.24 137.6 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.247 1.419 . . . . 2.71 114.423 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -14.3 84.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.685 1.194 . . . . 1.98 113.807 177.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -73.11 -17.83 24.38 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.449 2.1 . . . . 1.53 115.234 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.649 HD22 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -128.08 -21.75 3.57 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.399 1.0 . . . . 1.83 113.262 -178.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.649 ' N ' HD22 ' A' ' 34' ' ' LEU . 21.1 tt0 -82.28 82.64 7.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.435 0.636 . . . . 4.95 109.363 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.11 -13.56 4.44 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.337 -0.847 . . . . 1.94 111.15 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 5.3 ttt180 55.06 30.44 14.27 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.393 0.616 . . . . 5.36 110.266 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -145.25 144.23 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 114.986 -1.006 . . . . 2.97 109.939 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.07 136.16 15.76 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.142 -0.551 . . . . 1.99 113.264 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.29 -66.35 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.691 0.281 . . . . 6.59 110.577 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 64.47 153.35 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.312 0.577 . . . . 2.01 111.993 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.9 m -153.97 41.81 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.37 -0.832 . . . . 2.02 109.579 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -43.75 -36.48 2.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.397 -0.819 . . . . 2.23 111.48 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 16.6 t80 57.31 13.82 1.89 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.153 0.501 . . . . 2.33 110.047 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 47' ' ' LYS . . . 104.82 127.92 6.11 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.657 -0.701 . . . . 2.2 112.049 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 47.3 mtt -68.77 -0.57 5.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.516 0.674 . . . . 1.93 109.931 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 45' ' ' GLY . 57.4 pttt -53.82 157.13 2.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.789 -1.096 . . . . 3.35 109.684 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 7.9 mt 53.03 53.09 11.43 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 108.605 -0.887 . . . . 2.76 108.605 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.542 ' HB2' ' NE2' ' A' ' 58' ' ' GLN . 75.7 Cg_endo -77.88 166.71 24.8 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.941 2.427 . . . . 1.46 114.711 -177.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.24 143.04 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.974 -1.012 . . . . 0.83 108.667 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -48.87 8.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.679 0.992 . . . . 1.69 113.679 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -78.9 34.69 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.647 0.61 . . . . 2.56 112.647 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -144.2 137.5 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.97 111.293 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -67.55 161.75 62.76 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.493 -0.558 . . . . 1.96 109.493 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.435 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.6 Cg_exo -42.16 -46.89 7.16 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.764 2.31 . . . . 0.66 116.141 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' O ' HG12 ' A' ' 59' ' ' VAL . 12.9 pt-20 -77.71 -53.16 7.87 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.248 0.547 . . . . 1.82 111.649 -176.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 8.7 p-10 -70.04 -2.3 12.36 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.717 -0.793 . . . . 1.91 109.719 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.542 ' NE2' ' HB2' ' A' ' 49' ' ' PRO . 20.2 tt0 -80.36 -60.15 2.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.447 -0.797 . . . . 1.5 109.218 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 56' ' ' GLU . 2.6 p -47.59 -35.57 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 N-CA-C 108.457 -0.942 . . . . 1.22 108.457 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 62' ' ' GLN . 10.2 tp -69.88 -64.52 0.87 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.465 0.65 . . . . 1.05 109.41 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.413 ' CE2' ' HD3' ' A' ' 88' ' ' LYS . 10.8 m-30 -66.95 20.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.9 -1.046 . . . . 0.9 112.703 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 60' ' ' LEU . 38.4 tt0 -137.54 -67.81 0.48 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.515 0.931 . . . . 1.8 113.515 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 21.0 p -30.6 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.554 0.946 . . . . 1.05 113.554 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.576 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -131.98 151.63 51.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.686 -0.688 . . . . 2.05 111.464 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.63 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 30.2 mtt180 -105.2 -170.41 1.75 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.536 -0.542 . . . . 3.58 109.536 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.81 -179.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 4.25 111.069 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -117.12 164.85 14.14 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.184 -0.462 . . . . 4.35 111.413 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -167.69 -150.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.844 -0.616 . . . . 3.17 109.969 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 10.1 t70 -141.38 128.06 20.3 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.718 0.294 . . . . 2.39 111.418 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 t 51.94 86.03 0.04 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.101 -0.5 . . . . 0.99 111.238 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.07 160.5 43.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 1.26 110.909 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -168.17 -154.14 8.6 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.358 -0.925 . . . . 0.66 113.998 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.88 167.84 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.478 0.656 . . . . 0.83 112.046 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -120.22 135.62 54.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.638 -1.164 . . . . 2.27 110.047 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.423 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.9 mp -127.64 86.84 57.45 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 111.823 0.305 . . . . 0.34 111.823 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -57.69 127.55 25.73 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 121.975 1.783 . . . . 0.8 112.059 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 153' ' ' LEU . 21.7 mt -119.25 153.69 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.966 0.412 . . . . 0.38 111.138 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.432 ' N ' HG22 ' A' ' 77' ' ' ILE . 16.9 pttp -147.35 6.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.895 -0.593 . . . . 2.96 110.823 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -130.77 171.0 13.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.822 -0.172 . . . . 2.13 110.627 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.07 171.96 10.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.277 0.56 . . . . 0.37 111.577 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 -153.89 21.59 Favored Glycine 0 C--N 1.329 0.148 0 N-CA-C 109.901 -1.28 . . . . 0.21 109.901 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 9.5 mm-40 -98.07 110.25 22.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.856 1.328 . . . . 2.03 108.859 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -96.55 126.53 41.8 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.906 -0.776 . . . . 0.26 108.906 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.66 HG21 ' N ' ' A' ' 177' ' ' ALA . 13.8 t -115.81 116.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.401 -0.818 . . . . 0.54 111.78 -177.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.464 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.8 tt -94.06 105.15 17.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.761 -1.109 . . . . 1.23 111.029 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 42.9 t -108.07 135.59 46.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.163 -1.051 . . . . 1.31 108.163 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -150.05 148.8 29.46 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.952 -1.099 . . . . 1.37 112.365 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.585 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 2.2 tptm -104.59 118.82 37.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.457 -0.792 . . . . 2.97 110.011 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 115' ' ' LEU . 4.9 m-85 -106.01 137.67 43.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.458 -0.941 . . . . 0.3 108.458 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.428 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -150.63 175.8 11.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.026 -0.67 . . . . 0.41 111.898 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -176.3 141.58 0.43 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.728 -0.669 . . . . 3.97 110.626 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.4 m -144.26 52.24 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.295 -0.411 . . . . 3.81 111.104 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -130.4 -29.17 2.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 2.89 111.306 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -135.11 -176.86 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 2.0 111.145 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -158.4 88.47 0.93 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.017 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -152.29 142.82 22.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 2.96 111.183 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.9 m -115.01 153.38 30.75 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.0 -0.545 . . . . 1.55 111.774 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 52.03 27.58 4.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.635 -0.711 . . . . 2.33 112.144 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -134.27 -47.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 2.51 109.636 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -98.99 86.52 3.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.719 -0.673 . . . . 3.1 109.541 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.17 150.32 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 1.31 109.892 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -127.13 179.04 5.63 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 113.065 0.765 . . . . 0.69 113.065 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -123.6 137.58 54.71 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.124 -0.489 . . . . 2.01 111.256 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -135.19 125.83 44.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.414 -0.357 . . . . 0.46 111.922 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -130.35 151.2 51.11 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.825 0.676 . . . . 1.85 112.825 -178.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 9.5 p -124.6 120.76 59.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 115.425 -0.807 . . . . 1.1 110.021 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.475 ' OD1' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER 56.68 25.85 10.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.524 -0.917 . . . . 1.77 108.524 -176.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.58 57.29 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.16 -0.927 . . . . 0.41 112.987 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.454 ' CG ' HG11 ' A' ' 142' ' ' VAL . 89.1 m-70 -110.48 112.25 24.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.428 0.899 . . . . 0.46 113.428 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 p -70.41 112.66 6.87 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.023 0.44 . . . . 0.66 111.221 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.34 -37.61 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 0.8 110.124 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.87 90.31 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 109.337 -0.616 . . . . 0.51 109.337 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 2.3 ptpp? -108.25 84.58 1.96 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.165 0.983 . . . . 2.44 112.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.6 p30 149.92 31.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.437 -2.165 . . . . 2.56 108.142 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -56.32 98.87 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.146 0.498 . . . . 1.1 112.056 -177.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -105.87 80.76 1.57 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.828 -1.175 . . . . 1.99 107.828 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.1 mt -51.0 -47.03 30.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.085 -0.962 . . . . 0.63 112.721 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.662 0.267 . . . . 0.9 111.671 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.29 -27.63 64.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.979 0.363 . . . . 0.76 111.979 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -68.86 -58.54 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.069 0.396 . . . . 2.68 112.069 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.5 m -90.54 -40.47 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.939 0.348 . . . . 1.41 111.939 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.34 -82.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 1.06 112.439 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -99.99 169.69 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.512 0.196 . . . . 3.51 110.782 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 m -49.88 97.91 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.36 -0.382 . . . . 1.68 110.984 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.9 p -150.94 -170.12 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.8 109.96 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.512 ' HB1' ' HZ3' ' A' ' 88' ' ' LYS . . . -96.6 131.11 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.741 0.645 . . . . 0.44 112.741 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -106.32 147.08 29.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.572 -0.899 . . . . 0.38 108.572 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -144.83 127.08 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.437 0.532 . . . . 2.09 112.437 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -114.8 135.61 53.99 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.766 -0.652 . . . . 2.28 109.568 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.54 120.86 66.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.4 -0.818 . . . . 0.71 110.083 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.88 89.18 51.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.353 -0.385 . . . . 1.38 111.947 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.17 146.62 94.26 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.97 1.78 . . . . 0.22 111.709 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.6 mt -138.6 156.86 29.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.41 -0.359 . . . . 0.21 110.751 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 p -133.53 108.56 8.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.068 0.461 . . . . 1.11 111.349 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 139' ' ' LYS . 18.3 mt -109.67 125.69 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-N 115.667 -0.697 . . . . 0.23 110.224 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -149.12 141.69 24.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 1.91 111.157 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt 61.36 14.24 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.9 -0.591 . . . . 3.11 111.212 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.78 8.76 59.13 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.606 -0.807 . . . . 0.32 113.402 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.595 ' O ' HG23 ' A' ' 135' ' ' ILE . 33.3 mtmt -112.34 165.2 12.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.34 0.57 . . . . 2.19 110.669 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.507 ' CD1' HD11 ' A' ' 153' ' ' LEU . 8.2 tt -127.16 139.74 52.74 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 112.616 0.598 . . . . 0.37 112.616 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.448 ' OG ' HG22 ' A' ' 146' ' ' VAL . 36.1 t -126.44 116.03 20.51 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.626 -0.715 . . . . 0.9 110.447 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 142' ' ' VAL . 4.3 p -112.32 104.53 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.094 -0.957 . . . . 0.53 110.575 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 61.75 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 2.05 112.009 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.17 9.87 4.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.352 -0.927 . . . . 0.6 113.914 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -124.38 118.87 27.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.147 0.473 . . . . 2.02 110.019 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.448 HG22 ' OG ' ' A' ' 141' ' ' SER . 21.2 t -107.62 130.61 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.477 0.656 . . . . 1.3 112.432 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 t -145.12 143.11 30.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 114.939 -1.028 . . . . 1.12 109.742 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.6 p -55.85 141.36 39.24 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.111 0.411 . . . . 1.11 112.111 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -79.09 143.15 35.82 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.168 -0.679 . . . . 0.28 109.168 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.9 96.45 3.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.776 1.028 . . . . 1.55 113.776 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.66 -57.33 2.55 Favored Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.978 1.151 . . . . 0.46 115.978 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HB2' ' C ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -153.54 174.72 14.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.934 0.867 . . . . 1.8 112.667 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.507 HD11 ' CD1' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -97.06 130.79 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.964 -1.495 . . . . 1.24 106.964 176.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.408 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.4 t -120.71 112.74 19.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.267 -0.973 . . . . 1.28 112.978 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 57.5 t -98.28 104.04 15.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.081 -0.509 . . . . 0.59 110.548 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 mt-10 -108.47 144.91 35.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.407 -0.815 . . . . 2.48 110.922 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.97 138.16 42.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.637 -0.505 . . . . 1.54 109.637 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.6 t -112.25 143.59 21.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.22 -0.9 . . . . 0.77 111.261 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -74.95 148.45 39.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.533 -0.758 . . . . 1.97 111.375 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -108.14 -9.2 28.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.943 -0.646 . . . . 1.12 111.941 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.45 -61.89 0.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.616 0.246 . . . . 3.81 110.489 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -172.69 -28.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.316 -0.402 . . . . 3.82 111.048 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -108.73 90.54 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 1.4 111.589 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -53.82 165.82 0.7 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 109.397 -0.594 . . . . 2.0 109.397 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -37.67 100.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.779 1.653 . . . . 2.58 111.575 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -52.0 -57.0 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.975 . . . . 3.71 112.384 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 61.3 t -103.04 133.69 46.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 120.495 -0.482 . . . . 0.92 112.253 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -132.59 135.29 45.81 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 115.873 -0.603 . . . . 1.2 111.065 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.585 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -126.23 35.57 4.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.806 . . . . 0.22 112.611 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -33.36 131.43 0.21 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.499 0.499 . . . . 1.02 111.366 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.458 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -150.89 101.26 2.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.254 -0.43 . . . . 0.33 110.198 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -107.43 123.32 62.63 Favored 'Isoleucine or valine' 0 C--O 1.265 1.873 0 CA-C-O 122.858 1.313 . . . . 0.69 112.587 179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.9 ptm -114.76 165.24 13.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 113.507 -1.678 . . . . 1.26 110.045 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HZ2' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -119.14 145.17 46.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 115.058 1.503 . . . . 1.82 115.058 -177.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 101.81 -37.61 3.56 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 112.095 -2.32 . . . . 0.22 118.749 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.482 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.06 157.48 0.32 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.883 2.341 . . . . 0.29 114.358 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.66 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.12 -22.85 26.87 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.673 -1.149 . . . . 0.57 108.861 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.53 -31.03 70.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.206 -0.906 . . . . 2.31 110.86 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -49.78 -63.29 1.16 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.354 -0.61 . . . . 2.37 109.354 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.7 t 62.2 130.53 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.716 -0.675 . . . . 2.57 111.924 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -42.34 121.51 2.0 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.737 1.624 . . . . 2.08 112.649 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 49.0 ttm -134.8 127.01 30.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 6.04 110.696 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.0 159.91 38.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 5.3 111.126 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -71.25 146.27 91.99 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.887 -0.597 . . . . 8.05 109.747 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.1 125.86 15.39 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.451 1.434 . . . . 9.14 112.482 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -134.6 135.02 22.81 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.997 -0.547 . . . . 9.87 110.226 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.52 -97.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.694 1.596 . . . . 11.69 112.017 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.09 39.92 15.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.928 -0.653 . . . . 12.62 112.646 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.83 90.21 5.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 14.44 110.387 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.324 -0.846 . . . . 15.7 110.8 179.904 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.472 -0.251 . . . . 9.15 112.472 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.76 -11.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 7.36 110.929 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -132.52 37.85 3.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 7.76 110.667 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.4 t 62.69 166.73 0.12 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.091 -0.504 . . . . 4.02 111.015 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -118.54 7.16 13.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.677 -0.773 . . . . 1.28 112.703 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 tp -63.69 -41.39 98.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.4 0.619 . . . . 0.41 109.669 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.691 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -59.83 -20.34 56.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.096 -0.956 . . . . 0.33 110.599 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.09 -18.5 63.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.436 -0.347 . . . . 2.09 111.35 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -107.7 -26.73 10.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.696 -0.401 . . . . 1.99 111.476 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.4 p -45.84 145.48 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.756 -0.378 . . . . 0.21 111.505 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -133.48 -18.86 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 C-N-CA 119.861 -0.736 . . . . 0.86 110.345 177.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.493 ' O ' HG22 ' A' ' 172' ' ' ILE . 44.0 t90 -175.22 144.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.591 -0.444 . . . . 0.28 110.311 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -162.05 142.82 10.49 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.667 0.247 . . . . 0.2 111.667 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.68 128.95 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.988 1.107 . . . . 0.67 113.988 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 169' ' ' ALA . 10.1 t30 -114.26 93.7 4.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.904 -0.776 . . . . 1.27 108.904 176.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.556 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -63.7 97.41 0.15 Allowed 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.442 -0.799 . . . . 0.37 109.757 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.564 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . 176.93 -77.8 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.122 -1.399 . . . . 0.67 113.196 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -77.16 -125.36 0.26 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.204 -0.522 . . . . 1.12 112.759 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.548 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -162.72 121.48 2.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 120.858 0.361 . . . . 2.02 110.744 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.0 p 35.11 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.809 -0.632 . . . . 1.22 112.289 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.56 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 55.9 t60 -117.78 152.47 35.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.157 -0.617 . . . . 0.34 112.575 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.7 t -123.67 103.6 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.469 -0.787 . . . . 1.18 110.427 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.45 151.29 47.03 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.275 -0.42 . . . . 1.17 110.731 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 25' ' ' HIS . 14.7 m -43.09 -48.69 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 O-C-N 124.367 1.042 . . . . 0.6 112.888 -178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.404 ' N ' HG23 ' A' ' 24' ' ' VAL . 46.3 m-70 -57.74 -29.73 65.0 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.319 0.58 . . . . 0.46 110.069 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.83 33.81 1.8 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.142 -0.935 . . . . 0.29 111.666 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.1 mm -103.39 123.5 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.607 -0.516 . . . . 0.43 109.607 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 9.6 t60 -104.38 134.97 46.69 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.614 1.338 . . . . 0.52 114.614 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CD1' ' C ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -97.72 129.31 44.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.564 -0.902 . . . . 3.0 108.564 176.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -82.43 113.15 19.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.647 0.61 . . . . 2.9 112.647 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -28.12 140.64 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.445 -1.252 . . . . 2.71 113.499 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.499 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 1.6 m-20 -14.75 83.57 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.814 1.246 . . . . 1.98 114.079 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -102.46 -0.1 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.35 2.033 . . . . 1.53 113.783 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.549 HD22 ' C ' ' A' ' 72' ' ' GLY . 30.4 tp -126.27 -60.76 1.25 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.404 0.52 . . . . 1.83 112.404 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' H ' ' NH2' ' A' ' 65' ' ' ARG . 51.8 mt-10 -72.2 90.45 1.23 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.061 0.457 . . . . 4.95 110.081 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 38' ' ' VAL . . . 90.22 -28.51 7.33 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.166 -0.774 . . . . 1.94 111.166 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 45.15 36.48 2.12 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.915 0.486 . . . . 5.36 111.258 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 36' ' ' GLY . 73.2 t -140.1 141.9 32.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.765 -0.652 . . . . 2.97 110.15 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.04 101.51 0.05 OUTLIER Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.067 -0.587 . . . . 1.99 113.081 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -141.28 -78.82 0.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.45 0.166 . . . . 6.59 110.64 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 61.12 113.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.984 0.421 . . . . 2.01 111.409 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.1 m -73.03 -41.72 63.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 2.02 110.677 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 38.74 43.54 0.72 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.171 -0.468 . . . . 2.23 111.408 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -105.41 32.72 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 2.33 110.139 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.45 17.75 5.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.827 -0.702 . . . . 2.2 112.823 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.9 mtt -52.14 -32.23 34.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.22 0.534 . . . . 1.93 109.891 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 39.1 tptt -74.93 159.06 32.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.371 -0.831 . . . . 3.35 109.722 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 7.7 mt 64.81 62.23 1.27 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.591 0.234 . . . . 2.76 110.806 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 53.7 Cg_exo -59.68 129.17 29.68 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.425 2.084 . . . . 1.46 112.229 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.725 HG21 ' HB2' ' A' ' 126' ' ' ALA . 2.0 mt -63.2 111.67 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.758 0.789 . . . . 0.83 109.503 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mt -46.94 -52.48 14.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.171 -1.377 . . . . 1.69 113.937 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -65.75 -0.68 2.29 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.046 0.387 . . . . 2.56 112.046 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.9 t -128.18 142.08 51.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.685 0.624 . . . . 0.97 112.685 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -69.15 158.84 85.5 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.848 -0.615 . . . . 1.96 109.497 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.9 Cg_exo -40.07 -56.69 1.37 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 123.188 2.592 . . . . 0.66 116.446 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 12.5 pt-20 -71.45 -53.36 14.23 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.318 0.58 . . . . 1.82 111.264 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.67 -5.03 22.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.126 -0.694 . . . . 1.91 109.126 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -77.59 -46.98 20.51 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.683 -0.858 . . . . 1.5 108.683 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -55.09 -42.57 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.378 -0.971 . . . . 1.22 108.378 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.491 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 13.0 tp -63.53 -63.48 1.17 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.537 -0.542 . . . . 1.05 109.537 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.496 ' CD2' ' HG2' ' A' ' 88' ' ' LYS . 3.3 m-85 -51.13 -12.38 0.13 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.501 -0.772 . . . . 0.9 110.632 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.508 ' O ' ' O ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -123.59 -126.21 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.587 -0.733 . . . . 1.8 111.239 -178.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 167' ' ' VAL . 26.6 p 45.49 128.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.655 0.782 . . . . 1.05 112.81 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 167' ' ' VAL . 0.0 OUTLIER -124.79 154.82 40.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.441 0.638 . . . . 2.05 112.65 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.564 ' HD3' ' N ' ' A' ' 17' ' ' GLY . 18.2 mtp180 -123.3 -171.74 2.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.01 -0.995 . . . . 3.58 110.281 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.4 -178.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 4.25 111.043 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.98 163.25 39.32 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.434 -0.348 . . . . 4.35 110.963 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.56 -93.76 0.06 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.504 -0.316 . . . . 3.17 111.631 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -173.15 127.97 0.45 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.813 0.301 . . . . 2.39 111.813 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.5 t 52.45 93.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.096 -0.502 . . . . 0.99 111.976 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -160.58 161.44 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 1.26 110.588 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' C ' HD22 ' A' ' 34' ' ' LEU . . . -164.07 177.56 39.77 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.978 -1.106 . . . . 0.66 114.632 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -100.89 161.73 13.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 0.83 111.958 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -115.49 122.32 45.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.952 -1.022 . . . . 2.27 111.137 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.53 109.63 45.7 Favored Pre-proline 0 C--O 1.224 -0.251 0 CA-C-O 119.367 -0.349 . . . . 0.34 111.179 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -81.85 130.43 6.67 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.297 1.142 . . . . 0.8 112.106 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 51.9 mt -121.78 148.41 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.847 0.356 . . . . 0.38 111.324 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -139.41 -0.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 2.96 111.039 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.429 ' HG3' ' NZ ' ' A' ' 174' ' ' LYS . 12.6 mm-40 -123.74 166.02 16.28 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.659 0.266 . . . . 2.13 110.878 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -119.7 172.95 7.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.273 0.559 . . . . 0.37 111.175 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.04 -147.23 18.9 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.02 -1.232 . . . . 0.21 110.02 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mt-10 -105.87 109.44 21.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.603 1.201 . . . . 2.03 109.805 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -96.65 127.22 42.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.046 -0.724 . . . . 0.26 109.046 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.654 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.3 t -113.36 117.06 54.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.383 -0.826 . . . . 0.54 111.48 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.21 104.79 16.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.23 111.312 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -105.3 137.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.918 -1.037 . . . . 1.31 108.976 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.488 ' N ' HD23 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -156.14 135.42 12.2 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.501 -0.88 . . . . 1.37 112.368 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.698 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 3.5 mptt -97.38 127.47 43.36 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.918 -0.713 . . . . 2.97 109.331 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CD2' HD21 ' A' ' 115' ' ' LEU . 3.1 m-85 -106.94 137.12 45.6 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.217 -0.66 . . . . 0.3 109.217 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -134.51 153.16 52.08 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.75 -0.38 . . . . 0.41 110.35 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -124.41 -75.59 0.6 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.469 -0.332 . . . . 3.97 111.19 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 93' ' ' TYR . 36.9 t 66.3 160.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.482 -0.326 . . . . 3.81 111.413 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.468 ' N ' HG12 ' A' ' 92' ' ' VAL . 0.3 OUTLIER 82.03 -64.59 0.13 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.256 0.623 . . . . 2.89 111.902 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -86.6 158.16 19.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.976 0.417 . . . . 2.0 111.563 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.418 ' HA ' ' CE1' ' A' ' 118' ' ' PHE . . . -134.66 84.36 2.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.388 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.437 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 26.7 mt-30 -146.13 140.64 26.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.376 -0.375 . . . . 2.96 111.636 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 119' ' ' ASP . 33.2 p -124.54 154.54 40.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 1.55 111.755 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 47.22 29.2 1.14 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.767 -0.651 . . . . 2.33 111.829 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -133.96 -48.11 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.259 -0.645 . . . . 2.51 109.259 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -93.21 88.79 6.17 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 3.1 109.133 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.73 152.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.531 -0.759 . . . . 1.31 109.55 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -134.37 176.28 8.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.986 0.736 . . . . 0.69 112.986 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -121.42 139.44 53.45 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.06 -0.518 . . . . 2.01 111.206 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.68 130.6 42.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.641 -0.709 . . . . 0.46 112.04 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -131.81 153.84 49.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.14 0.793 . . . . 1.85 113.14 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 20.4 m -121.92 120.71 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.638 -1.165 . . . . 1.1 109.613 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.502 ' HA ' ' H ' ' A' ' 154' ' ' SER . 4.4 t-20 54.28 27.17 7.6 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.998 -0.741 . . . . 1.77 108.998 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.07 23.67 29.19 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.708 -1.133 . . . . 0.41 112.914 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.6 m-70 -122.97 108.73 13.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.209 0.818 . . . . 0.46 113.209 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 p -62.48 115.9 4.64 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.91 0.386 . . . . 0.66 111.642 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 t -106.38 -36.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.8 109.878 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.458 HG11 ' OE2' ' A' ' 129' ' ' GLU . 2.1 t -127.84 92.29 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.851 -0.426 . . . . 0.51 109.851 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 1.3 ptpt -105.8 76.99 1.22 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.715 1.245 . . . . 2.44 111.983 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 3.4 p30 155.71 27.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.221 -2.263 . . . . 2.56 109.073 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 89' ' ' PHE . 40.5 tp -60.88 102.17 0.18 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.628 0.728 . . . . 1.1 112.531 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 36.0 p-10 -112.06 89.43 3.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.528 -1.215 . . . . 1.99 108.406 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.0 -54.05 15.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 0.63 113.526 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 13.1 t80 -56.55 -40.07 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.88 0.326 . . . . 0.9 111.88 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 97' ' ' SER . 19.4 t70 -67.65 -28.81 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.124 0.416 . . . . 0.76 112.124 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 11.6 mmm180 -75.98 -58.69 3.13 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.511 0.56 . . . . 2.68 112.511 -178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -87.1 -40.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.937 0.347 . . . . 1.41 111.937 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.76 -94.93 0.75 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 1.06 112.284 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 125' ' ' THR . 73.6 m80 -112.92 110.08 19.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.656 0.265 . . . . 3.51 111.286 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.2 m 56.05 -132.42 1.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.187 -0.46 . . . . 1.68 111.245 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 123' ' ' HIS . 11.0 p 57.94 -171.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.303 0.241 . . . . 0.8 111.006 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.725 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -114.28 139.5 49.37 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.591 0.96 . . . . 0.44 113.591 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.4 t60 -100.31 150.86 22.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.55 -1.204 . . . . 0.38 107.844 176.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -145.37 122.33 11.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.26 -0.576 . . . . 2.09 112.208 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.458 ' OE2' HG11 ' A' ' 112' ' ' VAL . 46.5 mt-10 -119.71 141.67 49.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.513 -0.767 . . . . 2.28 109.512 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 mt -123.4 136.23 60.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.683 -0.69 . . . . 0.71 111.229 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 131' ' ' ILE . 4.2 mp -134.29 89.5 27.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 1.38 111.631 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.01 144.07 92.18 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.72 1.613 . . . . 0.22 111.305 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 21.5 mt -135.41 154.85 36.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.563 -0.29 . . . . 0.21 111.181 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -131.09 107.08 8.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 1.11 110.635 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.9 mt -106.98 129.65 60.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.917 -0.583 . . . . 0.23 110.55 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -147.88 140.5 24.61 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.798 0.332 . . . . 1.91 110.814 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.434 ' NZ ' ' HB2' ' A' ' 137' ' ' LYS . 0.6 OUTLIER 55.66 28.51 12.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.554 0.692 . . . . 3.11 110.06 -179.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.29 27.92 62.92 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.221 -0.899 . . . . 0.32 112.703 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 62.4 mttp -121.89 146.87 46.69 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.919 0.359 . . . . 2.19 110.797 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -107.67 131.31 54.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.146 0.498 . . . . 0.37 112.197 -177.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.592 ' N ' HD23 ' A' ' 140' ' ' LEU . 32.3 t -121.32 110.36 16.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.53 -0.759 . . . . 0.9 109.618 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.1 p -103.66 108.28 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.321 0.582 . . . . 0.53 110.968 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 60.94 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.645 -0.707 . . . . 2.05 112.022 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -137.92 12.45 3.64 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.47 -0.871 . . . . 0.6 113.158 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -116.88 141.14 48.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.863 0.331 . . . . 2.02 110.263 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.46 136.95 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 1.3 111.142 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.8 t -157.93 127.31 5.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.723 -0.672 . . . . 1.12 109.824 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.2 p -58.03 142.9 45.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.294 -0.412 . . . . 1.11 111.535 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -79.42 122.03 25.9 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 109.125 -0.694 . . . . 0.28 109.125 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 t -111.18 91.36 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.156 -0.618 . . . . 1.55 112.6 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 59.04 -33.26 0.03 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 117.269 1.668 . . . . 0.46 117.269 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -160.87 154.97 22.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.501 1.651 . . . . 1.8 113.868 -176.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.482 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -87.2 127.28 35.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.96 -1.126 . . . . 1.24 107.96 176.19 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.502 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -118.11 114.2 22.72 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.382 0.882 . . . . 1.28 113.382 -176.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.83 103.29 14.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.44 -0.578 . . . . 0.59 109.44 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 39.4 mt-10 -107.67 139.44 42.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.409 -0.814 . . . . 2.48 111.447 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -136.11 138.44 42.06 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.011 -0.54 . . . . 1.54 110.002 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.453 ' CG2' HH21 ' A' ' 105' ' ' ARG . 12.0 t -115.14 143.62 24.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.95 -1.023 . . . . 0.77 111.466 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -63.74 148.16 49.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.975 -1.011 . . . . 1.97 110.931 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.43 -29.8 8.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 1.12 111.721 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -145.53 -55.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.545 0.212 . . . . 3.81 111.011 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -142.24 -83.21 0.19 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.588 -0.278 . . . . 3.82 111.51 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.14 125.16 29.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.107 0.48 . . . . 1.4 111.52 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 166' ' ' LYS . 1.3 m-20 -59.98 171.14 0.95 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.323 -0.853 . . . . 2.0 110.32 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -28.89 -29.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 123.312 2.675 . . . . 2.58 114.318 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ASN . 15.6 tptp 85.28 -75.39 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.619 0.575 . . . . 3.71 112.364 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 64' ' ' GLU . 3.5 t -96.34 135.08 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 120.606 -0.438 . . . . 0.92 112.017 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.22 134.96 45.95 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.98 -0.555 . . . . 1.2 112.425 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.513 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -124.4 35.43 4.81 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.228 -0.896 . . . . 0.22 112.769 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.424 HD13 ' H ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -37.48 138.99 0.29 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.15 0.5 . . . . 1.02 111.888 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.7 OUTLIER -157.71 100.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.47 -0.786 . . . . 0.33 110.24 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.3 tt -106.26 125.35 61.95 Favored 'Isoleucine or valine' 0 C--O 1.264 1.867 0 CA-C-O 122.758 1.266 . . . . 0.69 112.553 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.583 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 1.7 ppp? -115.14 162.38 17.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 112.988 -1.915 . . . . 1.26 109.525 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.429 ' NZ ' ' HG3' ' A' ' 79' ' ' GLU . 32.2 tttt -120.34 144.15 48.01 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 115.272 1.582 . . . . 1.82 115.272 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.68 -36.8 4.1 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 112.397 -2.183 . . . . 0.22 118.398 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.462 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.48 155.15 0.3 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.908 2.354 . . . . 0.29 115.177 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.654 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.73 -24.61 25.08 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 114.566 -1.197 . . . . 0.57 108.972 175.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 180' ' ' VAL . 19.8 m-20 -57.11 -34.78 68.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.324 -0.853 . . . . 2.31 110.657 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -52.9 -52.07 58.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.222 -0.658 . . . . 2.37 109.222 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 178' ' ' ASP . 57.8 t 62.85 120.71 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 115.482 -0.781 . . . . 2.57 111.705 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -46.27 111.01 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.628 1.552 . . . . 2.08 112.29 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -152.2 179.81 8.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.424 -0.353 . . . . 6.04 110.953 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 183' ' ' LEU . 2.4 pt? -165.3 128.91 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 5.3 110.679 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -62.67 144.89 95.96 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.419 -0.585 . . . . 8.05 109.419 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.1 123.48 11.95 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.231 1.287 . . . . 9.14 111.648 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.485 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 57.3 t-80 -134.73 143.95 48.59 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.883 -0.599 . . . . 9.87 110.124 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 186' ' ' HIS . 89.0 Cg_endo -73.43 -39.99 1.78 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.813 1.675 . . . . 11.69 112.221 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 46.38 74.23 0.25 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.895 -0.593 . . . . 12.62 112.775 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.6 mt -63.12 112.69 2.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 14.44 110.639 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.13 -0.938 . . . . 15.7 110.817 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.129 0 N-CA-C 112.474 -0.25 . . . . 9.15 112.474 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.63 112.42 24.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 7.36 110.81 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.7 mtt -87.01 -6.39 58.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 7.76 110.769 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.1 m -146.38 138.7 25.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 4.02 110.902 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.47 75.55 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.984 -0.626 . . . . 1.28 112.345 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.34 -50.32 54.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.147 0.499 . . . . 0.41 110.219 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.598 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.26 -20.4 4.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.362 -0.835 . . . . 0.33 111.311 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.15 -27.8 38.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.407 0.521 . . . . 2.09 112.407 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 37.4 mmtt -95.29 -22.75 17.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.717 -0.393 . . . . 1.99 111.49 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.7 p -43.79 143.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 120.584 0.231 . . . . 0.21 111.615 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 pt -136.91 -23.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 120.013 -0.675 . . . . 0.86 110.487 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.489 ' O ' HG22 ' A' ' 172' ' ' ILE . 73.3 t90 -172.74 140.94 1.03 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.049 -0.523 . . . . 0.28 110.091 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -159.88 143.94 14.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.271 0.471 . . . . 0.2 112.271 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG11 ' CE2' ' A' ' 73' ' ' TYR . 4.2 t -147.02 130.98 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 113.807 1.04 . . . . 0.67 113.807 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 15.6 t-20 -114.43 95.25 5.17 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 114.887 -1.051 . . . . 1.27 108.553 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.681 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -60.18 92.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.265 -1.013 . . . . 0.37 108.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.62 ' HA3' ' OG1' ' A' ' 63' ' ' THR . . . -177.27 -95.34 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 O-C-N 124.582 1.176 . . . . 0.67 114.55 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -66.47 -122.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.112 -0.566 . . . . 1.12 114.039 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -159.09 119.86 3.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.388 -0.406 . . . . 2.02 110.158 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.716 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.0 m 31.61 95.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.512 -0.767 . . . . 1.22 112.68 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.683 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 22.8 t60 -123.59 139.96 53.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.787 -0.765 . . . . 0.34 112.5 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 22' ' ' VAL . 3.6 p -115.03 104.07 16.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.668 -0.696 . . . . 1.18 110.582 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.08 157.03 29.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.194 -0.912 . . . . 1.17 110.662 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 m -43.73 -47.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 O-C-N 124.367 1.042 . . . . 0.6 113.277 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -62.57 -20.18 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.318 0.58 . . . . 0.46 110.386 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.34 34.89 3.25 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.208 -0.905 . . . . 0.29 112.542 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.01 114.84 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 120.459 -0.496 . . . . 0.43 110.455 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.683 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.5 t60 -100.42 136.35 40.43 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.915 1.45 . . . . 0.52 114.915 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.716 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.23 135.99 42.85 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.698 -1.137 . . . . 3.0 108.753 177.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -86.29 106.99 17.75 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.796 0.685 . . . . 2.9 112.303 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.619 ' HB3' ' NZ ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -34.21 137.06 0.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.121 -0.945 . . . . 2.71 113.296 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.496 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER 3.0 79.7 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 114.748 -1.115 . . . . 1.98 113.551 178.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -96.82 -25.11 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.188 1.925 . . . . 1.53 114.095 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -112.58 -30.76 7.0 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.814 -0.354 . . . . 1.83 110.976 -179.288 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.872 ' N ' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -70.78 79.11 0.61 Allowed 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.229 -0.656 . . . . 4.95 109.229 179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 38' ' ' VAL . . . 74.64 -10.44 8.76 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.966 -1.254 . . . . 1.94 109.966 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER 59.27 7.88 1.0 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.737 -0.732 . . . . 5.36 111.231 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 36' ' ' GLY . 16.7 m -148.91 117.77 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 115.935 -0.575 . . . . 2.97 110.252 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.77 -139.03 2.6 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.555 -0.831 . . . . 1.99 112.631 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -146.04 -69.22 0.27 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.447 0.165 . . . . 6.59 111.27 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -177.75 -58.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.605 -0.27 . . . . 2.01 111.283 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.6 t 63.02 41.07 8.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 2.02 110.525 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' HB2' ' SD ' ' A' ' 46' ' ' MET . 7.0 p-10 -77.89 73.45 4.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.937 -0.574 . . . . 2.23 110.185 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -97.48 -17.1 19.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.833 -0.621 . . . . 2.33 110.999 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.98 35.5 4.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.715 -0.755 . . . . 2.2 112.645 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.466 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . 74.6 mmm -86.34 -3.54 59.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.467 . . . . 1.93 110.468 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -81.08 16.22 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.651 -0.704 . . . . 3.35 111.196 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.2 tp -148.39 62.01 6.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 2.76 110.216 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 85.1 Cg_exo -50.06 124.22 12.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.985 2.457 . . . . 1.46 113.736 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.01 109.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.537 -0.912 . . . . 0.83 108.537 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -54.55 26.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.579 -1.191 . . . . 1.69 114.103 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -74.62 28.56 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.53 0.937 . . . . 2.56 113.53 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t -141.11 145.08 35.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.137 0.494 . . . . 0.97 112.133 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.1 t30 -63.47 146.9 96.08 Favored Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 115.484 -0.78 . . . . 1.96 109.596 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.632 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.2 Cg_exo -40.81 -58.89 0.88 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 122.631 2.221 . . . . 0.66 115.249 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -62.21 -54.37 41.91 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 122.298 1.047 . . . . 1.82 110.76 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -69.83 -11.64 61.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.036 -0.983 . . . . 1.91 110.215 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.632 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -64.45 -45.71 86.26 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.491 -1.67 . . . . 1.5 106.491 176.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 63' ' ' THR . 74.8 t -54.19 -51.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.403 -1.271 . . . . 1.22 109.352 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.9 tp -70.49 -7.2 41.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.586 -0.734 . . . . 1.05 111.426 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.0 m-30 -120.08 16.03 12.42 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.478 -0.783 . . . . 0.9 109.719 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.548 ' HG2' ' N ' ' A' ' 63' ' ' THR . 30.6 tt0 -141.25 -109.92 0.14 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.305 -0.861 . . . . 1.8 110.596 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.62 ' OG1' ' HA3' ' A' ' 17' ' ' GLY . 69.2 p 37.26 -156.02 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 119.082 -0.485 . . . . 1.05 110.298 -177.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 12.6 pt-20 -174.86 -53.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.593 1.701 . . . . 2.05 115.593 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.551 ' NH2' ' HB2' ' A' ' 35' ' ' GLU . 7.9 mtp180 70.57 -172.79 0.17 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.062 0.392 . . . . 3.58 110.056 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -87.25 178.83 6.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.519 -0.309 . . . . 4.25 111.106 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -150.05 171.99 15.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.379 -0.373 . . . . 4.35 111.121 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.41 -102.5 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.475 -0.33 . . . . 3.17 111.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -169.85 131.68 1.08 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.646 0.26 . . . . 2.39 111.028 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.541 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 21.7 t 53.21 93.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.252 -0.431 . . . . 0.99 111.495 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -168.85 168.83 10.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 1.26 110.975 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -171.37 -146.2 5.15 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.248 -0.977 . . . . 0.66 113.86 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.681 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 58.9 m-85 -135.87 172.72 12.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.719 0.771 . . . . 0.83 112.908 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.06 135.76 53.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.068 -1.424 . . . . 2.27 110.17 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.474 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.7 mp -129.35 86.34 56.66 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 111.706 0.262 . . . . 0.34 111.706 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.73 126.13 21.39 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.109 1.873 . . . . 0.8 112.512 177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -121.05 149.89 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.38 110.933 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.03 2.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 2.96 111.425 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.633 ' HG2' ' NZ ' ' A' ' 174' ' ' LYS . 8.0 tp10 -132.11 165.99 22.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.835 0.35 . . . . 2.13 110.092 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -116.41 178.85 4.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.244 0.545 . . . . 0.37 111.642 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.87 -148.08 18.66 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 109.972 -1.251 . . . . 0.21 109.972 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 11.1 mm-40 -105.97 110.53 22.84 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.701 1.251 . . . . 2.03 109.235 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.28 126.36 41.44 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 108.954 -0.758 . . . . 0.26 108.954 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.653 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.7 t -114.5 121.24 66.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.346 -0.843 . . . . 0.54 112.032 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 85' ' ' LEU . 6.5 tt -103.56 105.62 15.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.864 -1.062 . . . . 1.23 110.635 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.22 132.12 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.24 -0.891 . . . . 1.31 108.816 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -147.47 138.78 23.78 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.241 -0.984 . . . . 1.37 112.824 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.61 ' C ' ' HD3' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -98.95 126.61 44.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.097 -0.956 . . . . 2.97 109.024 178.329 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.38 146.13 32.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.551 -0.75 . . . . 0.3 110.548 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.558 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -142.84 146.36 34.06 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.088 -0.506 . . . . 0.41 109.832 178.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 92' ' ' VAL . 32.2 tt0 -118.5 -56.08 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 3.97 110.845 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 91' ' ' GLU . 8.4 m 47.95 177.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.62 -0.718 . . . . 3.81 112.576 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 70.93 -69.23 0.19 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.567 -0.742 . . . . 2.89 111.472 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -88.61 178.75 6.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.018 0.437 . . . . 2.0 111.266 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.96 82.21 1.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.687 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -137.41 143.49 41.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 2.96 111.019 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 99' ' ' GLN . 20.4 m -99.0 -88.4 0.33 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.686 0.624 . . . . 1.55 112.686 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.86 36.22 0.17 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.903 0.383 . . . . 2.33 111.558 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 97' ' ' SER . 1.8 mt-30 -133.79 -41.3 0.85 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.016 -0.538 . . . . 2.51 109.697 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -94.39 75.86 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.293 -0.632 . . . . 3.1 109.293 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.33 154.33 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.707 -0.678 . . . . 1.31 109.851 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -139.64 173.85 11.11 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 111.968 0.359 . . . . 0.69 111.968 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.92 137.08 54.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.589 -0.444 . . . . 2.01 110.812 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.6 t -132.06 129.68 60.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 112.598 0.592 . . . . 0.46 112.598 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 2.7 mtt180 -134.89 149.59 50.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.591 -0.731 . . . . 1.85 112.82 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 14.0 m -119.28 120.8 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.313 -0.858 . . . . 1.1 109.99 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.506 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.11 27.23 9.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.42 0.628 . . . . 1.77 109.342 -176.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.5 21.33 41.08 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.016 -0.993 . . . . 0.41 112.671 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 82.8 m-70 -119.16 113.73 21.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.079 0.77 . . . . 0.46 113.079 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 p -64.49 124.7 22.49 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.507 -0.477 . . . . 0.66 111.046 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.19 -32.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.833 -0.621 . . . . 0.8 109.531 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.12 90.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.51 110.151 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 18.1 ptpt -104.19 137.85 41.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.033 -0.531 . . . . 2.44 110.41 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 22.6 m-20 87.47 18.24 0.07 Allowed 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.025 -1.472 . . . . 2.56 107.025 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 tp -45.78 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.983 -1.462 . . . . 1.1 111.763 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -102.89 90.41 3.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.162 -0.927 . . . . 1.99 109.317 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -52.15 -47.94 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 0.63 112.637 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.77 -44.61 96.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.936 0.347 . . . . 0.9 111.936 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.87 -27.73 63.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.159 0.429 . . . . 0.76 112.159 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -70.9 -58.1 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.247 0.462 . . . . 2.68 112.247 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -99.96 -40.29 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.073 0.398 . . . . 1.41 112.073 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.77 -134.36 8.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.458 -0.877 . . . . 1.06 112.568 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -83.79 120.46 26.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.585 0.231 . . . . 3.51 111.009 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.0 p 48.18 -121.96 1.47 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.095 -0.502 . . . . 1.68 110.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.9 p 51.13 -167.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.672 0.272 . . . . 0.8 111.635 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.416 ' HA ' ' HZ1' ' A' ' 88' ' ' LYS . . . -106.88 136.31 46.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.36 1.245 . . . . 0.44 114.36 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.1 t60 -108.8 141.51 40.73 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.267 -1.383 . . . . 0.38 107.267 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.29 119.33 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.772 0.656 . . . . 2.09 112.772 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.88 136.66 52.83 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.82 -0.627 . . . . 2.28 109.922 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.1 mt -112.51 133.33 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.44 -0.8 . . . . 0.71 110.639 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.82 85.75 34.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.349 0.499 . . . . 1.38 112.349 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.18 146.57 90.7 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.876 1.717 . . . . 0.22 111.784 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 134' ' ' SER . 23.7 mt -136.7 156.93 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 0.21 110.854 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -132.83 106.95 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 1.11 110.836 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 139' ' ' LYS . 25.7 mt -103.29 126.45 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.798 -0.637 . . . . 0.23 109.609 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 88.0 mttt -148.08 138.15 22.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.878 -0.329 . . . . 1.91 111.208 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 61.61 23.55 13.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 3.11 110.572 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.09 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.041 -0.599 . . . . 0.32 112.227 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.7 ' O ' HG23 ' A' ' 135' ' ' ILE . 59.3 mttt -114.72 159.03 21.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.383 0.135 . . . . 2.19 111.073 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 141' ' ' SER . 6.1 tt -121.09 124.15 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.076 0.465 . . . . 0.37 111.288 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 140' ' ' LEU . 24.5 t -114.1 109.53 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.674 -0.694 . . . . 0.9 110.014 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.4 p -103.57 106.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 0.53 111.031 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.95 -92.0 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.883 -0.599 . . . . 2.05 111.814 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.87 37.6 2.28 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.596 -0.811 . . . . 0.6 113.046 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.09 137.28 25.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.16 -0.311 . . . . 2.02 110.16 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.02 140.34 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.97 0.414 . . . . 1.3 110.976 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -162.69 126.93 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.901 -0.59 . . . . 1.12 110.447 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.7 t -56.22 140.82 43.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.867 -0.606 . . . . 1.11 112.406 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -79.62 139.24 37.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.403 -0.817 . . . . 0.28 109.284 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 36.0 p -136.11 95.88 3.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.223 0.823 . . . . 1.55 113.223 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.23 -60.7 1.46 Allowed Glycine 0 C--N 1.331 0.282 0 N-CA-C 115.549 0.98 . . . . 0.46 115.549 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.607 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -148.68 176.44 10.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.061 0.931 . . . . 1.8 112.978 -178.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.506 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -101.55 127.25 48.34 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.685 -1.228 . . . . 1.24 107.685 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.468 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.3 t -115.18 115.93 27.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.421 -0.912 . . . . 1.28 113.433 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.411 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 61.8 t -93.78 97.54 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.249 -0.649 . . . . 0.59 109.249 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 2.5 tt0 -108.04 135.74 48.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 2.48 111.407 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -130.84 143.2 50.57 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.747 -0.66 . . . . 1.54 109.729 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.6 t -122.66 144.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.421 -0.809 . . . . 0.77 111.653 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 146.36 30.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.738 -0.664 . . . . 1.97 110.88 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.9 -17.24 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.868 -0.682 . . . . 1.12 112.14 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -138.44 -61.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 3.81 110.429 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -175.25 150.9 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.097 -0.501 . . . . 3.82 110.877 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.18 89.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.194 -0.457 . . . . 1.4 111.437 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 70' ' ' SER . 1.4 m-20 -54.76 169.35 0.41 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.017 -0.538 . . . . 2.0 109.792 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.503 ' HD2' ' OD1' ' A' ' 164' ' ' ASN . 2.8 Cg_endo -36.4 105.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.321 2.014 . . . . 2.58 111.63 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -60.53 -46.74 89.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.269 -0.878 . . . . 3.71 112.34 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 25.1 t -116.1 135.02 57.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 112.807 0.669 . . . . 0.92 112.807 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -137.54 137.41 38.57 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 113.389 0.885 . . . . 1.2 113.389 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 15' ' ' ASN . . . -125.03 38.6 4.16 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.62 -1.173 . . . . 0.22 111.397 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.5 tp -50.11 127.05 15.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.737 -0.665 . . . . 1.02 111.448 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -142.09 115.5 8.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.667 -0.697 . . . . 0.33 110.831 -178.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -115.99 129.63 72.03 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 CA-C-O 123.126 1.441 . . . . 0.69 112.994 178.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.575 ' SD ' ' HB ' ' A' ' 84' ' ' VAL . 3.0 ppp? -124.24 168.4 13.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 112.957 -1.929 . . . . 1.26 109.834 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.633 ' NZ ' ' HG2' ' A' ' 79' ' ' GLU . 13.8 ptmt -120.45 156.05 32.26 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.167 1.543 . . . . 1.82 115.167 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 86.46 -34.87 3.4 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 111.833 -2.439 . . . . 0.22 118.082 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 177.62 158.55 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.209 2.004 . . . . 0.29 114.249 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.653 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.44 -23.73 27.75 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.331 -0.849 . . . . 0.57 110.425 177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.59 -29.68 66.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.692 -0.686 . . . . 2.31 111.649 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.14 -43.67 91.13 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.032 -0.267 . . . . 2.37 110.538 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 94.8 t -44.01 101.34 0.25 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.879 -0.601 . . . . 2.57 111.599 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.6 139.36 38.74 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.012 1.808 . . . . 2.08 112.617 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.6 mmt -147.18 127.01 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.9 -0.591 . . . . 6.04 110.692 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.24 122.23 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.029 -0.532 . . . . 5.3 111.146 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -52.36 149.61 9.99 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.961 -0.563 . . . . 8.05 110.313 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.64 124.36 12.27 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.653 1.569 . . . . 9.14 112.037 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -134.68 132.92 20.88 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.241 -0.436 . . . . 9.87 110.48 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.49 -36.57 2.92 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.989 1.793 . . . . 11.69 112.444 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -87.68 -101.33 0.89 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.934 -0.65 . . . . 12.62 112.618 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.9 104.24 1.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.731 0.301 . . . . 14.44 110.409 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 190' ' ' GLU . 1.4 pm0 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.123 -0.941 . . . . 15.7 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.561 -0.216 . . . . 9.15 112.561 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.27 83.7 1.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 7.36 110.85 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.2 mtt 56.63 80.8 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 7.76 110.983 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -98.92 -25.31 14.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 4.02 110.661 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.37 73.99 1.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.923 -0.656 . . . . 1.28 112.833 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.413 HD11 ' SD ' ' A' ' 173' ' ' MET . 22.1 tp -74.42 -49.54 22.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.143 0.497 . . . . 0.41 109.812 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.635 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.95 -21.72 22.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.822 . . . . 0.33 111.162 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.7 -19.78 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 2.09 111.909 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -101.44 -23.39 14.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.949 -0.301 . . . . 1.99 111.282 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.1 p -45.71 141.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.735 0.303 . . . . 0.21 111.725 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.28 -21.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.324 -0.551 . . . . 0.86 110.355 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.487 ' O ' HG22 ' A' ' 172' ' ' ILE . 60.4 t90 -173.83 144.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.28 109.71 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -164.31 144.91 8.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.628 0.603 . . . . 0.2 112.628 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.72 129.49 6.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 113.661 0.986 . . . . 0.67 113.661 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 60' ' ' LEU . 49.1 t30 -111.52 87.1 2.47 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.934 -1.136 . . . . 1.27 107.934 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.892 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -57.52 103.67 0.14 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.447 -1.251 . . . . 0.37 109.983 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.618 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 154.2 -17.95 0.62 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 113.898 -1.501 . . . . 0.67 115.576 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.7 -126.56 2.77 Favored Glycine 0 N--CA 1.459 0.191 0 C-N-CA 119.367 -1.396 . . . . 1.12 113.529 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -165.67 120.23 1.23 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.905 0.383 . . . . 2.02 111.695 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 76.2 p 32.88 94.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.244 -0.889 . . . . 1.22 112.882 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.664 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.3 t60 -128.9 137.61 51.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.826 -0.75 . . . . 0.34 112.351 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.0 p -113.68 105.17 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-O 121.387 0.613 . . . . 1.18 111.462 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 156.53 36.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.513 -0.767 . . . . 1.17 109.851 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 m -43.35 -46.72 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.761 1.023 . . . . 0.6 113.761 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -63.54 -13.91 45.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.083 0.468 . . . . 0.46 110.914 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.71 33.04 5.45 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.501 -0.772 . . . . 0.29 112.527 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 mm -103.92 112.23 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.184 0.516 . . . . 0.43 110.497 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 8.2 t60 -98.64 136.24 39.0 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.447 1.277 . . . . 0.52 114.447 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.637 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.89 132.32 43.58 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.73 -1.123 . . . . 3.0 108.649 177.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.516 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 22.8 mtt-85 -84.04 103.75 13.53 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 124.27 0.981 . . . . 2.9 112.685 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 30' ' ' ARG . 15.9 ttmm -14.61 124.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.003 1.112 . . . . 2.71 114.003 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -13.84 81.5 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 124.912 1.285 . . . . 1.98 113.822 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -110.22 21.7 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.188 2.592 . . . . 1.53 113.305 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.799 ' H ' HH12 ' A' ' 65' ' ' ARG . 1.5 tt -58.52 -75.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.917 -0.313 . . . . 1.83 110.461 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 34' ' ' LEU . 3.6 mt-10 177.44 107.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.678 0.621 . . . . 4.95 112.678 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.12 -0.86 60.53 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.678 -0.773 . . . . 1.94 112.439 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.722 ' HB2' HH21 ' A' ' 65' ' ' ARG . 1.0 OUTLIER -128.42 75.69 1.65 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.915 -0.314 . . . . 5.36 110.78 -178.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.0 123.65 65.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 2.97 111.018 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.22 64.04 3.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.93 -0.652 . . . . 1.99 112.85 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -145.17 -67.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.556 0.217 . . . . 6.59 110.884 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 64.81 120.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.285 -0.416 . . . . 2.01 111.118 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 9.2 t -96.42 57.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 2.02 111.031 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.34 23.56 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.153 -0.476 . . . . 2.23 110.185 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -54.4 102.71 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.7 -0.682 . . . . 2.33 110.911 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.94 106.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.788 -0.72 . . . . 2.2 112.653 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 41.9 mmm -84.83 -3.83 58.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 1.93 110.189 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 162.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.813 -0.63 . . . . 3.35 110.027 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.51 53.63 6.31 Favored Pre-proline 0 N--CA 1.464 0.227 0 N-CA-C 109.645 -0.502 . . . . 2.76 109.645 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HB2' ' CD ' ' A' ' 58' ' ' GLN . 42.0 Cg_endo -82.14 168.48 15.17 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.509 2.139 . . . . 1.46 112.728 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 125' ' ' THR . 1.2 mp -70.88 137.56 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.83 110.567 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.28 -48.15 7.56 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.098 0.777 . . . . 1.69 113.098 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -76.44 36.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.046 0.758 . . . . 2.56 113.046 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -151.45 145.01 24.92 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.075 0.464 . . . . 0.97 111.776 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 58' ' ' GLN . 16.9 t30 -58.96 144.84 81.39 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.543 -0.753 . . . . 1.96 110.822 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.67 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 14.6 Cg_exo -40.98 -53.68 2.82 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.949 2.433 . . . . 0.66 115.383 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -64.92 -55.28 20.23 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 122.474 1.131 . . . . 1.82 110.442 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -69.51 -9.25 53.02 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.721 -1.127 . . . . 1.91 109.733 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.67 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 30.1 tt0 -66.32 -49.68 66.18 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.834 -1.543 . . . . 1.5 106.834 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.32 -46.01 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.985 -1.007 . . . . 1.22 109.385 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.475 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 11.4 tp -72.29 -12.99 61.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.409 -0.814 . . . . 1.05 111.376 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.403 ' O ' HG12 ' A' ' 50' ' ' ILE . 6.7 m-30 -120.71 20.61 11.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.6 -0.727 . . . . 0.9 111.494 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -137.86 -59.61 0.65 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.35 0.87 . . . . 1.8 113.35 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 82.8 p -39.53 143.87 0.19 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.213 0.82 . . . . 1.05 113.213 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.618 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.6 OUTLIER -127.28 145.06 50.92 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.897 -0.592 . . . . 2.05 111.51 -179.258 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.799 HH12 ' H ' ' A' ' 34' ' ' LEU . 47.6 ttt180 -107.34 172.0 7.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.895 -0.593 . . . . 3.58 110.015 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -57.72 174.97 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.829 0.347 . . . . 4.25 110.97 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.526 ' HB2' ' OD1' ' A' ' 164' ' ' ASN . 2.7 p-10 -150.26 167.48 26.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 4.35 111.632 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.45 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 9.8 tp10 -163.02 -83.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.042 -0.526 . . . . 3.17 111.311 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 2.9 p30 -173.37 132.43 0.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.398 0.142 . . . . 2.39 110.845 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t 43.4 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.426 -0.352 . . . . 0.99 110.425 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.483 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 0.6 OUTLIER -149.3 158.22 44.0 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.8 -0.36 . . . . 1.26 111.569 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.45 -149.21 7.71 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.24 -0.981 . . . . 0.66 114.367 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.463 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -129.71 168.84 15.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.543 0.687 . . . . 0.83 112.536 -177.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.52 132.52 55.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.451 -1.25 . . . . 2.27 110.348 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.429 ' C ' ' HB2' ' A' ' 152' ' ' LYS . 4.4 mp -124.88 86.89 55.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.437 0.532 . . . . 0.34 112.437 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -55.37 132.41 52.05 Favored 'Trans proline' 0 N--CA 1.474 0.364 0 C-N-CA 122.271 1.981 . . . . 0.8 112.325 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.93 151.31 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.231 -0.441 . . . . 0.38 111.067 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -140.84 1.38 1.68 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.173 -0.467 . . . . 2.96 111.193 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -124.34 172.98 8.7 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.592 0.234 . . . . 2.13 110.819 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -127.24 165.37 19.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.379 0.609 . . . . 0.37 111.658 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.06 26.51 Favored Glycine 0 C--N 1.329 0.144 0 N-CA-C 109.874 -1.29 . . . . 0.21 109.874 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -96.95 107.25 19.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.95 1.375 . . . . 2.03 108.857 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 1.9 m-85 -95.39 127.46 41.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.573 0.702 . . . . 0.26 109.189 -178.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.604 HG21 ' N ' ' A' ' 177' ' ' ALA . 17.1 t -118.04 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.853 -1.067 . . . . 0.54 113.284 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.48 105.96 17.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.121 -0.945 . . . . 1.23 110.381 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.4 106.12 18.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.14 -0.689 . . . . 1.31 109.14 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.475 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -116.35 134.21 55.14 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.486 -0.486 . . . . 1.37 112.248 -178.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.535 ' NZ ' ' HB1' ' A' ' 126' ' ' ALA . 10.6 tptp -106.59 115.89 30.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.272 -1.01 . . . . 2.97 108.272 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 9.9 m-85 -104.77 143.64 32.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.535 -0.543 . . . . 0.3 109.535 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 167' ' ' VAL . . . -149.63 155.62 40.55 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.088 -0.645 . . . . 0.41 111.001 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -165.32 152.62 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.95 0.405 . . . . 3.97 111.238 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.03 -21.83 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.75 -0.659 . . . . 3.81 110.401 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -70.76 135.0 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 2.89 111.057 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 61.39 97.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.075 -0.511 . . . . 2.0 110.871 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.53 79.07 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.174 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 118' ' ' PHE . 2.4 pp0? -135.25 157.22 47.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 2.96 110.768 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.418 ' HB3' ' OD2' ' A' ' 119' ' ' ASP . 10.8 m -137.65 147.72 45.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 1.55 111.708 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 54.03 24.75 4.93 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.868 -0.606 . . . . 2.33 111.288 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -125.32 -56.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.602 -0.518 . . . . 2.51 109.602 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -94.63 96.78 9.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.069 -0.715 . . . . 3.1 109.069 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.529 HG12 ' OD2' ' A' ' 116' ' ' ASP . 0.6 OUTLIER -109.2 148.99 12.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.569 . . . . 1.31 110.553 -178.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -120.35 -178.27 3.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.839 0.681 . . . . 0.69 112.839 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -130.98 143.08 50.46 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 115.876 -0.602 . . . . 2.01 112.131 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.22 132.68 46.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.778 -0.646 . . . . 0.46 112.151 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 12.9 ptt180 -134.35 151.65 51.35 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 115.318 -0.855 . . . . 1.85 112.738 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 10.7 m -124.99 123.95 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.752 -1.113 . . . . 1.1 110.384 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.464 ' HA ' ' H ' ' A' ' 154' ' ' SER . 7.0 t-20 52.72 26.79 4.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.991 -0.744 . . . . 1.77 108.991 -177.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.81 29.34 18.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.961 -1.018 . . . . 0.41 112.666 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 80.3 m-70 -129.43 111.16 12.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.266 0.839 . . . . 0.46 113.266 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.8 p -65.75 119.21 10.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.022 0.439 . . . . 0.66 111.259 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.52 -33.48 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.625 -0.716 . . . . 0.8 110.015 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.58 90.54 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.214 -0.661 . . . . 0.51 109.214 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -103.39 77.1 1.48 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 122.295 1.045 . . . . 2.44 111.406 -179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 2.5 p30 156.87 35.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 113.67 -1.605 . . . . 2.56 109.152 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 93.81 0.14 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.292 0.568 . . . . 1.1 111.677 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.529 ' OD2' HG12 ' A' ' 101' ' ' VAL . 6.4 m-20 -104.58 81.12 1.75 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.766 -1.568 . . . . 1.99 106.766 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.3 mt -50.35 -38.29 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.972 -1.013 . . . . 0.63 112.821 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 96' ' ' GLN . 14.1 t80 -71.09 -43.46 67.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.862 -0.335 . . . . 0.9 111.476 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 97' ' ' SER . 9.4 t70 -66.12 -27.35 67.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.657 0.265 . . . . 0.76 111.38 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -72.18 -58.6 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.488 0.551 . . . . 2.68 112.488 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 m -96.33 -40.4 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.943 0.349 . . . . 1.41 111.943 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.89 -98.85 1.89 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.721 . . . . 1.06 112.046 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -68.56 159.43 31.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.026 -0.361 . . . . 3.51 110.026 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.4 p -57.4 94.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 1.68 110.963 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 50' ' ' ILE . 23.8 p -140.75 -148.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 0.8 110.029 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.535 ' HB1' ' NZ ' ' A' ' 88' ' ' LYS . . . -112.8 133.84 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.747 0.647 . . . . 0.44 112.747 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.522 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 1.9 t60 -111.53 149.29 31.59 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.494 -0.928 . . . . 0.38 108.494 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' HZ3' ' A' ' 88' ' ' LYS . 19.5 t70 -141.73 132.07 25.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.31 0.576 . . . . 2.09 112.517 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.96 114.36 16.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.137 -0.938 . . . . 2.28 109.891 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.19 129.99 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 0.71 110.55 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.4 89.52 47.19 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 116.417 -0.356 . . . . 1.38 111.933 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -64.05 150.57 88.08 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.056 1.837 . . . . 0.22 112.011 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 134' ' ' SER . 34.2 mt -140.55 157.26 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.336 . . . . 0.21 111.018 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 35.4 p -133.53 106.41 7.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 1.11 110.747 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 139' ' ' LYS . 32.5 mt -105.5 126.51 60.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 115.761 -0.654 . . . . 0.23 109.865 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' A' ' 134' ' ' SER . 50.4 mttp -148.38 143.59 26.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.769 0.319 . . . . 1.91 110.961 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt 57.69 13.89 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 3.11 111.287 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.15 23.48 27.12 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.641 -0.79 . . . . 0.32 113.075 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.516 ' O ' HG23 ' A' ' 135' ' ' ILE . 1.3 mmmm -123.57 155.48 37.56 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.236 0.518 . . . . 2.19 110.41 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 141' ' ' SER . 5.7 tt -113.45 129.47 56.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.076 0.465 . . . . 0.37 111.878 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.566 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.0 t -116.66 110.01 17.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.653 -0.703 . . . . 0.9 109.472 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 142' ' ' VAL . 7.5 p -103.11 104.55 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.966 -0.561 . . . . 0.53 111.011 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 57.96 -91.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.965 -0.561 . . . . 2.05 111.856 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.0 21.9 6.12 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.554 -0.831 . . . . 0.6 113.414 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -127.79 136.08 50.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.056 -0.349 . . . . 2.02 110.056 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.15 136.96 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.049 0.452 . . . . 1.3 111.141 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.4 m -155.93 175.3 14.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.761 -0.654 . . . . 1.12 109.26 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.29 141.78 32.67 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.604 -0.438 . . . . 1.11 111.757 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -77.63 129.99 36.3 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.477 -0.935 . . . . 0.28 108.477 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 69.3 p -126.61 94.92 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.506 0.928 . . . . 1.55 113.506 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.03 -51.24 0.74 Allowed Glycine 0 CA--C 1.52 0.371 0 N-CA-C 116.328 1.291 . . . . 0.46 116.328 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.539 ' N ' ' HE2' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -156.37 164.31 38.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 118.443 1.121 . . . . 1.8 112.618 -177.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.39 127.11 35.49 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.357 -1.349 . . . . 1.24 107.357 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.464 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.7 t -113.42 112.91 24.42 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 119.698 -0.801 . . . . 1.28 112.988 -176.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 104.06 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.277 -0.419 . . . . 0.59 110.344 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -125.11 156.94 37.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.226 0.536 . . . . 2.48 111.357 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.87 145.23 41.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.338 -0.846 . . . . 1.54 110.065 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 t -115.31 143.92 24.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.414 -0.812 . . . . 0.77 111.02 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -75.92 144.59 40.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.483 -0.78 . . . . 1.97 111.116 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -94.62 -31.76 7.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.827 -0.701 . . . . 1.12 111.745 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.42 -56.96 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.458 . . . . 3.81 109.925 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -172.45 148.07 1.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.654 -0.703 . . . . 3.82 110.372 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 65.42 71.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.277 0.56 . . . . 1.4 111.07 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -50.25 169.67 0.19 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 114.93 -1.032 . . . . 2.0 109.443 178.171 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -37.22 110.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 121.773 1.649 . . . . 2.58 111.979 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -64.27 -69.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.091 -0.959 . . . . 3.71 112.93 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 63' ' ' THR . 91.9 t -87.27 132.1 33.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 112.044 0.386 . . . . 0.92 112.044 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.892 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.58 123.41 21.29 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.759 0.662 . . . . 1.2 112.669 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . . . -118.84 40.46 3.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.748 -1.115 . . . . 0.22 112.985 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 tp -56.05 129.16 38.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.462 0.649 . . . . 1.02 111.035 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -139.95 114.03 8.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.041 -0.982 . . . . 0.33 109.743 -178.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.648 HD13 ' N ' ' A' ' 173' ' ' MET . 0.2 OUTLIER -111.23 126.78 68.64 Favored 'Isoleucine or valine' 0 C--O 1.258 1.513 0 CA-C-O 122.947 1.356 . . . . 0.69 113.353 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.648 ' N ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -121.61 165.95 14.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.141 -1.845 . . . . 1.26 109.539 -179.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 10.6 ptmt -120.36 142.9 48.74 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 114.886 1.439 . . . . 1.82 114.886 -177.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.4 -34.89 5.4 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 112.837 -1.983 . . . . 0.22 117.737 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.41 ' C ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 178.27 158.26 0.47 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.393 2.096 . . . . 0.29 114.26 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.604 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.18 -27.96 24.22 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 114.729 -1.123 . . . . 0.57 110.034 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -59.23 -29.05 67.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.6 -0.727 . . . . 2.31 111.153 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.9 -49.54 71.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.385 . . . . 2.37 110.138 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 22.1 t -38.72 100.38 0.21 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 115.872 -0.603 . . . . 2.57 111.588 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.47 115.05 1.71 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.039 1.826 . . . . 2.08 112.602 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 67.9 mtt -109.84 149.06 30.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 6.04 110.583 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 183' ' ' LEU . 1.9 pt? -154.24 128.92 9.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.002 0.43 . . . . 5.3 110.938 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -62.77 148.04 92.25 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.878 -0.601 . . . . 8.05 109.899 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.08 127.17 19.55 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.557 1.505 . . . . 9.14 112.032 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.601 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 41.4 t60 -130.76 129.53 22.68 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.111 -0.495 . . . . 9.87 110.683 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.601 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 10.3 Cg_endo -84.52 -32.65 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.178 1.918 . . . . 11.69 112.906 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 156.76 157.53 8.4 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.376 -0.916 . . . . 12.62 112.723 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.22 153.15 33.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 14.44 110.785 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.343 -0.837 . . . . 15.7 110.723 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.507 -0.237 . . . . 9.15 112.507 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.98 20.83 6.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.828 0.346 . . . . 7.36 110.945 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 tpt -146.4 -55.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 7.76 110.677 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.4 p -68.72 172.38 6.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 4.02 110.489 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.69 67.69 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 1.28 112.484 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.4 tp -80.27 -47.23 14.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.25 0.547 . . . . 0.41 110.344 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.546 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -53.85 -21.54 7.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.246 -0.888 . . . . 0.33 111.77 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.98 -23.41 41.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.637 0.606 . . . . 2.09 112.637 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.57 -21.27 15.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.618 -0.433 . . . . 1.99 111.871 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.6 p -44.37 144.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 121.146 -0.221 . . . . 0.21 111.245 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 pt -135.86 -20.33 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 119.686 -0.806 . . . . 0.86 111.258 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.457 ' O ' HG22 ' A' ' 172' ' ' ILE . 23.5 t90 -174.07 139.54 0.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.765 -0.374 . . . . 0.28 110.17 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -160.21 142.04 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.101 0.408 . . . . 0.2 112.101 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.9 t -147.52 129.29 6.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 114.567 1.321 . . . . 0.67 114.567 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' LEU . 15.6 t30 -115.23 96.72 5.81 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.089 0.471 . . . . 1.27 110.385 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.905 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -68.16 114.19 6.45 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 115.683 -0.689 . . . . 0.37 109.709 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 145.61 -36.06 1.37 Allowed Glycine 0 C--N 1.342 0.882 0 O-C-N 124.767 1.292 . . . . 0.67 113.674 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.5 -132.37 6.2 Favored Glycine 0 N--CA 1.454 -0.102 0 C-N-CA 120.313 -0.946 . . . . 1.12 113.36 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.31 120.75 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.588 0.233 . . . . 2.02 110.669 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 77.8 p 28.46 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.598 -0.728 . . . . 1.22 112.672 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.591 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 75.8 t60 -119.11 151.6 38.0 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 119.921 -0.712 . . . . 0.34 112.343 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.59 103.71 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.27 -0.877 . . . . 1.18 109.969 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.83 153.19 42.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.074 -0.512 . . . . 1.17 110.305 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 25' ' ' HIS . 11.4 m -43.76 -51.26 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 124.17 0.919 . . . . 0.6 113.212 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.4 ' N ' HG23 ' A' ' 24' ' ' VAL . 84.7 m-70 -58.68 -17.92 26.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.134 0.492 . . . . 0.46 110.532 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.11 35.51 3.92 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.367 -0.833 . . . . 0.29 112.432 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.7 mm -103.62 121.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.858 -0.423 . . . . 0.43 109.858 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 11.4 t60 -103.27 134.75 46.14 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.686 1.365 . . . . 0.52 114.686 -176.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -99.23 132.52 44.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.055 -0.975 . . . . 3.0 108.77 176.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.436 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 50.1 mtt180 -87.51 108.45 19.04 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.666 0.604 . . . . 2.9 112.047 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 32' ' ' ASP . 39.0 tttt -23.57 135.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.947 0.899 . . . . 2.71 112.97 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 4.1 p-10 -11.41 84.04 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 124.228 0.955 . . . . 1.98 112.884 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 13.5 Cg_endo -97.65 -10.3 0.58 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.51 2.14 . . . . 1.53 114.856 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -114.58 -16.51 11.86 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.845 -0.742 . . . . 1.83 112.809 -178.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.496 ' N ' HD13 ' A' ' 34' ' ' LEU . 12.6 mm-40 -96.14 72.92 2.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 4.95 110.914 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.85 -2.99 47.11 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.601 -0.809 . . . . 1.94 111.187 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 33.49 64.28 0.32 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.03 -0.585 . . . . 5.36 111.527 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.59 141.28 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.585 -0.734 . . . . 2.97 110.626 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -42.72 101.99 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 CA-C-N 116.239 -0.437 . . . . 1.99 113.437 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.732 ' HB3' HH22 ' A' ' 65' ' ' ARG . 58.4 ttt180 -175.11 148.4 0.99 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.732 0.301 . . . . 6.59 110.563 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.24 -60.4 0.28 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.379 -0.373 . . . . 2.01 110.964 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t 61.68 97.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 2.02 111.317 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -95.73 -26.25 15.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.532 . . . . 2.23 110.31 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.9 t80 64.28 -75.52 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.768 -0.651 . . . . 2.33 111.007 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.55 112.83 0.56 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.602 -0.808 . . . . 2.2 112.693 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.1 mtt -81.33 -1.54 45.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.351 0.596 . . . . 1.93 109.396 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -48.96 -22.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.892 -1.049 . . . . 3.35 112.102 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.51 73.72 4.16 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.156 -0.683 . . . . 2.76 109.156 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HB2' ' CD ' ' A' ' 58' ' ' GLN . 16.6 Cg_endo -90.39 170.46 3.84 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.674 2.249 . . . . 1.46 114.322 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 61' ' ' TYR . 1.1 mp -75.4 148.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.095 -0.957 . . . . 0.83 110.16 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.48 -51.75 4.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.176 0.806 . . . . 1.69 113.176 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -74.25 36.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.205 0.817 . . . . 2.56 113.205 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.4 t -150.32 149.48 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 0.97 112.041 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 58' ' ' GLN . 44.1 t30 -64.29 147.07 97.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.511 -0.768 . . . . 1.96 109.925 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.666 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 20.8 Cg_exo -41.7 -50.62 4.79 Favored 'Trans proline' 0 C--N 1.359 1.13 0 C-N-CA 122.366 2.044 . . . . 0.66 114.218 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -55.36 14.26 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.934 0.873 . . . . 1.82 110.978 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' OD1' HD23 ' A' ' 60' ' ' LEU . 14.2 t70 -67.96 -11.37 58.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.649 -0.705 . . . . 1.91 109.387 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.666 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 20.9 tt0 -65.95 -49.23 68.64 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.007 -1.479 . . . . 1.5 107.007 177.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.7 t -51.15 -47.51 32.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.011 -0.995 . . . . 1.22 109.193 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 tp -71.52 -13.34 61.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.028 -0.987 . . . . 1.05 111.787 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.456 ' O ' HG12 ' A' ' 50' ' ' ILE . 8.0 m-30 -121.4 21.21 11.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.712 -0.676 . . . . 0.9 111.244 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -140.15 -59.75 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.569 0.951 . . . . 1.8 113.569 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.541 ' HB ' ' C ' ' A' ' 17' ' ' GLY . 37.9 p -45.54 136.86 5.43 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.985 0.735 . . . . 1.05 112.985 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.557 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.5 pt-20 -121.49 150.06 42.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.985 -0.552 . . . . 2.05 111.417 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.732 HH22 ' HB3' ' A' ' 40' ' ' ARG . 12.7 ttt85 -117.66 147.76 42.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 3.58 110.343 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -74.14 148.78 41.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 4.25 111.778 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -153.38 -173.87 4.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.762 -0.654 . . . . 4.35 110.276 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -122.7 -69.96 0.8 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.644 0.259 . . . . 3.17 111.286 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -160.75 138.81 9.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.477 -0.329 . . . . 2.39 110.28 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t 54.32 87.97 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.814 -0.439 . . . . 0.99 109.814 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.598 ' HE1' ' ND2' ' A' ' 164' ' ' ASN . 3.0 p90 -133.43 136.12 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.189 0.519 . . . . 1.26 111.1 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.44 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -154.25 -156.8 7.84 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.401 -0.818 . . . . 0.66 113.594 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.4 ' CE1' HD23 ' A' ' 170' ' ' LEU . 0.7 OUTLIER -139.3 163.89 31.28 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.163 0.506 . . . . 0.83 111.213 -178.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -116.04 114.11 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.21 -0.904 . . . . 2.27 110.667 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.7 mp -105.73 112.56 64.49 Favored Pre-proline 0 C--O 1.224 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.34 111.548 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.01 141.44 11.83 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 120.219 1.114 . . . . 0.8 111.604 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 78' ' ' LYS . 57.0 mt -132.25 151.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.039 0.447 . . . . 0.38 111.675 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' N ' HG22 ' A' ' 77' ' ' ILE . 99.6 mttt -142.95 -4.58 0.92 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.837 -0.62 . . . . 2.96 110.958 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -119.57 173.05 7.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.552 0.215 . . . . 2.13 110.817 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.0 OUTLIER -127.26 175.63 8.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.242 0.544 . . . . 0.37 111.425 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.3 -146.86 18.51 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 109.965 -1.254 . . . . 0.21 109.965 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 19.2 mt-10 -104.68 109.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.722 1.261 . . . . 2.03 109.433 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.13 127.46 42.15 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.229 -0.656 . . . . 0.26 109.229 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.632 HG21 ' N ' ' A' ' 177' ' ' ALA . 21.4 t -113.87 120.83 64.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.995 -1.002 . . . . 0.54 112.388 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -94.01 105.8 17.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.931 -1.032 . . . . 1.23 111.367 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 48.2 t -106.17 116.22 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.069 -0.969 . . . . 1.31 108.859 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 133.6 45.17 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.3 -0.56 . . . . 1.37 110.978 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.459 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 9.2 tptp -100.13 118.8 37.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 119.605 -0.838 . . . . 2.97 109.16 177.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 1.3 m-85 -105.94 136.62 45.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.14 -1.059 . . . . 0.3 108.14 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 91' ' ' GLU . . . -153.78 169.13 24.11 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.42 -0.912 . . . . 0.41 112.025 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 21.4 tt0 175.08 137.71 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.807 -0.633 . . . . 3.97 110.225 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.2 t -141.83 95.68 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.288 . . . . 3.81 111.234 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -146.45 -77.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 2.89 111.438 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -92.43 -33.75 14.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 2.0 110.808 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 56.71 92.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 1.0 111.747 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -174.22 151.27 1.63 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.032 -0.531 . . . . 2.96 110.449 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 98' ' ' GLN . 18.2 m -86.36 179.07 6.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.357 -0.383 . . . . 1.55 111.941 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 97' ' ' SER . 84.1 mm-40 70.84 -68.55 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.421 -0.809 . . . . 2.33 111.29 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -62.42 -17.61 59.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 2.51 110.662 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 1.7 mptm? -110.43 52.23 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 3.1 110.305 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.409 HG22 ' C ' ' A' ' 114' ' ' ASP . 0.8 OUTLIER -109.59 133.95 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.295 -0.632 . . . . 1.31 109.295 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 164' ' ' ASN . 61.2 m-85 -138.89 170.91 15.14 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.552 0.945 . . . . 0.69 113.552 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 157' ' ' PHE . 5.1 m-20 -112.89 136.95 51.96 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.555 -0.458 . . . . 2.01 110.444 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.02 128.98 65.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 111.997 0.369 . . . . 0.46 111.997 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 109' ' ' HIS . 15.7 ptt180 -133.63 147.55 51.47 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.351 0.871 . . . . 1.85 113.351 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m -122.18 120.59 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 114.761 -1.108 . . . . 1.1 109.807 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.504 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 55.38 27.21 9.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.308 0.575 . . . . 1.77 109.49 -176.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.39 14.07 57.67 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.224 -0.898 . . . . 0.41 112.938 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 79.0 m-70 -110.66 111.19 22.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.264 0.839 . . . . 0.46 113.264 -178.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -69.25 112.6 5.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.004 0.43 . . . . 0.66 110.418 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.67 -37.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 0.8 110.848 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.33 91.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.134 -0.626 . . . . 0.51 111.121 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 10.9 ptmm? -101.88 146.75 27.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.374 -0.83 . . . . 2.44 109.706 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 5.4 m-20 77.24 33.27 0.43 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.865 -1.061 . . . . 2.56 108.741 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.14 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.532 -0.758 . . . . 1.1 112.126 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 44.7 p-10 -101.52 84.21 2.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.151 -0.685 . . . . 1.99 109.151 176.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.2 pt -51.25 -37.24 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.648 -0.706 . . . . 0.63 112.231 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -57.08 -44.69 83.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.543 -0.298 . . . . 0.9 111.57 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.19 -28.18 63.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.83 0.308 . . . . 0.76 111.83 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -72.25 -58.82 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.205 0.446 . . . . 2.68 112.205 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.3 m -88.63 -40.41 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 111.846 0.313 . . . . 1.41 111.846 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.73 -93.37 0.65 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.747 -0.739 . . . . 1.06 111.94 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.472 ' O ' HG23 ' A' ' 125' ' ' THR . 61.0 m80 -115.08 110.4 19.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.517 0.198 . . . . 3.51 110.952 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.7 p 54.42 -144.84 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.269 -0.423 . . . . 1.68 111.21 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 123' ' ' HIS . 5.5 p 68.45 -172.67 0.19 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.987 0.515 . . . . 0.8 111.743 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.45 141.67 37.38 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.769 0.655 . . . . 0.44 112.769 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 15.7 t60 -101.88 157.4 16.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.606 -0.724 . . . . 0.38 109.103 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -143.0 113.51 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.464 0.542 . . . . 2.09 112.464 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -108.12 116.88 32.77 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.678 -0.692 . . . . 2.28 110.078 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.7 mt -109.66 130.0 63.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.72 -0.673 . . . . 0.71 110.109 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.71 89.53 25.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.34 0.496 . . . . 1.38 112.34 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -61.53 149.65 88.76 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.943 1.762 . . . . 0.22 111.926 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 26.1 mt -140.06 156.71 25.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.21 111.101 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 133' ' ' ILE . 39.9 t -130.6 107.24 9.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 1.11 110.82 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 26.2 mt -107.6 129.03 62.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.811 -0.631 . . . . 0.23 110.393 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -147.62 139.35 24.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 1.91 110.771 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp 54.57 28.39 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 3.11 110.646 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.16 28.37 58.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.32 112.544 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.548 ' NZ ' ' HB2' ' A' ' 139' ' ' LYS . 4.4 ttmp? -121.89 146.04 47.5 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.386 -0.228 . . . . 2.19 110.386 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 141' ' ' SER . 5.4 tt -114.17 130.71 56.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.107 0.48 . . . . 0.37 112.077 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.57 ' N ' HD23 ' A' ' 140' ' ' LEU . 22.2 t -127.07 110.01 12.48 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.617 -0.72 . . . . 0.9 109.73 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 144' ' ' GLY . 3.2 p -102.94 131.34 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.53 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 46.96 -90.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.821 0.304 . . . . 2.05 111.821 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . -136.66 25.87 3.07 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.694 -0.765 . . . . 0.6 113.346 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -124.03 142.68 50.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.69 -0.485 . . . . 2.02 109.69 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.49 145.97 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 1.3 111.404 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.2 t -163.3 167.85 21.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.381 -0.6 . . . . 1.12 109.381 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.6 139.58 35.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.561 -0.456 . . . . 1.11 111.482 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -79.24 123.95 27.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.535 -1.283 . . . . 0.28 107.535 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.1 m -129.24 94.23 3.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.418 -0.913 . . . . 1.55 112.874 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.32 -48.79 1.84 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 116.778 1.471 . . . . 0.46 116.778 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -159.44 154.56 25.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.997 1.398 . . . . 1.8 113.817 -176.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -86.58 131.77 34.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.352 -0.981 . . . . 1.24 108.352 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.443 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.5 t -118.14 114.77 23.56 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.807 -0.757 . . . . 1.28 112.53 -177.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.55 111.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.743 -0.383 . . . . 0.59 111.35 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' CD ' ' HA3' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -140.22 160.57 39.66 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.162 0.506 . . . . 2.48 111.302 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -132.96 140.45 47.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.459 -0.791 . . . . 1.54 109.789 177.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.44 144.63 13.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.353 -0.839 . . . . 0.77 111.989 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.579 ' NZ ' ' HB2' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -57.62 136.01 56.76 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.116 -0.947 . . . . 1.97 111.435 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.85 -32.16 2.52 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.869 -0.605 . . . . 1.12 111.644 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -143.0 -65.46 0.39 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.696 0.284 . . . . 3.81 110.26 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -176.86 152.2 0.93 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.128 -0.487 . . . . 3.82 110.975 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 64.08 40.97 6.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.942 -0.572 . . . . 1.4 112.406 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.709 ' N ' ' HD2' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -60.4 -39.26 66.18 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-O 118.804 -0.617 . . . . 2.0 110.01 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 164' ' ' ASN . 95.5 Cg_exo -23.51 -59.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.415 2.744 . . . . 2.58 111.786 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 164' ' ' ASN . 10.3 ptmm? 32.35 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.603 -1.181 . . . . 3.71 113.06 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 64' ' ' GLU . 46.0 t -96.16 133.62 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 121.045 -0.262 . . . . 0.92 111.295 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.905 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -131.48 126.83 36.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.204 -0.598 . . . . 1.2 111.689 -179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.459 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -122.37 37.03 4.49 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.957 1.095 . . . . 0.22 113.957 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -35.45 134.37 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.001 0.429 . . . . 1.02 111.889 179.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.51 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -155.16 101.76 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.732 -0.667 . . . . 0.33 109.831 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.501 HD13 ' N ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -110.05 123.8 66.25 Favored 'Isoleucine or valine' 0 C--O 1.259 1.572 0 CA-C-O 123.037 1.398 . . . . 0.69 112.93 179.33 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.501 ' N ' HD13 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -114.19 160.55 18.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.256 -1.793 . . . . 1.26 108.768 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.415 ' HG2' ' N ' ' A' ' 175' ' ' GLY . 4.0 tmtt? -119.93 141.07 49.96 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.43 1.27 . . . . 1.82 114.43 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 174' ' ' LYS . . . 104.97 -33.92 6.19 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 112.695 -2.048 . . . . 0.22 117.639 175.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.29 156.33 0.41 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.2 2.0 . . . . 0.29 114.601 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.632 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -86.26 -26.22 25.11 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 114.994 -1.003 . . . . 0.57 110.277 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.77 -9.98 11.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.913 -0.585 . . . . 2.31 111.594 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.47 -65.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.535 -0.302 . . . . 2.37 111.012 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 180' ' ' VAL . 3.2 p -42.19 100.85 0.23 Allowed Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.383 0.427 . . . . 2.57 111.318 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.88 114.92 1.57 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.815 1.676 . . . . 2.08 112.575 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 41.9 tpp -131.25 146.28 52.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.952 -0.567 . . . . 6.04 110.541 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 183' ' ' LEU . 3.4 mm? -98.09 121.93 40.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 5.3 110.69 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -55.05 147.82 32.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 8.05 110.172 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.87 126.92 17.49 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.59 1.526 . . . . 9.14 112.207 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -134.05 133.27 21.85 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.113 -0.494 . . . . 9.87 110.098 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.5 -37.72 3.98 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.028 1.819 . . . . 11.69 112.48 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.48 -171.98 42.74 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.913 -0.66 . . . . 12.62 112.392 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.5 mt -111.81 120.03 40.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 14.44 110.826 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.227 -0.892 . . . . 15.7 110.998 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.395 -0.282 . . . . 9.15 112.395 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.79 28.79 14.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.316 . . . . 7.36 111.077 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 ttt -83.1 103.47 12.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.273 -0.421 . . . . 7.76 110.706 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.2 p -126.92 159.32 34.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 4.02 110.612 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.6 56.72 0.13 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.717 -0.754 . . . . 1.28 112.472 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 tp -57.8 -43.85 85.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.228 0.537 . . . . 0.41 110.333 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -54.62 -21.53 10.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.233 -0.894 . . . . 0.33 111.371 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.5 -23.4 46.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.012 0.375 . . . . 2.09 112.012 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -97.12 -23.09 16.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.761 -0.376 . . . . 1.99 111.375 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 7' ' ' ALA . 7.0 p -44.86 145.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 120.623 0.249 . . . . 0.21 111.613 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.98 -32.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.123 -0.631 . . . . 0.86 110.848 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.492 ' O ' HG22 ' A' ' 172' ' ' ILE . 71.2 t90 -166.23 124.06 1.44 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.842 -0.343 . . . . 0.28 110.304 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.15 141.97 28.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.489 -0.323 . . . . 0.2 111.785 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 170' ' ' LEU . 2.5 t -147.56 130.89 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 113.442 0.904 . . . . 0.67 113.442 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 60' ' ' LEU . 21.0 t-20 -110.14 89.44 3.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 107.865 -1.161 . . . . 1.27 107.865 175.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.674 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -58.33 99.07 0.04 OUTLIER 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.008 -0.996 . . . . 0.37 109.605 -177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.72 -88.99 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.736 -1.12 . . . . 0.67 114.355 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' ' HB ' ' A' ' 63' ' ' THR . . . -78.56 -117.7 0.22 Allowed Glycine 0 CA--C 1.512 -0.127 0 C-N-CA 121.085 -0.579 . . . . 1.12 113.419 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -145.04 148.52 33.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.635 -0.135 . . . . 2.02 110.635 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 64.6 m -12.36 120.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.171 0.804 . . . . 1.22 113.171 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 29.0 t60 -139.09 150.42 45.7 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.095 0.474 . . . . 0.34 111.915 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.57 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.573 -0.74 . . . . 1.18 111.298 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 154.75 41.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 1.17 110.472 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 25' ' ' HIS . 12.0 m -44.35 -51.23 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 124.081 0.863 . . . . 0.6 113.147 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.408 ' N ' HG23 ' A' ' 24' ' ' VAL . 80.3 m-70 -58.16 -18.52 26.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.268 0.556 . . . . 0.46 110.354 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 34.96 4.02 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.333 -0.849 . . . . 0.29 112.232 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -103.64 121.34 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 0.43 110.084 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 12.7 t60 -101.08 135.82 41.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 114.271 1.211 . . . . 0.52 114.271 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -102.86 136.78 42.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.975 -1.12 . . . . 3.0 107.975 176.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.435 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 48.8 mtt180 -91.42 108.06 19.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.178 0.513 . . . . 2.9 112.247 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' NZ ' ' HA2' ' A' ' 39' ' ' GLY . 63.5 tttm -25.1 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.724 -1.126 . . . . 2.71 113.818 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.603 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 6.0 m-20 -7.31 80.27 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.875 1.27 . . . . 1.98 113.886 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 17.3 Cg_endo -101.22 12.71 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.623 2.215 . . . . 1.53 113.826 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 35' ' ' GLU . 7.9 tt -113.4 -62.91 1.52 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.895 0.331 . . . . 1.83 111.895 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.595 ' H ' ' NH2' ' A' ' 65' ' ' ARG . 12.6 mm-40 -56.97 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.926 0.393 . . . . 4.95 110.246 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.74 -2.28 41.39 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.685 -0.966 . . . . 1.94 110.685 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 49.17 38.42 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.973 -0.613 . . . . 5.36 110.942 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 m -143.36 177.48 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.559 -0.746 . . . . 2.97 110.335 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.533 ' HA2' ' NZ ' ' A' ' 31' ' ' LYS . . . -52.6 92.94 0.01 OUTLIER Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.947 -0.645 . . . . 1.99 113.229 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.542 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 5.9 mmp_? -151.13 75.34 1.19 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.825 0.345 . . . . 6.59 110.552 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.15 -54.49 4.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 2.01 111.327 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.6 t 55.04 63.54 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 2.02 110.251 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.31 50.88 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.664 -0.698 . . . . 2.23 110.689 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -71.34 -54.19 11.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.014 -0.539 . . . . 2.33 111.003 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.99 36.43 2.71 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.709 -0.757 . . . . 2.2 112.35 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.2 ttt -67.87 -17.8 64.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 1.93 111.017 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.573 ' NZ ' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -71.22 -167.76 0.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.016 -0.538 . . . . 3.35 110.598 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.528 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 62.7 mt 50.04 57.28 17.85 Favored Pre-proline 0 C--N 1.333 -0.144 0 N-CA-C 110.227 -0.286 . . . . 2.76 110.227 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 84.2 Cg_exo -54.44 138.77 74.37 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.984 2.456 . . . . 1.46 113.227 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.467 HG21 ' HB2' ' A' ' 126' ' ' ALA . 2.8 mt -57.99 145.0 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 0.83 108.316 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.1 -22.79 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.17 1.174 . . . . 1.69 114.17 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -103.77 36.57 2.28 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.226 -0.59 . . . . 2.56 111.827 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.5 t -142.49 146.43 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.017 0.437 . . . . 0.97 111.607 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.6 t30 -62.54 145.27 95.13 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 115.786 -0.643 . . . . 1.96 109.436 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.584 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 15.7 Cg_exo -39.95 -54.98 1.88 Allowed 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.687 2.258 . . . . 0.66 114.984 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.9 mm-40 -64.95 -53.9 39.06 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.264 1.03 . . . . 1.82 110.64 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -2.57 23.53 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.143 -0.935 . . . . 1.91 110.549 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 32.9 tt0 -75.69 -56.75 4.38 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.509 -0.923 . . . . 1.5 108.509 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.835 ' O ' HG23 ' A' ' 63' ' ' THR . 7.2 p -52.84 -44.62 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.528 -0.916 . . . . 1.22 108.528 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.63 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 10.0 tp -58.4 -67.18 0.38 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 119.738 -0.785 . . . . 1.05 109.989 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.71 -8.55 0.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.611 -0.722 . . . . 0.9 111.757 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 49' ' ' PRO . 24.6 tt0 -115.74 -116.81 0.32 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 111.934 0.346 . . . . 1.8 111.934 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 59' ' ' VAL . 71.6 p 51.24 -173.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.125 0.17 . . . . 1.05 110.925 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 63' ' ' THR . 0.8 OUTLIER 175.22 154.11 0.15 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.512 0.196 . . . . 2.05 110.567 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.603 ' NH2' ' HB3' ' A' ' 32' ' ' ASP . 3.1 ptm180 -143.36 176.81 8.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.808 0.337 . . . . 3.58 111.162 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -52.93 155.01 2.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.009 -0.541 . . . . 4.25 111.927 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -133.16 158.1 43.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.703 -0.68 . . . . 4.35 110.827 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.43 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 10.7 tp10 -133.48 -93.86 0.33 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.353 -0.385 . . . . 3.17 110.971 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' A' ' 68' ' ' GLU . 2.9 p30 -172.76 125.37 0.47 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.603 0.239 . . . . 2.39 110.796 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 t 49.8 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.99 111.076 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -161.01 161.38 31.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.492 -0.483 . . . . 1.26 111.936 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.27 -160.52 20.0 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.527 -0.844 . . . . 0.66 114.251 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.674 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -122.2 163.07 20.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.813 0.816 . . . . 0.83 112.93 -177.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.531 ' CG ' ' HG3' ' A' ' 152' ' ' LYS . 3.5 t70 -113.54 105.5 13.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 113.91 -1.495 . . . . 2.27 110.331 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.562 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -96.1 106.5 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.58 -0.282 . . . . 0.34 110.535 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.75 121.81 3.78 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 121.216 1.277 . . . . 0.8 113.121 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.532 HG22 ' H ' ' A' ' 79' ' ' GLU . 3.7 mt -135.98 151.76 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.458 0.647 . . . . 0.38 111.327 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -144.79 37.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.5 -1.296 . . . . 2.96 107.5 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 77' ' ' ILE . 15.0 mm-40 -134.63 142.43 46.88 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.78 -1.1 . . . . 2.13 110.374 -177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.27 149.64 29.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.464 0.65 . . . . 0.37 111.625 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.41 -154.58 25.61 Favored Glycine 0 CA--C 1.512 -0.129 0 N-CA-C 110.058 -1.217 . . . . 0.21 110.058 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 20.2 mt-10 -102.39 109.66 21.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 118.979 1.39 . . . . 2.03 109.667 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.456 ' OH ' ' HB2' ' A' ' 79' ' ' GLU . 44.4 m-85 -95.99 126.59 41.34 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.211 -1.033 . . . . 0.26 108.211 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.65 HG21 ' N ' ' A' ' 177' ' ' ALA . 41.9 t -112.14 113.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.612 0.72 . . . . 0.54 111.728 -177.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 tt -98.57 104.35 16.38 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.481 -1.236 . . . . 1.23 110.194 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.95 137.27 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.253 -1.017 . . . . 1.31 108.253 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -149.25 139.26 22.07 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.45 -0.9 . . . . 1.37 112.77 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' H ' ' HB3' ' A' ' 169' ' ' ALA . 14.5 tptt -94.26 123.36 37.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.57 -1.195 . . . . 2.97 109.708 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.5 143.03 35.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 0.3 110.072 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.425 ' HB3' HG11 ' A' ' 167' ' ' VAL . . . -141.26 153.22 45.11 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.444 -0.344 . . . . 0.41 110.364 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.82 141.24 29.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 3.97 111.012 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.95 173.78 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 3.81 110.844 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 63.0 9.81 4.02 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.046 -0.525 . . . . 2.89 111.106 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -149.53 115.22 5.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.193 -0.458 . . . . 2.0 110.176 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.11 93.69 4.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 1.0 111.526 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -169.91 149.87 3.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 2.96 110.898 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 p -109.15 156.77 19.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.152 -0.476 . . . . 1.55 111.506 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 48.47 34.9 5.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.871 -0.604 . . . . 2.33 111.574 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.3 -46.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 2.51 109.577 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.559 ' NZ ' ' HB3' ' A' ' 100' ' ' LYS . 1.2 mmmp? -101.23 85.89 2.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.787 . . . . 3.1 109.508 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.1 m -109.31 144.16 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.084 -0.507 . . . . 1.31 110.306 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -126.63 -175.04 3.28 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 116.278 -0.419 . . . . 0.69 112.08 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.42 144.75 40.32 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 2.01 110.861 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -134.19 138.14 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 115.939 -0.573 . . . . 0.46 112.542 -177.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.423 HH21 HG21 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -142.85 148.99 37.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.611 0.967 . . . . 1.85 113.611 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 22.2 m -113.01 121.66 65.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.275 0 CA-C-N 114.629 -1.169 . . . . 1.1 109.827 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.611 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 9.5 t30 51.58 26.95 3.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.245 -0.889 . . . . 1.77 110.124 -176.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.15 21.97 21.28 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.545 -1.207 . . . . 0.41 113.137 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 80.8 m-70 -122.86 109.38 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.175 0.806 . . . . 0.46 113.175 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 21.8 p -60.34 120.52 10.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.054 0.454 . . . . 0.66 111.341 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 109' ' ' HIS . 11.5 t -113.73 -29.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.647 -0.706 . . . . 0.8 109.94 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.455 HG11 ' OE1' ' A' ' 129' ' ' GLU . 2.2 t -137.29 91.98 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 116.109 -0.496 . . . . 0.51 110.186 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 6.7 ptpp? -99.66 134.24 42.83 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.77 0.795 . . . . 2.44 110.461 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 13.9 m-20 90.42 32.3 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.109 -1.859 . . . . 2.56 109.52 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.554 HD21 ' OE2' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -54.7 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.922 -0.581 . . . . 1.1 111.43 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -98.67 81.96 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.992 -1.114 . . . . 1.99 107.992 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.0 mt -50.94 -48.62 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.97 -1.013 . . . . 0.63 112.5 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.14 -54.01 51.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.31 . . . . 0.9 111.327 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.35 -27.31 55.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.601 -0.272 . . . . 0.76 111.705 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -72.46 -59.23 2.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.601 0.593 . . . . 2.68 112.601 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 -41.2 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.541 0.571 . . . . 1.41 112.541 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.34 -141.26 16.69 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.535 -0.84 . . . . 1.06 113.174 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 125' ' ' THR . 58.7 m-70 -53.48 110.31 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.677 0.275 . . . . 3.51 111.01 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.2 m 44.8 -97.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 1.68 111.126 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 p 48.8 -178.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.039 0.447 . . . . 0.8 111.466 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -106.02 130.41 53.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.406 -0.361 . . . . 0.44 111.957 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -110.49 142.48 42.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.792 -0.818 . . . . 0.38 108.792 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -135.31 131.51 36.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.055 0.761 . . . . 2.09 113.055 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.554 ' OE2' HD21 ' A' ' 115' ' ' LEU . 22.8 mt-10 -132.15 121.13 23.25 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.315 -0.857 . . . . 2.28 109.884 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.73 136.41 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.036 -0.529 . . . . 0.71 111.066 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.3 mt -135.85 86.58 26.86 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.888 0.699 . . . . 1.38 112.888 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -64.03 138.57 62.96 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.706 1.604 . . . . 0.22 111.527 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.5 mt -128.62 153.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.627 -0.261 . . . . 0.21 110.572 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 141' ' ' SER . 67.1 p -132.52 108.39 9.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.379 . . . . 1.11 111.707 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.0 mt -105.31 126.63 60.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.944 -0.571 . . . . 0.23 110.032 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -148.09 144.52 27.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.394 -0.367 . . . . 1.91 110.578 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.49 20.72 7.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 3.11 110.218 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.8 28.45 50.79 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.862 -0.685 . . . . 0.32 112.564 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 22.7 ttpt -131.17 142.41 50.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 2.19 111.083 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 141' ' ' SER . 5.6 tt -96.06 133.43 40.32 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.847 -0.615 . . . . 0.37 112.39 -177.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.604 ' N ' HD23 ' A' ' 140' ' ' LEU . 23.1 t -118.1 117.19 28.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.858 . . . . 0.9 109.419 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 p -118.3 98.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.967 -0.56 . . . . 0.53 111.478 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.3 -97.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.859 -0.61 . . . . 2.05 112.224 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -115.92 21.51 12.27 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.538 -0.839 . . . . 0.6 113.485 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -137.76 145.95 43.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.934 -0.395 . . . . 2.02 109.934 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.31 148.65 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.838 0.352 . . . . 1.3 111.663 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.6 m -162.25 135.87 6.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.002 -0.544 . . . . 1.12 110.609 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 50.2 p -54.03 136.4 41.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.087 -0.506 . . . . 1.11 111.53 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.17 123.47 27.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.505 . . . . 0.28 109.708 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 152' ' ' LYS . 2.1 t -110.08 90.21 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.922 -0.711 . . . . 1.55 111.98 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 44.36 -5.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 117.201 1.64 . . . . 0.46 117.201 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.592 ' NZ ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -162.11 152.28 16.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.776 1.788 . . . . 1.8 113.756 -178.049 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.456 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -98.38 124.51 43.09 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.453 -1.314 . . . . 1.24 107.453 176.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -107.96 102.5 11.67 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.918 0.71 . . . . 1.28 112.918 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 56.2 t -100.36 117.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.418 -0.513 . . . . 0.59 110.605 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.78 42.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.348 -0.541 . . . . 2.48 111.521 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.06 148.99 51.06 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.273 -0.876 . . . . 1.54 110.543 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.423 HG21 HH21 ' A' ' 105' ' ' ARG . 80.6 t -118.91 142.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.056 -0.975 . . . . 0.77 110.585 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -81.48 146.55 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.726 -0.67 . . . . 1.97 111.483 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.24 -18.9 15.6 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.695 -0.684 . . . . 1.12 111.509 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -147.19 -75.62 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.585 0.231 . . . . 3.81 110.754 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -152.2 153.58 34.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.829 0.347 . . . . 3.82 111.514 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 56.15 86.77 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.956 -0.566 . . . . 1.4 111.958 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.7 169.96 0.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.118 -0.468 . . . . 2.0 109.913 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -40.35 104.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.573 1.516 . . . . 2.58 111.515 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -55.23 -56.75 16.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.052 -0.977 . . . . 3.71 112.645 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 63' ' ' THR . 21.3 t -106.38 133.89 49.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 112.534 0.568 . . . . 0.92 112.534 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 3.7 t -135.56 131.79 36.39 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.847 0.684 . . . . 1.2 112.847 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.574 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . . . -119.23 38.69 3.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.793 -1.094 . . . . 0.22 112.514 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 8.4 tp -48.43 127.29 12.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.374 0.669 . . . . 1.02 111.786 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 171' ' ' PHE . 0.3 OUTLIER -143.48 111.14 5.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.381 -0.827 . . . . 0.33 110.528 -178.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -111.5 123.95 67.81 Favored 'Isoleucine or valine' 0 C--O 1.258 1.552 0 CA-C-O 122.758 1.266 . . . . 0.69 112.175 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.72 166.87 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.75 -1.568 . . . . 1.26 109.807 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.46 ' NZ ' ' HB2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -117.56 137.37 52.63 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.295 1.591 . . . . 1.82 115.295 -176.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 99.19 -35.4 4.71 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 118.791 2.276 . . . . 0.22 118.791 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.0 OUTLIER 178.51 160.58 0.61 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.237 2.019 . . . . 0.29 113.969 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.65 ' N ' HG21 ' A' ' 84' ' ' VAL . . . -85.68 -23.51 27.4 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.11 -0.95 . . . . 0.57 110.544 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -65.81 -5.32 8.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 2.31 111.645 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -81.21 -63.7 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.64 -0.255 . . . . 2.37 111.121 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 180' ' ' VAL . 2.7 p -42.0 101.06 0.23 Allowed Pre-proline 0 CA--C 1.54 0.594 0 O-C-N 123.454 0.471 . . . . 2.57 111.627 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.86 137.11 35.64 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.05 1.834 . . . . 2.08 112.652 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.6 ttt -140.23 112.91 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 6.04 110.333 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.66 144.26 8.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 5.3 111.295 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -119.38 150.03 48.76 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.784 -0.644 . . . . 8.05 110.015 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -44.26 124.43 5.05 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 121.635 1.557 . . . . 9.14 112.418 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.699 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 79.3 t60 -130.91 137.78 31.53 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 116.218 -0.446 . . . . 9.87 110.613 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.699 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 68.6 Cg_endo -76.19 -38.08 1.25 Allowed 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.227 1.951 . . . . 11.69 112.56 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 52.26 84.4 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.996 -0.547 . . . . 12.62 112.758 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 69.7 mt -65.55 117.08 7.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.371 . . . . 14.44 110.71 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.348 -0.834 . . . . 15.7 110.713 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' NGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_